PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yang, Y; Gorzelanny, C; Bauer, AT; Halter, N; Komljenovic, D; Bauerle, T; Borsig, L; Roblek, M; Schneider, SW				Yang, Y.; Gorzelanny, C.; Bauer, A. T.; Halter, N.; Komljenovic, D.; Baeuerle, T.; Borsig, L.; Roblek, M.; Schneider, S. W.			Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity	ONCOGENE			English	Article							NF-KAPPA-B; AGGRESSIVE TUMOR PHENOTYPE; ENDOTHELIAL GROWTH-FACTOR; CELL INVASION; NUDE-MICE; RECIPROCAL REGULATION; CLINICAL-SIGNIFICANCE; VASCULAR ENDOTHELIUM; CANCER METASTASIS; CERVICAL-CANCER	Heparanase-1 (HPSE) plays a pivotal role in structural remodeling of the ECM and the glycocalyx, thus conferring protumorigenic, proangiogenic and prometastatic properties to many cancer entities. In addition to its extracellular function, recent studies suggest an intracellular activity of HPSE with a largely unknown significance during tumor progression. Therefore, we investigated the relevance of the dual functions of HPSE to malignant melanoma in vitro, as well as in different mouse melanoma models based on the intradermal or intravenous injection of melanoma cells. Consistent with its extracellular action, an HPSE deficiency led to a reduced shedding of the glycocalyx accompanied by a reduced availability of vascular endothelial growth factor, affecting tumor growth and vascularization. In contrast, we measured an elevated expression of the protumorigenic factors pentraxin-3, tissue factor, TNF-alpha and most prominently, MMP-9, upon HPSE knockdown. In vivo, an HPSE deficiency was related to increased lymph node metastasis. Since the inhibition of its extracellular function with heparin was unable to block the gene regulatory impact of HPSE, we proposed an intracellular mechanism. Immunostaining revealed a counter-staining of HPSE and NF-kappa B in the nucleus, suggesting a close relationship between both proteins. This finding was further supported by the discovery of a direct charge-driven molecular interaction between HPSE and DNA by using atomic force microscopy and a co-precipitation approach. Our findings are novel and point towards a dual function for HPSE in malignant melanoma with a protumorigenic extracellular activity and a tumor-suppressive nuclear action. The identification of molecular strategies to shuttle extracellular HPSE into the nuclei of cancer cells could provide new therapeutic options.	[Yang, Y.; Gorzelanny, C.; Bauer, A. T.; Halter, N.; Schneider, S. W.] Heidelberg Univ, Med Fac Mannheim, Dept Dermatol Expt Dermatol, D-68167 Mannheim, Germany; [Komljenovic, D.] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany; [Baeuerle, T.] Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Borsig, L.; Roblek, M.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Borsig, L.; Roblek, M.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Schneider, SW (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Dermatol Expt Dermatol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	stefan.schneider@medma.uni-heidelberg.de		Borsig, Lubor/0000-0003-2263-9545; Bauerle, Tobias/0000-0002-0206-6199	Deutsche Forschungsgemeinschaft [SFB/Transregio 23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Katja Oehme for the excellent technical help and advice in dynamic contrast-enhanced magnetic resonance imaging experiments. We acknowledge Prof. Viktor Umansky (Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany) for providing a melanoma cell line from ret transgenic mice. This work was supported by the Deutsche Forschungsgemeinschaft within the SFB/Transregio 23 (project A9 to SWS, project Z1 to DK).	Andela VB, 2000, CANCER RES, V60, P6557; AUBERT C, 1980, J NATL CANCER I, V64, P1029; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Borczuk AC, 2008, ONCOGENE, V27, P557, DOI 10.1038/sj.onc.1210662; Boyango I, 2014, CANCER RES, V74, P4504, DOI 10.1158/0008-5472.CAN-13-2962; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; Cao HJ, 2005, WORLD J GASTROENTERO, V11, P903, DOI 10.3748/wjg.v11.i6.903; Carrer A, 2012, CANCER RES, V72, P6371, DOI 10.1158/0008-5472.CAN-12-0762; Cohen-Kaplan V, 2012, J BIOL CHEM, V287, P6668, DOI 10.1074/jbc.M111.271346; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; Desch A, 2012, AM J PATHOL, V181, P693, DOI 10.1016/j.ajpath.2012.04.012; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Gorzelanny C, 2007, BIOMACROMOLECULES, V8, P3035, DOI 10.1021/bm0703214; HART IR, 1979, AM J PATHOL, V97, P587; Hong X, 2012, INT J ONCOL, V40, P494, DOI 10.3892/ijo.2011.1229; Hostettler N, 2007, FASEB J, V21, P3562, DOI 10.1096/fj.07-8450com; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kashani-Sabet M, 2004, J CLIN ONCOL, V22, P617, DOI 10.1200/JCO.2004.06.047; Kelly T, 2003, CANCER RES, V63, P8749; Kerk N, 2010, J INVEST DERMATOL, V130, P2259, DOI 10.1038/jid.2010.136; Liu XY, 2013, INT J BIOL SCI, V9, P564, DOI 10.7150/ijbs.5425; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038659; Ludwig T, 2002, AM J PHYSIOL-RENAL, V283, pF319, DOI 10.1152/ajprenal.00327.2001; Merz M, 2011, EUR J CANCER, V47, P277, DOI 10.1016/j.ejca.2010.08.019; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Niwa Y, 2001, CLIN CANCER RES, V7, P285; OETH PA, 1994, MOL CELL BIOL, V14, P3772, DOI 10.1128/MCB.14.6.3772; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Roy M, 2005, NEOPLASIA, V7, P253, DOI 10.1593/neo.04493; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sato T, 2004, J SURG ONCOL, V87, P174, DOI 10.1002/jso.20097; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Schubert SY, 2004, LAB INVEST, V84, P535, DOI 10.1038/labinvest.3700084; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; Strozyk EA, 2014, EXP DERMATOL, V23, P670, DOI 10.1111/exd.12505; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; VLODAVSKY I, 1994, INVAS METAST, V14, P290; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Wu WJ, 2010, ONCOL REP, V23, P255, DOI 10.3892/or_00000631; Zak J, 2000, PFLUG ARCH EUR J PHY, V440, P179, DOI 10.1007/s004240000282; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhao F, 2009, CLIN CANCER RES, V15, P4382, DOI 10.1158/1078-0432.CCR-09-0399; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	58	31	33	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2015	34	47					5832	5842		10.1038/onc.2015.40	http://dx.doi.org/10.1038/onc.2015.40			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW5KV	25745999	Green Accepted			2022-12-26	WOS:000365035200006
J	Mourer, T; Jacques, JF; Brault, A; Bisaillon, M; Labbe, S				Mourer, Thierry; Jacques, Jean-Francois; Brault, Ariane; Bisaillon, Martin; Labbe, Simon			Shu1 Is a Cell-surface Protein Involved in Iron Acquisition from Heme in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-surface Protein; Heme; Iron Metabolism; Transcription Regulation; Yeast Physiology	GLOBAL TRANSCRIPTIONAL RESPONSES; BINDING FACTOR PHP4; FISSION YEAST; CRYPTOCOCCUS-NEOFORMANS; CANDIDA-ALBICANS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; CAPSULE FORMATION; TRANSPORT-SYSTEM; FACTOR FEP1	Iron is an essential metal cofactor that is required for many biological processes. Eukaryotic cells have consequently developed different strategies for its acquisition. Until now, Schizosaccharomyces pombe was known to use reductive iron uptake and siderophore-bound iron transport to scavenge iron from the environment. Here, we report the identification of a gene designated shu1(+) that encodes a protein that enables S. pombe to take up extracellular heme for cell growth. When iron levels are low, the transcription of shu1(+) is induced, although its expression is repressed when iron levels rise. The iron-dependent down-regulation of shu1(+) requires the GATA-type transcriptional repressor Fep1, which strongly associates with a proximal promoter region of shu1(+)in vivo in response to iron repletion. HA(4)-tagged Shu1 localizes to the plasma membrane in cells expressing a functional shu1(+)-HA(4) allele. When heme biosynthesis is selectively blocked in mutated S. pombe cells, their ability to acquire exogenous hemin or the fluorescent heme analog zinc mesoporphyrin IX is dependent on the expression of Shu1. Further analysis by absorbance spectroscopy and hemin-agarose pulldown assays showed that Shu1 interacts with hemin, with a K-D of approximate to 2.2 m. Taken together, results reported here revealed that S. pombe possesses an unexpected pathway for heme assimilation, which may also serve as a source of iron for cell growth.	[Mourer, Thierry; Jacques, Jean-Francois; Brault, Ariane; Bisaillon, Martin; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci Sante, 3201,Pavillon Z-8,Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Mourer, Thierry/0000-0003-1651-6768	Natural Sciences and Engineering Research Council of Canada [MOP-238238-2010-15, MOP-396029-2010-DAS]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grants MOP-238238-2010-15 and MOP-396029-2010-DAS (to S. L.).	Askwith C, 1997, J BIOL CHEM, V272, P401; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Brown WV, 2011, J CLIN LIPIDOL, V5, P1, DOI 10.1016/j.jacl.2010.11.010; Cadieux B, 2013, J INFECT DIS, V207, P1339, DOI 10.1093/infdis/jit029; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hogle SL, 2014, METALLOMICS, V6, P1107, DOI 10.1039/c4mt00031e; Hu GG, 2013, INFECT IMMUN, V81, P292, DOI 10.1128/IAI.01037-12; Jacques JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098959; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kornitzer D, 2009, CURR OPIN MICROBIOL, V12, P377, DOI 10.1016/j.mib.2009.05.005; Korolnek T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00126; Kronstad JW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003498; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; Lian TS, 2005, MOL MICROBIOL, V55, P1452, DOI 10.1111/j.1365-2958.2004.04474.x; Lindner P, 1893, WOCHENSCHRIFT BRAUER, V10, P1298; Bailao EFLC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002856; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2010, APPL ENVIRON MICROB, V76, P3806, DOI 10.1128/AEM.00659-10; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Paul V. D., 2015, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbamcr.2014.12.18, DOI 10.1016/J.BBAMCR.2014.12.18]; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pendrak ML, 2004, J BIOL CHEM, V279, P3426, DOI 10.1074/jbc.M311550200; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Pouliot B, 2010, EUKARYOT CELL, V9, P59, DOI 10.1128/EC.00262-09; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Protchenko O, 2006, J BIOL CHEM, V281, P21445, DOI 10.1074/jbc.M512812200; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rustici G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r73; Santos R, 2003, MICROBIOL-SGM, V149, P579, DOI 10.1099/mic.0.26108-0; Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Teoh AL, 2004, INT J FOOD MICROBIOL, V95, P119, DOI 10.1016/j.ijfoodmicro.2003.12.020; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172	50	25	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10176	10190		10.1074/jbc.M115.642058	http://dx.doi.org/10.1074/jbc.M115.642058			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25733668	Green Published, hybrid			2022-12-26	WOS:000353241100024
J	Xu, HM; Malinin, NL; Awasthi, N; Schwarz, RE; Schwarz, MA				Xu, Haiming; Malinin, Nikolay L.; Awasthi, Niranjan; Schwarz, Roderich E.; Schwarz, Margaret A.			The N Terminus of Pro-endothelial Monocyte-activating Polypeptide II (EMAP II) Regulates Its Binding with the C Terminus, Arginyl-tRNA Synthetase, and Neurofilament Light Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISYNTHETASE COMPLEX; AIMP1/P43 MUTATION; SH-SY5Y CELLS; CYTOKINE; P43; EXPRESSION; NEOVASCULARIZATION; COMPONENT; PHOSPHORYLATION; IDENTIFICATION	Pro-endothelial monocyte-activating polypeptide II (EMAP II), one component of the multi-aminoacyl tRNA synthetase complex, plays multiple roles in physiological and pathological processes of protein translation, signal transduction, immunity, lung development, and tumor growth. Recent studies have determined that pro-EMAP II has an essential role in maintaining axon integrity in central and peripheral neural systems where deletion of the C terminus of pro-EMAP II has been reported in a consanguineous Israeli Bedouin kindred suffering from Pelizaeus-Merzbacher-like disease. We hypothesized that the N terminus of pro-EMAP II has an important role in the regulation of protein-protein interactions. Using a GFP reporter system, we defined a putative leucine zipper in the N terminus of human pro-EMAP II protein (amino acid residues 1-70) that can form specific strip-like punctate structures. Through GFP punctum analysis, we uncovered that the pro-EMAP II C terminus (amino acids 147-312) can repress GFP punctum formation. Pulldown assays confirmed that the binding between the pro-EMAP II N terminus and its C terminus is mediated by a putative leucine zipper. Furthermore, the pro-EMAP 11 1-70 amino acid region was identified as the binding partner of arginyl-tRNA synthetase, a polypeptide of the multi-aminoacyl tRNA synthetase complex. We also determined that the punctate GFP pro-EMAP II 1-70 amino acid aggregate colocalizes and binds to the neurofilament light subunit protein that is associated with pathologic neurofilament network disorganization and degeneration of motor neurons. These findings indicate the structure and binding interaction of pro-EMAP II protein and suggest a role of this protein in pathological neurodegenerative diseases.	[Xu, Haiming; Schwarz, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Malinin, Nikolay L.; Awasthi, Niranjan; Schwarz, Roderich E.; Schwarz, Margaret A.] Indiana Univ Sch Med, South Bend, IN 46617 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University South Bend	Schwarz, MA (corresponding author), Indiana Univ Sch Med South Bend, Dept Pediat, 1234 Notre Dame Ave, South Bend, IN 46617 USA.	schwarma@iupui.edu	Malinin, Nikolay/Z-5308-2019	Malinin, Nikolay/0000-0002-2654-1783	National Institutes of Health [R01HL60061, 5R01HL114977]; University of Texas Southwestern Simmons Comprehensive Cancer Center; Lilly Endowment, Inc. Physician Scientist Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114977, R01HL060061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Simmons Comprehensive Cancer Center; Lilly Endowment, Inc. Physician Scientist Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL60061 and 5R01HL114977 (to M. A. S.). This work was also supported by the University of Texas Southwestern Simmons Comprehensive Cancer Center (to M. A. S.) and the Lilly Endowment, Inc. Physician Scientist Initiative (to M. A. S.).	Ahn HC, 2003, FEBS LETT, V542, P119, DOI 10.1016/S0014-5793(03)00362-4; Awasthi N, 2009, LAB INVEST, V89, P38, DOI 10.1038/labinvest.2008.106; Biancheri R, 2011, AM J HUM GENET, V88, P391, DOI 10.1016/j.ajhg.2011.02.003; Boespflug-Tanguy O, 2011, AM J HUM GENET, V88, P392, DOI 10.1016/j.ajhg.2010.12.015; Deineko V, 2006, PROTEIN PEPTIDE LETT, V13, P687, DOI 10.2174/092986606777790584; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Gauthier DJ, 2008, PROTEOMICS, V8, P3848, DOI 10.1002/pmic.200700969; Guo H, 2014, J NEUROSCI RES, V92, P1374, DOI 10.1002/jnr.23403; Han JM, 2007, AM J PATHOL, V170, P2042, DOI 10.2353/ajpath.2007.061266; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P25106; Kao J, 1993, Behring Inst Mitt, P92; Kim G, 2010, BIOCHEM BIOPH RES CO, V397, P100, DOI 10.1016/j.bbrc.2010.05.075; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim SS, 2011, TUMORI, V97, P380, DOI 10.1700/912.10038; Kim T, 2000, J BIOL CHEM, V275, P21768, DOI 10.1074/jbc.M002404200; Kim TS, 2008, VACCINE, V26, P5928, DOI 10.1016/j.vaccine.2008.08.051; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Lee SW, 2008, EXPERT OPIN DRUG DIS, V3, P945, DOI 10.1517/17460441.3.8.945; Lee YS, 2008, BIOCHEM BIOPH RES CO, V371, P395, DOI 10.1016/j.bbrc.2008.04.099; Li GB, 2014, INT J MOL SCI, V15, P15845, DOI 10.3390/ijms150915845; Liu J, 2006, EXP CELL RES, V312, P2231, DOI 10.1016/j.yexcr.2006.03.024; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Park SG, 2006, P NATL ACAD SCI USA, V103, P14913, DOI 10.1073/pnas.0602045103; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Perfeito R, 2014, MOL CELL NEUROSCI, V62, P51, DOI 10.1016/j.mcn.2014.08.002; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Schwarz M, 1999, AM J PHYSIOL-LUNG C, V276, pL365, DOI 10.1152/ajplung.1999.276.2.L365; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Schwarz MA, 2005, EXP CELL RES, V311, P229, DOI 10.1016/j.yexcr.2005.09.008; Schwarz MA, 2004, AM J RESP CELL MOL, V30, P784, DOI 10.1165/rcmb.2003-0145OC; Schwarz MA, 2000, MECH DEVELOP, V95, P123, DOI 10.1016/S0925-4773(00)00361-0; Schwarz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033101; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Tanaka K, 2012, J BIOCHEM, V151, P611, DOI 10.1093/jb/mvs033; Trinh R, 2004, MOL IMMUNOL, V40, P717, DOI 10.1016/j.molimm.2003.08.006; van Horssen R, 2006, CYTOKINE GROWTH F R, V17, P339, DOI 10.1016/j.cytogfr.2006.08.001; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Wu PC, 1999, CANCER RES, V59, P205; Yamamoto M, 2000, ANTICANCER RES, V20, P4081; Zhang FR, 2002, AM J PHYSIOL-LUNG C, V282, pL1239, DOI 10.1152/ajplung.00141.2001; Zhang X, 2014, NEUROSCIENCE, V280, P88, DOI 10.1016/j.neuroscience.2014.08.052; Zhu XD, 2009, P NATL ACAD SCI USA, V106, P15944, DOI 10.1073/pnas.0901872106; Zogovic N, 2015, J NEUROCHEM, V133, P223, DOI 10.1111/jnc.12980	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9753	9766		10.1074/jbc.M114.630533	http://dx.doi.org/10.1074/jbc.M114.630533			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25724651	hybrid, Green Published			2022-12-26	WOS:000352729400036
J	Shankar, J; Nabi, IR				Shankar, Jay; Nabi, Ivan R.			Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; E-CADHERIN; TUMOR PROGRESSION; GENE-EXPRESSION; RHO; PATHWAY; CARCINOMA; DYNAMICS; INVASION; DISEASE	Epithelial-mesenchymal transition (EMT) is associated with loss of the cell-cell adhesion molecule E-cadherin and disruption of cell-cell junctions as well as with acquisition of migratory properties including reorganization of the actin cytoskeleton and activation of the RhoA GTPase. Here we show that depolymerization of the actin cytoskeleton of various metastatic cancer cell lines with Cytochalasin D (Cyt D) reduces cell size and F-actin levels and induces E-cadherin expression at both the protein and mRNA level. Induction of E-cadherin was dose dependent and paralleled loss of the mesenchymal markers N-cadherin and vimentin. E-cadherin levels increased 2 hours after addition of Cyt D in cells showing an E-cadherin mRNA response but only after 10-12 hours in HT-1080 fibrosarcoma and MDA-MB-231 cells in which E-cadherin mRNA level were only minimally affected by Cyt D. Cyt D treatment induced the nuclear-cytoplasmic translocation of EMT-associated SNAI 1 and SMAD1/2/3 transcription factors. In non-metastatic MCF-7 breast cancer cells, that express E-cadherin and represent a cancer cell model for EMT, actin depolymerization with Cyt D induced elevated E-cadherin while actin stabilization with Jasplakinolide reduced E-cadherin levels. Elevated E-cadherin levels due to Cyt D were associated with reduced activation of Rho A. Expression of dominant-negative Rho A mutant increased and dominant-active Rho A mutant decreased E-cadherin levels and also prevented Cyt D induction of E-cadherin. Reduced Rho A activation downstream of actin remodelling therefore induces E-cadherin and reverses EMT in cancer cells. Cyt D treatment inhibited migration and, at higher concentrations, induced cytotoxicity of both HT-1080 fibrosarcoma cells and normal Hs27 fibroblasts, but only induced mesenchymal-epithelial transition in HT-1080 cancer cells. Our studies suggest that actin remodelling is an upstream regulator of EMT in metastatic cancer cells.	[Shankar, Jay; Nabi, Ivan R.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Nabi, IR (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	irnabi@mail.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513	Cancer Research Society grant; Canadian Breast Cancer Foundation Postdoctoral Fellowship; Canadian Cancer Society Research Institute Innovation Grant	Cancer Research Society grant; Canadian Breast Cancer Foundation Postdoctoral Fellowship; Canadian Cancer Society Research Institute Innovation Grant	This work was supported by a Cancer Research Society grant (IRN), a Canadian Breast Cancer Foundation Postdoctoral Fellowship (JS) and a Canadian Cancer Society Research Institute Innovation Grant (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Gordon MC, 2005, DEV FUTURE TRENDS AN; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Huang FY, 2012, EUR J CANCER, V48, P2260, DOI 10.1016/j.ejca.2011.12.018; Iwaya K, 2007, MODERN PATHOL, V20, P339, DOI 10.1038/modpathol.3800741; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.37; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Newman DJ, 2004, J NAT PROD, V67, P1216, DOI 10.1021/np040031y; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; STEVENSON BR, 1994, J CELL SCI, V107, P367; Su HT, 2013, MOL CANCER RES, V11, P768, DOI 10.1158/1541-7786.MCR-12-0511; Tavares ALP, 2006, DEV DYNAM, V235, P1589, DOI 10.1002/dvdy.20771; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tripathi V, 2014, ONCOGENE, V33, P724, DOI 10.1038/onc.2013.7; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeng QQ, 2012, P NATL ACAD SCI USA, V109, P1127, DOI 10.1073/pnas.1111053108; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	34	96	96	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119954	10.1371/journal.pone.0119954	http://dx.doi.org/10.1371/journal.pone.0119954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756282	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700055
J	Laukkanen, MO; Cammarota, F; Esposito, T; Salvatore, M; Castellone, MD				Laukkanen, Mikko O.; Cammarota, Francesca; Esposito, Tiziana; Salvatore, Marco; Castellone, Maria D.			Extracellular Superoxide Dismutase Regulates the Expression of Small GTPase Regulatory Proteins GEFs, GAPs, and GDI	PLOS ONE			English	Article							EC-SOD; PANCREATIC-CANCER; DIFFERENTIAL EXPRESSION; BETA-CATENIN; CELL-LINES; GROWTH; KINASE; OVEREXPRESSION; RECEPTOR; THERAPY	Extracellular superoxide dismutase (SOD3), which catalyzes the dismutation of superoxide anions to hydrogen peroxide at the cell membranes, regulates the cellular growth in a dose-dependent manner. This enzyme induces primary cell proliferation and immortalization at low expression levels whereas it activates cancer barrier signaling through the p53-p21 pathway at high expression levels, causing growth arrest, senescence, and apoptosis. Because previous reports suggested that the SOD3-induced reduction in the rates of cellular growth and migration also occurred in the absence of functional p53 signaling, in the current study we investigated the SOD3-induced growth-suppressive mechanisms in anaplastic thyroid cancer cells. Based on our data, the robust over-expression of SOD3 increased the level of phosphorylation of the EGFR, ERBB2, RYK, ALK, FLT3, and EPHA10 receptor tyrosine kinases with the consequent downstream activation of the SRC, FYN, YES, HCK, and LYN kinases. However, pull-down experiments focusing on the small GTPase RAS, RAC, CDC42, and RHO revealed a reduced level of growth and migration signal transduction, such as the lack of stimulation of the mitogen pathway, in the SOD3 over-expressing cells, which was confirmed by MEK1/2 and ERK1/2 Western blotting analysis. Interestingly, the mRNA expression analyses indicated that SOD3 regulated the expression of guanine nucleotide-exchange factors (RHO GEF16, RAL GEF RGL1), GTPase-activating proteins (ARF-GAP ADAP2, RAS GAP RASAL1, RGS4), and a Rho guanine nucleotide-disassociation inhibitor (RHO GDI 2) in a dose dependent manner, thus controlling signaling through the small G protein GTPases. Therefore, our current data may suggest the occurrence of dose-dependent SOD3-driven control of the GTP loading of small G proteins indicating a novel growth regulatory mechanism of this enzyme.	[Laukkanen, Mikko O.; Cammarota, Francesca; Esposito, Tiziana] IRCCS SDN, Naples, Italy; [Salvatore, Marco] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy; [Castellone, Maria D.] CNR, Inst Expt Endocrinol & Oncol IEOS, I-80125 Naples, Italy; [Castellone, Maria D.] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Laukkanen, MO (corresponding author), IRCCS SDN, Naples, Italy.	mlaukkanen@sdn-napoli.it	Laukkanen, Mikko/K-5868-2016; Salvatore, Marco/K-8083-2016	Laukkanen, Mikko/0000-0002-1004-7131; CASTELLONE, MARIADOMENICA/0000-0003-0507-8037; Salvatore, Marco/0000-0001-9734-7702; Cammarota, Francesca/0000-0002-3691-1514	Fondazione SDN [RC2010-M-0001]	Fondazione SDN	This work was supported by Fondazione SDN (decision number RC2010-M-0001, http://www.sdn-napoli.it/).	BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Castellone MD, 2014, ANTIOXID REDOX SIGN, V21, P1460, DOI 10.1089/ars.2013.5475; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; D'Uva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080742; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; Hu LD, 2007, ONCOL REP, V17, P1383; Irani K, 1998, BIOCHEM PHARMACOL, V55, P1339; JIA R, 1992, J VIROL, V66, P5975, DOI 10.1128/JVI.66.10.5975-5987.1992; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kim SH, 2005, ONCOL RES, V15, P333, DOI 10.3727/096504005776449725; Kwon MJ, 2012, ANTIOXID REDOX SIGN, V16, P297, DOI 10.1089/ars.2011.4066; Laatikainen LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024456; Laatikainen LE, 2010, ENDOCR-RELAT CANCER, V17, P785, DOI 10.1677/ERC-10-0021; Laukkanen MO, 2002, CIRCULATION, V106, P1999, DOI 10.1161/01.CIR.0000031331.05368.9D; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Oliver AW, 2011, BRIT J CANCER, V104, P324, DOI 10.1038/sj.bjc.6606026; Pechlivanis M, 2006, BBA-PROTEINS PROTEOM, V1764, P1914, DOI 10.1016/j.bbapap.2006.09.017; Pesse B, 2005, J MOL CELL CARDIOL, V38, P765, DOI 10.1016/j.yjmcc.2005.02.020; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Sibenaller ZA, 2014, FREE RADICAL BIO MED, V69, P357, DOI 10.1016/j.freeradbiomed.2014.02.002; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Svensk AM, 2004, AM J CLIN PATHOL, V122, P395, DOI 10.1309/A45QHB0QRRX6CT9A; Tanaka M, 2001, GENE THER, V8, P149, DOI 10.1038/sj.gt.3301362; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Teoh ML, 2007, CLIN CANCER RES, V13, P7441, DOI 10.1158/1078-0432.CCR-07-0851; Teoh MLT, 2009, CANCER RES, V69, P6355, DOI 10.1158/0008-5472.CAN-09-1195; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Timeus F, 2001, LAB INVEST, V81, P1025, DOI 10.1038/labinvest.3780314; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Wheeler MD, 2003, MOL CANCER RES, V1, P871	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0121441	10.1371/journal.pone.0121441	http://dx.doi.org/10.1371/journal.pone.0121441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751262	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700039
J	Viljoen, KS; Dakshinamurthy, A; Goldberg, P; Blackburn, JM				Viljoen, Katie S.; Dakshinamurthy, Amirtha; Goldberg, Paul; Blackburn, Jonathan M.			Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECALIS; MLH1 METHYLATION; DNA METHYLATION; IN-VIVO; CARCINOGENESIS; QUANTIFICATION; TUMORIGENESIS; COLONIZATION	Various studies have presented clinical or in vitro evidence linking bacteria to colorectal cancer, but these bacteria have not previously been concurrently quantified by qPCR in a single cohort. We quantify these bacteria (Fusobacterium spp., Streptococcus gallolyticus, Enterococcus faecalis, Enterotoxigenic Bacteroides fragilis (ETBF), Enteropathogenic Escherichia coli (EPEC), and afaC- or pks-positive E. coli) in paired tumour and normal tissue samples from 55 colorectal cancer patients. We further investigate the relationship between a) the presence and b) the level of colonisation of each bacterial species with site and stage of disease, age, gender, ethnicity and MSI-status. With the exception of S. gallolyticus, we detected all bacteria profiled here in both tumour and normal samples at varying frequencies. ETBF (FDR = 0.001 and 0.002 for normal and tumour samples) and afaC-positive E. coli (FDR = 0.03, normal samples) were significantly enriched in the colon compared to the rectum. ETBF (FDR = 0.04 and 0.002 for normal and tumour samples, respectively) and Fusobacterium spp. (FDR = 0.03 tumour samples) levels were significantly higher in late stage (III/IV) colorectal cancers. Fusobacterium was by far the most common bacteria detected, occurring in 82% and 81% of paired tumour and normal samples. Fusobacterium was also the only bacterium that was significantly higher in tumour compared to normal samples (p = 6e-5). We also identified significant associations between high-level colonisation by Fusobacterium and MSI-H (FDR = 0.05), age (FDR = 0.03) or pks-positive E. coli (FDR = 0.01). Furthermore, we exclusively identified atypical EPEC in our cohort, which has not been previously reported in association with colorectal cancer. By quantifying colorectal cancer-associated bacteria across a single cohort, we uncovered inter-and intra-individual patterns of colonization not previously recognized, as well as important associations with clinicopathological features, especially in the case of Fusobacterium and ETBF.	[Viljoen, Katie S.; Dakshinamurthy, Amirtha; Blackburn, Jonathan M.] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Goldberg, Paul] Groote Schuur Hosp, Surg Gastroenterol Unit, Dept Surg, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Blackburn, JM (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Med Biochem, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	jonathan.blackburn@uct.ac.za		Goldberg, Paul/0000-0003-1612-7519	Cancer Association of South Africa	Cancer Association of South Africa	This study was supported by the Cancer Association of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulamir AS, 2010, MOL CANCER, V9, P1, DOI [10.1186/1476-4598-9-1, DOI 10.1186/1476-4598-9-1]; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Balish E, 2002, AM J PATHOL, V160, P2253, DOI 10.1016/S0002-9440(10)61172-8; Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064; Biarc J, 2004, CARCINOGENESIS, V25, P1477, DOI 10.1093/carcin/bgh091; Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609; Bonnet M, 2014, CLIN CANCER RES, V20, P859, DOI 10.1158/1078-0432.CCR-13-1343; BREMNER CG, 1970, CANCER, V26, P991, DOI 10.1002/1097-0142(197011)26:5<991::AID-CNCR2820260505>3.0.CO;2-J; Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964; CAMPBELL BJ, 2003, GLYCOCONJUGATE J, V18, P851; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Corredoira-Sanchez J, 2012, CLIN INFECT DIS, V55, P491, DOI 10.1093/cid/cis434; Cronje L, 2009, SAMJ S AFR MED J, V99, P103; Cronje L, 2009, S AFR J SCI, V105, P68, DOI 10.1590/s0038-23532009000100023; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; Degiannis E, 1995, Trop Gastroenterol, V16, P55; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Dutilh BE, 2013, BEST PRACT RES CL GA, V27, P85, DOI 10.1016/j.bpg.2013.03.008; Ellmerich S, 2000, CARCINOGENESIS, V21, P753, DOI 10.1093/carcin/21.4.753; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Gebert J, 2012, HISTOCHEM CELL BIOL, V138, P339, DOI 10.1007/s00418-012-0957-9; Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x; Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Jass Jeremy R, 2004, Fam Cancer, V3, P93; Kaz A, 2007, INT J CANCER, V120, P1922, DOI 10.1002/ijc.22544; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kostic AD, 2013, CANCER IMMUNOL RES, V1, P150, DOI 10.1158/2326-6066.CIR-13-0101; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Lindor BNM, 2002, IMMUNOHISTOCHEMISTRY, V20, P1043; Loukola A, 2001, CANCER RES, V61, P4545; Machado AMD, 2010, BBA-REV CANCER, V1806, P58, DOI 10.1016/j.bbcan.2010.01.007; Maddocks ODK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005517; Maddocks ODK, 2013, MBIO, V4, DOI 10.1128/mBio.00152-13; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; McCoy WC, 1951, J MED ASS STATE ALAB, V21; Miquel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012714; Mundy R, 2007, MICROBIOL-SGM, V153, P959, DOI 10.1099/mic.0.2006/003467-0; Ollikainen M, 2007, ONCOGENE, V26, P4541, DOI 10.1038/sj.onc.1210236; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Patil DT, 2012, MODERN PATHOL, V25, P1423, DOI 10.1038/modpathol.2012.98; Phillips AD, 2000, GUT, V47, P377, DOI 10.1136/gut.47.3.377; Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Sedgley CM, 2005, ARCH ORAL BIOL, V50, P575, DOI 10.1016/j.archoralbio.2004.10.017; Speake D, 2011, INT J SURG ONCOL, V2011, DOI 10.1155/2011/653163; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wheeler JMD, 2000, J MED GENET, V37, P588, DOI 10.1136/jmg.37.8.588; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang GM, 1999, CLIN INFECT DIS, V29, P590, DOI 10.1086/598639; Zhang J, 2006, CANCER RES, V66, P659, DOI 10.1158/0008-5472.CAN-05-4043; Zhang XH, 2013, J MED MICROBIOL, V62, P1665, DOI 10.1099/jmm.0.054551-0	71	132	137	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119462	10.1371/journal.pone.0119462	http://dx.doi.org/10.1371/journal.pone.0119462			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751261	Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700023
J	Bird, CW; Candelaria-Cook, FT; Magcalas, CM; Davies, S; Valenzuela, CF; Savage, DD; Hamilton, DA				Bird, Clark W.; Candelaria-Cook, Felicha T.; Magcalas, Christy M.; Davies, Suzy; Valenzuela, C. Fernando; Savage, Daniel D.; Hamilton, Derek A.			Moderate Prenatal Alcohol Exposure Enhances GluN2B Containing NMDA Receptor Binding and Ifenprodil Sensitivity in Rat Agranular Insular Cortex	PLOS ONE			English	Article							LONG-TERM-POTENTIATION; INDUCED LEARNING-DEFICITS; ETHANOL EXPOSURE; FETAL ALCOHOL; SOCIAL-BEHAVIOR; SYNAPTIC PLASTICITY; SEX-DIFFERENCES; SPECTRUM DISORDERS; SUBUNIT EXPRESSION; NUCLEUS-ACCUMBENS	Prenatal exposure to alcohol affects the expression and function of glutamatergic neurotransmitter receptors in diverse brain regions. The present study was undertaken to fill a current gap in knowledge regarding the regional specificity of ethanol-related alterations in glutamatergic receptors in the frontal cortex. We quantified subregional expression and function of glutamatergic neurotransmitter receptors (AMPARs, NMDARs, GluN2B-containing NMDARs, mGluR1s, and mGluR5s) by radioligand binding in the agranular insular cortex (AID), lateral orbital area (LO), prelimbic cortex (PrL) and primary motor cortex (M1) of adult rats exposed to moderate levels of ethanol during prenatal development. Increased expression of GluN2B-containing NMDARs was observed in AID of ethanol-exposed rats compared to modest reductions in other regions. We subsequently performed slice electrophysiology measurements in a whole-cell patch-clamp preparation to quantify the sensitivity of evoked NMDAR-mediated excitatory postsynaptic currents (EPSCs) in layer II/III pyramidal neurons of AID to the GluN2B negative allosteric modulator ifenprodil. Consistent with increased GluN2B expression, ifenprodil caused a greater reduction in NMDAR-mediated EPSCs from prenatal alcohol-exposed rats than saccharin-exposed control animals. No alterations in AMPAR-mediated EPSCs or the ratio of AMPARs/NMDARs were observed. Together, these data indicate that moderate prenatal alcohol exposure has a significant and lasting impact on GluN2B-containing receptors in AID, which could help to explain ethanol-related alterations in learning and behaviors that depend on this region.	[Bird, Clark W.; Magcalas, Christy M.; Hamilton, Derek A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Davies, Suzy; Valenzuela, C. Fernando; Savage, Daniel D.; Hamilton, Derek A.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Hamilton, DA (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	dahamilt@unm.edu	Hamilton, Derek A/H-4447-2013	Hamilton, Derek A/0000-0001-7021-3288; Bird, Clark/0000-0001-7712-6531; Candelaria-Cook, Felicha/0000-0002-1416-9099	National Institutes of Health [R01 AA019462, R01 AA019884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019884, R01AA019462, T32AA014127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by National Institutes of Health (www.nih.gov) grants R01 AA019462 to DAH and R01 AA019884 to DDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Allan AM, 1997, ALCOHOL CLIN EXP RES, V21, P1534; Allan AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096200; AUTTIRAMO I, 1991, NEUROPEDIATRICS, V22, P59, DOI 10.1055/s-2008-1071418; Badanich KA, 2013, NEUROPSYCHOPHARMACOL, V38, P1176, DOI 10.1038/npp.2013.12; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bellinger FP, 2002, DEV BRAIN RES, V136, P77, DOI 10.1016/S0165-3806(02)00363-2; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Brady ML, 2013, J NEUROSCI, V33, P1062, DOI 10.1523/JNEUROSCI.1217-12.2013; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Fabio MC, 2013, PHARMACOL BIOCHEM BE, V103, P842, DOI 10.1016/j.pbb.2012.12.009; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P273; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P529; Chasnoff IJ, 2010, J DEV BEHAV PEDIATR, V31, P192, DOI 10.1097/DBP.0b013e3181d5a4e2; Clayton DA, 2002, J NEUROSCI, V22, P3628; Colvin L, 2007, ALCOHOL CLIN EXP RES, V31, P276, DOI 10.1111/j.1530-0277.2006.00303.x; CONRY J, 1990, ALCOHOL CLIN EXP RES, V14, P650, DOI 10.1111/j.1530-0277.1990.tb01222.x; Costa ET, 2000, J BIOL CHEM, V275, P38268, DOI 10.1074/jbc.M004136200; Croxford J, 1999, S AFR MED J, V89, P962; DAY NL, 1993, CLIN OBSTET GYNECOL, V36, P232, DOI 10.1097/00003081-199306000-00005; DeCoteau WE, 1997, BEHAV BRAIN RES, V88, P239, DOI 10.1016/S0166-4328(97)00044-2; Dettmer TS, 2003, ALCOHOL CLIN EXP RES, V27, P677, DOI 10.1097/01.ALC.0000060521.32215.E9; Diaz MR, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00046; DiazGranados JL, 1997, ALCOHOL CLIN EXP RES, V21, P874, DOI 10.1097/00000374-199708000-00016; Duncan GE, 2009, BRAIN RES, V1265, P186, DOI 10.1016/j.brainres.2009.02.002; Duncan GE, 2004, BEHAV BRAIN RES, V153, P507, DOI 10.1016/j.bbr.2004.01.008; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Frizelle PA, 2006, MOL PHARMACOL, V70, P1022, DOI 10.1124/mol.106.024042; Gabbott PLA, 2003, BRAIN RES, V993, P59, DOI 10.1016/j.brainres.2003.08.056; Garcia-Algar O, 2008, THER DRUG MONIT, V30, P249, DOI 10.1097/FTD.0b013e31816a8657; GOODLETT CR, 1995, NEUROBIOL LEARN MEM, V64, P265, DOI 10.1006/nlme.1995.0009; Grant TM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.871; Hamilton DA, 2003, BEHAV BRAIN RES, V143, P85, DOI 10.1016/S0166-4328(03)00028-7; Hamilton DA, 2014, BEHAV BRAIN RES, V269, P44, DOI 10.1016/j.bbr.2014.04.029; Hamilton DA, 2010, BEHAV BRAIN RES, V214, P66, DOI 10.1016/j.bbr.2010.05.048; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; HANNIGAN JH, 1991, NEUROTOXICOL TERATOL, V13, P649, DOI 10.1016/0892-0362(91)90049-3; HASHIMOTO K, 1994, EUR J PHARM-MOLEC PH, V266, P67, DOI 10.1016/0922-4106(94)90211-9; Honse Y, 2003, ALCOHOL CLIN EXP RES, V27, P1993, DOI 10.1097/01.ALC.0000099029.55026.C6; Honse Y, 2003, NEUROSCIENCE, V122, P689, DOI 10.1016/S0306-4522(03)00603-1; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hughes PD, 1998, ALCOHOL CLIN EXP RES, V22, P1255, DOI 10.1111/j.1530-0277.1998.tb03906.x; Hughes PD, 2001, DEV BRAIN RES, V129, P135, DOI 10.1016/S0165-3806(01)00192-4; Incerti M, 2010, OBSTET GYNECOL, V115, P350, DOI 10.1097/AOG.0b013e3181cb59da; Jacobs SA, 2014, GENES BRAIN BEHAV, V13, P376, DOI 10.1111/gbb.12123; Jacobs SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036387; Kelly SJ, 1997, NEUROTOXICOL TERATOL, V19, P383, DOI 10.1016/S0892-0362(97)00064-0; KELLY SJ, 1994, NEUROTOXICOL TERATOL, V16, P377, DOI 10.1016/0892-0362(94)90026-4; Kelly SJ, 2000, NEUROTOXICOL TERATOL, V22, P143, DOI 10.1016/S0892-0362(99)00073-2; Kesner RP, 2007, NEUROBIOL LEARN MEM, V88, P82, DOI 10.1016/j.nlm.2007.02.002; Kim SM, 2014, DRUG ALCOHOL DEPEN, V141, P124, DOI 10.1016/j.drugalcdep.2014.05.017; Kodituwakku PW, 2007, NEUROSCI BIOBEHAV R, V31, P192, DOI 10.1016/j.neubiorev.2006.06.020; Kristjanson AF, 2007, ALCOHOL CLIN EXP RES, V31, P299, DOI 10.1111/j.1530-0277.2006.00315.x; Lawrence RC, 2012, NEUROTOXICOL TERATOL, V34, P128, DOI 10.1016/j.ntt.2011.08.002; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LUNDQUIST F, 1959, BIOCHEM J, V72, P409, DOI 10.1042/bj0720409; Mameli M, 2005, J NEUROSCI, V25, P8027, DOI 10.1523/JNEUROSCI.2434-05.2005; Marchetta Claire M., 2012, Morbidity and Mortality Weekly Report, V61, P534; Mattson SN, 2013, ALCOHOL CLIN EXP RES, V37, P517, DOI 10.1111/j.1530-0277.2012.01952.x; Mattson SN, 1999, J INT NEUROPSYCH SOC, V5, P462, DOI 10.1017/S1355617799555082; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; May PA, 2011, INT J ENV RES PUB HE, V8, P2331, DOI 10.3390/ijerph8062331; McGivern RF, 1998, ALCOHOL CLIN EXP RES, V22, P868, DOI 10.1097/00000374-199806000-00015; Middleton FA, 2012, DEV NEUROSCI-BASEL, V34, P115, DOI 10.1159/000337858; Miguez HA, 2009, ACTA PSIQUIAT PSICOL, V55, P76; Mihalick SM, 2001, NEUROTOXICOL TERATOL, V23, P453, DOI 10.1016/S0892-0362(01)00168-4; MOLINA JC, 1987, NEUROTOXICOL TERATOL, V9, P121, DOI 10.1016/0892-0362(87)90088-2; Montaron MF, 1996, NEUROSCIENCE, V71, P371, DOI 10.1016/0306-4522(95)00455-6; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mooney SM, 2011, BEHAV BRAIN RES, V216, P358, DOI 10.1016/j.bbr.2010.08.014; Moraes CL, 2007, REV SAUDE PUBL, V41, P695, DOI 10.1590/S0034-89102007000500002; Naseer MI, 2014, NEUROL SCI, V35, P1681, DOI 10.1007/s10072-014-1812-7; Nguyen TT, 2013, NEUROTOXICOL TERATOL, V35, P14, DOI 10.1016/j.ntt.2012.11.003; Nixon K, 2004, ALCOHOL CLIN EXP RES, V28, P105, DOI 10.1097/01.ALC.0000106311.88523.7B; Nizhnikov ME, 2014, ALCOHOL CLIN EXP RES, V38, P1630, DOI 10.1111/acer.12416; Osborn JA, 1998, ALCOHOL CLIN EXP RES, V22, P685, DOI 10.1097/00000374-199805000-00021; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Patten AR, 2013, NEUROSCI LETT, V551, P7, DOI 10.1016/j.neulet.2013.05.051; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Peadon E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-584; Pinheiro SN, 2005, REV SAUDE PUBL, V39, P593, DOI 10.1590/S0034-89102005000400012; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; Rice JP, 2014, ALCOHOL CLIN EXP RES, V38, p112A; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; Riebe I, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-14; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Roebuck-Spencer TM, 2004, J INT NEUROPSYCH SOC, V10, P536, DOI 10.1017/S1355617704104116; Samudio-Ruiz SL, 2010, ALCOHOL CLIN EXP RES, V34, P342, DOI 10.1111/j.1530-0277.2009.01096.x; Savage DD, 2010, ALCOHOL CLIN EXP RES, V34, P1793, DOI 10.1111/j.1530-0277.2010.01266.x; SAVAGE DD, 1991, ALCOHOL, V8, P193, DOI 10.1016/0741-8329(91)90806-8; Shea KM, 2012, BEHAV PHARMACOL, V23, P105, DOI 10.1097/FBP.0b013e32834ed866; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sickmann HM, 2014, HIPPOCAMPUS, V24, P54, DOI 10.1002/hipo.22203; Simmons RW, 2010, ALCOHOL, V44, P371, DOI 10.1016/j.alcohol.2010.02.013; Sinai L, 2012, GENES BRAIN BEHAV, V11, P559, DOI 10.1111/j.1601-183X.2012.00775.x; Sliwowska JH, 2014, ALCOHOL CLIN EXP RES, V38, P152, DOI 10.1111/acer.12224; Smith MD, 2002, NEUROSCIENCE, V109, P517, DOI 10.1016/S0306-4522(01)00490-0; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; Toso L, 2006, AM J OBSTET GYNECOL, V194, P681, DOI 10.1016/j.ajog.2006.01.003; Toso L, 2005, AM J OBSTET GYNECOL, V193, P1534, DOI 10.1016/j.ajog.2005.02.105; Tunc-Ozcan E, 2013, ALCOHOL CLIN EXP RES, V37, P1986, DOI 10.1111/acer.12183; VACCARINO FM, 1992, MOL BRAIN RES, V12, P233, DOI 10.1016/0169-328X(92)90089-T; Valenzuela CF, 2012, TRENDS NEUROSCI, V35, P284, DOI 10.1016/j.tins.2012.01.006; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Varaschin RK, 2014, ALCOHOL CLIN EXP RES, V38, P1902, DOI 10.1111/acer.12430; Varaschin RK, 2010, J PHARMACOL EXP THER, V334, P191, DOI 10.1124/jpet.109.165027; Walker MJ, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-52; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wang HY, 2013, BRAIN RES, V1520, P36, DOI 10.1016/j.brainres.2013.04.054; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WEINBERG J, 1992, ALCOHOL, V9, P219, DOI 10.1016/0741-8329(92)90057-H; Wenzel A, 1997, J NEUROCHEM, V68, P469; WHISHAW IQ, 1983, PHYSIOL BEHAV, V30, P471, DOI 10.1016/0031-9384(83)90154-3; WHISHAW IQ, 1989, BEHAV BRAIN RES, V32, P101, DOI 10.1016/S0166-4328(89)80078-6; Williams L, 2014, ALCOHOL CLIN EXP RES, V38, P116, DOI 10.1111/acer.12225; Xiang XJ, 2011, BEHAV BRAIN RES, V222, P326, DOI 10.1016/j.bbr.2011.03.068; Zamzow DR, 2013, J NEUROSCI, V33, P12300, DOI 10.1523/JNEUROSCI.0312-13.2013; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhou R, 2010, NEUROSCIENCE, V170, P749, DOI 10.1016/j.neuroscience.2010.07.055; ZIMMERBERG B, 1990, BRAIN RES, V537, P115, DOI 10.1016/0006-8993(90)90347-E	124	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118721	10.1371/journal.pone.0118721	http://dx.doi.org/10.1371/journal.pone.0118721			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747876	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400026
J	Buchacz, K; Chen, MJ; Parisi, MK; Yoshida-Cervantes, M; Antunez, E; Delgado, V; Moss, NJ; Scheer, S				Buchacz, Kate; Chen, Miao-Jung; Parisi, Maree Kay; Yoshida-Cervantes, Maya; Antunez, Erin; Delgado, Viva; Moss, Nicholas J.; Scheer, Susan			Using HIV Surveillance Registry Data to Re-Link Persons to Care: The RSVP Project in San Francisco	PLOS ONE			English	Article							NEW-YORK-CITY; UNITED-STATES; ANTIRETROVIRAL THERAPY; PUBLIC-HEALTH; MEDICAL-CARE; PREVENTION; ENGAGEMENT; RETENTION; SUPPRESSION; INFECTION	Background Persons with unsuppressed HIV viral load (VL) who disengage from care may experience poor clinical outcomes and potentially transmit HIV. We assessed the feasibility and yield of using the San Francisco Department of Public Health (SFDPH) enhanced HIV surveillance system (eHARS) to identify and re-engage such persons in care. Methods Using SFDPH eHARS data as of 4/20/2012 (index date), we selected HIV-infected adults who were alive, had no reported VL or CD4 cell count results in the past nine months (proxy for "out-of-care") and a VL > 200 copies/mL drawn nine to 15 months earlier. We prioritized cases residing locally for investigation, and used information from eHARS and medical and public health databases to contact them for interview and referral to the SFDPH linkage services (LINCS). Twelve months later, we matched-back to eHARS data to assess how HIV laboratory reporting delays affected original eligibility, and if persons had any HIV laboratory results performed and reported within 12 months after index date ('new labs'). Results Among 434 eligible persons, 282 were prioritized for investigation, of whom 75 (27%) were interviewed, 79 (28%) could not be located, and 48 (17%) were located out of the area. Among the interviewed, 54 (72%) persons accepted referral to LINCS. Upon match-back to eHARS data, 324 (75%) in total were confirmed as eligible, including 221 (78%) of the investigated; most had new labs. Conclusions Among the investigated persons presumed out-of-care, we interviewed and offered LINCS referral to about one-quarter, demonstrating the feasibility but limited yield of our project. Matching to updated surveillance data revealed that a substantial minority did not disengage from care and that most re-engaged in HIV care. Verifying persons' HIV care status with medical providers and improving timeliness of transfer and cross-jurisdictional sharing of HIV laboratory data may aid future efforts.	[Buchacz, Kate] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Chen, Miao-Jung; Parisi, Maree Kay; Yoshida-Cervantes, Maya; Antunez, Erin; Delgado, Viva; Scheer, Susan] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Moss, Nicholas J.] Alameda Cty Publ Hlth Dept, Oakland, CA USA	Centers for Disease Control & Prevention - USA; San Francisco Department of Public Health	Scheer, S (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA.	Susan.Scheer@sfdph.org			Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention (CDC) provides funding to the San Francisco Department of Public Health and to other state and local health departments in the United States to conduct surveillance of HIV disease in accordance with their own disease reporting regulations. CDC provides technical guidance for the collection of data by the state and local health departments and data are sent to CDC for national-level analyses. Aside from CDC's support to surveillance of HIV disease, the authors received no specific funding for this work. Role of the Sponsors: The CDC reviewed and approved final submission but the findings and conclusions in this report are those of the authors and do not necessarily represent the views of the CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Bureau of AIDS Tuberculosis and Sexually Transmitted Infections Department of Disease Control Ministry of Public Health, 2019, THAIL NAT GUID HIV A; Buskin S. E., 2011, J HIV AIDS SURVEILLA, V3, P3; Buskin SE, 2014, SEX TRANSM DIS, V41, P35, DOI 10.1097/OLQ.0000000000000072; California Department of Public Health Office of AIDS, 2011, HIV AIDS CAS REP; California Department of Public Health Office of AIDS, 2013, CONT HIV CAR CAL; Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH RES P; Centers for Disease Control and Prevention, 2003, GUIDANCE CDC DEP HLT, V52, P12; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; *DEP HLTH HUM SERV, 2008, GUID US ANT AG HIV I; Department of Health and Human Services, 2013, GUID US ANT AG HIV I; Department of Health and Human Services, 2013, HIV AIDS BUR HAB HIV; Department of Health and Human Services, 2011, HIGH IMP HIV PREV CD; Dombrowski JC, 2012, AIDS, V26, P77, DOI 10.1097/QAD.0b013e32834dcee9; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS116, DOI 10.1097/QAI.0b013e3181fbca6e; Fairchild AL, 2011, NEW ENGL J MED, V365, P685, DOI 10.1056/NEJMp1107294; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner EM, 2013, COLARADO J INT ASS P, V12, P384, DOI DOI 10.1177/2325957413500532; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Hall HI, 2007, J PUBLIC HEALTH MAN, V13, P519; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Hsu LC, 2011, AIDS CARE, V23, P383, DOI 10.1080/09540121.2010.507740; Magnus M, 2012, INT J MED INFORM, V81, pE30, DOI 10.1016/j.ijmedinf.2012.06.005; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Muthulingam D, 2013, JAIDS-J ACQ IMM DEF, V63, P112, DOI 10.1097/QAI.0b013e3182894555; Office of National AIDS Policy, 2013, NAT HIV AIDS STRAT U; Project Inform, 2012, US SURV OTH DAT IMPR; San Francisco Department of Public Health, 2012, HIV AIDS EP ANN REP; San Francisco Department of Public Health, 2014, LINK INT NAV COMPR S; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Sweeney P, 2013, MILBANK Q, V91, P558, DOI 10.1111/milq.12018; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Udeagu CC, 2012, J INT AIDS SOC, V15, P146; Udeagu CCN, 2013, AIDS, V27, P2271, DOI 10.1097/QAD.0b013e328362fdde; Valdiserri RO, 2013, PUBLIC HEALTH REP, V128, P12; Wohl AR, 2011, AIDS CARE, V23, P988, DOI 10.1080/09540121.2010.542125	44	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118923	10.1371/journal.pone.0118923	http://dx.doi.org/10.1371/journal.pone.0118923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25748668	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400031
J	Carr-Harris, C; Gottesfeld, AS; Moore, JW				Carr-Harris, Charmaine; Gottesfeld, Allen S.; Moore, Jonathan W.			Juvenile Salmon Usage of the Skeena River Estuary	PLOS ONE			English	Article							CHINOOK SALMON; SOCKEYE-SALMON; BRITISH-COLUMBIA; INDIVIDUAL IDENTIFICATION; STOCK COMPOSITION; MARINE MORTALITY; PACIFIC SALMON; PUGET-SOUND; CHUM SALMON; PINK SALMON	Migratory salmon transit estuary habitats on their way out to the ocean but this phase of their life cycle is more poorly understood than other phases. The estuaries of large river systems in particular may support many populations and several species of salmon that originate from throughout the upstream river. The Skeena River of British Columbia, Canada, is a large river system with high salmon population-and species-level diversity. The estuary of the Skeena River is under pressure from industrial development, with two gas liquefaction terminals and a potash loading facility in various stages of environmental review processes, providing motivation for understanding the usage of the estuary by juvenile salmon. We conducted a juvenile salmonid sampling program throughout the Skeena River estuary in 2007 and 2013 to investigate the spatial and temporal distribution of different species and populations of salmon. We captured six species of juvenile anadromous salmonids throughout the estuary in both years, and found that areas proposed for development support some of the highest abundances of some species of salmon. Specifically, the highest abundances of sockeye (both years), Chinook in 2007, and coho salmon in 2013 were captured in areas proposed for development. For example, juvenile sockeye salmon were 2-8 times more abundant in the proposed development areas. Genetic stock assignment demonstrated that the Chinook salmon and most of the sockeye salmon that were captured originated from throughout the Skeena watershed, while some sockeye salmon came from the Nass, Stikine, Southeast Alaska, and coastal systems on the northern and central coasts of British Columbia. These fish support extensive commercial, recreational, and First Nations fisheries throughout the Skeena River and beyond. Our results demonstrate that estuary habitats integrate species and population diversity of salmon, and that if proposed development negatively affects the salmon populations that use the estuary, then numerous fisheries would also be negatively affected.	[Carr-Harris, Charmaine; Gottesfeld, Allen S.] Skeena Fisheries Commiss, Kispiox, BC, Canada; [Carr-Harris, Charmaine; Moore, Jonathan W.] Simon Fraser Univ, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Carr-Harris, C (corresponding author), Skeena Fisheries Commiss, 3135 Barnes Crescent, Kispiox, BC, Canada.	ccarrharris@gmail.com			Lax Kw'alaams Fisheries Program; Liber Ero Foundation; Simon Fraser University; Mitacs; SkeenaWild Conservation Trust	Lax Kw'alaams Fisheries Program; Liber Ero Foundation; Simon Fraser University; Mitacs; SkeenaWild Conservation Trust	Financial support for this project was provided by: Lax Kw'alaams Fisheries Program to CCH (http://www.laxkwalaams.ca/corporate/index.php?page=fishery), Liber Ero Foundation to JWM, Simon Fraser University to JWM (http://www.sfu.ca), Mitacs to CCH (http://www.mitacs.ca/), and SkeenaWild Conservation Trust to JWM and CCH (http://skeenawild.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argue AW, 2005, CAN TECH REP FISH AQ, V2601; Barraclough WE, 1978, DISTRIBUTION JUVENIL, P826; BAX NJ, 1983, CAN J FISH AQUAT SCI, V40, P426, DOI 10.1139/f83-061; Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Beacham TD, 2006, T AM FISH SOC, V135, P861, DOI 10.1577/T05-241.1; Beacham TD, 2014, N AM J FISH MANAGE, V34, P335, DOI 10.1080/02755947.2014.880761; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Blyth GY, 1991, SALMON CANNERIES BRI; Bond MH, 2008, CAN J FISH AQUAT SCI, V65, P2242, DOI 10.1139/F08-131; Bottom DL, 2005, ESTUAR COAST SHELF S, V64, P79, DOI 10.1016/j.ecss.2005.02.008; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Cox-Rogers S, 2012, CAN TECH REP FISH AQ, P2956; English KK., 2012, DATASETS EXTENDED TI; Gibson RB, 2012, IMPACT ASSESS PROJ A, V30, P179, DOI 10.1080/14615517.2012.720417; Gottesfeld A., 2008, SKEENA RIVER FISH TH; Gottesfeld AS, 2009, J FISH DIS, V32, P45, DOI 10.1111/j.1365-2761.2008.01003.x; Government of Canada, 2012, EC ACTION PLAN, V2012, P89; Healey M., 1982, ESTUARINE COMP, P315; HEALEY MC, 1979, FISH B-NOAA, V77, P653; Heard W.R., 1991, P119; Higgins RJ, 1973, BIOL ASSESSMENT FISH; Hoos LM, 1975, ESTUARY WORKING GROU, V3; Hooton R.S., 2011, SKEENA STEELHEAD UNK; Hutchings JA, 2013, FISHERIES, V38, P497, DOI 10.1080/03632415.2013.848345; IWATA M, 1984, CAN J FISH AQUAT SCI, V41, P744, DOI 10.1139/f84-086; Joint Northern Boundary Technical Committee, 2014, 141 TCNB JOINT NO BO; Karieva P, 2010, SCIENCE, V290, P977; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; LEVY DA, 1982, CAN J FISH AQUAT SCI, V39, P270, DOI 10.1139/f82-038; Lyons DE, 2007, NORTHWEST SCI, V81, P91, DOI 10.3955/0029-344X-81.2.91; MACDONALD JS, 1988, CAN J FISH AQUAT SCI, V45, P1366, DOI 10.1139/f88-160; Magnusson A, 2003, ESTUARIES, V26, P1094, DOI 10.1007/BF02803366; Manzer JI, 1956, PROG REP FISH RES BO, V106, P24; Manzer JI, 1969, J FISH RES BD CAN; Meador JP, 2014, CAN J FISH AQUAT SCI, V71, P162, DOI 10.1139/cjfas-2013-0130; Mobrand LE, 1997, CAN J FISH AQUAT SCI, V54, P2964, DOI 10.1139/cjfas-54-12-2964; Moore KD, 2013, CONSERV LETT, V6, P1, DOI 10.1111/j.1755-263X.2012.00300.x; Morrell M., 2000, STATUS SALMON SPAWNI; Mortensen D, 2000, FISH B-NOAA, V98, P319; Munsch SH, 2014, N AM J FISH MANAGE, V34, P814, DOI 10.1080/02755947.2014.910579; Neaves P.I., 2005, CBAYES COMPUTER PROG; Neher TDH, 2013, T AM FISH SOC, V142, P1481, DOI 10.1080/00028487.2013.815660; Orsi J. A., 2012, N PAC ANADR FISH COM, V8, P130; PARKER RR, 1968, J FISH RES BOARD CAN, V25, P757, DOI 10.1139/f68-068; PARKER RR, 1971, J FISH RES BOARD CAN, V28, P1503, DOI 10.1139/f71-231; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Pella J, 2001, FISH B-NOAA, V99, P151; Price MHH, 2013, T AM FISH SOC, V142, P989, DOI 10.1080/00028487.2013.790842; Price MHH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016851; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinones RM, 2005, T AM FISH SOC, V134, P1147, DOI 10.1577/T04-092.1; R Core Team, 2021, R LANGUAGE ENV STAT; Reimers P. E, 1973, RES REPORTS FISH COM, V4, P1; Roegner GC, 2010, T AM FISH SOC, V139, P1211, DOI 10.1577/T09-082.1; Rutherford DT, 1995, CAN TECH REP FISH AQ, P2295; Safriel U, 1968, IBIS, P110; Semmens BX, 2008, CAN J FISH AQUAT SCI, V65, P2053, DOI 10.1139/F08-107; SHREFFLER DK, 1992, ESTUARIES, V15, P204, DOI 10.2307/1352693; Simenstad CA, 2000, ECOL ENG, V15, P283, DOI 10.1016/S0925-8574(00)00082-3; Simmons RK, 2013, MAR ECOL PROG SER, V481, P211, DOI 10.3354/meps10190; Smith HD, 1987, SOCKEYE SALMON POPUL, P280; Stantec, 2014, PAC NW LNG ENV IMP A; Straty R. R., 1980, SALMONID ECOSYSTEMS, P247; THORPE JE, 1994, ESTUARIES, V17, P76, DOI 10.2307/1352336; Toft JD, 2007, N AM J FISH MANAGE, V27, P465, DOI 10.1577/M05-158.1; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Weitkamp LA, 2014, REV FISH BIOL FISHER, V24, P713, DOI 10.1007/s11160-014-9345-y; Withler RE, 2000, CAN J FISH AQUAT SCI, V57, P1985, DOI 10.1139/cjfas-57-10-1985; WOOD CC, 1987, CAN J FISH AQUAT SCI, V44, P941, DOI 10.1139/f87-112; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	73	24	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118988	10.1371/journal.pone.0118988	http://dx.doi.org/10.1371/journal.pone.0118988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749488	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400035
J	Starmans, LWE; Moonen, RPM; Aussems-Custers, E; Daemen, MJAP; Strijkers, GJ; Nicolay, K; Grull, H				Starmans, Lucas W. E.; Moonen, Rik P. M.; Aussems-Custers, Erica; Daemen, Mat J. A. P.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger			Evaluation of Iron Oxide Nanoparticle Micelles for Magnetic Particle Imaging (MPI) of Thrombosis	PLOS ONE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ENERGY-TRANSFER; PROTEIN CORONA; DIAGNOSIS; SURFACE; MRI	Magnetic particle imaging (MPI) is an emerging medical imaging modality that directly visualizes magnetic particles in a hot-spot like fashion. We recently developed an iron oxide nanoparticle-micelle (ION-Micelle) platform that allows highly sensitive MPI. The goal of this study was to assess the potential of the ION-Micelles for MPI-based detection of thrombi. To this aim, an in vivo carotid artery thrombosis mouse model was employed and ex vivo magnetic particle spectrometer (MPS) measurements of the carotid arteries were performed. In addition, we studied the effect of functionalization of the ION-Micelle nanoplatform with fibrin-binding peptides (FibPeps) with respect to nanoparticle thrombus uptake and hence thrombus detection. In vivo quantitative MR imaging pre- and post-ION-Micelle injection was performed as reference for visualization of ION-micelle uptake. ION-Micelles significantly decreased T-2 values in the thrombi with respect to pre-injection T-2 values (p < 0.01) and significantly increased ex vivo MPS thrombus signal with respect to the noninjured, contralateral carotid (p < 0.01). Functionalization of the ION-Micelles with the FibPep peptides did not result in an increased MPS thrombus signal with respect to the non-fibrin binding ION-Micelles. The lack of a significant increased thrombus uptake for the FibPep-ION-Micelles indicates that (non-fibrin-specific) entrapment of nanoparticles in the meshlike thrombi is the key contributor to thrombus nanoparticle uptake. Therefore, (nontargeted) ION-Micelles might be of value for noninvasive MPI-based diagnosis, characterization and treatment monitoring of thrombosis.	[Starmans, Lucas W. E.; Moonen, Rik P. M.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Aussems-Custers, Erica] Philips Res, Appl Chem, Eindhoven, Netherlands; [Daemen, Mat J. A. P.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Grull, Holger] Philips Res, Oncol Solut, Eindhoven, Netherlands	Eindhoven University of Technology; Philips; Philips Research; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Philips; Philips Research	Grull, H (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	h.gruell@tue.nl		Grull, Holger/0000-0002-0993-9300; Strijkers, Gustav/0000-0001-6700-5058; Moonen, Rik/0000-0002-2294-0226; Nicolay, Klaas/0000-0002-4179-616X; Daemen, Mat/0000-0003-1076-199X; Starmans, Luc/0000-0003-4569-1725	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK [01C-202]	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK	This research was supported by the Center for Translational Molecular Medicine (http://www.ctmm.nl) and the Netherlands Heart Foundation (www.hartstichting.nl): PARISK, grant 01C-202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Biederer S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/205007; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; Chen DX, 2009, J APPL PHYS, V106, DOI 10.1063/1.3211307; Coolen BF, 2014, MAGN RESON MED, V72, P409, DOI 10.1002/mrm.24952; Dai Q, 2014, ANGEW CHEM INT EDIT, V53, P5093, DOI 10.1002/anie.201309464; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Jansen CHP, 2011, CIRCULATION, V124, P416, DOI 10.1161/CIRCULATIONAHA.110.965442; Kim DE, 2013, ANN NEUROL, V73, P617, DOI 10.1002/ana.23849; Kronzon I, 2006, CIRCULATION, V114, P63, DOI 10.1161/CIRCULATIONAHA.105.593418; Litmanovich D, 2009, AM J ROENTGENOL, V193, P928, DOI 10.2214/AJR.08.2166; Lu Y, 2014, CHEST, V145, P1079, DOI 10.1378/chest.13-2090; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; MARKEL A, 1995, ANGIOLOGY, V46, P65, DOI 10.1177/000331979504600109; Omran H, 1999, HEART, V81, P192, DOI 10.1136/hrt.81.2.192; Sachs UJH, 2007, CIRC RES, V100, P979, DOI 10.1161/01.RES.0000261936.85776.5f; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Schmitz SA, 2001, RADIOLOGY, V221, P237, DOI 10.1148/radiol.2211001632; Srichai MB, 2006, AM HEART J, V152, P75, DOI 10.1016/j.ahj.2005.08.021; Starmans LWE, 2011, CONTRAST MEDIA MOL I, V6, P100, DOI 10.1002/cmmi.411; Starmans LWE, 2013, MOL PHARMACEUT, V10, P4309, DOI 10.1021/mp400406x; Starmans LWE, 2013, CONTRAST MEDIA MOL I, V8, P229, DOI 10.1002/cmmi.1521; Starmans LWE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057335; van Bochove GS, 2012, EUR J INORG CHEM, P2115, DOI 10.1002/ejic.201200010; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Wolters M, 2013, J THROMB HAEMOST, V11, P1766, DOI 10.1111/jth.12340; Zhao YM, 2014, SMALL, V10, P1163, DOI 10.1002/smll.201301962; Zhao YM, 2013, ACS NANO, V7, P10362, DOI 10.1021/nn404782p	27	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119257	10.1371/journal.pone.0119257	http://dx.doi.org/10.1371/journal.pone.0119257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746677	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400059
J	Aschebrook-Kilfoy, B; Argos, M; Pierce, BL; Tong, L; Jasmine, F; Roy, S; Parvez, F; Ahmed, A; Islam, T; Kibriya, MG; Ahsan, H				Aschebrook-Kilfoy, Briseis; Argos, Maria; Pierce, Brandon L.; Tong, Lin; Jasmine, Farzana; Roy, Shantanu; Parvez, Faruque; Ahmed, Alauddin; Islam, Tariqul; Kibriya, Muhammad G.; Ahsan, Habibul			Genome-Wide Association Study of Parity in Bangladeshi Women	PLOS ONE			English	Article							FUNCTIONAL GENETIC POLYMORPHISMS; FEMALE REPRODUCTIVE DISORDERS; HERITABILITY; INFERTILITY; FERTILITY; TRAITS	Human fertility is a complex trait determined by gene-environment interactions in which genetic factors represent a significant component. To better understand inter-individual variability in fertility, we performed one of the first genome-wide association studies (GWAS) of common fertility phenotypes, lifetime number of pregnancies and number of children in a developing country population. The fertility phenotype data and DNA samples were obtained at baseline recruitment from individuals participating in a large prospective cohort study in Bangladesh. GWAS analyses of fertility phenotypes were conducted among 1,686 married women. One SNP on chromosome 4 was non-significantly associated with number of children at P <10(-7) and number of pregnancies at P <10(-6). This SNP is located in a region without a gene within 1 Mb. One SNP on chromosome 6 was non-significantly associated with extreme number of children at P <10(-6). The closest gene to this SNP is HDGFL1, a hepatoma-derived growth factor. When we excluded hormonal contraceptive users, a SNP on chromosome 5 was non-significantly associated at P <10(-5) for number of children and number of pregnancies. This SNP is located near C5orf64, an open reading frame, and ZSWIM6, a zinc ion binding gene. We also estimated the heritability of these phenotypes from our genotype data using GCTA (Genome-wide Complex Trait Analysis) for number of children (h(g)(2) = 0.149, SE = 0.24, p-value = 0.265) and number of pregnancies (h(g)(2) = 0.007, SE = 0.22, p-value = 0.487). Our genome-wide association study and heritability estimates of number of pregnancies and number of children in Bangladesh did not confer strong evidence of common variants for parity variation. However, our results suggest that future studies may want to consider the role of 3 notable SNPs in their analysis.	[Aschebrook-Kilfoy, Briseis; Argos, Maria; Pierce, Brandon L.; Tong, Lin; Jasmine, Farzana; Roy, Shantanu; Kibriya, Muhammad G.; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Pierce, Brandon L.; Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Ahmed, Alauddin; Islam, Tariqul] UChicago Res Bangladesh Ltd, Dhaka, Bangladesh; [Parvez, Faruque] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Columbia University; University of Chicago; University of Chicago	Ahsan, H (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	habib@uchicago.edu		Pierce, Brandon/0000-0002-7829-952X	National Institutes of Health [P42 ES10349]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grant ## P42 ES10349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ansermet F, 2010, J CHILD SEX ABUS, V19, P337, DOI 10.1080/10538711003788991; Bangladesh Bank, 2015, FOR DIR INV FDI BANG; Berry DP, 2012, ANIMAL, V6, P1206, DOI 10.1017/S1751731112000067; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Choi J, 2007, INT J UROL, V14, P431, DOI 10.1111/j.1442-2042.2007.01741.x; Fidler AT, 1999, PUBLIC HEALTH REP, V114, P494, DOI 10.1093/phr/114.6.494; Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; International Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB), 2002, HLTH DEM SURV SYST M, V33; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kohler HP, 2006, INT J ANDROL, V29, P46, DOI 10.1111/j.1365-2605.2005.00606.x; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; Krausz C, 2007, ARCH ANDROLOGY, V53, P125, DOI 10.1080/01485010701271786; Layman LC, 2003, ENDOCRIN METAB CLIN, V32, P549, DOI 10.1016/S0889-8529(03)00040-9; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MITRA S, 1997, BANGLADESH DEMOGRAPH; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Penagaricano F, 2012, ANIM GENET, V43, P65, DOI 10.1111/j.1365-2052.2012.02350.x; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Tempfer CB, 2009, HUM REPROD UPDATE, V15, P97, DOI 10.1093/humupd/dmn040; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoon SH, 2010, HUM REPROD, V25, P283, DOI 10.1093/humrep/dep375	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118488	10.1371/journal.pone.0118488	http://dx.doi.org/10.1371/journal.pone.0118488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742292	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100020
J	Eom, SY; Yim, DH; Lee, CH; Choe, KH; An, JY; Lee, KY; Kim, YD; Kim, H				Eom, Sang-Yong; Yim, Dong-Hyuk; Lee, Chul-Ho; Choe, Kang-Hyeon; An, Jin Young; Lee, Kye Young; Kim, Yong-Dae; Kim, Heon			Interactions between Paraoxonase 1 Genetic Polymorphisms and Smoking and Their Effects on Oxidative Stress and Lung Cancer Risk in a Korean Population	PLOS ONE			English	Article							1 PON1 GENE; SERUM PARAOXONASE; PLASMA PARAOXONASE; ARYLESTERASE ACTIVITIES; DNA-DAMAGE; SUSCEPTIBILITY; ASSOCIATION; TOBACCO; MYELOPEROXIDASE; DETERMINANTS	Background Few studies in epidemiology have evaluated the effects of gene-environment interaction on oxidative stress, even though this interaction is an important etiologic factor in lung carcinogenesis. We investigated the effects of the genetic polymorphisms of paraoxonase 1 (PON1), smoking, and the interaction between the two on lung cancer risk and oxidative stress. Methods This study's subjects consisted of 416 newly diagnosed lung cancer patients and an equal number of matched controls. The GoldenGate assay was used for genotypic analyses of the PON1 gene. Urinary 8-hydroxydeoxyguanosine (8-OHdG) and thiobarbituric acid reactive substances levels were measured as indicators of oxidative stress. Results The PON1 rs662 AA genotype showed a significantly lower risk of lung cancer than the GG genotype (OR = 0.60, 95% CI: 0.36-0.99). The protective effect of the PON1 rs662 AA genotype on lung cancer risk was limited to non-smokers. Lung cancer patients who had the rs662 A allele showed a dose-dependent association between smoking status and oxidative stress markers. Among non-smoking lung cancer patients, urinary 8-OHdG levels were significantly lower in individuals with the rs662 GA and AA genotypes than in those with the GG genotype. Furthermore, we found a significant interaction effect between PON1 rs662 and smoking status on urinary 8-OHdG levels in lung cancer patients. Conclusions Our results suggest that the protective effect of PON1 rs662 SNP against lung carcinogenesis and the induction of oxidative stress might be modulated by the interaction between PON1 genetic polymorphisms and tobacco smoking.	[Eom, Sang-Yong; Yim, Dong-Hyuk; Kim, Yong-Dae; Kim, Heon] Chungbuk Natl Univ, Coll Med, Dept Prevent Med, Cheongju, South Korea; [Eom, Sang-Yong; Yim, Dong-Hyuk; Choe, Kang-Hyeon; An, Jin Young; Kim, Yong-Dae; Kim, Heon] Chungbuk Natl Univ, Coll Med, Med Res Inst, Cheongju, South Korea; [Eom, Sang-Yong; Yim, Dong-Hyuk; Kim, Yong-Dae; Kim, Heon] Chungbuk Natl Univ, Ctr Farmers Safety & Hlth, Cheongju, South Korea; [Lee, Chul-Ho] Korea Environm Corp, Asbestos Damage Relief Ctr, Inchon, South Korea; [Lee, Kye Young; Kim, Yong-Dae] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Lee, Kye Young] Konkuk Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University; Chungbuk National University; Konkuk University; Konkuk University Medical Center	Kim, H (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Prevent Med, Cheongju, South Korea.	kimheon@cbu.ac.kr	Eom, Sang-Yong/B-5705-2016	Eom, Sang-Yong/0000-0002-4559-8152; Kim, Heon/0000-0003-0329-5249	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120330]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120330).	Agarwal R, 2002, J CHROMATOGR B, V775, P121, DOI 10.1016/S1570-0232(02)00273-8; Ahsan H, 2004, JAMA-J AM MED ASSOC, V292, P3026, DOI 10.1001/jama.292.24.3026; Aksoy-Sagirli P, 2011, ANTICANCER RES, V31, P2225; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Antognelli C, 2005, PROSTATE, V63, P240, DOI 10.1002/pros.20184; Aydin O, 2013, CLIN LAB, V59, P1231, DOI 10.7754/Clin.Lab.2012.120914; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Conesa-Zamora P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-228; Costa LG, 2005, BIOCHEM PHARMACOL, V69, P541, DOI 10.1016/j.bcp.2004.08.027; Costa LG, 2003, BIOMARKERS, V8, P1, DOI 10.1080/13547500210148315; Crawford A, 2012, GENE, V501, P89, DOI 10.1016/j.gene.2012.04.011; Elkiran ET, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-48; Eom SY, 2011, J KOREAN MED SCI, V26, P720, DOI 10.3346/jkms.2011.26.6.720; Fang DH, 2012, MOL BIOL REP, V39, P6801, DOI 10.1007/s11033-012-1505-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaidukov L, 2006, J LIPID RES, V47, P2492, DOI 10.1194/jlr.M600297-JLR200; Halliwell B., 2007, FREE RADICALS BIOL M; Harik-Khan RI, 1998, AM J RESP CRIT CARE, V158, P1459, DOI 10.1164/ajrccm.158.5.9712006; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; In KH, 2009, LUNG CANCER, V64, P232, DOI 10.1016/j.lungcan.2008.08.005; Ji GX, 2012, FREE RADICAL BIO MED, V52, P775, DOI 10.1016/j.freeradbiomed.2011.11.032; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kang HJ, 2005, NUCLEIC ACIDS RES, V33, pD518; Karaman E, 2010, J CRANIOFAC SURG, V21, P1745, DOI 10.1097/SCS.0b013e3181f4040a; Kurtul N, 2014, INHAL TOXICOL, V26, P235, DOI 10.3109/08958378.2013.878007; Lee Chul-Ho, 2005, J Prev Med Public Health, V38, P345; Loke WM, 2012, FREE RADICAL RES, V46, P1230, DOI 10.3109/10715762.2012.701291; Lurie G, 2008, CANCER EPIDEM BIOMAR, V17, P2070, DOI 10.1158/1055-9965.EPI-08-0145; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mackness B, 2010, IUBMB LIFE, V62, P480, DOI 10.1002/iub.347; Min J, 2006, REPROD TOXICOL, V22, P418, DOI 10.1016/j.reprotox.2006.01.003; Nishio E, 1997, BIOCHEM BIOPH RES CO, V236, P289, DOI 10.1006/bbrc.1997.6961; Ozturk O, 2009, ANTICANCER RES, V29, P4041; Parry H, 1997, AM J CLIN PATHOL, V107, P64; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rainwater DL, 2009, HEREDITY, V102, P147, DOI 10.1038/hdy.2008.110; Rodrigo L, 2001, CHEM-BIOL INTERACT, V137, P123, DOI 10.1016/S0009-2797(01)00225-3; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Saadat M, 2012, CANCER EPIDEMIOL, V36, pE101, DOI 10.1016/j.canep.2011.10.015; Seo T, 2008, ANN EPIDEMIOL, V18, P330, DOI 10.1016/j.annepidem.2007.10.002; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang H, 2012, J INVEST MED, V60, P592, DOI 10.2310/JIM.0b013e318245d557; Zengi O, 2012, CLIN CHEM LAB MED, V50, P529, DOI 10.1515/CCLM.2011.792	47	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119100	10.1371/journal.pone.0119100	http://dx.doi.org/10.1371/journal.pone.0119100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741997	Green Submitted, gold, Green Published			2022-12-26	WOS:000350688100081
J	Hussain, RS; McGarvey, ST; Fruzzetti, LM				Hussain, Rashid S.; McGarvey, Stephen T.; Fruzzetti, Lina M.			Partition and Poliomyelitis: An Investigation of the Polio Disparity Affecting Muslims during India's Eradication Program	PLOS ONE			English	Article							UTTAR-PRADESH; HEALTH; IMMUNIZATION; CAMPAIGN; RESISTANCE; DISCRIMINATION; PERCEPTIONS; ATTITUDES; LESSONS; HISTORY	Background Significant disparities in the incidence of polio existed during its eradication campaign in India. In 2006, Muslims, who comprise 16% of the population in affected states, comprised 70% of paralytic polio cases. This disparity was initially blamed on the Muslims and a rumor that the vaccination program was a plot to sterilize their children. Using the framework of structural violence, this paper describes how the socio-political and historical context of Muslim populations in India shaped the polio disparity. Methods and Findings A qualitative study utilizing methods of rapid ethnography was conducted from May-August 2009 in Aligarh, Uttar Pradesh, India. Field methods included participant observation of vaccination teams, historical document research, and 107 interviews with both Global Polio Eradication Initiative (GPEI) stakeholders and families with vaccine-eligible children. Almost all respondents agreed that Aligarh was a highly segregated city, mostly due to riots after Partition and during the 1990s. Since the formation of segregated neighborhoods, most respondents described that "Muslim areas" had been underdeveloped compared to "Hindu areas," facilitating the physical transmission of poliovirus. Distrust of the government and resistance to vaccination were linked to this disparate development and fears of sterilization influenced by the "Family Planning Program" from 1976-1977. Conclusions Ethnic violence and social marginalization since the Partition and during the rise of Hindu nationalism led to distrust of the government, the formation of segregated slums, and has made Muslims victims of structural violence. This led to the creation of disease-spreading physical environments, lowered vaccine efficacy, and disproportionately higher levels of resistance to vaccination. The causes of the polio disparity found in this study elucidate the nature of possible other health disparities affecting minorities in India. Limitations This study is limited by the manual coding of the transcribed data, size, and some dialectal difficulties in translation.	[Hussain, Rashid S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Int Hlth Inst, Dept Epidemiol, Providence, RI 02912 USA; [McGarvey, Stephen T.; Fruzzetti, Lina M.] Brown Univ, Dept Anthropol, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Hussain, RS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	Rashid_Hussain@med.brown.edu			Watson Institute for International Studies' Brown International Scholars Program	Watson Institute for International Studies' Brown International Scholars Program	This project was made possible by funding from the Watson Institute for International Studies' Brown International Scholars Program. The Watson Institute was not involved in the collection, analysis, and interpretation of the data.	Abimbola S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001529; Allen K, 2003, BBC WORLD NEWS HLTH; [Anonymous], 2003, TIMES INDIA; Ansari MA, 2007, J R SOC PROMO HEALTH, V127, P276, DOI 10.1177/1466424007083705; Ansari MA, 2014, SE ASIA J PUBLIC HLT, V3, P23; Arokiasamy P, 2012, J BIOSOC SCI, V54, P167; Asadullah NM, 2009, SOCIAL DIVISIONS SCH; Aylward B, 2011, VACCINE, V29, pD80, DOI 10.1016/j.vaccine.2011.10.005; Bhattacharya S, 2009, AM J PUBLIC HEALTH, V99, P1176, DOI 10.2105/AJPH.2008.135624; Bonell C, 2006, BMJ-BRIT MED J, V333, P346, DOI 10.1136/bmj.333.7563.346; Bonu S, 2003, SOC SCI MED, V57, P1807, DOI 10.1016/S0277-9536(03)00056-X; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Brass PaulR., 2005, PRODUCTION HINDU MUS; C Chaturvedi G., 2008, VITAL DROP COMMUNICA; Chatterjee A, 2013, VACCINE, V31, P1268, DOI 10.1016/j.vaccine.2012.12.060; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; Choudhury P, 2011, VACCINE, V29, P8317, DOI 10.1016/j.vaccine.2011.08.099; Closser S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001528; DeVotta Neil, 2002, J INT AFF, V56, P53; Farmer P.E, 2001, INFECT INEQUALITIES; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; GAYER L., 2012, MUSLIMS INDIAN CITIE; Gilmartin D, 1998, J ASIAN STUD, V57, P1068, DOI 10.2307/2659304; GOI-Ministry of Home Affairs, 2001, POP REL COMM; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Greene JA, 2004, CULT MED PSYCHIAT, V28, P401, DOI 10.1023/B:MEDI.0000046429.55801.c8; GREENOUGH P, 1995, SOC SCI MED, V41, P633, DOI 10.1016/0277-9536(95)00035-6; GWATKIN DR, 1979, POPUL DEV REV, V5, P29, DOI 10.2307/1972317; Hardy Peter, 1972, MUSLIMS BRIT INDIA; Harris KJ, 1997, HUM ORGAN, V56, P375, DOI 10.17730/humo.56.3.w525025611458003; Heath AF, 2010, DIVERSITY CHANGE MOD; Hussain RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046274; Jeffery P, 2008, MOD ASIAN STUD, V42, P519, DOI 10.1017/S0026749X07003162; Jeffery P, 2011, CONTEMP SOUTH ASIA, V19, P117, DOI 10.1080/09584935.2010.537744; Jeffery P, 2010, SOC SCI MED, V71, P1711, DOI 10.1016/j.socscimed.2010.05.002; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kishore J, 2003, NATL MED J INDIA, V16, P131; Kleinman A., 1988, ILLNESS NARRATIVES; Krieger N, 2005, J EPIDEMIOL COMMUN H, V59, P350, DOI 10.1136/jech.2004.024562; Kumar S, 2012, HEALTH POLICY PLANN, V27, P516, DOI 10.1093/heapol/czr075; Leach M, 2008, B WORLD HEALTH ORGAN, V86, P418, DOI 10.2471/BLT.08.054726; McNeil D. G., 2012, NY TIMES; Mohammadi D, 2012, LANCET, V380, P460, DOI 10.1016/S0140-6736(12)61279-3; Obadare E, 2005, PATTERNS PREJUDICE, V39, P265, DOI 10.1080/00313220500198185; Obregon R, 2010, J HEALTH COMMUN, V15, P25, DOI 10.1080/10810731003695367; Pallansch MA, 2006, NEW ENGL J MED, V355, P2508, DOI 10.1056/NEJMp068200; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Pipes D, 2005, CONSPIRACY THEORY SP; Poortinga W, 2008, HEALTH PLACE, V14, P562, DOI 10.1016/j.healthplace.2007.10.003; Rauf TA, 2011, EC POLITICAL WEEKLY, V46; Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025; Robbins A, 2012, J PUBLIC HEALTH POL, V33, P387, DOI 10.1057/jphp.2012.37; Rubincam Clara, 2009, Health Hum Rights, V11, P87; Secretariat C, 2006, SOC EC ED STAT MUSL; Sensarma P, 2012, HEALTH SOC CARE COMM, V20, P645, DOI 10.1111/j.1365-2524.2012.01080.x; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Singh J, 2008, ISLAM HINDUISMS BLUR; Singh M, 2009, TIME MAGAZINE; Singh P., 2012, PLOS ONE, V7; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Thacker N, 2007, INDIAN PEDIATR, V44, P81; Thacker Naveen, 2004, Indian Journal of Pediatrics, V71, P241, DOI 10.1007/BF02724277; Thacker N, 2013, J TROP PEDIATRICS, V59, P266, DOI 10.1093/tropej/fmt008; The World Health Organization and the Government of India, 2009, NAT POL SURV PROJ AL; Thompson AK, 2006, BMC MED ETHICS, V7, P12, DOI [10.1186/1472-6939-7-12, DOI 10.1186/1472-6939-7-12]; VAN DER VEER P., 1994, RELIG NATL HINDUS MU; Varshney A., 2003, ETHNIC CONFLICT CIVI; Washburn S, 2013, CIAS FAKE VACCINATIO; Weiss WM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-117; Williams DR, 2008, AM J PUBLIC HEALTH, V98, pS29, DOI 10.2105/AJPH.98.Supplement_1.S29; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Zakaria Rafiq, 2004, INDIAN MUSLIMS HAVE	75	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0115628	10.1371/journal.pone.0115628	http://dx.doi.org/10.1371/journal.pone.0115628			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742622	gold, Green Submitted, Green Published			2022-12-26	WOS:000350688100001
J	Li, J; Chanrion, M; Sawey, E; Wang, T; Chow, E; Tward, A; Su, Y; Xue, W; Lucito, R; Zender, L; Lowe, SW; Bishop, JM; Powers, S				Li, Jinyu; Chanrion, Maia; Sawey, Eric; Wang, Tim; Chow, Edward; Tward, Aaron; Su, Yi; Xue, Wen; Lucito, Robert; Zender, Lars; Lowe, Scott W.; Bishop, J. Michael; Powers, Scott			Reciprocal Interaction of Wnt and RXR-alpha Pathways in Hepatocyte Development and Hepatocellular Carcinoma	PLOS ONE			English	Article							BETA-CATENIN; SOMATIC MUTATIONS; LIVER-CANCER; GENE; IDENTIFICATION; CLASSIFICATION; ACTIVATION; SURVIVAL; RECEPTOR	Genomic analysis of human hepatocellular carcinoma (HCC) is potentially confounded by the differentiation state of the hepatic cell-of-origin. Here we integrated genomic analysis of mouse HCC (with defined cell-of-origin) along with normal development. We found a major shift in expression of Wnt and RXR-alpha pathway genes (up and down, respectively) coincident with the transition from hepatoblasts to hepatocytes. A combined Wnt and RXR-alpha gene signature categorized HCCs into two subtypes (high Wnt, low RXR-alpha and low Wnt, high RXR-alpha), which matched cell-of-origin in mouse models and the differentiation state of human HCC. Suppression of RXR-alpha levels in hepatocytes increased Wnt signaling and enhanced tumorigenicity, whereas ligand activation of RXR-alpha achieved the opposite. These results corroborate that there are two main HCC subtypes that correspond to the degree of hepatocyte differentation and that RXR-alpha, in part via Wnt signaling, plays a key functional role in the hepatocyte-like subtype and potentially could serve as a selective therapeutic target.	[Li, Jinyu; Chanrion, Maia; Sawey, Eric; Wang, Tim; Su, Yi; Lucito, Robert; Powers, Scott] Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY 11740 USA; [Chow, Edward] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Tward, Aaron; Bishop, J. Michael] Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA; [Tward, Aaron; Bishop, J. Michael] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Xue, Wen; Zender, Lars; Lowe, Scott W.; Powers, Scott] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; National University of Singapore; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cold Spring Harbor Laboratory	Powers, S (corresponding author), Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY 11740 USA.	rscottpowers@gmail.com	Lucito, Robert/AID-7159-2022	Chow, Edward/0000-0002-3075-1898; Wang, Timothy/0000-0001-5730-3019; Powers, Scott/0000-0003-2769-1932	National Cancer Institute [R01CA124648]; NATIONAL CANCER INSTITUTE [U01CA168409, P01CA013106, R01CA124648, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding by R01CA124648 National Cancer Institute (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2010, HEPATOLOGY, V51, P1401, DOI 10.1002/hep.23488; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cha SM, 2012, J HAND SURG-AM, V37A, P2481, DOI 10.1016/j.jhsa.2012.07.031; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Choi JI, 2012, J KOREAN MED SCI, V27, P1265, DOI 10.3346/jkms.2012.27.10.1265; Cleary SP, 2013, HEPATOLOGY; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gu DQ, 2002, TRANSPLANTATION, V73, P1818, DOI 10.1097/00007890-200206150-00020; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kim SM, 2012, HEPATOLOGY, V55, P1443, DOI 10.1002/hep.24813; Lee SY, 2014, FISH SHELLFISH IMMUN, V37, P11, DOI 10.1016/j.fsi.2014.01.006; Lee S, 2013, J GERIATR ONCOL, V4, P382, DOI 10.1016/j.jgo.2013.03.001; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Miyoshi Y, 1998, CANCER RES, V58, P2524; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Sell S, 2002, SEMIN CELL DEV BIOL, V13, P419, DOI 10.1016/S1084952102001295; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Thorgeirsson SS, 2011, J HEPATOL; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Villanueva A, 2011, J HEPATOL; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yao H, 2011, Blood Cancer J, V1, pe43, DOI 10.1038/bcj.2011.41; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	36	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118480	10.1371/journal.pone.0118480	http://dx.doi.org/10.1371/journal.pone.0118480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738607	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000350685900040
J	Vandegehuchte, ML; Raschein, U; Schutz, M; Gwiazdowicz, DJ; Risch, AC				Vandegehuchte, Martijn L.; Raschein, Ursina; Schuetz, Martin; Gwiazdowicz, Dariusz J.; Risch, Anita C.			Indirect Short- and Long-Term Effects of Aboveground Invertebrate and Vertebrate Herbivores on Soil Microarthropod Communities	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; SUB-ALPINE GRASSLANDS; SPECIES-DIVERSITY; PLANT DIVERSITY; DECOMPOSITION PROCESSES; LITTER DECOMPOSITION; GROUND COMMUNITIES; NUTRIENT DYNAMICS; FEEDING GUILDS; RED DEER	Recognition is growing that besides ungulates, small vertebrate and invertebrate herbivores are important drivers of grassland functioning. Even though soil microarthropods play key roles in several soil processes, effects of herbivores-especially those of smaller body size-on their communities are not well understood. Therefore, we progressively excluded large, medium and small vertebrate and invertebrate herbivores for three growing seasons using size-selective fences in two vegetation types in subalpine grasslands; short-grass and tall-grass vegetation generated by high and low historical levels of ungulate grazing. Herbivore exclusions generally had few effects on microarthropod communities, but exclusion of all herbivore groups resulted in decreased total springtail and Poduromorpha richness compared with exclusion of only ungulates and medium-sized mammals, regardless of vegetation type. The tall-grass vegetation had a higher total springtail richness and mesostigmatid mite abundance than the short-grass vegetation and a different oribatid mite community composition. Although several biotic and abiotic variables differed between the exclusion treatments and vegetation types, effects on soil microarthropods were best explained by differences in nutrient and fibre content of the previous year's vegetation, a proxy for litter quality, and to a lesser extent soil temperature. After three growing seasons, smaller herbivores had a stronger impact on these functionally important soil microarthropod communities than large herbivores. Over longer time-scales, however, large grazers created two different vegetation types and thereby influenced microarthropod communities bottomup, e.g. by altering resource quality. Hence, both short-and long-term consequences of herbivory affected the structure of the soil microarthropod community.	[Vandegehuchte, Martijn L.; Raschein, Ursina; Schuetz, Martin; Risch, Anita C.] Swiss Fed Inst Forest Snow & Landscape Res, Res Unit Community Ecol, Birmensdorf, Switzerland; [Raschein, Ursina] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Gwiazdowicz, Dariusz J.] Poznan Univ Life Sci, Fac Forestry, Poznan, Poland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Zurich; Poznan University of Life Sciences	Vandegehuchte, ML (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res, Res Unit Community Ecol, Birmensdorf, Switzerland.	martijn.vandegehuchte@wsl.ch	Risch, Anita C./A-9836-2012	Risch, Anita C./0000-0003-0531-8336; Vandegehuchte, Martijn L./0000-0003-1283-4654; Gwiazdowicz, Dariusz/0000-0002-0064-2316	Swiss National Science Foundation, SNF [31003A_122009/1, 31003A_140939/1]	Swiss National Science Foundation, SNF(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation, SNF grant-no 31003A_122009/1 and SNF grant-no 31003A_140939/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, ECOL LETT, V14, P1246, DOI 10.1111/j.1461-0248.2011.01694.x; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Bakker ES, 2004, OECOLOGIA, V138, P91, DOI 10.1007/s00442-003-1402-5; Ball BA, 2014, SOIL BIOL BIOCHEM, V69, P71, DOI 10.1016/j.soilbio.2013.10.048; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1007, DOI 10.1016/S0038-0717(99)00014-0; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg MP, 2004, PEDOBIOLOGIA, V48, P589, DOI 10.1016/j.pedobi.2004.07.006; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bradford MA, 2008, SOIL BIOL BIOCHEM, V40, P1253, DOI 10.1016/j.soilbio.2007.12.001; Carrillo Y, 2011, SOIL BIOL BIOCHEM, V43, P1440, DOI 10.1016/j.soilbio.2011.03.011; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Clapperton MJ, 2002, PEDOBIOLOGIA, V46, P496, DOI 10.1078/0031-4056-00155; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Cole L, 2008, SOIL BIOL BIOCHEM, V40, P505, DOI 10.1016/j.soilbio.2007.09.018; Cole L, 2005, SOIL BIOL BIOCHEM, V37, P1707, DOI 10.1016/j.soilbio.2005.02.005; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crawley MJ, 1989, RELATIVE IMPORTANCE, P45; CROSSLEY DA, 1991, AGR ECOSYST ENVIRON, V34, P187, DOI 10.1016/0167-8809(91)90104-6; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Dombos M, 2001, SOIL BIOL BIOCHEM, V33, P2037, DOI 10.1016/S0038-0717(01)00125-0; Eisenhauer N, 2011, SOIL BIOL BIOCHEM, V43, P1697, DOI 10.1016/j.soilbio.2011.04.015; FRANK DA, 1990, OIKOS, V57, P57, DOI 10.2307/3565736; Grayston SJ, 2005, SOIL BIOL BIOCHEM, V37, P1157, DOI 10.1016/j.soilbio.2004.11.014; Haase J, 2008, ECOLOGY, V89, P3072, DOI 10.1890/07-1983.1; Haynes AG, 2014, PLANT SOIL, V374, P579, DOI 10.1007/s11104-013-1905-8; Hedlund K, 2003, OIKOS, V103, P45, DOI 10.1034/j.1600-0706.2003.12511.x; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Howe HF, 2006, ECOLOGY, V87, P3007, DOI 10.1890/0012-9658(2006)87[3007:MADEOM]2.0.CO;2; Hunter MD, 2001, AGR FOREST ENTOMOL, V3, P77, DOI 10.1046/j.1461-9563.2001.00100.x; Ilieva-Makulec K, 2006, EUR J SOIL BIOL, V42, pS244, DOI 10.1016/j.ejsobi.2006.07.030; Joern A, 2013, ANNU REV ENTOMOL, V58, P19, DOI 10.1146/annurev-ento-120811-153540; Lessard JP, 2012, BASIC APPL ECOL, V13, P59, DOI 10.1016/j.baae.2011.11.001; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; NEELY CL, 1991, SOIL BIOL BIOCHEM, V23, P947, DOI 10.1016/0038-0717(91)90175-J; Olofsson J, 2008, OECOLOGIA, V156, P825, DOI 10.1007/s00442-008-1038-6; Petersen H, 2004, PEDOBIOLOGIA, V48, P559, DOI 10.1016/j.pedobi.2004.06.003; Risch AC, 2013, ECOSYSTEMS, V16, P1192, DOI 10.1007/s10021-013-9676-x; Sabais ACW, 2011, ACTA OECOL, V37, P195, DOI 10.1016/j.actao.2011.02.002; Salamon JA, 2006, SOIL BIOL BIOCHEM, V38, P209, DOI 10.1016/j.soilbio.2005.04.033; Salamon JA, 2004, OIKOS, V106, P51, DOI 10.1111/j.0030-1299.2004.12905.x; Schadler M, 2003, OIKOS, V100, P203, DOI 10.1034/j.1600-0706.2003.11821.x; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schneider K., 2004, PHYTOPHAGA-PALERMO, VXIV, P247; Schneider K, 2009, SOIL BIOL BIOCHEM, V41, P170, DOI 10.1016/j.soilbio.2008.10.013; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Schon NL, 2012, APPL SOIL ECOL, V53, P98, DOI 10.1016/j.apsoil.2011.11.003; Schutz M, 2006, ECOSYSTEMS, V9, P624, DOI 10.1007/s10021-006-0091-4; Schutz M, 2003, FOREST ECOL MANAG, V181, P177, DOI 10.1016/S0378-1127(03)00131-2; Schweitzer JA, 2005, OIKOS, V110, P133, DOI 10.1111/j.0030-1299.2005.13650.x; SEASTEDT TR, 1984, ANNU REV ENTOMOL, V29, P25, DOI 10.1146/annurev.en.29.010184.000325; Sinka M, 2007, APPL SOIL ECOL, V36, P92, DOI 10.1016/j.apsoil.2006.12.004; Sinka M, 2009, ECOL ENTOMOL, V34, P588, DOI 10.1111/j.1365-2311.2009.01106.x; Szanser M, 2011, SOIL BIOL BIOCHEM, V43, P9, DOI 10.1016/j.soilbio.2010.08.031; Tom N, 2006, NEW ZEAL J AGR RES, V49, P261, DOI 10.1080/00288233.2006.9513717; Ukabi S, 2009, J ARID ENVIRON, V73, P907, DOI 10.1016/j.jaridenv.2009.04.001; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Wickings K, 2013, PEDOBIOLOGIA, V56, P105, DOI 10.1016/j.pedobi.2013.01.001	61	17	17	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118679	10.1371/journal.pone.0118679	http://dx.doi.org/10.1371/journal.pone.0118679			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738942	gold, Green Published			2022-12-26	WOS:000350685900061
J	Warren-Myers, F; Dempster, T; Fjelldal, PG; Hansen, T; Swearer, SE				Warren-Myers, Fletcher; Dempster, Tim; Fjelldal, Per Gunnar; Hansen, Tom; Swearer, Stephen E.			An Industry-Scale Mass Marking Technique for Tracing Farmed Fish Escapees	PLOS ONE			English	Article							SALMON SALMO-SALAR; ENRICHED STABLE-ISOTOPES; INDUCED ABDOMINAL LESIONS; PERCH MACQUARIA-AMBIGUA; ATLANTIC SALMON; TRANSGENERATIONAL MARKING; BATCH MARKING; WILD SALMON; OTOLITHS; L.	Farmed fish escape and enter the environment with subsequent effects on wild populations. Reducing escapes requires the ability to trace individuals back to the point of escape, so that escape causes can be identified and technical standards improved. Here, we tested if stable isotope otolith fingerprint marks delivered during routine vaccination could be an accurate, feasible and cost effective marking method, suitable for industrial-scale application. We tested seven stable isotopes, Ba-134, Ba-135, Ba-136, Ba-137, Sr-86, Sr-87 and Mg-26, on farmed Atlantic salmon reared in freshwater, in experimental conditions designed to reflect commercial practice. Marking was 100% successful with individual Ba isotopes at concentrations as low as 0.001 mu g.g(-1) fish and for Sr isotopes at 1 mu g. g(-1) fish. Our results suggest that 63 unique fingerprint marks can be made at low cost using Ba (0.0002-0.02 $US per mark) and Sr (0.46-0.82 $US per mark) isotopes. Stable isotope fingerprinting during vaccination is feasible for commercial application if applied at a company level within the world's largest salmon producing nations. Introducing a mass marking scheme would enable tracing of escapees back to point of origin, which could drive greater compliance, better farm design and improved management practices to reduce escapes.	[Warren-Myers, Fletcher; Dempster, Tim; Swearer, Stephen E.] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia; [Fjelldal, Per Gunnar; Hansen, Tom] Inst Marine Res, Matre Aquaculture Res Stn, Matredal, Norway	University of Melbourne; Institute of Marine Research - Norway	Warren-Myers, F (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia.	fwwm@student.unimelb.edu.au	SWEARER, STEPHEN/AAC-1527-2020; Swearer, Stephen/X-4882-2018; Dempster, Tim/E-9630-2011	SWEARER, STEPHEN/0000-0001-6381-9943; Swearer, Stephen/0000-0001-6381-9943; Dempster, Tim/0000-0001-8041-426X	Norwegian Fisheries and Aquaculture Research Fund [900710]	Norwegian Fisheries and Aquaculture Research Fund	Funding was provided by the Norwegian Fisheries and Aquaculture Research Fund ( project #900710), http://www.fao.org/docrep/008/a0012e/a0012e09.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aunsmo A, 2008, J FISH DIS, V31, P515, DOI 10.1111/j.1365-2761.2007.00899.x; Bjornsson BT, 2000, GEN COMP ENDOCR, V119, P17, DOI 10.1006/gcen.2000.7439; Brudeseth BE, 2013, FISH SHELLFISH IMMUN, V35, P1759, DOI 10.1016/j.fsi.2013.05.029; Crook DA, 2009, N AM J FISH MANAGE, V29, P279, DOI 10.1577/M07-224.1; Crozier WW, 2000, FISHERIES MANAG ECOL, V7, P437, DOI 10.1046/j.1365-2400.2000.00219.x; de Braux E, 2014, ICES J MAR SCI, V71, P2530, DOI 10.1093/icesjms/fsu091; de Vries MC, 2005, GEOCHIM COSMOCHIM AC, V69, P4061, DOI 10.1016/j.gca.2005.03.052; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Glover KA, 2013, BMC GENET, V14, P1, DOI [10.1186/1471-2156-14-1, DOI 10.1186/1471-2156-14-1]; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060924; Grini A, 2011, J FISH DIS, V34, P531, DOI 10.1111/j.1365-2761.2011.01265.x; Hansen LP, 2006, ICES J MAR SCI, V63, P1211, DOI 10.1016/j.icesjms.2006.04.022; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Martinez I, 2009, FOOD CHEM, V116, P766, DOI 10.1016/j.foodchem.2009.03.026; MCCORMICK SD, 1987, CAN J FISH AQUAT SCI, V44, P1462, DOI 10.1139/f87-175; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1016/S1054-3139(97)80004-5; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Munro AR, 2009, J FISH BIOL, V75, P668, DOI 10.1111/j.1095-8649.2009.02352.x; RICKER W E, 1975, P382; SHEARER KD, 1992, FISH PHYSIOL BIOCHEM, V9, P387, DOI 10.1007/BF02274219; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P147, DOI 10.3354/aei00017; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P117, DOI 10.3354/aei00013; Sorum U, 2004, AQUACULTURE, V232, P333, DOI 10.1016/S0044-8486(03)00529-5; Toledo-Guedes K, 2001, MAR ECOL, V31, P26; Vander Haegen GE, 2005, N AM J FISH MANAGE, V25, P1161, DOI 10.1577/M04-011.1; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Warren-Myers F, 2014, AQUACULT ENV INTERAC, V5, P143, DOI 10.3354/aei00103; Williamson DH, 2009, J FISH BIOL, V74, P891, DOI 10.1111/j.1095-8649.2008.02176.x; Woodcock SH, 2011, ECOL FRESHW FISH, V20, P157, DOI 10.1111/j.1600-0633.2010.00475.x; Woodcock SH, 2011, N AM J FISH MANAGE, V31, P843, DOI 10.1080/02755947.2011.623760	38	11	11	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118594	10.1371/journal.pone.0118594	http://dx.doi.org/10.1371/journal.pone.0118594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738955	Green Accepted, Green Published, gold			2022-12-26	WOS:000350685900052
J	Zhou, MJ; Daubresse, M; Stafford, RS; Alexander, GC				Zhou, Meijia; Daubresse, Matthew; Stafford, Randall S.; Alexander, G. Caleb			National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012	PLOS ONE			English	Article							ANTIHYPERTENSIVE MEDICATION USE; PLACEBO-LIKE TOLERABILITY; BLOOD-PRESSURE CONTROL; ORAL RENIN INHIBITOR; CLINICAL-PRACTICE; REAL-LIFE; ALISKIREN; MANAGEMENT; ADULTS; EFFICACY	Importance Hypertension is common and costly. Over the past decade, new antihypertensive therapies have been developed, several have lost patent protection and additional evidence regarding the safety and effectiveness of these agents has accrued. Objective To examine trends in the use of antihypertensive therapies in the United States between 1997 and 2012. Design, Setting and Participants We used nationally representative audit data from the IMS Health National Disease and Therapeutic Index to examine the ambulatory pharmacologic treatment of hypertension. Outcome Measures Our primary unit of analysis was a visit where hypertension was a reported diagnosis and treated with a pharmacotherapy (treatment visit). We restricted analyses to the use of six therapeutic classes of antihypertensive medications among individuals 18 years or older. Results Annual hypertension treatment visits increased from 56.9 million treatment visits (95% confidence intervals [CI], 53.9-59.8) in 1997 to 83.3 million visits (CI 79.2-87.3) in 2008, then declined steadily to 70.9 million visits (CI 66.7-75.0) by 2012. Angiotensin receptor blocker utilization increased substantially from 3% of treatment visits in 1997 to 18% by 2012, whereas calcium channel blocker use decreased from 27% to 18% of visits. Rates of diuretic and beta-blocker use remained stable and represented 24%-30% and 14-16% of visits, respectively. Use of direct renin inhibitor accounted for fewer than 2% of annual visits. The proportion of visits treated using fixed-dose combination therapies increased from 28% to 37% of visits. Conclusions Several important changes have occurred in the landscape of antihypertensive treatment in the United States during the past decade. Despite their novel mechanism of action, the adoption rate of direct renin inhibitors remains low.	[Zhou, Meijia; Daubresse, Matthew; Alexander, G. Caleb] Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Zhou, Meijia; Daubresse, Matthew; Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Stafford, Randall S.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Stanford, CA 94305 USA; [Alexander, G. Caleb] Johns Hopkins Med, Div Gen Internal Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; Johns Hopkins University; Johns Hopkins Medicine	Alexander, GC (corresponding author), Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	galexand@jhsph.edu	Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality [RO1 HS0189960]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Alexander is supported by the Agency for Healthcare Research and Quality (RO1 HS0189960). The funding sources had no role in the design and conduct of the study, analysis, or interpretation of the data; and preparation or final approval of the manuscript prior to publication.	Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chauhan D, 2008, J CLIN PHARM THER, V33, P339, DOI 10.1111/j.1365-2710.2008.00925.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fung V, 2007, CLIN THER, V29, P972, DOI 10.1016/j.clinthera.2007.05.010; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gradman AH, 2005, CIRCULATION, V111, P1012, DOI 10.1161/01.CIR.0000156466.02908.ED; Grimm RH, 2011, J CLIN HYPERTENS, V13, P654, DOI 10.1111/j.1751-7176.2011.00510.x; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Gupta H, 2010, J PHARM BIOALLIED SC, V2, P2, DOI 10.4103/0975-7406.62694; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Higashi A, 2011, J GEN INTERN MED, V26, P1465, DOI 10.1007/s11606-011-1796-4; Hoyert DL, 2011, NATL VITAL STAT REP, V61, P1; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kushiro T, 2006, HYPERTENS RES, V29, P997, DOI 10.1291/hypres.29.997; Ma J, 2006, HYPERTENSION, V48, P846, DOI 10.1161/01.HYP.0000240931.90917.0c; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Psaty BM, 2002, ARCH INTERN MED, V162, P2325, DOI 10.1001/archinte.162.20.2325; Rabbani A, 2008, AM J HYPERTENS, V21, P509, DOI 10.1038/ajh.2008.31; Sica DA, 2002, DRUGS, V62, P443, DOI 10.2165/00003495-200262030-00003; Sosner P, 2013, J HYPERTENS, V31, P1491, DOI 10.1097/HJH.0b013e328360f716; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0; Stanton A, 2003, HYPERTENSION, V42, P1137, DOI 10.1161/01.HYP.0000101688.17370.87; Tocci G, 2012, HIGH BLOOD PRESS CAR, V19, P73, DOI 10.2165/11632170-000000000-00000; Verpooten GA, 2011, INT J CLIN PRACT, V65, P54, DOI 10.1111/j.1742-1241.2010.02562.x; Volpe M, 2012, J HYPERTENS, V30, P194, DOI 10.1097/HJH.0b013e32834e1c66; Zell ER, P SURV RES METH SECT	27	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119292	10.1371/journal.pone.0119292	http://dx.doi.org/10.1371/journal.pone.0119292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738503	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900101
J	Leifeld, J; Meyer, S; Budge, K; Sebastia, MT; Zimmermann, M; Fuhrer, J				Leifeld, Jens; Meyer, Stefanie; Budge, Karen; Sebastia, Maria Teresa; Zimmermann, Michael; Fuhrer, Juerg			Turnover of Grassland Roots in Mountain Ecosystems Revealed by Their Radiocarbon Signature: Role of Temperature and Management	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; ORGANIC-MATTER; CARBON; SOIL; PRODUCTIVITY; DYNAMICS; PATTERNS; AGE; TERRESTRIAL; LONGEVITY	Root turnover is an important carbon flux component in grassland ecosystems because it replenishes substantial parts of carbon lost from soil via heterotrophic respiration and leaching. Among the various methods to estimate root turnover, the root's radiocarbon signature has rarely been applied to grassland soils previously, although the value of this approach is known from studies in forest soils. In this paper, we utilize the root's radiocarbon signatures, at 25 plots, in mountain grasslands of the montane to alpine zone of Europe. We place the results in context of a global data base on root turnover and discuss driving factors. Root turnover rates were similar to those of a subsample of the global data, comprising a similar temperature range, but measured with different approaches, indicating that the radiocarbon method gives reliable, plausible and comparable results. Root turnover rates (0.06-1.0 y(-1)) scaled significantly and exponentially with mean annual temperatures. Root turnover rates indicated no trend with soil depth. The temperature sensitivity was significantly higher in mountain grassland, compared to the global data set, suggesting additional factors influencing root turnover. Information on management intensity from the 25 plots reveals that root turnover may be accelerated under intensive and moderate management compared to low intensity or semi-natural conditions. Because management intensity, in the studied ecosystems, co-varied with temperature, estimates on root turnover, based on mean annual temperature alone, may be biased. A greater recognition of management as a driver for root dynamics is warranted when effects of climatic change on belowground carbon dynamics are studied in mountain grasslands.	[Leifeld, Jens; Fuhrer, Juerg] Climate Air Pollut Grp, Agroscope, Zurich, Switzerland; [Meyer, Stefanie] Univ Jena, Inst Geog, Jena, Germany; [Sebastia, Maria Teresa] Forest Sci Ctr Catalonia, Lleida, Spain; [Sebastia, Maria Teresa] Univ Lleida, Dept HBJ, ETSEA, Lleida, Spain; [Zimmermann, Michael] Univ Nat Resources & Life Sci Vienna, Dept Forest & Soil Sci, Vienna, Austria	Swiss Federal Research Station Agroscope; Friedrich Schiller University of Jena; Centre Tecnologic Forestal de Catalunya (CTFC); Universitat de Lleida; University of Natural Resources & Life Sciences, Vienna	Leifeld, J (corresponding author), Climate Air Pollut Grp, Agroscope, Zurich, Switzerland.	jens.leifeld@agroscope.admin.ch	Zimmermann, Michael/F-7547-2010; Leifeld, Jens/GYR-0349-2022; Leifeld, Jens/A-3298-2014; Sebastia, M. Teresa/B-5479-2013	Zimmermann, Michael/0000-0002-5162-2008; Leifeld, Jens/0000-0002-7245-9852; Leifeld, Jens/0000-0002-7245-9852; Sebastia, M. Teresa/0000-0002-9017-3575	Swiss National Science Foundation [200021-115891]; Swiss State Secretariat for Education and Research [C07.0031]; Spanish Ministry of Science and Innovation, (project CAPAS) [CGL2010-22378-C03-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss State Secretariat for Education and Research; Spanish Ministry of Science and Innovation, (project CAPAS)(Ministry of Science and Innovation, Spain (MICINN))	KB received support from the Swiss National Science Foundation, project 200021-115891 (www.snf.ch). SM received support from the Swiss State Secretariat for Education and Research, project C07.0031 (www.sbfi.admin.ch). MTS received support from the Spanish Ministry of Science and Innovation, (project CAPAS, CGL2010-22378-C03-01) (www.idi.mineco.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolinder MA, 2007, AGR ECOSYST ENVIRON, V118, P29, DOI 10.1016/j.agee.2006.05.013; Budge K, 2011, BIOGEOSCIENCES, V8, P1911, DOI 10.5194/bg-8-1911-2011; Budge K, 2011, THESIS U ZURICH; Crawford MC, 1998, ADV SOIL S, P381; Crow SE, 2009, GLOBAL CHANGE BIOL, V15, P2003, DOI 10.1111/j.1365-2486.2009.01850.x; Dietl W., 1986, SCHWEIZERISCHE LANDW, V64, P241; European Commission, AGR ENV; Fitter AH, 1998, OECOLOGIA, V114, P20, DOI 10.1007/s004420050415; Garcia-Pausas J, 2011, PLANT SOIL, V340, P315, DOI 10.1007/s11104-010-0601-1; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gaul D, 2009, FUNCT PLANT BIOL, V36, P11, DOI 10.1071/FP08195; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gill RA, 2002, GLOBAL ECOL BIOGEOGR, V11, P79, DOI 10.1046/j.1466-822X.2001.00267.x; HARKNESS DD, 1986, RADIOCARBON, V28, P328, DOI 10.1017/S0033822200007426; Klumpp K, 2009, J ECOL, V97, P876, DOI 10.1111/j.1365-2745.2009.01549.x; Kucharik CJ, 2006, GLOBAL CHANGE BIOL, V12, P122, DOI 10.1111/j.1365-2486.2005.01053.x; Leifeld J, 2013, BIOGEOCHEMISTRY, V112, P59, DOI 10.1007/s10533-011-9689-5; Leifeld J, 2009, GLOBAL CHANGE BIOL, V15, P668, DOI 10.1111/j.1365-2486.2008.01782.x; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20092; Luo YQ, 2003, GLOBAL CHANGE BIOL, V9, P1118, DOI 10.1046/j.1365-2486.2003.00642.x; Meyer S, 2012, BIOGEOSCIENCES, V9, P853, DOI 10.5194/bg-9-853-2012; Meyer S, 2012, THESIS U ZURICH; Milchunas DG, 2009, ECOSYSTEMS, V12, P1381, DOI 10.1007/s10021-009-9295-8; Pfimlin A, 2003, GRASSLAND SCI EUROPE, V8, P1; Pucheta E, 2004, AUSTRAL ECOL, V29, P201, DOI 10.1111/j.1442-9993.2004.01337.x; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Riedo M, 1998, ECOL MODEL, V105, P141, DOI 10.1016/S0304-3800(97)00110-5; Scott JT, 2012, NEW ZEAL J AGR RES, V55, P147, DOI 10.1080/00288233.2012.662896; Solly E, 2013, BIOGEOSCIENCES, V10, P4833, DOI 10.5194/bg-10-4833-2013; Soussana JF, 2012, ECOL MODEL, V231, P134, DOI 10.1016/j.ecolmodel.2012.02.002; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Synal HA, 2007, NUCL INSTRUM METH B, V259, P7, DOI 10.1016/j.nimb.2007.01.138; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P217, DOI 10.1111/j.1365-2486.2005.001063.x; von Haden AC, 2014, AGR ECOSYST ENVIRON, V185, P188, DOI 10.1016/j.agee.2013.12.027	36	24	25	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119184	10.1371/journal.pone.0119184	http://dx.doi.org/10.1371/journal.pone.0119184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734640	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700057
J	Lemmens, RJM; Janssen-Potten, YJM; Timmermans, AAA; Smeets, RJEM; Seelen, HAM				Lemmens, Ryanne J. M.; Janssen-Potten, Yvonne J. M.; Timmermans, Annick A. A.; Smeets, Rob J. E. M.; Seelen, Henk A. M.			Recognizing Complex Upper Extremity Activities Using Body Worn Sensors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; WEARABLE SENSORS; STROKE; ARM; CLASSIFICATION; CHILDREN; LIFE	To evaluate arm-hand therapies for neurological patients it is important to be able to assess actual arm-hand performance objectively. Because instruments that measure the actual quality and quantity of specific activities in daily life are lacking, a new measure needs to be developed. The aims of this study are to a) elucidate the techniques used to identify upper extremity activities, b) provide a proof-of-principle of this method using a set of activities tested in a healthy adult and in a stroke patient, and c) provide an example of the method's applicability in daily life based on readings taken from a healthy adult. Multiple devices, each of which contains a tri-axial accelerometer, a tri-axial gyroscope and a tri-axial magnetometer were attached to the dominant hand, wrist, upper arm and chest of 30 healthy participants and one stroke patient, who all performed the tasks 'drinking', 'eating' and 'brushing hair' in a standardized environment. To establish proof-of-principle, a prolonged daily life recording of 1 participant was used to identify the task 'drinking'. The activities were identified using multi-array signal feature extraction and pattern recognition algorithms and 2D-convolution. The activities 'drinking', 'eating' and 'brushing hair' were unambiguously recognized in a sequence of recordings of multiple standardized daily activities in a healthy participant and in a stroke patient. It was also possible to identify a specific activity in a daily life recording. The long term aim is to use this method to a) identify arm-hand activities that someone performs during daily life, b) determine the quantity of activity execution, i.e. amount of use, and c) determine the quality of arm-hand skill performance.	[Lemmens, Ryanne J. M.; Janssen-Potten, Yvonne J. M.; Smeets, Rob J. E. M.; Seelen, Henk A. M.] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, NL-6200 MD Maastricht, Netherlands; [Lemmens, Ryanne J. M.; Janssen-Potten, Yvonne J. M.; Smeets, Rob J. E. M.; Seelen, Henk A. M.] Adelante, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Timmermans, Annick A. A.] Hasselt Univ, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Smeets, Rob J. E. M.] Maastricht Univ, Med Ctr, Dept Rehabil Med, NL-6200 MD Maastricht, Netherlands	Maastricht University; Hasselt University; Maastricht University	Lemmens, RJM (corresponding author), Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, NL-6200 MD Maastricht, Netherlands.	r.lemmens@adelante-zorggroep.nl	Smeets, Rob JEM/D-1522-2011	Smeets, Rob JEM/0000-0002-9503-366X; Timmermans, Annick/0000-0002-5461-947X	Adelante; Centre of Expertise in Rehabilitation and Audiology; Hoensbroek; Netherlands	Adelante; Centre of Expertise in Rehabilitation and Audiology; Hoensbroek; Netherlands(Netherlands Government)	This paper was funded by Adelante, Centre of Expertise in Rehabilitation and Audiology, Hoensbroek, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner M, 2008, J HAND SURG-AM, V33A, P1337, DOI 10.1016/j.jhsa.2008.02.032; Bai J, 2011, ELECTRON J STAT, V6, P559; Broeks JG, 1999, DISABIL REHABIL, V21, P357; CHEN JJJ, 1992, IEEE T BIO-MED ENG, V39, P9, DOI 10.1109/10.108122; Ermes M, 2008, IEEE T INF TECHNOL B, V12, P20, DOI 10.1109/TITB.2007.899496; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Gyllensten IC, 2011, IEEE T BIO-MED ENG, V58, P2656, DOI 10.1109/TBME.2011.2160723; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Janssen L, 2011, RES DEV DISABIL, V32, P963, DOI 10.1016/j.ridd.2011.02.002; Lemmens RJM, PLOS ONE IN PRESS; Lemmens RJM, 2014, BMC NEUROLOGY, P14; Lemmens RJM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-21; Leutheuser H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075196; Lyden K, 2014, MED SCI SPORT EXER, V46, P386, DOI 10.1249/MSS.0b013e3182a42a2d; Magill RA, 2007, MOTOR LEARNING CONTR, P2; Min CH, 2008, IEEE ENG MED BIO, P5192, DOI 10.1109/IEMBS.2008.4650384; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; Sokal B, 2013, ARCH PHYS MED REHABI; Strohrmann C, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-83; Timmermans Annick A. A., 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P98, DOI 10.1109/ICORR.2009.5209558; Timmermans AAA, 2009, DISABIL REHABIL, V31, P1344, DOI 10.1080/09638280902823664; Uswatte G, 2009, REHABIL PSYCHOL, V54, P398, DOI 10.1037/a0017501; VANSANT AF, 1988, PHYS THER, V68, P1330, DOI 10.1093/ptj/68.9.1330; Wagner JF, 2006, COGNITION INSTRUCT, V24, P1, DOI 10.1207/s1532690xci2401_1; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	27	25	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118642	10.1371/journal.pone.0118642	http://dx.doi.org/10.1371/journal.pone.0118642			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734641	Green Submitted, Green Published, gold			2022-12-26	WOS:000350314700043
J	Levine, SL; Tan, JG; Mueller, GM; Bachman, PM; Jensen, PD; Uffman, JP				Levine, Steven L.; Tan, Jianguo; Mueller, Geoffrey M.; Bachman, Pamela M.; Jensen, Peter D.; Uffman, Joshua P.			Independent Action between DvSnf7 RNA and Cry3Bb1 Protein in Southern Corn Rootworm, Diabrotica undecimpunctata howardi and Colorado Potato Beetle, Leptinotarsa decemlineata	PLOS ONE			English	Article							INSECTICIDAL ACTIVITY; BT-MAIZE; TOXICITY; HYBRIDS; POTENTIATION; COLEOPTERA; CRY1A.105; SYNERGISM; EFFICACY; CRY2AB2	In recent years, corn rootworm (CRW)-resistant maize events producing two or more CRW-active Bt proteins have been commercialized to enhance efficacy against the target pest(s) by providing multiple modes of action (MoA). The maize hybrid MON 87411 has been developed that produces the CRW-active Cry3Bb1 Bt protein (hereafter Cry3Bb1) and expresses a RNAi-mediated MoA that also targets CRW. As part of an environmental risk assessment for MON 87411, the potential for an interaction between the CRW-active DvSnf7 RNA (hereafter DvSnf7) and Cry3Bb1 was assessed in 12-day diet incorporation bioassays with the southern corn rootworm (SCR, Diabrotica undecimpunctata howardi). The potential for an interaction between DvSnf7 and Cry3Bb1 was evaluated with two established experimental approaches. The first approach evaluated each substance alone and in combination over three different response levels. For all three response levels, observed responses were shown to be additive and not significantly different from predicted responses under the assumption of independent action. The second approach evaluated the potential for a fixed sub-lethal concentration of Cry3Bb1 to decrease the median lethal concentration (LC50) of DvSnf7 and vice-versa. With this approach, the LC50 value of DvSnf7 was not altered by a sub-lethal concentration of Cry3Bb1 and vice-versa. In addition, the potential for an interaction between the Cry3Bb1 and DvSnf7 was tested with Colorado potato beetle (CPB, Leptinotarsa decemlineata), which is sensitive to Cry3Bb1 but not DvSnf7. CPB assays also demonstrated that DvSnf7 does not alter the activity of Cry3Bb1. The results from this study provide multiple lines of evidence that DvSnf7 and Cry3Bb1 produced in MON 87411 have independent action.	[Levine, Steven L.; Tan, Jianguo; Mueller, Geoffrey M.; Bachman, Pamela M.; Jensen, Peter D.; Uffman, Joshua P.] Monsanto Co, Regulatory Sci, St Louis, MO 63167 USA	Monsanto	Levine, SL (corresponding author), Monsanto Co, Regulatory Sci, St Louis, MO 63167 USA.	steven.l.levine@monsanto.com; jianguo.tan@monsanto.com			Monsanto Company	Monsanto Company	Monsanto Company funded this study. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; [Anonymous], 2009, FIFRA SCI ADV PAN M; [Anonymous], 2003, US EPA NEW CORN PEST; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belden JB, 2006, ENVIRON TOXICOL CHEM, V25, P623, DOI 10.1897/05-370R.1; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Center for Environmental Risk Assessment ( CERA), 2013, GM CROP DAT; DELECLUSE A, 1988, MOL GEN GENET, V214, P42, DOI 10.1007/BF00340177; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devos Y, 2013, TRANSGENIC RES, V22, P269, DOI 10.1007/s11248-012-9657-4; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; DONOVAN WP, 1992, APPL ENVIRON MICROB, V58, P3921, DOI 10.1128/AEM.58.12.3921-3927.1992; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Faust M, 2000, J ENVIRON QUAL, V29, P1063, DOI 10.2134/jeq2000.00472425002900040005x; Faust M, 2003, AQUAT TOXICOL, V63, P43, DOI 10.1016/S0166-445X(02)00133-9; Finney DJ, 1942, ANN APPL BIOL, V29, P82, DOI 10.1111/j.1744-7348.1942.tb06923.x; Head G, 2014, CROP PROT, V57, P38, DOI 10.1016/j.cropro.2013.11.025; Koci J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083985; Kodell Ralph L., 1991, STAT TOXICOLOGY, P559; Konemann WH, 1996, FOOD CHEM TOXICOL, V34, P1025, DOI 10.1016/S0278-6915(97)00070-7; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Marra M. C., 2012, AgBioForum, V15, P217; MARRONE PG, 1985, J ECON ENTOMOL, V78, P290, DOI 10.1093/jee/78.1.290; Meissle M, 2009, ENTOMOL EXP APPL, V131, P308, DOI 10.1111/j.1570-7458.2009.00859.x; OECD, 2007, ORGAN EC COOPERATION, P1, DOI DOI 10.1787/16812328; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Poch G, 1995, CAN J PHYSIOL PHARM, V73, P1574; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rule DM, 2014, J ECON ENTOMOL, V107, P403, DOI 10.1603/EC12448; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1, DOI [10.1007/s00018-008-8483-6, DOI 10.1007/S00018-008-8483-6]; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; WU D, 1985, FEBS LETT, V190, P232, DOI 10.1016/0014-5793(85)81290-4; YU YM, 1987, J GEN APPL MICROBIOL, V33, P459, DOI 10.2323/jgam.33.459; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	41	33	36	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118622	10.1371/journal.pone.0118622	http://dx.doi.org/10.1371/journal.pone.0118622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734482	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700041
J	Walter, BA; Likhitpanichkul, M; Illien-Junger, S; Roughley, PJ; Hecht, AC; Iatridis, JC				Walter, Benjamin A.; Likhitpanichkul, Morakot; Illien-Junger, Svenja; Roughley, Peter J.; Hecht, Andrew C.; Iatridis, James C.			TNF alpha Transport Induced by Dynamic Loading Alters Biomechanics of Intact Intervertebral Discs	PLOS ONE			English	Article							EARLY DEGENERATIVE CHANGES; NECROSIS-FACTOR-ALPHA; ORGAN-CULTURE SYSTEM; FACET JOINT INJURY; GENE-EXPRESSION; AGGRECAN DEGRADATION; SPINAL-CORD; MODEL; COMPRESSION; CATABOLISM	Objective Intervertebral disc (IVD) degeneration is an important contributor to the development of back pain, and a key factor relating pain and degeneration are the presence of pro-inflammatory cytokines and IVD motion. There is surprisingly limited understanding of how mechanics and inflammation interact in the IVD. This study investigated interactions between mechanical loading and pro-inflammatory cytokines in a large animal organ culture model to address fundamental questions regarding (i.) how inflammatory mediators arise within the IVD, (ii.) how long inflammatory mediators persist, and (iii.) how inflammatory mediators influence IVD biomechanics. Methods Bovine caudal IVDs were cultured for 6 or 20-days under static & amp; dynamic loading with or without exogenous TNF alpha in the culture medium, simulating a consequence of inflammation of the surrounding spinal tissues. TNF alpha transport within the IVD was assessed via immunohistochemistry. Changes in IVD structural integrity (dimensions, histology & amp; aggrecan degradation), biomechanical behavior (Creep, Recovery & amp; Dynamic stiffness) and pro-inflammatory cytokines in the culture medium (ELISA) were assessed. Results TNF alpha was able to penetrate intact IVDs when subjected to dynamic loading but not static loading. Once transported within the IVD, pro-inflammatory mediators persisted for 4-8 days after TNF alpha removal. TNF alpha exposure induced changes in IVD biomechanics (reduced diurnal displacements & amp; increased dynamic stiffness). Discussion This study demonstrated that exposure to TNF alpha, as might occur from injured surrounding tissues, can penetrate healthy intact IVDs, induce expression of additional pro-inflammatory cytokines and alter IVD mechanical behavior. We conclude that exposure to pro-inflammatory cytokine may be an initiating event in the progression of IVD degeneration in addition to being a consequence of disease.				james.iatridis@mssm.edu	Walter, Ben A/E-9220-2015; Illien-Junger, Svenja/B-9105-2018; Illien-Junger, Svenja/AAV-1853-2020	Illien-Junger, Svenja/0000-0001-9895-0693; Illien-Junger, Svenja/0000-0001-9895-0693; Iatridis, James/0000-0002-2186-0590	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR057397, R01AR064157]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064157, R01AR057397] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR057397 and R01AR064157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Albert HB, 2011, EUR SPINE J, V20, P1355, DOI 10.1007/s00586-011-1794-6; Albro MB, 2010, J BIOMECH, V43, P2267, DOI 10.1016/j.jbiomech.2010.04.041; Alipui DO, 2014, T ORS P 2014; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Cortes DH, 2014, J BIOMECHANICS; Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0; Ferguson SJ, 2004, J BIOMECH, V37, P213, DOI 10.1016/S0021-9290(03)00250-1; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Hiyama A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4379; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056; Huang CY, 2008, J BIOMECH, V41, P1184, DOI 10.1016/j.jbiomech.2008.02.002; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Kras JV, 2014, SPINE, V39, P207, DOI 10.1097/BRS.0000000000000107; Kras JV, 2013, J NEUROSCI RES, V91, P1312, DOI 10.1002/jnr.23254; Kras JV, 2013, SPINE, V38, P217, DOI 10.1097/BRS.0b013e3182685ba1; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Laudier D, 2007, J ORTHOP RES, V25, P390, DOI 10.1002/jor.20304; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; MacLean JJ, 2003, SPINE, V28, P973, DOI 10.1097/00007632-200305150-00004; Markova DZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4301; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; OSHIMA H, 1993, J ORTHOP RES, V11, P332, DOI 10.1002/jor.1100110304; Ponnappan RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3494; Purmessur D, 2013, BIOCHEM BIOPH RES CO, V433, P151, DOI 10.1016/j.bbrc.2013.02.034; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Stevens AL, 2009, MOL CELL PROTEOMICS, V8, P1475, DOI 10.1074/mcp.M800181-MCP200; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Walter BA, 2014, J BIOMECHANICS; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang XM, 2009, PAIN, V142, P275, DOI 10.1016/j.pain.2009.02.001; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Wuertz K, 2013, GLOB SPINE J, V3, P175, DOI 10.1055/s-0033-1347299; Wuertz K, 2009, BIOCHEM BIOPH RES CO, V379, P824, DOI 10.1016/j.bbrc.2008.12.145	42	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118358	10.1371/journal.pone.0118358	http://dx.doi.org/10.1371/journal.pone.0118358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734788	Green Published, gold			2022-12-26	WOS:000350314700023
J	Hu, F; Deng, X; Yang, X; Jin, H; Gu, D; Lv, X; Wang, C; Zhang, Y; Huo, X; Shen, Q; Luo, Q; Zhao, F; Ge, T; Zhao, F; Chu, W; Shu, H; Yao, M; Fan, J; Qin, W				Hu, F.; Deng, X.; Yang, X.; Jin, H.; Gu, D.; Lv, X.; Wang, C.; Zhang, Y.; Huo, X.; Shen, Q.; Luo, Q.; Zhao, F.; Ge, T.; Zhao, F.; Chu, W.; Shu, H.; Yao, M.; Fan, J.; Qin, W.			Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1 alpha to promote the metastasis of hepatocellular carcinoma	ONCOGENE			English	Article							INDUCIBLE FACTORS; RAB11; TARGET; PRAS40; AKT; DIFFERENTIATION; PROLIFERATION; MECHANISMS; TRANSPORT; FAMILY	Hypoxic microenvironment is a powerful driving force for the invasion and metastasis of hepatocellular carcinoma (HCC). Hypoxia-inducible factor 1 alpha (HIF-1 alpha), as a crucial regulator of transcriptional responses to hypoxia, induces the expression of multiple target genes involved in different steps of HCC metastatic process. It is critical to find target genes associated with metastasis under hypoxia for shedding new light on molecular mechanism of HCC metastasis. In this study, we uncovered that hypoxia could induce the upregulation of Rab11-family interacting protein 4 (Rab11-FIP4) and activation of Rab11-FIP4 promoter by HIF-1a. The overexpression of Rab11-FIP4 significantly enhanced the mobility and invasiveness of HCC cells in vitro, also contributed to distant lung metastasis in vivo, whereas silencing of Rab11-FIP4 decreased the ability of migration and invasion in HCC cells in vitro and suppressed lung metastasis in vivo. Rab11-FIP4 facilitated HCC metastasis through the phosphorylation of PRAS40, which was regulated by mTOR. Furthermore, the expression level of Rab11-FIP4 was significantly increased in HCC tissues and high expression of Rab11-FIP4 was closely correlated with vascular invasion and poor prognosis in HCC patients. A markedly positive correlation between the expression of Rab11-FIP4 and HIF-1 alpha was observed in HCC tissues and combination of Rab11-FIP4 and HIF-1 alpha was a more valuable predictor of poor prognosis for HCC patients. In conclusion, Rab11-FIP4 is a target gene of HIF-1 alpha and has a pro-metastatic role in HCC, suggesting that Rab11-FIP4 may be a promising candidate target for HCC treatment.	[Hu, F.; Deng, X.; Ge, T.] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Hu, F.; Deng, X.; Jin, H.; Gu, D.; Wang, C.; Zhang, Y.; Huo, X.; Shen, Q.; Luo, Q.; Ge, T.; Zhao, F.; Chu, W.; Shu, H.; Yao, M.; Qin, W.] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200032, Peoples R China; [Yang, X.; Fan, J.] Zhongshan Hosp, Chinese Minist Educ, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Yang, X.; Fan, J.] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Gu, D.] Guangdong Med Coll, Dept Pathophysiol, Dongguan, Peoples R China; [Lv, X.; Zhao, F.] Nantong Univ, Coll Med, Basic Med Res Ctr, Nantong, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University; Guangdong Medical University; Nantong University	Qin, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, 25 Ln 2200 Xie Tu Rd, Shanghai 200032, Peoples R China.	jiafan99@yahoo.com; wxqin@sjtu.edu.cn		Xu, Changlong/0000-0001-7104-9029	National Key Sci-Tech Special Project of China [2012ZX10002011-004]; National Natural Science Foundation of China [81201627, 81371883]; Shanghai Municipal Program of International Cooperation in Science and Technology [12410709800]; Research Fund for the Doctoral Program of Higher Education of China [20120073110091]; Key Basic Research Program of Shanghai Committee of Science and Technology [11JC1412201]; State Key Laboratory of Oncogenes and Related Genes [91-1201, 91-1305]; Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201243]; Key Discipline and Specialty Foundation of Shanghai Municipal Commission of Health and Family Planning	National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Program of International Cooperation in Science and Technology; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Basic Research Program of Shanghai Committee of Science and Technology; State Key Laboratory of Oncogenes and Related Genes; Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine; Key Discipline and Specialty Foundation of Shanghai Municipal Commission of Health and Family Planning	This work was supported by grants from National Key Sci-Tech Special Project of China (2012ZX10002011-004), National Natural Science Foundation of China (81201627 and 81371883), Shanghai Municipal Program of International Cooperation in Science and Technology (12410709800), Research Fund for the Doctoral Program of Higher Education of China (20120073110091), Key Basic Research Program of Shanghai Committee of Science and Technology (11JC1412201), Grant from the State Key Laboratory of Oncogenes and Related Genes (91-1201, 91-1305), Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201243) and Key Discipline and Specialty Foundation of Shanghai Municipal Commission of Health and Family Planning.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Deneka M, 2002, NAT CELL BIOL, V4, pE33, DOI 10.1038/ncb0202-e33; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Krzyzaniak MA, 2009, TRAFFIC, V10, P1439, DOI 10.1111/j.1600-0854.2009.00967.x; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Muto A, 2007, DEV DYNAM, V236, P214, DOI 10.1002/dvdy.21009; Nagase T, 2001, DNA RES, V8, P319, DOI 10.1093/dnares/8.6.319; Nascimento Emmani B. M., 2009, Archives of Physiology and Biochemistry, V115, P163, DOI 10.1080/13813450902988580; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wallace DM, 2002, BIOCHEM BIOPH RES CO, V292, P909, DOI 10.1006/bbrc.2002.6736; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x; Xiong XX, 2014, NEUROBIOL DIS, V66, P43, DOI 10.1016/j.nbd.2014.02.006	37	31	34	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2015	34	49					6007	6017		10.1038/onc.2015.49	http://dx.doi.org/10.1038/onc.2015.49			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RO	25745995				2022-12-26	WOS:000366113500007
J	Cheng, X; Yang, Y; Fan, Z; Yu, L; Bai, H; Zhou, B; Wu, X; Xu, H; Fang, M; Shen, A; Chen, Q; Xu, Y				Cheng, X.; Yang, Y.; Fan, Z.; Yu, L.; Bai, H.; Zhou, B.; Wu, X.; Xu, H.; Fang, M.; Shen, A.; Chen, Q.; Xu, Y.			MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription	ONCOGENE			English	Article							PRO-INFLAMMATORY TRANSCRIPTION; BRAHMA-RELATED GENE-1; TGF-BETA; MRTF-A; MESENCHYMAL TRANSITION; LEUKEMIA 1; MATRIX-METALLOPROTEINASE-9; INDUCTION; CHROMATIN; REPRESSION	Malignant tumors are exemplified by excessive proliferation and aggressive migration/invasion contributing to increased mortality of cancer patients. Matrix metalloproteinase 9 (MMP9) expression is positively correlated with lung cancer malignancy. The mechanism underlying an elevated MMP9 expression is not clearly defined. We demonstrate here that the transcriptional modulator megakaryocytic leukemia 1 (MKL1) was activated by hypoxia and transforming growth factor (TGF-beta), two prominent pro-malignancy factors, in cultured lung cancer cells. MKL1 levels were also increased in more invasive types of lung cancer in humans. Depletion of MKL1 in lung cancer cells attenuated migration and invasion both in vitro and in vivo. Overexpression of MKL1 potentiated the induction of MMP9 transcription by hypoxia and TGF-beta, whereas MKL1 silencing diminished MMP9 expression. Of interest, MKL1 knockdown eliminated histone H3K4 methylation surrounding the MMP9 promoter. Further analyses revealed that MKL1 recruited ASH2, a component of the H3K4 methyltransferase complex, to activate MMP9 transcription. Depletion of ASH2 ameliorated cancer cell migration and invasion in an MMP9-dependent manner. Together our data indicate that MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.	[Cheng, X.; Yang, Y.; Fan, Z.; Yu, L.; Bai, H.; Zhou, B.; Wu, X.; Xu, H.; Fang, M.; Chen, Q.; Xu, Y.] Nanjing Med Univ, Key Lab Cardiovasc Dis, Nanjing 210029, Jiangsu, Peoples R China; [Cheng, X.; Yang, Y.; Fan, Z.; Yu, L.; Bai, H.; Zhou, B.; Wu, X.; Xu, H.; Fang, M.; Chen, Q.; Xu, Y.] Nanjing Med Univ, Dept Pathophysiol, Nanjing 210029, Jiangsu, Peoples R China; [Cheng, X.] Jiangsu Inst Nucl Med, Wuxi, Peoples R China; [Yang, Y.] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Fang, M.] Jiangsu Jiankang Vocat Univ, Dept Nursing, Nanjing, Jiangsu, Peoples R China; [Shen, A.] Nantong Univ, Coll Med, Dept Key Lab Inflammat & Mol Targets, Nantong, Peoples R China	Nanjing Medical University; Nanjing Medical University; China Pharmaceutical University; Nantong University	Xu, Y (corresponding author), Nanjing Med Univ, Key Lab Cardiovasc Dis, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	mmfangnjmu@yahoo.com; yxu2005@gmail.com	Zhou, Bisheng/M-3143-2016; Zhou, Bisheng/K-2160-2019; Yu, Liming/AAH-6983-2021; wu, xin/GRS-8615-2022	Yu, Liming/0000-0002-6702-7625; Zhou, Bisheng/0000-0003-1551-0612	National Basic Science Project of China [2012CB517503]; National Natural Science Foundation of China [31270805, 31200645, 81402550, 91439106]; Natural Science Foundation of Jiangsu Province [BK2012043, BK20140906, BK21041498]; Education Commission of Jiangsu Province [14KJA31001]; Program for New Century Excellent Talents in University of China [NCET-11-0991]; Ministry of Education [212059, 20123234110008]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Science Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Education Commission of Jiangsu Province; Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Ministry of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported, in part, by grants from the National Basic Science Project of China (2012CB517503), National Natural Science Foundation of China (31270805, 31200645, 81402550, 91439106), Natural Science Foundation of Jiangsu Province (BK2012043, BK20140906, BK21041498), Education Commission of Jiangsu Province (14KJA31001), the Program for New Century Excellent Talents in University of China (NCET-11-0991), Ministry of Education (212059, 20123234110008) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). YX is a fellow at the Collaborative Innovative Center for Cardiovascular Translational Medicine.	Ballerini P, 2003, LEUKEMIA, V17, P1193, DOI 10.1038/sj.leu.2402914; Basu S, 2007, CELL MICROBIOL, V9, P2804, DOI 10.1111/j.1462-5822.2007.00997.x; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chang C, 2013, MOL CELL BIOL, V33, P3795, DOI 10.1128/MCB.00434-13; Chen DW, 2013, CARDIOVASC RES, V100, P363, DOI 10.1093/cvr/cvt214; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Cock-Rada AM, 2012, CANCER RES, V72, P810, DOI 10.1158/0008-5472.CAN-11-1052; Cox G, 2000, CLIN CANCER RES, V6, P2349; Fang F, 2013, CIRC RES, V113, P986, DOI 10.1161/CIRCRESAHA.113.301296; Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655; Gilles L, 2009, BLOOD, V114, P4221, DOI 10.1182/blood-2009-03-209932; Gurbuz I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-22; Hampl V, 2013, EMBO MOL MED, V5, P1367, DOI 10.1002/emmm.201202406; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; Jakopovic M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00261; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kim JE, 2008, EXP MOL MED, V40, P514, DOI 10.3858/emm.2008.40.5.514; Kim J, 2010, BIOCHEM BIOPH RES CO, V401, P412, DOI 10.1016/j.bbrc.2010.09.068; Kong XC, 2009, J MOL CELL CARDIOL, V46, P292, DOI 10.1016/j.yjmcc.2008.10.023; Larrieu D, 2010, CELL CYCLE, V9, P3984, DOI 10.4161/cc.9.19.13208; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Lin YW, 2013, J PATHOL, V230, P277, DOI 10.1002/path.4179; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Lundin A, 2013, CANCER LETT, V338, P89, DOI 10.1016/j.canlet.2012.08.014; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Moutsopoulos NM, 2008, CURR OPIN IMMUNOL, V20, P234, DOI 10.1016/j.coi.2008.04.003; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Osada H, 2005, MOL CARCINOGEN, V44, P233, DOI 10.1002/mc.20135; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Pinto CA, 2003, CLIN CANCER RES, V9, P3098; Rintoul RC, 2001, LANCET ONCOL, V2, P437, DOI 10.1016/S1470-2045(00)00421-6; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Robert I, 2009, ONCOGENE, V28, P1626, DOI 10.1038/onc.2009.6; Schaaij-Visser TBM, 2013, BBA-PROTEINS PROTEOM, V1834, P2242, DOI 10.1016/j.bbapap.2013.01.029; Shaposhnikov D, 2013, CELL CYCLE, V12, P1762, DOI 10.4161/cc.24839; Shaposhnikov D, 2012, CELL CYCLE, V11, P141, DOI 10.4161/cc.11.1.18499; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sienel W, 2003, INT J CANCER, V103, P647, DOI 10.1002/ijc.10841; Sun LN, 2013, J CELL SCI, V126, P3939, DOI 10.1242/jcs.127381; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tang ZY, 2013, CELL, V154, P297, DOI 10.1016/j.cell.2013.06.027; Tian WF, 2015, J HEPATOL, V62, P165, DOI 10.1016/j.jhep.2014.07.029; Tian WF, 2013, HEPATOLOGY, V58, P576, DOI 10.1002/hep.26207; Tsai YP, 2014, INT J CANCER, V134, P249, DOI 10.1002/ijc.28190; Ung YC, 2007, JNCI-J NATL CANCER I, V99, P1753, DOI 10.1093/jnci/djm232; Wan M, 2013, J BIOL CHEM, V288, P5039, DOI 10.1074/jbc.M112.424515; Weinl C, 2013, J CLIN INVEST, V123, P2193, DOI 10.1172/JCI64201; Wood SL, 2014, CANCER TREAT REV, V40, P558, DOI 10.1016/j.ctrv.2013.10.001; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Yan XL, 2013, HEPATOLOGY, V57, P2274, DOI 10.1002/hep.26257; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Yang YY, 2014, NUCLEIC ACIDS RES, V42, P10460, DOI 10.1093/nar/gku776; Yang YY, 2013, NUCLEIC ACIDS RES, V41, P6005, DOI 10.1093/nar/gkt311; Yoshio T, 2010, CARCINOGENESIS, V31, P1185, DOI 10.1093/carcin/bgq065; Yu LM, 2014, J CELL SCI, V127, P4645, DOI 10.1242/jcs.152314; Yuan ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083895; Zhong Q, 2013, DIABETES, V62, P2559, DOI 10.2337/db12-1141; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	65	47	50	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2015	34	44					5570	5581		10.1038/onc.2015.14	http://dx.doi.org/10.1038/onc.2015.14			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9FX	25746000				2022-12-26	WOS:000364594000006
J	Lajoie, DM; Roberts, SA; Zobel-Thropp, PA; Delahaye, JL; Bandarian, V; Binford, GJ; Cordes, MHJ				Lajoie, Daniel M.; Roberts, Sue A.; Zobel-Thropp, Pamela A.; Delahaye, Jared L.; Bandarian, Vahe; Binford, Greta J.; Cordes, Matthew H. J.			Variable Substrate Preference among Phospholipase D Toxins from Sicariid Spiders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOXOSCELES-INTERMEDIA VENOM; BROWN RECLUSE SPIDER; DERMONECROTIC TOXIN; SPHINGOMYELINASE-D; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; MEMBRANE PHOSPHOLIPIDS; CATALYTIC MECHANISM; EVOLUTIONARY RELATIONSHIP; PHOSPHODIESTERASE GDPD	Venoms of the sicariid spiders contain phospholipase D enzyme toxins that can cause severe dermonecrosis and even death in humans. These enzymes convert sphingolipid and lysolipid substrates to cyclic phosphates by activating a hydroxyl nucleophile present in both classes of lipid. The most medically relevant substrates are thought to be sphingomyelin and/or lysophosphatidylcholine. To better understand the substrate preference of these toxins, we used P-31 NMR to compare the activity of three related but phylogenetically diverse sicariid toxins against a diverse panel of sphingolipid and lysolipid substrates. Two of the three showed significantly faster turnover of sphingolipids over lysolipids, and all three showed a strong preference for positively charged (choline and/or ethanolamine) over neutral (glycerol and serine) headgroups. Strikingly, however, the enzymes vary widely in their preference for choline, the headgroup of both sphingomyelin and lysophosphatidylcholine, versus ethanolamine. An enzyme from Sicarius terrosus showed a strong preference for ethanolamine overcholine, whereas two paralogous enzymes from Loxosceles arizonica either preferred choline or showed no significant preference. Intrigued by the novel substrate preference of the Sicarius enzyme, we solved its crystal structure at 2.1 angstrom resolution. The evolution of variable substrate specificity may help explain the reduced dermonecrotic potential of some natural toxin variants, because mammalian sphingolipids use primarily choline as a positively charged headgroup; it may also be relevant for sicariid predatory behavior, because ethanolamine-containing sphingolipids are common in insect prey.	[Lajoie, Daniel M.; Roberts, Sue A.; Bandarian, Vahe; Cordes, Matthew H. J.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Zobel-Thropp, Pamela A.; Delahaye, Jared L.; Binford, Greta J.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA	University of Arizona	Cordes, MHJ (corresponding author), Univ Arizona, Dept Chem & Biochem, 1041 E Lowell St,Biosci West 436, Tucson, AZ 85721 USA.	cordes@email.arizona.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM072623, R15GM097676] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Light-source SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health Grant P41GM103393 from NIGMS.	Alarcon-Chaidez FJ, 2009, PARASITE IMMUNOL, V31, P210, DOI 10.1111/j.1365-3024.2009.01095.x; Appel MH, 2008, BBA-GEN SUBJECTS, V1780, P167, DOI 10.1016/j.bbagen.2007.11.007; BANERJEE P, 1995, CHEM PHYS LIPIDS, V77, P65, DOI 10.1016/0009-3084(95)02455-R; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Bey TA, 1997, ANN EMERG MED, V30, P701, DOI 10.1016/S0196-0644(97)70092-1; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; BRIDGES RG, 1973, COMP BIOCHEM PHYSIOL, V44, P191, DOI 10.1016/0305-0491(73)90356-8; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Catalan A, 2011, J BIOCHEM MOL TOXIC, V25, P393, DOI 10.1002/jbt.20399; Catalan A, 2014, TOXICON, V81, P43, DOI 10.1016/j.toxicon.2014.01.011; Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005; Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015; Chaves-Moreira D, 2011, J CELL BIOCHEM, V112, P2529, DOI 10.1002/jcb.23177; Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; da Silveira RB, 2007, BIOCHIMIE, V89, P289, DOI 10.1016/j.biochi.2006.12.002; da Silveira RB, 2006, BIOCHIMIE, V88, P1241, DOI 10.1016/j.biochi.2006.02.008; de Andrade SA, 2006, TOXICON, V47, P380, DOI 10.1016/j.toxicon.2005.12.005; de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053; Ferrara GID, 2009, TOXICON, V53, P743, DOI 10.1016/j.toxicon.2009.02.013; ELSAYED MY, 1985, BIOCHIM BIOPHYS ACTA, V831, P133, DOI 10.1016/0167-4838(85)90160-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Ghosh A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003980; Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023; HENDERSON TO, 1974, BIOCHEMISTRY-US, V13, P623, DOI 10.1021/bi00700a034; Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Kurpiewski G, 1981, Int J Tissue React, V3, P39; Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011; Lajoie DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072372; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Lopes PH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002394; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magalhaes GS, 2013, BIOCHIMIE, V95, P1773, DOI 10.1016/j.biochi.2013.06.002; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Wille ACM, 2013, TOXICON, V67, P17, DOI 10.1016/j.toxicon.2013.01.027; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEWLANDS G, 1988, S AFR MED J, V73, P235; Olvera A, 2006, TOXICON, V48, P64, DOI 10.1016/j.toxicon.2006.04.010; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; Ribeiro ROS, 2007, TOXICON, V50, P1162, DOI 10.1016/j.toxicon.2007.08.001; Richardson-Boedler C., 1999, BR HOMEOPATH J, V88, P24; Rivero Elena Riet Correa, 2006, Ann Diagn Pathol, V10, P36, DOI 10.1016/j.anndiagpath.2005.04.006; ROBERTS MF, 1991, METHOD ENZYMOL, V197, P31; RUSSELL FE, 1969, TOXICON, V7, P109, DOI 10.1016/0041-0101(69)90073-7; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ullah A, 2011, ACTA CRYSTALLOGR F, V67, P234, DOI 10.1107/S1744309110050931; Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; VanAswegen G, 1997, TOXICON, V35, P1149, DOI 10.1016/S0041-0101(96)00203-6; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; Vuitika L, 2013, J CELL BIOCHEM, V114, P2479, DOI 10.1002/jcb.24594; Wilkins MR, 1999, METH MOL B, V112, P531; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zobel-Thropp PA, 2012, TOXICON, V60, P265, DOI 10.1016/j.toxicon.2012.04.350	79	23	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10994	11007		10.1074/jbc.M115.636951	http://dx.doi.org/10.1074/jbc.M115.636951			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752604	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000353404500036
J	Pery, E; Sheehy, A; Nebane, NM; Brazier, AJ; Misra, V; Rajendran, KS; Buhrlage, SJ; Mankowski, MK; Rasmussen, L; White, EL; Ptak, RG; Gabuzda, D				Pery, Erez; Sheehy, Ann; Nebane, N. Miranda; Brazier, Andrew Jay; Misra, Vikas; Rajendran, Kottampatty S.; Buhrlage, Sara J.; Mankowski, Marie K.; Rasmussen, Lynn; White, E. Lucile; Ptak, Roger G.; Gabuzda, Dana			Identification of a Novel HIV-1 Inhibitor Targeting Vif-dependent Degradation of Human APOBEC3G Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agent; Cytidine Deaminase; High Throughput Screening (HTS); Human Immunodeficiency Virus (HIV); Viral Protein; Virology	IMMUNODEFICIENCY-VIRUS TYPE-1; VIRION INFECTIVITY FACTOR; E3 UBIQUITIN LIGASE; SMALL-MOLECULE INHIBITION; AMINO-ACID-RESIDUES; CD4(+) T-CELLS; CYTIDINE DEAMINATION; ANTIVIRAL ACTIVITY; SOCS-BOX; CBF-BETA	Background: The interaction between HIV Vif protein and innate antiviral factor APOBEC3G represents a potential therapeutic target. Results: Screening for inhibitors of Vif-APOBEC3G interaction identified a small molecule, N.41, that protects APOBEC3G from Vif-mediated degradation and exhibits antiviral activity. Conclusion: N.41 is a lead for further development as an antiviral. Significance: These findings suggest new strategies for developing anti-HIV therapeutics. APOBEC3G (A3G) is a cellular cytidine deaminase that restricts HIV-1 replication by inducing G-to-A hypermutation in viral DNA and by deamination-independent mechanisms. HIV-1 Vif binds to A3G, resulting in its degradation via the 26 S proteasome. Therefore, this interaction represents a potential therapeutic target. To identify compounds that inhibit interaction between A3G and HIV-1 Vif in a high throughput format, we developed a homogeneous time-resolved fluorescence resonance energy transfer assay. A 307,520 compound library from the NIH Molecular Libraries Small Molecule Repository was screened. Secondary screens to evaluate dose-response performance and off-target effects, cell-based assays to identify compounds that attenuate Vif-dependent degradation of A3G, and assays testing antiviral activity in peripheral blood mononuclear cells and T cells were employed. One compound, N.41, showed potent antiviral activity in A3G(+) but not in A3G(-) T cells and had an IC50 as low as 8.4 m and a TC50 of >100 m when tested against HIV-1(Ba-L) replication in peripheral blood mononuclear cells. N.41 inhibited the Vif-A3G interaction and increased cellular A3G levels and incorporation of A3G into virions, thereby attenuating virus infectivity in a Vif-dependent manner. N.41 activity was also species- and Vif-dependent. Preliminary structure-activity relationship studies suggest that a hydroxyl moiety located at a phenylamino group is critical for N.41 anti-HIV activity and identified N.41 analogs with better potency (IC50 as low as 4.2 m). These findings identify a new lead compound that attenuates HIV replication by liberating A3G from Vif regulation and increasing its innate antiviral activity.	[Pery, Erez; Brazier, Andrew Jay; Misra, Vikas; Rajendran, Kottampatty S.; Gabuzda, Dana] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Buhrlage, Sara J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Pery, Erez; Rajendran, Kottampatty S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gabuzda, Dana] Harvard Univ, Sch Med, Dept Neurol Microbiol, Boston, MA 02115 USA; [Sheehy, Ann] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Nebane, N. Miranda; Rasmussen, Lynn; White, E. Lucile] Southern Res Inst High Throughput Screening Ctr, Birmingham, AL 35205 USA; [Mankowski, Marie K.; Ptak, Roger G.] So Res Inst, Dept Infect Dis Res, Frederick, MD 21701 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; College of the Holy Cross	Gabuzda, D (corresponding author), CLS 1010,450 Brookline Ave, Boston, MA 02215 USA.	dana_gabuzda@dfci.harvard.edu			Harvard Center for AIDS Research Grant [P30 AI060354]; Dana-Farber Cancer Institute/Harvard Cancer Center Research Grant [P30 CA06516]; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R21AI067032, R21AI087458] Funding Source: NIH RePORTER	Harvard Center for AIDS Research Grant; Dana-Farber Cancer Institute/Harvard Cancer Center Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Caroline Shamu and staff at the Institute of Chemistry and Cell Biology Longwood Screening Facility, Harvard Medical School, Boston, MA, for helpful discussions and advice during performance of the high throughput screening and Dr. Marintha Heil, Southern Research Institute Department of Infectious Disease Research, for helpful discussions and advice. Core facilities received support from the Harvard Center for AIDS Research Grant P30 AI060354 and Dana-Farber Cancer Institute/Harvard Cancer Center Research Grant P30 CA06516.	Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; BUCKHEIT RW, 1991, AIDS RES HUM RETROV, V7, P295, DOI 10.1089/aid.1991.7.295; Cen S, 2010, J BIOL CHEM, V285, P16546, DOI 10.1074/jbc.M109.085308; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Dang Y, 2010, J VIROL, V84, P8561, DOI 10.1128/JVI.00960-10; Dang Y, 2010, J VIROL, V84, P5741, DOI 10.1128/JVI.00079-10; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; GONCALVES J, 1994, J VIROL, V68, P704, DOI 10.1128/JVI.68.2.704-712.1994; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kao Sandra, 2004, Retrovirology, V1, P27, DOI 10.1186/1742-4690-1-27; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Knecht W, 2000, FEBS LETT, V467, P27, DOI 10.1016/S0014-5793(00)01117-0; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; LOUWAGIE J, 1994, AIDS RES HUM RETROV, V10, P561, DOI 10.1089/aid.1994.10.561; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Wang XD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-94; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zuo T, 2012, J VIROL, V86, P5497, DOI 10.1128/JVI.06957-11	70	28	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10504	10517		10.1074/jbc.M114.626903	http://dx.doi.org/10.1074/jbc.M114.626903			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724652	Green Published, hybrid			2022-12-26	WOS:000353241100049
J	Ahn, YS; Jeong, KS				Ahn, Yeon-Soon; Jeong, Kyoung Sook			Mortality Due to Malignant and Non-Malignant Diseases in Korean Professional Emergency Responders	PLOS ONE			English	Article							WORLD-TRADE-CENTER; FIRE FIGHTERS; STRUCTURAL FIRES; FIREFIGHTERS; CANCER; SYMPTOMS; OVERHAUL; COHORT; RISK	Objective This study was conducted to estimate the cause-specific mortality in male emergency responders (ER), compare with that of Korean men. Mortality was also compared between more experienced firefighters (i.e., firefighters employed >= 20 years and firefighters employed >= 10 to <20 years) and less experienced firefighters and non-firefighters (i.e., firefighters employed <10 years and non-firefighters) to investigate associations between mortality and exposure to occupational hazards. Methods The cohort was comprised of 33,442 males who were employed as ERs between 1980 and 2007 and not deceased as of 1991. Work history was merged with the death registry from the National Statistical Office of Korea to follow-up on mortality between 1992 and 2007. Standardized mortality ratios (SMR) for ERs were calculated in reference to the Korean male population. Adjusted relative risks (ARRs) of mortalities for firefighters employed >= 20 years and >= 10 years to <20 years were calculated in reference to non-firefighters and firefighters employed <10 years. Results Overall (SMR=0.43, 95% CI=0.39-0.47) and some kinds of cause-specific mortalities were significantly lower among ERs compared with the Korean male population. No significant increase in mortality was observed across the major ICD-10 classifications among ERs. Mortality due to exposure to smoke, fire, and flames (SMR=3.11, 95% CI=1.87-4.85), however, was significantly increased among ERs. All-cause mortality (ARR=1.46, 95% CI=1.13-1.89), overall cancer mortality (ARR=1.54, 95% CI=1.02-2.31) and mortality of external injury, poisoning and external causes (ARR=3.13, 95% CI=1.80-5.46) were significantly increased among firefighters employed >= 20 years compared to those of non-firefighters and firefighters employed <10 years. Conclusions An increase in mortality due to all cancer and external injury, poisoning, and external causes in firefighters employed >= 20 years compared with non- firefighters and firefighters employed <10 years suggests occupational exposure.	[Ahn, Yeon-Soon; Jeong, Kyoung Sook] Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea	Dongguk University; NHIS Ilsan Hospital	Ahn, YS (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea.	ysahn@dongguk.ac.kr	Jeong, Kyoung Sook/AAI-6244-2021	Jeong, Kyoung Sook/0000-0002-6897-8289	Korea National Emergency Management Agency [KFI-2009-Next generation-001]	Korea National Emergency Management Agency	This study was supported by Grant No. KFI-2009-Next generation-001 from Korea National Emergency Management Agency.	Ahn Y.S., 2011, ANAL RISK FACTORS RE; Ahn YS, 2012, AM J IND MED, V55, P768, DOI 10.1002/ajim.22068; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Austin CC, 2001, J TOXICOL ENV HEAL A, V63, P437, DOI 10.1080/152873901300343470; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Baris D, 2001, AM J IND MED, V39, P463, DOI 10.1002/ajim.1040; BEAUMONT JJ, 1991, AM J IND MED, V19, P357, DOI 10.1002/ajim.4700190309; Bogucki S, 2005, TXB CLIN OCCUPATIONA, P275; Bolstad-Johnson DM, 2000, AIHAJ, V61, P636, DOI 10.1202/0002-8894(2000)061<0636:COFEDF>2.0.CO;2; BRANDTRAUF PW, 1988, BRIT J IND MED, V45, P606; Burgess JL, 2004, J OCCUP ENVIRON MED, V46, P1013, DOI 10.1097/01.jom.0000141668.70006.52; Burgess JL, 2001, J OCCUP ENVIRON MED, V43, P467, DOI 10.1097/00043764-200105000-00007; Choi BCK, 2000, J OCCUP ENVIRON MED, V42, P1021, DOI 10.1097/00043764-200010000-00009; Fahy R F., 2009, FIREFIGHTER FATALITI; Feldman DM, 2004, CHEST, V125, P1256, DOI 10.1378/chest.125.4.1256; Gaughan DM, 2008, J OCCUP ENVIRON MED, V50, P1019, DOI 10.1097/JOM.0b013e3181754161; GUIDOTTI TL, 1993, AM J IND MED, V23, P921, DOI 10.1002/ajim.4700230608; GUIDOTTI TL, 1992, INT ARCH OCC ENV HEA, V64, P1, DOI 10.1007/BF00625945; Haas NS, 2003, INT J OCCUP ENV HEAL, V9, P95, DOI 10.1179/oeh.2003.9.2.95; IARC working group, 2010, PAINT FIR SHIFTW, P403; JANKOVIC J, 1991, ANN OCCUP HYG, V35, P581, DOI 10.1093/annhyg/35.6.581; Kim KS, 2008, STATUS HLTH MANAGEME; LeMasters GK, 2006, J OCCUP ENVIRON MED, V48, P1189, DOI 10.1097/01.jom.0000246229.68697.90; LOWRY WT, 1985, J FORENSIC SCI, V30, P59; Ma FC, 2005, AM J IND MED, V47, P509, DOI 10.1002/ajim.20160; MUSK AW, 1978, BRIT J IND MED, V35, P104; Mustajbegovi J, 2001, AM J IND MED, V40, P55, DOI 10.1002/ajim.1071; NEMA, 2009, 2009 MAJ STAT NAT EM; Park RM, 2005, AM J IND MED, V48, P194, DOI 10.1002/ajim.20197; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Ribeiro M, 2009, AM J IND MED, V52, P261, DOI 10.1002/ajim.20669; Scannell CH, 1995, OCCUP MED, V10, P789; TORNLING G, 1994, AM J IND MED, V25, P219, DOI 10.1002/ajim.4700250208; VENA JE, 1987, AM J IND MED, V11, P671, DOI 10.1002/ajim.4700110608; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120305	10.1371/journal.pone.0120305	http://dx.doi.org/10.1371/journal.pone.0120305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756281	gold, Green Published			2022-12-26	WOS:000351275700065
J	Ding, JM; Wang, CF; Xie, ZR; Li, JJ; Yang, YJ; Mu, YL; Tang, XH; Xu, B; Zhou, JP; Huang, ZX				Ding, Junmei; Wang, Chaofan; Xie, Zhenrong; Li, Junjun; Yang, Yunjuan; Mu, Yuelin; Tang, Xianghua; Xu, Bo; Zhou, Junpei; Huang, Zunxi			Properties of a Newly Identified Esterase from Bacillus sp K91 and Its Novel Function in Diisobutyl Phthalate Degradation	PLOS ONE			English	Article							MICROCOCCUS SP YGJ1; ACID-ESTERS; DIPENTYL PHTHALATE; MOLECULAR-CLONING; ESCHERICHIA-COLI; GORDONIA SP; PURIFICATION; EXPRESSION; GENE; METABOLISM	The widely used plasticizer phthalate esters (PAEs) have become a public concern because of their effects on environmental contamination and toxicity on mammals. However, the biodegradation of PAEs, especially diisobutyl phthalate (DiBP), remains poorly understood. In particular, genes involved in the hydrolysis of these compounds were not conclusively identified. In this study, the CarEW gene, which encodes an enzyme that is capable of hydrolyzing rho-nitrophenyl esters of fatty acids, was cloned from a thermophilic bacterium Bacillus sp. K91 and heterologously expressed in Escherichia coli BL21 using the pEASYE2 expression system. The enzyme showed a monomeric structure with a molecular mass of approximately 53.76 kDa and pl of 4.88. The enzyme exhibited maximal activity at pH 7.5 and 45 degrees C, with rho-NP butyrate as the best substrate. The enzyme was fairly stable within the pH range from 7.0 to 8.5. High-pressure liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS) were employed to detect the catabolic pathway of DiBP. Two intermediate products were identified, and a potential biodegradation pathway was proposed. Altogether, our findings present a novel DiBP degradation enzyme and indicate that the purified enzyme may be a promising candidate for DiBP detoxification and for environmental protection.	[Ding, Junmei; Wang, Chaofan; Xie, Zhenrong; Li, Junjun; Yang, Yunjuan; Mu, Yuelin; Tang, Xianghua; Xu, Bo; Huang, Zunxi] Yunnan Normal Univ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Minist Educ, Kunming 650500, Yunnan, Peoples R China; [Ding, Junmei; Wang, Chaofan; Li, Junjun; Yang, Yunjuan; Mu, Yuelin; Tang, Xianghua; Xu, Bo; Huang, Zunxi] Yunnan Normal Univ, Key Lab Enzyme Engn, Kunming 650500, Yunnan, Peoples R China	Yunnan Normal University; Yunnan Normal University	Huang, ZX (corresponding author), Yunnan Normal Univ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Minist Educ, Kunming 650500, Yunnan, Peoples R China.	huangzunxi@163.com			National Natural Science Foundation Program of PR China [31160229]	National Natural Science Foundation Program of PR China(National Natural Science Foundation of China (NSFC))	This project was supported by a grant from National Natural Science Foundation Program of PR China (31160229) to Z. Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, CURR MICROBIOL, V52, P340, DOI 10.1007/s00284-005-0124-9; Akita K, 2001, BIOSCI BIOTECH BIOCH, V65, P1680, DOI 10.1271/bbb.65.1680; Bajkin Ivana, 2014, Med Pregl, V67, P172; Beverly BEJ, 2014, TOXICOL SCI, V141, P524, DOI 10.1093/toxsci/kfu149; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang HK, 1998, J BACTERIOL, V180, P6529, DOI 10.1128/JB.180.24.6529-6537.1998; Chatterjee S, 2003, BIOCHEM BIOPH RES CO, V309, P36, DOI 10.1016/S0006-291X(03)01513-4; Christensen KLY, 2014, REGUL TOXICOL PHARM, V69, P380, DOI 10.1016/j.yrtph.2014.04.019; Eaton RW, 2001, J BACTERIOL, V183, P3689, DOI 10.1128/JB.183.12.3689-3703.2001; EATON RW, 1982, J BACTERIOL, V151, P48, DOI 10.1128/JB.151.1.48-57.1982; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graham P R, 1973, Environ Health Perspect, V3, P3, DOI 10.2307/3428023; Gu JD, 2005, WATER SCI TECHNOL, V52, P241, DOI 10.2166/wst.2005.0269; Habe H, 2003, APPL MICROBIOL BIOT, V61, P44, DOI 10.1007/s00253-002-1166-6; Hara H, 2010, APPL ENVIRON MICROB, V76, P1516, DOI 10.1128/AEM.02621-09; HWANG CS, 1993, J BIOL CHEM, V268, P14278; Jiao YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075977; LEE YP, 1993, BIOCHIM BIOPHYS ACTA, V1169, P156; Luo ZH, 2012, PROCESS BIOCHEM, V47, P687, DOI 10.1016/j.procbio.2012.01.015; Luo ZH, 2009, MAR POLLUT BULL, V58, P765, DOI 10.1016/j.marpolbul.2009.03.005; Maruyama K, 2005, J BIOCHEM, V137, P27, DOI 10.1093/jb/mvi004; Miyazaki M, 2003, BIOCHEM J, V370, P101, DOI 10.1042/BJ20021446; Nishioka T, 2006, APPL ENVIRON MICROB, V72, P2394, DOI 10.1128/AEM.72.4.2394-2399.2006; NOZAWA T, 1988, J BACTERIOL, V170, P5778, DOI 10.1128/jb.170.12.5778-5784.1988; Nthangeni MB, 2005, J MICROBIOL METH, V61, P225, DOI 10.1016/j.mimet.2004.11.021; Pant N, 2014, ENVIRON SCI POLLUT R, V21, P11066, DOI 10.1007/s11356-014-2986-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pindel EV, 1997, J BIOL CHEM, V272, P14769, DOI 10.1074/jbc.272.23.14769; Qiu YL, 2004, APPL ENVIRON MICROB, V70, P1617, DOI 10.1128/AEM.70.3.1617-1626.2004; SAEGER VW, 1976, APPL ENVIRON MICROB, V31, P29, DOI 10.1128/AEM.31.1.29-34.1976; Saito T, 2010, CHEMOSPHERE, V81, P1544, DOI 10.1016/j.chemosphere.2010.08.020; Shapiro SD, 2004, SCI TOTAL ENVIRON, V321, P201, DOI 10.1016/j.scitotenv.2003.09.007; SHELTON DR, 1984, ENVIRON SCI TECHNOL, V18, P93, DOI 10.1021/es00120a008; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JL, 2000, CHEMOSPHERE, V41, P1245, DOI 10.1016/S0045-6535(99)00552-4; Weir SM, 2014, CHEMOSPHERE, V103, P44, DOI 10.1016/j.chemosphere.2013.10.097; Wu J, 2013, APPL MICROBIOL BIOT, V97, P2483, DOI 10.1007/s00253-012-4232-8; Zhang XY, 2014, APPL ENVIRON MICROB, V80, P6870, DOI 10.1128/AEM.02072-14	42	36	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119216	10.1371/journal.pone.0119216	http://dx.doi.org/10.1371/journal.pone.0119216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746227	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400057
J	Sharma, S; Citti, C; Sagne, E; Marenda, MS; Markham, PF; Browning, GF				Sharma, Shukriti; Citti, Chistine; Sagne, Eveline; Marenda, Marc S.; Markham, Philip F.; Browning, Glenn F.			Development and Host Compatibility of Plasmids for Two Important Ruminant Pathogens, Mycoplasma bovis and Mycoplasma agalactiae	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; ORIC PLASMIDS; ACHOLEPLASMA-LAIDLAWII; SPIROPLASMA-CITRI; GENE DISRUPTION; GALLISEPTICUM; PNEUMONIA; CONSTRUCTION; REPLICATION; CHROMOSOME	Mycoplasma bovis is a cause of pneumonia, mastitis, arthritis and otitis media in cattle throughout the world. However, despite its clinical significance, there is a paucity of tools to genetically manipulate it, impeding our capacity to further explore the molecular basis of its virulence. To address this limitation, we developed a series of homologous and heterologous replicable plasmids from M. bovis and M. agalactiae. The shortest replicable oriC plasmid based on the region downstream of dnaA in M. bovis was 247 bp and contained two DnaA boxes, while oriC plasmids based on the region downstream of dnaA in M. agalactiae strains 5632 and PG2 were 219 bp and 217 bp in length, respectively, and contained only a single DnaA box. The efficiency of transformation in M. bovis and M. agalactiae was inversely correlated with the size of the oriC region in the construct, and, in general, homologous oriC plasmids had a higher transformation efficiency than heterologous oriC plasmids. The larger pWholeoriC45 and pMM21-7 plasmids integrated into the genomic oriC region of M. bovis, while the smaller oriC plasmids remained extrachromosomal for up to 20 serial passages in selective media. Although specific gene disruptions were not be achieved in M. bovis in this study, the oriC plasmids developed here could still be useful as tools in complementation studies and for expression of exogenous genes in both M. bovis and M. agalactiae.	[Sharma, Shukriti; Marenda, Marc S.; Markham, Philip F.; Browning, Glenn F.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia; [Citti, Chistine; Sagne, Eveline] INRA, ENVT, UMR 1225, F-31076 Toulouse, France	University of Melbourne; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Browning, GF (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia.	glenfb@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014	Browning, Glenn Francis/0000-0002-0903-2469; Citti, Christine/0000-0003-4754-6003; MARENDA, MARC/0000-0001-6778-1110	Australian Government Australia Award scholarship	Australian Government Australia Award scholarship(Australian Government)	SS was supported by an Australian Government Australia Award scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam AB, 2010, APPL ENVIRON MICROB, V76, P6951, DOI 10.1128/AEM.00056-10; ALUOTTO B B, 1970, International Journal of Systematic Bacteriology, V20, P35; Arcangioli MA, 2008, VET J, V177, P89, DOI 10.1016/j.tvjl.2007.03.008; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; CAO J, 1994, J BACTERIOL, V176, P4459, DOI 10.1128/jb.176.14.4459-4462.1994; Caswell JL, 2010, VET CLIN N AM-FOOD A, V26, P365, DOI 10.1016/j.cvfa.2010.03.003; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Chopra-Dewasthaly R, 2008, MOL MICROBIOL, V67, P1196, DOI 10.1111/j.1365-2958.2007.06103.x; Cordova CMM, 2002, J BACTERIOL, V184, P5426, DOI 10.1128/JB.184.19.5426-5435.2002; Dhandayuthapani S, 1999, P NATL ACAD SCI USA, V96, P5227, DOI 10.1073/pnas.96.9.5227; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Duret S, 1999, J BACTERIOL, V181, P7449, DOI 10.1128/JB.181.24.7449-7456.1999; DYBVIG K, 1992, PLASMID, V28, P262, DOI 10.1016/0147-619X(92)90058-I; DYBVIG K, 1987, SCIENCE, V235, P1392, DOI 10.1126/science.3029869; Gagea MI, 2006, J VET DIAGN INVEST, V18, P29, DOI 10.1177/104063870601800105; Janis C, 2005, APPL ENVIRON MICROB, V71, P2888, DOI 10.1128/AEM.71.6.2888-2893.2005; Kadoya R, 2002, MOL MICROBIOL, V45, P73, DOI 10.1046/j.1365-2958.2002.03016.x; Lartigue C, 2003, NUCLEIC ACIDS RES, V31, P6610, DOI 10.1093/nar/gkg848; Lartigue C, 2002, PLASMID, V48, P149, DOI 10.1016/S0147-619X(02)00121-X; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Maglennon GA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-63; MAHAIRAS GG, 1989, PLASMID, V21, P43, DOI 10.1016/0147-619X(89)90085-1; Markham PF, 2003, J BACTERIOL, V185, P2538, DOI 10.1128/JB.185.8.2538-2547.2003; Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8; Qi J, 2012, PLOS ONE, V7, DOI [10.1371/journal. pone.0038239, DOI 10.1371/J0URNAL.P0NE.0038239, 10.1371/journal.pone.0038239]; Qin MH, 1997, J BACTERIOL, V179, P6311, DOI 10.1128/jb.179.20.6311-6317.1997; RENAUDIN J, 1995, J BACTERIOL, V177, P2870, DOI 10.1128/jb.177.10.2870-2877.1995; Renaudin J, 2005, MYCOPLASMAS: MOLECULAR BIOLOGY PATHOGENICITY AND STRATEGIES FOR CONTROL, P3; Renaudin J., 2014, MOLLICUTES MOL BIOL, P55; Rocha E, 2005, MYCOPLASMAS: MOLECULAR BIOLOGY PATHOGENICITY AND STRATEGIES FOR CONTROL, P31; Rodriguez F, 1996, J COMP PATHOL, V115, P151, DOI 10.1016/S0021-9975(96)80037-5; ROSENGARTEN R, 1999, MYCOPLASMAS RUMINANT, V3, P14; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sharma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097100; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119000	10.1371/journal.pone.0119000	http://dx.doi.org/10.1371/journal.pone.0119000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746296	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400037
J	Angeletti, D; Sandalova, T; Wahlgren, M; Achour, A				Angeletti, Davide; Sandalova, Tatyana; Wahlgren, Mats; Achour, Adnane			Binding of Subdomains 1/2 of PfEMP1-DBL1 alpha to Heparan Sulfate or Heparin Mediates Plasmodium falciparum Rosetting	PLOS ONE			English	Article							CEREBRAL MALARIA; IN-VIVO; PFEMP1; PROTEIN; DOMAIN; ERYTHROCYTES; ANTIGEN; CELLS	The capacity of Plasmodium falciparum parasitized erythrocytes (pRBC) to adhere to the endothelial lining in the microvasculature and to red blood cells (RBC) is associated with the virulence of the parasite, the pathogenesis and development of severe malaria. Rosetting, the binding of uninfected RBC to pRBC, is frequently observed in individuals with severe malaria and is mediated by the N-terminal NTS-DBL1 alpha domain of the adhesin Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) expressed at the surface of the pRBC. Heparan sulfate has been suggested to be an important receptor for the NTS-DBL1 alpha variant IT4(var60) expressed by the parasite FCR3S1.2. Here, we have determined the binding site of NTS-DBL1 alpha (IT4var60) to the RBC and heparin using a set of recombinant, mutated proteins expressed in and purified from E. coli. All the variants were studied for their ability to bind to RBC, their capacities to disrupt FCR3S1.2 rosettes, their affinities for heparin and their binding to rosette-disruptive mAbs. Our results suggest that NTS-DBL1 alpha mediates binding to RBC through a limited number of basic amino acid residues localized on the surface of subdomains 1 (SD1) and 2 (SD2). The SD2-binding site is localized in close proximity to one of two previously identified binding sites in the rosetting PfEMP1 of the parasite PaloAlto-varO. The binding site in SD2 of NTS-DBL1 alpha could represent a template for the development of anti-rosetting drugs.	[Angeletti, Davide; Sandalova, Tatyana; Achour, Adnane] Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden; [Angeletti, Davide; Wahlgren, Mats] Karolinska Inst, Dept Microbiol, Tumor & Cell Biol MTC, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Wahlgren, M (corresponding author), Karolinska Inst, Dept Microbiol, Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se; adnane.achour@ki.se	Angeletti, Davide/H-7350-2019	Angeletti, Davide/0000-0002-5256-1972; Achour, Adnane/0000-0003-0432-710X; Sandalova, Tatyana/0000-0002-7694-6420	Karolinska Institute; European Union (EvimalaR); Swedish Research Council; Karolinska Institutet; Swedish International Development Cooperation Agency (Sida/SAREC)	Karolinska Institute(Karolinska Institutet); European Union (EvimalaR); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish International Development Cooperation Agency (Sida/SAREC)	This study was supported by a grant from the Karolinska Institute (AA) as well as grants from the European Union (EvimalaR), the Swedish Research Council, Karolinska Institutet, and the Swedish International Development Cooperation Agency (Sida/SAREC)(MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2013, METHODS MALARIA RES; Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599; Barragan A, 2000, INFECT IMMUN, V68, P2971, DOI 10.1128/IAI.68.5.2971-2975.2000; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Dahlback M, 2010, TRENDS PARASITOL, V26, P230, DOI 10.1016/j.pt.2010.02.002; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; KAUL DK, 1991, BLOOD, V78, P812; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Miller LH, 2002, MOL BIOCHEM PARASIT, V120, P321, DOI 10.1016/S0166-6851(02)00011-7; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Siddiqui AA, 2012, INFECT IMMUN, V80, P2920, DOI 10.1128/IAI.00206-12; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WHO, 2012, WORLD MALARIA REPORT 2012, P1	42	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118898	10.1371/journal.pone.0118898	http://dx.doi.org/10.1371/journal.pone.0118898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742651	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100058
J	Wang, Q; Lin, H; Shen, Q; Fan, XP; Bai, NL; Zhao, YH				Wang, Qun; Lin, Hui; Shen, Qi; Fan, Xiaoping; Bai, Naling; Zhao, Yuhua			Characterization of Cellulase Secretion and Cre1-Mediated Carbon Source Repression in the Potential Lignocellulose-Degrading Strain Trichoderma asperellum T-1	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; CREA GENE; EXPRESSION; MUTANT; ENZYMES	Trichoderma asperellum, a traditional bio-control species, was demonstrated to be an excellent candidate for lignocellulose degradation in this work. Comparing to the representatively industrial strain of Trichoderma reeseiQM6a, T. asperellum T-1 showed more robust growth, stronger spore production, faster secretion of lignocellulose-decomposing enzymes and better pH tolerance. The reducing sugar released by strain T-1 on the second day of fermentation was 87% higher than that of strain QM6a, although the maximum reducing sugar yield and the cellulase production persistence of the strain T-1 were lower. Our experiment found that the cellulase secretion was strongly inhibited by glucose, suggesting the existence of carbon source repression pathway in T. asperellum T-1. The inhibiting effect was enhanced with an increase in glucose concentration and was closely related to mycelium growth. SDS-PAGE and secondary mass-spectrum identification confirmed that the expression of endo-1,4-beta-xylanase I in T. asperellum T-1 was down-regulated when glucose was added. The factor Cre1, which plays an important role in the down-regulation of the endo-1,4-beta-xylanase I gene, was investigated by bioinformatics methods. The protein structure of Cre1, analyzed using multiple protein sequence alignment, indicates the existence of the Zn-fingers domain. Then, the binding sites of Cre1 on the endo-1,4-beta-xylanase I gene promoter were further elucidated. This study is the first report about Cre1-mediated carbon repression in the bio-control strain T. asperellum T-1. All of the above results provided good references for better understanding T. asperellum T-1 and improving its application for lignocellulose degradation.	[Wang, Qun; Shen, Qi; Fan, Xiaoping; Bai, Naling; Zhao, Yuhua] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Hui] Zhejiang Acad Agr Sci, Inst Environm Resource & Soil Fertilizer, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences	Zhao, YH (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	yhzhao225@zju.edu.cn	LIN, HUI/AEA-6702-2022; Fan, Xiaoping/N-7412-2019	LIN, HUI/0000-0002-5446-8069; Fan, Xiaoping/0000-0003-0172-4070				Abu Bakar NK, 2012, BIORESOURCES, V7, P3627; Akira ST, 1996, BIOSCI BIOTECH BIOCH, V60, P173; [Anonymous], 2001, ELECT J BIOTECHN; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Chandra M, 2009, BIORESOURCE TECHNOL, V100, P1659, DOI 10.1016/j.biortech.2008.09.011; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; ELGOGARY S, 1989, P NATL ACAD SCI USA, V86, P6138, DOI 10.1073/pnas.86.16.6138; Gurr S. J., 1987, SPECIAL PUBLICATIONS, P93; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ibrahim MF, 2013, APPL BIOCHEM BIOTECH, V170, P1320, DOI 10.1007/s12010-013-0275-2; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Jonkers W, 2009, MOL MICROBIOL, V74, P1100, DOI 10.1111/j.1365-2958.2009.06922.x; Kannan Neethu, 2012, Advances in Bioscience and Biotechnology, V3, P1160, DOI 10.4236/abb.2012.38142; Lin H, 2011, BIORESOURCE TECHNOL, V102, P10569, DOI 10.1016/j.biortech.2011.08.095; Marcello CM, 2010, MICROBIOL RES, V165, P75, DOI 10.1016/j.micres.2008.08.002; Marx IJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-172; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Orejas M, 2001, J BACTERIOL, V183, P1517, DOI 10.1128/JB.183.5.1517-1523.2001; Raghuwanshi S, 2014, FUEL, V124, P183, DOI 10.1016/j.fuel.2014.01.107; Roy P, 2008, FUNGAL GENET BIOL, V45, P657, DOI 10.1016/j.fgb.2007.10.016; Rubeena M., 2013, Advances in Bioscience and Biotechnology, V4, P214, DOI 10.4236/abb.2013.42030; SAKAI A, 1990, MOL CELL BIOL, V10, P4130, DOI 10.1128/MCB.10.8.4130; Sarrocco S, 2009, J PLANT PATHOL, V91, P331; Sriram S, 2013, CURR SCI INDIA, V104, P1332; STRAUSS J, 1995, FEBS LETT, V376, P103, DOI 10.1016/0014-5793(95)01255-5; Sunil SA, 2012, MOL CELL PROTEOMICS, V11; Takashima S, 1998, BIOSCI BIOTECH BIOCH, V62, P2364, DOI 10.1271/bbb.62.2364; Vautard G, 1999, FEBS LETT, V453, P54, DOI 10.1016/S0014-5793(99)00691-2; Wang YaJing, 2010, Scientia Agricultura Sinica, V43, P1852	32	6	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119237	10.1371/journal.pone.0119237	http://dx.doi.org/10.1371/journal.pone.0119237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741694	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100094
J	Koeppen, AH; Ramirez, RL; Becker, AB; Bjork, ST; Levi, S; Santambrogio, P; Parsons, PJ; Kruger, PC; Yang, KX; Feustel, PJ; Mazurkiewicz, JE				Koeppen, Arnulf H.; Ramirez, R. Liane; Becker, Alyssa B.; Bjork, Sarah T.; Levi, Sonia; Santambrogio, Paolo; Parsons, Patrick J.; Kruger, Pamela C.; Yang, Karl X.; Feustel, Paul J.; Mazurkiewicz, Joseph E.			The Pathogenesis of Cardiomyopathy in Friedreich Ataxia	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUE; MITOCHONDRIAL FERRITIN; IRON; HEPCIDIN; DISEASE; INFLAMMATION; HYPERTROPHY; HEARTS; LIVER; LIFE	Friedreich ataxia (FA) is an autosomal recessive disease with a complex neurological phenotype, but the most common cause of death is heart failure. This study presents a systematic analysis of 15 fixed and 13 frozen archival autopsy tissues of FA hearts and 10 normal controls (8 frozen) by measurement of cardiomyocyte hypertrophy; tissue frataxin assay; Xray fluorescence (XRF) of iron (Fe) and zinc (Zn) in polyethylene glycol-embedded samples of left and right ventricular walls (LVW, RVW) and ventricular septum (VS); metal quantification in bulk digests by inductively-coupled plasma optical emission spectrometry (ICP-OES); Fe histochemistry; and immunohistochemistry and immunofluorescence of cytosolic and mitochondrial ferritins and of the inflammatory markers CD68 and hepcidin. FA cardiomyocytes were significantly larger than normal and surrounded by fibrotic endomysium. Frataxin in LVW was reduced to less than 15 ng/g wet weight (normal 235.4 +/- 75.1 ng/g). All sections displayed characteristic Fe-reactive inclusions in cardiomyocytes, and XRF confirmed significant regional Fe accumulation in LVW and VS. In contrast, ICP-OES analysis of bulk extracts revealed normal total Fe levels in LVW, RVW, and VS. Cardiac Zn remained normal by XRF and assay of bulk digests. Cytosolic and mitochondrial ferritins exhibited extensive co-localization in cardiomyocytes, representing translational and transcriptional responses to Fe, respectively. Fe accumulation progressed from a few small granules to coarse aggregates in phagocytized cardiomyocytes. All cases met the "Dallas criteria" of myocarditis. Inflammatory cells contained CD68 and cytosolic ferritin, and most also expressed the Fe-regulatory hormone hepcidin. Inflammation is an important factor in the pathogenesis of FA cardiomyopathy but may be more evident in advanced stages of the disease. Hepcidin-induced failure of Fe export from macrophages is a likely contributory cause of damage to the heart in FA. Frataxin replacement and anti-inflammatory agents are potential therapies in FA cardiomyopathy.	[Koeppen, Arnulf H.] Vet Affairs Med Ctr, Res Neurol & Pathol Serv, Albany, NY 12208 USA; [Koeppen, Arnulf H.] Albany Med Coll, Dept Neurol & Pathol, Albany, NY 12208 USA; [Ramirez, R. Liane; Becker, Alyssa B.; Bjork, Sarah T.] Vet Affairs Med Ctr, Res Serv, Albany, NY USA; [Levi, Sonia; Santambrogio, Paolo] Ist Sci San Raffaele, I-20132 Milan, Italy; [Levi, Sonia] Univ Vita Salute San Raffaele, Milan, Italy; [Parsons, Patrick J.; Kruger, Pamela C.; Yang, Karl X.] New York State Dept Hlth, Div Environm Hlth Sci, Wadsworth Ctr, Albany, NY USA; [Parsons, Patrick J.; Yang, Karl X.] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA; [Feustel, Paul J.; Mazurkiewicz, Joseph E.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Albany Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College	Koeppen, AH (corresponding author), Vet Affairs Med Ctr, Res Neurol & Pathol Serv, Albany, NY 12208 USA.	arnulf.koeppen@med.va.gov	levi, sonia/A-3161-2015; Santambrogio, Paolo/AAN-3837-2020; Parsons, Patrick/ABE-2655-2020; Feustel, Paul/AAW-5157-2021; Parsons, Patrick J/I-2985-2015	levi, sonia/0000-0002-5092-0847; Santambrogio, Paolo/0000-0002-5481-2130; Parsons, Patrick/0000-0001-9133-875X; Feustel, Paul/0000-0002-6963-4349; Parsons, Patrick J/0000-0001-9133-875X	National Institutes of Health [R01 NS069454, 2 U42 OD011158]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069454] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Friedreich's Ataxia Research Alliance (FARA) supported all aspects of this work including staff salaries and purchases of supplies and services. FARA also supported the tissue donation program. National Ataxia Foundation supported the tissue donation program. National Institutes of Health supported the tissue donation program and pertinent laboratory work (grant number R01 NS069454). NDRI receives financial support from the National Institutes of Health (grant number 2 U42 OD011158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aretz T, 1986, AM J CARDIOVASC PATH, V1, P3; Condo I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; DEMICHELE G, 1989, J NEUROL NEUROSUR PS, V52, P1398, DOI 10.1136/jnnp.52.12.1398; Drysdale J, 2002, BLOOD CELL MOL DIS, V29, P376, DOI 10.1006/bcmd.2002.0577; Friedreich N, 1863, VIRCHOWS ARCH PATHOL, V26, P391, DOI 10.1515/9783112391280-017; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; KITZMAN DW, 1988, MAYO CLIN PROC, V63, P137, DOI 10.1016/S0025-6196(12)64946-5; Koeppen AH, 2012, CEREBELLUM, V11, P845, DOI 10.1007/s12311-012-0383-5; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kruger PC, 2010, ACCREDIT QUAL ASSUR, V15, P451, DOI 10.1007/s00769-010-0660-2; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Lane DJR, 2013, BIOCHEM J, V453, P321, DOI 10.1042/BJ20130079; Li JJ, 2012, ARTERIOSCL THROM VAS, V32, P1158, DOI 10.1161/ATVBAHA.112.246108; LUZZAGO A, 1986, BIOCHIM BIOPHYS ACTA, V872, P61, DOI 10.1016/0167-4838(86)90147-0; Merle U, 2007, ENDOCRINOLOGY, V148, P2663, DOI 10.1210/en.2006-1331; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; OLSON LJ, 1987, J AM COLL CARDIOL, V10, P1239, DOI 10.1016/S0735-1097(87)80124-9; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Ramirez RL, 2012, AM J CARDIOL, V110, P1820, DOI 10.1016/j.amjcard.2012.08.018; Rodriguez R, 2014, INFECT IMMUN, V82, P745, DOI 10.1128/IAI.00983-13; Russell DS, 1946, J PATHOL BACTERIOL, V63, P739; Schrag M, 2010, BIOMETALS, V23, P1123, DOI 10.1007/s10534-010-9359-4; Singal PK, 2003, CARDIAC REMODELING F; Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633; Sullivan JL, 2007, EXP BIOL MED, V232, P1014, DOI 10.3181/0703-MR-54; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; Zhang XL, 2010, BBA-GEN SUBJECTS, V1800, P1262, DOI 10.1016/j.bbagen.2010.08.005	32	77	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116396	10.1371/journal.pone.0116396	http://dx.doi.org/10.1371/journal.pone.0116396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738292	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900010
J	Li, D; Xie, XJ; Wang, J; Bian, YJ; Li, QZ; Gao, XJ; Wang, CM				Li, Dan; Xie, Xuejiao; Wang, Jie; Bian, Yanjie; Li, Qingzhang; Gao, Xuejun; Wang, Chunmei			MiR-486 Regulates Lactation and Targets the PTEN Gene in Cow Mammary Glands	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; MICRORNA; DIFFERENTIATION; EXPRESSION; PROTEIN; INVOLVEMENT; NETWORKS; BREAST; GROWTH	Mammary gland development is controlled by several genes. Although miRNAs have been implicated in mammary gland function, the mechanism by which miR-486 regulates mammary gland development and lactation remains unclear. We investigated miR-486 expression in cow mammary gland using qRT-PCR and ISH and show that miR-486 expression was higher during the high-quality lactation period. We found that miR-486 targets phosphoinositide signaling in the cow mammary gland by directly downregulating PTEN gene expression and by altering the expression of downstream genes that are important for the function of the mammary gland, such as AKT, mTOR. We analyzed the effect of beta-casein, lactose and triglyceride secretion in bovine mammary gland epithelial cells (BMECs) transfected by an inhibitor and by mimics of miR-486. Our results identify miR-486 as a downstream regulator of PTEN that is required for the development of the cow mammary gland.	[Li, Dan; Xie, Xuejiao; Wang, Jie; Bian, Yanjie; Li, Qingzhang; Gao, Xuejun; Wang, Chunmei] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, CM (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China.	wangcm-1@163.com			Major State Basic Research Development Program of China (973 Program) [2011CB100804]; Heilongjiang Department of Education Project Program [1154z1004]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Heilongjiang Department of Education Project Program	This study was supported by Major State Basic Research Development Program of China (973 Program, No. 2011CB100804); Heilongjiang Department of Education Project Program, No. 1154z1004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; BLACKBURN DE, 1982, NUCLEIC ACIDS RES, V10, P2295, DOI 10.1093/nar/10.7.2295; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gimm O, 2000, CANCER RES, V60, P6822; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Kim YJ, 2012, STEM CELLS DEV, V21, P1749, DOI 10.1089/scd.2011.0429; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2001, BMC Mol Biol, V2, P2, DOI 10.1186/1471-2199-2-2; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Torres J, 2001, EUR J CANCER, V37, P114, DOI 10.1016/S0959-8049(00)00366-X; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang M, 2012, J DAIRY SCI, V95, P6529, DOI 10.3168/jds.2012-5748; Wang ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102118; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Yamada KM, 2001, J CELL SCI, V114, P2375	34	41	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118284	10.1371/journal.pone.0118284	http://dx.doi.org/10.1371/journal.pone.0118284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738494	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900029
J	Lohr, M; Folkmann, JK; Sheykhzade, M; Jensen, LJ; Kermanizadeh, A; Loft, S; Moller, P				Lohr, Mille; Folkmann, Janne K.; Sheykhzade, Majid; Jensen, Lars J.; Kermanizadeh, Ali; Loft, Steffen; Moller, Peter			Hepatic Oxidative Stress, Genotoxicity and Vascular Dysfunction in Lean or Obese Zucker Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DIESEL EXHAUST PARTICLES; DNA-DAMAGE; 8-OXO-7,8-DIHYDRO-2'-DEOXYGUANOSINE EXCRETION; NONALCOHOLIC STEATOHEPATITIS; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLYCEMIC CONTROL; GENE-EXPRESSION	Metabolic syndrome is associated with increased risk of cardiovascular disease, which could be related to oxidative stress. Here, we investigated the associations between hepatic oxidative stress and vascular function in pressurized mesenteric arteries from lean and obese Zucker rats at 14, 24 and 37 weeks of age. Obese Zucker rats had more hepatic fat accumulation than their lean counterparts. Nevertheless, the obese rats had unaltered age-related level of hepatic oxidatively damaged DNA in terms of formamidopyrimidine DNA glycosylase (FPG) or human oxoguanine DNA glycosylase (hOGG1) sensitive sites as measured by the comet assay. There were decreasing levels of oxidatively damaged DNA with age in the liver of lean rats, which occurred concurrently with increased expression of Ogg1. The 37 week old lean rats also had higher expression level of Hmox1 and elevated levels of DNA strand breaks in the liver. Still, both strain of rats had increased protein level of HMOX1 in the liver at 37 weeks. The external and lumen diameters of mesenteric arteries increased with age in obese Zucker rats with no change in media cross-sectional area, indicating outward re-modelling without hypertrophy of the vascular wall. There was increased maximal response to acetylcholine-mediated endothelium-dependent vasodilatation in both strains of rats. Collectively, the results indicate that obese Zucker rats only displayed a modest mesenteric vascular dysfunction, with no increase in hepatic oxidative stress-generated DNA damage despite substantial hepatic steatosis.	[Lohr, Mille; Folkmann, Janne K.; Kermanizadeh, Ali; Loft, Steffen; Moller, Peter] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, DK-1014 Copenhagen K, Denmark; [Sheykhzade, Majid] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen O, Denmark; [Jensen, Lars J.] Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, DK-1870 Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen	Moller, P (corresponding author), Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Oster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark.	pemo@sund.ku.dk	Kermanizadeh, Ali/AAD-6281-2019; Jensen, Lars Jørn/A-9340-2008	Kermanizadeh, Ali/0000-0002-2989-9078; Jensen, Lars Jørn/0000-0003-4559-7456; Sheykhzade, Majid/0000-0002-4561-0326; Loft, Steffen/0000-0001-9552-8518	Danish Research Councils	Danish Research Councils(Det Frie Forskningsrad (DFF))	Funding provided by Danish Research Councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Barregard L, 2013, ANTIOXID REDOX SIGN, V18, P2377, DOI 10.1089/ars.2012.4714; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bouvet C, 2007, HYPERTENSION, V50, P248, DOI 10.1161/HYPERTENSIONAHA.107.088716; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Collins AR, 2012, ARTERIOSCL THROM VAS, V32, P2839, DOI 10.1161/ATVBAHA.112.300345; Danielsen PH, 2010, TOXICOL SCI, V118, P574, DOI 10.1093/toxsci/kfq290; Dybdahl M, 2003, CARCINOGENESIS, V24, P1759, DOI 10.1093/carcin/bgg147; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ersson C, 2013, MUTAGENESIS, V28, P279, DOI 10.1093/mutage/get001; Folkmann JK, 2007, MUTAGENESIS, V22, P105, DOI 10.1093/mutage/gel059; Folkmann JK, 2012, TOXICOL SCI, V129, P98, DOI 10.1093/toxsci/kfs180; Forchhammer L, 2012, MUTAGENESIS, V27, P665, DOI 10.1093/mutage/ges032; Forchhammer L, 2010, MUTAGENESIS, V25, P113, DOI 10.1093/mutage/gep048; Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Imrie H, 2010, BBA-MOL CELL BIOL L, V1801, P320, DOI 10.1016/j.bbalip.2009.09.025; Johansson C, 2010, MUTAGENESIS, V25, P125, DOI 10.1093/mutage/gep055; Kitade M, 2006, HEPATOLOGY, V44, P983, DOI 10.1002/hep.21338; Laurant P, 2004, CAN J PHYSIOL PHARM, V82, P269, DOI 10.1139/Y04-026; Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313; Loft S, 2013, CANCER EPIDEM BIOMAR, V22, P1289, DOI 10.1158/1055-9965.EPI-13-0229; Loft S, 2012, FREE RADICAL BIO MED, V52, P167, DOI 10.1016/j.freeradbiomed.2011.10.439; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mendez-Gonzalez J, 2011, BBA-MOL CELL BIOL L, V1811, P1186, DOI 10.1016/j.bbalip.2011.07.019; Mikkelsen L, 2009, FREE RADICAL BIO MED, V47, P608, DOI 10.1016/j.freeradbiomed.2009.05.030; Mingorance C, 2009, BRIT J NUTR, V102, P1145, DOI 10.1017/S0007114509389230; Moller P, 2010, FREE RADICAL BIO MED, V48, P1275, DOI 10.1016/j.freeradbiomed.2010.02.003; Mozaffari MS, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-51; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Oltman CL, 2006, AM J PHYSIOL-HEART C, V291, pH1780, DOI 10.1152/ajpheart.01297.2005; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Risom L, 2003, ARCH TOXICOL, V77, P651, DOI 10.1007/s00204-003-0502-7; Risom L, 2003, CARCINOGENESIS, V24, P1847, DOI 10.1093/carcin/bgg144; Risom L, 2003, FREE RADICAL RES, V37, P957, DOI 10.1080/1071576031000150788; Risom L, 2007, FREE RADICAL RES, V41, P172, DOI 10.1080/10715760601024122; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Romanko OP, 2005, AM J PHYSIOL-HEART C, V289, pH2097, DOI 10.1152/ajpheart.00213.2005; Salcedo A, 2007, HEPATOL RES, V37, P811, DOI 10.1111/j.1872-034X.2007.00135.x; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Stoll P, 2011, WORLD J GASTROENTERO, V17, P4184, DOI 10.3748/wjg.v17.i37.4184; Su K, 2012, J BIOL CHEM, V287, P28564, DOI 10.1074/jbc.M112.360081; Subramanian R, 2003, EUR J PHARMACOL, V477, P143, DOI 10.1016/j.ejphar.2003.08.003; Tenorio NM, 2013, CLINICS, V68, P385, DOI 10.6061/clinics/2013(03)OA16; Vesterdal LK, 2014, TOXICOL APPL PHARM, V274, P350, DOI 10.1016/j.taap.2013.10.001; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Winczura A, 2012, FREE RADICAL RES, V46, P442, DOI 10.3109/10715762.2012.658516; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Young EJ, 2008, DIABETOLOGIA, V51, P872, DOI 10.1007/s00125-008-0934-y; Zhang YKJ, 2012, TOXICOL APPL PHARM, V264, P305, DOI 10.1016/j.taap.2012.09.014; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x	53	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118773	10.1371/journal.pone.0118773	http://dx.doi.org/10.1371/journal.pone.0118773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738756	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900068
J	Hayakawa, S; Takaku, Y; Hwang, JS; Horiguchi, T; Suga, H; Gehring, W; Ikeo, K; Gojobori, T				Hayakawa, Shiho; Takaku, Yasuharu; Hwang, Jung Shan; Horiguchi, Takeo; Suga, Hiroshi; Gehring, Walter; Ikeo, Kazuho; Gojobori, Takashi			Function and Evolutionary Origin of Unicellular Camera-Type Eye Structure	PLOS ONE			English	Article							ACTIN-FILAMENTS; LIGHT; DINOFLAGELLATE; MICROTUBULES; PHOTORECEPTOR; ADAPTATION; MOVEMENT; PROTEINS; EYESPOT; RETINA	The ocelloid is an extraordinary eyespot organelle found only in the dinoflagellate family Warnowiaceae. It contains retina- and lens-like structures called the retinal body and the hyalosome. The ocelloid has been an evolutionary enigma because of its remarkable resemblance to the multicellular camera-type eye. To determine if the ocelloid is functionally photoreceptive, we investigated the warnowiid dinoflagellate Erythropsidinium. Here, we show that the morphology of the retinal body changed depending on different illumination conditions and the hyalosome manifests the refractile nature. Identifying a rhodopsin gene fragment in Erythropsidinium ESTs that is expressed in the retinal body by in situ hybridization, we also show that ocelloids are actually light sensitive photoreceptors. The rhodopsin gene identified is most closely related to bacterial rhodopsins. Taken together, we suggest that the ocelloid is an intracellular camera-type eye, which might be originated from endosymbiotic origin.				takashi.gojobori@kaust.edu.sa	Horiguchi, Takeo/D-7612-2012; Hwang, Jung Shan/AAJ-3014-2020	Horiguchi, Takeo/0000-0002-6118-8460; Hwang, Jung Shan/0000-0002-0908-2036	Grants-in-Aid for Scientific Research [26891021] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arendt D, 2009, PHILOS T R SOC B, V364, P2809, DOI 10.1098/rstb.2009.0104; BURNSIDE B, 1976, J SUPRAMOL STR CELL, V5, P257, DOI 10.1002/jss.400050302; CALMAN BG, 1992, VISUAL NEUROSCI, V9, P365, DOI 10.1017/S0952523800010774; CARTER SB, 1967, NATURE, V213, P261, DOI 10.1038/213261a0; Danne JC, 2012, PROTIST, V163, P76, DOI 10.1016/j.protis.2011.03.002; Darwin C, 1870, ORIGIN SPECIES MEANS; Fishman RS, 2008, ARCH OPHTHALMOL-CHIC, V126, P1586, DOI 10.1001/archopht.126.11.1586; FRANCIS D, 1967, J EXP BIOL, V47, P495; Gehring WJ, 2014, WIRES DEV BIOL, V3, P1, DOI 10.1002/wdev.96; Gomez F, 2008, EUR J PROTISTOL, V44, P291, DOI 10.1016/j.ejop.2008.03.002; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Greuet C., 1987, Botanical Monographs (Oxford), V21, P119; GREUET C, 1978, CYTOBIOLOGIE, V17, P114; Greuet C, 1968, PROTISTOLOGICA, P209; Greuet C, 1977, PROTISTOLOGICA, P127; HAUPT W, 1982, ANNU REV PLANT PHYS, V33, P205, DOI 10.1146/annurev.pp.33.060182.001225; Hehenberger E, 2014, GENOME BIOL EVOL, V6, P2321, DOI 10.1093/gbe/evu182; HEVERS W, 1995, TISSUE CELL, V27, P405, DOI 10.1016/S0040-8166(95)80061-1; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Horiguchi Takeo, 1999, Phycological Research, V47, P101, DOI 10.1111/j.1440-1835.1999.tb00290.x; Jekely G, 2009, PHILOS T R SOC B, V364, P2795, DOI 10.1098/rstb.2009.0072; Jonasova K, 2008, SEMIN CELL DEV BIOL, V19, P71, DOI 10.1016/j.semcdb.2007.10.005; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kofoid C. A., 1921, MEMOIRS U CALIFORNIA, DOI [10.5962/bhl.title.24995, DOI 10.5962/BHL.TITLE.24995]; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Kreimer G, 1999, PROTIST, V150, P311, DOI 10.1016/S1434-4610(99)70032-5; Meyer-Rochow VB, 2001, ZOOL SCI, V18, P1175, DOI 10.2108/zsj.18.1175; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sato Y, 2001, J CELL SCI, V114, P269; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka G, 2006, ZOOL J LINN SOC-LOND, V147, P97, DOI 10.1111/j.1096-3642.2006.00216.x; Taylor F. J. R., 1987, BIOL DINOFLAGELLATES; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Torres SC, 1997, CELL TISSUE RES, V290, P167, DOI 10.1007/s004410050918	40	22	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118415	10.1371/journal.pone.0118415	http://dx.doi.org/10.1371/journal.pone.0118415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734540	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700028
J	Zhang, C; Xie, H; Cheng, X; Wang, DW; Li, Y; Xu, CL; Huang, X				Zhang, Chao; Xie, Hui; Cheng, Xi; Wang, Dong-Wei; Li, Yu; Xu, Chun-Ling; Huang, Xin			Molecular Identification and Functional Characterization of the Fatty Acid- and Retinoid-Binding Protein Gene Rs-far-1 in the Burrowing Nematode Radopholus similis (Tylenchida: Pratylenchidae)	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PARASITIC NEMATODES; EXPRESSION; RNA; INTERFERENCE	Fatty acid-and retinoid-binding protein (FAR) is a nematode-specific protein expressed in the nematode hypodermis. It is involved in nematode development, reproduction, and infection and can disrupt the plant defense reaction. In this study, we obtained the full-length sequence of the far gene from Radopholus similis (Rs-far-1), which is 828 bp long and includes a 558 bp ORF encoding 186 amino acids. A protein homology analysis revealed that Rs-FAR-1 is 75% similar to Mj-FAR-1 from Meloidogyne javanica. A neighbor-joining phylogenetic tree was inferred and showed that Rs-FAR-1 is most similar to Pv-FAR-1 from Pratylenchus vulnus. A fluorescence-based ligand-binding analysis confirmed that Rs-FAR-1 can combine with fatty acids and retinol. qPCR was used to assess Rs-far-1 expression levels at different developmental stages in different R. similis populations, and its expression was 2.5 times greater in the highly pathogenic Rs-C population than in the less pathogenic Rs-P population. The highest expression was found in females, followed by eggs, juveniles and males. When R. similis was treated with Rs-far-1 dsRNA for 36 h, the reproduction and pathogenicity decreased significantly. In situ hybridization revealed Rs-far-1 transcripts in the R. similis hypodermis. Additionally, R. similis treated with Rs-far-1 dsRNA or water were inoculated into Arabidopsis thaliana. Allene oxide synthase (AOS) expression in A. thaliana was upregulated during early infection in both treatments and then returned to the expression levels of the control plant. Compared with the control plant, AOS expression significantly decreased in A. thaliana inoculated with water-treated R. similis but significantly increased in A. thaliana inoculated with Rs-far-1 dsRNA-treated R. similis. This finding indicates that Rs-far-1 regulates AOS expression in A. thaliana. Rs-FAR-1 plays a critical role in R. similis development, reproduction, and infection and can disturb the plant defense reaction. Therefore, Rs-far-1 is an important target gene to control R. similis.				xiehui@scau.edu.cn	Wang, Dongwei/M-7768-2017	Wang, Dongwei/0000-0001-5226-4241	National Natural Science Foundation of China [31371920]; Special Fund for Agro-Scientific Research in the Public Interest [200903040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest	This work was funded by National Natural Science Foundation of China (No. 31371920) and Special Fund for Agro-Scientific Research in the Public Interest (No. 200903040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsing JJ, 2002, NEMATOLOGY, V4, P421, DOI 10.1163/156854102760199259; ARAGAKI M, 1984, PLANT DIS, V68, P509, DOI 10.1094/PD-69-509; Bae H, 2009, PLANT CELL TISS ORG, V98, P311, DOI 10.1007/s11240-009-9565-3; Bakhetia M, 2005, TRENDS PLANT SCI, V10, P362, DOI 10.1016/j.tplants.2005.06.007; Basavaraju S, 2003, MOL BIOCHEM PARASIT, V126, P63, DOI 10.1016/S0166-6851(02)00253-0; Bath JL, 2009, J NEMATOL, V41, P228; Block A, 2005, MOL PLANT PATHOL, V6, P79, DOI 10.1111/j.1364-3703.2004.00265.x; Cheng X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066011; Clermont-Dauphin C, 2004, SOIL USE MANAGE, V20, P105, DOI 10.1079/SUM2003231; Cotten J., 1993, P593; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; de Boer JM, 1998, J NEMATOL, V30, P309; De Waele D., 2002, P175, DOI 10.1079/9780851994666.0175; Fairbairn DJ, 2007, PLANTA, V226, P1525, DOI 10.1007/s00425-007-0588-x; FALLAS GA, 1994, NEMATROPICA, V24, P175; Fogain R, 2000, NEMATOLOGY, V2, P129, DOI 10.1163/156854100509015; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Haegeman A, 2010, MOL PLANT PATHOL, V11, P315, DOI [10.1111/J.1364-3703.2010.00614.X, 10.1111/j.1364-3703.2010.00614.x]; Iberkleid I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064586; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kimber MJ, 2007, FASEB J, V21, P1233, DOI 10.1096/fj.06-7343com; Lee D. L., 2002, BIOL NEMATODES; Maier TR, 2013, MOL PLANT MICROBE IN, V26, P31, DOI 10.1094/MPMI-05-12-0121-FI; OBANNON JH, 1977, J NEMATOL, V9, P16; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; SARAH JL, 1989, NEMATROPICA, V19, P199; Sarah JL, 1913, BURROWING NEMATODE B; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; Smant G, 1997, PHYTOPATHOLOGY, V87, P839, DOI 10.1094/PHYTO.1997.87.8.839; Smith IM, 1998, DISTRIBUTION MAPS QU; Tsang MMC, 2004, ANN APPL BIOL, V145, P309, DOI 10.1111/j.1744-7348.2004.tb00388.x; Tsang MMC, 2003, CROP PROT, V22, P589, DOI 10.1016/S0261-2194(02)00235-1; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Zhang C, 2012, EUR J PLANT PATHOL, V133, P899, DOI 10.1007/s10658-012-0015-4	36	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118414	10.1371/journal.pone.0118414	http://dx.doi.org/10.1371/journal.pone.0118414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734501	Green Submitted, gold, Green Published			2022-12-26	WOS:000350314700027
J	Tykvart, J; Barinka, C; Svoboda, M; Navratil, V; Soucek, R; Hubalek, M; Hradilek, M; Sacha, P; Lubkowski, J; Konvalinka, J				Tykvart, Jan; Barinka, Cyril; Svoboda, Michal; Navratil, Vaclav; Soucek, Radko; Hubalek, Martin; Hradilek, Martin; Sacha, Pavel; Lubkowski, Jacek; Konvalinka, Jan			Structural and Biochemical Characterization of a Novel Aminopeptidase from Human Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-CARBOXYPEPTIDASE-II; REACTION-MECHANISM; EXPRESSION; PEPTIDASE; CRYSTALLOGRAPHY; INHIBITION; PROTEINS; ENZYME; RAT	N-acetylated alpha-linked acidic dipeptidase-like protein (NAALADase L), encoded by the NAALADL1 gene, is a close homolog of glutamate carboxypeptidase II, a metallopeptidase that has been intensively studied as a target for imaging and therapy of solid malignancies and neuropathologies. However, neither the physiological functions nor structural features of NAALADase L are known at present. Here, we report a thorough characterization of the protein product of the human NAALADL1 gene, including heterologous overexpression and purification, structural and biochemical characterization, and analysis of its expression profile. By solving the NAALADase L x-ray structure, we provide the first experimental evidence that it is a zinc-dependent metallopeptidase with a catalytic mechanism similar to that of glutamate carboxypeptidase II yet distinct substrate specificity. Aproteome-based assay revealed that the NAALADL1 gene product possesses previously unrecognized aminopeptidase activity but no carboxy-or endopeptidase activity. These findings were corroborated by site-directed mutagenesis and identification of bestatin as a potent inhibitor of the enzyme. Analysis of NAALADL1 gene expression at both the mRNA and protein levels revealed the small intestine as the major site of protein expression and points toward extensive alternative splicing of the NAALADL1 gene transcript. Taken together, our data imply that the NAALADL1 gene product's primary physiological function is associated with the final stages of protein/peptide digestion and absorption in the human digestive system. Based on these results, we suggest a new name for this enzyme: human ileal aminopeptidase (HILAP).	[Tykvart, Jan; Svoboda, Michal; Navratil, Vaclav; Soucek, Radko; Hubalek, Martin; Hradilek, Martin; Sacha, Pavel; Konvalinka, Jan] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Gilead Sci & IOCB Res Ctr, CR-16610 Prague 6, Czech Republic; [Tykvart, Jan; Navratil, Vaclav; Sacha, Pavel; Konvalinka, Jan] Charles Univ Prague, Fac Nat Sci, Dept Biochem, Prague 2, Czech Republic; [Svoboda, Michal] Charles Univ Prague, Fac Nat Sci, Dept Phys & Macromol Chem, Prague 2, Czech Republic; [Barinka, Cyril] Acad Sci Czech Republic, Inst Biotechnol, Prague 4, Czech Republic; [Lubkowski, Jacek] NCI, Ctr Canc Res, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Gilead Sciences; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Konvalinka, J (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Flemingovo 2, Prague 16610 6, Czech Republic.	jan.konvalinka@uochb.cas.cz	Sacha, Pavel/G-9729-2014; Tykvart, Jan/G-6770-2014; Navrátil, Václav/G-6756-2014; Hubalek, Martin/H-1400-2014; Barinka, Cyril/G-9803-2014	Sacha, Pavel/0000-0001-6198-9826; Tykvart, Jan/0000-0002-6938-1513; Navrátil, Václav/0000-0002-6019-5394; Hubalek, Martin/0000-0003-0247-7956; Barinka, Cyril/0000-0003-2751-3060; Konvalinka, Jan/0000-0003-0695-9266	Grant Agency of the Czech Republic [P304-12-0847]; InterBioMed Project from Ministry of Education of the Czech Republic [LO 1302]; National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program; European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; United States Department of Energy [W-31-109-Eng38]; EMBO [1978, 249220]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); InterBioMed Project from Ministry of Education of the Czech Republic; National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Regional Development Fund(European Commission); United States Department of Energy(United States Department of Energy (DOE)); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by Grant Agency of the Czech Republic (Grant P304-12-0847) and InterBioMed Project LO 1302 from the Ministry of Education of the Czech Republic. This work was also supported in part by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program (to J. L.) and also in part by project "BIOCEV" (CZ.1.05/1.1.00/02.0109) from the European Regional Development Fund (to C. B.). The use of the Advanced Photon Source was supported by United States Department of Energy Contract W-31-109-Eng38.; Supported by EMBO Installation Grant 1978 and Installation Research Grant Project 249220.	Barinka C, 2002, J NEUROCHEM, V80, P477, DOI 10.1046/j.0022-3042.2001.00715.x; BARLOS K, 1991, INT J PEPT PROT RES, V37, P513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hlouchova K, 2007, J NEUROCHEM, V101, P682, DOI 10.1111/j.1471-4159.2006.04341.x; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Klusak V, 2009, BIOCHEMISTRY-US, V48, P4126, DOI 10.1021/bi900220s; Kozisek M, 2008, J VIROL, V82, P5869, DOI 10.1128/JVI.02325-07; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; Langone J. J., 1986, METHOD ENZYMOL, V121, P1; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navratil M, 2014, FEBS J, V281, P3228, DOI 10.1111/febs.12857; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pangalos MN, 1999, J BIOL CHEM, V274, P8470, DOI 10.1074/jbc.274.13.8470; Pavlicek J, 2012, CURR MED CHEM, V19, P1300, DOI 10.2174/092986712799462667; Rovenska M, 2008, PROSTATE, V68, P171, DOI 10.1002/pros.20676; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Sedo A, 2001, BBA-PROTEIN STRUCT M, V1550, P107, DOI 10.1016/S0167-4838(01)00278-3; Shneider BL, 1997, J BIOL CHEM, V272, P31006, DOI 10.1074/jbc.272.49.31006; Taylor A., 1996, THE AMINOPEPTIDASES, P1; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tykvart J, 2012, PROTEIN EXPRES PURIF, V82, P106, DOI 10.1016/j.pep.2011.11.016; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Woodward C., 2007, Agilent Technologies Application Note 5989-6297 EN, Patent No. 59896297; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	31	9	9	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11321	11336		10.1074/jbc.M114.628149	http://dx.doi.org/10.1074/jbc.M114.628149			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25752612	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000353719400010
J	Meyer, M; McEntee, RK; Nyotowidjojo, I; Chu, GX; LeWinter, MM				Meyer, Markus; McEntee, Rachel K.; Nyotowidjojo, Iwan; Chu, Guoxiang; LeWinter, Martin M.			Relationship of Exercise Capacity and Left Ventricular Dimensions in Patients with a Normal Ejection Fraction. An Exploratory Study	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; DIASTOLIC HEART-FAILURE; CARDIAC STRUCTURE; AMERICAN-SOCIETY; BED-REST; DISEASE; DYSFUNCTION; HYPERTROPHY; ATROPHY; VOLUME	Objectives Extreme endurance exercise is known to be associated with an enlargement of the left ventricular (LV) chamber, whereas inactivity results in inverse changes. It is unknown if these dimensional relationships exist in patients. Methods We analyzed the relationship of exercise capacity and LV dimension in a cohort of sequential patients with a normal ejection fraction undergoing stress echocardiography. In a total of 137 studies the following questions were addressed: (a) is there a difference in LV dimensions of patients with an excellent exercise capacity versus patients with a poor exercise capacity, (b) how is LV dimension and exercise capacity affected by LV wall thickness and (c) how do LV dimensions of patients who are unable to walk on a treadmill compare to the above groups. Results Patients with a poor exercise capacity or who are unable to physically exercise have a 34 percent smaller LV cavity size when compared to patients with an excellent exercise capacity (p<0.001). This reduction in LV chamber size is associated with concentric LV hypertrophy and a reciprocal increase in resting heart rate. In addition, cardiac output reserve is further blunted by chronotropic incompetence and a tachycardia-induced LV volume reduction. In conclusion the relationship of exercise capacity and cardiac dimensions described in extreme athletes also applies to patients. Our exploratory analysis suggests that patients who cannot sufficiently exercise have small LV cavities.	[Meyer, Markus; McEntee, Rachel K.; Nyotowidjojo, Iwan; Chu, Guoxiang; LeWinter, Martin M.] Univ Vermont, Coll Med, Div Cardiol, Burlington, VT 05405 USA	University of Vermont	Meyer, M (corresponding author), Univ Vermont, Coll Med, Div Cardiol, Burlington, VT 05405 USA.	markus.meyer@vtmednet.org		Meyer, Markus/0000-0002-4398-5642	American Heart Association Scientist Development Grant [0730056N]; NIH [1R21HL94807-01]; NIH Institutional Training Grant [T32 HL07647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122744, T32HL007647, R21HL094807] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by an American Heart Association Scientist Development Grant 0730056N (MM), NIH grants 1R21HL94807-01 (MM) and NIH Institutional Training Grant T32 HL07647 (MML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel E, 2004, J AM COLL CARDIOL, V44, P144, DOI 10.1016/j.jacc.2004.02.057; ALPERT MA, 1985, AM J CARDIOL, V55, P783, DOI 10.1016/0002-9149(85)90156-0; Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Baggish AL, 2008, J APPL PHYSIOL, V104, P1121, DOI 10.1152/japplphysiol.01170.2007; Berry JD, 2013, CIRC-HEART FAIL, V6, P627, DOI 10.1161/CIRCHEARTFAILURE.112.000054; Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; CUOCOLO A, 1990, CIRCULATION, V81, P978, DOI 10.1161/01.CIR.81.3.978; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Fujimoto N, 2010, CIRCULATION, V122, P1797, DOI 10.1161/CIRCULATIONAHA.110.973784; Gaasch WH, 2011, J AM COLL CARDIOL, V58, P1733, DOI 10.1016/j.jacc.2011.07.022; Grewal J, 2009, JAMA-J AM MED ASSOC, V301, P286, DOI 10.1001/jama.2008.1022; HIGGINBOTHAM MB, 1986, CIRC RES, V58, P281, DOI 10.1161/01.RES.58.2.281; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Jorgensen K, 2003, CHEST, V124, P1863, DOI 10.1378/chest.124.5.1863; Kass DA, 2010, J CARD FAIL, V16, P17, DOI 10.1016/j.cardfail.2009.08.008; Kitzman DW, 2010, CIRC-HEART FAIL, V3, P659, DOI 10.1161/CIRCHEARTFAILURE.110.958785; KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levine BD, 1997, CIRCULATION, V96, P517; LeWinter MM, 2011, BRAUNWALDS HEART DIS, P1651; Linzbach AJ, 1960, J AM COLL CARDIOL, V5, P370; LIU CP, 1993, CIRCULATION, V88, P1893, DOI 10.1161/01.CIR.88.4.1893; Manders E, 2014, J AM COLL CARDIOL, V64, P28, DOI 10.1016/j.jacc.2014.04.031; Meyer M, 2014, J AM COLL CARDIOL, V64, P38, DOI 10.1016/j.jacc.2014.04.027; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Pellikka PA, 2007, J AM SOC ECHOCARDIOG, V20, P1021, DOI 10.1016/j.echo.2007.07.003; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; SAWADA SG, 1991, CIRCULATION, V83, P1605, DOI 10.1161/01.CIR.83.5.1605; Schoos MM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-84; Selby DE, 2011, J AM COLL CARDIOL, V58, P147, DOI 10.1016/j.jacc.2010.10.069; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Wachter R, 2009, EUR HEART J, V30, P3027, DOI 10.1093/eurheartj/ehp341; Watz H, 2010, CHEST, V138, P32, DOI 10.1378/chest.09-2810; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	39	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119432	10.1371/journal.pone.0119432	http://dx.doi.org/10.1371/journal.pone.0119432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756359	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700046
J	Seth, A; Ritchie, FK; Wibowo, N; Lua, LHL; Middelberg, APJ				Seth, Arjun; Ritchie, Fiona K.; Wibowo, Nani; Lua, Linda H. L.; Middelberg, Anton P. J.			Non-Carrier Nanoparticles Adjuvant Modular Protein Vaccine in a Particle-Dependent Manner	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; IMMUNE-RESPONSE; PATHOGEN RECOGNITION; L1 CAPSOMERES; IN-VITRO; DELIVERY; SIZE; IMMUNIZATION; PLATFORM; MICROPARTICLES	Nanoparticles are increasingly used to adjuvant vaccine formulations due to their biocompatibility, ease of manufacture and the opportunity to tailor their size, shape, and physicochemical properties. The efficacy of similarly-sized silica (Si-OH), poly (D,L-lactic-co-glycolic acid) (PLGA) and poly caprolactone (PCL) nanoparticles (nps) to adjuvant recombinant capsomere presenting antigenic M2e modular peptide from Influenza A virus (CapM2e) was investigated in vivo. Formulation of CapM2e with Si-OH or PLGA nps significantly boosted the immunogenicity of modular capsomeres, even though CapM2e was not actively attached to the nanoparticles prior to injection (i.e., formulation was by simple mixing). In contrast, PCL nps showed no significant adjuvant effect using this simple-mixing approach. The immune response induced by CapM2e alone or formulated with nps was antibody-biased with very high antigen-specific antibody titer and less than 20 cells per million splenocytes secreting interferon gamma. Modification of silica nanoparticle surface properties through amine functionalization and pegylation did not lead to significant changes in immune response. This study confirms that simple mixing-based formulation can lead to effective adjuvanting of antigenic protein, though with antibody titer dependent on nanoparticle physicochemical properties.	[Seth, Arjun; Ritchie, Fiona K.; Wibowo, Nani; Middelberg, Anton P. J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Lua, Linda H. L.] Univ Queensland, Prot Express Facil, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Middelberg, APJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	a.middelberg@uq.edu.au	Lua, Linda/B-4879-2010	Lua, Linda/0000-0002-9756-7083; Ritchie, Fiona/0000-0002-4545-6402; Middelberg, Anton/0000-0001-5922-5704	Queensland State Government	Queensland State Government	Funding for this study was provided by the Queensland State Government in the form of a Premier's Fellowship to APJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Champion JA, 2009, PHARM RES-DORDR, V26, P244, DOI 10.1007/s11095-008-9626-z; Chu CH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/18/185601; Correia-Pinto JF, 2013, INT J PHARMACEUT, V440, P27, DOI 10.1016/j.ijpharm.2012.04.047; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dey AK, 2011, EXPERT REV VACCINES, V10, P227, DOI 10.1586/ERV.10.142; Diwan M, 2002, J CONTROL RELEASE, V85, P247, DOI 10.1016/S0168-3659(02)00275-4; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Fifis T, 2004, VACCINE, V23, P258, DOI 10.1016/j.vaccine.2004.05.022; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Ibanez LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059081; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Kohli AK, 2004, INT J PHARMACEUT, V275, P13, DOI 10.1016/j.ijpharm.2003.10.038; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Liew MWO, 2012, BIOCHEM ENG J, V67, P88, DOI 10.1016/j.bej.2012.05.007; Lua LHL, 2014, BIOTECHNOL BIOENG, V111, P425, DOI 10.1002/bit.25159; Manish M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061885; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Middelberg APJ, 2011, VACCINE, V29, P7154, DOI 10.1016/j.vaccine.2011.05.075; Moon JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031472; Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905; Murata Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-81; Nakanishi T, 1999, J CONTROL RELEASE, V61, P233, DOI 10.1016/S0168-3659(99)00097-8; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Niikura K, 2013, ACS NANO, V7, P3926, DOI 10.1021/nn3057005; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI 10.1586/ERV.10.89; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Pejawar-Gaddy S, 2010, CANCER IMMUNOL IMMUN, V59, P1685, DOI 10.1007/s00262-010-0895-0; Plotkin S.L., 2004, VACCINES-BASEL, V5, P1; Raghuvanshi RS, 2002, INT J PHARMACEUT, V245, P109, DOI 10.1016/S0378-5173(02)00342-3; Rivera-Hernandez T, 2013, VACCINE, V31, P1950, DOI 10.1016/j.vaccine.2013.02.013; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Rose RC, 1998, J VIROL, V72, P6151, DOI 10.1128/JVI.72.7.6151-6154.1998; Roy S, 2010, LANGMUIR, V26, P18125, DOI 10.1021/la103212d; Sapp M, 2009, VIROLOGY, V384, P400, DOI 10.1016/j.virol.2008.12.022; Sayin B, 2008, INT J PHARMACEUT, V363, P139, DOI 10.1016/j.ijpharm.2008.06.029; Schadlich L, 2009, J VIROL, V83, P7690, DOI 10.1128/JVI.02588-08; Schussek S, 2013, INFECT IMMUN, V81, P3586, DOI 10.1128/IAI.00544-13; Senger T, 2010, VACCINE, V28, P1583, DOI 10.1016/j.vaccine.2009.11.048; Singh J, 2006, METHODS, V38, P96, DOI 10.1016/j.ymeth.2005.11.003; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Souza J, 2012, BIOMED RES INT, V2012; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Vallhov H, 2012, SMALL, V8, P2116, DOI 10.1002/smll.201102620; Wibowo N, 2014, VACCINE, V32, P3664, DOI 10.1016/j.vaccine.2014.04.043; Wibowo N, 2013, CHEM ENG SCI, V103, P12, DOI 10.1016/j.ces.2012.04.001; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Yan SY, 2013, J COLLOID INTERF SCI, V395, P1, DOI 10.1016/j.jcis.2012.11.061; Zhang WF, 2014, BIOMATERIALS, V35, P6086, DOI 10.1016/j.biomaterials.2014.04.022; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069; Zhou C, 2012, VACCINE, V30, P3463, DOI 10.1016/j.vaccine.2012.03.021	61	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117203	10.1371/journal.pone.0117203	http://dx.doi.org/10.1371/journal.pone.0117203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756283	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700015
J	Kumar, A; Tiwary, BK; Kachhap, S; Nanda, AK; Chakraborty, R				Kumar, Arvind; Tiwary, Bipransh Kumar; Kachhap, Sangita; Nanda, Ashis Kumar; Chakraborty, Ranadhir			An Escherichia coli Strain, PGB01, Isolated from Feral Pigeon Faeces, Thermally Fit to Survive in Pigeon, Shows High Level Resistance to Trimethoprim	PLOS ONE			English	Article							GROWTH-RATE; INTEGRONS; TEMPERATURE; SUSCEPTIBILITY; IDENTIFICATION; ENTEROCOCCUS; POPULATIONS; MECHANISMS; BACTERIA	In this study, of the hundred Escherichia coli strains isolated from feral Pigeon faeces, eighty five strains were resistant to one or more antibiotics and fifteen sensitive to all the antibiotics tested. The only strain (among all antibiotic-resistant E. coli isolates) that possessed class 1 integron was PGB01. The dihydrofolate reductase gene of the said integron was cloned, sequenced and expressed in E. coli JM109. Since PGB01 was native to pigeon's gut, we have compared the growth of PGB01 at two different temperatures, 42 degrees C (normal body temperature of pigeon) and 37 degrees C (optimal growth temperature of E. coli; also the human body temperature), with E. coli K12. It was found that PGB01 grew better than the laboratory strain E. coli K12 at 37 degrees C as well as at 42 degrees C. In the thermal fitness assay, it was observed that the cells of PGB01 were better adapted to 42 degrees C, resembling the average body temperature of pigeon. The strain PGB01 also sustained more microwave mediated thermal stress than E. coli K12 cells. The NMR spectra of the whole cells of PGB01 varied from E. coli K12 in several spectral peaks relating some metabolic adaptation to thermotolerance. On elevating the growth temperature from 37 degrees C to 42 degrees C, susceptibility to kanamycin (both strains were sensitive to it) of E. coli K12 was increased, but in case of PGB01 no change in susceptibility took place. We have also attempted to reveal the basis of trimethoprim resistance phenotype conferred by the dfrA7 gene homologue of PGB01. Molecular Dynamics (MD) simulation study of docked complexes, PGB01-DfrA7 and E. coli TMP-sensitive-Dfr with trimethoprim (TMP) showed loss of some of the hydrogen and hydrophobic interaction between TMP and mutated residues in PGB01-DfrA7-TMP complex compared to TMP-sensitive-Dfr-TMP complex. This loss of interaction entails decrease in affinity of TMP for PGB01-DfrA7 compared to TMP-sensitive-Dfr.	[Kumar, Arvind; Tiwary, Bipransh Kumar; Chakraborty, Ranadhir] Univ N Bengal, Dept Biotechnol, OMICS Lab, Darjeeling 734013, India; [Kumar, Arvind] Univ Delhi, Lignocellulose Biotechnol Lab, Dept Microbiol, New Delhi 110021, India; [Kachhap, Sangita] CSIR Inst Microbial Technol, Bioinformatis Ctr, Chandigarh, India; [Nanda, Ashis Kumar] Univ N Bengal, Dept Chem, Darjeeling 734013, India	University of North Bengal; University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of North Bengal	Chakraborty, R (corresponding author), Univ N Bengal, Dept Biotechnol, OMICS Lab, Darjeeling 734013, India.	rcnbusiliguri@gmail.com	CHAKRABORTY, RANADHIR/M-4439-2016; kachhap, sangita/X-2198-2019	kachhap, sangita/0000-0003-2009-1782; Kumar, Arvind/0000-0003-3405-2426; Tiwary, Bipransh/0000-0002-9479-8740	 [DBT-JRF/05-06/71/29.08.05];  [Biotechnology/BIO-CARe/06/141/2010-2011]	; 	AK was provided with independent Ph.D fellowships (Award No. DBT-JRF/05-06/71/29.08.05.). BKT was provided with fellowship funded by Biotechnology/BIO-CARe/06/141/2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT IL, 1960, BACTERIOL REV, V24, P16, DOI 10.1128/MMBR.24.1.16-34.1960; Bergey DH, 1984, BERGEYS MANUAL SYSTE; Bourne R, 2001, J CLIN MICROBIOL, V39, P2916, DOI 10.1128/JCM.39.8.2916-2923.2001; Bronikowski AM, 2001, EVOLUTION, V55, P33; Caldas T, 1999, MICROBIOL-SGM, V145, P2543, DOI 10.1099/00221287-145-9-2543; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Cooper VS, 2001, EVOLUTION, V55, P889, DOI 10.1554/0014-3820(2001)055[0889:EOTDOG]2.0.CO;2; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Gross WB, 1994, ESCHERICHIA COLI DOM, P237; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; ISHIGURO EE, 1985, J BACTERIOL, V164, P1233, DOI 10.1128/JB.164.3.1233-1237.1985; Jamshidi A, 2010, AFR J MICROBIOL RES, V4, P2371; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ko J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-198; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Kumar A, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-19; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; LEROI AM, 1994, P NATL ACAD SCI USA, V91, P1917, DOI 10.1073/pnas.91.5.1917; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; MACKOWIAK PA, 1981, AM J CLIN PATHOL, V76, P57; Martinez-Freijo P, 1998, J ANTIMICROB CHEMOTH, V42, P689, DOI 10.1093/jac/42.6.689; MATTHEWS DA, 1985, J BIOL CHEM, V260, P381; Menon S, 2007, Indian J Med Microbiol, V25, P330; Morabito S, 2001, VET MICROBIOL, V82, P275, DOI 10.1016/S0378-1135(01)00393-5; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mukherjee S, 2006, RES MICROBIOL, V157, P220, DOI 10.1016/j.resmic.2005.08.003; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Ponce-Rivas E, 2012, APPL ENVIRON MICROB, V78, P5444, DOI 10.1128/AEM.00660-12; Radimersky T, 2010, J APPL MICROBIOL, V109, P1687, DOI 10.1111/j.1365-2672.2010.04797.x; RAY PH, 1971, J GEN MICROBIOL, V66, P133, DOI 10.1099/00221287-66-2-133; Reisinger E, 1996, SCAND J INFECT DIS, V28, P155, DOI 10.3109/00365549609049067; Roberts Mary F., 2006, V39, P103; RON EZ, 1971, J BACTERIOL, V107, P391, DOI 10.1128/JB.107.2.391-396.1971; Shaffer MF, 1936, J EXP MED, V64, P281, DOI 10.1084/jem.64.2.281; Sharma SK, 1999, J MICROBIOL METH, V39, P45, DOI 10.1016/S0167-7012(99)00101-3; Silva VL, 2009, CURR MICROBIOL, V59, P302, DOI 10.1007/s00284-009-9434-7; SMALL PM, 1986, INFECT IMMUN, V52, P484, DOI 10.1128/IAI.52.2.484-487.1986; Sonntag AK, 2005, BERL MUNCH TIERARZTL, V118, P464; Tanaka C, 2005, J VET MED SCI, V67, P951, DOI 10.1292/jvms.67.951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiwary BK, 2014, INT J PHARM PHARM S, V6, P2393; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	44	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119329	10.1371/journal.pone.0119329	http://dx.doi.org/10.1371/journal.pone.0119329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750990	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700020
J	Escobar, MAH; Uribe, SV; Chiappe, R; Estades, CF				Escobar, Martin A. H.; Uribe, Sandra V.; Chiappe, Romina; Estades, Cristian F.			Effect of Clearcutting Operations on the Survival Rate of a Small Mammal	PLOS ONE			English	Article							SPRUCE-FIR FORESTS; SHORT-TERM IMPACT; TIMBER HARVEST; SILVICULTURAL SYSTEMS; BIRD POPULATIONS; SOIL COMPACTION; BOREAL FOREST; CENTRAL CHILE; HOME-RANGE; COMMUNITIES	Clearcutting is a common timber harvesting technique that represents a significant and abrupt change in habitat conditions for wildlife living in industrial forests. Most research on this type of impact has focused on comparing populations or communities in mature forests/plantations and the resulting clearcut stands. However, this approach does not separate the effect of changes in habitat attributes from direct mortality produced by the intensive use of heavy machinery required for cutting down trees and dragging them to a road. Because knowing the fate of individuals after a disturbance is important for modelling landscape-scale population dynamics in industrial forests, we conducted a study in South-Central Chile to understand the short-term response to clearcutting operations of the long-haired Akodont (Abrothrix longipillis), a forest specialist mouse. Between 2009 and 2013 we radio-tracked a total of 51 adult male Akodonts, before, during and after the clearcutting of the pine plantations in which they lived. A minimum of 52.4% of the individuals died as a direct cause of the timbering operations, being crushed by vehicles or logs during logging operations. Our observations suggest that, instead of fleeing the area, the response of long-haired Akodonts to the approaching machinery is to hide under the forest litter or in burrows, which exposes them to a serious risk of death. The real mortality rate associated to clearcutting may be higher than that estimated by us because of some methodological biases (i.e. individuals with crushed radiotransmitters not recorded) and the fact that additional mortality sources may affect the population in the weeks following logging operations (e.g. higher exposure to predation, effects of site preparation for the new plantation, etc).	[Escobar, Martin A. H.; Uribe, Sandra V.; Chiappe, Romina; Estades, Cristian F.] Univ Chile, Fac Ciencias Forest & Conservac Nat, Lab Ecol Vida Silvestre, Santiago, Chile	Universidad de Chile	Estades, CF (corresponding author), Univ Chile, Fac Ciencias Forest & Conservac Nat, Lab Ecol Vida Silvestre, Santiago, Chile.	cestades@u.uchile.cl	Estades, Cristian F/A-5221-2008	Estades, Cristian F/0000-0002-4479-7774	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [1080463, 1120314]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funding for this study was provided by "Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt) by grants 1080463 and 1120314 to CFE. MAHE was supported by a "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT) grant during his Ph.D. studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampoorter E, 2007, FOREST ECOL MANAG, V241, P162, DOI 10.1016/j.foreco.2007.01.019; ASH A N, 1988, Journal of the Elisha Mitchell Scientific Society, V104, P116; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; Bliss JC, 2000, J FOREST, V98, P4; Brennan KEC, 2011, AUSTRAL ECOL, V36, P131, DOI 10.1111/j.1442-9993.2010.02127.x; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; Di Rienzo J., INFOSTAT VERSION 201; Estades CF, 1999, ECOL APPL, V9, P573, DOI 10.1890/1051-0761(1999)009[0573:DFBCIA]2.0.CO;2; Estades CF, 2012, BIODIVERS CONSERV, P77; Ferron J, 1998, CAN J FOREST RES, V28, P1335, DOI 10.1139/cjfr-28-9-1335; Fuller AK, 2004, FOREST ECOL MANAG, V191, P373, DOI 10.1016/j.foreco.2004.01.014; Gajardo R., 1994, VEGETACION NATURAL C; Hagan JM, 1996, CONSERV BIOL, V10, P188, DOI 10.1046/j.1523-1739.1996.10010188.x; HANSIS R, 1995, HUM ORGAN, V54, P95, DOI 10.17730/humo.54.1.yj5338v42768002r; Hartmann H, 2010, FOREST CHRON, V86, P354, DOI 10.5558/tfc86354-3; INFOR, 2013, AN FOR B EST; Iroume A, 2006, HYDROL PROCESS, V20, P37, DOI 10.1002/hyp.5897; Jacob J, 2004, ECOSCIENCE, V11, P16, DOI 10.1080/11956860.2004.11682805; Jones Clyde, 1996, P115; Kerr G, 1999, FORESTRY, V72, P191, DOI 10.1093/forestry/72.3.191; Klenner W, 2003, CAN J FOREST RES, V33, P2283, DOI 10.1139/X03-142; LEVINE RL, 1979, FOREST SCI, V25, P317; LUCKENBACH RA, 1983, J APPL ECOL, V20, P265, DOI 10.2307/2403392; Mann-Fischer G., 1978, GAYANA ZOOL, V40, P1; MANNAN RW, 1984, J WILDLIFE MANAGE, V48, P1219, DOI 10.2307/3801783; McDonald J.H., 2009, HDB BIOL STAT; Mendonca M, 2007, TR0733 ERDCCERL USA; Metcalf CJE, 2007, ANIM CONSERV, V10, P478, DOI 10.1111/j.1469-1795.2007.00138.x; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Munoz-Pedreros A., 2009, MAMIFEROS CHILE; MUNOZPEDREROS A, 1992, REV CHIL HIST NAT, V65, P417; Niwa CG, 2001, NORTHWEST SCI, V75, P141; Acuna MP, 2011, BIOL CONSERV, V144, P1577, DOI 10.1016/j.biocon.2011.02.003; PETRANKA JW, 1994, FOREST ECOL MANAG, V67, P135, DOI 10.1016/0378-1127(94)90012-4; Picchio R, 2012, FOREST ECOL MANAG, V285, P38, DOI 10.1016/j.foreco.2012.08.008; Potvin F, 2005, CAN J FOREST RES, V35, P151, DOI 10.1139/X04-151; Prescott CE, 1997, FOREST ECOL MANAG, V95, P253, DOI 10.1016/S0378-1127(97)00027-3; Previtali MA, 2010, ECOLOGY, V91, P582, DOI 10.1890/08-2308.1; Reinert HK, 2011, J WILDLIFE MANAGE, V75, P19, DOI 10.1002/jwmg.35; Saavedra B, 2005, MAMMALIA, V69, P337, DOI 10.1515/mamm.2005.027; Sallabanks R, 2000, WILDLIFE SOC B, V28, P1144; San Martin J, 1996, ECOLOGIA BOSQUES NAT, P163, DOI 10.1016/ j. watres. 2013.08.031; Selmants PC, 2003, FOREST ECOL MANAG, V185, P275, DOI 10.1016/S0378-1127(03)00224-X; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Spellerberg IF, 1996, BIODIVERS CONSERV, V5, P447, DOI 10.1007/BF00056390; Steel RGD, 1988, BIOESTADISTICA PRINC, V1; Sullivan TP, 1999, J APPL ECOL, V36, P327, DOI 10.1046/j.1365-2664.1999.00408.x; Thompson ID, 2003, FOREST ECOL MANAG, V177, P441, DOI 10.1016/S0378-1127(02)00453-X; Tilghman JM, 2012, BIOL CONSERV, V152, P1, DOI 10.1016/j.biocon.2012.03.030; Todd BD, 2008, BIOL INVASIONS, V10, P539, DOI 10.1007/s10530-007-9150-9; TRENT TT, 1974, J WILDLIFE MANAGE, V38, P459, DOI 10.2307/3800877; Turcotte F, 2000, CAN J FOREST RES, V30, P202, DOI 10.1139/cjfr-30-2-202; Villasenor NR, 2013, EUR J WILDLIFE RES, V59, P749, DOI 10.1007/s10344-013-0730-y; Wegge P, 2011, FOREST ECOL MANAG, V261, P1520, DOI 10.1016/j.foreco.2011.01.041; White G.C., 1990, ANAL WILDLIFE RADIO; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	58	25	25	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118883	10.1371/journal.pone.0118883	http://dx.doi.org/10.1371/journal.pone.0118883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748217	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400028
J	Thampi, N; Gurol-Urganci, I; Crowcroft, NS; Sander, B				Thampi, Nisha; Gurol-Urganci, Ipek; Crowcroft, Natasha S.; Sander, Beate			Pertussis Post-Exposure Prophylaxis among Household Contacts: A Cost-Utility Analysis	PLOS ONE			English	Article							HYPERTROPHIC PYLORIC-STENOSIS; BORDETELLA-PERTUSSIS; ECONOMIC-EVALUATION; UNITED-STATES; ERYTHROMYCIN PROPHYLAXIS; EPIDEMIOLOGIC FEATURES; VACCINATION STRATEGIES; WHOOPING-COUGH; FUTURE COSTS; WHOLE-CELL	Background Recent pertussis outbreaks have prompted re-examination of post-exposure prophylaxis (PEP) strategies, when immunization is not immediately protective. Chemoprophylaxis is recommended to household contacts; however there are concerns of clinical failure and significant adverse events, especially with erythromycin among infants who have the highest disease burden. Newer macrolides offer fewer side effects at higher drug costs. We sought to determine the cost-effectiveness of PEP strategies from the health care payer perspective. Methods A Markov model was constructed to examine 4 mutually exclusive strategies: erythromycin, azithromycin, clarithromycin, or no intervention, stratified by age group of contacts ("infant", "child", and "adult"). Transition probabilities, costs and quality-adjusted life years (QALYs) were derived from the literature. Chronic neurologic sequelae were modeled over a lifetime, with costs and QALYs discounted at 5%. Associated health outcomes and costs were compared, and incremental cost-effectiveness ratios (ICER) were calculated in 2012 Canadian dollars. Deterministic and probabilistic sensitivity analyses were performed to evaluate the degree of uncertainty in the results. Findings Azithromycin offered the highest QALYs in all scenarios. While this was the dominant strategy among infants, it produced an ICER of $16,963 per QALY among children and $2,415 per QALY among adults. Total QALYs with azithromycin were 19.7 for a 5-kg infant, 19.4 for a 10-year-old child, and 18.8 for a 30-year-old adult. The costs of azithromycin PEP among infants, children and adults were $1,976, $132 and $90, respectively. While results were sensitive to changes in PEP effectiveness (11% to 87%), disease transmission (variable among age groups) and hospitalization costs ($379 to $59,644), the choice of strategy remained unchanged. Interpretation Pertussis PEP is a cost-effective strategy compared with no intervention and plays an important role in contact management, potentially in outbreak situations. From a healthcare payer perspective, azithromycin is the optimal strategy among all contact groups.	[Thampi, Nisha] Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON K1H 8L1, Canada; [Thampi, Nisha] Univ Ottawa, Ottawa, ON, Canada; [Gurol-Urganci, Ipek] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Crowcroft, Natasha S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Crowcroft, Natasha S.; Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada; [Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Sander, Beate] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Sander, Beate] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University of Toronto; University of Toronto	Thampi, N (corresponding author), Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON K1H 8L1, Canada.	nthampi@cheo.on.ca	Sander, Beate/P-7665-2018	Sander, Beate/0000-0003-2128-9133; Gurol-Urganci, Ipek/0000-0002-6517-3485				Altunaiji S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004404.pub3; Bank of Canada, 2012, INFLATION CALCULATOR; Bank of Canada, 2012, EXCHANGE RATES; Bank of Canada, 2012, YEAR AVERAGE OF EXCH; Bettinger JA, 2007, PEDIATR INFECT DIS J, V26, P31, DOI 10.1097/01.inf.0000247055.81541.04; BINKIN NJ, 1992, PEDIATR INFECT DIS J, V11, P653; BORTOLUSSI R, 1995, PEDIATR INFECT DIS J, V14, P870, DOI 10.1097/00006454-199510000-00010; Briggs A, 2006, DECISION MODELLING F; Bureau of Labor Statistics, 2012, CPI INFLATION CALCUL; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS48, DOI 10.1097/01.inf.0000160929.35004.86; Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation, 2016, PROBIOTICS ANTIBIOTI; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P73; Cherry J D, 1984, Curr Probl Pediatr, V14, P1; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Cherry JD, 1998, ANN INTERN MED, V128, P64, DOI 10.7326/0003-4819-128-1-199801010-00010; Clark TA, 2012, J PEDIATR-US, V161, P980, DOI 10.1016/j.jpeds.2012.07.014; Cohen E, 2012, PEDIATRICS, V130, pE1463, DOI 10.1542/peds.2012-0175; Coudeville L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006284; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Davis JP, 2005, PEDIATR INFECT DIS J, V24, pS109, DOI 10.1097/01.inf.0000166156.14422.9b; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; De Serres G, 2000, J INFECT DIS, V182, P174, DOI 10.1086/315648; DESERRES G, 1995, PEDIATR INFECT DIS J, V14, P969, DOI 10.1097/00006454-199511000-00009; Dodhia H, 2002, J PUBLIC HEALTH MED, V24, P200, DOI 10.1093/pubmed/24.3.200; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; FINE PEM, 1982, LANCET, V1, P666; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Goins WP, 2012, CLIN INFECT DIS, V54, P938, DOI 10.1093/cid/cir973; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; GROB PR, 1981, LANCET, V1, P772; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Halperin SA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e42; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; *HLTH CAN, 2003, CAN COMMUN DIS REP, V2953, P1; Honein MA, 1999, LANCET, V354, P2101, DOI 10.1016/S0140-6736(99)10073-4; HOPPE JE, 1989, EUR J CLIN MICROBIOL, V8, P653, DOI 10.1007/BF01968151; Iskedjian M, 2001, PHARMACOECONOMICS, V19, P551, DOI 10.2165/00019053-200119050-00009; Iskedjian M, 2010, VACCINE, V28, P714, DOI 10.1016/j.vaccine.2009.10.079; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; KOPLAN JP, 1979, NEW ENGL J MED, V301, P906, DOI 10.1056/NEJM197910253011703; Kuczmarski R J, 2000, Adv Data, P1; Langley JM, 2004, PEDIATRICS, V114, pE96, DOI 10.1542/peds.114.1.e96; Lebel MH, 2001, PEDIATR INFECT DIS J, V20, P1149, DOI 10.1097/00006454-200112000-00011; Lee GM, 2005, PEDIATRICS, V115, P1675, DOI 10.1542/peds.2004-2509; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2008, VACCINE, V26, P3673, DOI 10.1016/j.vaccine.2008.04.068; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; Lee RH, 2008, J HEALTH ECON, V27, P809, DOI 10.1016/j.jhealeco.2007.09.011; Mahon BE, 2001, J PEDIATR-US, V139, P380, DOI 10.1067/mpd.2001.117577; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; MILLER CL, 1976, BRIT MED J, V1, P117, DOI 10.1136/bmj.1.6002.117; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; Morrison W, 2007, PEDIATR INFECT DIS J, V26, P186, DOI 10.1097/01.inf.0000253063.87338.60; O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57; Oh PI, 1996, CLIN THER, V18, P160, DOI 10.1016/S0149-2918(96)80188-3; Ontario Ministry of Health and Long-Term Care, 2011, ONTARIO CASE COSTING; Ontario Ministry of Health and Long-Term Care, 2008, ONTARIO DRUG BENEFIT; Ontario Ministry of Health and Long-Term Care, 2013, ONTARIO DRUG BENEFIT; Pichichero ME, 1997, ARCH PEDIAT ADOL MED, V151, P35, DOI 10.1001/archpedi.1997.02170380039006; Public Health Ontario, 2012, MONTHLY INFECTIOUS D; Rodgers L, 2013, CLIN INFECT DIS, V56, P322, DOI 10.1093/cid/cis888; Roehr B, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4627; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; SPRAUER MA, 1992, AM J DIS CHILD, V146, P177, DOI 10.1001/archpedi.1992.02160140043018; Statistics Canada, 2011, DEATHS AND MORTALITY; Statistics Canada, 2012, CANADIAN VITAL STATI; STEKETEE RW, 1988, J INFECT DIS, V157, P434, DOI 10.1093/infdis/157.3.434; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Tiwari Tejpratap, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tjepkema M, 2011, HEALTH REPORTS, P22; Tozzi AE, 2003, PEDIATRICS, V112, P1069, DOI 10.1542/peds.112.5.1069; Ungar WJ, 2011, PHARMACOECONOMICS, V29, P641, DOI 10.2165/11591570-000000000-00000; Vickers D, 2006, CAN MED ASSOC J, V175, P1213, DOI 10.1503/cmaj.051637; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Westra TA, 2010, CLIN THER, V32, P1479, DOI 10.1016/j.clinthera.2010.07.017; WHO, 2003, WHO GUIDE TO COST EF; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041	82	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119271	10.1371/journal.pone.0119271	http://dx.doi.org/10.1371/journal.pone.0119271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747269	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000350689400062
J	Blake, SJP; Ching, ALH; Kenna, TJ; Galea, R; Large, J; Yagita, H; Steptoe, RJ				Blake, Stephen J. P.; Ching, Alan L. H.; Kenna, Tony J.; Galea, Ryan; Large, Justin; Yagita, Hideo; Steptoe, Raymond J.			Blockade of PD-1/PD-L1 Promotes Adoptive T-Cell Immunotherapy in a Tolerogenic Environment	PLOS ONE			English	Article							RESTING DENDRITIC CELLS; EFFECTOR FUNCTION; PERIPHERAL TOLERANCE; ANTI-PD-1 ANTIBODY; ANTITUMOR IMMUNITY; REGULATORY T; PD-1; PATHWAY; LIGAND; COMBINATION	Adoptive cellular immunotherapy using in vitro expanded CD8(+) T cells shows promise for tumour immunotherapy but is limited by eventual loss of function of the transferred T cells through factors that likely include inactivation by tolerogenic dendritic cells (DC). The co-inhibitory receptor programmed death-1 (PD-1), in addition to controlling T-cell responsiveness at effector sites in malignancies and chronic viral diseases is an important modulator of dendritic cell-induced tolerance in naive T cell populations. The most potent therapeutic capacity amongst CD8(+) T cells appears to lie within Tcm or Tcm-like cells but memory T cells express elevated levels of PD-1. Based on established trafficking patterns for Tcm it is likely Tcm-like cells interact with lymphoid-tissue DC that present tumour-derived antigens and may be inherently tolerogenic to develop therapeutic effector function. As little is understood of the effect of PD-1/PD-L1 blockade on Tcm-like CD8(+) T cells, particularly in relation to inactivation by DC, we explored the effects of PD-1/PD-L1 blockade in a mouse model where resting DC tolerise effector and memory CD8(+) T cells. Blockade of PD-1/PDL-1 promoted effector differentiation of adoptively-transferred Tcm-phenotype cells interacting with tolerising DC. In tumour-bearing mice with tolerising DC, effector activity was increased in both lymphoid tissues and the tumour-site and anti-tumour activity was promoted. Our findings suggest PD-1/PD-L1 blockade may be a useful adjunct for adoptive immunotherapy by promoting effector differentiation in the host of transferred Tcm-like cells.	[Blake, Stephen J. P.; Ching, Alan L. H.; Kenna, Tony J.; Galea, Ryan; Large, Justin; Steptoe, Raymond J.] Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	University of Queensland; Juntendo University	Steptoe, RJ (corresponding author), Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia.	r.steptoe@uq.edu.au	Steptoe, Raymond/B-3843-2011; Kenna, Tony/A-6035-2011	Steptoe, Raymond/0000-0002-6513-6406; Kenna, Tony/0000-0001-6844-3463	National Health and Medical Research Council [631402, GNT1013066]; Australian Research Council [FT110100372]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Funding was provided by the National Health and Medical Research Council (http://www.nhmrc.gov.au/) Project Grants (631402, GNT1013066) and an Australian Research Council (http://www.arc.gov.au/) ARC Future Fellowship (FT110100372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Berrien-Elliott MM, 2013, CANCER RES, V73, P605, DOI 10.1158/0008-5472.CAN-12-2179; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Currie AJ, 2009, J IMMUNOL, V183, P7898, DOI 10.4049/jimmunol.0901060; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Fiorenza S, 2012, J IMMUNOL, V189, P5622, DOI 10.4049/jimmunol.1200709; Goldberg MV, 2007, BLOOD, V110, P186, DOI 10.1182/blood-2006-12-062422; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; Huang XP, 2004, EUR J IMMUNOL, V34, P1351, DOI 10.1002/eji.200324734; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kenna TJ, 2008, BLOOD, V111, P2091, DOI 10.1182/blood-2007-07-103200; Kenna TJ, 2010, J IMMUNOL, V184, P598, DOI 10.4049/jimmunol.0900032; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2012, J IMMUNOTHER, V35, P651, DOI 10.1097/CJI.0b013e31827806e6; Kuipers H, 2006, EUR J IMMUNOL, V36, P2472, DOI 10.1002/eji.200635978; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; McDonnell AM, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/539519; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Reynoso ED, 2009, J IMMUNOL, V182, P2102, DOI 10.4049/jimmunol.0802769; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sierro SR, 2011, EUR J IMMUNOL, V41, P2217, DOI 10.1002/eji.201041235; Steptoe RJ, 2007, J IMMUNOL, V178, P2094, DOI 10.4049/jimmunol.178.4.2094; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsushima F, 2007, BLOOD, V110, P180, DOI 10.1182/blood-2006-11-060087; Wang AR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004306; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Xu DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056539; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yang SC, 2011, CANCER IMMUNOL IMMUN, V60, P739, DOI 10.1007/s00262-011-0977-7; Zhou QF, 2010, J IMMUNOL, V185, P5082, DOI 10.4049/jimmunol.1001821; Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	61	28	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119483	10.1371/journal.pone.0119483	http://dx.doi.org/10.1371/journal.pone.0119483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741704	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100115
J	Reed, C; Chaves, SS; Kirley, PD; Emerson, R; Aragon, D; Hancock, EB; Butler, L; Baumbach, J; Hollick, G; Bennett, NM; Laidler, MR; Thomas, A; Meltzer, MI; Finelli, L				Reed, Carrie; Chaves, Sandra S.; Kirley, Pam Daily; Emerson, Ruth; Aragon, Deborah; Hancock, Emily B.; Butler, Lisa; Baumbach, Joan; Hollick, Gary; Bennett, Nancy M.; Laidler, Matthew R.; Thomas, Ann; Meltzer, Martin I.; Finelli, Lyn			Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United States	PLOS ONE			English	Article							SEASONAL INFLUENZA; HOSPITALIZATIONS; VIRUS; CHILDREN; VACCINE; INFECTION; DEATHS	Annual estimates of the influenza disease burden provide information to evaluate programs and allocate resources. We used a multiplier method with routine population-based surveillance data on influenza hospitalization in the United States to correct for under-reporting and estimate the burden of influenza for seasons after the 2009 pandemic. Five sites of the Influenza Hospitalization Surveillance Network (FluSurv-NET) collected data on the frequency and sensitivity of influenza testing during two seasons to estimate under-detection. Population-based rates of influenza-associated hospitalization and Intensive Care Unit admission from 2010-2013 were extrapolated to the U. S. population from FluSurv-NET and corrected for under-detection. Influenza deaths were calculated using a ratio of deaths to hospitalizations. We estimated that influenza-related hospitalizations were under-detected during 2010-11 by a factor of 2.1 (95% CI 1.7-2.9) for age < 18 years, 3.1 (2.4-4.5) for ages 18-64 years, and 5.2 (95% CI 3.8-8.3) for age 65+. Results were similar in 2011-12. Extrapolated estimates for 3 seasons from 2010-2013 included: 114,192-624,435 hospitalizations, 18,491-95,390 ICU admissions, and 4,915-27,174 deaths per year; 54-70% of hospitalizations and 71-85% of deaths occurred among adults aged 65+. Influenza causes a substantial disease burden in the U. S. that varies by age and season. Periodic estimation of multipliers across multiple sites and age groups improves our understanding of influenza detection in sentinel surveillance systems. Adjusting surveillance data using a multiplier method is a relatively simple means to estimate the impact of influenza and the subsequent value of interventions to prevent influenza.	[Reed, Carrie; Chaves, Sandra S.; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Kirley, Pam Daily; Emerson, Ruth] Calif Emerging Infect Program, Oakland, CA USA; [Aragon, Deborah] Colorado Dept Publ Hlth & Environm, Colorado Emerging Infect Program, Denver, CO USA; [Hancock, Emily B.; Butler, Lisa; Baumbach, Joan] New Mexico Emerging Infect Program, Santa Fe, NM USA; [Hollick, Gary; Bennett, Nancy M.] Univ Rochester, Sch Med & Dent, New York Emerging Infect Program, Rochester, NY USA; [Laidler, Matthew R.; Thomas, Ann] Oregon Publ Hlth Div, Portland, OR USA; [Meltzer, Martin I.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; California Emerging Infections Program; Colorado Department of Public Health & Environment; University of Rochester; Centers for Disease Control & Prevention - USA	Reed, C (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	creed1@cdc.gov	Finelli, Lyn/AAK-2360-2020; Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472				Biggerstaff M, 2013, CLIN INFECT DIS, V57, pS12, DOI 10.1093/cid/cit273; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; Bresee J, 2013, MMWR-MORBID MORTAL W, V62, P997; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Grijalva CG, 2007, EPIDEMIOL INFECT, V135, P951, DOI 10.1017/S095026880600762X; Grijalva CG, 2006, EMERG INFECT DIS, V12, P103; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; McDonald SA, 2014, INFLUENZA OTHER RESP, V8, P33, DOI 10.1111/irv.12201; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Talbot HK, 2010, INFECT CONT HOSP EP, V31, P683, DOI 10.1086/653202; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Wakeling I, 2014, SAS MACRO FITTING BE; Young-Xu YN, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-58; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6	24	228	232	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118369	10.1371/journal.pone.0118369	http://dx.doi.org/10.1371/journal.pone.0118369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738736	Green Submitted, gold, Green Published			2022-12-26	WOS:000350685900032
J	Menezes, RST; Brady, SG; Carvalho, AF; Del Lama, MA; Costa, MA				Telles Menezes, Rodolpho Santos; Brady, Sean Gary; Carvalho, Antonio Freire; Del Lama, Marco Antonio; Costa, Marco Antonio			Molecular Phylogeny and Historical Biogeography of the Neotropical Swarm-Founding Social Wasp Genus Synoeca (Hymenoptera: Vespidae)	PLOS ONE			English	Article							CYANEA HYMENOPTERA; GENETIC DIVERSITY; ATLANTIC FOREST; BIODIVERSITY; INFERENCE; SAUSSURE; BRAZIL	The Neotropical Region harbors high biodiversity and many studies on mammals, reptiles, amphibians and avifauna have investigated the causes for this pattern. However, there is a paucity of such studies that focus on Neotropical insect groups. Synoeca de Saussure, 1852 is a Neotropical swarm-founding social wasp genus with five described species that is broadly and conspicuously distributed throughout the Neotropics. Here, we infer the phylogenetic relationships, diversification times, and historical biogeography of Synoeca species. We also investigate samples of the disjoint populations of S. septentrionalis that occur in both northwestern parts of South America through Central American and the Brazilian Atlantic rainforests. Our results showed that the interspecific relationships for Synoeca could be described as follows: (S. chalibea+S. virginea) + (S. cyanea + (S. septentrionalis/S. surinama)). Notably, samples of S. septentrionalis and S. surinama collected in the Atlantic Forest were interrelated and may be the result of incomplete lineage sorting and/or mitochondrial introgression among them. Our Bayesian divergence dating analysis revealed recent Plio-Pleistocene diversification in Synoeca. Moreover, our biogeographical analysis suggested an Amazonian origin of Synoeca, with three main dispersal events subsequently occurring during the Plio-Pleistocene.	[Telles Menezes, Rodolpho Santos; Costa, Marco Antonio] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, Bahia, Brazil; [Telles Menezes, Rodolpho Santos; Brady, Sean Gary] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Carvalho, Antonio Freire; Del Lama, Marco Antonio] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil	Universidade Estadual de Santa Cruz; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade Federal de Sao Carlos	Menezes, RST (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, Bahia, Brazil.	rodolphostm1@hotmail.com	Menezes, Rodolpho Santos Telles/B-2952-2014; Costa, Marco A/H-8035-2015; Carvalho, Antônio F./D-1954-2016	Menezes, Rodolpho Santos Telles/0000-0002-6612-3543; Carvalho, Antônio F./0000-0002-4270-4554	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq - 485276/2012-7]; Universidade Estadual de Santa Cruz [PROPP UESC - 00220.1100.395]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior "CAPES"; Brazilian Ministry of Education [BEX-12106/13-5]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [BOL0494/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Estadual de Santa Cruz; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior "CAPES"; Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	The authors are grateful for financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 485276/2012-7) and Universidade Estadual de Santa Cruz (PROPP UESC - 00220.1100.395). RSTM is thankful to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior "CAPES"; Brazilian Ministry of Education) for the scholarship BEX-12106/13-5 and to Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (BOL0494/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andena SR, 2009, ENTOMOL AM-NY, V115, P81, DOI 10.1664/07-RA-002R.1; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Behling H, 2000, QUATERNARY SCI REV, V19, P981, DOI 10.1016/S0277-3791(99)00046-3; Bermudes EGC, 1982, ACTA AMAZONICA, V12, P665; Bermudes EGC, 1981, REV BRAS BIOL, V26, P71; Bermudez EGC, 1981, ACTA AMAZONICA, V11, P377; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carpenter JM, 2013, ZOOTAXA, V3682, P421, DOI 10.11646/zootaxa.3682.3.3; Carpenter JM, 1997, AM MUS NOVIT, P3203; Carvalho AF, 2014, GENET MOL RES, V13, P89, DOI 10.4238/2014.January.8.7; CASTELLON E G, 1980, Acta Amazonica, V10, P883; CASTELLON E G, 1980, Acta Amazonica, V10, P679; Cely CC, 2011, ZOOTAXA, P43, DOI 10.11646/zootaxa.2899.1.2; COATES AG, 1992, GEOL SOC AM BULL, V104, P814, DOI 10.1130/0016-7606(1992)104<0814:COTIOP>2.3.CO;2; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elisei T, 2005, SOCIOBIOLOGY, V46, P317; Han HY, 1997, MOL PHYLOGENET EVOL, V7, P17, DOI 10.1006/mpev.1996.0370; He X.-J., 2014, RASP RECONSTRUCT ANC; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Knowles LL, 2010, ESTIMATING SPECIES T; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Menezes RST, 2011, ZOOKEYS, P75, DOI 10.3897/zookeys.151.1882; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Noda SCM, 2003, SOCIOBIOLOGY, V41, P547; Noll Fernando B., 2004, American Museum Novitates, V3467, P1, DOI 10.1206/0003-0082(2004)467<0001:EOCINW>2.0.CO;2; Rambaut A., 2009, FIGTREE TREE FIGURE; Rambaut A, 2009, TRACER V 1 5; Richards O.W., 1978, SOCIAL WASPS AM EXCL; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANZOLINI P E, 1974, Papeis Avulsos de Zoologia (Sao Paulo), V28, P61; Wenzel John W., 1998, American Museum Novitates, V3224, P1; Zwickl D. J, 2006, GENETIC ALGORITHM AP	44	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119151	10.1371/journal.pone.0119151	http://dx.doi.org/10.1371/journal.pone.0119151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738705	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900094
J	Vanderelst, D; Peremans, H; Razak, NA; Verstraelen, E; Dimitriadis, G				Vanderelst, Dieter; Peremans, Herbert; Razak, Norizham Abdul; Verstraelen, Edouard; Dimitriadis, Greg			The Aerodynamic Cost of Head Morphology in Bats: Maybe Not as Bad as It Seems	PLOS ONE			English	Article							BIG BROWN BAT; EPTESICUS-FUSCUS; PHYLLOSTOMUS-DISCOLOR; ECHOLOCATION BEHAVIOR; SPECTRAL CUES; EXTERNAL EAR; DIRECTIONALITY; FURROWS; STYLE	At first sight, echolocating bats face a difficult trade-off. As flying animals, they would benefit from a streamlined geometric shape to reduce aerodynamic drag and increase flight efficiency. However, as echolocating animals, their pinnae generate the acoustic cues necessary for navigation and foraging. Moreover, species emitting sound through their nostrils often feature elaborate noseleaves that help in focussing the emitted echolocation pulses. Both pinnae and noseleaves reduce the streamlined character of a bat's morphology. It is generally assumed that by compromising the streamlined charactered of the geometry, the head morphology generates substantial drag, thereby reducing flight efficiency. In contrast, it has also been suggested that the pinnae of bats generate lift forces counteracting the detrimental effect of the increased drag. However, very little data exist on the aerodynamic properties of bat pinnae and noseleaves. In this work, the aerodynamic forces generated by the heads of seven species of bats, including noseleaved bats, are measured by testing detailed 3D models in a wind tunnel. Models of Myotis daubentonii, Macrophyllum macrophyllum, Micronycteris microtis, Eptesicus fuscus, Rhinolophus formosae, Rhinolophus rouxi and Phyllostomus discolor are tested. The results confirm that non-streamlined facial morphologies yield considerable drag forces but also generate substantial lift. The net effect is a slight increase in the lift-to-drag ratio. Therefore, there is no evidence of high aerodynamic costs associated with the morphology of bat heads.	[Vanderelst, Dieter] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Vanderelst, Dieter; Peremans, Herbert] Univ Antwerp, Dept Engn Management, Act Percept Lab, B-2020 Antwerp, Belgium; [Razak, Norizham Abdul; Verstraelen, Edouard; Dimitriadis, Greg] Univ Sains Malaysia, Sch Aerosp Engn, Perai 14300, Pulau Pinang, Malaysia	University of Bristol; University of Antwerp; Universiti Sains Malaysia	Vanderelst, D (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	dieter.vanderelst@bristol.ac.uk	Razak, Norizham A Abdul/S-5964-2018	Razak, Norizham A Abdul/0000-0001-8249-3272; Dimitriadis, Grigorios/0000-0003-1684-7372	FWO [1.5.152.11N]; IEF	FWO(FWO); IEF	This study was funded by FWO grant 1.5.152.11N awarded to Herbert Peremans. Dieter Vanderelst was funded in part by an FWO postdoctoral fellowship and an IEF Marie Curie Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 2009, UNDERSTANDING FLIGHT; Barlow J.B., 1999, LOW SPEED WIND TUNNE; Bullen R, 2001, AUST J ZOOL, V49, P235, DOI 10.1071/ZO00037; Chiu C, 2007, ROLE EXTERNAL EAR VE; De Mey F, 2008, J ACOUST SOC AM, V124, P2123, DOI 10.1121/1.2968703; Eger J.L., 2003, Mammalian Species, V731, P1, DOI 10.1644/731; Eisenberg JF, 2000, MAMMALS NEOTROPICS, V3; FENTON MB, 1972, CAN J ZOOLOG, V50, P287, DOI 10.1139/z72-039; Firzlaff U, 2004, HEARING RES, V197, P74, DOI 10.1016/j.heares.2004.06.009; Firzlaff U, 2003, HEARING RES, V181, P27, DOI 10.1016/S0378-5955(03)00164-3; Garcia D, 2011, EXP FLUIDS, V50, P1247, DOI 10.1007/s00348-010-0985-y; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Gardiner JD, 2011, CAN J ZOOL, V89, P90, DOI 10.1139/Z10-096; Gardiner JD, 2008, ACTA CHIROPTEROL, V10, P313, DOI 10.3161/150811008X414881; Geipel I, 2013, PERCEPTION SILENT MO; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Hartley D. J., 1987, J ACOUST SOC AM, V82, P1987, DOI DOI 10.1121/1.395684; HOLDERIED MW, 2001, THESIS F ALEXANDER U; Jakobsen L, 2013, NATURE, V493, P93, DOI 10.1038/nature11664; Kunz TH, 1988, ECOLOGICAL BEHAV MET; Kurta A., 1990, MAMM SPECIES, V356, P1, DOI DOI 10.2307/3504258; Kwiecinski Gary G., 2006, Mammalian Species, P1, DOI 10.1644/801.1; Mogdans J, 1988, ROLE PINNA MOVEMENT; Muijres FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037335; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Nowak RM, 1994, WALKERS BATS WORLD; OBRIST MK, 1993, J EXP BIOL, V180, P119; Schnitzler HU, 2011, J COMP PHYSIOL A, V197, P541, DOI 10.1007/s00359-010-0569-6; SCHNITZLER HU, 1985, J COMP PHYSIOL A, V157, P39, DOI 10.1007/BF00611093; Schnyder HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112178; Seibert AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060752; Siemers BM, 2001, J EXP BIOL, V204, P3843; SIMMONS JA, 1969, J ACOUST SOC AM, V46, P1054, DOI 10.1121/1.1911804; Smith P, 2008, MAMMALS OF PARAGUAY; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Tennekes H., 2009, SIMPLE SCI FLIGHT; Vanderelst D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00191; Vanderelst D, 2012, J R SOC INTERFACE, V9, P1100, DOI 10.1098/rsif.2011.0812; Vanderelst D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002268; Vanderelst D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020627; Vanderelst D, 2010, LECT NOTES ARTIF INT, V6226, P136, DOI 10.1007/978-3-642-15193-4_13; Vanderelst D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011893; Vaughan TA., 1959, FUNCTIONAL MORPHOLOG; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271; WOTTON JM, 1995, J ACOUST SOC AM, V98, P1423, DOI 10.1121/1.413410; Wotton JM, 2000, J ACOUST SOC AM, V107, P1034, DOI 10.1121/1.428283; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701	50	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118545	10.1371/journal.pone.0118545	http://dx.doi.org/10.1371/journal.pone.0118545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739038	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900045
J	Roland, WSU; Sanders, MPA; van Buren, L; Gouka, RJ; Gruppen, H; Vincken, JP; Ritschel, T				Roland, Wibke S. U.; Sanders, Marijn P. A.; van Buren, Leo; Gouka, Robin J.; Gruppen, Harry; Vincken, Jean-Paul; Ritschel, Tina			Snooker Structure-Based Pharmacophore Model Explains Differences in Agonist and Blocker Binding to Bitter Receptor hTAS2R39	PLOS ONE			English	Article							ACTIVATE; IDENTIFICATION; REQUIREMENTS; ASSAY; T2R1; PTC	The human bitter taste receptor hTAS2R39 can be activated by many dietary (iso)flavonoids. Furthermore, hTAS2R39 activity can be blocked by 6-methoxyflavanones, 4'-fluoro-6-methoxyflavanone in particular. A structure-based pharmacophore model of the hTAS2R39 binding pocket was built using Snooker software, which has been used successfully before for drug design of GPCRs of the rhodopsin subfamily. For the validation of the model, two sets of compounds, both of which contained actives and inactives, were used: (i) an (iso) flavonoid-dedicated set, and (ii) a more generic, structurally diverse set. Agonists were characterized by their linear binding geometry and the fact that they bound deeply in the hTAS2R39 pocket, mapping the hydrogen donor feature based on T5.45 and N3.36, analogues of which have been proposed to play a key role in activation of GPCRs. Blockers lack hydrogen-bond donors enabling contact to the receptor. Furthermore, they had a crooked geometry, which could sterically hinder movement of the TM domains upon receptor activation. Our results reveal characteristics of hTAS2R39 agonist and bitter blocker binding, which might facilitate the development of blockers suitable to counter the bitterness of dietary hTAS2R39 agonists in food applications.	[Sanders, Marijn P. A.; Ritschel, Tina] Radboud Univ Nijmegen, Med Ctr, CMBI, Computat Discovery & Design Grp CDD, NL-6500 HB Nijmegen, Netherlands; [van Buren, Leo; Gouka, Robin J.] Unilever R&D, NL-3133 AT Vlaardingen, Netherlands	Radboud University Nijmegen; Unilever	Ritschel, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, CMBI, Computat Discovery & Design Grp CDD, NL-6500 HB Nijmegen, Netherlands.	tina.ritschel@radboudumc.nl		Vincken, Jean-Paul/0000-0001-8540-4327				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2013, CHEM SENSES, V38, P475, DOI 10.1093/chemse/bjt016; Behrens M, 2013, SEMIN CELL DEV BIOL, V24, P215, DOI 10.1016/j.semcdb.2012.08.006; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bohin MC, 2013, J AGR FOOD CHEM, V61, P10010, DOI 10.1021/jf4030823; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Dai WM, 2011, J RECEPT SIG TRANSD, V31, P229, DOI 10.3109/10799893.2011.578141; Fletcher JN, 2011, J AGR FOOD CHEM, V59, P13117, DOI 10.1021/jf204359q; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Hellfritsch C, 2012, J AGR FOOD CHEM, V60, P6782, DOI 10.1021/jf301297n; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Levit Anat, 2012, Methods Mol Biol, V914, P179, DOI 10.1007/978-1-62703-023-6_11; Ley JP, 2012, J AGR FOOD CHEM, V60, P6303, DOI 10.1021/jf301335z; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Marchiori A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064675; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Molecular Operating Environment (MOE), 2011, MOL OP ENV MOE 2011; Narukawa M, 2011, BIOCHEM BIOPH RES CO, V405, P620, DOI 10.1016/j.bbrc.2011.01.079; Renner S, 2004, J MED CHEM, V47, P4653, DOI 10.1021/jm031139y; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Sanders MPA, 2011, J CHEM INF MODEL, V51, P2277, DOI 10.1021/ci200088d; Sanders MPA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-332; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Tan J, 2012, J CHEM INF MODEL, V52, P1875, DOI 10.1021/ci300133a; Thalmann S, 2013, BIOCHEM BIOPH RES CO, V435, P267, DOI 10.1016/j.bbrc.2013.04.066; Ueno Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1188, DOI 10.1271/bbb.100893; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009	38	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118200	10.1371/journal.pone.0118200	http://dx.doi.org/10.1371/journal.pone.0118200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729848	Green Published, Green Submitted, gold			2022-12-26	WOS:000350684900018
J	Sarkar, M; Khare, V; Guturi, KKN; Das, N; Ghosh, MK				Sarkar, M.; Khare, V.; Guturi, K. K. N.; Das, N.; Ghosh, M. K.			The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; CANCER CELLS; EXPRESSION; PATHWAY; AKT; OVEREXPRESSION; PROGRESSION; ACTIVATION; KINASE; PLAYS	Increased abundance of proto-oncogene AKT and reduced expression of tumor suppressor Forkhead box O3 (FOXO3a), the downstream target of AKT, is frequent in carcinogenesis. Mechanistic insights of AKT gene regulation are limited. DEAD box RNA helicase p68 is overexpressed in various cancers and acts as a transcriptional co-activator of several transcription factors, including beta-catenin. Here, we report a novel mechanism of p68-mediated transcriptional activation of AKT, and its ensuing effect on FOXO3a, in colon carcinogenesis. Interestingly, we found that the expression of p68 and AKT exhibits strong positive correlation in normal and colon carcinoma patient samples. In addition, p68 increased both AKT messenger RNA (mRNA) and protein, enhanced AKT promoter activity in multiple colon cancer cell lines. Conversely, p68 knockdown led to reduced AKT mRNA and protein, diminished AKT promoter activity. Here, we demonstrated that p68 occupies AKT promoter with beta-catenin as well as nuclear factor-kappa B (NF-kappa B) and cooperates with these in potentiating AKT transcription. Furthermore, p68 and FOXO3a expression followed inverse correlation in the same set of colon carcinoma samples. We observed that p68 significantly reduced FOXO3a protein level in an AKT-dependent manner. Studies in primary tumors and metastatic lung nodules generated in mice colorectal allograft model, using syngeneic cells stably expressing p68, corroborated our in vitro findings. Hence, a new mechanism of oncogenesis is attributed to p68 by upregulation of AKT and consequent nuclear exclusion and degradation of tumor suppressor FOXO3a.	[Sarkar, M.; Khare, V.; Guturi, K. K. N.; Das, N.; Ghosh, M. K.] Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Sarkar, M (corresponding author), Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	mrinal.res@gmail.com		Sarkar, Dr Moumita/0000-0002-7437-5353	CSIR, India [EMPOWER-OLP-002, MEDCHEM-BSC0108, CSIR-MAYO: MLP-0017]	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	We thank Dr Frances V Fuller-Pace, Dr KM Yamada and Dr B Alman for gifting us the pGS5-p68 construct, pGZ21dx vector and pBI-beta-catenin construct, respectively; Dr Uttara Chatterjee (Park Clinic, Kolkata, India) for providing human normal colon and colon carcinoma samples, associated pathological reports and helping in analysis of the related data; Dr Samit Adhya for kindly providing us the facility for animal lung imaging. This work is supported by grants from CSIR, India (EMPOWER-OLP-002, MEDCHEM-BSC0108 and CSIR-MAYO: MLP-0017).	Bhattacharya S, 2014, FEBS J, V281, P3061, DOI 10.1111/febs.12843; Bhowmik A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059798; Bullock MD, 2013, BRIT J CANCER, V109, P387, DOI 10.1038/bjc.2013.355; Cai BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041742; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Du Qiang, 2010, For Immunopathol Dis Therap, V1, P155; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iwamoto M, 2000, CARCINOGENESIS, V21, P1935, DOI 10.1093/carcin/21.11.1935; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Johnson SM, 2010, J AM COLL SURGEONS, V210, P767, DOI 10.1016/j.jamcollsurg.2009.12.008; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Malinowsky K, 2014, BRIT J CANCER, V110, P2081, DOI 10.1038/bjc.2014.100; Mandal T, 2014, CELL SIGNAL, V26, P1725, DOI 10.1016/j.cellsig.2014.04.003; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Temraz S, 2013, INT J MOL SCI, V14, P17279, DOI 10.3390/ijms140917279; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang R, 2012, NEURO-ONCOLOGY, V14, P1116, DOI 10.1093/neuonc/nos131; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Zhang JX, 2011, NEURO-ONCOLOGY, V13, P600, DOI 10.1093/neuonc/nor034	39	35	39	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2015	34	47					5843	5856		10.1038/onc.2015.42	http://dx.doi.org/10.1038/onc.2015.42			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW5KV	25745998				2022-12-26	WOS:000365035200007
J	Piao, CM; Cai, L; Qiu, SL; Jia, LX; Song, WC; Du, J				Piao, Chunmei; Cai, Lun; Qiu, Shulan; Jia, Lixin; Song, Wenchao; Du, Jie			Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECAY-ACCELERATING FACTOR; INDUCED CARDIAC INFLAMMATION; MEMBRANE COFACTOR PROTEIN; SMALL-SUBUNIT P53R2; TUMOR MICROENVIRONMENT; REGULATORY PROTEINS; IN-VIVO; CONTRIBUTES; PROGRESSION; CARCINOMA	Complement 5a (C5a), a potent immune mediator generated by complement activation, promotes tumor growth; however, its role in tumor metastasis remains unclear. We demonstrate that C5a contributes to tumor metastases by modulating tumor inflammation in hepatic metastases of colon cancer. Colon cancer cell lines generate C5a under serum-free conditions, and C5a levels increase over time in a murine syngeneic colon cancer hepatic metastasis model. Furthermore, in the absence of C5a receptor or upon pharmacological inhibition of C5a production with an anti-C5 monoclonal antibody, tumor metastasis is severely impaired. A lack of C5a receptor in colon cancer metastatic foci reduces the infiltration of macrophages, neutrophils, and dendritic cells, and the role for C5a receptor on these cells were further verified by bone marrow transplantation experiments. Moreover, C5a signaling increases the expression of the chemokine monocyte chemoattractant protein-1 and the anti-inflammatory molecules arginase-1, interleukin 10, and transforming growth factor beta, but is inversely correlated with the expression of pro-inflammatory molecules, which suggests a mechanism for the role of C5a in the inflammatory microenvironment required for tumor metastasis. Our results indicate a new and potentially promising therapeutic application of complement C5a inhibitor for the treatment of malignant tumors.	[Piao, Chunmei; Cai, Lun; Qiu, Shulan; Jia, Lixin; Song, Wenchao; Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing 100029, Peoples R China; [Piao, Chunmei; Du, Jie] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ, Beijing 100029, Peoples R China	Capital Medical University; Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China.	jdu@bcm.edu		, Chunmei/0000-0002-2975-7336	Chinese High Technology Research and Development Program [2012AA02A201]; National Natural Science Foundation of China [81301797, 31090363, 81430050]; Beijing Natural Science Foundation [7122026]	Chinese High Technology Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Chinese High Technology Research and Development Program Grant 2012AA02A201, National Natural Science Foundation of China Grants 81301797, 31090363, and 81430050, and Beijing Natural Science Foundation Grant 7122026.	Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Gao D, 2009, TRENDS MOL MED, V15, P333, DOI 10.1016/j.molmed.2009.06.006; Ghebrehiwet B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00278; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hu HY, 2006, J PHARM SCI-US, V95, P192, DOI 10.1002/jps.20517; INOUE H, 1994, ACTA MED OKAYAMA, V48, P271; Ji RC, 2014, CANCER LETT, V346, P6, DOI 10.1016/j.canlet.2013.12.001; Lanca T, 2012, ONCOIMMUNOLOGY, V1, P717, DOI 10.4161/onci.20068; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Ma FF, 2014, J IMMUNOL, V192, P3365, DOI 10.4049/jimmunol.1301522; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Miwa T, 2013, J IMMUNOL, V190, P3552, DOI 10.4049/jimmunol.1202275; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Mueller-Ortiz SL, 2014, J IMMUNOL, V193, P1278, DOI 10.4049/jimmunol.1302787; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Niehans GA, 1996, AM J PATHOL, V149, P129; Ostrand-Rosenberg S, 2008, NAT BIOTECHNOL, V26, P1348, DOI 10.1038/nbt1208-1348; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Peerschke EIB, 2014, MOL IMMUNOL, V61, P100, DOI 10.1016/j.molimm.2014.06.011; Peng Q, 2009, J IMMUNOL, V183, P6058, DOI 10.4049/jimmunol.0804186; Piao C, 2009, ONCOGENE, V28, P2173, DOI 10.1038/onc.2009.84; Piao C, 2012, CELL CYCLE, V11, P3237, DOI 10.4161/cc.21591; Qiu SL, 2014, J BIOL CHEM, V289, P9449, DOI 10.1074/jbc.M113.543447; Rombouts K, 2013, CANCER LETT, V333, P244, DOI 10.1016/j.canlet.2013.01.040; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Saxena A, 2013, INT J COLORECTAL DIS, V28, P1267, DOI 10.1007/s00384-013-1664-2; SCHEELE J, 1990, BRIT J SURG, V77, P1241, DOI 10.1002/bjs.1800771115; Tang Hui, 2013, Adv Biosci Biotechnol, V4, P30; Thorsteinsson L, 1998, APMIS, V106, P869, DOI 10.1111/j.1699-0463.1998.tb00233.x; Wang SY, 2008, EXPERT OPIN BIOL TH, V8, P759, DOI [10.1517/14712598.8.6.759, 10.1517/14712598.8.6.759 ]; Wilczek E, 2008, INT J CANCER, V122, P2030, DOI 10.1002/ijc.23238; Wu YN, 2014, HYPERTENSION, V63, P1241, DOI 10.1161/HYPERTENSIONAHA.113.02843; Xu B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/437950; Yang M, 2014, CELL DEATH DIFFER, V21, P1290, DOI 10.1038/cdd.2014.45; Yang M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-43; Zhang CC, 2014, ARTERIOSCL THROM VAS, V34, P1240, DOI 10.1161/ATVBAHA.113.303120; Zheng J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-141; Zhou WD, 2012, IMMUNOBIOLOGY, V217, P225, DOI 10.1016/j.imbio.2011.07.016	50	60	61	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10667	10676		10.1074/jbc.M114.612622	http://dx.doi.org/10.1074/jbc.M114.612622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25739439	hybrid, Green Published			2022-12-26	WOS:000353404500010
J	Evans, JC; Robinson, CM; Shi, MJ; Webb, DJ				Evans, J. Corey; Robinson, Cristina M.; Shi, Mingjian; Webb, Donna J.			The Guanine Nucleotide Exchange Factor (GEF) Asef2 Promotes Dendritic Spine Formation via Rac Activation and Spinophilin-dependent Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendrite; Guanine Nucleotide Exchange Factor (GEF); Neuron; Rac (Rac GTPase); Rho (Rho GTPase); Synapse	LINKED MENTAL-RETARDATION; ACTIN-BASED PLASTICITY; HIPPOCAMPAL-NEURONS; RHO-GTPASE; CRYSTAL-STRUCTURE; BINDING-PROTEIN; CELL-MIGRATION; NMDA RECEPTOR; N-WASP; MORPHOGENESIS	Dendritic spines are actin-rich protrusions that establish excitatory synaptic contacts with surrounding neurons. Reorganization of the actin cytoskeleton is critical for the development and plasticity of dendritic spines, which is the basis for learning and memory. Rho family GTPases are emerging as important modulators of spines and synapses, predominantly through their ability to regulate actin dynamics. Much less is known, however, about the function of guanine nucleotide exchange factors (GEFs), which activate these GTPases, in spine and synapse development. In this study we show that the Rho family GEF Asef2 is found at synaptic sites, where it promotes dendritic spine and synapse formation. Knockdown of endogenous Asef2 with shRNAs impairs spine and synapse formation, whereas exogenous expression of Asef2 causes an increase in spine and synapse density. This effect of Asef2 on spines and synapses is abrogated by expression of GEF activity-deficient Asef2 mutants or by knockdown of Rac, suggesting that Asef2-Rac signaling mediates spine development. Because Asef2 interacts with the F-actin-binding protein spinophilin, which localizes to spines, we investigated the role of spinophilin in Asef2-promoted spine formation. Spinophilin recruits Asef2 to spines, and knockdown of spinophilin hinders spine and synapse formation in Asef2-expressing neurons. Furthermore, inhibition of N-methyl-d-aspartate receptor (NMDA) activity blocks spinophilin-mediated localization of Asef2 to spines. These results collectively point to spinophilin-Asef2-Rac signaling as a novel mechanism for the development of dendritic spines and synapses.	[Evans, J. Corey; Robinson, Cristina M.; Shi, Mingjian; Webb, Donna J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Evans, J. Corey; Robinson, Cristina M.; Shi, Mingjian; Webb, Donna J.] Vanderbilt Univ, Kennedy Ctr Res Human Dev, Nashville, TN 37235 USA; [Webb, Donna J.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Webb, DJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	donna.webb@vanderbilt.edu		Shi, Mingjian/0000-0003-1569-9822	National Institutes of Health [GM092914, MH071674, GM008554]; National Center for Research Resources [S10RR025524]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092914, T32GM008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM092914 and MH071674 and by National Center for Research Resources Grant S10RR025524 (to D. J. W.).; Supported by National Institutes of Health Predoctoral Training Grant GM008554.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allison DW, 1998, J NEUROSCI, V18, P2423; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Becker JAJ, 2008, NEUROSCIENCE, V156, P950, DOI 10.1016/j.neuroscience.2008.07.070; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Dailey ME, 1996, J NEUROSCI, V16, P2983; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; DRENCKHAHN D, 1984, BRAIN RES, V300, P381, DOI 10.1016/0006-8993(84)90851-5; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gass JT, 2012, ACS CHEM NEUROSCI, V3, P494, DOI 10.1021/cn300013p; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Goslin K., 1998, CULTURING NERVE CELL, P339; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; GRAY EG, 1959, J ANAT, V93, P420; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jean L, 2013, J CELL SCI, V126, P5585, DOI 10.1242/jcs.131060; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2009, J BIOL CHEM, V284, P22436, DOI 10.1074/jbc.M109.020768; Kelker MS, 2007, BIOCHEMISTRY-US, V46, P2333, DOI 10.1021/bi602341c; Knaus Ulla G., 2007, V412, P59, DOI 10.1007/978-1-59745-467-4_5; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Lin WH, 2010, J BIOL CHEM, V285, P36010, DOI 10.1074/jbc.M110.129841; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Ma XM, 2003, J NEUROSCI, V23, P10593; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Muroya K, 2007, BIOCHEM BIOPH RES CO, V355, P85, DOI 10.1016/j.bbrc.2007.01.131; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ota KT, 2013, NEUROBIOL DIS, V57, P28, DOI 10.1016/j.nbd.2012.05.022; PAPA M, 1995, J NEUROSCI, V15, P1; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Rajagopal S, 2010, J BIOL CHEM, V285, P18060, DOI 10.1074/jbc.M109.051490; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sagara M, 2009, ONCOGENE, V28, P1357, DOI 10.1038/onc.2008.478; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Scott EK, 2003, J NEUROSCI, V23, P3118; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Stafstrom-Davis CA, 2001, LEARN MEMORY, V8, P272, DOI 10.1101/lm.42101; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; WEST M, 1990, FEBS LETT, V259, P245, DOI 10.1016/0014-5793(90)80019-F; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yoshizawa M, 2003, GENE EXPR PATTERNS, V3, P375, DOI 10.1016/S1567-133X(03)00002-4; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	80	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10295	10308		10.1074/jbc.M114.605543	http://dx.doi.org/10.1074/jbc.M114.605543			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25750125	Green Published, hybrid			2022-12-26	WOS:000353241100033
J	Planque, SA; Nishiyama, Y; Sonoda, S; Lin, Y; Taguchi, H; Hara, M; Kolodziej, S; Mitsuda, Y; Gonzalez, V; Sait, HBR; Fukuchi, K; Massey, RJ; Friedland, RP; O'Nuallain, B; Sigurdsson, EM; Paul, S				Planque, Stephanie A.; Nishiyama, Yasuhiro; Sonoda, Sari; Lin, Yan; Taguchi, Hiroaki; Hara, Mariko; Kolodziej, Steven; Mitsuda, Yukie; Gonzalez, Veronica; Sait, Hameetha B. R.; Fukuchi, Ken-ichiro; Massey, Richard J.; Friedland, Robert P.; O'Nuallain, Brian; Sigurdsson, Einar M.; Paul, Sudhir			Specific Amyloid beta Clearance by a Catalytic Antibody Construct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid- (Abeta); Antibody Engineering; Enzyme Catalysis; Immunotherapy; Innate Immunity; Catalytic Antibodies; Light Chain Variable Domain; Neurotoxicity	BLOOD-BRAIN-BARRIER; MODERATE ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; TRANSGENIC MICE; MOUSE MODEL; CHAIN ANTIBODIES; HEAVY-CHAIN; OLIGOMERS; PEPTIDES	Classical immunization methods do not generate catalytic antibodies (catabodies), but recent findings suggest that the innate antibody repertoire is a rich catabody source. We describe the specificity and amyloid (A)-clearing effect of a catabody construct engineered from innate immunity principles. The catabody recognized the A C terminus noncovalently and hydrolyzed A rapidly, with no reactivity to the A precursor protein, transthyretin amyloid aggregates, or irrelevant proteins containing the catabody-sensitive A dipeptide unit. The catabody dissolved preformed A aggregates and inhibited A aggregation more potently than an A-binding IgG. Intravenous catabody treatment reduced brain A deposits in a mouse Alzheimer disease model without inducing microgliosis or microhemorrhages. Specific A hydrolysis appears to be an innate immune function that could be applied for therapeutic A removal.	[Planque, Stephanie A.; Nishiyama, Yasuhiro; Sonoda, Sari; Taguchi, Hiroaki; Hara, Mariko; Kolodziej, Steven; Mitsuda, Yukie; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Lin, Yan; Gonzalez, Veronica; Sait, Hameetha B. R.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Lin, Yan; Gonzalez, Veronica; Sait, Hameetha B. R.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Fukuchi, Ken-ichiro] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Massey, Richard J.] Covalent Biosci Inc, Houston, TX 77054 USA; [Friedland, Robert P.] Univ Louisville, Dept Neurol, Sch Med, Louisville, KY 40202 USA; [O'Nuallain, Brian] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [O'Nuallain, Brian] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; New York University; New York University; University of Illinois System; University of Illinois Peoria; University of Louisville; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sigurdsson, EM (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, 450 East 29th St, New York, NY 10016 USA.	Einar.Sigurdsson@nyumc.org; Sudhir.Paul@uth.tmc.edu	Friedland, Robert/A-2834-2010	Friedland, Robert/0000-0001-5721-1843; Sigurdsson, Einar/0000-0003-1451-0952	National Institutes of Health [R01AG025304, 5U01AG033183, R01AG020197]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032611, U01AG033183, R01AG020197, R01AG025304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG025304, 5U01AG033183, and R01AG020197. S. A. P., Y. N., R. J. M., and S. P. have a financial interest in Covalent Bioscience, Inc. and patents concerning catalytic antibodies.	Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; Asuni AA, 2006, EUR J NEUROSCI, V24, P2530, DOI 10.1111/j.1460-9568.2006.05149.x; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Berger V, 2013, PROTEIN ENG DES SEL, V26, P581, DOI 10.1093/protein/gzt044; Chesneau V, 2000, BIOCHEM J, V351, P509, DOI 10.1042/0264-6021:3510509; Colcher D, 1998, Q J NUCL MED, V42, P225; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Efthimiopoulos S, 1996, P NATL ACAD SCI USA, V93, P8046, DOI 10.1073/pnas.93.15.8046; Fukuchi K, 2006, NEUROBIOL DIS, V23, P502, DOI 10.1016/j.nbd.2006.04.012; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Goodyear CS, 2005, SPRINGER SEMIN IMMUN, V26, P463, DOI 10.1007/s00281-004-0190-2; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kalinin S, 2013, NEUROBIOL AGING, V34, P2361, DOI 10.1016/j.neurobiolaging.2013.03.023; Kasturirangan S, 2010, BIOCHEMISTRY-US, V49, P4501, DOI 10.1021/bi902030m; Kitazume S, 2012, J BIOL CHEM, V287, P40817, DOI 10.1074/jbc.M112.398578; Kou JH, 2015, MOL NEUROBIOL, V51, P43, DOI 10.1007/s12035-014-8691-z; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Lei CY, 2013, J NEUROL NEUROSUR PS, V84, P693, DOI 10.1136/jnnp-2012-303948; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Li L, 1996, MOL IMMUNOL, V33, P593, DOI 10.1016/0161-5890(96)00021-1; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Morkuniene R, 2013, J NEUROCHEM, V126, P604, DOI 10.1111/jnc.12332; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Piazza F, 2013, ANN NEUROL, V73, P449, DOI 10.1002/ana.23857; Planque SA, 2014, J BIOL CHEM, V289, P13243, DOI 10.1074/jbc.M114.557231; POLLACK SJ, 1989, J AM CHEM SOC, V111, P5961, DOI 10.1021/ja00197a078; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Randall AD, 2010, NEUROPHARMACOLOGY, V59, P243, DOI 10.1016/j.neuropharm.2010.02.011; Robert R, 2012, ARCH BIOCHEM BIOPHYS, V526, P132, DOI 10.1016/j.abb.2012.02.022; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; SCHURR JM, 1966, SCIENCE, V152, P1064, DOI 10.1126/science.152.3725.1064; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Thomas FC, 2009, PHARM RES-DORDR, V26, P2486, DOI 10.1007/s11095-009-9964-5; Tucker HM, 2002, J NEUROSCI RES, V70, P249, DOI 10.1002/jnr.10417; Vasilevko V, 2007, J NEUROSCI, V27, P13376, DOI 10.1523/JNEUROSCI.2788-07.2007; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Zago Wagner, 2013, Alzheimers Dement, V9, pS105, DOI 10.1016/j.jalz.2012.11.010; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011	61	23	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10229	10241		10.1074/jbc.M115.641738	http://dx.doi.org/10.1074/jbc.M115.641738			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724648	hybrid, Green Published			2022-12-26	WOS:000353241100029
J	Damgaard, C; Magnussen, K; Enevold, C; Nilsson, M; Tolker-Nielsen, T; Holmstrup, P; Nielsen, CH				Damgaard, Christian; Magnussen, Karin; Enevold, Christian; Nilsson, Martin; Tolker-Nielsen, Tim; Holmstrup, Palle; Nielsen, Claus Henrik			Viable Bacteria Associated with Red Blood Cells and Plasma in Freshly Drawn Blood Donations	PLOS ONE			English	Article							DONOR-ARM DISINFECTION; STAPHYLOCOCCUS-EPIDERMIDIS; PROPIONIBACTERIUM-ACNES; TRANSFUSION; INFECTION; RISK; CONTAMINATION; ENDOCARDITIS; DIVERSION; PRODUCTS	Objectives Infection remains a leading cause of post-transfusion mortality and morbidity. Bacterial contamination is, however, detected in less than 0.1% of blood units tested. The aim of the study was to identify viable bacteria in standard blood-pack units, with particular focus on bacteria from the oral cavity, and to determine the distribution of bacteria revealed in plasma and in the red blood cell (RBC)-fraction. Design Cross-sectional study. Blood were separated into plasma and RBC-suspensions, which were incubated anaerobically or aerobically for 7 days on trypticase soy blood agar (TSA) or blue lactose plates. For identification colony PCR was performed using primers targeting 16S rDNA. Setting Blood donors attending Capital Region Blood Bank, Copenhagen University Hospital, Rig-shospitalet, Hvidovre, Denmark, October 29th to December 10th 2013. Participants 60 donors (>= 50 years old), self-reported medically healthy. Results Bacterial growth was observed on plates inoculated with plasma or RBCs from 62% of the blood donations. Growth was evident in 21 (35%) of 60 RBC-fractions and in 32 (53%) of 60 plasma-fractions versus 8 of 60 negative controls (p = 0.005 and p = 2.6x10(-6), respectively). Propionibacterium acnes was found in 23% of the donations, and Staphylococcus epidermidis in 38%. The majority of bacteria identified in the present study were either facultative anaerobic (59.5%) or anaerobic (27.8%) species, which are not likely to be detected during current routine screening. Conclusions Viable bacteria are present in blood from donors self-reported as medically healthy, indicating that conventional test systems employed by blood banks insufficiently detect bacteria in plasma. Further investigation is needed to determine whether routine testing for anaerobic bacteria and testing of RBC-fractions for adherent bacteria should be recommended.	[Damgaard, Christian; Enevold, Christian; Holmstrup, Palle; Nielsen, Claus Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark; [Damgaard, Christian; Enevold, Christian; Nielsen, Claus Henrik] Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol, Copenhagen, Denmark; [Magnussen, Karin] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Hvidovre, Denmark; [Magnussen, Karin] Copenhagen Univ Hosp, Rigshosp, Ctr Blood, Hvidovre, Denmark; [Nilsson, Martin; Tolker-Nielsen, Tim] Univ Copenhagen, Costerton Biofilm Ctr, Dept Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Damgaard, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark.	chrd@sund.ku.dk	Damgaard, Christian/S-8145-2019; Nilsson, Martin/AHH-2943-2022	Damgaard, Christian/0000-0003-2394-746X; Tolker-Nielsen, Tim/0000-0002-9751-474X; Nielsen, Claus Henrik/0000-0001-7543-9016; Magnussen, Karin/0000-0003-2039-4986; Enevold, Christian/0000-0002-2748-1997	Research Account, Danish Dental Association	Research Account, Danish Dental Association	This study was supported by a grant from the Research Account, Danish Dental Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartold PM, 2013, PERIODONTOL 2000, V62, P203, DOI 10.1111/j.1600-0757.2012.00450.x; Belstrom D, 2011, INFECT IMMUN, V79, P1559, DOI 10.1128/IAI.01036-10; Benjamin RJ, 2014, TRANSFUS MED REV, V28, P61, DOI 10.1016/j.tmrv.2014.01.001; Bolton-Maggs PHB, 2013, BRIT J HAEMATOL, V163, P303, DOI 10.1111/bjh.12547; Bosshard PP, 2004, J CLIN MICROBIOL, V42, P2065, DOI 10.1128/JCM.42.5.2065-2073.2004; Brecher ME, 2013, TRANSFUSION, V53, P911, DOI 10.1111/trf.12148; Cargill JS, 2012, J MED MICROBIOL, V61, P755, DOI 10.1099/jmm.0.039693-0; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Goldman M, 2001, TRANSFUSION, V41, P1075, DOI 10.1046/j.1537-2995.2001.41081075.x; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Klausen SS, 2014, TRANSFUS APHER SCI, V51, P87, DOI [10.1016/j.transci.2014.10.020, DOI 10.1016/J.TRANSCI.2014.10.020]; Kuehnert MJ, 2001, TRANSFUSION, V41, P1493, DOI 10.1046/j.1537-2995.2001.41121493.x; Kunishima S, 2001, TRANSFUSION, V41, P1126, DOI 10.1046/j.1537-2995.2001.41091126.x; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McDonald CP, 2006, TRANSFUSION MED, V16, P381, DOI 10.1111/j.1365-3148.2006.00697.x; McDonald CP, 2004, VOX SANG, V86, P178, DOI 10.1111/j.0042-9007.2004.00404.x; McLellan E, 2009, J MED MICROBIOL, V58, P144, DOI 10.1099/jmm.0.005553-0; Montag T, 2008, CLIN CHEM LAB MED, V46, P926, DOI 10.1515/CCLM.2008.176; MUDER RR, 1992, TRANSFUSION, V32, P771, DOI 10.1046/j.1537-2995.1992.32893032109.x; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; NG YC, 1988, CLIN EXP IMMUNOL, V71, P481; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P386, DOI 10.1128/CMR.00011-09; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perel P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001664; Perez P, 2001, TRANSFUSION, V41, P862, DOI 10.1046/j.1537-2995.2001.41070862.x; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Pessi T, 2013, CIRCULATION, V127, P1219, DOI 10.1161/CIRCULATIONAHA.112.001254; Pratt RJ, 2007, J HOSP INFECT, V65, pS1, DOI 10.1016/S0195-6701(07)60002-4; Horliana ACRT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098271; Regalado NG, 2009, TRAVEL MED INFECT DI, V7, P316, DOI 10.1016/j.tmaid.2009.06.001; Rogers MAM, 2006, AM HEART J, V152, P1028, DOI 10.1016/j.ahj.2006.07.009; Rogers MAM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-37; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; SEIFERT H, 1995, ZBL BAKT-INT J MED M, V282, P431; SHAYEGANI M, 1991, J CLIN MICROBIOL, V29, P2768, DOI 10.1128/JCM.29.12.2768-2773.1991; Soeterboek AM, 1997, VOX SANG, V72, P61, DOI 10.1046/j.1423-0410.1997.00061.x; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Walther-Wenke G, 2008, CLIN CHEM LAB MED, V46, P919, DOI 10.1515/CCLM.2008.151; Zhou WW, 2013, CAN J INFECT DIS MED, V24, P155, DOI 10.1155/2013/470413	43	61	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0120826	10.1371/journal.pone.0120826	http://dx.doi.org/10.1371/journal.pone.0120826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751254	Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700038
J	Bhattacharjee, A; Ghangal, R; Garg, R; Jain, M				Bhattacharjee, Annapurna; Ghangal, Rajesh; Garg, Rohini; Jain, Mukesh			Genome-Wide Analysis of Homeobox Gene Family in Legumes: Identification, Gene Duplication and Expression Profiling	PLOS ONE			English	Article							LEUCINE ZIPPER GENE; INTERACTING TRANSCRIPTION FACTORS; ABIOTIC STRESS RESPONSES; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; HOMEODOMAIN PROTEINS; MEDICAGO-TRUNCATULA; CELL-DIFFERENTIATION; LOTUS-JAPONICUS; GLYCINE-MAX	Homeobox genes encode transcription factors that are known to play a major role in different aspects of plant growth and development. In the present study, we identified homeobox genes belonging to 14 different classes in five legume species, including chickpea, soybean, Medicago, Lotus and pigeonpea. The characteristic differences within homeodomain sequences among various classes of homeobox gene family were quite evident. Genome-wide expression analysis using publicly available datasets (RNA-seq and microarray) indicated that homeobox genes are differentially expressed in various tissues/developmental stages and under stress conditions in different legumes. We validated the differential expression of selected chickpea homeobox genes via quantitative reverse transcription polymerase chain reaction. Genome duplication analysis in soybean indicated that segmental duplication has significantly contributed in the expansion of homeobox gene family. The Ka/Ks ratio of duplicated homeobox genes in soybean showed that several members of this family have undergone purifying selection. Moreover, expression profiling indicated that duplicated genes might have been retained due to sub-functionalization. The genome-wide identification and comprehensive gene expression profiling of homeobox gene family members in legumes will provide opportunities for functional analysis to unravel their exact role in plant growth and development.	[Bhattacharjee, Annapurna; Ghangal, Rajesh; Garg, Rohini; Jain, Mukesh] Natl Inst Plant Genome Res NIPGR, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), Natl Inst Plant Genome Res NIPGR, Funct & Appl Genom Lab, Aruna Asaf Ali Marg, New Delhi, India.	mjain@nipgr.ac.in	Jain, Mukesh/AAP-5816-2021	Jain, Mukesh/0000-0002-7622-1083	Department of Biotechnology, Government of India [BT/PR12919/AGR/02/676/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was funded by the Department of Biotechnology, Government of India, under the Next Generation Challenge Programme on Chickpea Genomics (grant number BT/PR12919/AGR/02/676/2009 from 2009-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bharathan G, 1997, P NATL ACAD SCI USA, V94, P13749, DOI 10.1073/pnas.94.25.13749; Bhattacharjee A., 2013, PLANT ACCLIMATION EN, P163, DOI [DOI 10.1007/978-1-4614-5001-6_7, 10.1007/978-1-4614-5001-6_7]; Burglin Thomas R., 1994, P25; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Chen H, 2003, PLANT PHYSIOL, V132, P1391, DOI 10.1104/pp.103.022434; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Chew W, 2013, INT J MOL SCI, V14, P8122, DOI 10.3390/ijms14048122; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; Deng X, 2002, PLANT MOL BIOL, V49, P601, DOI 10.1023/A:1015501205303; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; Deveaux Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-291; Deyhle F, 2007, DEV BIOL, V302, P154, DOI 10.1016/j.ydbio.2006.09.013; Dezar CA, 2005, TRANSGENIC RES, V14, P429, DOI 10.1007/s11248-005-5076-0; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Gago GM, 2002, PLANT CELL ENVIRON, V25, P633, DOI 10.1046/j.1365-3040.2002.00853.x; Garg R, 2015, PLANT MOL BIOL REP, V33, P388, DOI 10.1007/s11105-014-0753-x; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hofer J, 2001, PLANT MOL BIOL, V45, P387, DOI 10.1023/A:1010739812836; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Jain M, 2008, FEBS J, V275, P2845, DOI 10.1111/j.1742-4658.2008.06424.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Johannesson H, 2001, PLANT MOL BIOL, V45, P63, DOI 10.1023/A:1006423324025; Jorgensen JE, 1999, PLANT MOL BIOL, V40, P65, DOI 10.1023/A:1026463506376; Kurdyukov S, 2014, PLANT CELL REP, V33, P349, DOI 10.1007/s00299-013-1535-x; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liu JH, 2014, PLANT MOL BIOL REP, V32, P303, DOI 10.1007/s11105-013-0667-z; Luo HL, 2005, J EXP BOT, V56, P2673, DOI 10.1093/jxb/eri260; Masucci JD, 1996, DEVELOPMENT, V122, P1253; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Meijer AH, 2000, MOL GEN GENET, V263, P12, DOI 10.1007/PL00008671; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nagasaki H, 2001, PLANT CELL, V13, P2085, DOI 10.1105/tpc.13.9.2085; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; Ni YX, 2008, ACTA BIOCH BIOPH SIN, V40, P78, DOI 10.1111/j.1745-7270.2008.00371.x; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Steindler C, 1999, DEVELOPMENT, V126, P4235; Tan QKG, 2006, PLANT PHYSIOL, V140, P1095, DOI 10.1104/pp.105.070565; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wang YJ, 2005, PLANTA, V221, P831, DOI 10.1007/s00425-005-1496-6; Windhovel A, 2001, PLANT MOL BIOL, V45, P201, DOI 10.1023/A:1006450005648; Yoon J, 2014, PLANT J, V79, P717, DOI 10.1111/tpj.12581; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang SX, 2012, PLANT MOL BIOL, V80, P571, DOI 10.1007/s11103-012-9967-1	70	42	47	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119198	10.1371/journal.pone.0119198	http://dx.doi.org/10.1371/journal.pone.0119198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745864	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400056
J	Lee, H; Park, HY; Jeon, K; Jeong, BH; Hwang, JW; Lee, J; Cha, HS; Koh, EM; Kang, ES; Koh, WJ				Lee, Hyun; Park, Hye Yun; Jeon, Kyeongman; Jeong, Byeong-Ho; Hwang, Ji-Won; Lee, Jaejoon; Cha, Hoon-Suk; Koh, Eun-Mi; Kang, Eun-Suk; Koh, Won-Jung			QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; RHEUMATOLOGY BIOLOGICS REGISTER; ANTI-TNF THERAPY; SKIN-TEST; ANTIRHEUMATIC DRUGS; BRITISH SOCIETY; KOREAN PATIENTS; RISK; RECOMMENDATIONS; DIAGNOSIS	Background Patients undergoing anti-tumor necrosis factor (TNF) treatment are at an increased risk of reactivating a latent tuberculosis infection (LTBI). This study evaluated the effectiveness of the QuantiFERON-TB Gold In-Tube (QFT) assay for diagnosing LTBI in arthritis patients undergoing anti-TNF treatment. Methods We enrolled 342 consecutive patients from August 2007 to October 2013: 176 (51.5%) patients with ankylosing spondylitis and 166 (48.5%) with rheumatoid arthritis. Screening tests included tuberculin skin test (TST) and QFT assay. Positive QFT results, regardless of TST results, were considered an indicator for LTBI treatment. Results Bacillus Calmette-Guerin scars were found in 236 (69.0%) patients. Of 342 patients, TST and QFT were positive in 122 (35.7%) and 103 (30.1%) patients, respectively, and discordant in 101 (29.5%) patients. During a median follow-up duration of 41.7 months, five patients (1.5%) developed TB in a median of 20.8 months after initiation of anti-TNF treatment (428/100,000 person-years). TB did not occur in 62 TST+/QFT+ patients who received LTBI treatment. Of 41 TST-/QFT+ patients who received LTBI treatment, one (2.4%) developed TB 20.5 months after starting anti-TNF treatment (705/100,000 person-years). Of 60 TST+/QFT- patients who did not receive LTBI treatment, two (3.3%) developed TB 20.8 and 22.0 months after starting anti-TNF treatment (871/100,000 person-years). Of 179 TST-/QFT- patients, two (1.1%) developed TB 7.2 and 22.7 months, respectively, after initiating anti-TNF treatment (341/100,000 person-years). TB incidence rate during the follow-up period did not differ among TST-/QFT+, TST+/QFT-, and TST-/QFT- patients (P = 0.661). Conclusion QFT might be used instead of TST for diagnosing LTBI in patients before starting anti-TNF therapy in countries, such as Korea, where the TB prevalence is intermediate and the BCG vaccination is mandatory at birth. In the absence of a true gold standard test for LTBI, however, there is still a risk of TB development during anti-TNF treatment.	[Lee, Hyun; Park, Hye Yun; Jeon, Kyeongman; Jeong, Byeong-Ho; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Hwang, Ji-Won; Lee, Jaejoon; Cha, Hoon-Suk; Koh, Eun-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Rheumatol, Seoul, South Korea; [Kang, Eun-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	wjkoh@skku.edu	Koh, Won-Jung/D-9586-2018; park, hy/O-5934-2014; Koh, Won Jung/C-9595-2011; Jeon, Kyeongman/F-5963-2019; Lee, Hyun/G-1336-2018	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772; Jeong, Byeong-Ho/0000-0002-3124-1718; Lee, Hyun/0000-0002-1269-0913	Korean Health technology Ramp;D Project, Ministry for Health amp; Welfare, Republic of Korea [HI13C0871]	Korean Health technology Ramp;D Project, Ministry for Health amp; Welfare, Republic of Korea	This study was supported by a grant of the Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI13C0871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043508, 10.1371/journal.pone.0030275]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Beglinger C, 2007, SWISS MED WKLY, V137, P621; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Callhoff J, 2014, ANN RHEUM DIS; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Chang B, 2011, CLIN RHEUMATOL, V30, P1535, DOI 10.1007/s10067-011-1771-9; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; de Leon DP, 2008, J RHEUMATOL, V35, P776; de Leon DP, 2005, ANN RHEUM DIS, V64, P1360, DOI 10.1136/ard.2004.029041; Diel R, 2009, Pneumologie, V63, P329, DOI 10.1055/s-0029-1214673; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fonseca Joao Eurico, 2006, Acta Reumatol Port, V31, P247; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Hsia EC, 2012, ARTHRITIS RHEUM-US, V64, P2068, DOI 10.1002/art.34382; Jo KW, 2013, RESP MED, V107, P1797, DOI 10.1016/j.rmed.2013.08.011; Jung YJ, 2014, INT J TUBERC LUNG D, V18, P428, DOI 10.5588/ijtld.13.0644; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim JH, 2013, SEMIN ARTHRITIS RHEU, V42, P424, DOI 10.1016/j.semarthrit.2012.07.001; Kleinert S, 2012, ANN RHEUM DIS, V71, P1791, DOI 10.1136/annrheumdis-2011-200941; Korea Centers for Disease Control and Prevention, 2011, KOREAN GUIDELINES FO; Korea Centers for Disease Control and Prevention, 2014, KOREAN GUIDELINES FO; Lee E, 2002, CLIN INFECT DIS, V34, P365, DOI 10.1086/338149; Mariette X, 2003, Ann Rheum Dis, V62, P791, DOI 10.1136/ard.62.8.791; Mariette X, 2012, ANN RHEUM DIS, V71, P1783, DOI 10.1136/annrheumdis-2011-200408; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Tamborenea MN, 2010, RHEUMATOL INT, V30, P613, DOI 10.1007/s00296-009-1027-z; Ormerod LP, 2005, THORAX, V60, P800, DOI 10.1136/thx.2005.046797; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Park YK, 2013, TUBERC RESPIR DIS, V74, P104, DOI 10.4046/trd.2013.74.3.104; Sellam J, 2007, ANN RHEUM DIS, V66, P1610, DOI 10.1136/ard.2007.069799; Seong SS, 2007, J RHEUMATOL, V34, P706; Shim TS, 2014, TUBERC RESPIR DIS, V76, P261, DOI 10.4046/trd.2014.76.6.261; Singanayagam A, 2013, THORAX, V68, P955, DOI 10.1136/thoraxjnl-2013-203436; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smith R, 2011, CURR OPIN RHEUMATOL, V23, P377, DOI 10.1097/BOR.0b013e3283474d62; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Son CN, 2014, J KOREAN MED SCI, V29, P1090, DOI 10.3346/jkms.2014.29.8.1090; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wallis RS, 2008, ARTHRITIS RHEUM, V58, P947, DOI 10.1002/art.23285; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; Winthrop KL, 2012, ANN RHEUM DIS, V71, P1757, DOI 10.1136/annrheumdis-2012-201979	49	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119260	10.1371/journal.pone.0119260	http://dx.doi.org/10.1371/journal.pone.0119260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746854	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400060
J	Fan, WZ; Zhang, YQ; Wang, Y; Yao, XH; Yang, JY; Li, JP				Fan, Wenzhe; Zhang, Yingqiang; Wang, Yu; Yao, Xuehua; Yang, Jianyong; Li, Jiaping			Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization	PLOS ONE			English	Article							PROGNOSTIC VALUE; RESECTION; LIVER; SCORE	Purpose To evaluate whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) predict survival and metastasis in patients after transarterial chemoembolization (TACE) for recurrent hepatocellular carcinoma (RHCC). Materials and Methods Clinical and laboratory data from 132 RHCC patients treated with TACE from January 2003 to December 2012 were retrospectively reviewed. Prognostic factors were assessed by multivariate analysis, and the predictive values of NLR and PLR for overall survival (OS) and extrahepatic metastases were compared. Results Pretreatment mean NLR and PLR were 3.1 and 137, respectively. The 0.5-, 1-, and 2-year OS rates were 93.7%, 67.1%, and 10.1% in the low NLR group and 81.1%, 18.9%, and 3.8% in the high NLR group, respectively (P = 0.017). The corresponding OS rates in the low and high PLR groups were 92.5%, 58.1%, and 9.7% and 84.6%, 23.1%, and 2.6%, respectively (P = 0.030). The discriminatory performance predicting 1-year survival probability was significantly poorer for NLR (area under the curve [AUC] = 0.685, 95% confidence interval [CI] 0.598-0.763) than for PLR (AUC = 0.792, 95% CI 0.712-0.857; P = 0.0295), but was good for both ratios for predicting post-TACE extrahepatic metastasis. Multivariate analysis indicated that high PLR (hazard ratio [HR] = 0.373, 95% CI = 0.216-0.644, P < 0.001, vascular invasion (HR = 0.507, 95% CI = 0.310-0.832, P = 0.007), and multiple tumors (HR= 0.553, 95% CI = 0.333-0.919, P = 0.022) were independent prognostic factors for OS. Conclusions High NLR and PLR were both associated with poor prognosis and metastasis in RHCC patients treated with TACE, but high PLR was a better predictor of 1-year OS. High PLR, vascular invasion, and multiple tumors were independent, unfavorable prognostic factors.	[Fan, Wenzhe; Zhang, Yingqiang; Wang, Yu; Yao, Xuehua; Li, Jiaping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Jianyong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Imaging, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Li, JP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou 510275, Guangdong, Peoples R China.	lijiaping_2011@126.com			Specialized Research Fund for the Doctoral Program of Higher Education [20130171120083]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by a grant from the Specialized Research Fund for the Doctoral Program of Higher Education (No.20130171120083) (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermayr B, 2003, GUT, V52, P879, DOI 10.1136/gut.52.6.879; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; KASUGAI H, 1989, GASTROENTEROLOGY, V97, P965, DOI 10.1016/0016-5085(89)91505-9; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Lai Q, 2014, TRANSPL INT, V27, P32, DOI 10.1111/tri.12191; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meng MB, 2009, RADIOTHER ONCOL, V92, P184, DOI 10.1016/j.radonc.2008.11.002; Neagoe PE, 2009, GROWTH FACTORS, V27, P335, DOI 10.3109/08977190903155043; OKAZAKI M, 1993, HEPATO-GASTROENTEROL, V40, P320; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poon RTP, 2000, J SURG ONCOL, V73, P109, DOI 10.1002/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.3.CO;2-A; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Rougier P, 2007, SEMIN ONCOL, V34, pS12, DOI 10.1053/j.seminoncol.2007.01.007; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Shi M, 2010, WORLD J GASTROENTERO, V16, P264, DOI 10.3748/wjg.v16.i2.264; Shuto T, 1996, HEPATO-GASTROENTEROL, V43, P932; Smith RA, 2008, J GASTROINTEST SURG, V12, P1422, DOI 10.1007/s11605-008-0554-3; Sugimachi K, 2001, J Hepatobiliary Pancreat Surg, V8, P410, DOI 10.1007/s005340100002; Tuszynski GP, 1996, BIOESSAYS, V18, P71, DOI 10.1002/bies.950180113; Wada Y, 1998, HEPATOLOGY, V27, P407, DOI 10.1002/hep.510270214; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Wang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025295; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yau T, 2008, CANCER, V113, P2742, DOI 10.1002/cncr.23878; Zerbini A, 2010, GASTROENTEROLOGY, V138, P1931, DOI 10.1053/j.gastro.2009.12.051	32	60	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119312	10.1371/journal.pone.0119312	http://dx.doi.org/10.1371/journal.pone.0119312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742141	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100103
J	Mitter, C; Prayer, D; Brugger, PC; Weber, M; Kasprian, G				Mitter, Christian; Prayer, Daniela; Brugger, Peter C.; Weber, Michael; Kasprian, Gregor			In Vivo Tractography of Fetal Association Fibers	PLOS ONE			English	Article							MATTER DEVELOPMENT; BRAIN-DEVELOPMENT; DIFFUSION; WHITE; MR; CONNECTIVITY; UTERO; MATURATION; TRACTS; PREMYELINATION	Association fibers connect different cortical areas within the same hemisphere and constitute an essential anatomical substrate for a diverse range of higher cognitive functions. So far a comprehensive description of the prenatal in vivo morphology of these functionally important pathways is lacking. In the present study, diffusion tensor imaging (DTI) and tractography were used to visualize major association fiber tracts and the fornix in utero in preselected non-motion degraded DTI datasets of 24 living unsedated fetuses between 20 and 34 gestational weeks (GW). The uncinate fasciculus and inferior fronto-occipital fasciculus were depicted as early as 20 GW, while in vivo 3D visualization of the inferior longitudinal fasciculus, cingulum and fornix was successful in older fetuses during the third trimester. Provided optimal scanning conditions, in utero DTI and tractography have the potential to provide a more accurate anatomical definition of developing neuronal networks in the human fetal brain. Knowledge about the normal prenatal 3D association tract morphology may serve as reference for their assessment in common developmental diseases.	[Mitter, Christian; Prayer, Daniela; Weber, Michael; Kasprian, Gregor] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Neuroradiol & Musculoskeletal Radiol, Vienna, Austria; [Brugger, Peter C.] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Systemat Anat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Mitter, C (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Neuroradiol & Musculoskeletal Radiol, Vienna, Austria.	christian.mitter@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020; Weber, Michael/L-9836-2016	Kasprian, Gregor/0000-0003-3858-3347; Weber, Michael/0000-0002-8507-2219				ACR-SPR, 2010, PRACT PAR SAF OPT PE; Al-Mukhtar A, 2009, SEMIN PERINATOL, V33, P251, DOI 10.1053/j.semperi.2009.04.008; Bartolomeo P, 2007, CEREB CORTEX, V17, P2479, DOI 10.1093/cercor/bhl181; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Brugger PC, 2006, EUR J RADIOL, V57, P172, DOI 10.1016/j.ejrad.2005.11.017; Bui T, 2006, PEDIATR RADIOL, V36, P1133, DOI 10.1007/s00247-006-0266-3; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Counsell SJ, 2007, NEUROIMAGE, V34, P896, DOI 10.1016/j.neuroimage.2006.09.036; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Enders C. K., 2010, APPL MISSING DATA AN; Flechsig P., 1920, ANATOMIE MENSCHLICHE; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Garel C, 2001, AM J NEURORADIOL, V22, P184; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; GIRARD N, 1995, AM J NEURORADIOL, V16, P407; Hand JW, 2006, MAGN RESON MED, V55, P883, DOI 10.1002/mrm.20824; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Jiang SZ, 2009, MAGN RESON MED, V62, P645, DOI 10.1002/mrm.22032; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; Kasprian G, 2013, BRAIN, V136, P168, DOI 10.1093/brain/aws332; Kasprian G, 2011, CEREB CORTEX, V21, P1076, DOI 10.1093/cercor/bhq179; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Kretschmann H. J., 1986, BRAIN GROWTH; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Maas LC, 2004, NEUROIMAGE, V22, P1134, DOI 10.1016/j.neuroimage.2004.02.035; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Prayer D, 2006, EUR J RADIOL, V57, P199, DOI 10.1016/j.ejrad.2005.11.020; Prayer D, 2001, AM J NEURORADIOL, V22, P1572; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; SMITH FW, 1983, LANCET, V1, P61; Takahashi E, 2012, CEREB CORTEX, V22, P455, DOI 10.1093/cercor/bhr126; Takahashi E, 2010, NEUROIMAGE, V49, P1231, DOI 10.1016/j.neuroimage.2009.09.002; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Vasung L, 2011, BRAIN STRUCT FUNCT, V215, P237, DOI 10.1007/s00429-010-0279-4; Vasung L, 2010, J ANAT, V217, P400, DOI 10.1111/j.1469-7580.2010.01260.x; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yoo SS, 2005, INVEST RADIOL, V40, P110, DOI 10.1097/01.rli.0000149491.69201.cb	58	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119536	10.1371/journal.pone.0119536	http://dx.doi.org/10.1371/journal.pone.0119536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742520	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100119
J	Alsina, L; Basteiro, MG; de Paz, HD; Inigo, M; de Sevilla, MF; Trivino, M; Juan, M; Munoz-Almagro, C				Alsina, Laia; Basteiro, Maria G.; de Paz, Hector D.; Inigo, Melania; de Sevilla, Mariona F.; Trivino, Miriam; Juan, Manel; Munoz-Almagro, Carmen			Recurrent Invasive Pneumococcal Disease in Children: Underlying Clinical Conditions, and Immunological and Microbiological Characteristics	PLOS ONE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; IMMUNODEFICIENCY; IRAK-4; MYD88; IDENTIFICATION; PREVALENCE; DEFICIENCY; BACTEREMIA; NATIONWIDE	Purpose Clinical, immunological and microbiological characteristics of recurrent invasive pneumococcal disease (IPD) in children were evaluated, differentiating relapse from reinfection, in order to identify specific risk factors for both conditions. Methods All patients < 18 years-old with recurrent IPD admitted to a tertiary-care pediatric center from January 2004 to December 2011 were evaluated. An episode of IPD was defined as the presence of clinical findings of infection together with isolation and/or pneumococcal DNA detection by Real-Time PCR in any sterile body fluid. Recurrent IPD was defined as 2 or more episodes in the same individual at least 1 month apart. Among recurrent IPD, we differentiated relapse (same pneumococcal isolate) from reinfection. Results 593 patients were diagnosed with IPD and 10 patients died. Among survivors, 23 episodes of recurrent IPD were identified in 10 patients (1.7%). Meningitis was the most frequent form of recurrent IPD (10 episodes/4 children) followed by recurrent empyema (8 episodes/4 children). Three patients with recurrent empyema caused by the same pneumococcal clone ST306 were considered relapses and showed high bacterial load in their first episode. In contrast, all other episodes of recurrent IPD were considered reinfections. Overall, the rate of relapse of IPD was 0.5% and the rate of reinfection 1.2%. Five out of 7 patients with reinfection had an underlying risk factor: cerebrospinal fluid leak (n = 3), chemotherapy treatment (n = 1) and a homozygous mutation in MyD88 gene (n = 1). No predisposing risk factors were found in the remainder. Conclusions recurrent IPD in children is a rare condition associated with an identifiable risk factor in case of reinfection in almost 80% of cases. In contrast, recurrent IPD with pleuropneumonia is usually a relapse of infection.	[Alsina, Laia] Univ Barcelona, Hosp St Joan Deu, Allergy & Clin Immunol Dept, Barcelona, Spain; [Basteiro, Maria G.; de Sevilla, Mariona F.; Trivino, Miriam] Univ Barcelona, Hosp St Joan Deu, Dept Pediat, Barcelona, Spain; [de Paz, Hector D.; Inigo, Melania; Munoz-Almagro, Carmen] Univ Barcelona, Hosp St Joan Deu, Dept Mol Microbiol, Barcelona, Spain; [Juan, Manel] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Juan, Manel] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Alsina, Laia; Juan, Manel] Hosp St Joan Deu, Funct Unit Immunol, Barcelona, Spain; [Alsina, Laia; Juan, Manel] Hosp Clin Barcelona, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Munoz-Almagro, C (corresponding author), Univ Barcelona, Hosp St Joan Deu, Dept Mol Microbiol, Barcelona, Spain.	cma@hsjdbcn.org	MARIGOMEZ, Ionan/C-3909-2017; Muñoz-Almagro, Carmen/N-7248-2015; Juan, Manel/Q-2931-2019; Alsina, Laia/AID-4372-2022; Munoz-Almagro, Carmen/B-4308-2015; Alsina, Laia/GQI-3516-2022	MARIGOMEZ, Ionan/0000-0001-6274-541X; Muñoz-Almagro, Carmen/0000-0001-5586-404X; Munoz-Almagro, Carmen/0000-0001-5586-404X; Juan, Manel/0000-0002-3064-1648; de Paz Fernandez, Hector David/0000-0002-4190-5063; de Sevilla, Mariona F/0000-0003-3104-675X; Alsina, Laia/0000-0002-3559-0018	Fondo de Investigacion Sanitaria (FIS) [PI10/02058, PI13/01729, PI10/01404]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [GRC/2014 SGR 505]; Godia Foundation; Sant Joan de Deu Foundation	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Godia Foundation; Sant Joan de Deu Foundation	This work was supported by Fondo de Investigacion Sanitaria (FIS, project number PI10/02058 and PI13/01729 to CMA and PI10/01404 to MJ [http://www.isciii.es/ISCIII/es]), Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Project number GRC/2014 SGR 505 to CMA[http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp]), Godia Foundation and Sant Joan de Deu Foundation (to MI, HdP and CMA[http://www.fundacionfgodia.org/; http://www.fsjd.org/es]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer P, 2003, CLIN EXP IMMUNOL, V133, P364, DOI 10.1046/j.1365-2249.2003.02232.x; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; CDC, 2010, MMWR RECOMM REP, V59; Coccia MR, 1998, CLIN INFECT DIS, V26, P982, DOI 10.1086/513924; Currie AJ, 2004, J PEDIATR-US, V144, P512, DOI 10.1016/j.jpeds.2003.10.034; de Sevilla MF, 2012, PEDIATR INFECT DIS J, V31, P124, DOI 10.1097/INF.0b013e318241d09e; Einarsdottir HM, 2005, CLIN MICROBIOL INFEC, V11, P744, DOI 10.1111/j.1469-0691.2005.01221.x; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Esteva C, 2011, CLIN MICROBIOL INFEC, V17, P1441, DOI 10.1111/j.1469-0691.2011.03526.x; Gaschignard J, 2014, CLIN INFECT DIS, V59, P244, DOI 10.1093/cid/ciu274; Grant CC, 2003, ARCH DIS CHILD, V88, P712, DOI 10.1136/adc.88.8.712; Ingels H, 2014, SCAND J INFECT DIS, V46, P265, DOI 10.3109/00365548.2013.877156; Jeurissen A, 2007, CLIN CHEM, V53, P505, DOI 10.1373/clinchem.2006.080051; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Ku CL, 2005, IMMUNOL REV, V203, P10, DOI 10.1111/j.0105-2896.2005.00235.x; Mahlaoui N, 2011, J PEDIATR-US, V158, P142, DOI 10.1016/j.jpeds.2010.07.027; Mason EO, 2007, PEDIATR INFECT DIS J, V26, P480, DOI 10.1097/INF.0b013e31805ce277; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Mu-oz-Almagro C, 2011, J INFECTION, V63, P151, DOI DOI 10.1016/J.JINF.2011.06.002; Mufson MA, 2012, AM J MED SCI, V343, P303, DOI 10.1097/MAJ.0b013e31822d9860; Munoz-Almagro C, 2014, CLIN MICROBIOL INFEC, V20, pO745, DOI 10.1111/1469-0691.12615; Munoz-Almagro C, 2011, EUR J CLIN MICROBIOL, V30, P327, DOI 10.1007/s10096-010-1086-9; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; RodriguezCreixems M, 1996, ARCH INTERN MED, V156, P1429, DOI 10.1001/archinte.156.13.1429; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Turvey SE, 2007, PEDIATR INFECT DIS J, V26, P1074, DOI 10.1097/INF.0b013e318156fb93; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2006, PEDIATRICS, V118, P2498, DOI 10.1542/peds.2006-1845	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118848	10.1371/journal.pone.0118848	http://dx.doi.org/10.1371/journal.pone.0118848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738983	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900080
J	Bornsen, L; Christensen, JR; Ratzer, R; Hedegaard, C; Sondergaard, HB; Krakauer, M; Hesse, D; Nielsen, CH; Sorensen, PS; Sellebjerg, F				Boernsen, Lars; Christensen, Jeppe Romme; Ratzer, Rikke; Hedegaard, Chris; Sondergaard, Helle B.; Krakauer, Martin; Hesse, Dan; Nielsen, Claus H.; Sorensen, Per S.; Sellebjerg, Finn			Endogenous Interferon-beta-Inducible Gene Expression and Interferon-beta-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MESSENGER-RNA EXPRESSION; IFN-BETA; IN-VIVO; INTERLEUKIN-10 PRODUCTION; MONONUCLEAR-CELLS; THERAPY; DISEASE; CYTOKINES; ACTIVATION	Autoreactive CD4(+) T-cells are considered to play a major role in the pathogenesis of multiple sclerosis. In experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, exogenous and endogenous type I interferons restrict disease severity. Recombinant interferon-beta is used for treatment of multiple sclerosis, and some untreated multiple sclerosis patients have increased expression levels of type I interferon-inducible genes in immune cells. The role of endogenous type I interferons in multiple sclerosis is controversial: some studies found an association of high expression levels of interferon-beta-inducible genes with an increased expression of interleukin-10 and a milder disease course in untreated multiple sclerosis patients, whereas other studies reported an association with a poor response to treatment with interferon-beta. In the present study, we found that untreated multiple sclerosis patients with an increased expression of interferon-beta-inducible genes in peripheral blood mononuclear cells and interferon-beta-treated multiple sclerosis patients had decreased CD4(+) T-cell reactivity to the autoantigen myelin basic protein ex vivo. Interferon-beta-treated multiple sclerosis patients had increased IL10 and IL27 gene expression levels in monocytes in vivo. In vitro, neutralization of interleukin-10 and monocyte depletion increased CD4(+) T-cell reactivity to myelin basic protein while interleukin-10, in the presence or absence of monocytes, inhibited CD4(+) T-cell reactivity to myelin basic protein. Our findings suggest that spontaneous expression of interferon-beta-inducible genes in peripheral blood mononuclear cells from untreated multiple sclerosis patients and treatment with interferon-beta are associated with reduced myelin basic protein-induced T-cell responses. Reduced myelin basic protein-induced CD4(+) T-cell autoreactivity in interferon-beta-treated multiple sclerosis patients may be mediated by monocyte-derived interleukin-10.	[Boernsen, Lars; Christensen, Jeppe Romme; Ratzer, Rikke; Sondergaard, Helle B.; Krakauer, Martin; Hesse, Dan; Sorensen, Per S.; Sellebjerg, Finn] Univ Copenhagen, Rigshosp, Danish Multiple Sclerosis Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark; [Hedegaard, Chris; Nielsen, Claus H.] Univ Copenhagen, Rigshosp, Dept Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Bornsen, L (corresponding author), Univ Copenhagen, Rigshosp, Danish Multiple Sclerosis Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark.	boernsen@gmail.com	Krakauer, Martin/M-4657-2019	Krakauer, Martin/0000-0002-2191-1861; Sondergaard, Helle Bach/0000-0001-9435-0658; Nielsen, Claus Henrik/0000-0001-7543-9016; Sorensen, Per Soelberg/0000-0002-2818-3780; Hedegaard, Chris Juul/0000-0003-1333-8687; Romme Christensen, Jeppe/0000-0002-7727-3467; Sellebjerg, Finn/0000-0002-1333-9623; Hesse, Dan/0000-0002-9670-6037	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research [271-06-0246]; Danish Council for Strategic Research [2142-08-0039]	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by grants from the Danish Multiple Sclerosis Society, the Warwara Larsen Foundation, the Johnsen Foundation, the Danish Council for Independent Research [grant 271-06-0246] and the Danish Council for Strategic Research [grant 2142-08-0039]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2011, TRENDS IMMUNOL, V32, P272, DOI 10.1016/j.it.2011.03.008; Babaloo Z, 2013, IRAN J IMMUNOL, V10, P47, DOI IJIv10i1A6; Bushnell SE, 2012, NEUROLOGY, V79, P531, DOI 10.1212/WNL.0b013e318259e123; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; Calabresi PA, 1998, J NEUROIMMUNOL, V89, P198, DOI 10.1016/S0165-5728(98)00139-8; Calabresi PA, 1997, NEUROLOGY, V48, P1446, DOI 10.1212/WNL.48.5.1446; Carrieri PB, 1998, IMMUNOPHARM IMMUNOT, V20, P373, DOI 10.3109/08923979809034820; Chen X, 2011, FEBS LETT, V585, P3611, DOI 10.1016/j.febslet.2011.04.025; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; de Waal MR, 1991, J EXP MED, V174, P915, DOI DOI 10.1084/JEM.174.4.915; Galligan CL, 2010, MULT SCLER J, V16, P1458, DOI 10.1177/1352458510381259; Graber JJ, 2007, J NEUROIMMUNOL, V185, P168, DOI 10.1016/j.jneuroim.2007.01.011; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hallal-Longo DEM, 2007, J INTERF CYTOK RES, V27, P865, DOI 10.1089/jir.2007.0018; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hesse D, 2010, NEUROLOGY, V74, P1455, DOI 10.1212/WNL.0b013e3181dc1a94; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kieseier BC, 2011, CNS DRUGS, V25, P491, DOI 10.2165/11591110-000000000-00000; Korneck B, 2003, BRAIN RES BULL, V61, P321, DOI 10.1016/S0361-9230(03)00095-9; Krakauer M, 2008, MULT SCLER J, V14, P622, DOI 10.1177/1352458507087136; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Martin-Saavedra FM, 2007, MOL IMMUNOL, V44, P3597, DOI 10.1016/j.molimm.2007.03.002; NAVIKAS V, 1995, SCAND J IMMUNOL, V41, P171, DOI 10.1111/j.1365-3083.1995.tb03550.x; Nielsen CH, 2010, IMMUNOLOGY, V129, P291, DOI 10.1111/j.1365-2567.2009.03183.x; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; PORRINI AM, 1995, J NEUROIMMUNOL, V61, P27, DOI 10.1016/0165-5728(95)00070-I; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; RIECKMANN P, 1994, NEUROLOGY, V44, P1523, DOI 10.1212/WNL.44.8.1523; Rudick RA, 1998, NEUROLOGY, V50, P1294, DOI 10.1212/WNL.50.5.1294; Rudick RA, 1996, ANN NEUROL, V40, P618, DOI 10.1002/ana.410400412; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; van der Voort LF, 2010, ARCH NEUROL-CHICAGO, V67, P402, DOI 10.1001/archneurol.2010.21; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Yamaguchi KD, 2008, J NEUROIMMUNOL, V195, P116, DOI 10.1016/j.jneuroim.2007.12.007; Zafranskaya M, 2007, IMMUNOLOGY, V121, P29, DOI 10.1111/j.1365-2567.2006.02518.x	54	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118830	10.1371/journal.pone.0118830	http://dx.doi.org/10.1371/journal.pone.0118830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738751	Green Submitted, gold, Green Published			2022-12-26	WOS:000350685900077
J	Kannan, VC; Andriamalala, CN; Reynolds, TA				Kannan, Vijay C.; Andriamalala, Clara N.; Reynolds, Teri A.			The Burden of Acute Disease in Mahajanga, Madagascar - A 21 Month Study	PLOS ONE			English	Article							EMERGENCY-MEDICINE; TANZANIA	Background Efforts to develop effective and regionally-appropriate emergency care systems in sub-Saharan Africa are hindered by a lack of data on both the burden of disease in the region and on the state of existing care delivery mechanisms. This study describes the burden of acute disease presenting to an emergency unit in Mahajanga, Madagascar. Methods and Findings Handwritten patient registries on all emergency department patients presenting between 1 January 2011 and 30 September 2012 were reviewed and data entered into a database. Data included age, sex, diagnosis, and disposition. We classified diagnoses into Clinical Classifications Software (CCS) multi-level categories. The population was 53.5% male, with a median age of 31 years. The five most common presenting conditions were 1) Superficial injury; contusion, 2) Open wounds of head; neck; and trunk, 3) Open wounds of extremities, 4) Intracranial injury, and 5) Unspecified injury and poisoning. Trauma accounted for 48%, Infectious Disease for 15%, Mental Health 6.1%, Noncommunicable 29%, and Neoplasms 1.2%. The acuity seen was high, with an admission rate of 43%. Trauma was the most common reason for admission, representing 19% of admitted patients. Conclusions This study describes the burden of acute disease at a large referral center in northern Madagascar. The Centre Hopitalier Universitaire de Mahajanga sees a high volume of acutely ill and injured patients. Similar to other reports from the region, trauma is the most common pathology observed, though infectious disease was responsible for the majority of adult mortality. Typhoid fever other intestinal infections were the most lethal CCS-coded pathologies. By utilizing a widely understood classification system, we are able to highlight contrasts between Mahajanga's acute and overall disease burden as well as make comparisons between this region and the rest of the globe. We hope this study will serve to guide the development of context-appropriate emergency medicine systems in the region.	[Kannan, Vijay C.] Univ Texas Southwestern, Div Emergency Med, Dallas, TX USA; [Kannan, Vijay C.] Maricopa Cty Gen Hosp, Dept Emergency Med, Phoenix, AZ 85008 USA; Univ Mahajanga, Ctr Hosp, Mahajanga, Madagascar; [Reynolds, Teri A.] Muhimbili Natl Hosp, Dept Emergency Med, Dar Es Salaam, Tanzania; [Reynolds, Teri A.] Univ Calif San Francisco, Emergency Med & Global Hlth Sci, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Maricopa County General Hospital; University of California System; University of California San Francisco	Kannan, VC (corresponding author), Maricopa Cty Gen Hosp, Dept Emergency Med, Phoenix, AZ 85008 USA.	vijay.c.kannan@gmail.com		Kannan, Vijay/0000-0002-5413-3832	School of Medicine, University of Texas Southwestern; Department of Emergency Medicine and Global Health Sciences, University of California San Francisco	School of Medicine, University of Texas Southwestern; Department of Emergency Medicine and Global Health Sciences, University of California San Francisco	VK was supported by School of Medicine, University of Texas Southwestern, funding. TR was supported by Department of Emergency Medicine and Global Health Sciences, University of California San Francisco, funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombana JA, 1997, J PSYCHOSOM RES, V43, P489, DOI 10.1016/S0022-3999(97)00138-4; Cox M, 2007, EMERG MED AUSTRALAS, V19, P470, DOI 10.1111/j.1742-6723.2007.01012.x; House DR, 2014, AFR J EMERG MED, V4, P20, DOI 10.1016/j.afjem.2013.08.069; Kobusingye OC, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1261; Little RM, 2013, AFR J EMERG MED, V3, P164, DOI 10.1016/j.afjem.2013.03.004; LIU Y, 1994, AM J EMERG MED, V12, P247, DOI 10.1016/0735-6757(94)90252-6; Matoussi Nadia, 2007, Tunis Med, V85, P843; Periyanayagam U, 2012, AFR J EMERG MED, V2, P151, DOI 10.1016/j.afjem.2012.09.002; Ramalanjaona G, 1998, ANN EMERG MED, V31, P766, DOI 10.1016/S0196-0644(98)70237-9; Reynolds T, 2012, ANN EMERG MED, V60, pS39, DOI 10.1016/j.annemergmed.2012.06.084; Reynolds TA, 2013, AFR J EMERG MED, V3, P1, DOI 10.1016/j.afjem.2013.01.003; Wachira B, 2011, AFR J EMERG MED, V1, P160, DOI 10.1016/j.afjem.2011.10.008; WHO, WHO GLOB BURD DIS GB; WHO, WHO REG EST 2000 201; WHO, WHO MAD COUNTR PROF; World Health Organization, GLOB STAT REP NONC D	16	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119029	10.1371/journal.pone.0119029	http://dx.doi.org/10.1371/journal.pone.0119029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738300	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900091
J	Lewandowska, MK; Bakkum, DJ; Rompani, SB; Hierlemann, A				Lewandowska, Marta K.; Bakkum, Douglas J.; Rompani, Santiago B.; Hierlemann, Andreas			Recording Large Extracellular Spikes in Microchannels along Many Axonal Sites from Individual Neurons	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; MICROFLUIDIC CULTURE PLATFORM; DENSITY MICROELECTRODE ARRAY; DIFFERENTIAL CONDUCTION; DENDRITIC INTEGRATION; MAMMALIAN NEURONS; STIMULATION; LONG; RECONSTRUCTION; FABRICATION	The numerous connections between neuronal cell bodies, made by their dendrites and axons, are vital for information processing in the brain. While dendrites and synapses have been extensively studied, axons have remained elusive to a large extent. We present a novel platform to study axonal physiology and information processing based on combining an 11,011-electrode high-density complementary metal-oxide semiconductor microelectrode array with a poly(dimethylsiloxane) channel device, which isolates axons from somas and, importantly, significantly amplifies recorded axonal signals. The combination of the microelectrode array with recording and stimulation capability with the microfluidic isolation channels permitted us to study axonal signal behavior at great detail. The device, featuring two culture chambers with over 30 channels spanning in between, enabled long-term recording of single spikes from isolated axons with signal amplitudes of 100 mu V up to 2 mV. Propagating signals along axons could be recorded with 10 to 50 electrodes per channel. We (i) describe the performance and capabilities of our device for axonal electrophysiology, and (ii) present novel data on axonal signals facilitated by the device. Spontaneous action potentials with characteristic shapes propagated from somas along axons between the two compartments, and these unique shapes could be used to identify individual axons within channels that contained many axonal branches. Stimulation through the electrode array facilitated the identification of somas and their respective axons, enabling interfacing with different compartments of a single cell. Complex spike shapes observed in channels were traced back to single cells, and we show that more complicated spike shapes originate from a linear superposition of multiple axonal signals rather than signal distortion by the channels.	[Lewandowska, Marta K.; Bakkum, Douglas J.; Hierlemann, Andreas] Swiss Fed Inst Technol, Bio Engn Labs, Dept Biosyst Sci & Engn, Basel, Switzerland; [Rompani, Santiago B.] Friedrich Miescher Inst, Neural Circuits Lab, CH-4002 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Miescher Institute for Biomedical Research	Lewandowska, MK (corresponding author), Swiss Fed Inst Technol, Bio Engn Labs, Dept Biosyst Sci & Engn, Basel, Switzerland.	martal@bsse.ethz.ch	Hierlemann, Andreas/A-7046-2008	Hierlemann, Andreas/0000-0002-3838-2468; Rompani, Santiago/0000-0002-3994-3052	European Community through the European Research Council [267351]; Swiss National Science Foundation [PZ00P3_132245, 205321_157092/1]	European Community through the European Research Council; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by FP7 of the European Community through the European Research Council Advanced Grant 267351 "NeuroCMOS" (DB, AH) as well as the Swiss National Science Foundation Ambizione Grant PZ00P3_132245 (DB) and additionally through the Swiss National Science Foundation through Grant 205321_157092/1 (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2008, CURR OPIN NEUROBIOL, V18, P314, DOI 10.1016/j.conb.2008.08.006; Bakkum DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002088; Bakkum DJ, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00193; Bakkum DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3181; Barron DH, 1935, J PHYSIOL-LONDON, V85, P73, DOI 10.1113/jphysiol.1935.sp003303; Bhattacharjee N, 2010, INTEGR BIOL-UK, V2, P669, DOI 10.1039/c0ib00038h; Brewer GJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00165; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; CLARK J, 1968, BIOPHYS J, V8, P842, DOI 10.1016/S0006-3495(68)86524-5; Claverol-Tinture E, 2007, IEEE T BIO-MED ENG, V54, P331, DOI 10.1109/TBME.2006.880903; Claverol-Tinture E, 2005, J NEURAL ENG, V2, pL1, DOI 10.1088/1741-2560/2/2/L01; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Dworak BJ, 2009, LAB CHIP, V9, P404, DOI 10.1039/b806689b; Fiscella M, 2012, J NEUROSCI METH, V211, P103, DOI 10.1016/j.jneumeth.2012.08.017; FitzGerald JJ, 2008, IEEE T BIO-MED ENG, V55, P1136, DOI 10.1109/TBME.2007.909533; FitzGerald JJ, 2009, IEEE T BIO-MED ENG, V56, P1524, DOI 10.1109/TBME.2009.2013960; Frey U, 2009, BIOSENS BIOELECTRON, V24, P2191, DOI 10.1016/j.bios.2008.11.028; Frey U, 2010, IEEE J SOLID-ST CIRC, V45, P467, DOI 10.1109/JSSC.2009.2035196; Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669; Griscom L, 2002, SENSOR ACTUAT B-CHEM, V83, P15, DOI 10.1016/S0925-4005(01)01022-X; GROSSMAN Y, 1979, J PHYSIOL-LONDON, V295, P283, DOI 10.1113/jphysiol.1979.sp012969; GROSSMAN Y, 1979, J PHYSIOL-LONDON, V295, P307, DOI 10.1113/jphysiol.1979.sp012970; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Kanagasabapathi TT, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036010; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; LOEB GE, 1977, MED BIOL ENG COMPUT, V15, P195, DOI 10.1007/BF02442964; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Millet LJ, 2010, LAB CHIP, V10, P1525, DOI 10.1039/c001552k; Moorjani S, 2012, P MICROTAS, P401; Muller J, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00121; Nevill JT, 2011, SOFT MATTER, V7, P343, DOI 10.1039/c0sm00869a; OFFNER FF, 1954, ELECTROEN CLIN NEURO, V6, P507, DOI 10.1016/0013-4694(54)90069-3; Pan L, 2013, IEEE T NEUR SYS REH, V22, P453, DOI [10.1109/TNSRE.2013.2289911, DOI 10.1109/TNSRE.2013.2289911]; Pan LB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046031; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n; Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; SWADLOW HA, 1980, ANNU REV BIOPHYS BIO, V9, P143, DOI 10.1146/annurev.bb.09.060180.001043; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wang L, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026010; Wieringa PA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016001; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365	57	47	46	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118514	10.1371/journal.pone.0118514	http://dx.doi.org/10.1371/journal.pone.0118514			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734567	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700035
J	Ameri, P; Bruzzone, S; Mannino, E; Sociali, G; Andraghetti, G; Salis, A; Ponta, ML; Briatore, L; Adami, GF; Ferraiolo, A; Venturini, PL; Maggi, D; Cordera, R; Murialdo, G; Zocchi, E				Ameri, Pietro; Bruzzone, Santina; Mannino, Elena; Sociali, Giovanna; Andraghetti, Gabriella; Salis, Annalisa; Ponta, Monica Laura; Briatore, Lucia; Adami, Giovanni F.; Ferraiolo, Antonella; Venturini, Pier Luigi; Maggi, Davide; Cordera, Renzo; Murialdo, Giovanni; Zocchi, Elena			Impaired Increase of Plasma Abscisic Acid in Response to Oral Glucose Load in Type 2 Diabetes and in Gestational Diabetes	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; PEPTIDE-1 GLP-1 SECRETION; BILIOPANCREATIC DIVERSION	The plant hormone abscisic acid (ABA) is present and active in humans, regulating glucose homeostasis. In normal glucose tolerant (NGT) human subjects, plasma ABA (ABAp) increases 5-fold after an oral glucose load. The aim of this study was to assess the effect of an oral glucose load on ABAp in type 2 diabetes (T2D) subjects. We chose two sub-groups of patients who underwent an oral glucose load for diagnostic purposes: i) 9 treatment-naive T2D subjects, and ii) 9 pregnant women with gestational diabetes (GDM), who underwent the glucose load before and 8-12 weeks after childbirth. Each group was compared with matched NGT controls. The increase of ABAp in response to glucose was found to be abrogated in T2D patients compared to NGT controls. A similar result was observed in the women with GDM compared to pregnant NGT controls; 8-12 weeks after childbirth, however, fasting ABAp and ABAp response to glucose were restored to normal in the GDM subjects, along with glucose tolerance. We also retrospectively compared fasting ABAp before and after bilio-pancreatic diversion (BPD) in obese, but not diabetic subjects, and in obese T2D patients, in which BPD resulted in the resolution of diabetes. Compared to pre-BPD values, basal ABAp significantly increased 1 month after BPD in T2D as well as in NGT subjects, in parallel with a reduction of fasting plasma glucose. These results indicate an impaired hyperglycemia-induced ABAp increase in T2D and in GDM and suggest a beneficial effect of elevated ABAp on glycemic control.	[Ameri, Pietro; Andraghetti, Gabriella; Ponta, Monica Laura; Briatore, Lucia; Maggi, Davide; Cordera, Renzo; Murialdo, Giovanni] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Mannino, Elena; Sociali, Giovanna; Salis, Annalisa; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Mannino, Elena; Sociali, Giovanna; Salis, Annalisa; Zocchi, Elena] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Adami, Giovanni F.] Univ Genoa, Dept Surg Sci & Integrated Diagnost, I-16132 Genoa, Italy; [Ferraiolo, Antonella; Venturini, Pier Luigi] IRCSS San Martino IST, I-16132 Genoa, Italy; [Venturini, Pier Luigi] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother &, I-16132 Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Genoa	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto 15-1, I-16132 Genoa, Italy.	ezocchi@unige.it	Ameri, Pietro/K-8556-2016; maggi, davide/AAL-4687-2020; Cordera, Renzo/I-7229-2017; Bruzzone, Santina/A-4264-2015; Ponta, Monica Laura/AFM-9813-2022; Salis, Annalisa/R-9241-2018	Ameri, Pietro/0000-0001-7167-7287; Cordera, Renzo/0000-0002-5280-9691; Bruzzone, Santina/0000-0003-2034-3716; Ponta, Monica Laura/0000-0002-5761-1369; Salis, Annalisa/0000-0002-3082-2908; MAGGI, DAVIDE CARLO/0000-0003-3928-1295	Italian Ministry of Education, University and Scientific Research [2010MCLBCZ]; Fondazione CARIGE; Compagnia di S. Paolo [2012-ID-ROL316]; University of Genova [PRA2011]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo(Compagnia di San Paolo); University of Genova	This work was supported in part by the Italian Ministry of Education, University and Scientific Research (www.miur.it/; grant #2010MCLBCZ), by the Fondazione CARIGE (www.fondazionecarige.it/) and by the Compagnia di S. Paolo (www.compagniadisanpaolo.it/; grant #2012-ID-ROL316) to EZ; and by the University of Genova (www.unige.it/; PRA2011) to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Briatore L, 2008, OBESITY, V16, P77, DOI 10.1038/oby.2007.9; Briatore L, 2010, OBESITY, V18, P932, DOI 10.1038/oby.2010.28; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Castagneto M, 2012, CURR ATHEROSCLER REP, V14, P624, DOI 10.1007/s11883-012-0284-6; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Lugari R, 2004, HORM METAB RES, V36, P111, DOI 10.1055/s-2004-814222; Magnone M, 2012, FASEB J, V26, P1261, DOI 10.1096/fj.11-187351; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Valverde I, 2005, OBES SURG, V15, P387, DOI 10.1381/0960892053576613; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	16	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115992	10.1371/journal.pone.0115992	http://dx.doi.org/10.1371/journal.pone.0115992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723556	Green Published, gold, Green Submitted			2022-12-26	WOS:000350251200012
J	Sumida, M; Hane, M; Yabe, U; Shimoda, Y; Pearce, OMT; Kiso, M; Miyagi, T; Sawada, M; Varki, A; Kitajima, K; Sato, C				Sumida, Mizuki; Hane, Masaya; Yabe, Uichiro; Shimoda, Yasushi; Pearce, Oliver M. T.; Kiso, Makoto; Miyagi, Taeko; Sawada, Makoto; Varki, Ajit; Kitajima, Ken; Sato, Chihiro			Rapid Trimming of Cell Surface Polysialic Acid (PolySia) by Exovesicular Sialidase Triggers Release of Preexisting Surface Neurotrophin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATED POLYSIALYLTRANSFERASE; FUNCTIONAL IMPAIRMENTS; MEMBRANE-VESICLES; MAMMALIAN BRAIN; HUMAN SIGLEC-11; NERVOUS-SYSTEM; EXPRESSION; MICROGLIA; GLYCOPROTEINS; RESIDUES	As acidic glycocalyx on primary mouse microglial cells and a mouse microglial cell line Ra2, expression of polysialic acid (polySia/PSA), a polymer of the sialic acid Neu5Ac (N-acetylneuraminic acid), was demonstrated. PolySia is known to modulate cell adhesion, migration, and localization of neurotrophins mainly on neural cells. PolySia on Ra2 cells disappeared very rapidly after an inflammatory stimulus. Results of knockdown and inhibitor studies indicated that rapid surface clearance of polySia was achieved by secretion of endogenous sialidase Neu1 as an exovesicular component. Neu1-mediated polySia turnover was accompanied by the release of brain-derived neurotrophic factor normally retained by polySia molecules. Introduction of a single oxygen atom change into polySia by exogenous feeding of the non-neural sialic acid Neu5Gc (N-glycolylneuraminic acid) caused resistance to Neu1-induced polySia turnover and also inhibited the associated release of brain-derived neurotrophic factor. These results indicate the importance of rapid turnover of the polySia glycocalyx by exovesicular sialidases in neurotrophin regulation.	[Sumida, Mizuki; Hane, Masaya; Yabe, Uichiro; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Sumida, Mizuki; Hane, Masaya; Yabe, Uichiro; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shimoda, Yasushi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Pearce, Oliver M. T.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Pearce, Oliver M. T.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi 9818558, Japan; [Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Dept Brain Funct, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagaoka University of Technology; University of California System; University of California San Diego; University of California System; University of California San Diego; Gifu University; Tohoku Medical & Pharmaceutical University; Nagoya University	Kitajima, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	kitajima@agr.nagoya-u.ac.jp; chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Regan, Clinton/E-6250-2012	Naganawa, Shinji/0000-0002-0214-613X; Pearce, Oliver/0000-0003-3953-1629	National Institutes of Health [R01GM32373]; Ministry of Education, Science, Sports, and Culture [23570133, 23110002, 24110506, 26110708]; Hayashi Foundation; CREST of Japan Science and Technology Agency; Naito Foundation Subsidy for Promotion of Specific Research Projects; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Foundation; CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Naito Foundation Subsidy for Promotion of Specific Research Projects; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM32373 (to O. P. and A. V.). This work was also supported in part by Grants-in-aid for Scientific Research (C) (23570133) and Scientific Research on Innovative Areas (23110002, Deciphering sugar chain-based signals regulating integrative neural functions) (24110506 and 26110708) from the Ministry of Education, Science, Sports, and Culture and the Hayashi Foundation (to C. S.) and CREST of Japan Science and Technology Agency and the Naito Foundation Subsidy for Promotion of Specific Research Projects (to K. K.).	Adachi T, 2007, BIOCHEM BIOPH RES CO, V358, P848, DOI 10.1016/j.bbrc.2007.04.197; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Arar S, 2007, CARBOHYD RES, V342, P1110, DOI 10.1016/j.carres.2007.02.016; Azuma Y, 2007, BIOL PHARM BULL, V30, P1680, DOI 10.1248/bpb.30.1680; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Chen TY, 2011, J IMMUNOL, V186, P2219, DOI 10.4049/jimmunol.1002991; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Flori F, 2007, FERTIL STERIL, V88, P1212, DOI 10.1016/j.fertnstert.2007.01.209; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Mackowiak M, 2005, BRAIN RES, V1055, P149, DOI 10.1016/j.brainres.2005.07.001; Magesh S, 2008, BIOORG MED CHEM LETT, V18, P532, DOI 10.1016/j.bmcl.2007.11.084; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Pshezhetsky AV, 2011, GLYCOCONJUGATE J, V28, P441, DOI 10.1007/s10719-011-9350-5; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2004, TRENDS GLYCOSCI GLYC, V16, P331, DOI 10.4052/tigg.16.331; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 1998, J BIOL CHEM, V273, P2575, DOI 10.1074/jbc.273.5.2575; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sawada M, 1998, FEBS LETT, V433, P37, DOI 10.1016/S0014-5793(98)00879-5; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Suzumura A, 1998, BRAIN RES, V787, P139, DOI 10.1016/S0006-8993(97)01166-9; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010	54	68	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13202	13214		10.1074/jbc.M115.638759	http://dx.doi.org/10.1074/jbc.M115.638759			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25750127	Green Published, hybrid			2022-12-26	WOS:000354975700022
J	Liu, L; Leung, LH; Cooney, AJ; Chen, CY; Rosengare, TK; Ma, YP; Yang, JC				Liu, Liang; Leung, Lai-Han; Cooney, Austin J.; Chen, Changyi; Rosengare, Todd K.; Ma, Yupo; Yang, Jianchang			Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; STEM/PROGENITOR CELLS; GENE SALL4; RAR-ALPHA; TRANSCRIPTION; TARGET; IDENTIFICATION; ACCUMULATION; RECRUITMENT; INHIBITION	All-trans retinoic acid (ATRA) is a differentiation agent that revolutionized the treatment of acute promyelocytic leukemia. However, it has not been useful for other types of acute myeloid leukemia (AML). Here we explored the effect of SALL4, a stem cell factor, on ATRA-induced AML differentiation in both ATRA-sensitive and ATRA-resistant AML cells. Aberrant SALL4 expression has been found in nearly all human AML cases, whereas, in normal bone marrow and peripheral blood cells, its expression is only restricted to hematopoietic stem/progenitor cells. We reason that, in AMLs, SALL4 activation may prevent cell differentiation and/or protect self-renewal that is seen in normal hematopoietic stem/progenitor cells. Indeed, our studies show that ATRA-mediated myeloid differentiation can be largely blocked by exogenous expression of SALL4, whereas ATRA plus SALL4 knockdown causes significantly increased AML differentiation and cell death. Mechanistic studies indicate that SALL4 directly associates with retinoic acid receptor alpha and modulates ATRA target gene expression. SALL4 is shown to recruit lysine-specific histone demethylase 1 (LSD1) to target genes and alter the histone methylation status. Furthermore, coinhibition of LSD1 and SALL4 plus ATRA treatment exhibited the strongest anti-AML effect. These findings suggest that SALL4 plays an unfavorable role in ATRA-based regimes, highlighting an important aspect of leukemia therapy.	[Liu, Liang; Yang, Jianchang] SUNY Stony Brook, Dept Surg, Stony Brook, NY 11794 USA; [Ma, Yupo; Yang, Jianchang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Leung, Lai-Han; Cooney, Austin J.] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Macau 519020, Peoples R China; [Cooney, Austin J.; Chen, Changyi; Rosengare, Todd K.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Macau University of Science & Technology; Baylor College of Medicine	Yang, JC (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	jianchang.yang@bcm.edu			American Cancer Society [RSG-12-216-01-LIB]; New York State Stem Cell Science [C0281148, C026716]	American Cancer Society(American Cancer Society); New York State Stem Cell Science	This work was supported by American Cancer Society Research Scholar Grant RSG-12-216-01-LIB (to J. Y.) and New York State Stem Cell Science Grants C0281148 (to Y. M.) and C026716 (to the Stony Brook Stem Cell Center).	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Brown G., 2012, LEUK RES TREATMENT; Glasow A, 2005, BLOOD, V105, P341, DOI 10.1182/blood-2004-03-1074; Jeong HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018372; Jones JE, 2009, LEUKEMIA, V23, P1933, DOI 10.1038/leu.2009.118; Klein ES, 2000, J BIOL CHEM, V275, P19401, DOI 10.1074/jbc.M002472200; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Launay S, 2003, BLOOD, V101, P3220, DOI 10.1182/blood-2002-09-2730; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Liu L, 2013, J BIOL CHEM, V288, P34719, DOI 10.1074/jbc.M113.506568; Lubbert M., 2014, CANCER, V121, P498; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Nigten J, 2005, LEUKEMIA, V19, P799, DOI 10.1038/sj.leu.2403699; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Ozpolat B, 2003, J PHARM PHARM SCI, V6, P292; Sakamoto K, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.25; Savory JGA, 2014, DEV BIOL, V395, P199, DOI 10.1016/j.ydbio.2014.09.013; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2012, CURR OPIN HEMATOL, V19, P287, DOI 10.1097/MOH.0b013e328353c684; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zeng SS, 2014, J HEPATOL, V60, P127, DOI 10.1016/j.jhep.2013.08.024; Zhang X, 2015, CANCER LETT, V357, P55, DOI 10.1016/j.canlet.2014.11.037	31	9	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10599	10609		10.1074/jbc.M114.634790	http://dx.doi.org/10.1074/jbc.M114.634790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25737450	Green Published, hybrid			2022-12-26	WOS:000353404500003
J	Tenopoulou, M; Chen, J; Bastin, J; Bennett, MJ; Ischiropoulos, H; Doulias, PT				Tenopoulou, Margarita; Chen, Jie; Bastin, Jean; Bennett, Michael J.; Ischiropoulos, Harry; Doulias, Paschalis-Thomas			Strategies for Correcting Very Long Chain Acyl- CoA Dehydrogenase Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Mitochondrial Metabolism; Nitric Oxide; Post-transcriptional Regulation; S-Nitrosylation; -Oxidation Disorder; Pediatric Disorder; Very Long Chain Acyl-CoA Dehydrogenase; Very Long Chain Acyl-CoA Dehydrogenase Deficiency	PROTEIN S-NITROSYLATION; COENZYME-A DEHYDROGENASE; ACID OXIDATION DISORDERS; NITRIC-OXIDE; GUANYLATE-CYCLASE; MUTATION ANALYSIS; SUDDEN-DEATH; IDENTIFICATION; FIBROBLASTS; GENOTYPE	Background: VLCAD deficiency is a mitochondrial fatty acid -oxidation disorder. Results:S-Nitrosylation of Cys-237 in VLCAD increased enzymatic activity and normalized -oxidation capacity and acylcarnitine levels in VLCAD-deficient cells. Conclusion: Correction of VLCAD deficiency alleviates disease-associated metabolic derangement and biomarker accumulation. Significance: Data provide proof-of-concept for a potential therapeutic approach that may significantly impact the lives of children and adults with -oxidation deficiencies. Very long acyl-CoA dehydrogenase (VLCAD) deficiency is a genetic pediatric disorder presenting with a spectrum of phenotypes that remains for the most part untreatable. Here, we present a novel strategy for the correction of VLCAD deficiency by increasing mutant VLCAD enzymatic activity. Treatment of VLCAD-deficient fibroblasts, which express distinct mutant VLCAD protein and exhibit deficient fatty acid -oxidation, with S-nitroso-N-acetylcysteine induced site-specific S-nitrosylation of VLCAD mutants at cysteine residue 237. Cysteine 237 S-nitrosylation was associated with an 8-17-fold increase in VLCAD-specific activity and concomitant correction of acylcarnitine profile and -oxidation capacity, two hallmarks of the disorder. Overall, this study provides biochemical evidence for a potential therapeutic modality to correct -oxidation deficiencies.	[Tenopoulou, Margarita; Ischiropoulos, Harry; Doulias, Paschalis-Thomas] Childrens Hosp Philadelphia, Res Inst, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Chen, Jie; Bennett, Michael J.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Michael Palmieri Metab Lab,Childrens Hosp Philade, Philadelphia, PA 19104 USA; [Ischiropoulos, Harry] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Bastin, Jean] Univ Paris 05, INSERM, F-75270 Paris 6, France	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Doulias, PT (corresponding author), Childrens Hosp Philadelphia, Res Inst, Abramson Pediat Res Ctr 416D, Philadelphia, PA 19104 USA.	doulias@email.chop.edu	Bastin, Jean/E-3083-2016; DeltaOmicronUpsilonLambdaIotaAlphaSigma, PiAlphaSigmaChiAlphaLambdaEtaSigma-ThetaOmegaMuAlphaSigma/AAY-1665-2020	Doulias, Paschalis-Thomas/0000-0001-7891-3131; Bastin, Jean/0000-0001-8350-8667	National Institutes of Health [HL054926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL054926.	Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Andresen BS, 1996, J INHERIT METAB DIS, V19, P169, DOI 10.1007/BF01799421; Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1995, AM J HUM GENET, V57, P273; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Baruteau J, 2013, J INHERIT METAB DIS, V36, P795, DOI 10.1007/s10545-012-9542-6; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Djouadi F, 2005, HUM MOL GENET, V14, P2695, DOI 10.1093/hmg/ddi303; Doulias PT, 2013, J PROTEOMICS, V92, P195, DOI 10.1016/j.jprot.2013.05.033; Doulias PT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003252; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engbers HM, 2005, J INHERIT METAB DIS, V28, P1151, DOI 10.1007/s10545-005-0190-y; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Ficicioglu C, 2010, J PEDIATR-US, V156, P492, DOI 10.1016/j.jpeds.2009.10.031; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Gobin-Limballe S, 2007, AM J HUM GENET, V81, P1133, DOI 10.1086/522375; Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; Isackson PJ, 2013, MUSCLE NERVE, V47, P224, DOI 10.1002/mus.23498; IZAI K, 1992, J BIOL CHEM, V267, P1027; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McGoey RR, 2011, J PEDIATR-US, V158, P1031, DOI 10.1016/j.jpeds.2011.01.063; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Schiff M, 2013, MOL GENET METAB, V109, P21, DOI 10.1016/j.ymgme.2013.02.002; Shen JJ, 2000, J INHERIT METAB DIS, V23, P27, DOI 10.1023/A:1005694712583; Souri M, 1996, AM J HUM GENET, V58, P97; Souri M, 1998, FEBS LETT, V426, P187, DOI 10.1016/S0014-5793(98)00343-3; Spiekerkoetter U, 2006, HORM METAB RES, V38, P625, DOI 10.1055/s-2006-954581; Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x; Spiekerkoetter U, 2010, J PEDIATR-US, V157, P668, DOI 10.1016/j.jpeds.2010.04.063; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P527, DOI 10.1007/s10545-010-9090-x; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wood JC, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e19; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	54	4	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10486	10494		10.1074/jbc.M114.635102	http://dx.doi.org/10.1074/jbc.M114.635102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737446	Green Published, hybrid			2022-12-26	WOS:000353241100047
J	Liu, J; Ai, HW; Xiong, Y; Li, F; Wen, Z; Liu, WY; Li, TY; Qin, K; Wu, JG; Liu, YL				Liu, Jia; Ai, Hongwu; Xiong, Ying; Li, Fu; Wen, Zhou; Liu, Weiyong; Li, Tongya; Qin, Kai; Wu, Jianguo; Liu, Yingle			Prevalence and Correlation of Infectious Agents in Hospitalized Children with Acute Respiratory Tract Infections in Central China	PLOS ONE			English	Article							VIRAL-INFECTIONS; HUMAN METAPNEUMOVIRUS; SYNCYTIAL VIRUS; PATHOGENS; INFANTS; PNEUMONIA; SURVEILLANCE; ASSAYS	Acute respiratory tract infections (ARTIs) are associated with significant morbidity and mortality worldwide, especially in children under the age of 5 years. Almost 2 million children die from ARTIs each year, and most of them are from developing countries. The prevalence and correlation of pathogens in ARTIs are poorly understood, but are critical for improving case prevention, treatment, and management. In this study, we investigated the prevalence and correlation of infectious agents in children with ARTIs. A total of 39,756 children with one or more symptoms, including fever, cough, sore throat, tonsillitis, pharyngitis, herpangina, pneumonia, and bronchiolitis, were enrolled in the study. All patients were hospitalized in Wuhan Children's Hospital between October 1, 2010 and September 30, 2012, and were evaluated for infectious agents. Pathogens, including Mycoplasma pneumoniae, influenza A virus, influenza B virus, adenoviruses, respiratory syncytial virus, parainfluenza virus, Legionella pneumophila, Chlamydophila pneumoniae, and Coxiella burnetii, were screened simultaneously in patient blood samples using anti-pathogen IgM tests. Regression analysis was used to reveal correlations among the pathogens. Our results showed that one or more pathogens were identified in 10,206 patients, and that Mycoplasma pneumoniae, adenoviruses, and influenza B virus were the leading infectious agents. Mixed-infections of pathogens were detected in 2,391 cases, with Mycoplasma pneumoniae as the most frequent pathogen. The most common agents in the co-infections were Mycoplasma pneumoniae and influenza B virus. Regression analysis revealed a linear correlation between the proportion of mixed infections and the incidence of multi-pathogen infections. The prevalence of infectious agents in children with ARTIs was determined. Equations were established to estimate multiple infections by single-pathogen detection. This revealed a linear correlation for pathogens in children with ARTIs. This study provides useful information for improving case prevention and management.	[Liu, Jia; Xiong, Ying; Li, Fu; Wen, Zhou; Liu, Weiyong; Li, Tongya; Qin, Kai; Wu, Jianguo; Liu, Yingle] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Jia; Xiong, Ying; Li, Fu; Wen, Zhou; Liu, Weiyong; Li, Tongya; Qin, Kai; Wu, Jianguo; Liu, Yingle] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ai, Hongwu] Wuhan Childrens Hosp, Dept Clin Lab, Wuhan, Peoples R China	Wuhan University; Wuhan University	Wu, JG (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	jwu@whu.edu.cn; mvlwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program (973 Program) [2012CB518900]; National Natural Science Foundation of China [31230005, 81171525]; National Mega Project on Major Infectious Disease Prevention [2012ZX10002006-003, 2012ZX10004-207]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention	This work was supported by research grants from the Major State Basic Research Development Program (973 Program) (2012CB518900), the National Natural Science Foundation of China (31230005 and 81171525), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bielawska-Drozd A, 2014, VET MICROBIOL, V174, P600, DOI 10.1016/j.vetmic.2014.09.034; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Chalker VJ, 2012, EUROSURVEILLANCE, V17, P5; Dwigh A, 1996, NELLSON TXB PEDIAT, V1, P824; El-Sahrigy S. A. F., 2006, Journal of Medical Sciences (Pakistan), V6, P793; Fabbiani M, 2009, J MED VIROL, V81, P750, DOI 10.1002/jmv.21457; Gonzalez-Del Vecchio M, 2014, MEDICINE, V93, P364, DOI 10.1097/MD.0000000000000218; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Jacobs E, 2012, EUROSURVEILLANCE, V17, P2; Jin Y, 2012, CLIN MICROBIOL INFEC, V18, P74, DOI 10.1111/j.1469-0691.2011.03541.x; KELLOGG JA, 1991, ARCH PATHOL LAB MED, V115, P451; Kim MR, 2000, J INFECTION, V41, P152, DOI 10.1053/jinf.2000.0715; Lin TY, 2004, J CLIN VIROL, V30, P81, DOI 10.1016/j.jcv.2003.08.014; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Long SS, 1999, PRINCIPLES PRACTICE; Lu R, 2010, PLOS ONE, V7; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Nir-Paz R, 2012, EUROSURVEILLANCE, V17, P5; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Huong PLT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1304; Polkowska A, 2012, EUROSURVEILLANCE, V17, P8; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; Rastawicki W, 1998, Euro Surveill, V3, P99; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; Tang LF, 2008, INDIAN PEDIATR, V45, P971; Tjhie JHT, 2000, SCAND J INFECT DIS, V32, P13, DOI 10.1080/00365540050164155; TRISTRAM DA, 1988, AM J DIS CHILD, V142, P834, DOI 10.1001/archpedi.1988.02150080040017; Tseng Ren-Ku, 1995, Journal of the Formosan Medical Association, V94, pS126; Weigl JAI, 2000, EUR J CLIN MICROBIOL, V19, P336, DOI 10.1007/s100960050490; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Zamberi S, 2003, Med J Malaysia, V58, P681; Zavattoni M, 2003, MICROBIOLOGICA, V26, P133; Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477	39	29	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119170	10.1371/journal.pone.0119170	http://dx.doi.org/10.1371/journal.pone.0119170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751402	Green Submitted, gold, Green Published			2022-12-26	WOS:000350692700017
J	Bronner, A; Morignat, E; Henaux, V; Madouasse, A; Gay, E; Calavas, D				Bronner, Anne; Morignat, Eric; Henaux, Viviane; Madouasse, Aurelien; Gay, Emilie; Calavas, Didier			Devising an Indicator to Detect Mid-Term Abortions in Dairy Cattle: A First Step Towards Syndromic Surveillance of Abortive Diseases	PLOS ONE			English	Article							VIRUS SEROTYPE 8; BLUETONGUE VIRUS; BOVINE ABORTION; INFECTION; OUTBREAKS; FERTILITY; ALGORITHM; FRANCE; DEATH; COWS	Bovine abortion surveillance is essential for human and animal health because it plays an important role in the early warning of several diseases. Due to the limited sensitivity of traditional surveillance systems, there is a growing interest for the development of syndromic surveillance. Our objective was to assess whether, routinely collected, artificial insemination (AI) data could be used, as part of a syndromic surveillance system, to devise an indicator of mid-term abortions in dairy cattle herds in France. A mid-term abortion incidence rate (MAIR) was computed as the ratio of the number of mid-term abortions to the number of female-weeks at risk. A mid-term abortion was defined as a return-to-service (i.e. a new AI) taking place 90 to 180 days after the previous AI. Weekly variations in the MAIR in heifers and parous cows were modeled with a time-dependent Poisson model at the departement level (French administrative division) during the period of 2004 to 2010. The usefulness of monitoring this indicator to detect a disease-related increase in mid-term abortions was evaluated using data from the 2007-2008 episode of bluetongue serotype 8 (BT8) in France. An increase in the MAIR was identified in heifers and parous cows in 47% (n = 24) and 71% (n = 39) of the departements. On average, the weekly MAIR among heifers increased by 3.8% (min-max: 0.02-57.9%) when the mean number of BT8 cases that occurred in the previous 8 to 13 weeks increased by one. The weekly MAIR among parous cows increased by 1.4% (0.01-8.5%) when the mean number of BT8 cases occurring in the previous 6 to 12 weeks increased by one. These results underline the potential of the MAIR to identify an increase in mid-term abortions and suggest that it is a good candidate for the implementation of a syndromic surveillance system for bovine abortions.	[Bronner, Anne; Morignat, Eric; Henaux, Viviane; Gay, Emilie; Calavas, Didier] ANSES Lyon, Unite Epidemiol, F-69364 Lyon 07, France; [Madouasse, Aurelien] INRA, Biol Epidemiol & Anal Risque & Sante Anim, UMR1300, F-44307 Nantes, France; [Madouasse, Aurelien] LUNAM Univ, Oniris Ecole Natl Vet Agroalimentaire & Alimentat, UMR BioEpAR, F-44307 Nantes, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Bronner, A (corresponding author), ANSES Lyon, Unite Epidemiol, 31 Ave Tony Garnier, F-69364 Lyon 07, France.	anne.bronner@anses.fr	Madouasse, Aurélien/AAC-2814-2019	Madouasse, Aurélien/0000-0002-9254-5707				Anderson ML, 2007, THERIOGENOLOGY, V68, P474, DOI 10.1016/j.theriogenology.2007.04.001; [Anonymous], 2005, EFSA OPINION SCI PAN; [Anonymous], 2011, LANCET, V378, P1833, DOI [10.1016/S0140-6736(11)60834-9, DOI 10.1016/S0140-6736(11)60834-9]; Bolker B, 2013, PACKAGE BBMLE; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Bronner A, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-93; Bronner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063246; Brugger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060330; Buehler JW, 2004, FRAMEWORK EVALUATING; Burnham K. P., 1998, MODEL SELECTION INFE; Curriero FC, 2005, VECTOR-BORNE ZOONOT, V5, P267, DOI 10.1089/vbz.2005.5.267; Dal Pozzo F, 2009, VET J, V182, P142, DOI 10.1016/j.tvjl.2009.05.004; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P352, DOI 10.1111/j.1865-1682.2008.01044.x; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Elbers A.R., 2007, NATURE SEVERITY DIS; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fediaevsky A., 2011, B EPIDEMIOL SANTE AN, V46, P10; Haile-Mariam M, 2013, J DAIRY SCI, V96, P655, DOI 10.3168/jds.2012-5671; Hohle M, 2007, COMPUTATION STAT, V22, P571, DOI 10.1007/s00180-007-0074-8; InVS, 2008, RAPP ANN 2007; KALLELA K, 1984, NORD VET MED, V36, P305; Mailles A., 2012, EURO SURVEILL, V17; Malher X, 2006, THERIOGENOLOGY, V65, P1215, DOI 10.1016/j.theriogenology.2005.08.003; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Marceau A, 2014, J DAIRY SCI, V97, P6135, DOI 10.3168/jds.2013-7346; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; Mounaix B, 2008, IMPACT TECHNICO EC F; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Nusinovici S, 2012, THERIOGENOLOGY, V78, P1140, DOI 10.1016/j.theriogenology.2012.05.010; Nusinovici S, 2011, THESIS U NANTES ANGE; Nusinovici S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100137; OIE, 2012, OIE COUNTR REP; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAY AC, 1986, J AM VET MED ASSOC, V188, P1187; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Riet-Correa F, 2012, J APPL TOXICOL, V32, P245, DOI 10.1002/jat.1754; Robinson DL, 2007, LIVEST SCI, V110, P174, DOI 10.1016/j.livsci.2006.11.004; Santman-Berends IMGA, 2010, THERIOGENOLOGY, V74, P1377, DOI 10.1016/j.theriogenology.2010.06.008; Shone SM, 2006, J MED ENTOMOL, V43, P393, DOI 10.1603/0022-2585(2006)043[0393:CPDOAS]2.0.CO;2; Stengel B, 1995, EPIDEMIOLOGIE PRINCI; STILL PE, 1971, NATURE, V234, P563, DOI 10.1038/234563a0; Triple-S, 2014, SYNDROMIC SURVEILLAN; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Yahav I, 2007, LECT NOTES COMPUT SC, V4506, P91; Yamamoto T, 2008, PREV VET MED, V86, P57, DOI 10.1016/j.prevetmed.2008.03.004; Zientara S, 2010, B EPIDEMIOL SANTE AN, V35, P2, DOI [10.3945/jn.111.146258, DOI 10.3945/JN.111.146258]	51	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119012	10.1371/journal.pone.0119012	http://dx.doi.org/10.1371/journal.pone.0119012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746469	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400038
J	Bull, C; Christensen, H; Fenech, M				Bull, Caroline; Christensen, Helen; Fenech, Michael			Cortisol Is Not Associated with Telomere Shortening or Chromosomal Instability in Human Lymphocytes Cultured under Low and High Folate Conditions	PLOS ONE			English	Article							FOLIC-ACID DEFICIENCY; LIFE-STYLE CHANGES; DNA-DAMAGE; ALZHEIMERS-DISEASE; STRESS-RESPONSE; LENGTH; HOMOCYSTEINE; CANCER; RISK; MAINTENANCE	Chronic psychological stress and nutritional deficiencies are factors that impact negatively on human health and disease risk. Chronic stress has been associated with accelerated leukocyte telomere shortening in numerous cohorts, however, a mechanistic link has proven elusive. This study tested the hypotheses that chronic exposure to the stress hormone, cortisol, causes telomere shortening and chromosome instability (CIN) in vitro, and that these effects would be further exacerbated by folate (vitamin B9) deficiency. Primary human lymphocytes were maintained in vitrofor 12 days in medium containing either 25 nM folic acid (FA(low)) or 100 nM FA (FA(high)), together with either 0, 400, 1000 or 3500 nM cortisol. The interactive effects of cortisol and FA were examined by comparing telomere length (TL), biomarkers of DNA damage, and cytostasis. At day 12 TL was 5-17% longer in lymphocytes cultured in FA(low) conditions (mean +/- SD; 10.2% +/- 1.6), compared with those in FA(high) medium (9.1% +/- 1, p = 0.02). Refuting the hypothesis, TL was consistently greater in the presence of cortisol. The effect of FA deficiency on the frequency of DNA damage was significant for nucleoplasmic bridges, circular nuclei, micronuclei and nuclear buds, (p < 0.0001 - 0.001). The effect of cortisol, however, was negligible, only reaching statistical significance for the frequency of fused nuclei (p = 0.04). Cortisol was significantly associated with reduced cell division and growth and had an apparent protective effect on cell viability in the FA(low) conditions. Conclusions: Both chronic cortisol exposure, and folate deficiency, resulted in telomere elongation, however, the effect of cortisol was marginal relative to that of folate. Cortisol was not associated with increased chromosomal instability, but caused a significant reduction in cell division and growth. Together these results indicate that cortisol is not directly genotoxic and that the telomere shortening associated with increased psychological stress in vivo may not be explained by a direct effect of cortisol.	[Bull, Caroline; Fenech, Michael] CSIRO, Anim Food & Hlth Sci, Nutr Genom & DNA Damage Diagnost Lab, Adelaide, SA, Australia; [Bull, Caroline] Univ Adelaide, Sch Mol & Biomed Sci, Dept Microbiol & Immunol, Adelaide, SA, Australia; [Christensen, Helen] Prince Wales Hosp, Black Dog Inst, Randwick, NSW 2031, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; Black Dog Institute	Bull, C (corresponding author), CSIRO, Anim Food & Hlth Sci, Nutr Genom & DNA Damage Diagnost Lab, Adelaide, SA, Australia.	caroline.bull@csiro.au	Bull, Caroline F/H-4966-2013; Christensen, Helen/F-5053-2012	Bull, Caroline F/0000-0002-4478-2230; Christensen, Helen/0000-0003-0435-2065	Science Industry Endowment Fund (SIEF) John Stocker Postdoctoral Research Fellowship; CSIRO's Preventative Health Research Flagship	Science Industry Endowment Fund (SIEF) John Stocker Postdoctoral Research Fellowship; CSIRO's Preventative Health Research Flagship	CB was supported by a Science Industry Endowment Fund (SIEF) John Stocker Postdoctoral Research Fellowship and CSIRO's Preventative Health Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizaki M, 2007, METABOLISM, V56, P222, DOI 10.1016/j.metabol.2006.09.017; Beetstra S, 2005, MUTAT RES-FUND MOL M, V578, P317, DOI 10.1016/j.mrfmmm.2005.05.012; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Berg AL, 2006, CLIN CHEM LAB MED, V44, P628, DOI 10.1515/CCLM.2006.114; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; Bull C, 2008, P NUTR SOC, V67, P146, DOI 10.1017/S0029665108006988; Bull CF, 2014, CANCER PREV RES, V7, P128, DOI 10.1158/1940-6207.CAPR-13-0264; Bull CF, 2012, ENVIRON MOL MUTAGEN, V53, P311, DOI 10.1002/em.21688; Bull CF, 2009, REJUV RES, V12, P341, DOI 10.1089/rej.2009.0868; Cascalheira JF, 2008, ANN NUTR METAB, V53, P67, DOI 10.1159/000158636; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Crott JW, 2001, CANCER EPIDEM BIOMAR, V10, P1089; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Djurhuus CB, 2004, AM J PHYSIOL-ENDOC M, V286, pE488, DOI 10.1152/ajpendo.00199.2003; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003; Fenech Michael F, 2010, Genome Integr, V1, P11, DOI 10.1186/2041-9414-1-11; Fenech MF, 2010, AM J CLIN NUTR, V91, p1438S, DOI 10.3945/ajcn.2010.28674D; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Flint MS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3189; Gidron Y, 2008, CURR OPIN ONCOL, V20, P386, DOI 10.1097/CCO.0b013e3282fbcd0d; Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Heaphy CM, 2011, J CELL MOL MED, V15, P1227, DOI 10.1111/j.1582-4934.2011.01284.x; Hinterberger M, 2013, J AM GERIATR SOC, V61, P648, DOI 10.1111/jgs.12178; Hooshmand B, 2010, NEUROLOGY, V75, P1408, DOI 10.1212/WNL.0b013e3181f88162; Humphreys J, 2012, BIOL RES NURS, V14, P115, DOI 10.1177/1099800411398479; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kennedy DO, 2010, PSYCHOPHARMACOLOGY, V211, P55, DOI 10.1007/s00213-010-1870-3; Kuebler U, 2013, PSYCHONEUROENDOCRINO, V38, P1381, DOI 10.1016/j.psyneuen.2012.12.003; Malvandi AM, 2010, STRESS, V13, P276, DOI 10.3109/10253890903296710; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Mishra GD, 2009, PUBLIC HEALTH NUTR, V12, P166, DOI 10.1017/S1368980008002413; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Paul L, 2009, J NUTR, V139, P1273, DOI 10.3945/jn.109.104984; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Shalev I, 2012, BIOESSAYS, V34, P943, DOI 10.1002/bies.201200084; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Tucker Katherine L, 2005, J Med Invest, V52 Suppl, P252, DOI 10.2152/jmi.52.252; Umegaki K, 2000, MUTAGENESIS, V15, P261, DOI 10.1093/mutage/15.3.261; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; von Kanel R, 2003, ANN BEHAV MED, V26, P42, DOI 10.1207/S15324796ABM2601_06; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; York TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055337	53	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119367	10.1371/journal.pone.0119367	http://dx.doi.org/10.1371/journal.pone.0119367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748629	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400070
J	Hengen, KB; Nelson, NR; Stang, KM; Johnson, SM; Smith, SM; Watters, JJ; Mitchell, GS; Behan, M				Hengen, Keith B.; Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Smith, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary			Daily Isoflurane Exposure Increases Barbiturate Insensitivity in Medullary Respiratory and Cortical Neurons via Expression of epsilon-Subunit Containing GABA (A)Rs	PLOS ONE			English	Article							DELTA-SUBUNIT; NEUROSTEROID MODULATION; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; RECEPTORS; EXCITABILITY; PLASTICITY; CURRENTS; RHYTHM; BRAIN	The parameters governing GABA(A) receptor subtype expression patterns are not well understood, although significant shifts in subunit expression may support key physiological events. For example, the respiratory control network in pregnant rats becomes relatively insensitive to barbiturates due to increased expression of epsilon-subunit-containing GABA(A)Rs in the ventral respiratory column. We hypothesized that this plasticity may be a compensatory response to a chronic increase in inhibitory tone caused by increased central neurosteroid levels. Thus, we tested whether increased inhibitory tone was sufficient to induce epsilon-subunit upregulation on respiratory and cortical neurons in adult rats. Chronic intermittent increases in inhibitory tone in male and female rats was induced via daily 5-min exposures to 3% isoflurane. After 7d of treatment, phrenic burst frequency was less sensitive to barbiturate in isoflurane-treated male and female rats in vivo. Neurons in the ventral respiratory group and cortex were less sensitive to pentobarbital in vitro following 7d and 30d of intermittent isoflurane-exposure in both male and female rats. The pentobarbital insensitivity in 7d isoflurane-treated rats was reversible after another 7d. We hypothesize that increased inhibitory tone in the respiratory control network and cortex causes a compensatory increase in epsilon-subunit-containing GABA(A)Rs.	[Hengen, Keith B.] Brandeis Univ, Neurosci Training Program, Waltham, MA 02254 USA; [Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Smith, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary] Brandeis Univ, Sch Vet Med, Dept Comparat Biosci, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Hengen, KB (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	khengen@brandeis.edu		Hengen, Keith/0000-0001-5017-4090	National Institutes of Health [R01 AG18760, R01 NS049033]; NIH [T32 HL 7654-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health R01 AG18760 (MB) and R01 NS049033 (JJW). At the time this work was completed, KBH was supported by a training grant provided by the NIH (PI GM; T32 HL 7654-24). None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramian AM, 2014, P NATL ACAD SCI USA, V111, P7132, DOI 10.1073/pnas.1403285111; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Cagetti E, 2003, MOL PHARMACOL, V63, P53, DOI 10.1124/mol.63.1.53; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Grasshoff C, 2006, BRIT J ANAESTH, V97, P687, DOI 10.1093/bja/ael239; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Gutierrez ML, 2014, NEUROSCIENCE, V257, P119, DOI 10.1016/j.neuroscience.2013.10.077; Hengen KB, 2011, AM J PHYSIOL-REG I, DOI [10.1152/ajpregu.0067.2010, DOI 10.1152/AJPREGU.0067.2010]; Hengen KB, 2013, NEURON, V80, P335, DOI 10.1016/j.neuron.2013.08.038; Hengen KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030608; Hengen KB, 2009, AM J PHYSIOL-REG I, V297, pR1028, DOI 10.1152/ajpregu.00239.2009; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Irnaten M, 2002, ANESTHESIOLOGY, V97, P717, DOI 10.1097/00000542-200209000-00027; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; Kang MH, 1998, ALCOHOL CLIN EXP RES, V22, P2165; Lambo ME, 2013, J NEUROSCI, V33, P8810, DOI 10.1523/JNEUROSCI.4502-12.2013; Lesch A, 2014, BRIT J PHARMACOL, V171, P2645, DOI 10.1111/bph.12524; Liang J, 2009, J NEUROPHYSIOL, V102, P224, DOI 10.1152/jn.90484.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKenzie G, 2014, PSYCHOPHARMACOLOGY, V231, P3333, DOI 10.1007/s00213-013-3423-z; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maguire Jamie, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS84, DOI 10.1016/j.psyneuen.2009.06.019; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Marutha Ravindran CR, 2007, BRAIN RES; Meera P, 2010, MOL PHARMACOL, V78, P918, DOI 10.1124/mol.109.062687; Orser BA, 2006, J CLIN SLEEP MED, V2, pS12; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Ren J, 2006, J PHYSIOL-LONDON, V574, P535, DOI 10.1113/jphysiol.2006.108829; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sanna E, 2009, J NEUROSCI, V29, P1755, DOI 10.1523/JNEUROSCI.3684-08.2009; Sebe JY, 2010, EUR J NEUROSCI, V32, P1310, DOI 10.1111/j.1460-9568.2010.07373.x; Sekine S, 2006, NEUROCHEM RES, V31, P439, DOI 10.1007/s11064-005-9024-4; Sergeeva OA, 2005, J NEUROSCI, V25, P88, DOI 10.1523/JNEUROSCI.3209-04.2005; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tokuda K, 2011, J NEUROSCI, V31, P9905, DOI 10.1523/JNEUROSCI.1660-11.2011; Wagner DA, 2005, J NEUROSCI, V25, P10462, DOI 10.1523/JNEUROSCI.1658-05.2005; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; Wang X, 2011, J PHYSIOL-LONDON, V589, P5431, DOI 10.1113/jphysiol.2011.215392; Wang X, 2009, ANESTH ANALG, V108, P142, DOI 10.1213/ane.0b013e31818d8b79; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zuperku EJ, 2002, RESP PHYSIOL NEUROBI, V131, P121, DOI 10.1016/S1569-9048(02)00042-3	53	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119351	10.1371/journal.pone.0119351	http://dx.doi.org/10.1371/journal.pone.0119351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748028	Green Submitted, gold, Green Published			2022-12-26	WOS:000350689400067
J	Singh, N; Wang, C; Cooper, R				Singh, Narinderpal; Wang, Changlu; Cooper, Richard			Role of Vision and Mechanoreception in Bed Bug, Cimex lectularius L. Behavior	PLOS ONE			English	Article							CARBON-DIOXIDE; COLOR-VISION; SPECTRAL SENSITIVITY; CHEMICAL LURE; TRAP COLOR; DIPTERA; ATTRACTION; COLEOPTERA; CAPTURES; HETEROPTERA	The role of olfactory cues such as carbon dioxide, pheromones, and kairomones in bed bug, Cimex lectularius L. behavior has been demonstrated. However, the role of vision and mechanoreception in bed bug behavior is poorly understood. We investigated bed bug vision by determining their responses to different colors, vertical objects, and their ability to detect colors and vertical objects under low and complete dark conditions. Results show black and red paper harborages are preferred compared to yellow, green, blue, and white harborages. A bed bug trapping device with a black or red exterior surface was significantly more attractive to bed bugs than that with a white exterior surface. Bed bugs exhibited strong orientation behavior toward vertical objects. The height (15 vs. 30 cm tall) and color (brown vs. black) of the vertical object had no significant effect on orientation behavior of bed bugs. Bed bugs could differentiate color and detect vertical objects at very low background light conditions, but not in complete darkness. Bed bug preference to different substrate textures (mechanoreception) was also explored. Bed bugs preferred dyed tape compared to painted tape, textured painted plastic, and felt. These results revealed that substrate color, presence of vertical objects, and substrate texture affect host-seeking and harborage-searching behavior of bed bugs. Bed bugs may use a combination of vision, mechanoreception, and chemoreception to locate hosts and seek harborages.	[Singh, Narinderpal; Wang, Changlu; Cooper, Richard] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Singh, N (corresponding author), Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA.	nsingh@aesop.rutgers.edu			U.S. Department of Housing and Urban Development Healthy Homes Technical Studies grant program [NJLHH0197-09]; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate project [NJ08127]	U.S. Department of Housing and Urban Development Healthy Homes Technical Studies grant program; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate project	This project was funded by a grant from the U.S. Department of Housing and Urban Development Healthy Homes Technical Studies grant program (NJLHH0197-09)CW. Partial support was provided by the New Jersey Agricultural Experiment Station and by the USDA-National Institute for Food and Agriculture, Hatch Multistate project number NJ08127 CW NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aak A, 2014, PHYSIOL ENTOMOL, V39, P199, DOI 10.1111/phen.12062; ABOUL-NASR A E, 1967, Bulletin de la Societe Entomologique d'Egypte, V51, P43; Aboul-Nasr A. E., 1968, Bulletin de la Societe Entomologique d'Egypte, V52, P353; Aboul-Nasr AE, 1968, B SOC ENTOMOL EGYPT, V52, P363; ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Anderson JF, 2009, MED VET ENTOMOL, V23, P99, DOI 10.1111/j.1365-2915.2008.00790.x; Benoit Joshua B., 2011, Insects, V2, P151, DOI 10.3390/insects2020151; BRADBURY WC, 1974, CAN J ZOOL, V52, P251, DOI 10.1139/z74-030; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; BROWNE SM, 1981, J MED ENTOMOL, V18, P505, DOI 10.1093/jmedent/18.6.505; Cammaerts MC, 2009, BELG J ZOOL, V139, P40; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; Cilek JE, 2003, FLA ENTOMOL, V86, P420, DOI 10.1653/0015-4040(2003)086[0000:AOCPCB]2.0.CO;2; COLLETT TS, 1980, J COMP PHYSIOL, V138, P271, DOI 10.1007/BF00657045; DeValois RL, 1997, READINGS COLOR, V2, P93; GRANOVSKY TA, 1983, ENVIRON ENTOMOL, V12, P744, DOI 10.1093/ee/12.3.744; HAMILTON DW, 1971, J ECON ENTOMOL, V64, P430, DOI 10.1093/jee/64.2.430; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Jacobs GH, 1981, COMP COLOR VISION, P209; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; KOEHLER PG, 1987, ANN ENTOMOL SOC AM, V80, P820, DOI 10.1093/aesa/80.6.820; Kusakabe Y., 1990, Japanese Journal of Sanitary Zoology, V41, P219; Lanier G.N., 1983, P161; LEHANE MJ, 1991, BIOL BLOOD SUCKING I, P288; LEHRER M, 1994, VISION RES, V34, P2363, DOI 10.1016/0042-6989(94)90282-8; LEVINSON HZ, 1974, J INSECT PHYSIOL, V20, P1231, DOI 10.1016/0022-1910(74)90229-7; Liburd OE, 1998, J ECON ENTOMOL, V91, P243, DOI 10.1093/jee/91.1.243; Lie R., 1981, MANAGEMENT INSECT PE, P175; Lindh JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001661; Machial LA, 2012, AGR FOREST ENTOMOL, V14, P286, DOI 10.1111/j.1461-9563.2012.00568.x; Menzel R., 1979, HDB SENSORY PHYSL, V7 / 6 / 6, P503, DOI DOI 10.1007/978-3-642-66999-6_9; Menzel Randolf, 1991, P262; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Mramba F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002063; Nalepa CA, 2005, ENVIRON ENTOMOL, V34, P425, DOI 10.1603/0046-225X-34.2.425; Pinero JC, 2006, ENTOMOL EXP APPL, V121, P261, DOI [10.1111/j.1570-8703.2006.00485.x, 10.1111/j.1570-7458.2006.00485.x]; Rayaisse JB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001491; Reddy GVP, 2009, J CHEM ECOL, V35, P111, DOI 10.1007/s10886-008-9580-6; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reis Matthew D., 2011, Insects, V2, P186, DOI 10.3390/insects2020186; Reisenman CE, 2000, J COMP PHYSIOL A, V186, P961, DOI 10.1007/s003590000149; Reisenman CE, 2006, J COMP PHYSIOL A, V192, P39, DOI 10.1007/s00359-005-0045-x; Reza AMS, 2006, ISJ-INVERT SURVIV J, V3, P84; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; Roubos CR, 2008, J AGR URBAN ENTOMOL, V25, P99, DOI 10.3954/1523-5475-25.2.99; Semeao AA, 2011, J STORED PROD RES, V47, P88, DOI 10.1016/j.jspr.2011.01.002; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Siljander E, 2007, ENTOMOL EXP APPL, V125, P215, DOI 10.1111/j.1570-7458.2007.00617.x; Singh N, 2013, J ECON ENTOMOL, V106, P1802, DOI 10.1603/EC13075; Singh Narinderpal, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/273613; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; STEINBRECHT RA, 1976, TISSUE CELL, V8, P615, DOI 10.1016/0040-8166(76)90035-5; Strom BL, 2001, ANN ENTOMOL SOC AM, V94, P948, DOI 10.1603/0013-8746(2001)094[0948:EOSCOT]2.0.CO;2; Suchy James T., 2011, Insects, V2, P22, DOI 10.3390/insects2010022; Szyndler MW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0174; Toews M.D., 2012, STORED PRODUCT PROTE, P243; Usinger R., 1966, MONOGRAPH CIMICIDAE, V7; Vaidyanathan R, 2013, AM J TROP MED HYG, V88, P619, DOI 10.4269/ajtmh.12-0493; VERNON RS, 1995, J ECON ENTOMOL, V88, P288, DOI 10.1093/jee/88.2.288; Wang C., 2012, P POST DEM TRACK, P4; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Weeks ENI, 2011, B ENTOMOL RES, V101, P1, DOI 10.1017/S0007485309990599; Wehner R, 1997, EXS, V84, P145	64	12	13	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118855	10.1371/journal.pone.0118855	http://dx.doi.org/10.1371/journal.pone.0118855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748041	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400027
J	Berghauzen-Maciejewska, K; Wardas, J; Kosmowska, B; Glowacka, U; Kuter, K; Ossowska, K				Berghauzen-Maciejewska, Klemencja; Wardas, Jadwiga; Kosmowska, Barbara; Glowacka, Urszula; Kuter, Katarzyna; Ossowska, Krystyna			Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson's Disease: An Influence of Chronic Pramipexole in Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; UNPREDICTABLE MILD STRESS; DEPRESSIVE-LIKE BEHAVIOR; DEEP BRAIN-STIMULATION; DENTATE GYRUS; LATERAL HABENULA; LEARNED HELPLESSNESS; DOPAMINERGIC-NEURONS; CELL-PROLIFERATION; SUBSTANTIA-NIGRA	Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic pathways in rats, modelling preclinical stages of Parkinson's disease, induces a depressive-like behaviour which is reversed by chronic treatment with pramipexole. The purpose of the present study was to examine the role of brain derived neurotrophic factor (BDNF) signalling in the aforementioned model of depression. Therefore, we investigated the influence of 6-hydoxydopamine (6-OHDA) administration into the ventral region of the caudate-putamen on mRNA levels of BDNF and tropomyosin-related kinase B (trkB) receptor. The BDNF and trkB mRNA levels were determined in the nigrostriatal and limbic structures by in situ hybridization 2 weeks after the operation. Pramipexole (1 mg/kg sc twice a day) and imipramine (10 mg/kg ip once a day) were injected for 2 weeks. The lesion lowered the BDNF and trkB mRNA levels in the hippocampus [CA1, CA3 and dentate gyrus (DG)] and amygdala (basolateral/lateral) as well as the BDNF mRNA content in the habenula (medial/lateral). The lesion did not influence BDNF and trkB expression in the caudate-putamen, substantia nigra, nucleus accumbens (shell and core) and ventral tegmental area (VTA). Chronic imipramine reversed the lesion-induced decreases in BDNF mRNA in the DG. Chronic pramipexole increased BDNF mRNA, but decreased trkB mRNA in the VTA in lesioned rats. Furthermore, it reduced BDNF and trkB mRNA expression in the shell and core of the nucleus accumbens, BDNF mRNA in the amygdala and trkB mRNA in the caudate-putamen in these animals. The present study indicates that both the 6-OHDA-induced dopaminergic lesion and chronic pramipexole influence BDNF signalling in limbic structures, which may be related to their pro-depressive and antidepressant activity in rats, respectively.	[Berghauzen-Maciejewska, Klemencja; Wardas, Jadwiga; Kosmowska, Barbara; Glowacka, Urszula; Kuter, Katarzyna; Ossowska, Krystyna] Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, PL-31343 Krakow, Poland	Polish Academy of Sciences	Berghauzen-Maciejewska, K (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, 12 Smetna St, PL-31343 Krakow, Poland.	klemberg@if-pan.krakow.pl	Kosmowska, Barbara/ADS-2341-2022; Kosmowska, Barbara/R-7972-2016	Wardas, Jadwiga/0000-0002-0208-1946; Berghauzen-Maciejewska, Klemencja/0000-0001-7969-8517; Kuter, Katarzyna/0000-0001-8210-6447; Ossowska, Krystyna/0000-0002-8381-6632; Kosmowska, Barbara/0000-0003-4581-6196; Glowacka, Urszula/0000-0002-1552-3117	project "Depression-Mechanisms-Therapy" [POIG.01.01.02-12-004/09-00]; EU from the European Regional Development Fund as a part of the Operative Programme "Innovative Economy"; KNOW - Ministry of Science and Higher Education, Republic of Poland	project "Depression-Mechanisms-Therapy"; EU from the European Regional Development Fund as a part of the Operative Programme "Innovative Economy"; KNOW - Ministry of Science and Higher Education, Republic of Poland	The study was supported by the project "Depression-Mechanisms-Therapy" (POIG.01.01.02-12-004/09-00) co-financed by the EU from the European Regional Development Fund as a part of the Operative Programme "Innovative Economy 2007-2013". Klemencja Berghauzen-Maciejewska is a holder of scholarship from the KNOW sponsored by Ministry of Science and Higher Education, Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Aydemir O, 2005, PROG NEURO-PSYCHOPH, V29, P261, DOI 10.1016/j.pnpbp.2004.11.009; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berghauzen-Maciejewska K, 2014, BEHAV BRAIN RES, V271, P343, DOI 10.1016/j.bbr.2014.06.029; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bessa JM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.39; Bonito-Oliva A, 2014, BIOL PSYCHIAT, V75, P701, DOI 10.1016/j.biopsych.2013.02.015; Byrum CE, 1999, PROG NEURO-PSYCHOPH, V23, P175, DOI 10.1016/S0278-5846(98)00106-7; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Collier TJ, 2005, EXP NEUROL, V191, pS60, DOI 10.1016/j.expneurol.2004.08.018; Conner JM, 1997, J NEUROSCI, V17, P2295; Du F, 2005, EUR J NEUROSCI, V22, P2422, DOI 10.1111/j.1460-9568.2005.04438.x; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2005, NEUROBIOL AGING, V26, pS88, DOI 10.1016/j.neurobiolaging.2005.08.018; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Fanous S, 2010, NEUROSCIENCE, V167, P598, DOI 10.1016/j.neuroscience.2010.02.064; Favier M, 2014, MOVEMENT DISORD, V29, P912, DOI 10.1002/mds.25837; Gervasoni N, 2005, NEUROPSYCHOBIOLOGY, V51, P234, DOI 10.1159/000085725; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Hoyer C, 2012, NEUROPSYCHOBIOLOGY, V65, P147, DOI 10.1159/000335243; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Knott C, 2002, PARKINSONISM RELAT D, V8, P329, DOI 10.1016/S1353-8020(02)00008-1; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kuter K, 2011, PHARMACOL REP, V63, P1383; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; Larsen MH, 2008, EUR J PHARMACOL, V578, P114, DOI 10.1016/j.ejphar.2007.08.050; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Lecca S, 2014, EUR J NEUROSCI, V39, P1170, DOI 10.1111/ejn.12480; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Liu DX, 2014, BEHAV BRAIN RES, V264, P9, DOI 10.1016/j.bbr.2014.01.039; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luo JX, 2013, BEHAV BRAIN RES, V253, P48, DOI 10.1016/j.bbr.2013.07.014; MANDELL AJ, 1961, CALIF MED, V95, P12; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; Mao QQ, 2014, BEHAV BRAIN RES, V261, P140, DOI 10.1016/j.bbr.2013.12.020; Mcchetti I, 2007, NEUROTOX RES, V12, P135, DOI 10.1007/BF03033922; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Numan S, 1997, EUR J NEUROSCI, V9, P489, DOI 10.1111/j.1460-9568.1997.tb01626.x; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Paxinos G, 2007, RAT BRAIN STEREOTAXI, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Pelled G, 2007, J MAGN RESON IMAGING, V26, P863, DOI 10.1002/jmri.21051; Pendolino V, 2014, EXP NEUROL, V261, P377, DOI 10.1016/j.expneurol.2014.07.006; Peyron C, 1996, J COMP NEUROL, V364, P402; Pierucci M, 2009, ANN NY ACAD SCI, V1155, P316, DOI 10.1111/j.1749-6632.2008.03679.x; Prinz A, 2013, EXP NEUROL, V248, P236, DOI 10.1016/j.expneurol.2013.06.015; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Reus GZ, 2013, BEHAV BRAIN RES, V242, P40, DOI 10.1016/j.bbr.2012.11.044; Reus GZ, 2011, NEUROCHEM RES, V36, P460, DOI 10.1007/s11064-010-0364-3; Rogoz Z, 2007, J PHYSIOL PHARMACOL, V58, P219; SAKAI K, 1977, BRAIN RES, V137, P11, DOI 10.1016/0006-8993(77)91010-1; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Savitz J, 2010, NEUROIMAGE, V49, P2966, DOI 10.1016/j.neuroimage.2009.11.025; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Smith JP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00121; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Song L, 2006, PHARMACOL BIOCHEM BE, V83, P186, DOI 10.1016/j.pbb.2006.01.004; Sourani D, 2012, EUR J NEUROSCI, V36, P2822, DOI 10.1111/j.1460-9568.2012.08200.x; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Sun XP, 2014, NEUROENDOCRINOL LETT, V35, P129; Suzuki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009260; Vaidya VA, 1999, NEUROSCI LETT, V262, P1, DOI 10.1016/S0304-3940(99)00006-3; Vaidya VA, 1997, J NEUROSCI, V17, P2785; Van Hoomissen JD, 2003, BRAIN RES, V974, P228, DOI 10.1016/S0006-8993(03)02584-8; VENERO JL, 1994, NEUROREPORT, V5, P429, DOI 10.1097/00001756-199401120-00014; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Walsh S, 2011, NEUROSCIENCE, V175, P251, DOI 10.1016/j.neuroscience.2010.12.005; Wang S, 2009, NEUROSCIENCE, V159, P850, DOI 10.1016/j.neuroscience.2008.12.051; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Zhou JW, 2000, NEUROREPORT, V11, P3289, DOI 10.1097/00001756-200009280-00048	93	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117698	10.1371/journal.pone.0117698	http://dx.doi.org/10.1371/journal.pone.0117698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739024	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900017
J	Cortes, V; Amigo, L; Zanlungo, S; Galgani, J; Robledo, F; Arrese, M; Bozinovic, F; Nervi, F				Cortes, Victor; Amigo, Ludwig; Zanlungo, Silvana; Galgani, Jose; Robledo, Fermin; Arrese, Marco; Bozinovic, Francisco; Nervi, Flavio			Metabolic Effects of Cholecystectomy: Gallbladder Ablation Increases Basal Metabolic Rate through G-Protein Coupled Bile Acid Receptor Gpbar1-Dependent Mechanisms in Mice	PLOS ONE			English	Article							BILIARY CHOLESTEROL SECRETION; ORGANIC SOLUTE TRANSPORTER; ALPHA-OST-BETA; ENERGY-METABOLISM; GALLSTONE DISEASE; TGR5; PLASMA; LIVER	Background & Aims Bile acids (BAs) regulate energy expenditure by activating G-protein Coupled Bile Acid Receptor Gpbar1/TGR5 by cAMP-dependent mechanisms. Cholecystectomy (XGB) increases BAs recirculation rates resulting in increased tissue exposure to BAs during the light phase of the diurnal cycle in mice. We aimed to determine: 1) the effects of XGB on basal metabolic rate (BMR) and 2) the roles of TGR5 on XGB-dependent changes in BMR. Methods BMR was determined by indirect calorimetry in wild type and Tgr5 deficient (Tgr5(-/-)) male mice. Bile flow and BAs secretion rates were measured by surgical diversion of biliary duct. Biliary BAs and cholesterol were quantified by enzymatic methods. BAs serum concentration and specific composition was determined by liquid chromatography/tandem mass spectrometry. Gene expression was determined by qPCR analysis. Results XGB increased biliary BAs and cholesterol secretion rates, and elevated serum BAs concentration in wild type and Tgr5(-/-) mice during the light phase of the diurnal cycle. BMR was similar to 25% higher in cholecystectomized wild type mice (p < 0.02), whereas no changes were detected in cholecystectomized Tgr5(-/-) mice compared to wild-type animals. Conclusion XGB increases BMR by TGR5-dependent mechanisms in mice.	[Amigo, Ludwig; Zanlungo, Silvana; Robledo, Fermin; Arrese, Marco; Nervi, Flavio] Pontificia Univ Catolica Chile, Dept Gastroenterol, Santiago, Chile; [Cortes, Victor; Galgani, Jose] Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Santiago, Chile; [Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Med, CASEB, Santiago, Chile; [Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Nervi, F (corresponding author), Pontificia Univ Catolica Chile, Dept Gastroenterol, Alameda 340, Santiago, Chile.	fnervi@med.puc.cl	ARRESE, MARCO/ABB-9061-2021	Zanlungo, Silvana/0000-0001-8383-9829; Cortes, Victor/0000-0002-1658-0965	FONDECYT (Fondo Nacional de Ciencia y Tecnologia) [1130146, 1141134, 1110455]	FONDECYT (Fondo Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by FONDECYT (Fondo Nacional de Ciencia y Tecnologia) Grants # 1130146 to FN, 1141134 to VC and 1110455 to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Amigo L, 2011, LIVER INT, V31, P52, DOI 10.1111/j.1478-3231.2010.02361.x; Bjursell M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064721; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Brufau G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-73; Bunnett NW, 2014, J PHYSIOL-LONDON, V592, P2943, DOI 10.1113/jphysiol.2014.271155; Chavez-Tapia NC, 2012, ANN HEPATOL, V11, P85, DOI 10.1016/S1665-2681(19)31490-5; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Dawson PA, 2014, J LIPID RES, V10; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; ERLINGER S, 1982, AM J PHYSIOL, V243, pG243, DOI 10.1152/ajpgi.1982.243.4.G243; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ioannou GN, 2010, AM J GASTROENTEROL, V105, P1364, DOI 10.1038/ajg.2009.737; Keitel V, 2011, DIGEST DIS, V29, P45, DOI 10.1159/000324127; KULLAKUBLICK GA, 1995, HEPATOLOGY, V21, P41, DOI 10.1016/0270-9139(95)90406-9; LEBOEUF RC, 1994, J LIPID RES, V35, P121; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; McNab BK, 1997, PHYSIOL ZOOL, V70, P718, DOI 10.1086/515881; NERVI F, 1988, J CLIN INVEST, V82, P1818, DOI 10.1172/JCI113797; Nervi F, 2013, AM J GASTROENTEROL, V108, P959, DOI 10.1038/ajg.2013.84; Nespolo Roberto F., 2003, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, V134A, P139, DOI 10.1016/S1095-6433(02)00220-9; PALOU A, 1981, HORM METAB RES, V13, P326, DOI 10.1055/s-2007-1019258; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Poole DP, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01487.x; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; RODA E, 1978, GUT, V19, P640, DOI 10.1136/gut.19.7.640; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ruhl CE, 2013, AM J GASTROENTEROL, V108, P952, DOI 10.1038/ajg.2013.70; Ruhl CE, 2011, GASTROENTEROLOGY, V140, P508, DOI 10.1053/j.gastro.2010.10.060; SHAFFER EA, 1977, J CLIN INVEST, V59, P828, DOI 10.1172/JCI108705; Shen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088189; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; VEERKAMP JH, 1986, BIOCHEM MED METAB B, V35, P248, DOI 10.1016/0885-4505(86)90080-0; VELOSO C, 1993, ECOLOGY, V74, P2003, DOI 10.2307/1940843; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038286; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Yu XH, 2014, CLIN CHIM ACTA, V428, P82, DOI 10.1016/j.cca.2013.11.010; Zanlungo S, 2004, CURR OPIN LIPIDOL, V15, P279, DOI 10.1097/00041433-200406000-00007	45	14	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118478	10.1371/journal.pone.0118478	http://dx.doi.org/10.1371/journal.pone.0118478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738495	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900038
J	Lacle, MM; van Diest, PJ; Goldschmeding, R; van der Wall, E; Nguyen, TQ				Lacle, Miangela M.; van Diest, Paul J.; Goldschmeding, Roel; van der Wall, Elsken; Nguyen, Tri Q.			Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; HEPATOCELLULAR-CARCINOMA; IMMUNOHISTOCHEMISTRY; TUMORS; CELLS	Connective tissue growth factor (CTGF/CCN2) is a member of the CCN family of secreted proteins that are believed to play an important role in the development of neoplasia. In particular, CTGF has been reported to play an important role in mammary tumorigenesis and to have prognostic value in female breast cancer (FBC). The aim of the present study was to investigate clinicopathologic correlations and prognostic value of CTGF in male breast cancer (MBC) and to compare these findings with FBC. For this, we studied CTGF protein expression by immunohistochemistry in 109 MBC cases and 75 FBC cases. In MBC, stromal CTGF expression was seen in the majority of the cases 78% (85/109) with high expression in 31/109 cases (28.4%), but expression in tumor cells was only seen in 9.2% (10/109) of cases. High stromal CTGF expression correlated with high grade and high proliferation index (> 15%) assessed by MIB-1 immunohistochemical staining. CTGF expression in tumor epithelial cells did not correlate with any of the clinicopathologic features. In FBC, stromal CTGF expression positively correlated with mitotic count and tumor CTGF expression was associated with triple negative status of the tumor (p = 0.002). Neither stromal nor tumor epithelial cell CTGF expression had prognostic value in MBC and FBC. In conclusion, stromal CTGF expression was seen in a high percentage of MBC and was correlated with high grade and high proliferation index. In view of the important role of the microenvironment in cancer progression, this might suggest that stromal CTGF could be an interesting target for novel therapies and molecular imaging. However, the lack of association with prognosis warrants caution. The potential role of CTGF as a therapeutic target for triple negative FBC deserves to be further studied.	[Lacle, Miangela M.; van Diest, Paul J.; Goldschmeding, Roel; Nguyen, Tri Q.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Wall, Elsken] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Diest, PJ (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.j.vandiest@umcutrecht.nl	Nguyen, Tri/A-9508-2009; Nguyen, Tri Q/AAN-9673-2021	Nguyen, Tri/0000-0001-6475-0706; Nguyen, Tri Q/0000-0001-6475-0706; Lacle, Miangela/0000-0003-3466-3569				Bocker W, 2002, VERH DEUT G, V86, P116; Boersema M, 2012, AM J TRANSPLANT, V12, P1429, DOI 10.1111/j.1600-6143.2012.04001.x; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Frazier KS, 1997, INT J BIOCHEM CELL B, V29, P153, DOI 10.1016/S1357-2725(96)00127-6; Jia XQ, 2011, CHINESE MED J-PEKING, V124, P3794, DOI 10.3760/cma.j.issn.0366-6999.2011.22.034; Johansson I, BREAST CANC RES, V14, pR31; Kornegoor R, 2012, MOD PATHOL; Kornegoor R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3220; Kornegoor R, 2012, BREAST CANCER RES TR, V135, P49, DOI 10.1007/s10549-012-2051-3; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Lacle MM, 2013, MODERN PATHOL, V26, P1461, DOI 10.1038/modpathol.2013.94; Lacle MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060138; Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; WeberChappuis K, 1996, EUR J CANCER, V32A, P1686, DOI 10.1016/0959-8049(96)00154-2; Xie D, 2001, CANCER RES, V61, P8917; Xiu M, 2012, WORLD J GASTROENTERO, V18, P7070, DOI 10.3748/wjg.v18.i47.7070; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6	21	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118957	10.1371/journal.pone.0118957	http://dx.doi.org/10.1371/journal.pone.0118957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738829	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900087
J	Stephan, Y; Sutin, AR; Terracciano, A				Stephan, Yannick; Sutin, Angelina R.; Terracciano, Antonio			How Old Do You Feel? The Role of Age Discrimination and Biological Aging in Subjective Age	PLOS ONE			English	Article							PEAK EXPIRATORY FLOW; SELF-RATED HEALTH; PERCEIVED DISCRIMINATION; TELOMERE LENGTH; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; COGNITIVE FUNCTION; MORTALITY; RISK; LIFE	Subjective age, or how young or old individuals experience themselves to be relative to their chronological age, is a crucial construct in gerontology. Subjective age is a significant predictor of important health outcomes, but little is known about the criteria by which individuals' subjectively evaluate their age. To identify psychosocial and biomedical factors linked to the subjective evaluation of age, this study examined whether perceived age discrimination and markers of biological aging are associated with subjective age. Participants were 4776 adults (M-age = 68) from the 2008 and 2010 waves of the Health and Retirement Study (HRS) who completed measures of subjective age, age discrimination, demographic variables, self-rated health and depression, and had physical health measures, including peak expiratory flow, grip strength, waist circumference, systolic and diastolic blood pressure. Telomere length was available for a subset of participants in the 2008 wave (n = 2214). Regression analysis indicated that perceived age discrimination, lower peak expiratory flow, lower grip strength, and higher waist circumference were associated with an older subjective age, controlling for sociodemographic factors, self-rated health, and depression. In contrast, blood pressure and telomere length were not related to subjective age. These findings are consistent with the hypothesis that how old a person feels depends in part on psychosocial and biomedical factors, including the experiences of ageism and perceptible indices of fitness and biological age.	[Stephan, Yannick] Univ Montpellier, F-34059 Montpellier, France; [Sutin, Angelina R.; Terracciano, Antonio] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	Universite de Montpellier; State University System of Florida; Florida State University	Stephan, Y (corresponding author), Univ Montpellier, F-34059 Montpellier, France.	yannick.stephan@univ-montp1.fr; antonio.terracciano@med.fsu.edu	Terracciano, Antonio/H-7403-2019	Terracciano, Antonio/0000-0001-5799-8885				Barnes LL, 2012, J INT NEUROPSYCH SOC, V18, P856, DOI 10.1017/S1355617712000628; Barnes LL, 2008, AM J PUBLIC HEALTH, V98, P1241, DOI 10.2105/AJPH.2007.114397; Barnes LL, 2011, J GERONTOL B-PSYCHOL, V66, P354, DOI 10.1093/geronb/gbr016; Barrett AE, 2003, J GERONTOL B-PSYCHOL, V58, pS101, DOI 10.1093/geronb/58.2.S101; Bergland A, 2014, AGING MENT HEALTH, V18, P653, DOI 10.1080/13607863.2013.869545; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Center for Disease Control and Prevention, 2010, BLOOD PRESS SIGNS SY; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Eibach RP, 2010, J EXP SOC PSYCHOL, V46, P643, DOI 10.1016/j.jesp.2010.03.002; Fisher G. G., 2000, DOCUMENTATION AFFECT; Fragoso CAV, 2008, J AM GERIATR SOC, V56, P1014, DOI 10.1111/j.1532-5415.2008.01687.x; Gana K, 2004, AGING MENT HEALTH, V8, P58, DOI 10.1081/13607860310001613347; Herd P, 2012, J GERONTOL B-PSYCHOL, V67, P503, DOI 10.1093/geronb/gbs048; Houston DK, 2005, INT J OBESITY, V29, P1457, DOI 10.1038/sj.ijo.0803043; Infurna FJ, 2010, PSYCHOL AGING, V25, P470, DOI 10.1037/a0017979; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Klein BEK, 2001, DIABETES CARE, V24, P1967, DOI 10.2337/diacare.24.11.1967; Kleinspehn-Ammerlahn A, 2008, J GERONTOL B-PSYCHOL, V63, pP377, DOI 10.1093/geronb/63.6.P377; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Koher-Gruhn D, 2012, J GERONTOL B-PSYCHOL, V67, P563, DOI 10.1093/geronb/gbr153; Kotter-Gruhn D, 2009, PSYCHOL AGING, V24, P654, DOI 10.1037/a0016510; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pelkonen M, 2003, AM J RESP CRIT CARE, V168, P494, DOI 10.1164/rccm.200208-954OC; Rubin DC, 2006, PSYCHON B REV, V13, P776, DOI 10.3758/BF03193996; Saum KU, 2014, EXP GERONTOL, V58, P250, DOI 10.1016/j.exger.2014.08.009; Stephan Y, 2014, AM J GERIAT PSYCHIAT, V22, P1180, DOI 10.1016/j.jagp.2013.03.007; Stephan Y, 2012, PSYCHOL AGING, V27, P875, DOI 10.1037/a0028301; Stephan Y, 2013, J GERONTOL B-PSYCHOL, V68, P1, DOI 10.1093/geronb/gbs037; Stephan Y, 2011, AGING MENT HEALTH, V15, P428, DOI 10.1080/13607863.2010.536138; Sutin AR, 2015, AM J GERIAT PSYCHIAT, V23, P171, DOI 10.1016/j.jagp.2014.03.007; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Uotinen V, 2005, AGE AGEING, V34, P368, DOI 10.1093/ageing/afi091; Weiss D, 2013, PSYCHOL AGING, V28, P1140, DOI 10.1037/a0033811; Weiss D, 2012, PSYCHOL AGING, V27, P153, DOI 10.1037/a0024887; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305	48	96	97	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119293	10.1371/journal.pone.0119293	http://dx.doi.org/10.1371/journal.pone.0119293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738579	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900102
J	Wu, X; Yamamoto, H; Nakanishi, H; Yamamoto, Y; Inoue, A; Tei, M; Hirose, H; Uemura, M; Nishimura, J; Hata, T; Takemasa, I; Mizushima, T; Hossain, S; Akaike, T; Matsuura, N; Doki, Y; Mori, M				Wu, Xin; Yamamoto, Hirofumi; Nakanishi, Hiroyuki; Yamamoto, Yuki; Inoue, Akira; Tei, Mitsuyoshi; Hirose, Hajime; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Hossain, Sharif; Akaike, Toshihiro; Matsuura, Nariaki; Doki, Yuichiro; Mori, Masaki			Innovative Delivery of siRNA to Solid Tumors by Super Carbonate Apatite	PLOS ONE			English	Article							RNA NANOPARTICLES; SYSTEMIC DELIVERY; POLYMERIC MICELLES; INTERFERING RNA; IN-VIVO; CANCER; THERAPEUTICS; ATELOCOLLAGEN; DNA; ACCUMULATION	RNA interference (RNAi) technology is currently being tested in clinical trials for a limited number of diseases. However, systemic delivery of small interfering RNA (siRNA) to solid tumors has not yet been achieved in clinics. Here, we introduce an in vivo pH-sensitive delivery system for siRNA using super carbonate apatite (sCA) nanoparticles, which is the smallest class of nanocarrier. These carriers consist simply of inorganic ions and accumulate specifically in tumors, yet they cause no serious adverse events in mice and monkeys. Intravenously administered sCA-siRNA abundantly accumulated in the cytoplasm of tumor cells at 4 h, indicating quick achievement of endosomal escape. sCA-survivin-siRNA induced apoptosis in HT29 tumors and significantly inhibited in vivo tumor growth of HCT116, to a greater extent than two other in vivo delivery reagents. With innovative in vivo delivery efficiency, sCA could be a useful nanoparticle for the therapy of solid tumors.	[Wu, Xin; Yamamoto, Hirofumi; Inoue, Akira; Tei, Mitsuyoshi; Hirose, Hajime; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg, Gastroenterol Surg, Suita, Osaka, Japan; [Wu, Xin] Japan Soc Promot Sci, Tokyo, Japan; [Nakanishi, Hiroyuki; Yamamoto, Yuki] Nakanishi Gastroenterol Res Inst, Sakai, Osaka, Japan; [Hossain, Sharif; Akaike, Toshihiro] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Hossain, Sharif; Akaike, Toshihiro] Fdn Adv Int Sci, Biomat Ctr Regenerat Med Engn, Tsukuba, Ibaraki, Japan; [Matsuura, Nariaki] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan	Osaka University; Japan Society for the Promotion of Science; Tokyo Institute of Technology; Osaka Medical Center for Cancer & Cardiovascular Diseases	Yamamoto, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg, Gastroenterol Surg, Suita, Osaka, Japan.	hyamamoto@gesurg.med.osaka-u.ac.jp	Nakanishi, Hiroyuki/AAD-9324-2020; Nishimura, Junichi/K-8390-2015	Nakanishi, Hiroyuki/0000-0003-3982-3314; Nishimura, Junichi/0000-0001-8220-3423	KAKENHI [21390360, 30322184, 24390315]; Grants-in-Aid for Scientific Research [23220014] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI) to H.Y. (No. 21390360, 30322184, 24390315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmawla S, 2011, MOL THER, V19, P1312, DOI 10.1038/mt.2011.35; Bian S, 2012, CRYST GROWTH DES, V12, P3481, DOI 10.1021/cg2016885; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cho ST, 2013, INT J UROL, V20, P208, DOI 10.1111/j.1442-2042.2012.03131.x; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Chowdhury EH, 2006, GENE, V376, P87, DOI 10.1016/j.gene.2006.02.028; Christie RJ, 2012, ACS NANO, V6, P5174, DOI 10.1021/nn300942b; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Friend DS, 1996, BBA-BIOMEMBRANES, V1278, P41, DOI 10.1016/0005-2736(95)00219-7; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gnessin E, 2011, J ENDOUROL, V25, P1519, DOI 10.1089/end.2010.0698; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guo PX, 2012, NUCLEIC ACID THER, V22, P226, DOI 10.1089/nat.2012.0350; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Guo S, 2006, GENE THER, V13, P814, DOI 10.1038/sj.gt.3302716; Haque F, 2012, NANO TODAY, V7, P245, DOI 10.1016/j.nantod.2012.06.010; Hossain S, 2010, J CONTROL RELEASE, V147, P101, DOI 10.1016/j.jconrel.2010.06.024; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Khaled A, 2005, NANO LETT, V5, P1797, DOI 10.1021/nl051264s; Kim SH, 2008, J CONTROL RELEASE, V129, P107, DOI 10.1016/j.jconrel.2008.03.008; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mu P, 2009, INT J CANCER, V125, P2978, DOI 10.1002/ijc.24382; Nag K., 2013, J NANOMEDICINE NANOT, V4, P174, DOI [10.4172/2157-7439.1000174, DOI 10.4172/2157-7439.1000174]; Ochiya T, 1999, NAT MED, V5, P707, DOI 10.1038/9560; OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Pittella F, 2012, J CONTROL RELEASE, V161, P868, DOI 10.1016/j.jconrel.2012.05.005; Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0; Rahman MA, 2012, J CONTROL RELEASE, V159, P384, DOI 10.1016/j.jconrel.2012.01.045; Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005; Science Council of Japan, 2006, GUID PROP COND AN EX; Shu D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt885; Shu D, 2011, NAT NANOTECHNOL, V6, P658, DOI [10.1038/nnano.2011.105, 10.1038/NNANO.2011.105]; Shu Y, 2014, ADV DRUG DELIVER REV, V66, P74, DOI 10.1016/j.addr.2013.11.006; Shu Y, 2013, RNA, V19, P767, DOI 10.1261/rna.037002.112; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Tamura A, 2010, NANOMEDICINE-UK, V5, P1089, DOI [10.2217/nnm.10.76, 10.2217/NNM.10.76]; Yagi N, 2009, CANCER RES, V69, P6531, DOI 10.1158/0008-5472.CAN-08-3945; Yamamoto H, 2008, CANCER SCI, V99, P1709, DOI 10.1111/j.1349-7006.2008.00870.x; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang SY, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000678; Zhou JH, 2013, PHARMACEUTICALS, V6, P85, DOI 10.3390/ph6010085; Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109	53	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116022	10.1371/journal.pone.0116022	http://dx.doi.org/10.1371/journal.pone.0116022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738937	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900007
J	Ellwardt, L; van Tilburg, T; Aartsen, M; Wittek, R; Steverink, N				Ellwardt, Lea; van Tilburg, Theo; Aartsen, Marja; Wittek, Rafael; Steverink, Nardi			Personal Networks and Mortality Risk in Older Adults: A Twenty-Year Longitudinal Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SOCIAL NETWORKS; LIFE-STYLE; LONELINESS; SUPPORT; HEALTH; AGE; METAANALYSIS; TIES	Background Research on aging has consistently demonstrated an increased chance of survival for older adults who are integrated into rich networks of social relationships. Theoretical explanations state that personal networks offer indirect psychosocial and direct physiological pathways. We investigate whether effects on and pathways to mortality risk differ between functional and structural characteristics of the personal network. The objective is to inquire which personal network characteristics are the best predictors of mortality risk after adjustment for mental, cognitive and physical health. Methods and Findings Empirical tests were carried out by combining official register information on mortality with data from the Longitudinal Aging Study Amsterdam (LASA). The sample included 2,911 Dutch respondents aged 54 to 85 at baseline in 1992 and six follow-ups covering a time span of twenty years. Four functional characteristics (emotional and social loneliness, emotional and instrumental support) and four structural characteristics (living arrangement, contact frequency, number of contacts, number of social roles) of the personal network as well as mental, cognitive and physical health were assessed at all LASA follow-ups. Statistical analyses comprised of Cox proportional hazard regression models. Findings suggest differential effects of personal network characteristics on survival, with only small gender differences. Mortality risk was initially reduced by functional characteristics, but disappeared after full adjustment for the various health variables. Mortality risk was lowest for older adults embedded in large (HR = 0.986, 95% CI 0.979-0.994) and diverse networks (HR = 0.948, 95% CI 0.917-0.981), and this effect continued to show in the fully adjusted models. Conclusions Functional characteristics (i.e. emotional and social loneliness) are indirectly associated with a reduction in mortality risk, while structural characteristics (i.e. number of contacts and number of social roles) have direct protective effects. More research is needed to understand the causal mechanisms underlying these relations.	[Ellwardt, Lea] Univ Cologne, Cologne Grad Sch Management Econ & Social Sci CGS, D-50931 Cologne, Germany; [van Tilburg, Theo; Aartsen, Marja] Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands; [Wittek, Rafael; Steverink, Nardi] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Wittek, Rafael; Steverink, Nardi] Univ Groningen, Interuniv Ctr Social Sci Theory & Methodol ICS, Groningen, Netherlands; [Steverink, Nardi] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands	University of Cologne; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; University of Groningen	Ellwardt, L (corresponding author), Univ Cologne, Cologne Grad Sch Management Econ & Social Sci CGS, D-50931 Cologne, Germany.	ellwardt@wiso.uni-koeln.de	Steverink, Nardi/F-1936-2013; Ellwardt, Lea/ABE-5867-2021; Aartsen, Marja/U-2676-2019; van Tilburg, Theo/F-1269-2010; Wittek, Rafael/E-5560-2012	Ellwardt, Lea/0000-0001-9292-2392; Aartsen, Marja/0000-0003-4246-7621; van Tilburg, Theo/0000-0002-1005-6732; Wittek, Rafael/0000-0002-8473-6984	Healthy Aging, Population and Society (HAPS), an investment of the University of Groningen strategic research focus Healthy Aging; Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	Healthy Aging, Population and Society (HAPS), an investment of the University of Groningen strategic research focus Healthy Aging; Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	This research is financed by Healthy Aging, Population and Society (HAPS), an investment of the University of Groningen strategic research focus Healthy Aging. The Longitudinal Aging Study Amsterdam is largely supported by a grant from the Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen MJ, 2004, J SOC PERS RELAT, V21, P249, DOI 10.1177/0265407504041386; Barefoot JC, 2005, AM J EPIDEMIOL, V161, P960, DOI 10.1093/aje/kwi128; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; CARSTENSEN LL, 1993, NEBR SYM MOTIV, V40, P209; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Ellwardt L, 2015, SOC SCI MED, V125, P107, DOI 10.1016/j.socscimed.2014.05.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Holt-Lunstad J, 2003, HEALTH PSYCHOL, V22, P388, DOI 10.1037/0278-6133.22.4.388; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Iecovich E, 2011, INT J AGING HUM DEV, V72, P243, DOI 10.2190/AG.72.3.e; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kroenke CH, 2012, BREAST CANCER RES TR, V133, P375, DOI 10.1007/s10549-012-1962-3; Litwin H, 2006, GERONTOLOGIST, V46, P735, DOI 10.1093/geront/46.6.735; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Nyqvist F, 2014, SOC INDIC RES, V116, P545, DOI 10.1007/s11205-013-0288-9; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Shor E, 2013, SOC NETWORKS, V35, P626, DOI 10.1016/j.socnet.2013.08.004; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; van Groenou MB, 2013, J AGING HEALTH, V25, P274, DOI 10.1177/0898264312468033; van Tilburg T, 1998, J GERONTOL B-PSYCHOL, V53, pS313, DOI 10.1093/geronb/53B.6.S313; Wrzus C, 2013, PSYCHOL BULL, V139, P53, DOI 10.1037/a0028601; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	60	62	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0116731	10.1371/journal.pone.0116731	http://dx.doi.org/10.1371/journal.pone.0116731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734570	Green Published, gold			2022-12-26	WOS:000350314700007
J	Wada, T; Iwamoto, T; Tamaru, A; Seto, J; Ahiko, T; Yamamoto, K; Hase, A; Maeda, S; Yamamoto, T				Wada, Takayuki; Iwamoto, Tomotada; Tamaru, Aki; Seto, Junji; Ahiko, Tadayuki; Yamamoto, Kaori; Hase, Atushi; Maeda, Shinji; Yamamoto, Taro			Clonality and Micro-Diversity of a Nationwide Spreading Genotype of Mycobacterium tuberculosis in Japan	PLOS ONE			English	Article							BEIJING FAMILY STRAINS; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; PHYLOGENY; OUTBREAKS; BACTERIA; LOCI	Mycobacterium tuberculosis transmission routes can be estimated from genotypic analysis of clinical isolates from patients. In Japan, still a middle-incidence country of TB, a unique genotype strain designated as 'M-strain' has been isolated nationwide recently. To ascertain the history of the wide spread of the strain, 10 clinical isolates from different areas were subjected to genome-wide analysis based on deep sequencers. Results show that all isolates possessed common mutations to those of referential strains. The greatest number of accumulated single nucleotide variants (SNVs) from the oldest coalescence was 13 nucleotides, indicating high clonality of these isolates. When an SNV common to the isolates was used as a surrogate marker of the clone, authentic clonal isolates with variation in a reliable subset of variable number of tandem repeat (VNTR) genotyping method can be selected successfully from clinical isolates populations of M. tuberculosis. When the authentic clones can also be assigned to sub-clonal groups by SNVs derived from the genomic comparison, they are classifiable into three sub-clonal groups with a bias of geographical origins. Feedback from genomic analysis of clinical isolates of M. tuberculosis to genotypic markers will be an efficient strategy for the big data in various settings for public health actions against TB.	[Wada, Takayuki; Yamamoto, Taro] Nagasaki Univ, Dept Int Hlth, Inst Trop Med, Nagasaki 852, Japan; [Iwamoto, Tomotada] Kobe Inst Hlth, Dept Microbiol, Kobe, Hyogo, Japan; [Tamaru, Aki] Osaka Prefectural Inst Publ Hlth, Dept Microbiol, Osaka 537, Japan; [Seto, Junji; Ahiko, Tadayuki] Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, Yamagata 9900031, Japan; [Yamamoto, Kaori; Hase, Atushi] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Osaka 543, Japan; [Maeda, Shinji] Res Inst TB, Dept Mycobacterium Reference & Res, Tokyo, Japan	Nagasaki University; Osaka Prefectural Institute of Public Health	Wada, T (corresponding author), Nagasaki Univ, Dept Int Hlth, Inst Trop Med, Nagasaki 852, Japan.	twada@nagasaki-u.ac.jp	Iwamoto, Tomotada/I-8944-2019	Iwamoto, Tomotada/0000-0002-2650-0308; Seto, Junji/0000-0003-2227-5315	Ministry of Health, Labour and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants); JSPS [24689034, 22790585]	Ministry of Health, Labour and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Ministry of Health, Labour and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants). This work was also supported in part by Grant-in-Aid for Young Scientists (A) (24689034) and (B) (22790585) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Asante-Poku A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092675; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Cole EC, 1998, AM J INFECT CONTROL, V26, P453, DOI 10.1016/S0196-6553(98)70046-X; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Luo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089726; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Molhuizen HOF, 1998, METH MOL B, V101, P381, DOI 10.1385/0-89603-471-2:381; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Nakajima C, 2013, J CLIN MICROBIOL, V51, P2025, DOI 10.1128/JCM.03404-12; Nakanishi N, 2013, INFECT GENET EVOL, V16, P174, DOI 10.1016/j.meegid.2013.02.007; Ohkado A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-138; Ojo OO, 2010, INFECT GENET EVOL, V10, P1110, DOI 10.1016/j.meegid.2010.07.008; Parish T, 1998, METHOD MOL BIOL, P31; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sails AD, 2011, THORAX, V66, P709, DOI 10.1136/thx.2011.158881; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; The Research Institute of Tuberculosis, JATA STAT TUB 2012 S; The Research Institute of Tuberculosis, JATA TRENDS NOT RAT; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Vassiloyanakopoulos A, 1999, Euro Surveill, V4, P96; Wada Takayuki, 2013, Kekkaku, V88, P393; Wada T, 2012, INFECT GENET EVOL, V12, P1392, DOI 10.1016/j.meegid.2012.04.029; Wada Takayuki, 2010, Kekkaku, V85, P845; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Walker TM, 2013, CLIN MICROBIOL INFEC, V19, P796, DOI 10.1111/1469-0691.12183; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118495	10.1371/journal.pone.0118495	http://dx.doi.org/10.1371/journal.pone.0118495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734518	gold, Green Submitted, Green Published			2022-12-26	WOS:000350314700034
J	Camargo, LM; Zhang, XD; Loerch, P; Caceres, RM; Marine, SD; Uva, P; Ferrer, M; de Rinaldis, E; Stone, DJ; Majercak, J; Ray, WJ; Chen, YA; Shearman, MS; Mizuguchi, K				Camargo, Luiz Miguel; Zhang, Xiaohua Douglas; Loerch, Patrick; Caceres, Ramon Miguel; Marine, Shane D.; Uva, Paolo; Ferrer, Marc; de Rinaldis, Emanuele; Stone, David J.; Majercak, John; Ray, William J.; Chen Yi-An; Shearman, Mark S.; Mizuguchi, Kenji			Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing	PLOS ONE			English	Article							AMYLOID-PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; ARGININE METABOLISM; IDENTIFIES VARIANTS; GENE; BETA; ASSOCIATION; EXPRESSION; DIFFERENTIATION	The progressive aggregation of Amyloid-beta (A beta) in the brain is a major trait of Alzheimer's Disease (AD). A beta is produced as a result of proteolytic processing of the beta-amyloid precursor protein (APP). Processing of APP is mediated by multiple enzymes, resulting in the production of distinct peptide products: the non-amyloidogenic peptide sAPP alpha and the amyloidogenic peptides sAPP beta, A beta 40, and A beta 42. Using a pathway-based approach, we analyzed a large-scale siRNA screen that measured the production of different APP proteolytic products. Our analysis identified many of the biological processes/pathways that are known to regulate APP processing and have been implicated in AD pathogenesis, as well as revealing novel regulatory mechanisms. Furthermore, we also demonstrate that some of these processes differentially regulate APP processing, with some mechanisms favouring production of certain peptide species over others. For example, synaptic transmission having a bias towards regulating A beta 40 production over A beta 42 as well as processes involved in insulin and pancreatic biology having a bias for sAPP beta production over sAPP alpha. In addition, some of the pathways identified as regulators of APP processing contain genes (CLU, BIN1, CR1, PICALM, TREM2, SORL1, MEF2C, DSG2, EPH1A) recently implicated with AD through genome wide association studies (GWAS) and associated meta-analysis. In addition, we provide supporting evidence and a deeper mechanistic understanding of the role of diabetes in AD. The identification of these processes/pathways, their differential impact on APP processing, and their relationships to each other, provide a comprehensive systems biology view of the "regulatory landscape" of APP.	[Camargo, Luiz Miguel; Loerch, Patrick; Caceres, Ramon Miguel; Shearman, Mark S.] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Zhang, Xiaohua Douglas] Merck & Co Inc, Merck Res Labs, Beijing, Peoples R China; [Marine, Shane D.; Ferrer, Marc] Merck & Co Inc, Merck Res Labs, N Wales, PA USA; [Uva, Paolo; de Rinaldis, Emanuele] Merck Res Labs, Inst Recerca Biol Mol, Pomezia, Italy; [Stone, David J.; Majercak, John; Ray, William J.] Merck & Co Inc, Merck Res Labs, West Point, PA USA; [Chen Yi-An; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka, Japan	Merck & Company; Merck & Company; Merck & Company; Merck & Company; National Institute of Health Sciences - Japan	Camargo, LM (corresponding author), Novartis Inst Biomed Res, Cambridge, England.	miguelcamargo@novartis.com	Uva, Paolo/A-2877-2011; Ray, William J/E-9834-2016; Mizuguchi, Kenji/GVS-5857-2022	Uva, Paolo/0000-0002-9524-8492; Mizuguchi, Kenji/0000-0003-3021-7078; Zhang, Xiaohua Douglas/0000-0002-2486-7931; Ray, William/0000-0002-4491-167X	Merck Co; Novartis; CRS4 Bioinformatica; Merck Serono; Boehringer Ingelheim; Takeda Pharmaceuticals	Merck Co(Merck & Company); Novartis(Novartis); CRS4 Bioinformatica; Merck Serono(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Merck & Co funded the work presented in this manuscript. All authors, with the exception of Kenji Mizuguchi (KM) and Chen Yi-An (CYA), were employed by Merck & Co during the time the research was conducted. The funder, Merck & Co provided support in the form of salaries for authors LMC, XDZ, PL, MC, SDM, PU, MF, EDR, DJS, JM, WJR and MSS during the course of the study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Novartis, CRS4 Bioinformatica, Merck Serono, Boehringer Ingelheim, and Takeda Pharmaceuticals provided support in the form of salaries for authors LMC, PU, MS, JM, and WJR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Beher D, 2005, EXPERT OPIN INV DRUG, V14, P1385, DOI 10.1517/13543784.14.11.1385; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cerami EG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-497; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Currais A, 2012, AGING CELL; Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012; Djogo N, 2013, NEUROBIOL DIS, V56, P104, DOI 10.1016/j.nbd.2013.04.014; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Guerreiro R., 2012, N ENGL J MED; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hokama M, 2014, CEREB CORTEX, V24, P2476, DOI 10.1093/cercor/bht101; Huang HP, 2000, J BIOMED SCI, V7, P27, DOI 10.1159/000025426; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104617; Kaplow IM, 2009, NAT METHODS, V6, P476, DOI 10.1038/nmeth0709-476; Killick R, 2012, MOL PSYCHIAT; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kwak YD, 2014, BIOCHEM BIOPH RES CO, V447, P394, DOI 10.1016/j.bbrc.2014.03.139; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Levine DM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r93; Liu P, 2014, NEUROBIOL AGING, V35, P1992, DOI 10.1016/j.neurobiolaging.2014.03.013; Liu P, 2011, NEUROSCIENCE, V193, P269, DOI 10.1016/j.neuroscience.2011.07.054; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Morgan K, 2011, NEUROPATH APPL NEURO, V37, P353, DOI 10.1111/j.1365-2990.2011.01181.x; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; National Diabetes Information Clearinghouse (NDIC) (National Institute of Diabetes and Digestive and Kidney Diseases N, 2007, MON FORMS DIAB NEON; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ong WY, 2013, J ALZHEIMERS DIS, V35, P643, DOI 10.3233/JAD-121990; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pavlidis Paul, 2002, Pac Symp Biocomput, P474; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rivkin A, 2010, BIOORG MED CHEM LETT, V20, P2279, DOI 10.1016/j.bmcl.2010.02.008; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Wiesinger H, 2001, PROG NEUROBIOL, V64, P365, DOI 10.1016/S0301-0082(00)00056-3; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang XD, 2011, BIOINFORMATICS, V27, P2775, DOI 10.1093/bioinformatics/btr474; Zhou LG, 2011, BEHAV BRAIN RES, V222, P274, DOI 10.1016/j.bbr.2011.03.043; Zhou SX, 2007, BIOCHEMISTRY-US, V46, P2553, DOI 10.1021/bi602509c	74	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115369	10.1371/journal.pone.0115369	http://dx.doi.org/10.1371/journal.pone.0115369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723573	Green Published, gold			2022-12-26	WOS:000350251200006
J	Parisi, T; Bronson, RT; Lees, JA				Parisi, T.; Bronson, R. T.; Lees, J. A.			Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer	ONCOGENE			English	Article							PROSTATE-CANCER; DEFICIENT CELLS; MOLECULAR-BASIS; BETA-CATENIN; RB; PRB; TUMORS; TUMORIGENESIS; EXPRESSION; MICE	The retinoblastoma gene (Rb) is mutated at significant frequency in various human epithelial tumors, including colorectal cancer, and is strongly associated with metastatic disease. However, sole inactivation of Rb in the mouse has so far failed to yield epithelial cancers. Here, we specifically inactivate Rb and/or p53 in the urogenital epithelium and the intestine. We find that the loss of both tumor suppressors is unable to yield tumors in the transitional epithelium lining the bladder, kidneys and ureters. Instead, these mice develop highly metastatic tumors of neuroendocrine, not epithelial, origin within the urogenital tract to give prostate cancer in the males and vaginal tumors in the females. Additionally, we discovered that the sole inactivation of Rb in the intestine was sufficient to induce formation of metastatic colorectal adenocarcinomas. These tumors closely mirror the human disease in regard to the age of onset, histological appearance, invasiveness and metastatic potential. Like most human colorectal carcinomas, our murine Rb-deficient tumors demonstrate genomic instability and they show activation of beta-catenin. Deregulation of the Wnt/beta-catenin pathway is specific to the intestinal tumors, as genomic instability but not activation of beta-catenin was observed in the neuroendocrine tumors. To date, attempts to generate genetically engineered mouse models of colorectal cancer tumors have yielded mostly cancer of the small intestine, which rarely occurs in humans. Our system provides the opportunity to accurately model and study colorectal cancer in the mouse via a single gene mutation.	[Parisi, T.; Lees, J. A.] Koch Inst Integrat Canc Res, Cambridge, MA USA; [Bronson, R. T.] Tufts Cummings Sch Vet Med, Dept Pathol, North Grafton, MA USA; [Lees, J. A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lees, JA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jalees@mit.edu			NIH/NCI [P30-CA14051, P01-CA42063, RO1-CA121921]; NATIONAL CANCER INSTITUTE [R01CA121921, P01CA042063, P30CA014051] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to Omer Yilmaz for scientific suggestions and professional evaluation of the pathology slides, Kevin Haigis for unpublished information and reagents, A. Amsterdam and S. Frank for critical reading of the manuscript, and the Koch Institute Swanson Biotechnology Center for technical support, particularly the Histology Core. This work was supported by NIH/NCI grants to the Koch Institute (P30-CA14051), and to JAL (P01-CA42063 and RO1-CA121921), a Ludwig Scholar at MIT.	Aparicio A, 2011, NAT REV UROL, V8, P562, DOI 10.1038/nrurol.2011.107; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; GOPE R, 1990, J NATL CANCER I, V82, P310, DOI 10.1093/jnci/82.4.310; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Horst D, 2009, CANCER, V115, P2063, DOI 10.1002/cncr.24254; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Humphrey PA, 2012, HISTOPATHOLOGY, V60, P59, DOI 10.1111/j.1365-2559.2011.04039.x; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Johnson RL, 2013, CANCER METAST REV, V32, P39, DOI 10.1007/s10555-012-9404-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kucherlapati MH, 2008, P NATL ACAD SCI USA, V105, P15493, DOI 10.1073/pnas.0802933105; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Manning AL, 2014, MOL CELL, V53, P993, DOI 10.1016/j.molcel.2014.01.032; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Moran A, 2010, WORLD J GASTRO ONCOL, V2, P151, DOI 10.4251/wjgo.v2.i3.151; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nandan MO, 2010, CURR COLORECT CANC R, V6, P51, DOI 10.1007/s11888-010-0046-1; Parisi T, 2009, ONCOGENE, V28, P500, DOI 10.1038/onc.2008.406; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Rosenberg JE, 2009, GENE DEV, V23, P655, DOI 10.1101/gad.1789109; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Terry S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00060; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yang HS, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-6; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zeineldin M, 2013, CANCER RES, V73, P2389, DOI 10.1158/0008-5472.CAN-12-4607; Zhang ZT, 1999, CANCER RES, V59, P3512; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	45	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2015	34	48					5890	5899		10.1038/onc.2015.30	http://dx.doi.org/10.1038/onc.2015.30			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CX1CO	25745996	Green Submitted, Green Accepted			2022-12-26	WOS:000365434000003
J	Wanders, D; Burk, DH; Cortez, CC; Van, NT; Stone, KP; Baker, M; Mendoza, T; Mynatt, RL; Gettys, TW				Wanders, Desiree; Burk, David H.; Cortez, Cory C.; Van, Nancy T.; Stone, Kirsten P.; Baker, Mollye; Mendoza, Tamra; Mynatt, Randall L.; Gettys, Thomas W.			UCP1 is an essential mediator of the effects of methionine restriction on energy balance but not insulin sensitivity	FASEB JOURNAL			English	Article						adipose tissue; amino acid; FGF21; housing temperature; obesity	WHITE ADIPOSE-TISSUE; MITOCHONDRIAL UNCOUPLING PROTEIN; LIFE-SPAN; UCP1-INDEPENDENT THERMOGENESIS; ADAPTIVE THERMOGENESIS; IN-VIVO; MICE; MOUSE; RATS; BROWN	Dietary methionine restriction (MR) by 80% increases energy expenditure (EE), reduces adiposity, and improves insulin sensitivity. We propose that the MR-induced increase in EE limits fat deposition by increasing sympathetic nervous system-dependent remodeling of white adipose tissue and increasing uncoupling protein 1 (UCP1) expression in both white and brown adipose tissue. In independent assessments of the role of UCP1 as a mediator of MR's effects on EE and insulin sensitivity, EE did not differ between wild-type (WT) and Ucp1(-/-) mice on the control diet, but MR increased EE by 31% and reduced adiposity by 25% in WT mice. In contrast, MR failed to increase EE or reduce adiposity in Ucp1(-/-) mice. However, MR was able to increase overall insulin sensitivity by 2.2-fold in both genotypes. Housing temperatures used to minimize (28 degrees C) or increase (23 degrees C) sympathetic nervous system activity revealed temperature-independent effects of the diet on EE. Metabolomics analysis showed that genotypic and dietary effects on white adipose tissue remodeling resulted in profound increases in fatty acid metabolism within this tissue. These findings establish that UCP1 is required for the MR-induced increase in EE but not insulin sensitivity and suggest that diet-induced improvements in insulin sensitivity are not strictly derived from dietary effects on energy balance.	[Wanders, Desiree; Cortez, Cory C.; Van, Nancy T.; Stone, Kirsten P.; Baker, Mollye; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Burk, David H.] Pennington Biomed Res Ctr, Cell Biol & Bioimaging Core, Baton Rouge, LA 70808 USA; [Mendoza, Tamra; Mynatt, Randall L.] Gene Nutrient Interact Pennington Biomed Res Ctr, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Mynatt, Randall L/N-1980-2017; Stone, Kirsten/AAB-3804-2019; Burk, David/D-2056-2009; Gettys, Thomas W/N-1964-2017	Mynatt, Randall L/0000-0003-4399-0019; Stone, Kirsten/0000-0001-5511-1638; Gettys, Thomas W/0000-0001-7125-7995; Wanders, Desiree/0000-0003-2638-3954	American Diabetes Association [1-12-BS-58]; U.S. National Institutes of Health (NIH) [DK096311, DK098687, DK089641]; Mouse Metabolic Phenotyping Center Consortium [NIH U24 DK059637]; NIH [P20 GM103528, 2P30 DK072476]; NIH Nutrition Obesity Research Centers Grant [2P30 DK072476]; NIH National Research Service Award [1 F32 DK098918]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, T32DK064584, R01DK098687, R01DK096311, R01DK089641, U24DK059637, F32DK098918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, P30GM118430] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mouse Metabolic Phenotyping Center Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nutrition Obesity Research Centers Grant; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank C. Tramonte for administrative support. This work was supported in part by the American Diabetes Association 1-12-BS-58 (T.W.G.), U.S. National Institutes of Health (NIH) Grants DK096311 (to T.W.G.), DK098687 (to R.L.M.), DK089641 (to R.L.M.), and the Mouse Metabolic Phenotyping Center Consortium (NIH U24 DK059637). This work also made use of the Genomics and Cell Biology and Bioimaging core facilities supported by NIH P20 GM103528 (to T.W.G.) and NIH 2P30 DK072476. This research project used the Transgenic and Animal Phenotyping core facilities that are supported in part by the NIH Nutrition Obesity Research Centers Grant 2P30 DK072476) (to R.L.M.). D.W. is supported by NIH National Research Service Award 1 F32 DK098918. The authors thank M. Orgeron, K. Dille, and A. Pierse for their technical support.	ASHWELL M, 1985, J AUTONOM NERV SYST, V14, P377, DOI 10.1016/0165-1838(85)90083-9; ASHWELL M, 1983, FEBS LETT, V161, P108, DOI 10.1016/0014-5793(83)80740-6; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Blaxter K. L., 1986, J ANIMAL SCI S2, V63, P1; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Di Buono M, 2001, AM J CLIN NUTR, V74, P761; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Ghosh S, 2014, FASEB J, V28, P2577, DOI 10.1096/fj.14-249458; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Mossenbock K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110428; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Muise ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073011; Munzberg H., 2013, HDB OBESITY, P137; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Okamatsu-Ogura Y, 2011, EXP BIOL MED, V236, P1274, DOI 10.1258/ebm.2011.011143; ORENTREICH N, 1993, J NUTR, V123, P269; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Zhao ZJ, 2010, J EXP BIOL, V213, P3988, DOI 10.1242/jeb.046821; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	43	56	57	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2603	2615		10.1096/fj.14-270348	http://dx.doi.org/10.1096/fj.14-270348			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25742717	Green Published, Green Submitted			2022-12-26	WOS:000355209500036
J	Flanagan, JJ; Mukherjee, I; Barlowe, C				Flanagan, John J.; Mukherjee, Indrani; Barlowe, Charles			Examination of Sec22 Homodimer Formation and Role in SNARE-dependent Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; TRANSPORT VESICLES; PROTEIN-TRANSPORT; SYNAPTIC VESICLE; GOLGI TRANSPORT; BIOCHEMICAL REQUIREMENTS; NEUROTRANSMITTER RELEASE; TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein complexes play essential roles in catalyzing intracellular membrane fusion events although the assembly pathway and molecular arrangement of SNARE complexes in membrane fusion reactions are not well understood. Here we monitored interactions of the R-SNARE protein Sec22 through a cysteine scanning approach and detected efficient formation of cross-linked Sec22 homodimers in cellular membranes when cysteine residues were positioned in the SNARE motif or C terminus of the transmembrane domain. When specific Sec22 cysteine derivatives are present on both donor COPII vesicles and acceptor Golgi membranes, the formation of disulfide cross-links provide clear readouts on trans-and cis-SNARE arrangements during this fusion event. The Sec22 transmembrane domain was required for efficient homodimer formation and for membrane fusion suggesting a functional role for Sec22 homodimers. We propose that Sec22 homodimers promote assembly of higher-order SNARE complexes to catalyze membrane fusion. Sec22 is also reported to function in macroautophagy and in formation of endoplasmic reticulum-plasma membrane contact sites therefore homodimer assembly may regulate Sec22 activity across a range of cellular processes.	[Flanagan, John J.; Mukherjee, Indrani; Barlowe, Charles] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Geisel Sch Med Dartmouth, HB 7200, Hanover, NH 03755 USA.	charles.barlowe@dartmouth.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM52549, GM070096]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052549, F32GM070096, R37GM052549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52549 (to C. B.) and GM070096 (to J. J. F.).	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fdez E, 2008, MOL BIOL CELL, V19, P3379, DOI 10.1091/mbc.E08-01-0010; Fdez E, 2010, J CELL SCI, V123, P2473, DOI 10.1242/jcs.061325; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Hernandez JM, 2014, P NATL ACAD SCI USA, V111, P12037, DOI 10.1073/pnas.1407435111; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Laage R, 1997, EUR J BIOCHEM, V249, P540, DOI 10.1111/j.1432-1033.1997.00540.x; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433; Lupashin VV, 1996, J CELL BIOL, V132, P277, DOI 10.1083/jcb.132.3.277; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Parkinson K, 2014, NAT CELL BIOL, V16, P87, DOI 10.1038/ncb2887; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Rizo J, 2012, J MOL CELL BIOL, V4, P270, DOI 10.1093/jmcb/mjs036; Roy R, 2004, BIOCHEMISTRY-US, V43, P4964, DOI 10.1021/bi0362875; Roy R, 2006, BIOCHEMISTRY-US, V45, P7654, DOI 10.1021/bi052620o; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2013, CURR TOP MEMBR, V72, P193, DOI 10.1016/B978-0-12-417027-8.00006-4; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P4173, DOI 10.1021/bi052178+; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010	61	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10657	10666		10.1074/jbc.M114.626911	http://dx.doi.org/10.1074/jbc.M114.626911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25750128	Green Published, hybrid			2022-12-26	WOS:000353404500009
J	Watanabe, T; Sekine, S; Naguro, I; Sekine, Y; Ichijo, H				Watanabe, Takeshi; Sekine, Shiori; Naguro, Isao; Sekine, Yusuke; Ichijo, Hidenori			Apoptosis Signal-regulating Kinase 1 (ASK1)-p38 Pathway-dependent Cytoplasmic Translocation of the Orphan Nuclear Receptor NR4A2 Is Required for Oxidative Stress-induced Necrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CELL-DEATH; STEROID-RECEPTOR; NUR77; PROTEIN; ACTIVATION; MACROPHAGE; EXPRESSION; NURR1; ASK1	p38 mitogen-activated protein kinases (MAPKs) play important roles in various cellular stress responses, including cell death, which is roughly categorized into apoptosis and necrosis. Although p38 signaling has been extensively studied, the molecular mechanisms of p38-mediated cell death are unclear. ASK1 is a stress-responsive MAP3K that acts as an upstream kinase of p38 and is activated by various stresses, such as oxidative stress. Here, we show that NR4A2, a member of the NR4A nuclear receptor family, acts as a necrosis promoter downstream of ASK1-p38 pathway during oxidative stress. Although NR4A2 is well known as a nucleus-localized transcription factor, we found that it is translocated into the cytosol after phosphorylation by p38. Because the phosphorylation site mutants of NR4A2 cannot rescue the cell death-promoting activity, ASK1-p38 pathway-dependent phosphorylation and subsequent cytoplasmic translocation of NR4A2 may be required for oxidative stress-induced cell death. In addition, NR4A2-mediated cell death does not depend on caspases and receptor-interacting protein 1 (RIP1)-RIP3 complex, suggesting that NR4A2 promotes an RIP kinase-independent necrotic type of cell death. Our findings may enable a more precise understanding of molecular mechanisms that regulate oxidative stress-induced and p38-mediated necrosis.	[Watanabe, Takeshi; Sekine, Shiori; Naguro, Isao; Sekine, Yusuke; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan; [Watanabe, Takeshi] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Sekine, Yusuke] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Cambridge	Ichijo, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ichijo@mol.f.u-tokyo.ac.jp	Sekine, Yusuke/AHI-8340-2022; Naguro, Isao/P-1337-2019	Naguro, Isao/0000-0002-0338-8026; Ichijo, Hidenori/0000-0002-5005-6438; Sekine, Yusuke/0000-0003-0345-1416; Watanabe, Takeshi/0000-0002-4532-0556	KAKENHI from the Japan Society for the Promotion of Science; MEXT; Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences; GCOE program; National Institute of Biomedical Innovation; Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research [25650004, 26111007, 26114009] Funding Source: KAKEN	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences; GCOE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from the Japan Society for the Promotion of Science and MEXT, the Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, the GCOE program, the "Understanding of Environmental Bases for Brain Health" that was conducted under the Strategic Research Program for Brain Sciences by MEXT, the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation, the Naito Foundation Natural Science Scholarship, the Cosmetology Research Foundation, and the Tokyo Biochemical Research Foundation.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Erdo F, 2004, ACTA NEUROPATHOL, V107, P127, DOI 10.1007/s00401-003-0789-8; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Garcia-Yague AJ, 2013, J BIOL CHEM, V288, P5506, DOI 10.1074/jbc.M112.439190; Kim JY, 2011, APOPTOSIS, V16, P114, DOI 10.1007/s10495-010-0550-4; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; NOSSERI C, 1994, EXP CELL RES, V212, P367, DOI 10.1006/excr.1994.1156; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sekine Y, 2011, J CELL SCI, V124, P3006, DOI 10.1242/jcs.085902; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xing L, 2009, BIOCHEMISTRY-US, V48, P6402, DOI 10.1021/bi900655f; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	31	31	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10791	10803		10.1074/jbc.M114.623280	http://dx.doi.org/10.1074/jbc.M114.623280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752609	Green Published, hybrid			2022-12-26	WOS:000353404500020
J	Ciaranello, AL; Myer, L; Kelly, K; Christensen, S; Daskilewicz, K; Doherty, K; Bekker, LG; Hou, T; Wood, R; Francke, JA; Wools-Kaloustian, K; Freedberg, KA; Walensky, RP				Ciaranello, Andrea L.; Myer, Landon; Kelly, Kathleen; Christensen, Sarah; Daskilewicz, Kristen; Doherty, Katie; Bekker, Linda-Gail; Hou, Taige; Wood, Robin; Francke, Jordan A.; Wools-Kaloustian, Kara; Freedberg, Kenneth A.; Walensky, Rochelle P.			Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SINGLE-DOSE NEVIRAPINE; CAPE-TOWN; HIV TRANSMISSION; PREGNANT-WOMEN; PILOT PROGRAM; THERAPY; PREVENTION; PERIPARTUM; ZIDOVUDINE	Background Many prevention of mother-to-child HIV transmission (PMTCT) programs currently prioritize antiretroviral therapy (ART) for women with advanced HIV. Point-of-care (POC) CD4 assays may expedite the selection of three-drug ART instead of zidovudine, but are costlier than traditional laboratory assays. Methods We used validated models of HIV infection to simulate pregnant, HIV-infected women (mean age 26 years, gestational age 26 weeks) in a general antenatal clinic in South Africa, and their infants. We examined two strategies for CD4 testing after HIV diagnosis: laboratory (test rate: 96%, result-return rate: 87%, cost: $14) and POC (test rate: 99%, result-return rate: 95%, cost: $26). We modeled South African PMTCT guidelines during the study period (WHO "Option A"): antenatal zidovudine (CD4 <= 350/mu L) or ART (CD4 > 350/mu L). Outcomes included MTCT risk at weaning (age 6 months), maternal and pediatric life expectancy (LE), maternal and pediatric lifetime healthcare costs (2013 USD), and cost-effectiveness ($/life-year saved). Results In the base case, laboratory led to projected MTCT risks of 5.7%, undiscounted pediatric LE of 53.2 years, and undiscounted PMTCT plus pediatric lifetime costs of $1,070/infant. POC led to lower modeled MTCT risk (5.3%), greater pediatric LE (53.4 years) and lower PMTCT plus pediatric lifetime costs ($1,040/infant). Maternal outcomes following laboratory were similar to POC (LE: 21.2 years; lifetime costs: $23,860/person). Compared to laboratory, POC improved clinical outcomes and reduced healthcare costs. Conclusions In antenatal clinics implementing Option A, the higher initial cost of a one-time POC CD4 assay will be offset by cost-savings from prevention of pediatric HIV infection.	[Ciaranello, Andrea L.; Freedberg, Kenneth A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Kelly, Kathleen; Christensen, Sarah; Doherty, Katie; Hou, Taige; Francke, Jordan A.; Freedberg, Kenneth A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Gen Med, Boston, MA 02114 USA; [Ciaranello, Andrea L.; Hou, Taige; Freedberg, Kenneth A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Myer, Landon; Daskilewicz, Kristen] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, ZA-7925 Cape Town, South Africa; [Bekker, Linda-Gail; Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Wools-Kaloustian, Kara] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Cape Town; University of Cape Town; Indiana University System; Indiana University Bloomington; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Ciaranello, AL (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.	aciaranello@partners.org; rwalensky@partners.org	, Andrea/ABB-3330-2021; Bekker, Linda-Gail/AAZ-8929-2020	, Andrea/0000-0002-4268-3263; Walensky, Rochelle P./0000-0002-8795-379X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	March of Dimes Foundation; National Institutes of Health (NIAID) [K01 AI078754, R01 AI058736, R01 AI093269]; East African IeDEA Consortium [U01 AI069911]; IMPAACT network [U01 AI068632]; Massachusetts General Hospital Executive Committee on Research; Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [N01-DK-9-001/HHSN267200800001C]; National Cancer Institute; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616]; National Institute of Mental Health (NIMH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, U01AI068632, R01AI058736, UM1AI068632, K01AI078754, U01AI069911, UM1AI068616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); East African IeDEA Consortium; IMPAACT network; Massachusetts General Hospital Executive Committee on Research; Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the March of Dimes Foundation (ALC, LM, KK, SC, K. Daskilewicz, K. Doherty, LGB, TH), National Institutes of Health (NIAID) (K01 AI078754 (ALC), R01 AI058736 ((KK, K. Doherty, TH, KAF, RPW), R01 AI093269 (KAF, RPW), East African IeDEA Consortium U01 AI069911, <SUP>star</SUP>and IMPAACT network U01 AI068632<SUP>star star</SUP> (KK, SC, K. Doherty, TH, KAF, RW)), the Massachusetts General Hospital Executive Committee on Research (ALC), and the Elizabeth Glaser Pediatric AIDS Foundation (ALC, LM). Point-of-care CD4 measurement devices for use in the pilot evaluation were donated by Alere Healthcare. The funders and the suppliers of CD4 measurement devices had no role in study design, interpretation of results, or decision to publish. <SUP>star</SUP>Overall support for the IeDEA network is provided by the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Cancer Institute. <SUP>star star</SUP>Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Support of the sites was provided by the National Institute of Allergy and Infectious Diseases (NIAID) and the NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network funded by NICHD (contract number N01-DK-9-001/HHSN267200800001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, CURR OPIN HIV AIDS, V8, P474, DOI 10.1097/COH.0b013e328363a8f2; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Balakrishnan P, 2011, INDIAN J MED RES, V134, P823, DOI 10.4103/0971-5916.92628; Black Samantha, 2013, S Afr Med J, V103, P557, DOI 10.7196/samj.6565; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Ciaranello A, 2014, PEDIATR INFECT DIS J, V33, P623, DOI 10.1097/INF.0000000000000223; Ciaranello AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083389; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; Cleary S, 2005, HLTH SYSTEMS TRUST S; Clinton Health Access Initiative, 2012, ANT ARV CEIL PRIC LI; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Dabis F, 2005, AIDS, V19, P309; Department of Health Republic of South Africa, 2012, 5 DEP HLTH REP S AFR; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Fitzgerald FC, 2010, SAMJ S AFR MED J, V100, P827, DOI 10.7196/SAMJ.4045; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Goga A, 2012, IMPACT NATL PREVENTI; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Gopalappa C, 2014, AIDS, V28, pS5, DOI 10.1097/QAD.0000000000000083; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; International Monetary Fund (IMF), 2014, WORLD EC OUTL DAT; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Jani IV, 2011, COST COMP POINT OF C; Kellerman SE, 2013, AIDS, V27, pS225, DOI 10.1097/QAD.0000000000000107; Kesho Bora Study Group, 2011, LANCET INFECT DIS, V1, P159; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Myer L, 2013, COMMUNICATION; Myer L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18649; Myer L, 2012, AIDS CARE, V24, P986, DOI 10.1080/09540121.2012.668173; National Institutes of Health: IMPAACT Trial Network, 2012, PROMISE STUD PROM MA; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; South Africa National Department of Health, 2010, CLIN GUID PMTCT PREV; South Africa National Department of Health, 2010, ANT TREATM GUID; South African Department of Health, 2013, S AFR ANT TREATM GUI; South African National Department of Health, 2010, GUID MAN HIV CHILDR; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Thairu L, 2011, AIDS CARE, V23, P814, DOI 10.1080/09540121.2010.541416; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas LS, 2006, COSTING HIV AIDS SER; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; UNAIDS, 2012, REP GLOB AIDS EP GEN; UNITAID, 2014, HIV AIDS DIAGN TECHN; Vander Plaetse B, 2005, HEALTH POLICY PLANN, V20, P243, DOI 10.1093/heapol/czi028; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Vyankandondera J, 2003, REDUCING RISK HIV 1; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2010, WHO CHOICE COST EFF; World Health Organization, 2010, NEW GUID PREV MOTH T; World Health Organization, 2013, CONS GUID US ANT TRE; World Health Organization, 2010, ANTIRETROVIRAL THERA; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization Department of Maternal Newborn Child and Adolescent Health, 2014, DOES PROV POINT CAR	83	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117751	10.1371/journal.pone.0117751	http://dx.doi.org/10.1371/journal.pone.0117751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756498	gold, Green Published			2022-12-26	WOS:000351275700017
J	Cohen, BC; Shamay, A; Argov-Argaman, N				Cohen, Bat-Chen; Shamay, Avi; Argov-Argaman, Nurit			Regulation of Lipid Droplet Size in Mammary Epithelial Cells by Remodeling of Membrane Lipid Composition-A Potential Mechanism	PLOS ONE			English	Article							MILK-FAT GLOBULE; GLAND; GENES; ACIDS; BIOSYNTHESIS; METHYLATION; PRECURSORS; PGC-1-BETA; EXPRESSION; SECRETION	Milk fat globule size is determined by the size of its precursors-intracellular lipid droplets-and is tightly associated with its composition. We examined the relationship between phospholipid composition of mammary epithelial cells and the size of both intracellular and secreted milk fat globules. Primary culture of mammary epithelial cells was cultured in medium without free fatty acids (control) or with 0.1 mM free capric, palmitic or oleic acid for 24 h. The amount and composition of the cellular lipids and the size of the lipid droplets were determined in the cells and medium. Mitochondrial quantity and expression levels of genes associated with mitochondrial biogenesis and polar lipid composition were determined. Cells cultured with oleic and palmitic acids contained similar quantities of triglycerides, 3.1- and 3.8-fold higher than in controls, respectively (P < 0.0001). When cultured with oleic acid, 22% of the cells contained large lipid droplets (> 3 mu m) and phosphatidylethanolamine concentration was higher by 23 and 63% compared with that in the control and palmitic acid treatments, respectively (P < 0.0001). In the presence of palmitic acid, only 4% of the cells contained large lipid droplets and the membrane phosphatidylcholine concentration was 22% and 16% higher than that in the control and oleic acid treatments, respectively (P < 0.0001). In the oleic acid treatment, approximately 40% of the lipid droplets were larger than 5 mu m whereas in that of the palmitic acid treatment, only 16% of the droplets were in this size range. Triglyceride secretion in the oleic acid treatment was 2- and 12-fold higher compared with that in the palmitic acid and control treatments, respectively. Results imply that membrane composition of bovine mammary epithelial cells plays a role in controlling intracellular and secreted lipid droplets size, and that this process is not associated with cellular triglyceride content.	[Cohen, Bat-Chen; Argov-Argaman, Nurit] Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel; [Shamay, Avi] Minist Agr, Dept Anim Sci, Volcani Ctr, Rehovot, Israel	Hebrew University of Jerusalem; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Argov-Argaman, N (corresponding author), Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel.	argov.nurit@mail.huji.ac.il	argovArgaman, Nurit/AAB-1846-2020					Argov-Argaman N, 2012, J DAIRY SCI, V95, P5776, DOI 10.3168/jds.2012-5569; Argov-Argaman N, 2014, J DAIRY SCI, V97, P6286, DOI 10.3168/jds.2014-8174; Argov-Argaman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068707; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; BITMAN J, 1990, J DAIRY SCI, V73, P1208, DOI 10.3168/jds.S0022-0302(90)78784-X; Briard V, 2003, EUR J LIPID SCI TECH, V105, P677, DOI 10.1002/ejlt.200300812; Briard-Bion V, 2008, J AGR FOOD CHEM, V56, P9374, DOI 10.1021/jf801333j; Burgess JW, 2005, J LIPID RES, V46, P350, DOI 10.1194/jlr.M400438-JLR200; Couvreur S, 2007, J DAIRY SCI, V90, P392, DOI 10.3168/jds.S0022-0302(07)72640-1; DEENEY JT, 1985, EUR J CELL BIOL, V38, P16; DILLEHAY DL, 1994, J NUTR, V124, P615, DOI 10.1093/jn/124.5.615; DYLEWSKI DP, 1984, EUR J CELL BIOL, V35, P99; Feuermann Y, 2006, J ENDOCRINOL, V191, P407, DOI 10.1677/joe.1.06913; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hadsell DL, 2011, PHYSIOL GENOMICS, V43, P271, DOI 10.1152/physiolgenomics.00133.2010; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horl G, 2011, J BIOL CHEM, V286, P17338, DOI 10.1074/jbc.M111.234534; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lopez C, 2008, J AGR FOOD CHEM, V56, P5226, DOI 10.1021/jf7036104; Lopez C, 2011, FOOD CHEM, V125, P355, DOI 10.1016/j.foodchem.2010.09.005; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; Menard O, 2010, FOOD CHEM, V120, P544, DOI 10.1016/j.foodchem.2009.10.053; Mesilati-Stahy R, 2014, FOOD CHEM, V145, P562, DOI 10.1016/j.foodchem.2013.08.077; Mesilati-Stahy R, 2011, J AGR FOOD CHEM, V59, P7427, DOI 10.1021/jf201373j; Michalski MC, 2005, J DAIRY SCI, V88, P1927, DOI 10.3168/jds.S0022-0302(05)72868-X; Michalski MC, 2003, LAIT, V83, P131, DOI 10.1051/lait:2003003; Mikhaleva NI, 2001, FEBS LETT, V493, P85, DOI 10.1016/S0014-5793(01)02288-8; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; O'Mahony JA, 2005, J DAIRY RES, V72, P338, DOI 10.1017/S0022029905001044; Pereira L, 2012, INT J CELL BIOL; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Rodriguez-Cruz M, 2006, J LIPID RES, V47, P553, DOI 10.1194/jlr.M500407-JLR200; Russell TD, 2011, J CELL SCI, V124, P3247, DOI 10.1242/jcs.082974; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stringer DM, 2010, BBA-MOL CELL BIOL L, V1801, P1375, DOI 10.1016/j.bbalip.2010.08.011; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Vesper H, 1999, J NUTR, V129, P1239, DOI 10.1093/jn/129.7.1239; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walstra P, 1974, MILK FAT GLOBULE EMU; Walther Tobias C, 2009, Biochim Biophys Acta, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wiking L, 2004, INT DAIRY J, V14, P909, DOI 10.1016/j.idairyj.2004.03.005; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhou Y, 2008, J DAIRY SCI, V91, P100, DOI 10.3168/jds.2007-0509	54	48	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121645	10.1371/journal.pone.0121645	http://dx.doi.org/10.1371/journal.pone.0121645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756421	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275700077
J	Borst, JP; Nijboer, M; Taatgen, NA; van Rijn, H; Anderson, JR				Borst, Jelmer P.; Nijboer, Menno; Taatgen, Niels A.; van Rijn, Hedderik; Anderson, John R.			Using Data-Driven Model-Brain Mappings to Constrain Formal Models of Cognition	PLOS ONE			English	Article							INFORMATION-PROCESSING MODEL; PREFRONTAL CORTEX; PROBLEM STATE; MEMORY RETRIEVAL; CORTICAL REGIONS; DECISION-MAKING; CONTROL NETWORK; WORKING-MEMORY; GOOD FIT; FMRI	In this paper we propose a method to create data-driven mappings from components of cognitive models to brain regions. Cognitive models are notoriously hard to evaluate, especially based on behavioral measures alone. Neuroimaging data can provide additional constraints, but this requires a mapping from model components to brain regions. Although such mappings can be based on the experience of the modeler or on a reading of the literature, a formal method is preferred to prevent researcher-based biases. In this paper we used model-based fMRI analysis to create a data-driven model-brain mapping for five modules of the ACT-R cognitive architecture. We then validated this mapping by applying it to two new datasets with associated models. The new mapping was at least as powerful as an existing mapping that was based on the literature, and indicated where the models were supported by the data and where they have to be improved. We conclude that data-driven model-brain mappings can provide strong constraints on cognitive models, and that model-based fMRI is a suitable way to create such mappings.	[Borst, Jelmer P.; Anderson, John R.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Borst, Jelmer P.; Nijboer, Menno; Taatgen, Niels A.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	Carnegie Mellon University; University of Groningen; University of Groningen	Borst, JP (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	j.p.borst@rug.nl	Borst, Jelmer/C-4666-2008; Taatgen, Niels/A-3216-2008; van Rijn, Hedderik/L-3685-2014	Borst, Jelmer/0000-0002-4493-8223; Taatgen, Niels/0000-0001-7286-3460; van Rijn, Hedderik/0000-0002-0461-9850	ERC-StG grant [283597]; James S. McDonnell Scholar Award	ERC-StG grant; James S. McDonnell Scholar Award	This research was funded by ERC-StG grant 283597 awarded to NAT and by a James S. McDonnell Scholar Award awarded to JRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Anderson JR, 2008, CEREB CORTEX, V18, P904, DOI 10.1093/cercor/bhm123; Anderson JR, 2007, COGNITIVE PSYCHOL, V54, P185, DOI 10.1016/j.cogpsych.2006.06.003; Anderson JR, 2011, COGN AFFECT BEHAV NE, V11, P52, DOI 10.3758/s13415-010-0011-0; Anderson JR, 2008, COGNITIVE SCI, V32, P1323, DOI 10.1080/03640210802451588; Anderson JR, 2003, BEHAV BRAIN SCI, V26, P587, DOI 10.1017/S0140525X0300013X; Anderson JR, 2003, PSYCHON B REV, V10, P241, DOI 10.3758/BF03196490; Anderson JR, 1995, J LEARN SCI, V4, P167, DOI 10.1207/s15327809jls0402_2; Anderson JR, 2013, COGNITIVE SCI, V37, P1, DOI [10.1111/cogs.12010, DOI 10.1111/COGS.12010]; Anderson JR, 2007, HOW CAN THE HUMAN MI, DOI [10.1162/jocn.2008.20108, DOI 10.1162/JOCN.2008.20108]; BINDER JR, 1994, ANN NEUROL, V35, P662, DOI 10.1002/ana.410350606; Borst JP, 2013, ACTA PSYCHOL, V144, P373, DOI 10.1016/j.actpsy.2013.07.016; Borst JP, 2013, P NATL ACAD SCI USA, V110, P1628, DOI 10.1073/pnas.1221572110; Borst JP, 2011, NEUROIMAGE, V58, P137, DOI 10.1016/j.neuroimage.2011.05.084; Borst JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012966; Borst JP, 2010, J EXP PSYCHOL LEARN, V36, P363, DOI 10.1037/a0018106; Borst JP, 2015, MODEL BASED COGNITIV, DOI DOI 10.1016/J.TICS.2013.10.014; Borst JP, 2013, NEUROERGONOMICS; BRETT M, 2002, NEUROIMAGE, P16; Byrne MD, 2001, PSYCHOL REV, V108, P847, DOI 10.1037/0033-295X.108.4.847; Cabeza R, 2003, NEUROPSYCHOLOGIA, V41, P390, DOI 10.1016/S0028-3932(02)00170-7; Chen M. C., 2001, HUMAN FACTORS COMPUT, P281, DOI DOI 10.1145/634067.634234; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Davis T, 2012, CEREB CORTEX, V22, P260, DOI 10.1093/cercor/bhr036; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Forstmann BU, 2011, TRENDS COGN SCI, V15, P272, DOI 10.1016/j.tics.2011.04.002; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Glascher JP, 2010, WIRES COGN SCI, V1, P501, DOI 10.1002/wcs.57; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gluth S, 2012, J NEUROSCI, V32, P10686, DOI 10.1523/JNEUROSCI.0727-12.2012; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Huang J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1225; Just MA, 2007, COGN AFFECT BEHAV NE, V7, P153, DOI 10.3758/CABN.7.3.153; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Nijboer M, 2013, PROCEEDINGS OF THE 1; Nijboer M, 2014, NEUROIMAGE, V100, P60, DOI 10.1016/j.neuroimage.2014.05.082; Nijboer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079583; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Oberauer K, 2008, PSYCHOL REV, V115, P544, DOI 10.1037/0033-295X.115.3.544; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Pitt MA, 2002, PSYCHOL REV, V109, P472, DOI 10.1037//0033-295X.109.3.472; Pitt MA, 2002, TRENDS COGN SCI, V6, P421, DOI 10.1016/S1364-6613(02)01964-2; Qin YL, 2003, P NATL ACAD SCI USA, V100, P4951, DOI 10.1073/pnas.0431053100; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; Rodgers JL, 2002, PSYCHOL REV, V109, P599, DOI 10.1037//0033-295X.109.3.599; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Salvucci DD, 2014, J FRANKLIN I, V351, P98, DOI 10.1016/j.jfranklin.2012.06.013; Salvucci DD, 2011, THE MULTITASKING MIN; Shiffrin R, 2008, COGNITIVE SCI, V32, P1248, DOI 10.1080/03640210802414826; Sohn MH, 2005, NEUROIMAGE, V25, P21, DOI 10.1016/j.neuroimage.2004.11.001; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sohn MH, 2003, P NATL ACAD SCI USA, V100, P7412, DOI 10.1073/pnas.0832374100; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stocco A, 2008, J COGNITIVE NEUROSCI, V20, P1300, DOI 10.1162/jocn.2008.20089; Taatgen NA, 2008, CAMB HANDB PSYCHOL, P170; Tenison C, 2014, NEUROPSYCHOLOGIA, V54, P41, DOI 10.1016/j.neuropsychologia.2013.12.011; Tucker LR, 1951, REPORT NO 984; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Maanen L, 2011, J NEUROSCI, V31, P17488, DOI 10.1523/JNEUROSCI.2924-11.2011; van Vugt MK, 2014, NEUROIMAGE, V85, P685, DOI 10.1016/j.neuroimage.2013.09.076; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wintermute S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050154; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106	72	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119673	10.1371/journal.pone.0119673	http://dx.doi.org/10.1371/journal.pone.0119673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747601	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400084
J	Geue, C; Lorgelly, P; Lewsey, J; Hart, C; Briggs, A				Geue, Claudia; Lorgelly, Paula; Lewsey, James; Hart, Carole; Briggs, Andrew			Hospital Expenditure at the End-of-Life: What Are the Impacts of Health Status and Health Risks?	PLOS ONE			English	Article							TIME-TO-DEATH; CARE EXPENDITURE; MEDICAL EXPENDITURES; CIGARETTE-SMOKING; POPULATION; COSTS; MORTALITY; SCOTLAND; RENFREW; MIDSPAN	Background It is important for health policy and expenditure projections to understand the relationship between age, death and expenditure on health care (HC). Research has shown that older age groups incur lower hospital costs than previously anticipated and that remaining time to death (TTD) was a much stronger indicator for expenditure than age. How health behaviour or risk factors impact on HC utilisation and costs at the end of life is relatively unknown. Smoking and Body Mass Index (BMI) have featured most prominently and mixed findings exist as to the exact nature of this association. Methods This paper considers the relationship between TTD, age and expenditure for inpatient care in the last 12 quarters of life; and introduces measures of health status and risks. A longitudinal dataset covering 35 years is utilised, including baseline survey data linked to hospital and death records. The effect of age, TTD and health indicators on expenditure for inpatient care is estimated using a two-part model. Results As individuals approach death costs increase. This effect is highly significant (p<0.01) from the last until the 8th quarter before death and influenced by age. Statistically significant effects on costs were found for: smoking status, systolic blood pressure and lung function (FEV1). On average, smokers incurred lower quarterly costs in their last 12 quarters of life than non-smokers (similar to 7%). Participants' BMI at baseline did show a negative association with probability of HC utilisation however this effect disappeared when costs were estimated. Conclusions Health risk measures obtained at baseline provide a good indication of individuals' probability of needing medical attention later in life and incurring costs, despite the small size of the effect. Utilising a linked dataset, where such measures are available can add substantially to our ability to explain the relationship between TTD and costs.	[Geue, Claudia; Lewsey, James; Briggs, Andrew] Univ Glasgow, Inst Hlth & Wellbeing, Hlth Econ & Hlth Technol Assessment, Glasgow G12 8RZ, Lanark, Scotland; [Lorgelly, Paula] Monash Univ, Ctr Hlth Econ, Clayton, Vic 3800, Australia; Univ Glasgow, Inst Hlth & Wellbeing, Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow; Monash University; University of Glasgow	Geue, C (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Hlth Econ & Hlth Technol Assessment, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	Claudia.Geue@glasgow.ac.uk	Briggs, Andrew/ABA-9009-2020; Harding, Richard/G-9729-2012	Briggs, Andrew/0000-0002-0777-1997; Lorgelly, Paula/0000-0002-8990-9514	Medical Research Council (UK) [G0800122]; Chief Scientist Office [PDF/13/03] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office	This work was funded by a grant from the Medical Research Council (UK). Grant Number: G0800122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; Breyer F, 2015, EUR J HEALTH ECON, V16, P95, DOI 10.1007/s10198-014-0564-x; Carstairs V., 1991, DEPRIVATION HLTH SCO; Cleves M., 2008, INTRO SURVIVAL ANAL; Geue C, 2014, EUR J HEALTH ECON, V15, P885, DOI 10.1007/s10198-013-0543-7; Geue C, 2012, HEALTH ECON, V21, P1201, DOI 10.1002/hec.1785; Graham B, 2001, PROXIMITY DEATH ACUT; Gray AM, 2012, APPL METHODS COST EF, P72; Hart CL, 2005, INT J EPIDEMIOL, V34, P28, DOI 10.1093/ije/dyh348; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; HODGSON TA, 1992, MILBANK Q, V70, P81, DOI 10.2307/3350086; ISD Scotland, SCOTT HLTH SERV COST; Miller LS, 1998, PUBLIC HEALTH REP, V113, P447; Moorin R, 2012, J HEALTH SERV RES PO, V17, P197, DOI 10.1258/jhsrp.2012.011130; Moorin RE, 2008, HEALTH POLICY, V85, P380, DOI 10.1016/j.healthpol.2007.08.003; Payne G, 2007, MILBANK Q, V85, P213, DOI 10.1111/j.1468-0009.2007.00485.x; Popham F, 2010, HEALTH PLACE, V16, P759, DOI 10.1016/j.healthplace.2010.03.007; Seshamani M, 2004, AGE AGEING, V33, P556, DOI 10.1093/ageing/afh187; Seshamani M, 2004, HEALTH ECON, V13, P303, DOI 10.1002/hec.826; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Stearns SC, 2004, HEALTH ECON, V13, P315, DOI 10.1002/hec.831; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Wang FF, 2006, J OCCUP ENVIRON MED, V48, P668, DOI 10.1097/01.jom.0000225045.77734.f4; Whitley E, 2014, ANN BEHAV MED, V47, P148, DOI 10.1007/s12160-013-9539-x; Williams A, 1997, BRIT MED J, V314, P820, DOI 10.1136/bmj.314.7083.820; Zweifel P, 2004, GENEVA PAP R I-ISS P, V29, P652, DOI 10.1111/j.1468-0440.2004.00308.x; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119035	10.1371/journal.pone.0119035	http://dx.doi.org/10.1371/journal.pone.0119035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25746728	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000350689400039
J	McGill, LM; Shannon, AJ; Pisani, D; Felix, MA; Ramlov, H; Dix, I; Wharton, DA; Burnell, AM				McGill, Lorraine M.; Shannon, Adam J.; Pisani, Davide; Felix, Marie-Anne; Ramlov, Hans; Dix, Ilona; Wharton, David A.; Burnell, Ann M.			Anhydrobiosis and Freezing-Tolerance: Adaptations That Facilitate the Establishment of Panagrolaimus Nematodes in Polar Habitats	PLOS ONE			English	Article							PHYLOGENETIC NICHE CONSERVATISM; ANTARCTIC-NEMATODE; CRYOPROTECTIVE DEHYDRATION; ANTIFREEZE PROTEINS; DESICCATION-TOLERANCE; SURVIVAL; RECRYSTALLIZATION; EVOLUTION; DAVIDI; PLANTS	Anhydrobiotic animals can survive the loss of both free and bound water from their cells. While in this state they are also resistant to freezing. This physiology adapts anhydrobiotes to harsh environments and it aids their dispersal. Panagrolaimus davidi, a bacterial feeding anhydrobiotic nematode isolated from Ross Island Antarctica, can survive intracellular ice formation when fully hydrated. A capacity to survive freezing while fully hydrated has also been observed in some other Antarctic nematodes. We experimentally determined the anhydrobiotic and freezing-tolerance phenotypes of 24 Panagrolaimus strains from tropical, temperate, continental and polar habitats and we analysed their phylogenetic relationships. We found that several other Panagrolaimus isolates can also survive freezing when fully hydrated and that tissue extracts from these freezing-tolerant nematodes can inhibit the growth of ice crystals. We show that P. davidi belongs to a clade of anhydrobiotic and freezing- tolerant panagrolaimids containing strains from temperate and continental regions and that P. superbus, an early colonizer at Surtsey island, Iceland after its volcanic formation, is closely related to a species from Pennsylvania, USA. Ancestral state reconstructions show that anhydrobiosis evolved deep in the phylogeny of Panagrolaimus. The early-diverging Panagrolaimus lineages are strongly anhydrobiotic but weakly freezing-tolerant, suggesting that freezing tolerance is most likely a derived trait. The common ancestors of the davidi and the superbus clades were anhydrobiotic and also possessed robust freezing tolerance, along with a capacity to inhibit the growth and recrystallization of ice crystals. Unlike other endemic Antarctic nematodes, the life history traits of P. davidi do not show evidence of an evolved response to polar conditions. Thus we suggest that the colonization of Antarctica by P. davidi and of Surtsey by P. superbus may be examples of recent "ecological fitting" of freezing-tolerant anhydrobiotic propagules to the respective abiotic conditions in Ross Island and Surtsey.	[McGill, Lorraine M.; Shannon, Adam J.; Dix, Ilona; Burnell, Ann M.] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland; [Shannon, Adam J.] Technol Sci Grp Europe LLP, Knaresborough HG5 8QB, N Yorkshire, England; [Pisani, Davide] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Pisani, Davide] Univ Bristol, Sch Earth Sci, Bristol BS8 1UG, Avon, England; [Felix, Marie-Anne] Ecole Normale Super, Inst Biol, F-75230 Paris 05, France; [Ramlov, Hans] Roskilde Univ, Dept Sci Syst & Models, DK-4000 Roskilde, Denmark; [Wharton, David A.] Univ Otago, Dept Zool, Dunedin 9054, New Zealand	Maynooth University; University of Bristol; University of Bristol; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Roskilde University; University of Otago	Burnell, AM (corresponding author), Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland.	ann.burnell@nuim.ie	Pisani, Davide/ABD-5225-2021	Pisani, Davide/0000-0003-0949-6682; Ramlov, Hans/0000-0003-1113-0583; Wharton, David/0000-0001-6369-4984	Science Foundation Ireland [08/RFP/EOB166, 09/RFP/EOB2506]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This project was funded by Science Foundation Ireland (Projects 08/RFP/EOB166 and 09/RFP/EOB2506).	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Ansart A, 2014, EVOL ECOL, V28, P471, DOI 10.1007/s10682-013-9680-9; AROIAN RV, 1993, J NEMATOL, V25, P500; Barriere Antoine, 2006, WormBook, P1; Best RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057550; Bladursson S, 2007, NOMINATION SURTSEY U; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; BOSTROM S, 1988, NEMATOLOGICA, V34, P144, DOI 10.1163/002825988X00233; BRENNER S, 1974, GENETICS, V77, P71; Brown IM, 2004, NEMATOLOGY, V6, P883, DOI 10.1163/1568541044038641; Burnell AM, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P126, DOI 10.1079/9781845936877.0126; CALDWELL J R, 1981, British Antarctic Survey Bulletin, P33; Christner BC, 2010, APPL MICROBIOL BIOT, V85, P481, DOI 10.1007/s00253-009-2291-2; Clark MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-328; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Convey P, 2000, CRYO-LETT, V21, P327; Cornette R, 2011, IUBMB LIFE, V63, P419, DOI 10.1002/iub.463; Crisp MD, 2012, NEW PHYTOL, V196, P681, DOI 10.1111/j.1469-8137.2012.04298.x; CROWE JH, 1981, MOL PHYSIOL, V1, P145; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DAVIES PL, 1990, FASEB J, V4, P2460, DOI 10.1096/fasebj.4.8.2185972; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Farrant JM, 2011, CURR OPIN PLANT BIOL, V14, P340, DOI 10.1016/j.pbi.2011.03.018; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; FORGE TA, 1992, CAN J ZOOL, V70, P1553, DOI 10.1139/z92-214; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Galtier N, 1998, MOL BIOL EVOL, V15, P871, DOI 10.1093/oxfordjournals.molbev.a025991; GOLDMAN N, 1990, SYST ZOOL, V39, P345, DOI 10.2307/2992355; Graham LA, 2005, SCIENCE, V310, P461, DOI 10.1126/science.1115145; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Holmstrup M, 2002, P NATL ACAD SCI USA, V99, P5716, DOI 10.1073/pnas.082580699; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; KNIGHT CA, 1995, CRYOBIOLOGY, V32, P23, DOI 10.1006/cryo.1995.1002; KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lieu YC, 2000, PROTEIN EXPRES PURIF, V19, P148, DOI 10.1006/prep.2000.1219; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Nkem JN, 2006, POLAR BIOL, V29, P346, DOI 10.1007/s00300-005-0061-x; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; O'Meara BC, 2006, EVOLUTION, V60, P922; ODELL SJ, 1979, CRYOBIOLOGY, V16, P534, DOI 10.1016/0011-2240(79)90071-3; Orme CDL, 2013, CAPER COMP ANAL PHYL, DOI DOI 10.1371/journal.pone.0066213; OVERHOFF A, 1993, POLAR BIOL, V13, P151, DOI 10.1007/BF00238924; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Proctor MCF, 2007, BRYOLOGIST, V110, P595, DOI 10.1639/0007-2745(2007)110[595:DIBAR]2.0.CO;2; Ramlov H, 1996, CRYOBIOLOGY, V33, P607, DOI 10.1006/cryo.1996.0064; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Shannon AJ, 2005, J EXP BIOL, V208, P2433, DOI 10.1242/jeb.01629; Sinclair BJ, 2013, INTEGR COMP BIOL, V53, P545, DOI 10.1093/icb/ict004; SOHLENIUS B, 1988, NEMATOLOGICA, V34, P208, DOI 10.1163/002825988X00305; Sorensen JG, 2011, J INSECT PHYSIOL, V57, P1147, DOI 10.1016/j.jinsphys.2011.03.001; Swart A, 1996, S AFR J ZOOL, V31, P15; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 2005, CRYOBIOLOGY, V50, P21, DOI 10.1016/j.cryobiol.2004.09.004; Wharton DA, 2003, J EXP BIOL, V206, P215, DOI 10.1242/jeb.00083; WHARTON DA, 1993, FUND APPL NEMATOL, V16, P17; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; Womersley CZ, 1987, VISTAS NEMATOLOGY	73	17	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116084	10.1371/journal.pone.0116084	http://dx.doi.org/10.1371/journal.pone.0116084			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747673	gold, Green Submitted, Green Published			2022-12-26	WOS:000350689400003
J	Pachschwoll, C; Garcia, PE; Winkler, M; Schneeweiss, GM; Schonswetter, P				Pachschwoell, Clemens; Garcia, Pedro Escobar; Winkler, Manuela; Schneeweiss, Gerald M.; Schoenswetter, Peter			Polyploidisation and Geographic Differentiation Drive Diversification in a European High Mountain Plant Group (Doronicum clusii Aggregate, Asteraceae)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; NUCLEAR-DNA CONTENT; SENECIO-CARNIOLICUS ASTERACEAE; ARCTIC-ALPINE PHYLOGEOGRAPHY; POPULATION-STRUCTURE; GLACIAL REFUGIA; FLOW-CYTOMETRY; EASTERN ALPS; GENETIC-STRUCTURE; POSTGLACIAL COLONIZATION	Range shifts (especially during the Pleistocene), polyploidisation and hybridization are major factors affecting high-mountain biodiversity. A good system to study their role in the European high mountains is the Doronicum clusii aggregate (Asteraceae), whose four taxa (D. clusii s.s., D. stiriacum, D. glaciale subsp. glaciale and D. glaciale subsp. calcareum) are differentiated geographically, ecologically (basiphilous versus silicicolous) and/or via their ploidy levels (diploid versus tetraploid). Here, we use DNA sequences (three plastid and one nuclear spacer) and AFLP fingerprinting data generated for 58 populations to infer phylogenetic relationships, origin of polyploids-whose ploidy level was confirmed by chromosomally calibrated DNA ploidy level estimates-and phylogeographic history. Taxonomic conclusions were informed, among others, by a Gaussian clustering method for species delimitation using dominant multilocus data. Based on molecular data we identified three lineages: (i) silicicolous diploid D. clusii s. s. in the Alps, (ii) silicicolous tetraploid D. stiriacum in the eastern Alps (outside the range of D. clusii s. s.) and the Carpathians and (iii) the basiphilous diploids D. glaciale subsp. glaciale (eastern Alps) and D. glaciale subsp. calcareum (northeastern Alps); each taxon was identified as distinct by the Gaussian clustering, but the separation of D. glaciale subsp. calcareum and D. glaciale subsp. glaciale was not stable, supporting their taxonomic treatment as subspecies. Carpathian and Alpine populations of D. stiriacum were genetically differentiated suggesting phases of vicariance, probably during the Pleistocene. The origin (autopolyploid versus allopolyploid) of D. stiriacum remained unclear. Doronicum glaciale subsp. calcareum was genetically and morphologically weakly separated from D. glaciale subsp. glaciale but exhibited significantly higher genetic diversity and rarity. This suggests that the more widespread D. glaciale subsp. glaciale originated from D. glaciale subsp. calcareum, which is restricted to a prominent Pleistocene refugium previously identified in other alpine plant species.	[Pachschwoell, Clemens; Garcia, Pedro Escobar; Winkler, Manuela; Schneeweiss, Gerald M.] Univ Vienna, Dept Bot & Biodivers Res, A-1030 Vienna, Austria; [Garcia, Pedro Escobar] Nat Hist Museum, Dept Bot, A-1010 Vienna, Austria; [Winkler, Manuela] Univ Nat Resources & Life Sci Vienna, GLORIA Coordinat, Ctr Global Change & Sustainabil, A-1190 Vienna, Austria; [Winkler, Manuela] Austrian Acad Sci, Inst Interdisciplinary Mt Res, A-1190 Vienna, Austria; [Schoenswetter, Peter] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	University of Vienna; University of Natural Resources & Life Sciences, Vienna; Austrian Academy of Sciences; University of Innsbruck	Schneeweiss, GM (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, A-1030 Vienna, Austria.	gerald.schneeweiss@univie.ac.at	Schönswetter, Peter/T-8241-2017; Pachschwöll, Clemens/O-2582-2019; Schneeweiss, Gerald M./B-4344-2013; Winkler, Manuela/K-5434-2012; Pachschwöll, Clemens/D-3550-2014	Schönswetter, Peter/0000-0001-9225-4566; Pachschwöll, Clemens/0000-0002-8281-7545; Schneeweiss, Gerald M./0000-0003-2811-3317; Winkler, Manuela/0000-0002-8655-9555; 	Open Access Publishing Fund of the University of Vienna; Society for the Advancement of Plant Sciences (Vienna, Austria)	Open Access Publishing Fund of the University of Vienna; Society for the Advancement of Plant Sciences (Vienna, Austria)	This article was supported by the Open Access Publishing Fund of the University of Vienna. This work was financed by a grant of the Society for the Advancement of Plant Sciences (Vienna, Austria) to CP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2009, GLOBAL ECOL BIOGEOGR, V18, P223, DOI 10.1111/j.1466-8238.2008.00439.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Badanina V. A., 1997, Ukrayins'kyi Botanichnyi Zhurnal, V54, P372; Benedi C., 1992, INT ORGAN PLANT BIOS, V18/19, P6; Benham J, 1999, J AGR GENOMICS, V4, P399; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; Birks HH, 2008, PLANT ECOL DIVERS, V1, P135, DOI 10.1080/17550870802328652; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Brysting AK, 2011, TAXON, V60, P333, DOI 10.1002/tax.602004; Burnier J, 2009, MOL ECOL, V18, P3730, DOI 10.1111/j.1365-294X.2009.04281.x; Casazza G, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-56; Cavillier F, 1907, ANN CONSERV JARD BOT, V10, P177; Cavillier F, 1911, ANN CONSERV JARD BOT, V13-14, P195; Choler P, 2004, P NATL ACAD SCI USA, V101, P171, DOI 10.1073/pnas.2237235100; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CORRIVEAU J L, 1988, American Journal of Botany, V75, P1443, DOI 10.2307/2444695; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; Dillenberger MS, 2013, AM J BOT, V100, P1171, DOI 10.3732/ajb.1300060; Dixon CJ, 2009, MOL PHYLOGENET EVOL, V50, P74, DOI 10.1016/j.ympev.2008.10.009; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Doyle J. J., 1987, PHYTOCHEM B, P11; Dullinger S, 2012, GLOBAL ECOL BIOGEOGR, V21, P829, DOI 10.1111/j.1466-8238.2011.00732.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Essl F, 2011, J BIOGEOGR, V38, P604, DOI 10.1111/j.1365-2699.2010.02425.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FAVARGER C., 1949, BULL SOC NEUCHATEL SCI NAT, V72, P15; Favarger C, 1968, COLLECT BOT, V7, P325; FAVARGER C, 1991, POLISH BOT STUD, V2, P23; Favarger C., 1950, ARCH JUL KLAUS STIFT, V25, P472; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez IA, 2003, ANN MO BOT GARD, V90, P319, DOI 10.2307/3298534; Fernandez IA, 2001, FOLIA GEOBOT, V36, P423, DOI 10.1007/BF02899989; Fernandez IA, 2001, MOL PHYLOGENET EVOL, V20, P41, DOI 10.1006/mpev.2001.0954; Fischer MA, 2008, LIECHTENSTEIN SUDTIR; Frajman B, 2014, PHYTON-ANN REI BOT A, V54, P27; Garcia PE, 2012, MOL ECOL, V21, P1255, DOI 10.1111/j.1365-294X.2012.05456.x; Guggisberg A, 2009, SYST BIOL, V58, P55, DOI 10.1093/sysbio/syp010; GUNTHART A, 1926, PFLANZENLEBEN ALPEN, P1028; Gyorffy I, 1909, MAGYAR BOT LAPOK, V8, P47; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hausdorf B, 2010, SYST BIOL, V59, P491, DOI 10.1093/sysbio/syq039; Hennig C, 2012, PRABCLUS PACKAGE VER; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Hurdu Bogdan Iuliu, 2012, Contributii Botanice, V47, P25; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Joly S, 2007, SYST BIOL, V56, P857, DOI 10.1080/10635150701633153; Kadereit JW, 2004, PHILOS T R SOC B, V359, P265, DOI 10.1098/rstb.2003.1389; Kolar F, 2013, ANN BOT-LONDON, V111, P1095, DOI 10.1093/aob/mct074; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lihova J, 2009, J BIOGEOGR, V36, P104, DOI 10.1111/j.1365-2699.2008.01998.x; Lindner L, 2003, GEOL Q, V47, P269; Lopez P, 2012, ANN BOT-LONDON, V109, P351, DOI 10.1093/aob/mcr291; Lovka M., 1972, TAXON, V21, P333; Magauer M, 2014, BOT J LINN SOC, V176, P486, DOI 10.1111/boj.12214; MAJOVSKY J, 1978, Acta Facultatis Rerum Naturalium Universitatis Comenianae Botanica, V26, P1; Makos M, 2011, GEOL Q, V55, P253; Merxmuller H., 1953, JB VEREINS ZUM SCHUT, V18, P138; Merxmuller H., 1952, JB VER SCHUTZE ALPEN, V17, P96; Merxmuller H, 1954, JB VEREINS SCHUTZE A, V19, P97; Mraz P, 2007, J BIOGEOGR, V34, P2100, DOI 10.1111/j.1365-2699.2007.01765.x; Muller H, 1881, ALPENBLUMEN IHRE BEF; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ortiz MA, 2008, MOL ECOL, V17, P3654, DOI 10.1111/j.1365-294X.2008.03835.x; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Pachschwoell Clemens, 2013, Contributii Botanice, V48, P7; Pachschwoll C, 2011, BIOLOGIA, V66, P977, DOI 10.2478/s11756-011-0111-5; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Peruzzi L, 2012, PLANT BIOSYST, V146, P867, DOI 10.1080/11263504.2011.634445; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Polatschek A., 1966, OSTERR BOT Z, V113, P101; Pritchard JK, 2000, GENETICS, V155, P945; Ronikier M, 2012, MOL ECOL, V21, P5561, DOI 10.1111/mec.12030; Ronikier M, 2011, TAXON, V60, P373, DOI 10.1002/tax.602008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanz M, 2014, BOT J LINN SOC, V174, P214, DOI 10.1111/boj.12132; Schmickl R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042691; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schneeweiss GM, 2010, J BIOGEOGR, V37, P2016, DOI 10.1111/j.1365-2699.2010.02350.x; Schneeweiss GM, 2011, MOL ECOL, V20, P190, DOI 10.1111/j.1365-294X.2010.04927.x; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schonswetter P, 2003, BOT J LINN SOC, V141, P437, DOI 10.1046/j.0024-4074.2002.00134.x; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Schonswetter P, 2007, MOL PHYLOGENET EVOL, V42, P92, DOI 10.1016/j.ympev.2006.06.016; Schonswetter P, 2009, TAXON, V58, P1326, DOI 10.1002/tax.584020; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SKALINSKA M, 1950, ACTA SOC BOTANICORUM, V20, P45, DOI DOI 10.5586/ASBP.1950.003; Slovak M, 2012, BIOL J LINN SOC, V105, P741, DOI 10.1111/j.1095-8312.2011.01826.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Sonnleitner M, 2010, ANN BOT-LONDON, V106, P967, DOI 10.1093/aob/mcq192; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stejskal J, 1931, ACTA PALAEOBOT, V6, P55; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stuessy T.F., 2009, PLANT TAXONOMY SYSTE; Suda J., 2006, CURR PROTOCOL CYTOM, V38; Suda J, 2007, AM J BOT, V94, P1391, DOI 10.3732/ajb.94.8.1391; Suda J, 2006, TAXON, V55, P447, DOI 10.2307/25065591; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Tackenberg O, 2008, J VEG SCI, V19, P109, DOI 10.3170/2007-8-18338; TASENKEVICH L A, 1989, Botanicheskii Zhurnal (St. Petersburg), V74, P1669; Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275; Thiel-Egenter C, 2011, J BIOGEOGR, V38, P772, DOI 10.1111/j.1365-2699.2010.02441.x; Travnicek P, 2011, ANN BOT-LONDON, V107, P77, DOI 10.1093/aob/mcq217; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Tribsch A, 2002, AM J BOT, V89, P2024, DOI 10.3732/ajb.89.12.2024; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Tribsch A, 2010, DATA MINING FOR GLOBAL TRENDS IN MOUNTAIN BIODIVERSITY, P89; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vierhapper F, 1900, STERR BOT Z, V50, P173; Vierhapper F, 1900, STERR BOT Z, V50, P202; Vierhapper F, 1900, STERR BOT Z, V50, P109; Vierhapper F, 1900, STERR BOT Z, V50, P257; Vierhapper F, 1900, STERR BOT Z, V50, P501; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wcis H, 1952, B INT ACAD POL B1 SM, V1951, P147; Widder FJ, 1934, MITT NATURWISS VEREI, V71, P132; Willis KJ, 2004, PHILOS T R SOC B, V359, P159, DOI 10.1098/rstb.2003.1387; Winkler M, 2013, BOT J LINN SOC, V173, P622, DOI 10.1111/boj.12104; Winkler M, 2012, MOL ECOL, V21, P4618, DOI 10.1111/j.1365-294X.2012.05705.x; Winkler M, 2010, MOL PHYLOGENET EVOL, V54, P571, DOI 10.1016/j.ympev.2009.08.009	144	17	18	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118197	10.1371/journal.pone.0118197	http://dx.doi.org/10.1371/journal.pone.0118197			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749621	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400015
J	McGuire, AL; Bennett, SC; Lansley, SM; Popowicz, ND; della Vergiliana, JFV; Wong, D; Lee, YCG; Chakera, A				McGuire, Amanda L.; Bennett, Sophia C.; Lansley, Sally M.; Popowicz, Natalia D.; della Vergiliana, Julius F. Varano; Wong, Daniel; Lee, Y. C. Gary; Chakera, Aron			Preclinical Assessment of Adjunctive tPA and DNase for Peritoneal Dialysis Associated Peritonitis	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTRAPERITONEAL UROKINASE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR DNA; BIOFILM FORMATION; OUTCOMES; PATIENT; SURFACE; INFECTIONS	A major complication of peritoneal dialysis is the development of peritonitis, which is associated with reduced technique and patient survival. The inflammatory response elicited by infection results in a fibrin and debris-rich environment within the peritoneal cavity, which may reduce the effectiveness of antimicrobial agents and predispose to recurrence or relapse of infection. Strategies to enhance responses to antimicrobial agents therefore have the potential to improve patient outcomes. This study presents pre-clinical data describing the compatibility of tPA and DNase in combination with antimicrobial agents used for the treatment of PD peritonitis. tPA and DNase were stable in standard dialysate solution and in the presence of antimicrobial agents, and were safe when given intraperitoneally in a mouse model with no evidence of local or systemic toxicity. Adjunctive tPA and DNase may have a role in the management of patients presenting with PD peritonitis.	[McGuire, Amanda L.; Bennett, Sophia C.; Chakera, Aron] Harry Perkins Inst Med Res, Translat Renal Res Grp, Perth, WA, Australia; [McGuire, Amanda L.; Bennett, Sophia C.; Chakera, Aron] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Lansley, Sally M.; Popowicz, Natalia D.; della Vergiliana, Julius F. Varano; Lee, Y. C. Gary] Sch Med & Pharmacol, Ctr Asthma Allergy Resp Res, Lung Inst Western Australia, Pleural Dis Unit, Perth, WA, Australia; [Wong, Daniel] QEII Med Ctr, PathWest Lab Med WA, Dept Anat Pathol, Perth, WA, Australia; [Lee, Y. C. Gary] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia; [Chakera, Aron] Sir Charles Gairdner Hosp, Renal Dept, Perth, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Chakera, A (corresponding author), Harry Perkins Inst Med Res, Translat Renal Res Grp, Perth, WA, Australia.	aron.chakera@uwa.edu.au	Lee, Y C Gary/H-5264-2014; Popowicz, Natalia/M-7505-2018	Popowicz, Natalia/0000-0003-0200-1819; Lee, Yun Chor Gary/0000-0002-0036-511X; McGuire, Amanda/0000-0002-1261-9236				AHRENHOLZ DH, 1980, SURGERY, V88, P41; Boateng EA, 2011, J RENAL CARE, V37, P190, DOI 10.1111/j.1755-6686.2011.00244.x; Boudville N, 2012, J AM SOC NEPHROL, V23, P1398, DOI 10.1681/ASN.2011121135; Brown F, 2007, PERITON DIALYSIS INT, V27, P565; DASGUPTA MK, 1991, ADV PERIT D, V7, P165; Davies SJ, 2013, NAT REV NEPHROL, V9, P399, DOI 10.1038/nrneph.2013.100; de Boer AW, 1999, PEDIATR NEPHROL, V13, P284, DOI 10.1007/s004670050609; Duch JM, 2001, AM J KIDNEY DIS, V37, P149, DOI 10.1016/S0272-6386(01)80069-X; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Gadallah M F, 2000, Adv Perit Dial, V16, P233; Ghaffari A, 2013, PD 1 PERITONEAL DIAL; Ghali JR, 2011, PERITON DIALYSIS INT, V31, P651, DOI 10.3747/pdi.2010.00131; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hanlon GW, 2004, J PHARM PHARMACOL, V56, P847, DOI 10.1211/0022357023817; Hurst K, 2012, ANZDATA REGISTRY REP, pXXIII; Ince A, 2002, AM J SURG, V183, P67, DOI 10.1016/S0002-9610(01)00850-9; INNES A, 1994, NEPHROL DIAL TRANSPL, V9, P797; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jager KJ, 2004, AM J KIDNEY DIS, V43, P891, DOI 10.1053/j.ajkd.2003.12.051; Johnson D, 2006, ANZDATA REGISTRY REP, P88; Kim GC, 2000, AM J KIDNEY DIS, V36, P1000, DOI 10.1053/ajkd.2000.19102; Kumar VA, 2013, PERIT DIAL INT; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Marcus RJ, 2008, EXPERT OPIN BIOL TH, V8, P1159, DOI 10.1517/14712598.8.8.1159 ; Mastrosimone S, 2002, PERITON DIALYSIS INT, V22, P91; MCINTOSH ME, 1985, EUR J CLIN PHARMACOL, V28, P187, DOI 10.1007/BF00609690; Miles R, 2009, KIDNEY INT, V76, P622, DOI 10.1038/ki.2009.202; de Bustillo EM, 2011, NEFROLOGIA, V31, P723, DOI 10.3265/Nefrologia.pre2011.Oct.10987; MURPHY G, 1991, INT J ARTIF ORGANS, V14, P87, DOI 10.1177/039139889101400206; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Piccolo F, 2014, ANN AM THORACIC SOC; Pihl M, 2013, PERITON DIALYSIS INT, V33, P51, DOI 10.3747/pdi.2011.00320; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; READ RR, 1989, KIDNEY INT, V35, P614, DOI 10.1038/ki.1989.30; Sepandj F, 2003, PERITON DIALYSIS INT, V23, P77; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; Shea M, 2001, Adv Perit Dial, V17, P249; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Tong MKH, 2005, J NEPHROL, V18, P204; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Walker A, 2013, NEPHROLOGY CARLTON; Wiggins KJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005284.pub2; Worland MA, 1998, ANN PHARMACOTHER, V32, P1216, DOI 10.1345/aph.16153; Zorzanello Mary M, 2004, Nephrol Nurs J, V31, P534; Zorzanello MM, 2004, J AM NEPHROLOGY NURS, V31, P534	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119238	10.1371/journal.pone.0119238	http://dx.doi.org/10.1371/journal.pone.0119238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742006	gold, Green Submitted, Green Published			2022-12-26	WOS:000350688100095
J	Hashizume, O; Yamanashi, H; Taketo, MM; Nakada, K; Hayashi, JI				Hashizume, Osamu; Yamanashi, Haruka; Taketo, Makoto M.; Nakada, Kazuto; Hayashi, Jun-Ichi			A Specific Nuclear DNA Background Is Required for High Frequency Lymphoma Development in Transmitochondrial Mice with G13997A mtDNA	PLOS ONE			English	Article							MUTATIONS; TUMORS; GENE; GENERATION; DISEASES; MODELS	We previously found that mouse mitochondrial DNA (mtDNA) with a G13997A mutation (G13997A mtDNA) controls not only the transformation of cultured lung carcinoma cells from poorly metastatic into highly metastatic cells, but also the transformation of lymphocytes into lymphomas in living C57BL/6 (B6) mice. Because the nuclear genetic background of the B6 strain makes the strain prone to develop lymphomas, here we examined whether G13997A mtDNA independently induces lymphoma development even in mice with the nuclear genetic background of the A/J strain, which is not prone to develop lymphomas. Our results showed that the B6 nuclear genetic background is required for frequent lymphoma development in mice with G13997A mtDNA. Moreover, G13997A mtDNA in mice did not enhance the malignant transformation of lung adenomas into adenocarcinomas or that of hepatocellular carcinomas from poorly metastatic into highly metastatic carcinomas. Therefore, G13997A mtDNA enhances the frequency of lymphoma development under the abnormalities in the B6 nuclear genome, and does not independently control tumor development and tumor progression.	[Hashizume, Osamu; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Yamanashi, Haruka] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyou Ku, Kyoto, Japan; [Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Hayashi, Jun-Ichi] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Kyoto University; University of Tsukuba; University of Tsukuba	Hayashi, JI (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp			Japan Society for the Promotion of Science [25250011, 23240058, 24117503]; World Premier International Research Center Initiative; Ministry of Education, Culture, Sports, Science and Technology-Japan; Grants-in-Aid for Scientific Research [23240058] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Premier International Research Center Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research A 25250011 (to JH), Scientific Research A 23240058 (to KN), and Scientific Research on Innovative Areas 24117503 (to JH) from the Japan Society for the Promotion of Science. This work was supported also by the World Premier International Research Center Initiative; Ministry of Education, Culture, Sports, Science and Technology-Japan (to KN and J-IH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2005, BIOCHEM BIOPH RES CO, V327, P1028, DOI 10.1016/j.bbrc.2004.12.105; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krupke DM, 2008, NAT REV CANCER, V8, P459, DOI 10.1038/nrc2390; Manenti G, 2002, INT J CANCER, V99, P555, DOI 10.1002/ijc.10386; Miller YE, 2003, CANCER LETT, V198, P139, DOI 10.1016/S0304-3835(03)00309-4; Miyoshi H, 2002, CANCER RES, V62, P2261; Nakau M, 2002, CANCER RES, V62, P4549; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Shimizu A, 2014, P NATL ACAD SCI USA, V111, P3104, DOI 10.1073/pnas.1318109111; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118561	10.1371/journal.pone.0118561	http://dx.doi.org/10.1371/journal.pone.0118561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738506	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900047
J	Tan, C; Liu, S; Tan, SK; Zeng, XY; Yu, HP; Li, AH; Bei, CH; Qiu, XQ				Tan, Chao; Liu, Shun; Tan, Shengkui; Zeng, Xiaoyun; Yu, Hongping; Li, Anhua; Bei, Chunhua; Qiu, Xiaoqiang			Polymorphisms in MicroRNA Target Sites of Forkhead Box O Genes Are Associated with Hepatocellular Carcinoma	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; CANCER CELLS; EXPRESSION; RESOURCE; DIFFERENTIATION; PROLIFERATION; APOPTOSIS; DISEASE; ARREST	The forkhead box O (FOXO) transcription factors play important roles in various cancer development including Hepatocellular Carcinoma (HCC). In this study we conducted a hospital-based case control study including 1049 cases (HCC patients) and 1052 controls (nontumor patients) to examine whether single nucleotide polymorphisms (SNPs) within microRNA (miRNA) target sites of FOXO genes confer HCC susceptibility. A total of three miRNA target site SNPs in the 3' untranslated regions (UTR) of FOXO1 (rs17592236), FOXO3 (rs4946936) and FOXO4 (rs4503258) were analyzed. No statistically significant differences were found in genotype distribution for rs17592236, rs4946936, and rs4503258 between the HCC patient group and the tumor-free control group using single factor chi-square analysis (P> 0.05). However, multivariate logistic regression analysis showed that the CT/TT genotype in rs17592236 was significantly associated with decreased risk of HCC development (P = 0.010, OR = 0.699, 95% CI: 0.526-0.927) as compared to the CC genotype in rs17592236. Additionally, a genetic interaction was found between rs17592236 and rs4503258 (P = 0.003, OR = 0.755, 95% CI: 0.628-0.908). Functional dual luciferase reporter assays verified that the rs17592236 SNP was a target site of human miRNA miR-137. Together, these results indicate that the rs17592236 polymorphism is associated with decreasing of HCC hereditary susceptibility likely through modulating the binding affinity of miR-137 to the 3' UTR in FOXO1 messenger RNA (mRNA). Further knowledge obtained from this study may provide important evidence for the prevention and targeted therapy of HCC.	[Tan, Chao; Liu, Shun; Zeng, Xiaoyun; Li, Anhua; Qiu, Xiaoqiang] Guangxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanning, Guangxi, Peoples R China; [Tan, Shengkui; Yu, Hongping; Bei, Chunhua] Guilin Med Univ, Sch Publ Hlth, Dept Epidemiol, Guilin, Guangxi, Peoples R China	Guangxi Medical University; Guilin Medical University	Qiu, XQ (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanning, Guangxi, Peoples R China.	xqqiu9999@sina.com		Bei, chunhua/0000-0001-7515-3464	National Natural Science Foundation of China [81241100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was financially supported by grant from the National Natural Science Foundation of China (grant No. 81241100). XQ is the recipient of the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Chun HB, 2011, CHINESE J PUBLIC HLT, V27, P309; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fei M, 2009, MED ONCOL, V26, P178, DOI 10.1007/s12032-008-9105-8; Fendler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080807; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Huang CY, 2013, J NUTR BIOCHEM, V24, P1596, DOI 10.1016/j.jnutbio.2013.01.010; Jones SM, 2000, ONCOGENE, V19, P5558, DOI 10.1038/sj.onc.1203858; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Lee SY, 2013, CELL CYCLE, V12, P67, DOI 10.4161/cc.22962; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Lu MD, 2009, PATHOL ONCOL RES, V15, P679, DOI 10.1007/s12253-009-9171-z; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maiese K, 2009, MED RES REV, V29, P395, DOI 10.1002/med.20139; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Niedan S, 2014, ONCOGENE, V33, P3927, DOI 10.1038/onc.2013.361; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Pezzoli K, 2007, ENVIRON HEALTH PERSP, V115, P564, DOI 10.1289/ehp.9817; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Tomasetti M, 2014, ANTIOXID REDOX SIGN, V21, P2109, DOI 10.1089/ars.2013.5215; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; Yang J, 2008, MUTAT RES-FUND MOL M, V638, P205, DOI 10.1016/j.mrfmmm.2007.08.007; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zeng XY, 2009, CHINESE J CANC PREVE, V16, P1629; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954	41	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119210	10.1371/journal.pone.0119210	http://dx.doi.org/10.1371/journal.pone.0119210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739100	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900099
J	Varga, S; Laaksonen, E; Siikamaki, P; Kytoviita, MM				Varga, Sandra; Laaksonen, Ester; Siikamaki, Pirkko; Kytoviita, Minna-Maarit			Absence of Sex Differential Plasticity to Light Availability during Seed Maturation in Geranium sylvaticum	PLOS ONE			English	Article							REPRODUCTIVE OUTPUT; HERMAPHRODITES; POLLINATION; ALLOCATION; FEMALES; POLLEN; RATIO; MACULATUM; EVOLUTION; SYMBIOSIS	Sex-differential plasticity (SDP) hypothesis suggests that since hermaphrodites gain fitness through both pollen and seed production they may have evolved a higher degree of plasticity in their reproductive strategy compared to females which achieve fitness only through seed production. SDP may explain the difference in seed production observed between sexes in gynodioecious species in response to resource (nutrients or water) availability. In harsh environments, hermaphrodites decrease seed production whereas females keep it relatively similar regardless of the environmental conditions. Light availability can be also a limiting resource and thus could theoretically affect differently female and hermaphrodite seed output even though this ecological factor has been largely overlooked. We tested whether the two sexes in the gynodioecious species Geranium sylvaticum differ in their tolerance to light limitation during seed maturation in the field. We used a fully factorial block experiment exposing female and hermaphrodite plants to two different light environments (control and shade) after their peak flowering period. Specifically, we measured fruit and seed production in response to decreased light availability and compared it between the sexes. Shading reduced the number of fruits and seeds produced, but the decrease was similar between the sexes. Furthermore, shading delayed seed production by three days in both sexes, but did not affect seed mass, seed P content, or the probability of re-flowering the following year. Our results give no evidence for reproductive SDP in response to light during seed maturation.	[Varga, Sandra; Kytoviita, Minna-Maarit] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Laaksonen, Ester] Univ Oulu, Dept Biol, Oulu 90014, Finland; [Siikamaki, Pirkko] Metsahallitus, Kuusamo 93601, Finland	University of Jyvaskyla; University of Oulu	Varga, S (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, Jyvaskyla 40014, Finland.	Sandra.varga@jyu.fi	Varga, Sandra/AAO-7881-2021	Varga, Sandra/0000-0001-9799-714X; Kytoviita, Minna-Maarit/0000-0002-8928-6951	Academy of Finland; Societas Biologica Fennica Vanamo; Oulanka Foundation	Academy of Finland(Academy of Finland); Societas Biologica Fennica Vanamo; Oulanka Foundation	This study was funded by the Academy of Finland (SV) and Societas Biologica Fennica Vanamo and Oulanka Foundation grants (EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1994, OIKOS, V70, P35, DOI 10.2307/3545696; Alonso C, 2008, ECOSCIENCE, V15, P358, DOI 10.2980/15-3-3115; Ashman T. L., 2006, ECOLOGY EVOLUTION FL, P204; ASHMAN TL, 1994, AM J BOT, V81, P433, DOI 10.2307/2445492; Asikainen E, 2005, AM J BOT, V92, P487, DOI 10.3732/ajb.92.3.487; Asikainen E, 2005, ANN BOT-LONDON, V95, P879, DOI 10.1093/aob/mci094; Asikainen E, 2003, AM J BOT, V90, P226, DOI 10.3732/ajb.90.2.226; Asikainen E., 2004, THESIS TURKU U; Barr CM, 2004, P ROY SOC B-BIOL SCI, V271, P1935, DOI 10.1098/rspb.2004.2820; BERTIN RI, 1993, AM MIDL NAT, V129, P52, DOI 10.2307/2426435; Case Andrea L., 2005, P126; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH D, 1989, J THEOR BIOL, V139, P327, DOI 10.1016/S0022-5193(89)80212-7; Delph LF, 2005, NEW PHYTOL, V166, P119, DOI 10.1111/j.1469-8137.2005.01339.x; Delph LF, 2003, EVOL DEV, V5, P34, DOI 10.1046/j.1525-142X.2003.03006.x; DELPH LF, 1990, EVOLUTION, V44, P134, DOI 10.1111/j.1558-5646.1990.tb04284.x; Delph LF, 1999, AM J BOT, V86, P140, DOI 10.2307/2656963; Dorken ME, 2008, EVOLUTION, V62, P971, DOI 10.1111/j.1558-5646.2008.00336.x; Dufay M, 2012, ANN BOT-LONDON, V109, P505, DOI 10.1093/aob/mcr062; Gutterman Y., 2000, Seeds: the ecology of regeneration in plant communities, P59, DOI 10.1079/9780851994321.0059; HERRERA CM, 1995, ECOLOGY, V76, P1516, DOI 10.2307/1938153; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Jacobs MS, 2003, AM NAT, V161, P837, DOI 10.1086/375174; Jacquemyn H, 2010, J ECOL, V98, P1204, DOI 10.1111/j.1365-2745.2010.01697.x; JOHN MK, 1970, SOIL SCI, V109, P214, DOI 10.1097/00010694-197004000-00002; Jurgens A, 2002, SEX PLANT REPROD, V14, P279, DOI 10.1007/s00497-001-0124-2; Korhonen J, 2004, CAN J BOT, V82, P89, DOI [10.1139/B03-142, 10.1139/b03-142]; LEWIS D., 1941, NEW PHYTOT, V40, P56, DOI 10.1111/j.1469-8137.1941.tb07028.x; LLOYD DG, 1976, THEOR POPUL BIOL, V9, P299, DOI 10.1016/0040-5809(76)90050-2; LLOYD DG, 1974, HEREDITY, V32, P11, DOI 10.1038/hdy.1974.2; McCauley DE, 2009, ANN BOT-LONDON, V104, P611, DOI 10.1093/aob/mcp141; Spigler RB, 2011, NEW PHYTOL, V190, P1058, DOI 10.1111/j.1469-8137.2011.03657.x; Spigler RB, 2013, ANN BOT, V109, P531; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Toivonen E, 2012, ANN BOT-LONDON, V109, P1159, DOI 10.1093/aob/mcs037; Vaarama A., 1967, ANN ACAD SCI FENNI A, V108, P1; Van Etten ML, 2008, INT J PLANT SCI, V169, P271, DOI 10.1086/524109; Van Etten ML, 2009, NEW PHYTOL, V183, P649, DOI 10.1111/j.1469-8137.2009.02940.x; Varga S, 2014, PLANT BIOLOGY, V16, P306, DOI 10.1111/plb.12050; Varga S, 2010, FUNCT ECOL, V24, P750, DOI 10.1111/j.1365-2435.2010.01708.x; Varga S, 2009, PLANT ECOL, V202, P325, DOI 10.1007/s11258-008-9492-0; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1	43	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118981	10.1371/journal.pone.0118981	http://dx.doi.org/10.1371/journal.pone.0118981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738943	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000350685900088
J	Zhan, C; Yan, L; Wang, L; Ma, J; Jiang, W; Zhang, YX; Shi, Y; Wang, Q				Zhan, Cheng; Yan, Li; Wang, Lin; Ma, Jun; Jiang, Wei; Zhang, Yongxing; Shi, Yu; Wang, Qun			Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis	PLOS ONE			English	Article							NUCLEAR TRANSLOCATION; POOR-PROGNOSIS; PKM2 EXPRESSION; HIF-1-ALPHA; HEXOKINASE; CARCINOMA; CANCER; OVEREXPRESSION; IDENTIFICATION; PROLIFERATION	Muscle type of pyruvate kinase (PKM) is one of the key mediators of the Warburg effect and tumor metabolism. Due to alternative splicing, there are at least 12 known isoforms of the PKM gene, of which PKM1 and PKM2 are two major isoforms with only a 23 amino acid sequenced difference but quite different characteristics and functions. It was previously thought the isoform switch from PKM1 to PKM2 resulted in high PKM2 expression in tumors, providing a great advantage to tumor cells. However, this traditional view was challenged by two recent studies; one study claimed that this isoform switch does not occur during the Warburg effect; the other study asserted that the isoform switch is tissue-specific. Here, we reanalyzed the RNA sequencing data of 25 types of human tumors from The Cancer Genome Atlas Data Portal, and confirmed that PKM2 was the major isoform in the tumors and was highly elevated in addition to the entire PKM gene. We further demonstrated that the expression level of PKM1 significantly declined even though there was substantially increased expression of the entire PKM gene. The proportion of PKM1 in total transcript variants also significantly declined in tumors but the proportion of PKM2 did not change accordingly. Therefore, we conclude that the isoform switch of PKM1 does indeed occur, but it switches to other isoforms rather than PKM2. Considering the change in the expression levels of PKM1, PKM2 and the entire PKM gene, we propose that the upregulation of PKM2 is primarily due to elevated transcriptional levels of the entire PKM gene, instead of the isoform switch.	[Zhan, Cheng; Wang, Lin; Ma, Jun; Jiang, Wei; Zhang, Yongxing; Shi, Yu; Wang, Qun] Fudan Univ, Dept Thorac Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Yan, Li] Fudan Univ, Dept Radiat Oncol, Eye & ENT Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shi, Y (corresponding author), Fudan Univ, Dept Thorac Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China.	shi.yu@zs-hospital.sh.cn; wang.qun@zs-hospital.sh.cn	Zhan, Cheng/F-3265-2014; wang, lin/HHM-2225-2022; Yan, Li/ABC-8451-2020; wang, lina/HGC-1592-2022	Zhan, Cheng/0000-0001-8745-9276; Yan, Li/0000-0002-0697-7838; Jiang, Wei/0000-0003-0904-3990	National Natural Science Foundation of China [81401875, 81472225]; Natural Science Foundation of Shanghai, China [14ZR1406000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai)	This study was supported by the National Natural Science Foundation of China (Grant Nos. 81401875, 81472225) (http://www.nsfc.gov.cn/) and Natural Science Foundation of Shanghai, China (Grant No. 14ZR1406000) (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluemlein K, 2011, ONCOTARGET, V2, P393; Chen J, 2014, J CANCER RES CLIN, V140, P1205, DOI 10.1007/s00432-014-1644-0; Chen J, 2014, TUMOR BIOL, V35, P3743, DOI 10.1007/s13277-013-1496-2; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dando I, 2013, BBA-MOL CELL RES, V1833, P672, DOI 10.1016/j.bbamcr.2012.10.028; Dang CV, 2008, ERNST SCHERING FOUND, V4, P35, DOI 10.1007/2789_2008_088; Dennison JB, 2013, CLIN CANCER RES, V19, P3703, DOI 10.1158/1078-0432.CCR-13-0623; Desai S, 2013, ONCOTARGET; Diaz-Jullien C, 2011, BBA-PROTEINS PROTEOM, V1814, P355, DOI 10.1016/j.bbapap.2010.10.004; Falkenius J, 2013, MELANOMA RES, V23, P452, DOI 10.1097/CMR.0000000000000027; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Girgis H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-101; Guo Y, 2014, INT J MOL SCI, V15, P7974, DOI 10.3390/ijms15057974; He GD, 2014, ASIA PAC J CLIN NUTR, V23, P174, DOI 10.6133/apjcn.2014.23.1.14; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Hur H, 2013, INT J ONCOL, V42, P44, DOI 10.3892/ijo.2012.1687; Ignacak J, 2003, COMP BIOCHEM PHYS B, V134, P425, DOI 10.1016/S1096-4959(02)00283-X; Kress S, 1998, J CANCER RES CLIN, V124, P315, DOI 10.1007/s004320050175; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2014, CLIN TRANSL ONCOL, V16, P200, DOI 10.1007/s12094-013-1063-8; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Lu HQ, 2013, MOL CANCER THER, V12, P2187, DOI 10.1158/1535-7163.MCT-12-1245; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mamczur P, 2013, BBA-MOL CELL RES, V1833, P2812, DOI 10.1016/j.bbamcr.2013.07.013; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peng SY, 2008, ONCOL REP, V19, P1045; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Puzone R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-97; Saman DM, 2014, DM-DIS MON, V60, P150, DOI 10.1016/j.disamonth.2014.02.003; Sato-Tadano A, 2013, CANCER SCI, V104, P1380, DOI 10.1111/cas.12238; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Song Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-65; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tang ZJ, 2012, J BIOENERG BIOMEMBR, V44, P117, DOI 10.1007/s10863-012-9420-9; Teng YC, 2013, J OBSTET GYNAECOL RE, V39, P317, DOI 10.1111/j.1447-0756.2012.01970.x; Wang DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061262; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yao Y, 2014, TUMOUR BIOL; Yuan C, 2014, HISTOPATHOLOGY; Zhan C, 2013, DIS ESOPHAGUS, V26, P746, DOI 10.1111/dote.12023; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153; Zhang XL, 2013, PATHOL RES PRACT, V209, P510, DOI 10.1016/j.prp.2013.06.005	49	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118663	10.1371/journal.pone.0118663	http://dx.doi.org/10.1371/journal.pone.0118663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738776	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900059
J	Pedraz, M; Martin-Velasco, AI; Garcia-Marchena, N; Araos, P; Serrano, A; Romero-Sanchiz, P; Suarez, J; Castilla-Ortega, E; Barrios, V; Campos-Cloute, R; Ruiz, JJ; Torrens, M; Chowen, JA; Argente, J; de la Torre, R; Santin, LJ; Villanua, MA; de Fonseca, FR; Pavon, FJ				Pedraz, Maria; Isabel Martin-Velasco, Ana; Garcia-Marchena, Nuria; Araos, Pedro; Serrano, Antonia; Romero-Sanchiz, Pablo; Suarez, Juan; Castilla-Ortega, Estela; Barrios, Vicente; Campos-Cloute, Rafael; Jesus Ruiz, Juan; Torrens, Marta; Ann Chowen, Julie; Argente, Jesus; de la Torre, Rafael; Javier Santin, Luis; Angeles Villanua, Maria; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco			Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity	PLOS ONE			English	Article							GROWTH-FACTOR-I; NEUROTROPHIC FACTOR; RESEARCH INTERVIEW; MENTAL-DISORDERS; DSM-5 CRITERIA; BRAIN; INSULIN; DEPRESSION; ALCOHOL; NEUROPLASTICITY	Recent studies have identified biomarkers related to the severity and pathogenesis of cocaine addiction and common comorbid psychiatric disorders. Monitoring these plasma mediators may improve the stratification of cocaine users seeking treatment. Because the neurotrophic factors are involved in neural plasticity, neurogenesis and neuronal survival, we have determined plasma concentrations of brain-derived neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1) and IGF-1 binding protein 3 (IGFBP-3) in a cross-sectional study with abstinent cocaine users who sought outpatient treatment for cocaine (n = 100) and age/body mass matched controls (n = 85). Participants were assessed with the diagnostic interview 'Psychiatric Research Interview for Substance and Mental Disorders'. Plasma concentrations of these peptides were not different in cocaine users and controls. They were not associated with length of abstinence, duration of cocaine use or cocaine symptom severity. The pathological use of cocaine did not influence the association of IGF-1 with age observed in healthy subjects, but the correlation between IGF-1 and IGFBP-3 was not significantly detected. Correlation analyses were performed between these peptides and other molecules sensitive to addiction: BDNF concentrations were not associated with inflammatory mediators, lipid derivatives or IGF-1 in cocaine users, but correlated with chemokines (fractalkine/CX3CL1 and SDF-1/CXCL12) and N-acyl-ethanolamines (N-palmitoyl-, N-oleoyl-, N-arachidonoyl-, N-linoleoyl- and N-dihomo-y-linolenoyl-ethanolamine) in controls; IGF-1 concentrations only showed association with IGFBP-3 concentrations in controls; and IGFBP-3 was only correlated with N-stearoyl-ethanolamine concentrations in cocaine users. Multiple substance use disorders and life-time comorbid psychopathologies were common in abstinent cocaine users. Interestingly, plasma BDNF concentrations were exclusively found to be decreased in users diagnosed with both primary and cocaine-induced disorders for mood and anxiety disorders. In summary, BDNF, IGF-1 and IGFBP-3 were not affected by a history of pathological use of cocaine supported by the absence of associations with other molecules sensitive to cocaine addiction. However, BDNF was affected by comorbid mood disorders. Further research is necessary to elucidate the role of BDNF and IGF-1 in the transition to cocaine addiction and associated psychiatric comorbidity.	[Pedraz, Maria; Garcia-Marchena, Nuria; Araos, Pedro; Serrano, Antonia; Romero-Sanchiz, Pablo; Suarez, Juan; Castilla-Ortega, Estela; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [Isabel Martin-Velasco, Ana; Angeles Villanua, Maria] Univ Complutense Madrid, Fac Med, Dept Physiol, Madrid, Spain; [Barrios, Vicente; Ann Chowen, Julie; Argente, Jesus] Hosp Infantil Univ Nino Jesus, Inst Invest La Princesa, Dept Pediat & Pediat Endocrinol, Madrid, Spain; [Barrios, Vicente; Ann Chowen, Julie; Argente, Jesus] Univ Autonoma Madrid, Dept Pediat, Madrid, Spain; [Barrios, Vicente; Ann Chowen, Julie; Argente, Jesus; de la Torre, Rafael; Rodriguez de Fonseca, Fernando] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Campos-Cloute, Rafael] Ctr Tratamiento Ambulatorio Mijas Costa Diputac M, Mijas, Spain; [Jesus Ruiz, Juan] Ctr Prov Drogodependencia Diputac Malaga, Malaga, Spain; [Torrens, Marta; de la Torre, Rafael] Inst Hosp Mar Invest Med IMIM, Neurosci Program, Barcelona, Spain; [Torrens, Marta] Inst Neuropsiquiatria & Addicc INAD Parc Salut MA, Barcelona, Spain; [Torrens, Marta] Univ Autonoma Barcelona UAB, Dept Psychiat, Barcelona, Spain; [de la Torre, Rafael] Univ Pompeu Fabra CEXS UPF, Fac Ciencies Salut & Vida, Barcelona, Spain; [Javier Santin, Luis] Univ Malaga, Fac Psicol, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain	Universidad de Malaga; Complutense University of Madrid; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Pompeu Fabra University; Universidad de Malaga	de Fonseca, FR (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain.	fernando.rodriguez@ibima.eu; javier.pavon@ibima.eu	Castilla-Ortega, Estela/K-2811-2015; Santin, Luis Javier LJ/G-4364-2011; Argente, Jesús/M-5226-2019; Chowen, Julie/C-8979-2011; Pavón Morón, Francisco Javier/AAG-9721-2020; de la Torre, Rafael/D-3561-2018; Suarez, Juan/I-5188-2015; Sabador, Vicente Barrios/N-6982-2016; Romero-Sanchiz, Pablo/B-8454-2011; Martín, Ana Isabel/K-5301-2014; GÓMEZ, PEDRO FERNANDO ARAOS/AAX-1715-2021; Santin, Luis Javier/G-4364-2011	Castilla-Ortega, Estela/0000-0002-4496-1167; Santin, Luis Javier LJ/0000-0003-0894-8536; Argente, Jesús/0000-0001-5826-0276; Chowen, Julie/0000-0002-4770-2291; Pavón Morón, Francisco Javier/0000-0002-5256-8904; de la Torre, Rafael/0000-0002-6765-1866; Suarez, Juan/0000-0001-5254-9802; Sabador, Vicente Barrios/0000-0002-5507-7545; Romero-Sanchiz, Pablo/0000-0002-3683-3835; Martín, Ana Isabel/0000-0002-4445-590X; GÓMEZ, PEDRO FERNANDO ARAOS/0000-0001-5172-8796; Pedraz, Maria/0000-0002-1923-6692; Santin, Luis Javier/0000-0003-1755-6497; Serrano, Antonia/0000-0002-8017-9754; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795	Institut de Salud Carlos III (ISC-III); Red de Trastornos Adictivos UE-FEDER [RD12/0028]; Ministerio de Economia y Competitividad [PI13/02261]; Plan Nacional sobre Drogas [049/2009, 049/2013]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia UE-FEDER [CTS-433]; Consejeria de Salud y Bienestar Social, Junta Andalucia [PI0228-2013, PI0823-2012]; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014-SGR-680]; ISC-III [CP12/03109, CP14/00173, CP14/00212]	Institut de Salud Carlos III (ISC-III)(Instituto de Salud Carlos III); Red de Trastornos Adictivos UE-FEDER; Ministerio de Economia y Competitividad(Spanish Government); Plan Nacional sobre Drogas; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia UE-FEDER; Consejeria de Salud y Bienestar Social, Junta Andalucia; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya(Generalitat de Catalunya); ISC-III(Instituto de Salud Carlos III)	The present study has been supported by Institut de Salud Carlos III (ISC-III), Red de Trastornos Adictivos UE-FEDER 2012 (RD12/0028); Ministerio de Economia y Competitividad (PI13/02261); Plan Nacional sobre Drogas 049/2009 and 049/2013; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia UE-FEDER (CTS-433); Consejeria de Salud y Bienestar Social, Junta Andalucia (PI0228-2013 and PI0823-2012); Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya (2014-SGR-680). JS, AS and FJP hold a "Miguel Servet" research contract from ISC-III (CP12/03109, CP14/00173 and CP14/ 00212, respectively). PR-S holds a "Rio Hortega" research contract from ISC-III (CM13/0115). EC-O holds a "Sara Borrell" research contract from ISC-III (CD 12/00455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Araos P, 2015, ADDICT BIOL, V20, P756, DOI 10.1111/adb.12156; Araos P, 2014, ADICCIONES, V26, P15, DOI 10.20882/adicciones.124; Bao Q, 2014, MOL CELL ENDOCRINOL, V394, P115, DOI 10.1016/j.mce.2014.07.005; BEITNERJOHNSON D, 1993, ANN NY ACAD SCI, V692, P246; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Castren E, 2004, MOL NEUROBIOL, V29, P289, DOI 10.1385/MN:29:3:289; Corominas-Roso M, 2013, NEUROPSYCHOBIOLOGY, V68, P146, DOI 10.1159/000353259; Corominas-Roso M, 2013, EUR NEUROPSYCHOPHARM, V23, P1078, DOI 10.1016/j.euroneuro.2012.08.016; Corominas-Roso M, 2013, INT J NEUROPSYCHOPH, V16, P1267, DOI 10.1017/S1461145712001629; D'Sa C, 2011, BIOL PSYCHIAT, V70, P706, DOI 10.1016/j.biopsych.2011.05.013; Deuschle M, 1997, PSYCHONEUROENDOCRINO, V22, P493, DOI 10.1016/S0306-4530(97)00046-2; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Domenici Enrico, 2007, Expert Opin Med Diagn, V1, P235, DOI 10.1517/17530059.1.2.235; Garcia-Valdecasas-Campelo E, 2007, ALCOHOL ALCOHOLISM, V42, P533, DOI 10.1093/alcalc/agm065; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Haile CN, 2012, PHARMACOL THERAPEUT, V134, P260, DOI 10.1016/j.pharmthera.2012.01.010; Hall K., 1999, Journal of Endocrinological Investigation, V22, P48; Han C, 2014, ALCOHOL ALCOHOL S1, V49, pi49; Hashiguchi Y, 1996, BRAIN RES BULL, V40, P99, DOI 10.1016/0361-9230(96)00045-7; Hasin D, 2006, AM J PSYCHIAT, V163, P689, DOI 10.1176/appi.ajp.163.4.689; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Hasin DS, 2012, DRUG ALCOHOL DEPEN, V122, P28, DOI 10.1016/j.drugalcdep.2011.09.005; Hasin DS, 1996, AM J PSYCHIAT, V153, P1195; Herrero MJ, 2008, ADDICTION, V103, P284, DOI 10.1111/j.1360-0443.2007.02076.x; Pavon FJ, 2013, ADDICT BIOL, V18, P955, DOI 10.1111/adb.12107; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kenna HA, 2014, J AFFECT DISORDERS, V156, P214, DOI 10.1016/j.jad.2013.01.054; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P78, DOI 10.1016/j.pnpbp.2006.06.024; Leggio L, 2008, ALCOHOL CLIN EXP RES, V32, P450, DOI 10.1111/j.1530-0277.2007.00589.x; Lin F, 2014, PSYCHONEUROENDOCRINO, V42, P118, DOI 10.1016/j.psyneuen.2014.01.006; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Malberg JE, 2007, NEUROPSYCHOPHARMACOL, V32, P2360, DOI 10.1038/sj.npp.1301358; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Molle RD, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.126; Morgello S, 2006, INT J METH PSYCH RES, V15, P131, DOI 10.1002/mpr.189; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Piccinni A, 2008, J AFFECT DISORDERS, V105, P279, DOI 10.1016/j.jad.2007.05.005; Reece AS, 2013, NEUROENDOCRINOL LETT, V34, P18; Rivera P, 2013, EUR J NEUROSCI, V37, P105, DOI 10.1111/ejn.12012; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rosa A R, 2014, Psychol Med, V44, P2409, DOI 10.1017/S0033291714000014; Sinha R, 2011, CURR PSYCHIAT REP, V13, P398, DOI 10.1007/s11920-011-0224-0; Sordi AO, 2014, PSYCHOPHARMACOLOGY, V231, P4031, DOI 10.1007/s00213-014-3542-1; Stouthart PJHM, 2003, PSYCHONEUROENDOCRINO, V28, P612, DOI 10.1016/S0306-4530(02)00045-8; Suliman S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00055; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231; Torrens M, 2006, NEUROTOX RES, V10, P253, DOI 10.1007/BF03033361; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Trueba-Saiz A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.102; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Viola TW, 2014, J PSYCHIATR NEUROSCI, V39, P206, DOI 10.1503/jpn.130027; von Diemen L, 2014, INT J NEUROPSYCHOPH, V17, P33, DOI 10.1017/S146114571300103X	58	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118610	10.1371/journal.pone.0118610	http://dx.doi.org/10.1371/journal.pone.0118610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734326	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700039
J	Hazaymeh, K; Hassan, QK				Hazaymeh, Khaled; Hassan, Quazi K.			Fusion of MODIS and Landsat-8 Surface Temperature Images: A New Approach	PLOS ONE			English	Article							REFLECTANCE; RESOLUTION; MODEL; PRODUCTS	Here, our objective was to develop a spatio-temporal image fusion model (STI-FM) for enhancing temporal resolution of Landsat-8 land surface temperature (LST) images by fusing LST images acquired by the Moderate Resolution Imaging Spectroradiometer (MODIS); and implement the developed algorithm over a heterogeneous semi-arid study area in Jordan, Middle East. The STI-FM technique consisted of two major components: (i) establishing a linear relationship between two consecutive MODIS 8-day composite LST images acquired at time 1 and time 2; and (ii) utilizing the above mentioned relationship as a function of a Landsat-8 LST image acquired at time 1 in order to predict a synthetic Landsat-8 LST image at time 2. It revealed that strong linear relationships (i.e., r(2), slopes, and intercepts were in the range 0.93-0.94, 0.94-0.99; and 2.97-20.07) existed between the two consecutive MODIS LST images. We evaluated the synthetic LST images qualitatively and found high visual agreements with the actual Landsat-8 LST images. In addition, we conducted quantitative evaluations of these synthetic images; and found strong agreements with the actual Landsat-8 LST images. For example, r(2), root mean square error (RMSE), and absolute average difference (AAD)-values were in the ranges 084-0.90, 0.061-0.080, and 0.003-0.004, respectively.	[Hazaymeh, Khaled; Hassan, Quazi K.] Univ Calgary, Schulich Sch Engn, Dept Geomat Engn, Calgary, AB, Canada	University of Calgary	Hassan, QK (corresponding author), Univ Calgary, Schulich Sch Engn, Dept Geomat Engn, 2500 Univ Dr NW, Calgary, AB, Canada.	qhassan@ucalgary.ca		Hazaymeh, Khaled/0000-0002-2162-7385; Hassan, Quazi K./0000-0002-7034-359X	Yarmouk University - Jordan; National Sciences and Engineering Research Council (NSERC) - Canada	Yarmouk University - Jordan; National Sciences and Engineering Research Council (NSERC) - Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The funders or sources of support include Yarmouk University - Jordan, and the National Sciences and Engineering Research Council (NSERC) - Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akther MS, 2011, BOREAL ENVIRON RES, V16, P407; Anderson MC, 2011, HYDROL EARTH SYST SC, V15, P223, DOI 10.5194/hess-15-223-2011; Anyamba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092538; Cammalleri C, 2013, WATER RESOUR RES, V49, P4672, DOI 10.1002/wrcr.20349; Chowdhury EH, 2013, NAT HAZARDS, V67, P321, DOI 10.1007/s11069-013-0564-7; Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882; Feng M, 2013, REMOTE SENS ENVIRON, V134, P276, DOI 10.1016/j.rse.2013.02.031; Feng M, 2012, COMPUT GEOSCI-UK, V38, P9, DOI 10.1016/j.cageo.2011.04.011; Fu DJ, 2013, REMOTE SENS-BASEL, V5, P6346, DOI 10.3390/rs5126346; Gao F, 2006, IEEE T GEOSCI REMOTE, V44, P2207, DOI 10.1109/TGRS.2006.872081; Hassan QK, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2740040; Hassan QK, 2013, J PLANT ECOL, V6, P84, DOI 10.1093/jpe/rts010; Huang B, 2013, IEEE GEOSCI REMOTE S, V10, P1011, DOI 10.1109/LGRS.2012.2227930; JME (Jordan Ministry of Environment), 2006, NAT STRAT ACT PLAN C; Kerr YH, 2004, THERMAL REMOTE SENSING IN LAND SURFACE PROCESSES, P33; Kim J, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063569; Li YY, 2012, INT J APPL EARTH OBS, V19, P127, DOI 10.1016/j.jag.2012.05.001; Li ZL, 2013, REMOTE SENS ENVIRON, V131, P14, DOI 10.1016/j.rse.2012.12.008; Liu H, 2012, REMOTE SENS ENVIRON, V117, P57, DOI 10.1016/j.rse.2011.06.023; Mildrexler DJ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001486; Moran MS, 2004, THERMAL REMOTE SENSING IN LAND SURFACE PROCESSES, P257; Oguro Y., 2011, Applied and Environmental Soil Science, V2011, P948135, DOI 10.1155/2011/948135; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3112, DOI 10.1016/j.rse.2008.03.009; Shen HF, 2013, INT J REMOTE SENS, V34, P4367, DOI 10.1080/01431161.2013.777488; Tang RL, 2010, REMOTE SENS ENVIRON, V114, P540, DOI 10.1016/j.rse.2009.10.012; USGS, 2013, US USGS LANDS 8 PROD; USGS (U.S. Geological Survey), 2014, LANDS 8 L8 OP LAND I; Vermote E.F., 2011, MODIS SURFACE REFLEC; Walker JJ, 2012, REMOTE SENS ENVIRON, V117, P381, DOI 10.1016/j.rse.2011.10.014; Wan Z, 2004, INT J REMOTE SENS, V25, P261, DOI 10.1080/0143116031000116417; Wan Z., 2013, MODIS LAND SURFACE T; Weng QH, 2014, REMOTE SENS ENVIRON, V145, P55, DOI 10.1016/j.rse.2014.02.003; Wu PH, 2013, INT J DIGIT EARTH, V6, P113, DOI 10.1080/17538947.2013.783131; Yu Y, 2008, IEEE T GEOSCI REMOTE, V46, P179, DOI 10.1109/TGRS.2007.909097; Zhang W, 2013, REMOTE SENS-BASEL, V5, P5346, DOI 10.3390/rs5105346; Zhao SH, 2009, J EARTH SYST SCI, V118, P345, DOI 10.1007/s12040-009-0027-4; Zhu XL, 2010, REMOTE SENS ENVIRON, V114, P2610, DOI 10.1016/j.rse.2010.05.032	37	25	25	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117755	10.1371/journal.pone.0117755	http://dx.doi.org/10.1371/journal.pone.0117755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730279	Green Published, Green Submitted, gold			2022-12-26	WOS:000350684900014
J	Lu, QH; Adler, PN				Lu, Qiuheng; Adler, Paul N.			The diaphanous Gene of Drosophila Interacts Antagonistically with multiple wing hairs and Plays a Key Role in Wing Hair Morphogenesis	PLOS ONE			English	Article							PLANAR CELL POLARITY; ORGAN PRECURSOR CELL; TISSUE POLARITY; F-ACTIN; DUSKY-LIKE; PROTEIN; FORMIN; FAT; BRISTLES; ENCODES	The Drosophila wing is covered by an array of distally pointing hairs that has served as a key model system for studying planar cell polarity (PCP). The adult cuticular hairs are formed in the pupae from cell extensions that contain extensive actin filaments and microtubules. The importance of the actin cytoskeleton for hair growth and morphogenesis is clear from the wide range of phenotypes seen in mutations in well-known actin regulators. Formin proteins promote the formation of long actin filaments of the sort thought to be important for hair growth. We report here that the formin encoding diaphanous (dia) gene plays a key role in hair morphogenesis. Both loss of function mutations and the expression of a constitutively active Dia led to cells forming both morphologically abnormal hairs and multiple hairs. The conserved frizzled (fz)/starry night (stan) PCP pathway functions to restrict hair initiation and activation of the cytoskeleton to the distal most part of wing cells. It also ensures the formation of a single hair per cell. Our data suggest that the localized inhibition of Dia activity may be part of this mechanism. We found the expression of constitutively active Dia greatly expands the region for activation of the cytoskeleton and that dia functions antagonistically with multiple wing hairs (mwh), the most downstream member of the fz/stan pathway. Further we established that purified fragments of Dia and Mwh could be co-immunoprecipitated suggesting the genetic interaction could reflect a direct physical interaction.	[Lu, Qiuheng; Adler, Paul N.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Adler, Paul N.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Adler, PN (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	pna@virginia.edu			National Institutes of Health [GM037163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health, GM037163 to PNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2013, DEV BIOL, V379, P76, DOI 10.1016/j.ydbio.2013.04.012; Adler PN, 2012, CURR TOP DEV BIOL, V101, P1, DOI 10.1016/B978-0-12-394592-1.00001-6; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Adler PN, 1998, DEVELOPMENT, V125, P959; Adler PN, 2000, GENESIS, V28, P82, DOI 10.1002/1526-968X(200010)28:2<82::AID-GENE60>3.0.CO;2-Z; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Axelrod JD, 2001, GENE DEV, V15, P1182; Bitan A, 2012, DEVELOPMENT, V139, P1987, DOI 10.1242/dev.076893; Blair A, 2006, DEVELOPMENT, V133, P1789, DOI 10.1242/dev.02320; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRYANT PJ, 1988, DEV BIOL, V128, P386, DOI 10.1016/0012-1606(88)90300-4; CANT K, 1994, J CELL BIOL, V125, P369, DOI 10.1083/jcb.125.2.369; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Dickinson WJ, 1997, CELL MOTIL CYTOSKEL, V38, P9; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Fei XY, 2002, J CELL SCI, V115, P3797, DOI 10.1242/jcs.00065; Franke JD, 2010, DEV BIOL, V345, P117, DOI 10.1016/j.ydbio.2010.06.028; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; Gomes JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004485; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guild GM, 2005, MOL BIOL CELL, V16, P3620, DOI 10.1091/mbc.E05-03-0185; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harumoto T, 2010, DEV CELL, V19, P389, DOI 10.1016/j.devcel.2010.08.004; He B, 2001, MECH DEVELOP, V104, P69, DOI 10.1016/S0925-4773(01)00368-9; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Johnston CA, 2013, J CELL SCI, V126, P4436, DOI 10.1242/jcs.129544; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; Kiehart DP, 1989, EMBO J, V8; Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Kuhn S, 2014, SMALL GTPASES, P5; Lawrence PA, 2008, NAT CELL BIOL, V10, P1379, DOI 10.1038/ncb1208-1379; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Matis M, 2014, ELIFE, V3, DOI 10.7554/eLife.02893; Matis M, 2013, GENE DEV, V27, P2207, DOI 10.1101/gad.228098.113; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nagaraj R, 2012, DEVELOPMENT, V139, P906, DOI 10.1242/dev.074252; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; PARKHURST SM, 1985, CELL, V41, P429, DOI 10.1016/S0092-8674(85)80016-7; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; PETERSEN NS, 1994, GENETICS, V136, P173; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Ren N, 2006, GENETICS, V172, P1643, DOI 10.1534/genetics.105.051433; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Sharma P, 2013, PROG MOL BIOL TRANSL, V116, P215, DOI 10.1016/B978-0-12-394311-8.00010-8; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; WILLIAMS JA, 1988, EMBO J, V7, P1355, DOI 10.1002/j.1460-2075.1988.tb02951.x; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; Yan J, 2009, DEV BIOL, V333, P186, DOI 10.1016/j.ydbio.2009.06.027; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	73	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115623	10.1371/journal.pone.0115623	http://dx.doi.org/10.1371/journal.pone.0115623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730111	gold, Green Published, Green Submitted			2022-12-26	WOS:000350684900006
J	Liu, NA; Sun, JY; Kono, K; Horikoshi, Y; Ikura, T; Tong, X; Haraguchi, T; Tashiro, S				Liu, Ning-Ang; Sun, Jiying; Kono, Kazuteru; Horikoshi, Yasunori; Ikura, Tsuyoshi; Tong, Xing; Haraguchi, Tokuko; Tashiro, Satoshi			Regulation of homologous recombinational repair by lamin B1 in radiation-induced DNA damage	FASEB JOURNAL			English	Article						B-type lamins; nuclear envelope; progeria syndrome; RAD51; recombinational DNA repair	STRAND BREAK REPAIR; A-TYPE LAMINS; RAD51 GENE; CELL-CYCLE; DEFECTIVE MATURATION; NUCLEAR LAMINS; EXPRESSION; PROGERIA; PROTEIN; ORGANIZATION	DNA double-strand breaks (DSBs) are the major lethal lesion induced by ionizing radiation (IR). RAD51-dependent homologous recombination (HR) is one of the most important pathways in DSB repair and genome integrity maintenance. However, the mechanism of HR regulation by RAD51 remains unclear. To understand the mechanism of RAD51-dependent HR, we searched for interacting partners of RAD51 by a proteomics analysis and identified lamin B1 in human cells. Lamins are nuclear lamina proteins that play important roles in the structural organization of the nucleus and the regulation of chromosome functions. Immunoblotting analyses revealed that siRNA-mediated lamin B1 depletion repressed the DNA damage-dependent increase of RAD51 after IR. The repression was abolished by the proteasome inhibitor MG132, suggesting that lamin B1 stabilizes RAD51 by preventing proteasome-mediated degradation in cells with IR-induced DNA damage. We also showed that lamin B1 depletion repressed RAD51 focus formation and decreased the survival rates after IR. On the basis of these results, we propose that lamin B1 promotes DSB repair and cell survival by maintaining the RAD51 protein levels for HR upon DSB induction after IR.	[Liu, Ning-Ang; Sun, Jiying; Kono, Kazuteru; Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima, Hiroshima 7348553, Japan; [Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam RcMcD, Hiroshima, Hiroshima 7348553, Japan; [Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Dept Mutagenesis, Lab Chromatin Dynam, Kyoto, Japan; [Tong, Xing] Soochow Univ, Coll Med, Lab Ctr, Suzhou, Peoples R China; [Haraguchi, Tokuko] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo, Japan	Hiroshima University; Hiroshima University; Kyoto University; Soochow University - China; National Institute of Information & Communications Technology (NICT) - Japan	Tashiro, S (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Minami Ku, Kasumi 1-2-3, Hiroshima, Hiroshima 7348553, Japan.	ktashiro@hiroshima-u.ac.jp	Horikoshi, Yasunori/G-8988-2019; Liu, Ning-Ang/GLN-4757-2022		Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank M. Jasin, J. Kobayashi, and K. Komatsu for providing the U2OS-DRGFP cells and are grateful to K. Fujioka for technical assistance with the SCE assay. This work was supported by Grants-in-Aid and the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Atwell S, 2012, NUCLEIC ACIDS RES, V40, P11769, DOI 10.1093/nar/gks1131; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Butin-Israeli V., 2014, MOL CELL BIOL; Butin-Israeli V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069169; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Constantinescu D, 2010, EXP CELL RES, V316, P2747, DOI 10.1016/j.yexcr.2010.05.015; Daboussi F, 2002, CELL SIGNAL, V14, P969, DOI 10.1016/S0898-6568(02)00052-9; De Vos WH, 2010, BBA-GEN SUBJECTS, V1800, P448, DOI 10.1016/j.bbagen.2010.01.002; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dreesen O, 2013, NUCLEUS-AUSTIN, V4, P283, DOI 10.4161/nucl.25808; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Du LQ, 2011, MED ONCOL, V28, P1481, DOI 10.1007/s12032-010-9605-1; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Fojo T, 2001, J NATL CANCER I, V93, P1434, DOI 10.1093/jnci/93.19.1434; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gonzalo S, 2014, ADV EXP MED BIOL, V773, P377, DOI 10.1007/978-1-4899-8032-8_17; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Hosoya N, 2012, EMBO REP, V13, P44, DOI 10.1038/embor.2011.221; Huang S, 2008, EXP CELL RES, V314, P82, DOI 10.1016/j.yexcr.2007.08.004; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kobayashi J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-34; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nishibuchi I, 2014, INT J RADIAT ONCOL, V89, P736, DOI 10.1016/j.ijrobp.2014.03.031; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierce Andrew J, 2005, Methods Mol Biol, V291, P373; Raderschall E, 2002, CANCER RES, V62, P219; Redwood AB, 2011, CELL CYCLE, V10, P3652, DOI 10.4161/cc.10.21.18201; Redwood AB, 2011, CELL CYCLE, V10, P2549, DOI 10.4161/cc.10.15.16531; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; ROBER RA, 1989, DEVELOPMENT, V105, P365; Russell JS, 2003, CANCER RES, V63, P7377; Sakogawa K, 2013, CANCER SCI, V104, P1593, DOI 10.1111/cas.12281; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shi L, 2012, RADIAT RES, V177, P533, DOI 10.1667/RR2849.1; Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yamamoto A, 1996, MOL GEN GENET, V251, P1	69	17	18	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2514	2525		10.1096/fj.14-265546	http://dx.doi.org/10.1096/fj.14-265546			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25733566	Green Submitted			2022-12-26	WOS:000355209500028
J	Choi, JY; Duraisingh, MT; Marti, M; Ben Mamoun, C; Voelker, DR				Choi, Jae-Yeon; Duraisingh, Manoj T.; Marti, Matthias; Ben Mamoun, Choukri; Voelker, Dennis R.			From Protease to Decarboxylase THE MOLECULAR METAMORPHOSIS OF PHOSPHATIDYLSERINE DECARBOXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PHOSPHATIDYLETHANOLAMINE; GENE; IDENTIFICATION; MECHANISM; MUTANTS; YEAST; ACID	Phosphatidylserine decarboxylase (PSDs) play a central role in the synthesis of phosphatidylethanolamine in numerous species of prokaryotes and eukaryotes. PSDs are unusual decarboxylase containing a pyruvoyl prosthetic group within the active site. The covalently attached pyruvoyl moiety is formed in a concerted reaction when the PSD proenzyme undergoes an endoproteolytic cleavage into a large beta-subunit, and a smaller alpha-subunit, which harbors the prosthetic group at its N terminus. The mechanism of PSD proenzyme cleavage has long been unclear. Using a coupled in vitro transcription/translation system with the soluble Plasmodium knowlesi enzyme (PkPSD), we demonstrate that the post-translational processing is inhibited by the serine protease inhibitor, phenylmethylsulfonyl fluoride. Comparison of PSD sequences across multiple phyla reveals a uniquely conserved aspartic acid within an FFXRX6RX12PXD motif, two uniquely conserved histidine residues within a PXXYHXXHXP motif, and a uniquely conserved serine residue within a GS(S/T) motif, suggesting that PSDs belong to the D-H-S serine protease family. The function of the conserved D-H-S residues was probed using site-directed mutagenesis of PkPSD. The results from these mutagenesis experiments reveal that Asp-139, His-198, and Ser-308 are all essential for endoproteolytic processing of PkPSD, which occurs in cis. In addition, within the GS(S/T) motif found in all PSDs, the Gly-307 residue is also essential, but the Ser/Thr-309 is non-essential. These results define the mechanism whereby PSDs begin their biochemical existence as proteases that execute one autoendoproteolytic cleavage reaction to give rise to a mature PSD harboring a pyruvoyl prosthetic group.	[Choi, Jae-Yeon; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Basic Sci Sect, Denver, CO 80206 USA; [Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Duraisingh, Manoj T.; Marti, Matthias] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	National Jewish Health; Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Voelker, DR (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org			National Institutes of Health [GM104485, AI097218, AI09486]; Bill and Melinda Gates Foundation [OPP1086229, OPP1069779, 1021571]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM104485 (to D.R.V) and AI097218 and AI09486 and Bill and Melinda Gates Foundation Grants OPP1086229, OPP1069779, and 1021571 (to C.B.M.).	Bale S, 2010, AMINO ACIDS, V38, P451, DOI 10.1007/s00726-009-0404-y; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; de Villiers J, 2010, CHEM-EUR J, V16, P10030, DOI 10.1002/chem.201000622; DOWHAN W, 1992, METHOD ENZYMOL, V209, P348; DOWHAN W, 1992, METHOD ENZYMOL, V209, P287; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kuge O, 1996, BIOCHEM J, V319, P33, DOI 10.1042/bj3190033; LI QX, 1988, J BIOL CHEM, V263, P11516; LI QX, 1990, J BIOL CHEM, V265, P4111; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; SATRE M, 1978, J BIOL CHEM, V253, P479; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; VANPOELJE PD, 1990, ANNU REV BIOCHEM, V59, P29, DOI 10.1146/annurev.bi.59.070190.000333; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X	30	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10972	10980		10.1074/jbc.M115.642413	http://dx.doi.org/10.1074/jbc.M115.642413			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25724650	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000353404500034
J	Anthony, SM; Howard, ME; Hailemichael, Y; Overwijk, WW; Schluns, KS				Anthony, Scott M.; Howard, Megan E.; Hailemichael, Yared; Overwijk, Willem W.; Schluns, Kimberly S.			Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways	PLOS ONE			English	Article							DENDRITIC CELLS; IL-15 EXPRESSION; ANTITUMOR-ACTIVITY; CUTTING EDGE; NK CELLS; ALPHA; TRANS; HOMEOSTASIS; INDUCTION; RECEPTOR	Interleukin (IL)-15 associates with IL-15R alpha on the cell surface where it can be cleaved into soluble cytokine/receptor complexes that have the potential to stimulate CD8 T cells and NK cells. Unfortunately, little is known about the in vivo production of soluble IL-15R alpha/IL-15 complexes (sIL-15 complexes), particularly regarding the circumstances that induce them and the mechanisms responsible. The main objective of this study was to elucidate the signals leading to the generation of sIL-15 complexes. In this study, we show that sIL-15 complexes are increased in the serum of mice in response to Interferon (IFN)-alpha. In bone marrow derived dendritic cells (BMDC), IFN-alpha increased the activity of ADAM17, a metalloproteinase implicated in cleaving IL-15 complexes from the cell surface. Moreover, knocking out ADAM17 in BMDCs prevented the ability of IFN-alpha to induce sIL-15 complexes demonstrating ADAM17 as a critical protease mediating cleavage of IL-15 complexes in response to type I IFNs. Type I IFN signaling was required for generating sIL-15 complexes as in vivo induction of sIL-15 complexes by Poly I:C stimulation or total body irradiation (TBI) was impaired in IFNAR-/- mice. Interestingly, serum sIL-15 complexes were also induced in mice infected with Vesicular stomatitis virus (VSV) or mice treated with agonistic CD40 antibodies; however, sIL-15 complexes were still induced in IFNAR-/- mice after VSV infection or CD40 stimulation indicating pathways other than type I IFNs induce sIL-15 complexes. Overall, this study has shown that type I IFNs, VSV infection, and CD40 stimulation induce sIL-15 complexes suggesting the generation of sIL-15 complexes is a common event associated with immune activation. These findings reveal an unrealized mechanism for enhanced immune responses occurring during infection, vaccination, inflammation, and autoimmunity.	[Anthony, Scott M.; Howard, Megan E.; Schluns, Kimberly S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Anthony, Scott M.; Overwijk, Willem W.; Schluns, Kimberly S.] Univ Texas Houston, Grad Sch Biomed Sci, Grad Program Immunol, Houston, TX 77025 USA; [Hailemichael, Yared; Overwijk, Willem W.] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Schluns, KS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	kschluns@mdanderson.org	Schluns, Kimberly/R-5635-2019	Anthony, Scott/0000-0002-1590-7401	National Institutes of Health (NIH) [CA009598]; NIH [R01 CA143077]; MD Anderson Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009598, P30CA016672, R01CA143077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health (NIH) training grant CA009598 (to SMA), NIH R01 CA143077 (to WWO) and by the MD Anderson Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center (to KSS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bamford RN, 1998, J IMMUNOL, V160, P4418; Bamford RN, 1996, J LEUKOCYTE BIOL, V59, P476, DOI 10.1002/jlb.59.4.476; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Colpitts SL, 2013, J IMMUNOL, V191, P3017, DOI 10.4049/jimmunol.1301389; Colpitts SL, 2012, J IMMUNOL, V188, P2483, DOI 10.4049/jimmunol.1103609; Doherty TM, 1996, J IMMUNOL, V156, P735; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois SP, 2005, P NATL ACAD SCI USA, V102, P8662, DOI 10.1073/pnas.0503360102; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khawam K, 2009, CANCER RES, V69, P1561, DOI 10.1158/0008-5472.CAN-08-3198; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Mitani A, 1999, IMMUNOLOGY, V97, P92; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Nestle FO, 2005, J INVEST DERMATOL, V125, pXIV, DOI 10.1111/j.0022-202X.2005.23923.x; Nishimura H, 2000, J EXP MED, V191, P157, DOI 10.1084/jem.191.1.157; Nishimura H, 1996, J IMMUNOL, V156, P663; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sakai T, 1998, GASTROENTEROLOGY, V114, P1237, DOI 10.1016/S0016-5085(98)70430-5; Sandau MM, 2007, J IMMUNOL, V179, P120, DOI 10.4049/jimmunol.179.1.120; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sikora AG, 2009, J IMMUNOL, V182, P7398, DOI 10.4049/jimmunol.0802982; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Stonier SW, 2008, BLOOD, V112, P4546, DOI 10.1182/blood-2008-05-156307; Tamzalit F, 2014, P NATL ACAD SCI USA, V111, P8565, DOI 10.1073/pnas.1405514111; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Verbist KC, 2011, J IMMUNOL, V186, P174, DOI 10.4049/jimmunol.1002613; Villadsen LS, 2003, J CLIN INVEST, V112, P1571, DOI 10.1172/JCI200318986; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Zhang ML, 2012, J IMMUNOL, V188, P6156, DOI 10.4049/jimmunol.1102604; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	46	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120274	10.1371/journal.pone.0120274	http://dx.doi.org/10.1371/journal.pone.0120274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756182	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700063
J	Boe, AE; Eren, M; Morales-Nebreda, L; Murphy, SB; Budinger, GRS; Mutlu, GM; Miyata, T; Vaughan, DE				Boe, Amanda E.; Eren, Mesut; Morales-Nebreda, Luisa; Murphy, Sheila B.; Budinger, G. R. Scott; Mutlu, Goekhan M.; Miyata, Toshio; Vaughan, Douglas E.			Nitric Oxide Prevents Alveolar Senescence and Emphysema in a Mouse Model	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR SYSTEM; SMOKE-INDUCED EMPHYSEMA; PULMONARY-EMPHYSEMA; OXIDATIVE STRESS; SYNTHASE; HYPERTENSION; INHIBITION; MICE; EXPRESSION; GROWTH	N-omega-nitro-L-arginine methyl ester (L-NAME) treatment induces arteriosclerosis and vascular senescence. Here, we report that the systemic inhibition of nitric oxide (NO) production by L-NAME causes pulmonary emphysema. L-NAME-treated lungs exhibited both the structural (alveolar tissue destruction) and functional (increased compliance and reduced elastance) characteristics of emphysema development. Furthermore, we found that L-NAME-induced emphysema could be attenuated through both genetic deficiency and pharmacological inhibition of plasminogen activator inhibitor-1 (PAI-1). Because PAI-1 is an important contributor to the development of senescence both in vitro and in vivo, we investigated whether L-NAME-induced senescence led to the observed emphysematous changes. We found that L-NAME treatment was associated with molecular and cellular evidence of premature senescence in mice, and that PAI-1 inhibition attenuated these increases. These findings indicate that NO serves to protect and defend lung tissue from physiological aging.	[Boe, Amanda E.; Eren, Mesut; Morales-Nebreda, Luisa; Murphy, Sheila B.; Budinger, G. R. Scott; Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Boe, Amanda E.; Murphy, Sheila B.; Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Mutlu, Goekhan M.] Univ Chicago, Dept Med, Pulm & Crit Care Sect, Chicago, IL 60637 USA; [Miyata, Toshio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Sendai, Miyagi 980, Japan	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago; Tohoku University	Vaughan, DE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	d-vaughan@northwestern.edu	Mutlu, Gokhan/HIR-2545-2022; Miyata, Toshio/A-4872-2010; Eren, Mesut/J-3818-2016	Morales-Nebreda, Luisa/0000-0002-7126-0518	National Institutes of Health [1P01HL108795-01, R01HL051387]; Northwestern University's Center for Advanced Microscopy; Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108795, R01HL051387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University's Center for Advanced Microscopy; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants 1P01HL108795-01 and R01HL051387, both awarded to DEV by the National Institutes of Health (www.nih.gov). This work was also supported by Northwestern University's Center for Advanced Microscopy and a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera JA, 2001, AM J RESP CRIT CARE, V164, P709, DOI 10.1164/ajrccm.164.4.2101023; Boe AE, 2013, CIRCULATION; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ferrer E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-76; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Ito H, 2013, SURG TODAY, V43, P293, DOI 10.1007/s00595-012-0293-7; Kaikita K, 2002, J MOL CELL CARDIOL, V34, P617, DOI 10.1006/jmcc.2002.2001; Kaikita K, 2001, CIRCULATION, V104, P839, DOI 10.1161/hc3301.092803; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Lanzetti M, 2012, FREE RADICAL BIO MED, V53, P1993, DOI 10.1016/j.freeradbiomed.2012.09.015; Leuwerke SM, 2002, AM J PHYSIOL-LUNG C, V282, pL1272, DOI 10.1152/ajplung.00490.2001; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Siafakas Nikolaos M, 2007, Int J Chron Obstruct Pulmon Dis, V2, P453; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; To M, 2013, CHEST, V144, P515, DOI 10.1378/chest.12-2381; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valenca SS, 2011, PULM PHARMACOL THER, V24, P587, DOI 10.1016/j.pupt.2011.05.006; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Xu X, 2009, EXP LUNG RES, V35, P795, DOI 10.3109/01902140902912519; Zhang Y, 2012, J INT MED RES, V40, P976, DOI 10.1177/147323001204000316	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116504	10.1371/journal.pone.0116504	http://dx.doi.org/10.1371/journal.pone.0116504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756287	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275700005
J	Alvankarian, J; Majlis, BY				Alvankarian, Jafar; Majlis, Burhanuddin Yeop			Exploiting the Oxygen Inhibitory Effect on UV Curing in Microfabrication: A Modified Lithography Technique	PLOS ONE			English	Article							FRONTAL PHOTOPOLYMERIZATION; MICROFLUIDIC DEVICE; ACRYLATE COATINGS	Rapid prototyping (RP) of microfluidic channels in liquid photopolymers using standard lithography (SL) involves multiple deposition steps and curing by ultraviolet (UV) light for the construction of a microstructure layer. In this work, the conflicting effect of oxygen diffusion and UV curing of liquid polyurethane methacrylate (PUMA) is investigated in microfabrication and utilized to reduce the deposition steps and to obtain a monolithic product. The conventional fabrication process is altered to control for the best use of the oxygen presence in polymerization. A novel and modified lithography technique is introduced in which a single step of PUMA coating and two steps of UV exposure are used to create a microchannel. The first exposure is maskless and incorporates oxygen diffusion into PUMA for inhibition of the polymerization of a thin layer from the top surface while the UV rays penetrate the photopolymer. The second exposure is for transferring the patterns of the microfluidic channels from the contact photomask onto the uncured material. The UV curing of PUMA as the main substrate in the presence of oxygen is characterized analytically and experimentally. A few typical elastomeric microstructures are manufactured. It is demonstrated that the obtained heights of the fabricated structures in PUMA are associated with the oxygen concentration and the UV dose. The proposed technique is promising for the RP of molds and microfluidic channels in terms of shorter processing time, fewer fabrication steps and creation of microstructure layers with higher integrity.	[Alvankarian, Jafar; Majlis, Burhanuddin Yeop] Natl Univ Malaysia, Inst Microengn & Nanoelect, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya	Alvankarian, J (corresponding author), Natl Univ Malaysia, Inst Microengn & Nanoelect, Bangi, Selangor, Malaysia.	alvankarian@gmail.com			Universiti Kebangsaan Malaysia (UKM); Ministry of Higher Education of Malaysia [DIP-2012-16]	Universiti Kebangsaan Malaysia (UKM); Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	The present research was financially supported by Universiti Kebangsaan Malaysia (UKM) and Ministry of Higher Education of Malaysia under grant DIP-2012-16 (Nanoelectronics and MEMS sensors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvankarian J, 2013, BIOMICROFLUIDICS, P7; Alvankarian J, 2012, SEM EL ICSE 2012 10, P333; Alvankarian J, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/3/035006; [Anonymous], 2001, PROGR POLYM SCI, V26, P605; [Anonymous], CONSIDERATI IN PRESS; Buhler N, 1995, PURE APPL CHEM, V67, P7; Cabral JT, 2004, LANGMUIR, V20, P10020, DOI 10.1021/la049501e; Cramer NB, 2008, POLYMER, V49, P4756, DOI 10.1016/j.polymer.2008.08.051; Cui YY, 2007, POLYMER, V48, P5994, DOI 10.1016/j.polymer.2007.08.013; Cui YY, 2007, EUR POLYM J, V43, P3912, DOI 10.1016/j.eurpolymj.2007.06.047; Decker C, 2004, JCT RES, V1, P127, DOI 10.1007/s11998-004-0007-1; Dendukuri D, 2008, MACROMOLECULES, V41, P8547, DOI 10.1021/ma801219w; Haraldsson KT, 2006, SENSOR ACTUAT B-CHEM, V113, P454, DOI 10.1016/j.snb.2005.03.096; Jeong HE, 2009, NANOSCALE, V1, P331, DOI 10.1039/b9nr00106a; Jeong HE, 2008, LAB CHIP, V8, P1787, DOI 10.1039/b810348h; Kuo JS, 2009, LAB CHIP, V9, P870, DOI 10.1039/b818873d; Littlejohns JV, 2007, CHEM ENG J, V129, P67, DOI 10.1016/j.cej.2006.11.002; Natarajan S, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045021; Studer K, 2003, PROG ORG COAT, V48, P101, DOI 10.1016/S0300-9440(03)00149-8; Studer K, 2003, PROG ORG COAT, V48, P92, DOI 10.1016/S0300-9440(03)00120-6	20	18	18	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119658	10.1371/journal.pone.0119658	http://dx.doi.org/10.1371/journal.pone.0119658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747514	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400083
J	Juhasz, G; Gonda, X; Hullam, G; Eszlari, N; Kovacs, D; Lazary, J; Pap, D; Petschner, P; Elliott, R; Deakin, JFW; Anderson, IM; Antal, P; Lesch, KP; Bagdy, G				Juhasz, Gabriella; Gonda, Xenia; Hullam, Gabor; Eszlari, Nora; Kovacs, David; Lazary, Judit; Pap, Dorottya; Petschner, Peter; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir; Antal, Peter; Lesch, Klaus-Peter; Bagdy, Gyorgy			Variability in the Effect of 5-HTTLPR on Depression in a Large European Population: The Role of Age, Symptom Profile, Type and Intensity of Life Stressors	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; S-ALLELE; POLYMORPHISM; ASSOCIATION; EVENTS; ANXIETY; METAANALYSIS; NEUROTICISM; HYPOTHESIS; MODERATION	Background Although 5-HTTLPR has been shown to influence the risk of life stress-induced depression in the majority of studies, others have produced contradictory results, possibly due to weak effects and/or sample heterogeneity. Methods In the present study we investigated how age, type and intensity of life-stressors modulate the effect of 5-HTTLPR on depression and anxiety in a European population cohort of over 2300 subjects. Recent negative life events (RLE), childhood adversity (CHA), lifetime depression, Brief Symptoms Inventory (BSI) depression and anxiety scores were determined in each subject. Besides traditional statistical analysis we calculated Bayesian effect strength and relevance of 5-HTTLPR genotypes in specified models. Results The short (s) low expressing allele showed association with increased risk of depression related phenotypes, but all nominally significant effects would turn to non-significant after correction for multiple testing in the traditional analysis. Bayesian effect strength and relevance analysis, however, confirmed the role of 5-HTTLPR. Regarding current (BSI) and lifetime depression 5-HTTLPR-by-RLE interactions were confirmed. Main effect, with other words direct association, was supported with BSI anxiety. With more frequent RLE the prevalence or symptoms of depression increased in ss carriers. Although CHA failed to show an interaction with 5-HTTLPR, in young subjects CHA sensitized towards the depression promoting effect of even mild RLE. Furthermore, the direct association of anxiety with the s allele was driven by young (<= 30) individuals. Limitations Our study is cross-sectional and applies self-report questionnaires. Conclusions Albeit 5-HTTLPR has only weak/moderate effects, the s allele is directly associated with anxiety and modulates development of depression in homogeneous subgroups.	[Juhasz, Gabriella; Gonda, Xenia; Eszlari, Nora; Kovacs, David; Pap, Dorottya; Petschner, Peter; Bagdy, Gyorgy] Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1085 Budapest, Hungary; [Juhasz, Gabriella; Gonda, Xenia; Hullam, Gabor; Eszlari, Nora; Kovacs, David; Pap, Dorottya; Petschner, Peter; Antal, Peter; Bagdy, Gyorgy] Semmelweis Univ, Hungarian Acad Sci, MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary; [Juhasz, Gabriella; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir] Univ Manchester, Fac Med & Human Sci, Sch Community Based Med, Neurosci & Psychiat Unit, Manchester, Lancs, England; [Juhasz, Gabriella; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Gonda, Xenia; Lazary, Judit] Semmelweis Univ, Kutvolgyi Clin Ctr, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary; [Hullam, Gabor; Antal, Peter] Budapest Univ Technol & Econ, Dept Measurement & Informat Syst, Budapest, Hungary; [Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Div Mol Psychiat, Wurzburg, Germany; [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci MHENS, Dept Translat Neurosci, NL-6200 MD Maastricht, Netherlands	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; University of Manchester; University of Manchester; Semmelweis University; Budapest University of Technology & Economics; University of Wurzburg; Maastricht University	Juhasz, G (corresponding author), Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1085 Budapest, Hungary.	gabriella.juhasz@manchester.ac.uk	Eszlari, Nora/D-8826-2015; Gonda, Xenia/B-2713-2008; Juhasz, Gabriella/O-1753-2017; Bagdy, György/O-3893-2017; Lesch, Klaus-Peter/J-4906-2013; Petschner, Peter/O-1697-2017; Antal, Peter/G-7894-2012	Eszlari, Nora/0000-0003-4913-028X; Gonda, Xenia/0000-0001-9015-4203; Juhasz, Gabriella/0000-0002-5975-4267; Bagdy, György/0000-0001-8141-3410; Lesch, Klaus-Peter/0000-0001-8348-153X; Petschner, Peter/0000-0002-3198-858X; Anderson, Ian M/0000-0003-2205-9209; Deakin, John/0000-0002-2750-962X; Hullam, Gabor/0000-0002-4765-2351; Elliott, Rebecca/0000-0002-7602-010X; Antal, Peter/0000-0002-4370-2198	Sixth Framework Program of the European Union, NewMood [LSHM-CT-2004-503474]; National Institute for Health Research Manchester Biomedical Research Centre; Hungarian Brain Research Program [KTIA_13_NAP-A-II/14]; National Development Agency [KTIA_NAP_13-1-2013-0001]; Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); Hungarian Academy of Sciences;  [TAMOP-4.2.1.B-09/1/KMR-2010-0001]	Sixth Framework Program of the European Union, NewMood; National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Hungarian Brain Research Program; National Development Agency; Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	The study was supported by the Sixth Framework Program of the European Union, NewMood, LSHM-CT-2004-503474; by the National Institute for Health Research Manchester Biomedical Research Centre; the TAMOP-4.2.1.B-09/1/KMR-2010-0001; by the Hungarian Brain Research Program (Grant KTIA_13_NAP-A-II/14) and National Development Agency (Grant KTIA_NAP_13-1-2013-0001); the Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group). Dr. Gonda is a recipient of the Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAL P, 2006, P 3 EUR WORKSH PROB, P9; Bagdy Gyorgy, 2013, Expert Opin Med Diagn, V7, P417, DOI 10.1517/17530059.2013.821979; Bagdy Gyorgy, 2012, Neuropsychopharmacol Hung, V14, P213; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Culverhouse RC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-304; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699; First MB, 2002, STRUCTURED CLIN INTE; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gonda X, 2007, PSYCHIAT RES, V149, P261, DOI 10.1016/j.psychres.2006.05.014; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hullam Gabor, 2012, Neuropsychopharmacol Hung, V14, P273; Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kendler KS, 2012, MOL PSYCHIATR, V17, P377, DOI 10.1038/mp.2011.182; Kirilly E, 2012, ACTA PHYSIOL, V205, P41, DOI 10.1111/j.1748-1716.2012.02402.x; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Lazary J, 2011, TRENDS PHARMACOL SCI, V32, P270, DOI 10.1016/j.tips.2011.02.013; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Madigan D, 1996, COMMUN STAT THEORY, V25, P2493, DOI 10.1080/03610929608831853; McLaughlin KA, 2010, PSYCHOL MED, V40, P1647, DOI 10.1017/S0033291709992121; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; SNAITH RP, 1982, BRIT J PSYCHIAT, V141, P518, DOI 10.1192/bjp.141.5.518; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Uher R, 2011, J AFFECT DISORDERS, V135, P56, DOI 10.1016/j.jad.2011.03.010	45	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116316	10.1371/journal.pone.0116316	http://dx.doi.org/10.1371/journal.pone.0116316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747798	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400004
J	Larsen, MH; Johnsson, JI; Winberg, S; Wilson, ADM; Hammenstig, D; Thornqvist, PO; Midwood, JD; Aarestrup, K; Hoglund, E				Larsen, Martin H.; Johnsson, Jorgen I.; Winberg, Svante; Wilson, Alexander D. M.; Hammenstig, David; Thornqvist, Per-Ove; Midwood, Jonathan D.; Aarestrup, Kim; Hoglund, Erik			Effects of Emergence Time and Early Social Rearing Environment on Behaviour of Atlantic Salmon: Consequences for Juvenile Fitness and Smolt Migration	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; LIFE-HISTORY STRATEGIES; RAINBOW-TROUT; BROWN TROUT; ECOLOGICAL CONSEQUENCES; COPING STYLES; SALAR L; GROWTH; PERSONALITY; WILD	Consistent individual differences in behaviour have been well documented in a variety of animal taxa, but surprisingly little is known about the fitness and life-history consequences of such individual variation. In wild salmonids, the timing of fry emergence from gravel spawning nests has been suggested to be coupled with individual behavioural traits. Here, we further investigate the link between timing of spawning nest emergence and behaviour of Atlantic salmon (Salmo salar), test effects of social rearing environment on behavioural traits in fish with different emergence times, and assess whether behavioural traits measured in the laboratory predict growth, survival, and migration status in the wild. Atlantic salmon fry were sorted with respect to emergence time from artificial spawning nest into three groups: early, intermediate, and late. These emergence groups were hatchery-reared separately or in co-culture for four months to test effects of social rearing environment on behavioural traits. Twenty fish from each of the six treatment groups were then subjected to three individual-based behavioural tests: basal locomotor activity, boldness, and escape response. Following behavioural characterization, the fish were released into a near-natural experimental stream. Results showed differences in escape behaviour between emergence groups in a net restraining test, but the social rearing environment did not affect individual behavioural expression. Emergence time and social environment had no significant effects on survival, growth, and migration status in the stream, although migration propensity was 1.4 to 1.9 times higher for early emerging individuals that were reared separately. In addition, despite individuals showing considerable variation in behaviour across treatment groups, this was not translated into differences in growth, survival, and migration status. Hence, our study adds to the view that fitness (i.e., growth and survival) and life-history predictions from laboratory measures of behaviour should be made with caution and ideally tested in nature.	[Larsen, Martin H.; Aarestrup, Kim] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Freshwater Fisheries & Ecol, Silkeborg, Denmark; [Johnsson, Jorgen I.; Hammenstig, David] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Winberg, Svante; Thornqvist, Per-Ove] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Wilson, Alexander D. M.; Midwood, Jonathan D.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Wilson, Alexander D. M.; Midwood, Jonathan D.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Hoglund, Erik] Tech Univ Denmark, Natl Inst Aquat Resources, Aquaculture Sect, Hirtshals, Denmark; [Hoglund, Erik] Univ Agder, Res Secretariat, Kristiansand, Norway	Technical University of Denmark; University of Gothenburg; Uppsala University; Carleton University; Carleton University; Technical University of Denmark; University of Agder	Larsen, MH (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Sect Freshwater Fisheries & Ecol, Silkeborg, Denmark.	mhala@aqua.dtu.dk	Wilson, Alexander/B-3329-2011; Winberg, Svante/ABB-6458-2021; Aarestrup, Kim/AAK-9155-2021	Wilson, Alexander/0000-0002-7696-1671; Winberg, Svante/0000-0003-4252-3144; Aarestrup, Kim/0000-0001-8521-6270; Hage Larsen, Martin/0000-0001-9521-835X	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was conducted as part of the strategic project SMOLTPRO, financed by the Swedish Research Council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas O., 2011, ATLANTIC SALMON ECOL; Adriaenssens B, 2013, ECOL LETT, V16, P47, DOI 10.1111/ele.12011; Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Adriaenssens B, 2009, TRENDS ECOL EVOL, V24, P179, DOI 10.1016/j.tree.2008.12.003; Andersson MA, 2013, J FISH BIOL, V83, P214, DOI 10.1111/jfb.12153; Andersson MA, 2013, PHYSIOL BEHAV, V116, P30, DOI 10.1016/j.physbeh.2013.03.019; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; BRANNAS E, 1995, EVOL ECOL, V9, P411, DOI 10.1007/BF01237763; Brockmark S, 2010, P ROY SOC B-BIOL SCI, V277, P3035, DOI 10.1098/rspb.2010.0561; Brockmark S, 2010, CAN J FISH AQUAT SCI, V67, P288, DOI 10.1139/F09-185; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; CHANDLER GL, 1988, T AM FISH SOC, V117, P432, DOI 10.1577/1548-8659(1988)117<0432:AGAIOJ>2.3.CO;2; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Conrad JL, 2009, J FISH BIOL, V75, P1410, DOI 10.1111/j.1095-8649.2009.02372.x; DELEANIZ CG, 1993, CAN J ZOOL, V71, P1454, DOI 10.1139/z93-201; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; GLASS NR, 1969, J FISH RES BOARD CAN, V26, P2643, DOI 10.1139/f69-256; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Griffiths S.W., 2011, FISH COGNITION BEHAV, P186, DOI [DOI 10.1002/9781444342536.CH9, 10.1002/9781444342536.ch9]; GUSTAFSONMARJANEN KI, 1983, CAN J FISH AQUAT SCI, V40, P813, DOI 10.1139/f83-106; Gyuris E, 2012, ANIM BEHAV, V84, P103, DOI 10.1016/j.anbehav.2012.04.014; Harwood AJ, 2003, ANIM BEHAV, V65, P1141, DOI 10.1006/anbe.2003.2125; Hojesjo J, 1999, J FISH BIOL, V55, P1009, DOI 10.1111/j.1095-8649.1999.tb00736.x; Hojesjo J, 2002, BEHAV ECOL SOCIOBIOL, V52, P102, DOI 10.1007/s00265-002-0493-z; Hojesjo J, 2011, BEHAV ECOL SOCIOBIOL, V65, P1801, DOI 10.1007/s00265-011-1188-0; Johnsson JI, 1999, FUNCT ECOL, V13, P514, DOI 10.1046/j.1365-2435.1999.00341.x; Jonsson E, 1996, P ROY SOC B-BIOL SCI, V263, P647, DOI 10.1098/rspb.1996.0097; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Larsen M.H., 2013, ANIM BIOTELEM, V1, P1, DOI [10.1186/2050-3385-1-19, DOI 10.1186/2050-3385-1-19]; Lundqvist H, 2010, CONSERVATION MONITORING IN FRESHWATER HABITATS: A PRACTICAL GUIDE AND CASE STUDIES, P207, DOI 10.1007/978-1-4020-9278-7_20; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; Martins CIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028084; MASON JC, 1965, J FISH RES BOARD CAN, V22, P173, DOI 10.1139/f65-015; METCALFE NB, 1992, J FISH BIOL, V41, P93, DOI 10.1111/j.1095-8649.1992.tb03871.x; METCALFE NB, 1995, ANIM BEHAV, V49, P431, DOI 10.1006/anbe.1995.0056; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Niemela PT, 2014, TRENDS ECOL EVOL, V29, P245, DOI 10.1016/j.tree.2014.02.007; Olsen EM, 2001, N AM J FISH MANAGE, V21, P967, DOI 10.1577/1548-8675(2001)021&lt;0967:AEOVIE&gt;2.0.CO;2; Petersson E, 1996, J FISH BIOL, V48, P776, DOI 10.1111/j.1095-8649.1996.tb01471.x; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Pottinger TG, 2006, AQUACULTURE, V256, P140, DOI 10.1016/j.aquaculture.2006.01.023; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Schuett W, 2011, DEV PSYCHOBIOL, V53, P631, DOI 10.1002/dev.20538; Sigourney DB, 2005, N AM J FISH MANAGE, V25, P1016, DOI 10.1577/M04-075.1; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sloman KA, 2010, PHYSIOL BEHAV, V99, P599, DOI 10.1016/j.physbeh.2010.01.027; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Vaz-Serrano J, 2011, PHYSIOL BEHAV, V103, P359, DOI 10.1016/j.physbeh.2011.02.025; Wilson AJW, 2005, MARINERS MIRROR, V91, P111; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	66	7	7	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119127	10.1371/journal.pone.0119127	http://dx.doi.org/10.1371/journal.pone.0119127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747862	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000350689400046
J	Linhares, MB; Belloy, L; Origgi, FC; Lechner, I; Segner, H; Ryser-Degiorgis, MP				Linhares, Mainity Batista; Belloy, Luc; Origgi, Francesco C.; Lechner, Isabel; Segner, Helmut; Ryser-Degiorgis, Marie-Pierre			Investigating the Role of Free-Ranging Wild Boar (Sus scrofa) in the Re-Emergence of Enzootic Pneumonia in Domestic Pig Herds: A Pathological, Prevalence and Risk-Factor Study	PLOS ONE			English	Article							MYCOPLASMA-HYOPNEUMONIAE INFECTION; RESPIRATORY SYNDROME VIRUS; TIME PCR ASSAYS; SAMPLING SITES; BODY CONDITION; OUTDOOR PIGS; SWINE; TRANSMISSION; POPULATION; DISPERSAL	Enzootic pneumonia (EP) caused by Mycoplasma hyopneumoniae has a significant economic impact on domestic pig production. A control program carried out from 1999 to 2003 successfully reduced disease occurrence in domestic pigs in Switzerland, but recurrent outbreaks suggested a potential role of free-ranging wild boar (Sus scrofa) as a source of reinfection. Since little is known on the epidemiology of EP in wild boar populations, our aims were: (1) to estimate the prevalence of M. hyopneumoniae infections in wild boar in Switzerland; (2) to identify risk factors for infection in wild boar; and (3) to assess whether infection in wild boar is associated with the same gross and microscopic lesions typical of EP in domestic pigs. Nasal swabs, bronchial swabs and lung samples were collected from 978 wild boar from five study areas in Switzerland between October 2011 and May 2013. Swabs were analyzed by qualitative real time PCR and a histopathological study was conducted on lung tissues. Risk factor analysis was performed using multivariable logistic regression modeling. Overall prevalence in nasal swabs was 26.2% (95% CI 23.3-29.3%) but significant geographical differences were observed. Wild boar density, occurrence of EP out-breaks in domestic pigs and young age were identified as risk factors for infection. There was a significant association between infection and lesions consistent with EP in domestic pigs. We have concluded that M. hyopneumoniae is widespread in the Swiss wild boar population, that the same risk factors for infection of domestic pigs also act as risk factors for infection of wild boar, and that infected wild boar develop lesions similar to those found in domestic pigs. However, based on our data and the outbreak pattern in domestic pigs, we propose that spillover from domestic pigs to wild boar is more likely than transmission from wild boar to pigs.	[Linhares, Mainity Batista; Origgi, Francesco C.; Segner, Helmut; Ryser-Degiorgis, Marie-Pierre] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Belloy, Luc] Inst Galli Valerio, Dept Terr & Environm, Lab Anal Vet, Lausanne, Switzerland; [Lechner, Isabel] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern; University of Bern	Ryser-Degiorgis, MP (corresponding author), Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland.	marie-pierre.ryser@vetsuisse.unibe.ch	LINHARES, Mainity BATISTA/AAU-5647-2021; Ryser-Degiorgis, Marie-Pierre/AAN-5249-2020	LINHARES, Mainity BATISTA/0000-0003-4988-6984; Ryser-Degiorgis, Marie-Pierre/0000-0003-1062-870X; Lechner, Isabel/0000-0001-5155-9734	Swiss Federal Food Safety and Veterinary Office (FSVO) [1.11.16]; University of Bern; Institut Galli-Valerio	Swiss Federal Food Safety and Veterinary Office (FSVO); University of Bern; Institut Galli-Valerio(Centre National de la Recherche Scientifique (CNRS))	The study was funded by the Swiss Federal Food Safety and Veterinary Office (FSVO; www.blv.admin.ch; contract nr. 1.11.16), with a contribution from the University of Bern and of the Institut Galli-Valerio (salary of mentors, infrastructure, materials). It is always part of contracts with the FSVO that study results should be published, as the FSVO wants to encourage the large distribution of research results. However, the FSVO has no influence on the studies' outcome or on the prepared manuscripts.	Abril C, 2011, VET MICROBIOL, V150, P405, DOI 10.1016/j.vetmic.2011.02.056; Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; [Anonymous], 2013, METEOSCHWEIZ 2013 KL, P1; [Anonymous], 2012, METEOSCHWEIZ 2012 KL, P1; Arey DS, 1998, LIVEST PROD SCI, V56, P61, DOI 10.1016/S0301-6226(98)00144-4; ASAI T, 1993, VET IMMUNOL IMMUNOP, V38, P253, DOI 10.1016/0165-2427(93)90085-I; Ashford RW, 2003, EMERG INFECT DIS, V9, P1495; Batista L, 2004, J SWINE HEALTH PROD, V12, P75; Batista Linhares M, 2012, JOINT 61 WDA 10 BIEN, P438; Beerli O, 2015, VET J, V203, P131, DOI 10.1016/j.tvjl.2014.10.023; Belthoff JR, 1998, ANIM BEHAV, V55, P405, DOI 10.1006/anbe.1997.0625; Blanchard B, 1996, MICROBIOL-SGM, V142, P1855, DOI 10.1099/13500872-142-7-1855; Bochev I., 2007, Bulgarian Journal of Veterinary Medicine, V10, P131; Boitani L, 2010, AM SOC MAMMAL, V75, P600; Bundesamt fur Lebensmittelsicherheit und Veterinarwesen BLV, 2014, THEM TIERG ENZ PNEUM; Butler JE, 2009, VET IMMUNOL IMMUNOP, V128, P147, DOI 10.1016/j.vetimm.2008.10.321; Cahill Sean, 2004, Galemys, V16, P37; Calsamiglia M, 1999, SWINE HEALTH PROD, V7, P263; Calsamiglia M, 2000, VET REC, V146, P530, DOI 10.1136/vr.146.18.530; Calsamiglia M, 2000, VET MICROBIOL, V76, P299, DOI 10.1016/S0378-1135(00)00245-5; Canton of Lucern, 2014, ANN CANT LUC; Caswell J.L., 2007, PATHOLOGY DOMESTIC A, V6th ed., P591; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chiari M, 2014, EUR J WILDLIFE RES, V60, P187, DOI 10.1007/s10344-013-0763-2; Choi C, 2006, J COMP PATHOL, V134, P40, DOI 10.1016/j.jcpa.2005.06.009; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Dawson A, 2002, VET REC, V151, P535, DOI 10.1136/vr.151.18.535; Dennis MM, 2008, VET MICROBIOL, V131, P154, DOI 10.1016/j.vetmic.2008.02.017; DONE SH, 1991, VET REC, V128, P582, DOI 10.1136/vr.128.25.582; Dubosson CR, 2004, VET MICROBIOL, V102, P55, DOI 10.1016/j.vetmic.2004.05.007; Fablet C, 2010, VET MICROBIOL, V143, P238, DOI 10.1016/j.vetmic.2009.12.001; Fano E, 2005, CAN J VET RES, V69, P223; Federal Office for the Environment, 2014, OP DAT FED OFF ENV F; Fernandez-Llario P, 2003, FOLIA ZOOL, V52, P143; Fernandez-Llario P., 1996, Miscellania Zoologica (Barcelona), V19, P9; Gonseth Y, 2001, UMWELT MAT, V137, P1; GOODWIN RFW, 1985, VET REC, V116, P690, DOI 10.1136/vr.116.26.690; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; He Y, 2011, TROP ANIM HEALTH PRO, V43, P695, DOI 10.1007/s11250-010-9755-3; Hebeisen C, 2008, EUR J WILDLIFE RES, V54, P391, DOI 10.1007/s10344-007-0156-5; Hebeisen C, 2007, THESIS U NEUCHATEL; Hyun Y, 1998, J ANIM SCI, V76, P721; Keuling O, 2010, THESIS TU DRESDEN; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Koppel C, 2007, EUR J WILDLIFE RES, V53, P212, DOI 10.1007/s10344-006-0080-0; Kuhnert P, 2011, VET MICROBIOL, V152, P191, DOI 10.1016/j.vetmic.2011.04.026; Kurth KT, 2002, J VET DIAGN INVEST, V14, P463, DOI 10.1177/104063870201400603; Leuenberger R, 2004, THESIS U BASEL; Lopez A, 2007, PATHOLOGIC BASIS VET, P510; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; Maes D, 1996, VET QUART, V18, P104, DOI 10.1080/01652176.1996.9694628; Maes D, 1999, VACCINE, V17, P1024, DOI 10.1016/S0264-410X(98)00254-0; Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122; Marois C, 2007, VET MICROBIOL, V120, P96, DOI 10.1016/j.vetmic.2006.10.015; Marois C, 2010, J APPL MICROBIOL, V108, P1523, DOI 10.1111/j.1365-2672.2009.04556.x; Marois C, 2007, JOURN RECH PORC FRAN, V39, P433; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; Matheusen B, 2001, J VET MED B, V48, P733, DOI 10.1046/j.1439-0450.2001.00503.x; Maunsell FP, 2011, J VET INTERN MED, V26, P772; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Mermod L, 2014, COMMUNICATION; MESSIER S, 1991, AM J VET RES, V52, P1497; Meylan S, 2002, HORM BEHAV, V42, P319, DOI 10.1006/hbeh.2002.1827; Meyns T, 2007, VET MICROBIOL, V120, P87, DOI 10.1016/j.vetmic.2006.10.010; Meyns T, 2006, VACCINE, V24, P7081, DOI 10.1016/j.vaccine.2006.07.004; MORRIS CR, 1995, CAN J VET RES, V59, P197; MORRIS CR, 1995, PREV VET MED, V21, P323, DOI 10.1016/0167-5877(94)00384-U; NEW JC, 1994, J WILDLIFE DIS, V30, P103, DOI 10.7589/0090-3558-30.1.103; Ochs H, 2004, BVET MAG, V33, P32; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Pieters M, 2009, VET MICROBIOL, V134, P261, DOI 10.1016/j.vetmic.2008.08.016; Pollock JM, 2006, VET MICROBIOL, V112, P141, DOI 10.1016/j.vetmic.2005.11.032; Ross RF, 1999, DIS SWINE, P701; Ruiz A, 2002, CAN J VET RES, V66, P79; Ryser-Degiorgis MP, 2009, VET MICROBIOL, V134, P368, DOI 10.1016/j.vetmic.2008.08.005; Schoning JM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054253, 10.1371/journal.pone.0060336]; Sibila M, 2007, VET MICROBIOL, V121, P352, DOI 10.1016/j.vetmic.2006.12.028; Sibila M, 2004, CAN J VET RES, V68, P12; Sibila M, 2010, VET MICROBIOL, V144, P214, DOI 10.1016/j.vetmic.2009.12.019; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Silverin B, 1997, ANIM BEHAV, V53, P451, DOI 10.1006/anbe.1996.0295; Sivakumar P, 2005, VET MICROBIOL, V108, P263, DOI 10.1016/j.vetmic.2005.04.002; Sorensen V, 1997, VET MICROBIOL, V54, P23, DOI 10.1016/S0378-1135(96)01266-7; Sparklin BD, 2009, J WILDLIFE MANAGE, V73, P497, DOI 10.2193/2007-585; Stark KDC, 1998, APPL ENVIRON MICROB, V64, P543; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; STARK KDC, 1992, VET REC, V131, P532; Stark KDC, 1999, VET J, V158, P164, DOI 10.1053/tvjl.1998.0346; Stark KDC, 2001, SCHWEIZ ARCH TIERH, V143, P63; Strait EL, 2008, J CLIN MICROBIOL, V46, P2491, DOI 10.1128/JCM.02366-07; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thacker EL, 2004, J SWINE HEALTH PROD, V12, P252; Thacker EL, 2007, ANIM HEAL RES REV, V5, P317; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Truve J, 2003, WILDLIFE BIOL, V9, P51, DOI 10.2981/wlb.2003.056; Vengust G, 2006, J VET MED B, V53, P24, DOI 10.1111/j.1439-0450.2006.00899.x; Verdin E, 2000, VET MICROBIOL, V76, P31, DOI 10.1016/S0378-1135(00)00228-5; Vicca J, 2003, VET MICROBIOL, V97, P177, DOI 10.1016/J.VETMIC.2003.08.008; Vicente J, 2004, VET RES, V35, P243, DOI 10.1051/vetres:2004008; Vicente J, 2002, J WILDLIFE DIS, V38, P649, DOI 10.7589/0090-3558-38.3.649; Villarreal I, 2009, VACCINE, V27, P1875, DOI 10.1016/j.vaccine.2008.12.005; Villarreal I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-2; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Woolley LK, 2012, VET MICROBIOL, V161, P186, DOI 10.1016/j.vetmic.2012.07.025; Wu N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-116; Wu N, 2011, J WILDLIFE DIS, V47, P868, DOI 10.7589/0090-3558-47.4.868; YAGIHASHI T, 1993, VET MICROBIOL, V34, P155, DOI 10.1016/0378-1135(93)90169-8; Zeeh F, 2005, SCHWEIZ ARCH TIERH, V147, P373, DOI 10.1024/0036-7281.147.9.373; Zellweger K, 2004, SCHWEIZ ARCH TIERH, V146, P471, DOI 10.1024/0036-7281.146.10.471	109	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119060	10.1371/journal.pone.0119060	http://dx.doi.org/10.1371/journal.pone.0119060			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747151	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400041
J	Faiao-Flores, F; Suarez, JAQ; Fruet, AC; Maria-Engler, SS; Pardi, PC; Maria, DA				Faiao-Flores, Fernanda; Quincoces Suarez, Jose Agustin; Fruet, Andrea Costa; Maria-Engler, Silvya Stuchi; Pardi, Paulo Celso; Maria, Durvanei Augusto			Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression	PLOS ONE			English	Article							RESISTANCE; ANEMIA; DEATH	Malignant melanoma is a highly aggressive form of skin cancer with a high mortality rate if not discovered in early stages. Although a limited number of treatment options for melanoma currently exist, patients with a more aggressive form of this cancer frequently decline treatment. DM-1 is a sodium phenolate and curcumin analog with proven anticancer, anti-proliferative and anti-metastatic properties. In this paper, the DM-1 compound showed in vivo antitumor activity alone or in combination with chemotherapeutic DTIC in B16F10 melanoma-bearing mice. Beneficial effects such as melanoma tumor burden reduction with pyknotic nuclei, decreased nuclei/cytoplasmic ratio and nuclear degradation occurred after DM-1 treatment. No toxicological changes were observed in the liver, kidneys, spleen and lungs after DM-1 monotherapy or DTIC combined therapy. DTIC+DM-1 treatment induced the recovery of anemia arising from melanoma and immunomodulation. Both DM-1 treatment alone and in combination with DTIC induced apoptosis with the cleavage of caspase-3, -8 and -9. Furthermore, melanoma tumors treated with DM-1 showed a preferential apoptotic intrinsic pathway by decreasing Bcl-2/Bax ratio. Considering the chemoresistance exhibited by melanoma towards conventional chemotherapy drugs, DM-1 compound in monotherapy or in combination therapy provides a promising improvement in melanoma treatment with a reduction of side effects.	[Faiao-Flores, Fernanda; Fruet, Andrea Costa; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Chem & Toxicol, Sao Paulo, Brazil; [Quincoces Suarez, Jose Agustin] Anhanguera Univ Sao Paulo, Organ Synth Lab, UNIAN, Sao Paulo, Brazil; [Pardi, Paulo Celso] Anhanguera Univ Sao Paulo, Lab Expt Pathol, UNIAN, Sao Paulo, Brazil; [Maria, Durvanei Augusto] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Faiao-Flores, F (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Chem & Toxicol, Sao Paulo, Brazil.	fernandafaiao@usp.br; durvanei@usp.br	Maria-Engler, Silvya/ABC-2016-2020; Engler, Silvya Stuchi Maria/K-5936-2016; Faião-Flores, Fernanda/F-7111-2012; Pardi, Paulo Celso/AAW-1540-2020; Pardi, Paulo C/B-8965-2012	Maria-Engler, Silvya/0000-0003-4771-6041; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Faião-Flores, Fernanda/0000-0003-3449-9930; 	Sao Paulo Research Foundation [Fapesp 2008/56397-8, 2011/50435-8]; National Council for Scientific and Technological Development [CNPq 573663/2008-4]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Sao Paulo Research Foundation (Fapesp 2008/56397-8 and 2011/50435-8) and the National Council for Scientific and Technological Development (CNPq 573663/2008-4) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AC, 1953, CANCER-AM CANCER SOC, V6, P1, DOI 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C; Brasil. Ministerio da Saude, 2007, MEMENTO TERAPEUTICO; Burgoyne LA, 1999, EXP CELL RES, DOI [10.1038/cddis.2013.237, DOI 10.1038/CDDIS.2013.237]; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Coit DG, 2013, J NATL COMPR CANC NE, V11, P395, DOI 10.6004/jnccn.2013.0055; DELEVE LD, 1994, J PHARMACOL EXP THER, V268, P1261; Eberle J, 2008, EXP DERMATOL, V17, P1, DOI 10.1111/j.1600-0625.2007.00655.x; Faiao-Flores F, 2012, TUMOUR BIOL J INT SO, DOI [10.1007/413277-011-0293-z, DOI 10.1007/413277-011-0293-Z]; Faiao-Flores F, 2008, APPL CANC RES, V28, P72; Faiao-Flores F, 2013, TUMOR BIOL, V34, P1119, DOI 10.1007/s13277-013-0653-y; Faiao-Flores F, 2013, TUMOR BIOL, V34, P1235, DOI 10.1007/s13277-013-0666-6; Ferrario E, 2004, CANCER TREAT REV, V30, P563, DOI 10.1016/j.ctrv.2004.04.005; Fischer AH, 2010, J CELL BIOCHEM, V110, P795, DOI 10.1002/jcb.22585; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Glaspy JA, 2002, ONCOLOGY-NY, V16, P35; Gonzalez FHD, 2003, INTRO BIOQUIMICA CLI; Grazia G, 2014, INT J ONCOL, DOI [10.3892/942014. 2491, DOI 10.3892/942014.2491]; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035; Hayes AW, 2001, PRINCIPLES METHODS T; Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Kretzer IF, 2012, CELL ONCOL, V35, P451, DOI 10.1007/s13402-012-0104-6; Leiter U, 2014, HAUTARZT, V65, P600, DOI 10.1007/s00105-013-2735-6; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Markovic SN, 2007, MAYO CLIN PROC; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Pasquali S, 2015, HEAD NECK-J SCI SPEC, V37, P1596, DOI 10.1002/hed.23801; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Quincoces Suarez JA, 2009, Patent No. [PCTBR2009/ 000375, 2009000375]; Quincoces Suarez JA, 2007, Patent No. [PCT/ BR2007/ 000175, 2007000175]; Quincoces Suarez JA, 2013, Patent No. [WO 2008/003155, 2008003155]; Quincoces Suarez JA, 2010, Patent No. [WO2010/142007, 2010142007]; Quincoces Suarez JA, 2013, Japan-Patent, Patent No. 5317290; Quincoces Suarez JA, 2010, BIOORGAN MED CHEM, DOI [10.1016/1.bmc. 2010.07.026, DOI 10.1016/1.BMC.2010.07.026]; Quincoces Suarez JA, 2013, Brazilian Patent, Patent No. [PI 0602640-0, 06026400]; Quincoces Suarez JA, 2009, [Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in human and animals, Brazilian Patent], Patent No. [PI 0902039-0, 09020390]; Ruby AJ, 1995, CANCER LETTER; Siegel R., 2015, CA-CANCER J CLIN, V65, P29, DOI [10.3322/caac.21254, DOI 10.3322/CAAC.21254, DOI 10.3322/caac.21208]; Vikey AK, 2012, ORAL ONCOL, DOI [10.1016/j.oraloncology, DOI 10.1016/J.ORALONCOLOGY]; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071130; Zhang G, 2014, ONCOL LETT, V8, P248, DOI 10.3892/ol.2014.2121	43	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118702	10.1371/journal.pone.0118702	http://dx.doi.org/10.1371/journal.pone.0118702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742310	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100034
J	Rao, SQ; Lang, JH; Zhu, L; Chen, J				Rao, Shuquan; Lang, Jinghe; Zhu, Lan; Chen, Juan			Exome Sequencing Identifies a Novel Gene, WNK1, for Susceptibility to Pelvic Organ Prolapse (POP)	PLOS ONE			English	Article							WOMEN; FIBROBLASTS; KINASES	Pelvic organ prolapse (POP) is a common gynecological disorder; however, the genetic components remain largely unidentified. Exome sequencing has been widely used to identify pathogenic gene mutations of several diseases because of its high chromosomal coverage and accuracy. In this study, we performed whole exome sequencing (WES), for the first time, on 8 peripheral blood DNA samples from representative POP cases. After filtering the sequencing data from the dbSNP database (build 138) and the 1000 Genomes Project, 2 missense variants in WNK1, c. 2668G > A (p. G890R) and c. 6761C> T (p. P2254L), were identified and further validated via Sanger sequencing. In validation stage, the c. 2668G > A (p. G890R) variant and 8 additional variants were detected in 11 out of 161 POP patients. All these variants were absent in 231 healthy controls. Functional experiments showed that fibroblasts from the utero-sacral ligaments of POP with WNK1 mutations exhibited loose and irregular alignment compared with fibroblasts from healthy controls. In sum, our study identified a novel gene, WNK1, for POP susceptibility, expanded the causal mutation spectrums of POP, and provided evidence for the genetic diagnosis and medical management of POP in the future.	[Rao, Shuquan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Rao, Shuquan] Tsinghua Univ, Peking Union Med Coll, Beijing 100005, Peoples R China; [Lang, Jinghe; Zhu, Lan; Chen, Juan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100005, Peoples R China; [Lang, Jinghe; Zhu, Lan; Chen, Juan] Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100005, Peoples R China.	pumchcj@sina.com			National Natural Science Foundation of China [81070474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81070474). URL: http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 2011, CURR BIOL, V21, P1979, DOI 10.1016/j.cub.2011.11.002; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chiaffarino F, 1999, EUR J OBSTET GYN R B, V82, P63, DOI 10.1016/S0301-2115(98)00175-4; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Dai Yu-xin, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P342; Dietz HP, 2002, INT UROGYNECOL J PEL, V13, P284, DOI 10.1007/s001920200062; Ewies AAA, 2008, MOL HUM REPROD, V14, P127, DOI 10.1093/molehr/gam090; Ferrari MM, 2012, ARCH GYNECOL OBSTET, V285, P1581, DOI 10.1007/s00404-011-2199-9; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Jack GS, 2006, INT UROGYNECOL J, V17, P498, DOI 10.1007/s00192-005-0054-x; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Jelovsek JE, 2006, AM J OBSTET GYNECOL, V194, P1455, DOI 10.1016/j.ajog.2006.01.060; Jeon MJ, 2009, J UROLOGY, V181, P1213, DOI 10.1016/j.juro.2008.11.027; Kim JY, 2014, EUR J OBSTET GYN R B, V175, P205, DOI 10.1016/j.ejogrb.2014.01.028; Kong D, 2008, BIOPHYS J, V95, P4034, DOI [10.1529/biophysj.108.131342, 10.1529/biophysj.l08.131342]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Luber KM, 2001, AM J OBSTET GYNECOL, V184, P1496, DOI 10.1067/mob.2001.114868; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Newhouse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005003; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nikolova G, 2007, HUM GENET, V120, P847, DOI 10.1007/s00439-006-0267-1; Poncet S, 2005, AM J OBSTET GYNECOL, V192, P426, DOI 10.1016/j.ajog.2004.09.018; Potulska-Chromik A, 2012, ACTA BIOCHIM POL, V59, P413; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Ruiz-Zapata AM, 2013, INT UROGYNECOL J, V24, P1567, DOI 10.1007/s00192-013-2069-z; Serysheva E, 2013, EMBO REP, V14, P718, DOI 10.1038/embor.2013.88; Skorupski P, 2013, INT UROGYNECOL J, V24, P1033, DOI 10.1007/s00192-012-1970-1; Soderberg MW, 2007, ACTA OBSTET GYNECOL, V83, P1193; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Zhen, 2012, Zhonghua Yi Xue Za Zhi, V92, P1669; Weber AM, 2001, INT UROGYNECOL J PEL, V12, P178, DOI 10.1007/PL00004033; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yu L, 2014, J MED GENET, V51, P197, DOI 10.1136/jmedgenet-2013-101989; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	40	3	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119482	10.1371/journal.pone.0119482	http://dx.doi.org/10.1371/journal.pone.0119482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739019	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900107
J	Kruglikov, IL				Kruglikov, Ilja L.			Microstructural Inhomogeneity of Electrical Conductivity in Subcutaneous Fat Tissue	PLOS ONE			English	Article							INSULATING SPHERES; ULTRASOUND; MIXTURE	Microscopic peculiarities stemming from a temperature increase in subcutaneous adipose tissue (sWAT) after applying a radio-frequency (RF) current, must be strongly dependent on the type of sWAT. This effect is connected with different electrical conductivities of pathways inside (triglycerides in adipocytes) and outside (extra-cellular matrix) the cells and to the different weighting of these pathways in hypertrophic and hyperplastic types of sWAT. The application of the RF current to hypertrophic sWAT, which normally has a strongly developed extracellular matrix with high concentrations of hyaluronan and collagen in a pericellular space of adipocytes, can produce, micro-structurally, a highly inhomogeneous temperature distribution, characterized by strong temperature gradients between the pericellular sheath of the extra-cellular matrix around the hypertrophic adipocytes and their volumes. In addition to normal temperature effects, which are generally considered in body contouring, these temperature gradients can produce thermo-mechanical stresses on the cells' surfaces. Whereas these stresses are relatively small under normal conditions and cannot cause any direct fracturing or damage of the cell structure, these stresses can, under some supportive conditions, be theoretically increased by several orders of magnitude, causing the thermo-mechanical cell damage. This effect cannot be realized in sWAT of normal or hyperplastic types where the peri-cellular structures are under-developed. It is concluded that the results of RF application in body contouring procedures must be strongly dependent on the morphological structure of sWAT.	Wellcomet GmbH, D-76229 Karlsruhe, Germany		Kruglikov, IL (corresponding author), Wellcomet GmbH, Greschbachstr 2-4, D-76229 Karlsruhe, Germany.	i.kruglikov@welicomet.de	Kruglikov, Ilja L./K-3077-2019					Alkhouli N, 2013, AM J PHYSIOL-ENDOC M, V305, pE1427, DOI 10.1152/ajpendo.00111.2013; Arnoczky S P, 2000, J Am Acad Orthop Surg, V8, P305; Berjano EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-24; Comley K, 2012, INT J IMPACT ENG, V46, P1, DOI 10.1016/j.ijimpeng.2011.12.009; Comley K, 2010, INT J SOLIDS STRUCT, V47, P2982, DOI 10.1016/j.ijsolstr.2010.07.001; Feng Y, 2003, MATER CHEM PHYS, V78, P196, DOI 10.1016/S0254-0584(02)00334-6; Garcia O, 2013, AESTHET SURG J, V33, P117, DOI 10.1177/1090820X12469627; Grimnes S., 2011, BIOIMPEDANCE BIOELEC; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kruglikov I.L., 2014, J COSMETICS DERMATOL, V04, P117; Kruglikov IL, 2014, J COSMETICS DERMATOL, V4, P207; Kruglikov IL, 2012, AM J COSMETIC SURG, V29, P196; Kruglikov IL, 2012, AM J COSMETIC SURG, V29, P121; Kruglikov IL, 2013, KOSMETISCHE MED, V34, P166; Lackey DE, 2014, AM J PHYSIOL-ENDOC M, V306, pE233, DOI 10.1152/ajpendo.00476.2013; Lozano JNJ, 2013, LASER SURG MED, V45, P326, DOI 10.1002/lsm.22146; OTTAVI H, 1978, J PHYS C SOLID STATE, V11, P1311, DOI 10.1088/0022-3719/11/7/021; Pavselj N, 2011, INT J HEAT MASS TRAN, V54, P2294, DOI 10.1016/j.ijheatmasstransfer.2011.02.035; TROADEC JP, 1981, J PHYS-PARIS, V42, P113, DOI 10.1051/jphys:01981004201011300; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054	22	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117072	10.1371/journal.pone.0117072	http://dx.doi.org/10.1371/journal.pone.0117072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734656	gold, Green Published, Green Submitted			2022-12-26	WOS:000350314700008
J	Nieminen, P; Ryokas, E; Mustonen, AM				Nieminen, Petteri; Ryokas, Esko; Mustonen, Anne-Mari			Experiential Thinking in Creationism-A Textual Analysis	PLOS ONE			English	Article							EVOLUTION; MUSCLES; BELIEF; BIASES	Creationism is a religiously motivated worldview in denial of biological evolution that has been very resistant to change. We performed a textual analysis by examining creationist and pro-evolutionary texts for aspects of "experiential thinking", a cognitive process different from scientific thought. We observed characteristics of experiential thinking as follows: testimonials (present in 100% of sampled creationist texts), such as quotations, were a major form of proof. Confirmation bias (100% of sampled texts) was represented by ignoring or dismissing information that would contradict the creationist hypothesis. Scientifically irrelevant or flawed information was re-interpreted as relevant for the falsification of evolution (75-90% of sampled texts). Evolutionary theory was associated to moral issues by demonizing scientists and linking evolutionary theory to atrocities (63-93% of sampled texts). Pro-evolutionary rebuttals of creationist claims also contained testimonials (93% of sampled texts) and referred to moral implications (80% of sampled texts) but displayed lower prevalences of stereotypical thinking (47% of sampled texts), confirmation bias (27% of sampled texts) and pseudodiagnostics (7% of sampled texts). The aspects of experiential thinking could also be interpreted as argumentative fallacies. Testimonials lead, for instance, to ad hominem and appeals to authorities. Confirmation bias and simplification of data give rise to hasty generalizations and false dilemmas. Moral issues lead to guilt by association and appeals to consequences. Experiential thinking and fallacies can contribute to false beliefs and the persistence of the claims. We propose that science educators would benefit from the systematic analysis of experiential thinking patterns and fallacies in creationist texts and pro-evolutionary rebuttals in order to concentrate on scientific misconceptions instead of the scientifically irrelevant aspects of the creationist-evolutionist debate.				petteri.nieminen@uef.fi						Behe MJ, EDGE EVOLUTION SEARC; Bergman, 1999, CEN TECHNICAL J, V13, P101; Bergman J, 2012, J CREATION, V26, P48; Bergman J, 2005, IMPACT, P383; Bergman J, 2004, IMPACT, P367; Boudry M, 2011, RELIGION, V41, P449, DOI 10.1080/0048721X.2011.600464; Brace RA, 2004, BIBLE EVOLUTOIN I WA; Brace RA, 2006, UTTER FAILURE 19 20; Buchanan S, 2012, GORILLA ORANGUTAN CH; Buchanan S, 2010, ASSESSING LIMITS EVO; Burgess S, 2006, DESIGNER HUMANS; Burgess S, 2007, HUMANS PURPOSELY DES; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Carrier R, 2010, CHRISTIAN DELUSION W, P396; Carter RW, 2010, CHIMPANZEE CHROMOSOM; Conway Morris S., 1998, CRUCIBLE CREATION BU; Creation Ministries International, 2014, SJ GOULD RAC; Darwin C, 1859, ORIGIN SPECIES MEANS; Davis P, 1993, PANDAS PEOPLE CENTRA; Dawkins R, 1989, SELFISH GENE; Dawkins R., 1989, NY TIMES; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Diogo R, 2011, J ANAT, V219, P273, DOI 10.1111/j.1469-7580.2011.01403.x; Diogo R, 2009, J ANAT, V215, P300, DOI 10.1111/j.1469-7580.2009.01111.x; Doherty ME, 1981, SCI THINKING, P158; Doyle S, 2007, J CREATION, V21, P11; Eldredge N, 1985, RETHINKING DARWINIAN; Episcopal Church in the United States of America the Committee on Science Technology and Faith of the Executive Council, 2005, CAT CREAT EP UND; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Evangelical Church in Germany, 2008, EV KIRCH ZIEHT KLAR; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Evowiki, 2008, EV RAC; Fogelin RJ, 1987, ARGUMENTATION, V1, P255; GOULD S J, 1977, Paleobiology, V3, P115; Gould S. J., 1980, PANDAS THUMB, P179; Gould S. J., 1977, ONTOGENY PHYLOGENY; Gould SJ, 1997, NAT HIST, V106, P16; Grigg R, 2005, CREATION, V28, P18; Gurney RJM, 2010, CREATION, V32, P53; Hafiz Y., 2013, HUFFINGTON POST; Harker BR, 2011, J CREATION, V25, P121; Harris WS, 2003, NATL CATHOLIC BIOETH, P531; Henke KR, 2014, YOUNG EARTH CREATION; Henry H, 2011, EVOLUTION STAMP CO 2; Hodge B, 2007, FINLAND SCH SCHOOTIN; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; John II Paul, 1996, MESSAGE PONTIFICAL A; Johnson P., 1993, DARWIN TRIAL; Johnson PE, 1995, REASON BALANE CASE N; Kahneman D., 2011, THINKING FAST SLOW; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Landau M., 1989, CREATION EVOLUTION J, V9, P1; Laudan L., 1983, PHYS PHILOS PSYCHOAN, P111, DOI DOI 10.1007/978-94-009-7055-7_6; Leisola M, 2012, ALUSTA VIIMEISEEN AI, P6; Lindeman M, 1998, SCAND J PSYCHOL, V39, P257, DOI 10.1111/1467-9450.00085; Lindeman M, 2000, J Health Psychol, V5, P195, DOI 10.1177/135910530000500210; Lindeman M, 2011, PSYCHOL HEALTH, V26, P371, DOI 10.1080/08870440903440707; Luskin C., 2008, INTELLIGENT DESIGN 1, P215; MacCoun RJ, 1998, ANNU REV PSYCHOL, V49, P259, DOI 10.1146/annurev.psych.49.1.259; Mackie John L., 1982, MIRACLE THEISM ARGUM; Marsden N, 2005, CREATION, V28, P36; McGrath Alister, 2010, SCI RELIG NEW INTRO; Mitroff Ian I., 1981, SCI THINKING, P170; Morris HM, 1972, REMARKABLE BIRTH PLA; Morris HM, 2001, IMPACT, P332; Morris JD, 2006, ACTS FACTS, P35; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nieminen P, 2014, EVOL EDUC OUTREACH, V7, P11, DOI [10.1186/s12052-014-0011-6, DOI 10.1186/s12052-014-0011-6]; NUMBERS RL, 1982, SCIENCE, V218, P538, DOI 10.1126/science.6750792; Numbers RL, 2011, HIST PHIL LIFE SCI, V33, P129; Pacini R, 1999, J PERS SOC PSYCHOL, V76, P972, DOI 10.1037/0022-3514.76.6.972; Paley W., 1809, NATURAL THEOLOGY, V12th; Panda's Thumb archive, 2010, CREAT Y CHROM; Pannenberg W, 1997, CREATION THEORY EVOL, VXXXV, P21; Pennock RT, 2002, SCI ED, V11, P111; Pigliucci M, 2004, PHILOS NOW, P46; Poole M, 2007, USERS GUIDE SCI BELI; Popper K., 1978, DIALECTICA, V32, P339, DOI [10.1111/j.1746-8361.1978.tb01321.x, DOI 10.1111/J.1746-8361.1978.TB01321.X]; Puolimatka T, 2010, TIEDEKESKUSTELUN AVO; Puolimatka T, 2009, USKO TIEDE EVOLUUTIO; Purves W. K., 2004, LIFE SCI BIOL; Putz R., 2009, SOBOTTA ATLAS HUMAN, V14th; Reinikainen P, 2013, EVOLUUTIO VAI LUOMIN; Reinikainen P, 2003, DINOSAURUSTEN ARVOIT; Reinikainen P, 2013, ENKELEITA ALEMMAKSI; Reinikainen P, 2011, DARWIN VAI ALYKAS SU; Reinikainen P, 1991, UNOHDETTU GENESIS; Sarfati J, 2005, REINFORCING DARWIN H; Scott EC, 1997, ANNU REV ANTHROPOL, V26, P263, DOI 10.1146/annurev.anthro.26.1.263; Sherman S. J., 1984, HDB SOCIAL COGNITION, V1, P189; Stanley S. M., 1979, MACROEVOLUTION PATTE; Stanovich KE, 1997, J EDUC PSYCHOL, V89, P342, DOI 10.1037/0022-0663.89.2.342; Stanovich KE, 2013, CURR DIR PSYCHOL SCI, V22, P259, DOI 10.1177/0963721413480174; Steering Committee on Science and Creationism, 1999, SCI CREAT VIEW NAT A; Swenson K, 2001, RADIO DATING RUBBLE; TalkOrigins archive, 2001, CLAIM CA610; TalkOrigins archive, 2001, CLAIM CA321; TalkOrigins archive, 2003, CLAIM CA012; TalkOrigins archive, 2000, CLAIM CA310; TalkOrigins archive, 2001, CLAIM CA006 1; TalkOrigins archive, 2003, CLAIM CC001; TalkOrigins archive, 2001, CLAIM CA602; TalkOrigins archive, 2001, CLAIM CA005; TalkOrigins archive, 2003, CLAIM CA041 1; Thomas B, 2010, ARE HUMANS CLOSE CHI; van Eemeren Frans H., 1992, ARGUMENTATION COMMUN; Wiens Roger C., 2002, RADIOMETRIC DATING C; Wilkins JS, 2011, SYNTHESE, V178, P207, DOI 10.1007/s11229-009-9544-6; Wolpert Lewis, 1994, UNNATURAL NATURE SCI; Young W, 1985, FALLACIES CREATIONIS	110	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118314	10.1371/journal.pone.0118314	http://dx.doi.org/10.1371/journal.pone.0118314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CC4HV	25734650	Green Submitted, Green Published, gold			2022-12-26	WOS:000350314700022
J	Riou, J; Lefevre, T; Parizot, I; Lhuissier, A; Chauvin, P				Riou, Julien; Lefevre, Thomas; Parizot, Isabelle; Lhuissier, Anne; Chauvin, Pierre			Is There Still a French Eating Model? A Taxonomy of Eating Behaviors in Adults Living in the Paris Metropolitan Area in 2010	PLOS ONE			English	Article							CLASS DISCOVERY; FAMILY; MEALS; FREQUENCY; PATTERNS; CHILDREN; FRANCE; DIET; FOOD	Background Meal times in France still represent an important moment in everyday life. The model of three rigorously synchronized meals is still followed by a majority of people, while meal frequencies have flattened in other European or North-American countries. We aimed to examine the "French model" of eating behavior by identifying and characterizing distinct meal patterns. Methods Analyses were based on data from the SIRS cohort, a representative survey of the adult population in the Paris area. A clustering algorithm was applied to meal variables (number, time, location, with whom the meal is usually shared and activities associated with meals). Regression models were used to investigate associations between patterns and socio-demographic, social environment and perceived food quality variables. Results Five different patterns were identified among 2994 participants. The first three types (prevalence 33%, 17% and 24%) followed a three-meal pattern, with differences in locations and social interactions mainly related to time constraints and age. More marked differences were observed in the remaining two types. In the fourth type (prevalence 13%), individuals ate one or two meals per day, often with an irregular schedule, at home and in front of the television. They frequently were unemployed and had lower income. Breakfast skipping, increased snacking and a low adherence to dietary guidelines suggested that this behavior might have health consequences. In the fifth type (12%), people also ate two meals or less per day, possibly with the same consequences on food quality. However, meals were often taken outside the home, in social settings, and individuals following this pattern were typically active, integrated, young people, suggesting that this pattern might be an adaptation to a modern urban lifestyle. Conclusions While a majority of the population still follows the three-meal pattern, our analysis distinguished two other eating patterns associated with specific sociological profiles.	[Riou, Julien; Lefevre, Thomas; Chauvin, Pierre] Univ Paris 06, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Epidemiol & Social Med, Sorbonne Univ,Dept Social Epidemiol,UMR S 1136, F-75013 Paris, France; [Riou, Julien; Lefevre, Thomas; Chauvin, Pierre] INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, UMR S 1136, F-75013 Paris, France; [Lefevre, Thomas] Hop Jean Verdier, Dept Forens Med, AP HP, F-93140 Bondy, France; [Parizot, Isabelle] CNRS, Ctr Maurice Halbwachs, UMR 8097, Res Team Social Inequal, F-75014 Paris, France; [Lhuissier, Anne] INRA, ALISS UR1303, F-94205 Ivry, France; [Lhuissier, Anne] Univ Oxford, Dept Sociol, Oxford OX1 3UQ, England	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Riou, J (corresponding author), Univ Paris 06, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Epidemiol & Social Med, Sorbonne Univ,Dept Social Epidemiol,UMR S 1136, F-75013 Paris, France.	julien.riou.k@gmail.com	Thomas, Lefèvre/AAE-8350-2022; Riou, Julien/AAA-9152-2022; Chauvin, Pierre/S-2981-2019	Chauvin, Pierre/0000-0002-9183-6406; Riou, Julien/0000-0002-3808-2852; Lefevre, Thomas/0000-0003-3038-479X	National Research Agency (ANR) within the framework of the National Food Research Program [ANR-07-PNRA-002-01]; Institute for Public Health Research (IReSP) [2008-87]; French Interministerial Committee for Urban Affairs [2009-273]	National Research Agency (ANR) within the framework of the National Food Research Program(French National Research Agency (ANR)); Institute for Public Health Research (IReSP); French Interministerial Committee for Urban Affairs	This study was supported by the National Research Agency (ANR) within the framework of the National Food Research Program (grant number ANR-07-PNRA-002-01; URL: http://www.agence-nationale-recherche.fr). The SIRS survey was also supported by the Institute for Public Health Research (IReSP) (grant number 2008-87; URL: http://www.iresp.net) and the French Interministerial Committee for Urban Affairs (grant number 2009-273; URL: http://www.ville.gouv.fr/?le-commissariat-general-a-l, 9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caillavet F, 2005, ALIMENTATION POPULAT, P44; De Saint Pol T, 2012, INSEE PREMIERE, P1417; De Saint Pol T., 2006, EC STAT, V400, P45; Diaz-Mendez C, 2014, INT J COMP SOCIOL, V55, P24, DOI 10.1177/0020715213519657; Escalon H, 2009, BAROMETRE SANTE NUTR, P424; Eurostat, 2004, EUR SPEND THEIR TIM; FANTASIA R, 1995, THEOR SOC, V24, P201, DOI 10.1007/BF00993397; FISCHLER Claude, 1990, HOMNIVORE GOUT CUISI; Fulkerson JA, 2014, J NUTR EDUC BEHAV, V46, P2, DOI 10.1016/j.jneb.2013.07.012; Grignon C., 1996, Food & Foodways, V6, P205; Hammons AJ, 2011, PEDIATRICS, V127, pE1565, DOI 10.1542/peds.2010-1440; Hebel P, 2013, CONSOMM MODES VIE; HERPIN N, 1988, REV FR SOCIOL, V29, P503, DOI 10.2307/3321627; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Lhuissier A, 2014, ANTHR FOOD, pS10; Lhuissier A, 2013, APPETITE, V63, P59, DOI 10.1016/j.appet.2012.12.012; Lund TB, 2014, APPETITE, V82, P143, DOI 10.1016/j.appet.2014.07.004; Makela J, 1999, APPETITE, V32, P73, DOI 10.1006/appe.1998.0198; Martin-Fernandez J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-486; Mestdag I, 2009, SOCIOL REV, V57, P703, DOI 10.1111/j.1467-954X.2009.01868.x; Monteleone E, 2009, MEALS SCI PRACTICE I, P704; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Pereira M, 2011, J NUTR, V141, P163, DOI 10.3945/jn.109.114405; Poulain JP, 2002, APPETITE, V39, P43, DOI 10.1006/appe.2001.0461; R Core Team, 2021, R LANGUAGE ENV STAT; Simpson TI, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-590; Skafida V, 2013, SOCIOL HEALTH ILL, V35, P906, DOI 10.1111/1467-9566.12007; Sobal J, 2003, APPETITE, V41, P181, DOI 10.1016/S0195-6663(03)00078-3; Sobal J, 2011, PUBLIC HEALTH NUTR, V14, P1555, DOI 10.1017/S1368980011000127; Tavoularis G, 2010, CONSOMM MODES VIE, V232, P1; Todd J.E., 2010, ERR90 USDA; Tovar A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-84; Venables WN., 2002, MODERN APPL STAT S 4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	35	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119161	10.1371/journal.pone.0119161	http://dx.doi.org/10.1371/journal.pone.0119161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734543	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700056
J	Kumar, CSC; Loh, WS; Chandraju, S; Win, YF; Tan, WK; Quah, CK; Fun, HK				Kumar, C. S. Chidan; Loh, Wan-Sin; Chandraju, Siddegowda; Win, Yip-Foo; Tan, Weng Kang; Quah, Ching Kheng; Fun, Hoong-Kun			Synthesis, Structural and Antioxidant Studies of Some Novel N-Ethyl Phthalimide Esters	PLOS ONE			English	Article							DERIVATIVES; DESIGN	A series of N-ethyl phthalimide esters 4(a-n) were synthesized and characterized by spectroscopic studies. Further, the molecular structure of majority of compounds were analysed by single crystal X-ray diffraction studies. The X-ray analysis revealed the importance of substituents on the crystal stability and molecular packing. All the synthesized compounds were tested for in vitro antioxidant activity by DPPH radical scavenging, FRAP and CUPRAC methods. Few of them have shown good antioxidant activity.	[Kumar, C. S. Chidan; Loh, Wan-Sin; Quah, Ching Kheng; Fun, Hoong-Kun] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town, Malaysia; [Kumar, C. S. Chidan] Alvas Inst Engn & Technol, Dept Chem, Mijar, Karnataka, India; [Chandraju, Siddegowda] Univ Mysore, Sir MV PG Ctr, Dept Sugar Technol & Chem, Tubinakere, Karnataka, India; [Win, Yip-Foo] Univ Tunku Abdul Rahman, Fac Sci, Dept Chem Sci, Bandar Barat, Perak, Malaysia; [Tan, Weng Kang] Klin Kesihatan Batu Kawa, Kuching, Sarawak, Malaysia; [Fun, Hoong-Kun] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia	Universiti Sains Malaysia; University of Mysore; Universiti Tunku Abdul Rahman (UTAR); King Saud University	Kumar, CSC (corresponding author), Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town, Malaysia.	chidankumar@gmail.com; ckquah@usm.my	Quah, Ching Kheng/A-5525-2009; Loh, Wansin/C-7581-2009; Fun, Hoong-Kun/A-3561-2009	Quah, Ching Kheng/0000-0002-3279-4349; Loh, Wansin/0000-0003-4718-0363; 	Universiti Sains Malaysia (USM); Malaysian Government; USM for Fundamental Research Grant Scheme (FRGS) [203/PFIZIK/6711411]; Deanship of Scientific Research at King Saud University [RGP VPP-207]	Universiti Sains Malaysia (USM)(Universiti Sains Malaysia); Malaysian Government; USM for Fundamental Research Grant Scheme (FRGS); Deanship of Scientific Research at King Saud University(King Saud University)	CSCK thanks Universiti Sains Malaysia (USM) for a postdoctoral research fellowship. WSL thanks Malaysian Government for MyBrain15 (MyPhD) scholarship. CKQ thanks Malaysian Government and USM for Fundamental Research Grant Scheme (FRGS) (203/PFIZIK/6711411). The authors extend their appreciation to The Deanship of Scientific Research at King Saud University for the funding the work through the research group project No. RGP VPP-207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes R, 1998, BIOORG MED CHEM LETT, V8, P3071, DOI 10.1016/S0960-894X(98)00558-7; Apak R, 2008, MICROCHIM ACTA, V160, P413, DOI 10.1007/s00604-007-0777-0; Babu IS, 2013, PHARM CHEM, V5, P198; BAILLEUX V, 1994, CHEM PHARM BULL, V42, P1817; BERNSTEIN J, 1995, ANGEW CHEM INT EDIT, V34, P1555, DOI 10.1002/anie.199515551; Bruker AXS Inc, 2009, SAINT SADABS; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Heller E, 2009, TETRAHEDRON LETT, V50, P1321, DOI 10.1016/j.tetlet.2009.01.035; Kumar CSC, 2014, Z KRIST-CRYST MATER, V229, P328, DOI 10.1515/zkri-2013-1709; Lai LS, 2001, J AGR FOOD CHEM, V49, P963, DOI 10.1021/jf001146k; Machado AL, 2005, BIOORG MED CHEM LETT, V15, P1169, DOI 10.1016/j.bmcl.2004.12.012; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pavia D.L., 2001, INTRO SPECTROSCOPY, Vthird; Pozharskii F, 1997, HETEROCYCLES LIFE SO, P301, DOI [10.1002/prac.19983400517, DOI 10.1002/PRAC.19983400517]; Salat K, 2013, MINI-REV MED CHEM, V13, P335; Samee W, 2011, AFR J PHARM PHARMACO, V5, P477, DOI 10.5897/AJPP10.156; Sena Vera L. M., 2003, Farmaco (Lausanne), V58, P1283, DOI 10.1016/S0014-827X(03)00185-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Toth G, 2007, CURR PHARM DESIGN, V13, P3476, DOI 10.2174/138161207782794284; Vogel AI, 1998, TXB PRACTICAL ORGANI, P1065; Zamani K, 2005, TURK J CHEM, V29, P171; Zhang QS, 2012, J AM CHEM SOC, V134, P14706, DOI 10.1021/ja306538w	22	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119440	10.1371/journal.pone.0119440	http://dx.doi.org/10.1371/journal.pone.0119440			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742494	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000350688100112
J	Munksgaard, NC; Zwart, C; Kurita, N; Bass, A; Nott, J; Bird, MI				Munksgaard, Niels C.; Zwart, Costijn; Kurita, Naoyuki; Bass, Adrian; Nott, Jon; Bird, Michael I.			Stable Isotope Anatomy of Tropical Cyclone Ita, North-Eastern Australia, April 2014	PLOS ONE			English	Article							HYDROGEN ISOTOPES; WATER ISOTOPES; DELTA-D; VARIABILITY; PRECIPITATION; OXYGEN	The isotope signatures registered in speleothems during tropical cyclones (TC) provides information about the frequency and intensity of past TCs but the precise relationship between isotopic composition and the meteorology of TCs remain uncertain. Here we present continuous delta O-18 and delta H-2 data in rainfall and water vapour, as well as in discrete rainfall samples, during the passage of TC Ita and relate the evolution in isotopic compositions to local and synoptic scale meteorological observations. High-resolution data revealed a close relationship between isotopic compositions and cyclonic features such as spiral rainbands, periods of stratiform rainfall and the arrival of subtropical and tropical air masses with changing oceanic and continental moisture sources. The isotopic compositions in discrete rainfall samples were remarkably constant along the similar to 450 km overland path of the cyclone when taking into account the direction and distance to the eye of the cyclone at each sampling time. Near simultaneous variations in delta O-18 and delta H-2 values in rainfall and vapour and a near-equilibrium rainfall-vapour isotope fractionation indicates strong isotopic exchange between rainfall and surface inflow of vapour during the approach of the cyclone. In contrast, after the passage of spiral rainbands close to the eye of the cyclone, different moisture sources for rainfall and vapour are reflected in diverging d-excess values. High-resolution isotope studies of modern TCs refine the interpretation of stable isotope signatures found in speleothems and other paleo archives and should aim to further investigate the influence of cyclone intensity and longevity on the isotopic composition of associated rainfall.	[Munksgaard, Niels C.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Munksgaard, Niels C.; Zwart, Costijn; Bass, Adrian; Nott, Jon; Bird, Michael I.] James Cook Univ, Coll Sci,Technol & Engn, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Kurita, Naoyuki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Charles Darwin University; James Cook University; Nagoya University	Munksgaard, NC (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	niels.munksgaard@cdu.edu.au	Bird, Michael/G-5364-2010; Bass, Adrian Michael/A-6133-2016; Kurita, Naoyuki/C-6120-2014; Nott, Jonathan/H-5156-2011	Bird, Michael/0000-0003-1801-8703; Bass, Adrian Michael/0000-0003-3982-6582; Nott, Jonathan/0000-0001-7258-017X	Australian Research Council [LE130100159]	Australian Research Council(Australian Research Council)	This work was supported by Grant LE130100159 from the Australian Research Council http://www.arc.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; EHHALT DH, 1970, J GEOPHYS RES, V75, P2323, DOI 10.1029/JC075i012p02323; Frappier AB, 2007, GEOLOGY, V35, P111, DOI 10.1130/G23145A.1; Fudeyasu H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009313; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Gedzelman S, 2003, MON WEATHER REV, V131, P1112, DOI 10.1175/1520-0493(2003)131<1112:PHWSIO>2.0.CO;2; Gimeno L, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000389; Good SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091117; Haig J, 2014, NATURE, V505, P667, DOI 10.1038/nature12882; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; Jouzel J, 2013, WATER RESOUR RES, V49, P7469, DOI 10.1002/2013WR013508; Kurita N, 2012, ATMOS MEAS TECH, V5, P2069, DOI 10.5194/amt-5-2069-2012; Kurita N, 2013, J GEOPHYS RES-ATMOS, V118, P10376, DOI 10.1002/jgrd.50754; Kurita N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015209; Lawrence JR, 1996, GEOPHYS RES LETT, V23, P527, DOI 10.1029/96GL00425; Lawrence JR, 2002, J ATMOS CHEM, V41, P67, DOI 10.1023/A:1013808530364; Lawrence JR, 1998, CHEM GEOL, V144, P153, DOI 10.1016/S0009-2541(97)00090-9; Lee JE, 2008, HYDROL PROCESS, V22, P1, DOI 10.1002/hyp.6637; Li ZH, 2011, CHEM GEOL, V284, P138, DOI 10.1016/j.chemgeo.2011.02.015; Liu JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014403; Lonfat M, 2004, MON WEATHER REV, V132, P1645, DOI 10.1175/1520-0493(2004)132<1645:PDITCU>2.0.CO;2; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Miller DL, 2006, P NATL ACAD SCI USA, V103, P14294, DOI 10.1073/pnas.0606549103; Munksgaard NC, 2012, HYDROL PROCESS, V26, P3630, DOI 10.1002/hyp.9505; Munksgaard NC, 2011, RAPID COMMUN MASS SP, V25, P3706, DOI 10.1002/rcm.5282; Nott J, 2007, EARTH PLANET SC LETT, V255, P367, DOI 10.1016/j.epsl.2006.12.023; Risi C, 2010, Q J ROY METEOR SOC, V136, P227, DOI 10.1002/qj.485; Rozanski K, 1993, GEOPHYS MONOGR SER, P78; Trenberth KE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008303	29	42	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119728	10.1371/journal.pone.0119728	http://dx.doi.org/10.1371/journal.pone.0119728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742628	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000350688100127
J	Nieto-Gonzalez, JL; Holm, MM; Vardya, I; Christensen, T; Wiborg, O; Jensen, K				Nieto-Gonzalez, Jose Luis; Holm, Mai Marie; Vardya, Irina; Christensen, Trine; Wiborg, Ove; Jensen, Kimmo			Presynaptic Plasticity as a Hallmark of Rat Stress Susceptibility and Antidepressant Response	PLOS ONE			English	Article							CHRONIC MILD STRESS; NEUROTRANSMITTER RELEASE; CHROMATIN REGULATION; MODEL; DEPRESSION; HIPPOCAMPUS; RESILIENCE; ESCITALOPRAM; RESISTANCE; DRUG	Two main questions are important for understanding and treating affective disorders: why are certain individuals susceptible or resilient to stress, and what are the features of treatment response and resistance? To address these questions, we used a chronic mild stress (CMS) rat model of depression. When exposed to stress, a fraction of rats develops anhedonic-like behavior, a core symptom of major depression, while another subgroup of rats is resilient to CMS. Furthermore, the anhedonic-like state is reversed in about half the animals in response to chronic escitalopram treatment (responders), while the remaining animals are resistant (non-responder animals). Electrophysiology in hippocampal brain slices was used to identify a synaptic hallmark characterizing these groups of animals. Presynaptic properties were investigated at GABAergic synapses onto single dentate gyrus granule cells. Stress-susceptible rats displayed a reduced probability of GABA release judged by an altered paired-pulse ratio of evoked inhibitory postsynaptic currents (IPSCs) (1.48 +/- 0.25) compared with control (0.81 +/- 0.05) and stress-resilient rats (0.78 +/- 0.03). Spontaneous IPSCs (sIPSCs) occurred less frequently in stress-susceptible rats compared with control and resilient rats. Finally, a subset of stress-susceptible rats responding to selective serotonin reuptake inhibitor (SSRI) treatment showed a normalization of the paired-pulse ratio (0.73 +/- 0.06) whereas non-responder rats showed no normalization (1.2 +/- 0.2). No changes in the number of parvalbumin-positive interneurons were observed. Thus, we provide evidence for a distinct GABAergic synaptopathy which associates closely with stress-susceptibility and treatment-resistance in an animal model of depression.	[Nieto-Gonzalez, Jose Luis; Holm, Mai Marie; Vardya, Irina; Jensen, Kimmo] Aarhus Univ, Dept Biomed, Synapt Physiol Lab, DK-8000 Aarhus C, Denmark; [Christensen, Trine; Wiborg, Ove; Jensen, Kimmo] Aarhus Univ Hosp, Translat Neuropsychiat Unit, DK-8240 Risskov, Denmark; [Jensen, Kimmo] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	Aarhus University; Aarhus University; University of Gothenburg	Nieto-Gonzalez, JL (corresponding author), Aarhus Univ, Dept Biomed, Synapt Physiol Lab, Bldg 1160, DK-8000 Aarhus C, Denmark.	jlnieto@us.es	Nieto-Gonzalez, Jose L/B-7165-2013	Nieto-Gonzalez, Jose L/0000-0003-1757-4951; Jensen, Kimmo/0000-0001-8895-6194; Holm, Mai/0000-0001-7347-8724	Lundbeck Foundation; Danish MRC; Velux Foundation; Lundbeck Foundation [R67-2010-6537] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish MRC(Danish Medical Research Council); Velux Foundation(Velux Fonden); Lundbeck Foundation(Lundbeckfonden)	The present study was supported by the Lundbeck Foundation, The Danish MRC and the Velux Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bergstrom A, 2008, BRAIN RES, V1196, P41, DOI 10.1016/j.brainres.2007.12.025; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Cabezas C, 2006, J NEUROPHYSIOL, V95, P3024, DOI 10.1152/jn.00739.2005; Christensen T, 2011, NEUROSCIENCE, V196, P66, DOI 10.1016/j.neuroscience.2011.08.024; Christiansen S, 2012, STRESS, V15, P647, DOI 10.3109/10253890.2011.654370; Czeh B, 2005, NEUROPSYCHOPHARMACOL, V30, P67, DOI 10.1038/sj.npp.1300581; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Drasbek KR, 2006, CEREB CORTEX, V16, P1134, DOI 10.1093/cercor/bhj055; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Gao SF, 2011, NEUROSCIENTIST, V17, P124, DOI 10.1177/1073858410361780; Girotti M, 2006, NEUROSCIENCE, V138, P1067, DOI 10.1016/j.neuroscience.2005.12.002; Gorman Jack M, 2006, Gend Med, V3, P93, DOI 10.1016/S1550-8579(06)80199-3; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Henningsen K, 2009, BEHAV BRAIN RES, V198, P136, DOI 10.1016/j.bbr.2008.10.039; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Holm MM, 2011, HIPPOCAMPUS, V21, P422, DOI 10.1002/hipo.20758; Holm MM, 2009, J NEUROSCI, V29, P12412, DOI 10.1523/JNEUROSCI.2978-09.2009; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Huang FS, 2007, EUR J NEUROSCI, V25, P3253, DOI 10.1111/j.1460-9568.2007.05539.x; Jayatissa MN, 2008, NEUROPHARMACOLOGY, V54, P530, DOI 10.1016/j.neuropharm.2007.11.009; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Kennedy SH, 2006, J PSYCHIATR NEUROSCI, V31, P122; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Wiborg O, 2013, CELL TISSUE RES, V354, P155, DOI 10.1007/s00441-013-1664-0; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Williams SR, 1998, J PHYSIOL-LONDON, V510, P477, DOI 10.1111/j.1469-7793.1998.477bk.x; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	47	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119993	10.1371/journal.pone.0119993	http://dx.doi.org/10.1371/journal.pone.0119993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742132	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100131
J	Bernhardt, AM; Wilking, C; Gilbert-Diamond, D; Emond, JA; Sargent, JD				Bernhardt, Amy M.; Wilking, Cara; Gilbert-Diamond, Diane; Emond, Jennifer A.; Sargent, James D.			Children's Recall of Fast Food Television Advertising-Testing the Adequacy of Food Marketing Regulation	PLOS ONE			English	Article								Background and Aim In the United States, the fast food companies McDonald's and Burger King participate in marketing self-regulation programs that aim to limit emphasis on premiums and promote emphasis of healthy food choices. We determine what children recall from fast food television advertisements aired by these companies. Methods One hundred children aged 3-7 years were shown McDonald's and Burger King children's (MDC & BKC) and adult (MDA & BKA) meal ads, randomly drawn from ads that aired on national US television from 2010-11. Immediately after seeing the ad, children were asked to recall what they had seen and transcripts evaluated for descriptors of food, healthy food (apples or milk), and premiums/tie-ins. Results Premiums/tie-ins were common in children's but rarely appeared in adult ads, and all children's ads contained images of healthy foods (apples and milk). Participants were significantly less likely to recall any food after viewing the children's vs. the adult ad (MDC 32% [95% confidence interval 23, 41] vs. MDA 68% [59, 77]) p < 0.001; BKC 46% [39, 56] vs. BKA 67% [58, 76] respectively, p = 0.002). For children's ads alone and for both restaurants, recall frequency for all food was not significantly different from premium/tie-ins, and participants were significantly more likely to recall other food items than apples or milk. Moreover, premiums/tie-ins were recalled much more frequently than healthy food (MDC 45% [35, 55] vs. 9% [3, 15] p< 0.001; BKC 54% [44, 64] vs. 2% [0, 5] respectively, p< 0.001). Conclusions Children's net impressions of television fast food advertising indicate that industry self-regulation failed to achieve a de-emphasis on toy premiums and tie-ins and did not adequately communicate healthy menu choices. The methods devised for this study could be used to monitor and better regulate advertising patterns of practice.	[Bernhardt, Amy M.; Gilbert-Diamond, Diane; Emond, Jennifer A.; Sargent, James D.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA; [Wilking, Cara] Northeastern Univ, Sch Law, Publ Hlth Advocacy Inst, Boston, MA 02115 USA; [Gilbert-Diamond, Diane; Emond, Jennifer A.; Sargent, James D.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA; [Sargent, James D.] Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA	Dartmouth College; Norris Cotton Cancer Center; Northeastern University; Dartmouth College; Dartmouth College	Sargent, JD (corresponding author), Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA.	james.d.sargent@dartmouth.edu	Sargent, James D/I-2773-2013		Robert Wood Johnson Foundation Healthy Eating Research Program [69552]; Prouty research program of the Norris Cotton Cancer Center; National Institutes of Health [HD076097]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD076097] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Healthy Eating Research Program(Robert Wood Johnson Foundation (RWJF)); Prouty research program of the Norris Cotton Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the Robert Wood Johnson Foundation Healthy Eating Research Program, grant #69552, (PI JDS) and the Prouty research program of the Norris Cotton Cancer Center; Gilbert-Diamond is funded by HD076097 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advertising Self Regulatory Council (ASRC), 2010, CARU REF HAR ADV FTC; Barnes B., 2013, NY TIMES; Bernhardt AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072479; Botha S., 2012, REV FOOD MARKETING C; Boyland EJ, 2011, PEDIATRICS, V128, pE93, DOI 10.1542/peds.2010-1859; Burger King Corp, 2009, BURG KING CORPS 4 SU; Burger King Corp, 2007, BURG KING CORP PLEDG; Children's Advertising Review Unit, 2009, SELF REG PROGR CHILD; Christakis DA, 2013, PEDIATRICS, V131, P431, DOI 10.1542/peds.2012-1493; Graff S, 2012, HEALTH AFFAIR, V31, P392, DOI 10.1377/hlthaff.2011.0609; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; HAYES DS, 1980, DEV PSYCHOL, V16, P410, DOI 10.1037/0012-1649.16.5.410; Maher JK, 2006, J ADVERTISING, V35, P23, DOI 10.2753/JOA0091-3367350102; McDonald's USA, 2010, MCDON US SUPP UPD FE; McDonald's USA, 2007, MCDON US SUPP; Nestle M, 2006, NEW ENGL J MED, V354, P2527, DOI 10.1056/NEJMp068014; R Core Team, 2021, R LANGUAGE ENV STAT; Stitt C, 2008, HEALTH COMMUN, V23, P573, DOI 10.1080/10410230802465258; The Public Health Advocacy Institute, 2013, MCDON REP VIOL CARU; Vader AM, 2009, PREV CHRONIC DIS, V6	20	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119300	10.1371/journal.pone.0119300	http://dx.doi.org/10.1371/journal.pone.0119300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738653	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900103
J	Song, YB; Wang, F; Wang, B; Tao, SH; Zhang, HP; Liu, S; Ramirez, O; Zeng, QY				Song, Yuanbin; Wang, Fan; Wang, Bin; Tao, Shaohua; Zhang, Huiping; Liu, Sai; Ramirez, Oscar; Zeng, Qiyi			Time Series Analyses of Hand, Foot and Mouth Disease Integrating Weather Variables	PLOS ONE			English	Article							ENTEROVIRUS 71; RISK-FACTORS; CIRCULATION; ASSOCIATION; INFECTION; GUANGZHOU; EPIDEMIC; SHENZHEN; HUMIDITY; CHILDREN	Background The past decade witnessed an increment in the incidence of hand foot mouth disease (HFMD) in the Pacific Asian region; specifically, in Guangzhou China. This emphasized the requirement of an early warning system designed to allow the medical community to better prepare for outbreaks and thus minimize the number of fatalities. Methods Samples from 1,556 inpatients (hospitalized) and 11,004 outpatients (non-admitted) diagnosed with HFMD were collected in this study from January 2009 to October 2013. Seasonal Autoregressive Integrated Moving Average (SARIMA) model was applied to establish high predictive model for inpatients and outpatient as well as three viral serotypes (EV71, Pan-EV and CA16). To integrate climate variables in the data analyses, data from eight climate variables were simultaneously obtained during this period. Significant climate variable identified by correlation analyses was executed to improve time series modeling as external repressors. Results Among inpatients with HFMD, 248 (15.9%) were affected by EV71, 137 (8.8%) were affected by Pan-EV+, and 436 (28.0%) were affected by CA16. Optimal Univariate SARIMA model was identified: (2,0,3)(1,0,0) 52 for inpatients, (0,1,0)(0,0,2) 52 for outpatients as well as three serotypes (EV71, (1,0,1)(0,0,1) 52; CA16, (1,0,1)(0,0,0) 52; Pan-EV, (1,0,1) (0,0,0) 52). Using climate as our independent variable, precipitation (PP) was first identified to be associated with inpatients (r = 0.211, P = 0.001), CA16-serotype (r = 0.171, P = 0.007) and outpatients (r = 0.214, P = 0.01) in partial correlation analyses, and was then shown a significant lag in cross-autocorrelation analyses. However, inclusion of PP [lag -3 week] as external repressor showed a moderate impact on the predictive performance of the SARIMA model described here-in. Conclusion Climate patterns and HFMD incidences have been shown to be strongly correlated. The SARIMA model developed here can be a helpful tool in developing an early warning system for HFMD.	[Song, Yuanbin; Wang, Bin; Tao, Shaohua; Zeng, Qiyi] Southern Med Univ, Pediat Ctr, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Fan] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Ramirez, Oscar] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Zhang, Huiping] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Liu, Sai] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Southern Medical University - China; University of Pennsylvania; Yale University; Yale University; Yale University	Ramirez, O (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA.	oscar.ramirez@yale.edu; ZQY_88@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Zhang, Huiping/0000-0002-4902-0104; WANG, FAN/0000-0001-9806-5037	Guangzhou medicine technology major projects [201102A211007]; National Natural Science Foundation of China [81272070]; Southern Medical University research projects for young scientist [B1012039]	Guangzhou medicine technology major projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Southern Medical University research projects for young scientist	This work was supported by Guangzhou medicine technology major projects (grant 201102A211007), partly by National Natural Science Foundation of China (grant 81272070), and Southern Medical University research projects for young scientist (grant B1012039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUANGZH STAT YB 2013; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Bo YC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-358; Box G. E., 1970, J AM STAT ASSOC, V65, P1509, DOI [10.1080/01621459.1970.10481180, DOI 10.1080/01621459.1970.10481180]; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen CJ, 2013, INT CONF BIOMETR; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Chinese Ministry of Health, HAND FOOT MOUTH DIS; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Fang YR, 2014, SCAND J INFECT DIS, V46, P515, DOI 10.3109/00365548.2014.907929; Feng HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087916; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Investigators P, 2011, PROP COR DAT PROT; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee BY, 2010, VACCINE, V28, P7731, DOI 10.1016/j.vaccine.2010.09.065; Li T, 2014, EPIDEMIOL INFECT, V142, P1741, DOI 10.1017/S0950268813002938; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087603; Li XC, 2013, ATHEROSCLEROSIS, V231, P136, DOI 10.1016/j.atherosclerosis.2013.08.031; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Quenel P, 1998, EUR J EPIDEMIOL, V14, P275, DOI 10.1023/A:1007467814485; Rajendran K, 2011, INDIAN J MED RES, V133, P138; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang YR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-539; WHO/WPRO, 2010, COMM DIS SURV RESP R; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-57; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	39	29	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117296	10.1371/journal.pone.0117296	http://dx.doi.org/10.1371/journal.pone.0117296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729897	Green Published, gold, Green Submitted			2022-12-26	WOS:000350684900012
J	Tremblay, M; Gallant, F; Lavalliere, M; Chiasson, M; Silvey, D; Behm, D; Albert, WJ; Johnson, MJ				Tremblay, Mathieu; Gallant, Francois; Lavalliere, Martin; Chiasson, Martine; Silvey, Dustin; Behm, David; Albert, Wayne J.; Johnson, Michel J.			Driving Performance on the Descending Limb of Blood Alcohol Concentration (BAC) in Undergraduate Students: A Pilot Study	PLOS ONE			English	Article							FIELD-OF-VIEW; HEART-RATE-VARIABILITY; YOUNG; DRINKING; RELIABILITY; EXPECTANCY; VALIDITY; DRIVERS; CRASHES; TRENDS	Young drivers are overrepresented in collisions resulting in fatalities. It is not uncommon for young drivers to socially binge drink and decide to drive a vehicle a few hours after consumption. To better understand the risks that may be associated with this behaviour, the present study has examined the effects of a social drinking bout followed by a simulated drive in undergraduate students on the descending limb of their BAC (blood alcohol concentration) curve. Two groups of eight undergraduate students (n = 16) took part in this study. Participants in the alcohol group were assessed before drinking, then at moderate and low BAC as well as 24 hours post-acute consumption. This group consumed an average of 5.3 +/- 1.4 (mean +/- SD) drinks in an hour in a social context and were then submitted to a driving and a predicted crash risk assessment. The control group was assessed at the same time points without alcohol intake or social context.; at 8 a.m., noon, 3 p.m. and 8 a.m. the next morning. These multiple time points were used to measure any potential learning effects from the assessment tools (i.e. driving simulator and useful field of view test (UFOV)). Diminished driving performance at moderate BAC was observed with no increases in predicted crash risk. Moderate correlations between driving variables were observed. No association exists between driving variables and UFOV variables. The control group improved measures of selective attention after the third asessement. No learning effect was observed from multiple sessions with the driving simulator. Our results show that a moderate BAC, although legal, increases the risky behaviour. Effects of alcohol expectancy could have been displayed by the experimental group. UFOV measures and predicted crash risk categories were not sentitive enough to predict crash risk for young drivers, even when intoxicated.	[Tremblay, Mathieu; Chiasson, Martine; Albert, Wayne J.] Univ New Brunswick, Fac Kinesiol, Fredericton, NB, Canada; [Gallant, Francois; Johnson, Michel J.] Univ Moncton, Ecole Kinesiol & Loisir, Moncton, NB E1A 3E9, Canada; [Tremblay, Mathieu; Gallant, Francois; Chiasson, Martine; Johnson, Michel J.] Univ Moncton, Hlth Driver Res Grp, Moncton, NB E1A 3E9, Canada; [Lavalliere, Martin] MIT, AgeLab, Cambridge, MA 02139 USA; [Lavalliere, Martin] Univ New England, Transportat Ctr, Cambridge, MA USA; [Silvey, Dustin; Behm, David] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada	University of New Brunswick; University of Moncton; University of Moncton; Massachusetts Institute of Technology (MIT); University of New England - Maine; Memorial University Newfoundland	Johnson, MJ (corresponding author), Univ Moncton, Ecole Kinesiol & Loisir, Moncton, NB E1A 3E9, Canada.	michel.johnson@umoncton.ca	Lavalliere, Martin/AFU-5311-2022; Behm, David George/I-6509-2019	Lavalliere, Martin/0000-0003-0247-0308; Behm, David George/0000-0002-9406-6056; Tremblay, Mathieu/0000-0002-9507-9051				Bentley SA, 2012, INVEST OPHTH VIS SCI, V53, P6763, DOI 10.1167/iovs.12-9718; Burian SE, 2003, HUM PSYCHOPHARM CLIN, V18, P175, DOI 10.1002/hup.473; CPHA, 2011, TOO HIGH COST PUBL H, V20; Dry MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050977; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; French MT, 2014, P 6 ANN M EC RISK BE, P20; Hegg-Deloye S, 2010, P 20 CAN MULT ROAD S, P14; Karpyak VM, 2014, ALCOHOL CLIN EXP RES, V38, P9, DOI 10.1111/acer.12270; Kypri K, 2005, ALCOHOL ALCOHOLISM, V40, P447, DOI 10.1093/alcalc/agh178; Lambert-Belanger A, 2012, J SAFETY RES, V43, P333, DOI 10.1016/j.jsr.2012.10.011; MADD Canada, 2014, YOUTH SERV STAT LINK; Martin TL, 2013, J FORENSIC SCI, V58, P1238, DOI 10.1111/1556-4029.12227; McGwin G, 1999, ACCIDENT ANAL PREV, V31, P181; Moskowitz H., 2000, REV LIT EFFECTS LOW; Oei TPS, 2004, ADDICT BEHAV, V29, P159, DOI 10.1016/S0306-4603(03)00076-5; Richards E, 2006, VISION RES, V46, P4217, DOI 10.1016/j.visres.2006.08.011; Romanowicz M, 2011, ALCOHOL CLIN EXP RES, V35, P1092, DOI 10.1111/j.1530-0277.2011.01442.x; Roudsari B, 2009, TRAFFIC INJ PREV, V10, P410, DOI 10.1080/15389580903131506; Sahami S, 2009, TRANSPORT RES REC, P94, DOI 10.3141/2138-13; Schnabel E., 2012, ALCOHOL DRIVING REL; Studer J, 2014, INT J DRUG POLICY, V25, P700, DOI 10.1016/j.drugpo.2014.02.002; Testa M, 2006, ALCOHOL CLIN EXP RES, V30, P339, DOI 10.1111/j.1530-0277.2006.00039.x; Traffic Injury Research Foundation, 2013, ALC CRASH PROBL CAN; Vanlaar W, 2012, ACCIDENT ANAL PREV, V48, P297, DOI 10.1016/j.aap.2012.01.030; WHO, 2009, ALCOHOL AND INJURIES: EMERGENCY DEPARTMENT STUDIES IN AN INTERNATIONAL PERSPECTIVE, P1; Williams AF, 2006, INJURY PREV, V12, P4, DOI 10.1136/ip.2006.011783; Wood JM, 2014, GERONTOLOGY, V60, P315, DOI 10.1159/000356753	28	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118348	10.1371/journal.pone.0118348	http://dx.doi.org/10.1371/journal.pone.0118348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723618	Green Accepted, Green Published, gold			2022-12-26	WOS:000350251200056
J	van der Kooij, K; Brenner, E; van Beers, RJ; Smeets, JBJ				van der Kooij, Katinka; Brenner, Eli; van Beers, Robert J.; Smeets, Jeroen B. J.			Visuomotor Adaptation: How Forgetting Keeps Us Conservative	PLOS ONE			English	Article							MOTOR MEMORIES; DECAY; SAVINGS	Even when provided with feedback after every movement, adaptation levels off before biases are completely removed. Incomplete adaptation has recently been attributed to forgetting: the adaptation is already partially forgotten by the time the next movement is made. Here we test whether this idea is correct. If so, the final level of adaptation is determined by a balance between learning and forgetting. Because we learn from perceived errors, scaling these errors by a magnification factor has the same effect as subjects increasing the amount by which they learn from each error. In contrast, there is no reason to expect scaling the errors to affect forgetting. The magnification factor should therefore influence the balance between learning and forgetting, and thereby the final level of adaptation. We found that adaptation was indeed more complete for larger magnification factors. This supports the idea that incomplete adaptation is caused by part of what has been learnt quickly being forgotten.	[van der Kooij, Katinka; Brenner, Eli; van Beers, Robert J.; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van der Kooij, K (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	k.vander.kooij@vu.nl	van Beers, Robert J/R-7248-2018; Smeets, Jeroen/B-4198-2008	van Beers, Robert J/0000-0003-3847-8918; Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843; van der Kooij, Katinka/0000-0002-4190-7827	Netherlands Organization for Scientific Research, NWO Vici grant [453-08-004]; Stichting Technologie en Wetenschap (STW), Open Technology Program (OTP) grant [12668]	Netherlands Organization for Scientific Research, NWO Vici grant(Netherlands Organization for Scientific Research (NWO)); Stichting Technologie en Wetenschap (STW), Open Technology Program (OTP) grant	This work was supported by a grant from the Netherlands Organization for Scientific Research (www.nwo.nl), NWO Vici grant 453-08-004 to JBJS and by grant by Stichting Technologie en Wetenschap (STW), Open Technology Program (OTP) grant 12668 to JBJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley RJ, 2003, J NEUROSCI, V23, P3066; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; CHOE CS, 1974, J EXP PSYCHOL, V102, P1076, DOI 10.1037/h0036325; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Fernandez-Ruiz J, 2004, COGNITIVE BRAIN RES, V20, P92, DOI 10.1016/j.cogbrainres.2004.01.007; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Galea JM, 2010, DISSOCIATING THE ROL; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Ingram JN, 2013, CURR BIOL, V23, P1107, DOI 10.1016/j.cub.2013.04.079; Kitago T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00307; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Patton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0046466; Pekny SE, 2011, J NEUROSCI, V31, P13829, DOI 10.1523/JNEUROSCI.1704-11.2011; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Schot WD, 2012, PERCEPTION, V41, P991, DOI 10.1068/p7261; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sousa R, 2010, VISION RES, V50, P1786, DOI 10.1016/j.visres.2010.05.035; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2013, J NEUROPHYSIOL, V109, P1890, DOI 10.1152/jn.00845.2012; Vaswani PA, 2013, J NEUROSCI, V33, P7700, DOI 10.1523/JNEUROSCI.0124-13.2013; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Welch R. B., 1978, PERCEPTUAL MODIFICAT; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	35	59	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117901	10.1371/journal.pone.0117901	http://dx.doi.org/10.1371/journal.pone.0117901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723763	Green Published, gold			2022-12-26	WOS:000350251200042
J	Noy, PJ; Lodhia, P; Khan, K; Zhuang, X; Ward, DG; Verissimo, AR; Bacon, A; Bicknell, R				Noy, P. J.; Lodhia, P.; Khan, K.; Zhuang, X.; Ward, D. G.; Verissimo, A. R.; Bacon, A.; Bicknell, R.			Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth	ONCOGENE			English	Article							LECTIN-LIKE DOMAIN; ENDOTHELIAL MARKERS; IDENTIFICATION; EXPRESSION; ADHESION; CELLS	We previously identified CLEC14A as a tumour endothelial marker. Here we show that CLEC14A is a regulator of sprouting angiogenesis in vitro and in vivo. Using a human umbilical vein endothelial cell spheroid-sprouting assay, we found CLEC14A to be a regulator of sprout initiation. Analysis of endothelial sprouting in aortic ring and in vivo subcutaneous sponge assays from clec14a(+/+) and clec14a(-/-) mice revealed defects in sprouting angiogenesis in CLEC14A-deficient animals. Tumour growth was retarded and vascularity reduced in clec14a(-/)-mice. Pull-down and co-immunoprecipitation experiments confirmed that MMRN2 binds to the extracellular region of CLEC14A. The CLEC14A-MMRN2 interaction was interrogated using mouse monoclonal antibodies. Monoclonal antibodies were screened for their ability to block this interaction. Clone C4, but not C2, blocked CLEC14A-MMRN2 binding. C4 antibody perturbed tube formation and endothelial sprouting in vitro and in vivo, with a similar phenotype to loss of CLEC14A. Significantly, tumour growth was impaired in C4-treated animals and vascular density was also reduced in the C4-treated group. We conclude that CLEC14A-MMRN2 binding has a role in inducing sprouting angiogenesis during tumour growth, which has the potential to be manipulated in future antiangiogenic therapy design.	[Noy, P. J.; Lodhia, P.; Khan, K.; Zhuang, X.; Verissimo, A. R.; Bicknell, R.] Univ Birmingham, Sch Med, Coll Med & Dent Sci, Angiogenesis Lab,Inst Biomed Res,Sch Immun & Infe, Birmingham, W Midlands, England; [Noy, P. J.; Lodhia, P.; Khan, K.; Zhuang, X.; Verissimo, A. R.; Bicknell, R.] Univ Birmingham, Sch Med, Coll Med & Dent Sci, Angiogenesis Lab,Inst Biomed Res,Sch Canc Sci, Birmingham, W Midlands, England; [Ward, D. G.] Univ Birmingham, Sch Canc Sci, Inst Canc Studies, Birmingham, W Midlands, England; [Bacon, A.] Univ Birmingham, Sch Med, Inst Biomed Res, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Bicknell, R (corresponding author), Univ Birmingham, Sch Med, Coll Med & Dent Sci, Angiogenesis Lab,Inst Biomed Res,Sch Immun & Infe, Birmingham, W Midlands, England.	r.bicknell@bham.ac.uk	Khan, Kabir/U-8350-2018	Khan, Kabir/0000-0001-8453-3485; Bicknell, Roy/0000-0002-0941-8919; Noy, Peter/0000-0001-6142-8957; Zhuang, Alan Xiaodong/0000-0002-6870-9003	Cancer Research UK (CRUK) [C4719/A6766]; Portuguese Fundacao para a Ciencia e tecnologia; Technology Strategy Board [KTP007696]; MRC; University of Birmingham; Medical Research Council [1304704] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); Portuguese Fundacao para a Ciencia e tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Technology Strategy Board; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Birmingham; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dr Laurens van der Flier, Somantix and Dr Raj Mehta, Cancer Research Technology, for helpful discussions. PN was funded by Cancer Research UK (CRUK, grant number C4719/A6766 to RB). The Portuguese Fundacao para a Ciencia e tecnologia funded AV. XZ was funded by a knowledge transfer partnership (KTP007696) from the Technology Strategy Board. PL is funded by MRC and the University of Birmingham, and KK is funded by the University of Birmingham. The University of Birmingham Transgenic Mouse Facility is part of the MRC Centre for Immune Regulation.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Colombatti A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00093; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Desjobert C, 2009, BIOCHEM J, V417, P121, DOI 10.1042/BJ20080872; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Jin H, 2010, BLOOD, V116, P5773, DOI 10.1182/blood-2010-07-296210; Ki MK, 2013, ONCOGENE, V32, P5449, DOI 10.1038/onc.2013.156; Korff T, 2004, EXP CELL RES, V297, P415, DOI 10.1016/j.yexcr.2004.03.043; Lorenzon E, 2012, ONCOGENE, V31, P3136, DOI 10.1038/onc.2011.487; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Nanda A, 2006, P NATL ACAD SCI USA, V103, P3351, DOI 10.1073/pnas.0511306103; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pircher A, 2013, LUNG CANCER, V81, P252, DOI 10.1016/j.lungcan.2013.04.014; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; SANZMONCASI MP, 1994, LAB INVEST, V71, P366; Saunders Thomas L, 2003, Methods Mol Biol, V209, P125; Stapor PC., 2011, CARDIOVASC ENG TECHN, V2, P124, DOI [10.1007/S13239-011-0041-Y, DOI 10.1007/S13239-011-0041-Y]; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Welch-Reardon KM, 2014, J CELL SCI, V127, P2017, DOI 10.1242/jcs.143420; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wilson E, 2014, J CELL SCI, V127, P3039, DOI 10.1242/jcs.140434; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746; Ziyad Safiyyah, 2011, Genes Cancer, V2, P1085, DOI 10.1177/1947601911432334	33	35	38	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2015	34	47					5821	5831		10.1038/onc.2015.34	http://dx.doi.org/10.1038/onc.2015.34			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW5KV	25745997	Green Accepted, Green Submitted			2022-12-26	WOS:000365035200005
J	Sun, X; Ou, Z; Xie, M; Kang, R; Fan, Y; Niu, X; Wang, H; Cao, L; Tang, D				Sun, X.; Ou, Z.; Xie, M.; Kang, R.; Fan, Y.; Niu, X.; Wang, H.; Cao, L.; Tang, D.			HSPB1 as a novel regulator of ferroptotic cancer cell death	ONCOGENE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; HSP27 PHOSPHORYLATION; DRUG-RESISTANCE; IRON; KINASE; HEAT-SHOCK-PROTEIN-27; ACTIVATION; MIGRATION; APOPTOSIS	Ferroptosis is an iron-dependent form of non-apoptotic cell death, but its molecular mechanism remains largely unknown. Here, we demonstrate that heat shock protein beta-1 (HSPB1) is a negative regulator of ferroptotic cancer cell death. Erastin, a specific ferroptosis-inducing compound, stimulates heat shock factor 1 (HSF1)-dependent HSPB1 expression in cancer cells. Knockdown of HSF1 and HSPB1 enhances erastin-induced ferroptosis, whereas heat shock pretreatment and overexpression of HSPB1 inhibits erastin-induced ferroptosis. Protein kinase C-mediated HSPB1 phosphorylation confers protection against ferroptosis by reducing iron-mediated production of lipid reactive oxygen species. Moreover, inhibition of the HSF1-HSPB1 pathway and HSPB1 phosphorylation increases the anticancer activity of erastin in human xenograft mouse tumor models. Our findings reveal an essential role for HSPB1 in iron metabolism with important effects on ferroptosis-mediated cancer therapy.	[Sun, X.; Ou, Z.; Fan, Y.; Niu, X.; Tang, D.] Guangzhou Med Univ, Key Lab Major Obstetr Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Sun, X.; Ou, Z.; Fan, Y.; Niu, X.; Tang, D.] Guangzhou Med Univ, Key Lab Reprod, Guangzhou, Guangdong, Peoples R China; [Sun, X.; Ou, Z.; Fan, Y.; Niu, X.; Tang, D.] Guangzhou Med Univ, Genet Guangdong Higher Educ Inst, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Xie, M.; Cao, L.] Cent S Univ, Dept Pediat, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Kang, R.; Tang, D.] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA USA; [Wang, H.] N Shore Univ Hosp, Dept Emergency Med, Feinstein Inst Med Res, Manhasset, NY USA	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwell Health; North Shore University Hospital	Sun, X (corresponding author), Univ Pittsburgh, Dept Surg, Hillman Canc Ctr G27A, 5117 Ctr Ave, Pittsburgh, PA 15260 USA.	xiaofangsun@hotmail.com; tangd2@upmc.edu	Kang, Rui/ABD-5291-2021; Tang, Daolin/ABD-5062-2021; Tang, Daolin/B-2905-2010; Wang, Haichao/AAU-2237-2021	Kang, Rui/0000-0003-2725-1574; Tang, Daolin/0000-0002-1903-6180; Wang, Haichao/0000-0002-0211-9000	National Institutes of Health [R01CA160417]; Pancreatic Cancer Action Network-AACR Career Development Award [13-20-25-TANG]; National Natural Science Foundation-Guangdong Joint Fund [U1132005]; Science and Information Technology of Guangzhou Key Project [2011Y1-00038]; National Center of Complementary and Alternative Medicine [R01AT005076]; National Institute of General Medical Sciences [R01GM063075]; NATIONAL CANCER INSTITUTE [R01CA160417] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network-AACR Career Development Award; National Natural Science Foundation-Guangdong Joint Fund; Science and Information Technology of Guangzhou Key Project; National Center of Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christine Heiner (Department of Surgery, University of Pittsburgh) for her critical reading of the manuscript. This work was supported by the National Institutes of Health (R01CA160417 to DT), a 2013 Pancreatic Cancer Action Network-AACR Career Development Award (Grant Number 13-20-25-TANG), The National Natural Science Foundation-Guangdong Joint Fund (U1132005 to XS) and Science and Information Technology of Guangzhou Key Project (2011Y1-00038 to XS). HW is supported by grants from the National Center of Complementary and Alternative Medicine (R01AT005076) and the National Institute of General Medical Sciences (R01GM063075).	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Butt E, 2001, J BIOL CHEM, V276, P7108, DOI 10.1074/jbc.M009234200; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Chen HY, 2006, INT J BIOCHEM CELL B, V38, P1402, DOI 10.1016/j.biocel.2006.02.006; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Guay J, 1997, J CELL SCI, V110, P357; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Huot J, 1996, CANCER RES, V56, P273; JAKOB U, 1993, J BIOL CHEM, V268, P1517; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lee YJ, 2005, J BIOL CHEM, V280, P18108, DOI 10.1074/jbc.M501131200; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; OESTERREICH S, 1993, CANCER RES, V53, P4443; Ramanathan R, 2014, J AGR FOOD CHEM, V62, P2112, DOI 10.1021/jf404900y; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Tang DL, 2005, SHOCK, V23, P434, DOI 10.1097/01.shk.0000159556.95285.df; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang QH, 2013, AUTOPHAGY, V9, P451, DOI 10.4161/auto.23691; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066	45	274	300	17	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 5	2015	34	45					5617	5625		10.1038/onc.2015.32	http://dx.doi.org/10.1038/onc.2015.32			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GA	25728673	Green Accepted			2022-12-26	WOS:000364594300003
J	Li, ZX; Moniz, H; Wang, S; Ramiah, A; Zhang, FM; Moremen, KW; Linhardt, RJ; Sharp, JS				Li, Zixuan; Moniz, Heather; Wang, Shuo; Ramiah, Annapoorani; Zhang, Fuming; Moremen, Kelley W.; Linhardt, Robert J.; Sharp, Joshua S.			High Structural Resolution Hydroxyl Radical Protein Footprinting Reveals an Extended Robo1-Heparin Binding Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; MASS-SPECTROMETRY; AXON GUIDANCE; PHOTOCHEMICAL OXIDATION; SLIT; ROBO; ROUNDABOUT; RECEPTORS; MIDLINE; MORPHOGENESIS	Interaction of transmembrane receptors of the Robo family and the secreted protein Slit provides important signals in the development of the central nervous system and regulation of axonal midline crossing. Heparan sulfate, a sulfated linear polysaccharide modified in a complex variety of ways, serves as an essential co-receptor in Slit-Robo signaling. Previous studies have shown that closely related heparin octasaccharides bind to Drosophila Robo directly, and surface plasmon resonance analysis revealed that Robo1 binds more tightly to full-length unfractionated heparin. For the first time, we utilized electron transfer dissociation-based high spatial resolution hydroxyl radical protein footprinting to identify two separate binding sites for heparin interaction with Robo1: one binding site at the previously identified site for heparin dp8 and a second binding site at the N terminus of Robo1 that is disordered in the x-ray crystal structure. Mutagenesis of the identified N-terminal binding site exhibited a decrease in binding affinity as measured by surface plasmon resonance and heparin affinity chromatography. Footprinting also indicated that heparin binding induces a minor change in the conformation and/or dynamics of the Ig2 domain, but no major conformational changes were detected. These results indicate a second low affinity binding site in the Robo-Slit complex as well as suggesting the role of the Ig2 domain of Robo1 in heparin-mediated signal transduction. This study also marks the first use of electron transfer dissociation-based high spatial resolution hydroxyl radical protein footprinting, which shows great utility for the characterization of protein-carbohydrate complexes.	[Li, Zixuan; Moniz, Heather; Wang, Shuo; Ramiah, Annapoorani; Moremen, Kelley W.; Sharp, Joshua S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA	University System of Georgia; University of Georgia; Rensselaer Polytechnic Institute	Sharp, JS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	jsharp@ccrc.uga.edu	Moremen, Kelley/AAD-4661-2019		National Institutes of Health, NIGMS as part of the Research Resource for Integrated Glycotechnology [P41GM103390]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS as part of the Research Resource for Integrated Glycotechnology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant P41GM103390 as part of the Research Resource for Integrated Glycotechnology.	Aye TT, 2005, ANAL CHEM, V77, P5814, DOI 10.1021/ac050353m; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chance MR, 2001, BIOCHEM BIOPH RES CO, V287, P614, DOI 10.1006/bbrc.2001.5628; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Englund C, 2002, DEVELOPMENT, V129, P4941; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Evans TA, 2012, DEV BIOL, V363, P266, DOI 10.1016/j.ydbio.2011.12.046; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Fukuhara N, 2008, J BIOL CHEM, V283, P16226, DOI 10.1074/jbc.M800688200; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gau BC, 2009, ANAL CHEM, V81, P6563, DOI 10.1021/ac901054w; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Goldsmith SC, 2001, J BIOMOL STRUCT DYN, V19, P405, DOI 10.1080/07391102.2001.10506750; Hambly DM, 2005, J AM SOC MASS SPECTR, V16, P2057, DOI 10.1016/j.jasms.2005.09.008; Hernaiz M, 2000, BIOCHEM BIOPH RES CO, V276, P292, DOI 10.1006/bbrc.2000.3453; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jumper CC, 2012, ANAL CHEM, V84, P4411, DOI 10.1021/ac300120z; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Konermann L, 2010, ANAL CHEM, V82, P6667, DOI 10.1021/ac101326f; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li XY, 2013, J AM SOC MASS SPECTR, V24, P1767, DOI 10.1007/s13361-013-0719-5; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Sharp JS, 2004, ANAL CHEM, V76, P672, DOI 10.1021/ac0302004; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Watson C, 2009, ANAL CHEM, V81, P2496, DOI 10.1021/ac802252y; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Zhang FM, 2013, BIOCHIMIE, V95, P2345, DOI 10.1016/j.biochi.2013.08.018	40	42	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10729	10740		10.1074/jbc.M115.648410	http://dx.doi.org/10.1074/jbc.M115.648410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752613	Green Published, hybrid			2022-12-26	WOS:000353404500015
J	Li, JY; Yue, YY; Dong, XH; Jia, WS; Li, K; Liang, D; Dong, ZJ; Wang, XX; Nan, XX; Zhang, QX; Zhao, QS				Li, Jingyun; Yue, Yunyun; Dong, Xiaohua; Jia, Wenshuang; Li, Kui; Liang, Dong; Dong, Zhangji; Wang, Xiaoxiao; Nan, Xiaoxi; Zhang, Qinxin; Zhao, Qingshun			Zebrafish foxc1a Plays a Crucial Role in Early Somitogenesis by Restricting the Expression of aldh1a2 Directly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast Growth Factor (FGF); MyoD; Retinoic Acid; Transcription Activator-like Effector Nuclease (TALEN); Zebrafish; aldh1a2; deltaC; foxc1a; Paraxial Mesoderm; Somitogenesis	HELIX TRANSCRIPTION FACTORS; RETINOIC ACID CONTROLS; ONE-EYED PINHEAD; SEGMENTATION CLOCK; SOMITE FORMATION; NO TAIL; EMBRYONIC-DEVELOPMENT; WILD-TYPE; IN-VIVO; GENE	Foxc1a is a member of the forkhead transcription factors. It plays an essential role in zebrafish somitogenesis. However, little is known about the molecular mechanisms underlying its controlling somitogenesis. To uncover how foxc1a regulates zebrafish somitogenesis, we generated foxc1a knock-out zebrafish using TALEN (transcription activator-like effector nuclease) technology. The foxc1a null embryos exhibited defective somites at early development. Analyses on the expressions of the key genes that control processes of somitogenesis revealed that foxc1a controlled early somitogenesis by regulating the expression of myod1. In the somites of foxc1a knock-out embryos, expressions of fgf8a and deltaC were abolished, whereas the expression of aldh1a2 (responsible for providing retinoic acid signaling) was significantly increased. Once the increased retinoic acid level in the foxc1a null embryos was reduced by knocking down aldh1a2, the reduced expression of myod1 was partially rescued by resuming expressions of fgf8a and deltaC in the somites of the mutant embryos. Moreover, a chromatin immunoprecipitation assay on zebrafish embryos revealed that Foxc1a bound aldh1a2 promoter directly. On the other hand, neither knocking down fgf8a nor inhibiting Notch signaling affected the expression of aldh1a2, although knocking down fgf8a reduced expression of deltaC in the somites of zebrafish embryos at early somitogenesis and vice versa. Taken together, our results demonstrate that foxc1a plays an essential role in early somitogenesis by controlling Fgf and Notch signaling through restricting the expression of aldh1a2 in paraxial mesoderm directly.	[Li, Jingyun; Yue, Yunyun; Dong, Xiaohua; Jia, Wenshuang; Li, Kui; Liang, Dong; Dong, Zhangji; Wang, Xiaoxiao; Nan, Xiaoxi; Zhang, Qinxin; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Li, Jingyun] Nanjing Med Univ, Maternal & Child Hlth Med Inst, Nanjing Maternal & Child Hlth Care Hosp, Nanjing 210004, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			Ministry of Science and Technology of China [2011CB943804]; National Natural Science Foundation of China [31171434]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) Grant [20130091110051]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) Grant(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by Ministry of Science and Technology of China Grant 2011CB943804, National Natural Science Foundation of China Grant 31171434, and Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) Grant 20130091110051.	Araki I, 2001, GENESIS, V30, P157, DOI 10.1002/gene.1054; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bajard L, 2014, DEVELOPMENT, V141, P1381, DOI 10.1242/dev.093435; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bessarab DA, 2008, DEV BIOL, V323, P216, DOI 10.1016/j.ydbio.2008.08.015; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Choorapoikayil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039073; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dong ZJ, 2014, ZEBRAFISH, V11, P265, DOI 10.1089/zeb.2014.0974; Dong ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028897; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Echeverri K, 2007, DEV BIOL, V301, P388, DOI 10.1016/j.ydbio.2006.10.003; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Fujii T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023491; Griffin KJP, 2002, NAT CELL BIOL, V4, P821, DOI 10.1038/ncb862; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jackson HE, 2013, MECH DEVELOP, V130, P447, DOI 10.1016/j.mod.2013.06.001; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Li JY, 2012, ANAT REC, V295, P268, DOI 10.1002/ar.21520; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; O'Brien LL, 2011, DEV BIOL, V358, P318, DOI 10.1016/j.ydbio.2011.08.005; Oates AC, 2002, DEVELOPMENT, V129, P2929; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Porazzi P, 2012, ENDOCRINOLOGY, V153, P5645, DOI 10.1210/en.2011-1888; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Reifers F, 1998, DEVELOPMENT, V125, P2381; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Shanmugalingam S, 1998, MECH DEVELOP, V78, P85, DOI 10.1016/S0925-4773(98)00150-6; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Sun L, 2005, MATRIX BIOL, V24, P69, DOI 10.1016/j.matbio.2004.12.002; Takke C, 1999, DEVELOPMENT, V126, P3005; Topczewska JM, 2001, MECH DEVELOP, V100, P343, DOI 10.1016/S0925-4773(00)00534-7; Topczewska JM, 2001, GENE DEV, V15, P2483, DOI 10.1101/gad.907401; Veldman MB, 2012, CIRC RES, V110, P220, DOI 10.1161/CIRCRESAHA.111.251298; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Warga RA, 2003, DEV BIOL, V261, P391, DOI 10.1016/S0012-1606(03)00328-2; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034; Xu F, 2009, MECH DEVELOP, V126, P771, DOI 10.1016/j.mod.2009.09.001; Xu YF, 2000, DEV DYNAM, V219, P201, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1043>3.3.CO;2-9; Zhao QS, 2005, GENE EXPR PATTERNS, V5, P363, DOI 10.1016/j.modgep.2004.09.011	70	23	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10216	10228		10.1074/jbc.M114.612572	http://dx.doi.org/10.1074/jbc.M114.612572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724646	Green Published, hybrid			2022-12-26	WOS:000353241100028
J	Saarenheimo, J; Rissanen, AJ; Arvola, L; Nykanen, H; Lehmann, MF; Tiirola, M				Saarenheimo, Jatta; Rissanen, Antti J.; Arvola, Lauri; Nykanen, Hannu; Lehmann, Moritz F.; Tiirola, Marja			Genetic and Environmental Controls on Nitrous Oxide Accumulation in Lakes	PLOS ONE			English	Article							DENITRIFYING BACTERIA; MICROBIAL COMMUNITY; NATURAL WATERS; RIBOSOMAL-RNA; END-PRODUCT; NOSZ GENES; DENITRIFICATION; NITRATE; SOILS; N2O	We studied potential links between environmental factors, nitrous oxide (N2O) accumulation, and genetic indicators of nitrite and N2O reducing bacteria in 12 boreal lakes. Denitrifying bacteria were investigated by quantifying genes encoding nitrite and N2O reductases (nirS/nirK and nosZ, respectively, including the two phylogenetically distinct clades nosZ(I) and nosZ(II)) in lake sediments. Summertime N2O accumulation and hypolimnetic nitrate concentrations were positively correlated both at the inter-lake scale and within a depth transect of an individual lake (Lake Vanajavesi). The variability in the individual nirS, nirK, nosZ(I), and nosZ(II) gene abundances was high (up to tenfold) among the lakes, which allowed us to study the expected links between the ecosystem's nir-vs-nos gene inventories and N2O accumulation. Inter-lake variation in N2O accumulation was indeed connected to the relative abundance of nitrite versus N2O reductase genes, i.e. the (nirS+nirK)/nosZ(I) gene ratio. In addition, the ratios of (nirS+ nirK)/nosZ(I) at the inter-lake scale and (nirS+ nirK)/nosZ(I+II) within Lake Vanajavesi correlated positively with nitrate availability. The results suggest that ambient nitrate concentration can be an important modulator of the N2O accumulation in lake ecosystems, either directly by increasing the overall rate of denitrification or indirectly by controlling the balance of nitrite versus N2O reductase carrying organisms.	[Saarenheimo, Jatta; Rissanen, Antti J.; Nykanen, Hannu; Tiirola, Marja] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Arvola, Lauri] Univ Helsinki, Lammi Biol Stn, Lammi 16900, Finland; [Lehmann, Moritz F.] Univ Basel, Dept Environm Sci, CH-4058 Basel, Switzerland	University of Jyvaskyla; University of Helsinki; University of Basel	Saarenheimo, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland.	jatta.saarenheimo@jyu.fi	Saarenheimo, Jatta/AAX-1560-2021; Lehmann, Moritz F/A-3301-2014	Saarenheimo, Jatta/0000-0002-2580-2830; Lehmann, Moritz F/0000-0003-0626-5942; Tiirola, Marja/0000-0001-5589-3748; Rissanen, Antti Juhani/0000-0002-5678-3361	Academy of Finland [260797, 136455]; VVY; Maj and Tor Nessling Foundation; EnSTE graduate school	Academy of Finland(Academy of Finland); VVY; Maj and Tor Nessling Foundation; EnSTE graduate school	This study was supported by the Academy of Finland (MT project 260797 and HN project 136455), the VVY, the Maj and Tor Nessling Foundation, and EnSTE graduate school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellido JL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000923; BLEAKLEY BH, 1982, APPL ENVIRON MICROB, V44, P1342, DOI 10.1128/AEM.44.6.1342-1348.1982; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Ducey TF, 2011, J ENVIRON QUAL, V40, P610, DOI 10.2134/jeq2010.0387; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; FERRELL RT, 1967, J CHEM ENG DATA, V12, P111, DOI 10.1021/je60032a036; Freymond CV, 2013, BIOGEOSCIENCES, V10, P8373, DOI 10.5194/bg-10-8373-2013; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; GREENBERG EP, 1977, CAN J MICROBIOL, V23, P903, DOI 10.1139/m77-133; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; JACKSON MA, 1991, FEBS LETT, V291, P41, DOI 10.1016/0014-5793(91)81099-T; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Kelso BHL, 1997, APPL ENVIRON MICROB, V63, P4679, DOI 10.1128/AEM.63.12.4679-4685.1997; Kim OS, 2011, AQUAT ECOL, V45, P99, DOI 10.1007/s10452-010-9335-7; Knapp CW, 2009, ENVIRON SCI TECHNOL, V43, P4273, DOI 10.1021/es9001407; Kortelainen P., 2000, VERH INT VER LIMNOL, V27, P1410, DOI 10.1080/03680770.1998.11901468; Kraft B, 2014, SCIENCE, V345, P676, DOI 10.1126/science.1254070; Lide D. R., 1995, CRC HDB CHEM PHYS; Magalhaes C, 2008, MICROB ECOL, V55, P259, DOI 10.1007/s00248-007-9273-7; Maljanen M, 2009, BIOGEOSCIENCES, V6, P2461, DOI 10.5194/bg-6-2461-2009; Martins G, 2011, FEMS MICROBIOL ECOL, V77, P666, DOI 10.1111/j.1574-6941.2011.01145.x; McCrackin ML, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003897; McCrackin ML, 2010, ECOLOGY, V91, P528, DOI 10.1890/08-2210.1; Mengis M, 1997, BIOGEOCHEMISTRY, V38, P281, DOI 10.1023/A:1005814020322; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rissanen AJ, 2013, AQUAT MICROB ECOL, V69, P1, DOI 10.3354/ame01619; Rissanen AJ, 2011, AQUAT MICROB ECOL, V64, P27, DOI 10.3354/ame01506; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Swerts M, 1996, BIOL FERT SOILS, V23, P229, DOI 10.1007/s003740050165; Tatariw C, 2013, ECOLOGY, V94, P2249, DOI 10.1890/12-1765.1; Wallenstein MD, 2005, PEDOBIOLOGIA, V49, P665, DOI 10.1016/j.pedobi.2005.05.005; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Weiss RF., DEEP SEA RES, V17, P721; Whitfield CJ, 2011, SCI TOTAL ENVIRON, V410, P217, DOI 10.1016/j.scitotenv.2011.09.045; WOOD ED, 1967, J MAR BIOL ASSOC UK, V47, P23, DOI 10.1017/S002531540003352X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	50	42	44	12	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121201	10.1371/journal.pone.0121201	http://dx.doi.org/10.1371/journal.pone.0121201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756328	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275700076
J	Yip, BHK; Chung, RY; Chung, VCH; Kim, J; Chan, IWT; Wong, MCS; Wong, SYS; Griffiths, SM				Yip, Benjamin H. K.; Chung, Roger Y.; Chung, Vincent C. H.; Kim, Jean; Chan, Iris W. T.; Wong, Martin C. S.; Wong, Samuel Y. S.; Griffiths, Sian M.			Is Alcohol Use Disorder Identification Test (AUDIT) or Its Shorter Versions More Useful to Identify Risky Drinkers in a Chinese Population? A Diagnostic Study	PLOS ONE			English	Article							BRIEF SCREENING-TEST; PRIMARY-CARE; HEAVY DRINKING; BINGE DRINKING; CURVE; PREVALENCE; PREDICTION; HEALTH; TOOL	Objective To examine the diagnostic performance of shorter versions of Alcohol Use Disorder Identification Test (AUDIT), including Alcohol Consumption (AUDIT-C), in identifying risky drinkers in primary care settings using conventional performance measures, supplemented by decision curve analysis and reclassification table. Study design and Setting A cross-sectional study of adult males in general outpatient clinics in Hong Kong. The study included only patients who reported at least sometimes drinking alcoholic beverages. Timeline follow back alcohol consumption assessment method was used as the reference standard. A Chinese translated and validated 10-item AUDIT (Ch-AUDIT) was used as a screening tool of risky drinking. Results Of the participants, 21.7% were classified as risky drinkers. AUDIT-C has the best overall performance among the shorter versions of Ch-AUDIT. The AUC of AUDIT-C was comparable to Ch-AUDIT (0.898 vs 0.901, p-value = 0.959). Decision curve analysis revealed that when the threshold probability ranged from 15-30%, the AUDIT-C had a higher net-benefit than all other screens. AUDIT-C improved the reclassification of risky drinking when compared to Ch-AUDIT (net reclassification improvement = 0.167). The optimal cut-off of AUDIT-C was at >= 5. Conclusion Given the rising levels of alcohol consumption in the Chinese regions, this Chinese translated 3-item instrument provides convenient and time-efficient risky drinking screening and may become an increasingly useful tool.	[Chung, Vincent C. H.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Jockey Club, Hong Kong, Hong Kong, Peoples R China; Prince Wales Hosp, Sch Publ Hlth Bldg, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Chung, VCH (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Jockey Club, Hong Kong, Hong Kong, Peoples R China.	vchung@cuhk.edu.hk	Yip, Benjamin/AAC-7845-2019; Wong, Martin/L-4568-2014; WONG, Samuel Yeung Shan/D-7311-2013; Chung, Vincent CH/K-2447-2013; Chung, Roger Y. N./B-7288-2016	Yip, Benjamin/0000-0002-4749-7611; Wong, Martin/0000-0001-7706-9370; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Chung, Vincent CH/0000-0002-5947-4492; /0000-0002-5799-5913	Faculty Of Medicine Direct Grant for Research, The Chinese University of Hong Kong [2010.2.058]	Faculty Of Medicine Direct Grant for Research, The Chinese University of Hong Kong	This study was funded by the Faculty Of Medicine Direct Grant for Research, The Chinese University of Hong Kong (Ref No. 2010.2.058). URL: http://www.cuhk.edu.hk/rao/about_rao.html. The funding was received by Prof SMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto M, 2006, ALCOHOL CLIN EXP RES, V30, P1884, DOI 10.1111/j.1530-0277.2006.00233.x; Aalto M, 2011, INT J GERIATR PSYCH, V26, P881, DOI 10.1002/gps.2498; Aalto M, 2009, DRUG ALCOHOL DEPEN, V103, P25, DOI 10.1016/j.drugalcdep.2009.02.013; Babor TF, 2001, BRIEF INTERVENTION F; Bray JW, 2012, J STUD ALCOHOL DRUGS, V73, P911, DOI 10.15288/jsad.2012.73.911; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chung VCH, 2013, ALCOHOL ALCOHOLISM, V48, P720, DOI 10.1093/alcalc/agt065; Coltart C, 2011, LANCET, V378, P1215, DOI 10.1016/S0140-6736(11)61461-X; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fleming MF, 1998, AM J PUBLIC HEALTH, V88, P90, DOI 10.2105/AJPH.88.1.90; Gomez A, 2005, J STUD ALCOHOL, V66, P305, DOI 10.15288/jsa.2005.66.305; Hao W., 2000, J SUBST USE, V5, P71, DOI [DOI 10.3109/14659890009053065, 10.3109/14659890009053065]; Hodgson R, 2002, ALCOHOL ALCOHOLISM, V37, P61, DOI 10.1093/alcalc/37.1.61; Hospital Authority, 2014, GENERAL OUT PATIENT; Kim JH, 2008, ALCOHOL ALCOHOLISM, V43, P360, DOI 10.1093/alcalc/agm181; Kim JW, 2013, ALCOHOL ALCOHOLISM, V48, P68, DOI 10.1093/alcalc/ags082; Kriston L, 2008, ANN INTERN MED, V149, P879, DOI 10.7326/0003-4819-149-12-200812160-00007; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li Q, 2011, ALCOHOL ALCOHOLISM, V46, P416, DOI 10.1093/alcalc/agr012; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; O'Connor PG, 1998, NEW ENGL J MED, V338, P592, DOI 10.1056/NEJM199802263380907; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Piccinelli M, 1997, BRIT MED J, V314, P420, DOI 10.1136/bmj.314.7078.420; Pun VC, 2013, J EPIDEMIOL COMMUN H, V67, P514, DOI 10.1136/jech-2012-201859; Purshouse RC, 2013, ALCOHOL ALCOHOLISM, V48, P180, DOI 10.1093/alcalc/ags103; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318; US National Institute on Alcohol Abuse and Alcoholism, 2007, HELPING PATIENTS WHO; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2013, STAT MED, V32, P1865, DOI 10.1002/sim.5601; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vinson DC, 2004, ANN FAM MED, V2, P398, DOI 10.1370/afm.83; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	41	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117721	10.1371/journal.pone.0117721	http://dx.doi.org/10.1371/journal.pone.0117721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756353	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700016
J	Madelin, G; Babb, J; Xia, D; Regatte, RR				Madelin, Guillaume; Babb, James; Xia, Ding; Regatte, Ravinder R.			Repeatability of Quantitative Sodium Magnetic Resonance Imaging for Estimating Pseudo-Intracellular Sodium Concentration and Pseudo-Extracellular Volume Fraction in Brain at 3 T	PLOS ONE			English	Article							INVERSION-RECOVERY; WATER-CONTENT; DIFFUSION; MRI; SPACE; RATIONALE; SEQUENCES; DESIGN	The purpose of this study is to assess the repeatability of the quantification of pseudo-intracellular sodium concentration (C-1) and pseudo-extracellular volume fraction (a) estimated in brain in vivo using sodium magnetic resonance (MRI) at 3 T. Eleven healthy subjects were scanned twice, with two sodium MRI acquisitions (with and without fluid suppression by inversion recovery), and two double inversion recovery (DIR) proton MRI. DIR MRIs were used to create masks of gray and white matter (GM, WM), that were subsequently applied to the C-1 and a maps calculated from sodium MRI and a tissue three-compartment model, in order to measure the distributions of these two parameters in GM, WM or full brain (GM+WM) separately. The mean, median, mode, standard deviation (std), skewness and kurtosis of the C-1 and a distributions in whole GM, WM and full brain were calculated for each subject, averaged over all data, and used as parameters for the repeatability assessment. The coefficient of variation (CV) was calculated as a measure of reliability for the detection of intra-subject changes in C-1 and alpha for each parameter, while intraclass correlation (ICC) was used as a measure of repeatability. It was found that the CV of most of the parameters was around 10-20% (except for C-1 kurtosis which is about 40%) for C-1 and a measurements, and that ICC was moderate to very good (0.4 to 0.9) for C-1 parameters and for some of the a parameters (mainly skewness and kurtosis). In conclusion, the proposed method could allow to reliably detect changes of 50% and above of the different measurement parameters of C-1 and ain neuropathologies (multiple sclerosis, tumor, stroke, Alzheimer's disease) compared to healthy subjects, and that skewness and kurtosis of the distributions of C-1 and aseem to be the more sensitive parameters to these changes.	[Madelin, Guillaume; Babb, James; Xia, Ding; Regatte, Ravinder R.] NYU, Dept Radiol, Ctr Biomed Imaging, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Madelin, G (corresponding author), NYU, Dept Radiol, Ctr Biomed Imaging, Langone Med Ctr, 560 1St Ave, New York, NY 10016 USA.	guillaume.madelin@nyumc.org	Regatte, Ravinder/K-2364-2014	Regatte, Ravinder/0000-0002-4607-7682; Madelin, Guillaume/0000-0002-5556-5792; Babb, James/0000-0003-1798-1186	CTSI Pilot Project Award at NYU Langone Medical Center from National Institutes of Health/National Center for Advancing Translational Sciences [UL1 TR000038]; National Institutes of Health [R01 AR060238]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060238, R03AR065763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051] Funding Source: NIH RePORTER	CTSI Pilot Project Award at NYU Langone Medical Center from National Institutes of Health/National Center for Advancing Translational Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the following funding: CTSI Pilot Project Award at NYU Langone Medical Center from National Institutes of Health/National Center for Advancing Translational Sciences grant UL1 TR000038 (GM), and National Institutes of Health R01 AR060238 (RRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminghafari M, 2006, COMPUT STAT DATA AN, V50, P2381, DOI 10.1016/j.csda.2004.12.010; [Anonymous], 2012, SPM8 MANUAL FIL METH; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BAKAY L, 1970, Brain Behavior and Evolution, V93, P693, DOI 10.1093/brain/93.4.693; Boada FE, 2005, CURR TOP DEV BIOL, V70, P77, DOI 10.1016/S0070-2153(05)70004-1; Boada FE, 2012, TRANSL STROKE RES, V3, P236, DOI 10.1007/s12975-012-0168-7; Bottomley P, 2012, SODIUM MRI MAN TECHN; Busse RF, 2006, MAGN RESON MED, V55, P1030, DOI 10.1002/mrm.20863; CAMERON IL, 1980, CANCER RES, V40, P1493; CHEEK DB, 1961, J PEDIATR-US, V58, P103, DOI 10.1016/S0022-3476(61)80068-1; Fleiss J. L, 2011, DESIGN ANAL CLIN EXP, V73; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Jerschow A, 2005, PROG NUCL MAG RES SP, V46, P63, DOI 10.1016/j.pnmrs.2004.12.001; Kline RP, 2000, CLIN CANCER RES, V6, P2146; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lee JS, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3253970; Lodish H, 2000, MOL CELL BIOL; Lu A, 2010, SODIUM MAGNETIC RESO; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Madelin G, 2014, PROG NUCL MAG RES SP, V79, P14, DOI 10.1016/j.pnmrs.2014.02.001; Madelin G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04763; Madelin G, 2013, J MAGN RESON IMAGING, V38, P511, DOI 10.1002/jmri.24168; Meara SJP, 2005, MAGNET RESON MED, V54, P241, DOI 10.1002/mrm.20541; Mellon EA, 2009, AM J NEURORADIOL, V30, P978, DOI 10.3174/ajnr.A1495; Nagel AM, 2011, INVEST RADIOL, V46, P539, DOI 10.1097/RLI.0b013e31821ae918; Neeb H, 2008, NEUROIMAGE, V42, P1094, DOI 10.1016/j.neuroimage.2008.03.060; Nicholson C, 2011, COMPUT VIS SCI, V14, P309, DOI 10.1007/s00791-012-0185-9; Ouwerkerk R, 2003, RADIOLOGY, V227, P529, DOI 10.1148/radiol.2272020483; Ouwerkerk R, 2011, METHODS MOL BIOL, V711, P175, DOI 10.1007/978-1-61737-992-5_8; Pipe JG, 2011, MAGN RESON MED, V66, P1303, DOI 10.1002/mrm.22918; Pipe JG, 1999, MAGNET RESON MED, V41, P179, DOI 10.1002/(SICI)1522-2594(199901)41:1<179::AID-MRM25>3.0.CO;2-V; ROSE AM, 1994, CLIN CHEM, V40, P1674; Sabati M, 2013, MAGN RESON IMAGING, V31, P1752, DOI 10.1016/j.mri.2013.08.001; Schepkin VD, 2012, MAGN RESON MED, V67, P1159, DOI 10.1002/mrm.23077; Stobbe R, 2005, MAGN RESON MED, V54, P1305, DOI 10.1002/mrm.20696; Sykova E, 1997, NEUROSCIENTIST, V3, P28, DOI 10.1177/107385849700300113; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Thulborn KR, 2005, NEUROIMAG CLIN N AM, V15, P639, DOI 10.1016/j.nic.2005.08.003; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; ZSNAGY I, 1983, CANCER RES, V43, P5395	46	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118692	10.1371/journal.pone.0118692	http://dx.doi.org/10.1371/journal.pone.0118692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751272	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700008
J	Hippler, FWR; Boaretto, RM; Quaggio, JA; Boaretto, AE; Abreu, CH; Mattos, D				Rieger Hippler, Franz Walter; Boaretto, Rodrigo Marcelli; Quaggio, Jose Antonio; Boaretto, Antonio Enedi; Abreu-Junior, Cassio Hamilton; Mattos, Dirceu, Jr.			Uptake and Distribution of Soil Applied Zinc by Citrus Trees-Addressing Fertilizer Use Efficiency with Zn-68 Labeling	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; WILD-TYPE; FOLIAR; MANGANESE; BORON; L.; DEFICIENCY; ABSORPTION; MECHANISM; MUTANT	The zinc (Zn) supply increases the fruit yield of Citrus trees that are grown, especially in the highly weathered soils of the tropics due to the inherently low nutrient availability in the soil solution. Leaf sprays containing micronutrients are commonly applied to orchards, even though the nutrient supply via soil could be of practical value. This study aimed to evaluate the effect of Zn fertilizers that are applied to the soil surface on absorption and partitioning of the nutrient by citrus trees. A greenhouse experiment was conducted with one-year-old sweet orange trees. The plants were grown in soils with different textures (18.1 or 64.4% clay) that received 1.8 g Zn per plant, in the form of either ZnO or ZnSO4 enriched with the stable isotope Zn-68. Zinc fertilization increased the availability of the nutrient in the soil and the content in the orange trees. Greater responses were obtained when ZnSO4 was applied to the sandy loam soil due to its lower specific metal adsorption compared to that of the clay soil. The trunk and branches accumulated the most fertilizer-derived Zn (Zn-dff) and thus represent the major reserve organ for this nutrient in the plant. The trees recovered up to 4% of the applied Zn-dff. Despite this relative low recovery, the Zn requirement of the trees was met with the selected treatment based on the total leaf nutrient content and increased Cu/Zn-SOD activity in the leaves. We conclude that the efficiency of Zn fertilizers depends on the fertilizer source and the soil texture, which must be taken into account by guidelines for fruit crop fertilization via soil, in substitution or complementation of traditional foliar sprays.	[Rieger Hippler, Franz Walter; Boaretto, Rodrigo Marcelli; Mattos, Dirceu, Jr.] Inst Agron IAC, Ctr Citricultura Sylvio Moreira, Sao Paulo, Brazil; [Quaggio, Jose Antonio] Inst Agron IAC, Ctr Solos & Recursos Ambientais, Sao Paulo, Brazil; [Boaretto, Antonio Enedi; Abreu-Junior, Cassio Hamilton] Univ Sao Paulo, CENA, BR-09500900 Sao Paulo, Brazil	Instituto Agronomico de Campinas (IAC); Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo	Mattos, D (corresponding author), Inst Agron IAC, Ctr Citricultura Sylvio Moreira, Sao Paulo, Brazil.	ddm@centrodecitricultura.br	Mattos-Jr, Dirceu/F-3217-2012; Abreu-Junior, Cassio Hamilton/H-5024-2012; Rieger Hippler, Franz Walter/F-2872-2015; Hippler, Franz Walter Rieger/T-6988-2017	Mattos-Jr, Dirceu/0000-0002-6149-9189; Abreu-Junior, Cassio Hamilton/0000-0002-5955-4652; Rieger Hippler, Franz Walter/0000-0002-7545-001X; Hippler, Franz Walter Rieger/0000-0002-7545-001X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/17589-9, 2010/02981-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo #2010/17589-9 (http://www.bv.fapesp.br/en/auxilios/30606/efficiency-of-micronutrients-application-and-use-by-citrus-trees/)to Jose Antonio Quaggio and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo # 2010/02981-0 (http://www.bv.fapesp.br/en/bolsas/113380/efficiency-of-soil-application-of-micronutrients- in-citrus/) to Franz Walter Rieger Hippler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway BJ., 2008, ZINC SOILS CROP NUTR, P135; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Bataglia OC, 1983, IAC B TECNICO, P48; Benedicto A, 2011, J AGR FOOD CHEM, V59, P8829, DOI 10.1021/jf2002574; Boaretto AE, 2002, ACTA HORTIC, P203, DOI 10.17660/ActaHortic.2002.594.22; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan RF, 2005, AUST J EXP AGR ANIM, V46, P1615; Bustan A, 1998, PLANT CELL ENVIRON, V21, P217, DOI 10.1046/j.1365-3040.1998.00267.x; CAKMAK I, 1986, PHYSIOL PLANTARUM, V68, P483, DOI 10.1111/j.1399-3054.1986.tb03386.x; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; de Abreu CA, 1998, COMMUN SOIL SCI PLAN, V29, P1961, DOI 10.1080/00103629809370085; de Lima OF, 1998, COMMUN SOIL SCI PLAN, V29, P825, DOI 10.1080/00103629809369988; Franco HCJ, 2011, SUGAR TECH, V13, P86, DOI 10.1007/s12355-010-0057-x; Gislerod H. R., 1999, Acta Horticulturae, P345; Gomes-Junior RA, 2006, CHEMOSPHERE, V65, P1330, DOI 10.1016/j.chemosphere.2006.04.056; Goos RJ, 2000, BIOL FERT SOILS, V31, P343, DOI 10.1007/s003740050666; Haslett BS, 2001, ANN BOT-LONDON, V87, P379, DOI 10.1006/anbo.2000.1349; KRAUS TE, 1995, CAN J BOT, V73, P797, DOI 10.1139/b95-088; Lehto T, 2004, NEW PHYTOL, V163, P333, DOI 10.1111/j.1469-8137.2004.01105.x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; LONERAGAN JF, 1993, DEV PLANT SOIL SCI, V55, P119; Lopez-Millan AF, 2005, PLANT SCI, V168, P1015, DOI 10.1016/j.plantsci.2004.11.018; Lopez-Valdivia LM, 2002, J AGR FOOD CHEM, V50, P1455, DOI 10.1021/jf010978v; Martinez Hermínia Emilia Prieto, 2005, Cienc. Rural, V35, P491, DOI 10.1590/S0103-84782005000300001; Mattos Jr D, 2005, CITROS, P198; McBeath TM, 2014, PLANT SOIL, V374, P843, DOI 10.1007/s11104-013-1919-2; Nebauer SG, 2011, TREE PHYSIOL, V31, P169, DOI 10.1093/treephys/tpq103; NEL D J, 1984, South African Journal of Plant and Soil, V1, P39; Pestana M, 2001, J PLANT NUTR, V24, P1913, DOI 10.1081/PLN-100107603; Pilon M, 2011, BBA-BIOENERGETICS, V1807, P989, DOI 10.1016/j.bbabio.2010.11.002; Quaggio JA, 2003, PESQUI AGROPECU BRAS, V38, P627, DOI 10.1590/S0100-204X2003000500011; Quaggio JA, 2011, BOAS PRATICAS USO EF, P373; Sanchez EE, 2006, J HORTIC SCI BIOTECH, V81, P839, DOI 10.1080/14620316.2006.11512147; Sanchez EE, 2002, ACTA HORTIC, P363, DOI 10.17660/ActaHortic.2002.594.45; Sartori RH, 2008, REV BRAS FRUTIC, V30, P523, DOI 10.1590/S0100-29452008000200044; Shenker M, 2004, J PLANT PHYSIOL, V161, P197, DOI 10.1078/0176-1617-00931; Smith PJ, 2008, SIGHT SOUND, V18, P53; Sposito G., 1989, The chemistry of soils.; Srivastava AK, 2006, J PLANT NUTR, V29, P1061, DOI 10.1080/01904160600689183; Stomph TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00008; Westfall D. G., 1999, Better Crops with Plant Food, V83, P18; Wu CY, 2011, J ZHEJIANG UNIV-SC B, V12, P408, DOI 10.1631/jzus.B1000291; Yin XH, 2011, AGRON J, V103, P1794, DOI 10.2134/agronj2011.0166; Zhang QL, 1999, J AM SOC HORTIC SCI, V124, P312, DOI 10.21273/JASHS.124.3.312	44	26	26	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0116903	10.1371/journal.pone.0116903	http://dx.doi.org/10.1371/journal.pone.0116903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751056	Green Submitted, Green Published, gold			2022-12-26	WOS:000350692700004
J	Delplanque, A; Wawrzynczyk, D; Jaworski, P; Matczyszyn, K; Pawlik, K; Buckle, M; Nyk, M; Nogues, C; Samoc, M				Delplanque, Aleksandra; Wawrzynczyk, Dominika; Jaworski, Pawel; Matczyszyn, Katarzyna; Pawlik, Krzysztof; Buckle, Malcolm; Nyk, Marcin; Nogues, Claude; Samoc, Marek			DNA Base Pair Resolution Measurements Using Resonance Energy Transfer Efficiency in Lanthanide Doped Nanoparticles	PLOS ONE			English	Article							UPCONVERTING NAYF4 NANOPARTICLES; UP-CONVERSION NANOPARTICLES; SURFACE MODIFICATION; ACID; NANOMATERIALS; OXIDATION; STRATEGY; GROWTH	Lanthanide-doped nanoparticles are of considerable interest for biodetection and bioimaging techniques thanks to their unique chemical and optical properties. As a sensitive luminescence material, they can be used as (bio) probes in Forster Resonance Energy Transfer (FRET) where trivalent lanthanide ions (La3+) act as energy donors. In this paper we present an efficient method to transfer ultrasmall (ca. 8 nm) NaYF4 nanoparticles dispersed in organic solvent to an aqueous solution via oxidation of the oleic acid ligand. Nanoparticles were then functionalized with single strand DNA oligomers (ssDNA) by inducing covalent bonds between surface carboxylic groups and a 5' amine modified-ssDNA. Hybridization with the 5' fluorophore (Cy5) modified complementary ssDNA strand demonstrated the specificity of binding and allowed the fine control over the distance between Eu3+ ions doped nanoparticle and the fluorophore by varying the number of the dsDNA base pairs. First, our results confirmed nonradiative resonance energy transfer and demonstrate the dependence of its efficiency on the distance between the donor (Eu3+) and the acceptor (Cy5) with sensitivity at a nanometre scale.	[Delplanque, Aleksandra; Nogues, Claude] ENS Cachan, IDA FR3242, LBPA, F-94235 Cachan, France; [Wawrzynczyk, Dominika; Matczyszyn, Katarzyna; Nyk, Marcin; Samoc, Marek] Wroclaw Univ Technol, Inst Phys & Theoret Chem, PL-50370 Wroclaw, Poland; [Jaworski, Pawel; Pawlik, Krzysztof] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Pawlik, Krzysztof] Wroclaw Med Univ, Dept Toxicol, PL-50556 Wroclaw, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; Wroclaw University of Science & Technology; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University	Matczyszyn, K (corresponding author), Wroclaw Univ Technol, Inst Phys & Theoret Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	katarzyna.matczyszyn@pwr.edu.pl; claude.nogues@lbpa.ens-cachan.fr	Pawlik, Krzysztof Jakub/F-2637-2011; Nyk, Marcin/E-8815-2012; Pawlik, Krzysztof Kuba/P-5677-2019; Samoc, Marek/AAK-9439-2020	Pawlik, Krzysztof Jakub/0000-0002-5881-9292; Nyk, Marcin/0000-0002-0329-4038; Pawlik, Krzysztof Kuba/0000-0002-5881-9292; Samoc, Marek/0000-0002-5404-2455; Matczyszyn, Katarzyna/0000-0001-8578-8340; Wawrzynczyk, Dominika/0000-0002-8485-9562	Harmonia grant [DEC-2012/04/M/ST500340]; Opus grant [DEC-2013/09/B/ST5/0347]; programme Bourse Master Ile-de-France; Erasmus Mundus MONABIPHOT	Harmonia grant; Opus grant; programme Bourse Master Ile-de-France; Erasmus Mundus MONABIPHOT	This work was supported by Harmonia grant DEC-2012/04/M/ST500340 and Opus grant DEC-2013/09/B/ST5/0347. AD is grateful for funding from the programme Bourse Master Ile-de-France and Erasmus Mundus MONABIPHOT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer JC, 2010, LANGMUIR, V26, P1157, DOI 10.1021/la902260j; Cao TY, 2011, BIOMATERIALS, V32, P2959, DOI 10.1016/j.biomaterials.2010.12.050; CHEN GR, 2010, IEEE CIRC SYST MAG, V10, P4, DOI DOI 10.1021/NN100457J; Chen J, 2012, SENSORS-BASEL, V12, P2414, DOI 10.3390/s120302414; Chen ZG, 2008, J AM CHEM SOC, V130, P3023, DOI 10.1021/ja076151k; Eliseeva SV, 2010, CHEM SOC REV, V39, P189, DOI 10.1039/b905604c; Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Ghosh P, 2008, J PHYS CHEM C, V112, P3223, DOI 10.1021/jp7099114; Gnach A, 2012, NANO TODAY, V7, P532, DOI 10.1016/j.nantod.2012.10.006; Gu JQ, 2008, J PHYS CHEM C, V112, P6589, DOI 10.1021/jp801203w; Hemmer E, 2013, NANOSCALE, V5, P11339, DOI 10.1039/c3nr02286b; Jiang GC, 2012, LANGMUIR, V28, P3239, DOI 10.1021/la204020m; Kong DY, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/7/075601; Kumar M, 2009, LANGMUIR, V25, P6024, DOI 10.1021/la900936p; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEMIEUX RU, 1955, CAN J CHEM, V33, P1701, DOI 10.1139/v55-208; Li D, 2010, J PHYS CHEM C, V114, P8219, DOI 10.1021/jp100893k; Lin M, 2012, BIOTECHNOL ADV, V30, P1551, DOI 10.1016/j.biotechadv.2012.04.009; Liu YS, 2013, NANOSCALE, V5, P1369, DOI 10.1039/c2nr33239f; Selvin PR, 1996, IEEE J SEL TOP QUANT, V2, P1077, DOI 10.1109/2944.577339; Shimoyama A, 2013, PHOTODIAGN PHOTODYN, V10, P607, DOI 10.1016/j.pdpdt.2013.07.005; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Wang C, 2011, BIOMATERIALS, V32, P1110, DOI 10.1016/j.biomaterials.2010.09.069; Wang F, 2009, CHEM SOC REV, V38, P976, DOI 10.1039/b809132n; Wang GF, 2011, ACCOUNTS CHEM RES, V44, P322, DOI 10.1021/ar100129p; Wang LY, 2007, CHEM-EUR J, V13, P4203, DOI 10.1002/chem.200700005; Wawrzynczyk D, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1707-1; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Xiong LQ, 2010, BIOMATERIALS, V31, P7078, DOI 10.1016/j.biomaterials.2010.05.065; Yao CZ, 2012, TRAC-TREND ANAL CHEM, V39, P60, DOI 10.1016/j.trac.2012.07.007; Yi GS, 2007, CHEM MATER, V19, P341, DOI 10.1021/cm062447y; Zeng SJ, 2011, CRYSTENGCOMM, V13, P1384, DOI 10.1039/c0ce00325e; Zhang P, 2006, J AM CHEM SOC, V128, P12410, DOI 10.1021/ja0644024; Zhang QB, 2009, J COLLOID INTERF SCI, V336, P171, DOI 10.1016/j.jcis.2009.04.024; Zimmermann FO, 2005, TETRAHEDRON LETT, V46, P3201, DOI 10.1016/j.tetlet.2005.03.052	36	3	3	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0117277	10.1371/journal.pone.0117277	http://dx.doi.org/10.1371/journal.pone.0117277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748446	Green Published, gold			2022-12-26	WOS:000350689400008
J	Tandon, M; Salamoun, JM; Carder, EJ; Farber, E; Xu, SP; Deng, F; Tang, H; Wipf, P; Wang, QJ				Tandon, Manuj; Salamoun, Joseph M.; Carder, Evan J.; Farber, Elisa; Xu, Shuping; Deng, Fan; Tang, Hua; Wipf, Peter; Wang, Q. Jane			SD-208, a Novel Protein Kinase D Inhibitor, Blocks Prostate Cancer Cell Proliferation and Tumor Growth In Vivo by Inducing G2/M Cell Cycle Arrest	PLOS ONE			English	Article							ACTIVATION LOOP SER(744); MOLECULAR-CLONING; PHORBOL ESTERS; DNA-SYNTHESIS; EXPRESSION; POTENT; CONTRIBUTES; CHEMISTRY; APOPTOSIS; BOMBESIN	Protein kinase D (PKD) has been implicated in many aspects of tumorigenesis and progression, and is an emerging molecular target for the development of anticancer therapy. Despite recent advancement in the development of potent and selective PKD small molecule inhibitors, the availability of in vivo active PKD inhibitors remains sparse. In this study, we describe the discovery of a novel PKD small molecule inhibitor, SD-208, from a targeted kinase inhibitor library screen, and the synthesis of a series of analogs to probe the structureactivity relationship (SAR) vs. PKD1. SD-208 displayed a narrow SAR profile, was an ATP-competitive pan-PKD inhibitor with low nanomolar potency and was cell active. Targeted inhibition of PKD by SD-208 resulted in potent inhibition of cell proliferation, an effect that could be reversed by overexpressed PKD1 or PKD3. SD-208 also blocked prostate cancer cell survival and invasion, and arrested cells in the G2/M phase of the cell cycle. Mechanistically, SD-208-induced G2/M arrest was accompanied by an increase in levels of p21 in DU145 and PC3 cells as well as elevated phosphorylation of Cdc2 and Cdc25C in DU145 cells. Most importantly, SD-208 given orally for 24 days significantly abrogated the growth of PC3 subcutaneous tumor xenografts in nude mice, which was accompanied by reduced proliferation and increased apoptosis and decreased expression of PKD biomarkers including survivin and Bcl-xL. Our study has identified SD-208 as a novel efficacious PKD small molecule inhibitor, demonstrating the therapeutic potential of targeted inhibition of PKD for prostate cancer treatment.	[Tandon, Manuj; Carder, Evan J.; Xu, Shuping; Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Salamoun, Joseph M.; Farber, Elisa; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15261 USA; [Deng, Fan] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [Tang, Hua] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Wang, QJ (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	qjw1@pitt.edu	Wang, Qiming Jane/B-6064-2012; Wipf, Peter/AAG-1771-2021	Wang, Qiming Jane/0000-0002-9502-4851; Wipf, Peter/0000-0001-7693-5863	National Institutes of Health [R01CA129127, R01CA142580]; oversea Hong Kong and Macao Scholars Collaborative Research Fund of NSFC in China [81328020]; NATIONAL CANCER INSTITUTE [R01CA142580, R01CA129127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); oversea Hong Kong and Macao Scholars Collaborative Research Fund of NSFC in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health grant R01CA129127, R01CA142580, and oversea Hong Kong and Macao Scholars Collaborative Research Fund of NSFC in China (Grant #81328020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2003, ONCOGENE, V22, P8271, DOI 10.1038/sj.onc.1207158; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Backes AC, 2008, EXPERT OPIN DRUG DIS, V3, P1409, DOI 10.1517/17460440802579975; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; Guo JX, 2013, CANCER CHEMOTH PHARM, V71, P331, DOI 10.1007/s00280-012-2010-z; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hassan S, 2009, ONCOGENE, V28, P4386, DOI 10.1038/onc.2009.291; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Huck B, 2014, J BIOL CHEM, V289, P3138, DOI 10.1074/jbc.M113.502633; Huynh QK, 2006, ARCH BIOCHEM BIOPHYS, V450, P141, DOI 10.1016/j.abb.2006.02.014; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Karan D, 2003, INT J CANCER, V103, P285, DOI 10.1002/ijc.10813; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Mak P, 2008, BIOCHEM BIOPH RES CO, V373, P618, DOI 10.1016/j.bbrc.2008.06.097; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Takagaki N, 2005, INT J ONCOL, V26, P185; Tandon M, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0075601; Tandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044653; Trauzold A, 2003, ONCOGENE, V22, P8939, DOI 10.1038/sj.onc.1207001; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200	43	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119346	10.1371/journal.pone.0119346	http://dx.doi.org/10.1371/journal.pone.0119346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747583	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000350689400064
J	Xu, L; Xiong, W; Yang, JK; Li, J; Tao, XW				Xu, Li; Xiong, Wei; Yang, Jiang-Ke; Li, Jia; Tao, Xing-Wu			Recombinant Escherichia coli Strains with Inducible Campylobacter jejuni Single Domain Hemoglobin CHb Expression Exhibited Improved Cell Growth in Bioreactor Culture	PLOS ONE			English	Article							VITREOSCILLA HEMOGLOBIN; TRANSCRIPTIONAL REGULATOR; GLOBIN GENE; PROMOTER; FNR; PURIFICATION; METABOLISM; RESISTANCE	Maintaining an appropriate concentration of dissolved oxygen in aqueous solution is critical for efficient operation of a bioreactor, requiring sophisticated engineering design and a system of regulation to maximize oxygen transfer from the injected air bubbles to the cells. Bacterial hemoglobins are oxygen-binding proteins that transfer oxygen from the environment to metabolic processes and allow bacteria to grow even under microaerophilic conditions. To improve the oxygen utilization efficiency of cells and overcome the oxygen shortage in bioreactors, the gene coding for the Campylobacter jejuni single domain hemoglobin (CHb) gene was artificially synthesized and functionally expressed under the control of inducible expression promoters P-T7 and P-vgh in Escherichia coli. The effects of the recombinants P-T7-CHb and P-vgh-CHb on cell growth were evaluated in aerobic shake flasks, anaerobic capped bottles and a 5-L bioreactor, and a pronounced improvement in cell biomass was observed for CHb-expressing cells. To determine the growth curves, CHb gene expression, and CHb oxygen-binding capacity of specific recombinants with different promoters, we determined the time course of CHb gene expression in the two recombinants by semi-quantitative RT-PCR and CO differential spectrum assays. Based on the growth patterns of the two recombinants in the bioreactor, we proposed different recombinant types with optimal performance under specific culture conditions.	[Xu, Li; Xiong, Wei; Yang, Jiang-Ke; Li, Jia; Tao, Xing-Wu] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China	Wuhan Polytechnic University	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China.	jiangke.yang@gmail.com	XU, LIWU/GYR-0963-2022		Science and Technology Supporting Program of Hubei Province; Science and Technology Research Program of the Education Department of Hubei Province [D20131703]; Chinese Ministry of Education [212118]	Science and Technology Supporting Program of Hubei Province; Science and Technology Research Program of the Education Department of Hubei Province; Chinese Ministry of Education(Ministry of Education, China)	Science and Technology Supporting Program of Hubei Province (2014), Key Project of Science and Technology Research Program of the Education Department of Hubei Province (no. D20131703), the Key Project of Chinese Ministry of Education (no. 212118).	Benz GT, 2008, CHEM ENG PROG, V104, P32; BLAKEBROUGH N, 1963, BIOTECHNOL BIOENG, V5, P59, DOI 10.1002/bit.260050110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIKSHIT KL, 1989, J GEN MICROBIOL, V135, P2601; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; Guardia Alba M J, 2001, J Biotechnol, V84, P107; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; JOSHI M, 1994, BIOCHEM BIOPH RES CO, V202, P535, DOI 10.1006/bbrc.1994.1961; KHOSLA C, 1989, J BACTERIOL, V171, P5995, DOI 10.1128/jb.171.11.5995-6004.1989; KHOSLA C, 1988, NATURE, V331, P633, DOI 10.1038/331633a0; Lin JM, 2003, J IND MICROBIOL BIOT, V30, P362, DOI 10.1007/s10295-003-0054-0; Pablos TE, 2014, BIOTECHNOL J, V9, P791, DOI 10.1002/biot.201300388; Pablos TE, 2011, BIOTECHNOL J, V6, P993, DOI 10.1002/biot.201000405; Park KW, 2002, J BIOL CHEM, V277, P33334, DOI 10.1074/jbc.M203820200; Ramandeep, 2001, J BIOL CHEM, V276, P24781, DOI 10.1074/jbc.M009808200; Rehm BHA, 2001, BIOCHEM J, V358, P263, DOI 10.1042/0264-6021:3580263; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Stark BC, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210002; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TSAI PS, 1995, BIOTECHNOL PROGR, V11, P288, DOI 10.1021/bp00033a008; Unden G, 1997, MOL MICROBIOL, V25, P205, DOI 10.1046/j.1365-2958.1997.4731841.x; Van't Riet K, 1991, BASIC BIOREACTOR DES, P33; Wainwright LM, 2006, BIOCHEMISTRY-US, V45, P6003, DOI 10.1021/bi052247k; WEBSTER DA, 1966, J BIOL CHEM, V241, P3308; WEBSTER DA, 1988, ADV INORG BIOCHEM, V7, P245; Yang JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036607; Zhang W, 2013, FEMS MICROBIOL LETT, V343, P127, DOI 10.1111/1574-6968.12139	28	7	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116503	10.1371/journal.pone.0116503	http://dx.doi.org/10.1371/journal.pone.0116503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748170	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400006
J	Harris, AC; LeSage, MG; Shelley, D; Perry, JL; Pentel, PR; Owens, SM				Harris, Andrew C.; LeSage, Mark G.; Shelley, David; Perry, Jennifer L.; Pentel, Paul R.; Owens, S. Michael			The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats	PLOS ONE			English	Article							BRAIN REWARD FUNCTION; METHAMPHETAMINE ADDICTION; INDIVIDUAL-DIFFERENCES; CHRONIC AMPHETAMINE; NICOTINE; WITHDRAWAL; DECREASES; PHARMACOTHERAPY; ANTAGONISTS; SMOKING	Passive immunization with monoclonal antibodies (mAbs) against (+)-methamphetamine (METH) is being evaluated for the treatment of METH addiction. A human/mouse chimeric form of the murine anti-METH mAb7F9 has entered clinical trials. This study examined the effects of murine mAb7F9 on certain addiction-related behavioral effects of METH in rats as measured using intracranial self-stimulation (ICSS). Initial studies indicated that acute METH (0.1-0.56 mg/kg, s.c.) lowered the minimal (threshold) stimulation intensity that maintained ICSS. METH (0.3 mg/kg, s.c.) also blocked elevations in ICSS thresholds (anhedonia-like behavior) during spontaneous withdrawal from a chronic METH infusion (10 mg/kg/day x 7 days). In studies examining effects of i.v. pretreatment with mAb7F9 (at 30, 100, or 200 mg/kg), 200 mg/kg blocked the ability of an initial injection of METH (0.3 mg/kg, s.c.) to reduce baseline ICSS thresholds, but was less capable of attenuating the effect of subsequent daily injections of METH. MAb7F9 (200 mg/kg) also produced a small but significant reduction in the ability of METH (0.3 mg/kg, s.c.) to reverse METH withdrawal-induced elevations in ICSS thresholds. These studies demonstrate that mAb7F9 can partially attenuate some addiction-related effects of acute METH in an ICSS model, and provide some support for the therapeutic potential of mAb7F9 for the treatment of METH addiction.	[Harris, Andrew C.; LeSage, Mark G.; Shelley, David; Perry, Jennifer L.; Pentel, Paul R.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA; [Harris, Andrew C.; LeSage, Mark G.; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Owens, S. Michael] Univ Arkansas Med Sci, Coll Med, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Arkansas System; University of Arkansas Medical Sciences	Harris, AC (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA.	harr0547@umn.edu	LeSage, Mark G./AAS-8628-2020		National Institute on Drug Abuse [U01-DA023900]; Minneapolis Medical Research Translational Addiction Research Program; National Center for Advancing Translational Sciences [UL1TR000039]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA023900] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Minneapolis Medical Research Translational Addiction Research Program; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the National Institute on Drug Abuse (U01-DA023900 awarded to SMO), the Minneapolis Medical Research Translational Addiction Research Program (awarded to ACH), and the National Center for Advancing Translational Sciences (UL1TR000039 awarded to SMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer CT, 2013, BRIT J PHARMACOL, V168, P850, DOI 10.1111/j.1476-5381.2012.02214.x; Byrnes-Blake KA, 2003, EUR J PHARMACOL, V461, P119, DOI 10.1016/S0014-2999(03)01313-X; Caggiula AR, 2009, NEBR SYM MOTIV, V55, P91, DOI 10.1007/978-0-387-78748-0_6; Carroll FI, 2009, J MED CHEM, V52, P7301, DOI 10.1021/jm901134w; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; Cryan JF, 2003, BIOL PSYCHIAT, V54, P49, DOI 10.1016/S0006-3223(02)01730-4; Elkashef A, 2008, SUBST ABUS, V29, P31, DOI 10.1080/08897070802218554; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Gentry WB, 2010, CLIN PHARMACOL THER, V88, P390, DOI 10.1038/clpt.2010.155; Gentry WB, 2009, HUM VACCINES, V5, P206, DOI 10.4161/hv.5.4.7456; Gentry WB, 2006, INT IMMUNOPHARMACOL, V6, P968, DOI 10.1016/j.intimp.2006.01.008; Hambuchen MD, 2014, VACCINE; Harris AC, 2008, EXP CLIN PSYCHOPHARM, V16, P86, DOI 10.1037/1064-1297.16.1.86; Harris AC, 2011, PSYCHOPHARMACOLOGY, V217, P153, DOI 10.1007/s00213-011-2273-9; Harris AC, 2010, PHARMACOL BIOCHEM BE, V96, P217, DOI 10.1016/j.pbb.2010.05.008; Harris AC, 2009, PSYCHOPHARMACOLOGY, V205, P599, DOI 10.1007/s00213-009-1567-7; Harrison AA, 2002, PSYCHOPHARMACOLOGY, V160, P56, DOI 10.1007/s00213-001-0953-6; Higley AE, 2011, J PSYCHOPHARMACOL, V25, P263, DOI 10.1177/0269881109358201; Jang CG, 2013, PSYCHOPHARMACOLOGY, V225, P753, DOI 10.1007/s00213-012-2864-0; KORNETSKY C, 1979, FED PROC, V38, P2473; Laurenzana EM, 2009, VACCINE, V27, P7011, DOI 10.1016/j.vaccine.2009.09.072; Laurenzana EM, 2003, DRUG METAB DISPOS, V31, P1320, DOI 10.1124/dmd.31.11.1320; Laurenzana EM, 2014, HUM VACC IMMUNOTHER, V10; Lin D, 2000, PHARMACOL BIOCHEM BE, V65, P407, DOI 10.1016/S0091-3057(99)00213-0; Lin D, 1999, PSYCHOPHARMACOLOGY, V145, P283, DOI 10.1007/s002130051060; Manbeck KE, 2014, PHARMACOL BIOCHEM BE, V116, P84, DOI 10.1016/j.pbb.2013.11.002; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; McMillan DE, 2004, J PHARMACOL EXP THER, V309, P1248, DOI 10.1124/jpet.103.061762; McMillan DE, 2002, BEHAV PHARMACOL, V13, P465; Meredith CW, 2005, HARVARD REV PSYCHIAT, V13, P141, DOI 10.1080/10673220591003605; Miyata H, 2011, CURR NEUROPHARMACOL, V9, P63, DOI 10.2174/157015911795017218; Owens SM, 2011, CNS NEUROL DISORD-DR, V10, P892; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Paterson NE, 2000, PSYCHOPHARMACOLOGY, V152, P440, DOI 10.1007/s002130000559; Paterson NE, 2008, NICOTINE TOB RES, V10, P995, DOI 10.1080/14622200802097571; Paterson NE, 2009, BEHAV PHARMACOL, V20, P211, DOI 10.1097/FBP.0b013e32832c7083; Peterson EC, 2014, ADV PHARMACOL, V69, P107, DOI 10.1016/B978-0-12-420118-7.00003-2; Roiko SA, 2009, PHARMACOL BIOCHEM BE, V93, P105, DOI 10.1016/j.pbb.2009.04.011; Rose ME, 2008, ANN CLIN PSYCHIATRY, V20, P145, DOI 10.1080/10401230802177656; Stevens MW, 2014, MABS-AUSTIN, V6, P547, DOI 10.4161/mabs.27620; Thorn DA, 2012, EUR J PHARMACOL, V680, P69, DOI 10.1016/j.ejphar.2012.01.037; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118787	10.1371/journal.pone.0118787	http://dx.doi.org/10.1371/journal.pone.0118787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742165	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100047
J	Zhang, NN; Sun, XJ; Sun, MJ; Zhu, ST; Wang, L; Ma, D; Wang, YJ; Zhang, ST; Li, P				Zhang, Nana; Sun, Xiujing; Sun, Mingjiong; Zhu, Shengtao; Wang, Li; Ma, Dan; Wang, Yongjun; Zhang, Shutian; Li, Peng			4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Promotes Esophageal Squamous Cell Carcinoma Growth via Beta-Adrenoceptors In Vitro and In Vivo	PLOS ONE			English	Article							EPITHELIAL-CELLS; CANCER CELLS; PROLIFERATION; EPIDEMIOLOGY; ACTIVATION; EXPRESSION; RECEPTORS; SURVIVAL; BLOCKERS; INVASION	Cigarette smoke is a risk factor for esophageal squamous cell carcinoma (ESCC). It contains several carcinogens known to initiate and promote tumorigenesis as well as metastasis. The nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is one of the strongest carcinogens in tobacco and our previous studies have shown its proliferation-promoting role in the progression of ESCC. Recently, NNK was identified as an agonist for both beta1- and beta2-adrenoceptors. Thus, we hypothesized that the cancer-promoting effect of NNK was likely mediated through beta-adrenoceptors in ESCC. Therefore, we investigated the comprehensive role of NNK in ESCC in vitro and in vivo, and found that NNK promoted many oncogenic features including ESCC cell proliferation and xenograft tumor growth as well as ESCC cell migration and invasion. Western blotting showed that NNK induced significant up-regulation of phosphorylated ERK1/2, cyclin D1, Bcl-2, and vascular endothelial growth factor as well as down-regulation of Bax. Importantly, the oncogenic effects of NNK in ESCC and the altered protein expression were reversed to some extent by down-regulation of beta1- and beta2-adrenoceptors with the beta2-adrenoceptor showing a greater rescue effect. Taken together, our in vitro and in vivo results demonstrate that NNK plays an oncogenic role in ESCC through beta-adrenoceptors. Furthermore, beta2-adrenoceptor might play a more important role in this process. Our findings might provide a chemoprevention and therapy strategy for cigarette smoke-related ESCC carcinogenesis.	[Zhang, Nana; Sun, Xiujing; Sun, Mingjiong; Zhu, Shengtao; Wang, Li; Ma, Dan; Wang, Yongjun; Zhang, Shutian; Li, Peng] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China	Capital Medical University	Zhang, ST (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China.	zhangst@ccmu.edu.cn; lipeng@ccmu.edu.cn			National Natural Science Foundation of China [81071974, 81272447]; Beijing Natural Science Foundation [7122055]; National Key Basic Research Program of China [2012CB526600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by funds from the National Natural Science Foundation of China (81071974), Beijing Natural Science Foundation (7122055), National Natural Science Foundation of China (81272447), and National Key Basic Research Program of China (2012CB526600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2013, LUNG CANCER, V82, P390, DOI 10.1016/j.lungcan.2013.09.012; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; Assayag J, 2014, EUR J CANCER, V50, P2838, DOI 10.1016/j.ejca.2014.08.006; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; Choi CH, 2014, J CANCER RES CLIN, V140, P1179, DOI 10.1007/s00432-014-1658-7; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Duell EJ, 2012, MOL CARCINOGEN, V51, P40, DOI 10.1002/mc.20786; Hicks BM, 2013, ANN ONCOL, V24, P3100, DOI 10.1093/annonc/mdt381; Ho YS, 2005, TOXICOL APPL PHARM, V205, P133, DOI 10.1016/j.taap.2004.09.019; Huang RY, 2011, ONCOGENE, V30, P106, DOI 10.1038/onc.2010.390; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lambert R, 2007, ENDOSCOPY, V39, P550, DOI 10.1055/s-2007-966530; Li P, 2009, DRUG CHEM TOXICOL, V32, P175, DOI 10.1080/01480540902875253; Lin XP, 2012, HEPATO-GASTROENTEROL, V59, P584, DOI 10.5754/hge11271; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu CT, 2013, DIGEST DIS SCI, V58, P1256, DOI 10.1007/s10620-012-2429-4; Liu X, 2008, J CELL BIOCHEM, V105, P53, DOI 10.1002/jcb.21802; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Mennecier G, 2014, MOL CARCINOGEN, V53, P392, DOI 10.1002/mc.21987; Nagaraja AS, 2013, EXPERT OPIN INV DRUG, V22, P1359, DOI 10.1517/13543784.2013.825250; Nishimura K, 1998, Nihon Kokyuki Gakkai Zasshi, V36, P428; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Pluchino LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108698; Shen J, 2012, CANCER LETT, V318, P106, DOI 10.1016/j.canlet.2011.12.008; Spechler SJ, 2012, JAMA-J AM MED ASSOC, V310, P627; Sun XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077353; Tang J, 2013, SEMIN CANCER BIOL, V23, P533, DOI 10.1016/j.semcancer.2013.08.009; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Wang J, 2012, ASIAN PAC J CANCER P, V13, P2207, DOI 10.7314/APJCP.2012.13.5.2207; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Wong MCS, 2015, INT J CARDIOL, V179, P178, DOI 10.1016/j.ijcard.2014.10.028; Wu WKK, 2005, CANCER RES, V65, P5272, DOI 10.1158/0008-5472.CAN-05-0205; Yuan JM, 2011, CARCINOGENESIS, V32, P1366, DOI 10.1093/carcin/bgr125; Zhang D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-146; Zhang SY, 2009, CHEM RES TOXICOL, V22, P949, DOI 10.1021/tx900040j	37	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118845	10.1371/journal.pone.0118845	http://dx.doi.org/10.1371/journal.pone.0118845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742648	gold, Green Submitted, Green Published			2022-12-26	WOS:000350688100051
J	Yang, ML; Wu, Y; Jin, S; Hou, JY; Mao, YJ; Liu, WB; Shen, YC; Wu, LF				Yang, Minglei; Wu, Ying; Jin, Shan; Hou, Jinyan; Mao, Yingji; Liu, Wenbo; Shen, Yangcheng; Wu, Lifang			Flower Bud Transcriptome Analysis of Sapium sebiferum (Linn.) Roxb. and Primary Investigation of Drought Induced Flowering: Pathway Construction and G-Quadruplex Prediction Based on Transcriptome	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; SIGNALING PATHWAYS; FLORAL INDUCTION; JATROPHA-CURCAS; SALICYLIC-ACID; GENE; ARABIDOPSIS; STRESS; EXPRESSION; FAMILY	Sapium sebiferum (Linn.) Roxb. (Chinese Tallow Tree) is a perennial woody tree and its seeds are rich in oil which hold great potential for biodiesel production. Despite a traditional woody oil plant, our understanding on S. sebiferum genetics and molecular biology remains scant. In this study, the first comprehensive transcriptome of S. sebiferum flower has been generated by sequencing and de novo assembly. A total of 149,342 unigenes were generated from raw reads, of which 24,289 unigenes were successfully matched to public database. A total of 61 MADS box genes and putative pathways involved in S. sebiferum flower development have been identified. Abiotic stress response network was also constructed in this work, where 2,686 unigenes are involved in the pathway. As for lipid biosynthesis, 161 unigenes have been identified in fatty acid (FA) and triacylglycerol (TAG) biosynthesis. Besides, the G-Quadruplexes in RNA of S. sebiferum also have been predicted. An interesting finding is that the stress-induced flowering was observed in S. sebiferum for the first time. According to the results of semi-quantitative PCR, expression tendencies of flowering-related genes, GA1, AP2 and CRY2, accorded with stress-related genes, such as GRX50435 and PRX parallel to 39562. This transcriptome provides functional genomic information for further research of S. sebiferum, especially for the genetic engineering to shorten the juvenile period and improve yield by regulating flower development. It also offers a useful database for the research of other Euphorbiaceae family plants.	[Yang, Minglei; Wu, Ying; Jin, Shan; Hou, Jinyan; Mao, Yingji; Liu, Wenbo; Shen, Yangcheng; Wu, Lifang] Chinese Acad Sci, Key Lab Ion Beam Bioengn, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China; [Yang, Minglei; Wu, Ying; Jin, Shan; Hou, Jinyan; Mao, Yingji; Liu, Wenbo; Shen, Yangcheng; Wu, Lifang] Chinese Acad Sci, Bioenergy Forest Res Ctr State Forestry Adm, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China; [Wu, Ying; Mao, Yingji; Liu, Wenbo; Wu, Lifang] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Wu, Ying] Henan Univ Sci & Technol, Coll Food & Bioengn, Luoyang, Henan, Peoples R China; [Shen, Yangcheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Henan University of Science & Technology; Anhui University	Wu, LF (corresponding author), Chinese Acad Sci, Key Lab Ion Beam Bioengn, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China.	lfwu@ipp.ac.cn	Mao, Yingji/AAW-7766-2020	Mao, Yingji/0000-0001-9737-1526; Jin, Shan/0000-0001-7531-9997	Special Fund for Forest Scientific Research in the Public Welfare [201404110]; National Nature Science Foundation of China [11375232]; Fund of Hefei Center of Physical Science and Technology [2012FXCX006]	Special Fund for Forest Scientific Research in the Public Welfare; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Hefei Center of Physical Science and Technology	This research was supported by Special Fund for Forest Scientific Research in the Public Welfare (201404110), National Nature Science Foundation of China (11375232), and Fund of Hefei Center of Physical Science and Technology (2012FXCX006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; Deng J., 2010, COTTON SCI, V22, P6; Dewalt SJ, 2006, MOL ECOL NOTES, V6, P505, DOI 10.1111/j.1471-8286.2006.01296.x; Di Antonio M, 2012, METHODS, V57, P84, DOI 10.1016/j.ymeth.2012.01.008; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Divakara BN, 2010, APPL ENERG, V87, P732, DOI 10.1016/j.apenergy.2009.07.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Jack T, 2001, TRENDS PLANT SCI, V6, P310, DOI 10.1016/S1360-1385(01)01987-2; Jaryan V, 2014, ENVIRON MONIT ASSESS, V186, P4423, DOI 10.1007/s10661-014-3708-7; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kumar O, 2007, CELLULAR MOL BIOL, V53, P10; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Leseberg CH, 2006, GENE, V378, P84, DOI 10.1016/j.gene.2006.05.022; Liotenberg S, 1999, PLANT PHYSIOL BIOCH, V37, P341, DOI 10.1016/S0981-9428(99)80040-0; Makkar HRS, 2009, EUR J LIPID SCI TECH, V111, P773, DOI 10.1002/ejlt.200800244; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Mullen MA, 2010, NUCLEIC ACIDS RES, V38, P8149, DOI 10.1093/nar/gkq804; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Nakagawa M, 2012, SCI HORTIC-AMSTERDAM, V139, P108, DOI 10.1016/j.scienta.2012.03.005; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Park SY, 2004, MOL GENET GENOMICS, V271, P339, DOI 10.1007/s00438-004-0986-8; Peng X, 2008, CHINESE WILD PLANT R, V27; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Takahashi H, 2012, J BIOSCI BIOENG, V114, P570, DOI 10.1016/j.jbiosc.2012.05.017; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Wada KC, 2010, PLANT SIGNAL BEHAV, V5, P944, DOI 10.4161/psb.5.8.11826; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Wang CX, 2007, PLANT CELL REP, V26, P1357, DOI 10.1007/s00299-007-0336-5; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xing S, 2006, PLANT BIOLOGY, V8, P547, DOI 10.1055/s-2006-924278; Xing SP, 2005, DEVELOPMENT, V132, P1555, DOI 10.1242/dev.01725; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yang Z, 2007, HUBEI FORESTRY SCI T, V6, P3	61	24	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118479	10.1371/journal.pone.0118479	http://dx.doi.org/10.1371/journal.pone.0118479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738565	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900039
J	Kanu, N; Gronroos, E; Martinez, P; Burrell, RA; Goh, XY; Bartkova, J; Maya-Mendoza, A; Mistrik, M; Rowan, AJ; Patel, H; Rabinowitz, A; East, P; Wilson, G; Santos, CR; McGranahan, N; Gulati, S; Gerlinger, M; Birkbak, NJ; Joshi, T; Alexandrov, LB; Stratton, MR; Powles, T; Matthews, N; Bates, PA; Stewart, A; Szallasi, Z; Larkin, J; Bartek, J; Swanton, C				Kanu, N.; Groenroos, E.; Martinez, P.; Burrell, R. A.; Goh, X. Yi; Bartkova, J.; Maya-Mendoza, A.; Mistrik, M.; Rowan, A. J.; Patel, H.; Rabinowitz, A.; East, P.; Wilson, G.; Santos, C. R.; McGranahan, N.; Gulati, S.; Gerlinger, M.; Birkbak, N. J.; Joshi, T.; Alexandrov, L. B.; Stratton, M. R.; Powles, T.; Matthews, N.; Bates, P. A.; Stewart, A.; Szallasi, Z.; Larkin, J.; Bartek, J.; Swanton, C.			SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair	ONCOGENE			English	Article							HOMOLOGOUS RECOMBINATION; MUTATIONAL PROCESSES; DAMAGE RESPONSE; COPY NUMBER; HISTONE; GENE; METHYLATION; INSTABILITY; FACT; HETEROGENEITY	Defining mechanisms that generate intratumour heterogeneity and branched evolution may inspire novel therapeutic approaches to limit tumour diversity and adaptation. SETD2 (Su(var), Enhancer of zeste, Trithorax-domain containing 2) trimethylates histone-3 lysine-36 (H3K36me3) at sites of active transcription and is mutated in diverse tumour types, including clear cell renal carcinomas (ccRCCs). Distinct SETD2 mutations have been identified in spatially separated regions in ccRCC, indicative of intratumour heterogeneity. In this study, we have addressed the consequences of SETD2 loss-of-function through an integrated bioinformatics and functional genomics approach. We find that bi-allelic SETD2 aberrations are not associated with microsatellite instability in ccRCC. SETD2 depletion in ccRCC cells revealed aberrant and reduced nucleosome compaction and chromatin association of the key replication proteins minichromosome maintenance complex component (MCM7) and DNA polymerase delta hindering replication fork progression, and failure to load lens epithelium-derived growth factor and the Rad51 homologous recombination repair factor at DNA breaks. Consistent with these data, we observe chromosomal breakpoint locations are biased away from H3K36me3 sites in SETD2 wild-type ccRCCs relative to tumours with bi-allelic SETD2 aberrations and that H3K36me3-negative ccRCCs display elevated DNA damage in vivo. These data suggest a role for SETD2 in maintaining genome integrity through nucleosome stabilization, suppression of replication stress and the coordination of DNA repair.	[Kanu, N.; Birkbak, N. J.; Swanton, C.] UCL Canc Inst, London, England; [Groenroos, E.; Martinez, P.; Burrell, R. A.; Goh, X. Yi; Rowan, A. J.; Patel, H.; Rabinowitz, A.; East, P.; Wilson, G.; Santos, C. R.; McGranahan, N.; Gulati, S.; Gerlinger, M.; Birkbak, N. J.; Matthews, N.; Bates, P. A.; Stewart, A.; Swanton, C.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Bartkova, J.; Maya-Mendoza, A.; Bartek, J.] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Mistrik, M.; Bartek, J.] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, CR-77147 Olomouc, Czech Republic; [Birkbak, N. J.; Joshi, T.; Szallasi, Z.] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, Kongens Lyngby, Denmark; [Alexandrov, L. B.; Stratton, M. R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, Cambridgeshire, England; [Powles, T.] Univ London, Expt Canc Med Ctr, Barts Canc Inst, London, England; [Szallasi, Z.] Childrens Hosp, Boston, MA 02115 USA; [Larkin, J.] Royal Marsden Hosp, Dept Med, London SW3 6JJ, England	University of London; University College London; Cancer Research UK; Danish Cancer Society; Palacky University Olomouc; Technical University of Denmark; University of Cambridge; Wellcome Trust Sanger Institute; University of London; Queen Mary University London; Harvard University; Boston Children's Hospital; Royal Marsden NHS Foundation Trust	Bartek, J (corresponding author), Danish Canc Soc, Res Ctr, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; charles.swanton@cancer.org.uk	Gronroos, Eva/P-6951-2015; Bates, Paul A/AAF-8561-2020; McGranahan, Nicholas/ABD-6561-2021; Alexandrov, Ludmil/AAS-1454-2021	Bates, Paul A/0000-0003-0621-0925; McGranahan, Nicholas/0000-0001-9537-4045; Alexandrov, Ludmil/0000-0003-3596-4515; Santos, Claudio/0000-0002-8766-2247; Birkbak, Nicolai/0000-0003-1613-9587; Martinez, Pierre/0000-0001-7069-4413; Swanton, Charles/0000-0002-4299-3018; Patel, Harshil/0000-0003-2707-7940; Gronroos, Eva/0000-0001-8303-5409; Gerlinger, Marco/0000-0003-2719-299X; Mistrik, Martin/0000-0002-2321-0348; Maya-Mendoza, Apolinar/0000-0001-7452-9896; Larkin, James/0000-0001-5569-9523; Szallasi, Zoltan/0000-0001-5395-7509	NHGRI [H3K36me3, H3K27me3]; Cancer Research UK; Breast Cancer Research Foundation; Medical Research Council [G0902275, G0701935/2]; Danish Cancer Society; Lundbeck Foundation [R93-A8990]; Ministry of the interior of the Czech Republic [VG20102014001]; National Program of Sustainability [LO1304]; Danish Council for Independent Research [DFF-1331-00262]; NIHR RMH/ICR Biomedical Research Centre for Cancer; EC [259303, 259892]; UCL Overseas Research Scholarship; European Research Council; Prostate Cancer Foundation; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Rosetrees Trust; Cancer Research UK [18377, 10748, 17786, 19310] Funding Source: researchfish; Medical Research Council [G0701935] Funding Source: researchfish; Rosetrees Trust [M179] Funding Source: researchfish; The Francis Crick Institute [10001, 10002, 10359, 10169, 10303, 10174, 10170, 10172] Funding Source: researchfish; MRC [G0701935, G0902275] Funding Source: UKRI	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK); Breast Cancer Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Ministry of the interior of the Czech Republic; National Program of Sustainability; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); NIHR RMH/ICR Biomedical Research Centre for Cancer; EC(European CommissionEuropean Commission Joint Research Centre); UCL Overseas Research Scholarship; European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Rosetrees Trust(Rosetrees Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr Simon Boulton and our colleagues for critical discussions of this work. The results published here are in part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/ (dbGaP accession number: phs000178.v5.p5). We acknowledge the Encyclopedia of DNA Elements (ENCODE) Consortium, funded by the NHGRI, from which we obtained data for H3K36me3 and H3K27me3 analyses. We thank all funding boards for their continued support. The research leading to these results is supported by Cancer Research UK (XYG, RAB, EG, PM, PE, SG, C Santos, AJR, NM, PAB, AS and C Swanton), Breast Cancer Research Foundation (C Swanton and NK), Medical Research Council (ID: G0902275 to MG and C Santos; ID: G0701935/2 to AJR and C Swanton), the Danish Cancer Society (AMM, J Bartkova and J Bartek), the Lundbeck Foundation (R93-A8990 to J Bartek), the Ministry of the interior of the Czech Republic (grant VG20102014001 to MM and J Bartek), the National Program of Sustainability (grant LO1304 to MM and J Bartek), the Danish Council for Independent Research (grant DFF-1331-00262 to J Bartek), NIHR RMH/ICR Biomedical Research Centre for Cancer (JL), the EC Framework 7 (PREDICT 259303 to XYG, EG, PM, MG, TJ and C Swanton; DDResponse 259892 to J Bartek and J Bartkova and RESPONSIFY ID: 259303 to C Swanton), UCL Overseas Research Scholarship (SG). C Swanton is also supported by the European Research Council, Rosetrees Trust and The Prostate Cancer Foundation. This research is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Abe T, 2011, J BIOL CHEM, V286, P30504, DOI 10.1074/jbc.M111.264721; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Altavilla G, 2010, ONCOL REP, V24, P927, DOI 10.3892/or_00000938; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Carvalho S, 2013, NUCLEIC ACIDS RES, V41, P2881, DOI 10.1093/nar/gks1472; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Mejlvang J, 2014, J CELL BIOL, V204, P29, DOI 10.1083/jcb.201305017; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ortiz-Estevez M, 2012, BIOINFORMATICS, V28, P1793, DOI 10.1093/bioinformatics/bts248; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Statham AL, 2010, BIOINFORMATICS, V26, P1662, DOI 10.1093/bioinformatics/btq247; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zaret K, 2005, CURR PROT MOL BIOL	58	105	108	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2015	34	46					5699	5708		10.1038/onc.2015.24	http://dx.doi.org/10.1038/onc.2015.24			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GC	25728682	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000364594600002
J	Lau, E; Sedy, J; Sander, C; Shaw, MA; Feng, Y; Scortegagna, M; Claps, G; Robinson, S; Cheng, P; Srivas, R; Soonthornvacharin, S; Ideker, T; Bosenberg, M; Gonzalez, R; Robinson, W; Chanda, SK; Ware, C; Dummer, R; Hoon, D; Kirkwood, JM; Ronai, ZA				Lau, E.; Sedy, J.; Sander, C.; Shaw, M. A.; Feng, Y.; Scortegagna, M.; Claps, G.; Robinson, S.; Cheng, P.; Srivas, R.; Soonthornvacharin, S.; Ideker, T.; Bosenberg, M.; Gonzalez, R.; Robinson, W.; Chanda, S. K.; Ware, C.; Dummer, R.; Hoon, D.; Kirkwood, J. M.; Ronai, Z. A.			Transcriptional repression of IFN beta 1 by ATF2 confers melanoma resistance to therapy	ONCOGENE			English	Article							METASTATIC MELANOMA; INTERFERON-BETA; RAF INHIBITION; IFN-BETA; KAPPA-B; CELLS; BIOCHEMOTHERAPY; EXPRESSION; INDUCTION; CANCER	The resistance of melanoma to current treatment modalities represents a major obstacle for durable therapeutic response, and thus the elucidation of mechanisms of resistance is urgently needed. The crucial functions of activating transcription factor-2 (ATF2) in the development and therapeutic resistance of melanoma have been previously reported, although the precise underlying mechanisms remain unclear. Here, we report a protein kinase C-epsilon (PKC epsilon)- and ATF2-mediated mechanism that facilitates resistance by transcriptionally repressing the expression of interferon-beta 1 (IFN beta 1) and downstream type-I IFN signaling that is otherwise induced upon exposure to chemotherapy. Treatment of early-stage melanomas expressing low levels of PKC epsilon with chemotherapies relieves ATF2-mediated transcriptional repression of IFN beta 1, resulting in impaired S-phase progression, a senescence-like phenotype and increased cell death. This response is lost in late-stage metastatic melanomas expressing high levels of PKC epsilon. Notably, nuclear ATF2 and low expression of IFN beta 1 in melanoma tumor samples correlates with poor patient responsiveness to biochemotherapy or neoadjuvant IFN-alpha 2a. Conversely, cytosolic ATF2 and induction of IFN beta 1 coincides with therapeutic responsiveness. Collectively, we identify an IFN beta 1-dependent, cell-autonomous mechanism that contributes to the therapeutic resistance of melanoma via the PKC epsilon-ATF2 regulatory axis.	[Lau, E.; Sedy, J.; Feng, Y.; Scortegagna, M.; Claps, G.; Soonthornvacharin, S.; Chanda, S. K.; Ware, C.; Ronai, Z. A.] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA; [Sander, C.; Kirkwood, J. M.] Univ Pittsburgh, Ctr Canc, Pittsburgh, PA USA; [Shaw, M. A.; Hoon, D.] John Wayne Canc Inst, Santa Monica, CA USA; [Robinson, S.; Gonzalez, R.; Robinson, W.] Univ Colorado, Div Med Oncol, Aurora, CO USA; [Cheng, P.; Dummer, R.] Univ Zurich, Dept Dermatol, Zurich, Switzerland; [Srivas, R.] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA; [Ideker, T.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Bosenberg, M.] Yale Univ, Sch Med, New Haven, CT USA	Sanford Burnham Prebys Medical Discovery Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; John Wayne Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Zurich; Stanford University; University of California System; University of California San Diego; Yale University	Lau, E (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	elau@sbmri.org; ronai@sbmri.org	Hoon, Dave SB/C-7146-2018; Cheng, Phil/AAN-8567-2021; gonzález, rene/W-2081-2019; Claps, Giuseppina/G-6180-2018	Hoon, Dave SB/0000-0003-1915-3683; Cheng, Phil/0000-0003-2940-006X; Robinson, William/0000-0003-1875-9691; RONAI, ZEEV/0000-0002-3859-0400; Ideker, Trey/0000-0002-1708-8454; Srivas, Rohith/0000-0001-9495-9949; Claps, Giuseppina/0000-0002-3064-0063; Sedy, John/0000-0002-6428-1054	NCI [CA128814, CA179170, CA164679, CA177322, CA121973]; Hervey Family Non-endowment Fund at The San Diego Foundation; Melanoma Research Foundation;  [CA172705];  [CA121949]; NATIONAL CANCER INSTITUTE [T32CA121949, K99CA172705, P01CA177322, R01CA164679, P01CA128814, R01CA179170, P50CA121973, R01CA172017, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hervey Family Non-endowment Fund at The San Diego Foundation; Melanoma Research Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Serge Fuchs (UPENN) and members of the Ronai laboratory for crucial scientific discussions and critical reading of this manuscript. Additional thanks to Mitch Levesque and Valerie Amann for their assistance in providing patient samples from the Department of Dermatology, University of Zurich. We are grateful to Jian-Liang Li of the SBMRI Bioinformatics Core, as well as the SBMRI Flow Cytometry and Histology Core, for technical support. Support from NCI P01 (CA128814), R01 (CA179170), Hervey Family Non-endowment Fund at The San Diego Foundation and a Melanoma Research Foundation grant to ZAR are gratefully acknowledged. Support from NCI Grants R01 (CA164679) and P01 (CA177322) to CW and P50 SPORE (CA121973) to JMK is also gratefully acknowledged. EL has been supported by K99 (CA172705) and T32 (CA121949) Grants.	Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bhoumik A, 2004, P NATL ACAD SCI USA, V101, P4222, DOI 10.1073/pnas.0400195101; Eiro N, 2014, J IMMUNOTHER, V37, P366, DOI 10.1097/CJI.0000000000000045; Gajewski TF, 2012, CANCER IMMUNOL IMMUN, V61, P1343, DOI 10.1007/s00262-012-1305-6; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Haferkamp S, 2013, J INVEST DERMATOL, V133, P1601, DOI 10.1038/jid.2013.6; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ives NJ, 2007, J CLIN ONCOL, V25, P5426, DOI 10.1200/JCO.2007.12.0253; Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Koyanagi K, 2005, J CLIN ONCOL, V23, P8057, DOI 10.1200/JCO.2005.02.0958; Koyanagi K, 2010, CLIN CANCER RES, V16, P2402, DOI 10.1158/1078-0432.CCR-10-0037; Lau E, 2012, CELL, V148, P543, DOI 10.1016/j.cell.2012.01.016; Maeda S, 2014, J BIOL CHEM, V289, P23786, DOI 10.1074/jbc.M114.551879; Malmgaard L, 2002, J VIROL, V76, P4520, DOI 10.1128/JVI.76.9.4520-4525.2002; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pencheva N, 2014, CELL, V156, P986, DOI 10.1016/j.cell.2014.01.038; Rao RD, 2006, CANCER, V106, P375, DOI 10.1002/cncr.21611; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rubin Krista M, 2013, Semin Oncol Nurs, V29, P195, DOI 10.1016/j.soncn.2013.06.005; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Ryu H, 2014, CANCER LETT, V352, P220, DOI 10.1016/j.canlet.2014.06.018; Schuchter LM, 2004, J CLIN ONCOL, V22, P7, DOI 10.1200/JCO.2004.10.907; Snijders AM, 2014, ONCOTARGET, V5, P4011, DOI 10.18632/oncotarget.2148; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Testori A, 2009, ANN ONCOL, V20, P22, DOI 10.1093/annonc/mdp257; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Varsano T, 2013, CLIN CANCER RES, V19, P2710, DOI 10.1158/1078-0432.CCR-12-2689; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Yue CY, 2015, INT J CANCER, V136, P117, DOI 10.1002/ijc.29004	35	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2015	34	46					5739	5748		10.1038/onc.2015.22	http://dx.doi.org/10.1038/onc.2015.22			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GC	25728676	Green Accepted			2022-12-26	WOS:000364594600006
J	Talaber, G; Tuckermann, JP; Okret, S				Talaber, Gergely; Tuckermann, Jan Peter; Okret, Sam			ACTH controls thymocyte homeostasis independent of glucocorticoids	FASEB JOURNAL			English	Article						adrenalectomy; glucocorticoid receptor ablation; glucocorticoid resistance; thymus	DOUBLE SUPRARENALECTOMY; THYMUS; GLAND; HETEROGENEITY; REGENERATION; SUBPOPULATIONS; MACROPHAGES; EXPRESSION; RECEPTORS; PROTECTS	It has been known for decades that lowering the circulating glucocorticoid (GC) concentration as in Addison's disease or after removing the adrenals results in thymus enlargement, largely due to thymocyte expansion. This has been attributed to the loss of the proapoptotic effects on thymocytes by adrenal GCs. Here, we test this concept and report that ACTH directly controls thymic growth post-adrenalectomy (ADX) independent of the proapoptotic effect of GCs. This was supported by the finding that ADX caused thymus enlargement and a 1.7-fold (P < 0.001) increase in thymocyte number in GR(LckCre) mice resistant to GC-induced thymocyte apoptosis, similar to the increase seen in wildtype mice (2.2-fold; P < 0.01). We show by immunostaining that melanocortin receptor subtype 2, which selectively binds ACTH, is partly expressed on the thymic epithelium. Furthermore, ACTH in comparison to vehicle induced a 2.0-fold (P < 0.01) increase in fetal thymic organ culture thymocyte numbers in vitro and enhanced 2.2-fold (P < 0.05) the expression of delta-like ligand 4, a factor that supports T-cell development. Additionally, adrenalectomized GRLckCre mice treated with ACTH under conditions that repressed endogenous ACTH secretion showed increased thymocyte cellularity (1.9-fold; P < 0.01) and splenic naive T-cell numbers (2.5-fold; P < 0.001) compared to when treated with PBS. Altogether, our results show that ACTH directly controls thymocyte homeostasis independent of GCs. These results revise the old paradigm behind compensatory thymus growth following ADX, now demonstrating that ACTH has a central role in regulating thymocyte expansion when systemic GC concentration is low.	[Talaber, Gergely; Okret, Sam] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Tuckermann, Jan Peter] Univ Ulm, Inst Comparat Mol Endocrinol, D-89069 Ulm, Germany	Karolinska Institutet; Ulm University	Okret, S (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7-9, S-14183 Huddinge, Sweden.	sam.okret@ki.se			Swedish Cancer Society; Deutsche Forschungsgemeinschaft [DFG Tu220/6-2, SPP 1468]	Swedish Cancer Society(Swedish Cancer Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge the expert help of Dr. Jose Inzunza (Department of Biosciences and Nutrition, Karolinska Institutet, Novum, Huddinge, Sweden) in performing adrenalectomy. This study was funded by the Swedish Cancer Society and the Deutsche Forschungsgemeinschaft (DFG Tu220/6-2) in the priority program SPP 1468 Immunobone.	BATANERO E, 1992, BRAIN BEHAV IMMUN, V6, P249, DOI 10.1016/0889-1591(92)90047-R; Benjamins JA, 2013, GLIA, V61, P1206, DOI 10.1002/glia.22504; Berki T, 2002, INT IMMUNOL, V14, P463, DOI 10.1093/intimm/14.5.463; Boehm T, 2013, NAT REV IMMUNOL, V13, P831, DOI 10.1038/nri3534; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Cooray SN, 2011, MOL CELL ENDOCRINOL, V331, P215, DOI 10.1016/j.mce.2010.07.015; Esashi E, 2003, J IMMUNOL, V171, P2773, DOI 10.4049/jimmunol.171.6.2773; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; Ferrando-Martinez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2; Ferrero I, 2013, EUR J IMMUNOL, V43, P2845, DOI 10.1002/eji.201343527; Garcia-Peydro M, 2006, J IMMUNOL, V177, P3711, DOI 10.4049/jimmunol.177.6.3711; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gray DHD, 2007, J IMMUNOL, V178, P4956, DOI 10.4049/jimmunol.178.8.4956; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hoeflich A, 2009, J MOL ENDOCRINOL, V42, P191, DOI 10.1677/JME-08-0160; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Jaffe HL, 1924, J EXP MED, V40, P753, DOI 10.1084/jem.40.6.753; Jaffe HL, 1924, J EXP MED, V40, P619, DOI 10.1084/jem.40.5.619; Jaffe HL, 1924, J EXP MED, V40, P325, DOI 10.1084/jem.40.3.325; Johnson EW, 2001, J BIOL REG HOMEOS AG, V15, P156; Kawiak J, 1996, FOLIA HISTOCHEM CYTO, V34, P75; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kyrou I, 2009, CURR OPIN PHARMACOL, V9, P787, DOI 10.1016/j.coph.2009.08.007; Liddicoat DR, 2014, IMMUNOL CELL BIOL, V92, P148, DOI 10.1038/icb.2013.76; Padgett EL, 2000, INT J IMMUNOPHARMACO, V22, P285, DOI 10.1016/S0192-0561(99)00083-1; Pazirandeh A, 1999, FASEB J, V13, P893, DOI 10.1096/fasebj.13.8.893; Pruett Stephen B., 2004, BMC Immunology, V5; Qiao SJ, 2009, ENDOCRINOLOGY, V150, P4163, DOI 10.1210/en.2009-0195; ROCHA B, 1985, EUR J IMMUNOL, V15, P1131, DOI 10.1002/eji.1830151112; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Si J, 2013, KIDNEY INT, V83, P635, DOI 10.1038/ki.2012.447; Stojic-Vukanic Z, 2009, EXP BIOL MED, V234, P1067, DOI 10.3181/0902-RM-63; Talaber G, 2013, MOL CELL ENDOCRINOL, V380, P89, DOI 10.1016/j.mce.2013.05.007; Taves MD, 2011, AM J PHYSIOL-ENDOC M, V301, pE11, DOI 10.1152/ajpendo.00100.2011; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Weyand CM, 2003, EXP GERONTOL, V38, P833, DOI 10.1016/S0531-5565(03)00090-1; Wiegers GJ, 2001, EUR J IMMUNOL, V31, P2293, DOI 10.1002/1521-4141(200108)31:8<2293::AID-IMMU2293>3.0.CO;2-I; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Xing YW, 2010, J MOL ENDOCRINOL, V45, P59, DOI 10.1677/JME-10-0006; Zaidi M, 2010, P NATL ACAD SCI USA, V107, P8782, DOI 10.1073/pnas.0912176107	42	23	27	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2526	2534		10.1096/fj.14-268508	http://dx.doi.org/10.1096/fj.14-268508			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25733567				2022-12-26	WOS:000355209500029
J	Chatterjee, N; Das, S; Bose, D; Banerjee, S; Jha, T; Das Saha, K				Chatterjee, Nabanita; Das, Subhadip; Bose, Dipayan; Banerjee, Somenath; Jha, Tarun; Das Saha, Krishna			Lipid from Infective L. donovani Regulates Acute Myeloid Cell Growth via Mitochondria Dependent MAPK Pathway	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NITRIC-OXIDE SYNTHESIS; INDUCED APOPTOSIS; U937 CELLS; MONONUCLEAR-CELLS; CYTOCHROME-C; CANCER-CELLS; P38 MAPK; ACTIVATION; INJURY	The microbial source, which includes live, attenuated, or genetically modified microbes or their cellular component(s) or metabolites, has gained increasing significance for therapeutic intervention against several pathophysiological conditions of disease including leukemia, which remains an incurable disease till now despite recent advances in the medical sciences. We therefore took up the present study to explore if the leishmanial lipid (pLLD) isolated from L. donovani can play an anti-neoplastic role in acute myeloid leukemia cells by regulating cellular growth. Indeed pLLD significantly inhibited cell proliferation of four AML cell lines (HL-60, MOLT-4, U937, and K562). Scanning electron microscopy and DNA fragmentation analysis revealed that it significantly induced apoptosis of U937 cells through morphological alteration. Occurrence of apoptosis was checked by using Annexin exposure and this established that the cell cycle was arrested at G0/G1 phase in time-dependent manner. pLLD increased the intracellular ROS with alteration of mitochondrial membrane potential, as detected using DCFDA. It also regulated the expression of apoptosis-related proteins like Bax, Bcl2, Bad and t-Bid besides causing cleavage of PARP as determined by western blot analysis. Treatment of U937 cells with pLLD induced the activation of extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK) 1/2, p38, and caspases 9/3. The results suggest that pLLD induces apoptosis in acute myeloid leukemia cells possibly via increasing intracellular ROS and regulating the MAPK pathway.	[Chatterjee, Nabanita; Das, Subhadip; Bose, Dipayan; Banerjee, Somenath; Das Saha, Krishna] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata 700032, W Bengal, India; [Jha, Tarun] Jadavpur Univ, Div Med & Pharmaceut Chem, Dept Pharmaceut Technol, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Jadavpur University	Das Saha, K (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	krishnaiicb@yahoo.com	Bose, Dipayan/Q-5230-2019; Banerjee, Somenath/AAA-1540-2021; Jha, Tarun/AAH-3939-2019; Chatterjee, Nabanita/GPX-3468-2022; Chatterjee, N/AAN-9821-2020	Bose, Dipayan/0000-0003-4789-2838; Banerjee, Somenath/0000-0002-1527-7550; Jha, Tarun/0000-0002-9996-738X; 	CSIR; Indian Council of Medical Research (ICMR; India)	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR; India)(Indian Council of Medical Research (ICMR))	The CSIR and Indian Council of Medical Research (ICMR; India) financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa S, 2000, INFECT IMMUN, V68, P4611, DOI 10.1128/IAI.68.8.4611-4615.2000; Azuma H, 2003, ANTICANCER RES, V23, P3183; Balestieri FMP, 2002, MICROBES INFECT, V4, P23, DOI 10.1016/S1286-4579(01)01505-2; Bishop JF, 1997, SEMIN ONCOL, V24, P57; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cai J, 2002, BIOL PHARM BULL, V25, P193, DOI 10.1248/bpb.25.193; Chatterjee N, 2014, J LEUKOCYTE BIOL, V96, P325, DOI 10.1189/jlb.3A1113-582R; Chatterjee N, 2012, TOXICOL APPL PHARM, V264, P182, DOI 10.1016/j.taap.2012.07.032; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Das S, 2012, CELL PHYSIOL BIOCHEM, V29, P251, DOI 10.1159/000337606; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Dhuley JN, 1999, COMP IMMUNOL MICROB, V22, P15, DOI 10.1016/S0147-9571(98)00021-6; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fernandes J, 2012, MED HYPOTHESES, V78, P435, DOI 10.1016/j.mehy.2011.12.014; Fu SL, 2008, J SURG RES, V148, P77, DOI 10.1016/j.jss.2008.03.005; Ghosh S, 2005, BRIT J HAEMATOL, V128, P35, DOI 10.1111/j.1365-2141.2004.05256.x; GIRALT SA, 1994, BLOOD, V84, P3603, DOI 10.1182/blood.V84.11.3603.bloodjournal84113603; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kwan JM, 2009, LEUKEMIA RES, V33, P1392, DOI 10.1016/j.leukres.2009.01.024; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Li YZ, 1999, MOL MED, V5, P232, DOI 10.1007/BF03402120; Liew JCJ, 2010, J BIOSCI BIOENG, V110, P338, DOI 10.1016/j.jbiosc.2010.02.017; Liu XS, 2006, PLANTA MED, V72, P501, DOI 10.1055/s-2006-931534; Majumdar KN, 2008, ARTHRITIS RHEUM-US, V58, P696, DOI 10.1002/art.23295; MALMGREN RA, 1955, CANCER RES, V15, P473; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Minamino M, 2003, MICROBIOL-SGM, V149, P2071, DOI 10.1099/mic.0.25922-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUKHOPADHYAY R, 1994, BIOCHEM PHARMACOL, V47, P253, DOI 10.1016/0006-2952(94)90014-0; Pal S, 2004, INT J CANCER, V111, P270, DOI 10.1002/ijc.20246; Pramanik M, 2013, CHEM COMMUN, V49, P9461, DOI 10.1039/c3cc44989k; PROUDFOOT L, 1995, EUR J IMMUNOL, V25, P745, DOI 10.1002/eji.1830250318; Repicky A, 2009, CANCER LETT, V277, P55, DOI 10.1016/j.canlet.2008.11.026; Sinha D, 1999, LEUKEMIA, V13, P119, DOI 10.1038/sj.leu.2401239; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tanner EA, 2011, DEVELOPMENT, V138, P327, DOI 10.1242/dev.057943; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Watabe M, 1998, ONCOGENE, V16, P779, DOI 10.1038/sj.onc.1201592; Wei MQ, 2008, CANCER LETT, V259, P16, DOI 10.1016/j.canlet.2007.10.034	44	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0120509	10.1371/journal.pone.0120509	http://dx.doi.org/10.1371/journal.pone.0120509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750993	Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700036
J	Korhonen, M; Muuronen, A; Arponen, O; Mustonen, P; Hedman, M; Jakala, P; Vanninen, R; Taina, M				Korhonen, Miika; Muuronen, Antti; Arponen, Otso; Mustonen, Pirjo; Hedman, Marja; Jakala, Pekka; Vanninen, Ritva; Taina, Mikko			Left Atrial Appendage Morphology in Patients with Suspected Cardiogenic Stroke without Known Atrial Fibrillation	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; THROMBUS FORMATION; RISK; VOLUME; CT	The left atrial appendage (LAA) is the typical origin for intracardiac thrombus formation. Whether LAA morphology is associated with increased stroke/TIA risk is controversial and, if it does, which morphological type most predisposes to thrombus formation. We assessed LAA morphology in stroke patients with cryptogenic or suspected cardiogenic etiology and in age-and gender-matched healthy controls. LAA morphology and volume were analyzed by cardiac computed tomography in 111 patients (74 males; mean age 60 +/- 11 years) with acute ischemic stroke of cryptogenic or suspected cardiogenic etiology other than known atrial fibrillation (AF). A subgroup of 40 patients was compared to an age-and gender-matched control group of 40 healthy individuals (21 males in each; mean age 54 +/- 9 years). LAA was classified into four morphology types (Cactus, ChickenWing, WindSock, Cauli-Flower) modified with a quantitative qualifier. The proportions of LAA morphology types in the main stroke group, matched stroke subgroup, and control group were as follows: Cactus (9.0%, 5.0%, 20.0%), ChickenWing (23.4%, 37.5%, 10.0%), WindSock (47.7%, 35.0%, 67.5%), and CauliFlower (19.8%, 22.5%, 2.5%). The distribution of morphology types differed significantly (P<0.001) between the matched stroke subgroup and control group. The proportion of single-lobed LAA was significantly higher (P<0.001) in the matched stroke subgroup (55%) than the control group (6%). LAA volumes were significantly larger (P<0.001) in both stroke study groups compared to controls patients. To conclude, LAA morphology differed significantly between stroke patients and controls, and single-lobed LAAs were overrepresented and LAA volume was larger in patients with acute ischemic stroke of cryptogenic or suspected cardiogenic etiology.	[Korhonen, Miika; Muuronen, Antti; Arponen, Otso; Hedman, Marja; Vanninen, Ritva; Taina, Mikko] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Korhonen, Miika; Muuronen, Antti; Arponen, Otso; Vanninen, Ritva; Taina, Mikko] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Korhonen, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Miika.Korhonen@kuh.fi						Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Anselmino M, 2014, HEART RHYTHM, V11, P2, DOI 10.1016/j.hrthm.2013.10.020; Bansil Shalini, 2004, J Stroke Cerebrovasc Dis, V13, P12, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.004; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Chang SH, 2007, J CARDIOVASC ELECTR, V18, P47, DOI 10.1111/j.1540-8167.2006.00655.x; Christiaens L, 2010, INT J CARDIOL, V140, P189, DOI 10.1016/j.ijcard.2008.11.055; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Erol B, 2011, EUR J RADIOL, V80, pE346, DOI 10.1016/j.ejrad.2010.11.008; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Hunter RJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P351, DOI 10.1161/CIRCEP.111.965541; Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065; Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036; Koplay M, 2012, EUR J RADIOL, V81, P1575, DOI 10.1016/j.ejrad.2011.04.060; Makino N, 2013, J AM COLL CARDIOL, V61, pE272, DOI 10.1016/S0735-1097(13)60272-7; Miller DJ, 2013, J NEUROL SCI, V324, P57, DOI 10.1016/j.jns.2012.10.001; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Okuyama H, 2006, CIRC J, V70, P971, DOI 10.1253/circj.70.971; Park HC, 2013, INT J CARDIOVAS IMAG, V29, P935, DOI 10.1007/s10554-012-0161-y; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Shi AW, 2012, J INT MED RES, V40, P1560, DOI 10.1177/147323001204000436; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Taina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090903; Walker DT, 2012, J INTERV CARD ELECTR, V34, P173, DOI 10.1007/s10840-011-9638-1; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamamoto M, 2014, CIRC-CARDIOVASC IMAG, V7, P337, DOI 10.1161/CIRCIMAGING.113.001317	28	36	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118822	10.1371/journal.pone.0118822	http://dx.doi.org/10.1371/journal.pone.0118822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751618	Green Submitted, Green Published, gold			2022-12-26	WOS:000350692700011
J	Zhang, X; Ren, JC; Yan, L; Tang, YQ; Zhang, WH; Li, DW; Zang, YW; Kong, F; Xu, ZH				Zhang, Xiang; Ren, Juchao; Yan, Lei; Tang, Yueqing; Zhang, Wenhua; Li, Dawei; Zang, Yuanwei; Kong, Feng; Xu, Zhonghua			Cytoplasmic Expression of Pontin in Renal Cell Carcinoma Correlates with Tumor Invasion, Metastasis and Patients' Survival	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; HEPATOCELLULAR-CARCINOMA; IN-VIVO; REPTIN; GENE; TRANSCRIPTION; OVEREXPRESSION; TRANSFORMATION; PROFILES; REVEALS	Renal cell carcinoma (RCC) is the most lethal of all genitourinary malignancies. Distant metastasis represents the major cause of death in patients with RCC. Recent studies have implicated the AAA+ ATPase pontin in many cellular activities that are highly relevant to carcinogenesis. In this study, we demonstrate for the first time that pontin was up-regulated in RCC, and plays a previously unknown pro-invasive role in the metastatic progression of RCC through epithelial-to-mesenchymal transition (EMT) pathway. 28 pairs of freshly frozen clear cell RCC samples and the matched normal renal tissues analyzed by quantitative RT-PCR and western blotting demonstrated that pontin was up-regulated in clear cell RCC tissues than in normal renal tissues. In addition, immunohistochemistry was used to evaluate subcellular pontin expression in 95 RCC patients, and found that overexpression of pontin in cytoplasm positively correlated with the metastatic features, predicting unfavorable outcomes of RCC patients. Furthermore, in vitro experiments show pontin was predominantly expressed in cytoplasm of RCC cell lines, and a significant suppression of cell migration and invasion in pontin siRNA treated RCC cell lines was observed. Mechanistic studies show that pontin depletion up-regulated the E-cadherin protein and down-regulated vimentin protein, and decreased nuclear beta-catenin expression, suggesting the involvement of EMT in pontin induced metastatic progression. Together, our data suggest pontin as a potential prognostic biomarker in RCC, and provide new promising therapeutic targets for clinical intervention of kidney cancers.	[Zhang, Xiang; Ren, Juchao; Yan, Lei; Tang, Yueqing; Zhang, Wenhua; Li, Dawei; Zang, Yuanwei; Xu, Zhonghua] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China; [Zhang, Xiang; Ren, Juchao; Zang, Yuanwei] Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhang, Xiang; Ren, Juchao; Zang, Yuanwei] Shandong Univ, Key Lab Cardiovasc Prote Shandong Prov, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Kong, Feng] Shandong Univ, Hosp 2, Cent Lab, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Ren, JC (corresponding author), Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China.	rjchao1983@163.com; xuzhonghuamd@aliyun.com			National Natural Science Foundation of China [81372335]; National Science Foundation of Shandong [ZR2010HM103]; China Postdoctoral Science Foundation [2014M551915]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Shandong(Natural Science Foundation of Shandong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This project was supported by the National Natural Science Foundation of China (No. 81372335), National Science Foundation of Shandong (No. ZR2010HM103) and China Postdoctoral Science Foundation (No. 2014M551915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Berasain C, 2010, J HEPATOL, V52, P633, DOI 10.1016/j.jhep.2010.01.020; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Eble JN, 2004, WHO CLASSIFICATION T, P12; Eisengart LJ, 2012, ARCH PATHOL LAB MED, V136, P490, DOI 10.5858/arpa.2010-0308-RA; Feng Y, 2003, CANCER RES, V63, P8726; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2007, P NATL ACAD SCI USA, V104, P20793, DOI 10.1073/pnas.0710343105; Lauscher JC, 2007, HUM PATHOL, V38, P978, DOI 10.1016/j.humpath.2007.01.005; Lauscher JC, 2012, ONCOL REP, V28, P1619, DOI 10.3892/or.2012.1968; Li WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-132; Maslon MM, 2010, J MOL BIOL, V404, P418, DOI 10.1016/j.jmb.2010.09.035; Menard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029; Ren JC, 2013, UROL ONCOL-SEMIN ORI, V31, P1358, DOI 10.1016/j.urolonc.2012.01.004; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang FL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003031; Whitehead J, 2008, HFSP J, V2, P286, DOI 10.2976/1.2955566; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X	32	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118659	10.1371/journal.pone.0118659	http://dx.doi.org/10.1371/journal.pone.0118659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751257	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700006
J	Pilosof, S; Morand, S; Krasnov, BR; Nunn, CL				Pilosof, Shai; Morand, Serge; Krasnov, Boris R.; Nunn, Charles L.			Potential Parasite Transmission in Multi-Host Networks Based on Parasite Sharing	PLOS ONE			English	Article							ECOLOGICAL NETWORKS; INFECTIOUS-DISEASE; HOST; DIVERSITY; DYNAMICS; POPULATIONS; CENTRALITY; REGRESSION; PATTERNS; WILD	Epidemiological networks are commonly used to explore dynamics of parasite transmission among individuals in a population of a given host species. However, many parasites infect multiple host species, and thus multi-host networks may offer a better framework for investigating parasite dynamics. We investigated the factors that influence parasite sharing - and thus potential transmission pathways - among rodent hosts in Southeast Asia. We focused on differences between networks of a single host species and networks that involve multiple host species. In host-parasite networks, modularity (the extent to which the network is divided into subgroups of rodents that interact with similar parasites) was higher in the multi-species than in the single-species networks. This suggests that phylogeny affects patterns of parasite sharing, which was confirmed in analyses showing that it predicted affiliation of individuals to modules. We then constructed "potential transmission networks" based on the host-parasite networks, in which edges depict the similarity between a pair of individuals in the parasites they share. The centrality of individuals in these networks differed between multi-and single-species networks, with species identity and individual characteristics influencing their position in the networks. Simulations further revealed that parasite dynamics differed between multi-and single-species networks. We conclude that multi-host networks based on parasite sharing can provide new insights into the potential for transmission among hosts in an ecological community. In addition, the factors that determine the nature of parasite sharing (i.e. structure of the host-parasite network) may impact transmission patterns.	[Pilosof, Shai] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Albert Katz Int Sch Desert Studies, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Morand, Serge] ISEM, CNRS, Montpellier, France; [Morand, Serge] Ctr Cooperat Int Rech Agron Dev, Unite Rech Anim & Gest Integree Risques, Montpellier, France; [Morand, Serge] CICML, Minist Hlth Lao PDR, Viangchan, Laos; [Krasnov, Boris R.] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Nunn, Charles L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Nunn, Charles L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Ben Gurion University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Ben Gurion University; Duke University; Duke University	Pilosof, S (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Albert Katz Int Sch Desert Studies, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel.	shainova@gmail.com	Krasnov, Boris R./ABG-8403-2021; Pilosof, Shai/AAX-8055-2020; Krasnov, Boris R./F-2234-2012; Morand, Serge/M-5433-2018	Krasnov, Boris R./0000-0002-0382-3331; Pilosof, Shai/0000-0003-0430-5568; Krasnov, Boris R./0000-0002-0382-3331; Morand, Serge/0000-0003-3986-7659	French National Research Agency bio diversity Community Ecology of Rodent and their Pathogens project [ANR 07 BDIV 012 CERoPath]; Kreitman Foundation Fellowship, Ben-Gurion University of the Negev	French National Research Agency bio diversity Community Ecology of Rodent and their Pathogens project(French National Research Agency (ANR)); Kreitman Foundation Fellowship, Ben-Gurion University of the Negev	This work was supported by the French National Research Agency bio diversity Community Ecology of Rodent and their Pathogens project ANR 07 BDIV 012 CERoPath. (http://www.agence-nationale-recherche.fr/). SP was funded by the Kreitman Foundation Fellowship, Ben-Gurion University of the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K., 2013, MUMIN MULTI MODEL IN; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canright Geoffrey S., 2006, ComPlexUs, V3, P131, DOI 10.1159/000094195; Cooper N, 2012, ECOL LETT, V15, P1370, DOI 10.1111/j.1461-0248.2012.01858.x; Corbin E, 2008, MAMMAL REV, V38, P108, DOI 10.1111/j.1365-2907.2007.00112.x; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; Craft Meggan E, 2011, Interdiscip Perspect Infect Dis, V2011, P676949, DOI 10.1155/2011/676949; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Gomez JM, 2012, P ROY SOC B-BIOL SCI, V279, P1754, DOI 10.1098/rspb.2011.2244; Goslee SC, 2007, ECODIST PACKAGE DISS; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick A.M., 2012, NAT ED KNOWL, V3, P55; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krasnov BR, 2012, AM NAT, V179, P501, DOI 10.1086/664612; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lima DP, 2012, J ANIM ECOL, V81, P905, DOI 10.1111/j.1365-2656.2012.01967.x; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Gomez JM, 2013, P NATL ACAD SCI USA, V110, P7738, DOI 10.1073/pnas.1220716110; Newman M.E.J., 2010, NETWORKS INTRO; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Pilosof S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6172; Pilosof S, 2013, J ANIM ECOL, V82, P987, DOI 10.1111/1365-2656.12090; Poisot T, 2013, PARASITOLOGY, V140, P1340, DOI 10.1017/S0031182013000851; Poisot T, 2012, METHODS ECOL EVOL, V3, P537, DOI 10.1111/j.2041-210X.2011.00174.x; Poulin R, 2010, TRENDS PARASITOL, V26, P492, DOI 10.1016/j.pt.2010.05.008; R Development Core Team, 2014, R LANG ENV STAT COMP; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Tur C, 2014, J ANIM ECOL, V83, P306, DOI 10.1111/1365-2656.12130; VanderWaal KL, 2014, BIOL CONSERV, V169, P136, DOI 10.1016/j.biocon.2013.11.008; VanderWaal KL, 2014, J ANIM ECOL, V83, P406, DOI 10.1111/1365-2656.12137; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Wells K, 2013, METHODS ECOL EVOL, V4, P1, DOI 10.1111/j.2041-210x.2012.00249.x; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	54	45	47	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0117909	10.1371/journal.pone.0117909	http://dx.doi.org/10.1371/journal.pone.0117909			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748947	gold, Green Submitted, Green Published			2022-12-26	WOS:000350689400011
J	Sowa, J; Bobula, B; Glombik, K; Slusarczyk, J; Basta-Kaim, A; Hess, G				Sowa, Joanna; Bobula, Bartosz; Glombik, Katarzyna; Slusarczyk, Joanna; Basta-Kaim, Agnieszka; Hess, Grzegorz			Prenatal Stress Enhances Excitatory Synaptic Transmission and Impairs Long-Term Potentiation in the Frontal Cortex of Adult Offspring Rats	PLOS ONE			English	Article							MOTOR CORTEX; GLUTAMATERGIC TRANSMISSION; PREFRONTAL CORTEX; RESTRAINT STRESS; FIELD POTENTIALS; BRAIN; PLASTICITY; HIPPOCAMPUS; PROTEINS; LEVEL	The effects of prenatal stress procedure were investigated in 3 months old male rats. Prenatally stressed rats showed depressive-like behavior in the forced swim test, including increased immobility, decreased mobility and decreased climbing. In ex vivo frontal cortex slices originating from prenatally stressed animals, the amplitude of extracellular field potentials (FPs) recorded in cortical layer II/III was larger, and the mean amplitude ratio of pharmacologically-isolated NMDA to the AMPA/kainate component of the field potential-smaller than in control preparations. Prenatal stress also resulted in a reduced magnitude of long-term potentiation (LTP). These effects were accompanied by an increase in the mean frequency, but not the mean amplitude, of spontaneous excitatory postsynaptic currents (sEPSCs) in layer II/III pyramidal neurons. These data demonstrate that stress during pregnancy may lead not only to behavioral disturbances, but also impairs the glutamatergic transmission and long-term synaptic plasticity in the frontal cortex of the adult offspring.	[Sowa, Joanna; Bobula, Bartosz; Hess, Grzegorz] Polish Acad Sci, Inst Pharmacol, Dept Physiol, Krakow, Poland; [Glombik, Katarzyna; Slusarczyk, Joanna; Basta-Kaim, Agnieszka] Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, Krakow, Poland; [Hess, Grzegorz] Jagiellonian Univ, Inst Zool, PL-30060 Krakow, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Jagiellonian University	Basta-Kaim, A (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, Krakow, Poland.	basta@if-pan.krakow.pl	Bobula, Bartosz/P-8260-2019; Hess, Grzegorz/HGQ-0966-2022	Bobula, Bartosz/0000-0001-5167-9277; Glombik, Katarzyna/0000-0002-7695-2556; Basta-Kaim, Agnieszka/0000-0002-3109-0040	European Regional Development Fund [POIG. 01.01.02-12-004/09-00]; project: Interdisciplinary PhD Studies "Molecular sciences for medicine"; European Social Fund within the Human Capital Operational Programme; KNOW - Ministry of Science and Higher Education, Poland; Department of Physiology	European Regional Development Fund(European Commission); project: Interdisciplinary PhD Studies "Molecular sciences for medicine"; European Social Fund within the Human Capital Operational Programme; KNOW - Ministry of Science and Higher Education, Poland; Department of Physiology	BB and AB-K were supported by the grant POIG. 01.01.02-12-004/09-00 part 2.4 "Depression-Mechanisms-Therapy" financed by European Regional Development Fund; KG was supported by the project: Interdisciplinary PhD Studies "Molecular sciences for medicine" (co-financed by the European Social Fund within the Human Capital Operational Programme; J. Sowa and J. Slusarczyk are holders of scholarships from the KNOW sponsored by the Ministry of Science and Higher Education, Poland; GH was supported by the statutory funds of the Department of Physiology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0081775; Basta-Kaim A, 2014, NEUROSCIENCE, V274, P59, DOI 10.1016/j.neuroscience.2014.05.010; Basta-Kaim A, 2014, EUR NEUROPSYCHOPHARM, V24, P1546, DOI 10.1016/j.euroneuro.2014.07.002; Bobula B, 2003, NEUROSCIENCE, V120, P765, DOI 10.1016/S0306-4522(03)00380-4; Bobula B, 2011, PHARMACOL REP, V63, P1404; Bobula B, 2008, PHARMACOL REP, V60, P865; Budziszewska B, 2010, J PHYSIOL PHARMACOL, V61, P207; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DUNCAN GE, 1993, J NEUROSCI, V13, P3932; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Fujioka A, 2006, NEUROSCIENCE, V141, P907, DOI 10.1016/j.neuroscience.2006.04.046; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; HESS G, 1994, NEUROSCIENCE, V61, P225, DOI 10.1016/0306-4522(94)90226-7; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Maccari S, 2001, Stress, V4, P169; Mairesse J, 2013, INT J NEUROPSYCHOPH, V16, P323, DOI 10.1017/S1461145711001970; Markham JA, 2011, PSYCHOPHARMACOLOGY, V214, P89, DOI 10.1007/s00213-010-2035-0; Martin ED, 2012, CEREB CORTEX, V22, P1717, DOI 10.1093/cercor/bhr216; Molina DP, 2013, AGE, V35, P1575, DOI 10.1007/s11357-012-9460-4; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Monfils MH, 2004, NEUROSCIENCE, V125, P329, DOI 10.1016/j.neuroscience.2004.01.048; Morley-Fletcher S, 2003, BRAIN RES, V989, P246, DOI 10.1016/S0006-8993(03)03293-1; Mychasiuk R, 2012, SYNAPSE, V66, P308, DOI 10.1002/syn.21512; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Saez I, 2009, J NEUROSCI, V29, P15286, DOI 10.1523/JNEUROSCI.2980-09.2009; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P509, DOI 10.1113/jphysiol.2002.022095; Son GH, 2006, J NEUROSCI, V26, P3309, DOI 10.1523/JNEUROSCI.3850-05.2006; Stoltz S, 1999, BEHAV BRAIN RES, V106, P127, DOI 10.1016/S0166-4328(99)00100-X; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Szczesny E, 2013, PHARMACOL REP, V65, P1622, DOI 10.1016/S1734-1140(13)71523-8; Szymanska M, 2009, PSYCHONEUROENDOCRINO, V34, P822, DOI 10.1016/j.psyneuen.2008.12.012; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tokarski K, 2008, NEUROSCIENCE, V153, P789, DOI 10.1016/j.neuroscience.2008.03.007; Tokarski K, 2011, J PHYSIOL PHARMACOL, V62, P663; Wabno J, 2013, J NEURAL TRANSM, V120, P711, DOI 10.1007/s00702-012-0919-3; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yaka R, 2007, BEHAV BRAIN RES, V179, P126, DOI 10.1016/j.bbr.2007.01.018; Yang JL, 2006, HIPPOCAMPUS, V16, P431, DOI 10.1002/hipo.20181; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Zhang XH, 2013, NEUROSCIENCE, V250, P333, DOI 10.1016/j.neuroscience.2013.04.031	52	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119407	10.1371/journal.pone.0119407	http://dx.doi.org/10.1371/journal.pone.0119407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749097	gold, Green Submitted, Green Published			2022-12-26	WOS:000350689400072
J	Wang, C; Gao, C; Meng, K; Qiao, HS; Wang, Y				Wang, Chen; Gao, Chao; Meng, Kui; Qiao, Haishi; Wang, Yong			Human Adipocytes Stimulate Invasion of Breast Cancer MCF-7 Cells by Secreting IGFBP-2	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; MATRIX METALLOPROTEINASES; TISSUE; GROWTH; EXPRESSION; ENDOCRINE; PHENOTYPE; PARACRINE; OBESITY	Background and Aims A better understanding of the effects of human adipocytes on breast cancer cells may lead to the development of new treatment strategies. We explored the effects of adipocytes on the migration and invasion of breast cancer cells both in vitro and in vivo. Methods To study the reciprocal effects of adipocytes and cancer cells, we co-cultured human mature adipocytes and breast cancer cells in a system devoid of heterogeneous cell-cell contact. To analyze the factors that were secreted from adipocytes and that affected the invasive abilities of breast cancer cells, we detected different cytokines in various co-culture media. To study the communication of mature adipocytes and breast cancer cells in vivo, we chose 10 metastatic pathologic samples and 10 non-metastatic pathologic samples to do immunostaining. Results The co-culture media of human MCF-7 breast cancer cells and human mature adipocytes increased motility of MCF-7 cells. In addition, MMP-2 was remarkably up-regulated, whereas E-cadherin was down-regulated in these MCF-7 cells. Based on our co-culture medium chip results, we chose four candidate cytokines and tested their influence on metastasis individually. We found that IGFBP-2 enhanced the invasion ability of MCF-7 cells in vitro more prominently than did the other factors. In vivo, metastatic human breast tumors had higher levels of MMP-2 than did non-metastatic tumor tissue, whereas adipocytes around metastatic breast tumors had higher levels of IGFBP-2 than did adipocytes surrounding non-metastatic breast tumors. Conclusions IGFBP-2 secreted by mature adipocytes plays a key role in promoting the metastatic ability of MCF-7 breast cancer cells.	[Wang, Chen; Qiao, Haishi; Wang, Yong] Nanjing Univ, Sch Med, State Key Lab Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Chen; Qiao, Haishi; Wang, Yong] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China; [Gao, Chao] Jiangsu Prov Hosp, Ctr Clin Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Meng, Kui] Nanjing Univ, Gulou Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University; Nanjing University	Wang, Y (corresponding author), Nanjing Univ, Sch Med, State Key Lab Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China.	njuwangyong@163.com	wang, chen/GWM-9481-2022; qiao, haishi/ABE-5765-2021		Fundamental Research Funds for the Central Universities [021414350002, 021414340131]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This article is supported by the Fundamental Research Funds for the Central Universities: 021414350002 and 021414340131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Carter JC, 2009, PPAR RES, V2009, DOI 10.1155/2009/345320; Celis JE, 2005, MOL CELL PROTEOMICS, V4, P492, DOI 10.1074/mcp.M500030-MCP200; D'Esposito V, 2012, DIABETOLOGIA, V55, P2811, DOI 10.1007/s00125-012-2629-7; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Dirat B, 2010, ENDOCR DEV, V19, P45, DOI 10.1159/000316896; Drabsch Y, 2011, J MAMMARY GLAND BIOL, V16, P97, DOI 10.1007/s10911-011-9217-1; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Foulstone EJ, 2013, ENDOCRINOLOGY, V154, P1780, DOI 10.1210/en.2012-1970; Gnerlich JL, 2013, ANN SURG ONCOL, V20, pS731, DOI 10.1245/s10434-013-3274-1; Guerrero J, 2010, BREAST CANCER RES TR, V119, P497, DOI 10.1007/s10549-009-0491-1; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Kang XH, 2005, TISSUE ENG, V11, P458, DOI 10.1089/ten.2005.11.458; Kim JH, 2008, CANCER LETT, V261, P253, DOI 10.1016/j.canlet.2007.11.020; Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Miyoshi Y, 2006, INT J CANCER, V118, P1414, DOI 10.1002/ijc.21543; Motrescu ER, 2008, BIOL CHEM, V389, P1037, DOI 10.1515/BC.2008.110; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Ryden M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1847, DOI 10.1152/ajpendo.00040.2007; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Slattery ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063165; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Todorovic-Rakovic N, 2013, J INTERF CYTOK RES, V33, P563, DOI 10.1089/jir.2013.0023; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	32	54	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119348	10.1371/journal.pone.0119348	http://dx.doi.org/10.1371/journal.pone.0119348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747684	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400065
J	Li, F; Ma, JQ; Geng, SS; Wang, JL; Liu, JR; Zhang, J; Sheng, XY				Li, Feng; Ma, Jingqiu; Geng, Shanshan; Wang, Junli; Liu, Jinrong; Zhang, Jie; Sheng, Xiaoyang			Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; INTESTINAL PERMEABILITY; PROTEIN CALPROTECTIN; BARRIER FUNCTION; BIRTH-WEIGHT; L1 PROTEIN; MARKER; INFANTS; GRANULOCYTES	Objective Fecal calprotectin (FC) is an established biomarker of gut inflammation. The aim of this study was to evaluate FC concentrations in healthy children between 1 and 18 months of age. Methods Healthy children aged 1-18 months were enrolled in this study at the Department of Children's Health Care in Shanghai, China. Children's stool samples were collected and analyzed, and FC concentration was determined using a commercially available enzyme-linked immunosorbent assay (ELISA). The children's weights and lengths were measured. Parents were asked to complete a brief questionnaire regarding several clinical and sociodemographic factors. Results The FC concentrations were unevenly distributed; the median FC concentration was 174.3 mu g/g (range: 6.0-1097.7 mu g/g) or 2.241 log10 mu g/g (range: 0.775-3.041 log10 mu g/g) for all 288 children. The children were divided into several age groups: 1-3 months, 3-6 months, 6-9 months, 9-12 months and 12-18 months. The median FC concentrations for these age groups were 375.2 mu g/g (2.574 log10 mu g/g), 217.9 mu g/g (2.338 log10 mu g/g), 127.7 mu g/g (2.106 log10 mu g/g), 96.1 mu g/g (1.983 log10 mu g/g) and 104.2 mu g/g (2.016 log10 mu g/g), respectively. A significant correlation between age and FC concentration was found (r=-0.490, p < 0.001). A simple correlation analysis of weight-for-length Z-scores or weight-for-age Z-scores vs. FC concentrations showed that these variables were negatively correlated (Spearman's rho=-0.287, p < 0.001; Spearman's rho=-0.243, p < 0.001, respectively). Conclusions The FC levels of children aged 1-18 months exhibit a downward trend with increasing age and are greater than the normal levels observed in healthy adults. In healthy children aged <6 months, FC levels are high. In children aged 6-18 months, FC concentrations are relatively low but are still higher than those of children aged >4 years.	[Li, Feng; Ma, Jingqiu; Geng, Shanshan; Wang, Junli; Liu, Jinrong; Zhang, Jie; Sheng, Xiaoyang] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Children & Adolescents Hlth Care,MOE Shangha, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Sheng, XY (corresponding author), Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Children & Adolescents Hlth Care,MOE Shangha, Shanghai 200030, Peoples R China.	shengxiaoyangcn@aliyun.com			Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [11DZ2260500]; National Natural Science Foundation of China [81172686, 81302446]; Shanghai Science and Technology Commission Pujiang Talent Program of China [08PJ14082]	Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission Pujiang Talent Program of China	This study was funded by Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (No.11DZ2260500), National Natural Science Foundation of China (No.81172686, No.81302446) and Shanghai Science and Technology Commission Pujiang Talent Program of China (No.08PJ14082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir O, 2012, J MATERN FETAL NEONA; Baldassarre M. E., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P1; BERNTZEN HB, 1990, SCAND J CLIN LAB INV, V50, P769, DOI 10.3109/00365519009091071; BJERKE K, 1993, GUT, V34, P1357, DOI 10.1136/gut.34.10.1357; Boussac M, 2000, ELECTROPHORESIS, V21, P665, DOI 10.1002/(SICI)1522-2683(20000201)21:3<665::AID-ELPS665>3.0.CO;2-U; BRANDTZAEG P, 1987, AM J CLIN PATHOL, V87, P700, DOI 10.1093/ajcp/87.6.700; Bunn SK, 2001, J PEDIATR GASTR NUTR, V33, P14, DOI 10.1097/00005176-200107000-00003; Bunn SK, 2001, J PEDIATR GASTR NUTR, V32, P171, DOI 10.1097/00005176-200102000-00015; Campbell DI, 2003, J NUTR, V133, P1332; Campeotto F, 2004, ARCH DIS CHILD-FETAL, V89, pF353, DOI 10.1136/adc.2002.022368; Campeotto F, 2009, J PEDIATR GASTR NUTR, V48, P507, DOI 10.1097/MPG.0b013e318186c4a6; Canani RB, 2004, DIGEST LIVER DIS, V36, P467, DOI 10.1016/j.dld.2004.02.009; Caplan A, 2005, J PEDIATR GASTR NUTR, V41, P305, DOI 10.1097/01.mpg.0000172749.71726.13; Chen CC, 2012, J PEDIATR GASTR NUTR, V55, P541, DOI 10.1097/MPG.0b013e318262a718; Dorosko SM, 2008, BREASTFEED MED, V3, P117, DOI 10.1089/bfm.2007.0036; Ezri J, 2011, Rev Med Suisse, V7, P69; Fagerberg UL, 2003, J PEDIATR GASTR NUTR, V37, P468, DOI 10.1097/00005176-200310000-00013; Gaya DR, 2005, QJM-INT J MED, V98, P435, DOI 10.1093/qjmed/hci069; Hestvik E, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-9; Husebye E, 2001, AM J GASTROENTEROL, V96, P2683; Josefsson S, 2007, J PEDIATR GASTR NUTR, V44, P407, DOI 10.1097/MPG.0b013e3180320643; Kapel N, 2010, J PEDIATR GASTR NUTR, V51, P542, DOI 10.1097/MPG.0b013e3181e2ad72; Kukkonen K, 2010, PEDIAT ALLERG IMM-UK, V21, P67, DOI 10.1111/j.1399-3038.2009.00907.x; Li F, 2014, EARLY HUM DEV, V90, P471, DOI 10.1016/j.earlhumdev.2014.06.005; Liu JR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-129; Manz M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-5; NASH S, 1987, J CLIN INVEST, V80, P1104, DOI 10.1172/JCI113167; Nissen AC, 2004, J PEDIATR GASTR NUTR, V38, P107, DOI 10.1097/00005176-200401000-00025; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Pang T, 2015, J GASTROEN HEPATOL, V30, P866, DOI 10.1111/jgh.12842; Poullis A, 2003, J GASTROEN HEPATOL, V18, P756, DOI 10.1046/j.1440-1746.2003.03014.x; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Roseth AG, 1997, DIGESTION, V58, P176, DOI 10.1159/000201441; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Rouge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011083; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; Savino F, 2010, NEONATOLOGY, V97, P299, DOI 10.1159/000255161; Silberer H, 2005, CLIN LAB, V51, P117; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P1392, DOI 10.1002/ibd.20490; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P40, DOI 10.1002/ibd.20312; Splichal I, 2005, IMMUNOBIOLOGY, V209, P681, DOI 10.1016/j.imbio.2004.09.009; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Striz I, 2004, PHYSIOL RES, V53, P245; Summerton CB, 2002, EUR J GASTROEN HEPAT, V14, P841, DOI 10.1097/00042737-200208000-00005; Sykora J, 2010, ACTA PAEDIATR, V99, P1389, DOI 10.1111/j.1651-2227.2010.01843.x; Tamboli CP, 2003, GASTROENTEROLOGY, V124, P1972, DOI 10.1016/S0016-5085(03)00552-3; Thuijls G, 2010, ANN SURG, V251, P1174, DOI 10.1097/SLA.0b013e3181d778c4; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Tomas AB, 2007, REV ESP ENFERM DIG, V99, P689, DOI 10.4321/s1130-01082007001200002; Ton H, 2000, CLIN CHIM ACTA, V292, P41, DOI 10.1016/S0009-8981(99)00206-5; van Elburg RM, 2003, ARCH DIS CHILD-FETAL, V88, P52; Vaos G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/542363; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Voganatsi A, 2001, J LEUKOCYTE BIOL, V70, P130; von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236	57	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119574	10.1371/journal.pone.0119574	http://dx.doi.org/10.1371/journal.pone.0119574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742018	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100123
J	Robiou-du-Pont, S; Li, AH; Christie, S; Sohani, ZN; Meyre, D				Robiou-du-Pont, Sebastien; Li, Aihua; Christie, Shanice; Sohani, Zahra N.; Meyre, David			Should We Have Blind Faith in Bioinformatics Software? Illustrations from the SNAP Web-Based Tool	PLOS ONE			English	Article							ASSOCIATION; ANNOTATION; AGREEMENT; HAPMAP	Bioinformatics tools have gained popularity in biology but little is known about their validity. We aimed to assess the early contribution of 415 single nucleotide polymorphisms (SNPs) associated with eight cardio-metabolic traits at the genome-wide significance level in adults in the Family Atherosclerosis Monitoring In earLY Life (FAMILY) birth cohort. We used the popular web-based tool SNAP to assess the availability of the 415 SNPs in the Illumina Cardio-Metabochip genotyped in the FAMILY study participants. We then compared the SNAP output with the Cardio-Metabochip file provided by Illumina using chromosome and chromosomal positions of SNPs from NCBI Human Genome Browser (Genome Reference Consortium Human Build 37). With the HapMap 3 release 2 reference, 201 out of 415 SNPs were reported as missing in the Cardio-Metabochip by the SNAP output. However, the Cardio-Metabochip file revealed that 152 of these 201 SNPs were in fact present in the Cardio-Metabochip array (false negative rate of 36.6%). With the more recent 1000 Genomes Project release, we found a false-negative rate of 17.6% by comparing the outputs of SNAP and the Illumina product file. We did not find any 'false positive' SNPs (SNPs specified as available in the Cardio-Metabochip by SNAP, but not by the Cardio-Metabochip Illumina file). The Cohen's Kappa coefficient, which calculates the percentage of agreement between both methods, indicated that the validity of SNAP was fair to moderate depending on the reference used (the HapMap 3 or 1000 Genomes). In conclusion, we demonstrate that the SNAP outputs for the Cardio-Metabochip are invalid. This study illustrates the importance of systematically assessing the validity of bioinformatics tools in an independent manner. We propose a series of guidelines to improve practices in the fast-moving field of bioinformatics software implementation.	[Robiou-du-Pont, Sebastien; Li, Aihua; Christie, Shanice; Sohani, Zahra N.; Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Sohani, Zahra N.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Sohani, Zahra N.] Hamilton Gen Hosp, Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University; McMaster University; Population Health Research Institute; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	meyred@mcmaster.ca	Meyre, David/D-7315-2011; Robiou-du-Pont, Sébastien/O-1692-2015	Meyre, David/0000-0003-4850-7444; Robiou-du-Pont, Sébastien/0000-0002-4569-0039	Tier 2 Canada Research Chair; Heart and Stroke Foundation of Ontario [NA 7293]; Ontario Graduate Scholarships	Tier 2 Canada Research Chair(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Graduate Scholarships(Ontario Graduate Scholarship)	DM is supported by a Tier 2 Canada Research Chair. SRP is supported by the Heart and Stroke Foundation of Ontario (grant # NA 7293 "Early genetic origins of cardiovascular risk factors"). AL and ZNS are funded by Ontario Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beck K., 2001, MANIFESTO AGILE SOFT; Choquet H, 2011, CURR GENOMICS, V12, P154, DOI 10.2174/138920211795677921; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liefeld T, 2005, BIOINFORMATICS, V21, P3681, DOI 10.1093/bioinformatics/bti587; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McCullough BD, 2006, J MONEY CREDIT BANK, V38, P1093, DOI 10.1353/mcb.2006.0061; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; Ouzounis CA, 2003, BIOINFORMATICS, V19, P2176, DOI 10.1093/bioinformatics/btg309; Rother K, 2012, BRIEF BIOINFORM, V13, P244, DOI 10.1093/bib/bbr035; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wilson GV, 2013, ARXIV12100530	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118925	10.1371/journal.pone.0118925	http://dx.doi.org/10.1371/journal.pone.0118925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742008	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100060
J	Schmeltz, MT; Sembajwe, G; Marcotullio, PJ; Grassman, JA; Himmelstein, DU; Woolhandler, S				Schmeltz, Michael T.; Sembajwe, Grace; Marcotullio, Peter J.; Grassman, Jean A.; Himmelstein, David U.; Woolhandler, Stephanie			Identifying Individual Risk Factors and Documenting the Pattern of Heat-Related Illness through Analyses of Hospitalization and Patterns of Household Cooling	PLOS ONE			English	Article							EMERGENCY-DEPARTMENTS; AMBIENT-TEMPERATURE; CASE-CROSSOVER; PUBLIC-HEALTH; EXTREME HEAT; US CITIES; MORTALITY; WAVE; VULNERABILITY; MORBIDITY	Background As climate change increases the frequency and intensity of extreme heat events researchers and public health officials must work towards understanding the causes and outcomes of heat-related morbidity and mortality. While there have been many studies on both heat-related illness (HRI), there are fewer on heat-related morbidity than on heat-related mortality. Objective To identify individual and environmental risk factors for hospitalizations and document patterns of household cooling. Methods We performed a pooled cross-sectional analysis of secondary U.S. data, the Nationwide Inpatient Sample. Risk ratios were calculated from multivariable models to identify risk factors for hospitalizations. Hierarchical modeling was also employed to identify relationships between individual and hospital level predictors of hospitalizations. Patterns of air conditioning use were analyzed among the vulnerable populations identified. Results Hospitalizations due to HRI increased over the study period compared to all other hospitalizations. Populations at elevated risk for HRI hospitalization were blacks, males and all age groups above the age of 40. Those living in zip-codes in the lowest income quartile and the uninsured were also at an increased risk. Hospitalizations for HRI in rural and small urban clusters were elevated, compared to urban areas. Conclusions Risk factors for HRI include age greater than 40, male gender and hospitalization in rural areas or small urban clusters. Our analysis also revealed an increasing pattern of HRI hospitalizations over time and decreased association between common comorbidities and heat illnesses which may be indicative of underreporting.	[Schmeltz, Michael T.; Sembajwe, Grace; Grassman, Jean A.; Himmelstein, David U.; Woolhandler, Stephanie] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Sembajwe, Grace; Marcotullio, Peter J.; Himmelstein, David U.; Woolhandler, Stephanie] CUNY, Hunter Coll, New York, NY USA; [Marcotullio, Peter J.] CUNY, Inst Sustainable Cities, New York, NY 10021 USA; [Grassman, Jean A.] CUNY Brooklyn Coll, Hlth & Nutr Sci, Brooklyn, NY 11210 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY)	Schmeltz, MT (corresponding author), CUNY, Sch Publ Hlth, New York, NY 10021 USA.	mschmeltz@gc.cuny.edu	; Sembajwe, Grace/H-3288-2017	Schmeltz, Michael/0000-0003-4764-9723; Sembajwe, Grace/0000-0002-7163-4743; Marcotullio, Peter/0000-0001-8133-1204	Division Of Behavioral and Cognitive Sci [1229429] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Abrahamson V, 2009, J PUBLIC HEALTH-UK, V31, P119, DOI 10.1093/pubmed/fdn102; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bassil KL, 2008, CAN J PUBLIC HEALTH, V99, P339, DOI 10.1007/BF03403768; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Chow WTL, 2012, PROF GEOGR, V64, P286, DOI 10.1080/00330124.2011.600225; Conlon KC, 2011, MATURITAS, V69, P197, DOI 10.1016/j.maturitas.2011.04.004; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; D'lppoliti D, 2010, ENVIRON HEALTH, V9; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4; Fowler DR, 2013, MMWR-MORBID MORTAL W, V62, P433; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Healthcare Cost and Utilization Project (HCUP), 2013, OVERVIEW OF THE NATI; Hess JJ, 2014, ENVIRON HEALTH PERSP, V122, P1209, DOI 10.1289/ehp.1306796; Houchens R, 2007, HCUP METHODS SERIES; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Isaac M, 2009, ENERG POLICY, V37, P507, DOI 10.1016/j.enpol.2008.09.051; Johnson DP, 2014, GEOCARTO INT, V29, P65, DOI 10.1080/10106049.2013.799718; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Kalkstein AJ, 2007, INT J BIOMETEOROL, V52, P43, DOI 10.1007/s00484-006-0073-4; Kenny GP, 2010, CAN MED ASSOC J, V182, P1053, DOI 10.1503/cmaj.081050; Kershaw SE, 2012, ENVIRON MONIT ASSESS, V184, P7329, DOI 10.1007/s10661-011-2502-z; Kestens Y, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-7; Khalaj B, 2010, INT ARCH OCC ENV HEA, V83, P833, DOI 10.1007/s00420-010-0534-2; Kilbourne EM, 2002, AM J PREV MED, V22, P328, DOI 10.1016/S0749-3797(02)00412-9; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Kondo M, 2013, ENVIRON HEALTH PREV, V18, P251, DOI 10.1007/s12199-012-0313-7; Kovats R. S., 2003, CLIMATE CHANGE HUMAN, P181; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Kravchenko J, 2013, AM J PREV MED, V44, P274, DOI 10.1016/j.amepre.2012.11.015; Li B, 2012, CLIMATIC CHANGE, V110, P959, DOI [10.1007/s10584-011-0120-y, 10.1007/s10584-011-0120-v]; Li TT, 2013, NAT CLIM CHANGE, V3, P717, DOI [10.1038/nclimate1902, 10.1038/NCLIMATE1902]; Lugo-Amador NM, 2004, EMERG MED CLIN N AM, V22, P315, DOI 10.1016/j.emc.2004.01.004; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Nunes B, 2011, OCCUP ENVIRON MED, V68, P218, DOI 10.1136/oem.2010.058396; O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; Ostro B, 2010, AM J EPIDEMIOL, V172, P1053, DOI 10.1093/aje/kwq231; Reid CE, 2012, ENVIRON HEALTH PERSP, V120, P715, DOI 10.1289/ehp.1103766; Reid CE, 2009, ENVIRON HEALTH PERSP, V117, P1730, DOI 10.1289/ehp.0900683; Richard L, 2011, HEALTH EDUC RES, V26, P77, DOI 10.1093/her/cyq072; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Stone B, 2010, ENVIRON HEALTH PERSP, V118, P1425, DOI 10.1289/ehp.0901879; Tan JG, 2010, INT J BIOMETEOROL, V54, P75, DOI 10.1007/s00484-009-0256-x; United States Census Bureau, 2013, 2010 CENSUS URBAN AN; United States Energy Information Administration (EIA), 2013, RESIDENTIAL ENERGY C; Vaneckova P, 2008, ENVIRON RES, V108, P361, DOI 10.1016/j.envres.2008.07.015; Vaneckova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055459; Wheeler K, 2013, MMWR-MORBID MORTAL W, V62, P617; Wilby R., 2003, WEATHER, V58, P251, DOI DOI 10.1256/WEA.183.02; Xu ZW, 2012, ENVIRON RES, V117, P120, DOI 10.1016/j.envres.2012.07.002; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Yeo Theresa Pluth, 2004, AACN Clin Issues, V15, P280, DOI 10.1097/00044067-200404000-00013; Yun GY, 2011, APPL ENERG, V88, P2191, DOI 10.1016/j.apenergy.2011.01.010; Zhang Y, 2013, SCI TOTAL ENVIRON, V442, P1, DOI 10.1016/j.scitotenv.2012.10.042	66	13	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118958	10.1371/journal.pone.0118958	http://dx.doi.org/10.1371/journal.pone.0118958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742021	Green Published, gold			2022-12-26	WOS:000350688100067
J	Okuno, T; Ishitani, T; Yokomizo, T				Okuno, Toshiaki; Ishitani, Tohru; Yokomizo, Takehiko			Biochemical Characterization of Three BLT Receptors in Zebrafish	PLOS ONE			English	Article							LEUKOTRIENE B-4 RECEPTOR; PROTEIN-COUPLED RECEPTOR; 12-HYDROXYHEPTADECATRIENOIC ACID; CELL MOVEMENTS; GASTRULATION; MIGRATION; INFLAMMATION; EXPRESSION	The leukotriene B-4 (LTB4) receptor 1 (BLT1) is a high affinity receptor for LTB4, a chemotactic and inflammatory eicosanoid. The LTB4 receptor 2 (BLT2) was originally identified as a low affinity receptor for LTB4, and, more recently, as a high affinity receptor for 12-hydroxy-heptadecatrienoic acid (12-HHT). The zebrafish BLT receptors have not been previously identified and the in vivo functions of these receptors have been unknown. In this paper, we describe one zebrafish BLT1-like receptor, Blt1, and two zebrafish BLT2-like receptors, Blt2a and Blt2b. Cells expressing Blt1 exhibited LTB4-induced intracellular [Ca2+] increases, inhibition of cAMP production, ligand-dependent [S-35]GTP gamma S binding, and transforming growth factor-alpha (TGF alpha) shedding activity in a dose-dependent manner, similar to human BLT1. Cells expressing Blt2a and Blt2b exhibited 12-HHT- and LTB4-induced intracellular [Ca2+] increases, inhibition of cAMP production, [S-35]GTP gamma S binding, and TGF alpha shedding activity, with a dose-dependency similar to human BLT2. Reverse transcription (RT)-PCR analysis and whole-mount in situ hybridization revealed that blt1, blt2a, blt2b, zebrafish LTA(4) hydrolase (lta4h), and zebrafish 5-lipoxiganase (5lo) are expressed in zebrafish embryos. Knockdown of blt1 by morpholino antisense oligonucleotides resulted in delayed epiboly at gastrulation. Consistently, knockdown of lta4h, an enzyme mediating LTB4 production, induced a phenotype similar to knockdown of blt1. These results suggest that the LTB4-BLT1 axis is involved in epiboly in zebrafish development.	[Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Okuno, Toshiaki; Yokomizo, Takehiko] Kyushu Univ, Dept Med Biochem, Fukuoka 812, Japan; [Ishitani, Tohru] Kyushu Univ, Div Cell Regulat Syst, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan	Juntendo University; Kyushu University; Kyushu University	Okuno, T (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan.	tokuno@juntendo.ac.jp	Yokomizo, Takehiko/P-5673-2016; , Tohru/AAH-8979-2020	Yokomizo, Takehiko/0000-0002-5219-1553; , Tohru/0000-0002-6200-7043	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390083, 22116001, 22116002, 25460374, 24102522]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (nos. 21390083, 22116001, and 22116002 to T.Y.; and nos. 25460374 and 24102522 to T.O.), the Naito Foundation, the Ono Medical Research Foundation, the Uehara Memorial Foundation, the Takeda Science Foundation, and the Inamori Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Basu S, 2007, J BIOL CHEM, V282, P10005, DOI 10.1074/jbc.M609552200; Bischel LL, 2013, LAB CHIP, V13, P1732, DOI 10.1039/c3lc50099c; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Costa MFD, 2010, J LEUKOCYTE BIOL, V87, P323, DOI 10.1189/jlb.0809563; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Johansson AS, 2011, PROSTAG LEUKOTR ESS, V84, P109, DOI 10.1016/j.plefa.2010.11.003; Kavelaars A, 2003, J IMMUNOL, V171, P6128, DOI 10.4049/jimmunol.171.11.6128; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063; Matsunaga Y, 2013, FASEB J, V27, P3306, DOI 10.1096/fj.12-217000; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Moraes J, 2010, ATHEROSCLEROSIS, V212, P406, DOI 10.1016/j.atherosclerosis.2010.06.009; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; WARGA RM, 1990, DEVELOPMENT, V108, P569; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	38	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117888	10.1371/journal.pone.0117888	http://dx.doi.org/10.1371/journal.pone.0117888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738285	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900019
J	Yi, SN; He, WQ; Zhan, L; Qi, ZY; Zhu, CL; Luo, WB; Li, H				Yi, Shengnan; He, Weiqi; Zhan, Lei; Qi, Zhengyang; Zhu, Chuanlin; Luo, Wenbo; Li, Hong			Emotional Noun Processing: An ERP Study with Rapid Serial Visual Presentation	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ELECTROPHYSIOLOGICAL EVIDENCE; TEMPORAL DYNAMICS; WORDS; BRAIN; ADJECTIVES; AROUSAL; FACE; LATERALIZATION; SUPPRESSION	Reading is an important part of our daily life, and rapid responses to emotional words have received a great deal of research interest. Our study employed rapid serial visual presentation to detect the time course of emotional noun processing using event-related potentials. We performed a dual-task experiment, where subjects were required to judge whether a given number was odd or even, and the category into which each emotional noun fit. In terms of P1, we found that there was no negativity bias for emotional nouns. However, emotional nouns elicited larger amplitudes in the N170 component in the left hemisphere than did neutral nouns. This finding indicated that in later processing stages, emotional words can be discriminated from neutral words. Furthermore, positive, negative, and neutral words were different from each other in the late positive complex, indicating that in the third stage, even different emotions can be discerned. Thus, our results indicate that in a three-stage model the latter two stages are more stable and universal.	[Yi, Shengnan; He, Weiqi; Zhan, Lei; Qi, Zhengyang; Zhu, Chuanlin; Luo, Wenbo] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Luo, Wenbo] Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China; [Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China	Liaoning Normal University; Chongqing University of Arts & Sciences; Shenzhen University	Luo, WB (corresponding author), Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China.	wenbo9390@sina.com			National Natural Science Foundation of China [31371033, 31170984]; Special Public-welfare Project of the Ministry of Health [201002003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Public-welfare Project of the Ministry of Health	The work was supported by the National Natural Science Foundation of China (31371033 and 31170984) the Special Public-welfare Project of the Ministry of Health (201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Barbeau EJ, 2008, CEREB CORTEX, V18, P997, DOI 10.1093/cercor/bhm140; Bayer M, 2012, PSYCHOPHYSIOLOGY, V49, P959, DOI 10.1111/j.1469-8986.2012.01381.x; Bayer M, 2010, INT J PSYCHOPHYSIOL, V78, P299, DOI 10.1016/j.ijpsycho.2010.09.004; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Fischler I, 2006, PROG BRAIN RES, V156, P185, DOI 10.1016/S0079-6123(06)56009-1; Gao X, 2011, INT J PSYCHOPHYSIOL, V82, P133, DOI 10.1016/j.ijpsycho.2011.07.015; Gianotti LRR, 2008, BRAIN TOPOGR, V20, P143, DOI 10.1007/s10548-007-0041-2; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Luo WB, 2013, BIOL PSYCHOL, V92, P395, DOI 10.1016/j.biopsycho.2012.11.019; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mercure E, 2008, J COGNITIVE NEUROSCI, V20, P2070, DOI 10.1162/jocn.2008.20137; NAUMANN E, 1992, J PSYCHOPHYSIOL, V6, P285; Onitsuka T, 2009, BRAIN IMAGING BEHAV, V3, P240, DOI 10.1007/s11682-009-9066-3; Palazova M, 2011, NEUROPSYCHOLOGIA, V49, P2766, DOI 10.1016/j.neuropsychologia.2011.06.005; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; REISENZEIN R, 1994, J PERS SOC PSYCHOL, V67, P525, DOI 10.1037/0022-3514.67.3.525; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schapkin SA, 2000, ACTA NEUROBIOL EXP, V60, P17; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Simon G, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-21; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; van Hooff JC, 2008, INT J PSYCHOPHYSIOL, V67, P23, DOI 10.1016/j.ijpsycho.2007.09.002; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188; Zhang DD, 2013, BRAIN RES, V1512, P78, DOI 10.1016/j.brainres.2013.03.044	38	25	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118924	10.1371/journal.pone.0118924	http://dx.doi.org/10.1371/journal.pone.0118924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738633	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900085
J	Bos, SD; Page, CM; Andreassen, BK; Elboudwarej, E; Gustavsen, MW; Briggs, F; Quach, H; Leikfoss, IS; Bjolgerud, A; Berge, T; Harbo, HF; Barcellos, LF				Bos, Steffan D.; Page, Christian M.; Andreassen, Bettina K.; Elboudwarej, Emon; Gustavsen, Mane W.; Briggs, Farren; Quach, Hong; Leikfoss, Ingvild S.; Bjolgerud, Anja; Berge, Tone; Harbo, Hanne F.; Barcellos, Lisa F.			Genome-Wide DNA Methylation Profiles Indicate CD8+T Cell Hypermethylation in Multiple Sclerosis	PLOS ONE			English	Article							EPIGENETICS; TWINS	Objective Determine whether MS-specific DNA methylation profiles can be identified in whole blood or purified immune cells from untreated MS patients. Methods Whole blood, CD4+ and CD8+ T cell DNA from 16 female, treatment naive MS patients and 14 matched controls was profiled using the HumanMethylation450K BeadChip. Genotype data were used to assess genetic homogeneity of our sample and to exclude potential SNP-induced DNA methylation measurement errors. Results As expected, significant differences between CD4+ T cells, CD8+ T cells and whole blood DNA methylation profiles were observed, regardless of disease status. Strong evidence for hypermethylation of CD8+ T cell, but not CD4+ T cell or whole blood DNA in MS patients compared to controls was observed. Genome-wide significant individual CpG-site DNA methylation differences were not identified. Furthermore, significant differences in gene DNA methylation of 148 established MS-associated risk genes were not observed. Conclusion While genome-wide significant DNA methylation differences were not detected for individual CpG-sites, strong evidence for DNA hypermethylation of CD8+ T cells for MS patients was observed, indicating a role for DNA methylation in MS. Further, our results suggest that large DNA methylation differences for CpG-sites tested here do not contribute to MS susceptibility. In particular, large DNA methylation differences for CpG-sites within 148 established MS candidate genes tested in our study cannot explain missing heritability. Larger studies of homogenous MS patients and matched controls are warranted to further elucidate the impact of CD8+ T cell and more subtle DNA methylation changes in MS development and pathogenesis.	[Bos, Steffan D.; Page, Christian M.; Gustavsen, Mane W.; Leikfoss, Ingvild S.; Bjolgerud, Anja; Berge, Tone; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Bos, Steffan D.; Page, Christian M.; Gustavsen, Mane W.; Leikfoss, Ingvild S.; Bjolgerud, Anja; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Andreassen, Bettina K.] Univ Oslo, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Andreassen, Bettina K.] Univ Oslo, Akershus Univ Hosp, Inst Clin Med, Epigen, Oslo, Norway; [Elboudwarej, Emon; Briggs, Farren; Quach, Hong; Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of California System; University of California Berkeley	Bos, SD (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	s.d.bos@medisin.uto.no	Bos, Steffan D/L-7896-2016; Briggs, Farren/Q-2164-2019; Page, Christian/J-7129-2019	Bos, Steffan D/0000-0002-2975-7520; Briggs, Farren/0000-0003-0903-1359; Page, Christian/0000-0002-1897-3666	Norwegian Research Council [196776/V50]; National Institutes of Health/National Institute of Environmental Health Sciences [R01 ES017080]; Molecular Life Sciences fund at the University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Molecular Life Sciences fund at the University of Oslo	Funding for this study was provided through "The Norwegian Research Council" grant ID 196776/V50 (SDB, AB, MWG, HFH), the National Institutes of Health/National Institute of Environmental Health Sciences grant ID R01 ES017080 (LB) and the Molecular Life Sciences fund at the University of Oslo (SDB, CMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Altorok N, 2014, ARTHRITIS RHEUMATOL, V66, P731, DOI 10.1002/art.38264; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Broux B, 2013, CRIT REV IMMUNOL, V33, P283; Calabrese R, 2012, MULT SCLER J, V18, P299, DOI 10.1177/1352458511421055; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Graves MC, 2014, MULT SCLER J, V20, P1033, DOI 10.1177/1352458513516529; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Huynh JL, 2014, NAT NEUROSCI, V17, P121, DOI 10.1038/nn.3588; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Kumagai C, 2012, J NEUROIMMUNOL, V246, P51, DOI 10.1016/j.jneuroim.2012.03.003; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nielsen Helene Myrtue, 2013, Subcell Biochem, V61, P455, DOI 10.1007/978-94-007-4525-4_20; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; R Core Team, 2013, LANG ENV STAT COMP, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Whitaker JW, 2013, GENOME MED, V5, DOI 10.1186/gm444; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	36	68	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117403	10.1371/journal.pone.0117403	http://dx.doi.org/10.1371/journal.pone.0117403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734800	Green Published, gold			2022-12-26	WOS:000350314700009
J	Li, ZY; Ren, M; Tian, JW; Jiang, SQ; Liu, YJ; Zhang, L; Wang, ZZ; Song, QQ; Liu, C; Wu, T				Li, Ziyao; Ren, Min; Tian, Jiawei; Jiang, Shuangquan; Liu, Yujie; Zhang, Lei; Wang, Zhenzhen; Song, Qianqian; Liu, Chong; Wu, Tong			The Differences in Ultrasound and Clinicopathological Features between Basal-Like and Normal-Like Subtypes of Triple Negative Breast Cancer	PLOS ONE			English	Article							CARCINOMAS; FIBROADENOMA; PROGNOSIS; RECEPTOR; BIOPSY; TUMORS	Purpose The aim of this study was to identify the ultrasound features and clinicopathological characteristics of basal-like subtype of triple negative breast cancers (TNBCs). Materials and Methods This study was approved by the ethical board of the Second Affiliated Hospital of Harbin Medical University. The patients' clinicopathological information was available. The ultrasound features of 62 tumors from 62 TNBC patients were interpreted. The immunohistochemical results of cytokertain5/6 (CK5/6) and Epidermal Growth Factor Receptor (EGFR) were used to classify the tumor into basal-like and normal-like groups. The association of the ultrasound features interpreted by experienced ultrasound doctors with the immunohistochemical classification was studied. Results Of the 62 TNBC cases, 42 (67.7%) exhibited the basal-like phenotype and 20 (32.3%) exhibited the normal-like phenotype based on the immunohistochemical CK5/6 and EGFR markers. Of all the tumors, 90.3% were invasive carcinomas. The basal-like tumors were significantly associated with a maximum diameter on ultrasound of more than 20 mm (36, 85.7%) (P = 0.0014). The normal-like tumors usually exhibited lateral shadows (15, 75%) (P = 0.0115) as well as microlobulated margins (12, 60%) (P = 0.0204) compared to the basal-like subtype. Other ultrasound features showed no significant differences between the two groups. Conclusions Although ultrasound cannot yet be used to differentiate between the basal-like subtype and normal-like subtype of TNBC, ultrasound can be used to provide some useful information to the clinicians.	[Li, Ziyao; Ren, Min; Tian, Jiawei; Jiang, Shuangquan; Liu, Yujie; Zhang, Lei; Wang, Zhenzhen; Liu, Chong; Wu, Tong] Harbin Med Univ, Affiliated Hosp 2, Dept Ultrasound, Harbin, Heilongjiang Pr, Peoples R China; [Song, Qianqian] Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Ren, M (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ultrasound, Harbin, Heilongjiang Pr, Peoples R China.	1455168546@qq.com; juvtian2004@163.com	song, qian/HDL-9868-2022		National Natural Science Foundations of China [81271647, 81071216, 81101103]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	The project was supported by the National Natural Science Foundations of China (Grant NO. 81271647, NO. 81071216 and NO. 81101103). Jiawei Tian received the previous two and Ying Wang received the last one.	ADLER DD, 1990, ULTRASOUND MED BIOL, V16, P553, DOI 10.1016/0301-5629(90)90020-D; Au-Yong ITH, 2009, EUR RADIOL, V19, P2342, DOI 10.1007/s00330-009-1418-2; Banerjee S, 2006, J CLIN PATHOL, V59, P729, DOI 10.1136/jcp.2005.033043; Billar JAY, 2010, ANN SURG ONCOL, V17, pS384, DOI 10.1245/s10434-010-1260-4; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Boisserie-Lacroix M, 2013, Diagn Interv Imaging, V94, P1069, DOI 10.1016/j.diii.2013.04.010; Boisserie-Lacroix M, 2013, ONCOLOGIST, V18, P802, DOI 10.1634/theoncologist.2013-0380; Cakir A, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-145; Choccalingam C, 2012, BREAST CANCER-BASIC, V6, P21, DOI 10.4137/BCBCR.S8611; COLEBEUGLET C, 1983, AM J ROENTGENOL, V140, P369, DOI 10.2214/ajr.140.2.369; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dogan BE, 2012, ANN ONCOL, V23, P23, DOI 10.1093/annonc/mds191; FORNAGE BD, 1989, RADIOLOGY, V172, P671, DOI 10.1148/radiology.172.3.2549564; FORNAGE BD, 1990, J ULTRAS MED, V9, P559; Guerra I, 2003, J CLIN PATHOL-MOL PA, V56, P323, DOI 10.1136/mp.56.6.323; Ko ES, 2010, EUR RADIOL, V20, P1111, DOI 10.1007/s00330-009-1656-3; Krizmanich-Conniff KM, 2012, AM J ROENTGENOL, V199, P458, DOI 10.2214/AJR.10.6096; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Luparia A, 2013, RADIOL MED, V118, P1119, DOI 10.1007/s11547-013-0941-z; Rakha EA, 2007, J CLIN PATHOL, V60, P1300, DOI 10.1136/jcp.2006.045377; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Rao C, 2013, J CLIN DIAGN RES, V7, P1361, DOI 10.7860/JCDR/2013/5823.3129; REINER A, 1990, CANCER RES, V50, P7057; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Taucher S, 2003, CANCER, V98, P2547, DOI 10.1002/cncr.11828; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145; UENO E, 1988, ULTRASOUND MED BIOL, V14, P53, DOI 10.1016/0301-5629(88)90047-6	29	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0114820	10.1371/journal.pone.0114820	http://dx.doi.org/10.1371/journal.pone.0114820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734578	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700001
J	Yuan, WW; Yuan, Y; Zhang, T; Wu, SY				Yuan, Weiwei; Yuan, Ye; Zhang, Tao; Wu, Shiyong			Role of Bmi-1 in Regulation of Ionizing Irradiation-Induced Epithelial-Mesenchymal Transition and Migration of Breast Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR; RADIATION; INVASION; METASTASIS; EXPRESSION; CARCINOMA	Radiotherapy is a widely used treatment for cancer. However, recent studies suggest that ionizing radiation (IR) can promote tumor invasion and metastasis. Bmi-1, a member of the polycomb group protein family, has been observed as a regulator of oxidative stress and promotes metastasis in some tumors. But, its potential role in the metastasis induced by IR of breast cancer has not been explored. In our study, we found that increased levels of Bmi-1 were correlated to EMT of breast cancer cells. Through analyzing the EMT state and metastasis of breast cancer induced by IR, we found the metastatic potential of breast cancer cells can either be inhibited or accelerated by IR following a time-dependent pattern. Silencing Bmi-1 completely abolished the ability of the IR to alter, reduce or increase, the migration of breast cancer cells. Also, when Bmi-1 was knocked down, the effect of inhibition of PI3K/AKT signaling on EMT affected by IR was blocked. These results suggest that Bmi-1 is a key gene in regulation of EMT and migration of breast cancer cells induced by IR through activation of PI3K/AKT signaling; therefore, Bmi-1 could be a new target for inhibiting metastasis caused by IR.	[Yuan, Weiwei; Zhang, Tao] Gen Hosp Chengdu Mil Dist, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Yuan, Weiwei; Yuan, Ye; Wu, Shiyong] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Yuan, Weiwei; Yuan, Ye; Wu, Shiyong] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Zhang, T (corresponding author), Gen Hosp Chengdu Mil Dist, Dept Oncol, Chengdu, Sichuan, Peoples R China.	zhangtao269@126.com; wus1@ohio.edu			National Institutes of Health [RO1CA086928]; China Scholarship Council; Department of Chemistry and Biochemistry, Ohio University; NATIONAL CANCER INSTITUTE [R01CA086928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Department of Chemistry and Biochemistry, Ohio University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Institutes of Health RO1CA086928 (S. Wu) and PhD Cooperation Program Fund (to W. Yuan) from China Scholarship Council and graduate assistantship (to Y. Yuan) from the Department of Chemistry and Biochemistry, Ohio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031870; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cheng HW, 2013, LIFE SCI, V93, P798, DOI 10.1016/j.lfs.2013.09.029; Darzynkiewicz Z, 2012, CRIT REV CL LAB SCI, V49, P199, DOI 10.3109/10408363.2012.738808; Guo BH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-10; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kavanagh JN, 2013, ANTIOXID REDOX SIGN, V18, P2458, DOI 10.1089/ars.2012.5151; Kim JH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/718302; Kyjacova L, 2015, CELL DEATH DIFFER, V22, P898, DOI 10.1038/cdd.2014.97; Lee S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/967462; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Li XL, 2013, INT J ONCOL, V43, P793, DOI 10.3892/ijo.2013.1992; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Moncharmont C, 2014, CRIT REV ONCOL HEMAT, V92, P133, DOI 10.1016/j.critrevonc.2014.05.006; Multhoff G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00058; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036209; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; VONESSEN CF, 1991, CLIN EXP METASTAS, V9, P77, DOI 10.1007/BF01756381; Xu ZS, 2011, ONCOL REP, V25, P409, DOI 10.3892/or.2010.1078; Zhang XY, 2014, TUMOR BIOL, V35, P739, DOI 10.1007/s13277-013-1100-9; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956	25	29	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118799	10.1371/journal.pone.0118799	http://dx.doi.org/10.1371/journal.pone.0118799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734775	Green Submitted, gold, Green Published			2022-12-26	WOS:000350314700044
J	Pesch, YY; Riedel, D; Behr, M				Pesch, Yanina-Yasmin; Riedel, Dietmar; Behr, Matthias			Obstructor A Organizes Matrix Assembly at the Apical Cell Surface to Promote Enzymatic Cuticle Maturation in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chitin; Drosophila; Epidermis; Extracellular Matrix; Functional Genomics; Membrane; Molecular Genetics; Cuticle	PHYLOGENETIC ANALYSIS; EXTRACELLULAR-MATRIX; DOMAIN ORGANIZATION; CHITIN SYNTHASES; AIRWAY CLEARANCE; PROTEINS; FAMILY; SECRETION; KNICKKOPF; GROWTH	Assembly and maturation of the apical extracellular matrix (aECM) is crucial for protecting organisms, but underlying molecular mechanisms remain poorly understood. Epidermal cells secrete proteins and enzymes that assemble at the apical cell surface to provide epithelial integrity and stability during developmental growth and upon tissue damage. We analyzed molecular mechanisms of aECM assembly and identified the conserved chitin-binding protein Obst-A (Obstructor A) as an essential regulator. We show in Drosophila that Obst-A is required to coordinate protein and chitin matrix packaging at the apical cell surface during development. Secreted by epidermal cells, the Obst-A protein is specifically enriched in the apical assembly zone where matrix components are packaged into their highly ordered architecture. In obst-A null mutant larvae, the assembly zone is strongly diminished, resulting in severe disturbance of matrix scaffold organization and impaired aECM integrity. Furthermore, enzymes that support aECM stability are mislocalized. As a biological consequence, cuticle architecture, integrity, and function are disturbed in obst-A mutants, finally resulting in immediate lethality upon wounding. Our studies identify a new core organizing center, the assembly zone that controls aECM assembly at the apical cell surface. We propose a genetically conserved molecular mechanism by which Obst-A forms a matrix scaffold to coordinate trafficking and localization of proteins and enzymes in the newly deposited aECM. This mechanism is essential for maturation and stabilization of the aECM in a growing and remodeling epithelial tissue as an outermost barrier.	[Pesch, Yanina-Yasmin; Behr, Matthias] Univ Bonn, Dept Mol Dev Biol, Life & Med Sci Inst LIMES, D-53115 Bonn, Germany; [Pesch, Yanina-Yasmin; Behr, Matthias] Univ Leipzig, Dept Cell Dev Biol, Translat Ctr Regenerat Med TRM, D-04103 Leipzig, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Grp, D-37077 Gottingen, Germany	University of Bonn; Leipzig University; Max Planck Society	Behr, M (corresponding author), Univ Bonn, Dept Mol Dev Biol, Life & Med Sci Inst LIMES, D-53115 Bonn, Germany.	matthias.behr@uni-leipzig.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257	Deutsche Forschungsgemeinschaft [SFB645-C5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB645-C5 (to M. B.).	Arakane Y, 2012, PLOS GENET, V8, P612, DOI 10.1371/journal.pgen.1002682; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Barry MK, 1999, INSECT BIOCHEM MOLEC, V29, P319, DOI 10.1016/S0965-1748(99)00004-1; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chaudhari SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004537; Chaudhari SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003268; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Hsiao YC, 2013, ACTA BIOMATER, V9, P8214, DOI 10.1016/j.actbio.2013.06.002; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; KAZNOWSKI CE, 1985, J INSECT PHYSIOL, V31, P801, DOI 10.1016/0022-1910(85)90073-3; Kramer K. J., 2005, COMPREHENSIVE MOL IN, P11; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2007, MATRIX BIOL, V26, P337, DOI 10.1016/j.matbio.2007.02.001; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Nisole A, 2010, J INSECT PHYSIOL, V56, P1427, DOI 10.1016/j.jinsphys.2009.12.006; Noh MY, 2014, INSECT BIOCHEM MOLEC, V53, P22, DOI 10.1016/j.ibmb.2014.07.005; PETERS W, 1986, HISTOCHEMISTRY, V84, P155, DOI 10.1007/BF00499827; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Shaik KS, 2012, EUR J CELL BIOL, V91, P204, DOI 10.1016/j.ejcb.2011.11.005; Stumpges B, 2011, FEBS LETT, V585, P3316, DOI 10.1016/j.febslet.2011.09.018; Tiklova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067415; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; WOLFGANG WJ, 1987, TISSUE CELL, V19, P827, DOI 10.1016/0040-8166(87)90023-1; Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010	40	45	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10071	10082		10.1074/jbc.M114.614933	http://dx.doi.org/10.1074/jbc.M114.614933			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737451	hybrid, Green Published			2022-12-26	WOS:000353241100014
J	Evans, ML; Hori, TS; Rise, ML; Fleming, IA				Evans, Melissa L.; Hori, Tiago S.; Rise, Matthew L.; Fleming, Ian A.			Transcriptomic Responses of Atlantic Salmon (Salmo salar) to Environmental Enrichment during Juvenile Rearing	PLOS ONE			English	Article							WILD; FITNESS; GROWTH; EXPRESSION; BRAIN; DOMESTICATION; CONSERVATION; ADAPTATION; ANIMALS	Captive rearing programs (hatcheries) are often used in conservation and management efforts for at-risk salmonid fish populations. However, hatcheries typically rear juveniles in environments that contrast starkly with natural conditions, which may lead to phenotypic and/or genetic changes that adversely affect the performance of juveniles upon their release to the wild. Environmental enrichment has been proposed as a mechanism to improve the efficacy of population restoration efforts from captive-rearing programs; in this study, we examine the influence of environmental enrichment during embryo and yolk-sac larval rearing on the transcriptome of Atlantic salmon (Salmo salar). Full siblings were reared in either a hatchery environment devoid of structure or an environment enriched with gravel substrate. At the end of endogenous feeding by juveniles, we examined patterns of gene transcript abundance in head tissues using the cGRASP-designed Agilent 4x44K microarray. Significance analysis of microarrays (SAM) indicated that 808 genes were differentially transcribed between the rearing environments and a total of 184 gene ontological (GO) terms were over-or under-represented in this gene list, several associated with mitosis/cell cycle and muscle and heart development. There were also pronounced differences among families in the degree of transcriptional response to rearing environment enrichment, suggesting that gene-by-environment effects, possibly related to parental origin, could influence the efficacy of enrichment interventions.	[Evans, Melissa L.; Hori, Tiago S.; Rise, Matthew L.; Fleming, Ian A.] Mem Univ Newfoundland, Dept Ocean Sci, Ctr Ocean Sci, St John, NF A1C 5S7, Canada	Memorial University Newfoundland	Evans, ML (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Coastal Oregon Marine Expt Stn, 2030 SE Marine Sci Dr, Newport, OR 97365 USA.	melissa.lea.evans@gmail.com	Fleming, Ian/I-7217-2012	Hori, Tiago/0000-0002-6784-0800	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was conducted as part of the strategic project SMOLTPRO, financed by the Swedish Research Council Formas (http://www.smoltpro.science.gu.se) The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Anderson JH, 2013, EVOL APPL, V6, P165, DOI 10.1111/j.1752-4571.2012.00271.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Bamberger A, 2009, J FISH BIOL, V74, P1419, DOI 10.1111/j.1095-8649.2009.02208.x; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Berejikian BA, 2000, CAN J FISH AQUAT SCI, V57, P628, DOI 10.1139/f99-288; Bo TH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh026; Booman M, 2011, MAR BIOTECHNOL, V13, P733, DOI 10.1007/s10126-010-9335-6; Bougas B, 2013, HEREDITY, V110, P484, DOI 10.1038/hdy.2012.113; Brown C, 2002, FISH FISH, V3, P79, DOI 10.1046/j.1467-2979.2002.00077.x; CARUNCHO HJ, 1994, J ANAT, V184, P355; Celton M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-15; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Debes PV, 2012, MOL ECOL, V21, P2574, DOI 10.1111/j.1365-294X.2012.05567.x; Department of Fisheries and Oceans Canada, 2013, REC POT ASS S NEWF A, P43; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Einum Sigurd, 2001, Nordic Journal of Freshwater Research, V75, P56; FLEMING IA, 1994, CONSERV BIOL, V8, P886, DOI 10.1046/j.1523-1739.1994.08030863-13.x; Frank M, 1999, J NEUROCHEM, V73, P587, DOI 10.1046/j.1471-4159.1999.0730587.x; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Gonda A, 2009, J EVOLUTION BIOL, V22, P1721, DOI 10.1111/j.1420-9101.2009.01782.x; Gonda A, 2009, P ROY SOC B-BIOL SCI, V276, P2085, DOI 10.1098/rspb.2009.0026; HANSEN T, 1985, AQUACULTURE, V48, P177, DOI 10.1016/0044-8486(85)90103-6; HANSEN TJ, 1985, CAN J FISH AQUAT SCI, V42, P1073, DOI 10.1139/f85-133; Hon i TS, 2012, BMC GENOMICS, V13, P431, DOI [doi: 10.1186/1471-2164-13-431 PM ID: 22928584, DOI 10.1186/1471-2164-13-431]; Jantzen Stuart G, 2011, BMC Res Notes, V4, P88, DOI 10.1186/1756-0500-4-88; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jonsson B, 2011, FISH FISH SER, V33, P1, DOI 10.1007/978-94-007-1189-1_1; Kihslinger RL, 2006, COMP BIOCHEM PHYS A, V145, P145, DOI 10.1016/j.cbpa.2006.06.041; Kihslinger RL, 2006, J EXP BIOL, V209, P504, DOI 10.1242/jeb.02019; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Lema SC, 2005, COMP BIOCHEM PHYS A, V141, P327, DOI 10.1016/j.cbpb.2005.06.003; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; MARR D. H. A., 1963, ANIMAL BEHAVIOUR, V11, P412, DOI 10.1016/S0003-3472(63)80148-7; Mason G, 2013, ANIM BEHAV, V85, P1113, DOI 10.1016/j.anbehav.2013.02.002; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; Maynard DJ, 1994, REV SEMINATURAL CULT, P1; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Meier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085171; Milot E, 2013, EVOL APPL, V6, P472, DOI 10.1111/eva.12028; Naslund J, 2014, FISH FISH IN PRESS; Naslund J, 2013, CAN J FISH AQUAT SCI, V70, P585, DOI 10.1139/cjfas-2012-0302; Naslund J, 2012, CAN J FISH AQUAT SCI, V69, P1481, DOI [10.1139/F2012-074, 10.1139/f2012-074]; Normandeau E, 2009, EVOL APPL, V2, P489, DOI 10.1111/j.1752-4571.2009.00074.x; Pavey Scott A., 2011, BMC Ecology, V11, P31, DOI 10.1186/1472-6785-11-31; Peterson R, 1993, AQUACULT ENG, P85; Salvanes AGV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1331; Schwender H, 2006, NEWSLETTER R PROJECT, V6, P45; Simon RM, 2003, STAT BIOL HLTH, P205; Sneddon LU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018181; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tang SJ, 1999, FEBS LETT, V459, P95, DOI 10.1016/S0014-5793(99)01229-6; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; West-Eberhard Mary Jane, 2003, pi; Winkowski JJ, 2014, THESIS; Xu P, 2011, MAR BIOTECHNOL, V13, P215, DOI 10.1007/s10126-010-9283-1; Xu XY, 2011, COMP BIOCHEM PHYS B, V159, P115, DOI 10.1016/j.cbpb.2011.02.008; Yufera M, 2012, MAR BIOTECHNOL, V14, P423, DOI 10.1007/s10126-011-9422-3	62	12	13	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118378	10.1371/journal.pone.0118378	http://dx.doi.org/10.1371/journal.pone.0118378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742646	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000350688100016
J	Thandavarayan, RA; Giridharan, VV; Arumugam, S; Suzuki, K; Ko, KM; Krishnamurthy, P; Watanabe, K; Konishi, T				Thandavarayan, Rajarajan A.; Giridharan, Vijayasree V.; Arumugam, Somasundaram; Suzuki, Kenji; Ko, Kam Ming; Krishnamurthy, Prasanna; Watanabe, Kenichi; Konishi, Tetsuya			Schisandrin B Prevents Doxorubicin Induced Cardiac Dysfunction by Modulation of DNA Damage, Oxidative Stress and Inflammation through Inhibition of MAPK/p53 Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; LEFT-VENTRICULAR DYSFUNCTION; INDUCED CARDIOMYOPATHY; ANGIOTENSIN-II; ADRIAMYCIN CARDIOTOXICITY; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; INDUCED APOPTOSIS; REACTIVE OXYGEN	Doxorubicin (Dox) is a highly effective antineoplastic drug. However, Dox-induced apoptosis in cardiomyocytes leads to irreversible degenerative cardiomyopathy, which limits Dox clinical application. Schisandrin B (Sch B), a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, has been shown to protect against oxidative damage in liver, heart and brain tissues in rodents. In current study, we investigated possible protective effects of Sch B against Dox-induced cardiomyopathy in mice. Mice received a single injection of Dox (20 mg/kg IP). Five days after Dox administration, left ventricular (LV) performance was significantly depressed and was improved by Sch B treatment. Sch B prevented the Dox-induced increase in lipid peroxidation, nitrotyrosine formation, and metalloproteinase activation in the heart. In addition, the increased expression of phospho-p38 MAPK and phospho-MAPK activated mitogen kinase 2 levels by Dox were significantly suppressed by Sch B treatment. Sch B also attenuated Dox-induced higher expression of LV proinflammatory cytokines, cardiomyocyte DNA damage, myocardial apoptosis, caspase-3 positive cells and phopho-p53 levels in mice. Moreover, LV expression of NADPH oxidase subunits and reactive oxygen species were significantly less in Sch B treatment mice after Dox injection. These findings suggest that Sch B attenuates Dox-induced cardiotoxicity via antioxidative and anti-inflammatory effects.	[Thandavarayan, Rajarajan A.; Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Akiha Ku, Niigata, Japan; [Thandavarayan, Rajarajan A.; Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Giridharan, Vijayasree V.] JKK Nattraja Coll Pharm, Komarapalayam, Tamil Nadu, India; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol & Hepatol, Niigata, Japan; [Ko, Kam Ming] Hong Kong Univ Sci & Technol, Sect Biochem & Cell Biol, Hong Kong, Hong Kong, Peoples R China; [Konishi, Tetsuya] NUPALS, Basic Studies Generat Funct Foods, NUPALS Liaison RD Promot Devis, Akiha Ku, Niigata, Japan; [Konishi, Tetsuya] Changchun Univ Chinese Med, Changchun, Peoples R China	Niigata University; The Methodist Hospital System; The Methodist Hospital - Houston; Niigata University; Hong Kong University of Science & Technology; Changchun University of Chinese Medicine	Konishi, T (corresponding author), NUPALS, Basic Studies Generat Funct Foods, NUPALS Liaison RD Promot Devis, Akiha Ku, Higashi Jima 265-1, Niigata, Japan.	konishi@nupals.ac.jp	Arumugam, S./AAT-7570-2020	KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Arumugam, Somasundaram/0000-0002-2096-2552	NHLBI NIH HHS [R01 HL116729] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116729] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bien S, 2007, CANCER RES, V67, P10428, DOI 10.1158/0008-5472.CAN-07-1344; Caceres DD, 1999, PHYTOMEDICINE, V6, P217, DOI 10.1016/S0944-7113(99)80012-9; Chaubey RC, 2001, MUTAT RES-GEN TOX EN, V490, P187, DOI 10.1016/S1383-5718(00)00166-2; Chiu PY, 2006, BIOGERONTOLOGY, V7, P199, DOI 10.1007/s10522-006-9017-y; Force T, 1998, HYPERTENSION, V31, P152, DOI 10.1161/01.HYP.31.1.152; Giridharan VV, 2011, FREE RADICAL RES, V45, P950, DOI 10.3109/10715762.2011.571682; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guo LY, 2008, EUR J PHARMACOL, V591, P293, DOI 10.1016/j.ejphar.2008.06.074; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; IP SP, 1995, PLANTA MED, V61, P398, DOI 10.1055/s-2006-958123; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Konorev EA, 2002, FREE RADICAL BIO MED, V33, P988, DOI 10.1016/S0891-5849(02)00989-9; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Lou H, 2005, AM J PHYSIOL-HEART C, V288, pH1925, DOI 10.1152/ajpheart.01054.2004; Mak DHF, 1996, MOL CELL BIOCHEM, V165, P161; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MONTI E, 1995, ANTICANCER RES, V15, P193; Muller E, 1999, J CELL PHYSIOL, V181, P462, DOI 10.1002/(SICI)1097-4652(199912)181:3<462::AID-JCP10>3.0.CO;2-T; Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339; Nishida H, 2007, J PHARMACOL SCI, V104, P73, DOI 10.1254/jphs.FP0070100; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Olson LE, 2003, CANCER RES, V63, P6602; RINEHART JJ, 1974, ANN INTERN MED, V81, P475, DOI 10.7326/0003-4819-81-4-475; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Steenbergen C, 2002, BASIC RES CARDIOL, V97, P276, DOI 10.1007/s00395-002-0364-9; Takaya T, 2006, ATHEROSCLEROSIS, V186, P402, DOI 10.1016/j.atherosclerosis.2005.08.009; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Thandavarayan RA, 2008, BIOCHEM PHARMACOL, V75, P1797, DOI 10.1016/j.bcp.2008.02.003; Tian W, 2000, AM J PHYSIOL-RENAL, V279, pF593, DOI 10.1152/ajprenal.2000.279.4.F593; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Wang NY, 2002, CIRC J, V66, P763, DOI 10.1253/circj.66.763; Wang XJ, 1999, FREE RADICAL RES, V31, P449, DOI 10.1080/10715769900301011; Weinstein DM, 2000, J PHARMACOL EXP THER, V294, P396; Westermann D, 2006, DIABETOLOGIA, V49, P2507, DOI 10.1007/s00125-006-0385-2; Wold LE, 2005, CANCER DETECT PREV, V29, P294, DOI 10.1016/j.cdp.2004.07.008; Zhang GX, 2004, HYPERTENSION, V43, P117, DOI 10.1161/01.HYP.0000105110.12667.F8	52	77	83	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119214	10.1371/journal.pone.0119214	http://dx.doi.org/10.1371/journal.pone.0119214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742619	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100092
J	Cunha, FD; Molle, RD; Portella, AK; Benetti, CD; Noschang, C; Goldani, MZ; Silveira, PP				Cunha, Fabio da Silva; Molle, Roberta Dalle; Portella, Andre Krumel; Benetti, Carla da Silva; Noschang, Cristie; Goldani, Marcelo Zubaran; Silveira, Patricia Pelufo			Both Food Restriction and High-Fat Diet during Gestation Induce Low Birth Weight and Altered Physical Activity in Adult Rat Offspring: The "Similarities in the Inequalities" Model	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; OBESITY; REINFORCEMENT; MICE; MEN; PHENOTYPE; BENEFITS; EXERCISE; FAMINE; HEALTH	We have previously described a theoretical model in humans, called "Similarities in the Inequalities", in which extremely unequal social backgrounds coexist in a complex scenario promoting similar health outcomes in adulthood. Based on the potential applicability of and to further explore the "similarities in the inequalities" phenomenon, this study used a rat model to investigate the effect of different nutritional backgrounds during gestation on the willingness of offspring to engage in physical activity in adulthood. Sprague-Dawley rats were time mated and randomly allocated to one of three dietary groups: Control (Adlib), receiving standard laboratory chow ad libitum; 50% food restricted (FR), receiving 50% of the ad libitum-fed dam's habitual intake; or high-fat diet (HF), receiving a diet containing 23% fat. The diets were provided from day 10 of pregnancy until weaning. Within 24 hours of birth, pups were cross-fostered to other dams, forming the following groups: Adlib_Adlib, FR_Adlib, and HF_Adlib. Maternal chow consumption and weight gain, and offspring birth weight, growth, physical activity (one week of free exercise in running wheels), abdominal adiposity and biochemical data were evaluated. Western blot was performed to assess D2 receptors in the dorsal striatum. The "similarities in the inequalities" effect was observed on birth weight (both FR and HF groups were smaller than the Adlib group at birth) and physical activity (both FR_Adlib and HF_Adlib groups were different from the Adlib_Adlib group, with less active males and more active females). Our findings contribute to the view that health inequalities in fetal life may program the health outcomes manifested in offspring adult life (such as altered physical activity and metabolic parameters), probably through different biological mechanisms.	[Cunha, Fabio da Silva; Molle, Roberta Dalle; Benetti, Carla da Silva; Noschang, Cristie; Goldani, Marcelo Zubaran; Silveira, Patricia Pelufo] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Fac Med, Dept Pediat,Programa Posgrad Saude Crianca & Adol, Porto Alegre, RS, Brazil; [Portella, Andre Krumel] Univ Fed Ciencias Saude Porto Alegre, Dept Pediat, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre	Silveira, PP (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Fac Med, Dept Pediat,Programa Posgrad Saude Crianca & Adol, Porto Alegre, RS, Brazil.	00032386@ufrgs.br	Silveira, Patricia P/F-4897-2014; Portella, Andre Krumel/A-9333-2010; Silveira, Patricia/K-2364-2019; Goldani, Marcelo Zubaran/U-8596-2019	Silveira, Patricia P/0000-0001-8626-2519; Portella, Andre Krumel/0000-0003-3390-0016; Silveira, Patricia/0000-0001-8626-2519; 	PRONEX; FAPERGS/CNPq [10/0018.3]; Projeto IVAPSA-Impacto das Variacoes do Ambiente Perinatal sobre a Saude do Adulto; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE/HCPA); Pro-Pesquisa/PROPESQ/UFRGS; Coordination for the Improvement of Higher Education Personnel (CAPES); Capes - Brazil	PRONEX; FAPERGS/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Projeto IVAPSA-Impacto das Variacoes do Ambiente Perinatal sobre a Saude do Adulto; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE/HCPA); Pro-Pesquisa/PROPESQ/UFRGS; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Capes - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support from: PRONEX 2009, FAPERGS/CNPq 10/0018.3, Projeto IVAPSA-Impacto das Variacoes do Ambiente Perinatal sobre a Saude do Adulto; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE/HCPA); Pro-Pesquisa/PROPESQ/UFRGS; Coordination for the Improvement of Higher Education Personnel (CAPES). Cunha FS had a MSc supporting grant from Capes - Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MA, 2009, PEDIATR RES, V65, P215, DOI 10.1203/PDR.0b013e31818d6850; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Belke TW, 2007, J EXP ANAL BEHAV, V88, P199, DOI 10.1901/jeab.2007.62-06; BELKE TW, 1994, ANIM LEARN BEHAV, V22, P267, DOI 10.3758/BF03209834; Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; BUE JM, 1989, AM J OBSTET GYNECOL, V161, P234, DOI 10.1016/0002-9378(89)90272-X; Bungum TJ, 1997, AM J PREV MED, V13, P115, DOI 10.1016/S0749-3797(18)30208-3; COLLIER G, 1971, J COMP PHYSIOL PSYCH, V77, P155, DOI 10.1037/h0031588; Crimi E, 2009, NAT REV CARDIOL, V6, P292, DOI 10.1038/nrcardio.2009.8; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Deslandes A, 2009, NEUROPSYCHOBIOLOGY, V59, P191, DOI 10.1159/000223730; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Fernandes FS, 2010, J DEV ORIG HLTH DIS, V1, P255, DOI 10.1017/S204017441000019X; Ford SP, 2012, REPROD FERT DEVELOP, V24, P105, DOI 10.1071/RD11911; Francis TC, 2015, BIOL PSYCHIAT, V77, P212, DOI 10.1016/j.biopsych.2014.07.021; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hallal PC, 2006, BMJ-BRIT MED J, V332, P1002, DOI 10.1136/bmj.38776.434560.7C; Hamer M, 2009, EUR J CARDIOV PREV R, V16, P156, DOI 10.1097/HJR.0b013e32831f1b77; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; IVERSEN IH, 1993, J EXP ANAL BEHAV, V60, P219, DOI 10.1901/jeab.1993.60-219; James MH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00244; KAGAN J, 1954, J COMP PHYSIOL PSYCH, V47, P108, DOI 10.1037/h0058877; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Kantomaa MT, 2007, PREV MED, V44, P410, DOI 10.1016/j.ypmed.2007.01.008; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Kravitz AV, 2012, PHYSIOLOGY, V27, P167, DOI 10.1152/physiol.00004.2012; Landi F, 2008, PREV MED, V47, P422, DOI 10.1016/j.ypmed.2008.06.020; Lett BT, 2000, APPETITE, V34, P87, DOI 10.1006/appe.1999.0274; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liu M, 2006, PHARM STAT, V5, P7, DOI 10.1002/pst.189; Ma Y, 2012, REGION ANESTH PAIN M, V37, P99, DOI 10.1097/AAP.0b013e31823ebc74; Marais L, 2009, METAB BRAIN DIS, V24, P587, DOI 10.1007/s11011-009-9157-2; Martinez R, 2009, FOOD NUTR INSECURITY; Matthews PA, 2011, J PHYSIOL-LONDON, V589, P3969, DOI 10.1113/jphysiol.2011.212324; McMinn AM, 2013, EUR J PUBLIC HEALTH, V23, P805, DOI 10.1093/eurpub/cks160; McMullen S, 2012, MED HYPOTHESES, V78, P88, DOI 10.1016/j.mehy.2011.09.047; Miotto PM, 2013, MOLECULES, V18, P15094, DOI 10.3390/molecules181215094; Mo Frank, 2005, Int J Adolesc Med Health, V17, P49; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Organization WH, 2002, WORLD HLTH REP RED R, DOI [10.2134/jeq2014.02.0058, DOI 10.2134/JEQ2014.02.0058]; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Portella AK, 2012, J DEV ORIG HLTH DIS, V3, P140, DOI 10.1017/S2040174412000062; PREMACK D, 1964, J EXP ANAL BEHAV, V7, P91, DOI 10.1901/jeab.1964.7-91; Rabadan-Diehl C, 2013, J DEV ORIG HLTH DIS, V4, P3, DOI 10.1017/S2040174412000487; Raudsepp L, 2006, ACTA PAEDIATR, V95, P93, DOI 10.1080/08035250500323772; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Refinetti R, 2006, J COMP PHYSIOL A, V192, P701, DOI 10.1007/s00359-006-0093-x; Ross MG, 2005, AM J PHYSIOL-REG I, V288, pR25, DOI 10.1152/ajpregu.00418.2004; Shaw MA, 1997, J NUTR, V127, P64, DOI 10.1093/jn/127.1.64; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Sherwin CM, 1996, ANIM BEHAV, V51, P1087, DOI 10.1006/anbe.1996.0110; Silveira PP, 2010, INT J DEV NEUROSCI, V28, P111, DOI 10.1016/j.ijdevneu.2009.08.018; Silveira PP, 2006, BEHAV BRAIN RES, V173, P205, DOI 10.1016/j.bbr.2006.06.031; Silveira PP, 2005, LANCET, V366, P451, DOI 10.1016/S0140-6736(05)67054-7; Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; TIMBERLAKE W, 1979, ANIM LEARN BEHAV, V7, P461, DOI 10.3758/BF03209702; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Veitch J, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-11; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003	67	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118586	10.1371/journal.pone.0118586	http://dx.doi.org/10.1371/journal.pone.0118586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738800	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900050
J	Huang, AH; Pan, SH; Chang, WH; Hong, QS; Chen, JJW; Yu, SL				Huang, Ay-Huey; Pan, Szu-Hua; Chang, Wen-Hsin; Hong, Qi-Sheng; Chen, Jeremy J. W.; Yu, Sung-Liang			PARVA Promotes Metastasis by Modulating ILK Signalling Pathway in Lung Adenocarcinoma	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; AP-1 TRANSCRIPTION FACTOR; MEDIATED UP-REGULATION; ALPHA-PARVIN; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; CANCER; EXPRESSION; INVASION; PHOSPHORYLATION	alpha-parvin (PARVA) is known to be involved in the linkage of integrins, regulation of actin cytoskeleton dynamics and cell survival. However, the role that PARVA plays in cancer progression remains unclear. Here, using a lung cancer invasion cell line model and expression microarrays, we identify PARVA as a potential oncogene. The overexpression of PARVA increased cell invasion, colony-forming ability and endothelial cell tube formation. By contrast, knockdown of PARVA inhibited invasion and tube formation in vitro. Overexpression of PARVA also promoted tumorigenicity, angiogenesis and metastasis in in vivo mouse models. To explore the underlying mechanism, we compared the expression microarray profiles of PARVA-overexpressing cells with those of control cells to identify the PARVA-regulated signalling pathways. Pathway analysis showed that eight of the top 10 pathways are involved in invasion, angiogenesis and cell death. Next, to identify the direct downstream signalling pathway of PARVA, 371 significantly PARVA-altered genes were analysed further using a transcription factor target model. Seven of the top 10 PARVA-altered transcription factors shared a common upstream mediator, ILK. Lastly, we found that PARVA forms a complex with SGK1 and ILK to enhance the phosphorylation of ILK, which led to the phosphorylation of Akt and GSK3 beta. Notably, the inactivation of ILK reversed PARVA-induced invasion. Taken together, our findings imply that PARVA acts as an oncogene by activating ILK, and that this activation is followed by the activation of Akt and inhibition of GSK3 beta. To our knowledge, this is the first study to characterize the role of PARVA in lung cancer progression.	[Huang, Ay-Huey; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Pan, Szu-Hua] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chang, Wen-Hsin; Hong, Qi-Sheng; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Chung Hsing University; National Taiwan University; National Chung Hsing University; National Chung Hsing University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chen, JJW (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan.	jwchen@dragon.nchu.edu.tw; slyu@ntu.edu.tw		YU, SUNG-LIANG/0000-0003-4535-9036; Pan, Szu-Hua/0000-0002-0138-0434; Chang, Wen-Hsin/0000-0002-8027-302X; Chen, Jeremy J.W./0000-0003-1049-3825	National Science Council of the Republic of China [NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557]; Ministry of Education, Taiwan, under the ATU plan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, under the ATU plan(Ministry of Education, Taiwan)	This study was supported by the National Science Council of the Republic of China (grants NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557), as well as in part by the Ministry of Education, Taiwan, under the ATU plan. The authors thank the NCFPB C5 microarray core facility for technique support and the BCRC cell bank for providing the STR profiling data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Albasri A, 2011, ONCOGENE, V30, P2997, DOI 10.1038/onc.2011.26; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Barker HE, 2012, NAT REV CANC; Biswas S, 2012, CARCINOGENESIS, V33, P1717, DOI 10.1093/carcin/bgs222; Cattaneo MG, 2008, BRIT J PHARMACOL, V153, P728, DOI 10.1038/sj.bjp.0707609; Chan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016984; Chen CH, 2012, MOL CANCER RES, V10, P1319, DOI 10.1158/1541-7786.MCR-12-0189; Chen JJW, 2001, CANCER RES, V61, P5223; Cho ML, 2006, IMMUNOL LETT, V103, P159, DOI 10.1016/j.imlet.2005.10.020; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chun Jaesun, 2005, Integrative Biosciences, V9, P161; Devalliere J, 2012, FASEB J; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong TM, 2000, AM J RESP CELL MOL, V23, P355, DOI 10.1165/ajrcmb.23.3.4002; Jung KY, 2007, J AM SOC NEPHROL, V18, P66, DOI 10.1681/ASN.2006050421; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; Lee SL, 2011, J MED CHEM, V54, P6364, DOI 10.1021/jm2007744; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liang CH, 2012, CANC RES; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Papachristou DJ, 2008, EUR J CANCER, V44, P2518, DOI 10.1016/j.ejca.2008.07.021; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pignatelli J, 2012, J BIOL CHEM; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Schroeter MR, 2012, CARDIOVASC RES, V93, P170, DOI 10.1093/cvr/cvr275; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Tsai LN, 2008, MOL CELL BIOL, V28, P4240, DOI 10.1128/MCB.01489-07; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Yun SP, 2011, J CELL PHYSIOL, V226, P683, DOI 10.1002/jcp.22383; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	45	21	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118530	10.1371/journal.pone.0118530	http://dx.doi.org/10.1371/journal.pone.0118530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738875	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900043
J	Larsen, J; Weile, C; Antvorskov, JC; Engkilde, K; Nielsen, SMB; Josefsen, K; Buschard, K				Larsen, Jesper; Weile, Christian; Antvorskov, Julie Christine; Engkilde, Kare; Nielsen, Signe Marie Borch; Josefsen, Knud; Buschard, Karsten			Effect of Dietary Gluten on Dendritic Cells and Innate Immune Subsets in BALB/c and NOD Mice	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; CELIAC-DISEASE; T-CELLS; GLIADIN FRAGMENTS; WHEAT; AUTOIMMUNITY; INFLAMMATION; SENSITIVITY; ACTIVATION; MATURATION	The innate immune system is known to play an important role in oral tolerance to dietary antigens. This is important in development of celiac disease (CD) but may also be important in type 1 diabetes (T1D), and could potentially explain the reduced incidence of T1D in mice receiving a gluten-free (GF) diet. The direct in vivo effect of gluten on innate cells, and particularly dendritic cells (DC) is not sufficiently clarified. Therefore, we wished to investigate the innate cell populations of spontaneous diabetic NOD mice and healthy BALB/c mice kept on a GF or a standard (STD) gluten containing diet. We studied, by flow cytometry and reverse transcription-quantitative polymerase chain reaction (qRT-PCR), if dietary gluten induces changes in the activation of DCs and distribution of selected innate cells in lymphoid, pancreatic and intestinal tissues in BALB/c and NOD mice. We found that a GF diet increased the percentage of macrophages in BALB/c spleen and of CD11c(+) DCs in BALB/c and NOD spleen. Strictly gluten-free (SGF) diet increased the percentage of CD103(+) DCs in BALB/c mice and decreased percentages of CD11b(+) DCs in mesenteric and pancreatic lymph nodes in BALB/c mice. SGF diet in BALB/c mice also decreased DC expression of CD40, CCR7 and MHC-II in pancreatic lymph nodes. In conclusion, GF diet changes the composition of the innate immune system in BALB/c and NOD mice and increases expression of DC activation markers in NOD mice. These results contribute to the explanation of the low diabetes incidence in GF NOD mice. This mechanism may be important in development of type 1 diabetes, celiac disease and non-celiac gluten sensitivity.	[Larsen, Jesper; Weile, Christian; Antvorskov, Julie Christine; Engkilde, Kare; Nielsen, Signe Marie Borch; Josefsen, Knud; Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Larsen, J (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	jelars@gmail.com		Buschard, Karsten/0000-0002-0126-7423	"Kirsten & Freddy Johansens foundation"	"Kirsten & Freddy Johansens foundation"	The study was funded by "Kirsten & Freddy Johansens foundation", http://www.kf-j.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz EH, 2014, CLIN EXP IMMUNOL, V177, P391, DOI 10.1111/cei.12340; Antvorskov JC, 2014, DIABETOLOGIA, V57, P1770, DOI 10.1007/s00125-014-3265-1; Antvorskov JC, 2013, IMMUNOLOGY, V138, P23, DOI 10.1111/imm.12007; Antvorskov JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033315; Auricchio R, 2004, DIABETES, V53, P1680, DOI 10.2337/diabetes.53.7.1680; Badami E, 2011, DIABETES, V60, P2120, DOI 10.2337/db10-1201; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bosi E, 2006, DIABETOLOGIA, V49, P2824, DOI 10.1007/s00125-006-0465-3; Catassi C, 2013, NUTRIENTS, V5, P3839, DOI 10.3390/nu5103839; Chakir H, 2005, DIABETOLOGIA, V48, P1576, DOI 10.1007/s00125-005-1842-z; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Creusot RJ, 2014, DIABETES, V63, P20, DOI 10.2337/db13-0886; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Diana J, 2011, DISCOV MED, V11, P513; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Giordani L, 2014, EXP CELL RES, V321, P248, DOI 10.1016/j.yexcr.2013.11.008; Graham S, 2004, GUT, V53, P1437, DOI 10.1136/gut.2004.042481; Hanninen A, 1996, DIABETES, V45, P1173, DOI 10.2337/diabetes.45.9.1173; Hanninen A, 1998, J IMMUNOL, V160, P6018; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Larsen J, 2014, EUR J IMMUNOL, V44, P3056, DOI 10.1002/eji.201344264; LAVO B, 1989, AM J MED, V87, P655, DOI 10.1016/0002-9343(89)90726-2; Maurano F, 2005, DIABETOLOGIA, V48, P931, DOI 10.1007/s00125-005-1718-2; Nikulina M, 2004, J IMMUNOL, V173, P1925, DOI 10.4049/jimmunol.173.3.1925; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Roep BO, 2013, DIABETES, V62, P1821, DOI 10.2337/db13-0276; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmid S, 2004, CLIN IMMUNOL, V111, P108, DOI 10.1016/j.clim.2003.09.012; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Sildorf SM, 2012, BMJ CASE REP; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Terrazzano G, 2007, J IMMUNOL, V179, P372, DOI 10.4049/jimmunol.179.1.372; Troncone R, 2003, AM J GASTROENTEROL, V98, P590, DOI 10.1111/j.1572-0241.2003.07301.x; Tuckova L, 2002, J LEUKOCYTE BIOL, V71, P625; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yin N, 2012, J IMMUNOL, V188, P4921, DOI 10.4049/jimmunol.1103725; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	52	21	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118618	10.1371/journal.pone.0118618	http://dx.doi.org/10.1371/journal.pone.0118618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738288	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900055
J	Zhao, F; Li, MH; Wang, ZH; Fu, Z; Cui, YF; Chen, ZQ; Yu, JM				Zhao, Fen; Li, Minghuan; Wang, Zhiheng; Fu, Zheng; Cui, Yunfeng; Chen, Zhaoqiu; Yu, Jinming			F-18-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; 3'-DEOXY-3'-F-18-FLUOROTHYMIDINE PET; COMPUTED-TOMOGRAPHY; CELL PROLIFERATION; TARGET DELINEATION; RADIATION-THERAPY; GLIAL NEOPLASMS; F-18-FLT PET	Objective To compare the presence of post-operative residual disease by magnetic resonance imaging (MRI) and [F-18] fluorothymidine (FLT)-positron emission tomography (PET)-computer tomography (CT) in patients with malignant glioma and to estimate the impact of F-18-FLT PET on the delineation of post-operative target volumes for radiotherapy (RT) planning. Methods Nineteen patients with post-operative residual malignant gliomas were enrolled in this study. For each patient, F-18-FLT PET-CT and MRI were acquired in the same week, within 4 weeks after surgery but before the initiation of RT. The PET-CT and MRI data were co-registered based on mutual information. The residual tumor volume defined on the F-18-FLT PET (Vol-PET) was compared with that of gadolinium [Gd] enhancement on T1-weighted MRI (Vol-T1) and areas of hyperintensity on T2-weighted MRI (Vol-T2). Results The mean Vol-PET (14.61 cm(3)) and Vol-T1 (13.60 cm(3)) were comparable and smaller than the mean Vol-T2 (32.93 cm(3)). The regions of F-18-FLT uptake exceeded the contrast enhancement and the hyperintense area on the MRI in 14 (73.68%) and 8 patients (42.11%), respectively. In 5 (26.32%) of the 19 patients, Vol-PET extended beyond 25 mm from the margin of Vol-T1; in 2 (10.53%) patients, Vol-PET extended 20 mm from the margin of Vol-T2. Vol-PET was detected up to 35 mm away from the edge of Vol-T1 and 24 mm away from the edge of Vol-T2. In 16 (84.21%) of the 19 patients, the Vol-T1 extended beyond the Vol-PET. In all of the patients, at least some of the Vol-T2 was located outside of the Vol-PET. Conclusions The volumes of post-operative residual tumor in patients with malignant glioma defined by F-18-FLT uptake on PET are not always consistent with the abnormalities shown on post-operative MRI. Incorporation of F-18-FLT-PET in tumor delineation may have the potential to improve the definition of target volume in post-operative radiotherapy.	[Zhao, Fen; Li, Minghuan; Fu, Zheng; Chen, Zhaoqiu; Yu, Jinming] Shandong Acad Med Sci, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Peoples R China; [Zhao, Fen; Li, Minghuan; Yu, Jinming] Shandong Canc Hosp & Inst, Key Lab Radiat Oncol Shandong Prov, Jinan, Shandong, Peoples R China; [Wang, Zhiheng; Cui, Yunfeng] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Fu, Zheng] Shandong Canc Hosp & Inst, Dept Nucl Med, Jinan, Shandong, Peoples R China; [Chen, Zhaoqiu] Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Duke University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Yu, JM (corresponding author), Shandong Acad Med Sci, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Peoples R China.	chinasdyjm@gmail.com			Shandong Academy of Medical Sciences [2012-23]	Shandong Academy of Medical Sciences	Fen Zhao reports research grants from Shandong Academy of Medical Sciences (2012-23), during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors have nothing to disclose.	Aydin H, 2001, STRAHLENTHER ONKOL, V177, P424, DOI 10.1007/PL00002424; Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; Barwick T, 2009, NUCL MED COMMUN, V30, P908, DOI 10.1097/MNM.0b013e32832ee93b; CHAMBERLAIN MC, 1988, NEUROLOGY, V38, P1371, DOI 10.1212/WNL.38.9.1371; Chang EL, 2007, INT J RADIAT ONCOL, V68, P144, DOI 10.1016/j.ijrobp.2006.12.009; Chen W, 2005, J NUCL MED, V46, P945; Choi SJ, 2005, EUR J NUCL MED MOL I, V32, P653, DOI 10.1007/s00259-004-1742-3; Dowling C, 2001, AM J NEURORADIOL, V22, P604; GARDEN AS, 1991, RADIOTHER ONCOL, V20, P99, DOI 10.1016/0167-8140(91)90143-5; Grosu AL, 2005, INT J RADIAT ONCOL, V63, P64, DOI 10.1016/j.ijrobp.2005.01.045; Grosu AL, 2003, INT J RADIAT ONCOL, V56, P1450, DOI 10.1016/S0360-3016(03)00279-7; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Idema AJS, 2012, J NUCL MED, V53, P1904, DOI 10.2967/jnumed.112.105544; Jacobs AH, 2005, J NUCL MED, V46, P1948; Kaschten B, 1998, J NUCL MED, V39, P778; KELLY PJ, 1987, MAYO CLIN PROC, V62, P450, DOI 10.1016/S0025-6196(12)65470-6; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Kirkby NF, 2007, J THEOR BIOL, V245, P112, DOI 10.1016/j.jtbi.2006.09.007; Lee IH, 2009, INT J RADIAT ONCOL, V73, P479, DOI 10.1016/j.ijrobp.2008.04.050; Majos C, 2002, RADIOLOGY, V225, P556, DOI 10.1148/radiol.2252011592; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; Matsuo M, 2012, INT J RADIAT ONCOL, V82, P83, DOI 10.1016/j.ijrobp.2010.09.020; Meral R, 2006, CLIN ONCOL, V18, P93; MOSSKIN M, 1989, ACTA RADIOL, V30, P225; NELSON DF, 1993, INT J RADIAT ONCOL, V25, P193, DOI 10.1016/0360-3016(93)90340-2; OGAWA T, 1993, RADIOLOGY, V186, P45, DOI 10.1148/radiology.186.1.8380108; Pirzkall A, 2001, INT J RADIAT ONCOL, V50, P915, DOI 10.1016/S0360-3016(01)01548-6; Rieken S, 2013, RADIOTHER ONCOL, V109, P487, DOI 10.1016/j.radonc.2013.06.043; Saga T, 2006, CLIN NUCL MED, V31, P774, DOI 10.1097/01.rlu.0000246820.14892.d2; Schwarzenberg J, 2012, J NUCL MED, V53, P29, DOI 10.2967/jnumed.111.092387; Sherriff J, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120414; Spence AM, 2009, MOL IMAGING BIOL, V11, P343, DOI 10.1007/s11307-009-0215-2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; THORNTON AF, 1992, INT J RADIAT ONCOL, V24, P767, DOI 10.1016/0360-3016(92)90727-Y; Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Urtasun RC, 1996, INT J RADIAT ONCOL, V36, P1163, DOI 10.1016/S0360-3016(96)00429-4; WATANABE M, 1992, NEURORADIOLOGY, V34, P463, DOI 10.1007/BF00598951; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yue JB, 2010, J NUCL MED, V51, P528, DOI 10.2967/jnumed.109.072124	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118769	10.1371/journal.pone.0118769	http://dx.doi.org/10.1371/journal.pone.0118769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738617	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900067
J	Enright, J; Kao, RR				Enright, Jessica; Kao, Rowland R.			A Few Bad Apples: A Model of Disease Influenced Agent Behaviour in a Heterogeneous Contact Environment	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; MOUTH-DISEASE; CATTLE; BVD	For diseases that infect humans or livestock, transmission dynamics are at least partially dependent on human activity and therefore human behaviour. However, the impact of human behaviour on disease transmission is relatively understudied, especially in the context of heterogeneous contact structures such as described by a social network. Here, we use a strategic game, coupled with a simple disease model, to investigate how strategic agent choices impact the spread of disease over a contact network. Using beliefs that are based on disease status and that build up over time, agents choose actions that stochastically determine disease spread on the network. An agent's disease status is therefore a function of both his own and his neighbours actions. The effect of disease on agents is modelled by a heterogeneous payoff structure. We find that the combination of network shape and distribution of payoffs has a non-trivial impact on disease prevalence, even if the mean payoff remains the same. An important scenario occurs when a small percentage (called noncooperators) have little incentive to avoid disease. For diseases that are easily acquired when taking a risk, then even when good behavior can lead to disease eradication, a small increase in the percentage of noncooperators (less than 5%) can yield a large (up to 25%) increase in prevalence.				Jessica.Enright@glasgow.ac.uk; Rowland.Kao@glasgow.ac.uk		Enright, Jessica/0000-0002-0266-3292; Kao, Rowland/0000-0003-0919-6401	EPIC (Epidemiology, Population health and Infectious disease Control)	EPIC (Epidemiology, Population health and Infectious disease Control)	This work was supported by EPIC (Epidemiology, Population health and Infectious disease Control), website at: http://epicscotland.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gintis H., 2000, GAME THEORY EVOLVING; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Gunn GJ, 2004, VET J, V167, P143, DOI 10.1016/S1090-0233(03)00112-6; Heffernan C, 2008, PREV VET MED, V87, P358, DOI 10.1016/j.prevetmed.2008.05.007; McElreath R., 2007, MATH MODELS SOCIAL E; Moennig Volker, 2005, Animal Health Research Reviews, V6, P63, DOI 10.1079/AHR2005102; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Rich KM, 2007, AM J AGR ECON, V89, P682, DOI 10.1111/j.1467-8276.2007.01006.x; Rich KM, 2005, REV AGR ECON, V27, P456, DOI 10.1111/j.1467-9353.2005.00244.x; Skuce RA, 2012, VET MED INT, P1, DOI [10.1155/2012/621210, DOI 10.1155/2012/621210]; Stott AW, 2003, PREV VET MED, V59, P51, DOI 10.1016/S0167-5877(03)00062-X; The Scottish Government, VET GUID BVD ER PHAS	17	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118127	10.1371/journal.pone.0118127	http://dx.doi.org/10.1371/journal.pone.0118127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734661	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000350314700016
J	Santoni, G; Angleman, S; Welmer, AK; Mangialasche, F; Marengoni, A; Fratiglioni, L				Santoni, Gioia; Angleman, Sara; Welmer, Anna-Karin; Mangialasche, Francesca; Marengoni, Alessandra; Fratiglioni, Laura			Age-Related Variation in Health Status after Age 60	PLOS ONE			English	Article							MINI-MENTAL-STATE; PHYSICAL PERFORMANCE; MORTALITY; MULTIMORBIDITY; POPULATIONS; EDUCATION; SURVIVAL; DEMENTIA; SPEED	Background Disability, functionality, and morbidity are often used to describe the health of the elderly. Although particularly important when planning health and social services, knowledge about their distribution and aggregation at different ages is limited. We aim to characterize the variation of health status in a 60+ old population using five indicators of health separately and in combination. Methods 3080 adults 60+ living in Sweden between 2001 and 2004 and participating at the SNAC-K population-based cohort study. Health indicators: number of chronic diseases, gait speed, Mini Mental State Examination (MMSE), disability in instrumental-activities of daily living (I-ADL), and in personal-ADL (P-ADL). Results Probability of multimorbidity and probability of slow gait speed were already above 60% and 20% among sexagenarians. Median MMSE and median I-ADL showed good performance range until age 84; median P-ADL was close to zero up to age 90. Thirty% of sexagenarians and 11% of septuagenarians had no morbidity and no impairment, 92% and 80% of them had no disability. Twenty-eight% of octogenarians had multimorbidity but only 27% had some I-ADL disability. Among nonagenarians, 13% had severe disability and impaired functioning while 12% had multimorbidity and slow gait speed. Conclusions Age 80-85 is a transitional period when major health changes take place. Until age 80, most people do not have functional impairment or disability, despite the presence of chronic disorders. Disability becomes common only after age 90. This implies an increasing need of medical care after age 70, whereas social care, including institutionalization, becomes a necessity only in nonagenarians.	[Santoni, Gioia; Angleman, Sara; Welmer, Anna-Karin; Mangialasche, Francesca; Fratiglioni, Laura] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Santoni, Gioia; Angleman, Sara; Welmer, Anna-Karin; Mangialasche, Francesca; Fratiglioni, Laura] Stockholm Univ, S-10691 Stockholm, Sweden; [Welmer, Anna-Karin] Karolinska Univ Hosp, Stockholm, Sweden; [Mangialasche, Francesca] Univ Perugia, Dept Med, Sect Gerontol & Geriatr, I-06100 Perugia, Italy; [Marengoni, Alessandra] Univ Brescia, Dept Clin & Expt Sci, Geriatr Unit, Brescia, Italy; [Fratiglioni, Laura] Karolinska Inst, Stockholm Gerontol Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska University Hospital; University of Perugia; University of Brescia; Karolinska Institutet	Santoni, G (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden.	giola.santoni@ki.se	Welmer, Anna-Karin/AAL-3446-2021	Santoni, Giola/0000-0002-9094-5037; Welmer, Anna-Karin/0000-0001-5819-8724; Angleman, Sara/0000-0002-9520-5716; Mangialasche, Francesca/0000-0002-2686-3926; marengoni, alessandra/0000-0002-4851-1825	Ministry of Health and Social Affairs, Sweden; Ragnhild och Einar Lundstroms Minne foundation [LA2013-0412]; Swedish Research Council	Ministry of Health and Social Affairs, Sweden; Ragnhild och Einar Lundstroms Minne foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish National study on Aging and Care, SNAC, (www.snac.org) is financially supported by the Ministry of Health and Social Affairs, Sweden; the participating county councils and municipalities; and the Swedish Research Council. In addition, a specific grant (LA2013-0412) was obtained from Ragnhild och Einar Lundstroms Minne foundation (http://www.lindhes.se/stiftelseforvaltning/ansokanom-bidrag). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; Bottai M, 2010, STAT MED, V29, P309, DOI 10.1002/sim.3781; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Collerton J, 2009, BMJ, V339; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Jacobs JM, 2012, GERONTOLOGY, V58, P313, DOI 10.1159/000335238; Lafortune L, 2009, MED CARE, V47, P286, DOI 10.1097/MLR.0b013e3181894293; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Lee SJ, 2008, AM J PUBLIC HEALTH, V98, P1209, DOI 10.2105/AJPH.2007.130955; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Lowsky DJ, 2013, J GERONTOL A-BIOL; Marengoni Alessandra, 2011, J Comorb, V1, P11; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; NEUGARTEN BL, 1974, ANN AM ACAD POLIT SS, V415, P187, DOI 10.1177/000271627441500114; Njegovan V, 2001, J GERONTOL A-BIOL, V56, pM638, DOI 10.1093/gerona/56.10.M638; Rizzuto D, 2012, BMJ, V345; Schwenk M, 2014, GERONTOLOGY, V60, P79, DOI 10.1159/000354211; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; von Haehling S, 2012, J CACHEXIA SARCOPENI, V3, P213, DOI 10.1007/s13539-012-0089-z; Welmer AK, 2014, J GERONTOL A-BIOL; Welmer AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-641; Welmer AK, 2012, AGING CLIN EXP RES, V24, P480, DOI 10.3275/8584	28	78	78	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0120077	10.1371/journal.pone.0120077	http://dx.doi.org/10.1371/journal.pone.0120077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734828	gold, Green Published, Green Submitted			2022-12-26	WOS:000350314700066
J	Wang, XQ; Lu, ML; Shi, Y; Ou, Y; Cheng, XD				Wang, Xuequan; Lu, Meiling; Shi, Yang; Ou, Yu; Cheng, Xiaodong			Discovery of Novel New Delhi Metallo-beta-Lactamases-1 Inhibitors by Multistep Virtual Screening	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; NDM-1; ZINC; DOCKING; DISSEMINATION; RECOGNITION	The emergence of NDM-1 containing multi-antibiotic resistant "Superbugs" necessitates the needs of developing of novel NDM-1inhibitors. In this study, we report the discovery of novel NDM-1 inhibitors by multi-step virtual screening. From a 2,800,000 virtual drug-like compound library selected from the ZINC database, we generated a focused NDM-1 inhibitor library containing 298 compounds of which 44 chemical compounds were purchased and evaluated experimentally for their ability to inhibit NDM-1 in vitro. Three novel NDM-1 inhibitors with micromolar IC50 values were validated. The most potent inhibitor, VNI-41, inhibited NDM-1 with an IC50 of 29.6 +/- 1.3 mu M. Molecular dynamic simulation revealed that VNI-41 interacted extensively with the active site. In particular, the sulfonamide group of VNI-41 interacts directly with the metal ion Zn1 that is critical for the catalysis. These results demonstrate the feasibility of applying virtual screening methodologies in identifying novel inhibitors for NDM-1, a metallo-beta-lactamase with a malleable active site and provide a mechanism base for rational design of NDM-1 inhibitors using sulfonamide as a functional scaffold.				ouyu2008@126.com; xiaodong.cheng@uth.tmc.ectu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	National Natural Science Foundation of China [81302795, 81328023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No: 81302795 and No: 81328023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Arpin C, 2012, ANTIMICROB AGENTS CH, V56, P3432, DOI 10.1128/AAC.00230-12; Attene-Ramos M.S., 2014, ENCY TOXICOLOGY, V3rd, P916, DOI DOI 10.1016/B978-0-12-386454-3.00209-8; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brown MC, 2014, METHODS MOL BIOL, V1084, P227, DOI 10.1007/978-1-62703-658-0_12; Bush K, 1998, CLIN INFECT DIS, V27, pS48, DOI 10.1086/514922; Chen J., 2013, AM J BIOMED RES, V1, P120, DOI DOI 10.12691/AJBR-1-4-8; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; DALE JW, 1985, FEBS LETT, V191, P39, DOI 10.1016/0014-5793(85)80989-3; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P4343, DOI 10.1128/AAC.00409-10; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Feher M, 2000, J CHEM INF COMP SCI, V40, P495, DOI 10.1021/ci9900682; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Goto J, 2004, J MED CHEM, V47, P6804, DOI 10.1021/jm0493818; Green VL, 2011, ACTA CRYSTALLOGR F, V67, P1160, DOI 10.1107/S1744309111029654; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Hu X, 2004, J MOL GRAPH MODEL, V22, P293, DOI 10.1016/j.jmgm.2003.11.002; Hu X, 2003, J MOL GRAPH MODEL, V22, P115, DOI 10.1016/S1093-3263(03)00153-0; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; JAURIN B, 1981, P NATL ACAD SCI-BIOL, V78, P4897, DOI 10.1073/pnas.78.8.4897; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Kim Young Sook, 2011, Evid Based Complement Alternat Med, V2011, P761859, DOI 10.1093/ecam/nep078; Kim Y, 2013, FASEB J, V27, P1917, DOI 10.1096/fj.12-224014; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Labute P, 2005, J CHEM INF MODEL, V45, P215, DOI 10.1021/ci049915d; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061914; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Mincione F, 2007, CURR TOP MED CHEM, V7, P849, DOI 10.2174/156802607780636735; Mohamed MS, 2011, EUR J MED CHEM, V46, P6075, DOI 10.1016/j.ejmech.2011.10.030; Morar M, 2010, ANNU REV GENET, V44, P25, DOI 10.1146/annurev-genet-102209-163517; Olsen L, 2004, J COMPUT AID MOL DES, V18, P287, DOI 10.1023/B:JCAM.0000046821.15502.71; Rollinger Judith M., 2008, V65; Selevsek N, 2009, J BIOL CHEM, V284, P16419, DOI 10.1074/jbc.M109.001305; Shahid M, 2011, LANCET INFECT DIS, V11, P334, DOI 10.1016/S1473-3099(11)70074-3; Shen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062955; Stone NRH, 2011, J ANTIMICROB CHEMOTH, V66, P2677, DOI 10.1093/jac/dkr337; Tamilselvi A, 2008, J BIOL INORG CHEM, V13, P1039, DOI 10.1007/s00775-008-0407-2; Thomas PW, 2013, BIOORGAN MED CHEM, V21, P3138, DOI 10.1016/j.bmc.2013.03.031; U.S. Centers for Disease Control and Prevention, ANTIBIOTIC RESISTANC; Wailan AM, 2014, EXPERT REV ANTI-INFE, V12, P91, DOI 10.1586/14787210.2014.856756; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wildman SA, 2001, J CHEM INF COMP SCI, V41, P446, DOI 10.1021/ci0000880; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Yuan QH, 2012, ANTIMICROB AGENTS CH, V56, P5157, DOI 10.1128/AAC.05896-11; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	57	20	24	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118290	10.1371/journal.pone.0118290	http://dx.doi.org/10.1371/journal.pone.0118290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734558	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700021
J	Sloan, L; Morgan, J; Burnap, P; Williams, M				Sloan, Luke; Morgan, Jeffrey; Burnap, Pete; Williams, Matthew			Who Tweets? Deriving the Demographic Characteristics of Age, Occupation and Social Class from Twitter User Meta-Data	PLOS ONE			English	Article							BEHAVIOR	This paper specifies, designs and critically evaluates two tools for the automated identification of demographic data (age, occupation and social class) from the profile descriptions of Twitter users in the United Kingdom (UK). Meta-data data routinely collected through the Collaborative Social Media Observatory (COSMOS: http://www.cosmosproject.net/) relating to UK Twitter users is matched with the occupational lookup tables between job and social class provided by the Office for National Statistics (ONS) using SOC2010. Using expert human validation, the validity and reliability of the automated matching process is critically assessed and a prospective class distribution of UK Twitter users is offered with 2011 Census baseline comparisons. The pattern matching rules for identifying age are explained and enacted following a discussion on how to minimise false positives. The age distribution of Twitter users, as identified using the tool, is presented alongside the age distribution of the UK population from the 2011 Census. The automated occupation detection tool reliably identifies certain occupational groups, such as professionals, for which job titles cannot be confused with hobbies or are used in common parlance within alternative contexts. An alternative explanation on the prevalence of hobbies is that the creative sector is overrepresented on Twitter compared to 2011 Census data. The age detection tool illustrates the youthfulness of Twitter users compared to the general UK population as of the 2011 Census according to proportions, but projections demonstrate that there is still potentially a large number of older platform users. It is possible to detect "signatures" of both occupation and age from Twitter meta-data with varying degrees of accuracy (particularly dependent on occupational groups) but further confirmatory work is needed.	[Sloan, Luke; Williams, Matthew] Cardiff Univ, Cardiff Sch Social Sci, Cardiff CF10 3AX, S Glam, Wales; [Morgan, Jeffrey; Burnap, Pete] Cardiff Univ, Cardiff Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Sloan, L (corresponding author), Cardiff Univ, Cardiff Sch Social Sci, Cardiff CF10 3AX, S Glam, Wales.	SloanLS@cardiff.ac.uk	Williams, Matthew/E-9688-2016	Williams, Matthew/0000-0003-2566-6063; Burnap, Pete/0000-0003-0396-633X	Jisc; Economic and Social Research Council [ES/J009903/1, ES/K008013/1, ES/M003329/1]; National Centre Research for Methods; High Performance Computing Wales (Scaling the Computational Analysis of "Big Social Data" & Massive Temporal Social Media Datasets); Economic and Social Research Council [ES/F035098/1] Funding Source: researchfish; ESRC [ES/F035098/1, ES/J009903/1, ES/M003329/1, ES/K008013/1] Funding Source: UKRI	Jisc; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Centre Research for Methods; High Performance Computing Wales (Scaling the Computational Analysis of "Big Social Data" & Massive Temporal Social Media Datasets); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Collaborative Online Social Media Observatory (COSMOS) has received funding for platform development from Jisc (http://www.jisc.ac.uk/whatwedo/programmes/di_research/researchtools/COSMOS.aspx), the Economic and Social Research Council (ES/J009903/1, ES/K008013/1, ES/M003329/1), the National Centre Research for Methods (http://www.ncrm.ac.uk/research/MIP/prediction.php) and High Performance Computing Wales (Scaling the Computational Analysis of "Big Social Data" & Massive Temporal Social Media Datasets). Details of all other awards associated with the project can be found on the COSMOS website (http://www.cosmosproject.net/). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland R., 2013, WEB SOCIAL SCI CONCE; anetzko D, 2014, NETNOMICS EC RES ELE, P1, DOI DOI 10.1007/S11066-014-9087-Y; ARGAMON S, 2006, TEXT INTERDISCIPLINA, V23, P321; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Bechar-Israeli H., 1995, JCMC127 J COMPUTER M, V1, DOI [10.1111/j.1083-6101.1995.tb00325, DOI 10.1111/J.1083-6101.1995.TB00325]; BIS, 2013, SEIZ DAT OPP STRAT U; Burnap P, 2015, TECHNOL FORECAST SOC, V95, P96, DOI 10.1016/j.techfore.2013.04.013; Burnap P, 2015, INT J PARALLEL EMERG, V30, P80, DOI 10.1080/17445760.2014.902057; Burnap P, 2013, INT J SOC RES METHOD, V16, P215, DOI 10.1080/13645579.2013.774174; Duggan M, 2013, DEMOGRAPHICS SOCIAL; Edwards A, 2013, INT J SOC RES METHOD, V16, P245, DOI 10.1080/13645579.2013.774185; Erikson Robert, 1992, CONSTANT FLUX; Gayo-Avello D., 2012, I WANTED PREDICT ELE; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Goldthorpe J. H., 1997, CONSTRUCTING CLASSES; Goldthorpe J. H., 2007, SOCIOLOGY, V2, P101; Grasmuck S, 2009, J COMPUT-MEDIAT COMM, V15, P158, DOI 10.1111/j.1083-6101.2009.01498.x; HESA, 2014, UK PERF IND DEF; Housley W, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714545135; Ipsos MediaCT, 2014, TECH TRACK Q REL Q3; Joinson A. N, 2003, UNDERSTANDING PSYCHO; Markham A. N, 1998, LIFE ONLINE RES REAL; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; NatCen, 2014, RES US SOC MED US VI; Noguchi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095209; ONS, 2014, NAT STAT SOC CLASS N; Papaioannou P, 2013, NETNOMICS, V14, P47, DOI 10.1007/s11066-013-9079-3; Parker M, 2010, WORLD WIDE RES RESHA; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Savage M, 2007, SOCIOLOGY, V41, P885, DOI 10.1177/0038038507080443; Savage M, 2013, SOCIOLOGY, V47, P219, DOI 10.1177/0038038513481128; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; SMITH D., 2014, MANY PEOPLE USE TOP; Steinfield C, 2014, J COMPUT-MEDIAT COMM, V19, P1; Tam D., 2012, FACEBOOK PROCESSES M; Turkle S., 1995, LIFE SCREEN IDENTITY; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Wang T, 2013, TWEET FORMER VICE PR; Williams M, 2013, COSMOS ETHICS RESOUR; Williams M., 2006, VIRTUALLY CRIMINAL C; Williams ML, 2013, POLIC SOC, V23, P461, DOI 10.1080/10439463.2013.780225	45	187	189	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115545	10.1371/journal.pone.0115545	http://dx.doi.org/10.1371/journal.pone.0115545			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JF	25729900	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000350684900005
J	Woods, DL; Doss, Z; Herron, TJ; Arbogast, T; Younus, M; Ettlinger, M; Yund, EW				Woods, David L.; Doss, Zoe; Herron, Timothy J.; Arbogast, Tanya; Younus, Masood; Ettlinger, Marc; Yund, E. William			Speech Perception in Older Hearing Impaired Listeners: Benefits of Perceptual Training	PLOS ONE			English	Article							STOP-CONSONANT RECOGNITION; WORD-RECOGNITION; NOISE; IDENTIFICATION; PERFORMANCE; DISCRIMINATION; PLASTICITY; ADULTS; ARTICULATION; COMPRESSION	Hearing aids (HAs) only partially restore the ability of older hearing impaired (OHI) listeners to understand speech in noise, due in large part to persistent deficits in consonant identification. Here, we investigated whether adaptive perceptual training would improve consonant-identification in noise in sixteen aided OHI listeners who underwent 40 hours of computer-based training in their homes. Listeners identified 20 onset and 20 coda consonants in 9,600 consonant-vowel-consonant (CVC) syllables containing different vowels (/alpha/, /i/, or /u/) and spoken by four different talkers. Consonants were presented at three consonant-specific signal-to-noise ratios (SNRs) spanning a 12 dB range. Noise levels were adjusted over training sessions based on d' measures. Listeners were tested before and after training to measure (1) changes in consonant-identification thresholds using syllables spoken by familiar and unfamiliar talkers, and (2) sentence reception thresholds (SeRTs) using two different sentence tests. Consonant-identification thresholds improved gradually during training. Laboratory tests of d' thresholds showed an average improvement of 9.1 dB, with 94% of listeners showing statistically significant training benefit. Training normalized consonant confusions and improved the thresholds of some consonants into the normal range. Benefits were equivalent for onset and coda consonants, syllables containing different vowels, and syllables presented at different SNRs. Greater training benefits were found for hard-to-identify consonants and for consonants spoken by familiar than unfamiliar talkers. SeRTs, tested with simple sentences, showed less elevation than consonant-identification thresholds prior to training and failed to show significant training benefit, although SeRT improvements did correlate with improvements in consonant thresholds. We argue that the lack of SeRT improvement reflects the dominant role of top-down semantic processing in processing simple sentences and that greater transfer of benefit would be evident in the comprehension of more unpredictable speech material.	[Woods, David L.; Doss, Zoe; Herron, Timothy J.; Arbogast, Tanya; Younus, Masood; Ettlinger, Marc; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587	VA Research Service grant [1I01CX000583]; Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	VA Research Service grant; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by VA Research Service grant 1I01CX000583 to DLW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the agencies.	Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Ahlstrom JB, 2014, EAR HEARING, V35, P72, DOI 10.1097/AUD.0b013e3182a02274; Ahlstrom JB, 2009, EAR HEARING, V30, P203, DOI 10.1097/AUD.0b013e31819769c1; Alexander JM, 2009, J SPEECH LANG HEAR R, V52, P653, DOI 10.1044/1092-4388(2008/08-0038); Benichov J, 2012, EAR HEARING, V33, P262, DOI 10.1097/AUD.0b013e31822f680f; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Boothroyd A, 2010, J AM ACAD AUDIOL, V21, P601, DOI 10.3766/jaaa.21.9.6; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Burk MH, 2008, J SPEECH LANG HEAR R, V51, P759, DOI 10.1044/1092-4388(2008/054); Burk MH, 2007, J SPEECH LANG HEAR R, V50, P25, DOI 10.1044/1092-4388(2007/003); Burk MH, 2006, EAR HEARING, V27, P263, DOI 10.1097/01.aud.0000215980.21158.a2; Coez A, 2010, NEUROPSYCHOLOGIA, V48, P3057, DOI 10.1016/j.neuropsychologia.2010.06.016; Cox R M, 2001, J Am Acad Audiol, V12, P423; DUBNO JR, 1989, J ACOUST SOC AM, V85, P355, DOI 10.1121/1.397687; DUBNO JR, 1989, J ACOUST SOC AM, V85, P347, DOI 10.1121/1.397686; Dubno JR, 2013, AM J AUDIOL, V22, P335, DOI 10.1044/1059-0889(2013/12-0080); Eckman FR, 2003, SECOND LANG RES, V19, P169, DOI 10.1191/0267658303sr2190a; Ferguson MA, 2014, EAR HEARING, V35, pE110, DOI 10.1097/AUD.0000000000000020; Fu QJ, 2005, ACOUST RES LETT ONL, V6, P106, DOI 10.1121/1.1898345; Gold JR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00110; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; GORDONSALANT S, 1987, EAR HEARING, V8, P270, DOI 10.1097/00003446-198710000-00003; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hedrick MS, 1997, J SPEECH LANG HEAR R, V40, P1445, DOI 10.1044/jslhr.4006.1445; Henshaw H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062836; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; Humes LE, 2014, J ACOUST SOC AM, V136, pEL224, DOI 10.1121/1.4890663; Humes LE, 2009, EAR HEARING, V30, P613, DOI 10.1097/AUD.0b013e3181b00d90; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kuchinsky SE, 2014, PSYCHOPHYSIOLOGY; Kuk F, 2010, EAR HEARING, V31, P779, DOI 10.1097/AUD.0b013e3181e97bfb; Marriage JE, 2003, INT J AUDIOL, V42, P418, DOI 10.3109/14992020309080051; Miller James D, 2008, Hear J, V61, P29; Miller James D, 2008, Proc Meet Acoust, V2, P1; Moreno S, 2014, HEARING RES, V308, P84, DOI 10.1016/j.heares.2013.09.012; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oba SI, 2011, EAR HEAR; Olson AD, 2013, J AM ACAD AUDIOL, V24, P214, DOI 10.3766/jaaa.24.3.7; Phatak SA, 2009, J ACOUST SOC AM, V126, P2683, DOI 10.1121/1.3238257; Pichora-Fuller MK, 2012, AM J AUDIOL, V21, P351, DOI 10.1044/1059-0889(2012/12-0025); Pisoni David, 1997, TALKER VARIABILITY S, P9; Port RF, 2005, LANGUAGE, V81, P927, DOI 10.1353/lan.2005.0195; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reed Charlotte M, 2009, Trends Amplif, V13, P4, DOI 10.1177/1084713808325412; REVOILE SG, 1985, J ACOUST SOC AM, V77, P1263, DOI 10.1121/1.392199; Saripella R, 2011, J ACOUST SOC AM, V130, P3028, DOI 10.1121/1.3641407; Saunders GH, 2010, NCRAR SEMINAR SERIES; SCHWARTZ DM, 1979, J SPEECH HEAR DISORD, V44, P61, DOI 10.1044/jshd.4401.61; Stecker GC, 2006, J REHABIL RES DEV, V43, P537, DOI 10.1682/JRRD.2005.11.0171; Stewart R, 2009, J AM ACAD AUDIOL, V20, P147, DOI 10.3766/jaaa.20.2.7; Strelcyk O, 2013, J ACOUST SOC AM, V133, P1598, DOI 10.1121/1.4789894; Sweetow RW, 2006, J AM ACAD AUDIOL, V17, P538, DOI 10.3766/jaaa.17.8.2; Turner Christopher W, 2006, Audiol Neurootol, V11 Suppl 1, P2, DOI 10.1159/000095606; Watson Charles S, 2008, Hear J, V61, P26; Whittaker J., 1990, GRAPHICAL MODELS APP; Whitton JP, 2014, P NATL ACAD SCI USA, V111, pE2606, DOI 10.1073/pnas.1322184111; Wilson RH, 2003, J REHABIL RES DEV, V40, P329, DOI 10.1682/JRRD.2003.07.0329; Woods DL, 2012, J REHABIL RES DEV, V49, P1277, DOI 10.1682/JRRD.2011.08.0150; Woods DL, 2010, J REHABIL RES DEV, V47, P243, DOI 10.1682/JRRD.2009.04.0040; Woods DL, 2010, J ACOUST SOC AM, V127, P1609, DOI 10.1121/1.3293005; Woods DL, 2014, PLOS ONE IN PRESS; Yund EW, 2010, EAR HEARING, V31, P769, DOI 10.1097/AUD.0b013e3181e68e4a	64	13	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0113965	10.1371/journal.pone.0113965	http://dx.doi.org/10.1371/journal.pone.0113965			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JF	25730330	Green Published, gold, Green Submitted			2022-12-26	WOS:000350684900002
J	Mukherjee, S; Kim, J; Mooren, OL; Shahan, ST; Cohan, M; Cooper, JA				Mukherjee, Suranjana; Kim, Joanna; Mooren, Olivia L.; Shahan, Stefanie T.; Cohan, Megan; Cooper, John A.			Role of Cortactin Homolog HS1 in Transendothelial Migration of Natural Killer Cells	PLOS ONE			English	Article							ARP2/3 COMPLEX; PROTEIN; ADHESION; PHOSPHORYLATION; ACTIVATION; MECHANISMS; INTERACTS; RAC	Natural Killer (NK) cells perform many functions that depend on actin assembly, including adhesion, chemotaxis, lytic synapse assembly and cytolysis. HS1, the hematopoietic homolog of cortactin, binds to Arp2/3 complex and promotes actin assembly by helping to form and stabilize actin filament branches. We investigated the role of HS1 in transendothelial migration (TEM) by NK cells. Depletion of HS1 led to a decrease in the efficiency of TEM by NK cells, as measured by transwell assays with endothelial cell monolayers on porous filters. Transwell assays involve chemotaxis of NK cells across the filter, so to examine TEM more specifically, we imaged live-cell preparations and antibody-stained fixed preparations, with and without the chemoattractant SDF-1 alpha. We found small to moderate effects of HS1 depletion on TEM, including whether the NK cells migrated via the transcellular or paracellular route. Expression of HS1 mutants indicated that phosphorylation of HS1 tyrosines at positions 222, 378 and 397 was required for rescue in the transwell assay, but HS1 mutations affecting interaction with Arp2/3 complex or SH3-domain ligands had no effect. The GEF Vav1, a ligand of HS1 phosphotyrosine, influenced NK cell transendothelial migration. HS1 and Vav1 also affected the speed of NK cells migrating across the surface of the endothelium. We conclude that HS1 has a role in transendothelial migration of NK cells and that HS1 tyrosine phosphorylation may signal through Vav1.	[Mukherjee, Suranjana; Kim, Joanna; Mooren, Olivia L.; Shahan, Stefanie T.; Cohan, Megan; Cooper, John A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Cooper, JA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	jcooper@wustl.edu	Kim, Joanna/U-5556-2018; Cooper, John/D-4448-2014	Kim, Joanna/0000-0001-7877-9446; Cooper, John/0000-0002-0933-4571	National Institutes of Health [GM38542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM38542 to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAVENA P, 1991, J EXP MED, V173, P439, DOI 10.1084/jem.173.2.439; BIANCHI G, 1993, J IMMUNOL, V151, P5135; Brunati AM, 1999, J BIOL CHEM, V274, P7557, DOI 10.1074/jbc.274.11.7557; Burke TA, 2014, CURR BIOL, V24, P579, DOI 10.1016/j.cub.2014.01.072; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Butler B, 2009, CURR BIOL, V19, P1886, DOI 10.1016/j.cub.2009.10.029; Cavnar PJ, 2012, J BIOL CHEM, V287, P25466, DOI 10.1074/jbc.M112.364562; Dehring DAK, 2011, J IMMUNOL, V186, P4805, DOI 10.4049/jimmunol.1003102; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Galletta BJ, 2012, BIOPHYS J, V103, P2145, DOI 10.1016/j.bpj.2012.10.009; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kos FJ, 1998, IMMUNOL RES, V17, P303, DOI 10.1007/BF02786453; Lettau M, 2015, EUR J IMMUNOL, V45, P551, DOI 10.1002/eji.201444473; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lotze M.T., 2009, NATURAL KILLER CELLS; Martinez-Quiles N, 2013, OA IMMUNOLOGY, V1, P2; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Murphy K, 2017, JANEWAY'S IMMUNOBIOLOGY, 9TH EDITION, P37; Onken MD, 2014, CYTOSKELETON; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Sirotkin V, 2011, CURR BIOL, V21, pR552, DOI 10.1016/j.cub.2011.06.029; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Smith BA, 2013, P NATL ACAD SCI USA, V110, P1285, DOI 10.1073/pnas.1211164110; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Timonen T, 1997, J LEUKOCYTE BIOL, V62, P693, DOI 10.1002/jlb.62.6.693; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wittchen ES, 2005, CURR OPIN HEMATOL, V12, P14, DOI 10.1097/01.moh.0000147892.83713.a7; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387	36	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118153	10.1371/journal.pone.0118153	http://dx.doi.org/10.1371/journal.pone.0118153			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723543	Green Published, Green Submitted, gold			2022-12-26	WOS:000350251200046
J	Zhu, G; Fan, Z; Ding, M; Zhang, H; Mu, L; Ding, Y; Zhang, Y; Jia, B; Chen, L; Chang, Z; Wu, W				Zhu, G.; Fan, Z.; Ding, M.; Zhang, H.; Mu, L.; Ding, Y.; Zhang, Y.; Jia, B.; Chen, L.; Chang, Z.; Wu, W.			An EGFR/PI3K/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis	ONCOGENE			English	Article							EXCHANGE FACTOR TIAM1; RAC ACTIVATOR TIAM1; GROWTH-FACTOR; RHO-GTPASES; 14-3-3 PROTEINS; BREAST-CANCER; MOLECULAR-BASIS; INVASION; KINASES; GEF	Epidermal growth factor receptor (EGFR) signaling regulates cell growth and survival, and its overactivation drives cancer development. One important branch of EGFR signaling is through activation of GTPase Rac1, which further promotes cell proliferation, survival and cancer metastasis. Here, we show that EGFR activates Rac1 via inducing the accumulation of its specific guanine nucleotide exchange factor, T-cell lymphoma invasion and metastasis 1 (Tiam1) in non-small-cell lung cancer and colon cancer cells. Conversely, elevated Tiam1 is required for EGFR-induced tumorigenesis. In human lung adenocarcinoma and colon cancer specimens, Tiam1 expression strongly correlates with EGFR expression. We further reveal that AKT, a key downstream protein kinase of EGFR, phosphorylates Tiam1 at several consensus sites, facilitates the interaction of Tiam1 with scaffold proteins 14-3-3 and leads to an increase of Tiam1 stability. Subsequently, Tiam1 is dephosporylated and destabilized by PP2A. Together, our study identifies a bidirectional (phosphorylation and dephosphorylation) regulatory mechanism controlling Tiam1 stability and provides new insights on how EGFR signaling triggers Rac1 activation and cancer development.	[Zhu, G.; Fan, Z.; Mu, L.; Ding, Y.; Wu, W.] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhu, G.] Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Ding, M.] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Zhang, H.; Mu, L.; Chen, L.] Natl Inst Biol Sci, Beijing, Peoples R China; [Zhang, Y.; Chang, Z.] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Jia, B.] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing 100853, Peoples R China; [Jia, B.] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing 100853, Peoples R China	Tsinghua University; Tsinghua University; Peking University; National Institute of Biological Sciences, Beijing; Tsinghua University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Wu, W (corresponding author), Tsinghua Univ, Sch Life Sci, Qinghuayuan 1, Beijing 100084, Peoples R China.	wwu@mail.tsinghua.edu.cn	Chang, Zhijie/AAH-8109-2019; Zhang, Yanquan/D-5615-2017	Zhang, Yanquan/0000-0003-3527-9972; Chen, Liang/0000-0001-7300-6604	National Natural Science Foundation of China [31221064, 81272235]; Tsinghua-Peking Center for Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences	We thank Drs Ye-Guang Chen, John G. Collard, Chuanmao Zhang, Joseph R Testa and Yigong Shi for providing plasmids and reagents. We are grateful for Dr Haiteng Deng and Jieyuan Liu for mass spectrometry analysis. This work was supported by grants to WW from the National Natural Science Foundation of China (31221064 and 81272235). GZ is a postdoctoral fellow supported by Tsinghua-Peking Center for Life Sciences.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Arai A, 2005, CELL SIGNAL, V17, P497, DOI 10.1016/j.cellsig.2004.09.007; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Habas R, 2006, METHOD ENZYMOL, V406, P500, DOI 10.1016/S0076-6879(06)06038-1; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hofbauer SW, 2014, BLOOD, V123, P2181, DOI 10.1182/blood-2013-08-523563; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karpel-Massler G, 2013, MOL CANCER THER, V12, P1783, DOI 10.1158/1535-7163.MCT-13-0052; Kobayashi H, 2011, J BIOL CHEM, V286, P39259, DOI 10.1074/jbc.M111.255489; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Ramis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038770; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Steiner P, 2007, CLIN CANCER RES, V13, P1540, DOI 10.1158/1078-0432.CCR-06-1887; Strumane K, 2009, J CANCER RES CLIN, V135, P69, DOI 10.1007/s00432-008-0437-8; Su XN, 2014, GENE DEV, V28, P622, DOI 10.1101/gad.233239.113; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Viaud J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5080; Vlacich G, 2011, CANCER CELL, V20, P423, DOI 10.1016/j.ccr.2011.10.006; Wang L, 2013, J CELL SCI, V126, P1531, DOI 10.1242/jcs.124255; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294; Zhu GX, 2014, J BIOL CHEM, V289, P15482, DOI 10.1074/jbc.M114.553388	61	63	64	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2015	34	49					5971	5982		10.1038/onc.2015.45	http://dx.doi.org/10.1038/onc.2015.45			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RO	25746002				2022-12-26	WOS:000366113500004
J	Novoa, EM; Vargas-Rodriguez, O; Lange, S; Goto, Y; Suga, H; Musier-Forsyth, K; de Pouplana, LR				Maria Novoa, Eva; Vargas-Rodriguez, Oscar; Lange, Stefanie; Goto, Yuki; Suga, Hiroaki; Musier-Forsyth, Karin; Ribas de Pouplana, Lluis			Ancestral AlaX Editing Enzymes for Control of Genetic Code Fidelity Are Not tRNA-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthetase; phylogenetics; Protein Evolution; RNA Editing; tRNA; AlaX; Genetic Code; Mistranslation; Proofreading	ESCHERICHIA-COLI; QUALITY-CONTROL; IN-VIVO; SYNTHETASE; DOMAIN; AMINOACYLATION; MISTRANSLATION; RECOGNITION; PROTEIN; MECHANISM	Background: Both AlaRS editing domains and their free-standing editing forms, AlaX, are thought to exclusively deacylate mischarged tRNA(Ala). Results: Contrary to this belief, we find that AlaX-S deacylates Ser-tRNA(Ala) and Ser-tRNA(Thr). Conclusion: AlaX-S is likely to be the ancestor of AlaX, AlaRS editing, and bacterial-like ThrRS editing domains. Significance: The biochemical activities of AlaX-S link, for the first time, the activities of the AlaRS and ThrRS editing domains. Accurate protein synthesis requires the hydrolytic editing of tRNAs incorrectly aminoacylated by aminoacyl-tRNA synthetases (ARSs). Recognition of cognate tRNAs by ARS is less error-prone than amino acid recognition, and, consequently, editing domains are generally believed to act only on the tRNAs cognate to their related ARSs. For example, the AlaX family of editing domains, including the editing domain of alanyl-tRNA synthetase and the related free-standing trans-editing AlaX enzymes, are thought to specifically act on tRNA(Ala), whereas the editing domains of threonyl-tRNA synthetases are specific for tRNA(Thr). Here we show that, contrary to this belief, AlaX-S, the smallest of the extant AlaX enzymes, deacylates Ser-tRNA(Thr) in addition to Ser-tRNA(Ala) and that a single residue is important to determine this behavior. Our data indicate that promiscuous forms of AlaX are ancestral to tRNA-specific AlaXs. We propose that former AlaX domains were used to maintain translational fidelity in earlier stages of genetic code evolution when mis-serylation of several tRNAs was possible.	[Maria Novoa, Eva; Lange, Stefanie; Ribas de Pouplana, Lluis] Inst Res Biomed, Barcelona 08028, Catalonia, Spain; [Vargas-Rodriguez, Oscar; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA; [Goto, Yuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 1130033, Japan; [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies, Barcelona 08010, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University System of Ohio; Ohio State University; University of Tokyo; ICREA	de Pouplana, LR (corresponding author), Inst Res Biomed, C Baldiri Reixac 10, Barcelona 08028, Catalonia, Spain.	lluis.ribas@irbbarcelona.org	de Pouplana, Lluis Ribas/AAA-4738-2019; Novoa, Eva Maria/B-1004-2015; Novoa, Eva Maria/B-1004-2015	de Pouplana, Lluis Ribas/0000-0002-2087-0359; Novoa, Eva Maria/0000-0002-9367-6311; Vargas-Rodriguez, Oscar/0000-0002-2301-2800; Novoa, Eva Maria/0000-0001-5567-1299	National Institutes of Health [R01 GM049928]; Spanish Ministry of Education and Science [BIO2009-09776]; La Caixa/IRB international Ph.D. program fellowship; EMBO long-term postdoctoral fellowship; HFSP postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113656, R01GM049928] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); La Caixa/IRB international Ph.D. program fellowship; EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); HFSP postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM049928 (to K. M. F.). This work was also supported by Grant BIO2009-09776 (to L. R. d. P.) from the Spanish Ministry of Education and Science.; Supported by a La Caixa/IRB international Ph.D. program fellowship, an EMBO long-term postdoctoral fellowship, and an HFSP postdoctoral fellowship.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; Amirnovin R, 1997, J MOL EVOL, V44, P473, DOI 10.1007/PL00006170; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; Beebe K, 2004, P NATL ACAD SCI USA, V101, P5958, DOI 10.1073/pnas.0401530101; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; Das M, 2014, NUCLEIC ACIDS RES, V42, P3943, DOI 10.1093/nar/gkt1332; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Eddy Sean R, 2009, Genome Inform, V23, P205; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; Geslain R, 2004, TRENDS GENET, V20, P604, DOI 10.1016/j.tig.2004.09.012; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Huang Q, 2012, NUCLEIC ACIDS RES, V40, P10463, DOI 10.1093/nar/gks783; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ishijima J, 2006, PROTEINS, V62, P1133, DOI 10.1002/prot.20760; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; Murakami Hiroshi, 2006, Nucleic Acids Symp Ser (Oxf), P35, DOI 10.1093/nass/nrl018; Naganuma M, 2014, NATURE, V510, P507, DOI 10.1038/nature13440; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Ronneberg TA, 2000, P NATL ACAD SCI USA, V97, P13690, DOI 10.1073/pnas.250403097; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; Schimmel P, 2001, COLD SPRING HARB SYM, V66, P161, DOI 10.1101/sqb.2001.66.161; Schimmel P, 2011, PHILOS T R SOC B, V366, P2965, DOI 10.1098/rstb.2011.0158; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Torres-Larios A, 2002, NAT STRUCT BIOL, V9, P343, DOI 10.1038/nsb789; Vargas-Rodriguez O, 2013, J BIOL CHEM, V288, P14391, DOI 10.1074/jbc.M113.467795; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P1546, DOI 10.1073/pnas.54.6.1546; Yao P, 2008, NUCLEIC ACIDS RES, V36, P2728, DOI 10.1093/nar/gkn028	58	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10495	10503		10.1074/jbc.M115.640060	http://dx.doi.org/10.1074/jbc.M115.640060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724653	Green Published, hybrid			2022-12-26	WOS:000353241100048
J	Melero, R; Moro, F; Perez-Calvo, MA; Perales-Calvo, J; Quintana-Gallardo, L; Llorca, O; Muga, A; Valpuesta, JM				Melero, Roberto; Moro, Fernando; Angeles Perez-Calvo, Maria; Perales-Calvo, Judit; Quintana-Gallardo, Lucia; Llorca, Oscar; Muga, Arturo; Maria Valpuesta, Jose			Modulation of the Chaperone DnaK Allosterism by the Nucleotide Exchange Factor GrpE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-Kilodalton Heat Shock Protein (Hsp70); Chaperone; Chaperone DnaK (DnaK); Electron Microscopy (EM); Protein Folding; GrpE; Nucleotide Exchange Factor	ELECTRON-MICROSCOPY; HSP70 CHAPERONES; ATPASE DOMAIN; CELLULAR FUNCTIONS; CRYSTAL-STRUCTURE; BINDING; SUBSTRATE; CONFORMATION; SYSTEM; COMMUNICATION	Hsp70 chaperones comprise two domains, the nucleotide-binding domain (Hsp70(NBD)), responsible for structural and functional changes in the chaperone, and the substrate-binding domain (Hsp70(SBD)), involved in substrate interaction. Substrate binding and release in Hsp70 is controlled by the nucleotide state of DnaK(NBD), with ATP inducing the open, substrate-receptive DnaK(SBD) conformation, whereas ADP forces its closure. DnaK cycles between the two conformations through interaction with two cofactors, the Hsp40 co-chaperones (DnaJ in Escherichia coli) induce the ADP state, and the nucleotide exchange factors (GrpE in E. coli) induce the ATP state. X-ray crystallography showed that the GrpE dimer is a nucleotide exchange factor that works by interaction of one of its monomers with DnaK(NBD). DnaK(SBD) location in this complex is debated; there is evidence that it interacts with the GrpE N-terminal disordered region, far from DnaK(NBD). Although we confirmed this interaction using biochemical and biophysical techniques, our EM-based three-dimensional reconstruction of the DnaK-GrpE complex located DnaK(SBD) near DnaK(NBD). This apparent discrepancy between the functional and structural results is explained by our finding that the tail region of the GrpE dimer in the DnaK-GrpE complex bends and its tip contacts DnaK(SBD), whereas the DnaK(NBD)-DnaK(SBD) linker contacts the GrpE helical region. We suggest that these interactions define a more complex role for GrpE in the control of DnaK function.	[Melero, Roberto; Llorca, Oscar] Ctr Invest Biol CIB CSIC, Madrid 28040, Spain; [Moro, Fernando; Perales-Calvo, Judit; Muga, Arturo] Univ Basque Country, Fac Ciencias & Tecnol, Unidad Biofis CSIC UPV EHU, E-48080 Bilbao, Spain; [Moro, Fernando; Perales-Calvo, Judit; Muga, Arturo] Univ Basque Country, Fac Ciencias & Tecnol, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain; [Angeles Perez-Calvo, Maria; Quintana-Gallardo, Lucia; Maria Valpuesta, Jose] Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Llorca, O (corresponding author), Ramiro de Maeztu 9, Madrid 28040, Spain.	ollorca@cib.csic.es; arturo.muga@ehu.es; jmv@cnb.csic.es	Llorca, Oscar/K-1144-2014; Valpuesta, Jose M/AAA-6002-2019; Moro Pérez, Fernando/P-3891-2015; Valpuesta, José M/T-1977-2017; Muga, Arturo/N-1174-2014; Llorca, Oscar/P-2784-2019; Melero, Roberto/J-8780-2014	Llorca, Oscar/0000-0001-5705-0699; Moro Pérez, Fernando/0000-0002-3568-3388; Valpuesta, José M/0000-0001-7468-8053; Muga, Arturo/0000-0003-0345-6882; Llorca, Oscar/0000-0001-5705-0699; Melero, Roberto/0000-0001-9467-9381	Spanish Ministry of Economy and Innovation [BFU2013-44202, SAF2011-22988, BFU2013-47059]; Madrid Regional Government [S2013/MIT-2807, S2010/BMD-2316]; Basque Government [IT709-13]; Juan de la Cierva contract [JCI-2011-09536]	Spanish Ministry of Economy and Innovation(Spanish Government); Madrid Regional Government; Basque Government(Basque Government); Juan de la Cierva contract	This work was supported in part by Spanish Ministry of Economy and Innovation Grants BFU2013-44202 (to J. M. V.), SAF2011-22988 (to O. L.), and BFU2013-47059 (to A. M.), Madrid Regional Government Grants S2013/MIT-2807 (to J. M. V.) and S2010/BMD-2316 (to O. L.), and Basque Government Grant IT709-13 (to A. M.).; Recipient of Juan de la Cierva contract JCI-2011-09536.	Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chesnokova LS, 2003, BIOCHEMISTRY-US, V42, P9028, DOI 10.1021/bi0346493; Gelinas AD, 2003, BIOCHEMISTRY-US, V42, P9050, DOI 10.1021/bi034416b; Grimshaw JPA, 2001, J BIOL CHEM, V276, P6098, DOI 10.1074/jbc.M009290200; Groemping Y, 2001, J MOL BIOL, V305, P1173, DOI 10.1006/jmbi.2000.4373; Han WJ, 2003, BIOCHEM J, V369, P627, DOI 10.1042/BJ20020943; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Horst M, 1996, PROTEIN SCI, V5, P759; Kabani M, 2009, PROTEIN PEPTIDE LETT, V16, P623, DOI 10.2174/092986609788490186; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moro F, 2007, J MOL BIOL, V374, P1054, DOI 10.1016/j.jmb.2007.10.002; Muga A, 2008, CURR PROTEIN PEPT SC, V9, P552, DOI 10.2174/138920308786733903; Nakamura A, 2010, J MOL BIOL, V396, P1000, DOI 10.1016/j.jmb.2009.12.028; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Lopez-Blanco JR, 2013, J STRUCT BIOL, V184, P261, DOI 10.1016/j.jsb.2013.08.010; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2009, J STRUCT BIOL, V166, P234, DOI 10.1016/j.jsb.2009.02.007; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Taneva SG, 2010, BIOCHEMISTRY-US, V49, P1338, DOI 10.1021/bi901847q; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wu CC, 2012, J BIOL CHEM, V287, P21461, DOI 10.1074/jbc.M112.344358; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zahn M, 2013, J MOL BIOL, V425, P2463, DOI 10.1016/j.jmb.2013.03.041	42	18	18	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10083	10092		10.1074/jbc.M114.623371	http://dx.doi.org/10.1074/jbc.M114.623371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739641	hybrid, Green Published			2022-12-26	WOS:000353241100015
J	Acharya, D; Mukherjee, D; Podder, S; Ghosh, TC				Acharya, Debarun; Mukherjee, Dola; Podder, Soumita; Ghosh, Tapash C.			Investigating Different Duplication Pattern of Essential Genes in Mouse and Human	PLOS ONE			English	Article							PROTEIN CONNECTIVITY; EVOLUTIONARY RATES; DUPLICABILITY; COMPLEXITY	Gene duplication is one of the major driving forces shaping genome and organism evolution and thought to be itself regulated by some intrinsic properties of the gene. Comparing the essential genes among mouse and human, we observed that the essential genes avoid duplication in mouse while prefer to remain duplicated in humans. In this study, we wanted to explore the reasons behind such differences in gene essentiality by cross-species comparison of human and mouse. Moreover, we examined essential genes that are duplicated in humans are functionally more redundant than that in mouse. The proportion of paralog pseudogenization of essential genes is higher in mouse than that of humans. These duplicates of essential genes are under stringent dosage regulation in human than in mouse. We also observed slower evolutionary rate in the paralogs of human essential genes than the mouse counterpart. Together, these results clearly indicate that human essential genes are retained as duplicates to serve as backed up copies that may shield themselves from harmful mutations.	[Acharya, Debarun; Mukherjee, Dola; Podder, Soumita; Ghosh, Tapash C.] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Ghosh, TC (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	tapash@jcbose.ac.in	Acharya, Debarun/AAV-7259-2021	Acharya, Debarun/0000-0001-5609-9888; Mukherjee, Dola/0000-0003-3286-1473	University Grants Commission (UGC) [F.2-8/2002 (SA-I)]	University Grants Commission (UGC)(University Grants Commission, India)	Funding from University Grants Commission (UGC) Sanction Letter No. F.2-8/2002 (SA-I) dated 04.10.2012, received by DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baudot A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r76; Bhattacharya T, 2010, DNA RES, V17, P261, DOI 10.1093/dnares/dsq019; Chen WH, 2012, MOL BIOL EVOL, V29, P1703, DOI 10.1093/molbev/mss014; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; CLARK AG, 1994, P NATL ACAD SCI USA, V91, P2950, DOI 10.1073/pnas.91.8.2950; D'Antonio M, 2011, PLOS COMPUT BIOL, V7, DOI [10.1371/journal.pcbi.1002028, DOI 10.1371/JOURNAL.PCBI.1002028]; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; He XL, 2006, MOL BIOL EVOL, V23, P144, DOI 10.1093/molbev/msj015; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liang H, 2009, TRENDS GENET, V25, P441, DOI 10.1016/j.tig.2009.08.001; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Lynch M, 2000, GENETICS, V154, P459; Makino T, 2006, GENE, V385, P57, DOI 10.1016/j.gene.2006.06.028; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, EVOLUTION GENE DUPLI; STEPHENS SG, 1951, ADV GENET, V4, P247, DOI 10.1016/S0065-2660(08)60237-0; Su ZX, 2008, J MOL EVOL, V67, P705, DOI 10.1007/s00239-008-9170-9; Waterhouse RM, 2011, GENOME BIOL EVOL, V3, P75, DOI 10.1093/gbe/evq083; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100; Yang J, 2003, MOL BIOL EVOL, V20, P772, DOI 10.1093/molbev/msg078; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0120784	10.1371/journal.pone.0120784	http://dx.doi.org/10.1371/journal.pone.0120784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751152	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700037
J	Mader, A; von Bronk, B; Ewald, B; Kesel, S; Schnetz, K; Frey, E; Opitz, M				Mader, Andreas; von Bronk, Benedikt; Ewald, Benedikt; Kesel, Sara; Schnetz, Karin; Frey, Erwin; Opitz, Madeleine			Amount of Colicin Release in Escherichia coli Is Regulated by Lysis Gene Expression of the Colicin E2 Operon	PLOS ONE			English	Article							BINDING PROTEIN CSRA; K ACTIVITY GENE; CRYSTAL-STRUCTURE; MITOMYCIN-C; SOS; BACTERIOCINS; EVOLUTION; TRANSCRIPTION; BIODIVERSITY; REPRESSION	The production of bacteriocins in response to worsening environmental conditions is one means of bacteria to outcompete other microorganisms. Colicins, one class of bacteriocins in Escherichia coli, are effective against closely related Enterobacteriaceae. Current research focuses on production, release and uptake of these toxins by bacteria. However, little is known about the quantitative aspects of these dynamic processes. Here, we quantitatively study expression dynamics of the Colicin E2 operon in E. coli on a single cell level using fluorescence time-lapse microscopy. DNA damage, triggering SOS response leads to the heterogeneous expression of this operon including the cea gene encoding the toxin, Colicin E2, and the cel gene coding for the induction of cell lysis and subsequent colicin release. Advancing previous whole population investigations, our time-lapse experiments reveal that at low exogenous stress levels all cells eventually respond after a given time (heterogeneous timing). This heterogeneous timing is lost at high stress levels, at which a synchronized stress response of all cells 60 min after induction via stress can be observed. We further demonstrate, that the amount of colicin released is dependent on cel (lysis) gene expression, independent of the applied exogenous stress level. A heterogeneous response in combination with heterogeneous timing can be biologically significant. It might enable a bacterial population to endure low stress levels, while at high stress levels an immediate and synchronized population wide response can give single surviving cells of the own species the chance to take over the bacterial community after the stress has ceased.	[Mader, Andreas; von Bronk, Benedikt; Ewald, Benedikt; Kesel, Sara; Opitz, Madeleine] Univ Munich, Fac Phys, Ctr NanoSci, Munich, Germany; [Schnetz, Karin] Univ Cologne, Inst Genet, Cologne, Germany; [Frey, Erwin] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany; [Frey, Erwin] Univ Munich, Ctr NanoSci, Dept Phys, Munich, Germany	University of Munich; University of Cologne; University of Munich; University of Munich	Opitz, M (corresponding author), Univ Munich, Fac Phys, Ctr NanoSci, Geschwister Scholl Pl 1, Munich, Germany.	opitz@physik.uni-muenchen.de	Frey, Erwin/M-2613-2017	Frey, Erwin/0000-0001-8792-3358; Schnetz, Karin/0000-0003-4693-6202	DFG [LE 2484/4-1, FR 850/10-1, SPP 1617]; Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	DFG(German Research Foundation (DFG)); Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	This work was supported by DFG grant LE 2484/4-1 and FR 850/10-1 part of the SPP 1617, the Nano Initiative Munich (NIM) and the Center for Nanoscience (CeNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chak KF, 1996, P NATL ACAD SCI USA, V93, P6437, DOI 10.1073/pnas.93.13.6437; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; COLE ST, 1985, MOL GEN GENET, V198, P465, DOI 10.1007/BF00332940; Cursino L, 2002, BRAZ J MICROBIOL, V33, P185, DOI 10.1590/S1517-83822002000300001; Davidov Y, 2000, MUTAT RES-GEN TOX EN, V466, P97, DOI 10.1016/S1383-5718(99)00233-8; Dekker N, 1999, J BACTERIOL, V181, P3281, DOI 10.1128/JB.181.10.3281-3283.1999; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; DURKACZ BW, 1974, J BACTERIOL, V117, P940, DOI 10.1128/JB.117.3.940-946.1974; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Edelstein A., 2010, CURRENT PROTOCOLS MO; FRANK SA, 1994, EVOL ECOL, V8, P369, DOI 10.1007/BF01238189; Ghazaryan L, 2014, ANTON LEEUW INT J G, P1; Ghazaryan L, 2014, ANTON LEEUW INT J G, V105, P823, DOI 10.1007/s10482-014-0136-1; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; HARDY KG, 1972, J BACTERIOL, V112, P1007, DOI 10.1128/JB.112.2.1007-1009.1972; HARDY KG, 1974, MOL GEN GENET, V131, P313, DOI 10.1007/BF00264862; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; HERSCHMAN HR, 1967, J BACTERIOL, V94, P691, DOI 10.1128/JB.94.3.691-699.1967; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; James R, 1996, MICROBIOL-SGM, V142, P1569, DOI 10.1099/13500872-142-7-1569; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kamensek S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-283; Keller KL, 2001, MUTAT RES-DNA REPAIR, V486, P21, DOI 10.1016/S0921-8777(01)00077-5; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Ko TP, 1999, STRUCT FOLD DES, V7, P91, DOI 10.1016/S0969-2126(99)80012-4; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Mrak P, 2007, MOL GENET GENOMICS, V277, P391, DOI 10.1007/s00438-006-0185-x; Mulec J, 2003, J BACTERIOL, V185, P654, DOI 10.1128/JB.185.2.654-659.2003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; OZEKI H, 1959, NATURE, V184, P337, DOI 10.1038/184337a0; PUGSLEY AP, 1981, J BACTERIOL, V147, P186, DOI 10.1128/JB.147.1.186-192.1981; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P2673; PUGSLEY AP, 1983, MOL GEN GENET, V190, P379, DOI 10.1007/BF00331062; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; RILEY MA, 1993, MOL BIOL EVOL, V10, P1048; Riley MA, 1996, J IND MICROBIOL, V17, P151, DOI 10.1007/BF01574688; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; TYLER J, 1975, MOL GEN GENET, V140, P349, DOI 10.1007/BF00267325; vanderWal FJ, 1995, FEMS MICROBIOL REV, V17, P381, DOI 10.1016/0168-6445(95)00022-4; WATSON R, 1980, GENE, V10, P307, DOI 10.1016/0378-1119(80)90151-1; Weber MF, 2014, JOURNAL OF THE ROYAL, V11; Weng MW, 2010, NUCLEIC ACIDS RES, V38, P6976, DOI 10.1093/nar/gkq576; Wojdyla JA, 2012, J MOL BIOL, V417, P79, DOI 10.1016/j.jmb.2012.01.019; Yakhnin H, 2011, MOL MICROBIOL, V81, P689, DOI 10.1111/j.1365-2958.2011.07723.x; Yang TY, 2010, NUCLEIC ACIDS RES, V38, P3936, DOI 10.1093/nar/gkq177; Youssef S, 2011, INTEGR BIOL-UK, V3, P1095, DOI 10.1039/c1ib00035g	56	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119124	10.1371/journal.pone.0119124	http://dx.doi.org/10.1371/journal.pone.0119124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751274	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700016
J	Sakala, IG; Chaudhri, G; Eldi, P; Buller, RM; Karupiah, G				Sakala, Isaac G.; Chaudhri, Geeta; Eldi, Preethi; Buller, R. Mark; Karupiah, Gunasegaran			Deficiency in Th2 Cytokine Responses Exacerbate Orthopoxvirus Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; ECTROMELIA-VIRUS; GENETIC-RESISTANCE; POXVIRUS INFECTION; IMMUNE-RESPONSE; IL-4 RECEPTOR; MICE; EXPRESSION; DIFFERENTIATION; INTERLEUKIN-4	Ectromelia virus (ECTV) causes mousepox in mice, a disease very similar to smallpox in humans. ECTV and variola virus (VARV), the agent of smallpox, are closely related orthopoxviruses. Mousepox is an excellent small animal model to study the genetic and immunologic basis for resistance and susceptibility of humans to smallpox. Resistance to mousepox is dependent on a strong polarized type 1 immune response, associated with robust natural killer (NK) cell, cytotoxic T lymphocyte (CTL) and gamma interferon (IFN-gamma) responses. In contrast, ECTV-susceptible mice generate a type 2 response, associated with weak NK cell, CTL and IFN-gamma responses but robust IL-4 responses. Nonetheless, susceptible strains infected with mutant ECTV lacking virus-encoded IFN-gamma binding protein (vIFN-gamma bp) (ECTV-IFN-gamma bp Delta) control virus replication through generation of type 1 response. Since the IL-4/IL-13/STAT-6 signaling pathways polarize type 2/T helper 2 (Th2) responses with a corresponding suppression of IFN-gamma production, we investigated whether the combined absence of vIFN-gamma bp, and one or more host genes involved in Th2 response development, influence generation of protective immunity. Most mutant mouse strains infected with wild-type (WT) virus succumbed to disease more rapidly than WT animals. Conversely, the disease outcome was significantly improved in WT mice infected with ECTV-IFN-gamma bp Delta but absence of IL-4/IL-13/STAT-6 signaling pathways did not provide any added advantage. Deficiency in IL-13 or STAT-6 resulted in defective CTL responses, higher mortality rates and accelerated deaths. Deficiencies in IL-4/IL-13/STAT-6 signaling pathways significantly reduced the numbers of IFN-gamma producing CD4 and CD8 T cells, indicating an absence of a switch to a Th1-like response. Factors contributing to susceptibility or resistance to mousepox are far more complex than a balance between Th1 and Th2 responses.	[Sakala, Isaac G.; Chaudhri, Geeta; Eldi, Preethi; Karupiah, Gunasegaran] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Infect & Immun Grp, Canberra, ACT 2601, Australia; [Buller, R. Mark] St Louis Univ, Dept Mol Microbiol & Immunol, Hlth Sci Ctr, St Louis, MO 63103 USA	Australian National University; John Curtin School of Medical Research; Saint Louis University	Karupiah, G (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Infect & Immun Grp, Canberra, ACT 2601, Australia.	Guna.Karupiah@anu.edu.au	Karupiah, Gunasegaran/S-3561-2019; Karupiah, Gunasegaran/J-4707-2013	Karupiah, Gunasegaran/0000-0001-6306-4405; Chaudhri, Geeta/0000-0003-3388-2102; Eldi, Preethi/0000-0003-0772-3095	National Health and Medical Research Council of Australia [APP1007980, 471426]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) grant numbers APP1007980 and 471426. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 1996, TRENDS MICROBIOL, V4, P321, DOI 10.1016/0966-842X(96)10051-2; ALCAMI A, 1995, IMMUNOL TODAY, V16, P474, DOI 10.1016/0167-5699(95)80030-1; Alters SE, 1999, J IMMUNOTHER, V22, P229, DOI 10.1097/00002371-199905000-00005; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Apte SH, 2008, P NATL ACAD SCI USA, V105, P17475, DOI 10.1073/pnas.0809549105; AR R, 1972, SMALLPOX; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; Chen NH, 2011, VIROLOGY, V409, P328, DOI 10.1016/j.virol.2010.10.021; CHEN W, 1992, VIROLOGY, V187, P433, DOI 10.1016/0042-6822(92)90445-U; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; FENNER F, 1949, J IMMUNOL, V63, P341; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Jezek Z, 1988, HUMAN MONKEYPOX; Jin D, 2009, IMMUNOLOGY, V127, P187, DOI 10.1111/j.1365-2567.2008.02935.x; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KARUPIAH G, 1993, J VIROL, V67, P4214, DOI 10.1128/JVI.67.7.4214-4226.1993; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kienzle N, 2005, J IMMUNOL, V174, P2021, DOI 10.4049/jimmunol.174.4.2021; LIN H, 1993, J IMMUNOL, V151, P4562; Mahalingam S, 2001, P NATL ACAD SCI USA, V98, P6812, DOI 10.1073/pnas.111151098; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; MCFADDEN G, 1995, J LEUKOCYTE BIOL, V57, P731, DOI 10.1002/jlb.57.5.731; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Miller J., 2001, GERMS ULTIMATE WEAPO; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; NobenTrauth N, 1996, SCIENCE, V271, P987, DOI 10.1126/science.271.5251.987; Oldstone M.B.A., 1998, VIRUSES PLAGUES HIST; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Panchanathan V, 2005, P NATL ACAD SCI USA, V102, P12921, DOI 10.1073/pnas.0505180102; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Paul WE, 2010, IMMUNOL CELL BIOL, V88, P236, DOI 10.1038/icb.2010.2; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Scalzo AA, 2000, METH MOL B, V121, P163; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Stanford MM, 2007, IMMUNOL CELL BIOL, V85, P93, DOI 10.1038/sj.icb.7100033; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TranchotDiallo J, 1997, AM J REPROD IMMUNOL, V37, P215; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wijesundara DK, 2013, VACCINE, V31, P4548, DOI 10.1016/j.vaccine.2013.07.062; Wijesundara DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055788; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	56	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118685	10.1371/journal.pone.0118685	http://dx.doi.org/10.1371/journal.pone.0118685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751266	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000350692700007
J	Ahmad, MK; Khan, AA; Ali, SN; Mahmood, R				Ahmad, Mir Kaisar; Khan, Aijaz Ahmed; Ali, Shaikh Nisar; Mahmood, Riaz			Chemoprotective Effect of Taurine on Potassium Bromate-Induced DNA Damage, DNA-Protein Cross-Linking and Oxidative Stress in Rat Intestine	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; LIPID-PEROXIDATION; CARBOHYDRATE-METABOLISM; EXPRESSION; ACID; MELATONIN; ENZYMES; TISSUES; INJURY; LEVEL	Potassium bromate (KBrO3) is widely used as a food additive and is a major water disinfection by-product. It induces multiple organ toxicity in humans and experimental animals and is a probable human carcinogen. The present study reports the protective effect of dietary antioxidant taurine on KBrO3-induced damage to the rat intestine. Animals were randomly divided into four groups: control, KBrO3 alone, taurine alone and taurine+ KBrO3. Administration of KBrO3 alone led to decrease in the activities of intestinal brush border membrane enzymes while those of antioxidant defence and carbohydrate metabolism were also severely altered. There was increase in DNA damage and DNA-protein cross-linking. Treatment with taurine, prior to administration of KBrO3, resulted in significant attenuation in all these parameters but the administration of taurine alone had no effect. Histological studies supported these biochemical results showing extensive intestinal damage in KBrO3-treated animals and greatly reduced tissue injury in the taurine+ KBrO3 group. These results show that taurine ameliorates bromate induced tissue toxicity and oxidative damage by improving the antioxidant defence, tissue integrity and energy metabolism. Taurine can, therefore, be potentially used as a therapeutic/protective agent against toxicity of KBrO3 and related compounds.	[Ahmad, Mir Kaisar; Ali, Shaikh Nisar; Mahmood, Riaz] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India; [Khan, Aijaz Ahmed] Aligarh Muslim Univ, JN Med Coll, Fac Med, Dept Anat, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Mahmood, R (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India.	riazmahmood2002@yahoo.co.in		Mahmood, Riaz/0000-0001-6726-157X	University Grants Commission (SAP-DRS-III scheme)	University Grants Commission (SAP-DRS-III scheme)(University Grants Commission, India)	Financial support to the department from the University Grants Commission (SAP-DRS-III scheme) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ahmad MK, 2014, ENVIRON TOXICOL, V29, P138, DOI 10.1002/tox.20780; Ahmad MK, 2013, CHEMOSPHERE, V91, P1221, DOI 10.1016/j.chemosphere.2013.01.008; Ahmad MK, 2012, BIOCHIMIE, V94, P2776, DOI 10.1016/j.biochi.2012.09.001; Akay C, 2013, HUM EXP TOXICOL, V32, P522, DOI 10.1177/0960327113482692; Alam SS, 2011, ENVIRON TOXICOL PHAR, V31, P143, DOI 10.1016/j.etap.2010.10.001; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Atmaca G, 2004, YONSEI MED J, V45, P776, DOI 10.3349/ymj.2004.45.5.776; Birdsall T C, 1998, Altern Med Rev, V3, P128; Buege J A, 1978, Methods Enzymol, V52, P302; Bull RJ, 1999, TOXICOLOGY, P1041; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chou CT, 2013, AMINO ACIDS, V45, P811, DOI 10.1007/s00726-013-1524-y; Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509; Culling CFA, 1974, HANDBOOK OF HISTOPAT; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171; Environmental Protection Agency (EPA), 2001, TOXICOLOGICAL REVIEW; Farooq N, 2004, NUTR RES, V24, P407, DOI 10.1016/j.nutres.2004.01.004; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gay C, 2000, ANAL BIOCHEM, V284, P217, DOI 10.1006/abio.2000.4696; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hagar HH, 2006, CLIN EXP PHARMACOL P, V33, P189, DOI 10.1111/j.1440-1681.2006.04345.x; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Karbownik M, 2006, CELL BIOCHEM FUNCT, V24, P483, DOI 10.1002/cbf.1321; Khan RA, 2013, PAK J PHARM SCI, V26, P567; Khundmiri SJ, 2004, J NEPHROL, V17, P377; Kolisetty N, 2013, ARCH TOXICOL, V87, P1911, DOI 10.1007/s00204-013-1052-2; Konkel MS, 1986, J BIOL CHEM, V261, P6375; Kumari N, 2013, ADV EXP MED BIOL, V775, P19, DOI 10.1007/978-1-4614-6130-2_2; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Limonciel A, 2012, ARCH TOXICOL, V86, P1741, DOI 10.1007/s00204-012-0897-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Messina SA, 2000, ADV EXP MED BIOL, V483, P355; Motawi TK, 2007, J BIOCHEM MOL TOXIC, V21, P280, DOI 10.1002/jbt.20194; Nishioka H, 2006, TOXICOLOGY, V226, P181, DOI 10.1016/j.tox.2006.06.017; OGASAWARA M, 1994, ADV EXP MED BIOL, V359, P71; Roysommuti S, 2003, THAI J PHYSL SCI, V16, P17; Schaffer S, 2003, ADV EXP MED BIOL, V526, P307; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sener G, 2005, PHARMACOLOGY, V74, P37, DOI 10.1159/000083245; Shimizu M, 2009, ADV EXP MED BIOL, V643, P265, DOI 10.1007/978-0-387-75681-3_27; SHONK CE, 1964, CANCER RES, V24, P709; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stasiak M, 2010, NEUROENDOCRINOL LETT, V31, P363; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; VANDERVLIET A, 1992, FREE RADICAL BIO MED, V12, P499, DOI 10.1016/0891-5849(92)90103-N; VERJEE ZHM, 1969, EUR J BIOCHEM, V9, P439, DOI 10.1111/j.1432-1033.1969.tb00628.x; Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274; Yilmaz O, 2007, ENVIRON TOXICOL PHAR, V24, P79, DOI 10.1016/j.etap.2007.05.007; ZHITKOVICH A, 1992, CARCINOGENESIS, V13, P1485, DOI 10.1093/carcin/13.8.1485	56	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119137	10.1371/journal.pone.0119137	http://dx.doi.org/10.1371/journal.pone.0119137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748174	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400048
J	Hsu, CY; Liu, PH; Lee, YH; Hsia, CY; Huang, YH; Lin, HC; Chiou, YY; Lee, FY; Huo, TI				Hsu, Chia-Yang; Liu, Po-Hong; Lee, Yun-Hsuan; Hsia, Cheng-Yuan; Huang, Yi-Hsiang; Lin, Han-Chieh; Chiou, Yi-You; Lee, Fa-Yauh; Huo, Teh-Ia			Using Serum alpha-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; LIVER-TRANSPLANTATION; TRANSARTERIAL CHEMOEMBOLIZATION; PERFORMANCE STATUS; SYSTEM; MANAGEMENT; APOPTOSIS; SELECTION; CRITERIA; IMPACT	Background and Aims The prognostic ability of alpha-fetoprotein (AFP) for patients with hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal AFP cutoff level is still unclear. Methods A total of 2579 HCC patients were consecutively enrolled in Taiwan, where hepatitis B is the major etiology of chronic liver disease. Four frequently used AFP cutoff levels, 20, 200, 400, 1000 ng/mL, were investigated. One-to-one matched pairs between patients having AFP higher and lower than the cutoffs were selected by using the propensity model. The adjusted hazard ratios of survival difference were calculated with Cox proportional hazards model. Results Patients with a higher AFP level were associated with more severe cirrhosis, more frequent vascular invasion, higher tumor burden and poorer performance status (all p<0.0001). In the propensity model, 4 groups of paired patients were selected, and there was no difference found in the comparison of baseline characteristics (all p>0.05). Patients with AFP <20 ng/mL had significantly better long-term survival than patients with AFP >= 20 ng/mL (p<0.0001), and patients with AFP <400 ng/mL had significantly better overall outcome than patients with AFP >= 400 ng/mL (p = 0.0186). There was no difference of long-term survival between patients divided by AFP levels of 200 and 1000 ng/mL. The adjusted hazard ratios of AFP >= 20 ng/mL and AFP >= 400 ng/mL were 1.545 and 1.471 (95% confidence interval: 1.3-1.838 and 1.178-1.837), respectively. Conclusions This study shows the independently predictive ability of baseline serum AFP level in HCC patients. AFP levels of 20 and 400 ng/mL are considered feasible cutoffs to predict long-term outcome in unselected HCC patients.	[Hsu, Chia-Yang; Liu, Po-Hong; Lee, Yun-Hsuan; Hsia, Cheng-Yuan; Lin, Han-Chieh; Chiou, Yi-You; Lee, Fa-Yauh; Huo, Teh-Ia] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Hsu, Chia-Yang; Liu, Po-Hong; Lee, Yun-Hsuan; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, Fa-Yauh; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Chiou, Yi-You] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsu, Chia-Yang] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; University of California System; University of California Los Angeles	Huo, TI (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/HGB-9015-2022; Liu, Po-Hong/G-8459-2015	Liu, Po-Hong/0000-0001-6205-3704; Huang, Yi-Hsiang/0000-0001-5241-5425	Taipei Veterans General Hospital, Taiwan [V103C-008]; Ministry of Education, Aiming for the Top University Plan, Taiwan [103AC-P618]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); Ministry of Education, Aiming for the Top University Plan, Taiwan	This study was supported by the grants from Taipei Veterans General Hospital (V103C-008), Taiwan, and from the Ministry of Education, Aiming for the Top University Plan (103AC-P618), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Blank S, 2014, ANN SURG ONCOL, V21, P986, DOI 10.1245/s10434-013-3357-z; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Fujiki M, 2009, AM J TRANSPLANT, V9, P2362, DOI 10.1111/j.1600-6143.2009.02783.x; Gonwa T, 2004, LIVER TRANSPLANT, V10, P301, DOI 10.1002/lt.20017; Hakeem AR, 2012, ALIMENT PHARM THER, V35, P987, DOI 10.1111/j.1365-2036.2012.05060.x; Hsu CY, 2013, ANN SURG ONCOL, V20, P2035, DOI 10.1245/s10434-012-2847-8; Hsu CY, 2013, HEPATOL INT, V7, P188, DOI 10.1007/s12072-011-9338-z; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, J HEPATOL, V53, P108, DOI 10.1016/j.jhep.2010.01.038; Lee YH, 2013, HEPATOL INT, V7, P645, DOI 10.1007/s12072-012-9375-2; Lee YH, 2012, J GASTROEN HEPATOL, V27, P1581, DOI 10.1111/j.1440-1746.2012.07151.x; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Merani S, 2011, J HEPATOL, V55, P814, DOI 10.1016/j.jhep.2010.12.040; Mitsuhashi N, 2008, J GASTROEN HEPATOL, V23, pE189, DOI 10.1111/j.1440-1746.2008.05340.x; Perrone F, 2000, HEPATOLOGY, V31, P840; Ramirez AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035573; Shim JH, 2012, ANN SURG ONCOL, V19, P3687, DOI 10.1245/s10434-012-2416-1; Sotiropoulos GC, 2007, J AM COLL SURGEONS, V205, P661, DOI 10.1016/j.jamcollsurg.2007.05.023; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Toyoda H, 2008, J HEPATOL, V49, P223, DOI 10.1016/j.jhep.2008.04.013; Wang Y, 2012, ANN SURG ONCOL, V19, P3540, DOI 10.1245/s10434-012-2368-5; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XJ, 2008, CANCER LETT, V271, P281, DOI 10.1016/j.canlet.2008.06.017	26	33	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118825	10.1371/journal.pone.0118825	http://dx.doi.org/10.1371/journal.pone.0118825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738614	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900076
J	Kunicki, M; Lukaszuk, K; Jakiel, G; Liss, J				Kunicki, Michal; Lukaszuk, Krzysztof; Jakiel, Grzegorz; Liss, Joanna			Serum Dehydroepiandrosterone Sulphate Concentration Is Not a Predictive Factor in IVF Outcomes before the First Cycle of GnRH Agonist Administration in Women with Normal Ovarian Reserve	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; IN-VITRO FERTILIZATION; SINGLE-EMBRYO-TRANSFER; LIVE BIRTH; DHEA SUPPLEMENTATION; PREGNANCY RATE; STIMULATION; MODELS; IMPACT	Objective The aim of our study was to determine whether serum dehydroepiandrosterone sulphate (DHEAS) concentration and the models incorporating it could help clinicians to predict IVF outcomes in women with normal ovarian reserve undergoing their first long protocol. Study Design We performed a retrospective analysis of 459 women undergoing cycles of intracytoplasmic sperm injection (ICSI) for the first time in a long GnRH agonist protocol. Results Embryo transfer was performed in 407 women (88.7%). The fertilisation rate was 78.6%. The clinical pregnancy rate was 44.8% per started cycle and 50.6% per embryo transfer. Our univariate model revealed that the best predictors of clinical pregnancy were the number of mature oocytes, the number of embryos transferred and the number of good quality embryos, account for the clinical parameters that reflect ovarian reserve the best being AMH level and AFC. DHEAS did not predict clinical pregnancy (OR 1.001, 95% CI, 0.999-1.004). After adjusting for the number of embryos transferred and class of embryos in a multivariate model, the best predictors were age (OR 0.918, 95% CI, 0.867-0.972) and AFC (OR 1.022, 95% CI, 0.992-1.053). Serum DHEAS levels were positively correlated with AFC (r=0.098, P<0.039) and testosterone levels (r=0.371, P<0.001), as well as the number of mature oocytes (r=0.109, P<0.019); serum DHEAS levels were negatively correlated with age (r=-0.220, P<0.001), follicle-stimulating hormone (FSH), (r=-0.116, P<0.015) and sex hormone-binding globulin (SHBG), (r=-0.193, P<0.001). Conclusions DHEAS concentration (in addition to the known factors of ovarian reserve) does not predict clinical pregnancy in women with normal ovarian reserve who are undergoing ICSI.	[Kunicki, Michal; Jakiel, Grzegorz] INVICTA, Fertil & Reprod Ctr, Warsaw, Poland; [Lukaszuk, Krzysztof] Med Univ Gdansk, Fac Hlth Sci, Dept Obstet & Gynaecol Nursing, Gdansk, Poland; [Lukaszuk, Krzysztof] Univ Varmia & Masuria, Fac Med Sci, Dept Obstet & Gynaecol, Olsztyn, Poland; [Lukaszuk, Krzysztof; Liss, Joanna] NVICTA, Fertil & Reprod Ctr, Gdansk, Poland; [Jakiel, Grzegorz] Med Ctr Postgrad Educ, Dept Obstet & Gynecol, Warsaw, Poland	Fahrenheit Universities; Medical University Gdansk; Centre of Postgraduate Medical Education - Poland	Kunicki, M (corresponding author), INVICTA, Fertil & Reprod Ctr, Warsaw, Poland.	michal.kunicki@invicta.pl	MICHAŁ, kUNICKI/U-9114-2019; Lukaszuk, Krzysztof/ABD-1103-2021	MICHAŁ, kUNICKI/0000-0001-9672-3382; Lukaszuk, Krzysztof/0000-0001-5996-6991; Liss, Joanna/0000-0002-9199-5212; Jakiel, Grzegorz/0000-0002-6094-2273				Alebic MS, 2014, REPROD BIOMED ONLINE, V28, P191, DOI 10.1016/j.rbmo.2013.09.023; Alebic MS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/637919; Andersen AN, 2011, HUM REPROD, V26, P3413, DOI 10.1093/humrep/der318; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Casson PR, 2000, HUM REPROD, V15, P2129, DOI 10.1093/humrep/15.10.2129; COLAKOGLU M, 1986, Clinical and Experimental Obstetrics and Gynecology, V13, P32; Ferlitsch K, 2004, J ASSIST REPROD GEN, V21, P431, DOI 10.1007/s10815-004-8759-1; Frattarelli JL, 2006, FERTIL STERIL, V86, P51, DOI 10.1016/j.fertnstert.2005.12.028; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; Gnoth C, 2008, HUM REPROD, V23, P1359, DOI 10.1093/humrep/den108; Guo J, 2014, J SUN YAT S IN PRESS; Guo J, 2014, REPROD BIOMED ONLINE, V28, P723, DOI 10.1016/j.rbmo.2014.02.009; Hunault CC, 2002, FERTIL STERIL, V77, P725, DOI 10.1016/S0015-0282(01)03243-5; Kwee J, 2008, FERTIL STERIL, V90, P737, DOI 10.1016/j.fertnstert.2007.07.1293; La Marca A, 2011, REPROD BIOMED ONLINE, V22, P341, DOI 10.1016/j.rbmo.2010.11.005; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Lee TH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-100; Lukaszuk K, 2005, FERTIL STERIL, V83, P1372, DOI 10.1016/j.fertnstert.2004.11.055; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480; Ottosen LDM, 2007, J ASSIST REPROD GEN, V24, P29, DOI 10.1007/s10815-006-9082-9; *PRACT COMM, 2004, FERTIL STERIL, V82, P772; Verberg MFG, 2008, FERTIL STERIL, V89, P1159, DOI 10.1016/j.fertnstert.2007.05.020; Verhagen TEM, 2008, HUM REPROD UPDATE, V14, P95, DOI 10.1093/humupd/dmn001; Weghofer A, 2012, HUM REPROD, V27, P3287, DOI 10.1093/humrep/des265; Weghofer A, 2011, HUM REPROD, V26, P1905, DOI 10.1093/humrep/der134; Weissman A, 2011, GYNECOL ENDOCRINOL, V27, P1014, DOI 10.3109/09513590.2011.569611; Younis JS, 2010, FERTIL STERIL, V94, P655, DOI 10.1016/j.fertnstert.2009.03.036	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118570	10.1371/journal.pone.0118570	http://dx.doi.org/10.1371/journal.pone.0118570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738591	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900048
J	Lin, Q; Li, SJ; Dong, WC; Feng, C; Yin, XR; Xu, CJ; Sun, CD; Chen, KS				Lin, Qiong; Li, Shaojia; Dong, Wencheng; Feng, Chao; Yin, Xueren; Xu, Changjie; Sun, Chongde; Chen, Kunsong			Involvement of CitCHX and CitDIC in Developmental-Related and Postharvest-Hot-Air Driven Citrate Degradation in Citrus Fruits	PLOS ONE			English	Article							ORGANIC-ACID; FUNCTIONAL-CHARACTERIZATION; DICARBOXYLATE TRANSPORTER; EXPRESSION PROFILES; RETICULATA FRUIT; GRAPE BERRIES; RNA-SEQ; ARABIDOPSIS; MALATE; ACCUMULATION	Citrate is the predominant organic acid associated with taste in citrus fruit. Although citrate metabolism has been widely studied in recent years, the potential contributions of transport proteins to citrate content remain unclear. In the present study, high-acid citrus fruit Gaocheng ('GC', Citrus sp.) and low-acid citrus fruit Satsuma mandarin ('SM', Citrus unshiu Marc.) were selected for study, and the degradation of citrate was deduced to be the main cause of the difference in acidity in fully mature fruits. RNA-seq analysis was carried out on 'GC' and 'SM' fruit samples over the same time course, and the results indicated that citrate degradation occurred mainly through the glutamine pathway, catalyzed by CitAco3-CitGS2-CitGDU1, and also two transport-related genes, CitCHX and CitDIC, were shown to be associated with citrate degradation. These results were confirmed by real-time PCR. In postharvest 'GC' fruit, the expressions of these two transport-related genes were induced by 2-fold under hot air treatment, accompanied by a reduction of 7%-9% in total acid degradation. Transient expression of CitCHX and CitDIC in tobacco leaves was performed, and the citrate content was reduced by 62%, 75% and 78% following CitCHX, CitDIC and CitCHX plus CitDIC treatments, respectively, as compared with expression of an empty vector. Overall, these data indicated that two transport proteins, CitCHX and CitDIC, are not only involved in citrate degradation during fruit development, but also involved in postharvest hot air triggered citrate reduction.	[Lin, Qiong; Li, Shaojia; Dong, Wencheng; Feng, Chao; Yin, Xueren; Xu, Changjie; Sun, Chongde; Chen, Kunsong] Zhejiang Univ, Lab Hort Plant Growth Dev & Qual Improvement, Lab Fruit Qual Biol, State Agr Minist, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Sun, CD (corresponding author), Zhejiang Univ, Lab Hort Plant Growth Dev & Qual Improvement, Lab Fruit Qual Biol, State Agr Minist, Hangzhou 310058, Zhejiang, Peoples R China.	adesun2006@zju.edu.cn	Yin, Xue-ren/B-3893-2008; Xu, Changjie/D-2656-2009	Yin, Xue-ren/0000-0002-1282-4432; 	National Basic Research Program of China (973 program) [2011CB100602]; Program of International Science and Technology Cooperation [2011DFB31580]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD38B03]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Program of International Science and Technology Cooperation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	This research was supported by the National Basic Research Program of China (973 program) (2011CB100602), the Program of International Science and Technology Cooperation (2011DFB31580) and the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD38B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2012, MOL GENET GENOMICS, V287, P663, DOI 10.1007/s00438-012-0707-7; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Canel C, 1996, PLANT MOL BIOL, V31, P143, DOI 10.1007/BF00020613; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; Cercos M, 2006, PLANT MOL BIOL, V62, P513, DOI 10.1007/s11103-006-9037-7; Chanroj S, 2011, J BIOL CHEM, V286, P33931, DOI 10.1074/jbc.M111.252650; Chen M, 2013, PLANT MOL BIOL REP, V31, P1131, DOI 10.1007/s11105-013-0583-2; Chen M, 2012, SCI HORTIC-AMSTERDAM, V147, P118, DOI 10.1016/j.scienta.2012.09.011; Coursol S, 2000, BIOCHEM SOC T, V28, P821, DOI 10.1042/BST0280821; De Angeli A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2815; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gruber BD, 2010, J EXP BOT, V61, P1455, DOI 10.1093/jxb/erq023; Han DG, 2012, BIOL PLANTARUM, V56, P50, DOI 10.1007/s10535-012-0015-4; HARDY PJ, 1968, PLANT PHYSIOL, V43, P224, DOI 10.1104/pp.43.2.224; Hurth MA, 2005, PLANT PHYSIOL, V137, P901, DOI 10.1104/pp.104.058453; Katz E, 2007, PLANTA, V226, P989, DOI 10.1007/s00425-007-0545-8; Katz E, 2011, J EXP BOT, V62, P5367, DOI 10.1093/jxb/err197; Ligaba A, 2012, PLANT CELL ENVIRON, V35, P1185, DOI 10.1111/j.1365-3040.2011.02479.x; Lin Q, 2015, GENE, V554, P64, DOI 10.1016/j.gene.2014.10.025; LINN TC, 1979, J BIOL CHEM, V254, P1691; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Liu XF, 2013, PLANT MOL BIOL REP, V31, P1474, DOI 10.1007/s11105-013-0621-0; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Mei L, 2009, QUALITY EVALUATION W; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OLESKI N, 1987, PLANT PHYSIOL, V84, P997, DOI 10.1104/pp.84.4.997; Osorio Sonia, 2012, Methods Mol Biol, V860, P101, DOI 10.1007/978-1-61779-594-7_7; Pillitteri LJ, 2004, J AM SOC HORTIC SCI, V129, P846, DOI 10.21273/JASHS.129.6.0846; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Pratelli R, 2010, PLANT PHYSIOL, V152, P762, DOI 10.1104/pp.109.151746; Regalado A, 2013, PLANTA, V237, P693, DOI 10.1007/s00425-012-1786-8; RENTSCH D, 1991, PLANTA, V184, P532, DOI 10.1007/BF00197903; Rongala J, 2008, IDENTIFICATION LOCAL; Saunt J., 1990, CITRUS VARIETIES WOR; Shan LL, 2008, PLANTA, V227, P1243, DOI 10.1007/s00425-008-0696-2; Shimada T, 2005, PLANT SCI, V168, P1383, DOI 10.1016/j.plantsci.2005.01.013; Taniguchi M, 1997, PLANT PHYSIOL, V114, P285, DOI 10.1104/pp.114.1.285; Terrier N, 1998, PLANT PHYSIOL BIOCH, V36, P367, DOI 10.1016/S0981-9428(98)80078-8; Tovkach A, 2013, PLANT PHYSIOL, V161, P880, DOI 10.1104/pp.112.207142; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Yao YX, 2011, PLANT PHYSIOL BIOCH, V49, P1201, DOI 10.1016/j.plaphy.2011.05.012; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin YG, 2010, PLANT CELL PHYSIOL, V51, P1300, DOI 10.1093/pcp/pcq090; Yokosho K, 2009, PLANT PHYSIOL, V149, P297, DOI 10.1104/pp.108.128132; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758	50	15	19	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119410	10.1371/journal.pone.0119410	http://dx.doi.org/10.1371/journal.pone.0119410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738939	Green Submitted, gold, Green Published			2022-12-26	WOS:000350685900106
J	Zou, JF; Guo, QM; Shao, H; Li, B; Du, YX; Liu, MF; Liu, FL; Dai, LX; Lin, HJ; Su, SB; Guo, HR; Huang, CC				Zou, Jian-Fang; Guo, Qiming; Shao, Hua; Li, Bin; Du, Yuxiu; Liu, Maofeng; Liu, Fengling; Dai, Lixin; Lin, Hung-Jung; Su, Shih-Bin; Guo, How-Ran; Huang, Chien-Cheng			Lack of Pupil Reflex and Loss of Consciousness Predict 30-Day Neurological Sequelae in Patients with Carbon Monoxide Poisoning	PLOS ONE			English	Article							HYPERBARIC-OXYGEN; BRAIN; MANAGEMENT; TOXICITY; ISSUES	Background Predicting the neurological sequelae of carbon monoxide poisoning (COP) has not been well studied. We investigated the independent predictors of neurological sequelae in patients with COP and combined these predictors to predict the prognosis. Methods This study was conducted at four hospitals in Shandong Province, China. Data were retrospectively collected from 258 patients with COP between November 1990 and October 2011. Thirty-day neurological sequelae were the primary endpoints. Results A lack of pupil reflex and a loss of consciousness appear to be independent predictors for neurological sequelae in patients with COP. The presence of either one had a sensitivity of 77.0% (95% confidence interval [CI]: 69.3-83.2), a specificity of 47.1% (95% CI: 38.3-56.0), positive predictive value (PPV) of 62.9% (95% CI: 55.2-70.1), and a negative predictive value (NPV) of 63.6%(95% CI: 52.6-73.4). With both predictors present, the sensitivity was 11.5%(95% CI: 6.9 to 18.3), the specificity was 99.2 (95% CI: 94.7-100.0), the PPV was 94.1%(95% CI: 69.2-99.7), and the NPV was 49.0%(95% CI: 42.5-55.5). Conclusions The risk for neurological sequelae apparently increased with the number of independent predictors. In patients with both predictors, the risk for neurological sequelae was 94.1%. Almost all (99.2%) patients with neither predictor had no neurological sequelae. This finding may help physicians make decisions about and dispositions for patients with COP. For patients with a higher risk, earlier treatment and more appropriate utilization of health care services, including hyperbaric oxygen, should be considered.	[Zou, Jian-Fang; Guo, Qiming; Shao, Hua] Acad Med Sci, Clin Div Occupat Med, Inst Occupat Hlth & Occupat Med, Jinan, Shandong, Peoples R China; [Li, Bin] Natl Inst Occupat Hlth & Poison Control, Div Toxicol, Beijing, Peoples R China; [Du, Yuxiu] Second Peoples Hosp Dongying, Dept Med, Dongying, Shandong, Peoples R China; [Liu, Maofeng; Liu, Fengling] Qilu Petrochem Corp Hosp, Dept Med, Zibo, Shandong, Peoples R China; [Dai, Lixin] Second Peoples Hosp Kenli, Dept Med, Kenli, Shandong, Peoples R China; [Lin, Hung-Jung] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Lin, Hung-Jung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Guo, How-Ran; Huang, Chien-Cheng] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Huang, Chien-Cheng] Kuo Gen Hosp, Dept Emergency Med, Tainan, Taiwan	Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Southern Taiwan University of Science & Technology	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw; chienchenghuang@yahoo.com.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446				Colman AM, 2001, DICT PSYCHOL OXFORD; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Gorman D, 2003, TOXICOLOGY, V187, P25, DOI 10.1016/S0300-483X(03)00005-2; Hampson NB, 2001, UNDERSEA HYPERBAR M, V28, P157; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hampson Neil B., 1995, Journal of Emergency Medicine, V13, P227, DOI 10.1016/0736-4679(94)00144-8; Hu HJ, 2011, AM J EMERG MED, V29, P261, DOI 10.1016/j.ajem.2009.09.030; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lo CP, 2007, AM J ROENTGENOL, V189, pW205, DOI 10.2214/AJR.07.2425; O'Donnell P, 2000, CLIN RADIOL, V55, P273, DOI 10.1053/crad.1999.0369; Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6; Shprecher D, 2010, NEUROREHABILITATION, V26, P65, DOI 10.3233/NRE-2010-0536; Steriade M., 1997, THALAMUS; Thom SR, 2002, NEW ENGL J MED, V347, P1105, DOI 10.1056/NEJMe020103; Thom SR, 2006, TOXICOL APPL PHARM, V213, P152, DOI 10.1016/j.taap.2005.10.006; Weaver LK, 2007, AM J RESP CRIT CARE, V176, P491, DOI 10.1164/rccm.200701-026OC; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wolf SJ, 2008, ANN EMERG MED, V51, P138, DOI 10.1016/j.annemergmed.2007.10.012; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	21	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119126	10.1371/journal.pone.0119126	http://dx.doi.org/10.1371/journal.pone.0119126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738593	Green Submitted, gold, Green Published			2022-12-26	WOS:000350685900093
J	Borshchevskiy, V; Round, E; Bertsova, Y; Polovinkin, V; Gushchin, I; Ishchenko, A; Kovalev, K; Mishin, A; Kachalova, G; Popov, A; Bogachev, A; Gordeliy, V				Borshchevskiy, Valentin; Round, Ekaterina; Bertsova, Yulia; Polovinkin, Vitaly; Gushchin, Ivan; Ishchenko, Andrii; Kovalev, Kirill; Mishin, Alexey; Kachalova, Galina; Popov, Alexander; Bogachev, Alexander; Gordeliy, Valentin			Structural and Functional Investigation of Flavin Binding Center of the NqrC Subunit of Sodium-Translocating NADH: Quinone Oxidoreductase from Vibrio harveyi	PLOS ONE			English	Article							UBIQUINONE OXIDOREDUCTASE; THREONINE RESIDUE; PROSTHETIC GROUPS; REDOX PROPERTIES; FMN; REDUCTASE; MECHANISM; DOMAINS; PHENIX	Na+-translocating NADH: quinone oxidoreductase (NQR) is a redox-driven sodium pump operating in the respiratory chain of various bacteria, including pathogenic species. The enzyme has a unique set of redox active prosthetic groups, which includes two covalently bound flavin mononucleotide (FMN) residues attached to threonine residues in subunits NqrB and NqrC. The reason of FMN covalent bonding in the subunits has not been established yet. In the current work, binding of free FMN to the apo-form of NqrC from Vibrio harveyi was studied showing very low affinity of NqrC to FMN in the absence of its covalent bonding. To study structural aspects of flavin binding in NqrC, its holo-form was crystallized and its 3D structure was solved at 1.56A resolution. It was found that the isoalloxazine moiety of the FMN residue is buried in a hydrophobic cavity and that its pyrimidine ring is squeezed between hydrophobic amino acid residues while its benzene ring is extended from the protein surroundings. This structure of the flavin-binding pocket appears to provide flexibility of the benzene ring, which can help the FMN residue to take the bended conformation and thus to stabilize the one-electron reduced form of the prosthetic group. These properties may also lead to relatively weak noncovalent binding of the flavin. This fact along with periplasmic location of the FMN-binding domains in the vast majority of NqrC-like proteins may explain the necessity of the covalent bonding of this prosthetic group to prevent its loss to the external medium.	[Borshchevskiy, Valentin; Polovinkin, Vitaly; Gushchin, Ivan; Kovalev, Kirill; Mishin, Alexey; Gordeliy, Valentin] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Borshchevskiy, Valentin; Round, Ekaterina; Polovinkin, Vitaly; Gushchin, Ivan; Ishchenko, Andrii; Gordeliy, Valentin] Res Ctr Julich GmbH, Inst Complex Syst ICS 6 Struct Biochem, Julich, Germany; [Bertsova, Yulia; Bogachev, Alexander] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Kachalova, Galina] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia; [Popov, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Gordeliy, Valentin] Univ Grenoble Alpes, IBS, Grenoble, France; [Gordeliy, Valentin] CNRS, IBS, Grenoble, France; [Gordeliy, Valentin] CEA Grenoble, IBS, F-38054 Grenoble, France	Moscow Institute of Physics & Technology; Helmholtz Association; Research Center Julich; Lomonosov Moscow State University; Research Center of Biotechnology RAS; Russian Academy of Sciences; European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Bogachev, A (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	bogachev@belozersky.msu.ru; valentin.gordeliy@ibs.fr	Polovinkin, Vitaly/G-6627-2017; Bertsova, Yulia V./B-5505-2014; Gordeliy, Valentin I/J-3636-2013; Bogachev, Alexander V/E-5844-2012; kachalova, galina/AAD-9742-2019; Gushchin, Ivan/AAO-8829-2020; Kovalev, Kirill/J-6750-2015; Gushchin, Ivan/K-9197-2015; Borshchevskiy, Valentin I./F-2287-2014; Kachalova, Galina S/J-9437-2015; Mishin, Alexey V/F-2960-2014	Polovinkin, Vitaly/0000-0002-3630-5565; Gordeliy, Valentin I/0000-0001-5782-5896; Bogachev, Alexander V/0000-0003-3035-4494; Gushchin, Ivan/0000-0002-5348-6070; Gushchin, Ivan/0000-0002-5348-6070; Borshchevskiy, Valentin I./0000-0003-4398-9712; Kachalova, Galina S/0000-0002-8240-6287; Mishin, Alexey V/0000-0003-3759-380X; Popov, Alexander/0000-0002-3058-8912; Kovalev, Kirill/0000-0002-2229-181X	Russian foundation for basic research [13-04- 91320]; Helmholtz Association of German Research Centres [HRJRG-401]; RSCF [14-14-00128]; BMBF; Russian Federal Target Program "Research and Development" [14.587.21.0004]; GRAL [ANR-10-LABX-4901]; FRISBI [ANR-10-INSB-05-02]; Grenoble Instruct centre (ISBG) [UMS 3518 CNRS-CEA-UJF-EMBL]; Russian Science Foundation [14-14-00128] Funding Source: Russian Science Foundation	Russian foundation for basic research(Russian Foundation for Basic Research (RFBR)); Helmholtz Association of German Research Centres(Helmholtz Association); RSCF(Russian Science Foundation (RSF)); BMBF(Federal Ministry of Education & Research (BMBF)); Russian Federal Target Program "Research and Development"; GRAL; FRISBI; Grenoble Instruct centre (ISBG); Russian Science Foundation(Russian Science Foundation (RSF))	The work was supported by Russian foundation for basic research (research projects 13-04- 91320) and Helmholtz Association of German Research Centres (project ID: HRJRG-401) as well as the Russian state Program 5top100-programme for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science. NqrC purification and flavinylation as well as studying of FMN binding properties of apoNqrC' were supported by RSCF research project 14-14-00128. Crystallization, X-ray data collection and treatment were supported by RSCF research project 14-1400995. The work was supported by the program "Chaires d'excellence" edition 2008 of ANR France and CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement. Part of this work was supported by BMBF (PhoNa - Photonic Nanomaterials) and Russian Federal Target Program "Research and Development" (No 14.587.21.0004, unique identifier RFMEFI58714X0004). The work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-4901) within the Grenoble Partnership for Structural Biology (PSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Bertsova YV, 2014, BBA-BIOENERGETICS, V1837, P1122, DOI 10.1016/j.bbabio.2013.12.006; Bertsova YV, 2013, J BIOL CHEM, V288, P14276, DOI 10.1074/jbc.M113.455402; Bogachev AV, 2012, MOL MICROBIOL, V86, P1452, DOI 10.1111/mmi.12067; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; HAYASHI M, 1994, FEBS LETT, V356, P330, DOI 10.1016/0014-5793(94)01274-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li X, 2006, BIOCHEMISTRY-US, V45, P14781, DOI 10.1021/bi0610956; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Muralidhara BK, 2005, J MOL BIOL, V349, P87, DOI 10.1016/j.jmb.2005.03.054; Nicholas KB., 1997, GENEDOC TOOL EDITING; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Vohl G, 2014, ACTA CRYSTALLOGR F, V70, P987, DOI 10.1107/S2053230X14009881; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	30	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118548	10.1371/journal.pone.0118548	http://dx.doi.org/10.1371/journal.pone.0118548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734798	gold, Green Published			2022-12-26	WOS:000350314700037
J	Wang, M; Xu, X; Zhang, XX; Sun, S; Wu, CX; Hou, WS; Wang, QY; Han, TF				Wang, Miao; Xu, Xin; Zhang, Xinxin; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Wang, Qingyu; Han, Tianfu			Functional Analysis of GmCPDs and Investigation of Their Roles in Flowering	PLOS ONE			English	Article							GIBBERELLIN 20-OXIDASE; TRANSCRIPT LEVELS; FLORAL-INDUCTION; CIRCADIAN CLOCK; DE-ETIOLATION; CPD GENE; BRASSINOSTEROIDS; ARABIDOPSIS; EXPRESSION; CYTOCHROME-P450	The onset of floral development is a pivotal switch in the life of soybean. Brassinosteroids (BRs), a group of steroidal phytohormones with essential roles in plant growth and development, are associated with flowering induction. Genes involved in BR biosynthesis have been studied to a great extent in Arabidopsis, but the study of these genes has been limited in soybean. In this study, four CPD homologs (GmCPDs) catalyzing BR synthesis were isolated from soybean. Transcripts were mainly confined to cotyledons and leaves and were down-regulated in response to exogenous BR. Bioinformatic analysis showed strong sequence and structure similarity between GmCPDs and AtCPD as well as CPDs of other species. Overexpression of GmCPDs in an Arabidopsis BR-deficient mutant rescued the phenotype by restoring the biosynthesis pathway, revealing the functional roles of each GmCPDs in. Except for the rescue of root development, leaf expansion and plant type architecture, GmCPDs in expression also complemented the late flowering phenotype of Arabidopsis mutants deficient in CPD. Further evidence in soybean plants is that the expression levels of GmCPDs in are under photoperiod control in Zigongdongdou, a photoperiod-sensitive variety, and show a sudden peak upon floral meristem initiation. Together with increased GmCPDs in expression in the leaves and cotyledons of photoperiod- insensitive early-maturity soybean, it is clear that GmCPDs in contribute to flowering development and are essential in the early stages of flowering regulation.	[Wang, Miao; Xu, Xin; Zhang, Xinxin; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Han, Tianfu] Chinese Acad Agr Sci, Inst Crop Sci, Minist Agr, Key Lab Soybean Biol Beijing, Beijing 100081, Peoples R China; [Wang, Miao; Wang, Qingyu] Jilin Univ, Coll Plant Sci, Changchun 130062, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Jilin University	Wang, QY (corresponding author), Jilin Univ, Coll Plant Sci, Changchun 130062, Jilin, Peoples R China.	qywang@jlu.edu.cn; hantianfu@caas.cn			China Agriculture Research System [CARS-04]; CAAS Innovation Project	China Agriculture Research System; CAAS Innovation Project	This work was supported by the China Agriculture Research System (CARS-04) and CAAS Innovation Project to T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Ait-Ali T, 1999, PLANT PHYSIOL, V121, P783, DOI 10.1104/pp.121.3.783; Alabadi D, 2009, INT J DEV BIOL, V53, P1597, DOI 10.1387/ijdb.072423da; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bajguz A, 2003, PHYTOCHEMISTRY, V62, P1027, DOI 10.1016/S0031-9422(02)00656-8; Bancos S, 2006, PLANT PHYSIOL, V141, P299, DOI 10.1104/pp.106.079145; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; BATTEY NH, 1990, BOT REV, V56, P162, DOI 10.1007/BF02858534; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curtis DF, 2000, CROP SCI, V40, P1624, DOI 10.2135/cropsci2000.4061624x; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Gai JunYi, 2001, Scientia Agricultura Sinica, V34, P139; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Han TianFu, 1998, Acta Agronomica Sinica, V24, P168; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Jackson SD, 2000, PLANT PHYSIOL, V124, P423, DOI 10.1104/pp.124.1.423; Jia Zhen, 2011, Acta Agronomica Sinica, V37, P650, DOI 10.3724/SP.J.1006.2011.00650; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kim HB, 2006, PLANT PHYSIOL, V140, P548, DOI 10.1104/pp.105.067918; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Krumova S, 2013, J PHOTOCH PHOTOBIO B, V126, P97, DOI 10.1016/j.jphotobiol.2013.07.008; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Li JH, 2010, J EXP BOT, V61, P4221, DOI 10.1093/jxb/erq241; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li XiaoMei, 2005, Acta Agronomica Sinica, V31, P1437; Liu SH, 2014, GENE, V543, P145, DOI 10.1016/j.gene.2014.03.026; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Montoya T, 2005, PLANT J, V42, P262, DOI 10.1111/j.1365-313X.2005.02376.x; Noguchi T, 2000, PLANT PHYSIOL, V124, P201, DOI 10.1104/pp.124.1.201; Nomura T, 2007, PLANT PHYSIOL, V143, P1680, DOI 10.1104/pp.106.093096; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Ohnishi T, 2012, J BIOL CHEM, V287, P31551, DOI 10.1074/jbc.M112.392720; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Symons GM, 2008, J EXP BOT, V59, P17, DOI 10.1093/jxb/erm098; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Toyomasu T, 1998, PLANT PHYSIOL, V118, P1517, DOI 10.1104/pp.118.4.1517; Tsuda K, 2014, PLANT CELL, V26, P3488, DOI 10.1105/tpc.114.129122; Washburn CF, 2000, AM J BOT, V87, P1425, DOI 10.2307/2656869; Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Wollenberg AC, 2008, PLANT PHYSIOL, V148, P1681, DOI 10.1104/pp.108.125468; Wu CX, 2006, PLANTA, V223, P725, DOI 10.1007/s00425-005-0130-y; Xu Y, 2014, PLANT PHYSL BIOCH; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yang CJ, 2011, MOL PLANT, V4, P588, DOI 10.1093/mp/ssr020; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zhang YY, 2013, PLANT CELL, V25, P2504, DOI 10.1105/tpc.113.110296	59	13	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118476	10.1371/journal.pone.0118476	http://dx.doi.org/10.1371/journal.pone.0118476			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734273	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700032
J	Vivo, M; Matarese, M; Sepe, M; Di Martino, R; Festa, L; Calabro, V; La Mantia, G; Pollice, A				Vivo, Maria; Matarese, Maria; Sepe, Maria; Di Martino, Rosaria; Festa, Luisa; Calabro, Viola; La Mantia, Girolama; Pollice, Alessandra			MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells	PLOS ONE			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; TUMOR-SUPPRESSOR; P53; MDM2; P14(ARF); STABILIZATION; NUCLEOLAR; DOMAINS; OVEREXPRESSION; NUCLEAR	We here show a new relationship between the human p14ARF oncosuppressor and the MDM2 oncoprotein. MDM2 overexpression in various cancer cell lines causes p14ARF reduction inducing its degradation through the proteasome. The effect does not require the ubiquitin ligase activity of MDM2 and preferentially occurs in the cytoplasm. Interestingly, treatment with inhibitors of the PKC (Protein Kinase C) pathway and use of p14ARF phosphorylation mutants indicate that ARF phosphorylation could play a role in MDM2 mediated ARF degradation reinforcing our previous observations that ARF phosphorylation influences its stability and biological activity. Our study uncovers a new potentially important mechanism through which ARF and MDM2 can counterbalance each other during the tumorigenic process.	[Vivo, Maria; Matarese, Maria; Sepe, Maria; Di Martino, Rosaria; Festa, Luisa; Calabro, Viola; La Mantia, Girolama; Pollice, Alessandra] Univ Naples Federico II, Dipartimento Biol, Naples, Italy; [Matarese, Maria] CNR, IGB, I-80125 Naples, Italy; [Sepe, Maria] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Di Martino, Rosaria] CNR, IBP, I-80125 Naples, Italy; [Festa, Luisa] CNR, I-80125 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR)	Pollice, A (corresponding author), Univ Naples Federico II, Dipartimento Biol, Naples, Italy.	apollice@unina.it	Calabro, Viola/H-6156-2013; Vivo, Maria/S-3390-2017	Vivo, Maria/0000-0003-2458-4226; Calabro, Viola/0000-0002-6508-8889	Legge Regionale (Regione Campania) [5/2007]; Progetto "Campania Research in Experimental Medicine" (CREME)	Legge Regionale (Regione Campania); Progetto "Campania Research in Experimental Medicine" (CREME)	This work was supported by grants from Legge Regionale (Regione Campania) no 5/2007 to AP and GLM and Progetto "Campania Research in Experimental Medicine" (CREME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; den Besten W, 2005, CELL CYCLE, V4, P1593; Di Costanzo A, 2012, J BIOL CHEM, V287, P30170, DOI 10.1074/jbc.M112.349951; Eymin B, 2002, ONCOGENE, V21, P2750, DOI 10.1038/sj.onc.1205359; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Inoue R, 2005, BIOCHEM BIOPH RES CO, V330, P1314, DOI 10.1016/j.bbrc.2005.03.117; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lohrum MAE, 2000, CURR BIOL, V10, P539, DOI 10.1016/S0960-9822(00)00472-3; LUNA RMD, 1995, NATURE, V378, P203; Muniz VP, 2011, MOL CANCER RES, V9, P867, DOI 10.1158/1541-7786.MCR-10-0475; Pimkina J, 2009, AUTOPHAGY, V5, P397, DOI 10.4161/auto.5.3.7782; Pollice A, 2007, ONCOGENE, V26, P5154, DOI 10.1038/sj.onc.1210313; Pollice A, 2004, J BIOL CHEM, V279, P6345, DOI 10.1074/jbc.M310957200; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sepe M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022800, DOI 10.1371/J0URNAL.P0NE.0022800]; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Vivo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053631; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175	34	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117252	10.1371/journal.pone.0117252	http://dx.doi.org/10.1371/journal.pone.0117252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723571	gold, Green Published, Green Submitted			2022-12-26	WOS:000350251200026
J	Mannangatti, P; NarasimhaNaidu, K; Damaj, MI; Ramamoorthy, S; Jayanthi, LD				Mannangatti, Padmanabhan; NarasimhaNaidu, Kamalakkannan; Damaj, Mohamad Imad; Ramamoorthy, Sammanda; Jayanthi, Lankupalle Damodara			A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-OPIOID RECEPTOR; INSENSITIVE DOPAMINE TRANSPORTER; EXTRACELLULAR DOPAMINE; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; SURFACE EXPRESSION; SUBCELLULAR-LOCALIZATION; SEROTONIN TRANSPORTERS; INDUCED REINSTATEMENT	The noradrenergic and p38 mitogen-activated protein kinase (p38 MAPK) systems are implicated in cocaine-elicited behaviors. Previously, we demonstrated a role for p38 MAPK-mediated norepinephrine transporter (NET) Thr(30) phosphorylation in cocaine-induced NET up-regulation (Mannangatti, P., Arapulisamy, O., Shippenberg, T. S., Ramamoorthy, S., and Jayanthi, L. D. (2011) J. Biol. Chem. 286, 20239-20250). The present study explored the functional interaction between p38 MAPK-mediated NET regulation and cocaine-induced behaviors. In vitro cocaine treatment of mouse prefrontal cortex synaptosomes resulted in enhanced NET function, surface expression, and phosphorylation. Pretreatment with PD169316, a p38 MAPK inhibitor, completely blocked cocaine-mediated NET up-regulation and phosphorylation. In mice, in vivo administration of p38 MAPK inhibitor SB203580 completely blocked cocaine-induced NET up-regulation and p38 MAPK activation in the prefrontal cortex and nucleus accumbens. When tested for cocaine-induced locomotor sensitization and conditioned place preference (CPP), mice receiving SB203580 on cocaine challenge day or on postconditioning test day exhibited significantly reduced cocaine sensitization and CPP. A transactivator of transcription (TAT) peptide strategy was utilized to test the involvement of the NET-Thr(30) motif. In vitro treatment of synaptosomes with TAT-NET-Thr(30) (wild-type peptide) completely blocked cocaine-mediated NET up-regulation and phosphorylation. In vivo administration of TAT-NET-Thr(30) peptide but not TAT-NET-T30A (mutant peptide) completely blocked cocaine-mediated NET up-regulation and phosphorylation. In the cocaine CPP paradigm, mice receiving TAT-NET-Thr30 but not TAT-NET-T30A on postconditioning test day exhibited significantly reduced cocaine CPP. Following extinction, TAT-NET-Thr(30) when given prior to cocaine challenge significantly reduced reinstatement of cocaine CPP. These results demonstrate that the direct inhibition of p38 MAPK or the manipulation of NET-Thr(30) motif/phosphorylation via a TAT peptide strategy prevents cocaine-induced NET up-regulation, locomotor sensitization, and CPP, suggesting a role for Thr(30)-linked NET regulation in cocaine-elicited behaviors.	[Mannangatti, Padmanabhan; NarasimhaNaidu, Kamalakkannan; Damaj, Mohamad Imad; Ramamoorthy, Sammanda; Jayanthi, Lankupalle Damodara] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Virginia Commonwealth University	Jayanthi, LD (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	ljayanthi@vcu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01-GM081054, R01-MH083928]; Virginia Commonwealth University; department of Pharmacology and Toxicology, Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; department of Pharmacology and Toxicology, Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM081054 (to L. D. J.) and R01-MH083928 (to S. R.). This work was also supported by start-up funds from Virginia Commonwealth University (to L. D. J. and S. R.).; Recipient of postdoctoral support from the department of Pharmacology and Toxicology, Virginia Commonwealth University.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Arai A, 2008, SYNAPSE, V62, P632, DOI 10.1002/syn.20535; Arapulisamy O, 2013, J BIOL CHEM, V288, P28599, DOI 10.1074/jbc.M113.472878; ASTIER B, 1990, NEUROSCI LETT, V118, P141, DOI 10.1016/0304-3940(90)90612-D; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; AXELROD J, 1971, SCIENCE, V173, P598, DOI 10.1126/science.173.3997.598; Barker Eric L., 1995, P321; Borgkvist A, 2011, NEURON, V70, P803, DOI 10.1016/j.neuron.2011.05.024; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Bruss M, 1999, J NEURAL TRANSM, V106, P657, DOI 10.1007/s007020050187; CAO CJ, 1990, BIOCHEM PHARMACOL, V39, pR9, DOI 10.1016/0006-2952(90)90275-P; Carboni E, 2006, J NEUROCHEM, V96, P473, DOI 10.1111/j.1471-4159.2005.03556.x; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Chen H, 2009, NEUROSCI LETT, V452, P258, DOI 10.1016/j.neulet.2009.01.078; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Choe ES, 2002, NEUROREPORT, V13, P1013, DOI 10.1097/00001756-200206120-00006; Conrad KL, 2013, PSYCHOPHARMACOLOGY, V227, P109, DOI 10.1007/s00213-012-2944-1; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Devoto P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-31; Ding YS, 2010, SYNAPSE, V64, P30, DOI 10.1002/syn.20696; Doucet EL, 2013, BIOL PSYCHIAT, V74, P90, DOI 10.1016/j.biopsych.2012.11.029; Fan L, 2009, J PHARMACOL EXP THER, V328, P99, DOI 10.1124/jpet.108.145201; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fritz JD, 1998, J NEUROCHEM, V70, P2241; Fujita Y, 2012, PHARMACOL BIOCHEM BE, V101, P303, DOI 10.1016/j.pbb.2012.01.005; Gurguis GNM, 1999, PSYCHIAT RES, V89, P73, DOI 10.1016/S0165-1781(99)00103-1; Hall FS, 2002, NEUROSCIENCE, V115, P153, DOI 10.1016/S0306-4522(02)00379-2; Ignatowska-Jankowska BM, 2013, PSYCHOPHARMACOLOGY, V229, P591, DOI 10.1007/s00213-013-3117-6; Itzhak Y, 2012, ADDICT BIOL, V17, P706, DOI 10.1111/j.1369-1600.2011.00334.x; Jackson KJ, 2013, PSYCHOPHARMACOLOGY, V226, P763, DOI 10.1007/s00213-012-2716-y; Jackson KJ, 2012, GENES BRAIN BEHAV, V11, P993, DOI 10.1111/j.1601-183X.2012.00827.x; Jackson KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051154; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Jeannotte AM, 2009, NEUROSCI LETT, V467, P86, DOI 10.1016/j.neulet.2009.10.010; Kalivas PW, 2011, MOL PSYCHIATR, V16, P974, DOI 10.1038/mp.2011.46; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Kaye DM, 1997, AM J PHYSIOL-HEART C, V272, pH875, DOI 10.1152/ajpheart.1997.272.2.H875; Kivell B, 2014, NEUROPHARMACOLOGY, V86, P228, DOI 10.1016/j.neuropharm.2014.07.016; KLEVEN MS, 1990, PSYCHOPHARMACOLOGY, V101, P208, DOI 10.1007/BF02244128; Kota D, 2007, J PHARMACOL EXP THER, V322, P399, DOI 10.1124/jpet.107.121616; Li GH, 2005, J PHARMACOL EXP THER, V312, P112, DOI 10.1124/jpet.104.073494; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Mannangatti P, 2011, J BIOL CHEM, V286, P20239, DOI 10.1074/jbc.M111.226811; Marquez P, 2013, EUR J PHARMACOL, V707, P41, DOI 10.1016/j.ejphar.2013.03.021; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; MELLO NK, 1990, DRUG ALCOHOL DEPEN, V26, P103, DOI 10.1016/0376-8716(90)90117-W; Moron JA, 2003, J NEUROSCI, V23, P8480; Murphy Stephen, 2005, Cardiol Rev, V13, P3; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; O'Neill B, 2014, NEUROPHARMACOLOGY, V79, P626, DOI 10.1016/j.neuropharm.2013.12.023; Olive MF, 2005, MOL PHARMACOL, V67, P349, DOI 10.1124/mol.104.003319; Olive MF, 2004, MOL NEUROBIOL, V29, P139, DOI 10.1385/MN:29:2:139; Platt DM, 2007, J PHARMACOL EXP THER, V322, P894, DOI 10.1124/jpet.107.121806; Pum ME, 2008, PSYCHOPHARMACOLOGY, V201, P391, DOI 10.1007/s00213-008-1296-3; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rickhag M, 2013, J BIOL CHEM, V288, P27534, DOI 10.1074/jbc.M112.441295; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Smith JS, 2012, J NEUROSCI, V32, P1488, DOI 10.1523/JNEUROSCI.2980-11.2012; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Sorg BA, 1997, J PHARMACOL EXP THER, V281, P54; Steinkellner T, 2014, NEUROPSYCHOPHARMACOL, V39, P2681, DOI 10.1038/npp.2014.124; Tejeda HA, 2013, NEUROPSYCHOPHARMACOL, V38, P1770, DOI 10.1038/npp.2013.76; TELLA SR, 1995, PHARMACOL BIOCHEM BE, V51, P687, DOI 10.1016/0091-3057(94)00438-O; Tzschentke TM, 1998, BEHAV BRAIN RES, V97, P115, DOI 10.1016/S0166-4328(98)00034-5; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Valentini V, 2004, J NEUROCHEM, V88, P917, DOI 10.1046/j.1471-4159.2003.02238.x; Valjent E, 2005, M S-MED SCI, V21, P453, DOI 10.1051/medsci/2005215453; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Zhang L, 1998, MOL BRAIN RES, V59, P66, DOI 10.1016/S0169-328X(98)00138-7; Zhu CB, 2010, NEUROPSYCHOPHARMACOL, V35, P2510, DOI 10.1038/npp.2010.116	79	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10814	10827		10.1074/jbc.M114.612192	http://dx.doi.org/10.1074/jbc.M114.612192			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	CG6IX	25724654	Green Published, hybrid			2022-12-26	WOS:000353404500022
J	Pena-Munzenmayer, G; Catalan, MA; Kondo, Y; Jaramillo, Y; Liu, F; Shull, GE; Melvin, JE				Pena-Muenzenmayer, Gaspar; Catalan, Marcelo A.; Kondo, Yusuke; Jaramillo, Yasna; Liu, Frances; Shull, Gary E.; Melvin, James E.			Ae4 (Slc4a9) Anion Exchanger Drives Cl- Uptake-dependent Fluid Secretion by Mouse Submandibular Gland Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-/HCO3-EXCHANGER; SALIVARY-GLAND; UP-REGULATION; TARGETED DISRUPTION; INTERCALATED CELLS; INTRACELLULAR PH; ION-TRANSPORT; MICE LACKING; COTRANSPORTER; HCO3	Transcellular Cl- movement across acinar cells is the rate-limiting step for salivary gland fluid secretion. Basolateral Nkcc1 Na+-K+-2Cl(-) cotransporters play a critical role in fluid secretion by promoting the intracellular accumulation of Cl- above its equilibrium potential. However, salivation is only partially abolished in the absence of Nkcc1 cotransporter activity, suggesting that another Cl- uptake pathway concentrates Cl- ions in acinar cells. To identify alternative molecular mechanisms, we studied mice lacking Ae2 and Ae4 Cl-/HCO3- exchangers. We found that salivation stimulated by muscarinic and beta-adrenergic receptor agonists was normal in the submandibular glands of Ae2(-/-) mice. In contrast, saliva secretion was reduced by 35% in Ae4(-/-) mice. The decrease in salivation was not related to loss of Na+-K+-2Cl(-) cotransporter or Na+/H+ exchanger activity in Ae4(-/-) mice but correlated with reduced Cl- uptake during beta-adrenergic receptor activation of cAMP signaling. Direct measurements of Cl-/HCO3- exchanger activity revealed that HCO3--dependent Cl- uptake was reduced in the acinar cells of Ae2(-/-) and Ae4(-/-) mice. Moreover, Cl-/HCO3- exchanger activity was nearly abolished in double Ae4/Ae2 knock-out mice, suggesting that most of the Cl-/HCO3- exchanger activity in submandibular acinar cells depends on Ae2 and Ae4 expression. In conclusion, both Ae2 and Ae4 anion exchangers are functionally expressed in submandibular acinar cells; however, only Ae4 expression appears to be important for cAMP-dependent regulation of fluid secretion.	[Pena-Muenzenmayer, Gaspar; Catalan, Marcelo A.; Kondo, Yusuke; Jaramillo, Yasna; Liu, Frances; Melvin, James E.] NIDCR, Secretory Mech & Dysfunct Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Shull, Gary E.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Coll Med, Cincinnati, OH 45267 USA; [Kondo, Yusuke] Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kitakyushu, Fukuoka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Ohio; University of Cincinnati; Kyushu Dental University	Melvin, JE (corresponding author), NIDCR, Secretory Mech & Dysfunct Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	james.melvin@nih.gov	Catalan, Marcelo/ABE-7044-2021; Pena-Munzenmayer, Gaspar/ABD-2296-2021; Catalan, Marcelo/AAW-3848-2020; Regan, Clinton/E-6250-2012	Pena-Munzenmayer, Gaspar/0000-0001-6633-0545; Catalan, Marcelo/0000-0003-3544-2821; Kondo, Yusuke/0000-0002-1975-3796	National Institutes of Health (NIH), NIDCR, Division of Intramural Research; NIH [DK050594]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIEDE000727, ZIADE000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050594, R01DK050594] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIDCR, Division of Intramural Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIDCR, Division of Intramural Research (to the Secretory Mechanisms and Dysfunction Section) and NIH Grant DK050594 (to G. E. S.).	ATKINSON JC, 1994, J AM DENT ASSOC, V125, P409, DOI 10.14219/jada.archive.1994.0059; CASE RM, 1982, J PHYSIOL-LONDON, V322, P273, DOI 10.1113/jphysiol.1982.sp014037; Catalan MA, 2014, CELL CALCIUM, V55, P362, DOI 10.1016/j.ceca.2014.01.005; Catalan MA, 2010, J PHYSIOL-LONDON, V588, P713, DOI 10.1113/jphysiol.2009.183541; Chambrey R, 2013, P NATL ACAD SCI USA, V110, P7928, DOI 10.1073/pnas.1221496110; CHAO AC, 1989, BIOPHYS J, V56, P1071, DOI 10.1016/S0006-3495(89)82755-9; Coury F, 2013, P NATL ACAD SCI USA, V110, P2163, DOI 10.1073/pnas.1206392110; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Evans RL, 1999, J BIOL CHEM, V274, P29025, DOI 10.1074/jbc.274.41.29025; Evans RL, 2000, J BIOL CHEM, V275, P26720; Evans RL, 1997, J PHYSIOL-LONDON, V499, P351, DOI 10.1113/jphysiol.1997.sp021932; FAELLI A, 1984, PHARMACOL RES COMMUN, V16, P339, DOI 10.1016/S0031-6989(84)80002-8; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Flodby P, 2010, AM J RESP CELL MOL, V43, P173, DOI 10.1165/rcmb.2009-0226OC; Gawenis LR, 2010, AM J PHYSIOL-GASTR L, V298, pG493, DOI 10.1152/ajpgi.00178.2009; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Gonzalez-Begne M, 2007, J BIOL CHEM, V282, P35125, DOI 10.1074/jbc.M707266200; Grubb BR, 2000, AM J PHYSIOL-GASTR L, V279, pG707, DOI 10.1152/ajpgi.2000.279.4.G707; Grubb BR, 2001, AM J PHYSIOL-CELL PH, V281, pC615, DOI 10.1152/ajpcell.2001.281.2.C615; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Ko SBH, 2002, AM J PHYSIOL-CELL PH, V283, pC1206, DOI 10.1152/ajpcell.00512.2001; KOEFOEDJOHNSEN V, 1958, ACTA PHYSIOL SCAND, V42, P298, DOI 10.1111/j.1748-1716.1958.tb01563.x; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Lee MG, 2008, GUT, V57, P1037, DOI 10.1136/gut.2008.150961; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MELVIN JE, 1992, AM J PHYSIOL, V262, pG393, DOI 10.1152/ajpgi.1992.262.3.G393; Nakamoto T, 2007, AM J PHYSIOL-REG I, V292, pR2380, DOI 10.1152/ajpregu.00591.2006; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; NAUNTOFTE B, 1992, AM J PHYSIOL, V263, pG823, DOI 10.1152/ajpgi.1992.263.6.G823; Nguyen HV, 2004, AM J PHYSIOL-GASTR L, V286, pG312, DOI 10.1152/ajpgi.00158.2003; Nguyen HV, 2000, J PHYSIOL-LONDON, V523, P139, DOI 10.1111/j.1469-7793.2000.t01-2-00139.x; NOVAK I, 1986, PFLUG ARCH EUR J PHY, V407, P649, DOI 10.1007/BF00582647; Park K, 2000, J KOREAN MED SCI, V15, pS5, DOI 10.3346/jkms.2000.15.S.S5; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Parker MD, 2002, FASEB J, V16, pA796; PAULAIS M, 1992, J CLIN INVEST, V89, P1142, DOI 10.1172/JCI115695; PIRANI D, 1987, PFLUG ARCH EUR J PHY, V408, P178, DOI 10.1007/BF00581349; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; QUINTON PM, 1999, PHYSIOL REV, V79, P3; Reuss L, 2001, J MEMBRANE BIOL, V184, P211, DOI 10.1007/s00232-001-0096-z; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Romanenko VG, 2008, AM J PHYSIOL-GASTR L, V295, pG1058, DOI 10.1152/ajpgi.90384.2008; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; Seidler U, 2001, JOP, V2, P247; Sekler I, 1996, CELL, V86, P929, DOI 10.1016/S0092-8674(00)80168-3; Shahidullah M, 2013, AM J PHYSIOL-CELL PH, V305, pC492, DOI 10.1152/ajpcell.00057.2013; Simpson JE, 2007, AM J PHYSIOL-GASTR L, V292, pG1079, DOI 10.1152/ajpgi.00354.2006; Suzuki M, 2006, CELL MOL LIFE SCI, V63, P12, DOI 10.1007/s00018-005-5336-4; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tsuganezawa H, 2001, J BIOL CHEM, V276, P8180, DOI 10.1074/jbc.M004513200; VEGA FV, 1988, ACTA PHYSIOL SCAND, V134, P543, DOI 10.1111/j.1365-201X.1988.tb10633.x; Walker NM, 2002, GASTROENTEROLOGY, V123, P531, DOI 10.1053/gast.2002.34757; Xu J, 2003, AM J PHYSIOL-GASTR L, V285, pG1225, DOI 10.1152/ajpgi.00236.2003	58	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10677	10688		10.1074/jbc.M114.612895	http://dx.doi.org/10.1074/jbc.M114.612895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25745107	Green Published, hybrid			2022-12-26	WOS:000353404500011
J	Hussain, T; Mastrodimos, MB; Raju, SC; Glasgow, HL; Whitney, M; Friedman, B; Moore, JD; Kleinfeld, D; Steinbach, P; Messer, K; Pu, MY; Tsien, RY; Nguyen, QT				Hussain, Timon; Mastrodimos, Melina B.; Raju, Sharat C.; Glasgow, Heather L.; Whitney, Michael; Friedman, Beth; Moore, Jeffrey D.; Kleinfeld, David; Steinbach, Paul; Messer, Karen; Pu, Minya; Tsien, Roger Y.; Nguyen, Quyen T.			Fluorescently Labeled Peptide Increases Identification of Degenerated Facial Nerve Branches during Surgery and Improves Functional Outcome	PLOS ONE			English	Article							ENDONEURIAL CHANGES; RAT; WHISKING; HEAD; TRANSECTION; RECOVERY; MUSCLE; CORTEX	Nerve degeneration after transection injury decreases intraoperative visibility under white light (WL), complicating surgical repair. We show here that the use of fluorescently labeled nerve binding probe (F-NP41) can improve intraoperative visualization of chronically (up to 9 months) denervated nerves. In a mouse model for the repair of chronically denervated facial nerves, the intraoperative use of fluorescent labeling decreased time to nerve identification by 40% compared to surgeries performed under WL alone. Cumulative functional post-operative recovery was also significantly improved in the fluorescence guided group as determined by quantitatively tracking of the recovery of whisker movement at time intervals for 6 weeks post-repair. To our knowledge, this is the first description of an injectable probe that increases visibility of chronically denervated nerves during surgical repair in live animals. Future translation of this probe may improve functional outcome for patients with chronic denervation undergoing surgical repair.	[Hussain, Timon; Mastrodimos, Melina B.; Raju, Sharat C.; Nguyen, Quyen T.] Univ Calif San Diego, Div Head & Neck Surg, La Jolla, CA 92093 USA; [Glasgow, Heather L.; Whitney, Michael; Friedman, Beth; Tsien, Roger Y.; Nguyen, Quyen T.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Moore, Jeffrey D.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Steinbach, Paul; Tsien, Roger Y.] Howard Hughes Med Inst, San Diego, CA USA; [Messer, Karen; Pu, Minya] Univ Calif San Diego, Moores Canc Ctr, Div Biostat, La Jolla, CA 92093 USA; [Nguyen, Quyen T.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Nguyen, QT (corresponding author), Univ Calif San Diego, Div Head & Neck Surg, La Jolla, CA 92093 USA.	q1nguyen@ucsd.edu	Glasgow, Heather/ABA-9587-2020	Glasgow, Heather/0000-0002-6594-9837	NIH (NIBIB) [R01 EB014929-01]; Burroughs-Wellcome Fund-(CAMS); NIH [R01 NS058668, 03/01/2007-04/30/2018]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058668, R01NS027177] Funding Source: NIH RePORTER	NIH (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Burroughs-Wellcome Fund-(CAMS)(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by NIH (NIBIB) R01 EB014929-01 to QTN (Title: Testing Fluorescently Labeled Probes for Nerve Imaging during Surgery); Burroughs-Wellcome Fund-(CAMS) to QTN (Title: Testing surgery guided by molecular fluorescence imaging); NIH R01 NS058668 to DK, 03/01/2007-04/30/2018 (Title: Sensorimotor Loops in Vibrissa Somatosensation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascom D A, 2000, Facial Plast Surg, V16, P309, DOI 10.1055/s-2000-15545; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Danner CJ, 2008, OTOLARYNG CLIN N AM, V41, P619, DOI 10.1016/j.otc.2008.01.008; Dohm S, 2000, RESTOR NEUROL NEUROS, V16, P117; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Goh HKC, 2010, LANCET ONCOL, V11, P281, DOI 10.1016/S1470-2045(09)70379-1; Gordon T, 2004, NEUROL RES, V26, P174, DOI 10.1179/016164104225013806; Grosheva M, 2008, BIOL CHEM, V389, P873, DOI 10.1515/BC.2008.100; Guntinas-Lichius O, 2006, AM J SURG, V191, P61, DOI 10.1016/j.amjsurg.2005.05.054; Guntinas-Lichius O, 2005, EUR J NEUROSCI, V21, P391, DOI 10.1111/j.1460-9568.2005.03877.x; Guntinas-Lichius Orlando, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P133, DOI 10.1097/00020840-200404000-00014; Hayashi A, 2007, J RECONSTR MICROSURG, V23, P381, DOI 10.1055/s-2007-992344; Hohman MH, 2013, LARYNGOSCOPE; Hohman MH, 2013, LARYNGOSCOPE; Hohman MH, 2013, JAMA FACIAL PLA 1114; Iseli TA, 2010, LARYNGOSCOPE, V120, P478, DOI 10.1002/lary.20789; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Mehta RP, 2009, CLIN EXP OTORHINOLAR, V2, P1, DOI 10.3342/ceo.2009.2.1.1; Moore JD, 2013, NATURE, V497, P205, DOI 10.1038/nature12076; Ngeow WC, 2010, ORAL SURG ORAL MED O, V109, P357, DOI 10.1016/j.tripleo.2009.06.030; Ozmen OA, 2011, OTOL NEUROTOL, V32, P1341, DOI 10.1097/MAO.0b013e31822e952d; Reddy PG, 1999, LARYNGOSCOPE, V109, P894, DOI 10.1097/00005537-199906000-00010; ROYTTA M, 1988, ACTA NEUROPATHOL, V76, P35; ROYTTA M, 1987, ACTA NEUROPATHOL, V73, P323; Rudman KL, 2012, OTOLARYNG CLIN N AM, V45, P513, DOI 10.1016/j.otc.2011.12.015; Streppel M, 1998, NEUROBIOL AGING, V19, P83, DOI 10.1016/S0197-4580(97)00163-2; Volk GF, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-25; Wei Y, 2013, CELL TISSUE RES; Whitney MA, 2011, NAT BIOTECHNOL, V29, P352, DOI 10.1038/nbt.1764; Wu AP, 2011, LARYNGOSCOPE, V121, P805, DOI 10.1002/lary.21411; Yetiser S, 2007, ANN OTO RHINOL LARYN, V116, P542, DOI 10.1177/000348940711600710	35	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119600	10.1371/journal.pone.0119600	http://dx.doi.org/10.1371/journal.pone.0119600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751149	Green Published, gold			2022-12-26	WOS:000350692700029
J	Yang, JR; Kuo, CY; Huang, HY; Wu, FT; Huang, YL; Cheng, CY; Su, YT; Wu, HS; Liu, MT				Yang, Ji-Rong; Kuo, Chuan-Yi; Huang, Hsiang-Yi; Wu, Fu-Ting; Huang, Yi-Lung; Cheng, Chieh-Yu; Su, Yu-Ting; Wu, Ho-Sheng; Liu, Ming-Tsan			Characterization of Influenza A (H7N9) Viruses Isolated from Human Cases Imported into Taiwan	PLOS ONE			English	Article							AVIAN INFLUENZA; HUMAN INFECTION; A(H7N9) VIRUS; REASSORTMENT; DIVERSITY; MARKETS; ORIGIN	A novel avian influenza A (H7N9) virus causes severe human infections and was first identified in March 2013 in China. The H7N9 virus has exhibited two epidemiological peaks of infection, occurring in week 15 of 2013 and week 5 of 2014. Taiwan, which is geographically adjacent to China, faces a large risk of being affected by this virus. Through extensive surveillance, launched in April 2013, four laboratory-confirmed H7N9 cases imported from China have been identified in Taiwan. The H7N9 virus isolated from imported case 1 in May 2013 (during the first wave) was found to be closest genetically to a virus from wild birds and differed from the prototype virus, A/Anhui/1/2013, in the MP gene. The other three imported cases were detected in December 2013 and April 2014 (during the second wave). The viruses isolated from cases 2 and 4 were similar in the compositions of their 6 internal genes and distinct from A/Anhui/1/2013 in the PB2 and MP genes, whereas the virus isolated from case 3 exhibited a novel reassortment that has not been identified previously and was different from A/Anhui/1/2013 in the PB2, PA and MP genes. The four imported H7N9 viruses share similar antigenicity with A/Anhui/1/2013, and their HA and NA genes grouped together in their respective phylogenies. In contrast with the HA and NA genes, which exhibited a smaller degree of diversity, the internal genes were heterogeneous and provided potential distinctions between transmission sources in terms of both geography and hosts. It is important to strengthen surveillance of influenza and to share viral genetic data in real-time for reducing the threat of rapid and continuing evolution of H7N9 viruses.	[Yang, Ji-Rong; Kuo, Chuan-Yi; Huang, Hsiang-Yi; Wu, Fu-Ting; Huang, Yi-Lung; Cheng, Chieh-Yu; Su, Yu-Ting; Wu, Ho-Sheng; Liu, Ming-Tsan] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University	Wu, HS (corresponding author), Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan.	wuhs@cdc.gov.tw; mtliu@cdc.gov.tw			Centers for Disease Control, Ministry of Health and Welfare, Taiwan [MOHW103-CDC-C-315-000101, MOHW103-CDC-C-315-000601]	Centers for Disease Control, Ministry of Health and Welfare, Taiwan	This study was supported by grants from Centers for Disease Control, Ministry of Health and Welfare, Taiwan (MOHW103-CDC-C-315-000101 and MOHW103-CDC-C-315-000601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu W, 2014, J VIROL, V88, P13344, DOI 10.1128/JVI.01777-14; Lo YC, 2013, EURO SURVEILL, V18; Lu J, 2014, J VIROL, V88, P8297, DOI 10.1128/JVI.00630-14; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; To KKW, 2014, J INFECTION, V69, P60, DOI 10.1016/j.jinf.2014.02.012; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; WHO, 2014, WHO RISK ASSESSMENT; WHO, 2014, ANTIGENIC AND GENETI; WHO, 2013, REAL TIME RT PCR PRO; WHO, 2014, WHO HUMAN INFECTION; WHO, 2014, MAP AND EPIDEMIOLOGI; WHO, 2012, WHO INFORMATION FOR; World Health Organization, 2011, MANUAL FOR THE LABOR; Yang JR, 2014, J CLIN MICROBIOL, V52, P76, DOI 10.1128/JCM.02467-13; Yang JR, 2009, J CLIN MICROBIOL, V47, P3714, DOI 10.1128/JCM.01646-09; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu XF, 2014, J VIROL, V88, P3423, DOI 10.1128/JVI.02059-13; Zhang J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04846; Zhao BH, 2014, EMERG INFECT DIS, V20, P850, DOI 10.3201/eid2005.131707	32	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119792	10.1371/journal.pone.0119792	http://dx.doi.org/10.1371/journal.pone.0119792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748033	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400087
J	Azimi, MS; Myers, L; Lacey, M; Stewart, SA; Shi, Q; Katakam, PV; Mondal, D; Murfee, WL				Azimi, Mohammad S.; Myers, Leann; Lacey, Michelle; Stewart, Scott A.; Shi, Qirong; Katakam, Prasad V.; Mondal, Debasis; Murfee, Walter L.			An Ex Vivo Model for Anti-Angiogenic Drug Testing on Intact Microvascular Networks	PLOS ONE			English	Article							IN-VITRO; CHORIOALLANTOIC MEMBRANE; SHEAR-STRESS; GROWTH; VEGF; CANCER; TISSUE; ASSAY	New models of angiogenesis that mimic the complexity of real microvascular networks are needed. Recently, our laboratory demonstrated that cultured rat mesentery tissues contain viable microvascular networks and could be used to probe pericyte-endothelial cell interactions. The objective of this study was to demonstrate the efficacy of the rat mesentery culture model for anti-angiogenic drug testing by time-lapse quantification of network growth. Mesenteric windows were harvested from adult rats, secured in place with an insert, and cultured for 3 days according to 3 experimental groups: 1) 10% serum (angiogenesis control), 2) 10% serum + sunitinib (SU11248), and 3) 10% serum + bevacizumab. Labeling with FITC conjugated BSI-lectin on Day 0 and 3 identified endothelial cells along blood and lymphatic microvascular networks. Comparison between day 0 (before) and 3 (after) in networks stimulated by 10% serum demonstrated a dramatic increase in vascular density and capillary sprouting. Growing networks contained proliferating endothelial cells and NG2+ vascular pericytes. Media supplementation with sunitinib (SU11248) or bevacizumab both inhibited the network angiogenic responses. The comparison of the same networks before and after treatment enabled the identification of tissue specific responses. Our results establish, for the first time, the ability to evaluate an anti-angiogenic drug based on time-lapse imaging on an intact microvascular network in an ex vivo scenario.	[Azimi, Mohammad S.; Stewart, Scott A.; Shi, Qirong; Murfee, Walter L.] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Myers, Leann] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Lacey, Michelle] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Katakam, Prasad V.; Mondal, Debasis] Tulane Univ, Dept Pharmacol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University; Tulane University	Azimi, MS (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	mazimi@tulane.edu	K, P/AAL-6310-2021	Katakam, Prasad/0000-0002-4708-9140	National Institutes of Health [5-P20GM103629-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (5-P20GM103629-02) to WLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Albertsson P, 2012, APMIS, V120, P147, DOI 10.1111/j.1600-0463.2011.02830.x; Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Chan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050582; Chung AS, 2012, J PATHOL, V227, P404, DOI 10.1002/path.4052; Dib E, 2012, CURR EYE RES, V37, P567, DOI 10.3109/02713683.2011.635916; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Galie PA, 2014, P NATL ACAD SCI USA, V111, P7968, DOI 10.1073/pnas.1310842111; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hsu YH, 2013, LAB CHIP, V13, P81, DOI [10.1039/c2lc40787f, 10.1039/c2lc407871]; Kaunas R, 2011, CELL MOL BIOENG, V4, P547, DOI 10.1007/s12195-011-0208-5; Lennernas B, 2004, APMIS, V112, P201, DOI 10.1111/j.1600-0463.2004.apm1120306.x; Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074; NICOSIA RF, 1990, LAB INVEST, V63, P115; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; OLIVO M, 1992, ANAT RECORD, V234, P105, DOI 10.1002/ar.1092340112; Osusky Katherine L., 2004, Angiogenesis, V7, P225, DOI 10.1007/s10456-004-3149-y; Peirce SM, 2012, CURR OPIN HEMATOL, V19, P184, DOI 10.1097/MOH.0b013e3283523ea6; Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130; Skalak Thomas C., 1996, Microcirculation (Philadelphia), V3, P143, DOI 10.3109/10739689609148284; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Stapor PC, 2013, AM J PHYSIOL-HEART C, V304, pH235, DOI 10.1152/ajpheart.00552.2012; Stapor PC, 2012, J VASC RES, V49, P299, DOI 10.1159/000336714; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Sweat RS, 2012, LYMPHAT RES BIOL, V10, P198, DOI 10.1089/lrb.2012.0014; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Unoki N, 2010, INVEST OPHTH VIS SCI, V51, P2347, DOI 10.1167/iovs.09-4158; WILTING J, 1991, ANAT EMBRYOL, V183, P259; Yang M, 2012, JOVE-J VIS EXP, DOI 10.3791/3954	30	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119227	10.1371/journal.pone.0119227	http://dx.doi.org/10.1371/journal.pone.0119227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742654	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100093
J	Besic, V; Shi, HJ; Stubbs, RS; Hayes, MT				Besic, Vinko; Shi, Hongjun; Stubbs, Richard S.; Hayes, Mark T.			Aberrant Liver Insulin Receptor Isoform A Expression Normalises with Remission of Type 2 Diabetes after Gastric Bypass Surgery	PLOS ONE			English	Article							GROWTH-FACTOR-II; MESSENGER-RNA; NEONATAL HEPATOCYTES; SPLICE VARIANTS; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; HIGH-AFFINITY; HEPG2 CELLS; RESISTANCE; CANCER	Type 2 diabetes mellitus ( T2DM) results from a combination of progressive insulin resistance and loss of pancreatic beta cell function and/or mass. Insulin signalling occurs through the insulin receptor, (INSR) which is alternatively spliced into two isoforms: INSRA (-exon 11) and INSRB (+exon 11). Because the INSR isoforms have different functional characteristics, their relative expression ratio has been implicated in the pathogenesis of insulin resistance and T2DM. We studied levels of INSR isoform mRNA in liver samples taken from 46 individuals with or without T2DM at Roux-en-Y (RYGB) surgery, and on average 17 (+/- 5.6) months later in 16 of the same individuals (8 diabetic and non-diabetic patients). INSRA or INSRB was also overexpressed in HepG2 cells to ascertain their effect on AKT phosphorylation and PCK1 expression as markers of insulin-mediated metabolic signalling. We found the INSRB:A isoform ratio was reduced in individuals with T2DM in comparison to those with normal glucose tolerance and normalised with remission of diabetes. The INSRB:A ratio increased due to a reduction in the alternatively spliced INSRA isoform following remission of diabetes. Overexpressing INSRA isoform in HepG2 hepatoma cells reduced inhibition of PCK1 transcription and did not increase AKT phosphorylation in response to insulin load compared to the effect of overexpressing the B isoform. Data presented here revitalizes the role of the INSR isoforms in the pathogenesis of T2DM, and suggests that an abrogated INSRB:A ratio that favours the INSRA isoform may negatively impact insulin-mediated metabolic signalling.	[Besic, Vinko; Shi, Hongjun; Stubbs, Richard S.; Hayes, Mark T.] Univ Otago, Wakefield Biomed Res Unit, Dept Pathol & Mol Med, Wellington, New Zealand; [Stubbs, Richard S.] Wakefield Hosp, Wakefield Clin, Wellington, New Zealand; [Hayes, Mark T.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	University of Otago; Australian National University; John Curtin School of Medical Research	Besic, V (corresponding author), Univ Otago, Wakefield Biomed Res Unit, Dept Pathol & Mol Med, Wellington, New Zealand.	vinko.besic@otago.ac.nz; mark.hayes@anu.edu.au	Besic, Vinko/K-2955-2015	Besic, Vinko/0000-0002-8137-1019	Wellington Medical Research Foundation; Wakefield Gastroenterology Research Trust; Wakefield Clinic	Wellington Medical Research Foundation; Wakefield Gastroenterology Research Trust; Wakefield Clinic	This work was supported by the Wellington Medical Research Foundation, Wakefield Gastroenterology Research Trust and the Wakefield Clinic who provided contributions to salaries and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CM, 1993, J CLIN ENDOCR METAB, V76, P1380, DOI 10.1210/jc.76.5.1380; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; BENECKE H, 1992, J CLIN INVEST, V89, P2066, DOI 10.1172/JCI115819; Birkenfeld AL, 2011, J BIOL CHEM, V286, P36163, DOI 10.1074/jbc.M111.228817; Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bock G, 2007, DIABETES, V56, P1703, DOI 10.2337/db06-1776; Braatvedt G, 2006, NZ MED J, P119; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Campos GM, 2010, J GASTROINTEST SURG, V14, P15, DOI 10.1007/s11605-009-1060-y; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; De Meyts P, 2012, ENDOCRINOLOGY, V153, P2054, DOI 10.1210/en.2012-1234; Denley A, 2003, HORM METAB RES, V35, P778; Di Paola R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019462; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Escribano O, 2009, DIABETES, V58, P820, DOI 10.2337/db08-0551; Foo J, 2011, OBES SURG, V21, P1914, DOI 10.1007/s11695-011-0527-6; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gonzalez-Rodriguez A, 2008, AM J PHYSIOL-GASTR L, V295, pG338, DOI 10.1152/ajpgi.00514.2007; Harrington SC, 2012, GROWTH HORM IGF RES, V22, P108, DOI 10.1016/j.ghir.2012.04.001; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Lima MMO, 2010, J CLIN ENDOCR METAB, V95, P3871, DOI 10.1210/jc.2010-0085; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCLAIN DA, 1991, MOL ENDOCRINOL, V5, P734, DOI 10.1210/mend-5-5-734; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1993, P NATL ACAD SCI USA, V90, P2633, DOI 10.1073/pnas.90.7.2633; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728; Nevado C, 2006, ENDOCRINOLOGY, V147, P3709, DOI 10.1210/en.2005-1663; NORGREN S, 1994, P NATL ACAD SCI USA, V91, P1465, DOI 10.1073/pnas.91.4.1465; NORGREN S, 1993, DIABETES, V42, P675, DOI 10.2337/diabetes.42.5.675; NORGREN S, 1994, BIOCHEM BIOPH RES CO, V199, P277, DOI 10.1006/bbrc.1994.1225; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SELL SM, 1994, J BIOL CHEM, V269, P30769; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; SESTI G, 1995, DIABETOLOGIA, V38, P445, DOI 10.1007/BF00410282; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; White S, 2005, OBES SURG, V15, P155, DOI 10.1381/0960892053268282; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132	54	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119270	10.1371/journal.pone.0119270	http://dx.doi.org/10.1371/journal.pone.0119270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742416	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100098
J	Kim, CH; Kim, SJ; Lee, MJ; Kwon, YE; Kim, YL; Park, KS; Ryu, HJ; Park, JT; Han, SH; Yoo, TH; Kang, SW; Oh, HJ				Kim, Chan Ho; Kim, Seung Jun; Lee, Mi Jung; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; Ryu, Han Jak; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook; Oh, Hyung Jung			An Increase in Mean Platelet Volume from Baseline Is Associated with Mortality in Patients with Severe Sepsis or Septic Shock	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; GOAL-DIRECTED THERAPY; LONG-TERM MORTALITY; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; UNITED-STATES; VALIDATION; DYSFUNCTION; GUIDELINES; INFECTION	Introduction Mean platelet volume (MPV) is suggested as an index of inflammation, disease activity, and anti-inflammatory treatment efficacy in chronic inflammatory disorders; however, the effect of MPV on sepsis mortality remains unclear. Therefore, we investigated whether the change in MPV between hospital admission and 72 hours (Delta MPV72h-adm) predicts 28-day mortality in severe sepsis and/or septic shock. Methods We prospectively enrolled 345 patients admitted to the emergency department (ED) who received standardized resuscitation (early goal-directed therapy) for severe sepsis and/or septic shock between November 2007 and December 2011. Changes in platelet indices, including Delta MPV72h-adm, were compared between survivors and non-survivors by linear mixed model analysis. The prognostic value of Delta MPV72h-adm for 28-day mortality was ascertained by Cox proportional hazards model analysis. Results Thirty-five (10.1%) patients died within 28 days after ED admission. MPV increased significantly during the first 72 hours in non-survivors (P = 0.001) and survivors (P < 0.001); however, the rate of MPV increase was significantly higher in non-survivors (P = 0.003). Nonetheless, the difference in the platelet decline rate over the first 72 hours did not differ significantly between groups (P = 0.360). In multivariate analysis, Delta MPV72h-adm was an independent predictor of 28-day mortality, after adjusting for plausible confounders (hazard ratio, 1.44; 95% confidence interval, 1.01-2.06; P = 0.044). Conclusions An increase in MPV during the first 72 hours of hospitalization is an independent risk factor for adverse clinical outcomes. Therefore, continuous monitoring of MPV may be useful to stratify mortality risk in patients with severe sepsis and/or septic shock.	[Kim, Chan Ho; Kim, Seung Jun] Catholic Kwandong Univ, Int St Marys Hosp, Coll Med, Dept Internal Med, Inchon, South Korea; [Kim, Chan Ho; Kim, Seung Jun] Yonsei Univ, Grad Sch Med, Dept Med, Seoul 120749, South Korea; [Lee, Mi Jung; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; Ryu, Han Jak; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook; Oh, Hyung Jung] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Yoo, Tae-Hyun; Kang, Shin-Wook] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea	Catholic Kwandong University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University	Oh, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea.	ohjmd@naver.com	; Han, Seung Hyeok/K-4559-2018	Yoo, Tae-Hyun/0000-0002-9183-4507; Park, Jung Tak/0000-0002-2325-8982; Lee, Mi Jung/0000-0001-8888-029X; Kang, Shin-Wook/0000-0002-5677-4756; Han, Seung Hyeok/0000-0001-7923-5635	Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, and a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Akinosoglou K, 2014, THROMB RES, V133, P131, DOI 10.1016/j.thromres.2013.07.002; Bath P, 2004, STROKE, V35, P622, DOI 10.1161/01.STR.0000116105.26237.EC; Becchi C, 2006, MINERVA ANESTESIOL, V72, P749; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Braekkan SK, 2010, J THROMB HAEMOST, V8, P157, DOI 10.1111/j.1538-7836.2009.03498.x; Briggs C, 2009, INT J LAB HEMATOL, V31, P277, DOI 10.1111/j.1751-553X.2009.01160.x; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colkesen Y, 2012, CLIN CHEM LAB MED, V50, P631, DOI 10.1515/CCLM.2011.806; DASTUGUE N, 1982, NOUV PRESSE MED, V11, P2899; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Estevez-Loureiro R, 2009, THROMB RES, V124, P536, DOI 10.1016/j.thromres.2009.03.012; Garraud O, 2013, CRIT CARE, V17, DOI 10.1186/cc12716; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Gasparyan Armen Yuri, 2010, Inflammation & Allergy Drug Targets, V9, P45; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Huczek Z, 2005, J AM COLL CARDIOL, V46, P284, DOI 10.1016/j.jacc.2005.03.065; JACKSON SR, 1993, BLOOD REV, V7, P104, DOI 10.1016/S0268-960X(05)80020-7; Jones AE, 2007, CHEST, V132, P425, DOI 10.1378/chest.07-0234; Ju HY, 2014, PLATELETS, DOI [10.3109/ 095371042014.890179, DOI 10.3109/095371042014.890179]; Kayahan H, 2007, INT J COLORECTAL DIS, V22, P1429, DOI 10.1007/s00384-007-0330-y; Kitazawa T, 2013, INTERNAL MED, V52, P1487, DOI 10.2169/internalmedicine.52.9555; Leader A, 2012, ANN MED, V44, P805, DOI 10.3109/07853890.2011.653391; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shah B, 2013, AM J CARDIOL, V111, P185, DOI 10.1016/j.amjcard.2012.09.014; Shen J, 2009, THROMB RES, V123, P604, DOI 10.1016/j.thromres.2008.04.004; Shyamsundar M, 2013, CRIT CARE, V17, DOI 10.1186/cc12710; TANIGUCHI T, 1990, J SURG RES, V49, P400, DOI 10.1016/0022-4804(90)90187-7; Ucar H, 2014, PLATELETS, V25, P274, DOI 10.3109/09537104.2013.805406; VALTONEN V, 1993, EUR HEART J, V14, P20; VANDERLELIE J, 1983, J CLIN PATHOL, V36, P693, DOI 10.1136/jcp.36.6.693; Vincent JL, 2002, CRIT CARE MED, V30, pS313, DOI 10.1097/00003246-200205001-00022; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Yazici S, 2010, PLATELETS, V21, P122, DOI 10.3109/09537100903474373; Yazici S, 2010, PLATELETS, V21, P126, DOI 10.3109/09537100903470306; Yilmaz Z, 2008, VET CLIN PATH, V37, P159, DOI 10.1111/j.1939-165X.2008.00023.x; Zahar JR, 2011, CRIT CARE MED, V39, P1886, DOI 10.1097/CCM.0b013e31821b827c	41	90	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119437	10.1371/journal.pone.0119437	http://dx.doi.org/10.1371/journal.pone.0119437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742300	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100111
J	Liu, XQ; Gao, HH; Xiao, N; Liu, Y; Li, JN; Li, L				Liu, Xueqin; Gao, Huihui; Xiao, Nin; Liu, Yan; Li, Jinnian; Li, Lin			Outer Membrane Protein U (OmpU) Mediates Adhesion of Vibrio mimicus to Host Cells via Two Novel N-Terminal Motifs	PLOS ONE			English	Article							IN-VITRO; ADHERENCE; HEMAGGLUTININS; IDENTIFICATION; OUTBREAK; CHOLERAE; INVASION; CATFISH; GENES; LINE	Vibrio mimicus (V. mimicus) is a causative agent of ascites disease in aquatic animals. Our previous studies have demonstrated that the outer membrane protein U (OmpU) from V. mimicus is an immunoprotective antigen with six immunodominant linear B-cell epitopes. Although the N-terminus of OmpU contains potential binding motifs, it remained unclear whether OmpU possesses adhesion function. Here, the adhesive capacity of recombinant OmpU and V. mimicus to epithelioma papulosum cyprinid (EPC) cells was determined by immunofluorescence and adherence assay. The results showed that after co-incubated with rOmpU, an obvious visible green fluorescence could be observed on the EPC cell surface and the nuclei exhibited blue fluorescence; while the control cell surface did not show any signal, only nuclei exhibited blue fluorescence. The average number of wild-type strain adhered to each cell was 32.3 +/- 4.5. The average adhesion number of OmpU gene deletion mutant was significantly reduced to 10.8 +/- 0.5 (P < 0.01) and restored to 31.3 +/- 2.8 by complement strain (P > 0.05). Pretreatment of cells with rOmpU reduced the average adhesion number of wild-type strain to 9.7 +/- 2.9 (P < 0.01). Likewise, binding was significantly decreased to 8.8 +/- 3.2 (P < 0.01) due to blocking role of OmpU antibodies. To determine binding motifs of OmpU, six immunodominant B-cell epitope peptides labeled with FITC were employed in flow cytometry-based binding assay. Two FITC-labeled epitope peptides (aa90-101 and aa173-192) showed strong binding to EPC cells (the fluorescence positive cell rate was 99 +/- 0.6% and 98 +/- 0.3%, respectively), which could be specifically competed by excess corresponding unlabeled peptides, whereas the remaining four showed a low level of background binding. This is the first demonstration that OmpU possesses adhesion function and its N terminal 90-101 and 173-192 amino acid regions are critical sites for cell surface binding.	[Liu, Xueqin; Gao, Huihui; Xiao, Nin; Liu, Yan; Li, Jinnian; Li, Lin] Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei, Peoples R China	Anhui Agricultural University	Li, JN (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei, Peoples R China.	lijinnian2000@163.com	li, lijinnian/HDO-3498-2022		China Natural Science Foundation [31272696]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the China Natural Science Foundation (No.31272696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 1997, INFECT IMMUN, V65, P3662, DOI 10.1128/IAI.65.9.3662-3665.1997; Alam M, 2006, MICROBIOL IMMUNOL, V50, P845, DOI 10.1111/j.1348-0421.2006.tb03859.x; BROCKHOFF G, 1994, CYTOMETRY, V17, P75, DOI 10.1002/cyto.990170110; Cai SH, 2010, DIS AQUAT ORGAN, V90, P63, DOI 10.3354/dao02206; Cen JY, 2013, FISH SHELLFISH IMMUN, V34, P291, DOI 10.1016/j.fsi.2012.11.015; Chitov T, 2009, EUR J CLIN MICROBIOL, V28, P421, DOI 10.1007/s10096-008-0639-7; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Geng Y, 2014, AQUACULTURE, V433, P82, DOI 10.1016/j.aquaculture.2014.05.053; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Gu TianZhao, 1999, Journal of Nanjing Agricultural University, V22, P65; Klemm P, 2010, APPL MICROBIOL BIOT, V88, P451, DOI 10.1007/s00253-010-2805-y; Li XF, 2007, RESERVOIR FISHERIES, V27, P13; Ling SHM, 2000, MICROBIOL-SGM, V146, P7, DOI 10.1099/00221287-146-1-7; Ormonde P, 2000, J BACTERIOL, V182, P2326, DOI 10.1128/JB.182.8.2326-2328.2000; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; [戚莉芳 Qi Lifang], 2013, [中国微生态学杂志, Chinese Journal of Microecology], V25, P630; SANTOS Y, 1991, Journal of Aquatic Animal Health, V3, P297, DOI 10.1577/1548-8667(1991)003&lt;0297:CSAPOF&gt;2.3.CO;2; Shi L, 2000, J HEALTH SCI, V46, P63; Sincock SA, 2001, METHOD CELL BIOL, V64, P511; Singh DV, 2002, J CLIN MICROBIOL, V40, P4321, DOI 10.1128/JCM.40.11.4321-4324.2002; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; Sumio S, 2004, MICROBIOL IMMUNOL, V48, P547; UCHIMURA M, 1992, FEMS MICROBIOL LETT, V91, P73, DOI 10.1016/0378-1097(92)90565-6; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wang PingPing, 2012, African Journal of Biotechnology, V11, P8751, DOI 10.5897/AJB11.3858; Wang W, 2014, J FISHERY CHINA, V38, P138; Zhang X, 2014, AQUACULTURE, V432, P119, DOI 10.1016/j.aquaculture.2014.04.039; [朱兴国 Zhu Xingguo], 2002, [南京农业大学学报, Journal of Nanjing Agricultural University], V25, P82; Zhuang PeiDe, 2011, Chinese Journal of Zoonoses, V27, P112	29	24	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119026	10.1371/journal.pone.0119026	http://dx.doi.org/10.1371/journal.pone.0119026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742659	gold, Green Submitted, Green Published			2022-12-26	WOS:000350688100072
J	Sun, W; Meng, XY; Liang, LJ; Jiang, WS; Huang, YF; He, J; Hu, HY; Almqvist, J; Gao, X; Wang, L				Sun, Wei; Meng, Xiangyu; Liang, Lingjie; Jiang, Wangshu; Huang, Yafei; He, Jing; Hu, Haiyan; Almqvist, Jonas; Gao, Xiang; Wang, Li			Molecular and Biochemical Analysis of Chalcone Synthase from Freesia hybrid in Flavonoid Biosynthetic Pathway	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ANTHOCYANIN BIOSYNTHESIS; ENZYMATIC FORMATION; CELL-CULTURES; GENE; POLYKETIDE; EXPRESSION; ENZYMES; ACCUMULATION; INSIGHTS	Chalcone synthase (CHS) catalyzes the first committed step in the flavonoid biosynthetic pathway. In this study, the cDNA (FhCHS1) encoding CHS from Freesia hybrida was successfully isolated and analyzed. Multiple sequence alignments showed that both the conserved CHS active site residues and CHS signature sequence were found in the deduced amino acid sequence of FhCHS1. Meanwhile, crystallographic analysis revealed that protein structure of FhCHS1 is highly similar to that of alfalfa CHS2, and the biochemical analysis results indicated that it has an enzymatic role in naringenin biosynthesis. Moreover, quantitative real-time PCR was performed to detect the transcript levels of FhCHS1 in flowers and different tissues, and patterns of FhCHS1 expression in flowers showed significant correlation to the accumulation patterns of anthocyanin during flower development. To further characterize the functionality of FhCHS1, its ectopic expression in Arabidopsis thaliana tt4 mutants and Petunia hybrida was performed. The results showed that overexpression of FhCHS1 in tt4 mutants fully restored the pigmentation phenotype of the seed coats, cotyledons and hypocotyls, while transgenic petunia expressing FhCHS1 showed flower color alteration from white to pink. In summary, these results suggest that FhCHS1 plays an essential role in the biosynthesis of flavonoid in Freesia hybrida and may be used to modify the components of flavonoids in other plants.	[Sun, Wei; Meng, Xiangyu; Liang, Lingjie; He, Jing; Hu, Haiyan; Gao, Xiang; Wang, Li] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Jiang, Wangshu; Huang, Yafei; Almqvist, Jonas] Uppsala Univ, Uppsala Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Northeast Normal University - China; Uppsala University	Gao, X (corresponding author), NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China.	gaoxiang424@163.com; wanglee57@163.com			National Natural Science Foundation of China [31170276, 31300271]; Jilin provincial Government of the People's Republic of China [20130102061JC, 201201074, 20125035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin provincial Government of the People's Republic of China	This work was supported by the National Natural Science Foundation of China (31170276, 31300271) and Jilin provincial Government of the People's Republic of China (20130102061JC, 201201074, 20125035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2002, ORG LETT, V4, P3623, DOI 10.1021/ol0201409; Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Chandler SF, 2011, BIOTECHNOL LETT, V33, P207, DOI 10.1007/s10529-010-0424-4; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; Dare AP, 2013, PLANT J, V74, P398, DOI 10.1111/tpj.12140; Davis G, 2012, DNA CELL BIOL, V31, P939, DOI 10.1089/dna.2011.1589; Deng XB, 2014, NEW PHYTOL, V201, P1469, DOI 10.1111/nph.12610; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dong XY, 2001, PLANT PHYSIOL, V127, P46, DOI 10.1104/pp.127.1.46; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Fanali C, 2011, J SEP SCI, V34, P150, DOI 10.1002/jssc.201000665; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Helariutta Y, 1996, P NATL ACAD SCI USA, V93, P9033, DOI 10.1073/pnas.93.17.9033; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jiang CG, 2006, PHYTOCHEMISTRY, V67, P2531, DOI 10.1016/j.phytochem.2006.09.030; Jung CS, 2009, THEOR APPL GENET, V120, P45, DOI 10.1007/s00122-009-1158-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Koduri PKH, 2010, PLANT MOL BIOL, V72, P247, DOI 10.1007/s11103-009-9565-z; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; KREUZALER F, 1972, FEBS LETT, V28, P69, DOI 10.1016/0014-5793(72)80679-3; Kuckuck H, 1936, MOL GENET GENOMICS, V71, P429; LANZ T, 1991, J BIOL CHEM, V266, P9971; Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x; Ma LQ, 2009, PLANTA, V229, P457, DOI 10.1007/s00425-008-0845-7; Maleka M.F., 2013, PHILOS T GENET, V2, P55; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER P, 1987, NATURE, V330, P677, DOI 10.1038/330677a0; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Moore S, 2002, J EXP BOT, V53, P2023, DOI 10.1093/jxb/erf057; Morita H, 2000, BIOCHEM BIOPH RES CO, V279, P190, DOI 10.1006/bbrc.2000.3920; Napoli CA, 1999, PLANT PHYSIOL, V120, P615, DOI 10.1104/pp.120.2.615; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Pang YZ, 2005, PLANT SCI, V168, P1525, DOI 10.1016/j.plantsci.2005.02.003; Pelletier MK, 1999, PLANT MOL BIOL, V40, P45, DOI 10.1023/A:1026414301100; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Peter Goldbiatt JCM, 2008, THE IRIS FAMILY NATU; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Pourcel L, 2012, REC ADV POLYPHEN RES, V3, P143; Rahman RNZRA, 2012, INT J MOL SCI, V13, P9673, DOI 10.3390/ijms13089673; RYDER TB, 1987, MOL GEN GENET, V210, P219, DOI 10.1007/BF00325687; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SOMMER H, 1986, MOL GEN GENET, V202, P429, DOI 10.1007/BF00333273; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; Stracke R, 2009, PLANTA, V229, P427, DOI 10.1007/s00425-008-0841-y; Suh DY, 2000, BIOCHEM BIOPH RES CO, V275, P725, DOI 10.1006/bbrc.2000.3368; Sui X, 2011, PLANT CELL REP, V30, P1209, DOI 10.1007/s00299-011-1029-7; Teixeira S, 2005, FREE RADICAL BIO MED, V39, P1099, DOI 10.1016/j.freeradbiomed.2005.05.028; Trojan V, 2014, J CEREAL SCI, V59, P48, DOI 10.1016/j.jcs.2013.10.008; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078484; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yoshida K, 2010, J PLANT RES, V123, P801, DOI 10.1007/s10265-010-0325-6; Zhou XW, 2013, J BIOSCIENCES, V38, P593, DOI 10.1007/s12038-013-9339-2	66	77	98	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119054	10.1371/journal.pone.0119054	http://dx.doi.org/10.1371/journal.pone.0119054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742495	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100077
J	Zhang, XM; Kong, W; Wanda, SY; Xin, W; Alamuri, P; Curtiss, R				Zhang, Xiangmin; Kong, Wei; Wanda, Soo-Young; Xin, Wei; Alamuri, Praveen; Curtiss, Roy, III			Generation of Influenza Virus from Avian Cells Infected by Salmonella Carrying the Viral Genome	PLOS ONE			English	Article							A VIRUSES; ESCHERICHIA-COLI; PLASMID DNA; YERSINIA-PSEUDOTUBERCULOSIS; INTRACELLULAR BACTERIA; GENETIC REASSORTMENT; PROTECTIVE ANTIGENS; STABLE MAINTENANCE; VACCINE STRAINS; CLONED GENES	Domestic poultry serve as intermediates for transmission of influenza A virus from the wild aquatic bird reservoir to humans, resulting in influenza outbreaks in poultry and potential epidemics/pandemics among human beings. To combat emerging avian influenza virus, an inexpensive, heat-stable, and orally administered influenza vaccine would be useful to vaccinate large commercial poultry flocks and even migratory birds. Our hypothesized vaccine is a recombinant attenuated bacterial strain able to mediate production of attenuated influenza virus in vivo to induce protective immunity against influenza. Here we report the feasibility and technical limitations toward such an ideal vaccine based on our exploratory study. Five 8-unit plasmids carrying a chloramphenicol resistance gene or free of an antibiotic resistance marker were constructed. Influenza virus was successfully generated in avian cells transfected by each of the plasmids. The Salmonella carrier was engineered to allow stable maintenance and conditional release of the 8-unit plasmid into the avian cells for recovery of influenza virus. Influenza A virus up to 10(7) 50% tissue culture infective doses (TCID50)/ml were recovered from 11 out of 26 co-cultures of chicken embryonic fibroblasts (CEF) and Madin-Darby canine kidney (MDCK) cells upon infection by the recombinant Salmonella carrying the 8-unit plasmid. Our data prove that a bacterial carrier can mediate generation of influenza virus by delivering its DNA cargoes into permissive host cells. Although we have made progress in developing this Salmonella influenza virus vaccine delivery system, further improvements are necessary to achieve efficient virus production, especially in vivo.	[Zhang, Xiangmin; Kong, Wei; Wanda, Soo-Young; Xin, Wei; Alamuri, Praveen; Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA; [Zhang, Xiangmin] Wayne State Univ, Eugene Applebaum Coll Pharm Hlth Sci, Dept Pharmaceut Sci, Detroit, MI USA; [Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Wayne State University; Arizona State University; Arizona State University-Tempe	Zhang, XM (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	xiangmin.zhang@wayne.edu		Zhang, Xiangmin/0000-0001-9285-1619	National Institutes of Health [AI065779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093348, R01AI065779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI065779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Capua I, 2007, VACCINE, V25, P4987, DOI 10.1016/j.vaccine.2007.01.113; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; CHAMBERS TM, 1991, ARCH VIROL, V116, P261, DOI 10.1007/BF01319247; Chen H, 2009, REV SCI TECH OIE, V28, P267, DOI 10.20506/rst.28.1.1860; Chen ZY, 2006, VIROLOGY, V345, P416, DOI 10.1016/j.virol.2005.10.005; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Cicin-Sain L, 2003, J VIROL, V77, P8249, DOI 10.1128/JVI.77.15.8249-8255.2003; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Curtiss R, 2002, J CLIN INVEST, V110, P1061, DOI 10.1172/JCI200216941; CURTISS R, 1989, IMMUNOL INVEST, V18, P583, DOI 10.3109/08820138909112265; Curtiss R, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1009, DOI 10.1016/B978-012491543-5/50060-7; Curtiss R, 2010, CRIT REV IMMUNOL, V30, P255, DOI 10.1615/CritRevImmunol.v30.i3.30; Curtiss R, 2009, INFECT IMMUN, V77, P1071, DOI 10.1128/IAI.00693-08; Dean DA, 1997, EXP CELL RES, V230, P293, DOI 10.1006/excr.1996.3427; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Droge M, 1998, J BIOTECHNOL, V64, P75, DOI 10.1016/S0168-1656(98)00105-9; FARACI WS, 1988, BIOCHEMISTRY-US, V27, P3267, DOI 10.1021/bi00409a022; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; GENTSCHEV I, 1995, INFECT IMMUN, V63, P4202, DOI 10.1128/IAI.63.10.4202-4205.1995; Grillot-Courvalin C, 2002, CELL MICROBIOL, V4, P177, DOI 10.1046/j.1462-5822.2002.00184.x; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; GUO YJ, 1983, J GEN VIROL, V64, P177, DOI 10.1099/0022-1317-64-1-177; Hai R, 2011, J VIROL, V85, P6832, DOI 10.1128/JVI.00609-11; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; HEITMANN D, 1993, BIOSYSTEMS, V29, P37, DOI 10.1016/0303-2647(93)90080-V; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, VET MICROBIOL, V74, P71, DOI 10.1016/S0378-1135(00)00167-X; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kang HY, 2002, J BACTERIOL, V184, P307, DOI 10.1128/JB.184.1.307-312.2002; KIDA H, 1980, INFECT IMMUN, V30, P547; Killian Mary Lea, 2008, V436, P47, DOI 10.1007/978-1-59745-279-3_7; Kong QK, 2010, VACCINE, V28, P6094, DOI 10.1016/j.vaccine.2010.06.074; Kong QK, 2009, INFECT IMMUN, V77, P5572, DOI 10.1128/IAI.00831-09; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; Li YH, 2008, INFECT IMMUN, V76, P5238, DOI 10.1128/IAI.00720-08; LOCKMAN HA, 1990, J INFECT DIS, V162, P1397, DOI 10.1093/infdis/162.6.1397; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Marriott I, 1999, EUR J IMMUNOL, V29, P1107, DOI 10.1002/(SICI)1521-4141(199904)29:04<1107::AID-IMMU1107>3.0.CO;2-0; Mesika A, 2001, MOL THER, V3, P653, DOI 10.1006/mthe.2001.0312; Miao B, 2012, ONCOGENE, V31, P4317, DOI 10.1038/onc.2011.593; Munster VJ, 2006, VACCINE, V24, P6729, DOI 10.1016/j.vaccine.2006.05.060; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Neumann G, 2005, P NATL ACAD SCI USA, V102, P16825, DOI 10.1073/pnas.0505587102; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Osterhaus Albert D. M. E., 2008, V27, P1; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; Rand KN, 1996, TECH TIPS ONLINE, V1, P23; ROGERS SG, 1983, APPL ENVIRON MICROB, V46, P37, DOI 10.1128/AEM.46.1.37-43.1983; Santander J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015944; SCHAFFNER W, 1980, P NATL ACAD SCI-BIOL, V77, P2163, DOI 10.1073/pnas.77.4.2163; SCHULTZ U, 1991, VIROLOGY, V183, P61, DOI 10.1016/0042-6822(91)90118-U; Shi HY, 2013, CLIN VACCINE IMMUNOL, V20, P931, DOI 10.1128/CVI.00003-13; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Sims LD, 2007, DEV BIOLOGICALS, V130, P39; SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299; SMALL PLC, 1987, INFECT IMMUN, V55, P1674, DOI 10.1128/IAI.55.7.1674-1679.1987; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; Subramanian A, 1999, NAT BIOTECHNOL, V17, P873, DOI 10.1038/12860; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Sun W, 2014, INFECT IMMUN, V82, P4390, DOI 10.1128/IAI.02173-14; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Thanaketpaisarn O, 2008, J BIOTECHNOL, V133, P36, DOI 10.1016/j.jbiotec.2007.08.047; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Torres-Escobar A, 2010, INFECT IMMUN, V78, P2529, DOI 10.1128/IAI.00005-10; Villarreal-Chavez C, 2003, AVIAN DIS, V47, P1002, DOI 10.1637/0005-2086-47.s3.1002; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xin W, 2012, INFECT IMMUN, V80, P3621, DOI 10.1128/IAI.00620-12; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91; Zhang X, 1997, INFECT IMMUN, V65, P5381, DOI 10.1128/IAI.65.12.5381-5387.1997; Zhang XM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-31; Zhang XM, 2009, J VIROL, V83, P9296, DOI 10.1128/JVI.00781-09	89	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119041	10.1371/journal.pone.0119041	http://dx.doi.org/10.1371/journal.pone.0119041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742162	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100075
J	Grove, O; Berglund, AE; Schabath, MB; Aerts, HJWL; Dekker, A; Wang, H; Velazquez, ER; Lambin, P; Gu, YH; Balagurunathan, Y; Eikman, E; Gatenby, RA; Eschrich, S; Gillies, RJ				Grove, Olya; Berglund, Anders E.; Schabath, Matthew B.; Aerts, Hugo J. W. L.; Dekker, Andre; Wang, Hua; Velazquez, Emmanuel Rios; Lambin, Philippe; Gu, Yuhua; Balagurunathan, Yoganand; Eikman, Edward; Gatenby, Robert A.; Eschrich, Steven; Gillies, Robert J.			Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma	PLOS ONE			English	Article							TEXTURE ANALYSIS; POTENTIAL MARKER; CT IMAGES; CANCER; MUTATIONS	Two CT features were developed to quantitatively describe lung adenocarcinomas by scoring tumor shape complexity (feature 1: convexity) and intratumor density variation (feature 2: entropy ratio) in routinely obtained diagnostic CT scans. The developed quantitative features were analyzed in two independent cohorts (cohort 1: n = 61; cohort 2: n = 47) of patients diagnosed with primary lung adenocarcinoma, retrospectively curated to include imaging and clinical data. Preoperative chest CTs were segmented semi-automatically. Segmented tumor regions were further subdivided into core and boundary sub-regions, to quantify intensity variations across the tumor. Reproducibility of the features was evaluated in an independent test-retest dataset of 32 patients. The proposed metrics showed high degree of reproducibility in a repeated experiment (concordance, CCC >= 0.897; dynamic range, DR >= 0.92). Association with overall survival was evaluated by Cox proportional hazard regression, Kaplan-Meier survival curves, and the log-rank test. Both features were associated with overall survival (convexity: p = 0.008; entropy ratio: p = 0.04) in Cohort 1 but not in Cohort 2 (convexity: p = 0.7; entropy ratio: p = 0.8). In both cohorts, these features were found to be descriptive and demonstrated the link between imaging characteristics and patient survival in lung adenocarcinoma.	[Grove, Olya; Wang, Hua; Gu, Yuhua; Balagurunathan, Yoganand; Gatenby, Robert A.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA; [Berglund, Anders E.; Eschrich, Steven] H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL USA; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Eikman, Edward; Gatenby, Robert A.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA; [Dekker, Andre; Lambin, Philippe] Maastricht Univ, Res Inst GROW, MAASTRO Clin, Dept Radiat Oncol, NL-6229 ET Maastricht, Netherlands; [Wang, Hua] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Canc Inst & Hosp, Dept Radiol,Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Aerts, Hugo J. W. L.; Velazquez, Emmanuel Rios] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiat Oncol,Dana Farber Canc Inst, Boston, MA USA; [Aerts, Hugo J. W. L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Maastricht University; Maastricht University Medical Centre (MUMC); Tianjin Medical University; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gillies, RJ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA.	Robert.Gillies@Moffitt.org	Balagurunathan, Yoganand/AAH-9139-2021; Aerts, Hugo/ABF-2821-2020; Balagurunathan, Yoganand/AAF-9163-2020; Dekker, Andre/AAE-4830-2019; Aerts, Hugo/P-6350-2015; Schabath, Matthew B./J-3763-2016; Eschrich, Steven/K-6848-2013	Aerts, Hugo/0000-0002-2122-2003; Balagurunathan, Yoganand/0000-0002-5598-4727; Dekker, Andre/0000-0002-0422-7996; Aerts, Hugo/0000-0002-2122-2003; Schabath, Matthew B./0000-0003-3241-3216; Eschrich, Steven/0000-0002-9833-2788; Gillies, Robert/0000-0002-8888-7747; Berglund, Anders/0000-0002-0393-3530; Lambin, Philippe/0000-0001-7961-0191	National Cancer Institute; NIH/NCI, Radiomics of NSCLC [U01CA143062]; NIH/NCI, Radiomics of Lung Cancer Screening [P50CA119997]; Florida Biomedical Research Programs: King Team Science Grant [2KT01]; NATIONAL CANCER INSTITUTE [U01CA196405, U01CA143062, R25CA174664, P50CA119997, P30CA076292] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI, Radiomics of NSCLC; NIH/NCI, Radiomics of Lung Cancer Screening; Florida Biomedical Research Programs: King Team Science Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Cancer Institute: http://www.cancer.gov/, 1.NIH/NCI U01CA143062, Radiomics of NSCLC; 2. NIH/NCI P50CA119997, Radiomics of Lung Cancer Screening. Florida Biomedical Research Programs: http://researchtest.magnet.fsu.edu/newsletters/2013/July/documents/2013-2014%20SUMMER%20CALL%20King%20Program.pdf, King Team Science Grant 2KT01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607; Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005; Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002; Jaffe CC, 2012, RADIOLOGY, V264, P329, DOI 10.1148/radiol.12120871; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Nair VS, 2010, CHEST, V137, P1150, DOI 10.1378/chest.09-2356; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Prokop M, 2001, SPIRAL MULTISLICE CO, P1104; Ravanelli M, 2013, EUR RADIOL, V23, P3450, DOI 10.1007/s00330-013-2965-0; Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Shultz DB, 2014, CLIN LUNG CANCER, V15, P294, DOI 10.1016/j.cllc.2013.12.011; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Yang XK, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/412647; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593	28	155	158	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118261	10.1371/journal.pone.0118261	http://dx.doi.org/10.1371/journal.pone.0118261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739030	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900026
J	Hochst, B; Mikulec, J; Baccega, T; Metzger, C; Welz, M; Peusquens, J; Tacke, F; Knolle, P; Kurts, C; Diehl, L; Ludwig-Portugall, I				Hoechst, Bastian; Mikulec, Julita; Baccega, Tania; Metzger, Christina; Welz, Meike; Peusquens, Julia; Tacke, Frank; Knolle, Percy; Kurts, Christian; Diehl, Linda; Ludwig-Portugall, Isis			Differential Induction of Ly6G and Ly6C Positive Myeloid Derived Suppressor Cells in Chronic Kidney and Liver Inflammation and Fibrosis	PLOS ONE			English	Article							LIMITS TUMOR PROGRESSION; T-CELL; CYCLOOXYGENASE-2 INHIBITORS; IMMUNE SUPPRESSION; MOUSE MODEL; CANCER; ACCUMULATION; MECHANISM; EXPANSION; MICE	CD11b(+)Gr1(+) myeloid derived suppressor cells (MDSC) are known to be very potent suppressors of T cell immunity and can be further stratified into granulocytic MDSC and monocytic MDSC in mice based on expression of Ly6G or Ly6C, respectively. Here, using these markers and functional assays, we aimed to identify whether MDSC are induced during chronic inflammation leading to fibrosis in both kidney and liver and whether additional markers could more specifically identify these MDSC subsets. In an adenine-induced model of kidney inflammation/fibrosis suppressive Ly6Gpos MDSC were induced. The suppressive function within the Ly6G+MDSC population was exclusively present in IFN gamma R beta expressing cells. In contrast, in chronic inflammation in the liver induced by bile duct ligation, suppressive capacity was exclusively present in the Ly6Cpos MDSC subset. Gene expression analyses confirmed the differential origins and regulation of those MDSC subsets. Additionally, depletion of MDSC in either kidney or liver fibrosis enhanced fibrosis markers, indicating a protective role for MDSC in organ fibrosis. Thus, our data demonstrate that during liver inflammation and kidney fibrosis MDSC with similar function arise bearing a distinct marker profile and arising from different cell populations.	[Hoechst, Bastian; Mikulec, Julita; Metzger, Christina; Welz, Meike; Knolle, Percy; Diehl, Linda] Univ Bonn, Inst Mol Med, Bonn, Germany; [Hoechst, Bastian] Tech Univ Munich, Inst Mol Immunol, D-80290 Munich, Germany; [Baccega, Tania; Kurts, Christian; Ludwig-Portugall, Isis] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Peusquens, Julia; Tacke, Frank] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Diehl, Linda] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany	University of Bonn; Technical University of Munich; University of Bonn; RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Diehl, L (corresponding author), Univ Bonn, Inst Mol Med, Bonn, Germany.	li.diehl@uke.de; Isis.Ludwig-Portugall@ukb.uni-bonn.de	Höchst, Bastian/ABG-2094-2020; Tacke, Frank/ABF-2212-2020	Höchst, Bastian/0000-0002-5567-1173; Knolle, Percy A./0000-0003-2983-0414	German research council [SFB704]; medical faculty of the university of Bonn; SFB [TRR57]	German research council(German Research Foundation (DFG)); medical faculty of the university of Bonn; SFB(Austrian Science Fund (FWF))	LD was financially supported by a grant of the German research council (SFB704), BH by a BONFOR grant from the medical faculty of the university of Bonn, CK and ILP by SFB TRR57. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chou HS, 2012, TRANSPLANTATION, V93, P272, DOI 10.1097/TP.0b013e31823ffd39; Chou HS, 2011, HEPATOLOGY, V53, P1007, DOI 10.1002/hep.24162; Dietlin TA, 2007, J LEUKOCYTE BIOL, V81, P1205, DOI 10.1189/jlb.1006640; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Gujral JS, 2004, AM J PHYSIOL-GASTR L, V286, pG499, DOI 10.1152/ajpgi.00318.2003; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Lauvau G, 2014, CELL IMMUNOL, V291, P32, DOI 10.1016/j.cellimm.2014.07.007; Liu Y, 2008, CLIN IMMUNOL, V129, P471, DOI 10.1016/j.clim.2008.07.030; Luan Y, 2013, AM J TRANSPLANT, V13, P3123, DOI 10.1111/ajt.12461; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pestka Sidney, 1997, Cytokine and Growth Factor Reviews, V8, P189, DOI 10.1016/S1359-6101(97)00009-9; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Roth F, 2012, CANCER RES, V72, P1373, DOI 10.1158/0008-5472.CAN-11-2772; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Tamura M, 2009, HISTOCHEM CELL BIOL, V131, P483, DOI 10.1007/s00418-009-0557-5; Teteris SA, 2012, NEPHROLOGY, V17, P364, DOI 10.1111/j.1440-1797.2012.01581.x; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeng QL, 2014, MOL CELLS, V37, P66, DOI 10.14348/molcells.2014.2282; Zhang HY, 2014, J AUTOIMMUN, V53, P55, DOI 10.1016/j.jaut.2014.02.010; Zhao XQ, 2012, J CLIN INVEST, V122, P4094, DOI 10.1172/JCI64115; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	42	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119662	10.1371/journal.pone.0119662	http://dx.doi.org/10.1371/journal.pone.0119662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738302	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900109
J	Kelly, TR; McNeill, JB; Avens, L; Hall, AG; Goshe, LR; Hohn, AA; Godfrey, MH; Mihnovets, AN; Cluse, WM; Harms, CA				Kelly, Terra R.; McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.; Hohn, Aleta A.; Godfrey, Matthew H.; Mihnovets, A. Nicole; Cluse, Wendy M.; Harms, Craig A.			Clinical Pathology Reference Intervals for an In-Water Population of Juvenile Loggerhead Sea Turtles (Caretta caretta) in Core Sound, North Carolina, USA	PLOS ONE			English	Article							CHELONIA-MYDAS; BLOOD BIOCHEMISTRY; GREEN TURTLES; REFERENCE VALUES; PLASMA; HEMATOLOGY; PARAMETERS; CHEMISTRY; ANALYTES; PAMLICO	The loggerhead sea turtle (Caretta caretta) is found throughout the waters of the Atlantic, Pacific, and Indian Oceans. It is a protected species throughout much of its range due to threats such as habitat loss, fisheries interactions, hatchling predation, and marine debris. Loggerheads that occur in the southeastern U.S. are listed as "threatened" on the U.S. Endangered Species List, and receive state and federal protection. As part of an on-going population assessment conducted by the National Marine Fisheries Service, samples were collected from juvenile loggerhead sea turtles in Core Sound, North Carolina, between 2004 and 2007 to gain insight on the baseline health of the threatened Northwest Atlantic Ocean population. The aims of the current study were to establish hematologic and biochemical reference intervals for this population, and to assess variation of the hematologic and plasma biochemical analytes by season, water temperature, and sex and size of the turtles. Reference intervals for the clinical pathology parameters were estimated following Clinical Laboratory Standards Institute guidelines. Season, water temperature, sex, and size of the turtles were found to be significant factors of variation for parameter values. Seasonal variation could be attributed to physiological effects of decreasing photoperiod, cooler water temperature, and migration during the fall months. Packed cell volume, total protein, and albumin increased with increasing size of the turtles. The size-related differences in analytes documented in the present study are consistent with other reports of variation in clinical pathology parameters by size and age in sea turtles. As a component of a health assessment of juvenile loggerhead sea turtles in North Carolina, this study will serve as a baseline aiding in evaluation of trends for this population and as a diagnostic tool for assessing the health and prognosis for loggerhead sea turtles undergoing rehabilitation.	[Kelly, Terra R.; Harms, Craig A.] N Carolina State Univ, Environm Med Consortium, Raleigh, NC 27607 USA; [Kelly, Terra R.; Harms, Craig A.] N Carolina State Univ, Dept Clin Sci, Raleigh, NC 27607 USA; [McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.; Hohn, Aleta A.] NOAA, Natl Marine Fisheries Serv, Beaufort Lab, Beaufort, NC 28516 USA; [Godfrey, Matthew H.; Cluse, Wendy M.] North Carolina Wildlife Resources Commiss, Beaufort, NC 28516 USA; [Mihnovets, A. Nicole] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Harms, Craig A.] Ctr Marine Sci & Technol, Morehead City, NC 27606 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Oceanic Atmospheric Admin (NOAA) - USA; Columbia University	Harms, CA (corresponding author), N Carolina State Univ, Environm Med Consortium, 1060 William Moore Dr, Raleigh, NC 27607 USA.	craig_harms@ncsu.edu	Hohn, Aleta A/G-2888-2011	Hohn, Aleta A/0000-0002-9992-7062	National Fish and Wildlife Foundation [2004-0012-001]	National Fish and Wildlife Foundation	National Fish and Wildlife Foundation (http://www.nfwf.org/) #2004-0012-001.	Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Avens L, 2003, MAR BIOL, V143, P211, DOI 10.1007/s00227-003-1085-9; Basile Filomena, 2012, Comparative Clinical Pathology, V21, P1401, DOI 10.1007/s00580-011-1306-4; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; Braun-McNeill J, 2010, NMFSSEFSC605 NOAA; Braun-McNeill J, 2007, HERPETOLOGICA, V63, P275, DOI 10.1655/0018-0831(2007)63[275:SROTRR]2.0.CO;2; Campbell T., 2006, REPTILE MED SURG, P453, DOI 10.1016/B0-72-169327-X/50032-8; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; CLSI guideline EP28, 2010, DEFINING ESTABLISHIN, V3rd Ed; Deem SL, 2006, J ZOO WILDLIFE MED, V37, P464, DOI 10.1638/05-102.1; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Delgado C, 2011, J WILDLIFE DIS, V47, P523, DOI 10.7589/0090-3558-47.3.523; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Eisenhawer E, 2008, J ZOO WILDLIFE MED, V39, P208, DOI 10.1638/2007-0166R.1; Epperly Sheryan P., 2007, Endangered Species Research, V3, P283, DOI 10.3354/esr00054; EPPERLY SP, 1995, CONSERV BIOL, V9, P384, DOI 10.1046/j.1523-1739.1995.9020384.x; Fazio Esterina, 2012, Comparative Clinical Pathology, V21, P905, DOI 10.1007/s00580-011-1197-4; Flint M, 2010, VET J, V185, P299, DOI 10.1016/j.tvjl.2009.06.011; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; FRAIR W, 1982, COMP BIOCHEM PHYS A, V73, P337, DOI 10.1016/0300-9629(82)90164-5; Frye F.L., 1991, BIOMEDICAL SURG ASPE; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; George Robert H., 1997, P363; Hall AG, 2013, ENDANGER SPECIES RES, V22, P235, DOI 10.3354/esr00539; Hamann M, 2003, CRC MAR BIOL SER, P135; Harms CA, 2003, J WILDLIFE DIS, V39, P366, DOI 10.7589/0090-3558-39.2.366; Hasbun CR, 1998, COMP HAEMATOL INT, V8, P174, DOI 10.1007/BF02642510; Higgins BM, 2003, CRC MAR BIOL SER, P411; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Kakizoe Y, 2007, J ZOO WILDLIFE MED, V38, P77, DOI 10.1638/05-096.1; Keller JM, 2004, ENVIRON HEALTH PERSP, V112, P1074, DOI 10.1289/ehp.6923; Klaphake Eric, 2010, Veterinary Clinics of North America Exotic Animal Practice, V13, P375, DOI 10.1016/j.cvex.2010.05.007; Lahti A, 2004, CLIN CHEM, V50, P891, DOI 10.1373/clinchem.2003.027953; McClellan CM, 2011, MAR POLICY, V35, P241, DOI 10.1016/j.marpol.2010.10.008; National Marine Fisheries and U.S. Fish and Wildlife Service, 2008, REC PLAN NW ATL POP; Prieto-Torres DA, 2013, S AM J HERPETOL, V8, P147, DOI 10.2994/SAJH-D-13-00010.1; Pritchard P. C. H, 1997, BIOL SEA TURTLES, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Sasso CR, 2006, MAR ECOL PROG SER, V324, P287, DOI 10.3354/meps324287; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Stringer Elizabeth M., 2010, Journal of Herpetological Medicine and Surgery, V20, P122, DOI 10.5818/1529-9651-20.4.122; USFWS, 2014, SPEC PROF LOGG SEA T; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Walton RM, 2001, SEMIN AVIAN EXOT PET, V10, P59, DOI 10.1053/saep.2001.22053; WOOD FE, 1984, HERPETOLOGICA, V40, P331; Wyneken J., 2001, ANATOMY SEA TURTLES	48	21	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115739	10.1371/journal.pone.0115739	http://dx.doi.org/10.1371/journal.pone.0115739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738772	gold, Green Published			2022-12-26	WOS:000350685900005
J	Lohr, IH; Hulter, N; Bernhoff, E; Johnsen, PJ; Sundsfjord, A; Naseer, U				Lohr, Iren Hoyland; Hulter, Nils; Bernhoff, Eva; Johnsen, Pal Jarle; Sundsfjord, Arnfinn; Naseer, Umaer			Persistence of a pKPN3-Like CTX-M-15-Encoding IncFII(K) Plasmid in a Klebsiella pneumonia ST17 Host during Two Years of Intestinal Colonization	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; BETA-LACTAMASES; RESISTANCE; SEQUENCE; DISSEMINATION; EMERGENCE; OUTBREAK; SPREAD; EPIDEMIOLOGY	Objectives To characterize the CTX-M-15-encoding plasmid in a Klebsiella pneumoniae ST17 strain, responsible for an outbreak at a Norwegian neonatal intensive care unit and subsequent colonization of affected children for up to two years. To identify plasmid-mediated features relevant for the outbreak dynamics, and to investigate the plasmids capability of horizontal transfer, its segregational stability and plasmid-mediated fitness costs. Methods Plasmid profiling was performed by S1-nuclease PFGE, PCR-based replicon typing and Southern blot-hybridization. The complete sequence of the CTX-M-15-encoding plasmid was obtained by 454 sequencing. Plasmid self-transferability was investigated by broth- and filter mating, segregational stability was explored by serial passage, and plasmid-conferred fitness costs were examined in pairwise head-to-head competitions and by growth rate comparisons. Results CTX-M-15 was encoded by a similar to 180 kb IncFII(K) plasmid in K. pneumoniae ST17. S1-nuclease PFGE profiles of the first and the last CTX-M-15-producing K. pneumoniae isolates, recovered from the four children colonized the longest, suggested that the plasmid was stably maintained during intestinal carriage of up to two years. The DNA sequence of the pKPN3-like plasmid, pKp848CTX, uncovered a Tn3-like antibiotic resistance region and multiple heavy metal-and thermoresistance determinants. Plasmid pKp848CTX could not be transferred to Escherichia coli in vitro and we found no evidence to support horizontal plasmid transfer in vivo. Segregational plasmid loss ranging from 0.83% to 17.5% was demonstrated in evolved populations in vitro, but only minor fitness costs were associated with plasmid-carriage. Conclusions Plasmid pKp848CTX encodes phenotypic traits, which may have had an impact on the fitness and survival of the K. pneumoniae ST17 strain in the outbreak setting. The antibiotic resistance plasmid pKp848CTX was stably maintained during two years of intestinal colonization, conferring negligible fitness cost to its host, and thus seem well adapted to its K. pneumoniae host.	[Lohr, Iren Hoyland; Bernhoff, Eva] Stavanger Univ Hosp, Dept Med Microbiol, Stavanger, Norway; [Lohr, Iren Hoyland] Univ Bergen, Dept Clin Med, Bergen, Norway; [Hulter, Nils; Johnsen, Pal Jarle] UiT Arctic Univ Norway, Dept Pharm, Tromso, Norway; [Sundsfjord, Arnfinn; Naseer, Umaer] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Sundsfjord, Arnfinn] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Naseer, Umaer] Norwegian Inst Publ Hlth, Dept Food Borne Infect, Oslo, Norway	Stavanger University Hospital; University of Bergen; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian Institute of Public Health (NIPH)	Lohr, IH (corresponding author), Stavanger Univ Hosp, Dept Med Microbiol, Stavanger, Norway.	iren.hoyland.lohr@sus.no	Sundsfjord, Arnfinn/F-9668-2018; Johnsen, Pål J/A-5209-2011	Sundsfjord, Arnfinn/0000-0002-3728-2270; Johnsen, Pal Jarle/0000-0002-6455-6433; Hulter, Nils Fredrik/0000-0002-8873-5276	Western Norway Regional Health Authority [911640]	Western Norway Regional Health Authority	This work was supported by grants from The Western Norway Regional Health Authority (grant number 911640 to IHL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouache S, 2014, MICROB DRUG RESIST, V20, P30, DOI 10.1089/mdr.2012.0264; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bojer MS, 2012, APMIS, V120, P699, DOI 10.1111/j.1600-0463.2012.02885.x; Bojer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015467; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Center for Genomic Epidemiology, PMLST V 1 2; Chen L, 2013, ANTIMICROB AGENTS CH, V57, P1542, DOI 10.1128/AAC.02332-12; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dahlberg C, 2003, GENETICS, V165, P1641; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Dolejska M, 2013, ANTIMICROB AGENTS CH, V57, P1073, DOI 10.1128/AAC.01886-12; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Frasson I, 2012, J CLIN MICROBIOL, V50, P3768, DOI 10.1128/JCM.01892-12; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Johnsen PJ, 2002, MICROB DRUG RESIST, V8, P161, DOI 10.1089/107662902760326869; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P4493, DOI 10.1128/AAC.00175-10; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lohr IH, 2013, J ANTIMICROB CHEMOTH, V68, P1043, DOI 10.1093/jac/dks502; Lytsy B, 2008, APMIS, V116, P302, DOI 10.1111/j.1600-0463.2008.00922.x; Mataseje LF, 2014, J ANTIMICROB CHEMOTH, V69, P637, DOI 10.1093/jac/dkt445; Naseer U, 2007, APMIS, V115, P120, DOI 10.1111/j.1600-0463.2007.apm_547.x; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Naseer U, 2009, APMIS, V117, P526, DOI 10.1111/j.1600-0463.2009.02465.x; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; Novais A, 2007, ANTIMICROB AGENTS CH, V51, P796, DOI 10.1128/AAC.01070-06; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P524, DOI 10.1093/jac/dkp211; Peirano G, 2012, J ANTIMICROB CHEMOTH, V67, P1114, DOI 10.1093/jac/dks026; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Rettedal S, 2012, APMIS, V120, P612, DOI 10.1111/j.1600-0463.2012.02879.x; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sandegren L, 2012, J ANTIMICROB CHEMOTH, V67, P74, DOI 10.1093/jac/dkr405; Shin J, 2014, J ANTIMICROB CHEMOTH, V69, P969, DOI 10.1093/jac/dkt464; Starikova I, 2013, J ANTIMICROB CHEMOTH, V68, P2755, DOI 10.1093/jac/dkt270; Starikova I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003043; Sundsfjord A, 2004, APMIS, V112, P815, DOI 10.1111/j.1600-0463.2004.apm11211-1208.x; Suzuki H, 2010, J BACTERIOL, V192, P6045, DOI 10.1128/JB.00277-10; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09	52	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116516	10.1371/journal.pone.0116516	http://dx.doi.org/10.1371/journal.pone.0116516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738592	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900012
J	Yang, ZF; Mok, CKP; Liu, XQ; Li, XB; He, JF; Da Guan, W; Xu, YH; Pan, WQ; Chen, LY; Lin, YP; Wu, SG; Pan, SH; Huang, JC; Ding, GY; Zheng, K; Ke, CW; Lin, JY; Zhang, YH; Lee, HHY; Liu, WK; Yang, CG; Zhou, R; Peiris, JSM; Li, YM; Chen, RC; Chen, L; Zhong, NS				Yang, Zi Feng; Mok, Chris Ka Pun; Liu, Xiao Qing; Li, Xiao Bo; He, Jian Feng; Da Guan, Wen; Xu, Yong Hao; Pan, Wei Qi; Chen, Li Yan; Lin, Yong Ping; Wu, Shi Guan; Pan, Si Hua; Huang, Ji Cheng; Ding, Guo Yun; Zheng, Kui; Ke, Chang Wen; Lin, Jin Yan; Zhang, Yong Hui; Lee, Horace Hok Yeung; Liu, Wen Kuan; Yang, Chun Guang; Zhou, Rong; Peiris, Joseph Sriyal Malik; Li, Yi Min; Chen, Rong Chang; Chen, Ling; Zhong, Nan Shan			Clinical, Virological and Immunological Features from Patients Infected with Re-Emergent Avian-Origin Human H7N9 Influenza Disease of Varying Severity in Guangdong Province	PLOS ONE			English	Article							VIRUS; RESPONSES; CYTOKINE; CHINA	Background The second wave of avian influenza H7N9 virus outbreak in humans spread to the Guangdong province of China by August of 2013 and this virus is now endemic in poultry in this region. Methods Five patients with H7N9 virus infection admitted to our hospital during August 2013 to February 2014 were intensively investigated. Viral load in the respiratory tract was determined by quantitative polymerase chain reaction (Q-PCR) and cytokine levels were measured by bead-based flow cytometery. Results Four patients survived and one died. Viral load in different clinical specimens was correlated with cytokine levels in plasma and broncho-alveolar fluid (BALF), therapeutic modalities used and clinical outcome. Intravenous zanamivir appeared to be better than peramivir as salvage therapy in patients who failed to respond to oseltamivir. Higher and more prolonged viral load was found in the sputum or endotracheal aspirates compared to throat swabs. Upregulation of proinflammatory cytokines IP-10, MCP-1, MIG, MIP-1 alpha/beta, IL-1 beta and IL-8 was found in the plasma and BALF samples. The levels of cytokines in the plasma and viral load were correlated with disease severity. Reactivation of herpes simplex virus type 1 (HSV-1) was found in three out of five patients (60%). Conclusion Expectorated sputum or endotracheal aspirate specimens are preferable to throat swabs for detecting and monitoring H7N9 virus. Severity of the disease was correlated to the viral load in the respiratory tract as well as the extents of cytokinemia. Reactivation of HSV-1 may contribute to clinical outcome.	[Yang, Zi Feng; Liu, Xiao Qing; Da Guan, Wen; Xu, Yong Hao; Pan, Wei Qi; Chen, Li Yan; Lin, Yong Ping; Wu, Shi Guan; Pan, Si Hua; Liu, Wen Kuan; Yang, Chun Guang; Zhou, Rong; Li, Yi Min; Chen, Rong Chang; Chen, Ling; Zhong, Nan Shan] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Li, Xiao Bo; Huang, Ji Cheng; Ding, Guo Yun; Zheng, Kui] Guangdong Inspect & Quarantine Technol Ctr, Hlth Quarantine BSL 3 Lab, Guangzhou, Guangdong, Peoples R China; [He, Jian Feng; Ke, Chang Wen; Lin, Jin Yan; Zhang, Yong Hui] Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Mok, Chris Ka Pun; Lee, Horace Hok Yeung; Peiris, Joseph Sriyal Malik] Univ Hong Kong, HKU Li Ka Shing Fac Med, Influenza Res Ctr, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Mok, Chris Ka Pun; Lee, Horace Hok Yeung; Peiris, Joseph Sriyal Malik] Univ Hong Kong, HKU Pasteur Res Pole, Sch Publ Hlth, HKU Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of Hong Kong; University of Hong Kong	Chen, RC (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	malik@hku.hk; dryiminli@vip.163.com; chenrc@vip.163.com	Mok, Chris Ka Pun/ABD-2667-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Lee, Hok Yeung Horace/0000-0003-4360-9986; Mok, Chris Ka Pun/0000-0002-0525-6772; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	Municipal Science and Technology Bureau Foundation of Guangzhou [2014Y2-00031]; Emergency Response Project of Ministry of Science and Technology of China [KJYJ-2013-01-05]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX10004006]; University Grants Committee, Hong Kong [AoE/M-12/06]	Municipal Science and Technology Bureau Foundation of Guangzhou; Emergency Response Project of Ministry of Science and Technology of China; National Science and Technology Major Project of the Ministry of Science and Technology of China; University Grants Committee, Hong Kong	This study was supported by Municipal Science and Technology Bureau Foundation of Guangzhou (Grant no. 2014Y2-00031), Emergency Response Project of Ministry of Science and Technology of China (Grant no. KJYJ-2013-01-05), National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant no. 2014ZX10004006). CKPM and JSMP were supported by funding by grant AoE/M-12/06 from the University Grants Committee, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, JAMA-J AM MED ASSOC, DOI 10.1001/jama.2012.5669; Bradley-Stewart A, 2013, J CLIN VIROL, V58, P100, DOI 10.1016/j.jcv.2013.05.011; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cheng HW, 2014, J PAIN SYMPTOM MANAG, DOI [10.1016/j.jpainsymman.2014.12.002, DOI 10.1016/J.JPAINSYMMAN.2014.12.002]; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Liderot K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/376219; Lu J, 2014, J VIROL; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Shi JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054054, 10.1371/journal.pone.0077651]; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Wang XF, 2014, CLIN RESPIR J, V8, P410, DOI 10.1111/crj.12087; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Wu CL, 2013, J MED VIROL, V85, P760, DOI 10.1002/jmv.23492; Xiang NJ, 2013, EMERG INFECT DIS, V19, P1784, DOI 10.3201/eid1911.130865; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541; Zhang A, 2013, EUROSURVEILLANCE, V18, P38, DOI 10.2807/1560-7917.ES2013.18.50.20657; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	22	25	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117846	10.1371/journal.pone.0117846	http://dx.doi.org/10.1371/journal.pone.0117846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723593	Green Published, Green Submitted, gold			2022-12-26	WOS:000350251200040
J	Zhang, P; Elabd, S; Hammer, S; Solozobova, V; Yan, H; Bartel, F; Inoue, S; Henrich, T; Wittbrodt, J; Loosli, F; Davidson, G; Blattner, C				Zhang, P.; Elabd, S.; Hammer, S.; Solozobova, V.; Yan, H.; Bartel, F.; Inoue, S.; Henrich, T.; Wittbrodt, J.; Loosli, F.; Davidson, G.; Blattner, C.			TRIM25 has a dual function in the p53/Mdm2 circuit	ONCOGENE			English	Article							ESTROGEN-RESPONSIVE GENE; FINGER PROTEIN; BREAST-CANCER; RECEPTOR-ALPHA; P53 PATHWAY; ACETYLATION; EFP; ACTIVATION; 14-3-3-SIGMA; DEGRADATION	P53 is an important tumor suppressor that, upon activation, induces growth arrest and cell death. Control of p53 is thus of prime importance for proliferating cells, but also for cancer therapy, where p53 activity contributes to the eradication of tumors. Mdm2 functionally inhibits p53 and targets the tumor suppressor protein for degradation. In a genetic screen, we identified TRIM25 as a novel regulator of p53 and Mdm2. TRIM25 increased p53 and Mdm2 abundance by inhibiting their ubiquitination and degradation in 26 S proteasomes. TRIM25 co-precipitated with p53 and Mdm2 and interfered with the association of p300 and Mdm2, a critical step for p53 polyubiquitination. Despite the increase in p53 levels, p53 activity was inhibited in the presence of TRIM25. Downregulation of TRIM25 resulted in an increased acetylation of p53 and p53-dependent cell death in HCT116 cells. Upon genotoxic insults, TRIM25 dampened the p53-dependent DNA damage response. The downregulation of TRIM25 furthermore resulted in massive apoptosis during early embryogenesis of medaka, which was rescued by the concomitant downregulation of p53, demonstrating the functional relevance of the regulation of p53 by TRIM25 in an organismal context.	[Zhang, P.; Elabd, S.; Solozobova, V.; Yan, H.; Loosli, F.; Davidson, G.; Blattner, C.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Baden Wurttembe, Germany; [Zhang, P.; Yan, H.] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Hammer, S.; Bartel, F.] Univ Halle Wittenberg, Fac Med, Inst Pathol, D-06108 Halle, Germany; [Inoue, S.] Univ Tokyo, Dept Antiaging Med, Tokyo, Japan; [Henrich, T.] Osaka Univ, Int Coll, Chem Biol Combined Major Program, Osaka, Japan; [Wittbrodt, J.] Heidelberg Univ, Ctr Organismal Studies Dev Biol & Physiol, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; University of Tokyo; Osaka University; Ruprecht Karls University Heidelberg	Blattner, C (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, POB 3640, D-76021 Karlsruhe, Baden Wurttembe, Germany.	gary.davidson@kit.edu; christine.blattner@kit.edu	Blattner, Christine/ABI-2152-2020; Wittbrodt, Joachim/D-4735-2014; Loosli, Felix/H-7415-2013; Davidson, Gary/J-6059-2013; Blattner, Christine/H-2105-2013; Davidson, Gary/AAA-7321-2021	Blattner, Christine/0000-0002-7250-5273; Wittbrodt, Joachim/0000-0001-8550-7377; Blattner, Christine/0000-0002-7250-5273; Davidson, Gary/0000-0002-2264-5518; Zhang, Ping/0000-0001-7063-7769	DFG [FOR 1036]; COST Action [BM1307]	DFG(German Research Foundation (DFG)); COST Action(European Cooperation in Science and Technology (COST))	We thank Germana Meroni (CBM S.c.r.l., Trieste) for the TRIM25 plasmid, Yi Su for help with the screening and Christina Bauer, Tanja Kuhn, Beate Heydel and Cathrin Herder for technical assistance. PZ was a CSC fellow. GD acknowledges the funding from the DFG (FOR 1036) for the screening experiments. This work is supported by COST Action BM1307.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Bartel F, 2008, CLIN CANCER RES, V14, P89, DOI 10.1158/1078-0432.CCR-07-1192; Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Hurd C, 1999, ONCOGENE, V18, P1067, DOI 10.1038/sj.onc.1202398; Ikeda K, 2000, FEBS LETT, V472, P9, DOI 10.1016/S0014-5793(00)01421-6; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Nakayama H, 2005, PATHOL INT, V55, P707, DOI 10.1111/j.1440-1827.2005.01900.x; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Okumura N, 2002, JPN J CANCER RES, V93, P867, DOI 10.1111/j.1349-7006.2002.tb01331.x; Orimo A, 1999, P NATL ACAD SCI USA, V96, P12027, DOI 10.1073/pnas.96.21.12027; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shimada N, 2004, MOL CELL ENDOCRINOL, V218, P147, DOI 10.1016/j.mce.2003.12.008; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Souren M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r92; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Watanabe T, 2001, GYNECOL ONCOL, V81, P172, DOI 10.1006/gyno.2001.6132; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	28	54	56	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2015	34	46					5729	5738		10.1038/onc.2015.21	http://dx.doi.org/10.1038/onc.2015.21			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GC	25728675				2022-12-26	WOS:000364594600005
J	Tse, LA; Li, MJ; Chan, WC; Kwok, CH; Leung, SL; Wu, C; Yu, ITS; Yu, WC; Lao, XQ; Wang, XR; Wong, CKM; Lee, PMY; Wang, F; Yang, XR				Tse, Lap Ah; Li, Mengjie; Chan, Wing-cheong; Kwok, Chi-hei; Leung, Siu-lan; Wu, Cherry; Yu, Ignatius Tak-sun; Yu, Wai-cho; Lao, Xiangqian; Wang, Xiaorong; Wong, Carmen Ka-man; Lee, Priscilla Ming-yi; Wang, Feng; Yang, Xiaohong Rose			Familial Risks and Estrogen Receptor-Positive Breast Cancer in Hong Kong Chinese Women	PLOS ONE			English	Article							CONFER SUSCEPTIBILITY; COMMON VARIANTS; POPULATION; HISTORY	Purpose The role of family history to the risk of breast cancer was analyzed by incorporating menopausal status in Hong Kong Chinese women, with a particular respect to the estrogen receptor-positive (ER+) type. Methods Seven hundred and forty seven breast cancer incident cases and 781 hospital controls who had completed information on family cancer history in first-degree relatives (nature father, mother, and siblings) were recruited. Odds ratio for breast cancer were calculated by unconditional multiple logistic regression, stratified by menopausal status (a surrogate of endogenous female sex hormone level and age) and type of relative affected with the disease. Further subgroup analysis by tumor type according to ER status was investigated. Results Altogether 52 (6.96%) breast cancer cases and 23 (2.95%) controls was found that the patients' one or more first-degree relatives had a history of breast cancer, showing an adjusted odds ratio (OR) of 2.41 (95% CI: 1.45-4.02). An excess risk of breast cancer was restricted to the ER+ tumor (OR = 2.43, 95% CI: 1.38-4.28), with a relatively higher risk associated with an affected mother (OR = 3.97, 95% CI: 1.46-10.79) than an affected sister (OR = 2.06, 95% CI: 1.07-3.97), while the relative risk was more prominent in the subgroup of pre-menopausal women. Compared with the breast cancer overall, the familial risks to the ER+ tumor increased progressively with the number of affected first-degree relatives. Conclusions This study provides new insights on a relationship between family breast cancer history, menopausal status, and the ER+ breast cancer. A separate risk prediction model for ER+ tumor in Asian population is desired.	[Tse, Lap Ah; Li, Mengjie; Yu, Ignatius Tak-sun; Lao, Xiangqian; Wang, Xiaorong; Wong, Carmen Ka-man; Lee, Priscilla Ming-yi; Wang, Feng] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chan, Wing-cheong] North Dist Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwok, Chi-hei] Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China; [Leung, Siu-lan] Pamela Youde Nethersole Eastern Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Wu, Cherry] North Dist Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Yu, Wai-cho] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Yang, Xiaohong Rose] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	Chinese University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tse, LA (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	shelly@cuhk.edu.hk; fwang@cuhk.edu.hk	li, mengjie/GRS-3931-2022; Lao, Xiang Qian/M-5817-2017; Yu, Ignatius Tak Sun/A-9936-2008; wang, xiao/HGB-7081-2022	Lao, Xiang Qian/0000-0002-2645-0128; wang, xiao/0000-0002-4088-3341; Tse, Lap Ah/0000-0003-0355-6218; Wang, Feng/0000-0003-2618-201X; LEE, Priscilla Ming Yi/0000-0002-7688-0126	Research Grants Council of Hong Kong [474811]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Research Grants Council of Hong Kong [Grant number 474811]. The funding source had no role in the study design, data collection, data analysis, or interpretation of the findings.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Cummings SR, 2005, CANCER EPIDEM BIOMAR, V14, P1047, DOI 10.1158/1055-9965.EPI-04-0375; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; HOPPER JL, 1992, AM J EPIDEMIOL, V136, P1138, DOI 10.1093/oxfordjournals.aje.a116580; International Agency for Research on Cancer, GLOB 2012 EST CANC I; Kilfoy B, 2008, CANCER CAUSE CONTROL, V19, P1139, DOI 10.1007/s10552-008-9181-2; Leung GM, 2002, BRIT J CANCER, V87, P982, DOI 10.1038/sj.bjc.6600583; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ma HY, 2006, BREAST CANCER RES, V8, DOI [10.1186/bcr1525, 10.1186/bcr1512]; Mack TM, 2002, BRIT J CANCER, V87, P294, DOI 10.1038/sj.bjc.6600429; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; National Cancer Institute, GEN BREAST OV CANC; Neupane B, 2010, J CLIN EPIDEMIOL, V63, P926, DOI 10.1016/j.jclinepi.2009.11.006; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Ponder BAJ, 2005, COLD SH Q B, V70, P35, DOI 10.1101/sqb.2005.70.029; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; YUAN JM, 1988, CANCER RES, V48, P1949; Zhang B, 2014, BREAST CANCER RES TR, V146, P503, DOI 10.1007/s10549-014-3041-4	25	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120741	10.1371/journal.pone.0120741	http://dx.doi.org/10.1371/journal.pone.0120741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756203	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700074
J	Herget, ME; Hufford, KM; Mummey, DL; Shreading, LN				Herget, Mollie E.; Hufford, Kristina M.; Mummey, Daniel L.; Shreading, Lauren N.			Consequences of Seed Origin and Biological Invasion for Early Establishment in Restoration of a North American Grass Species	PLOS ONE			English	Article							LOCAL ADAPTATION; GENETIC DIFFERENTIATION; CHEATGRASS COMPETITION; GENOTYPIC DIVERSITY; ECOSYSTEM; PLANTS; COMMUNITIES; ECOTYPES; REMNANT	Local, wild-collected seeds of native plants are recommended for use in ecological restoration to maintain patterns of adaptive variation. However, some environments are so drastically altered by exotic, invasive weeds that original environmental conditions may no longer exist. Under these circumstances, cultivated varieties selected for improved germination and vigor may have a competitive advantage at highly disturbed sites. This study investigated differences in early establishment and seedling performance between wild and cultivated seed sources of the native grass, Poa secunda, both with and without competition from the invasive exotic grass, Bromus tectorum. We measured seedling survival and above-ground biomass at two experimental sites in western Montana, and found that the source of seeds selected for restoration can influence establishment at the restoration site. Cultivars had an overall advantage when compared with local genotypes, supporting evidence of greater vigor among cultivated varieties of native species. This advantage, however, declined rapidly in the presence of B. tectorum and most accessions were not significantly different for growth and survival in competition plots. Only one cultivar had a consistent advantage despite a strong decline in its performance when competing with invasive plants. As a result, cultivated varieties did not meet expectations for greater establishment and persistence relative to local genotypes in the presence of invasive, exotic species. We recommend the use of representative local or regional wild seed sources in restoration to minimize commercial selection, and a mix of individual accessions (wild, or cultivated when necessary) in highly invaded settings to capture vigorous genotypes and increase the odds native plants will establish at restoration sites.	[Herget, Mollie E.; Hufford, Kristina M.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Mummey, Daniel L.; Shreading, Lauren N.] MPG Ranch, Florence, MT USA	University of Wyoming	Herget, ME (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA.	mherget@uwyo.edu			MPG Ranch; University of Wyoming Reclamation and Restoration Center; Nature Conservancy	MPG Ranch; University of Wyoming Reclamation and Restoration Center; Nature Conservancy	This research has been made possible by funding from MPG Ranch (www.mpgranch.com) to MH and KH, the University of Wyoming Reclamation and Restoration Center (www.uwyo.edu/wrrc) to MH, and The Nature Conservancy (www.nature.org) to MH. MPG Ranch had a role in study design through co-authorship. The funder provided support in the form of salaries for authors DM and LS, but did not have any additional role in the data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AGUIRRE L, 1991, J RANGE MANAGE, V44, P347, DOI 10.2307/4002397; ALLARD RW, 1988, J HERED, V79, P225, DOI 10.1093/oxfordjournals.jhered.a110503; [Anonymous], 2006, SAS MIXED MODELS; Baer SG, 2014, EVOL APPL, V7, P323, DOI 10.1111/eva.12124; Bakker JD, 2003, ECOL APPL, V13, P137, DOI 10.1890/1051-0761(2003)013[0137:COGROY]2.0.CO;2; Banerjee MJ, 2006, RESTOR ECOL, V14, P339, DOI 10.1111/j.1526-100X.2006.00142.x; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Bischoff A, 2010, RESTOR ECOL, V18, P338, DOI 10.1111/j.1526-100X.2008.00454.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Brown CS, 2008, INVAS PLANT SCI MANA, V1, P399, DOI 10.1614/IPSM-08-082.1; Burton PJ., 2002, ECOLOGICAL RESTORATI, V20, P117, DOI [10.3368/er.20.2.117, DOI 10.3368/ER.20.2.117]; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Gasch CK, 2013, BIOL FERT SOILS, V49, P919, DOI 10.1007/s00374-013-0790-x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; Griffith AB, 2010, ECOLOGY, V91, P141, DOI 10.1890/08-1446.1; GUPTA SC, 1979, WATER RESOUR RES, V15, P1633, DOI 10.1029/WR015i006p01633; Gustafson D. J., 2005, Native Plants Journal, V6, P25, DOI 10.2979/NPJ.2005.6.1.25; Gustafson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091511; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; Hironaka M, 1972, GROWTH DEV SITANION; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Hufford KM, 2008, RESTOR ECOL, V16, P59, DOI 10.1111/j.1526-100X.2007.00262.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Humphrey LD, 2011, J ARID ENVIRON, V58, P405; Johnson RC, 2010, BOTANY, V88, P725, DOI 10.1139/B10-047; Jones TA, 2013, EVOL APPL, V6, P1109, DOI 10.1111/eva.12090; KELLOGG EA, 1985, J ARNOLD ARBORETUM, V66, P201, DOI 10.5962/bhl.part.13182; Klopf RP, 2011, RESTOR ECOL, V19, P112, DOI 10.1111/j.1526-100X.2009.00539.x; Lambert SM, 2011, NOTICE RELEASE MOUNT; Leger EA, 2008, ECOL APPL, V18, P1226, DOI 10.1890/07-1598.1; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lesica P, 1999, RESTOR ECOL, V7, P42, DOI 10.1046/j.1526-100X.1999.07105.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Majerus M., 2009, PLANT GUIDE SANDBERG; McKay JK, 2005, RESTOR ECOL, V13, P432, DOI 10.1111/j.1526-100X.2005.00058.x; Monsen SB, 2004, RESTORING W RANGES W, V2, P295; Peterson JS, 2002, PLANT FACT SHEET SAN; Rafferty DL, 2002, J RANGE MANAGE, V55, P70, DOI 10.2307/4003265; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rice KJ, 2008, RESTOR ECOL, V16, P12, DOI 10.1111/j.1526-100X.2007.00257.x; Schroder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071066; Sher AA, 2008, RESTOR ECOL, V16, P129, DOI 10.1111/j.1526-100X.2008.00355.x; Smith SL, 2007, RESTOR ECOL, V15, P369, DOI 10.1111/j.1526-100X.2007.00231.x; Stevens JM, 2011, RESTOR ECOL, V19, P399, DOI 10.1111/j.1526-100X.2009.00565.x; Stubbendieck J, 2011, N AM WILDLAND PLANTS; Vander Mijnsbrugge K, 2010, BASIC APPL ECOL, V11, P300, DOI 10.1016/j.baae.2009.09.002; Weisshuhn K, 2011, BASIC APPL ECOL, V12, P21, DOI 10.1016/j.baae.2010.11.005; Wilkinson DM, 2001, J APPL ECOL, V38, P1371, DOI 10.1046/j.0021-8901.2001.00669.x; Zar JH, 1999, BIOSTATISTICAL ANAL	52	14	14	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119889	10.1371/journal.pone.0119889	http://dx.doi.org/10.1371/journal.pone.0119889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741702	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100129
J	Li, JH; Wang, ZH; Zhu, XJ; Deng, ZH; Cai, CX; Qiu, LQ; Chen, W; Lin, YJ				Li, Jiang-Hua; Wang, Zhi-Hui; Zhu, Xiao-Juan; Deng, Zhao-Hui; Cai, Can-Xin; Qiu, Li-Qiang; Chen, Wei; Lin, Ya-Jun			Health Effects from Swimming Training in Chlorinated Pools and the Corresponding Metabolic Stress Pathways	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; TAURINE; CHLOROFORM; ASTHMA; PREVALENCE; ATTENDANCE; EXCRETION	Chlorination is the most popular method for disinfecting swimming pool water; however, although pathogens are being killed, many toxic compounds, called disinfection by-products (DBPs), are formed. Numerous epidemiological publications have associated the chlorination of pools with dysfunctions of the respiratory system and with some other diseases. However, the findings concerning these associations are not always consistent and have not been confirmed by toxicological studies. Therefore, the health effects from swimming in chlorinated pools and the corresponding stress reactions in organisms are unclear. In this study, we show that although the growth and behaviors of experimental rats were not affected, their health, training effects and metabolic profiles were significantly affected by a 12-week swimming training program in chlorinated water identical to that of public pools. Interestingly, the eyes and skin are the organs that are more directly affected than the lungs by the irritants in chlorinated water; instead of chlorination, training intensity, training frequency and choking on water may be the primary factors for lung damage induced by swimming. Among the five major organs (the heart, liver, spleen, lungs and kidneys), the liver is the most likely target of DBPs. Through metabolomics analysis, the corresponding metabolic stress pathways and a defensive system focusing on taurine were presented, based on which the corresponding countermeasures can be developed for swimming athletes and for others who spend a lot of time in chlorinated swimming pools.	[Li, Jiang-Hua; Zhu, Xiao-Juan; Deng, Zhao-Hui; Cai, Can-Xin; Qiu, Li-Qiang; Chen, Wei; Lin, Ya-Jun] Jiangxi Normal Univ, Inst Phys Educ, State Sports Gen Adm, Key Lab Training Monitoring & Intervent Sports Wa, Nanchang, Peoples R China; [Li, Jiang-Hua] Jiangxi Normal Univ, Jiangxi Prov Key Lab Chem Biol, Nanchang, Peoples R China; [Wang, Zhi-Hui] Beijing Econ Management Sch, Beijing, Peoples R China	Jiangxi Normal University; Jiangxi Normal University	Li, JH (corresponding author), Jiangxi Normal Univ, Inst Phys Educ, State Sports Gen Adm, Key Lab Training Monitoring & Intervent Sports Wa, Nanchang, Peoples R China.	lijianghua8@sina.com	li, jianghua/GXG-4735-2022		National Science Foundation of China [NSFC 21365013]; Jiangxi Provincial Education Department [GJJ 13240]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Education Department	This research was supported by the National Science Foundation of China (NSFC 21365013) and by the science project from the Jiangxi Provincial Education Department (GJJ 13240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard A, 2003, OCCUP ENVIRON MED, V60, P385, DOI 10.1136/oem.60.6.385; Bernard A, 2011, AM J RESP CRIT CARE, V183, P570, DOI 10.1164/rccm.201008-1306ED; Bougault V, 2012, J ALLERGY CLIN IMMUN, V129, P351, DOI 10.1016/j.jaci.2011.11.010; Cunningham C, 1998, BIOCHEM J, V330, P939, DOI 10.1042/bj3300939; Das J, 2012, FOOD FUNCT, V3, P1251, DOI 10.1039/c2fo30117b; Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171; Dawson C A, 1970, Med Sci Sports, V2, P51; Dzurik R, 2001, KIDNEY INT, V59, pS278; Florentin A, 2011, INT J HYG ENVIR HEAL, V214, P461, DOI 10.1016/j.ijheh.2011.07.012; Font-Ribera L, 2009, EUR RESPIR J, V34, P1304, DOI 10.1183/09031936.00180608; Font-Ribera L, 2011, AM J RESP CRIT CARE, V183, P582, DOI 10.1164/rccm.201005-0761OC; Gemma S, 1996, ENVIRON TOXICOL PHAR, V2, P233, DOI 10.1016/S1382-6689(96)00060-9; Gemma S, 2003, DRUG METAB DISPOS, V31, P266, DOI 10.1124/dmd.31.3.266; Goodman M, 2008, J ASTHMA, V45, P639, DOI 10.1080/02770900802165980; JACOBSEN JG, 1967, NATURE, V214, P1247, DOI 10.1038/2141247a0; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Lakind JS, 2010, ENVIRON SCI TECHNOL, V44, P3205, DOI 10.1021/es903241k; Levesque B, 2006, INT ARCH OCC ENV HEA, V80, P32, DOI 10.1007/s00420-006-0100-0; Lord R.S., 2008, LAB EVALUATIONS INTE; Lubick N, 2007, ENVIRON SCI TECHNOL, V41, P6634, DOI 10.1021/es0726198; Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x; Mansuy D, 1997, BIOCHEM BIOPH RES CO, V79, P513; Nickmilder M, 2007, OCCUP ENVIRON MED, V64, P37, DOI 10.1136/oem.2005.025452; POHL LR, 1977, BIOCHEM BIOPH RES CO, V79, P684, DOI 10.1016/0006-291X(77)91166-4; REUBER MD, 1979, ENVIRON HEALTH PERSP, V31, P171, DOI 10.2307/3429156; Ripps H, 2012, MOL VIS, V18, P2673; Roy A, 2009, FREE RADICAL RES, V43, P995, DOI 10.1080/10715760903164998; SPUSTOVA V, 1991, PHYSIOL RES, V40, P599; Tian JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075721; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; TUMASONIS CF, 1985, ECOTOX ENVIRON SAFE, V9, P233, DOI 10.1016/0147-6513(85)90026-0; Villanueva CM, 2004, EPIDEMIOLOGY, V15, P357, DOI 10.1097/01.ede.0000121380.02594.fc; Vittozzi L, 2000, ENVIRON TOXICOL PHAR, V8, P103, DOI 10.1016/S1382-6689(00)00031-4; World Health Organization (WHO), 2006, GUID SAF RECR WAT EN, V2	34	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119241	10.1371/journal.pone.0119241	http://dx.doi.org/10.1371/journal.pone.0119241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742134	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100096
J	Rijs, KJ; Van den Kommer, TN; Comijs, HC; Deeg, DJH				Rijs, Kelly J.; Van den Kommer, Tessa N.; Comijs, Hannie C.; Deeg, Dorly J. H.			Prevalence and Incidence of Memory Complaints in Employed Compared to Non-Employed Aged 55-64 Years and the Role of Employment Characteristics	PLOS ONE			English	Article							PSYCHOSOCIAL FACTORS; SUBJECTIVE FORGETFULNESS; PERSONALITY-TRAITS; COGNITIVE DECLINE; RISK-FACTOR; JOB STRAIN; ILL-HEALTH; FOLLOW-UP; OLDER; WORK	Objectives To examine the association of employment status and characteristics with prevalent and incident memory complaints (MC) in 55-64-year-olds. Methods Subjects were participants of the Longitudinal Aging Study Amsterdam (LASA). Respondents with baseline data were selected to examine the association of employment status (n = 1525) and employment characteristics (n = 1071) with prevalent MC (i.e., MC at baseline). Respondents without MC at baseline were selected to examine the association of employment (n = 526) and employment characteristics (n = 379; working hours, job prestige, job level, psychological job demands, iso-strain) with incident MC (i.e., no MC at baseline and MC at three-year follow-up). Associations were adjusted for relevant covariates (demographics, memory performance, physical health, mental health, personality traits). Logistic regression was applied. Data were weighed according to gender and age of the Dutch population. Results At baseline 20.5% reported MC. At three-year follow-up, 15.4% had incident MC. No associations were found between employment status and MC. Adjusted analysis revealed that individuals with high occupational cognitive demands were more likely to have prevalent MC. Conclusions Middle-aged workers are equally as likely to experience MC as non-working age-peers. Among workers, those with cognitively demanding work were more likely to experience MC, independent of memory performance. Memory decline due to ageing may be noticed sooner in 55-64-year-olds performing cognitively demanding work.	[Rijs, Kelly J.; Van den Kommer, Tessa N.; Deeg, Dorly J. H.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Comijs, Hannie C.; Deeg, Dorly J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands; [Comijs, Hannie C.] Vrije Univ Amsterdam, Med Ctr, GGZ InGeest Partner, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Rijs, KJ (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	kellyrijs@gmail.com	Rijs, Kelly/M-2191-2019		Dutch Ministry of Health, Welfare and Sport; Netherlands Organisation for Scientific Research (NWO), as part of the National Initiative Brain and Cognition (NIHC); Economic Structure Enhancing Fund (Fonds Economische Structuurversterking; Dutch acronym: FES)	Dutch Ministry of Health, Welfare and Sport; Netherlands Organisation for Scientific Research (NWO), as part of the National Initiative Brain and Cognition (NIHC)(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (Fonds Economische Structuurversterking; Dutch acronym: FES)	This study is based on data from the Longitudinal Aging Study Amsterdam, which is funded largely by the Dutch Ministry of Health, Welfare and Sport. Research performed in the current study is additionally supported with a grant from The Netherlands Organisation for Scientific Research (NWO), as part of the National Initiative Brain and Cognition (NIHC) and the Economic Structure Enhancing Fund (Fonds Economische Structuurversterking; Dutch acronym: FES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S, 2011, INT PSYCHOGERIATR, V23, P616, DOI 10.1017/S1041610210002024; Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; Balash Y, 2010, ACTA NEUROL SCAND, V121, P194, DOI 10.1111/j.1600-0404.2009.01159.x; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Blekesaune M, 2012, EUR J AGEING, V9, P199, DOI 10.1007/s10433-011-0212-6; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; BONGERS PM, 1993, SCAND J WORK ENV HEA, V19, P297, DOI 10.5271/sjweh.1470; Bosscher RJ, 1998, BEHAV RES THER, V36, P339, DOI 10.1016/S0005-7967(98)00025-4; Brisson C, 2000, J OCCUP ENVIRON MED, V42, P40, DOI 10.1097/00043764-200001000-00011; CBS Statline, DAT MAD AV STAT NETH; Comijs HC, 2002, J AFFECT DISORDERS, V72, P157, DOI 10.1016/S0165-0327(01)00453-0; Derouesne C, 1999, INT J GERIATR PSYCH, V14, P291, DOI 10.1002/(SICI)1099-1166(199904)14:4<291::AID-GPS902>3.3.CO;2-Z; Dik MG, 2001, NEUROLOGY, V57, P2217, DOI 10.1212/WNL.57.12.2217; Dufouil C, 2005, J AM GERIATR SOC, V53, P616, DOI 10.1111/j.1532-5415.2005.53209.x; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Gelissen J, 2006, SOC SCI RES, V35, P702, DOI 10.1016/j.ssresearch.2005.06.005; Handel M.J., 2012, OECD SOCIAL EMPLOYME, V143; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; Ilmarinen JE, 2001, OCCUP ENVIRON MED, V58, P546, DOI 10.1136/oem.58.8.546; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Jorm AF, 2004, PSYCHOL MED, V34, P1495, DOI 10.1017/S0033291704003162; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; Judge TA, 2002, J APPL PSYCHOL, V87, P530, DOI 10.1037//0021-9010.87.3.530; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Klein Hesselink DJ, 2012, WAT ZIJN MOGELIJKE O; Kompier M, 2005, SCAND J WORK ENV HEA, V31, P405, DOI 10.5271/sjweh.946; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Le H, 2011, J APPL PSYCHOL, V96, P113, DOI 10.1037/a0021016; Luteijn F, 1975, HANDELIDING BIJ NPV; Metternich B, 2010, PSYCHOTHER PSYCHOSOM, V79, P6, DOI 10.1159/000254901; Mol MEM, 2009, AGING MENT HEALTH, V13, P699, DOI 10.1080/13607860902845541; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Olesen SC, 2012, SOC PSYCH PSYCH EPID, V47, P735, DOI 10.1007/s00127-011-0375-7; Paradise MB, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-108; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Ponds RWHM, 1997, INT J AGING HUM DEV, V45, P207, DOI 10.2190/MVQ1-WB58-875H-Y4X0; Potter Guy G, 2009, Anxiety Stress Coping, V22, P475, DOI 10.1080/10615800802449610; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rijs KJ, 2014, ANN OCCUP HYG, V58, P152, DOI 10.1093/annhyg/met052; Rijs KJ, 2013, EUR J PUBLIC HEALTH, V23, P1013, DOI 10.1093/eurpub/cks159; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Sixma H, 1983, SISWO PUBLICATION, V291, P91; Stenfors CUD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060637; Stenfors CUD, 2014, BMC PSYCHOL, V2, P1; Valset K, 2007, SCAND J PUBLIC HEALT, V35, P157, DOI 10.1080/14034940600984635; Van Dalen H, 2013, WAAROM LEIDINGGEVEN; van den Berg T, 2010, OCCUP ENVIRON MED, V67, P845, DOI 10.1136/oem.2009.051730; Vestergren P, 2011, APPL COGNITIVE PSYCH, V25, P641, DOI 10.1002/acp.1734	50	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119192	10.1371/journal.pone.0119192	http://dx.doi.org/10.1371/journal.pone.0119192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742133	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100089
J	Steindor, M; Nkwouano, V; Mayatepek, E; Mackenzie, CR; Schramm, D; Jacobsen, M				Steindor, Mathis; Nkwouano, Vanesa; Mayatepek, Ertan; Mackenzie, Colin R.; Schramm, Dirk; Jacobsen, Marc			Rapid Detection and Immune Characterization of Mycobacterium abscessus Infection in Cystic Fibrosis Patients	PLOS ONE			English	Article							CHELONAE SUBSP-ABSCESSUS; T-CELL RESPONSES; TUBERCULIN; SENSITIVITY; AVIUM	Cystic fibrosis patients are highly susceptible to infections with non-tuberculous mycobacteria. Especially Mycobacterium abscessus infections are common but reliable diagnosis is hampered by non-specific clinical symptoms and insensitive mycobacterial culture. In the present study we established novel methods for rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. We performed Mycobacterium abscessus specific DNA-strip-and quantitative PCR-based analyses of non-cultured sputum samples to detect and characterize Mycobacterium abscessus infections. Concomitantly in vitro T-cell reactivation with purified protein derivatives (PPDs) from different mycobacterial species was used to determine Mycobacterium abscessus specific T-cell cytokine expression of infected cystic fibrosis patients. Four of 35 cystic fibrosis patients (11.4%) were Mycobacterium abscessus culture positive and showed concordant DNA-strip-test results. Quantitative PCR revealed marked differences of mycobacterial burden between cystic fibrosis patients and during disease course. Tandem-repeat analysis classified distinct Mycobacterium abscessus strains of infected cystic fibrosis patients and excluded patient-to-patient transmission. Mycobacterium abscessus specific T-cells were detected in the blood of cystic fibrosis patients with confirmed chronic infection and a sub-group of patients without evidence of Mycobacterium abscessus infection. Comparison of cytokine expression and phenotypic markers revealed increased proportions of CD40L positive T-cells that lack Interleukin-2 expression as a marker for chronic Mycobacterium abscessus infections in cystic fibrosis patients. Direct sputum examination enabled rapid diagnosis and quantification of Mycobacterium abscessus in cystic fibrosis patients. T-cell in vitro reactivation and cytokine expression analyses may contribute to diagnosis of chronic Mycobacterium abscessus infection.	[Steindor, Mathis; Nkwouano, Vanesa; Mayatepek, Ertan; Schramm, Dirk; Jacobsen, Marc] Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Mackenzie, Colin R.] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Mackenzie, Colin R.] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Jacobsen, M (corresponding author), Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany.	marc.jacobsen@med.uni-duesseldorf.de	MacKenzie, Colin R/E-9368-2011	MacKenzie, Colin R/0000-0001-7732-2698; Jacobsen, Marc/0000-0002-4703-5652	Jurgen Manchot Foundation	Jurgen Manchot Foundation	This study was supported by the Jurgen Manchot Foundation 'Molecules of Infection II' project to V. Nkwouano and M. Jacobsen. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bange FC, 1999, J CLIN MICROBIOL, V37, P3761, DOI 10.1128/JCM.37.11.3761-3763.1999; Blauwendraat C, 2012, EUR J CLIN MICROBIOL, V31, P1847, DOI 10.1007/s10096-011-1510-9; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Catherinot E, 2013, J CYST FIBROS, V12, P74, DOI 10.1016/j.jcf.2012.06.009; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Vrankrijker AMM, 2010, PAEDIATR RESPIR REV, V11, P246, DOI 10.1016/j.prrv.2010.07.003; Feske M, 2008, CLIN VACCINE IMMUNOL, V15, P1616, DOI 10.1128/CVI.00185-08; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; HANSEN KN, 1989, DAN MED BULL, V36, P399; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hill Uta G, 2012, J R Soc Med, V105 Suppl 2, pS14, DOI 10.1258/jrsm.2012.12s003; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Kang H, 2014, IMMUNOLOGY, V143, P661, DOI 10.1111/imm.12348; KUSUNOKI S, 1992, INT J SYST BACTERIOL, V42, P240, DOI 10.1099/00207713-42-2-240; Magdorf K, 2008, CLIN MICROBIOL INFEC, V14, P1079, DOI 10.1111/j.1469-0691.2008.02084.x; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Radhakrishnan DK, 2009, PEDIATR PULM, V44, P1100, DOI 10.1002/ppul.21106; Ratner D, 2012, AM J RESP CELL MOL, V46, P715, DOI 10.1165/rcmb.2011-0399RT; Rieber N, 2014, INT J BIOCHEM CELL B, V52, P108, DOI 10.1016/j.biocel.2014.01.017; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Warren JR, 2000, AM J RESP CRIT CARE, V161, P1559, DOI 10.1164/ajrccm.161.5.9908063; Whittier S, 1997, J CLIN MICROBIOL, V35, P2706, DOI 10.1128/JCM.35.10.2706-2708.1997; Wong YL, 2012, J CLIN MICROBIOL, V50, P3084, DOI 10.1128/JCM.00753-12	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119737	10.1371/journal.pone.0119737	http://dx.doi.org/10.1371/journal.pone.0119737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742660	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100128
J	Zhou, YJ; Shan, G; Sodergren, E; Weinstock, G; Walker, WA; Gregory, KE				Zhou, Yanjiao; Shan, Gururaj; Sodergren, Erica; Weinstock, George; Walker, W. Allan; Gregory, Katherine E.			Longitudinal Analysis of the Premature Infant Intestinal Microbiome Prior to Necrotizing Enterocolitis: A Case-Control Study	PLOS ONE			English	Article							EXTREMELY PRETERM INFANTS; GUT MICROBIOME; COLONIZATION; PATHOGENESIS; INFLAMMATION; OUTCOMES; TIME; DIET	Necrotizing enterocolitis (NEC) is an inflammatory disease of the newborn bowel, primarily affecting premature infants. Early intestinal colonization has been implicated in the pathogenesis of NEC. The objective of this prospective case-control study was to evaluate differences in the intestinal microbiota between infants who developed NEC and unaffected controls prior to disease onset. We conducted longitudinal analysis of the 16S rRNA genes of 312 samples obtained from 12 NEC cases and 26 age-matched controls with a median frequency of 7 samples per subject and median sampling interval of 3 days. We found that the microbiome undergoes dynamic development during the first two months of life with day of life being the major factor contributing to the colonization process. Depending on when the infant was diagnosed with NEC (i.e. early vs. late onset), the pattern of microbial progression was different for cases and controls. The difference in the microbiota was most overt in early onset NEC cases and controls. In proximity to NEC onset, the abundances of Clostridium sensu stricto from Clostridia class were significantly higher in early onset NEC subjects comparing to controls. In late onset NEC, Escherichia/Shigella among Gammaproteobacteria, showed an increasing pattern prior to disease onset, and was significantly higher in cases than controls six days before NEC onset. Cronobacter from Gammaproteobacteria was also significantly higher in late onset NEC cases than controls 1-3 days prior to NEC onset. Thus, the specific infectious agent associated with NEC may vary by the age of infant at disease onset. We found that intravenously administered antibiotics may have an impact on the microbial diversity present in fecal material. Longitudinal analysis at multiple time points was an important strategy utilized in this study, allowing us to appreciate the dynamics of the premature infant intestinal microbiome while approaching NEC at various points.	[Zhou, Yanjiao] Washington Univ, Genome Inst, St Louis, MO USA; [Zhou, Yanjiao] Washington Univ, Sch Med, Dept Pediat, St Louis, MO USA; [Shan, Gururaj] Rowan Univ, Cooper Med Sch, Camden, NJ USA; [Sodergren, Erica; Weinstock, George] Jackson Lab Genom Med, Farmington, CT USA; [Walker, W. Allan] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Dept Pediat, Boston, MA USA; [Gregory, Katherine E.] Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA; [Gregory, Katherine E.] Brigham & Womens Hosp, Dept Nursing, Boston, MA 02115 USA; [Walker, W. Allan; Gregory, Katherine E.] Harvard Univ, Sch Med, Boston, MA USA	Washington University (WUSTL); Washington University (WUSTL); Rowan University; Cooper Medical School of Rowan University; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gregory, KE (corresponding author), Brigham & Womens Hosp, Dept Newborn Med, 75 Francis St, Boston, MA 02115 USA.	kgregory1@partners.org	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Gregory, Katherine/0000-0002-0610-5386	pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; National Institutes of Health [K23 NR011320, R01 HD012437, P01 DK003506, R01 HD005126, P30 DK040561]; National Institutes of Health Common Fund [U54HG004968]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P01DK033506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K23NR011320] Funding Source: NIH RePORTER	pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was conducted with support from a pilot feasibility grant from the Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers to KEG and WAW; National Institutes of Health K23 NR011320 to KEG; National Institutes of Health Common Fund U54HG004968 to YZ, ES, and GW; National Institutes of Health R01 HD012437, P01 DK003506, R01 HD005126, P30 DK040561 to WAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Bates D, 2012, LME4 LINEAR MIXED EF; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Emami CN, 2012, J SURG RES, V172, P18, DOI 10.1016/j.jss.2011.04.019; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Gordon PV, 2007, J PERINATOL, V27, P661, DOI 10.1038/sj.jp.7211782; Grishin A, 2013, SEMIN PEDIATR SURG, V22, P69, DOI 10.1053/j.sempedsurg.2013.01.002; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallstrom M, 2004, EUR J CLIN MICROBIOL, V23, P463, DOI 10.1007/s10096-004-1146-0; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Hunter CJ, 2008, J INFECT DIS, V198, P586, DOI 10.1086/590186; Jenke AC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/150372; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Normann E, 2013, ACTA PAEDIATR, V102, P129, DOI 10.1111/apa.12059; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Torrazza RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083304; Wadhawan R, 2014, J PERINATOL, V34, P64, DOI 10.1038/jp.2013.128; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	42	106	112	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118632	10.1371/journal.pone.0118632	http://dx.doi.org/10.1371/journal.pone.0118632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741698	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100024
J	Dun, XP; Parkinson, DB				Dun, Xin-peng; Parkinson, David B.			Visualizing Peripheral Nerve Regeneration by Whole Mount Staining	PLOS ONE			English	Article							SCHWANN-CELL PROLIFERATION; WALLERIAN DEGENERATION; INJURED NERVES; MOUSE; AXON; REPAIR; MACROPHAGES; REGROWTH; PAIN	Peripheral nerve trauma triggers a well characterised sequence of events both proximal and distal to the site of injury. Axons distal to the injury degenerate, Schwann cells convert to a repair supportive phenotype and macrophages enter the nerve to clear myelin and axonal debris. Following these events, axons must regrow through the distal part of the nerve, re-innervate and finally are re-myelinated by Schwann cells. For nerve crush injuries (axonotmesis), in which the integrity of the nerve is maintained, repair may be relatively effective whereas for nerve transection (neurotmesis) repair will likely be very poor as few axons may be able to cross between the two parts of the severed nerve, across the newly generated nerve bridge, to enter the distal stump and regenerate. Analysing axon growth and the cell-cell interactions that occur following both nerve crush and cut injuries has largely been carried out by staining sections of nerve tissue, but this has the obvious disadvantage that it is not possible to follow the paths of regenerating axons in three dimensions within the nerve trunk or nerve bridge. To try and solve this problem, we describe the development and use of a novel whole mount staining protocol that allows the analysis of axonal regeneration, Schwann cell-axon interaction and re-vascularisation of the repairing nerve following nerve cut and crush injuries.	[Dun, Xin-peng; Parkinson, David B.] Univ Plymouth, Peninsula Sch Med & Dent, Plymouth PL4 8AA, Devon, England; [Dun, Xin-peng] Hubei Univ Sci & Technol, Xian Ning City, Hubei, Peoples R China	University of Plymouth; Hubei University of Science & Technology	Dun, XP (corresponding author), Univ Plymouth, Peninsula Sch Med & Dent, Plymouth PL4 8AA, Devon, England.	xin-peng.dun@plymouth.ac.uk		Dun, Xin-peng/0000-0003-2837-4672	UK Medical Research Council [MR/J012785/1]; National Natural Science Foundation of China [81371353]; MRC [MR/J012785/1] Funding Source: UKRI; Medical Research Council [MR/J012785/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MR/J012785/1, http://www.mrc.ac.uk) and the National Natural Science Foundation of China (81371353, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; BRUSHART TM, 1980, SCIENCE, V208, P603, DOI 10.1126/science.7367884; CHEN S, 1993, J COMP NEUROL, V333, P449, DOI 10.1002/cne.903330310; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hayashi A, 2007, EXP NEUROL, V207, P128, DOI 10.1016/j.expneurol.2007.06.004; Kiguchi N, 2014, J NEUROCHEM, V129, P169, DOI 10.1111/jnc.12614; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Lau J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-100; Levy D, 2001, J NEUROPATH EXP NEUR, V60, P411, DOI 10.1093/jnen/60.5.411; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Painter MW, 2014, NEURON, V83, P331, DOI 10.1016/j.neuron.2014.06.016; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436; Yang DP, 2008, MOL CELL NEUROSCI, V38, P80, DOI 10.1016/j.mcn.2008.01.017; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x; Zochodne DW, 1997, J ANAT, V191, P23, DOI 10.1046/j.1469-7580.1997.19110023.x	29	39	42	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119168	10.1371/journal.pone.0119168	http://dx.doi.org/10.1371/journal.pone.0119168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738874	Green Submitted, gold, Green Published			2022-12-26	WOS:000350685900096
J	Dupuis-Maurin, V; Brinza, L; Baguet, J; Plantamura, E; Schicklin, S; Chambion, S; Macari, C; Tomkowiak, M; Deniaud, E; Leverrier, Y; Marvel, J; Michallet, MC				Dupuis-Maurin, Valeryane; Brinza, Lilia; Baguet, Joel; Plantamura, Emilie; Schicklin, Stephane; Chambion, Solene; Macari, Claire; Tomkowiak, Martine; Deniaud, Emmanuelle; Leverrier, Yann; Marvel, Jacqueline; Michallet, Marie-Cecile			Overexpression of the Transcription Factor Sp1 Activates the OAS-RNAse L-RIG-I Pathway	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; DNA-BINDING; CELL-GROWTH; ER STRESS; SELF-RNA; APOPTOSIS; PHOSPHORYLATION; EXPRESSION; DIFFERENTIATION; RECOGNITION	Deregulated expression of oncogenes or transcription factors such as specificity protein 1 (Sp1) is observed in many human cancers and plays a role in tumor maintenance. Paradoxically in untransformed cells, Sp1 overexpression induces late apoptosis but the early intrinsic response is poorly characterized. In the present work, we studied increased Sp1 level consequences in untransformed cells and showed that it turns on an early innate immune transcriptome. Sp1 overexpression does not activate known cellular stress pathways such as DNA damage response or endoplasmic reticulum stress, but induces the activation of the OAS-RNase L pathway and the generation of small self-RNAs, leading to the upregulation of genes of the antiviral RIG-I pathway at the transcriptional and translational levels. Finally, Sp1-induced intrinsic innate immune response leads to the production of the chemokine CXCL4 and to the recruitment of inflammatory cells in vitro and in vivo. Altogether our results showed that increased Sp1 level in untransformed cells constitutes a novel danger signal sensed by the OAS-RNase L axis leading to the activation of the RIG-I pathway. These results suggested that the OAS-RNase L-RIG-I pathway may be activated in sterile condition in absence of pathogen.	[Dupuis-Maurin, Valeryane; Brinza, Lilia; Baguet, Joel; Plantamura, Emilie; Schicklin, Stephane; Chambion, Solene; Macari, Claire; Tomkowiak, Martine; Deniaud, Emmanuelle; Leverrier, Yann; Marvel, Jacqueline; Michallet, Marie-Cecile] Univ Lyon 1, ENS Lyon, CNRS, Ctr Int Rech Infectiol,INSERM U111,UMR5308, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marvel, J (corresponding author), Univ Lyon 1, ENS Lyon, CNRS, Ctr Int Rech Infectiol,INSERM U111,UMR5308, F-69365 Lyon, France.	jacqueline.marvel@inserm.fr; marie-cecile.michallet@inserm.fr	marvel, jacqueline/H-8638-2014; LEVERRIER, Yann/M-3767-2014	marvel, jacqueline/0000-0001-6241-459X; LEVERRIER, Yann/0000-0002-4227-5446	Institut National de la Sante et de la Recherche Medicale, Universite de Lyon I; Association pour la Recherche contre le Cancer; Ligue Regionale de Lutte contre le Cancer - Departement du Rhone; Fonds Europeen de Developpement Regional; Finovi foundation; association "Pense a Moelle"; association "Moelle Partage et Vie"	Institut National de la Sante et de la Recherche Medicale, Universite de Lyon I; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Regionale de Lutte contre le Cancer - Departement du Rhone; Fonds Europeen de Developpement Regional; Finovi foundation; association "Pense a Moelle"; association "Moelle Partage et Vie"	This work was supported by Institut National de la Sante et de la Recherche Medicale, Universite de Lyon I, Association pour la Recherche contre le Cancer, Ligue Regionale de Lutte contre le Cancer - Departement du Rhone, Fonds Europeen de Developpement Regional, Finovi foundation and associations "Pense a Moelle" and "Moelle Partage et Vie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bin LH, 2011, J ALLERGY CLIN IMMUN, V127, P430, DOI 10.1016/j.jaci.2010.11.013; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guan K, 2013, MOL CELL BIOL, V33, P3137, DOI 10.1128/MCB.00030-13; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuo LJ, 2008, IN VIVO, V22, P305; Leverrier Y, 1997, ONCOGENE, V14, P425, DOI 10.1038/sj.onc.1200845; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Lou Z, 2005, CANCER RES, V65, P1007; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nichols AF, 2003, NUCLEIC ACIDS RES, V31, P562, DOI 10.1093/nar/gkg152; Rajcani J, 2004, VIRUS GENES, V28, P293, DOI 10.1023/B:VIRU.0000025777.62826.92; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; SUNE C, 1995, J VIROL, V69, P6572; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118551	10.1371/journal.pone.0118551	http://dx.doi.org/10.1371/journal.pone.0118551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738304	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900046
J	Ji, FT; Zhu, Y				Ji, Feiteng; Zhu, Yan			A Novel Assay Reveals Hygrotactic Behavior in Drosophila	PLOS ONE			English	Article							MUSHROOM BODY; THERMORECEPTIVE SENSILLUM; RECEPTOR NEURONS; MAP; TASTE; REPRESENTATIONS; HYGROSENSATION; IDENTIFICATION; OSMOSENSATION; MECHANISMS	Humidity is one of the most important factors that determines the geographical distribution and survival of terrestrial animals. The ability to detect variation in humidity is conserved across many species. Here, we established a novel behavioral assay that revealed the thirsty Drosophila exhibits strong hygrotactic behavior, and it can locate water by detecting humidity gradient. In addition, exposure to high levels of moisture was sufficient to elicit proboscis extension reflex behavior in thirsty flies. Furthermore, we found that the third antennal segment was necessary for hygrotactic behavior in thirsty flies, while arista was required for the avoidance of moist air in hydrated flies. These results indicated that two types of hygroreceptor cells exist in Drosophila: one located in the third antennal segment that mediates hygrotactic behavior in thirst status, and the other located in arista which is responsible for the aversive behavior toward moist air in hydration status. Using a neural silencing screen, we demonstrated that synaptic output from the mushroom body alpha/beta surface and posterior neurons was required for both hygrotactic behavior and moisture-aversive behavior.	[Ji, Feiteng; Zhu, Yan] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Ji, Feiteng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	zhuyan@ibp.ac.cn			National Basic Research Program of China [2012CB825504]; National Natural Sciences Foundation of China [91232720, 31070925]; Bureau of International Cooperation; Chinese Academy of Sciences [GJHZ201302]; 100-Talents Program of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of International Cooperation; Chinese Academy of Sciences(Chinese Academy of Sciences); 100-Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	National Basic Research Program of China (2012CB825504), the National Natural Sciences Foundation of China (91232720 and 31070925), Bureau of International Cooperation, the Chinese Academy of Sciences (GJHZ201302), and 100-Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; BARZEEV M, 1967, NATURE, V213, P737, DOI 10.1038/213737b0; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Davis RL, 1996, CURR BIOL, V6, P146, DOI 10.1016/S0960-9822(02)00447-5; DEBELLE JS, 1995, NEURON, V15, P245; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Merivee E, 2010, J INSECT PHYSIOL, V56, P1671, DOI 10.1016/j.jinsphys.2010.06.017; Pedersen SF, 2011, J AM SOC NEPHROL, V22, P1587, DOI 10.1681/ASN.2010121284; PERTTUNEN V, 1952, NATURE, V169, P78, DOI 10.1038/169078a0; Piersanti S, 2011, J INSECT PHYSIOL, V57, P1391, DOI 10.1016/j.jinsphys.2011.07.005; Prager-Khoutorsky M, 2010, TRENDS NEUROSCI, V33, P76, DOI 10.1016/j.tins.2009.11.004; Russell J, 2014, P NATL ACAD SCI USA, V111, P8269, DOI 10.1073/pnas.1322512111; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sharif-Naeini R, 2008, KIDNEY INT, V73, P811, DOI 10.1038/sj.ki.5002788; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TICHY H, 1979, J COMP PHYSIOL, V132, P149, DOI 10.1007/BF00610718; TOMINAGA Y, 1982, CELL TISSUE RES, V226, P309, DOI 10.1007/BF00218361; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; YOKOHARI F, 1981, CELL TISSUE RES, V216, P525	40	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119162	10.1371/journal.pone.0119162	http://dx.doi.org/10.1371/journal.pone.0119162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738801	gold, Green Published			2022-12-26	WOS:000350685900095
J	Shastri, MD; Stewart, N; Eapen, M; Peterson, GM; Zaidi, STR; Gueven, N; Sohal, SS; Patel, RP				Shastri, Madhur D.; Stewart, Niall; Eapen, Mathew; Peterson, Gregory M.; Zaidi, Syed Tabish R.; Gueven, Nuri; Sohal, Sukhwinder Singh; Patel, Rahul P.			Opposing Effects of Low Molecular Weight Heparins on the Release of Inflammatory Cytokines from Peripheral Blood Mononuclear Cells of Asthmatics	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC APPLICATIONS; INHALED HEPARIN; DOWN-REGULATION; LICHEN-PLANUS; INHIBITION; PROLIFERATION; SEPARATION; ENOXAPARIN; BRONCHOCONSTRICTION; PREVALENCE	Background T-cell-mediated inflammatory cytokines, such as interleukin (IL)-4, IL-5, IL-13 and tumor necrosis factor-alpha (TNF-alpha), play an important role in the initiation and progression of inflammatory airways diseases. Low-molecular-weight heparins (LMWHs), widely used anticoagulants, possess anti-inflammatory properties making them potential treatment options for inflammatory diseases, including asthma. In the current study, we investigated the modulating effects of two LMWHs (enoxaparin and dalteparin) on the release of cytokines from stimulated peripheral blood mononuclear cells (PBMCs) of asthmatic subjects to identify the specific components responsible for the effects. Methods PBMCs from asthmatic subjects (consist of similar to 75% of T-cells) were isolated from blood taken from ten asthmatic subjects. The PBMCs were pre-treated in the presence or absence of different concentrations of LMWHs, and were then stimulated by phytohaemagglutinin for the release of IL-4, IL-5, IL-13 and TNF-alpha. LMWHs were completely or selectively desulfated and their anticoagulant effect, as well as the ability to modulate cytokine release, was determined. LMWHs were chromatographically fractionated and each fraction was tested for molecular weight determination along with an assessment of anticoagulant potency and effect on cytokine release. Results Enoxaparin inhibited cytokine release by more than 48%, whereas dalteparin increased their release by more than 25%. The observed anti-inflammatory effects of enoxaparin were independent of their anticoagulant activities. Smaller fractions, in particular dp4 (four saccharide units), were responsible for the inhibitory effect of enoxaparin. Whereas, the larger fractions, in particular dp22 (twenty two saccharide units), were associated with the stimulatory effect of dalteparin. Conclusion Enoxaparin and dalteparin demonstrated opposing effects on inflammatory markers. These observed effects could be due to the presence of structurally different components in the two LMWHs arising from different methods of depolymerisation. This study provides a platform for further studies investigating the usefulness of enoxaparin in various inflammatory diseases.	[Shastri, Madhur D.; Stewart, Niall; Peterson, Gregory M.; Zaidi, Syed Tabish R.; Gueven, Nuri; Patel, Rahul P.] Univ Tasmania, Fac Hlth, Div Pharm, Sch Med, Hobart, Tas, Australia; [Eapen, Mathew; Peterson, Gregory M.; Sohal, Sukhwinder Singh] Univ Tasmania, Fac Hlth, Sch Med, Breathe Well Ctr Res Excellence Chron Resp Dis &, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	Patel, RP (corresponding author), Univ Tasmania, Fac Hlth, Div Pharm, Sch Med, Hobart, Tas, Australia.	Rahul.Patel@utas.edu.au	Eapen, Mathew/AAB-9444-2021; Zaidi, Syed Tabish R./J-7336-2014	Guven, Nuri/0000-0003-3782-767X; Shastri, Madhur/0000-0002-1012-2779; Zaidi, Syed Tabish R./0000-0002-2031-1055; Patel, Rahul/0000-0001-9344-1013; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Peterson, Gregory/0000-0002-6764-3882; Eapen, Mathew/0000-0003-0570-7059	Starter Grant from Royal Hobart Hospital Research Foundation, Australia [H22074]; Research Enhancement Grant Schemes from University of Tasmania, Australia [105557]	Starter Grant from Royal Hobart Hospital Research Foundation, Australia; Research Enhancement Grant Schemes from University of Tasmania, Australia	Funding provided by a Starter Grant from Royal Hobart Hospital Research Foundation, Australia (Grant Number- H22074) awarded to RP, NS and SS, http://www.rhhresearchfoundation.org/index.php/site/research/ and a Research Enhancement Grant Schemes from University of Tasmania, Australia (Grant Number- 105557) awarded to RP and NG, http://www.utas.edu.au/research-admin/funding/funding-options/internal-funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, AM J RESP CRIT CARE, V160, P576, DOI 10.1164/ajrccm.160.2.9812076; AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Altinbas M, 2004, J THROMB HAEMOST, V2, P1266, DOI 10.1111/j.1538-7836.2004.00871.x; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Baram D, 1997, CLIN EXP IMMUNOL, V110, P485, DOI 10.1046/j.1365-2249.1997.4541471.x; Barblu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032874; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bloemen K, 2007, IMMUNOL LETT, V113, P6, DOI 10.1016/j.imlet.2007.07.010; BOWLER SD, 1993, AM REV RESPIR DIS, V147, P160, DOI 10.1164/ajrccm/147.1.160; Brown RA, 2006, PULM PHARMACOL THER, V19, P419, DOI 10.1016/j.pupt.2006.04.004; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Casu B., 2005, CHEM BIOL HEPARIN HE, P1, DOI DOI 10.1016/B978-008044859-6/50002-2; CEYHAN B, 1995, CHEST, V107, P1009, DOI 10.1378/chest.107.4.1009; Chen JL, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/752940; Chwae YJ, 2002, J IMMUNOL, V169, P3726, DOI 10.4049/jimmunol.169.7.3726; Diamant Z, 1996, AM J RESP CRIT CARE, V153, P1790, DOI 10.1164/ajrccm.153.6.8665036; Evans RC, 1997, ALIMENT PHARM THERAP, V11, P1037, DOI 10.1046/j.1365-2036.1997.00252.x; FLINT N, 1994, J CELL SCI, V107, P401; Guerrini Marco, 2012, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-23056-1_7; HANKE H, 1992, CIRCULATION, V85, P1548, DOI 10.1161/01.CIR.85.4.1548; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; Hochart H, 2006, BRIT J HAEMATOL, V133, P62, DOI 10.1111/j.1365-2141.2006.05959.x; Hodak E, 1998, J AM ACAD DERMATOL, V38, P564, DOI 10.1016/S0190-9622(98)70118-5; Khorana AA, 2003, ARTERIOSCL THROM VAS, V23, P2110, DOI 10.1161/01.ATV.0000090671.56682.D7; Kidd Parris, 2003, Altern Med Rev, V8, P223; LAM LH, 1976, BIOCHEM BIOPH RES CO, V69, P570, DOI 10.1016/0006-291X(76)90558-1; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Linhardt R. J., 1991, CHEM IND, V2, P45; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; Maurice MM, 1997, J IMMUNOL, V159, P2973; MCLEAN J, 1959, CIRCULATION, V19, P75, DOI 10.1161/01.CIR.19.1.75; Olie RA, 2000, CANCER RES, V60, P2805; Pacheco H, 2001, J DERMATOL TREAT, V12, P123; Papa A, 2000, ALIMENT PHARM THER, V14, P1403, DOI 10.1046/j.1365-2036.2000.00860.x; Patel RP, 2008, J PHARMACEUT BIOMED, V46, P30, DOI 10.1016/j.jpba.2007.10.009; Patel RP, 2009, J PHARM SCI-US, V98, P1118, DOI 10.1002/jps.21483; Patel RP, 2009, J PHARM SCI-US, V98, P1700, DOI 10.1002/jps.21556; Peters SP, 2006, RESP MED, V100, P1139, DOI 10.1016/j.rmed.2006.03.031; Rael EL, 2011, WORLD ALLERGY ORGAN, V4, P54, DOI 10.1097/WOX.0b013e31821188e0; Roy S, 2011, GLYCOBIOLOGY, V21, P1194, DOI 10.1093/glycob/cwr053; Ruiz-Calero V, 2001, ANALYST, V126, P169, DOI 10.1039/b007300h; Shastri MD, 2014, EXPERT OPIN INV DRUG, V23, P357, DOI 10.1517/13543784.2014.866092; Spahn JD, 1996, J IMMUNOL, V157, P2654; TAKAFUJI S, 1991, J IMMUNOL, V147, P3855; Teixeira LK, 2005, MEM I OSWALDO CRUZ, V100, P137, DOI 10.1590/S0074-02762005000900024; Thanawiroon C, 2003, J CHROMATOGR A, V1014, P215, DOI 10.1016/S0021-9673(03)00779-9; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Vignoli A, 2006, HAEMATOL-HEMATOL J, V91, P207; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026	53	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118798	10.1371/journal.pone.0118798	http://dx.doi.org/10.1371/journal.pone.0118798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738575	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900075
J	Sumi, A; Akiba, J; Ogasawara, S; Nakayama, M; Nomura, Y; Yasumoto, M; Sanada, S; Nakashima, O; Abe, T; Yano, H				Sumi, Akiko; Akiba, Jun; Ogasawara, Sachiko; Nakayama, Masamichi; Nomura, Yoriko; Yasumoto, Makiko; Sanada, Sakiko; Nakashima, Osamu; Abe, Toshi; Yano, Hirohisa			Des-gamma-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma	PLOS ONE			English	Article							CARBOXY PROTHROMBIN PRODUCTION; VITAMIN-K-ABSENCE; MICROVASCULAR INVASION; ALPHA-FETOPROTEIN; P-16 ANTIBODIES; TUMOR-MARKERS; SURVIVAL; BIOMARKER; PROGNOSIS; CANCER	Aim Des-gamma-carboxyprothrombin (DCP) has been used as a tumor marker for hepatocellular carcinoma (HCC). Recently the DCP/NX-DCP ratio, calculated by dividing DCP by NX-DCP, has been reported useful in detecting HCC. The purpose of this study is to clarify the significance of DCP and NX-DCP expression in HCC tissues. Methods HCC and non-HCC tissue samples were obtained from 157 patients and were immunohistochemically examined for DCP and NX-DCP expression using anti-DCP antibody and anti-NX-DCP antibody. DCP and NX-DCP expression scores were calculated by multiplying staining intensity grade by percentage of stained area. Serum DCP and NX-DCP levels were determined in 89 patients. We evaluated the relationship between tumor expression, serum level, and pathomorphological findings. Results Intrahepatic metastasis (im) was significantly more frequent in cases with high DCP expression than in cases with low DCP expression. High NX-DCP expression was associated with significantly lower histological grade, and less frequent im or portal vein invasion (vp) than low NX-DCP expression. Serum DCP was correlated with DCP expression, but serum NX-DCP was not correlated with NX-DCP expression. DCP-positive (>= 40 mAU/L), NX-DCP-positive (>= 90 mAU/L), and DCP/NX-DCP ratio-positive (>= 1.5) cases were associated with significantly larger tumor size and more frequent vp than negative cases. DCP was rarely expressed, but NX-DCP was frequently expressed in non-cancerous liver tissues. Patients with NX-DCP expression-negative tumors showed a lower survival rate than those with NX-DCP expression-positive tumors (p = 0.04), whereas the survival in serum NX-DCP-positive cases was lower than that of serum negative cases (p = 0.02). Conclusions DCP and NX-DCP were produced in HCC tissues, but differed in expression level and biological properties. DCP expression, serum DCP or NX-DCP level, and DCP/NX-DCP ratio were closely related to malignant properties of HCC.	[Sumi, Akiko; Akiba, Jun; Ogasawara, Sachiko; Nakayama, Masamichi; Nomura, Yoriko; Yasumoto, Makiko; Sanada, Sakiko; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Sumi, Akiko; Abe, Toshi] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 830, Japan; [Nakashima, Osamu] Kurume Univ Hosp, Dept Clin Lab Med, Kurume, Fukuoka, Japan	Kurume University; Kurume University; Kurume University	Sumi, A (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.	sumi_akiko@kurume-u.ac.jp						Fujioka M, 2001, HEPATOLOGY, V34, P1128, DOI 10.1053/jhep.2001.29202; Gouw ASH, 2011, LIVER TRANSPLANT, V17, pS72, DOI 10.1002/lt.22368; Hui AM, 2000, J HEPATOL, V33, P975, DOI 10.1016/S0168-8278(00)80131-2; Inagaki Y, 2011, J DIGEST DIS, V12, P481, DOI 10.1111/j.1751-2980.2011.00521.x; Inagaki Y, 2011, LIVER INT, V31, P22, DOI 10.1111/j.1478-3231.2010.02348.x; Japan LCSGo, 2010, GEN RUL CLIN PATH ST; Kudo Masatoshi, 2005, Clin Gastroenterol Hepatol, V3, pS144, DOI 10.1016/S1542-3565(05)00712-3; Matsubara M, 2012, J GASTROEN HEPATOL, V27, P1602, DOI 10.1111/j.1440-1746.2012.07173.x; Miyaaki H, 2007, J GASTROENTEROL, V42, P962, DOI 10.1007/s00535-007-2117-x; Miyahara K, 2013, HEPATOL RES, V43, P1064, DOI 10.1111/hepr.12055; Murata K, 2010, INT J ONCOL, V36, P161, DOI 10.3892/ijo_00000487; Murata K, 2009, INT J ONCOL, V35, P1005, DOI 10.3892/ijo_00000415; Nanashima A, 2013, ANTICANCER RES, V33, P2689; Naraki T, 2002, BBA-MOL BASIS DIS, V1586, P287, DOI 10.1016/S0925-4439(01)00107-7; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Rich N, 2014, BEST PRACT RES CL GA, V28, P843, DOI 10.1016/j.bpg.2014.07.018; Sakamoto N, 2013, J GASTROEN HEPATOL, V28, P755, DOI 10.1111/jgh.12138; Shirabe K, 2011, BRIT J SURG, V98, P261, DOI 10.1002/bjs.7311; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Takeji S, 2013, J GASTROEN HEPATOL, V28, P671, DOI 10.1111/jgh.12076; Tameda M, 2013, CANCER SCI, V104, P725, DOI 10.1111/cas.12149; Tanaka T, 2013, J GASTROEN HEPATOL, V28, P1348, DOI 10.1111/jgh.12166; Tang W, 2005, ONCOL REP, V13, P25; Tang W, 2003, INT J ONCOL, V22, P969; Thompson EW, 2011, NAT MED, V17, P1048, DOI 10.1038/nm.2437; Toyoda H, 2006, CLIN GASTROENTEROL H, V4, P111, DOI 10.1016/S1542-3565(05)00855-4; Toyoda H, 2012, CANCER SCI, V103, P921, DOI 10.1111/j.1349-7006.2012.02232.x; Uehara S, 2005, J GASTROEN HEPATOL, V20, P1545, DOI 10.1111/j.1440-1746.2005.03899.x	28	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118452	10.1371/journal.pone.0118452	http://dx.doi.org/10.1371/journal.pone.0118452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739032	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900036
J	Woehrling, EK; Parri, HR; Tse, EHY; Hill, EJ; Maidment, ID; Fox, GC; Coleman, MD				Woehrling, Elizabeth K.; Parri, H. Rheinallt; Tse, Erin H. Y.; Hill, Eric J.; Maidment, Ian D.; Fox, G. Christopher; Coleman, Michael D.			A Predictive In Vitro Model of the Impact of Drugs with Anticholinergic Properties on Human Neuronal and Astrocytic Systems	PLOS ONE			English	Article							MUSCARINIC RECEPTOR SUBTYPES; CENTRAL-NERVOUS-SYSTEM; CELL-LINE; ACETYLCHOLINE-RECEPTORS; ALZHEIMERS-DISEASE; STEADY-STATE; OLDER-ADULTS; HUMAN-BRAIN; RISK SCALE; DIFFERENTIATION	The link between off-target anticholinergic effects of medications and acute cognitive impairment in older adults requires urgent investigation. We aimed to determine whether a relevant in vitro model may aid the identification of anticholinergic responses to drugs and the prediction of anticholinergic risk during polypharmacy. In this preliminary study we employed a co-culture of human-derived neurons and astrocytes (NT2.N/A) derived from the NT2 cell line. NT2.N/A cells possess much of the functionality of mature neurons and astrocytes, key cholinergic phenotypic markers and muscarinic acetylcholine receptors (mAChRs). The cholinergic response of NT2 astrocytes to the mAChR agonist oxotremorine was examined using the fluorescent dye fluo-4 to quantitate increases in intracellular calcium [Ca2+]i. Inhibition of this response by drugs classified as severe (dicycloverine, amitriptyline), moderate (cyclobenzaprine) and possible (cimetidine) on the Anticholinergic Cognitive Burden (ACB) scale, was examined after exposure to individual and pairs of compounds. Individually, dicycloverine had the most significant effect regarding inhibition of the astrocytic cholinergic response to oxotremorine, followed by amitriptyline then cyclobenzaprine and cimetidine, in agreement with the ACB scale. In combination, dicycloverine with cyclobenzaprine had the most significant effect, followed by dicycloverine with amitriptyline. The order of potency of the drugs in combination frequently disagreed with predicted ACB scores derived from summation of the individual drug scores, suggesting current scales may underestimate the effect of polypharmacy. Overall, this NT2.N/A model may be appropriate for further investigation of adverse anticholinergic effects of multiple medications, in order to inform clinical choices of suitable drug use in the elderly.	[Woehrling, Elizabeth K.; Parri, H. Rheinallt; Tse, Erin H. Y.; Coleman, Michael D.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Hill, Eric J.; Maidment, Ian D.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Fox, G. Christopher] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Aston University; Aston University; University of East Anglia	Coleman, MD (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.d.coleman@aston.ac.uk	Coleman, Michael Damian/AAD-5503-2019	Coleman, MIchael D/0000-0002-5510-6852; Hill, Eric/0000-0002-9419-1500; Parri, Rheinallt/0000-0002-1412-2688; Tse, Erin Hsueh Ying/0000-0002-1135-1725; Fox, Chris/0000-0001-9480-5704; Maidment, Ian/0000-0003-4152-9704	British Brain Research Fund, United Kingdom (United Kingdom Registered Charity) [1140361]; British Brain Research Fund, United Kingdom [012013]; Biotechnology and Biological Sciences Research Council [BB/H008527/1] Funding Source: researchfish; BBSRC [BB/H008527/1] Funding Source: UKRI	British Brain Research Fund, United Kingdom (United Kingdom Registered Charity); British Brain Research Fund, United Kingdom; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by British Brain Research Fund, United Kingdom (United Kingdom Registered Charity: 1140361), Grant Number: 012013: www.brainresearchfund.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluigi MG, 2010, CHEM-BIOL INTERACT, V187, P299, DOI 10.1016/j.cbi.2010.03.031; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Ballon N, 2001, ENCEPHALE, V27, P373; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bourgeois J, 2012, DRUG AGING, V29, P759, DOI 10.1007/s40266-012-0003-6; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chancellor MB, 2012, DRUG AGING, V29, P259, DOI 10.2165/11597530-000000000-00000; Chapman H, 2007, BRAIN RES, V1129, P15, DOI 10.1016/j.brainres.2006.10.060; Chew ML, 2008, J AM GERIATR SOC, V56, P1333, DOI 10.1111/j.1532-5415.2008.01737.x; Corbel V, 2006, NEUROTOXICOLOGY, V27, P508, DOI 10.1016/j.neuro.2006.01.011; CORTES R, 1986, BRAIN RES, V362, P239, DOI 10.1016/0006-8993(86)90449-X; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; Darwish M, 2011, CLIN THER, V33, P746, DOI 10.1016/j.clinthera.2011.05.045; Elhusseiny A, 1999, J CEREBR BLOOD F MET, V19, P794, DOI 10.1097/00004647-199907000-00010; Fischer HS, 2000, REGUL PEPTIDES, V96, P59, DOI 10.1016/S0167-0115(00)00201-9; Fox C, 2014, AGE AGEING, V43, P604, DOI 10.1093/ageing/afu096; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Fu W, 2013, NEUROSCIENCE, V250, P520, DOI 10.1016/j.neuroscience.2013.07.029; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gil-Bea FJ, 2005, NEUROSCI LETT, V375, P37, DOI 10.1016/j.neulet.2004.10.062; Guillemain I, 2000, J COMP NEUROL, V422, P380, DOI 10.1002/1096-9861(20000703)422:3<380::AID-CNE5>3.0.CO;2-C; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Hill EJ, 2008, TOXICOLOGY, V249, P243, DOI 10.1016/j.tox.2008.05.014; Hill EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036098; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Kashyap M, 2014, J AM GERIATR SOC, V62, P336, DOI 10.1111/jgs.12632; Kersten H, 2014, BASIC CLIN PHARMACOL, V114, P151, DOI 10.1111/bcpt.12140; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Liu M, 2008, ANESTH ANALG, V107, P525, DOI 10.1213/ane.0b013e31817b4469; Liu XR, 2009, DRUG METAB DISPOS, V37, P787, DOI 10.1124/dmd.108.024125; Mangoni Arduino A, 2011, Expert Rev Clin Pharmacol, V4, P531, DOI 10.1586/ecp.11.44; Narayan SW, 2013, DRUG AGING, V30, P927, DOI 10.1007/s40266-013-0111-y; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Neelands TR, 2000, J NEUROPHYSIOL, V84, P2933, DOI 10.1152/jn.2000.84.6.2933; Pasina L, 2013, DRUG AGING, V30, P103, DOI 10.1007/s40266-012-0044-x; Patel AP, DICYCLOMINE HYDROCHL; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Podrygajlo G, 2010, DEV DYNAM, V239, P496, DOI 10.1002/dvdy.22193; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Resende RR, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-20; Rudolph JL, 2008, ARCH INTERN MED, V168, P508, DOI 10.1001/archinternmed.2007.106; Shelton MK, 2000, J NEUROCHEM, V74, P555, DOI 10.1046/j.1471-4159.2000.740555.x; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Thomas C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-86; Thullbery MD, 2005, J CELL BIOCHEM, V96, P599, DOI 10.1002/jcb.20530; Tice MAB, 1996, DEV BRAIN RES, V92, P70, DOI 10.1016/0165-3806(95)01515-9; TUNE L, 1980, ARCH GEN PSYCHIAT, V37, P293; Uusvaara J, 2011, DRUG AGING, V28, P131, DOI 10.2165/11585060-000000000-00000; van Assema DME, 2012, MOL IMAGING BIOL, V14, P771, DOI 10.1007/s11307-012-0556-0; Vijayaraghavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065936; Weber ML, 2013, NEUROPHARMACOLOGY, V72, P88, DOI 10.1016/j.neuropharm.2013.04.027; Winchell GA, 2002, J CLIN PHARMACOL, V42, P61, DOI 10.1177/0091270002042001007; Woehrling EK, 2011, NEUROTOX RES, V19, P472, DOI 10.1007/s12640-010-9202-2; Woehrling EK, 2010, NEUROTOX RES, V17, P103, DOI 10.1007/s12640-009-9084-3; WOLF BA, 1995, J BIOL CHEM, V270, P4916, DOI 10.1074/jbc.270.9.4916; ZELLER M, 1995, INT J DEV NEUROSCI, V13, P437, DOI 10.1016/0736-5748(95)00025-C	60	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118786	10.1371/journal.pone.0118786	http://dx.doi.org/10.1371/journal.pone.0118786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738989	Green Published, Green Accepted, gold			2022-12-26	WOS:000350685900071
J	Yadav, D; Dhillon, P				Yadav, Diwakar; Dhillon, Preeti			Assessing the Impact of Family Planning Advice on Unmet Need and Contraceptive Use among Currently Married Women in Uttar Pradesh, India	PLOS ONE			English	Article							FEMALE SEX WORKERS; CHILD HEALTH; MATERNAL HEALTH; ANTENATAL CARE; SERVICE UTILIZATION; PROPENSITY SCORES; DISTRICT; RISK	Background Counseling/advice is one of the key interventions to promote family planning (FP) in developing countries, including India. It helps to improve the quality of care and reduce maternal deaths. This paper investigates the continuity of maternal health (MH) service utilization from antenatal care to post-natal care and the impact this service utilization has on contraceptive use and on meeting the demand for family planning among currently married women in rural Uttar Pradesh, India. Methods and Findings The study assesses the impact of FP advice on unmet need and contraceptive use by adopting the propensity score matching method. It uses data from the District Level Household Survey (DLHS) (2007-08) that covered 76,147 currently married women (CMW) in the age group 15-44 years in Uttar Pradesh. Results show that the utilization of MH services [Antenatal care (ANC), institutional delivery, Postnatal care (PNC)] and FP advice during ANC and PNC has led to increase in current use of contraception by 3.7% (p<.01), 7.3% (p<.01) and 6.8% (p<.01), respectively. However, a greater utilization of these services has not translated into a reduction of unmet need for contraception at a similar manner. Conclusion MH service utilization including FP advice is more effective in increasing current use of spacing methods as compared to limiting methods. Findings support the need for "effective FP advice" interventions to reduce unintended births and unmet need. However, women from Scheduled Caste/Scheduled Tribe communities are less likely to receive MH services. Thus, efforts are required to ensure that currently married women across socio-economic backgrounds have equal opportunity to receive MH services and information on contraceptive use to meet the demand for family planning methods.	[Yadav, Diwakar] Populat Serv Int, 2-105 Vijayant Khand, Lucknow, Uttar Pradesh, India; [Dhillon, Preeti] Save Children, New Delhi, India	Save the Children	Yadav, D (corresponding author), Populat Serv Int, 2-105 Vijayant Khand, Lucknow, Uttar Pradesh, India.	yadavdiwakar7@gmail.com	Dhillon, Preeti/ABC-7955-2020	Dhillon, Preeti/0000-0001-9757-6492				Ahmed S, 2002, DEMOGRAPHY, V39, P75, DOI 10.1353/dem.2002.0001; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; [Anonymous], 2001, ASIA PAC POPUL J, DOI DOI 10.1136/BMJ.I2851; Anwar A., 2004, BANGLADESH INEQUALIT; Bhattacharjee P, 2013, AIDS CARE, V25, pS46, DOI 10.1080/09540121.2012.736607; Birungi H, 2006, ACCEPTABILITY SUSTAI; Briggs CJ, 2001, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD003318PMID:11687187, DOI 10.1002/14651858.CD003318]; Commission P, 2011, IND HUM DEV REPR; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Dixit P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066175; Do M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-6; Fagan EB, 2009, SOUTH MED J, V102, P260, DOI 10.1097/SMJ.0b013e318197fae4; Glasier AF, 1996, CONTRACEPTION, V53, P217, DOI 10.1016/0010-7824(96)00040-6; Guha M, 2012, J EPIDEMIOL COMMUN H, V66, pII55, DOI 10.1136/jech-2011-200562; Hotchkiss DR, 2005, POPUL RES POLICY REV, V24, P543, DOI 10.1007/s11113-005-4852-0; Hotchkiss DR, 1999, J BIOSOC SCI, V31, P145, DOI 10.1017/S0021932099001455; Howe LD, 2009, J EPIDEMIOL COMMUN H, V63, P871, DOI 10.1136/jech.2009.088021; HUNTINGTON D, 1994, STUD FAMILY PLANN, V25, P176, DOI 10.2307/2137943; India Go, 2011, 1 OFF REG GEN CENS C, V1; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S, DOI [10.1371/journal.pone.0071584, DOI 10.1371/JOURNAL.PONE.0071584]; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Joshi S., 2007, FAMILY PLANNING INVE; Juneja S, 2013, AIDS BEHAV, V17, P1040, DOI 10.1007/s10461-012-0314-y; KOENIG MA, 1992, STUD FAMILY PLANN, V23, P352, DOI 10.2307/1966893; Lechner M, 2002, J R STAT SOC A STAT, V165, P59, DOI 10.1111/1467-985X.0asp2; Lee JK, 2011, J GEN INTERN MED, V26, P731, DOI 10.1007/s11606-011-1647-3; Levitt C, 2004, BIRTH-ISS PERINAT C, V31, P203, DOI 10.1111/j.0730-7659.2004.00306.x; Liu L, 2008, POP STUD-J DEMOG, V62, P191, DOI 10.1080/00324720801897796; Lopez LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001863.pub3; Magoma M, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-64; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Ministry of Health and Family Welfare (MoHFW), 2005, NAT RUR HLTH MISS 20; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; MoHFW, 1997, REPR CHILD HLTH PROG; *MOHFW, 2000, NAT POP POL 2000; MoHFW, 2002, NAT HLTH POL 2002; Nikiema B, 2009, HEALTH POLICY PLANN, V24, P367, DOI 10.1093/heapol/czp017; Oakes JM, 2006, METHODS SOCIAL EPIDE, V1st; Ozvaris SB, 1997, ADV CONTRACEPTIVE DE, V13, P63; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Ram F, 2006, J BIOSOC SCI, V38, P433, DOI 10.1017/S0021932005026453; Renkert S, 2001, HEALTH PROMOT INT, V16, P381, DOI 10.1093/heapro/16.4.381; RGI, 2011, SAMPL REG SYST SRS; Ringheim K, 2011, INTEGRATING FAMILY P; Rodriguez-Barocio R., 1980, INT FAM PLAN PERSPEC, V6, P2, DOI [10.2307/2947963, DOI 10.2307/2947963]; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Seiber EE, 2005, SOC SCI MED, V61, P279, DOI 10.1016/j.socscimed.2004.11.068; Sines E., 2007, POSTNATAL CARE CRITI; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044931; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037037; Singh S, 2009, ADDING IT COSTS BENE; StataCorp, 2009, STAT STAT SOFTW REL; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sugathan KS, 2001, PROMOTING I DELIVRIE; Taylor C. E., 1987, Health Policy and Planning, V2, P150, DOI 10.1093/heapol/2.2.150; Toth C, 2008, RIGHT MESSAGE RIGHT; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Waddington C, 2008, INTEGRATED HLTH SERV; WHO, 2003, WORKING WITH INDIVID; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; World Health Organization, 2004, REPR HLTH STRAT ACC; Yadav D, 2012, STUDY SYNERGIES MATE; Yadav D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078361; Zerai A, 2001, Afr J Reprod Health, V5, P68, DOI 10.2307/3583432	68	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118584	10.1371/journal.pone.0118584	http://dx.doi.org/10.1371/journal.pone.0118584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738707	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900049
J	Zanette, RA; Bitencourt, PER; Kontoyiannis, DP; Fighera, RA; Flores, MM; Kommers, GD; Silva, PS; Ludwig, A; Moretto, MB; Alves, SH; Santurio, JM				Zanette, Regis A.; Bitencourt, Paula E. R.; Kontoyiannis, Dimitrios P.; Fighera, Rafael A.; Flores, Mariana M.; Kommers, Glaucia D.; Silva, Priscila S.; Ludwig, Aline; Moretto, Maria B.; Alves, Sydney H.; Santurio, Janio M.			Complex Interaction of Deferasirox and Pythium insidiosum: Iron-Dependent Attenuation of Growth In Vitro and Immunotherapy-Like Enhancement of Immune Responses In Vivo	PLOS ONE			English	Article							PYTHIOSIS; LYMPHOCYTES; MODEL	Pythium insidiosum iron acquisition mechanisms are unknown. We previously showed that the iron chelator deferasirox had weak activity in vitro and in rabbits with experimental pythiosis. Here we show that deferasirox causes damage to P. insidiosum hyphae in vitro, but that activity is diminished in the presence of exogenous iron. The tissue activity of the proinflammatory enzyme adenosine deaminase and the histological pattern observed in pythiosis lesions of rabbits treated with deferasirox were similar to the ones in animals treated with immunotherapy.	[Zanette, Regis A.; Ludwig, Aline; Alves, Sydney H.; Santurio, Janio M.] Fed Univ Santa Maria UFSM, Hlth Sci Ctr, Grad Program Pharmacol, Santa Maria, RS, Brazil; [Bitencourt, Paula E. R.; Silva, Priscila S.; Moretto, Maria B.; Alves, Sydney H.] Univ Fed Santa Maria, Hlth Sci Ctr, Grad Program Pharmaceut Sci, Santa Maria, RS, Brazil; [Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Fighera, Rafael A.; Flores, Mariana M.; Kommers, Glaucia D.] Univ Fed Santa Maria, Hlth Sci Ctr, Grad Program Vet Med, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); University of Texas System; UTMD Anderson Cancer Center; Universidade Federal de Santa Maria (UFSM)	Santurio, JM (corresponding author), Fed Univ Santa Maria UFSM, Hlth Sci Ctr, Grad Program Pharmacol, Santa Maria, RS, Brazil.	janio.santurio@gmail.com	Alves, Severino/L-8963-2013; ludwig, Aline/W-7037-2018; Zanette, RA/C-3139-2014; Santurio, Janio Morais/J-2392-2012; Alves, Sydney H/N-4159-2014	ludwig, Aline/0000-0002-0904-4953; Zanette, RA/0000-0003-4432-2231; Santurio, Janio Morais/0000-0001-6286-9076; Alves, Sydney H/0000-0001-5740-387X; Bitencourt, Paula/0000-0001-7828-518X	National Council for Scientific and Technological Development-CNPq [471114/2010-3]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul-CAPES/FAPERGS	National Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul-CAPES/FAPERGS	This work was supported by the National Council for Scientific and Technological Development-CNPq (grant number 471114/2010-3 to SHA) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul-CAPES/FAPERGS (to RAZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli L, 2012, CURR DRUG TARGETS, V13, P842, DOI 10.2174/138945012800564095; Azevedo MI, 2012, VET MICROBIOL, V159, P141, DOI 10.1016/j.vetmic.2012.03.030; Bach BC, 2013, CELL BIOCHEM FUNCT, V31, P476, DOI 10.1002/cbf.2921; Belle LP, 2011, CELL BIOCHEM BIOPHYS, V61, P297, DOI 10.1007/s12013-011-9212-6; Ben-Ami R, 2010, ANTIMICROB AGENTS CH, V54, P484, DOI 10.1128/AAC.00956-09; Casanova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051287; GiustiG HV, 1974, METHODS ENZYMATIC AN, P1092, DOI DOI 10.1016/B978-0-12-091302-2.50108-0; Ibrahim AS, 2007, J CLIN INVEST, V117, P2649, DOI 10.1172/JCI32338; Kontoyiannis DP, 2007, CANCER-AM CANCER SOC, V110, P1303, DOI 10.1002/cncr.22909; Krajaejun T, 2011, FUNGAL BIOL-UK, V115, P683, DOI 10.1016/j.funbio.2011.05.001; Lewis RE, 2011, ANTIMICROB AGENTS CH, V55, P411, DOI 10.1128/AAC.00792-10; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martins TB, 2012, J COMP PATHOL, V146, P122, DOI 10.1016/j.jcpa.2011.06.006; Minn Y, 1997, MYCOPATHOLOGIA, V138, P29, DOI 10.1023/A:1006889108673; Pan JH, 2014, INT J SURG CASE REP, V5, P677, DOI 10.1016/j.ijscr.2014.05.018; Pereira DIB, 2008, J MYCOL MED, V18, P129, DOI 10.1016/j.mycmed.2008.05.001; Pires L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085431; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schloemer N.J., 2013, INFECT DIS CLIN PRAC, V21, pe24, DOI [10.1097/IPC.0b013e318278f3b5, DOI 10.1097/IPC.0B013E318278F3B5]; Sudjaritruk T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-33; Zanette RA, 2013, J ANTIMICROB CHEMOTH, V68, P1144, DOI 10.1093/jac/dks534	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118932	10.1371/journal.pone.0118932	http://dx.doi.org/10.1371/journal.pone.0118932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738758	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900086
J	de Monteynard, LA; Dray-Spira, R; de Truchis, P; Grabar, S; Launay, O; Meynard, JL; Khuong-Josses, MA; Gilquin, J; Rey, D; Simon, A; Pavie, J; Mahamat, A; Matheron, S; Costagliola, D; Abgrall, S				de Monteynard, Laure-Amelie; Dray-Spira, Rosemary; de Truchis, Pierre; Grabar, Sophie; Launay, Odile; Meynard, Jean-Luc; Khuong-Josses, Marie-Aude; Gilquin, Jacques; Rey, David; Simon, Anne; Pavie, Juliette; Mahamat, Aba; Matheron, Sophie; Costagliola, Dominique; Abgrall, Sophie		French Hosp Database HIV	Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PEOPLE; GENDER; RISK	Objective To compare the time from entry into care for HIV infection until combination antiretroviral therapy (cART) initiation between migrants and non migrants in France, excluding late access to care. Methods Antiretroviral-naive HIV-1-infected individuals newly enrolled in the FHDH cohort between 2002-2010, with CD4 cell counts > 200/mu L and no previous or current AIDS events were included. In three baseline CD4 cell count strata (200-349, 350-499, >= 500/mu L), we examined the crude time until cART initiation within three years after enrolment according to geographic origin, and multivariable hazard ratios according to geographic origin, gender and HIV-transmission group, with adjustment for baseline age, enrolment period, region of care, plasma viral load, and HBV/HBC coinfection. Results Among 13338 individuals, 9605 (72.1%) were French natives (FRA), 2873 (21.4%) were migrants from sub-Saharan Africa/non-French West Indies (SSA/NFW), and 860 (6.5%) were migrants from other countries. Kaplan-Meier probabilities of cART initiation were significantly lower in SSA/NFW than in FRA individuals throughout the study period, regardless of the baseline CD4 stratum. After adjustment, the likelihood of cART initiation was respectively 15% (95% CI, 1-28) and 20% (95% CI, 2-38) lower in SSA/NFW men than in FRA men who had sex with men (MSM) in the 350-499 and >= 500 CD4 strata, while no difference was observed between other migrant groups and FRA MSM. Conclusion SSA/NFW migrant men living in France with CD4 > 350/mu L at entry into care are more likely to begin cART later than FRA MSM, despite free access to treatment. Administrative delays in obtaining healthcare coverage do not appear to be responsible.	[de Monteynard, Laure-Amelie; Dray-Spira, Rosemary; Costagliola, Dominique; Abgrall, Sophie] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [de Monteynard, Laure-Amelie; Dray-Spira, Rosemary; Grabar, Sophie; Costagliola, Dominique; Abgrall, Sophie] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [de Truchis, Pierre] Hop Raymond Poincare, Hop Univ Paris Ile France Ouest, Dept Med Aigue Specialisee, AP HP, Garches, France; [Grabar, Sophie; Launay, Odile] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Grabar, Sophie] Grp Hosp Cochin Broca Hotel Dieu, Unite Biostat & Epidemiol, AP HP, Paris, France; [Launay, Odile] Hop Cochin, AP HP, F-75674 Paris, France; [Meynard, Jean-Luc] Hop St Antoine, AP HP, Serv Malad Infect & Trop, F-75571 Paris, France; [Khuong-Josses, Marie-Aude] Hop Delafontaine, Ctr Hosp St Denis, Serv Malad Infect & Trop, St Denis, France; [Gilquin, Jacques] Hop Hotel Dieu, Unite Immunoinfectiol, AP HP, F-75181 Paris, France; [Rey, David] Hop Univ Strasbourg, Ctr Soins Infect VIH, Strasbourg, France; [Simon, Anne] Grp Hosp Pitie Salpetriere, AP HP, Dept Med Interne, F-75634 Paris, France; [Pavie, Juliette] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Clin, Paris, France; [Mahamat, Aba] Ctr Hosp Andree Rosemon, Serv Malad Infect & Trop, Cayenne, France; [Matheron, Sophie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75877 Paris 18, France; [Abgrall, Sophie] Hop Avicenne, AP HP, Serv Malad Infect & Trop, F-93009 Bobigny, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	de Monteynard, LA (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France.	lmonteynard@ccde.chups.jussieu.fr	Mahamat, Aba/V-7888-2019; Grabar, Sophie/AAM-9857-2020; TISSOT-DUPONT, Hervé/P-5808-2016; Matheron, Sophie/D-7420-2017; Costagliola, Dominique/H-5849-2011	Mahamat, Aba/0000-0001-8755-0424; Matheron, Sophie/0000-0001-7879-6553; Costagliola, Dominique/0000-0003-0765-0869; Cabie, Andre/0000-0003-0117-3061; Dray-Spira, Rosemary/0000-0001-7646-3667	Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS); INSERM; French Ministry of Health	Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Health	This work was supported by the Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS), INSERM, and the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2010, AIDS, V24, P763, DOI 10.1097/QAD.0b013e3283366747; [Anonymous], REC SANT PUBL DEP IN; [Anonymous], EUR GUID TREATM HIV; Berchet C, IRDES 2012; Bouvier G., 2010, DESCENDANTS IMMIGRES; Breton G, 2007, HIV MED, V8, P164, DOI 10.1111/j.1468-1293.2007.00447.x; Cazein F., 2014, Bulletin Epidemiologique Hebdomadaire, P154; Crawford T, 2012, J IMMIGR MINOR HEALT, V14, P82, DOI 10.1007/s10903-011-9455-8; de Sante Haute Autorite, 2011, LIST ACT PREST ALD 7; Department of STDS, 2013, FRANC AD NEW NAT POL; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; EACS, 2011, EUR GUID TREATM HIV; Elford J, 2008, SEX TRANSM INFECT, V84, P176, DOI 10.1136/sti.2007.029249; Fardet L, 2006, HIV MED, V7, P520, DOI 10.1111/j.1468-1293.2006.00414.x; Jarrin I, 2012, CLIN INFECT DIS, V54, P111, DOI 10.1093/cid/cir814; Lert F., 2013, Bulletin Epidemiologique Hebdomadaire, P300; Lot F., 2011, Bulletin Epidemiologique Hebdomadaire, P454; Mary-Krause M, 2014, INT J EPIDEMIOL; McMahon T, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-56; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Monge S, 2012, HIV MED, P273; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Morlat P, 2013, RPISE CHARGE MED PER, DOI [10.1056/NEJMoa1404231, DOI 10.1056/NEJMOA1404231]; Supervie V, 2013, 20 C RETR OPP INF AT; Thierry X., 2008, INED POPULAT SOC, V442, P1; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Yeni P, 2006, PRISE CHARGE MED PER, DOI [10.1056/NEJMoa1404231, DOI 10.1056/NEJMOA1404231]; Yeni P, 2010, PRISE CHARGE MED PER, DOI [10.1056/NEJMoa1404231, DOI 10.1056/NEJM0A1404231]	28	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118492	10.1371/journal.pone.0118492	http://dx.doi.org/10.1371/journal.pone.0118492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734445	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700033
J	Feller, C; Farcot, E; Mazza, C				Feller, Chrystel; Farcot, Etienne; Mazza, Christian			Self-Organization of Plant Vascular Systems: Claims and Counter-Claims about the Flux-Based Auxin Transport Model	PLOS ONE			English	Article							PATTERN-FORMATION; BIOSYNTHESIS; POLARITY	The plant hormone auxin plays a central role in growth and morphogenesis. In shoot apical meristems, auxin flux is polarized through its interplay with PIN proteins. Concentrationbased mathematical models of the flux can explain some aspects of phyllotaxis for the L1 surface layer, where auxin accumulation points act as sinks and develop into primordia. The picture differs in the interior of the meristem, where the primordia act as auxin sources, leading to the initiation of the vascular system. Self-organization of the auxin flux involves large numbers of molecules and is difficult to treat by intuitive reasoning alone; mathematical models are therefore vital to understand these phenomena. We consider a leading computational model based on the so-called flux hypothesis. This model has been criticized and extended in various ways. One of the basic counter-arguments is that simulations yield auxin concentrations inside canals that are lower than those seen experimentally. Contrary to what is claimed in the literature, we show that the model can lead to higher concentrations within canals for significant parameter regimes. We then study the model in the usual case where the response function F defining the model is quadratic and unbounded, and show that the steady state vascular patterns are formed of loopless directed trees. Moreover, we show that PIN concentrations can diverge in finite time, thus explaining why previous simulation studies introduced cut-offs which force the system to have bounded PIN concentrations. Hence, contrary to previous claims, extreme PIN concentrations are not due to numerical problems but are intrinsic to the model. On the other hand, we show that PIN concentrations remain bounded for bounded F, and simulations show that in this case, loops can emerge at steady state.				christian.mazza@unifr.ch						Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Draelants D, 2013, J MATH BIOL, V67, P1279, DOI 10.1007/s00285-012-0588-8; Farcot E, 2013, SIAM J APPL DYN SYST, V12, P1330, DOI 10.1137/120891538; Feller C, 2014, J MATH BIOL, V68, P879, DOI 10.1007/s00285-013-0655-9; Feugier FG, 2005, J THEOR BIOL, V236, P366, DOI 10.1016/j.jtbi.2005.03.017; Garnett P, 2010, BIOESSAYS, V32, P828, DOI 10.1002/bies.200900185; Heisler MG, 2006, J PLANT GROWTH REGUL, V25, P302, DOI 10.1007/s00344-006-0066-x; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; Kramer EM, 2009, TRENDS PLANT SCI, V14, P242, DOI 10.1016/j.tplants.2009.02.005; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; MITCHISON GJ, 1981, PHILOS T ROY SOC B, V295, P461, DOI 10.1098/rstb.1981.0154; MITCHISON GJ, 1980, PROC R SOC SER B-BIO, V207, P79, DOI 10.1098/rspb.1980.0015; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Rolland-Lagan AG, 2005, PLANT J, V44, P854, DOI 10.1111/j.1365-313X.2005.02581.x; SACHS T, 1969, ANN BOT-LONDON, V33, P263, DOI 10.1093/oxfordjournals.aob.a084281; Sahlin P, 2009, J THEOR BIOL, V258, P60, DOI 10.1016/j.jtbi.2009.01.019; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Stoma S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000207; van Berkel K, 2013, DEVELOPMENT, V140, P2253, DOI 10.1242/dev.079111; Walker ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054802; Zhao YD, 2008, CURR OPIN PLANT BIOL, V11, P16, DOI 10.1016/j.pbi.2007.10.008; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	28	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118238	10.1371/journal.pone.0118238	http://dx.doi.org/10.1371/journal.pone.0118238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734327	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700018
J	Hand, ES; Haller, SL; Peng, C; Rothenburg, S; Hersperger, AR				Hand, Erin S.; Haller, Sherry L.; Peng, Chen; Rothenburg, Stefan; Hersperger, Adam R.			Ectopic Expression of Vaccinia Virus E3 and K3 Cannot Rescue Ectromelia Virus Replication in Rabbit RK13 Cells	PLOS ONE			English	Article							HOST-RANGE; POXVIRUS VECTORS; CAUSATIVE AGENT; PROTEIN; PKR; RNA; INHIBITION; RESISTANCE; OUTBREAKS; DOMAINS	As a group, poxviruses have been shown to infect a wide variety of animal species. However, there is individual variability in the range of species able to be productively infected. In this study, we observed that ectromelia virus (ECTV) does not replicate efficiently in cultured rabbit RK13 cells. Conversely, vaccinia virus (VACV) replicates well in these cells. Upon infection of RK13 cells, the replication cycle of ECTV is abortive in nature, resulting in a greatly reduced ability to spread among cells in culture. We observed ample levels of early gene expression but reduced detection of virus factories and severely blunted production of enveloped virus at the cell surface. This work focused on two important host range genes, named E3L and K3L, in VACV. Both VACV and ECTV express a functional protein product from the E3L gene, but only VACV contains an intact K3L gene. To better understand the discrepancy in replication capacity of these viruses, we examined the ability of ECTV to replicate in wild-type RK13 cells compared to cells that constitutively express E3 and K3 from VACV. The role these proteins play in the ability of VACV to replicate in RK13 cells was also analyzed to determine their individual contribution to viral replication and PKR activation. Since E3L and K3L are two relevant host range genes, we hypothesized that expression of one or both of them may have a positive impact on the ability of ECTV to replicate in RK13 cells. Using various methods to assess virus growth, we did not detect any significant differences with respect to the replication of ECTV between wild-type RK13 compared to versions of this cell line that stably expressed VACV E3 alone or in combination with K3. Therefore, there remain unanswered questions related to the factors that limit the host range of ECTV.	[Hand, Erin S.; Hersperger, Adam R.] Albright Coll, Dept Biol, Reading, PA 19612 USA; [Haller, Sherry L.; Peng, Chen; Rothenburg, Stefan] Kansas State Univ, Div Biol, Lab Host Specif Virol, Manhattan, KS 66506 USA	Kansas State University	Hersperger, AR (corresponding author), Albright Coll, Dept Biol, Reading, PA 19612 USA.	ahersperger@albright.edu	Peng, Chen/AAI-6267-2020	Peng, Chen/0000-0001-6141-8775; Haller, Sherry L./0000-0002-4340-721X	Albright Creative Research Experience (ACRE) program; Albright College	Albright Creative Research Experience (ACRE) program; Albright College	This work was supported through the Albright Creative Research Experience (ACRE) program and other internal funding from Albright College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428; Beattie E, 1996, VIRUS GENES, V12, P89, DOI 10.1007/BF00370005; Bratke KA, 2013, INFECT GENET EVOL, V14, P406, DOI 10.1016/j.meegid.2012.12.002; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Brennan G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004002; BULLER RML, 1986, CURR TOP MICROBIOL, V127, P319; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; BURNET FM, 1946, J IMMUNOL, V53, P1; CARROLL K, 1993, J BIOL CHEM, V268, P12837; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; CHEN W, 1992, VIROLOGY, V187, P433, DOI 10.1016/0042-6822(92)90445-U; Condit RC, 2010, EMERG INFECT DIS, V16, P1022, DOI 10.3201/eid1606.100315; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; FENNER F, 1947, AUST J EXP BIOL MED, V25, P275, DOI 10.1038/icb.1947.39; FENNER F, 1947, AUST J EXP BIOL MED, V25, P257, DOI 10.1038/icb.1947.38; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Haller SL, 2014, INFECT GENET EVOL, V21, P15, DOI 10.1016/j.meegid.2013.10.014; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Kim YG, 2004, P NATL ACAD SCI USA, V101, P1514, DOI 10.1073/pnas.0308260100; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; Lee EH, 2010, FEBS LETT, V584, P4453, DOI 10.1016/j.febslet.2010.10.003; Mastrangelo MJ, 2000, J CLIN INVEST, V105, P1031, DOI 10.1172/JCI9819; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Mortimer P, 2006, REV MED VIROL, V16, P353, DOI 10.1002/rmv.506; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Rahman MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003465; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Rothenburg S, 2005, P NATL ACAD SCI USA, V102, P1602, DOI 10.1073/pnas.0408714102; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; Tscharke DC, 1999, J GEN VIROL, V80, P2751, DOI 10.1099/0022-1317-80-10-2751; Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1	39	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119189	10.1371/journal.pone.0119189	http://dx.doi.org/10.1371/journal.pone.0119189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734776	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700058
J	Hsiao, AY; Okitsu, T; Onoe, H; Kiyosawa, M; Teramae, H; Iwanaga, S; Kazama, T; Matsumoto, T; Takeuchi, S				Hsiao, Amy Y.; Okitsu, Teru; Onoe, Hiroaki; Kiyosawa, Mahiro; Teramae, Hiroki; Iwanaga, Shintaroh; Kazama, Tomohiko; Matsumoto, Taro; Takeuchi, Shoji			Smooth Muscle-Like Tissue Constructs with Circumferentially Oriented Cells Formed by the Cell Fiber Technology	PLOS ONE			English	Article							TRANSPLANTATION; STIFFNESS; ALIGNMENT; FLOW	The proper functioning of many organs and tissues containing smooth muscles greatly depends on the intricate organization of the smooth muscle cells oriented in appropriate directions. Consequently controlling the cellular orientation in three-dimensional (3D) cellular constructs is an important issue in engineering tissues of smooth muscles. However, the ability to precisely control the cellular orientation at the microscale cannot be achieved by various commonly used 3D tissue engineering building blocks such as spheroids. This paper presents the formation of coiled spring-shaped 3D cellular constructs containing circumferentially oriented smooth muscle-like cells differentiated from dedifferentiated fat (DFAT) cells. By using the cell fiber technology, DFAT cells suspended in a mixture of extracellular proteins possessing an optimized stiffness were encapsulated in the core region of alginate shell microfibers and uniformly aligned to the longitudinal direction. Upon differentiation induction to the smooth muscle lineage, DFAT cell fibers self-assembled to coiled spring structures where the cells became circumferentially oriented. By changing the initial core-shell microfiber diameter, we demonstrated that the spring pitch and diameter could be controlled. 21 days after differentiation induction, the cell fibers contained high percentages of ASMA-positive and calponin-positive cells. Our technology to create these smooth muscle-like spring constructs enabled precise control of cellular alignment and orientation in 3D. These constructs can further serve as tissue engineering building blocks for larger organs and cellular implants used in clinical treatments.	[Hsiao, Amy Y.; Okitsu, Teru; Onoe, Hiroaki; Kiyosawa, Mahiro; Iwanaga, Shintaroh; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Okitsu, Teru; Onoe, Hiroaki; Kiyosawa, Mahiro; Iwanaga, Shintaroh; Takeuchi, Shoji] Japan Sci & Technol Agcy, ERATO Takeuchi Biohybrid Innovat Project, Tokyo, Japan; [Onoe, Hiroaki] Shumei Univ, Fac Teacher Educ, Chiba, Japan; [Kazama, Tomohiko; Matsumoto, Taro] Nihon Univ, Sch Med, Dept Funct Morphol, Div Cell Regenerat & Transplantat, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Nihon University	Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takeuchi, Shoji/J-5349-2019	Takeuchi, Shoji/0000-0001-6946-0409	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship; Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan	A.Y. Hsiao is supported by Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Foreign Researchers. This work was supported by the Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2014, BIOMATERIALS, V35, P63, DOI 10.1016/j.biomaterials.2013.09.106; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Duong H, 2009, TISSUE ENG PT A, V15, P1865, DOI 10.1089/ten.tea.2008.0319; Gersh KC, 2010, J THROMB HAEMOST, V8, P2826, DOI 10.1111/j.1538-7836.2010.04118.x; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kikuta S, 2013, TISSUE ENG PT A, V19, P1792, DOI [10.1089/ten.tea.2012.0380, 10.1089/ten.TEA.2012.0380]; Kuribayashi-Shigetomi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051085; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Obinata D, 2011, INT J UROL, V18, P827, DOI 10.1111/j.1442-2042.2011.02865.x; Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]; Pappano A.J., 2010, BERNE LEVY PHYSL, Vsixth editionupdated ed, P370; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Sakuma T, 2009, J UROLOGY, V182, P355, DOI 10.1016/j.juro.2009.02.103; Shen JY, 2006, TISSUE ENG, V12, P2229, DOI 10.1089/ten.2006.12.2229; Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003	26	50	50	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119010	10.1371/journal.pone.0119010	http://dx.doi.org/10.1371/journal.pone.0119010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734774	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700051
J	Liechti, R; Ducray, AD; Jensen, P; Di Santo, S; Seiler, S; Jensen, CH; Meyer, M; Widmer, HR				Liechti, Remy; Ducray, Angelique D.; Jensen, Pia; Di Santo, Stefano; Seiler, Stefanie; Jensen, Charlotte H.; Meyer, Morten; Widmer, Hans Rudolf			Characterization of Fetal Antigen 1/Delta-Like 1 Homologue Expressing Cells in the Rat Nigrostriatal System: Effects of a Unilateral 6-Hydroxydopamine Lesion	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; GABAERGIC NEURONS; NERVOUS-SYSTEM; DIFFERENTIATION; MIDBRAIN; CALRETININ; BRAIN	Fetal antigen 1/delta-like 1 homologue (FA1/dlk1) belongs to the epidermal growth factor superfamily and is considered to be a non-canonical ligand for the Notch receptor. Interactions between Notch and its ligands are crucial for the development of various tissues. Moreover, FA1/dlk1 has been suggested as a potential supplementary marker of dopaminergic neurons. The present study aimed at investigating the distribution of FA1/dlk1-immunoreactive (-ir) cells in the early postnatal and adult midbrain as well as in the nigrostriatal system of 6-hydroxydopamine (6-OHDA)-lesioned hemiparkinsonian adult rats. FA1/dlk1-ir cells were predominantly distributed in the substantia nigra (SN) pars compacta (SNc) and in the ventral tegmental area. Interestingly, the expression of FA1/dlk1 significantly increased in tyrosine hydroxylase (TH)-ir cells during early postnatal development. Co-localization and tracing studies demonstrated that FA1/dlk1-ir cells in the SNc were nigrostriatal dopaminergic neurons, and unilateral 6-OHDA lesions resulted in loss of both FA1/dlk1-ir and TH-ir cells in the SNc. Surprisingly, increased numbers of FA1/dlk1-ir cells (by 70%) were detected in dopamine-depleted striata as compared to unlesioned controls. The higher number of FA1/dlk1-ir cells was likely not due to neurogenesis as colocalization studies for proliferation markers were negative. This suggests that FA1/dlk1 was up-regulated in intrinsic cells in response to the 6-OHDA-mediated loss of FA1/dlk1-expressing SNc dopaminergic neurons and/or due to the stab wound. Our findings hint to a significant role of FA1/dlk1 in the SNc during early postnatal development. The differential expression of FA1/dlk1 in the SNc and the striatum of dopamine-depleted rats could indicate a potential involvement of FA1/dlk1 in the cellular response to the degenerative processes.	[Liechti, Remy; Ducray, Angelique D.; Di Santo, Stefano; Seiler, Stefanie; Widmer, Hans Rudolf] Univ Bern, Inselspital, Neuroctr, Dept Neurosurg, CH-3010 Bern, Switzerland; [Liechti, Remy; Ducray, Angelique D.; Di Santo, Stefano; Seiler, Stefanie; Widmer, Hans Rudolf] Univ Bern, Inselspital, Regenerat Neurosci Cluster, CH-3010 Bern, Switzerland; [Jensen, Pia; Meyer, Morten] Univ Southern Denmark, Dept Neurobiol Res, Inst Mol Med, DK-5000 Odense C, Denmark; [Jensen, Charlotte H.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense C, Denmark; [Jensen, Charlotte H.] Univ Southern Denmark, Dept Cardiovasc & Renal Res, DK-5000 Odense C, Denmark	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Widmer, HR (corresponding author), Univ Bern, Inselspital, Neuroctr, Dept Neurosurg, CH-3010 Bern, Switzerland.	hanswi@insel.ch	Jensen, Charlotte Harken/P-4612-2014; Widmer, Hans R./AAC-8948-2022; Di Santo, Stefano/P-2433-2019; Jensen, Charlotte Harken/AAZ-1738-2020; Di Santo, Stefano/K-5739-2014; Widmer, Hans Rudolf/O-5172-2017	Jensen, Charlotte Harken/0000-0001-9683-8761; Di Santo, Stefano/0000-0002-4032-999X; Jensen, Charlotte Harken/0000-0001-9683-8761; Di Santo, Stefano/0000-0002-4032-999X; Widmer, Hans Rudolf/0000-0003-3378-8765	Swiss Parkinson Foundation; HANELA Foundation; Swiss National Science Foundation [3100A0-112529, 31003A_135565]; Danish Parkinson Association; IMK Almene Fond; Kirsten and Freddy Johansens Fond; Horslev Fonden	Swiss Parkinson Foundation; HANELA Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Parkinson Association; IMK Almene Fond; Kirsten and Freddy Johansens Fond; Horslev Fonden	This research was supported by the Swiss Parkinson Foundation, the HANELA Foundation and the Swiss National Science Foundation (No. 3100A0-112529 and 31003A_135565). Pia Jensen and Morten Meyer were supported by the Danish Parkinson Association, IMK Almene Fond, Kirsten and Freddy Johansens Fond and Horslev Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AlfahelKakunda A, 1997, DEV BRAIN RES, V103, P9, DOI 10.1016/S0165-3806(97)00101-6; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bauer M, 2008, J NEUROCHEM, V104, P1101, DOI 10.1111/j.1471-4159.2007.05037.x; Cannon JR, 2009, NEUROSCI LETT, V464, P14, DOI 10.1016/j.neulet.2009.08.023; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen L, 2011, J BIOL CHEM, V286, P32140, DOI 10.1074/jbc.M111.230110; Christophersen NS, 2007, EXP NEUROL, V204, P791, DOI 10.1016/j.expneurol.2007.01.014; Costaglioli P, 2001, FEBS LETT, V509, P413, DOI 10.1016/S0014-5793(01)03205-7; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Gonzalez-Hernandez T, 2004, J COMP NEUROL, V479, P198, DOI 10.1002/cne.20323; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; Harkness L, 2009, STEM CELL REV REP, V5, P353, DOI 10.1007/s12015-009-9099-4; Hontanilla B, 1997, SYNAPSE, V25, P359, DOI 10.1002/(SICI)1098-2396(199704)25:4<359::AID-SYN7>3.3.CO;2-G; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jensen CH, 2001, NEUROREPORT, V12, P3959, DOI 10.1097/00001756-200112210-00021; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Jensen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076592; Korotkova TM, 2004, MOL NEUROBIOL, V29, P243, DOI 10.1385/MN:29:3:243; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LAUDER JM, 1974, J COMP NEUROL, V155, P469, DOI 10.1002/cne.901550407; Lopez-Martin E, 1999, J COMP NEUROL, V406, P199, DOI 10.1002/(SICI)1096-9861(19990405)406:2<199::AID-CNE5>3.0.CO;2-Z; MARCHAND R, 1983, NEUROSCIENCE, V9, P373, DOI 10.1016/0306-4522(83)90300-7; McRitchie DA, 1996, J COMP NEUROL, V364, P121, DOI 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1; Meister B, 2013, J NEUROENDOCRINOL, V25, P617, DOI 10.1111/jne.12029; Meyer M, 1998, EXP BRAIN RES, V119, P345, DOI 10.1007/s002210050350; MOUATTPRIGENT A, 1994, BRAIN RES, V668, P62, DOI 10.1016/0006-8993(94)90511-8; Nemoto C, 1999, BRAIN RES, V846, P129, DOI 10.1016/S0006-8993(99)01950-2; OUIMET CC, 1984, J NEUROSCI, V4, P111; Park M, 2000, BRAIN DEV-JPN, V22, pS38; Paxinos G., 1986, RAT STEREOTAXIC COOR; Rajput PS, 2009, NEUROSCI RES, V65, P53, DOI 10.1016/j.neures.2009.05.005; Rodriguez M, 2001, EXP NEUROL, V169, P163, DOI 10.1006/exnr.2000.7624; ROGERS JH, 1992, NEUROSCIENCE, V51, P843, DOI 10.1016/0306-4522(92)90525-7; Samulewicz SJ, 2002, WOUND REPAIR REGEN, V10, P215, DOI 10.1046/j.1524-475X.2002.10404.x; Schaller B, 2005, BRAIN RES, V1036, P163, DOI 10.1016/j.brainres.2004.12.054; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; Tse YC, 2000, BRAIN RES, V854, P57, DOI 10.1016/S0006-8993(99)02292-1; Villanueva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036134	46	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116088	10.1371/journal.pone.0116088	http://dx.doi.org/10.1371/journal.pone.0116088			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723595	Green Published, Green Submitted, gold			2022-12-26	WOS:000350251200013
J	Nguyen, NPT; Tran, BX; Hwang, LY; Markham, CM; Swartz, MD; Phan, HTT; Nong, VM; Nguyen, CT; Nguyen, AH; Latkin, CA; Vidrine, DJ				Nhung Phuong Thi Nguyen; Tran, Bach Xuan; Hwang, Lu Y.; Markham, Christine M.; Swartz, Michael D.; Huong Thu Thi Phan; Vuong Minh Nong; Cuong Tat Nguyen; Anh Hue Nguyen; Latkin, Carl A.; Vidrine, Damon J.			Prevalence of Cigarette Smoking and Associated Factors in a Large Sample of HIV-Positive Patients Receiving Antiretroviral Therapy in Vietnam	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; QUALITY-OF-LIFE; TOBACCO USE; INFECTED PATIENTS; CESSATION; HIV/AIDS; INDIVIDUALS; POPULATION; STRATEGIES; HEALTH	Background Cigarette smoking presents a salient risk for HIV-positive populations. This study is among the first to examine smoking prevalence, nicotine dependence, and associated factors in a large sample of HIV-positive patients receiving antiretroviral therapy (ART) in Vietnam. Methods A cross-sectional study of 1133 HIV-positive people was conducted from January to September 2013 at 8 ART clinics in Hanoi (the capital) and Nam Dinh (a rural area). Smoking history and nicotine dependence (Fagerstrom Test of Nicotine Dependence-FTND) were assessed by participant self-report. Logistic regression and Tobit linear regression were performed to identify factors significantly associated with smoking outcomes. Results Prevalence of current, former, and never smokers in the sample was 36.1%, 9.5%, and 54.4%, respectively. The current smoking proportion was higher in males (59.7%) than females (2.6%). The mean FTND score was 3.6 (SD = 2.1). Males were more likely to currently smoke than females (OR = 23.4, 95% CI = 11.6-47.3). Individuals with problem drinking (OR = 1.8, 95% CI = 1.1-2.9) and ever drug use (OR = 3.7, 95% CI = 2.5-5.7) were more likely to be current smokers. Older age and currently feeling pain were associated with lower nicotine dependence. Conversely, receiving care in Nam Dinh, greater alcohol consumption, ever drug use, and a longer smoking duration were associated with greater nicotine dependence. Conclusions Given the high prevalence of smoking among HIV-positive patients, smoking screening and cessation support should be offered at ART clinics in Vietnam. Risk factors (i.e., substance use) linked with smoking behavior should be considered in prevention programs.	[Nhung Phuong Thi Nguyen; Hwang, Lu Y.; Markham, Christine M.; Swartz, Michael D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Nhung Phuong Thi Nguyen; Vidrine, Damon J.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Unit 1330, Houston, TX 77030 USA; [Tran, Bach Xuan; Vuong Minh Nong; Cuong Tat Nguyen; Anh Hue Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam; [Nhung Phuong Thi Nguyen] Hanoi Univ Pharm, Hanoi, Vietnam; [Huong Thu Thi Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam; [Tran, Bach Xuan; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Hanoi Medical University; Hanoi University of Pharmacy; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam.	bach@hmu.edu.vn	Nguyen, Nhung/J-8012-2019; Swartz, Michael/AEX-2820-2022	Nguyen, Nhung/0000-0002-8661-9597; Swartz, Michael/0000-0003-3953-8775				Tran BX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-27; Tran BX, 2013, B WORLD HEALTH ORGAN, V91, P475, DOI 10.2471/BLT.12.115147; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2013, DRUG ALCOHOL DEPEN, V127, P39, DOI 10.1016/j.drugalcdep.2012.06.009; Broom Jennifer, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P109, DOI 10.1177/1545109711418832; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Duval X, 2008, ANTIVIR THER, V13, P389; EQOLG, 2011, EQ 5D 5L US GUID BAS; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Furber AS, 2007, SEX TRANSM INFECT, V83, P41, DOI 10.1136/sti.2005.019505; Global Adult Tobacco Survey, 2010, GLOB AD TOB SURV VIE; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Higashi H, 2012, ADDICTION, V107, P658, DOI 10.1111/j.1360-0443.2011.03632.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Humfleet GL, 2009, AIDS EDUC PREV, V21, P54, DOI 10.1521/aeap.2009.21.3_supp.54; Jaquet A, 2009, INT J TUBERC LUNG D, V13, P1433; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Luo XF, 2014, DRUG ALCOHOL DEPEN, V134, P144, DOI 10.1016/j.drugalcdep.2013.09.023; Marshall MM, 2009, AIDS EDUC PREV, V21, P28, DOI 10.1521/aeap.2009.21.3_supp.28; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; National Committee for AIDS and Prostitution Prevention and Control, 2012, VIET NAM AIDS RESP P; Niaura R, 2012, CURR HIV-AIDS REP, V9, P375, DOI 10.1007/s11904-012-0138-4; O'Cleirigh C, 2014, AIDS BEHAV; Pacek LR, 2013, AIDS BEHAV; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Shirley DK, 2013, AIDS PATIENT CARE ST, V27, P604, DOI 10.1089/apc.2013.0128; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Tang AM, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/890308; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; The Joint United Nations Programme on HIV and AIDS (UNAIDS), 2013, UNAIDS REP GLOB HIV; Twisk J, 2009, J CLIN EPIDEMIOL, V62, P953, DOI 10.1016/j.jclinepi.2008.10.003; Vidrine DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-696; Vidrine DJ, 2012, NICOTINE TOB RES, V14, P106, DOI 10.1093/ntr/ntr121; Vidrine DJ, 2009, AIDS EDUC PREV, V21, P3, DOI 10.1521/aeap.2009.21.3_supp.3; Vietnam Authority of HIV/AIDS Control, 2014, REP CURR SIT HIV INF; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118185	10.1371/journal.pone.0118185	http://dx.doi.org/10.1371/journal.pone.0118185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723596	Green Published, gold, Green Submitted			2022-12-26	WOS:000350251200048
J	De Korte-Verhoef, MC; Pasman, HRW; Schweitzer, BPM; Francke, AL; Onwuteaka-Philipsen, BD; Deliens, L				De Korte-Verhoef, Maria C.; Pasman, H. Roeline W.; Schweitzer, Bart P. M.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc			How Could Hospitalisations at the End of Life Have Been Avoided? A Qualitative Retrospective Study of the Perspectives of General Practitioners, Nurses and Family Carers	PLOS ONE			English	Article							LUNG-CANCER PATIENTS; DEATH; HOME; NETHERLANDS; PLACE; PREFERENCES; POPULATION; REASONS	Background Although many patients prefer to stay and die at home at the end of life, many are hospitalised. Little is known about how to avoid hospitalisations for patients living at home. Aim To describe how hospitalisation at the end of life can be avoided, from the perspective of the GPs, nurses and family carers. Method A qualitative design with face-to-face interviews was used. Taking 30 cases of patients who died non-suddenly, 26 GPs, 15 nurses and 18 family carers were interviewed in depth. Of the 30 patients, 20 were hospitalised and 10 were not hospitalised in the last three months of life. Results Five key themes that could help avoid hospitalisation at the end of life emerged from the interviews. The key themes were: 1) marking the approach of death, and shifting the mindset; 2) being able to provide acute treatment and care at home; 3) anticipatory discussions and interventions to deal with expected severe problems; 4) guiding and monitoring the patient and family in a holistic way through the illness trajectory; 5) continuity of treatment and care at home. If these five key themes are adopted in an interrelated way, this could help avoid hospitalisations, according to GPs, nurses and family carers. Conclusions The five key themes described in this study can be seen as strategies that could help in avoiding hospitalisation at the end of life. It is recommended that for all patients residing at home, GPs and community nurses work together as a team from the moment that it is marked that death is approaching up to the end of life.	[De Korte-Verhoef, Maria C.; Pasman, H. Roeline W.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [De Korte-Verhoef, Maria C.; Pasman, H. Roeline W.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc] Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care VUmc, Inst Hlth & Care Res, Amsterdam, Netherlands; [Schweitzer, Bart P. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice, Amsterdam, Netherlands; [Francke, Anneke L.] NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Deliens, Luc] Univ Ghent, End of life Care Res Grp, Brussels, Belgium; [Deliens, Luc] Vrije Univ Brussel, Brussels, Belgium	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Institute for Health Services Research; Ghent University; Vrije Universiteit Brussel	De Korte-Verhoef, MC (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	eol@vumc.nl	Wu, Hsin-Lung/C-4134-2009	Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248; Deliens, Luc/0000-0002-8158-2422	ZonMw; Netherlands Organization for Health Research and Development [11510005]	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This study is funded by ZonMw, the Netherlands Organization for Health Research and Development (No. 11510005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2010, PALLIATIVE MED, V24, P166, DOI 10.1177/0269216309351381; Abel J, 2009, PALLIATIVE MED, V23, P616, DOI 10.1177/0269216309106460; Ahlner-Elmqvist M, 2004, PALLIATIVE MED, V18, P585, DOI 10.1191/0269216304pm924oa; Barbera L, 2008, J PAIN SYMPTOM MANAG, V35, P267, DOI 10.1016/j.jpainsymman.2007.04.019; Borgsteede SD, 2006, BRIT J GEN PRACT, V56, P20; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Choi J, 2010, SUPPORT CARE CANCER, V18, P1445, DOI 10.1007/s00520-009-0767-3; Claessen SJJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-42; de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012; De Korte-Verhoef MC, 2014, SUPPORT CARE CANCER, V22, P645, DOI 10.1007/s00520-013-2019-9; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; Dumont S, 2009, PALLIATIVE MED, V23, P708, DOI 10.1177/0269216309346546; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gott M, 2013, PALLIATIVE MED, V27, P747, DOI 10.1177/0269216312469263; Gott M, 2011, BMJ SUPPORT PALLIAT, V1, P42, DOI [10.1186/1472-684X-12-9, 10.1136/bmj.d1773]; Korte-Verhoef De, 2009, BETER THUIS STERVEN; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Ratner E, 2001, J AM GERIATR SOC, V49, P778, DOI 10.1046/j.1532-5415.2001.49155.x; Reyniers T, 2014, HEALTH PLACE, V27, P77, DOI 10.1016/j.healthplace.2014.02.002; Royal College of General Practitioners and Royal College of Nursing, 2012, MATT LIF DEATH HELP; Sandelowski M, 2012, QUAL HEALTH RES, V22, P1404, DOI 10.1177/1049732312450368; Schweitzer Bart P M, 2009, BMC Palliat Care, V8, P17, DOI 10.1186/1472-684X-8-17; Shaw KL, 2010, PALLIATIVE MED, V24, P317, DOI 10.1177/0269216310362005; Stajduhar KI, 2008, PALLIATIVE MED, V22, P85, DOI 10.1177/0269216307084612; Thoonsen B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-123; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; van der Plas AGM, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-14; Vos MS, 2011, LUNG CANCER, V72, P119, DOI 10.1016/j.lungcan.2010.07.007; Walsh EG, 2012, J AM GERIATR SOC, V60, P821, DOI 10.1111/j.1532-5415.2012.03920.x; Wowchuk SM, 2009, J PALLIAT MED, V12, P797, DOI 10.1089/jpm.2009.0048	31	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118971	10.1371/journal.pone.0118971	http://dx.doi.org/10.1371/journal.pone.0118971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756184	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700033
J	Nanduri, J; Vaddi, DR; Khan, SA; Wang, N; Makarenko, V; Semenza, GL; Prabhakar, NR				Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makarenko, Vladislav; Semenza, Gregg L.; Prabhakar, Nanduri R.			HIF-1 alpha Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase	PLOS ONE			English	Article							PROTEIN-KINASE-C; OXYGEN SPECIES GENERATION; OBSTRUCTIVE SLEEP-APNEA; OXIDATIVE STRESS; CAROTID-BODY; CHROMAFFIN CELLS; NOX FAMILY; PHOSPHORYLATION; RESPONSES; HYPERTENSION	Hypoxia-inducible factor 1 (HIF-1) mediates many of the systemic and cellular responses to intermittent hypoxia (IH), which is an experimental model that simulates O-2 saturation profiles occurring with recurrent apnea. IH-evoked HIF-1 alpha synthesis and stability are due to increased reactive oxygen species (ROS) generated by NADPH oxidases, especially Nox2. However, the mechanisms by which IH activates Nox2 are not known. We recently reported that IH activates xanthine oxidase (XO) and the resulting increase in ROS elevates intracellular calcium levels. Since Nox2 activation requires increased intracellular calcium levels, we hypothesized XO-mediated calcium signaling contributes to Nox activation by IH. We tested this possibility in rat pheochromocytoma PC12 cells subjected to IH consisting alternating cycles of hypoxia (1.5% O-2 for 30 sec) and normoxia (21% O-2 for 5 min). Kinetic analysis revealed that IH-induced XO preceded Nox activation. Inhibition of XO activity either by allopurinol or by siRNA prevented IH-induced Nox activation, translocation of the cytosolic subunits p47(phox) and p67(phox) to the plasma membrane and their interaction with gp91(phox). ROS generated by XO also contribute to IH-evoked Nox activation via calcium-dependent protein kinase C stimulation. More importantly, silencing XO blocked IH-induced upregulation of HIF-1 alpha demonstrating that HIF-1 alpha activation by IH requires Nox2 activation by XO.	[Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makarenko, Vladislav; Prabhakar, Nanduri R.] Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA; [Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makarenko, Vladislav; Prabhakar, Nanduri R.] Univ Chicago, Div Biol Sci, Ctr Syst Biol Sensing O2, Chicago, IL 60637 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat Med Oncol Radiat Oncol & Biol Chem, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Baltimore, MD USA	University of Chicago; University of Chicago; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Nanduri, J (corresponding author), Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA.	jnanduri@uchicago.edu	Vaddi, Damodara Reddy/AAU-1398-2020	Vaddi, Damodara Reddy/0000-0002-4441-0859	National Institute for Health [HL- -90554]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090554] Funding Source: NIH RePORTER	National Institute for Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NRP and GLS were funded by National Institute for Health HL- -90554. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Christou Kostas, 2003, Sleep Breath, V7, P105, DOI 10.1007/s11325-003-0105-9; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Grebe M, 2006, AM J RESP CRIT CARE, V173, P897, DOI 10.1164/rccm.200508-1223OC; Khan SA, 2011, ANTIOXID REDOX SIGN, V14, P533, DOI 10.1089/ars.2010.3213; Kumar GK, 2006, J PHYSIOL-LONDON, V575, P229, DOI 10.1113/jphysiol.2006.112524; Kuri BA, 2007, J PHYSIOL-LONDON, V584, P313, DOI 10.1113/jphysiol.2007.140624; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Makarenko VV, 2012, AM J PHYSIOL-CELL PH, V303, pC916, DOI 10.1152/ajpcell.00100.2012; Nanduri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075838; Nanduri J, 2009, P NATL ACAD SCI USA, V106, P1199, DOI 10.1073/pnas.0811018106; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; PARKS DA, 1985, GASTROENTEROLOGY, V89, P6, DOI 10.1016/0016-5085(85)90738-3; Peng YJ, 2009, J NEUROSCI, V29, P4903, DOI 10.1523/JNEUROSCI.4768-08.2009; Peng YJ, 2006, J PHYSIOL-LONDON, V577, P705, DOI 10.1113/jphysiol.2006.114033; Peng YJ, 2003, J APPL PHYSIOL, V94, P2342, DOI 10.1152/japplphysiol.00613.2002; Prabhakar NR, 2007, ANTIOXID REDOX SIGN, V9, P1397, DOI 10.1089/ars.2007.1732; Prabhakar NR, 2007, RESP PHYSIOL NEUROBI, V157, P148, DOI 10.1016/j.resp.2006.12.009; Prabhakar Nanduri R, 2006, Novartis Found Symp, V272, P95; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P230, DOI 10.1016/j.resp.2010.08.022; Prabhakar NR, 2006, NOVART FDN SYMP, V272, P100; Prabhakar NR, 2006, NOVART FDN SYMP, V272, P31; Raghuraman G, 2009, ANTIOXID REDOX SIGN, V11, P1777, DOI [10.1089/ars.2008.2368, 10.1089/ARS.2008.2368]; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; Sharma SD, 2009, J APPL PHYSIOL, V106, P12, DOI 10.1152/japplphysiol.90702.2008; Souvannakitti D, 2009, J NEUROPHYSIOL, V101, P2837, DOI 10.1152/jn.00036.2009; Suzuki YJ, 2006, FREE RADICAL BIO MED, V40, P1683, DOI 10.1016/j.freeradbiomed.2006.01.008; Brindeiro CMT, 2007, AM J PHYSIOL-HEART C, V293, pH2971, DOI 10.1152/ajpheart.00219.2007; Young T, 2008, SLEEP, V31, P1071; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Yuan GX, 2013, P NATL ACAD SCI USA, V110, pE1788, DOI 10.1073/pnas.1305961110; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Yuan GX, 2004, J PHYSIOL-LONDON, V557, P773, DOI 10.1113/jphysiol.2003.058503; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284	40	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119762	10.1371/journal.pone.0119762	http://dx.doi.org/10.1371/journal.pone.0119762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751622	gold, Green Published, Green Submitted			2022-12-26	WOS:000350692700034
J	Jounai, K; Sugimura, T; Ohshio, K; Fujiwara, D				Jounai, Kenta; Sugimura, Tetsu; Ohshio, Konomi; Fujiwara, Daisuke			Oral Administration of Lactococcus lactis Subsp lactis JCM5805 Enhances Lung Immune Response Resulting in Protection from Murine Parainfluenza Virus Infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; BIFIDOBACTERIUM-BREVE YIT4064; INFLUENZA-A VIRUS; SENDAI-VIRUS; T-CELLS; RESPIRATORY-TRACT; I INTERFERON; RNA VIRUSES; RIG-I; RECOGNITION	When activated by viral infection, plasmacytoid dendritic cells (pDCs) play a primary role in the immune response through secretion of IFN-alpha. Lactococcus lactis subsp. lactis JCM5805 (JCM5805) is a strain of lactic acid bacteria (LAB) that activates murine and human pDCs to express type I and type III interferons (IFNs). JCM5805 has also been shown to activate pDCs via a Toll-like receptor 9 (TLR9) dependent pathway. In this study, we investigated the anti-viral effects of oral administration of JCM5805 using a mouse model of murine parainfluenza virus (mPIV1) infection. JCM5805-fed mice showed a drastic improvement in survival rate, prevention of weight loss, and reduction in lung histopathology scores compared to control mice. We further examined the mechanism of anti-viral effects elicited by JCM5805 administration using naive mice. Microscopic observations showed that JCM5805 was incorporated into CD11c(+) immune cells in Peyer's patches (PP) and PP pDCs were significantly activated and the expression levels of IFNs were significantly increased. Interestingly, nevertheless resident pDCs at lung were not activated and expressions levels of IFNs at whole lung tissue were not influenced, the expressions of anti-viral factors induced by IFNs, such as Isg15, Oasl2, and Viperin, at lung were up-regulated in JCM5805-fed mice compared to control mice. Therefore expressed IFNs from intestine might be delivered to lung and IFN stimulated genes might be induced. Furthermore, elevated expressions of type I IFNs from lung lymphocytes were observed in response to mPIV1 ex vivo stimulation in JCM5805-fed mice compared to control. This might be due to increased ratio of pDCs located in lung were significantly increased in JCM5805 group. Taken together, a specific LAB strain might be able to affect anti-viral immunological profile in lung via activation of intestinal pDC leading to enhanced anti-viral phenotype in vivo.	[Jounai, Kenta] Koiwai Dairy Prod Co Ltd, Tech Dev Ctr, Sayama, Osaka, Japan; [Jounai, Kenta; Sugimura, Tetsu; Ohshio, Konomi; Fujiwara, Daisuke] Kirin Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa, Japan		Jounai, K (corresponding author), Koiwai Dairy Prod Co Ltd, Tech Dev Ctr, Sayama, Osaka, Japan.	Kenta_Jounai@kirin.co.jp						Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Goto H, 2013, BRIT J NUTR, V110, P1810, DOI 10.1017/S0007114513001104; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; Hori T, 2001, CLIN DIAGN LAB IMMUN, V8, P593, DOI 10.1128/CDLI.8.3.593-597.2001; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ichikawa S, 2009, BIOSCI BIOTECH BIOCH, V73, P1561, DOI 10.1271/bbb.90058; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jounai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032588; Kakuta S, 2002, J INTERF CYTOK RES, V22, P981, DOI 10.1089/10799900260286696; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Kondoh M, 2012, VIRAL IMMUNOL, V25, P86, DOI 10.1089/vim.2011.0056; Kotani Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091857; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Parcina M, 2008, J IMMUNOL, V181, P3823, DOI 10.4049/jimmunol.181.6.3823; PARKER JC, 1978, INFECT IMMUN, V19, P123, DOI 10.1128/IAI.19.1.123-130.1978; Piccioli D, 2009, BLOOD, V113, P4232, DOI 10.1182/blood-2008-10-186890; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sugimura T, 2013, CLIN IMMUNOL, V149, P509, DOI 10.1016/j.clim.2013.10.007; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Takeda S, 2011, INT IMMUNOPHARMACOL, V11, P1976, DOI 10.1016/j.intimp.2011.08.007; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; YASUI H, 1995, J INFECT DIS, V172, P403, DOI 10.1093/infdis/172.2.403; Yasui H, 1999, CLIN DIAGN LAB IMMUN, V6, P186, DOI 10.1128/CDLI.6.2.186-192.1999; Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x	48	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119055	10.1371/journal.pone.0119055	http://dx.doi.org/10.1371/journal.pone.0119055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746923	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400040
J	Taylor-Clark, TE; Wu, KY; Thompson, JA; Yang, K; Bahia, PK; Ajmo, JM				Taylor-Clark, Thomas E.; Wu, Kevin Y.; Thompson, Julie-Ann; Yang, Kiseok; Bahia, Parmvir K.; Ajmo, Joanne M.			Thy1.2 YFP-16 Transgenic Mouse Labels a Subset of Large-Diameter Sensory Neurons that Lack TRPV1 Expression	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; MICROSCOPIC ANALYSIS; NERVE REGENERATION; P2X RECEPTORS; NEURAL CREST; MICE; CHANNELS; LUNGS; TOUCH; PAIN	The Thy1.2 YFP-16 mouse expresses yellow fluorescent protein (YFP) in specific subsets of peripheral and central neurons. The original characterization of this model suggested that YFP was expressed in all sensory neurons, and this model has been subsequently used to study sensory nerve structure and function. Here, we have characterized the expression of YFP in the sensory ganglia (DRG, trigeminal and vagal) of the Thy1.2 YFP-16 mouse, using biochemical, functional and anatomical analyses. Despite previous reports, we found that YFP was only expressed in approximately half of DRG and trigeminal neurons and less than 10% of vagal neurons. YFP-expression was only found in medium and large-diameter neurons that expressed neurofilament but not TRPV1. YFP-expressing neurons failed to respond to selective agonists for TRPV1, P2X(2/3) and TRPM8 channels in Ca2+ imaging assays. Confocal analysis of glabrous skin, hairy skin of the back and ear and skeletal muscle indicated that YFP was expressed in some peripheral terminals with structures consistent with their presumed non-nociceptive nature. In summary, the Thy1.2 YFP-16 mouse expresses robust YFP expression in only a subset of sensory neurons. But this mouse model is not suitable for the study of nociceptive nerves or the function of such nerves in pain and neuropathies.	[Taylor-Clark, Thomas E.; Wu, Kevin Y.; Thompson, Julie-Ann; Yang, Kiseok; Bahia, Parmvir K.; Ajmo, Joanne M.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Taylor-Clark, TE (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	ttaylorc@health.usf.edu			National Heart, Lung & Blood Institute [R01 HL119802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119802] Funding Source: NIH RePORTER	National Heart, Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Heart, Lung & Blood Institute R01 HL119802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Belle MD, 2007, GENESIS, V45, P679, DOI 10.1002/dvg.20331; Bewick GS, 2014, MECHANOTRANSDUCTION; Burnstock G, 2000, BRIT J ANAESTH, V84, P476, DOI 10.1093/oxfordjournals.bja.a013473; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen YS, 2005, DIABETES, V54, P3112, DOI 10.2337/diabetes.54.11.3112; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fradette J, 1995, BIOCHEM CELL BIOL, V73, P635, DOI 10.1139/o95-070; GREGORY JE, 1979, J PHYSIOL-LONDON, V295, P251, DOI 10.1113/jphysiol.1979.sp012966; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Kollarik M, 2010, J PHYSIOL-LONDON, V588, P4303, DOI 10.1113/jphysiol.2010.192971; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; LAWSON SN, 1993, BRAIN RES BULL, V30, P239, DOI 10.1016/0361-9230(93)90250-F; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; MILLARD CL, 1988, J COMP NEUROL, V277, P183, DOI 10.1002/cne.902770203; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Nassenstein C, 2010, J PHYSIOL-LONDON, V588, P4769, DOI 10.1113/jphysiol.2010.195339; Nesuashvili L, 2013, MOL PHARMACOL, V83, P1007, DOI 10.1124/mol.112.084319; Niu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092027; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Roudaut Y, 2012, CHANNELS, V6, P234, DOI 10.4161/chan.22213; Shenton F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107073; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Suzuki M, 2012, P JPN ACAD B-PHYS, V88, P583, DOI 10.2183/pjab.88.583; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Unezaki S, 2009, J NEUROSCI METH, V178, P308, DOI 10.1016/j.jneumeth.2008.12.022; Wu HL, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/609796; Yan Y, 2011, EXP NEUROL, V232, P7, DOI 10.1016/j.expneurol.2011.06.013	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119538	10.1371/journal.pone.0119538	http://dx.doi.org/10.1371/journal.pone.0119538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746468	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400078
J	Wehmann, HN; Gustav, D; Kirkerud, NH; Galizia, CG				Wehmann, Henja-Niniane; Gustav, David; Kirkerud, Nicholas H.; Galizia, C. Giovanni			The Sound and the Fury-Bees Hiss when Expecting Danger	PLOS ONE			English	Article							PROBOSCIS EXTENSION RESPONSE; APIS-MELLIFERA; HONEY-BEES; COMMUNICATION; VOCALIZATIONS; BUMBLEBEES; BEHAVIOR; DEFENSE; COLONY	Honey bees are important model systems for the investigation of learning and memory and for a better understanding of the neuronal basics of brain function. Honey bees also possess a rich repertoire of tones and sounds, from queen piping and quacking to worker hissing and buzzing. In this study, we tested whether the worker bees' sounds can be used as a measure of learning. We therefore conditioned honey bees aversively to odours in a walking arena and recorded both their sound production and their movement. Bees were presented with two odours, one of which was paired with an electric shock. Initially, the bees did not produce any sound upon odour presentation, but responded to the electric shock with a strong hissing response. After learning, many bees hissed at the presentation of the learned odour, while fewer bees hissed upon presentation of another odour. We also found that hissing and movement away from the conditioned odour are independent behaviours that can co-occur but do not necessarily do so. Our data suggest that hissing can be used as a readout for learning after olfactory conditioning, but that there are large individual differences between bees concerning their hissing reaction. The basis for this variability and the possible ecological relevance of the bees' hissing remain to be investigated.	[Wehmann, Henja-Niniane; Gustav, David; Kirkerud, Nicholas H.; Galizia, C. Giovanni] Univ Konstanz, Neurobiol, Constance, Germany; [Kirkerud, Nicholas H.] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, Constance, Germany	University of Konstanz; Max Planck Society; University of Konstanz	Gustav, D (corresponding author), Univ Konstanz, Neurobiol, Constance, Germany.	david.gustav@uni-konstanz.de; giovanni.galizia@uni-konstanz.de	Galizia, C Giovanni/A-1771-2009	Galizia, C Giovanni/0000-0001-8292-6031; Kirkerud, Nicholas/0000-0002-8310-5523	Federal Ministry of Food and Agriculture (BMEL) via the Federal Office for Agriculture and Food (BLE)	Federal Ministry of Food and Agriculture (BMEL) via the Federal Office for Agriculture and Food (BLE)	NHK participates in the International Max-Planck Research School for Organismal Biology. This work was supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniadis EA, 1999, BEHAV BRAIN RES, V101, P1, DOI 10.1016/S0166-4328(98)00056-4; Armbruster L, 1922, ARCH BIENENK, V4, P221, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; AudacityTeam, 2012, AUD FREE AUD ED REC; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERG DS, 1973, BEHAV BIOL, V8, P733, DOI 10.1016/S0091-6773(73)80115-4; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Burg NMD, 2014, APIDOLOGIE, P1; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Chongsuvivatwong V, 2012, EPICALC EPIDEMIOLOGI; COLLINS AM, 1978, ANN ENTOMOL SOC AM, V71, P906, DOI 10.1093/aesa/71.6.906; ESCH H, 1961, Z VERGL PHYSIOL, V45, P1, DOI 10.1007/BF00297754; ESCH H, 1967, Z VERGL PHYSIOL, V56, P408, DOI 10.1007/BF00298058; Gelman A., 2013, ARM DATA ANAL USING; Gerber B, 1998, NEUROBIOL LEARN MEM, V69, P71, DOI 10.1006/nlme.1997.3801; GINSBURG N, 1960, J COMP PHYSIOL PSYCH, V53, P183, DOI 10.1037/h0048391; GINSBURG N, 1963, J COMP PHYSIOL PSYCH, V56, P1061, DOI 10.1037/h0047774; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Hansson A, 1945, LAUTERZEUGUNG LAUTAU; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; Harris JW, 1999, PHYSIOL ENTOMOL, V24, P285, DOI 10.1046/j.1365-3032.1999.00141.x; Hrncir M, 2006, CONT T ENT, P421; KERR WE, 1960, EVOLUTION, V14, P386, DOI 10.1111/j.1558-5646.1960.tb03100.x; Kinney C, 1998, J EXP ZOOL, V280, P107, DOI 10.1002/(SICI)1097-010X(19980201)280:2<107::AID-JEZ1>3.0.CO;2-S; KIRCHNER WH, 1993, APIDOLOGIE, V24, P297, DOI 10.1051/apido:19930309; Kirchner WH, 1999, INSECT SOC, V46, P239, DOI 10.1007/s000400050140; Kirkerud NH, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00029; Konorski J, 1948, CONDITIONED REFLEXES, VXIV; Labra A, 2007, COPEIA, P1019, DOI 10.1643/0045-8511(2007)7[1019:HSBTLP]2.0.CO;2; LANE H, 1960, SCIENCE, V132, P37, DOI 10.1126/science.132.3418.37; LAVERTY TM, 1988, ANIM BEHAV, V36, P733, DOI 10.1016/S0003-3472(88)80156-8; Ligges U, 2013, TUNER ANAL MUSIC; LINDAUER M, 1955, Z VERGL PHYSIOL, V37, P263, DOI 10.1007/BF00303153; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Maechler M., 2011, LME4 LINEAR MIXED EF; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; Martin P., 1963, Insectes Sociaux Paris, V10, P13, DOI 10.1007/BF02223520; MARTIN WF, 1971, COPEIA, P752; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; MICHAEL J, 1984, J EXP ANAL BEHAV, V42, P363, DOI 10.1901/jeab.1984.42-363; NELSON MC, 1980, BEHAV ECOL SOCIOBIOL, V6, P305, DOI 10.1007/BF00292773; Papachristoforou A, 2008, APIDOLOGIE, V39, P468, DOI 10.1051/apido:2008027; PETERS G, 1987, Bonner Zoologische Beitraege, V38, P315; Peters G., 1989, P14; PICKENS ANDREW L., 1928, AUK, V45, P302; R Core Team, 2021, R LANGUAGE ENV STAT; Rangel J, 2008, ANIM BEHAV, V76, P1943, DOI 10.1016/j.anbehav.2008.09.004; Rittschof CC, 2008, ANIM BEHAV, V75, P189, DOI 10.1016/j.anbehav.2007.04.026; SALZINGER K, 1962, J EXP ANAL BEHAV, V5, P383, DOI 10.1901/jeab.1962.5-383; SALZINGER K, 1959, J GEN PSYCHOL, V61, P65, DOI 10.1080/00221309.1959.9710241; SCHUSTERMAN RJ, 1965, SCIENCE, V150, P1743, DOI 10.1126/science.150.3704.1743; SCHUSTERMAN RJ, 1970, SCIENCE, V169, P498, DOI 10.1126/science.169.3944.498; Seeley T.D., 1979, Psyche (Cambridge), V86, P103, DOI 10.1155/1979/80869; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Sen Sarma M, 2002, ZOOLOGY, V105, P215, DOI 10.1078/0944-2006-00064; SPANGLER HG, 1991, J INSECT BEHAV, V4, P15, DOI 10.1007/BF01092547; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; WENNER ADRIAN M., 1962, ANIMAL BEHAVIOUR, V10, P79, DOI 10.1016/0003-3472(62)90135-5; WILSON WA, 1975, ANIM BEHAV, V23, P432, DOI 10.1016/0003-3472(75)90091-3	64	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118708	10.1371/journal.pone.0118708	http://dx.doi.org/10.1371/journal.pone.0118708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747702	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400025
J	Ansseau, E; Domire, JS; Wallace, LM; Eidahl, JO; Guckes, SM; Giesige, CR; Pyne, NK; Belayew, A; Harper, SQ				Ansseau, Eugenie; Domire, Jacqueline S.; Wallace, Lindsay M.; Eidahl, Jocelyn O.; Guckes, Susan M.; Giesige, Carlee R.; Pyne, Nettie K.; Belayew, Alexandra; Harper, Scott Q.			Aberrant Splicing in Transgenes Containing Introns, Exons, and V5 Epitopes: Lessons from Developing an FSHD Mouse Model Expressing a D4Z4 Repeat with Flanking Genomic Sequences	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DUX4 GENE; PATHOLOGIES; VECTORS; ENCODES; LOCUS	The DUX4 gene, encoded within D4Z4 repeats on human chromosome 4q35, has recently emerged as a key factor in the pathogenic mechanisms underlying Facioscapulohumeral muscular dystrophy (FSHD). This recognition prompted development of animal models expressing the DUX4 open reading frame (ORF) alone or embedded within D4Z4 repeats. In the first published model, we used adeno-associated viral vectors (AAV) and strong viral control elements (CMV promoter, SV40 poly A) to demonstrate that the DUX4 cDNA caused dose-dependent toxicity in mouse muscles. As a follow-up, we designed a second generation of DUX4-expressing AAV vectors to more faithfully genocopy the FSHD-permissive D4Z4 repeat region located at 4q35. This new vector (called AAV. D4Z4.V5.pLAM) contained the D4Z4/DUX4 promoter region, a V5 epitope-tagged DUX4 ORF, and the natural 3' untranslated region (pLAM) harboring two small introns, DUX4 exons 2 and 3, and the non-canonical poly A signal required for stabilizing DUX4 mRNA in FSHD. AAV. D4Z4. V5. pLAM failed to recapitulate the robust pathology of our first generation vectors following delivery to mouse muscle. We found that the DUX4. V5 junction sequence created an unexpected splice donor in the pre-mRNA that was preferentially utilized to remove the V5 coding sequence and DUX4 stop codon, yielding non-functional DUX4 protein with 55 additional residues on its carboxyl-terminus. Importantly, we further found that aberrant splicing could occur in any expression construct containing a functional splice acceptor and sequences resembling minimal splice donors. Our findings represent an interesting case study with respect to AAV. D4Z4. V5. pLAM, but more broadly serve as a note of caution for designing constructs containing V5 epitope tags and/or transgenes with downstream introns and exons.	[Ansseau, Eugenie; Belayew, Alexandra] Univ Mons, Res Inst Hlth Sci & Technol, Mol Biol Lab, B-7000 Mons, Belgium; [Domire, Jacqueline S.; Wallace, Lindsay M.; Eidahl, Jocelyn O.; Guckes, Susan M.; Giesige, Carlee R.; Pyne, Nettie K.; Harper, Scott Q.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA; [Giesige, Carlee R.; Harper, Scott Q.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Harper, Scott Q.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University of Mons; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harper, SQ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA.	Scott.Harper@nationwidechildrens.org	BELAYEW, Alexandra/D-5205-2013	BELAYEW, Alexandra/0000-0001-5115-2424; Domire, Jacqueline/0000-0003-3387-2465	FSHD Global Foundation; Chris Carrino Foundation; National Institutes of Health [1R01AR062123-01]; Muscular Dystrophy Association [218892]; Facioscapulohumeral Society [FSHS-JJFR-001]; NIH T32 training grant [1T32NS077984-01]; FSH Society; FNRS Belgium; CWBI (Walloon Region); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984] Funding Source: NIH RePORTER	FSHD Global Foundation; Chris Carrino Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Facioscapulohumeral Society; NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSH Society; FNRS Belgium(Fonds de la Recherche Scientifique - FNRS); CWBI (Walloon Region); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from: FSHD Global Foundation, The Chris Carrino Foundation, The National Institutes of Health (1R01AR062123-01, to SQH, URL: www.niams.nih.gov), The Muscular Dystrophy Association (218892, to SQH, URL: www.mda.org),The Facioscapulohumeral Society (FSHS-JJFR-001, to SQH, URL: www.fshsociety.org). During the course of this work, LMW was a fellow on an NIH T32 training grant (Muscle Disease and Biology, 1T32NS077984-01, URL: www.osuchildrensmusclegroup.org). During the course of this work, JSD was a fellow on the Ohio State University Systems and Integrative Biology Training Grant (URL: medicine.osu.edu/bsgp/program-overview/program-highlights/pages/index.aspx). EA travel to SH's laboratory was funded by the FSH Society (www.fshsociety.org), the FNRS Belgium (www.frs-fnrs.be) and the CWBI (Walloon Region; cwbi.fsagx.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Block GJ, 2013, HUM MOL GENET, V22, P4661, DOI 10.1093/hmg/ddt314; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Boudreau RL, 2011, NEUROMETHODS, V58, P19, DOI 10.1007/978-1-61779-114-7_2; Brizzard B, 2008, BIOTECHNIQUES, V44, P693, DOI 10.2144/000112841; Dandapat A, 2014, CELL REP, V8, P1484, DOI 10.1016/j.celrep.2014.07.056; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; FLANIGAN KM, 2013, FACIOSCAPULOHUMERAL, P288; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2011, HYBRIDOMA, V30, P125, DOI 10.1089/hyb.2010.0094; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hartweck LM, 2013, NEUROLOGY, V80, P392, DOI 10.1212/WNL.0b013e31827f075c; Himeda CL, 2014, MOL CELL BIOL, V34, P1942, DOI 10.1128/MCB.00149-14; Huichalaf C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115278; Jacob AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104444; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krom YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003415; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Wallace LM, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.16; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275	33	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118813	10.1371/journal.pone.0118813	http://dx.doi.org/10.1371/journal.pone.0118813			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742305	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100048
J	Chung, SH; Gillies, M; Sugiyama, Y; Zhu, L; Lee, SR; Shen, WY				Chung, Sook Hyun; Gillies, Mark; Sugiyama, Yuki; Zhu, Ling; Lee, So-Ra; Shen, Weiyong			Profiling of MicroRNAs Involved in Retinal Degeneration Caused by Selective Muller Cell Ablation	PLOS ONE			English	Article							GENE-EXPRESSION; NEUROTRANSMITTER RELEASE; KINASE-II; CYCLIN D2; PROTEIN; ACTIVATION; CALMODULIN; APOPTOSIS; NEUROPROTECTION; PROLIFERATION	Dysfunction of Muller cells has been implicated in the pathogenesis of several retinal diseases. In order to understand the potential contribution of Muller cells to retinal disease better, we have developed a transgenic model in which foci of Muller cell ablation can be selectively induced. MicroRNAs (miRNAs), small non-coding RNAs that are involved in post-transcriptional modulation, have critical functions in various biological processes. The aim of this study was to profile differential expression of miRNAs and to examine changes in their target genes 2 weeks after Muller cell ablation. We identified 20 miRNAs using the miScript HC PCR array. Data analysis using two target gene prediction databases (TargetScan and mirTarBase) revealed 78 overlapping target genes. DAVID and KEGG pathway analysis suggested that the target genes were generally involved in cell apoptosis, p53, neurotrophin, calcium, chemokine and Jak-STAT signalling pathways. Changes in seven target genes including Cyclin D2, Caspase 9, insulin-like growth factor 1, IL-1 receptor-associated kinase (IRAK), calmodulin (CALM) and Janus kinase 2 (Jak2), were validated with qRT-PCR and western blots. The cellular localisation of cleaved-caspase 9, Cyclin D2, Jak2 and CALM was examined by immunofluorescence studies. We found that the transcription of some miRNAs was positively, rather than negatively, correlated with their target genes. After confirming that overexpressed miR-133a-3p was localised to the outer nuclear layer in the damaged retina, we validated the correlation between miR-133a-3p and one of its predicted target genes, cyclin D2, with a luciferase assay in 661 photoreceptor cells. Results revealed by miRNA profiling, target gene analysis and validation were generally consistent with our previous findings that selective Muller cell ablation causes photoreceptor degeneration and neuroinflammation. Our data on alterations of miRNAs and their target gene expression after Muller cell ablation provide further insights into the potential role of Muller cell dysfunction in retinal disease.	[Chung, Sook Hyun; Gillies, Mark; Zhu, Ling; Lee, So-Ra; Shen, Weiyong] Univ Sydney, Save Sight Inst, Macular Res Grp, Clin Ophthalmol & Eye Hlth, Sydney, NSW 2006, Australia; [Sugiyama, Yuki] Univ Sydney, Save Sight Inst, Lens Res Grp, Clin Ophthalmol & Eye Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Chung, SH (corresponding author), Univ Sydney, Save Sight Inst, Macular Res Grp, Clin Ophthalmol & Eye Hlth, Sydney, NSW 2006, Australia.	sook.chung@sydney.edu.au	Sugiyama, Yuki/B-2656-2018	Sugiyama, Yuki/0000-0001-7830-0677	Lowy Medical Research Institute; National Health and Medical Research Council (NHMRC, Australia) [APP1028393]; Ophthalmic Research Institute of Australia; NHMRC	Lowy Medical Research Institute; National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from Lowy Medical Research Institute, National Health and Medical Research Council (NHMRC, Australia; APP1028393) and Ophthalmic Research Institute of Australia. Mark Gillies is a fellow of Sydney Medical School Foundation and supported by a NHMRC Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai M, 2007, ANTICANCER RES, V27, P2345; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chung SH, 2013, INVEST OPHTH VIS SCI, V54, P6578, DOI 10.1167/iovs.13-12311; Cossetti C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00117; DELORENZO RJ, 1982, FED PROC, V41, P2265; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Fabian MR, 2010, PROG MOL SUBCELL BIO, V50, P1, DOI 10.1007/978-3-642-03103-8_1; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan W, 2006, BRAIN RES, V1067, P48, DOI 10.1016/j.brainres.2005.10.030; Fan W, 2005, MOL BRAIN RES, V139, P306, DOI 10.1016/j.molbrainres.2005.06.008; Fan W, 2009, INVEST OPHTH VIS SCI, V50, P917, DOI 10.1167/iovs.08-2555; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; Goodall EF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00178; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P611, DOI 10.1167/iovs.10-6115; Jablonski MM, 2000, GLIA, V32, P192, DOI 10.1002/1098-1136(200011)32:2<192::AID-GLIA80>3.0.CO;2-6; Jang S, 2007, NEUROCHEM RES, V32, P1, DOI 10.1007/s11064-006-9215-7; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Ksiazek-Winiarek DJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/172351; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Lee S, 2013, ADV EXP MED BIOL, V768, P97, DOI 10.1007/978-1-4614-5107-5_7; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Mamidipudi V, 2002, J BIOL CHEM, V277, P28010, DOI 10.1074/jbc.M109730200; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Omran A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291826; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Powner MB, 2010, OPHTHALMOLOGY, V117, P2407, DOI 10.1016/j.ophtha.2010.04.001; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Shen WY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-137; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Silva VAO, 2011, MOL VIS, V17, P2228; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sundermeier TR, 2012, CELL MOL LIFE SCI, V69, P2739, DOI 10.1007/s00018-012-0976-7; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Ui-Tei K, 2000, APOPTOSIS, V5, P133, DOI 10.1023/A:1009676528805; Urbach A, 2013, BEHAV NEUROSCI, V127, P1, DOI 10.1037/a0031222; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Yu W, 2002, LAB INVEST, V82, P1229	60	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118949	10.1371/journal.pone.0118949	http://dx.doi.org/10.1371/journal.pone.0118949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741709	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100066
J	Loureiro, CL; Aguilar, JC; Aguiar, J; Muzio, V; Penton, E; Garcia, D; Guillen, G; Pujol, FH				Loureiro, Carmen L.; Aguilar, Julio C.; Aguiar, Jorge; Muzio, Verena; Penton, Eduardo; Garcia, Daymir; Guillen, Gerardo; Pujol, Flor H.			HBV Genotypic Variability in Cuba	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENETIC DIVERSITY; MOLECULAR CHARACTERIZATION; HEPATOCELLULAR-CARCINOMA; LATIN-AMERICA; BLOOD-DONORS; SUBGENOTYPES; INFECTION; EPIDEMIOLOGY; VENEZUELA	The genetic diversity of HBV in human population is often a reflection of its genetic admixture. The aim of this study was to explore the genotypic diversity of HBV in Cuba. The S genomic region of Cuban HBV isolates was sequenced and for selected isolates the complete genome or precore-core sequence was analyzed. The most frequent genotype was A (167/250, 67%), mainly A2 (149, 60%) but also A1 and one A4. A total of 77 isolates were classified as genotype D (31%), with co-circulation of several subgenotypes (56 D4, 2 D1, 5 D2, 7 D3/6 and 7 D7). Three isolates belonged to genotype E, two to H and one to B3. Complete genome sequence analysis of selected isolates confirmed the phylogenetic analysis performed with the S region. Mutations or polymorphisms in precore region were more common among genotype D compared to genotype A isolates. The HBV genotypic distribution in this Caribbean island correlates with the Y lineage genetic background of the population, where a European and African origin prevails. HBV genotypes E, B3 and H isolates might represent more recent introductions.	[Loureiro, Carmen L.; Pujol, Flor H.] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Ceular, Mol Virol Lab, Caracas, Venezuela; [Aguilar, Julio C.; Aguiar, Jorge; Muzio, Verena; Penton, Eduardo; Garcia, Daymir; Guillen, Gerardo] Ctr Ingn Genet & Biotecnol, Havana, Cuba	Venezuelan Institute Science Research; Centro de Ingenieria Genetica y Biotecnologia	Pujol, FH (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Ceular, Mol Virol Lab, Caracas, Venezuela.	fhpujol@gmail.com	Guillen, Gerardo/ABB-2586-2020; Aguilar, Julio Cesar/AAA-6403-2022; Pujol, Flor H/E-5687-2010	Pujol, Flor H/0000-0001-6086-6883; Loureiro Marino, Carmen Luisa/0000-0003-3665-1107	Proyecto de Cooperacion Cientifica Cuba-Venezuela PEI from Venezuela [20122000768]	Proyecto de Cooperacion Cientifica Cuba-Venezuela PEI from Venezuela	Proyecto de Cooperacion Cientifica Cuba-Venezuela PEI 20122000768 from Venezuela provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre R, 2007, MOL IMMUNOL, V44, P2426, DOI 10.1016/j.molimm.2006.10.017; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Araujo NM, 2008, HEPATOL RES, V38, P1194, DOI 10.1111/j.1872-034X.2008.00392.x; Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Blitz L, 1998, J CLIN MICROBIOL, V36, P648, DOI 10.1128/JCM.36.3.648-651.1998; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; de Guerra DC, 2011, HUM BIOL, V83, P345, DOI 10.3378/027.083.0302; Cento V, 2013, J INFECTION, V67, P303, DOI 10.1016/j.jinf.2013.05.008; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004; Echevarria JM, 2005, J MED VIROL, V76, P176, DOI 10.1002/jmv.20341; Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007; George E, 2006, CASS MIL STUD, P1; Ghany MG, 2015, CLIN GASTROENTEROL H, V13, P183, DOI 10.1016/j.cgh.2014.06.028; Gopalakrishnan D, 2013, WORLD J GASTROENTERO, V19, P9294, DOI 10.3748/wjg.v19.i48.9294; Gutierrez C, 2004, J MED VIROL, V73, P200, DOI 10.1002/jmv.20076; Huy TTT, 2006, ARCH VIROL, V151, P589, DOI 10.1007/s00705-005-0671-1; Jaspe RC, 2014, J MED MICROBIOL, V63, P1099, DOI 10.1099/jmm.0.067496-0; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105317; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092223; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lindh M, 2005, J CLIN VIROL, V34, P315, DOI 10.1016/j.jcv.2005.10.002; Lu XY, 1996, J VIROL, V70, P2277, DOI 10.1128/JVI.70.4.2277-2285.1996; MANGOLD CMT, 1993, J VIROL, V67, P4588, DOI 10.1128/JVI.67.8.4588-4597.1993; Meldal BHM, 2009, J GEN VIROL, V90, P1622, DOI 10.1099/vir.0.009738-0; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Pujol FH, 2005, J CLIN GASTROENTEROL, V39, P611, DOI 10.1097/01.mcg.0000170770.49394.92; Quintero A, 2002, ARCH VIROL, V147, P1829, DOI 10.1007/s00705-002-0842-2; Rodriguez-Frias F, 2006, J VIRAL HEPATITIS, V13, P343, DOI 10.1111/j.1365-2893.2005.00691.x; Sanchez LV, 2002, J MED VIROL, V68, P24, DOI 10.1002/jmv.10166; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Tanaka J, 2000, VACCINE, V18, pS17, DOI 10.1016/S0264-410X(99)00455-7; Telenta PFS, 1997, J CLIN MICROBIOL, V35, P1873, DOI 10.1128/JCM.35.7.1873-1875.1997; Valdivia Irina, 2005, Vaccimonitor, V14, P7; Valente F, 2010, MEM I OSWALDO CRUZ, V105, P970, DOI 10.1590/S0074-02762010000800004; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x	48	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118959	10.1371/journal.pone.0118959	http://dx.doi.org/10.1371/journal.pone.0118959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742179	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100068
J	Wang, Y; Cui, YZ; Zhou, XY; Han, JX				Wang, Yao; Cui, Yazhou; Zhou, Xiaoyan; Han, Jinxiang			Development of a High-Throughput Resequencing Array for the Detection of Pathogenic Mutations in Osteogenesis Imperfecta	PLOS ONE			English	Article							GENES	Objective Osteogenesis imperfecta (OI) is a rare inherited skeletal disease, characterized by bone fragility and low bone density. The mutations in this disorder have been widely reported to be on various exonal hotspots of the candidate genes, including COL1A1, COL1A2, CRTAP, LEPRE1, and FKBP10, thus creating a great demand for precise genetic tests. However, large genome sizes make the process daunting and the analyses, inefficient and expensive. Therefore, we aimed at developing a fast, accurate, efficient, and cheaper sequencing platform for OI diagnosis; and to this end, use of an advanced array-based technique was proposed. Method A CustomSeq Affymetrix Resequencing Array was established for high-throughput sequencing of five genes simultaneously. Genomic DNA extraction from 13 OI patients and 85 normal controls and amplification using long-range PCR (LR-PCR) were followed by DNA fragmentation and chip hybridization, according to standard Affymetrix protocols. Hybridization signals were determined using GeneChip Sequence Analysis Software (GSEQ). To examine the feasibility, the outcome from new resequencing approach was validated by conventional capillary sequencing method. Result Overall call rates using resequencing array was 96-98% and the agreement between microarray and capillary sequencing was 99.99%. 11 out of 13 OI patients with pathogenic mutations were successfully detected by the chip analysis without adjustment, and one mutation could also be identified using manual visual inspection. Conclusion A high-throughput resequencing array was developed that detects the disease-associated mutations in OI, providing a potential tool to facilitate large-scale genetic screening for OI patients. Through this method, a novel mutation was also found.	[Wang, Yao; Cui, Yazhou; Zhou, Xiaoyan; Han, Jinxiang] Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Key Lab Biotech Drugs, Minist Hlth, Jinan, Shandong, Peoples R China; [Wang, Yao] Shandong Acad Med Sci, Shandong Inst Endocrine & Metab Dis, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Han, JX (corresponding author), Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Key Lab Biotech Drugs, Minist Hlth, Jinan, Shandong, Peoples R China.	samshjx@sina.com		Cui, Yazhou/0000-0002-4732-6791	Key Projects in the National Science & Technology Support Program during the Twelve Five-Year Plan Period from Ministry of Science and Technology of the People's Republic of China	Key Projects in the National Science & Technology Support Program during the Twelve Five-Year Plan Period from Ministry of Science and Technology of the People's Republic of China	This study was supported by the Key Projects in the National Science & Technology Support Program during the Twelve Five-Year Plan Period from Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booij JC, 2011, OPHTHALMOLOGY, V118, P160, DOI 10.1016/j.ophtha.2010.04.022; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chiou KR, 2011, ATHEROSCLEROSIS, V216, P383, DOI 10.1016/j.atherosclerosis.2011.02.006; Choi SJ, 2011, BIOCHEM BIOPH RES CO, V407, P23, DOI 10.1016/j.bbrc.2011.02.078; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Fokstuen S, 2008, HUM MUTAT, V29, P879, DOI 10.1002/humu.20749; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Jensen LR, 2011, EUR J HUM GENET, V19, P717, DOI 10.1038/ejhg.2010.244; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Kataoka K, 2007, PEDIATR INT, V49, P564, DOI 10.1111/j.1442-200X.2007.02422.x; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Liu W, 2007, MOL VIS, V13, P360; McKnight AJ, 2006, J HUM GENET, V51, P383, DOI 10.1007/s10038-006-0368-7; Moul A, 2013, FETAL PEDIAT PATHOLO; Ogawa N, 2011, AM J CARDIOL, V108, P1801, DOI 10.1016/j.amjcard.2011.07.053; Ozcelik H, 2012, J MOL DIAGN, V14, P467, DOI 10.1016/j.jmoldx.2012.03.006; Pandya GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm918; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Shapiro JR, 2012, J MUSCULOSKEL NEURON, V12, P24; Szoke D, 2009, INT J MOL MED, V23, P217, DOI 10.3892/ijmm_00000120; Teekakirikul P, 2011, CURRENT SEQUENCING U, V7, P7, DOI DOI 10.1002/0471142905.hg0718s69; Ueno T, 2012, CANCER SCI, V103, P131, DOI 10.1111/j.1349-7006.2011.02105.x; Vaish AK, 2012, BMJ CASE REPORTS, V2012; Wilkins EJ, 2012, PARKINSONISM RELAT D, V18, P386, DOI 10.1016/j.parkreldis.2011.12.012; Zhang ZL, 2012, J BONE MINER METAB, V30, P69, DOI 10.1007/s00774-011-0284-6	29	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119553	10.1371/journal.pone.0119553	http://dx.doi.org/10.1371/journal.pone.0119553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742658	Green Submitted, gold, Green Published			2022-12-26	WOS:000350688100121
J	Clausen, MR; Zhang, XM; Yde, CC; Ditlev, DB; Lillefosse, HH; Madsen, L; Kristiansen, K; Liaset, B; Bertram, HC				Clausen, Morten Rahr; Zhang, Xumin; Yde, Christian C.; Ditlev, Ditte B.; Lillefosse, Haldis H.; Madsen, Lise; Kristiansen, Karsten; Liaset, Bjorn; Bertram, Hanne C.			Intake of Hydrolyzed Casein is Associated with Reduced Body Fat Accretion and Enhanced Phase II Metabolism in Obesity Prone C57BL/6J Mice	PLOS ONE			English	Article							LOW-CARBOHYDRATE DIET; HIGH-PROTEIN; MILK PROTEIN; HEPATIC LIPOGENESIS; RANDOMIZED-TRIAL; ADIPOSE-TISSUE; ENERGY-INTAKE; AMINO-ACIDS; MASS; GLUTATHIONE	The amount and form of dietary casein have been shown to affect energy metabolism and lipid accumulation in mice, but the underlying mechanisms are not fully understood. We investigated 48 hrs urinary metabolome, hepatic lipid composition and gene expression in male C57BL/6J mice fed Western diets with 16 or 32 energy% protein in the form of extensively hydrolyzed or intact casein. LC-MS based metabolomics revealed a very strong impact of casein form on the urinary metabolome. Evaluation of the discriminatory metabolites using tandem mass spectrometry indicated that intake of extensively hydrolyzed casein modulated Phase II metabolism associated with an elevated urinary excretion of glucuronic acid-and sulphate conjugated molecules, whereas glycine conjugated molecules were more abundant in urine from mice fed the intact casein diets. Despite the differences in the urinary metabolome, we observed no differences in hepatic expression of genes involved in Phase II metabolism, but it was observed that expression of Abcc3 encoding ATP binding cassette c3 (transporter of glucuronic acid conjugates) was increased in livers of mice fed hydrolyzed casein. As glucuronic acid is derived from glucose and sulphate is derived from cysteine, our metabolomic data provided evidence for changes in carbohydrate and amino acid metabolism and we propose that this modulation of metabolism was associated with the reduced glucose and lipid levels observed in mice fed the extensively hydrolyzed casein diets.	[Clausen, Morten Rahr; Zhang, Xumin; Yde, Christian C.; Ditlev, Ditte B.; Bertram, Hanne C.] Aarhus Univ, Dept Food Sci, Aarslev, Denmark; [Zhang, Xumin] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Lillefosse, Haldis H.; Madsen, Lise; Liaset, Bjorn] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Lillefosse, Haldis H.; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Aarhus University; Fudan University; University of Copenhagen	Clausen, MR (corresponding author), Aarhus Univ, Dept Food Sci, Aarslev, Denmark.	mortenr.clausen@food.au.dk	Kristiansen, Karsten/J-5148-2014; Bertram, Hanne Christine/I-8439-2019; Madsen, Lise/C-6246-2012	Kristiansen, Karsten/0000-0002-6024-0917; Bertram, Hanne Christine/0000-0002-1882-5321; Madsen, Lise/0000-0003-4468-1947; Liaset, Bjorn/0000-0002-8652-7801	Danish Strategic Research Council (FOSU); Danish Research Council FTP	Danish Strategic Research Council (FOSU); Danish Research Council FTP(Det Frie Forskningsrad (DFF))	The Danish Strategic Research Council (FOSU) is thanked for financial support through the project 'Health-promoting effects of milk-derived components' (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-strategiske-forskningsrad), and the Danish Research Council FTP for financial support through the project 'Advances in food quality and nutrition research through implementation of metabolomics technologies' (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2011, AM J CLIN NUTR, V93, P525, DOI 10.3945/ajcn.110.005850; Aoyama T, 2000, NUTRITION, V16, P349, DOI 10.1016/S0899-9007(00)00230-6; Baer DJ, 2011, J NUTR, V141, P1489, DOI 10.3945/jn.111.139840; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Beyoglu D, 2012, BIOCHEM PHARMACOL, V83, P1331, DOI 10.1016/j.bcp.2011.12.031; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Broccali G, 2005, PANMINERVA MED, V47, P123; BUTLER LE, 1988, TOXICOL APPL PHARM, V95, P301, DOI 10.1016/0041-008X(88)90166-4; Calbet JAL, 2004, EUR J NUTR, V43, P127, DOI 10.1007/s00394-004-0448-4; Dooley TP, 2000, BIOCHEM BIOPH RES CO, V277, P236, DOI 10.1006/bbrc.2000.3643; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005; Hamre K, 2001, AQUACULT NUTR, V7, P123, DOI 10.1046/j.1365-2095.2001.00162.x; Hao Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1097, DOI 10.1152/ajpendo.00524.2011; ITOH H, 1973, J NUTR, V103, P1709, DOI 10.1093/jn/103.12.1709; Johnston CS, 2002, J AM COLL NUTR, V21, P55, DOI 10.1080/07315724.2002.10719194; Kay HY, 2011, ANTIOXID REDOX SIGN, V15, P2135, DOI 10.1089/ars.2010.3834; Kim KM, 2004, PHYTOTHER RES, V18, P950, DOI 10.1002/ptr.1582; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Kristensen M, 2012, METABOLOMICS, V8, P64, DOI 10.1007/s11306-011-0282-7; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lacroix M, 2006, AM J CLIN NUTR, V84, P1070, DOI 10.1093/ajcn/84.5.1070; Layman DK, 2003, J NUTR, V133, P405, DOI 10.1093/jn/133.2.405; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lillefosse HH, 2014, J PROTEOME RES, V13, P2560, DOI 10.1021/pr500039t; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Ma T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021647; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Pichon L, 2006, J NUTR, V136, P1256, DOI 10.1093/jn/136.5.1256; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; RERAT AA, 1993, P NUTR SOC, V52, P335, DOI 10.1079/PNS19930069; Roux A, 2012, ANAL CHEM, V84, P6429, DOI 10.1021/ac300829f; SCHMEDES A, 1989, J AM OIL CHEM SOC, V66, P813, DOI 10.1007/BF02653674; Shelby MK, 2003, DRUG METAB DISPOS, V31, P326, DOI 10.1124/dmd.31.3.326; Shi J, 2011, INT DAIRY J, V21, P513, DOI 10.1016/j.idairyj.2011.03.006; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Stanstrup J, 2013, METABOLOMICS; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Takahira M, 2011, CIRC J, V75, P2235, DOI 10.1253/circj.CJ-10-1013; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; Tranberg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071439; Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005; Wen H, 2013, MOL CELL PROTEOMICS, V12, P575, DOI 10.1074/mcp.M112.021352; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Woodall GM, 1996, MUTAT RES-ENVIR MUTA, V360, P127, DOI 10.1016/0165-1161(96)00006-4; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yde CC, 2014, METABOLOMICS; Yde CC, 2012, BRIT J NUTR, V107, P1603, DOI 10.1017/S0007114511004909; Yin YL, 2004, ANIM SCI, V79, P283, DOI 10.1017/S1357729800090147; Zamek-Gliszczynski MJ, 2006, EUR J PHARM SCI, V27, P447, DOI 10.1016/j.ejps.2005.12.007; Zhang XM, 2012, ANAL CHEM, V84, P7785, DOI 10.1021/ac3013835	64	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118895	10.1371/journal.pone.0118895	http://dx.doi.org/10.1371/journal.pone.0118895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738501	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900083
J	Mas-Marti, E; Romani, AM; Munoz, I				Mas-Marti, Esther; Romani, Anna M.; Munoz, Isabel			Consequences of Warming and Resource Quality on the Stoichiometry and Nutrient Cycling of a Stream Shredder	PLOS ONE			English	Article							PARTICULATE ORGANIC-MATTER; LEAF-LITTER DECOMPOSITION; ECOLOGICAL STOICHIOMETRY; WATER TEMPERATURE; FEEDING ECOLOGY; GAMMARUS-PULEX; GROWTH-RATE; CONSTRAINTS; FOOD; FLOW	As a result of climate change, streams are warming and their runoff has been decreasing in most temperate areas. These changes can affect consumers directly by increasing their metabolic rates and modifying their physiology and indirectly by changing the quality of the resources on which organisms depend. In this study, a common stream detritivore (Echinogammarus berilloni Catta) was reared at two temperatures (15 and 20 degrees C) and fed Populus nigra L. leaves that had been conditioned either in an intermittent or permanent reach to evaluate the effects of resource quality and increased temperatures on detritivore performance, stoichiometry and nutrient cycling. The lower quality (i.e., lower protein, soluble carbohydrates and higher C: P and N:P ratios) of leaves conditioned in pools resulted in compensatory feeding and lower nutrient retention capacity by E. berilloni. This effect was especially marked for phosphorus, which was unexpected based on predictions of ecological stoichiometry. When individuals were fed pool-conditioned leaves at warmer temperatures, their growth rates were higher, but consumers exhibited less efficient assimilation and higher mortality. Furthermore, the shifts to lower C: P ratios and higher lipid concentrations in shredder body tissues suggest that structural molecules such as phospholipids are preserved over other energetic C-rich macromolecules such as carbohydrates. These effects on consumer physiology and metabolism were further translated into feces and excreta nutrient ratios. Overall, our results show that the effects of reduced leaf quality on detritivore nutrient retention were more severe at higher temperatures because the shredders were not able to offset their increased metabolism with increased consumption or more efficient digestion when fed pool-conditioned leaves. Consequently, the synergistic effects of impaired food quality and increased temperatures might not only affect the physiology and survival of detritivores but also extend to other trophic compartments through detritivore-mediated nutrient cycling.	[Mas-Marti, Esther; Munoz, Isabel] Univ Barcelona, Fac Biol, Dept Ecol, E-08028 Barcelona, Catalonia, Spain; [Romani, Anna M.] Univ Girona, Inst Aquat Ecol, Girona 17071, Catalonia, Spain	University of Barcelona; Universitat de Girona	Mas-Marti, E (corresponding author), Univ Barcelona, Fac Biol, Dept Ecol, Diagonal 643, E-08028 Barcelona, Catalonia, Spain.	emasmarti@ub.edu	Romaní, Anna M/L-7572-2014; Muñoz, Isabel/L-9414-2014	Romaní, Anna M/0000-0001-5183-8231; Muñoz, Isabel/0000-0001-8110-9435	Spanish Ministry of Economy and Competitiveness (Scarce) [Consolider-Ingenio CSD2009-00065]; Spanish Ministry of Economy and Competitiveness (CARBONET) [CGL2011-30474-C02-02]; EC 7th Framework Programme [603629-ENV-2013-6.2.1-Globaqua]; Government of Catalonia	Spanish Ministry of Economy and Competitiveness (Scarce); Spanish Ministry of Economy and Competitiveness (CARBONET); EC 7th Framework Programme; Government of Catalonia(Generalitat de Catalunya)	This project was funded by the Spanish Ministry of Economy and Competitiveness (Scarce, Consolider-Ingenio CSD2009-00065 and CARBONET, CGL2011-30474-C02-02) and the EC 7th Framework Programme (grant agreement 603629-ENV-2013-6.2.1-Globaqua). EMM held a doctoral fellowship (FI) from the Government of Catalonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna V, 2010, GLOBAL CHANGE BIOL, V16, P2638, DOI 10.1111/j.1365-2486.2010.02170.x; Acuna V, 2007, J N AM BENTHOL SOC, V26, P54, DOI 10.1899/0887-3593(2007)26[54:MARIOO]2.0.CO;2; AGNEW DJ, 1986, J EXP MAR BIOL ECOL, V103, P203, DOI 10.1016/0022-0981(86)90141-3; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; APHA AWWA WPCF, 1989, STAND METH DET WAT W, P1134; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, P5, DOI 10.1016/S0959-3780(98)00015-6; Assmann C, 2011, FRESHWATER BIOL, V56, P839, DOI 10.1111/j.1365-2427.2010.02530.x; Baerlocher MO, 2004, CAN J BOT, V82, P365, DOI [10.1139/B04-008, 10.1139/b04-008]; Baldy V, 1997, CR ACAD SCI III-VIE, V320, P747, DOI 10.1016/S0764-4469(97)84824-X; Barlocher Felix, 2005, P97, DOI 10.1007/1-4020-3466-0_14; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOULTON AJ, 1992, HYDROBIOLOGIA, V241, P107, DOI 10.1007/BF00008263; Bowman MF, 2005, FRESHWATER BIOL, V50, P1836, DOI 10.1111/j.1365-2427.2005.01454.x; BRATBAK G, 1984, APPL ENVIRON MICROB, V48, P755, DOI 10.1128/AEM.48.4.755-757.1984; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chergui H, 1997, ACTA OECOL, V18, P531, DOI 10.1016/S1146-609X(97)80039-2; CHERGUI H, 1990, ARCH HYDROBIOL, V120, P1; Connolly NM, 2013, HYDROBIOLOGIA, V718, P85, DOI 10.1007/s10750-013-1605-7; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Cross WF, 2007, ECOLOGY, V88, P2563, DOI 10.1890/06-1348.1; CUMMINS KW, 1979, ANNU REV ECOL SYST, V10, P147, DOI 10.1146/annurev.es.10.110179.001051; Danger M, 2013, FUNCT ECOL, V27, P807, DOI 10.1111/1365-2435.12079; Dewson ZS, 2007, J N AM BENTHOL SOC, V26, P401, DOI 10.1899/06-110.1; Villanueva VD, 2011, HYDROBIOLOGIA, V678, P155, DOI 10.1007/s10750-011-0837-7; Dieter D, 2011, AQUAT SCI, V73, P599, DOI 10.1007/s00027-011-0231-6; Dieter D, 2013, FRESHWATER BIOL, V58, P1918, DOI 10.1111/fwb.12180; Doi H, 2010, OIKOS, V119, P752, DOI 10.1111/j.1600-0706.2009.18540.x; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Evans-White MA, 2005, FRESHWATER BIOL, V50, P1853, DOI 10.1111/j.1365-2427.2005.01452.x; Feio MJ, 2000, HYDROBIOLOGIA, V439, P7, DOI 10.1023/A:1004189316952; Ferreira V, 2011, OECOLOGIA, V167, P279, DOI 10.1007/s00442-011-1976-2; Ferreira V, 2010, GLOBAL CHANGE BIOL, V16, P3284, DOI 10.1111/j.1365-2486.2009.02153.x; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Flores L, 2014, FRESHW SCI, V33, P134, DOI 10.1086/674578; Friberg N, 1999, FRESHWATER BIOL, V42, P625, DOI 10.1046/j.1365-2427.1999.00501.x; Friberg N, 2009, FRESHWATER BIOL, V54, P2051, DOI 10.1111/j.1365-2427.2009.02234.x; Frost PC, 2005, ARCH HYDROBIOL, V163, P463, DOI 10.1127/0003-9136/2005/0163-0463; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Garcia L, 2012, HYDROBIOLOGIA, V696, P123, DOI 10.1007/s10750-012-1188-8; Garcia-Berthou E, 1993, CAN J FISH AQUAT SCI, V50, P1394, DOI 10.1139/f93-159; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Geider RJ, 1996, LIMNOL OCEANOGR, V41, P1; GESSNER MO, 1993, APPL ENVIRON MICROB, V59, P502, DOI 10.1128/AEM.59.2.502-507.1993; Gessner MO, 1996, APPL ENVIRON MICROB, V62, P415, DOI 10.1128/AEM.62.2.415-419.1996; Gonzalez AL, 2014, FRESHWATER BIOL, V59, P737, DOI 10.1111/fwb.12300; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Hansen HP, 1983, METHODS SEAWATER ANA, P419; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Hartmann D., 2013, CLIMATE CHANGE 2013; Headley JV, 2002, J CHROMATOGR A, V958, P149, DOI 10.1016/S0021-9673(02)00326-6; Hervant F, 1999, J EXP BIOL, V202, P3587; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; Hirabayashi Y, 2008, HYDROLOG SCI J, V53, P754, DOI 10.1623/hysj.53.4.754; Hogg ID, 1996, ECOLOGY, V77, P395, DOI 10.2307/2265617; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kendrick MR, 2013, FRESHWATER BIOL, V58, P1820, DOI 10.1111/fwb.12170; KING JM, 1987, HYDROBIOLOGIA, V154, P165, DOI 10.1007/BF00026838; Koop JHE, 2011, AQUAT ECOL, V45, P547, DOI 10.1007/s10452-011-9375-7; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Larranaga A., 2008, THESIS U BASQUE COUN, P177; Mansfield Shawn D., 2005, P85, DOI 10.1007/1-4020-3466-0_12; Mayer Gerd, 2012, International Journal of Zoology, V2012, P1; Persson J, 2011, OECOLOGIA, V165, P123, DOI 10.1007/s00442-010-1756-4; Pozo J, 1997, J N AM BENTHOL SOC, V16, P602, DOI 10.2307/1468147; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P537, DOI DOI 10.1017/CBO9780511806384; Romani AM, 2013, HYDROBIOLOGIA, V719, P43, DOI 10.1007/s10750-012-1302-y; ROSSI L, 1978, OIKOS, V30, P109, DOI 10.2307/3543530; Sanpera-Calbet I., 2014, THESIS U BARCELONA, P169; Schlief J, 2007, INT REV HYDROBIOL, V92, P146, DOI 10.1002/iroh.200510950; Sterner RW, 2002, ECOLOGICAL STOICHIOM, P432; Suzuki-Ohno Y, 2012, OIKOS, V121, P569, DOI 10.1111/j.1600-0706.2011.19320.x; Theil-Nielsen J, 1998, ARCH HYDROBIOL, V141, P195; Timoner X, 2012, FRESHWATER BIOL, V57, P1565, DOI 10.1111/j.1365-2427.2012.02818.x; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; von Schiller D, 2011, AQUAT SCI, V73, P485, DOI 10.1007/s00027-011-0195-6; von Schiller D, 2008, ECOSYSTEMS, V11, P670, DOI 10.1007/s10021-008-9150-3; Vos JH, 2004, ARCH HYDROBIOL, V161, P469, DOI 10.1127/0003-9136/2004/0161-0469; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; WELTON JS, 1983, OIKOS, V41, P133, DOI 10.2307/3544355; WELTON JS, 1980, J ANIM ECOL, V49, P581, DOI 10.2307/4265; Ylla I, 2011, AQUAT SCI, V73, P523, DOI 10.1007/s00027-011-0211-x; Ylla I, 2010, HYDROBIOLOGIA, V657, P217, DOI 10.1007/s10750-010-0193-z; ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455	86	27	27	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118520	10.1371/journal.pone.0118520	http://dx.doi.org/10.1371/journal.pone.0118520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738818	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900042
J	Nowak-Machen, M; Hilberath, JN; Rosenberger, P; Schmid, E; Memtsoudis, SG; Angermair, J; Tuli, JK; Shernan, SK				Nowak-Machen, Martina; Hilberath, Jan N.; Rosenberger, Peter; Schmid, Eckhard; Memtsoudis, Stavros G.; Angermair, Johannes; Tuli, Jayshree K.; Shernan, Stanton K.			Influence of Intraaortic Balloon Pump Counterpulsation on Transesophageal Echocardiography Derived Determinants of Diastolic Function	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; BYPASS GRAFT-SURGERY; HEART-FAILURE; DOPPLER-ECHOCARDIOGRAPHY; FLOW PROPAGATION; CONSCIOUS DOGS; DYSFUNCTION; RECOMMENDATIONS; STIFFNESS; VELOCITY	Introduction Intraaortic balloon pump counterpulsation (IABP) is often used in patients with acute coronary syndrome for its favourable effects on left ventricular (LV) systolic function and coronary perfusion. However, the effects of IABP on LV diastolic function have not been comprehensively investigated. Acute diastolic dysfunction has been linked to increased morbidity and mortality. The aim of this study was to examine the influence of IABP on LV diastolic dysfunction using standard TEE derived parameters. Methods Intraoperative TEE was performed in 10 patients (mean age 65 +/- 11 yrs) undergoing urgent coronary artery bypass graft surgery (CABG), who had received an IABP preoperatively. TEE derived measures of diastolic dysfunction included early to late transmitral Doppler inflow velocity ratio (E/A), deceleration time (Dt), pulmonary venous systolic to diastolic Doppler velocity ratio (S/D), transmitral propagation velocity (Vp), and the ratio of early to late mitral annular tissue Doppler velocities (e'/a'). Statistical analyses included the Wilcoxon Sign-Rank test, and a p<0.05 was considered significant. Results Transmitral inflow E/A ratios increased significantly from 0.86 to 1.07 (p<0.05), while Dt decreased significantly from 218 to 180 ms (p<0.05) with the use of IABP. Significant increases in Vp (34 cm/s to 43 cm/s; p<0.05), and e'/a' (0.58 to 0.71; p<0.05) suggested a favourable influence of intraaortic counterpulsation on diastolic function. Conclusion The use of perioperative IABP significantly improves TEE derived parameters of diastolic function consistent with a favourable impact on LV relaxation in cardiac surgery patients undergoing CABG.	[Nowak-Machen, Martina; Hilberath, Jan N.; Rosenberger, Peter; Schmid, Eckhard; Angermair, Johannes] Univ Klinikum Tubingen, Klin Anaesthesiol & Intensivmed, Tubingen, Germany; [Hilberath, Jan N.; Shernan, Stanton K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Memtsoudis, Stavros G.] Hosp Special Surg, Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10021 USA; [Tuli, Jayshree K.] Univ Toronto, Dept Stat, Toronto, ON, Canada	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; University of Toronto	Nowak-Machen, M (corresponding author), Univ Klinikum Tubingen, Klin Anaesthesiol & Intensivmed, Tubingen, Germany.	martina.nowak-machen@med.uni-tuebingen.de		Hilberath, Jan N./0000-0002-0799-2941				Apostolakis EE, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-67; Bernard F, 2001, ANESTH ANALG, V92, P291, DOI 10.1213/00000539-200102000-00002; Cheung AT, 1996, ANESTHESIOLOGY, V84, P545, DOI 10.1097/00000542-199603000-00009; Djaiani GN, 2002, ANESTH ANALG, V95, P524, DOI 10.1097/00000539-200209000-00004; Ekery DL, 2003, AM HEART J, V145, P896, DOI 10.1016/S0002-8703(02)94786-1; Gill RM, 2006, AM J PHYSIOL-HEART C, V291, pH3154, DOI 10.1152/ajpheart.00052.2006; Groban L, 2005, CHEST, V128, P3652, DOI 10.1378/chest.128.5.3652; Grossman W, 2000, CIRCULATION, V101, P2020, DOI 10.1161/01.CIR.101.17.2020; Hilberath JN, 2010, J AM SOC ECHOCARDIOG, V23, P1115, DOI 10.1016/j.echo.2010.08.013; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Khir AW, 2003, EUR J CARDIO-THORAC, V24, P277, DOI 10.1016/S1010-7940(03)00268-9; KOMAMURA K, 1992, J CLIN INVEST, V89, P1825, DOI 10.1172/JCI115787; Lappas D G, 1999, Semin Thorac Cardiovasc Surg, V11, P125; Mathison M, 2000, ANN THORAC SURG, V70, P1355, DOI 10.1016/S0003-4975(00)01590-3; Matyal R, 2011, ANESTH ANALG, V113, P449, DOI 10.1213/ANE.0b013e31822649ac; MCKENNEY PA, 1994, J AM COLL CARDIOL, V24, P1189, DOI 10.1016/0735-1097(94)90097-3; MOULOPOULOS SD, 1962, AM HEART J, V63, P669, DOI 10.1016/0002-8703(62)90012-1; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Oki T, 1999, J AM SOC ECHOCARDIOG, V12, P308, DOI 10.1016/S0894-7317(99)70051-9; Ommen SR, 2000, CIRCULATION, V102, P1788; POWELL WJ, 1970, CIRC RES, V26, P753, DOI 10.1161/01.RES.26.6.753; Shanewise JS, 1999, J AM SOC ECHOCARDIOG, V12, P884, DOI 10.1016/S0894-7317(99)70199-9; SHIMAMOTO H, 1992, AM HEART J, V123, P1229, DOI 10.1016/0002-8703(92)91027-X; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Stone GW, 2003, J AM COLL CARDIOL, V41, P1940, DOI 10.1016/S0735-1097(03)00400-5; STORK T, 1995, CARDIOVASC DRUG THER, V9, P533, DOI 10.1007/BF00877866; Swaminathan M, 2011, ANN THORAC SURG, V91, P1844, DOI 10.1016/j.athoracsur.2011.02.008; Takatsuji H, 1996, J AM COLL CARDIOL, V27, P365, DOI 10.1016/0735-1097(96)81240-X	29	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118788	10.1371/journal.pone.0118788	http://dx.doi.org/10.1371/journal.pone.0118788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739068	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900072
J	Tomita, T; Ieguchi, K; Sawamura, T; Maru, Y				Tomita, Takeshi; Ieguchi, Katsuaki; Sawamura, Tatsuya; Maru, Yoshiro			Human Serum Amyloid A3 (SAA3) Protein, Expressed as a Fusion Protein with SAA2, Binds the Oxidized Low Density Lipoprotein Receptor	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; ENDOTHELIAL-CELLS; UP-REGULATION; HUMAN TRANSCRIPTOME; LUNG METASTASIS; GENE FUSIONS; TNF-ALPHA; LOX-1; ACTIVATION	Serum amyloid A3 (SAA3) possesses characteristics distinct from the other serum amyloid A isoforms, SAA1, SAA2, and SAA4. High density lipoprotein contains the latter three isoforms, but not SAA3. The expression of mouse SAA3 (mSAA3) is known to be up-regulated extrahepatically in inflammatory responses, and acts as an endogenous ligand for the toll-like receptor 4/MD-2 complex. We previously reported that mSAA3 plays an important role in facilitating tumor metastasis by attracting circulating tumor cells and enhancing hyperpermeability in the lungs. On the other hand, human SAA3 (hSAA3) has long been regarded as a pseudogene, which is in contrast to the abundant expression levels of the other isoforms. Although the nucleotide sequence of hSAA3 is very similar to that of the other SAAs, a single oligonucleotide insertion in exon 2 causes a frame-shift to generate a unique amino acid sequence. In the present study, we identified that hSAA3 was transcribed in the hSAA2-SAA3 fusion transcripts of several human cell lines. In the fusion transcript, hSAA2 exon 3 was connected to hSAA3 exon 1 or hSAA3 exon 2, located approximately 130kb downstream from hSAA2 exon 3 in the genome, which suggested that it is produced by alternative splicing. Furthermore, we succeeded in detecting and isolating hSAA3 protein for the first time by an immunoprecipitation-enzyme linked immune assay system using monoclonal and polyclonal antibodies that recognize the hSAA3 unique amino acid sequence. We also demonstrated that hSAA3 bound oxidized low density lipoprotein receptor (oxLDL receptor, LOX-1) and elevated the phosphorylation of ERK, the intracellular MAP-kinase signaling protein.	[Tomita, Takeshi; Ieguchi, Katsuaki; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo, Japan; [Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Dept Vasc Physiol, Suita, Osaka, Japan	Tokyo Women's Medical University; National Cerebral & Cardiovascular Center - Japan	Tomita, T (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Tokyo, Japan.	tomitat@research.twmu.ac.jp; ymaru@research.twmu.ac.jp	Sawamura, Tatsuya/E-7103-2010	Tomita, Takeshi/0000-0001-6815-2244	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21117008, 23590347]; Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan; Policy-Based Medical Service Foundation, Japan; Foundation for Promotion of Cancer Research in Japan; Sato Memorial Foundation for Cancer Research; Grants-in-Aid for Scientific Research [26440063] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan; Policy-Based Medical Service Foundation, Japan; Foundation for Promotion of Cancer Research in Japan; Sato Memorial Foundation for Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; 21117008 (Y.M.) and 23590347 (T.T.); the Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan; Policy-Based Medical Service Foundation, Japan; Foundation for Promotion of Cancer Research in Japan; and Sato Memorial Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2008, ATHEROSCLEROSIS, V198, P272, DOI 10.1016/j.atherosclerosis.2007.12.017; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Brooks YS, 2009, J BIOL CHEM, V284, P18033, DOI 10.1074/jbc.M109.006999; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Fujita Y, 2011, CLIN CHEM, V57, P1398, DOI 10.1373/clinchem.2011.168625; Fujita Y, 2009, CLIN CHEM, V55, P285, DOI 10.1373/clinchem.2008.119750; Gardiner GE, 2009, FEMS IMMUNOL MED MIC, V55, P404, DOI 10.1111/j.1574-695X.2009.00539.x; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Jorgensen JB, 2000, DEV COMP IMMUNOL, V24, P553, DOI 10.1016/S0145-305X(00)00022-7; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Kumon Y, 2001, SCAND J IMMUNOL, V53, P7, DOI 10.1046/j.1365-3083.2001.00829.x; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Larson MA, 2003, BIOCHEM BIOPH RES CO, V300, P531, DOI 10.1016/S0006-291X(02)02901-7; Liang M, 2007, CANCER LETT, V258, P31, DOI 10.1016/j.canlet.2007.08.003; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mattaliano MD, 2009, AM J PHYSIOL-CELL PH, V296, pC1329, DOI 10.1152/ajpcell.00513.2008; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; Smirnova IV, 2004, AM J PHYSIOL-RENAL, V287, pF25, DOI 10.1152/ajprenal.00449.2003; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Tomita T, 2011, ONCOGENE, V30, P3429, DOI 10.1038/onc.2011.53; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118835	10.1371/journal.pone.0118835	http://dx.doi.org/10.1371/journal.pone.0118835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738827	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900078
J	Wang, Y; Han, YP; Zhao, X; Li, YG; Teng, WL; Li, DM; Zhan, Y; Li, WB				Wang, Yan; Han, Yingpeng; Zhao, Xue; Li, Yongguang; Teng, Weili; Li, Dongmei; Zhan, Yong; Li, Wenbin			Mapping Isoflavone QTL with Main, Epistatic and QTL x Environment Effects in Recombinant Inbred Lines of Soybean	PLOS ONE			English	Article							LINKAGE MAP; ACCUMULATION; GENES; TRAITS; HEALTH; OIL	Soybean (Glycine max (L.) Merr.) isoflavone is important for human health and plant defense system. To identify novel quantitative trait loci (QTL) and epistatic QTL underlying isoflavone content in soybean, F-5:6, F-5:7 and F-5:8 populations of 130 recombinant inbred (RI) lines, derived from the cross of soybean cultivar 'Zhong Dou 27' (high isoflavone) and 'Jiu Nong 20' (low isoflavone), were analyzed with 95 new SSR markers. A new linkage map including 194 SSR markers and covering 2,312 cM with mean distance of about 12 cM between markers was constructed. Thirty four QTL for both individual and total seed isoflavone contents of soybean were identified. Six, seven, ten and eleven QTL were associated with daidzein (DZ), glycitein (GC), genistein (GT) and total isoflavone (TI), respectively. Of them 23 QTL were newly identified. The qTIF_1 between Satt423 and Satt569 shared the same marker Satt569 with qDZF_2, qGTF_1 and qTIF_2. The qGTD2_1 between Satt186 and Satt226 was detected in four environments and explained 3.41%-10.98% of the phenotypic variation. The qGTA2_1, overlapped with qGCA2_1 and detected in four environments, was close to the previously identified major QTL for GT, which were responsible for large a effects. QTL (qDZF_2, qGTF_1 and qTIF_2) between Satt144-Satt569 were either clustered or pleiotropic. The qGCM_1, qGTM_1 and qTIM_1 between Satt540-Sat_244 explained 2.02%-9.12% of the phenotypic variation over six environments. Moreover, the qGCE_1 overlapped with qGTE_1 and qTIE_1, the qTIH_2 overlapped with qGTH_1, qGCI_1 overlapped with qDZI_1, qTIL_1 overlapped with qGTL_1, and qTIO_1 overlapped with qGTO_1. In this study, some of unstable QTL were detected in different environments, which were due to weak expression of QTL, QTL by environment interaction in the opposite direction to a effects, and/or epistasis. The markers identified in multi-environments in this study could be applied in the selection of soybean cultivars for higher isoflavone content and in the map-based gene cloning.	[Wang, Yan; Han, Yingpeng; Zhao, Xue; Li, Yongguang; Teng, Weili; Li, Dongmei; Li, Wenbin] Northeast Agr Univ, Chinese Minist Educ, Key Lab Soybean Biol, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Yan; Han, Yingpeng; Zhao, Xue; Li, Yongguang; Teng, Weili; Li, Dongmei; Li, Wenbin] Northeast Agr Univ, Chinese Agr Minist, Key Lab Soybean Biol & Breeding Genet, Harbin, Heilongjiang Pr, Peoples R China; [Zhan, Yong] Agr Sci Acad, Shi He Zi, Xinjiang Provin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Zhan, Y (corresponding author), Agr Sci Acad, Shi He Zi, Xinjiang Provin, Peoples R China.	shzzhy@163.com; wenbinli@neau.edu.cn	Li, Yongguang/ACM-0755-2022	Li, Yongguang/0000-0002-9171-2729	National Key Project [2014BAD22B01]	National Key Project	This study was financially supported by National Key Project (2014BAD22B01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akond M., 2013, Journal of Agricultural Science (Toronto), V5, P20; Benhamou N, 1999, PLANT PHYSIOL BIOCH, V37, P703, DOI 10.1016/S0981-9428(00)86684-X; Bolon YT, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.08.0027; Brouns F, 2002, FOOD RES INT, V35, P187, DOI 10.1016/S0963-9969(01)00182-X; Cederroth CR, 2009, MOL CELL ENDOCRINOL, V304, P30, DOI 10.1016/j.mce.2009.02.027; Chen KI, 2012, APPL MICROBIOL BIOT, V96, P9, DOI 10.1007/s00253-012-4330-7; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Dhaubhadel S, 2003, PLANT MOL BIOL, V53, P733, DOI 10.1023/B:PLAN.0000023666.30358.ae; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Falconer D. S., 1996, Introduction to quantitative genetics.; Gutierrez-Gonzalez JJ, 2011, THEOR APPL GENET, V123, P1375, DOI 10.1007/s00122-011-1673-x; Gutierrez-Gonzalez JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-105; Gutierrez-Gonzalez JJ, 2009, THEOR APPL GENET, V119, P1069, DOI 10.1007/s00122-009-1109-z; Hoeck JA, 2000, CROP SCI, V40, P48, DOI 10.2135/cropsci2000.40148x; Janila P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00023; Kassem MA, 2006, THEOR APPL GENET, V113, P1015, DOI 10.1007/s00122-006-0361-8; Kassem MA, 2001, J BIOMED BIOTECHNOL, V1, P52; KOSSLAK RM, 1987, P NATL ACAD SCI USA, V84, P7428, DOI 10.1073/pnas.84.21.7428; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liang HZ, 2010, AGR SCI CHINA, V9, P1108, DOI 10.1016/S1671-2927(09)60197-8; Liu P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-132; Lozovaya VV, 2005, CROP SCI, V45, P1934, DOI 10.2135/cropsci2004.0567; Lozovaya VV, 2004, PLANT PHYSIOL BIOCH, V42, P671, DOI 10.1016/j.plaphy.2004.06.007; Mebrahtu T, 2004, PLANT FOOD HUM NUTR, V59, P55, DOI 10.1007/s11130-004-0023-4; Meksem K., 2001, Journal of Biomedicine and Biotechnology, V1, P38, DOI 10.1155/S1110724301000110; Meng FL, 2011, THEOR APPL GENET, V123, P1459, DOI 10.1007/s00122-011-1680-y; Munro IC, 2003, NUTR REV, V61, P1, DOI 10.1301/nr.2003.janr.1-33; Murphy SE, 2009, CROP SCI, V49, P1313, DOI 10.2135/cropsci2008.09.0533; Primomo VS, 2005, CROP SCI, V45, P2454, DOI 10.2135/cropsci2004.0672; Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w; Stafford HA, 1997, BOT REV, V63, P27, DOI 10.1007/BF02857916; Subramanian S, 2005, PLANT PHYSIOL, V137, P1345, DOI 10.1104/pp.104.057257; Subramanian S, 2004, PLANT MOL BIOL, V54, P623, DOI 10.1023/B:PLAN.0000040814.28507.35; Subramanian S, 2007, TRENDS PLANT SCI, V12, P282, DOI 10.1016/j.tplants.2007.06.006; Subramanian S, 2006, PLANT J, V48, P261, DOI 10.1111/j.1365-313X.2006.02874.x; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Trigiano R.N., 1998, HORTTECHNOLOGY, V3, P413, DOI [10.21273/HORTTECH.8.3.413, DOI 10.21273/HORTTECH.8.3.413]; TSUKAMOTO C, 1995, J AGR FOOD CHEM, V43, P1184, DOI 10.1021/jf00053a012; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-680; Yan WK, 2001, AGRON J, V93, P1111, DOI 10.2134/agronj2001.9351111x; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang K, 2011, GENES GENOM, V33, P685, DOI 10.1007/s13258-011-0043-z; Zeng GL, 2009, THEOR APPL GENET, V118, P1455, DOI 10.1007/s00122-009-0994-5; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; [张晶莹 Zhang Jingying], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P3909	49	26	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118447	10.1371/journal.pone.0118447	http://dx.doi.org/10.1371/journal.pone.0118447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738957	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900035
J	Utheim, O; Islam, R; Lyberg, T; Roald, B; Eidet, JR; de la Paz, MF; Dartt, DA; Raeder, S; Utheim, TP				Utheim, Oeygunn; Islam, Rakibul; Lyberg, Torstein; Roald, Borghild; Eidet, Jon Roger; Fideliz de la Paz, Maria; Dartt, Darlene A.; Raeder, Sten; Utheim, Tor Paaske			Serum-Free and Xenobiotic-Free Preservation of Cultured Human Limbal Epithelial Cells	PLOS ONE			English	Article							DENUDED AMNIOTIC MEMBRANE; EX-VIVO EXPANSION; FETAL CALF SERUM; STEM-CELLS; EXPRESSION; TRANSPLANTATION; PHENOTYPE; INTACT; ULTRASTRUCTURE; PROLIFERATION	Aim/Purpose of the Study To develop a one-week storage method, without serum and xenobiotics, that would maintain cell viability, morphology, and phenotype of cultured human limbal epithelial sheets. Materials and Methods Human limbal explants were cultured on intact human amniotic membranes for two weeks. The sheets were stored in a hermetically sealed container at 23 degrees C in either a serum-free medium with selected animal serum-derived compounds (Quantum 286) or a xenobioticfree medium (Minimal Essential Medium) for 4 and 7 days. Stored and non-stored cultures were analyzed for cell viability, amniotic membrane and epithelial sheet thickness, and a panel of immunohistochemical markers for immature cells (Delta Np63 alpha, p63, Bmi-1, C/EBP partial derivative, ABCG2 and K19), differentiated cells (K3 and Cx43), proliferation (PCNA), and apoptosis (Caspase-3). Results The cell viability of the cultures was 98 +/- 1% and remained high after storage. Mean central thickness of non-stored limbal epithelial sheets was 23 +/- 3 mu m, and no substantial loss of cells was observed after storage. The non-stored epithelial sheets expressed a predominantly immature phenotype with Delta Np63a positivity of more than 3% in 9 of 13 cultures. After storage, the expression of ABCG2 and C/EBP partial derivative was reduced for the 7 day Quantum 286-storage group; (P = 0.04), and Bmi1 was reduced after 4 day Quantum 286-storage; (P = 0.02). No other markers varied significantly. The expression of differentiation markers was unrelated to the thickness of the epithelia and amnioticmembrane, apart from ABCG2, which correlated negatively with thickness of limbal epithelia (R = -0.69, P = 0.01) and Delta Np63 alpha, which correlated negatively with amniotic membrane thickness (R = -0.59, P = 0.03). Conclusion Limbal epithelial cells cultured from explants on amniotic membrane can be stored at 23 degrees C in both serum-free and xenobiotic-free media, with sustained cell viability, ultrastructure, and Delta Np63 alpha-positivity after both 4 and 7 days.	[Utheim, Oeygunn; Islam, Rakibul; Lyberg, Torstein; Eidet, Jon Roger; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Oeygunn; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway; [Islam, Rakibul; Utheim, Tor Paaske] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Roald, Borghild] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Fideliz de la Paz, Maria] Univ Autonoma Barcelona, Inst Univ Barraquer, E-08193 Barcelona, Spain; [Dartt, Darlene A.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA USA; [Raeder, Sten] Norwegian Dry Eye Clin, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Autonomous University of Barcelona; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Utheim, O (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	utheim2@gmail.com		Islam, Rakibul/0000-0002-7174-9225	South-Eastern Norway Regional Health Authority [2010092]; NATIONAL EYE INSTITUTE [R01EY019470] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was funded by the South-Eastern Norway Regional Health Authority, grant number 2010092, project name "Treating blindness using novel tissue storage technology", url http://forskningsprosjekter.ihelse.net/visningprosjektrapport.aspx?reportId=7593 and http://www.helse-sorost.no/omoss_/english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 1997, B WORLD HEALTH ORGAN, V75, P505; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; BARNES D, 1980, CELL, V22, P649, DOI 10.1016/0092-8674(80)90540-1; Cancelas JA, 2000, BLOOD, V96, P498; Chachques JC, 2004, INT J CARDIOL, V95, pS29, DOI 10.1016/S0167-5273(04)90009-5; Chen CC, 2002, INVEST OPHTH VIS SCI, V43, P2593; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Crewe JM, 2001, INVEST OPHTH VIS SCI, V42, P1757; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; Ghoubay-Benallaoua D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081965; GIBBS CJ, 1985, NEW ENGL J MED, V313, P734, DOI 10.1056/NEJM198509193131207; Grueterich M, 2003, INVEST OPHTH VIS SCI, V44, P4230, DOI 10.1167/iovs.02-0943; Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63; Grueterich M, 2002, OPHTHALMOLOGY, V109, P1547, DOI 10.1016/S0161-6420(02)01105-3; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Hayashi R, 2010, TISSUE ENG PART C-ME, V16, P553, DOI [10.1089/ten.tec.2009.0277, 10.1089/ten.TEC.2009.0277]; Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kim M, 2002, CLIN CANCER RES, V8, P22; Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3; LAUWERYNS B, 1993, INVEST OPHTH VIS SCI, V34, P1991; Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4; LINDSTROM RL, 1976, AM J OPHTHALMOL, V82, P72, DOI 10.1016/0002-9394(76)90667-X; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; Meller D, 2002, BRIT J OPHTHALMOL, V86, P463, DOI 10.1136/bjo.86.4.463; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 2010, TRENDS MOL MED, DOI [10.1016/j.molmed.2010.1010.1003, DOI 10.1016/J.M0LMED.2010.1010.1003]; Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494; Raeder S, 2007, ACTA OPHTHALMOL SCAN, V85, P377, DOI 10.1111/j.1600-0420.2006.00873.x; Raeder S, 2010, CORNEA, V29, P439, DOI 10.1097/ICO.0b013e3181ba0c94; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; ROSENDAAL M, 1994, J CELL SCI, V107, P29; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Schwab I R, 1999, Trans Am Ophthalmol Soc, V97, P891; Schwab IR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1734, DOI 10.1001/archopht.124.12.1734; Selvaggi TA, 1997, BLOOD, V89, P776, DOI 10.1182/blood.V89.3.776; Sudha B, 2008, INDIAN J MED RES, V128, P149; Tseng SCG, 2010, CURR MOL MED, V10, P841; Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591; Utheim TP, 2009, INVEST OPHTH VIS SCI, V50, P5165, DOI 10.1167/iovs.08-2884; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1; VANHORN DL, 1975, ARCH OPHTHALMOL-CHIC, V93, P275, DOI 10.1001/archopht.1975.01010020285007; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	58	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118517	10.1371/journal.pone.0118517	http://dx.doi.org/10.1371/journal.pone.0118517			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734654	Green Submitted, gold, Green Published			2022-12-26	WOS:000350314700036
J	Marasco, CC; Enders, JR; Seale, KT; McLean, JA; Wikswo, JP				Marasco, Christina C.; Enders, Jeffrey R.; Seale, Kevin T.; McLean, John A.; Wikswo, John P.			Real-Time Cellular Exometabolome Analysis with a Microfluidic-Mass Spectrometry Platform	PLOS ONE			English	Article							SYSTEMS BIOLOGY; IN-VIVO; COCAINE; SUBPOPULATIONS; METABOLISM; DEVICES; CELLS; MS	To address the challenges of tracking the multitude of signaling molecules and metabolites that is the basis of biological complexity, we describe a strategy to expand the analytical techniques for dynamic systems biology. Using microfluidics, online desalting, and mass spectrometry technologies, we constructed and validated a platform well suited for sampling the cellular microenvironment with high temporal resolution. Our platform achieves success in: automated cellular stimulation and microenvironment control; reduced non-specific adsorption to polydimethylsiloxane due to surface passivation; real-time online sample collection; near real-time sample preparation for salt removal; and real-time online mass spectrometry. When compared against the benchmark of "in-culture" experiments combined with ultraperformance liquid chromatography-electrospray ionization-ion mobility-mass spectrometry (UPLC-ESI-IM-MS), our platform alleviates the volume challenge issues caused by dilution of autocrine and paracrine signaling and dramatically reduces sample preparation and data collection time, while reducing undesirable external influence from various manual methods of manipulating cells and media (e.g., cell centrifugation). To validate this system biologically, we focused on cellular responses of Jurkat T cells to microenvironmental stimuli. Application of these stimuli, in conjunction with the cell's metabolic processes, results in changes in consumption of nutrients and secretion of biomolecules (collectively, the exometabolome), which enable communication with other cells or tissues and elimination of waste. Naive and experienced T-cell metabolism of cocaine is used as an exemplary system to confirm the platform's capability, highlight its potential for metabolite discovery applications, and explore immunological memory of T-cell drug exposure. Our platform proved capable of detecting metabolomic variations between naive and experienced Jurkat T cells and highlights the dynamics of the exometabolome over time. Upregulation of the cocaine metabolite, benzoylecgonine, was noted in experienced T cells, indicating potential cellular memory of cocaine exposure. These metabolomics distinctions were absent from the analogous, traditional "in-culture" UPLC-ESI-IM-MS experiment, further demonstrating this platform's capabilities.	[Marasco, Christina C.; Enders, Jeffrey R.; Seale, Kevin T.; McLean, John A.; Wikswo, John P.] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37235 USA; [Marasco, Christina C.; Seale, Kevin T.; Wikswo, John P.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Enders, Jeffrey R.; McLean, John A.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Enders, Jeffrey R.; McLean, John A.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA; [Wikswo, John P.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Wikswo, John P.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wikswo, JP (corresponding author), Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, 221 Kirkland Hall, Nashville, TN 37235 USA.	john.wikswo@vanderilt.edu	Enders, Jeffrey/P-2574-2019	Marasco, Christina/0000-0003-0324-9314; Enders, Jeffrey/0000-0003-1224-1664	National Institutes of Health National Center for Advancing Translational Sciences under the NIH Common Fund [UH2TR000491]; National Institute on Drug Addiction Award [RC2DA028981]; Defense Threat Reduction Agency [HDTRA1-09-1-00-13]; Defense Advanced Research Projects Agency [W911NF-12-2-0036]; Vanderbilt Institute for Integrative Biosystems Research and Education; Systems Biology and Bioengineering Undergraduate Research Experience (SyBBURE) - Gideon Searle; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000491, UH2TR000491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028981] Funding Source: NIH RePORTER	National Institutes of Health National Center for Advancing Translational Sciences under the NIH Common Fund; National Institute on Drug Addiction Award; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Vanderbilt Institute for Integrative Biosystems Research and Education; Systems Biology and Bioengineering Undergraduate Research Experience (SyBBURE) - Gideon Searle; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research reported in this publication was supported in part by The National Institutes of Health (http://www.nih.gov/) National Center for Advancing Translational Sciences Award No. UH2TR000491 under the NIH Common Fund, and the National Institute on Drug Addiction Award No. RC2DA028981 through the American Recovery and Reinvestment Act of 2009; the Defense Threat Reduction Agency (http://www.dtra.mil/) under Grant HDTRA1-09-1-00-13; the Defense Advanced Research Projects Agency (http://www.darpa.mil/) under Grant W911NF-12-2-0036; the Vanderbilt Institute for Integrative Biosystems Research and Education (http://www.vanderbilt.edu/viibre/); and the Systems Biology and Bioengineering Undergraduate Research Experience (SyBBURE), funded by Gideon Searle (http://www.vanderbilt.edu/viibre/teachinginnovation.php). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies and organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; BAGASRA O, 1989, CLIN EXP IMMUNOL, V77, P289; Byrd TF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05117; Chan JH, 1999, ANAL CHEM, V71, P4437, DOI 10.1021/ac9906678; Chao C, 2008, DRUG ALCOHOL DEPEN, V94, P165, DOI 10.1016/j.drugalcdep.2007.11.010; Chen QS, 2012, ANAL CHEM, V84, P1695, DOI 10.1021/ac300003k; Darby SG, 2010, LAB CHIP, V10, P3218, DOI 10.1039/c0lc00087f; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Enders JR, 2010, IET SYST BIOL, V4, P416, DOI 10.1049/iet-syb.2010.0012; Enders JR, 2012, ANAL CHEM, V84, P8467, DOI 10.1021/ac3021032; Faley S, 2012, INTEGR BIOL-UK, V4, P368, DOI 10.1039/c2ib00086e; Faley SL, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3587095; Faley SL, 2009, LAB CHIP, V9, P2659, DOI 10.1039/b902083g; Fandino AS, 2002, CHEM RES TOXICOL, V15, P1543, DOI 10.1021/tx0255828; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Hughey JJ, 2007, 2007 IEEE/NIH LIFE SCIENCE SYSTEMS AND APPLICATIONS WORKSHOP, P132, DOI 10.1109/LSSA.2007.4400902; Jiang Y, 2001, ANAL CHEM, V73, P2048, DOI 10.1021/ac001474j; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Kubera M, 2004, EUR J PHARMACOL, V483, P309, DOI 10.1016/j.ejphar.2003.10.021; LeDuc PR, 2011, ANNU REV BIOMED ENG, V13, P369, DOI 10.1146/annurev-bioeng-071910-124651; Pacifici R, 2002, ANN NY ACAD SCI, V965, P421; Pellegrino T, 1998, J NEUROIMMUNOL, V83, P139, DOI 10.1016/S0165-5728(97)00230-0; Roth MD, 2005, J LEUKOCYTE BIOL, V78, P1198, DOI 10.1189/jlb.0405219; Seale KT, 2010, EXP BIOL MED, V235, P777, DOI 10.1258/ebm.2010.009379; Shotwell MS, 2013, BIOMETRICS, V69, P741, DOI 10.1111/biom.12066; Warner A, 2000, THER DRUG MONIT, V22, P266, DOI 10.1097/00007691-200006000-00006; Wikswo JP, 2014, EXP BIOL MED, V239, P1061, DOI 10.1177/1535370214542068; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k; Wikswo JP, 2013, IEEE T BIO-MED ENG, V60, P682, DOI 10.1109/TBME.2013.2244891; Wlodkowic D, 2011, METHODS MOL BIOL, V731, P285, DOI 10.1007/978-1-61779-080-5_23; Xia Y, 2000, ANAL CHEM, V72, P764, DOI 10.1021/ac990201p; Yates JR, 2000, TRENDS GENET, V16, P5, DOI 10.1016/S0168-9525(99)01879-X; Zaia J, 2004, MASS SPECTROM REV, V23, P161, DOI 10.1002/mas.10073	34	21	22	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117685	10.1371/journal.pone.0117685	http://dx.doi.org/10.1371/journal.pone.0117685			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723555	gold, Green Published, Green Submitted			2022-12-26	WOS:000350251200039
J	Yoshikawa, T; Osada, Y				Yoshikawa, Tetsuro; Osada, Yutaka			Dietary Compositions and Their Seasonal Shifts in Japanese Resident Birds, Estimated from the Analysis of Volunteer Monitoring Data	PLOS ONE			English	Article							CITIZEN-SCIENCE; ECOLOGICAL RESEARCH; FORAGING BEHAVIOR; FEEDING ECOLOGY; FOREST BIRDS; FOOD-WEB; BIOFILM; NETWORK; PROJECT; FINCHES	Determining the composition of a bird's diet and its seasonal shifts are fundamental for understanding the ecology and ecological functions of a species. Various methods have been used to estimate the dietary compositions of birds, which have their own advantages and disadvantages. In this study, we examined the possibility of using long-term volunteer monitoring data as the source of dietary information for 15 resident bird species in Kanagawa Prefecture, Japan. The data were collected from field observations reported by volunteers of regional naturalist groups. Based on these monitoring data, we calculated the monthly dietary composition of each bird species directly, and we also estimated unidentified items within the reported foraging episodes using Bayesian models that contained additional information regarding foraging locations. Next, to examine the validity of the estimated dietary compositions, we compared them with the dietary information for focal birds based on stomach analysis methods, collected from past literatures. The dietary trends estimated from the monitoring data were largely consistent with the general food habits determined from the previous studies of focal birds. Thus, the estimates based on the volunteer monitoring data successfully detected noticeable seasonal shifts in many of the birds from plant materials to animal diets during spring-summer. Comparisons with stomach analysis data supported the qualitative validity of the monitoring-based dietary information and the effectiveness of the Bayesian models for improving the estimates. This comparison suggests that one advantage of using monitoring data is its ability to detect dietary items such as fleshy fruits, flower nectar, and vertebrates. These results emphasize the potential importance of observation data collecting and mining by citizens, especially free descriptive observation data, for use in bird ecology studies.	[Yoshikawa, Tetsuro] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan; [Osada, Yutaka] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biodivers Sci, Tokyo, Japan	Forestry & Forest Products Research Institute - Japan; University of Tokyo	Yoshikawa, T (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan.	yoshikawa.tetsuro@gmail.com		Yoshikawa, Tetsuro/0000-0001-6998-275X	Japan Society for the Promotion of Science [2610007]; Grants-in-Aid for Scientific Research [14J10007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TY was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (http://www.jsps.go.jp/english), Grant Number 2610007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Corlett RT, 2004, BIOL REV, V79, P497, DOI 10.1017/S1464793103006341; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Gill F., 2010, IOC WORLD BIRD NAMES; GILL FB, 2007, ORNITHOLOGY; Gonzalez-Varo JP, 2010, ECOGRAPHY, V33, P185, DOI 10.1111/j.1600-0587.2009.06021.x; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Herrera LG, 2003, OECOLOGIA, V136, P439, DOI 10.1007/s00442-003-1293-5; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kanagawa Branch of The Wild Bird Society of Japan, 2007, BIRDS KAN 2001 05 LI; Kiyosu Y., 1966, ENCY WILD BIRDS JAPA; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Morrison ML, 1990, AVIAN FORAGING THEOR; Murakami M, 2000, P ROY SOC B-BIOL SCI, V267, P1597, DOI 10.1098/rspb.2000.1184; NEWTON I, 1967, IBIS, V109, P33, DOI 10.1111/j.1474-919X.1967.tb00005.x; NEWTON I, 1967, J ANIM ECOL, V36, P721, DOI 10.2307/2822; Plummer M, 2012, JAGS JUST ANTOTHER G; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redpath SM, 2001, CONDOR, V103, P184, DOI 10.1650/0010-5422(2001)103[0184:ARDCPP]2.0.CO;2; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Rosenberg K.V., 1990, Studies in Avian Biology, P80; RUNDLE WD, 1982, J FIELD ORNITHOL, V53, P249; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Sutherland WJ, 2004, TECH ECOL CONSERVAT, P233; Uchida S, 1931, ORNITHOLOGICAL MAMMA; Uchida S, 1922, 1 BUR AGR COMM; Uchida S, 1931, 5 BUR AGR COMM; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; WHEELWRIGHT NT, 1986, AUK, V103, P710, DOI 10.1093/auk/103.4.710; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Witmer MC, 1996, AUK, V113, P414, DOI 10.2307/4088908; Yoshikawa T, 2014, J ANIM ECOL, V83, P651, DOI 10.1111/1365-2656.12161; Yoshikawa T, 2012, OIKOS, V121, P1041, DOI 10.1111/j.1600-0706.2011.19888.x	44	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0119324	10.1371/journal.pone.0119324	http://dx.doi.org/10.1371/journal.pone.0119324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723544	Green Submitted, Green Published, gold			2022-12-26	WOS:000350251200070
J	Greenlee, MHW; Smith, JD; Platt, EM; Juarez, JR; Timms, LL; Greenlee, JJ				Greenlee, M. Heather West; Smith, Jodi D.; Platt, Ekundayo M.; Juarez, Jessica R.; Timms, Leo L.; Greenlee, Justin J.			Changes in Retinal Function and Morphology Are Early Clinical Signs of Disease in Cattle with Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; CREUTZFELDT-JAKOB-DISEASE; ELECTRORETINOGRAM B-WAVE; PROTEIN GENE PRNP; PRION PROTEIN; EXPERIMENTAL TRANSMISSION; CEREBROSPINAL-FLUID; PARKINSON DISEASE; SUFFOLK SHEEP; DEER	Bovine spongiform encephalopathy (BSE) belongs to a group of fatal, transmissible protein misfolding diseases known as transmissible spongiform encephalopathies (TSEs). All TSEs are caused by accumulation of misfolded prion protein (PrPSc) throughout the central nervous system (CNS), which results in neuronal loss and ultimately death. Like other protein misfolding diseases including Parkinson's disease and Alzheimer's disease, TSEs are generally not diagnosed until the onset of disease after the appearance of unequivocal clinical signs. As such, identification of the earliest clinical signs of disease may facilitate diagnosis. The retina is the most accessible part of the central nervous system, and retinal pathology in TSE affected animals has been previously reported. Here we describe antemortem changes in retinal function and morphology that are detectable in BSE inoculated animals several months (up to 11 months) prior to the appearance of any other signs of clinical disease. We also demonstrate that differences in the severity of these clinical signs reflect the amount of PrPSc accumulation in the retina and the resulting inflammatory response of the tissue. These results are the earliest reported clinical signs associated with TSE infection and provide a basis for understanding the pathology and evaluating therapeutic interventions.	[Greenlee, M. Heather West] Iowa State Univ, Dept Biomed Sci, Ames, IA 50010 USA; [Greenlee, M. Heather West; Platt, Ekundayo M.] Iowa State Univ, Interdept Toxicol Program, Ames, IA 50010 USA; [Smith, Jodi D.; Greenlee, Justin J.] Natl Anim Dis Ctr, Virus & Prion Res Unit, Ames, IA 50010 USA; [Platt, Ekundayo M.] Iowa State Univ, Dept Genet & Cell Biol, Ames, IA 50010 USA; [Juarez, Jessica R.; Timms, Leo L.] Iowa State Univ, Dept Anim Sci, Ames, IA 50010 USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Greenlee, MHW (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50010 USA.	mheather@iastate.edu	Greenlee, Justin/Y-5732-2019	Greenlee, Justin/0000-0003-2202-3054; Smith, Jodi/0000-0001-7952-8024	Agricultural Research Service; Agricultural Research Service, US Department of Agriculture [58-3625-5-114]	Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Agricultural Research Service, US Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the Agricultural Research Service 'Transmission, differentiation, and pathobiology of transmissible spongiform encephalopathies'; and the Specific Cooperative Agreement #58-3625-5-114 with the Agricultural Research Service, US Department of Agriculture. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bannach O, 2013, VET MICROBIOL, V166, P102, DOI 10.1016/j.vetmic.2013.05.021; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Fernandez-Borges N., 2013, INT J CELL BIOL, V2013, DOI [10.1155/2013/583498, DOI 10.1155/2013/583498]; Garcia-Martin E, 2014, RETINA-J RET VIT DIS, V34, P971, DOI 10.1097/IAE.0000000000000028; Garcia-Martin E, 2014, INVEST OPHTH VIS SCI, V55, P696, DOI 10.1167/iovs.13-13062; Garcia-Martin E, 2014, AM J OPHTHALMOL, V157, P470, DOI 10.1016/j.ajo.2013.09.028; Gharbiya M, 2014, J ALZHEIMERS DIS, V40, P907, DOI 10.3233/JAD-132039; Greenlee JJ, 2006, VET PATHOL, V43, P733, DOI 10.1354/vp.43-5-733; Greenlee JJ, 2012, J VET DIAGN INVEST, V24, P1087, DOI 10.1177/1040638712461249; Greenlee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038678; Haley NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081488; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hamir AN, 2008, VET PATHOL, V45, P297, DOI 10.1354/vp.45-3-297; Hamir AN, 2011, J VET DIAGN INVEST, V23, P407, DOI 10.1177/1040638711403404; Hamir AN, 2006, VET PATHOL, V43, P118, DOI 10.1354/vp.43-2-118; Hamir AN, 2006, J COMP PATHOL, V134, P63, DOI 10.1016/j.jcpa.2005.07.001; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Heckenlively J. R., 2006, PRINCIPLES PRACTICE, V2nd; Hortells P, 2006, BRAIN RES, V1108, P188, DOI 10.1016/j.brainres.2006.06.021; Ishikawa A, 2009, JPN J OPHTHALMOL, V53, P31, DOI 10.1007/s10384-008-0608-9; Jeffrey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091026; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Katz BJ, 2000, J NEURO-OPHTHALMOL, V20, P116, DOI 10.1097/00041327-200020020-00011; Konold Timm, 2012, BMC Res Notes, V5, P674, DOI [10.1186/1756-0500-4-259, 10.1186/1756-0500-5-674]; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Lacroux C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004202; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Luers L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072623; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; Moda F, 2014, NEW ENGL J MED, V371, P530, DOI 10.1056/NEJMoa1404401; Murayama Y, 2014, J GEN VIROL, V95, P2576, DOI 10.1099/vir.0.066225-0; Nichols TA, 2012, J VET DIAGN INVEST, V24, P746, DOI 10.1177/1040638712448060; Omori Y, 2012, J NEUROSCI, V32, P6126, DOI 10.1523/JNEUROSCI.0322-12.2012; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Regnier A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-25; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Ritchie DL, 2009, J GEN VIROL, V90, P3075, DOI 10.1099/vir.0.013227-0; Roth NM, 2014, MOVEMENT DISORD, V29, P1163, DOI 10.1002/mds.25896; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Satue M, 2014, BRIT J OPHTHALMOL, V98, P350, DOI 10.1136/bjophthalmol-2013-304152; Seelig DM, 2015, VET PATHOL, V52, P107, DOI 10.1177/0300985814524798; Shim H, 2012, J BIOL CHEM, V287, P14873, DOI 10.1074/jbc.M112.345751; Smith JD, 2008, J COMP PATHOL, V138, P12, DOI 10.1016/j.jcpa.2007.09.002; Smith JD, 2009, VET PATHOL, V46, P810, DOI 10.1354/vp.08-VP-0206-W-FL; Smith JD, 2009, VET REC, V165, P179, DOI 10.1136/vr.165.6.179; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Soto C, 2011, TRENDS MOL MED, V17, P14, DOI 10.1016/j.molmed.2010.09.001; Spraker TR, 2010, VET PATHOL, V47, P536, DOI 10.1177/0300985810363702; Vrentas CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-167; Watts JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003990	55	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119431	10.1371/journal.pone.0119431	http://dx.doi.org/10.1371/journal.pone.0119431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756286	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275700045
J	Ma, YL; Wei, JL; Zhang, Q; Chen, L; Wang, JY; Liu, JF; Ding, XD				Ma, Yunlong; Wei, Julong; Zhang, Qin; Chen, Lei; Wang, Jinyong; Liu, Jianfeng; Ding, Xiangdong			A Genome Scan for Selection Signatures in Pigs	PLOS ONE			English	Article							FALSE DISCOVERY RATE; REPRODUCTIVE TRAITS; POSITIVE SELECTION; WIDE SCAN; ASSOCIATION; MUTATION; GENES; QTL; DNA	Identifying signatures of selection can provide a straightforward insight into the mechanism of artificial selection and further uncover the causal genes related to the phenotypic variation. Based on Illumina Porcine60KSNP chip data, four complementary methods, Long-Range Haplotype (LRH), Tajima's D, Cross Population Extend Haplotype Homozygosity Test (XPEHH) and F-ST, were implemented in this study to detect the selection signatures in the whole genome of one typical Chinese indigenous breed, Rongchang, one Chinese cultivated breed, Songliao, and two western breeds, Landrace and Yorkshire. False Discovery Rate (FDR) was implemented to control the false positive rates. In our study, a total of 159, 127, 179 and 159 candidate selection regions with average length of 0.80 Mb, 0.73 Mb, 0.78 Mb and 0.73 Mb were identified in Landrace, Rongchang, Songliao and Yorkshire, respectively, that span approximately 128.00 Mb, 92.38 Mb, 130.30 Mb and 115.40 Mb and account for approximately 3.74-5.33% of genome across all autosomes. The selection regions of 11.52 Mb shared by Landrace and Yorkshire were the longest when chosen pairs from the pool of the four breeds were examined. The overlaps between Yorkshire and Songliao, approximately 9.20 Mb, were greater than those of Yorkshire and Rongchang. Meanwhile, the overlaps between Landrace and Songliao were greater than those of Landrace and Rongchang but less than those of Songliao and Ronchang. Bioinformatics analysis showed that the genes/QTLs relevant to fertility, coat color, and ear morphology were found in candidate selection regions. Some genes, such as LEMD3, MC1R, KIT, TRHR etc. that were reported under selection, were confirmed in our study, and this analysis also demonstrated the diversity of breeds.	[Ma, Yunlong; Wei, Julong; Zhang, Qin; Liu, Jianfeng; Ding, Xiangdong] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, JF (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China.	liujf@cau.edu.cn; xding@cau.edu.cn			program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; open project of Key Laboratory of pig, Ministry of Agriculture [13405]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Natural Science Foundation of China [31272418, 31272419]; earmarked fund for CARS-36	program for Changjiang Scholar and Innovation Research Team in University; open project of Key Laboratory of pig, Ministry of Agriculture; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for CARS-36	This work was supported provided by the program for Changjiang Scholar and Innovation Research Team in University (IRT1191), the open project of Key Laboratory of pig, Ministry of Agriculture (13405), the earmarked fund for CARS-36, National High Technology Research and Development Program of China (863 Program 2011AA100302) and the National Natural Science Foundation of China (31272418, 31272419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosse M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5392; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buske B, 2006, ANIM REPROD SCI, V95, P167, DOI 10.1016/j.anireprosci.2005.12.015; Chen KF, 2007, INT J BIOL SCI, V3, P153; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gianola D, 2010, GENET RES, V92, P141, DOI 10.1017/S0016672310000121; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Jiang XL, 2011, ANIM BIOTECHNOL, V22, P30, DOI 10.1080/10495398.2011.547745; Kijas JMH, 1998, GENETICS, V150, P1177; Kmiec M, 2006, J APPL GENET, V47, P139, DOI 10.1007/BF03194613; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Li FE, 2008, CZECH J ANIM SCI, V53, P139, DOI 10.17221/371-CJAS; Lin X, 2010, AM J PHYSIOL-REG I, V298, pR1435, DOI 10.1152/ajpregu.00634.2009; Ma YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094911; Makgahlela ML, 2009, S AFR J ANIM SCI, V39, P127; Meidtner K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-76; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pfaffelhuber P, 2007, POPULATION GENETICS; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Rischkowsky B, 2007, THE STATE OF THE WOR; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Suzuki Y, 2010, GENES GENET SYST, V85, P359, DOI 10.1266/ggs.85.359; TAJIMA F, 1989, GENETICS, V123, P585; Tetzlaff S, 2009, J ANIM BREED GENET, V126, P237, DOI 10.1111/j.1439-0388.2008.00781.x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wang HL, 2006, CYTOGENET GENOME RES, V115, P129, DOI 10.1159/000095232; Weller JI, 1998, GENETICS, V150, P1699; Wilkinson S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003453; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang SB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-7	46	16	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116850	10.1371/journal.pone.0116850	http://dx.doi.org/10.1371/journal.pone.0116850			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756180	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275700013
J	Wang, HF; Landrein, S; Dong, WP; Nie, ZL; Kondo, K; Funamoto, T; Wen, J; Zhou, SL				Wang, Hua-Feng; Landrein, Sven; Dong, Wen-Pan; Nie, Ze-Long; Kondo, Katsuhiko; Funamoto, Tsuneo; Wen, Jun; Zhou, Shi-Liang			Molecular Phylogeny and Biogeographic Diversification of Linnaeoideae (Caprifoliaceae s. l.) Disjunctly Distributed in Eurasia, North America and Mexico	PLOS ONE			English	Article							LINNAEEAE CAPRIFOLIACEAE; EASTERN ASIA; LAND-BRIDGE; EVOLUTION; DIPSACALES; HISTORY; NUCLEAR; ABELIA; GENES; GENUS	Linnaeoideae is a small subfamily of erect or creeping shrubs to small trees in Caprifoliaceae that exhibits a wide disjunct distribution in Eurasia, North America and Mexico. Most taxa of the subfamily occur in eastern Asia and Mexico but the monospecific genus Linnaea has a circumboreal to north temperate distribution. In this study, we conducted phylogenetic and biogeographic analyses for Linnaeoideae and its close relatives based on sequences of the nuclear ribosomal ITS and nine plastid (rbcL, trnS-G, matK, trnL-F, ndhA, trnD-psbM, petB-D, trnL-rpl32 and trnH-psbA) markers. Our results support that Linnaeoideae is monophyletic, consisting of four eastern Asian lineages (Abelia, Diabelia, Dipelta and Kolkwitzia), the Mexican Vesalea, and Linnaea. The Mexican Vesalea was formerly placed in Abelia, but it did not form a clade with the eastern Asian Abelia; instead Vesalea and Linnaea are sisters. The divergence time between the eastern Asian lineages and the Mexican Vesalea plus the Linnaea clade was dated to be 50.86 Ma, with a 95% highest posterior density of 42.8 Ma (middle Eocene) to 60.19 Ma (early Paleocene) using the Bayesian relaxed clock estimation. Reconstructed ancestral areas indicated that the common ancestor of Linnaea plus Vesalea may have been widespread in eastern Asia and Mexico or originated in eastern Asia during the Eocene and likely migrated across continents in the Northern Hemisphere via the North Atlantic Land Bridges or the Bering Land Bridge. The Qinling Mountains of eastern Asia are the modern-day center of diversity of Kolkwitzia-DipeltaDiabelia clade. The Diabeliaclade became highly diversified in Japan and eastern China. Populations of Diabelia serrata in Japan and eastern China were found to be genetically identical in this study, suggesting a recent disjunction across the East China Sea, following the last glacial event.	[Wang, Hua-Feng; Dong, Wen-Pan; Wen, Jun; Zhou, Shi-Liang] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Landrein, Sven] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Wang, Hua-Feng] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Nie, Ze-Long] Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou 416000, Hunan, Peoples R China; [Kondo, Katsuhiko] Tokyo Univ Agr, Fac Agr, Dept Agr, Lab Plant Genet & Breeding Sci, Atsugi, Kanagawa 2430034, Japan; [Funamoto, Tsuneo] Showa Pharmaceut Univ, Fundamental Educ & Res Ctr Pharmaceut Sci, Inst Biol, Machida, Tokyo 1948543, Japan; [Wen, Jun] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA; [Wang, Hua-Feng] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing Urban Ecosyst Res Stn, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Royal Botanic Gardens, Kew; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jishou University; Tokyo University of Agriculture; Showa Pharmaceutical University; Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Wen, J (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	wenj@si.edu; slzhou@ibcac.ac.cn		, Hua-Feng/0000-0003-3331-2898	Ministry of Science and Technology of China [2012AA021602, 2011FY120200, 2012BAC01B05]; National Natural Science Foundation of China [31270239, 41201049, 31129001]; IICT; Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); IICT; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was partly supported by grants from the Ministry of Science and Technology of China (2012AA021602, 2011FY120200, 2012BAC01B05), National Natural Science Foundation of China (31270239, 41201049, 31129001), IICT and the Innovation International Collaborative Team Grant from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Bell CD, 2005, AM J BOT, V92, P284, DOI 10.3732/ajb.92.2.284; Bell Charles D., 2001, Harvard Papers in Botany, V6, P481; BOUFFORD DE, 1983, ANN MO BOT GARD, V70, P423, DOI 10.2307/2992081; Boufford DE, 1998, PHYTOGEOGRAPHY QINLI; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Christenhusz MJM, 2013, PHYTOTAXA, V125, P25, DOI 10.11646/phytotaxa.125.1.4; Crane RP, 1986, TERT RES, V9, P21; Crave PR, 1998, MAGNOLIAS THEIR ALLI, P21; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Donoghue Michael J., 2001, Harvard Papers in Botany, V6, P459; DONOGHUE MJ, 1983, SYST BOT, V8, P45, DOI 10.2307/2418562; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Dorofeev P.I., 1963, TERTIARY FLORAS W SI; Dorofeev PI, 1957, CONTRIBUTIONS KNOWLE, P277; DOYLE JA, 1993, PALEOBIOLOGY, V19, P141, DOI 10.1017/S0094837300015840; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fang JY, 2002, ACTA BOT SIN, V44, P1105; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng Y, 2005, SYST BOT, V30, P786, DOI 10.1600/036364405775097851; FRIIS EM, 1985, BIOL SKR DAN VID SEL, V24, P1; Fritsch P, 1996, AM J BOT, V83, P342, DOI 10.2307/2446169; FUKUOKA N, 1968, ACTA PHYTOTAXON GEOBOT, V23, P82; FUKUOKA N, 1972, Memoirs of the Faculty of Science Kyoto University Series of Biology, V6, P15; Hara H, 1983, GINKGOANA, V5, P102; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hong D.Y., 1993, CATHAYA, V5, P1; Hopkins D. M, 1967, BERING LAND BRIDGE; Howarth DG, 2009, MOL BIOL EVOL, V26, P1245, DOI 10.1093/molbev/msp051; Hu JQ, 1988, FLORA REIPUBLICAE PO, V72, P112; Huang WP, 2013, BOT J LINN SOC, V171, P395, DOI 10.1111/j.1095-8339.2012.01321.x; Hulten E, 1968, FLORA ALASKA NEIGHBO; Hulten E, 1986, N TROPIC CANC, V2; Ickert-Bond SM, 2006, MOL PHYLOGENET EVOL, V39, P512, DOI 10.1016/j.ympev.2005.12.003; Ikuse M, 1954, J JAPANESE BOT, V29, P11; Jacobs B, 2010, MOL PHYLOGENET EVOL, V57, P741, DOI 10.1016/j.ympev.2010.08.007; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; Kim T, 1998, THESIS CHONBUK NATL; Kim YD, 1999, J PLANT RES, V112, P331, DOI 10.1007/PL00013887; LANCUCKA-SRODONIOWA M, 1967, Acta Palaeobotanica, V8, P1; Landrein S, 2013, INT J PLANT SCI, V174, P200, DOI 10.1086/668251; Landrein S, 2012, BOT J LINN SOC, V169, P692, DOI 10.1111/j.1095-8339.2012.01257.x; Landrein S, 2010, PHYTOTAXA, V3, P34; [李金璐 Li Jinlu], 2013, [植物学报, Chinese Bulletin of Botany], V48, P72; Lu LM, 2013, MOL PHYLOGENET EVOL, V68, P502, DOI 10.1016/j.ympev.2013.04.023; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; MANCHESTER SR, 1995, INT J PLANT SCI, V156, P709, DOI 10.1086/297293; Manchester SR, 1997, REV PALAEOBOT PALYNO, V96, P321; Manchester SR, 2009, J SYST EVOL, V47, P1, DOI 10.1111/j.1759-6831.2009.00001.x; McKenna M.C., 1983, STRUCTURE DEV GREENL, P351, DOI DOI 10.1007/978-1-4613-3485-9_19; Miller M.A., 2010, P GAT COMP ENV WORKS; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Nie ZL, 2009, J SYST EVOL, V47, P416, DOI 10.1111/j.1759-6831.2009.00045.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Pyck N, 2004, BELG J BOT, V137, P125; Qi XS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-41; Qi XS, 2012, AM J BOT, V99, pE304, DOI 10.3732/ajb.1100582; Qiu YX, 2009, TAXON, V58, P1226; Rambaut, 2008, FIGTREE V1 1 1 TREE; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rehder A, 1911, PLANTAE WILSONIANAE, V1, P118; Reid E, 1926, CATALOGUE CAINOZOIC; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakaguchi S, 2012, MOL ECOL, V21, P3823, DOI 10.1111/j.1365-294X.2012.05652.x; Sanderson MJ, 2001, AM J BOT, V88, P1499, DOI 10.2307/3558458; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Smith SA, 2009, J BIOGEOGR, V36, P2324, DOI 10.1111/j.1365-2699.2009.02160.x; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevens PF, 2013, ANGIOSPERM PHYLOGENY; Sun H, 2001, TAXON, V50, P1001, DOI 10.2307/1224717; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takhtajan A., 1987, SYSTEMA MAGNOLIOPHYT; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YC, 1994, ACTA PHYTOTAXON SIN, V32, P197; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Villarreal-Q JA, 2000, BRITTONIA, V52, P172, DOI 10.2307/2666508; Villarreal-Q JA, 2013, ACTA BOT MEX, V102, P99; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J., 2011, Contributions from the United States National Herbarium, V57, P5; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Wen J., 2010, DARWINS HERITAGE TOD, P252; Wen J., 1996, CURRENT TOPICS MOL E, P37; Wen Jun, 1998, Korean Journal of Plant Taxonomy, V28, P63; Winkworth RC, 2008, MOL PHYLOGENET EVOL, V46, P830, DOI 10.1016/j.ympev.2007.11.021; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Wu Z.Y., 1996, P 1 INT S FLORISTIC, P3, DOI DOI 10.1016/J.GENE.2014.07.049; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; Xie L, 2010, MOL PHYLOGENET EVOL, V56, P675, DOI 10.1016/j.ympev.2010.02.018; Yang QE., 2011, FLORA CHINA, V19, P616; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070449; Zhang WH, 2003, MOL PHYLOGENET EVOL, V26, P176, DOI 10.1016/S1055-7903(02)00303-2; Zhang ZY, 2002, TAXON, V51, P499, DOI 10.2307/1554862; Zhou SL, 2006, ACTA PHYTOTAXON SIN, V44, P467, DOI 10.1360/aps050174; Zhou Shi-Liang, 2004, Acta Botanica Yunnanica, V26, P405	108	29	29	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116485	10.1371/journal.pone.0116485	http://dx.doi.org/10.1371/journal.pone.0116485			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756215	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275700004
J	Couch, RD; Dailey, A; Zaidi, F; Navarro, K; Forsyth, CB; Mutlu, E; Engen, PA; Keshavarzian, A				Couch, Robin D.; Dailey, Allyson; Zaidi, Fatima; Navarro, Karl; Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip A.; Keshavarzian, Ali			Alcohol Induced Alterations to the Human Fecal VOC Metabolome	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; VOLATILE ORGANIC-COMPOUNDS; POSSIBLE MECHANISM; OXIDATIVE STRESS; LIVER-DISEASE; MALE RATS; COMPONENTS; BARRIER; STEATOHEPATITIS; IDENTIFICATION	Studies have shown that excessive alcohol consumption impacts the intestinal microbiota composition, causing disruption of homeostasis (dysbiosis). However, this observed change is not indicative of the dysbiotic intestinal microbiota function that could result in the production of injurious and toxic products. Thus, knowledge of the effects of alcohol on the intestinal microbiota function and their metabolites is warranted, in order to better understand the role of the intestinal microbiota in alcohol associated organ failure. Here, we report the results of a differential metabolomic analysis comparing volatile organic compounds (VOC) detected in the stool of alcoholics and non-alcoholic healthy controls. We performed the analysis with fecal samples collected after passage as well as with samples collected directly from the sigmoid lumen. Regardless of the approach to fecal collection, we found a stool VOC metabolomic signature in alcoholics that is different from healthy controls. The most notable metabolite alterations in the alcoholic samples include: (1) an elevation in the oxidative stress biomarker tetradecane; (2) a decrease in five fatty alcohols with anti-oxidant property; (3) a decrease in the short chain fatty acids propionate and isobutyrate, important in maintaining intestinal epithelial cell health and barrier integrity; (4) a decrease in alcohol consumption natural suppressant caryophyllene; (5) a decrease in natural product and hepatic steatosis attenuator camphene; and (6) decreased dimethyl disulfide and dimethyl trisulfide, microbial products of decomposition. Our results showed that intestinal microbiota function is altered in alcoholics which might promote alcohol associated pathologies.	[Couch, Robin D.; Dailey, Allyson; Zaidi, Fatima; Navarro, Karl] George Mason Univ, Dept Chem & Biochem, Manassas, VA 20109 USA; [Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip A.; Keshavarzian, Ali] Rush Univ, Div Digest Dis & Nutr, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Forsyth, Christopher B.] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Mol Biophys & Physiol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Univ Utrecht, Fac Sci, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	George Mason University; Rush University; Rush University; Rush University; Rush University; Utrecht University	Couch, RD (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA 20109 USA.	rcouch@gmu.edu			National Institutes of Health [1RC2AA019405]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health grant 1RC2AA019405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeosun CB, 2013, J ACUTE MED, V3, P138, DOI 10.1016/j.jacme.2013.07.002; Aja P.M., 2014, AM J PHYTOMED CLIN T, V2, P310, DOI DOI 10.1016/j.jht.2014.02.001; Al Mansouri S, 2014, PHARMACOL BIOCHEM BE, V124, P260, DOI 10.1016/j.pbb.2014.06.025; Alpendurada MD, 2000, J CHROMATOGR A, V889, P3; Amal H, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/4/047102; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; BIGATELLO LM, 1987, AM J GASTROENTEROL, V82, P11; BLANK ML, 1991, LIPIDS, V26, P166, DOI 10.1007/BF02544013; BOLAND W, 1984, ANAL VOLATILES; Bos R, 2002, J CHROMATOGR A, V966, P233, DOI 10.1016/S0021-9673(02)00704-5; Bukvicki D, 2012, MOLECULES, V17, P6982, DOI 10.3390/molecules17066982; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Chao W, ANAL VOLATILE FLAVOR; CHIN HW, 1993, J FOOD SCI, V58, P835, DOI 10.1111/j.1365-2621.1993.tb09370.x; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; Couch RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081163; Curran AM, 2010, J FORENSIC SCI, V55, P50, DOI 10.1111/j.1556-4029.2009.01236.x; Das AK, 2013, J ENVIRON BIOL, V34, P569; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dixon E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018471; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; GELMAN RA, 1975, NUTR METAB, V18, P169; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; GRANT BF, 1988, SEMIN LIVER DIS, V8, P12, DOI 10.1055/s-2008-1040525; Huang B, 2010, J AGR FOOD CHEM, V58, P441, DOI 10.1021/jf902643e; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Kim S, 2014, OBESITY, V22, P408, DOI 10.1002/oby.20554; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Mochalski P, 2014, J CHROMATOGR B, V959, P62, DOI 10.1016/j.jchromb.2014.04.006; Mochalski P, 2012, TOXICOL MECH METHOD, V22, P502, DOI 10.3109/15376516.2012.682664; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Nielsen BL, 2013, PHYSIOL BEHAV, V120, P150, DOI 10.1016/j.physbeh.2013.07.012; Nielsen BL, 2011, BEHAV BRAIN RES, V225, P584, DOI 10.1016/j.bbr.2011.08.026; Nikbin M, 2014, AVICENNA J PHYTOMEDI, V4, P182; Nurzynska-Wierdak R, 2014, NAT PROD COMMUN, V9, P703; Okwu D. E., 2010, Der Pharma Chemica, V2, P261; PARLIMENT TH, 1982, J AGR FOOD CHEM, V30, P1006, DOI 10.1021/jf00114a001; Phillips M, 2004, CLIN CHIM ACTA, V344, P189, DOI 10.1016/j.cccn.2004.02.025; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Quigley Eamonn M M, 2013, Gastroenterol Hepatol (N Y), V9, P560; Ramarathnam N, 1993, J AGR FOOD CHEM US; Rampin O, 2006, BEHAV BRAIN RES, V172, P169, DOI 10.1016/j.bbr.2006.04.005; Rao RK, 1997, AM J PHYSIOL-GASTR L, V273, pG812, DOI 10.1152/ajpgi.1997.273.4.G812; Rizzo WB, 2014, BBA-MOL CELL BIOL L, V1841, P377, DOI 10.1016/j.bbalip.2013.09.001; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005; SEGAL W, 1969, J BACTERIOL, V98, P908, DOI 10.1128/JB.98.3.908-913.1969; Seo SM, 2014, PESTIC BIOCHEM PHYS, V113, P55, DOI 10.1016/j.pestbp.2014.06.001; Smith CJ, 2002, J CHROMATOGR B, V778, P157, DOI 10.1016/S0378-4347(01)00456-X; Sreekanth R, 2013, J PHYS CHEM A, V117, P11261, DOI 10.1021/jp4081355; Voigt RM, 2013, ALCOHOL RES-CURR REV, V35, P87; Wang HJ, 2012, ANNU REV NUTR, V32, P343, DOI 10.1146/annurev-nutr-072610-145138; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018	63	45	45	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119362	10.1371/journal.pone.0119362	http://dx.doi.org/10.1371/journal.pone.0119362			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751150	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700021
J	Missan, DS; Mitchell, K; Subbaram, S; DiPersio, CM				Missan, Dara S.; Mitchell, Kara; Subbaram, Sita; DiPersio, C. Michael			Integrin alpha 3 beta 1 Signaling through MEK/ERK Determines Alternative Polyadenylation of the MMP-9 mRNA Transcript in Immortalized Mouse Keratinocytes	PLOS ONE			English	Article							BREAST-CANCER CELLS; 3' UNTRANSLATED REGIONS; BINDING PROTEIN HUR; GENE-EXPRESSION; TETRASPANIN CD151; REGULATES MMP-9; GELATINASE-B; KAPPA-B; 3'-UNTRANSLATED REGION; SUSTAINED ACTIVATION	Integrin alpha 3 beta 1 is highly expressed in both normal and tumorigenic epidermal keratinocytes where it regulates genes that control cellular function and extracellular matrix remodeling during normal and pathological tissue remodeling processes, including wound healing and development of squamous cell carcinoma (SCC). Previous studies identified a role for alpha 3 beta 1 in immortalized and transformed keratinocytes in the regulation of genes that promote tumorigenesis, invasion, and pro-angiogenic crosstalk to endothelial cells. One such gene, matrix metalloproteinase-9 (MMP-9), is induced by alpha 3 beta 1 through a post-transcriptional mechanism of enhanced mRNA stability. In the current study, we sought to investigate the mechanism through which alpha 3 beta 1 controls MMP-9 mRNA stability. First, we utilized a luciferase reporter assay to show that AU-rich elements (AREs) residing within the 3'-untranslated region (3'-UTR) of the MMP-9 mRNA renders the transcript unstable in a manner that is independent of alpha 3 beta 1. Next, we cloned a truncated variant of the MMP-9 mRNA which is generated through usage of an alternative, upstream polyadenylation signal and lacks the 3'-UTR region containing the destabilizing AREs. Using an RNase protection assay to distinguish "long" (full-length 3'-UTR) and "short" (truncated 3'-UTR) MMP-9 mRNA variants, we demonstrated that the shorter, more stable mRNA that lacks 3'-UTR AREs was preferentially generated in alpha 3 beta 1-expressing keratinocytes compared with alpha 3 beta 1-deficient (i.e., alpha 3-null) keratinocytes. Moreover, we determined that alpha 3 beta 1-dependent alternative polyadenylation was acquired by immortalized keratinocytes, as primary neonatal keratinocytes did not display alpha 3 beta 1-dependent differences in the long and short transcripts. Finally, pharmacological inhibition of the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway in alpha 3 beta 1-expressing keratinocytes caused a shift towards long variant expression, while Raf-1-mediated activation of ERK in alpha 3-null keratinocytes dramatically enhanced short variant expression, indicating a role for ERK/MAPK signaling in alpha 3 beta 1-mediated selection of the proximal polyadenylation site. These findings identify a novel mode of integrin alpha 3 beta 1-mediated gene regulation through alternative polyadenylation.	[Missan, Dara S.; Mitchell, Kara; Subbaram, Sita; DiPersio, C. Michael] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	DiPersio, CM (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	dipersm@mail.amc.edu		Missan, Dara/0000-0001-8094-5626	National Institutes of Health from the National Cancer Institute [R01CA129637]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR056390]; NATIONAL CANCER INSTITUTE [R01CA129637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056390] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants to CMD from the National Cancer Institute (R01CA129637) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR056390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DiPersio CM, 2000, J CELL SCI, V113, P2909; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Eberhardt W, 2002, MOL ENDOCRINOL, V16, P1752, DOI 10.1210/me.2001-0278; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Ernst J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007469; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Headley VV, 2004, MOL CELL BIOCHEM, V258, P109, DOI 10.1023/B:MCBI.0000012841.03400.42; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kim S, 2009, PHYTOMEDICINE, V16, P573, DOI 10.1016/j.phymed.2008.11.006; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; LEBWOHL DE, 1994, ONCOGENE, V9, P1925; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Liu DL, 2008, J BIOL CHEM, V283, P28010, DOI 10.1074/jbc.M804895200; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Longmate WM, 2014, J INVEST DERMATOL, V134, P1609, DOI 10.1038/jid.2014.10; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; MASURE S, 1993, EUR J BIOCHEM, V218, P129, DOI 10.1111/j.1432-1033.1993.tb18359.x; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-5; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Missan DS, 2014, J INVEST DERMATOL, V134, P2418, DOI 10.1038/jid.2014.166; Missan DS, 2012, CRIT REV EUKAR GENE, V22, P309, DOI 10.1615/CritRevEukarGeneExpr.v22.i4.50; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Morris AR, 2012, CLIN CANCER RES, V18, P5256, DOI 10.1158/1078-0432.CCR-12-0543; Naipauer J, 2013, BIOCHEM J, V454, P345, DOI 10.1042/BJ20130062; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; OKADA A, 1995, GENE, V164, P317, DOI 10.1016/0378-1119(95)00447-E; Poudel B, 2014, ONCOL LETT, V7, P215, DOI 10.3892/ol.2013.1655; Sachs N, 2012, P NATL ACAD SCI USA, V109, P21468, DOI 10.1073/pnas.1204614110; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sehgal I, 1999, MOL BIOL CELL, V10, P407, DOI 10.1091/mbc.10.2.407; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Subbaram S, 2014, J CELL SCI, V127, P1179, DOI 10.1242/jcs.131227; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; TANAKA H, 1993, BIOCHEM BIOPH RES CO, V190, P732, DOI 10.1006/bbrc.1993.1110; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Touriol C, 1999, J BIOL CHEM, V274, P21402, DOI 10.1074/jbc.274.30.21402; Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Xia YY, 1996, FEBS LETT, V382, P285, DOI 10.1016/0014-5793(96)00185-8; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Yanez-Mo M, 2008, BLOOD, V112, P3217, DOI 10.1182/blood-2008-02-139394; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	77	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119539	10.1371/journal.pone.0119539	http://dx.doi.org/10.1371/journal.pone.0119539			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751421	Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700026
J	Ardelt, PU; Ebbing, J; Adams, F; Reiss, C; Arap, W; Pasqualini, R; Bachmann, A; Wetterauer, U; Riedmiller, H; Kneitz, B				Ardelt, Peter U.; Ebbing, Jan; Adams, Fabian; Reiss, Cora; Arap, Wadih; Pasqualini, Renata; Bachmann, Alexander; Wetterauer, Ulrich; Riedmiller, Hubertus; Kneitz, Burkhard			An Anti-Ubiquitin Antibody Response in Transitional Cell Carcinoma of the Urinary Bladder	PLOS ONE			English	Article							BACILLE CALMETTE-GUERIN; CANCER SURVEILLANCE; IMMUNE-RESPONSE; TUMOR-CELLS; UBIQUITIN; IMMUNOTHERAPY; PROTEIN; BIOMARKERS; SYSTEM; BCG	Background To use combinatorial epitope mapping ("fingerprinting") of the antibody response to identify targets of the humoral immune response in patients with transitional cell carcinoma (TCC) of the bladder. Methods A combinatorial random peptide library was screened on the circulating pool of immunoglobulins purified from an index patient with a high risk TCC (pTa high grade plus carcinoma in situ) to identify corresponding target antigens. A patient cohort was investigated for antibody titers against ubiquitin. Results We selected, isolated, and validated an immunogenic peptide motif from ubiquitin as a dominant epitope of the humoral response. Patients with TCC had significantly higher antibody titers against ubiquitin than healthy donors (p<0.007), prostate cancer patients (p<0.0007), and all patients without TCC taken together (p<0.0001). Titers from superficial tumors were not significantly different from muscle invasive tumors (p = 0.0929). For antibody response against ubiquitin, sensitivity for detection of TCC was 0.44, specificity 0.96, positive predictive value 0.96 and negative predictive value 0.41. No significant titer changes were observed during the standard BCG induction immunotherapy. Conclusions This is the first report to demonstrate an anti-ubiquitin antibody response in patients with TCC. Although sensitivity of antibody production was low, a high specificity and positive predictive value make ubiquitin an interesting candidate for further diagnostic and possibly immune modulating studies.	[Ardelt, Peter U.; Ebbing, Jan; Bachmann, Alexander] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland; [Ardelt, Peter U.; Adams, Fabian; Wetterauer, Ulrich] Univ Freiburg, Sch Med, Dept Urol & Pediat Urol, D-79106 Freiburg, Germany; [Ardelt, Peter U.; Riedmiller, Hubertus; Kneitz, Burkhard] Bavarian Julius Maximilians Univ, Sch Med, Dept Urol, Wurzburg, Germany; [Reiss, Cora] Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Ctr Thrombosis & Hemostasis, D-55122 Mainz, Germany; [Arap, Wadih; Pasqualini, Renata] Univ New Mexico, Sch Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Arap, Wadih; Pasqualini, Renata] Univ New Mexico, Sch Med, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA	University of Basel; University of Freiburg; University of Wurzburg; Johannes Gutenberg University of Mainz; University of New Mexico; University of New Mexico	Ardelt, PU (corresponding author), Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.	Peter.Ardelt@usb.ch			medac, Wedel, Germany	medac, Wedel, Germany	This work was partly funded by a non restricted fund from medac, Wedel, Germany. The funders had no role in study design, data collection and Analysis, decision to publish or preparation of the manuscript. The other funding was internal from our institution.	Ardelt PU, 2010, CANCER-AM CANCER SOC, V116, P600, DOI 10.1002/cncr.24770; Atkins H, 2003, BRIT J CANCER, V89, P2312, DOI 10.1038/sj.bjc.6601474; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; BALDWIN RW, 1966, INT J CANCER, V1, P257, DOI 10.1002/ijc.2910010305; Bubenik J, 1973, INT J CANC, P11; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chamie K, 2013, CANCER-AM CANCER SOC, V119, P3219, DOI 10.1002/cncr.28147; Chen D, 2010, CURR PROTEIN PEPT SC, V11, P459, DOI 10.2174/138920310791824057; Choi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067891; Cooksley CD, 2008, UROLOGY, V71, P519, DOI 10.1016/j.urology.2007.10.056; HANSSON Y, 1983, CANCER IMMUNOL IMMUN, V16, P23; Heo CK, 2012, BMB REP, V45, P677, DOI 10.5483/BMBRep.2012.45.12.236; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Lamm DL, 2000, EUR UROL, V37, P41, DOI 10.1159/000052391; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Luo Y, 2001, CLIN EXP IMMUNOL, V123, P264, DOI 10.1046/j.1365-2249.2001.01428.x; LUTZEYER W, 1982, J UROLOGY, V127, P250, DOI 10.1016/S0022-5347(17)53725-8; Masdehors P, 2000, BLOOD, V96, P269, DOI 10.1182/blood.V96.1.269.013k10_269_274; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Pasqualini R, 2000, IN VIVO PHAGE DISPLA, P1; Pisipati S, 2009, BJU INT, V103, P1453, DOI 10.1111/j.1464-410X.2009.08441.x; Sharma P, 2007, SEMIN ONCOL, V34, P165, DOI 10.1053/j.seminoncol.2006.12.004; Smith GD, 2013, DIAGN CYTOPATHOL, V41, P437, DOI 10.1002/dc.22881; STUDER UE, 1985, UROL RES, V13, P123; Tilki D, 2011, EUR UROL, V60, P484, DOI 10.1016/j.eururo.2011.05.053; TROYE M, 1980, INT J CANCER, V25, P45, DOI 10.1002/ijc.2910250106; WANG GP, 1991, BRAIN RES, V566, P146, DOI 10.1016/0006-8993(91)91692-T; Yoder BJ, 2007, AM J CLIN PATHOL, V127, P295, DOI 10.1309/ADJL7E810U1H42BJ; Yossepowitch O, 2007, J UROLOGY, V177, P1277, DOI 10.1016/j.juro.2006.11.066; Zlotta AR, 2000, INT J CANCER, V87, P844, DOI 10.1002/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5; Zlotta AR, 1997, CLIN EXP IMMUNOL, V109, P157, DOI 10.1046/j.1365-2249.1997.4141313.x	32	0	0	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118646	10.1371/journal.pone.0118646	http://dx.doi.org/10.1371/journal.pone.0118646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742283	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100027
J	Balfer, J; Bajorath, J				Balfer, Jenny; Bajorath, Juergen			Systematic Artifacts in Support Vector Regression-Based Compound Potency Prediction Revealed by Statistical and Activity Landscape Analysis	PLOS ONE			English	Article							HEURISTIC METHOD; MACHINE; CHEMOINFORMATICS; REPRESENTATIONS; CLASSIFICATION; MODELS; UREAS	Support vector machines are a popular machine learning method for many classification tasks in biology and chemistry. In addition, the support vector regression (SVR) variant is widely used for numerical property predictions. In chemoinformatics and pharmaceutical research, SVR has become the probably most popular approach for modeling of non-linear structure-activity relationships (SARs) and predicting compound potency values. Herein, we have systematically generated and analyzed SVR prediction models for a variety of compound data sets with different SAR characteristics. Although these SVR models were accurate on the basis of global prediction statistics and not prone to overfitting, they were found to consistently mispredict highly potent compounds. Hence, in regions of local SAR discontinuity, SVR prediction models displayed clear limitations. Compared to observed activity landscapes of compound data sets, landscapes generated on the basis of SVR potency predictions were partly flattened and activity cliff information was lost. Taken together, these findings have implications for practical SVR applications. In particular, prospective SVR-based potency predictions should be considered with caution because artificially low predictions are very likely for highly potent candidate compounds, the most important prediction targets.	[Balfer, Jenny; Bajorath, Juergen] Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, D-53113 Bonn, Germany	University of Bonn	Bajorath, J (corresponding author), Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, Dahlmannstr 2, D-53113 Bonn, Germany.	bajorath@bit.uni-bonn.de						[Anonymous], 2011, MACCS STRUCT KEYS; [Anonymous], OECHEM TK VERS 2 0 0; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Balfer J, 2015, 31 CHEMBL DATA SETS; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dimova D, 2013, J CHEM INF MODEL, V53, P2275, DOI 10.1021/ci4004078; Drucker H, 1997, ADV NEUR IN, V9, P155; Fatemi MH, 2007, BIOORGAN MED CHEM, V15, P7746, DOI 10.1016/j.bmc.2007.08.057; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gombar VK, 2013, J CHEM INF MODEL, V53, P948, DOI 10.1021/ci400001u; Leong MK, 2007, CHEM RES TOXICOL, V20, P217, DOI 10.1021/tx060230c; Lind P, 2003, J CHEM INF COMP SCI, V43, P1855, DOI 10.1021/ci034107s; Pavlidis P, 2004, BIOINFORMATICS, V20, P586, DOI 10.1093/bioinformatics/btg461; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peltason L, 2007, J MED CHEM, V50, P5571, DOI 10.1021/jm0705713; Peltason L, 2010, J CHEM INF MODEL, V50, P1021, DOI 10.1021/ci100091e; Ralaivola L, 2005, NEURAL NETWORKS, V18, P1093, DOI 10.1016/j.neunet.2005.07.009; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Song MH, 2006, J CHEM INF MODEL, V46, P392, DOI 10.1021/ci050308f; Stumpfe D, 2014, J MED CHEM, V57, P18, DOI 10.1021/jm401120g; Sun M, 2009, CHEM BIOL DRUG DES, V73, P644, DOI 10.1111/j.1747-0285.2009.00814.x; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Varnek A, 2012, J CHEM INF MODEL, V52, P1413, DOI 10.1021/ci200409x; Vogt M, 2012, BIOORGAN MED CHEM, V20, P5317, DOI 10.1016/j.bmc.2012.03.030; Wassermann AM, 2010, J MED CHEM, V53, P8209, DOI 10.1021/jm100933w; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Xue CX, 2004, J CHEM INF COMP SCI, V44, P1693, DOI 10.1021/ci049820b; Yuan YN, 2009, EUR J MED CHEM, V44, P25, DOI 10.1016/j.ejmech.2008.03.004	33	13	13	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119301	10.1371/journal.pone.0119301	http://dx.doi.org/10.1371/journal.pone.0119301			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742011	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100102
J	Huang, WJ; Jeng, YM; Lai, HS; Fong, IU; Sheu, FYB; Lai, PL; Yuan, RH				Huang, Wei-Ju; Jeng, Yung-Ming; Lai, Hong-Shiee; Fong, Iok-U; Sheu, Fang-Yu Bonnie; Lai, Po-Lin; Yuan, Ray-Hwang			Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma	PLOS ONE			English	Article							CA-IX; EARLY RECURRENCE; BREAST-CANCER; ALPHA-FETOPROTEIN; OSTEOPONTIN; TUMORS; PROGRESSION; METASTASIS; PROTEIN; STAGE	Carbonic anhydrase IX (CA-IX), a hypoxia marker, correlates with tumor progression in a variety of human cancers. However, the role of CA-IX in hepatocellular carcinomas (HCCs) remains largely unknown. We examined the expression of 277 unifocal, resectable, primary HCC tumors using immunohistochemistry. The CA-IX protein was expressed in 110 of the 227 (48.5%) HCC tumors. The expression of CA-IX correlated with younger age (P = 0.0446), female sex (P = 0.0049), high serum a-fetoprotein levels (P<1x10(-6)), larger tumor size (P = 0.0031), high tumor grade P<1x10(-6)) and high tumor stage (P = 1.5x10(-6)). Patients with HCC tumors that expressed CA-IX were more likely to have lower 5-year disease-free survival (DFS; P = 0.0001) and 5-year overall survival (OS; P< 1x10(-6)). The multivariate analysis indicated that CA-IX expression was an independent predictor for high tumor stage (P = 0.0047) and DFS (P = 0.0456), and a borderline predictor for OS (P = 0.0762). Furthermore, CA-IX expression predicted poor DFS and OS in patients with high tumor stage (P = 0.0004 and P< 1x10(-6), respectively). Interestingly, CA-IX expression might contribute to the worse prognosis of female patients with advanced HCCs. Our study indicates the expression of the CA-IX protein is a crucial predictor of poor prognosis in resectable HCC, and it is also an unfavorable prognostic predictor in HCC patients with high tumor stage.	[Huang, Wei-Ju; Jeng, Yung-Ming; Fong, Iok-U] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10051, Taiwan; [Huang, Wei-Ju] Hsin Sheng Coll Med Care & Management, Dept Nursing, Longtan Township 32544, Taoyuan County, Taiwan; [Jeng, Yung-Ming; Lai, Po-Lin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10051, Taiwan; [Jeng, Yung-Ming; Lai, Hong-Shiee; Lai, Po-Lin; Yuan, Ray-Hwang] Natl Taiwan Univ, Coll Med, Taipei 10051, Taiwan; [Lai, Hong-Shiee; Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 10051, Taiwan; [Sheu, Fang-Yu Bonnie] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei 10051, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; National Taiwan University; National Taiwan University Hospital	Yuan, RH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, 1 Jen Ai Rd,Sect 1, Taipei 10051, Taiwan.	d83409009@ntu.edu.tw		Lai, Hong-Shiee/0000-0002-7958-2183; Yuan, Ray-Hwang/0000-0002-2767-633X; JENG, YUNG-MING/0000-0002-3878-4491				Abaza M, 2013, EXPERT REV ANTICANC, V13, P1229, DOI 10.1586/14737140.2013.843455; Bache M, 2006, INT J RADIAT ONCOL, V66, P1481, DOI 10.1016/j.ijrobp.2006.07.1376; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Brennan DJ, 2006, CLIN CANCER RES, V12, P6421, DOI 10.1158/1078-0432.CCR-06-0480; Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; Dong ZZ, 2013, MINI-REV MED CHEM, V13, P1295; Driessen A, 2006, ANN SURG, V243, P334, DOI 10.1097/01.sla.0000201452.09591.f3; Eckert AW, 2010, J ORAL PATHOL MED, V39, P313, DOI 10.1111/j.1600-0714.2009.00829.x; Edge SB, 2010, AJCC CANC STAGING MA; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Farinati F, 2009, EUR J GASTROEN HEPAT, V21, P1212, DOI 10.1097/MEG.0b013e32831a86f8; Fiaschi T, 2013, CELL CYCLE, V12, P1791, DOI 10.4161/cc.24902; Genega EM, 2010, AM J CLIN PATHOL, V134, P873, DOI 10.1309/AJCPPPR57HNJMSLZ; Giannini EG, 2015, HEPATOLOGY, V61, P184, DOI 10.1002/hep.27443; Haapasalo JA, 2006, CLIN CANCER RES, V12, P473, DOI 10.1158/1078-0432.CCR-05-0848; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Kaluz S, 2009, BIOCHIM BIOPHYS ACTA, V1795, P167; Lee-Kong SA, 2012, DIS COLON RECTUM, V55, P990, DOI 10.1097/DCR.0b013e31825bd80c; Li SS, 2011, HEPAT MON, V11, P821, DOI 10.5812/kowsar.1735143X.771; Liao SY, 2010, GYNECOL ONCOL, V116, P452, DOI 10.1016/j.ygyno.2009.10.062; Liu ZR, 2014, HISTOPATHOLOGY, V64, P921, DOI 10.1111/his.12341; Lock FE, 2013, ONCOGENE, V32, P5210, DOI 10.1038/onc.2012.550; Loncaster JA, 2001, CANCER RES, V61, P6394; Luong-Player A, 2014, AM J CLIN PATHOL, V141, P219, DOI 10.1309/AJCPVJDS28KNYZLD; Maseide K, 2004, CLIN CANCER RES, V10, P4464, DOI 10.1158/1078-0432.CCR-03-0541; McDonald PC, 2012, ONCOTARGET, V3, P84, DOI 10.18632/oncotarget.422; Nurwidya F, 2012, ANAT CELL BIOL, V45, P73, DOI 10.5115/acb.2012.45.2.73; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; PASTOREK J, 1994, ONCOGENE, V9, P2877; Peng SY, 2005, INT J ONCOL, V26, P1053; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Semenza G.L., 2002, TRENDS MOL MED; Sokkar P, 2012, J MOL MODEL, V18, P1691, DOI 10.1007/s00894-011-1150-0; Svastova E, 2012, J BIOL CHEM, V287, P3392, DOI 10.1074/jbc.M111.286062; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Takacova M, 2014, AM J PATHOL, V184, P953, DOI 10.1016/j.ajpath.2014.01.002; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Tanaka M, 2013, MOL MED REP, V7, P365, DOI 10.3892/mmr.2012.1201; Troost EGC, 2005, RADIOTHER ONCOL, V76, P194, DOI 10.1016/j.radonc.2005.06.031; Wykoff CC, 2000, CANCER RES, V60, P7075; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu SJ, 2011, ACTA PHARMACOL SIN, V32, P912, DOI 10.1038/aps.2011.24; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Yuan RH, 2014, J GASTROINTEST SURG, V18, P1784, DOI 10.1007/s11605-014-2596-z; Yuan RH, 2005, CLIN CANCER RES, V11, P2568, DOI 10.1158/1078-0432.CCR-04-2039	50	20	22	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119181	10.1371/journal.pone.0119181	http://dx.doi.org/10.1371/journal.pone.0119181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738958	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900097
J	Soffker, M; Trathan, P; Clark, J; Collins, MA; Belchier, M; Scott, R				Soeffker, Marta; Trathan, Phil; Clark, James; Collins, Martin A.; Belchier, Mark; Scott, Robert			The Impact of Predation by Marine Mammals on Patagonian Toothfish Longline Fisheries	PLOS ONE			English	Article							WHALE ORCINUS-ORCA; KILLER WHALES; SPERM-WHALES; SOUTH-GEORGIA; TWEEDIE DISTRIBUTION; DEPREDATION; CATCH; MOVEMENTS; PATTERNS; BYCATCH	Predatory interaction of marine mammals with longline fisheries is observed globally, leading to partial or complete loss of the catch and in some parts of the world to considerable financial loss. Depredation can also create additional unrecorded fishing mortality of a stock and has the potential to introduce bias to stock assessments. Here we aim to characterise depredation in the Patagonian toothfish (Dissostichus eleginoides) fishery around South Georgia focusing on the spatio-temporal component of these interactions. Antarctic fur seals (Arctocephalus gazella), sperm whales (Physeter macrocephalus), and orcas (Orcinus orca) frequently feed on fish hooked on longlines around South Georgia. A third of longlines encounter sperm whales, but loss of catch due to sperm whales is insignificant when compared to that due to orcas, which interact with only 5% of longlines but can take more than half of the catch in some cases. Orca depredation around South Georgia is spatially limited and focused in areas of putative migration routes, and the impact is compounded as a result of the fishery also concentrating in those areas at those times. Understanding the seasonal behaviour of orcas and the spatial and temporal distribution of "depredation hot spots" can reduce marine mammal interactions, will improve assessment and management of the stock and contribute to increased operational efficiency of the fishery. Such information is valuable in the effort to resolve the human-mammal conflict for resources.	[Soeffker, Marta; Scott, Robert] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Trathan, Phil; Belchier, Mark] British Antarctic Survey, Cambridge CB3 0ET, England; [Clark, James] Marine Resources Assessment Grp, London, England; [Belchier, Mark] Govt South Georgia & South Sandwich Isl, Stanley, Hong Kong, Peoples R China	Centre for Environment Fisheries & Aquaculture Science; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Soffker, M (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Pakefield Rd, Lowestoft, Suffolk, England.	marta.soffker@cefas.co.uk	Söffker, M./D-3258-2009; , Martin/ABE-6728-2020; Collins, Martin A/J-8560-2017	Söffker, M./0000-0002-7131-5486; 	Government of South Georgia and the South Sandwich Islands; Cefas Seedcorn funds; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Government of South Georgia and the South Sandwich Islands; Cefas Seedcorn funds; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project was funded by the Government of South Georgia and the South Sandwich Islands (MS, MAC, RS) with additional support from Cefas Seedcorn funds (MS). The funding bodies had no role in the study design, data analysis or decision to publish, but contributed to the preparation of the final manuscript.	Agnew DJ, 2000, CCAMLR SCI, V7, P119; Ainley David G., 2009, Aquatic Mammals, V35, P334, DOI 10.1578/AM.35.3.2009.334; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Atkinson A, 2001, MAR ECOL PROG SER, V216, P279, DOI 10.3354/meps216279; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Candy SG, 2004, CCAMLR SCI, V11, P59; Clark JM, 2010, CCAMLR SCI, V17, P163; CLARKE M R, 1980, Discovery Reports, V37, P1; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Collins MA, 2007, MAR BIOL, V152, P135, DOI 10.1007/s00227-007-0667-3; Collins MA, 2006, ADV MAR BIOL, V50, P191, DOI 10.1016/S0065-2881(05)50003-8; Crawley M.J., 2007, R BOOK; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Dunn P. K., 2013, R PACKAGE VERSION, V2, P7; Durban JW, 2012, BIOL LETTERS, V8, P274, DOI 10.1098/rsbl.2011.0875; Foote AD, 2010, EVOL ECOL, V24, P803, DOI 10.1007/s10682-009-9337-x; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Gilman Eric, 2006, Journal of Cetacean Research and Management, V8, P215; GUINET C., 2011, J AM CET SOC, V40, P33; Hamer DJ, 2012, MAR MAMMAL SCI, V28, pE345, DOI 10.1111/j.1748-7692.2011.00544.x; Hucke-Gaete R, 2004, CCAMLR SCI, V11, P127; Kock KH, 2006, POLAR BIOL, V29, P379, DOI 10.1007/s00300-005-0067-4; Moreno CA, 2008, CCAMLR SCI, V15, P79; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Noren DP, 2011, MAR MAMMAL SCI, V27, P60, DOI 10.1111/j.1748-7692.2010.00386.x; Peterson MJ, 2013, ICES J MAR SCI, V70, P1220, DOI 10.1093/icesjms/fst045; Peterson MJ, 2013, MAR POLICY, V42, P315, DOI 10.1016/j.marpol.2013.04.001; Pitman R., 2011, J AM CETACEAN SOC, V40, P39, DOI 10.1098/rsbl.2011.0875; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Purves MG, 2004, CCAMLR SCI, V11, P111; R Core Team, 2021, R LANGUAGE ENV STAT; Rabearisoa N, 2012, J EXP MAR BIOL ECOL, V432, P55, DOI 10.1016/j.jembe.2012.07.004; REID K, 1995, ANTARCT SCI, V7, P241, DOI 10.1017/S0954102095000344; Ripley B, 2019, TREE CLASSIFICATION; Roche C, 2007, CCAMLR SCI, V14, P67; Shono H, 2008, FISH RES, V93, P154, DOI 10.1016/j.fishres.2008.03.006; Staniland IJ, 2010, MAR BIOL, V157, P2383, DOI 10.1007/s00227-010-1503-8; Straley JM, 2014, ENDANGER SPECIES RES, V24, P125, DOI 10.3354/esr00595; Tixier P, 2010, CCAMLR SCI, V17, P179; Trathan P., 1998, CCAMLR SCI, V5, P9; Venables WN., 2002, MODERN APPL STAT S, V4; Visser Ingrid N., 2000, Aquatic Mammals, V26, P241	43	26	27	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118113	10.1371/journal.pone.0118113	http://dx.doi.org/10.1371/journal.pone.0118113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738698	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000350685900022
J	Yang, C; Li, J; Lin, H; Zhao, KQ; Zheng, CQ				Yang, Chen; Li, Jing; Lin, Hai; Zhao, Keqing; Zheng, Chunquan			Nasal Mucosa Derived-Mesenchymal Stem Cells from Mice Reduce Inflammation via Modulating Immune Responses	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ALLERGIC RHINITIS	Mesenchymal stem cells (MSCs) have arisen the attention to be a new attractive therapeutic tool treating autoimmune diseases such as allergic rhinitis (AR). AR is a chronic reversible allergic inflammation caused by the excessive activation of T-helper 2 (Th2) cells. Recently, MSCs have been proposed as a new therapy of AR as it can suppress some cytokines to control allogeneic Th2 response and functions. However, how MSCs function to reduce inflammation remains unclear. In this study, we aimed to investigate the role of ectomesenchymal stem cells (ECTO-MSCs) derived from nasal mucosa in eosinophilic inflammation and how it affects some immunoglobulins and cytokines. We used ovalbumin (OVA) as a sensitizer to induce nasal inflammation in mice by both injection and inhalation. In order to obtain deeper insights into the influences of ECTO-MSCs on nasal inflammation, the migration of ECTO-MSCs was assessed, the numbers of eosinophils and sneezing were counted, and several immunoglobulins and cytokines were measured. Here we show the ECTO-MSCs are able to migrate to inflammation site via tail vein injection. Eosinophils and sneezing were suppressed by ECTO-MSCs. Interestingly, IgE, interleukin (IL)-4, IL-5 and IL-10 secreted by Th-2 cells were down-regulated by ECTO-MSCs whereas IgG2 and IFN-gamma were up-regulated. In conclusion, we have observed that ECTO-MSCs are associated with enhanced Th-1 immune response to nasal inflammation and reduced Th-2 immune response. Given the contributions of Th-2 cells to AR, the injection of ECTO-MSCs can be a promising therapy of AR through balancing immune response.	[Yang, Chen; Li, Jing; Lin, Hai; Zhao, Keqing; Zheng, Chunquan] Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Yang, Chen] Shanghai Jiao Tong Univ, Dept Otolaryngol, Ruijin Hosp, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Zheng, CQ (corresponding author), Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China.	chunquanzheng@163.com			National Natural Science Foundation of China (NSFC) [81470672]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is funded by the National Natural Science Foundation of China (NSFC, 81470672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Ciprandi G, 2005, OTOLARYNG HEAD NECK, V133, P429, DOI 10.1016/j.otohns.2005.05.049; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Fu QL, 2012, ALLERGY, V67, P1215, DOI [10.1111/j.1398-9995.2012.02875.x, 10.1111/j.1398-9995.2012.02875.x.]; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Kelly JL, 1997, SURGERY, V122, P146, DOI 10.1016/S0039-6060(97)90003-9; Kidd Parris, 2003, Altern Med Rev, V8, P223; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; MAGGI E, 1994, ANN NY ACAD SCI, V725, P2, DOI 10.1111/j.1749-6632.1994.tb39784.x; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x; Wise AF, 2012, NEPHROLOGY, V17, P1, DOI 10.1111/j.1440-1797.2011.01501.x; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	24	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118849	10.1371/journal.pone.0118849	http://dx.doi.org/10.1371/journal.pone.0118849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739057	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900081
J	Lee, DH; Ng, J; Kim, SB; Sonn, CH; Lee, KM; Han, SB				Lee, Dae-Hee; Ng, Joanne; Kim, Sang-Beom; Sonn, Chung Hee; Lee, Kyung-Mi; Han, Seung-Beom			Effect of Donor Age on the Proportion of Mesenchymal Stem Cells Derived from Anterior Cruciate Ligaments	PLOS ONE			English	Article							SYNOVIAL-FLUID; STROMAL CELLS; TRABECULAR BONE; KNEE-JOINT; EXPRESSION; CARTILAGE; THROMBOSPONDIN-4; OSTEOARTHRITIS; CHONDROCYTES; INFLAMMATION	The characteristics of anterior cruciate ligament (ACL)-derived mesenchymal stem cells (MSCs), such as proportion and multilineage potential, can be affected by donor age. However, the qualitative and quantitative features of ACL MSCs isolated from younger and older individuals have not yet been compared directly. This study assessed the phenotypic and functional differences in ACL-MSCs isolated from younger and older donors and evaluated the correlation between ACL-MSC proportion and donor age. Torn ACL remnants were harvested from 36 patients undergoing ACL reconstruction (young: 29.67 +/- 10.92 years) and 33 undergoing TKA (old: 67.96 +/- 5.22 years) and the proportion of their MSCs were measured. The mean proportion of MSCs was slightly higher in older ACL samples of the TKA group than of the younger ACL reconstruction group (19.69 +/- 8.57% vs. 15.33 +/- 7.49%, p = 0.024), but the proportions of MSCs at passages 1 and 2 were similar. MSCs from both groups possessed comparable multilineage potentiality, as they could be differentiated into adipocytes, osteocytes, and chondrocytes at similar level. No significant correlations were observed between patient age and MSC proportions at passages 0-2 or between age and MSC proportion in both the ACL reconstruction and TKA groups. Multiple linear regression analysis found no significant predictor of MSC proportion including donor age for each passage. Microarray analysis identified several genes that were differentially regulated in ACLMSCs from old TKA patients compared to young ACL reconstruction patients. Genes of interest encode components of the extracellular matrix (ECM) and may thus play a crucial role in modulating tissue homeostasis, remodeling, and repair in response to damage or disease. In conclusion, the proportion of freshly isolated ACL-MSC was higher in elderly TKA patients than in younger patients with ACL tears, but their phenotypic and multilineage potential were comparable.	[Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea; [Ng, Joanne; Sonn, Chung Hee; Lee, Kyung-Mi] Korea Univ, Coll Med, Dept Biochem & Mol Biol, Div Brain,Korea Program Biomed Sci 21, Seoul 136705, South Korea; [Kim, Sang-Beom] Barunmadi Orthopaed, Songnam, Gyeonggi Do, South Korea; [Han, Seung-Beom] Korea Univ, Coll Med, Dept Orthopaed Surg, Seoul 136705, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, KM (corresponding author), Korea Univ, Coll Med, Dept Biochem & Mol Biol, Div Brain,Korea Program Biomed Sci 21, Seoul 136705, South Korea.	kyunglee@korea.ac.kr; oshan@korea.ac.kr	lee, dae hee/I-9390-2017	Lee, Kyung-Mi/0000-0002-5378-9258	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013R1A1A2A10010605, NRF-K20703001994-12A0500-03610, NRF-2013M3A9D3045719]; Korea University Grants [K1423281]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea University Grants	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A2A10010605, NRF-K20703001994-12A0500-03610, and NRF-2013M3A9D3045719). This work was also supported by Korea University Grants (K1423281). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng MT, 2009, CELL PROLIFERAT, V42, P448, DOI 10.1111/j.1365-2184.2009.00611.x; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; Elsaid KA, 2009, ARTHRITIS RHEUM-US, V60, P2997, DOI 10.1002/art.24800; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Frolova EG, 2014, MATRIX BIOL J INT SO; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Hasegawa A, 2012, ARTHRITIS RHEUM-US, V64, P696, DOI 10.1002/art.33417; HAUSER N, 1995, FEBS LETT, V368, P307, DOI 10.1016/0014-5793(95)00675-Y; Huang TF, 2008, CYTOTHERAPY, V10, P806, DOI 10.1080/14653240802474323; Jeong JA, 2005, STEM CELLS, V23, P584, DOI 10.1634/stemcells.2004-0304; Jones ARC, 2007, EUR CELLS MATER, V13, P40, DOI 10.22203/eCM.v013a04; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; Lee DH, 2011, CONNECT TISSUE RES, V52, P226, DOI 10.3109/03008207.2010.516850; Lee SY, 2008, BIOCHEM BIOPH RES CO, V376, P148, DOI 10.1016/j.bbrc.2008.08.138; Lemburg AK, 2004, VET IMMUNOL IMMUNOP, V97, P231, DOI 10.1016/j.vetimm.2003.09.007; Levy YD, 2013, ANN RHEUM DIS, V72, P271, DOI 10.1136/annrheumdis-2012-201730; Matsumoto T, 2012, STEM CELLS DEV, V21, P859, DOI 10.1089/scd.2010.0528; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Musumeci G, 2011, EXP BIOL MED, V236, P1333, DOI 10.1258/ebm.2011.011183; Noth U, 2002, J ORTHOP RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9; Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343; Ruan MZC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005409; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Schmidt TA, 2008, OSTEOARTHR CARTILAGE, V16, P90, DOI 10.1016/j.joca.2007.05.009; Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x	39	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117224	10.1371/journal.pone.0117224	http://dx.doi.org/10.1371/journal.pone.0117224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729860	gold, Green Published, Green Submitted			2022-12-26	WOS:000350684900011
J	Ninomiya, S; Kawano, M; Abe, T; Ishikawa, T; Takahashi, M; Tamura, M; Takahashi, Y; Nashimoto, M				Ninomiya, Sho; Kawano, Mitsuoki; Abe, Takashi; Ishikawa, Tatsuya; Takahashi, Masayuki; Tamura, Masato; Takahashi, Yoshiaki; Nashimoto, Masayuki			Potential Small Guide RNAs for tRNase Z(L) from Human Plasma, Peripheral Blood Mononuclear Cells, and Cultured Cell Lines	PLOS ONE			English	Article							HEPTAMER-TYPE SGRNA; Y RNAS; GENE-EXPRESSION; RIBOSOMAL-RNA; CLEAVAGE; ENDORIBONUCLEASE; ESTABLISHMENT; DIRECTION; APOPTOSIS; PROTEINS	Several pieces of evidence suggest that small RNA degradation products together with tRNase Z(L) appear to form another layer of the whole gene regulatory network. The degraded RNAsuch as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. We were curious whether there exist RNAs in plasma that can function as sgRNAs for tRNase Z(L), whether these RNAs are working as signaling molecules between cells to fulfill physiological roles, and whether there are any differences in plasma sgRNA species and levels between normal and pathological conditions. Here, we analyzed small plasma RNAs from three healthy persons and three multiple myeloma patients for potential sgRNAs by deep sequencing. We also examined small RNAs from peripheral blood mononuclear cells (PBMC) of three healthy persons and three myeloma patients and from various cultured human cell lines for sgRNAs. We found that read-number distribution patterns of plasma and PBMC RNAs differ between persons in the range of 5-40 nt and that there are many RNA species that exist significantly more or less abundantly in the plasma or PBMC of the myeloma patients than those of the healthy persons. Furthermore, we found that there are many potential sgRNAs in the 5-40-nt RNAs and that, among them, a 31-nt RNA fragment derived from 94-nt Y4-RNA, which can function as a 50-half-tRNA-type sgRNA, is overwhelmingly abundant in the plasma of 2/3 of the examinees. These observations suggest that the gene regulatory network via tRNase Z(L) and sgRNA may be extended intercellularly.	[Ninomiya, Sho; Kawano, Mitsuoki; Ishikawa, Tatsuya; Takahashi, Masayuki; Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan; [Kawano, Mitsuoki; Tamura, Masato] Hokkaido Univ, Grad Sch Dent Med, Dept Biochem & Mol Biol, Sapporo, Hokkaido, Japan; [Abe, Takashi] Niigata Univ, Dept Informat Engn, Niigata, Japan; [Takahashi, Yoshiaki] Niigata Univ, Grad Sch Hlth Sci, Biochem Lab, Niigata, Japan; [Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Res Inst Hlth Living, Niigata, Japan	Niigata University; Hokkaido University; Niigata University; Niigata University; Niigata University	Nashimoto, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mnashimoto@nupals.ac.jp	tamura, masato/B-7304-2009; Kawano, Mitsuoki/AAT-7600-2020; Kawano, Mitsuoki/GLS-2569-2022	tamura, masato/0000-0003-3700-5203; Kawano, Mitsuoki/0000-0003-1570-0491	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; JSPS [23650618, 24659269]	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency (to MN), the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (to MN), and the JSPS KAKENHI Grant Numbers 23650618 (to MN) and 24659269 (to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dhahbi JM, 2013, PHYSIOL GENOMICS, V45, P990, DOI 10.1152/physiolgenomics.00129.2013; DICKE RH, 1965, ASTROPHYS J, V142, P414, DOI 10.1086/148306; Elbarbary RA, 2009, FEBS LETT, V583, P3241, DOI 10.1016/j.febslet.2009.09.015; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; GALLAGHER R, 1979, BLOOD, V54, P713; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GORSKI JL, 1987, J MOL EVOL, V24, P236, DOI 10.1007/BF02111237; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Habu Y, 2005, NUCLEIC ACIDS RES, V33, P235, DOI 10.1093/nar/gki164; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jackowiak P, 2011, NUCLEIC ACIDS RES, V39, P7361, DOI 10.1093/nar/gkr450; Kawano M, 2010, BIOTECHNIQUES, V49, P751, DOI 10.2144/000113516; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; NASHIMOTO M, 1991, BIOCHEM BIOPH RES CO, V178, P1247, DOI 10.1016/0006-291X(91)91027-A; NASHIMOTO M, 1995, NUCLEIC ACIDS RES, V23, P3642, DOI 10.1093/nar/23.18.3642; NASHIMOTO M, 1993, NUCLEIC ACIDS RES, V21, P4696, DOI 10.1093/nar/21.20.4696; Nashimoto M, 1996, RNA, V2, P523; NASHIMOTO M, 1992, NUCLEIC ACIDS RES, V20, P3737, DOI 10.1093/nar/20.14.3737; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; PENZIAS AA, 1965, ASTROPHYS J, V142, P419, DOI 10.1086/148307; Rutjes SK, 1999, J BIOL CHEM, V274, P24799, DOI 10.1074/jbc.274.35.24799; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Sim S, 2011, WIRES RNA, V2, P686, DOI 10.1002/wrna.85; Takahashi M, 2014, LEUKEMIA RES, V38, P808, DOI 10.1016/j.leukres.2014.03.021; Takahashi M, 2013, CANCER LETT, V328, P362, DOI 10.1016/j.canlet.2012.10.016; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038496; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; TOGAWA A, 1982, INT J CANCER, V29, P495, DOI 10.1002/ijc.2910290502; Tuck AC, 2011, TRENDS GENET, V27, P422, DOI 10.1016/j.tig.2011.06.001; Verhagen APM, 2011, BIOESSAYS, V33, P674, DOI 10.1002/bies.201100048; Watanabe N, 2013, LEUKEMIA RES, V37, P580, DOI 10.1016/j.leukres.2013.01.015; Zhang AT, 2011, J CELL SCI, V124, P2058, DOI 10.1242/jcs.086561	53	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118631	10.1371/journal.pone.0118631	http://dx.doi.org/10.1371/journal.pone.0118631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730316	Green Published, gold, Green Submitted			2022-12-26	WOS:000350684900022
J	Artamonov, MV; Jin, L; Franke, AS; Momotani, K; Ho, RY; Dong, XR; Majesky, MW; Somlyo, AV				Artamonov, Mykhaylo V.; Jin, Li; Franke, Aaron S.; Momotani, Ko; Ho, Ruoya; Dong, Xiu Rong; Majesky, Mark W.; Somlyo, Avril V.			Signaling Pathways That Control Rho Kinase Activity Maintain the Embryonic Epicardial Progenitor State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Guanine Nucleotide Exchange Factor (GEF); Ras Homolog Gene Family; Member A (RhoA); Signal Transduction; Transformation; Epac; Rnds; Epicardial Cells; Epithelial to Mesenchymal Transformation; p190RhoGAP	VASCULAR SMOOTH-MUSCLE; NUCLEOTIDE EXCHANGE FACTOR; CA2+ SENSITIZATION; RND PROTEINS; PROEPICARDIAL CELLS; GENE-EXPRESSION; AVIAN HEART; TGF-BETA; IN-VIVO; DIFFERENTIATION	This study identifies signaling pathways that play key roles in the formation and maintenance of epicardial cells, a source of progenitors for coronary smooth muscle cells (SMCs). After epithelial to mesenchymal transition (EMT), mesenchymal cells invade the myocardium to form coronary SMCs. RhoA/Rho kinase activity is required for EMT and for differentiation into coronary SMCs, whereas cAMP activity is known to inhibit EMT in epithelial cells by an unknown mechanism. We use outgrowth of epicardial cells from E9.5 isolated mouse proepicardium (PE) explants, wild type and Epac1 null E12.5 mouse heart explants, adult rat epicardial cells, and immortalized mouse embryonic epicardial cells as model systems to identify signaling pathways that regulate RhoA activity to maintain the epicardial progenitor state. We demonstrate that RhoA activity is suppressed in the epicardial progenitor state, that the cAMP-dependent Rap1 GTP exchange factor (GEF), Epac, known to down-regulate RhoA activity through activation of Rap1 GTPase activity increased, that Rap1 activity increased, and that expression of the RhoA antagonistic Rnd proteins known to activate p190RhoGAP increased and associated with p190RhoGAP. Finally, EMT is associated with increased p63RhoGEF and RhoGEF-H1 protein expression, increased GEF-H1 activity, with a trend in increased p63RhoGEF activity. EMT is suppressed by partial silencing of p63RhoGEF and GEF-H1. In conclusion, we have identified new signaling molecules that act together to control RhoA activity and play critical roles in the maintenance of coronary smooth muscle progenitor cells in the embryonic epicardium. We suggest that their eventual manipulation could promote revascularization after myocardial injury.	[Artamonov, Mykhaylo V.; Jin, Li; Franke, Aaron S.; Momotani, Ko; Ho, Ruoya; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Dong, Xiu Rong; Majesky, Mark W.] Seattle Childrens Res Inst, Seattle, WA 98101 USA	University of Virginia; Seattle Children's Hospital	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Artamonov, Mykhaylo/AAD-3488-2021	Artamonov, Mykhaylo/0000-0002-0848-2054; Majesky, Mark/0000-0003-4267-6220	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL123650] Funding Source: Medline; NIGMS NIH HHS [R01 GM086457] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artamonov MV, 2013, J BIOL CHEM, V288, P34030, DOI 10.1074/jbc.M113.514596; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cario-Toumaniantz C, 2003, J PHYSIOL-LONDON, V552, P403, DOI 10.1113/jphysiol.2003.047738; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Dokic D, 2006, DEV BIOL, V299, P489, DOI 10.1016/j.ydbio.2006.08.054; Dunkerley HA, 2002, MOL PHARMACOL, V61, P1033, DOI 10.1124/mol.61.5.1033; Foster R, 1996, MOL CELL BIOL, V16, P2689; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Goh LL, 2012, J BIOL CHEM, V287, P31311, DOI 10.1074/jbc.M111.327056; Gong MC, 1997, J BIOL CHEM, V272, P10704; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; Lonjedo M, 2013, J BIOL CHEM, V288, P30872, DOI 10.1074/jbc.M113.511105; Lu J, 2001, DEV BIOL, V240, P404, DOI 10.1006/dbio.2001.0403; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Mack CP, 1999, CIRC RES, V84, P852; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Momotani K, 2008, BIOCHEM J, V412, P265, DOI 10.1042/BJ20071501; Momotani K, 2012, TRENDS CARDIOVAS MED, V22, P122, DOI 10.1016/j.tcm.2012.07.007; Momotani K, 2011, CIRC RES, V109, P993, DOI 10.1161/CIRCRESAHA.111.248898; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Mori K, 2009, J BIOL CHEM, V284, P5067, DOI 10.1074/jbc.M806853200; Munoz-Chapuli R, 2002, TEX HEART I J, V29, P243; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; PerezPomares JM, 1997, DEV DYNAM, V210, P96, DOI 10.1002/(SICI)1097-0177(199710)210:2<96::AID-AJA3>3.0.CO;2-4; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Roscioni SS, 2011, J CELL MOL MED, V15, P1551, DOI 10.1111/j.1582-4934.2010.01150.x; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Santibanez JF, 2003, INT J CANCER, V107, P715, DOI 10.1002/ijc.11457; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tang XL, 2010, CIRC J, V74, P390, DOI 10.1253/circj.CJ-09-0923; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tsapara A, 2010, MOL BIOL CELL, V21, P860, DOI 10.1091/mbc.E09-07-0567; van Triest Miranda, 2004, Methods Mol Biol, V250, P97; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wuertz CM, 2010, FASEB J, V24, P4865, DOI 10.1096/fj.10-155499; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1332, DOI 10.1152/ajprenal.00131.2006; Zhou B, 2008, REGEN MED, V3, P633, DOI 10.2217/17460751.3.5.633; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	65	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10353	10367		10.1074/jbc.M114.613190	http://dx.doi.org/10.1074/jbc.M114.613190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25733666	hybrid, Green Published			2022-12-26	WOS:000353241100037
J	Hayes, ML; Dang, KN; Diaz, MF; Mulligan, RM				Hayes, Michael L.; Dang, Kim N.; Diaz, Michael F.; Mulligan, R. Michael			A Conserved Glutamate Residue in the C-terminal Deaminase Domain of Pentatricopeptide Repeat Proteins Is Required for RNA Editing Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytidine Deaminase; Metalloenzyme; RNA-binding Protein; RNA Editing; RNA Metabolism; Chloroplasts; Zinc; DYW Deaminase Domain	CYTIDINE DEAMINASE; PPR PROTEINS; PHYSCOMITRELLA-PATENS; ARABIDOPSIS; SITE; MITOCHONDRIA; ZINC; IDENTIFICATION; TRANSCRIPTS; SUBSTRATE	Background: Pentatricopeptide repeat (PPR) proteins that are required for RNA editing frequently include a C-terminal DYW deaminase domain. Results: Mutagenesis of a glutamate residue in the conserved deaminase HXE motif results in loss of editing activity. Conclusion: The glutamate residue is required for editing. Significance: The DYW deaminase domain of PPR proteins has the molecular characteristics of a deaminase. Many transcripts expressed from plant organelle genomes are modified by C-to-U RNA editing. Nuclear encoded pentatricopeptide repeat (PPR) proteins include an RNA binding domain that provides site specificity. In addition, many PPR proteins include a C-terminal DYW deaminase domain with characteristic zinc binding motifs (CXXC, HXE) and has recently been shown to bind zinc ions. The glutamate residue of the HXE motif is catalytically required in the reaction catalyzed by cytidine deaminase. In this work, we examine the activity of the DYW deaminase domain through truncation or mutagenesis of the HXE motif. OTP84 is required for editing three chloroplast sites, and transgenes expressing OTP84 with C-terminal truncations were capable of editing only one of the three cognate sites at high efficiency. These results suggest that the deaminase domain of OTP84 is required for editing two of the sites, but another deaminase is able to supply the deamination activity for the third site. OTP84 and CREF7 transgenes were mutagenized to replace the glutamate residue of the HXE motif, and transgenic plants expressing OTP84-E824A and CREF7-E554A were unable to efficiently edit the cognate editing sites for these genes. In addition, plants expressing CREF7-E554A exhibited substantially reduced capacity to edit a non-cognate site, rpoA C200. These results indicate that the DYW deaminase domains of PPR proteins are involved in editing their cognate editing sites, and in some cases may participate in editing additional sites in the chloroplast.	[Hayes, Michael L.; Dang, Kim N.; Diaz, Michael F.; Mulligan, R. Michael] Univ Calif Irvine, Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Mulligan, RM (corresponding author), Univ Calif Irvine, 5217 McGaugh Hall, Irvine, CA 92697 USA.	rmmullig@uci.edu			National Science Foundation [MCB-0929423, DGE-1321846]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0929423 (to R. M. M.). In addition, this material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant DGE-1321846 (to M. F. D.).	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Carlow DC, 1998, BIOCHEMISTRY-US, V37, P1199, DOI 10.1021/bi971731n; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Fraley R. T., 1985, NAT BIOTECHNOL, DOI [10.1038/nbt0785-62, DOI 10.1038/NBT0785-62]; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hayes ML, 2007, METHOD ENZYMOL, V424, P459, DOI 10.1016/S0076-6879(07)24021-2; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakajima Y, 2005, J PLANT PHYSIOL, V162, P1347, DOI 10.1016/j.jplph.2005.02.009; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2014, PLANT J, V80, P870, DOI 10.1111/tpj.12687; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; RAJASEKHAR VK, 1993, PLANT CELL, V5, P1843, DOI 10.2307/3869699; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Roberson LM, 2006, RNA, V12, P1907, DOI 10.1261/rna.166906; Rudinger M, 2011, PLANT J, V67, P370, DOI 10.1111/j.1365-313X.2011.04600.x; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Spears JL, 2011, J BIOL CHEM, V286, P20366, DOI 10.1074/jbc.M111.243568; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Uchida M, 2011, FEBS LETT, V585, P2367, DOI 10.1016/j.febslet.2011.06.009; Verbitskiy D, 2010, PLANT SIGNAL BEHAV, V5, P558, DOI 10.4161/psb.11095; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; YU W, 1995, J BIOL CHEM, V270, P18227, DOI 10.1074/jbc.270.31.18227; Zehrmann A, 2011, RNA BIOL, V8, P67, DOI 10.4161/rna.8.1.14298	50	51	52	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10136	10142		10.1074/jbc.M114.631630	http://dx.doi.org/10.1074/jbc.M114.631630			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739442	Green Published, hybrid			2022-12-26	WOS:000353241100020
J	Sloan, CD; Nordsborg, RB; Jacquez, GM; Raaschou-Nielsen, O; Meliker, JR				Sloan, Chantel D.; Nordsborg, Rikke B.; Jacquez, Geoffrey M.; Raaschou-Nielsen, Ole; Meliker, Jaymie R.			Space-Time Analysis of Testicular Cancer Clusters Using Residential Histories: A Case-Control Study in Denmark	PLOS ONE			English	Article							LAST 20 YEARS; BIRTH COHORT; RISK; TRENDS; STATE; USA	Though the etiology is largely unknown, testicular cancer incidence has seen recent significant increases in northern Europe and throughout many Western regions. The most common cancer in males under age 40, age period cohort models have posited exposures in the in utero environment or in early childhood as possible causes of increased risk of testicular cancer. Some of these factors may be tied to geography through being associated with behavioral, cultural, sociodemographic or built environment characteristics. If so, this could result in detectable geographic clusters of cases that could lead to hypotheses regarding environmental targets for intervention. Given a latency period between exposure to an environmental carcinogen and testicular cancer diagnosis, mobility histories are beneficial for spatial cluster analyses. Nearest-neighbor based Q-statistics allow for the incorporation of changes in residency in spatial disease cluster detection. Using these methods, a space-time cluster analysis was conducted on a population-wide case-control population selected from the Danish Cancer Registry with mobility histories since 1971 extracted from the Danish Civil Registration System. Cases (N=3297) were diagnosed between 1991 and 2003, and two sets of controls (N=3297 for each set) matched on sex and date of birth were included in the study. We also examined spatial patterns in maternal residential history for those cases and controls born in 1971 or later (N=589 case-control pairs). Several small clusters were detected when aligning individuals by year prior to diagnosis, age at diagnosis and calendar year of diagnosis. However, the largest of these clusters contained only 2 statistically significant individuals at their center, and were not replicated in SaTScan spatial-only analyses which are less susceptible to multiple testing bias. We found little evidence of local clusters in residential histories of testicular cancer cases in this Danish population.	[Sloan, Chantel D.; Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Sloan, Chantel D.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Nordsborg, Rikke B.; Raaschou-Nielsen, Ole] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Jacquez, Geoffrey M.] BioMedware Inc, Ann Arbor, MI USA; [Jacquez, Geoffrey M.] SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA; [Meliker, Jaymie R.] SUNY Stony Brook, Program Publ Hlth, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Brigham Young University; Danish Cancer Society; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sloan, CD (corresponding author), SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA.	chantel.sloan@byu.edu	Raaschou-Nielsen, Ole/GOK-0338-2022; Sloan-Aagard, Chantel/GWC-7572-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Baastrup Nordsborg, Rikke/0000-0003-4374-8230; Meliker, Jaymie/0000-0002-6408-8596	US National Institute of Environmental Health Sciences [R21 ES015501]; National Cancer Institute [R03 CA125827, 5R44CA135818-03, 5R44CA112743-03]; Danish Cancer Society [DP08090]; Danish Agency for Science, Technology and Innovation [08-032484]; NATIONAL CANCER INSTITUTE [R03CA125827] Funding Source: NIH RePORTER	US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Cancer Society(Danish Cancer Society); Danish Agency for Science, Technology and Innovation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the US National Institute of Environmental Health Sciences (http://www.niehs.nih.gov), R21 ES015501, the National Cancer Institute (http://www.cancer.gov) R03 CA125827, 5R44CA135818-03, and 5R44CA112743-03 *JM), the Danish Cancer Society (grant number DP08090) and the Danish Agency for Science, Technology and Innovation (http://ufm.dk en) (reference number 08-032484)(RBN/ORN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN LM, 1986, CANCER RES, V46, P4812; Condon SK, 2013, CRIT REV TOXICOL, V43, P73, DOI 10.3109/10408444.2012.743504; Ekbom A, 1998, APMIS, V106, P225, DOI 10.1111/j.1699-0463.1998.tb01340.x; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; Genin M, 2013, J PUBLIC HEALTH-HEID, V21, P497, DOI 10.1007/s10389-013-0580-9; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goodman M, 2013, CRIT REV TOXICOL, V43, P75, DOI 10.3109/10408444.2012.743505; Goovaerts P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-32; Jacobsen R, 2006, INT J ANDROL, V29, P199, DOI 10.1111/j.1365-2605.2005.00605.x; Jacquez Geoffrey M, 2005, Environ Health, V4, P4, DOI 10.1186/1476-069X-4-4; Levine PH, 2014, WORLD J CLIN ONCOL, V5, P539, DOI 10.5306/wjco.v5.i3.539; McGlynn KA, 2003, CANCER, V97, P63, DOI 10.1002/cncr.11054; McKiernan JM, 1999, J UROLOGY, V162, P361, DOI 10.1016/S0022-5347(05)68560-6; Myrup C, 2010, INT J CANCER, V126, P217, DOI 10.1002/ijc.24736; Nordsborg RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060800; Nordsborg RB, 2011, INT J CANCER, V129, P2485, DOI 10.1002/ijc.25897; Pedersen CB, 2006, DAN MED BULL, V53, P441; Prener A, 1996, EPIDEMIOLOGY, V7, P14, DOI 10.1097/00001648-199601000-00004; Rosen A, 2011, EUR UROL, V60, P374, DOI 10.1016/j.eururo.2011.05.004; Ruark E, 2013, NAT GENET, V45, P686, DOI 10.1038/ng.2635; Schmiedel S, 2010, J UROLOGY, V183, P1378, DOI 10.1016/j.juro.2009.12.058; Sherman RL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130264; Sloan CD, 2012, SPAT SPATIO-TEMPORAL, V3, P297, DOI 10.1016/j.sste.2012.09.002; Storm HH, 1997, DAN MED BULL, V44, P535; Toledano MB, 2001, BRIT J CANCER, V84, P1482, DOI 10.1054/bjoc.2001.1739; Valberg M, 2014, AM J EPIDEMIOL, V179, P499, DOI 10.1093/aje/kwt267; Webster Thomas, 2006, Int J Health Geogr, V5, P26, DOI 10.1186/1476-072X-5-26; Wood HM, 2009, J UROLOGY, V181, P452, DOI 10.1016/j.juro.2008.10.074	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120285	10.1371/journal.pone.0120285	http://dx.doi.org/10.1371/journal.pone.0120285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756204	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700064
J	Stager, JC; Sporn, LA; Johnson, M; Regalado, S				Stager, J. Curt; Sporn, Lee Ann; Johnson, Melanie; Regalado, Sean			Of Paleo-Genes and Perch: What if an "Alien" Is Actually a Native?	PLOS ONE			English	Article							LAKE-SEDIMENTS; ANCIENT DNA; PATTERNS; COLONIZATION; POPULATION; GENETICS	Documenting whether a biotic taxon is native or alien to an ecosystem has theoretical value for ecological and evolutionary studies, and has practical value because it can potentially identify a taxon as a desirable component of an ecosystem or target it for removal. In some cases, however, such background information is inadequate or unavailable. Here we use paleo-DNA to re-evaluate the historical status of yellow perch in the 6 million acre Adiron-dack State Park of northern New York. Yellow perch DNA in a 2200-year sediment record reveals a long-term native status for these supposedly alien fish and challenges assumptions that they necessarily exclude native trout from upland lakes. Similar approaches could be applied to other species with uncertain historical distributions and could help to identify unrecognized pockets of biodiversity.	[Stager, J. Curt; Sporn, Lee Ann; Johnson, Melanie; Regalado, Sean] Paul Smiths Coll, Div Nat Sci, Paul Smiths, NY 12970 USA		Stager, JC (corresponding author), Paul Smiths Coll, Div Nat Sci, Paul Smiths, NY 12970 USA.	cstager@paulsmiths.edu			National Science Foundation [ATM-0401845]; Paul Smith's College; Div Atmospheric & Geospace Sciences [1358362] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Paul Smith's College; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by National Science Foundation (www.nsf.gov), grant ATM-0401845, to JCS. Paul Smith's College faculty research funds to JCS and LAS (www.paulsmiths.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Bissett A, 2005, LIMNOL OCEANOGR-METH, V3, P533, DOI 10.4319/lom.2005.3.533; Bryan MB, 2005, MOL ECOL, V14, P3757, DOI 10.1111/j.1365-294X.2005.02716.x; Burroughs J, 1904, WAKE ROBIN; Carlson DM, 2004, AM MIDL NAT, V152, P104, DOI 10.1674/0003-0031(2004)152[0104:SOFINY]2.0.CO;2; Clapp DF, 2004, FISHERIES, V29, P11, DOI 10.1577/1548-8446(2004)29[11:YPRAMI]2.0.CO;2; Cooper A, 2000, SCIENCE, V289, P1139; Daniels RA, 1998, GLOBAL ECOL BIOGEOGR, V7, P467, DOI 10.1046/j.1466-822X.1998.00313.x; Demong L, 2001, ROTENONE IN FISHERIES: ARE THE REWARDS WORTH THE RISKS?, P29; Epp LS, 2010, J PALEOLIMNOL, V43, P939, DOI 10.1007/s10933-009-9379-7; Fielder DG, 2008, J GREAT LAKES RES, V34, P506, DOI 10.3394/0380-1330(2008)34[506:EOFCTT]2.0.CO;2; Fuller P, 2014, PERCA FLAVESCENS; George CJ, 1981, PUBLICATIONS B NEW Y, VFW- P171; Greeley J. R., 1933, BIOL SURVEY UPPER HU, P54; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Harig AL, 1995, RESTORING INDIGENOUS; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Krieger DA, 1983, HABITAT SUITABILITY; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Mather F, 1884, MEMORANDA RELATING A, P113; Robinson JM, 2010, T AM FISH SOC, V139, P685, DOI 10.1577/T08-185.1; Sepulveda-Villet OJ, 2012, MOL ECOL, V21, P5795, DOI 10.1111/mec.12044; Sepulveda-Villet OJ, 2009, J GREAT LAKES RES, V35, P107, DOI 10.1016/j.jglr.2008.11.009; Stager JC, 2009, QUATERNARY RES, V72, P47, DOI 10.1016/j.yqres.2009.04.003; Stager J. Curt, 1997, Lake and Reservoir Management, V13, P175; Stager JC, 2003, ADIRONDACK J ENV STU, V10, P6; Stager JC, 2001, ADIRONDACK J ENV STU, V8, P22; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; United States Environmental Protection Agency, 1972, US EPA NAT EUTR SURV, DOI 10.1007/978-1-61779-591-6_21; Waldman JR, 2006, T AM FISH SOC, V135, P1076, DOI 10.1577/T05-055.1; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2005, P ROY SOC LONDON B, V272; Xiao X, 2005, APPL ENVIRON MICROB, V71, P7904, DOI 10.1128/AEM.71.12.7904-7909.2005	34	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119071	10.1371/journal.pone.0119071	http://dx.doi.org/10.1371/journal.pone.0119071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751263	Green Submitted, gold, Green Published			2022-12-26	WOS:000350692700015
J	Fouhy, F; Deane, J; Rea, MC; O'Sullivan, O; Ross, RP; O'Callaghan, G; Plant, BJ; Stanton, C				Fouhy, Fiona; Deane, Jennifer; Rea, Mary C.; O'Sullivan, Orla; Ross, R. Paul; O'Callaghan, Grace; Plant, Barry J.; Stanton, Catherine			The Effects of Freezing on Faecal Microbiota as Determined Using MiSeq Sequencing and Culture-Based Investigations	PLOS ONE			English	Article							GUT MICROBIOTA; STORAGE-CONDITIONS; DNA EXTRACTION; BACTERIAL; SAMPLES; COLLECTION; DIVERSITY; DISEASE; FLORA	Background High-throughput sequencing has enabled detailed insights into complex microbial environments, including the human gut microbiota. The accuracy of the sequencing data however, is reliant upon appropriate storage of the samples prior to DNA extraction. The aim of this study was to conduct the first MiSeq sequencing investigation into the effects of faecal storage on the microbiota, compared to fresh samples. Culture-based analysis was also completed. Methods Seven faecal samples were collected from healthy adults. Samples were separated into fresh (DNA extracted immediately), snap frozen on dry ice and frozen for 7 days at -80 degrees C prior to DNA extraction or samples frozen at -80 degrees C for 7 days before DNA extraction. Sequencing was completed on the Illumina MiSeq platform. Culturing of total aerobes, anaerobes and bifidobacteria was also completed. Results No significant differences at phylum or family levels between the treatment groups occurred. At genus level only Faecalibacterium and Leuconostoc were significantly different in the fresh samples compared to the snap frozen group (p = 0.0298; p = 0.0330 respectively). Diversity analysis indicated that samples clustered based on the individual donor, rather than by storage group. No significant differences occurred in the culture-based analysis between the fresh, snap or -80 degrees C frozen samples. Conclusions Using the MiSeq platform coupled with culture-based analysis, this study highlighted that limited significant changes in microbiota occur following rapid freezing of faecal samples prior to DNA extraction. Thus, rapid freezing of samples prior to DNA extraction and culturing, preserves the integrity of the microbiota.	[Fouhy, Fiona; Deane, Jennifer; Rea, Mary C.; O'Sullivan, Orla; Stanton, Catherine] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Deane, Jennifer; O'Callaghan, Grace; Plant, Barry J.] Natl Univ Ireland Univ Coll Cork, HRB Clin Res Facil, Cork, Ireland; [Deane, Jennifer] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Rea, Mary C.; O'Sullivan, Orla; O'Callaghan, Grace; Plant, Barry J.; Stanton, Catherine] Alimentary Pharmabiot Ctr, Cork, Ireland; [Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Coll Sci Engn & Food Sci SEFS, Cork, Ireland; [O'Callaghan, Grace; Plant, Barry J.] Natl Univ Ireland Univ Coll Cork, Cork Univ Hosp, Cork Adult Cyst Fibrosis Ctr, Cork, Cork, Ireland	Teagasc; Health Research Board - Ireland; University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Stanton, C (corresponding author), Teagasc Food Res Ctr, Fermoy, Cork, Ireland.	catherine.stanton@teagasc.ie	O'Sullivan, Orla/ABE-5980-2020; Stanton, Catherine/A-9549-2015; Ross, Paul/A-7584-2015	O'Sullivan, Orla/0000-0002-4332-1109; Stanton, Catherine/0000-0002-6724-7011; Ross, Paul/0000-0003-4876-8839; Deane, Jennifer/0000-0002-4058-3568; Fouhy, Fiona/0000-0002-8285-7694; Rea, Mary/0000-0003-3782-0232	Teagasc Walsh Fellowship; Science Foundation Ireland; Centre for Science, Engineering and Technology (SFI-CSET) [02/CE/B124]; FP7 [603038]; Science Foundation Ireland (SFI) [SFI/12/RC/2273]	Teagasc Walsh Fellowship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Centre for Science, Engineering and Technology (SFI-CSET)(Science Foundation Ireland); FP7; Science Foundation Ireland (SFI)(Science Foundation Ireland)	Jennifer Deane is in receipt of a Teagasc Walsh Fellowship. The authors and their work were supported by the Science Foundation Ireland and funded by the Centre for Science, Engineering and Technology (SFI-CSET) grant 02/CE/B124 and by FP7 funded CFMATTERS (Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified, Grant Agreement no. 603038). The Alimentary Pharmabiotic Centre is a research centre funded by Science Foundation Ireland (SFI). This publication has emanated from research supported in part by a research grant from Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Blaut M, 2002, BRIT J NUTR, V87, pS203, DOI 10.1079/BJN/2002539; Cani PD, 2013, BRIEFINGS FUNCTIONAL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cuthbertson L, 2014, J CLIN MICROBIOL, V52, P3011, DOI 10.1128/JCM.00764-14; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Gardiner GE, 2004, APPL ENVIRON MICROB, V70, P1895, DOI 10.1128/AEM.70.4.1895-1906.2004; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Matsuki T, 2014, ADV M C M, P90, DOI 10.1079/9781780640495.0090; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; O'Sullivan O, 2011, J APPL MICROBIOL, V111, P467, DOI 10.1111/j.1365-2672.2011.05067.x; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	25	182	192	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119355	10.1371/journal.pone.0119355	http://dx.doi.org/10.1371/journal.pone.0119355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748176	Green Submitted, gold, Green Published			2022-12-26	WOS:000350689400068
J	Ku, CH; Hung, HM; Leong, WC; Chen, HH; Lin, JL; Huang, WH; Yang, HY; Weng, CH; Lin, CM; Lee, SH; Wang, IK; Liang, CC; Chang, CT; Lin, WR; Yen, TH				Ku, Chung-Hsuan; Hung, Huei-Min; Leong, Wa Cheong; Chen, Hsiao-Hui; Lin, Ja-Liang; Huang, Wen-Hung; Yang, Huang-Yu; Weng, Cheng-Hao; Lin, Che-Min; Lee, Shwu-Hua; Wang, I-Kuan; Liang, Chih-Chia; Chang, Chiz-Tzung; Lin, Wey-Ran; Yen, Tzung-Hai			Outcome of Patients with Carbon Monoxide Poisoning at a Far-East Poison Center	PLOS ONE			English	Article							TERM MORTALITY; RISK-FACTORS; TAIWAN; MANAGEMENT; OXYGEN	Introduction Many cases of carbon monoxide poisoning in Taiwan are due to burning charcoal. Nevertheless, few reports have analyzed the mortality rate of these patients who survive to reach a hospital and die despite intensive treatment. Therefore, this study examined the clinical features, physiological markers, and outcomes after carbon monoxide poisoning and the associations between these findings. Methods We analyzed the records of 261 patients who were referred for management of carbon monoxide intoxication between 2000 and 2010. Patients were grouped according to status at discharge as alive (survivor, n = 242) or dead (non-survivor, n = 19). Demographic, clinical, laboratory, and mortality data were obtained for analysis. Results Approximately half of the cases (49.4%) attempted suicide by burning charcoal. Most of the patients were middle-aged adults (33 +/- 19 years), and were referred to our hospital in a relatively short period of time (6 +/- 10 hours). Carbon monoxide produced many serious complications after exposure: fever (26.1%), hypothermia (9.6%), respiratory failure (34.1%), shock (8.4%), myocardial infarction (8.0%), gastrointestinal upset (34.9%), hepatitis (18.4%), renal failure (25.3%), coma (18.0%) and rhabdomyolysis (21.8%). Furthermore, the non-survivors suffered greater incidences of hypothermia (P< 0.001), respiratory failure (P< 0.001), shock (P< 0.001), hepatitis ((P= 0.016), renal failure (P= 0.003), coma (P< 0.001) than survivors. All patients were treated with high concentration of oxygen therapy using non-rebreather mask. However, hyperbaric oxygen therapy was only used in 18.8% of the patients. In a multivariate-Cox-regression model, it was revealed that shock status was a significant predictor for mortality after carbon monoxide poisoning (OR 8.696, 95% CI 2.053-37.370, P= 0.003). Finally, Kaplan-Meier analysis confirmed that patients with shock suffered greater cumulative mortality than without shock (Log-rank test, Chi-square 147.404, P<0.001). Conclusion The mortality rate for medically treated carbon monoxide-poisoned patients at our center was 7.3%. Furthermore, the analysis indicates that shock was most strongly associated with higher risk of mortality.	[Ku, Chung-Hsuan; Leong, Wa Cheong; Chen, Hsiao-Hui; Lin, Ja-Liang; Huang, Wen-Hung; Yang, Huang-Yu; Weng, Cheng-Hao; Yen, Tzung-Hai] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan; [Ku, Chung-Hsuan; Hung, Huei-Min; Leong, Wa Cheong; Chen, Hsiao-Hui; Lin, Ja-Liang; Huang, Wen-Hung; Yang, Huang-Yu; Weng, Cheng-Hao; Yen, Tzung-Hai] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Div Clin Toxicol, Linkou, Taiwan; [Hung, Huei-Min] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Dept Pediat, Linkou, Taiwan; [Lin, Che-Min; Lee, Shwu-Hua] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Dept Psychiat, Linkou, Taiwan; [Wang, I-Kuan; Liang, Chih-Chia; Chang, Chiz-Tzung] China Med Univ, China Med Univ Hosp & Coll Med, Dept Nephrol, Taichung, Taiwan; [Lin, Wey-Ran] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Dept Gastroenterol, Linkou, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan.	m19570@adm.cgmh.org.tw	Lin, Chemin/AAG-9983-2019; Yen, Tzung-Hai/AAQ-4525-2020; huang, wen/GXW-0661-2022	Yen, Tzung-Hai/0000-0002-0907-1505; Lee, Shwu-Hua/0000-0001-5606-1118; YANG, HUANG-YU/0000-0001-6826-9717; Lin, Chemin/0000-0001-6889-4686	Chang Gung Memorial Hospital [CMRPG3D0681, CMRPG3D0071-2, CMRPG3D0011, CMRPG3E0361]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was funded by the Chang Gung Memorial Hospital (CMRPG3D0681, CMRPG3D0071-2, CMRPG3D0011, CMRPG3E0361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP C, P87; Amitai Y, 1998, ARCH NEUROL-CHICAGO, V55, P845, DOI 10.1001/archneur.55.6.845; Beppu T, 2014, AM J NEURORADIOL, V35, P625, DOI 10.3174/ajnr.A3489; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; COBURN RF, 1965, J CLIN INVEST, V44, P1899, DOI 10.1172/JCI105296; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Hampson NB, 2008, CRIT CARE MED, V36, P2523, DOI 10.1097/CCM.0b013e31818419d8; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hampson NB, 2009, CRIT CARE MED, V37, P1941, DOI 10.1097/CCM.0b013e3181a0064f; Hou XM, 2013, EUR NEUROL, V69, P275, DOI 10.1159/000346117; Hou YC, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-674; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105503; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Kessler SM, 2011, J PALLIAT MED, V14, P782, DOI 10.1089/jpm.2011.9682; Lee CTA, 2014, NAT GEOSCI, V7, P10, DOI 10.1038/ngeo2039; Lin CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112160; Lin CM, 2012, GEN HOSP PSYCHIAT, V34, P552, DOI 10.1016/j.genhosppsych.2012.03.015; Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Nuckton TJ, 2000, AM J EMERG MED, V18, P703, DOI 10.1053/ajem.2000.16313; Pan YJ, 2010, J AFFECT DISORDERS, V120, P254, DOI 10.1016/j.jad.2009.04.003; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Shie HG, 2007, INHAL TOXICOL, V19, P905, DOI 10.1080/08958370701432173; Smollin Craig, 2010, BMJ Clin Evid, V2010; Thom SR, 2010, CLIN TOXICOL, V48, P47, DOI 10.3109/15563650903468209; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065672; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Wolf SJ, 2008, ANN EMERG MED, V51, P138, DOI 10.1016/j.annemergmed.2007.10.012; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x	29	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118995	10.1371/journal.pone.0118995	http://dx.doi.org/10.1371/journal.pone.0118995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745854	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400036
J	Rashed, E; Lizano, P; Dai, HC; Thomas, A; Suzuki, CK; Depre, C; Qiu, HY				Rashed, Eman; Lizano, Paulo; Dai, Huacheng; Thomas, Andrew; Suzuki, Carolyn K.; Depre, Christophe; Qiu, Hongyu			Heat Shock Protein 22 (Hsp22) Regulates Oxidative Phosphorylation upon Its Mitochondrial Translocation with the Inducible Nitric Oxide Synthase in Mammalian Heart	PLOS ONE			English	Article							RAT LIVER MITOCHONDRIA; H11 KINASE; CARDIAC MYOCYTES; SWINE HEART; IN-VIVO; CHAPERONE; SURVIVAL; ISCHEMIA; HYPERTROPHY; INHIBITION	Objectives Stress-inducible heat shock protein 22 (Hsp22) confers protection against ischemia through induction of the inducible isoform of nitric oxide synthase (iNOS). Hsp22 overexpression in vivo stimulates cardiac mitochondrial respiration, whereas Hsp22 deletion in vivo significantly reduces respiration. We hypothesized that Hsp22-mediated regulation of mitochondrial function is dependent upon its mitochondrial translocation together with iNOS. Methods and Results Adenoviruses harboring either the full coding sequence of Hsp22 (Ad-WT-Hsp22) or a mutant lacking a N-terminal 20 amino acid putative mitochondrial localization sequence (Ad-N20-Hsp22) were generated, and infected in rat neonatal cardiomyocytes. Compared to beta-Gal control, WT-Hsp22 accumulated in mitochondria by 2.5 fold (P<0.05) and increased oxygen consumption rates by 2-fold (P<0.01). This latter effect was abolished upon addition of the selective iNOS inhibitor, 1400W. Ad-WT-Hsp22 significantly increased global iNOS expression by about 2.5-fold (P<0.01), and also increased iNOS mitochondrial localization by 4.5 fold vs beta-gal (P<0.05). Upon comparable overexpression, the N20-Hsp22 mutant did not show significant mitochondrial translocation or stimulation of mitochondrial respiration. Moreover, although N20-Hsp22 did increase global iNOS expression by 4.6fold, it did not promote iNOS mitochondrial translocation. Conclusion Translocation of both Hsp22 and iNOS to the mitochondria is necessary for Hsp22-mediated stimulation of oxidative phosphorylation.	[Rashed, Eman; Lizano, Paulo; Dai, Huacheng; Depre, Christophe; Qiu, Hongyu] Rutgers State Univ, New Jersey Med Sch, Dept Cell Biol & Mol Med, New Brunswick, NJ 08903 USA; [Thomas, Andrew] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, New Brunswick, NJ 08903 USA; [Suzuki, Carolyn K.] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, New Brunswick, NJ 08903 USA; [Qiu, Hongyu] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92350 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Loma Linda University	Qiu, HY (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Cell Biol & Mol Med, New Brunswick, NJ 08903 USA.	hqiu@llu.edu	Lizano, Paulo/GPX-3124-2022	Thomas, Andrew/0000-0002-9026-7467	United States National Institute of Health [1R01 HL115195-01]; American Heart Association [0835182N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115195] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is partially supported by a grant 1R01 HL115195-01 (http://www.nih.gov/) from United States National Institute of Health, (H. Q.) and a grant 0835182N from American Heart Association (https://research.americanheart.org) (H. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1897, DOI 10.1006/jmcc.2001.1462; Borutaite V, 2005, SHOCK, V23, P319, DOI 10.1097/01.shk.0000156672.36439.2d; Chen L, 2011, AM J PHYSIOL-HEART C, V300, pH1303, DOI 10.1152/ajpheart.00979.2010; Danan IJ, 2007, CARDIOVASC DRUG REV, V25, P14, DOI 10.1111/j.1527-3466.2007.00002.x; Depre C, 1999, CIRCULATION, V99, P578, DOI 10.1161/01.CIR.99.4.578; Depre C, 2006, CIRC RES, V98, P280, DOI 10.1161/01.RES.0000201284.45482.e8; Depre C, 2004, CIRC RES, V95, P433, DOI 10.1161/01.RES.0000138301.42713.18; Depre C, 2003, CARDIOVASC RES, V58, P126, DOI 10.1016/S0008-6363(02)00845-3; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; Depre C, 2001, P NATL ACAD SCI USA, V98, P9336, DOI 10.1073/pnas.171297498; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hase M, 2005, BIOCHEM J, V388, P475, DOI 10.1042/BJ20041314; Hedhli N, 2008, CARDIOVASC RES, V77, P497, DOI 10.1093/cvr/cvm054; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; Lacza Z, 2003, FREE RADICAL BIO MED, V35, P1217, DOI 10.1016/S0891-5849(03)00510-0; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li W, 2004, AM J PHYSIOL-HEART C, V286, pH47, DOI 10.1152/ajpheart.00730.2003; Lin MW, 2007, BIOCHEM PHARMACOL, V73, P1796, DOI 10.1016/j.bcp.2007.02.009; Lizano P, 2013, CARDIOVASC RES, V99, P685, DOI 10.1093/cvr/cvt136; McGreal RS, 2013, EXP EYE RES, V110, P10, DOI 10.1016/j.exer.2013.02.016; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; Minghetti L, 1997, GLIA, V19, P152, DOI 10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Sui XZ, 2009, CIRC RES, V104, P887, DOI 10.1161/CIRCRESAHA.108.192328; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Wang MJ, 2001, J NEUROCHEM, V77, P830, DOI 10.1046/j.1471-4159.2001.00295.x; Wang Y, 2002, J MOL CELL CARDIOL, V34, P5, DOI 10.1006/jmcc.2001.1482	35	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119537	10.1371/journal.pone.0119537	http://dx.doi.org/10.1371/journal.pone.0119537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746286	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400077
J	Shields, SD; Butt, RP; Dib-Hajj, SD; Waxman, SG				Shields, Shannon D.; Butt, Richard P.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.			Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							SODIUM-CHANNELS; AXON MEMBRANE; CONDUCTION; DYSFUNCTION; EXPRESSION	Cerebellar symptoms significantly diminish quality of life in patients with multiple sclerosis (MS). We previously showed that sodium channel Nav1.8, although normally restricted to peripheral somatosensory neurons, is upregulated in the cerebellum in MS, and that Nav1.8 expression is linked to ataxia and MS-like symptoms in mice. Furthermore, intracer-ebroventricular administration of the Nav1.8 blocker A-803467 temporarily reversed electrophysiological and behavioral manifestations of disease in a mouse MS model; unfortunately A-803467 is not orally bioavailable, diminishing the potential for translation to human patients. In the present study, we assessed the effect of per os (p.o.) dosing of a new orally bioavailable Nav1.8-selective blocker, PF-01247324, in transgenic mice expressing Nav1.8 in Purkinje neurons, and in wildtype mice in the experimental autoimmune encephalomyelitis (EAE) model. PF-01247324 was administered by oral gavage at 1000 mg/kg; control groups received an equal volume of vehicle. Behavioral assays of motor coordination, grip strength, and ataxia were performed. We observed significant improvements in motor coordination and cerebellar-like symptoms in mice that received PF-01247324 compared to control littermates that received vehicle. These preclinical proof-of-concept data suggest that PF-01247324, its derivatives, or other Nav1.8-selective blockers merit further study for providing symptomatic therapy for cerebellar dysfunction in MS and related disorders.	[Shields, Shannon D.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Shields, Shannon D.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; [Butt, Richard P.] Pfizer Global R&D, Neusentis UK, Cambridge, England; [Shields, Shannon D.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT USA	Yale University; Yale University; Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Waxman, SG (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	stephen.waxman@yale.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177	Medical Research Service and Rehabilitation Research Service, Department of Veterans' Affairs [RX000477, BX000605]; Pfizer Research; Neusentis UK, Pfizer Global RD	Medical Research Service and Rehabilitation Research Service, Department of Veterans' Affairs(US Department of Veterans Affairs); Pfizer Research; Neusentis UK, Pfizer Global RD	This work was supported by the Medical Research Service and Rehabilitation Research Service, Department of Veterans' Affairs [grant numbers RX000477 and BX000605] and a grant to Yale University from Pfizer Research. The Center for Neuroscience and Regeneration Research is a collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University. Neusentis UK, Pfizer Global R&D provided support in the form of a salary for author RBP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Black JA, 2000, P NATL ACAD SCI USA, V97, P11598, DOI 10.1073/pnas.97.21.11598; BOSTOCK H, 1978, J PHYSIOL-LONDON, V280, P273, DOI 10.1113/jphysiol.1978.sp012384; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; England S, 2009, 2009 NEUR M PLANN; ESPIR MLE, 1970, J NEUROL NEUROSUR PS, V33, P528, DOI 10.1136/jnnp.33.4.528; FOSTER RE, 1980, SCIENCE, V210, P661, DOI 10.1126/science.6159685; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; Mills RJ, 2007, COCHRANE DB SYST REV, V1; Payne CE, 2015, BRIT J PHAR IN PRESS; Ramsaransing G, 2000, BRIT MED J, V320, P1113, DOI 10.1136/bmj.320.7242.1113; Renganathan M, 2003, BRAIN RES, V959, P235, DOI 10.1016/S0006-8993(02)03750-2; Saab CY, 2004, EXP BRAIN RES, V158, P1, DOI 10.1007/s00221-004-1867-4; Shields SD, 2012, ANN NEUROL, V71, P186, DOI 10.1002/ana.22665; Solaro C, 2005, NEUROL SCI, V25, P307, DOI 10.1007/s10072-004-0362-9; SWINGLER RJ, 1992, Q J MED, V83, P325; WAXMAN SG, 1978, J NEUROL NEUROSUR PS, V41, P408, DOI 10.1136/jnnp.41.5.408; Waxman SG, 2002, ARCH NEUROL-CHICAGO, V59, P1377, DOI 10.1001/archneur.59.9.1377; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119067	10.1371/journal.pone.0119067	http://dx.doi.org/10.1371/journal.pone.0119067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747279	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400042
J	Chin, LH; Hsu, SP; Zhong, WB; Liang, YC				Chin, Li-Han; Hsu, Sung-Po; Zhong, Wen-Bin; Liang, Yu-Chih			Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells	PLOS ONE			English	Article							FACTOR RECEPTOR; BREAST-CANCER; IN-VITRO; EXPRESSION; KINASE; INVASION; GENE; PATHWAY; CYR61; CREB	Our previous studies have demonstrated that epidermal growth factor (EGF) can induce cell migration through the induction of cysteine-rich protein 61 (Cyr61) in human anaplastic thyroid cancer (ATC) cells. The aim of the present study was to determine the inhibitory effects of combined treatment with the peroxisome proliferator-activated receptor-gamma (PPAR gamma) ligand troglitazone and the cholesterol-lowering drug lovastatin at clinically achievable concentrations on ATC cell migration. Combined treatment with 5 mu M troglitazone and 1 mu M lovastatin exhibited no cytotoxicity but significantly inhibited EGF-induced migration, as determined using wound healing and Boyden chamber assays. Cotreatment with troglitazone and lovastatin altered the epithelial-to-mesenchymal-transition (EMT) -related marker gene expression of the cells; specifically, E-cadherin expression increased and vimentin expression decreased. In addition, cotreatment reduced the number of filopodia, which are believed to be involved in migration, and significantly inhibited EGF-induced Cyr61 mRNA and protein expression as well as Cyr61 secretion. Moreover, the phosphorylation levels of 2 crucial signal molecules for EGF-induced Cyr61 expression, the cAMP response element-binding protein (CREB) and extracellular signal-regulated kinase (ERK), were decreased in cells cotreated with troglitazone and lovastatin. Performing a transient transfection assay revealed that the combined treatment significantly suppressed Cyr61 promoter activity. These results suggest that combined treatment with low doses of troglitazone and lovastatin effectively inhibits ATC cell migration and may serve as a novel therapeutic strategy for metastatic ATC.	[Chin, Li-Han; Hsu, Sung-Po; Zhong, Wen-Bin] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Hsu, Sung-Po; Zhong, Wen-Bin] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan; [Liang, Yu-Chih] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Liang, Yu-Chih] Taipei Med Univ, Tradit Herbal Med Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Liang, YC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.	ycliang@tmu.edu.tw	Hsu, Sung-Po/I-8383-2019	HSU, SUNG-PO/0000-0001-7527-9040	National Science Council of the Republic of China [NSC 101-2320-B-038-017-MY3]; Taipei Medical University [TMU101-AE1-B45]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taipei Medical University	This work were supported by research grants from the National Science Council of the Republic of China (NSC 101-2320-B-038-017-MY3) and the Taipei Medical University (TMU101-AE1-B45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bolden A, 2012, PPAR RES, V2012, DOI 10.1155/2012/929052; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Ensinger C, 2004, ANN NY ACAD SCI, V1030, P69, DOI 10.1196/annals.1329.009; FRANSSILA KO, 1975, CANCER-AM CANCER SOC, V36, P1138, DOI 10.1002/1097-0142(197509)36:3<1138::AID-CNCR2820360346>3.0.CO;2-8; Gabrys D, 2008, STRAHLENTHER ONKOL, V184, P48, DOI 10.1007/s00066-008-1805-7; Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8; Guerra A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S44; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; HOELTING T, 1994, J CLIN ENDOCR METAB, V79, P401, DOI 10.1210/jc.79.2.401; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; Infante E, 2011, J LEUKOCYTE BIOL, V89, P577, DOI 10.1189/jlb.0810441; Kok SH, 2011, ARTHRITIS RHEUM-US, V63, P1010, DOI 10.1002/art.27433; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Kusama T, 2001, CANCER RES, V61, P4885; Li MY, 2006, J CELL PHYSIOL, V209, P428, DOI 10.1002/jcp.20738; Lin BR, 2007, MOL CANCER RES, V5, P1111, DOI 10.1158/1541-7786.MCR-06-0289; LIPPONEN P, 1994, BRIT J CANCER, V69, P1120, DOI 10.1038/bjc.1994.220; Malaguarnera R, 2005, ENDOCR-RELAT CANCER, V12, P953, DOI 10.1677/erc.1.00968; Motomura W, 2005, BIOCHEM BIOPH RES CO, V332, P89, DOI 10.1016/j.bbrc.2005.04.095; NICHOLSON S, 1991, BRIT J CANCER, V63, P146, DOI 10.1038/bjc.1991.30; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2001, J CLIN PATHOL-MOL PA, V54, P170, DOI 10.1136/mp.54.3.170; Shah PP, 2012, ONCOGENE, V31, P3124, DOI 10.1038/onc.2011.488; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Theocharis S, 2004, CANCER TREAT REV, V30, P545, DOI 10.1016/j.ctrv.2004.04.004; Thibault A, 1996, CLIN CANCER RES, V2, P483; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERLAAN BFAM, 1995, THYROID, V5, P67, DOI 10.1089/thy.1995.5.67; Wang IK, 2000, ONCOLOGY-BASEL, V59, P245, DOI 10.1159/000012168; Wang PS, 2008, MOL CARCINOGEN, V47, P905, DOI 10.1002/mc.20429; Xiao YJ, 2013, RHEUMATOL INT, V33, P389, DOI 10.1007/s00296-012-2383-7; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yao CJ, 2006, INT J CANCER, V118, P773, DOI 10.1002/ijc.21361; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219; Zhong WB, 2005, ENDOCR-RELAT CANCER, V12, P615, DOI 10.1677/erc.1.01012	38	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118674	10.1371/journal.pone.0118674	http://dx.doi.org/10.1371/journal.pone.0118674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742642	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100030
J	Costa, PS; Reis, MP; Avila, MP; Leite, LR; de Araujo, FMG; Salim, ACM; Oliveira, G; Barbosa, F; Chartone-Souza, E; Nascimento, AMA				Costa, Patricia S.; Reis, Mariana P.; Avila, Marcelo P.; Leite, Laura R.; de Araujo, Flavio M. G.; Salim, Anna C. M.; Oliveira, Guilherme; Barbosa, Francisco; Chartone-Souza, Edmar; Nascimento, Andrea M. A.			Metagenome of a Microbial Community Inhabiting a Metal-Rich Tropical Stream Sediment	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FRESH-WATER; SEQUENCE-ANALYSIS; BACTERIAL DIVERSITY; ARCHAEAL; REDUCTION; GENES; CRENARCHAEOTA; CONTAMINATION; RHIZOSPHERE	Here, we describe the metagenome and functional composition of a microbial community in a historically metal-contaminated tropical freshwater stream sediment. The sediment was collected from the Mina Stream located in the Iron Quadrangle (Brazil), one of the world's largest mining regions. Environmental DNA was extracted and was sequenced using SOLiD technology, and a total of 7.9 Gbp was produced. A taxonomic profile that was obtained by comparison to the Greengenes database revealed a complex microbial community with a dominance of Proteobacteria and Parvarcheota. Contigs were recruited by bacterial and archaeal genomes, especially Candidatus Nitrospira defluvii and Nitrosopumilus maritimus, and their presence implicated them in the process of N cycling in the Mina Stream sediment (MSS). Functional reconstruction revealed a large, diverse set of genes for ammonium assimilation and ammonification. These processes have been implicated in the maintenance of the N cycle and the health of the sediment. SEED subsystems functional annotation unveiled a high degree of diversity of metal resistance genes, suggesting that the prokaryotic community is adapted to metal contamination. Furthermore, a high metabolic diversity was detected in the MSS, suggesting that the historical arsenic contamination is no longer affecting the prokaryotic community. These results expand the current knowledge of the microbial taxonomic and functional composition of tropical metal-contaminated freshwater sediments.	[Costa, Patricia S.; Reis, Mariana P.; Avila, Marcelo P.; Barbosa, Francisco; Chartone-Souza, Edmar; Nascimento, Andrea M. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Leite, Laura R.; de Araujo, Flavio M. G.; Salim, Anna C. M.; Oliveira, Guilherme] Ctr Pesquisas Rene Rachou Fundacao Oswaldo Cruz, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Nascimento, AMA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	amaral@ufmg.br	Barbosa, Francisco/M-6225-2019; Barbosa, Francisco A. R./C-9730-2016; Nascimento, Andréa/ABD-9042-2020; Oliveira, Guilherme/E-2624-2014	Nascimento, Andréa/0000-0002-0447-3505; Costa, Patricia/0000-0002-2166-9497; Oliveira, Guilherme/0000-0003-0054-3438; Barbosa, Francisco Antonio/0000-0002-2026-6936	FAPEMIG [APQ 00801/12, APQ-00463-13]; CNPq [nu472411/2012-8]; CNPq/INCT [15206-7]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/INCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPEMIG APQ 00801/12 and APQ-00463-13, CNPq nu472411/2012-8, CNPq/INCT no 15206-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlett MA, 2010, CAN J MICROBIOL, V56, P32, DOI [10.1139/W09-099, 10.1139/w09-099]; Borba Ricardo Perobelli, 2004, Rem: Rev. Esc. Minas, V57, P45, DOI 10.1590/S0370-44672004000100009; Borba RP, 2000, REV BRASIL GEOCIENC, V30, P554; Bouskill NJ, 2010, ECOTOXICOLOGY, V19, P317, DOI 10.1007/s10646-009-0414-2; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brummer IHM, 2000, APPL ENVIRON MICROB, V66, P3078, DOI 10.1128/AEM.66.7.3078-3082.2000; Bruneel O, 2008, EXTREMOPHILES, V12, P563, DOI 10.1007/s00792-008-0160-z; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Bundschuh J, 2012, SCI TOTAL ENVIRON, V429, P2, DOI 10.1016/j.scitotenv.2011.06.024; Cardinali-Rezende J, 2012, BIORESOURCE TECHNOL, V119, P373, DOI 10.1016/j.biortech.2012.05.136; Cardinali-Rezende J, 2011, WORLD J MICROB BIOT, V27, P245, DOI 10.1007/s11274-010-0449-9; Costa PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095655; Dahnke K, 2010, MAR ECOL PROG SER, V408, P7, DOI 10.3354/meps08558; Dahnke K, 2012, BIOGEOSCIENCES DISCU, V9, P6987; Del Rio TG, 2010, STAND GENOMIC SCI, V2, P87, DOI 10.4056/sigs.661199; Deschamps Eleonora, 2002, Journal of Soils and Sediments, V2, P216, DOI 10.1007/BF02991043; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gillan DC, 2014, ENVIRON MICROBIOL, P1, DOI [10.1111/1462-2920.12620, DOI 10.1111/1462-2920.12620]; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gough HL, 2011, ISME J, V5, P543, DOI 10.1038/ismej.2010.132; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Gupta RS, 2011, ANTON LEEUW INT J G, V99, P133, DOI 10.1007/s10482-010-9488-3; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Jorgensen CJ, 2009, ENVIRON SCI TECHNOL, V43, P4851, DOI 10.1021/es803417s; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Krupanidhi S, 2008, INDIAN J MED RES, V128, P448; Legatzki A, 2003, J BACTERIOL, V185, P4354, DOI 10.1128/JB.185.15.4354-4361.2003; Leon C, 2012, WORLD J MICROB BIOT, V28, P1511, DOI 10.1007/s11274-011-0953-6; Liao VHC, 2011, J CONTAM HYDROL, V123, P20, DOI 10.1016/j.jconhyd.2010.12.003; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mailloux BJ, 2013, P NATL ACAD SCI USA, V110, P5331, DOI 10.1073/pnas.1213141110; Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Mondini C, 2003, EUR J SOIL BIOL, V39, P141, DOI 10.1016/S1164-5563(03)00029-3; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nies DH, 1997, METAL IONS IN GENE R; Nies DH, 2006, J MOL MICROB BIOTECH, V11, P82, DOI 10.1159/000092820; Novais A, 2010, ANTIMICROB AGENTS CH, V54, P825, DOI 10.1128/AAC.00959-09; Pankratov TA, 2006, INT J SYST EVOL MICR, V56, P2761, DOI 10.1099/ijs.0.64451-0; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Porat I, 2010, MICROB ECOL, V60, P784, DOI 10.1007/s00248-010-9734-2; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Reis MP, 2013, EXTREMOPHILES, V17, P301, DOI 10.1007/s00792-013-0517-9; Rezende PS, 2011, J BRAZIL CHEM SOC, V22, P910, DOI 10.1590/S0103-50532011000500014; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018; Soge OO, 2008, J ANTIMICROB CHEMOTH, V62, P674, DOI 10.1093/jac/dkn255; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Song B, 2009, FEMS MICROBIOL ECOL, V68, P108, DOI 10.1111/j.1574-6941.2009.00657.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Takeda M, 2012, ARCH MICROBIOL, V194, P667, DOI 10.1007/s00203-012-0801-6; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treude N, 2003, FEMS MICROBIOL ECOL, V44, P261, DOI 10.1016/S0168-6496(03)00048-5; Vishnivetskaya TA, 2011, APPL ENVIRON MICROB, V77, P302, DOI 10.1128/AEM.01715-10; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Xu J, 2011, HANDBOOK OF MOLECULA; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	72	42	43	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119465	10.1371/journal.pone.0119465	http://dx.doi.org/10.1371/journal.pone.0119465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742617	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100113
J	Haditsch, B; Roessler, A; Krisper, P; Frisch, H; Hinghofer-Szalkay, HG; Goswami, N				Haditsch, Bernd; Roessler, Andreas; Krisper, Peter; Frisch, Herwig; Hinghofer-Szalkay, Helmut G.; Goswami, Nandu			Volume Regulation and Renal Function at High Altitude across Gender	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; GLOMERULAR-FILTRATION-RATE; ATRIAL NATRIURETIC PEPTIDE; ACUTE-HYPOXIA; SERUM CREATININE; HUMANS; RESPONSES; EXPOSURE; HORMONES; SODIUM	Aims We investigated changes in volume regulating hormones and renal function at high altitudes and across gender. Methodology Included in this study were 28 subjects (n = 20 males; n = 8 females. ages: 19 - 65 yrs), who ascended to a height of 3440m (HA1), on the 3rd day and to 5050m (HA2), on the 14th day. Plasma and urinary creatinine and urinary osmolality as well as plasma levels of plasma renin activity (PRA), Aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP) were measured. The plasma volume loss (PVL) was estimated from plasma density and hematocrit. Glomerular filtration rate (GFR) was measured based on nocturnal (9 hour) creatinine clearance; this was compared with various methods for estimation of GFR. Results The mean 24-hour urine production increased significantly in both sexes across the expedition. But PVL reached significance only in males. No changes in Na+ in plasma, urine or its fractional excretion were seen at both altitudes. Urinary osmolality decreased upon ascent to the higher altitudes. ADH and PRA decreased significantly at both altitudes in males but only at HA2 in females. However, no changes in aldosterone were seen across the sexes and at different altitudes. ANP increased significantly only in males during the expedition. GFR, derived from 9-h creatinine clearance (CreaCl), decreased in both sexes at HA1 but remained stable at HA2. Conventional Crea[p]-based GFR estimates (eGFR) showed only poor correlation to CreaCl. Conclusions We report details of changes in hormonal patterns across high altitude sojourn. To our knowledge we are not aware of any study that has examined these hormones in same subjects and across gender during high altitude sojourn. Our results also suggest that depending on the estimation formula used, eGFR underestimated the observed decrease in renal function measured by CreaCl, thus opening the debate regarding the use of estimated glomerular filtration rates at high altitudes.	[Haditsch, Bernd; Roessler, Andreas; Hinghofer-Szalkay, Helmut G.; Goswami, Nandu] Med Univ Graz, Inst Physiol, Ctr Physiol Med, A-8010 Graz, Austria; [Krisper, Peter] Med Univ Graz, Div Nephrol, Dept Internal Med, A-8036 Graz, Austria; [Frisch, Herwig] Univ Hosp Vienna, Dept Pediat, A-1090 Vienna, Austria	Medical University of Graz; Medical University of Graz; University Hospital Vienna	Goswami, N (corresponding author), Med Univ Graz, Inst Physiol, Ctr Physiol Med, Harrachgasse 21, A-8010 Graz, Austria.	nandu.goswami@medunigraz.at	Roessler, Andreas/A-5751-2008	Roessler, Andreas/0000-0001-9543-8870	government of Styria; government of Graz; Friedrich Schmiedl Foundation; Lanyar Foundation; TravelMedCenter Leonding/Austria	government of Styria; government of Graz; Friedrich Schmiedl Foundation; Lanyar Foundation; TravelMedCenter Leonding/Austria	This study was supported by the government of Styria and the government of Graz, by a grant of the Friedrich Schmiedl Foundation and a grant of the Lanyar Foundation, and by the TravelMedCenter Leonding/Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHACK R, 1985, J LAB CLIN MED, V106, P12; BARTSCH P, 1988, J APPL PHYSIOL, V65, P1929, DOI 10.1152/jappl.1988.65.5.1929; BARTSCH P, 1991, AVIAT SPACE ENVIR MD, V62, P105; BERGER EY, 1949, J CLIN INVEST, V28, P648, DOI 10.1172/JCI102114; BLUME FD, 1984, JAMA-J AM MED ASSOC, V252, P524, DOI 10.1001/jama.252.4.524; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Goldfarb-Rumyantzev AS, 2014, NEPHROL DIAL TRANSPL, V29, P497, DOI 10.1093/ndt/gft051; Greenleaf JE, 2001, AVIAT SPACE ENVIR MD, V72, P522; Haditsch B, 2007, PHYSIOL RES, V56, P779, DOI 10.33549/physiolres.931032; Hildebrandt W, 2000, J APPL PHYSIOL, V88, P599, DOI 10.1152/jappl.2000.88.2.599; Hinghofer-Szalkay H, 2011, EUR J CLIN INVEST, V41, P1180, DOI 10.1111/j.1365-2362.2011.02523.x; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; HONIG A, 1989, AM J PHYSIOL, V257, pR1282, DOI 10.1152/ajpregu.1989.257.6.R1282; Hoyt R.W., 1996, BODY FLUID BALANCE E, P183; JAIN SC, 1980, AVIAT SPACE ENVIR MD, V51, P234; KOLLER EA, 1991, EUR J APPL PHYSIOL O, V62, P228, DOI 10.1007/BF00643747; KRZYWICKI HJ, 1971, J APPL PHYSIOL, V30, P806, DOI 10.1152/jappl.1971.30.6.806; LAWRENCE DL, 1990, AM J PHYSIOL, V258, pE243, DOI 10.1152/ajpendo.1990.258.2.E243; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159; Maresh CM, 2004, AM J PHYSIOL-ENDOC M, V286, pE20, DOI 10.1152/ajpendo.00332.2003; MILLEDGE JS, 1989, CLIN SCI, V77, P509, DOI 10.1042/cs0770509; MILLEDGE JS, 1982, J APPL PHYSIOL, V52, P320, DOI 10.1152/jappl.1982.52.2.320; Modesti PA, 2006, CIRCULATION, V114, P1410, DOI 10.1161/CIRCULATIONAHA.105.605527; OLSEN N, 1992, J APPL PHYSIOL, V73, P2036, DOI 10.1152/jappl.1992.73.5.2036; Pichler J, 2008, ACTA PHYSIOL, V192, P443, DOI 10.1111/j.1748-1716.2007.01758.x; Ramirez G, 1999, AVIAT SPACE ENVIR MD, V70, P73; RENNIE D, 1972, J APPL PHYSIOL, V32, P369, DOI 10.1152/jappl.1972.32.3.369; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roessler A, 2011, EUR J CLIN INVEST, V41, P863, DOI 10.1111/j.1365-2362.2011.02476.x; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Shah MB, 2006, WILD ENVIRON MED, V17, P171, DOI 10.1580/PR43-04; St_ampfli R, 1944, HELV PHYSIOL PHAR S3, VIII, P221; SWENSON ER, 1995, J APPL PHYSIOL, V78, P377, DOI 10.1152/jappl.1995.78.2.377; Zaccaria M, 1998, J CLIN ENDOCR METAB, V83, P570, DOI 10.1210/jc.83.2.570	36	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118730	10.1371/journal.pone.0118730	http://dx.doi.org/10.1371/journal.pone.0118730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742500	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100042
J	She, TT; Zhao, CK; Feng, JN; Wang, LX; Qu, LK; Fang, K; Cai, SQ; Shou, CC				She, Tiantian; Zhao, Chuanke; Feng, Junnan; Wang, Lixin; Qu, Like; Fang, Ke; Cai, Shaoqing; Shou, Chengchao			Sarsaparilla (Smilax Glabra Rhizome) Extract Inhibits Migration and Invasion of Cancer Cells by Suppressing TGF-beta 1 Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; AQUEOUS EXTRACT; TNF-ALPHA; GROWTH; HYPERSENSITIVITY; ARTHRITIS; TAXIFOLIN; DISTINCT; BETA; ID1	Sarsaparilla, also known as Smilax Glabra Rhizome (SGR), was shown to modulate immunity, protect against liver injury, lower blood glucose and suppress cancer. However, its effects on cancer cell adhesion, migration and invasion were unclear. In the present study, we found that the supernatant of water-soluble extract from SGR (SW) could promote adhesion, inhibit migration and invasion of HepG2, MDA-MB-231 and T24 cells in vitro, as well as suppress metastasis of MDA-MB-231 cells in vivo. Results of F-actin and vinculin dual staining showed the enhanced focal adhesion in SW-treated cells. Microarray analysis indicated a repression of TGF-beta 1 signaling by SW treatment, which was verified by real-time RT-PCR of TGF-beta 1-related genes and immunoblotting of TGFBR1 protein. SW was also shown to antagonize TGF-beta 1-promoted cell migration. Collectively, our study revealed a new antitumor function of Sarsaparilla in counteracting invasiveness of a subset of cancer cells by inhibiting TGF-beta 1 signaling.	[She, Tiantian; Zhao, Chuanke; Feng, Junnan; Wang, Lixin; Qu, Like; Fang, Ke; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Cai, Shaoqing] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China	Peking University; Peking University	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China.	cshou@vip.sina.com			National Basic Research Program of China [2010CB529303, 2013CB910504]	National Basic Research Program of China(National Basic Research Program of China)	Funding was provided by the National Basic Research Program of China (2010CB529303, 2013CB910504), http://www.973.gov.cn/Default_3.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Bhattacharya R, 2010, J ONCOL, V2010, DOI 10.1155/2010/856105; Cai Y, 2003, J PHARM PHARMACOL, V55, P691, DOI 10.1211/002235703765344612; Casaschi A, 2004, ATHEROSCLEROSIS, V176, P247, DOI 10.1016/j.atherosclerosis.2004.05.020; Chen L, 2007, J PHARMACEUT BIOMED, V43, P1715, DOI 10.1016/j.jpba.2007.01.007; Drumm ML, 2012, ANNU REV PATHOL-MECH, V7, P267, DOI 10.1146/annurev-pathol-011811-120900; Fei MJ, 2005, J ALLERGY CLIN IMMUN, V116, P1350, DOI 10.1016/j.jaci.2005.08.032; Gao YJ, 2011, TOXICOL LETT, V207, P112, DOI 10.1016/j.toxlet.2011.08.024; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI [doi: 10.1146/annu rev. cellbio.011209.122036 PMID: 19575647, DOI 10.1146/ANNU]; Gunn J, 2013, BIOACT FOOD CHRON, P381, DOI 10.1016/B978-0-12-397153-1.00042-1; HASEGAWA K, 1994, J CELL PHYSIOL, V158, P215, DOI 10.1002/jcp.1041580202; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Huang JS, 2013, FREE RADICAL BIO MED, V65, P1246, DOI 10.1016/j.freeradbiomed.2013.09.011; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Iddamaldeniya S S, 2006, J Carcinog, V5, P11, DOI 10.1186/1477-3163-5-11; Jia LB, 2012, CHIN J INTEGR MED, V18, P325, DOI 10.1007/s11655-011-0950-5; Jiang JY, 2003, J ETHNOPHARMACOL, V85, P53, DOI 10.1016/S0378-8741(02)00340-9; Jiang JY, 1997, PHARMACOL RES, V36, P309, DOI 10.1006/phrs.1997.0234; Lange K, 2008, CANCER RES, V68, P6942, DOI 10.1158/0008-5472.CAN-08-0347; Leyton J, 2002, EUR J PHARMACOL, V442, P179, DOI 10.1016/S0014-2999(02)01539-X; Liang H.L.M., 2003, CHIN J INTEG TRADIT, V9, P157; Liang YY, 2009, CELL RES, V19, P140, DOI 10.1038/cr.2008.321; Liu GX, 2013, MOLECULES, V18, P5265, DOI [doi: 10.3390/ molecules18055265 PMID: 23698042, DOI 10.3390/M0LECULES18055265]; Ma F, 2010, WORLD J GASTROENTERO, V16, P5629, DOI 10.3748/wjg.v16.i44.5629; Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114; Meng YG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-75; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Ren XD, 2000, J CELL SCI, V113, P3673; Sa F, 2008, CHEM-BIOL INTERACT, V171, P1, DOI 10.1016/j.cbi.2007.08.012; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Shi L, 2013, J ETHNOPHARMACOL, V150, P1038, DOI 10.1016/j.jep.2013.10.023; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Tewtrakul S, 2006, J ETHNOPHARMACOL, V105, P312, DOI 10.1016/j.jep.2005.11.021; Theriault A, 2000, J LIPID RES, V41, P1969; Tian HQ, 2010, CHIN J INTEGR MED, V16, P102, DOI 10.1007/s11655-010-0102-3; Tse TW, 2003, CLIN EXP DERMATOL, V28, P469, DOI 10.1046/j.1365-2230.2003.01322.x; Tsuchiya T, 2005, CANCER SCI, V96, P784, DOI 10.1111/j.1349-7006.2005.00113.x; Ulbricht C, 2001, NATURAL STANDARD DAT; Wang J, 2004, J PHARM PHARMACOL, V56, P495, DOI 10.1211/0022357023033; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Xu Q, 1999, EUR J PHARMACOL, V377, P93, DOI 10.1016/S0014-2999(99)00401-X; Yi HW, 2008, INT IMMUNOPHARMACOL, V8, P1467, DOI 10.1016/j.intimp.2008.06.006; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang GD, 2014, P NATL ACAD SCI USA, V111, P11127, DOI 10.1073/pnas.1410432111; Zheng ZG, 2013, J PHARMACEUT BIOMED, V77, P44, DOI 10.1016/j.jpba.2013.01.003	46	17	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118287	10.1371/journal.pone.0118287	http://dx.doi.org/10.1371/journal.pone.0118287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742000	Green Submitted, gold, Green Published			2022-12-26	WOS:000350688100011
J	Wallner, C; Schira, J; Wagner, JM; Schulte, M; Fischer, S; Hirsch, T; Richter, W; Abraham, S; Kneser, U; Lehnhardt, M; Behr, B				Wallner, Christoph; Schira, Jessica; Wagner, Johannes Maximilian; Schulte, Matthias; Fischer, Sebastian; Hirsch, Tobias; Richter, Wiltrud; Abraham, Stephanie; Kneser, Ulrich; Lehnhardt, Marcus; Behr, Bjoern			Application of VEGFA and FGF-9 Enhances Angiogenesis, Osteogenesis and Bone Remodeling in Type 2 Diabetic Long Bone Regeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FRACTURE REPAIR; CHONDROCYTE DIFFERENTIATION; MATRIX METALLOPROTEINASES; VASCULAR COMPLICATIONS; TISSUE INHIBITOR; GENE-EXPRESSION; CELLS; RAT; PROLIFERATION	Although bone regeneration is typically a reliable process, type 2 diabetes is associated with impaired or delayed healing processes. In addition, angiogenesis, a crucial step in bone regeneration, is often altered in the diabetic state. In this study, different stages of bone regeneration were characterized in an unicortical bone defect model comparing transgenic type 2 diabetic (db(-)/db(-)) and wild type (WT) mice in vivo. We investigated angiogenesis, callus formation and bone remodeling at early, intermediate and late time points by means of histomorphometry as well as protein level analyses. In order to enhance bone regeneration, defects were locally treated with recombinant FGF-9 or VEGFA. Histomorphometry of aniline blue stained sections indicated that bone regeneration is significantly decreased in db(-)/db(-) as opposed to WT mice at intermediate (5 days post operation) and late stages (7 days post operation) of bone regeneration. Moreover, immunohistochemical analysis revealed significantly decreased levels of RUNX-2, PCNA, Osteocalcin and PECAM-1 in db(-)/db(-) defects. In addition, osteoclastogenesis is impaired in db(-)/db(-) indicating altered bone remodeling. These results indicate significant impairments in angiogenesis and osteogenesis in type 2 diabetic bones. Importantly, angiogenesis, osteogenesis and bone remodeling could be reconstituted by application of recombinant FGF-9 and, in part, by VEGFA application. In conclusion, our study demonstrates that type 2 diabetes affects angiogenesis, osteogenesis and subsequently bone remodeling, which in turn leads to decreased bone regeneration. These effects could be reversed by local application of FGF-9 and to a lesser degree VEGFA. These data could serve as a basis for future therapeutic applications aiming at improving bone regeneration in the type 2 diabetic patient population.	[Wallner, Christoph; Schira, Jessica; Hirsch, Tobias; Abraham, Stephanie; Lehnhardt, Marcus; Behr, Bjoern] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Bochum, Germany; [Wagner, Johannes Maximilian; Schulte, Matthias; Fischer, Sebastian; Kneser, Ulrich] Heidelberg Univ, BG Trauma Hosp Ludwigshafen, Dept Plast Surg, Ludwigshafen, Germany; [Richter, Wiltrud] Univ Heidelberg Hosp, Res Ctr Expt Orthopaed, Heidelberg, Germany	Ruhr University Bochum; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Behr, B (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Univ Str 150, Bochum, Germany.	bjorn.behr@rub.de	Behr, Björn/AAS-1877-2021; Hirsch, Tobias/AAS-6707-2021; Richter, Wiltrud/V-3217-2017	Hirsch, Tobias/0000-0002-3641-2707; Richter, Wiltrud/0000-0003-4694-2768; , Sebastian/0000-0003-3445-1902; Schira-Heinen, Jessica/0000-0002-2184-9746	German Research Foundation (DFG) [BE 4169/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Funding from the German Research Foundation (DFG) (http://www.dfg.de/) # BE 4169/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zube L, 2009, J ORTHOP RES, V27, P1074, DOI 10.1002/jor.20842; Amin AH, 2010, LAB INVEST, V90, P985, DOI 10.1038/labinvest.2010.86; Beam HA, 2002, J ORTHOPAED RES, V20, P1210, DOI 10.1016/S0736-0266(02)00066-9; Behr B, 2011, TISSUE ENG PT A, V17, P2061, DOI [10.1089/ten.tea.2010.0719, 10.1089/ten.TEA.2010.0719]; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; Behr B, 2010, P NATL ACAD SCI USA, V107, P11853, DOI 10.1073/pnas.1003317107; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Catalfamo DL, 2013, ORAL DIS, V19, P303, DOI 10.1111/odi.12002; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; COZEN L, 1972, CLIN ORTHOP RELAT R, P134; Cunha J.S., 2014, CELL TISSUE RES; D'Souza DR, 2009, J BIOL CHEM, V284, P17947, DOI 10.1074/jbc.M109.002378; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Ding Daofang, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1432; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gandhi A, 2006, BONE, V38, P540, DOI 10.1016/j.bone.2005.10.019; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Gaston MS, 2007, J BONE JOINT SURG BR, V89B, P1553, DOI 10.1302/0301-620X.89B12; Gebauer GP, 2002, J ORTHOPAED RES, V20, P587, DOI 10.1016/S0736-0266(01)00136-X; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; GUARNERI MP, 1993, J ENDOCRINOL INVEST, V16, P505, DOI 10.1007/BF03348892; Han SY, 2006, NEPHROL DIAL TRANSPL, V21, P2406, DOI 10.1093/ndt/gfl238; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; He HB, 2004, ENDOCRINOLOGY, V145, P447, DOI 10.1210/en.2003-1239; HICKMAN J, 1989, ENDOCRINOLOGY, V124, P701, DOI 10.1210/endo-124-2-701; Horvat S, 1999, LAB ANIM, V33, P380, DOI 10.1258/002367799780487850; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96; Kahveci Z, 2000, BIOTECH HISTOCHEM, V75, P264, DOI 10.3109/10520290009085130; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774; Kawaguchi H, 2010, J BONE MINER RES, V25, P2459, DOI 10.1002/jbmr.146; Keyszer G, 1999, J RHEUMATOL, V26, P251; Khazai NB, 2009, CURR OPIN ENDOCRINOL, V16, P435, DOI 10.1097/MED.0b013e328331c7eb; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Isidro ML, 2010, CURR DIABETES REV, V6, P144, DOI 10.2174/157339910791162970; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Pavlidis D, 2009, EUR J ORTHODONT, V31, P565, DOI 10.1093/ejo/cjp053; Perlman MH, 1999, FOOT ANKLE INT, V20, P491, DOI 10.1177/107110079902000805; RALIS ZA, 1975, MED LAB TECHNOL, V32, P203; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x; Rowe NM, 1999, ANN PLAS SURG, V42, P470, DOI 10.1097/00000637-199905000-00002; Santana RB, 2003, DIABETES, V52, P1502, DOI 10.2337/diabetes.52.6.1502; Scheede-Bergdahl C, 2014, DIABETES VASC DIS RE, V11, P324, DOI 10.1177/1479164114535943; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Tatsuyama K, 2000, EUR J HISTOCHEM, V44, P269; Teishima J, 2014, ANTICANCER RES, V34, P695; Tyndall WA, 2003, CLIN ORTHOP RELAT R, P319, DOI 10.1097/01.blo.0000048138.30533.e2; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang AM, 2014, J BIOL CHEM, V289, P11410, DOI 10.1074/jbc.M113.541458; Wang Feng, 2010, Diabetes Res Clin Pract, V88, pe7, DOI 10.1016/j.diabres.2010.01.017; Weyer C, 2013, HYPOADIPONECTINEMIA; Williams GA, 2011, J BONE MINER RES, V26, P1698, DOI 10.1002/jbmr.367; Xu F, 2013, J HUAZHONG U SCI-MED, V33, P244, DOI 10.1007/s11596-013-1105-z; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Yang YQ, 2012, INT J ORAL SCI, V4, P64, DOI 10.1038/ijos.2012.33; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169	69	52	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118823	10.1371/journal.pone.0118823	http://dx.doi.org/10.1371/journal.pone.0118823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742620	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100050
J	Orstavik, O; Manfra, O; Andressen, KW; Andersen, GO; Skomedal, T; Osnes, JB; Levy, FO; Krobert, KA				Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Andersen, Geir Oystein; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen			The Inotropic Effect of the Active Metabolite of Levosimendan, OR-1896, Is Mediated through Inhibition of PDE3 in Rat Ventricular Myocardium	PLOS ONE			English	Article							CARDIAC TROPONIN-C; CALCIUM SENSITIZER; PAPILLARY-MUSCLES; CA2+ SENSITIVITY; PHOSPHORYLATION; PROTEIN; CONTRACTILE; TRANSIENTS; INFUSION; CARDIOMYOCYTES	Aims We recently published that the positive inotropic response (PIR) to levosimendan can be fully accounted for by phosphodiesterase (PDE) inhibition in both failing human heart and normal rat heart. To determine if the PIR of the active metabolite OR-1896, an important mediator of the long-term clinical effects of levosimendan, also results from PDE3 inhibition, we compared the effects of OR-1896, a representative Ca2+ sensitizer EMD57033 (EMD), levosimendan and other PDE inhibitors. Methods Contractile force was measured in rat ventricular strips. PDE assay was conducted on rat ventricular homogenate. cAMP was measured using RII_epac FRET-based sensors. Results OR-1896 evoked a maximum PIR of 33 +/- 10% above basal at 1 mu M. This response was amplified in the presence of the PDE4 inhibitor rolipram (89 +/- 14%) and absent in the presence of the PDE3 inhibitors cilostamide (0.5 +/- 5.3%) or milrinone (3.2 +/- 4.4%). The PIR was accompanied by a lusitropic response, and both were reversed by muscarinic receptor stimulation with carbachol and absent in the presence of beta-AR blockade with timolol. OR-1896 inhibited PDE activity and increased cAMP levels at concentrations giving PIRs. OR-1896 did not sensitize the concentration-response relationship to extracellular Ca2+. Levosimendan, OR-1896 and EMD all increased the sensitivity to beta-AR stimulation. The combination of either EMD and levosimendan or EMD and OR-1896 further sensitized the response, indicating at least two different mechanisms responsible for the sensitization. Only EMD sensitized the alpha(1)-AR response. Conclusion The observed PIR to OR-1896 in rat ventricular strips is mediated through PDE3 inhibition, enhancing cAMP-mediated effects. These results further reinforce our previous finding that Ca2+ sensitization does not play a significant role in the inotropic (and lusitropic) effect of levosimendan, nor of its main metabolite OR-1896.	[Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, Dept Pharmacol, Oslo, Norway; [Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Oslo Univ Hosp, N-0450 Oslo, Norway; [Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Andersen, Geir Oystein; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway; [Andersen, Geir Oystein] Oslo Univ Hosp, Dept Cardiol, N-0450 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Levy, FO (corresponding author), Univ Oslo, Fac Med, Dept Pharmacol, Oslo, Norway.	f.o.levy@medisin.uio.no	Andersen, Geir/AAR-3010-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Andressen, Kjetil Wessel/0000-0003-1094-1501	Norwegian Council on Cardiovascular Diseases; Research Council of Norway; Stiftelsen Kristian Gerhard Jebsen Foundation; Anders Jahre's Foundation for the Promotion of Science; Family Blix foundation; University of Oslo	Norwegian Council on Cardiovascular Diseases; Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen Foundation; Anders Jahre's Foundation for the Promotion of Science; Family Blix foundation; University of Oslo	This work was supported by The Norwegian Council on Cardiovascular Diseases, The Research Council of Norway, The Stiftelsen Kristian Gerhard Jebsen Foundation, Anders Jahre's Foundation for the Promotion of Science, The Family Blix foundation and grants from the University of Oslo. The cAMP sensor RII_epac was generously provided by Manuela Zaccolo (Oxford, UK). EMD57033 was generously provided by Dr. Norbert Beier of Merck KGaA (Darmstadt, Germany).	Afzal F, 2011, BRIT J PHARMACOL, V162, P54, DOI 10.1111/j.1476-5381.2010.00890.x; Andersen GO, 2004, AM J PHYSIOL-HEART C, V286, pH1354, DOI 10.1152/ajpheart.00549.2003; Antoniades C, 2007, PHARMACOL THERAPEUT, V114, P184, DOI 10.1016/j.pharmthera.2007.01.008; Boknik P, 1997, J PHARMACOL EXP THER, V280, P277; Brixius K, 2002, AM J PHYSIOL-HEART C, V282, pH131, DOI 10.1152/ajpheart.2002.282.1.H131; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; EDES I, 1995, CIRC RES, V77, P107, DOI 10.1161/01.RES.77.1.107; ENGLAND PJ, 1976, BIOCHEM J, V160, P295, DOI 10.1042/bj1600295; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; HAIKALA H, 1995, J CARDIOVASC PHARM, V25, P794, DOI 10.1097/00005344-199505000-00016; HAIKALA H, 1995, J MOL CELL CARDIOL, V27, P1859, DOI 10.1016/0022-2828(95)90009-8; Haikala H, 1997, CARDIOVASC RES, V34, P536, DOI 10.1016/S0008-6363(97)00057-6; Hasenfuss G, 1998, CIRCULATION, V98, P2141, DOI 10.1161/01.CIR.98.20.2141; Husebye T, 2013, EUR J HEART FAIL, V15, P565, DOI 10.1093/eurjhf/hfs215; Kaheinen P, 2006, BASIC CLIN PHARMACOL, V98, P74, DOI 10.1111/j.1742-7843.2006.pto_231.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kivikko M, 2002, INT J CLIN PHARM TH, V40, P465; Levy FO, 2013, N-S ARCH PHARMACOL, V386, P665, DOI 10.1007/s00210-013-0874-z; Lilleberg J, 2007, EUR J HEART FAIL, V9, P75, DOI 10.1016/j.ejheart.2006.04.012; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381, DOI 10.1042/bj1870381; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Orstavik O, 2014, BRIT J PHARMACOL, V171, P5169, DOI 10.1111/bph.12647; POLLESELLO P, 1994, J BIOL CHEM, V269, P28584; Qvigstad E, 2005, CARDIOVASC RES, V65, P869, DOI 10.1016/j.cardiores.2004.11.017; Sato S, 1998, J MOL CELL CARDIOL, V30, P1115, DOI 10.1006/jmcc.1998.0677; Segreti JA, 2008, J PHARMACOL EXP THER, V325, P331, DOI 10.1124/jpet.107.132530; SKOMEDAL T, 1987, ACTA PHYSIOL SCAND, V131, P347, DOI 10.1111/j.1748-1716.1987.tb08249.x; Skomedal T, 1997, J PHARMACOL EXP THER, V280, P721; SOLARO RJ, 1993, CIRC RES, V73, P981, DOI 10.1161/01.RES.73.6.981; Sorsa T, 2001, J BIOL CHEM, V276, P9337, DOI 10.1074/jbc.M007484200; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Szilagyi S, 2005, J CARDIOVASC PHARM, V46, P369, DOI 10.1097/01.fjc.0000175454.69116.9; Szilagyi S, 2004, EUR J PHARMACOL, V486, P67, DOI 10.1016/j.ejphar.2003.12.005; Takahashi R, 2000, EUR J PHARMACOL, V400, P103, DOI 10.1016/S0014-2999(00)00385-X; Takahashi R, 2000, J CARDIOVASC PHARM, V36, P118, DOI 10.1097/00005344-200007000-00016; Takahashi R, 2005, BRIT J PHARMACOL, V145, P1143, DOI 10.1038/sj.bjp.0706292; Takahashi R, 2002, N-S ARCH PHARMACOL, V366, P440, DOI 10.1007/s00210-002-0627-x; Teerlink JR, 2009, HEART FAIL REV, V14, P243, DOI 10.1007/s10741-009-9153-y; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115547	10.1371/journal.pone.0115547	http://dx.doi.org/10.1371/journal.pone.0115547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738589	Green Published, gold			2022-12-26	WOS:000350685900003
J	Qayyum, M; Khan, H; Rahim, MT; Ullah, I				Qayyum, Mubashir; Khan, Hamid; Rahim, M. Tariq; Ullah, Inayat			Modeling and Analysis of Unsteady Axisymmetric Squeezing Fluid Flow through Porous Medium Channel with Slip Boundary	PLOS ONE			English	Article							HOMOTOPY PERTURBATION METHOD	The aim of this article is to model and analyze an unsteady axisymmetric flow of non-conducting, Newtonian fluid squeezed between two circular plates passing through porous medium channel with slip boundary condition. A single fourth order nonlinear ordinary differential equation is obtained using similarity transformation. The resulting boundary value problem is solved using Homotopy Perturbation Method (HPM) and fourth order Explicit Runge Kutta Method (RK4). Convergence of HPM solution is verified by obtaining various order approximate solutions along with absolute residuals. Validity of HPM solution is confirmed by comparing analytical and numerical solutions. Furthermore, the effects of various dimensionless parameters on the longitudinal and normal velocity profiles are studied graphically.	[Qayyum, Mubashir; Khan, Hamid; Rahim, M. Tariq; Ullah, Inayat] Natl Univ Comp & Emerging Sci, Dept Math, Peshawar 25000, Pakistan		Qayyum, M (corresponding author), Natl Univ Comp & Emerging Sci, Dept Math, FAST Peshawar Campus, Peshawar 25000, Pakistan.	mubashir.qayyum@nu.edu.pk	Qayyum, Mubashir/I-8795-2019	Qayyum, Mubashir/0000-0002-6701-5640				Breugem WP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2792323; Domairry G, 2009, MATH PROBL ENG, V2009, DOI 10.1155/2009/603916; Elkouh AF, 1986, J TRIBOLOGY, V106, P223, DOI DOI 10.1115/1.3260889; GRIMM RJ, 1976, APPL SCI RES, V32, P149, DOI 10.1007/BF00383711; GUPTA PS, 1977, WEAR, V45, P177, DOI 10.1016/0043-1648(77)90072-2; Hamdan M.H., 2006, INT J PURE APPL MATH, V27, P491; Hamdan MH, 1998, APPL MATH COMPUT, V93, P83, DOI 10.1016/S0096-3003(97)10047-9; HAMZA EA, 1988, J TRIBOL-T ASME, V110, P375, DOI 10.1115/1.3261636; He JH, 2006, PHYS LETT A, V350, P87, DOI 10.1016/j.physleta.2005.10.005; He JH, 2003, APPL MATH COMPUT, V135, P73, DOI 10.1016/S0096-3003(01)00312-5; He JH, 2000, INT J NONLINEAR MECH, V35, P37, DOI 10.1016/S0020-7462(98)00085-7; He JH, 1999, COMPUT METHOD APPL M, V178, P257, DOI 10.1016/S0045-7825(99)00018-3; He JH, 2006, INT J MOD PHYS B, V20, P2561, DOI 10.1142/S0217979206034819; Ishizawa S, 1966, B JSME, V9, P533, DOI [10.1299/jsme1958.9.533, DOI 10.1299/JSME1958.9.533]; Islam S, 2008, J POROUS MEDIA, V11, P669, DOI 10.1615/JPorMedia.v11.i7.50; Islam S, 2007, J POROUS MEDIA, V10, P401, DOI 10.1615/JPorMedia.v10.i4.60; Islam S, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/349803; Khan H, 2012, ABSTR APPL AN; Kolyshkin A, 2007, MATH MODEL ANAL, V12, P101, DOI 10.3846/1392-6292.2007.12.101-106; Krylovas A, 2001, MATH MODEL ANAL, V6, P117; KUZMA DC, 1967, APPL SCI RES, V18, P15; Laun HM, 1999, J NON-NEWTON FLUID, V81, P1, DOI 10.1016/S0377-0257(98)00083-4; LEIDER PJ, 1974, IND ENG CHEM FUND, V13, P336, DOI 10.1021/i160052a007; Naduvinamani NB, 2001, TRIBOL INT, V34, P739, DOI 10.1016/S0301-679X(01)00064-0; Navier C, 1823, MEMOIRES LACADEMIE S, V6, P389; Nayfeh A. H., 1981, INTRO PERTURBATION T; Neto C, 2005, REP PROG PHYS, V68, P2859, DOI 10.1088/0034-4885/68/12/R05; Qayyum A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/034701; Siddiqui AM, 2006, INT J NONLIN SCI NUM, V7, P7; Siddiqui AM, 2006, INT J NONLIN SCI NUM, V7, P15; SINGH P, 1990, ING ARCH, V60, P274, DOI 10.1007/BF00577864; Stefan M. J., 1874, MATH NATURWISSEN, V69, P713; Tan WC, 2005, INT J NONLIN MECH, V40, P515, DOI 10.1016/j.ijnonlinmec.2004.07.016; Thorpe JF, 1967, DEV THEORETICAL APPL; TICHY JA, 1970, J LUBR TECHNOL, V92, P588, DOI 10.1115/1.3451480; VAFAI K, 1981, INT J HEAT MASS TRAN, V24, P195, DOI 10.1016/0017-9310(81)90027-2; Vafai K.J., 2005, HDB POROUS MEDIA, V2nd ed.; VERMA RL, 1981, WEAR, V72, P89, DOI 10.1016/0043-1648(81)90286-6; Zhou GL, 2014, INT J NUMER METHOD H, V24, P1331, DOI 10.1108/HFF-01-2013-0021	39	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117368	10.1371/journal.pone.0117368	http://dx.doi.org/10.1371/journal.pone.0117368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738864	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900015
J	Wang, Y; Yin, Y; Sun, YW; Zhou, Y; Chen, X; Ding, WN; Wang, W; Li, W; Xu, JR; Du, YS				Wang, Yao; Yin, Yan; Sun, Ya-wen; Zhou, Yan; Chen, Xue; Ding, Wei-na; Wang, Wei; Li, Wei; Xu, Jian-rong; Du, Ya-song			Decreased Prefrontal Lobe Interhemispheric Functional Connectivity in Adolescents with Internet Gaming Disorder: A Primary Study Using Resting-State fMRI	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; ORBITOFRONTAL CORTEX; ADDICTION; SCHIZOPHRENIA; COORDINATION; CHILDREN; REWARD	Purposes Recent neuroimaging studies have shown that people with Internet gaming disorder (IGD) have structural and functional abnormalities in specific brain areas and connections. However, little is known about the alterations of the interhemispheric resting-state functional connectivity (rsFC) in participants with IGD. In the present study, we used a newly developed voxel-mirrored homotopic connectivity (VMHC) method to investigate the interhemispheric rsFC of the whole brain in participants with IGD. Methods We compared interhemispheric rsFC between 17 participants with IGD and 24 healthy controls, group-matched on age, gender, and education status. All participants were provided written informed consent. Resting-state functional and structural magnetic resonance images were acquired for all participants. The rsFC between bilateral homotopic voxels was calculated. Regions showing abnormal VMHC in IGD participants were adopted as regions of interest for correlation analyses. Results Compared to healthy controls, IGD participants showed decreased VMHC between the left and right superior frontal gyrus (orbital part), inferior frontal gyrus (orbital part), middle frontal gyrus and superior frontal gyrus. Further analyses showed Chen Internet Addiction Scale (CIAS)-related VMHC in superior frontal gyrus (orbital part) and CIAS (r=-0.55, p=0.02, uncorrected). Conclusions Our findings implicate the important role of altered interhemispheric rsFC in the bilateral prefrontal lobe in the neuropathological mechanism of IGD, and provide further supportive evidence for the reclassification of IGD as a behavioral addiction.	[Wang, Yao; Yin, Yan; Sun, Ya-wen; Zhou, Yan; Chen, Xue; Ding, Wei-na; Xu, Jian-rong] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Ren Ji Hosp, Shanghai 200030, Peoples R China; [Du, Ya-song] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai 200030, Peoples R China; [Wang, Wei; Li, Wei] Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Air Force Military Medical University	Zhou, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Ren Ji Hosp, Shanghai 200030, Peoples R China.	clare1475@hotmail.com; xujianr@hotmail.com			National Natural Science Foundation of China [81171325, 81371622, 81371532, 81401393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81171325), National Natural Science Foundation of China (No. 81371622), National Natural Science Foundation of China (Nos. 81371532), and National Natural Science Foundation of China (81401393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2001, J AM COLL HEALTH, V50, P21, DOI 10.1080/07448480109595707; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Brand M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00375; Cao F, 2007, CHILD CARE HLTH DEV, V33, P275, DOI 10.1111/j.1365-2214.2006.00715.x; Chen SH, 2003, CHINESE J PSYCHOL, V45, P279, DOI [DOI 10.1037/T44491-000, 10.1037/t44491-000]; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Ding WN, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-20; Ding WN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059902, 10.1371/journal.pone.0061533]; Dong GH, 2013, PROG NEURO-PSYCHOPH, V46, P139, DOI 10.1016/j.pnpbp.2013.07.007; Dong GH, 2012, PSYCHIAT RES-NEUROIM, V203, P153, DOI 10.1016/j.pscychresns.2012.02.001; Han DH, 2010, CYBERPSYCH BEH SOC N, V13, P655, DOI 10.1089/cyber.2009.0327; Heitzeg MM, 2014, DRUG ALCOHOL DEPEN, V141, P51, DOI 10.1016/j.drugalcdep.2014.05.002; Hoeft F, 2008, J PSYCHIATR RES, V42, P253, DOI 10.1016/j.jpsychires.2007.11.010; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057831; Hong SB, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-11; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Huang HY, 2009, CYBERPSYCHOL BEHAV, V12, P675, DOI 10.1089/cpb.2009.0060; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kuss DJ, 2013, PSYCHOL RES BEHAV MA, V6, P125, DOI 10.2147/PRBM.S39476; Kuss DJ, 2012, BRAIN SCI, V2, P347, DOI 10.3390/brainsci2030347; Lam LT, 2009, INJURY PREV, V15, P403, DOI 10.1136/ip.2009.021949; Leung L, 2004, CYBERPSYCHOL BEHAV, V7, P333, DOI 10.1089/1094931041291303; Lin FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030253; Meng Y., 2014, ADDICTION BIOL; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rose JE, 2011, BIOL PSYCHIAT, V70, P794, DOI 10.1016/j.biopsych.2011.05.031; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schwarzkopf DS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00200; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; Weng CB, 2013, EUR J RADIOL, V82, P1308, DOI 10.1016/j.ejrad.2013.01.031; White T, 2011, SCHIZOPHRENIA BULL, V37, P222, DOI 10.1093/schbul/sbp088; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476; Zhou Y, 2013, AM J NEURORADIOL, V34, P1180, DOI 10.3174/ajnr.A3386; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	45	18	20	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118733	10.1371/journal.pone.0118733	http://dx.doi.org/10.1371/journal.pone.0118733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738502	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900065
J	Witthoft, N; Winawer, J; Eagleman, DM				Witthoft, Nathan; Winawer, Jonathan; Eagleman, David M.			Prevalence of Learned Grapheme-Color Pairings in a Large Online Sample of Synesthetes	PLOS ONE			English	Article							LARGE-SCALE; SYNAESTHESIA; IMAGERY	In this paper we estimate the minimum prevalence of grapheme-color synesthetes with letter-color matches learned from an external stimulus, by analyzing a large sample of English-speaking grapheme-color synesthetes. We find that at least 6% (400/6588 participants) of the total sample learned many of their matches from a widely available colored letter toy. Among those born in the decade after the toy began to be manufactured, the proportion of synesthetes with learned letter-color pairings approaches 15% for some 5-year periods. Among those born 5 years or more before it was manufactured, none have colors learned from the toy. Analysis of the letter-color matching data suggests the only difference between synesthetes with matches to the toy and those without is exposure to the stimulus. These data indicate learning of letter-color pairings from external contingencies can occur in a substantial fraction of synesthetes, and are consistent with the hypothesis that grapheme-color synesthesia is a kind of conditioned mental imagery.	[Witthoft, Nathan] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Winawer, Jonathan] NYU, Dept Psychol, New York, NY 10003 USA; [Winawer, Jonathan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Eagleman, David M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Stanford University; New York University; New York University; Baylor College of Medicine	Witthoft, N (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	witthoft@stanford.edu	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586	National Institutes of Health [RO1EY019279-01A1, R00EY022116]; Mind Science Foundation; NATIONAL EYE INSTITUTE [R01EY019279, R00EY022116, R01EY022318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mind Science Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NW was supported by the National Institutes of Health (http://grants.nih.gov/grants/oer.htm), RO1EY019279-01A1. JW was supported by the National Institutes of Health, R00EY022116. DME was supported by The Mind Science Foundation (http://www.mindscience.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JD, 2008, J EXP PSYCHOL HUMAN, V34, P446, DOI 10.1037/0096-1523.34.2.446; Asano M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00757; Barnett KJ, 2008, CONSCIOUS COGN, V17, P1032, DOI 10.1016/j.concog.2007.05.011; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; Beeli G, 2007, PSYCHOL SCI, V18, P788, DOI 10.1111/j.1467-9280.2007.01980.x; Berlin B, 1969, BASIC COLOR TERMS TH, DOI [10.3758/s13414-010-0055-9, DOI 10.3758/S13414-010-0055-9]; Bower G. H., 1972, COGNITION LEARN MEM, P51; Brang D, 2011, NEUROPSYCHOLOGIA, V49, P1355, DOI 10.1016/j.neuropsychologia.2011.01.002; Calkins M., 1893, AM J PSYCHOL, V5, P439, DOI [10.2307/1411912, DOI 10.2307/1411912]; Chabalier E., 1864, J MED LYON, V1, P92; Colizoli O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039799; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Galton F., 1880, FORTNIGHTLY REV, V24, P312; Howells TH, 1944, J EXP PSYCHOL, V34, P87, DOI 10.1037/h0054424; Jewanski J, 2011, J HIST NEUROSCI, V20, P284, DOI 10.1080/0964704X.2010.528240; Kadosh RC, 2007, TRENDS COGN SCI, V11, P177, DOI 10.1016/j.tics.2007.01.003; Leuba C, 1940, J EXP PSYCHOL, V26, P345, DOI 10.1037/h0057631; Marks L. E., 2005, SYNESTHESIA PERSPECT, P214; Martino G, 2001, CURR DIR PSYCHOL SCI, V10, P61, DOI 10.1111/1467-8721.00116; Meier B, 2009, NEUROPSYCHOLOGIA, V47, P1208, DOI 10.1016/j.neuropsychologia.2009.01.009; Mroczko-Wasowicz A., 2013, OXFORD HDB SYNESTHES, P165; Novich S, 2011, J NEUROPSYCHOL, V5, P353, DOI 10.1111/j.1748-6653.2011.02015.x; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; Pariyadath V, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00328; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Rothen N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00109; Simner J., 2005, COGNITIVE NEUROPSYCH, V22, P1; Simner J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00603; Simner J, 2009, BRAIN, V132, P57, DOI 10.1093/brain/awn292; Spector F, 2009, DEV PSYCHOL, V45, P175, DOI 10.1037/a0014171; Spence C., 2013, MULTISENSORY IMAGERY, P157, DOI [10.1007/978-1-4614-5879-1_9, DOI 10.1007/978-1-4614-5879-1_9]; Tomson SN, 2011, BEHAV BRAIN RES, V223, P48, DOI 10.1016/j.bbr.2011.03.071; Tyler C. W., 2005, SYNESTHESIA PERSPECT, P34; Ward J, 2003, COGNITION, V89, P237, DOI 10.1016/S0010-0277(03)00122-7; Watson MR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00098; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Witthoft N, 2013, PSYCHOL SCI, V24, P258, DOI 10.1177/0956797612452573; Yon D, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.00072, DOI 10.3389/FPSYG.2014.00072]	40	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118996	10.1371/journal.pone.0118996	http://dx.doi.org/10.1371/journal.pone.0118996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25739095	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900090
J	Abdellaoul, A; Hottenga, JJ; Willemsen, G; Bartels, M; van Beijsterveldt, T; Ehli, EA; Davies, GE; Brooks, A; Sullivan, PF; Penninx, BWJH; de Geus, EJ; Boomsma, DI				Abdellaoul, Abdel; Hottenga, Jouke-Jan; Willemsen, Gonneke; Bartels, Meike; van Beijsterveldt, Toos; Ehli, Erik A.; Davies, Gareth E.; Brooks, Andrew; Sullivan, Patrick F.; Penninx, Brenda W. J. H.; de Geus, Eco J.; Boomsma, Dorret I.			Educational Attainment Influences Levels of Homozygosity through Migration and Assortative Mating	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; MAJOR DEPRESSION; ASSOCIATION; STRATIFICATION; AUTOZYGOSITY; INTELLIGENCE; DISORDERS; SELECTION; GRADUATE; BIOBANK	Individuals with a higher education are more likely to migrate, increasing the chance of meeting a spouse with a different ancestral background. In this context, the presence of strong educational assortment can result in greater ancestry differences within more educated spouse pairs, while less educated individuals are more likely to mate with someone with whom they share more ancestry. We examined the association between educational attainment and F-roh (=the proportion of the genome consisting of runs of homozygosity [ROHs]) in similar to 2,000 subjects of Dutch ancestry. The subjects' own educational attainment showed a nominally significant negative association with F-roh (p = .045), while the contribution of parental education to offspring Froh was highly significant (father: p < 10(-5); mother: p = 9x10(-5)), with more educated parents having offspring with fewer ROHs. This association was significantly and fully mediated by the physical distance between parental birthplaces (paternal education: p(mediation) = 2.4 x 10(-4); maternal education: pmediation = 2.3 x 10(-4)), which itself was also significantly associated with Froh (p = 9 x 10(-5)). Ancestry-informative principal components from the offspring showed a significantly decreasing association with geography as parental education increased, consistent with the significantly higher migration rates among more educated parents. Parental education also showed a high spouse correlation (Spearman's. = .66, p = 3 x 10(-262)). We show that less educated parents are less likely to mate with the more mobile parents with a higher education, creating systematic differences in homozygosity due to ancestry differences not directly captured by ancestry-informative principal components (PCs). Understanding how behaviors influence the genomic structure of a population is highly valuable for studies on the genetic etiology of behavioral, cognitive, and social traits.	[Abdellaoul, Abdel; Hottenga, Jouke-Jan; Willemsen, Gonneke; Bartels, Meike; van Beijsterveldt, Toos; de Geus, Eco J.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Abdellaoul, Abdel; Bartels, Meike; Penninx, Brenda W. J. H.; de Geus, Eco J.; Boomsma, Dorret I.] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Willemsen, Gonneke; Bartels, Meike; Penninx, Brenda W. J. H.; de Geus, Eco J.; Boomsma, Dorret I.] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Ehli, Erik A.; Davies, Gareth E.] Avera McKennan Hosp & Univ Hlth Ctr, Avera Inst Human Genet, Sioux Falls, SD USA; [Brooks, Andrew] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rutgers State University New Brunswick; University of North Carolina; University of North Carolina Chapel Hill; Vrije Universiteit Amsterdam	Abdellaoul, A (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands.	a.abdellaoui@vu.nl	Penninx, Brenda WJH/S-7627-2017; Boomsma, Dorret I/AAX-4470-2020; de Geus, Eco J.C./M-9318-2015; Bartels, Meike/D-4492-2014	Penninx, Brenda WJH/0000-0001-7779-9672; de Geus, Eco J.C./0000-0001-6022-2666; Bartels, Meike/0000-0002-9667-7555; van Beijsterveldt, Toos/0000-0002-6617-4201; Willemsen, Gonneke/0000-0003-3755-0236	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW)10-000-1002 [904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008 Middelgroot-911-09-032, Spinozapremie 56-464-14192, 10-000-1002]; Center for Medical Systems Biology (CMSB, NWO Genomics); NBIC/BioAssist/RK [2008.024]; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL) [184.021.007]; VU University's Institute for Health and Care Research; Neuroscience Campus Amsterdam; European Science Foundation (ESF) [EU/QLRT-2001-01254]; European Community's Seventh Framework Program (FP7); ENGAGE [HEALTH-F4-2007-201413]; European Science Council (ERC) [230374]; Rutgers University Cell and DNA Repository (NIMH) [U24 MH068457-06]; Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA); National Institutes of Health (NIH) [R01D0042157-01A]; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health (NIMH) [MH081802]; Grand Opportunity from the NIMH [1RC2MH089951-01, 1RC2 MH089995-01]; CSMB; Netherlands Scientific Organization (NWO) [480-05-003]; Dutch Brain Foundation; department of Psychology and Education of the VU University Amsterdam; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089995, U24MH068457, RC2MH089951, R01MH081802] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW)10-000-1002; Center for Medical Systems Biology (CMSB, NWO Genomics); NBIC/BioAssist/RK; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL); VU University's Institute for Health and Care Research; Neuroscience Campus Amsterdam; European Science Foundation (ESF)(European Science Foundation (ESF)); European Community's Seventh Framework Program (FP7); ENGAGE; European Science Council (ERC)(European Research Council (ERC)); Rutgers University Cell and DNA Repository (NIMH); Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health (NIMH); Grand Opportunity from the NIMH; CSMB; Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Brain Foundation; department of Psychology and Education of the VU University Amsterdam; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW grants 904-61-090, 985-10-002,904-61-193,480-04-004, 400-05-717, Addiction-31160008 Middelgroot-911-09-032, Spinozapremie 56-464-14192, Geestkracht program grant 10-000-1002), Center for Medical Systems Biology (CMSB, NWO Genomics; http://www.cmsb.nl/), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL, 184.021.007), the VU University's Institute for Health and Care Research (EMGO+, http://www.emgo.nl) and Neuroscience Campus Amsterdam (NCA, http://www.neurosciencecampusamsterdam.nl), the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community's Seventh Framework Program (FP7/2007-2013), ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC Advanced, 230374), Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA) and the National Institutes of Health (NIH, R01D0042157-01A). Part of the genotyping was funded by the Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health (NIMH, MH081802) and by the Grand Opportunity grants 1RC2MH089951-01 and 1RC2 MH089995-01 from the NIMH. AA was supported by CSMB (http://www.cmsb.nl/). Most statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org), which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003), the Dutch Brain Foundation, and the department of Psychology and Education of the VU University Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui A, 2013, BEHAV GENET, V43, P455, DOI 10.1007/s10519-013-9610-1; Abdellaoui A, 2013, EUR J HUM GENET, V21, P1277, DOI 10.1038/ejhg.2013.48; Blossfeld HP, 2009, ANNU REV SOCIOL, V35, P513, DOI 10.1146/annurev-soc-070308-115913; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Boomsma DI, 2014, EUR J HUM GENET, V22, P221, DOI 10.1038/ejhg.2013.118; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Branigan AR, 2013, VARIATION HERITABILI, P13; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; DeRaad B, 1996, EUR J PERSONALITY, V10, P303, DOI 10.1002/(SICI)1099-0984(199612)10:5<303::AID-PER262>3.0.CO;2-2; Domingue BW, 2014, P NATL ACAD SCI USA; Esteve A, 2012, POPUL DEV REV, V38, P535, DOI 10.1111/j.1728-4457.2012.00515.x; Faggian A, 2006, ANN REGIONAL SCI, V40, P461, DOI 10.1007/s00168-006-0061-y; Faggian A, 2007, URBAN STUD, V44, P2511, DOI 10.1080/00420980701667177; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; HEATH AC, 1985, NATURE, V314, P734, DOI 10.1038/314734a0; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; JENSEN AR, 1983, PERS INDIV DIFFER, V4, P71, DOI 10.1016/0191-8869(83)90054-5; Kaufman AS, 2009, ARCH CLIN NEUROPSYCH, V24, P153, DOI 10.1093/arclin/acp015; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; MARE RD, 1991, AM SOCIOL REV, V56, P15, DOI 10.2307/2095670; Martin NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020128; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mingroni MA, 2004, INTELLIGENCE, V32, P65, DOI 10.1016/S0160-2896(03)00058-8; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; Mulder C, 2004, DEMOS, V20, P78; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Power RA, 2014, AM J MED GENET B, V165, P157, DOI 10.1002/ajmg.b.32217; Power RA, 2014, EUR J HUM GENET, V22, P386, DOI 10.1038/ejhg.2013.155; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Schwartz CR, 2013, ANNU REV SOCIOL, V39, P451, DOI 10.1146/annurev-soc-071312-145544; Tyler-Smith C, 2012, EUR J HUM GENET, V20, P129, DOI 10.1038/ejhg.2011.153; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127; Woodley MA, 2009, INTELLIGENCE, V37, P268, DOI 10.1016/j.intell.2008.10.007; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	48	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118935	10.1371/journal.pone.0118935	http://dx.doi.org/10.1371/journal.pone.0118935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734509	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700048
J	Lanier, HC; Gunderson, AM; Weksler, M; Fedorov, VB; Olson, LE				Lanier, Hayley C.; Gunderson, Aren M.; Weksler, Marcelo; Fedorov, Vadim B.; Olson, Link E.			Comparative Phylogeography Highlights the Double-Edged Sword of Climate Change Faced by Arctic- and Alpine-Adapted Mammals	PLOS ONE			English	Article							GLACIAL REFUGIA; SPERMOPHILUS-PARRYII; PLEISTOCENE REFUGIA; MOLECULAR PHYLOGENY; STATISTICAL TESTS; LEMMINGS LEMMUS; DNA DIVERSITY; NORTH-AMERICA; MITOCHONDRIAL; POPULATION	Recent studies suggest that alpine and arctic organisms may have distinctly different phylo-geographic histories from temperate or tropical taxa, with recent range contraction into interglacial refugia as opposed to post-glacial expansion out of refugia. We use a combination of phylogeographic inference, demographic reconstructions, and hierarchical Approximate Bayesian Computation to test for phylodemographic concordance among five species of alpine-adapted small mammals in eastern Beringia. These species (Collared Pikas, Hoary Marmots, Brown Lemmings, Arctic Ground Squirrels, and Singing Voles) vary in specificity to alpine and boreal-tundra habitat but share commonalities (e.g., cold tolerance and nunatak survival) that might result in concordant responses to Pleistocene glaciations. All five species contain a similar phylogeographic disjunction separating eastern and Beringian lineages, which we show to be the result of simultaneous divergence. Genetic diversity is similar within each haplogroup for each species, and there is no support for a post-Pleistocene population expansion in eastern lineages relative to those from Beringia. Bayesian skyline plots for four of the five species do not support Pleistocene population contraction. Brown Lemmings show evidence of late Quaternary demographic expansion without subsequent population decline. The Wrangell-St. Elias region of eastern Alaska appears to be an important zone of recent secondary contact for nearctic alpine mammals. Despite differences in natural history and ecology, similar phylogeographic histories are supported for all species, suggesting that these, and likely other, alpine-and arctic-adapted taxa are already experiencing population and/or range declines that are likely to synergistically accelerate in the face of rapid climate change. Climate change may therefore be acting as a double-edged sword that erodes genetic diversity within populations but promotes divergence and the generation of biodiversity.				hlanier@uwyo.edu	Weksler, Marcelo/A-7420-2010	Weksler, Marcelo/0000-0001-8111-4779; Lanier, Hayley/0000-0001-9337-4017; Olson, Link/0000-0002-2481-5701	Alaska Department of Fish and Game State Wildlife Grant [T-1-6]; National Science Foundation Doctoral Dissertation Improvement Grant [DEB-0808619]; Alaska EPSCoR Dissertation Enhancement Grant [NSF EPS0092040, 0346770]; American Society of Mammalogists; Alaska Quaternary Center David and Rachel Hopkins Fellowship	Alaska Department of Fish and Game State Wildlife Grant; National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Alaska EPSCoR Dissertation Enhancement Grant; American Society of Mammalogists; Alaska Quaternary Center David and Rachel Hopkins Fellowship	This work was supported by the following sources of funding: Alaska Department of Fish and Game (http://www.adfg.alaska.gov) State Wildlife Grant (Grant T-1-6) to LEO; National Science Foundation (http://www.nsf.gov) Doctoral Dissertation Improvement Grant (DEB-0808619) to LEO and HCL; Alaska EPSCoR (http://www.alaska.edu/epscor/) Dissertation Enhancement Grant (NSF EPS0092040, 0346770) to HCL; American Society of Mammalogists (http://www.mammalsociety.org) Grant in Aid of Research to HCL; and Alaska Quaternary Center (http://www.uaf.edu/aqc/) David and Rachel Hopkins Fellowship to HCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2005, MOL ECOL, V14, P2739, DOI 10.1111/j.1365-294X.2005.02621.x; BATZLI GO, 1995, OIKOS, V72, P88, DOI 10.2307/3546042; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Catto N, 1996, QUATERN INT, V32, P21, DOI 10.1016/S1040-6182(96)90012-9; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cook JA, SMALL MAMMAL INVENTO, P1; Cook JA, 2010, J MAMMAL, V91, P1401, DOI 10.1644/09-MAMM-A-386.1; Dalen L, 2006, MOL ECOL, V15, P2809, DOI 10.1111/j.1365-294X.2006.02983.x; Danby RK, 2005, ECOL APPL, V15, P405, DOI 10.1890/04-0043; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Dixon EJ, 2013, QUATERN INT, V285, P57, DOI 10.1016/j.quaint.2011.02.027; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUKRODKIN A, 1991, GEOGR PHYS QUATERN, V45, P79, DOI 10.7202/032847ar; Eddingsaas AA, 2004, J MAMMAL, V85, P601, DOI 10.1644/BRB-204; Ehrich D, 2005, J MAMMAL, V86, P380, DOI 10.1644/BER-126.1; Eidesen PB, 2007, J BIOGEOGR, V34, P1559, DOI 10.1111/j.1365-2699.2007.01719.x; Fay JC, 2000, GENETICS, V155, P1405; Fedorov V, 1999, BIOL J LINN SOC, V66, P357, DOI 10.1006/bijl.1998.0271; Fedorov VB, 2003, MOL ECOL, V12, P725, DOI 10.1046/j.1365-294X.2003.01776.x; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Fedorov VB, 1999, P ROY SOC B-BIOL SCI, V266, P621, DOI 10.1098/rspb.1999.0681; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Fickert T, 2007, ARCT ANTARCT ALP RES, V39, P245, DOI 10.1657/1523-0430(2007)39[245:DDGSAP]2.0.CO;2; Fleming MA, 2002, MOL ECOL, V11, P795, DOI 10.1046/j.1365-294X.2002.01472.x; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2012, P ROY SOC B-BIOL SCI, V279, P371, DOI 10.1098/rspb.2011.0482; Galbreath KE, 2011, EVOLUTION, V65, P1879, DOI 10.1111/j.1558-5646.2011.01287.x; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Gillis EA, 2005, OIKOS, V108, P231, DOI 10.1111/j.0030-1299.2005.13535.x; Griffin SC, 2008, BIOL CONSERV, V141, P1293, DOI 10.1016/j.biocon.2008.03.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunderson AM, 2012, J MAMMAL, V93, P66, DOI 10.1644/10-MAMM-A-380.1; Gunderson AM, 2009, J MAMMAL, V90, P859, DOI 10.1644/08-MAMM-A-253.1; GUTHRIE RD, 1973, J MAMMAL, V54, P970, DOI 10.2307/1379093; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Guthrie RD, 1973, QUATERNARY RES, V1, P474; Guthrie RD., 1982, PALEOECOLOGY BERINGI, P307, DOI [10.1016/b978-0-12-355860-2.50030-2, DOI 10.1016/B978-0-12-355860-2.50030-2, 10.1016/B978-0-12-355860-2.50030-2]; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Harington C.R., 2003, ANNOTATED BIBLIO QUA; Hein J., 2005, GENE GENEALOGIES VAR; Herron MD, 2004, MOL PHYLOGENET EVOL, V31, P1015, DOI 10.1016/j.ympev.2003.09.015; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hickerson MJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-268; Hickerson MJ, 2006, MOL ECOL, V15, P209, DOI 10.1111/j.1365-294X.2005.02718.x; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Hopkins D. M, 1967, BERING LAND BRIDGE; Hopkins DM, 1982, PALEOECOLOGY BERINGI; Hulten E, 1937, OUTLINE HIST ARCTIC; Humphries EM, 2011, MOL ECOL, V20, P573, DOI 10.1111/j.1365-294X.2010.04965.x; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; JOPLING AV, 1981, ARCTIC, V34, P3; Kurten B., 1980, PLEISTOCENE MAMMALS; Lagerholm VK, 2014, MOL ECOL, V23, P2060, DOI 10.1111/mec.12698; Lanier HC, 2013, J BIOGEOGR, V40, P466, DOI 10.1111/jbi.12035; Lanier HC, 2009, MOL PHYLOGENET EVOL, V53, P1, DOI 10.1016/j.ympev.2009.05.035; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lyons SK, 2005, AM NAT, V165, pE168, DOI 10.1086/429699; MACDONALD S O, 1987, Mammalian Species, P1, DOI 10.2307/3503971; MacDonald SO, 2009, RECENT MAMMALS OF ALASKA, P1; MacPherson AH, 1985, SYST ZOOL, V14, P153; Marr KL, 2008, J BIOGEOGR, V35, P1323, DOI 10.1111/j.1365-2699.2007.01879.x; Miller A, 2005, ANCHORAGE ALASKA LAK; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; MURRAY B M, 1969, Canadian Field-Naturalist, V83, P331; Near TJ, 2003, EVOLUTION, V57, P1610; Nei M., 1987, MOL EVOLUTIONARY GEN; PATTERSON B. D., 2007, DIGITAL DISTRIBUTION; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; PIELOU EC, 1991, ICE AGE RETURN LIFE; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Repenning C. A., 1964, Arctic, V17, P176; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Shafer ABA, 2011, EVOLUTION, V65, P125, DOI 10.1111/j.1558-5646.2010.01109.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sher A, 1999, NATURE, V397, P103, DOI 10.1038/16341; SIMPSON GEORGE GAYLORD, 1940, JOUR WASHINGTON ACAD SCI, V30, P137; Steppan SJ, 1999, SYST BIOL, V48, P715, DOI 10.1080/106351599259988; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Szeicz JM, 2001, QUATERNARY SCI REV, V20, P247, DOI 10.1016/S0277-3791(00)00119-0; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Topp CM, 2008, AUK, V125, P461, DOI 10.1525/auk.2008.06254; TYSER RW, 1980, AM MIDL NAT, V104, P32, DOI 10.2307/2424955; Waltari E, 2007, J BIOGEOGR, V34, P561, DOI 10.1111/j.1365-2699.2007.01705.x; Weksler M, 2010, J BIOGEOGR, V37, P1414, DOI 10.1111/j.1365-2699.2010.02310.x; Youngman P.M., 1975, Publications Zool natn Mus nat Sci Can, VNo. 10, P1; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zwickl D. J, 2006, GENETIC ALGORITHM AP	97	13	13	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118396	10.1371/journal.pone.0118396	http://dx.doi.org/10.1371/journal.pone.0118396			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734275	Green Submitted, Green Published, gold			2022-12-26	WOS:000350314700025
J	Amrine, KCH; Blanco-Ulate, B; Cantu, D				Amrine, Katherine C. H.; Blanco-Ulate, Barbara; Cantu, Dario			Discovery of Core Biotic Stress Responsive Genes in Arabidopsis by Weighted Gene Co-Expression Network Analysis	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; PLANT DEFENSE; INDUCED EXPRESSION; CONSERVATION; EVOLUTION; KINASE; ACID; PHOTOSYNTHESIS; INTEGRATION	Intricate signal networks and transcriptional regulators translate the recognition of pathogens into defense responses. In this study, we carried out a gene co-expression analysis of all currently publicly available microarray data, which were generated in experiments that studied the interaction of the model plant Arabidopsis thaliana with microbial pathogens. This work was conducted to identify (i) modules of functionally related co-expressed genes that are differentially expressed in response to multiple biotic stresses, and (ii) hub genes that may function as core regulators of disease responses. Using Weighted Gene Co-expression Network Analysis (WGCNA) we constructed an undirected network leveraging a rich curated expression dataset comprising 272 microarrays that involved microbial infections of Arabidopsis plants with a wide array of fungal and bacterial pathogens with biotrophic, hemibiotrophic, and necrotrophic lifestyles. WGCNA produced a network with scale-free and small-world properties composed of 205 distinct clusters of co-expressed genes. Modules of functionally related co-expressed genes that are differentially regulated in response to multiple pathogens were identified by integrating differential gene expression testing with functional enrichment analyses of gene ontology terms, known disease associated genes, transcriptional regulators, and cis-regulatory elements. The significance of functional enrichments was validated by comparisons with randomly generated networks. Network topology was then analyzed to identify intra-and inter-modular gene hubs. Based on high connectivity, and centrality in meta-modules that are clearly enriched in defense responses, we propose a list of 66 target genes for reverse genetic experiments to further dissect the Arabidopsis immune system. Our results show that statistical-based data trimming prior to network analysis allows the integration of expression datasets generated by different groups, under different experimental conditions and biological systems, into a functionally meaningful co-expression network.	[Amrine, Katherine C. H.; Blanco-Ulate, Barbara; Cantu, Dario] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	University of California System; University of California Davis	Cantu, D (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	dacantu@ucdavis.edu	Cantu, Dario/E-7658-2010; Blanco-Ulate, Barbara/K-9437-2017	Cantu, Dario/0000-0002-4858-1508; 	California Department of Food and Agriculture [11-0148-SA]; College of Agricultural and Environmental Sciences (UC Davis)	California Department of Food and Agriculture; College of Agricultural and Environmental Sciences (UC Davis)	This work was partially supported by funding to DC from the California Department of Food and Agriculture (project 11-0148-SA) and from the College of Agricultural and Environmental Sciences (UC Davis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alexa A, 2010, GENE SET ENRICHMENT; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Cai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095176; Carlson M. R., 2012, AFFYMETRIX ARABIDOPS; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chen XT, 2013, PLANT CELL REP, V32, P1589, DOI 10.1007/s00299-013-1469-3; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; He SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018750; Howles PA, 2006, PLANT J, V48, P606, DOI 10.1111/j.1365-313X.2006.02902.x; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang ZQ, 2011, NUCLEIC ACIDS RES, V39, pD1123, DOI 10.1093/nar/gkq1066; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Major IT, 2010, PHOTOSYNTH RES, V104, P41, DOI 10.1007/s11120-009-9507-2; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Michelmore RW, 2013, ANNU REV PHYTOPATHOL, V51, P291, DOI 10.1146/annurev-phyto-082712-102334; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Schulz P, 2013, PLANT PHYSIOL, V163, P523, DOI 10.1104/pp.113.222539; SESSA G, 1995, PLANT MOL BIOL, V28, P145, DOI 10.1007/BF00042046; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tully JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-421; van Dam S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-535; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	80	60	61	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118731	10.1371/journal.pone.0118731	http://dx.doi.org/10.1371/journal.pone.0118731			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730421	Green Published, gold, Green Submitted			2022-12-26	WOS:000350684900024
J	Gardebjer, EM; Anderson, ST; Pantaleon, M; Wlodek, ME; Moritz, KM				Gardebjer, Emelie M.; Anderson, Stephen T.; Pantaleon, Marie; Wlodek, Mary E.; Moritz, Karen M.			Maternal alcohol intake around the time of conception causes glucose intolerance and insulin insensitivity in rat offspring, which is exacerbated by a postnatal high-fat diet	FASEB JOURNAL			English	Article						developmental programming; metabolic pathways; diabetes; gluconeogenesis; gene expression	GROWTH RESTRICTION; SKELETAL-MUSCLE; IN-UTERO; FETAL; RESISTANCE; PREGNANCY; EXPOSURE; METHYLATION; DISEASE; ETHANOL	Alcohol consumption throughout pregnancy can cause metabolic dysregulation, including glucose intolerance in progeny. This study determined if periconceptional (PC) alcohol (12% v/v in a liquid diet) (PC:EtOH) consumed exclusively around conception results in similar outcomes in Sprague-Dawley rats. Control (C) rats were given a liquid diet containing no alcohol but matched to ensure equal caloric intake. PC maternal alcohol intake (from 4 days before conception until day 4 of gestation), resulted in offspring with elevated fasting plasma glucose (similar to 10-25%, P < 0.05), impaired glucose tolerance (P < 0.05), and decreased insulin sensitivity (P < 0.01) at 6 months of age. This was associated with increased hepatic gluconeogenesis and sex-specific alterations in peripheral protein kinase B (AKT) signaling. These changes were accompanied by increased mRNA expression of DNA methyltransferases (DNMTs) 1, 3a, and 3b (1.5- to 1.9-fold, P < 0.05) in fetal liver in late gestation, suggesting PC: EtOH may cause epigenetic changes that predispose offspring to metabolic dysfunction. Exposure to a postnatal (PN) high-fat and cholesterol diet (HFD) from 3 months of age caused hyperinsulinemia (similar to 2-fold increase, P < 0.001) and exacerbated the metabolic dysfunction in male offspring exposed to PC:EtOH but had no additive effects in females. Given many women may drink alcohol while planning a pregnancy, it is crucial to increase public awareness regarding the effects of alcohol consumption around conception on offspring health.	[Gardebjer, Emelie M.; Anderson, Stephen T.; Pantaleon, Marie; Moritz, Karen M.] Univ Queensland, Biomed Sci, St Lucia, Qld 4072, Australia; [Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia	University of Queensland; University of Melbourne	Moritz, KM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	k.moritz@uq.edu.au	wlodek, Mary/A-8939-2019; Anderson, Stephen T/F-5281-2013; Moritz, Karen/G-2508-2015	wlodek, Mary/0000-0002-8490-9099; Anderson, Stephen T/0000-0002-1176-4394; Moritz, Karen/0000-0002-8085-0034	National Health and Medical Research Council of Australia [1046137]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the funding provided by the National Health and Medical Research Council of Australia (1046137), and thank Kerri Tyrell, School of Biomedical Sciences, The University of Queensland, for expert assistance with the insulin assay.	ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; CARO JF, 1995, HORM METAB RES, V27, P19, DOI 10.1055/s-2007-979899; Chen L, 2004, J APPL PHYSIOL, V96, P167, DOI 10.1152/japplphysiol.00751.2003; Chen L, 2003, METABOLISM, V52, P454, DOI 10.1053/meta.2003.50073; Chen L, 2003, ENDOCRINOLOGY, V144, P500, DOI 10.1210/en.2002-220623; Colvin L, 2007, ALCOHOL CLIN EXP RES, V31, P276, DOI 10.1111/j.1530-0277.2006.00303.x; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Desai M, 1997, AM J PHYSIOL-GASTR L, V272, pG1083, DOI 10.1152/ajpgi.1997.272.5.G1083; Devaskar SU, 2007, REV ENDOCR METAB DIS, V8, P105, DOI 10.1007/s11154-007-9050-4; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; DUNCAN MH, 1995, LANCET, V346, P120, DOI 10.1016/S0140-6736(95)92143-5; Gardebjer EM, 2014, PLACENTA, V35, P50, DOI 10.1016/j.placenta.2013.10.008; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Haycock PC, 2009, BIOL REPROD, V81, P618, DOI 10.1095/biolreprod.108.074682; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Kafer GR, 2011, CELL REPROGRAM, V13, P391, DOI 10.1089/cell.2011.0011; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Lie S, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.109751; LOPEZTEJERO D, 1989, ALCOHOL, V6, P469, DOI 10.1016/0741-8329(89)90054-2; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Naimi TS, 2003, PEDIATRICS, V111, P1136; Peadon E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-584; Perkins A, 2013, INT J DEV NEUROSCI, V31, P391, DOI 10.1016/j.ijdevneu.2013.03.010; Probyn ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059718; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; Shelley P, 2009, AM J PHYSIOL-REG I, V297, pR675, DOI 10.1152/ajpregu.00146.2009; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Siebel AL, 2008, ENDOCRINOLOGY, V149, P3067, DOI 10.1210/en.2008-0128; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; WOLEVER TMS, 1986, AM J CLIN NUTR, V43, P167, DOI 10.1093/ajcn/43.1.167; Yao XH, 2006, J APPL PHYSIOL, V100, P642, DOI 10.1152/japplphysiol.01115.2005; Yao XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059680; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	48	47	48	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2690	2701		10.1096/fj.14-268979	http://dx.doi.org/10.1096/fj.14-268979			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25733565				2022-12-26	WOS:000356859100002
J	Reed, DM; Paschalaki, KE; Starke, RD; Mohamed, NA; Sharp, G; Fox, B; Eastwood, D; Bristow, A; Ball, C; Vessillier, S; Hansel, TT; Thorpe, SJ; Randi, AM; Stebbings, R; Mitchell, JA				Reed, Daniel M.; Paschalaki, Koralia E.; Starke, Richard D.; Mohamed, Nura A.; Sharp, Giles; Fox, Bernard; Eastwood, David; Bristow, Adrian; Ball, Christina; Vessillier, Sandrine; Hansel, Trevor T.; Thorpe, Susan J.; Randi, Anna M.; Stebbings, Richard; Mitchell, Jane A.			An autologous endothelial cell: peripheral blood mononuclear cell assay that detects cytokine storm responses to biologics	FASEB JOURNAL			English	Article						stem cells; TGN1412; coculture; personalized medicine	MONOCLONAL-ANTIBODY TGN1412; IN-VITRO; RELEASE SYNDROME; PROGENITOR CELLS; TRIAL; THERAPY; DISEASE; RISK; VIVO	There is an urgent unmet need for human tissue bioassays to predict cytokine storm responses to biologics. Current bioassays that detect cytokine storm responses in vitro rely on endothelial cells, usually from umbilical veins or cell lines, cocultured with freshly isolated peripheral blood mononuclear cells (PBMCs) from healthy adult volunteers. These assays therefore comprise cells from 2 separate donors and carry the disadvantage of mismatched tissues and lack the advantage of personalized medicine. Current assays also do not fully delineate mild (such as Campath) and severe (such as TGN1412) cytokine storm-inducing drugs. Here, we report a novel bioassay where endothelial cells grown from stem cells in the peripheral blood (blood outgrowth endothelial cells) and PBMCs from the same donor can be used to create an autologous coculture bioassay that responds by releasing a plethora of cytokines to authentic TGN1412 but only modestly to Campath and not to control antibodies such as Herceptin, Avastin, and Arzerra. This assay performed better than the traditional mixed donor assay in terms of cytokine release to TGN1412 and, thus, we suggest provides significant advancement and a definitive system by which biologics can be tested and paves the way for personalized medicine.	[Reed, Daniel M.; Mohamed, Nura A.; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Hammersmith Hosp, Dept Cardiothorac Pharmacol,Vasc Biol Sect, London SW3 6LY, England; [Paschalaki, Koralia E.; Starke, Richard D.; Randi, Anna M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Hammersmith Hosp, Vasc Sci, London SW3 6LY, England; [Mohamed, Nura A.] Qatar Fdn Res & Dev Div, Doha, Qatar; [Sharp, Giles; Fox, Bernard; Eastwood, David; Bristow, Adrian; Ball, Christina; Vessillier, Sandrine; Thorpe, Susan J.] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Hansel, Trevor T.] St Marys Hosp, Imperial Clin Resp Res Unit, London, England; [Stebbings, Richard] Medimmune, Cambridge, England	Imperial College London; Imperial College London; National Institute for Biological Standards & Control; Imperial College London; AstraZeneca; Medimmune	Mitchell, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Inst Cardiovasc Med Sci, Vasc Biol, Dovehouse St, London SW3 6LY, England.	j.a.mitchell@imperial.ac.uk	Mohamed, Nura/AAR-5025-2020; Stebbings, Richard/E-2117-2013; Paschalaki, Koralia/B-4465-2018; Vessillier, Sandrine/E-2502-2013	Stebbings, Richard/0000-0001-9628-2708; Fox, Bernard/0000-0001-6362-5196; Paschalaki, Koralia/0000-0002-4114-6140; Vessillier, Sandrine/0000-0002-9697-1834	Medical Research Council; Wellcome Trust Programme Grant [0852551Z108/Z]; Roche Limited (West Sussex, United Kingdom); MRC [G0600868] Funding Source: UKRI; British Heart Foundation [FS/10/47/28393] Funding Source: researchfish; Medical Research Council [G0600868] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); Roche Limited (West Sussex, United Kingdom); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge Drs. Graham Clarke and Margaret Rainer (Quintiles Drug Research Unit, London, United Kingdom) for helpful discussions. The authors also acknowledge Ms. Stefania Mataragka, Ms. Hime Gashaw, and Mr. Neil Galloway-Phillips for technical support. The authors thank the staff and patients at the Maternity Unit at the Royal Oldham Hospital (Oldham, United Kingdom) for donating umbilical cords, and donors of blood for blood outgrowth endothelial cell and peripheral blood mononuclear cell preparations. This work was funded by the Medical Research Council and a Wellcome Trust Programme Grant (0852551Z108/Z to J.A.M.). D.M.R. and J.A.M. are associated with the following patent filed in Europe: WO2014147216. J.A.M. has previously received consultancy fees from Roche Limited (West Sussex, United Kingdom).	Bailey L, 2013, J PHARMACOL TOX MET, V68, P231, DOI 10.1016/j.vascn.2012.12.003; Ball C, 2012, J IMMUNOL, V189, P5831, DOI 10.4049/jimmunol.1201795; Chung CH, 2008, ONCOLOGIST, V13, P725, DOI 10.1634/theoncologist.2008-0012; Czuczman MS, 2012, BLOOD, V119, P3698, DOI 10.1182/blood-2011-09-378323; Eastwood D, 2013, BRIT J CLIN PHARMACO, V76, P299, DOI 10.1111/bcp.12165; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; Findlay L, 2011, J IMMUNOL METHODS, V371, P134, DOI 10.1016/j.jim.2011.06.022; Findlay L, 2011, CYTOKINE, V55, P141, DOI 10.1016/j.cyto.2011.03.019; Findlay L, 2010, J IMMUNOL METHODS, V352, P1, DOI 10.1016/j.jim.2009.10.013; HUANG EH, 1994, TRANSPLANTATION, V57, P703, DOI 10.1097/00007890-199403150-00012; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Reed DM, 2014, BIOCHEM BIOPH RES CO, V455, P172, DOI 10.1016/j.bbrc.2014.10.140; Reed DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091119; Starke RD, 2013, BLOOD, V121, P2773, DOI 10.1182/blood-2012-06-435727; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Stebbings R, 2013, J IMMUNOTOXICOL, V10, P75, DOI 10.3109/1547691X.2012.711783; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Thill M, 2008, INVEST OPHTH VIS SCI, V49, P2696, DOI 10.1167/iovs.07-0955; Thorpe SJ, 2013, CYTOKINE, V64, P471, DOI 10.1016/j.cyto.2013.07.009; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; Wing MG, 1996, J CLIN INVEST, V98, P2819, DOI 10.1172/JCI119110; Wolf B, 2012, CYTOKINE, V60, P828, DOI 10.1016/j.cyto.2012.08.018	25	19	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2595	2602		10.1096/fj.14-268144	http://dx.doi.org/10.1096/fj.14-268144			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25746794				2022-12-26	WOS:000355209500035
J	Lee, HJ; Feliers, D; Mariappan, MM; Sataranatarajan, K; Choudhury, GG; Gorin, Y; Kasinath, BS				Lee, Hak Joo; Feliers, Denis; Mariappan, Meenalakshmi M.; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Gorin, Yves; Kasinath, Balakuntalam S.			Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; fibrosis; kidney; mammalian target of rapamycin (mTOR)	CYSTATHIONINE-GAMMA-LYASE; MESSENGER-RNA TRANSLATION; DIABETIC-NEPHROPATHY; PHOSPHODIESTERASE-5 INHIBITOR; RENAL ISCHEMIA/REPERFUSION; SPECIFICITY PROTEIN-1; CELL-PROLIFERATION; HIGH INSULIN; SYNTHASE; SILDENAFIL	Background: The mechanism underlying tadalafil regulation of diabetes-induced matrix synthesis in the kidney is unknown. Results: In podocytes, tadalafil stimulated inducible nitric-oxide synthase to generate hydrogen sulfide and inhibit high glucose-induced matrix protein synthesis. Conclusion: Tadalafil recruits nitric oxide and hydrogen sulfide to inhibit high glucose-induced matrix protein synthesis. Significance: Tadalafil may be tested for treating diabetic kidney disease. Diabetes-induced kidney cell injury involves an increase in matrix protein expression that is only partly alleviated by current treatment, prompting a search for new modalities. We have previously shown that hydrogen sulfide (H2S) inhibits high glucose-induced protein synthesis in kidney podocytes. We tested whether tadalafil, a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, ameliorates high glucose stimulation of matrix proteins by generating H2S in podocytes. Tadalafil abrogated high glucose stimulation of global protein synthesis and matrix protein laminin 1. Tadalafil inhibited high glucose-induced activation of mechanistic target of rapamycin complex 1 and laminin 1 accumulation in an AMP-activated protein kinase (AMPK)-dependent manner. Tadalafil increased AMPK phosphorylation by stimulating calcium-calmodulin kinase kinase . Tadalafil rapidly increased the expression and activity of the H2S-generating enzyme cystathionine -lyase (CSE) by promoting its translation. dl-Propargylglycine, a CSE inhibitor, and siRNA against CSE inhibited tadalafil-induced AMPK phosphorylation and abrogated the tadalafil effect on high glucose stimulation of laminin 1. In tadalafil-treated podocytes, we examined the interaction between H2S and nitric oxide (NO). N-Nitro-l-arginine methyl ester and 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one, inhibitors of NO synthase (NOS) and soluble guanylyl cyclase, respectively, abolished tadalafil induction of H2S and AMPK phosphorylation. Tadalafil rapidly augmented inducible NOS (iNOS) expression by increasing its mRNA, and siRNA for iNOS and 1400W, an iNOS blocker, inhibited tadalafil stimulation of CSE expression and AMPK phosphorylation. We conclude that tadalafil amelioration of high glucose stimulation of synthesis of proteins including matrix proteins in podocytes requires integration of the NO-H2S-AMPK axis leading to the inhibition of high glucose-induced mechanistic target of rapamycin complex 1 activity and mRNA translation.	[Lee, Hak Joo; Feliers, Denis; Mariappan, Meenalakshmi M.; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Gorin, Yves; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Lee, Hak Joo; Mariappan, Meenalakshmi M.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] South Texas Vet Healthcare Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, MC7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Kasinath@uthscsa.edu		Feliers, Denis/0000-0003-1952-1386	National Institutes of Health from National Cancer Institute [P30 CA54174]; National Institutes of Health from National Institute on Aging [P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK079996, R29DK050190, R01DK077295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, RC2AG036613] Funding Source: NIH RePORTER	National Institutes of Health from National Cancer Institute; National Institutes of Health from National Institute on Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Dan Riley for critical reading of the manuscript and Dr. Doug Yoon Lee for helpful suggestions. Images were generated in the Core Optical Imaging Facility, which is supported by the University of Texas Health Science Center at San Antonio (UTHSCSA) and National Institutes of Health Grants P30 CA54174 from the National Cancer Institute (to the Cancer Therapy and Research Center at UTHSCSA) and P01AG19316 from the National Institute on Aging.	Abe K, 1996, J NEUROSCI, V16, P1066; Aktug H, 2012, TURK J MED SCI, V42, P830, DOI 10.3906/sag-1104-38; Altaany Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005478; Ang SF, 2011, J IMMUNOL, V187, P4778, DOI 10.4049/jimmunol.1101559; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Chrysant SG, 2013, CURR HYPERTENS REP, V15, P475, DOI 10.1007/s11906-013-0377-9; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; COURTOY PJ, 1982, J HISTOCHEM CYTOCHEM, V30, P874, DOI 10.1177/30.9.7130672; d'Andon MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002664; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Fan K, 2014, CELL SIGNAL, V26, P2801, DOI 10.1016/j.cellsig.2014.08.023; Fang L, 2013, NEPHROL DIAL TRANSPL, V28, P1751, DOI 10.1093/ndt/gfs391; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Francescato HD, 2011, NEPHROL DIAL TRANSPL, V26, P479, DOI 10.1093/ndt/gfq447; Gharavi N, 2003, J PHARM PHARM SCI, V6, P302; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P3427, DOI 10.1093/ndt/gfn319; Holwerda KM, 2014, J AM SOC NEPHROL, V25, P717, DOI 10.1681/ASN.2013030291; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Jerums G, 2006, CONTEMP DIAB, P59; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kasinath BS, 2006, J AM SOC NEPHROL, V17, P3281, DOI 10.1681/ASN.2006050488; Kasinath BS, 2014, KIDNEY INT, V85, P1255, DOI 10.1038/ki.2013.529; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim KO, 2008, EXP MOL MED, V40, P286, DOI 10.3858/emm.2008.40.3.286; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Kotera J, 2000, J HISTOCHEM CYTOCHEM, V48, P685, DOI 10.1177/002215540004800512; Kuno Y, 2011, BRIT J PHARMACOL, V162, P1389, DOI 10.1111/j.1476-5381.2010.01149.x; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Liu XM, 2012, BIOCHEM PHARMACOL, V84, P1045, DOI 10.1016/j.bcp.2012.07.023; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mariappan MM, 2012, EXP DIABETES RES, DOI 10.1155/2012/749812; Matousovic K, 1997, J LAB CLIN MED, V130, P487, DOI 10.1016/S0022-2143(97)90125-6; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Poon BY, 2003, CIRCULATION, V108, P1107, DOI 10.1161/01.CIR.0000086321.04702.AC; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Sataranatarajan K, 2012, AGING CELL, V11, P1065, DOI 10.1111/acel.12008; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Shue EH, 2014, J PEDIATR SURG, V49, P39, DOI 10.1016/j.jpedsurg.2013.09.024; Si JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107832; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Sun WX, 2014, FREE RADICAL BIO MED, V68, P22, DOI 10.1016/j.freeradbiomed.2013.11.015; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Trachtman H, 2002, PEDIATR NEPHROL, V17, P20, DOI 10.1007/s004670200004; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Wang R, 2012, P NATL ACAD SCI USA, V109, P8801, DOI 10.1073/pnas.1206646109; Wangsiripaisan A, 1999, KIDNEY INT, V55, P2281, DOI 10.1046/j.1523-1755.1999.00484.x; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2012, J CELL PHYSIOL, V227, P3192, DOI 10.1002/jcp.24006; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Zdychova J, 2008, PHYSIOL RES, V57, P709, DOI 10.33549/physiolres.931337; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zhao SQ, 2011, INT IMMUNOPHARMACOL, V11, P468, DOI 10.1016/j.intimp.2010.12.017	78	34	34	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12014	12026		10.1074/jbc.M114.615377	http://dx.doi.org/10.1074/jbc.M114.615377			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25752605	Green Published, hybrid			2022-12-26	WOS:000354388600017
J	Han, XB; Xiao, ZS; Quarles, LD				Han, Xiaobin; Xiao, Zhousheng; Quarles, L. Darryl			Membrane and Integrative Nuclear Fibroblastic Growth Factor Receptor (FGFR) Regulation of FGF-23	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Cyclic AMP (cAMP); Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Osteoblast	VITAMIN-D METABOLISM; HYPOPHOSPHATEMIC RICKETS; GENE-EXPRESSION; PHOSPHATE HOMEOSTASIS; TRANSCRIPTION FACTORS; SIGNALING MODULE; BONE; CELLS; KLOTHO; MICE	Background: Mechanisms whereby local bone-derived factors regulate FGF-23 are unclear. Results: Low and high molecular weight FGF-2 stimulated FGF-23 promoter activity in osteoblasts through membrane FGFR-mediated PLC and MAPK activation of NFAT and Ets1 and integrative nuclear FGFR1 signaling involving cAMP/CBP/CREB signaling pathways, respectively. Conclusion: Membrane FGFR and intranucelar FGFR/CBP pathways regulate FGF-23 transcription. Significance: Paracrine/autocrine FGFs control hormonal FGF-23. Fibroblastic growth factor receptor 1 (FGFR1) signaling pathways are implicated in the regulation of FGF-23 gene transcription, but the molecular pathways remain poorly defined. We used low molecular weight (LMW, 18 kDa) FGF-2 and high molecular weight (HMW) FGF-2 isoforms, which, respectively, activate cell surface FGF receptors and intranuclear FGFR1, to determine the roles of membrane FGFRs and integrative nuclear FGFR1 signaling (INFS) in the regulation of FGF-23 gene transcription in osteoblasts. We found that LMW-FGF-2 induced NFAT and Ets1 binding to conserved cis-elements in the proximal FGF-23 promoter and stimulated FGF-23 promoter activity through PLC/calcineurin/NFAT and MAPK pathways in SaOS-2 and MC3T3-E1 osteoblasts. In contrast, HMW-FGF-2 stimulated FGF-23 promoter activity in osteoblasts through a cAMP-dependent binding of FGFR1 and cAMP-response element-binding protein (CREB) to a conserved cAMP response element (CRE) contiguous with the NFAT binding site in the FGF-23 promoter. Mutagenesis of the NFAT and CRE binding sites, respectively, inhibited the effects of LMW-FGF-2 and HMW-FGF-23 to stimulate FGF-23 promoter activity. FGF-2 activation of both membrane FGFRs and INFS-dependent FGFR1 pathways may provide a means to integrate systemic and local regulation of FGF-23 transcription under diverse physiological and pathological conditions.	[Han, Xiaobin; Xiao, Zhousheng; Quarles, L. Darryl] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coleman Bldg,Suite B216,956 Court Ave, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; xiao, zhousheng/0000-0002-3363-5673	National Institutes of Health [5R01AR045955]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AR045955 (to L. D. Q.).	Avitan-Hersh E, 2014, J CLIN ENDOCR METAB, V99, pE132, DOI 10.1210/jc.2013-2813; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Degnin CR, 2010, J CELL BIOCHEM, V110, P1046, DOI 10.1002/jcb.22629; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Du X, 2012, J CELL PHYSL, V227, P3731, DOI DOI 10.1002/JCP.24083; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Hoenderop JGJ, 2004, KIDNEY INT, V65, P531, DOI 10.1111/j.1523-1755.2004.00402.x; Homer-Bouthiette C, 2014, J BIOL CHEM, V289, P36303, DOI 10.1074/jbc.M114.619569; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Liang K, 1999, ENDOCRINOLOGY, V140, P5780; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Marie PJ, 2012, GENE, V498, P1, DOI 10.1016/j.gene.2012.01.086; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Nauman EA, 2003, CALCIFIED TISSUE INT, V73, P147, DOI 10.1007/s00223-002-1033-6; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Saini RK, 2013, CALCIFIED TISSUE INT, V92, P339, DOI 10.1007/s00223-012-9683-5; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Stachowiak MK, 2015, J CELL PHYSIOL, V230, P989, DOI 10.1002/jcp.24879; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stevens DA, 2003, MOL ENDOCRINOL, V17, P1751, DOI 10.1210/me.2003-0137; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Valtink M, 2012, INVEST OPHTH VIS SCI, V53, P3207, DOI 10.1167/iovs.12-9423; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wesseling-Perry K, 2013, PEDIATR NEPHROL, V28, P2207, DOI 10.1007/s00467-013-2547-z; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Wohrle S, 2013, J BONE MINER RES, V28, P899, DOI 10.1002/jbmr.1810; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wu AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057322; Xiao LP, 2013, J BONE MINER RES, V28, P35, DOI 10.1002/jbmr.1721; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Xiao Z., 2014, PLOS ONE, V9; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	63	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10447	10459		10.1074/jbc.M114.609230	http://dx.doi.org/10.1074/jbc.M114.609230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25752607	hybrid, Green Published			2022-12-26	WOS:000353241100044
J	Li, YL; Pierce, BG; Wang, Q; Keck, ZY; Fuerst, TR; Foung, SKH; Mariuzza, RA				Li, Yili; Pierce, Brian G.; Wang, Qian; Keck, Zhen-Yong; Fuerst, Thomas R.; Foung, Steven K. H.; Mariuzza, Roy A.			Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Crystal Structure; Glycosylation; Hepatitis C Virus (HCV); Vaccine; Neutralization	HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN; AMINO-TERMINUS; PROTEIN; BINDING; INFECTION; GLYCOSYLATION; EPITOPES; ENTRY; CD81	Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. A challenge for HCV vaccine development is to identify conserved epitopes able to elicit protective antibodies against this highly diverse virus. Glycan shielding is a mechanism by which HCV masks such epitopes on its E2 envelope glycoprotein. Antibodies to the E2 region comprising residues 412-423 (E2(412-423)) have broadly neutralizing activities. However, an adaptive mutation in this linear epitope, N417S, is associated with a glycosylation shift from Asn-417 to Asn-415 that enables HCV to escape neutralization by mAbs such as HCV1 and AP33. By contrast, the human mAb HC33.1 can neutralize virus bearing the N417S mutation. To understand how HC33.1 penetrates the glycan shield created by the glycosylation shift to Asn-415, we determined the structure of this broadly neutralizing mAb in complex with its E2(412-423) epitope to 2.0 resolution. The conformation of E2(412-423) bound to HC33.1 is distinct from the -hairpin conformation of this peptide bound to HCV1 or AP33, because of disruption of the -hairpin through interactions with the unusually long complementarity-determining region 3 of the HC33.1 heavy chain. Whereas Asn-415 is buried by HCV1 and AP33, it is solvent-exposed in the HC33.1-E2(412-423) complex, such that glycosylation of Asn-415 would not prevent antibody binding. Furthermore, our results highlight the structural flexibility of the E2(412-423) epitope, which may serve as an immune evasion strategy to impede induction of antibodies targeting this site by reducing its antigenicity.	[Li, Yili; Pierce, Brian G.; Wang, Qian; Fuerst, Thomas R.; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Li, Yili; Wang, Qian; Fuerst, Thomas R.; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Keck, Zhen-Yong; Foung, Steven K. H.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94304 USA	University System of Maryland; University of Maryland College Park; Stanford University	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Pierce, Brian/AAB-8965-2022	Pierce, Brian/0000-0003-4821-0368; Foung, Steven/0000-0001-7149-6160	National Institutes of Health [AI036900]; MPower Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036900, R37AI036900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MPower Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI036900 (to R. A. M.). This work was also supported by MPower Maryland.	Angus AGN, 2011, FUTURE MICROBIOL, V6, P279, DOI [10.2217/fmb.11.9, 10.2217/FMB.11.9]; [Anonymous], 2013, HEP C; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chung RT, 2013, AM J TRANSPLANT, V13, P1047, DOI 10.1111/ajt.12083; Deng L, 2014, P NATL ACAD SCI USA, V111, P10690, DOI 10.1073/pnas.1411317111; Dhillon S, 2010, J VIROL, V84, P5494, DOI 10.1128/JVI.02153-09; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Goffard A, 2003, BIOCHIMIE, V85, P295, DOI 10.1016/S0300-9084(03)00004-X; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Iacob RE, 2008, J AM SOC MASS SPECTR, V19, P428, DOI 10.1016/j.jasms.2007.11.022; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Keck ZY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004297; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kolawole AO, 2014, J VIROL, V88, P4543, DOI 10.1128/JVI.03685-13; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kong L, 2012, J VIROL, V86, P13085, DOI 10.1128/JVI.01939-12; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meola A, 2015, J VIROL, V89, P2170, DOI 10.1128/JVI.02190-14; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pantua H, 2013, J MOL BIOL, V425, P1899, DOI 10.1016/j.jmb.2013.02.025; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Potter JA, 2012, J VIROL, V86, P12923, DOI 10.1128/JVI.02052-12; Robin G, 2014, J MOL BIOL, V426, P3729, DOI 10.1016/j.jmb.2014.08.013; Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Schulz BL, 2012, GLYCOSYLATION, P21, DOI 10.5772/50260; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tarr AW, 2007, J GEN VIROL, V88, P2991, DOI 10.1099/vir.0.83065-0; Tarr AW, 2012, J VIROL, V86, P2739, DOI 10.1128/JVI.06492-11; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008	60	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10117	10125		10.1074/jbc.M115.643528	http://dx.doi.org/10.1074/jbc.M115.643528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737449	Green Published, hybrid			2022-12-26	WOS:000353241100018
J	Le Bec, J; Courbaud, B; Le Moguedec, G; Pelissier, R				Le Bec, Jimmy; Courbaud, Benoit; Le Moguedec, Gilles; Pelissier, Raphael			Characterizing Tropical Tree Species Growth Strategies: Learning from Inter-Individual Variability and Scale Invariance	PLOS ONE			English	Article							BASAL AREA INCREMENT; COMPETITION INDEXES; FOREST DYNAMICS; RANK REVERSALS; LOW-LIGHT; SIZE; ALLOMETRY; DIVERSITY; MORTALITY; SEEDLINGS	Understanding how tropical tree species differ in their growth strategies is critical to predict forest dynamics and assess species coexistence. Although tree growth is highly variable in tropical forests, species maximum growth is often considered as a major axis synthesizing species strategies, with fast-growing pioneer and slow-growing shade tolerant species as emblematic representatives. We used a hierarchical linear mixed model and 21-years long tree diameter increment series in a monsoon forest of the Western Ghats, India, to characterize species growth strategies and question whether maximum growth summarizes these strategies. We quantified both species responses to biotic and abiotic factors and individual tree effects unexplained by these factors. Growth responses to competition and tree size appeared highly variable among species which led to reversals in performance ranking along those two gradients. However, species-specific responses largely overlapped due to large unexplained variability resulting mostly from inter-individual growth differences consistent over time. On average one-third of the variability captured by our model was explained by covariates. This emphasizes the high dimensionality of the tree growth process, i.e. the fact that trees differ in many dimensions (genetics, life history) influencing their growth response to environmental gradients, some being unmeasured or unmeasurable. In addition, intraspecific variability increased as a power function of species maximum growth partly as a result of higher absolute responses of fast-growing species to competition and tree size. However, covariates explained on average the same proportion of intraspecific variability for slow-and fast-growing species, which showed the same range of relative responses to competition and tree size. These results reflect a scale invariance of the growth process, underlining that slow-and fast-growing species exhibit the same range of growth strategies.	[Le Bec, Jimmy; Pelissier, Raphael] IRD, UMR AMAP, Montpellier, France; [Le Bec, Jimmy] AgroParisTech, Paris, France; [Courbaud, Benoit] IRSTEA, UR EM, St Martin Dheres, France; [Le Moguedec, Gilles] INRA, UMR AMAP, F-34060 Montpellier, France; [Pelissier, Raphael] French Inst Pondicherry, Pondicherry, Tamil Nadu, India	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech; INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE	Le Bec, J (corresponding author), IRD, UMR AMAP, Montpellier, France.	jimmy.lebec@gmail.com	Pélissier, Raphaël/C-1224-2008	Pélissier, Raphaël/0000-0003-4845-5090	FCPR grant from the French Department of Agriculture, Agri-Food and Forest (MAAF); French Institute of Pondicherry; FIP researchers	FCPR grant from the French Department of Agriculture, Agri-Food and Forest (MAAF); French Institute of Pondicherry; FIP researchers	This study was conducted within the framework of JLB Ph.D. project, funded by a FCPR grant from the French Department of Agriculture, Agri-Food and Forest (MAAF). Data collection at UPSP benefited over the years from constant financial support from the French Institute of Pondicherry with occasional additional funds from various external projects headed by FIP researchers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, IEEE T AUTOM CONTROL, V19; Alder D, 2002, INT FOREST REV, V4, P196, DOI 10.1505/IFOR.4.3.196.17398; Antin C, 2013, TREES-STRUCT FUNCT, V27, P1485, DOI 10.1007/s00468-013-0896-7; Atkin OK, 1998, PLANT CELL ENVIRON, V21, P1007, DOI 10.1046/j.1365-3040.1998.00356.x; Beckage B, 2012, FRONT BIOGEOGR, V3, P145; Bloor JMG, 2003, J ECOL, V91, P77, DOI 10.1046/j.1365-2745.2003.00743.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark JS, 2007, ECOL LETT, V10, P647, DOI 10.1111/j.1461-0248.2007.01041.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; CLARK JS, 1990, ECOL MONOGR, V60, P135, DOI 10.2307/1943042; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Contreras MA, 2011, FOREST ECOL MANAG, V262, P1939, DOI 10.1016/j.foreco.2011.08.031; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Courbaud B, 2012, THEOR ECOL-NETH, V5, P61, DOI 10.1007/s12080-010-0095-8; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Eriksson O, 2002, CAN J BOT, V80, P635, DOI [10.1139/B02-044, 10.1139/b02-044]; Gillner S, 2013, FOREST ECOL MANAG, V302, P372, DOI 10.1016/j.foreco.2013.03.032; Gourlet-Fleury S, 2005, ANN FOREST SCI, V62, P785, DOI 10.1051/forest:2005084; Grime JP, 1994, EXPLOITATION ENV HET, P2; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Johnson DM, 2009, TREE PHYSIOL, V29, P879, DOI 10.1093/treephys/tpp031; Kendal Wayne S., 2004, Ecological Complexity, V1, P193, DOI 10.1016/j.ecocom.2004.05.001; Kitajima K, 2003, FUNCT ECOL, V17, P276, DOI 10.1046/j.1365-2435.2003.07101.x; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Kohyama TS, 2012, J ECOL, V100, P1501, DOI 10.1111/j.1365-2745.2012.02029.x; Lichstein JW, 2007, AM NAT, V170, P807, DOI 10.1086/522937; McMahon SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016253; Moravie MA, 1999, FOREST ECOL MANAG, V117, P221, DOI 10.1016/S0378-1127(98)00480-0; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newbery DM, 2009, PLANT ECOL, V201, P147, DOI 10.1007/s11258-008-9533-8; Ouedraogo DY, 2013, J ECOL, V101, P1459, DOI 10.1111/1365-2745.12165; Pascal JP, 1996, J TROP ECOL, V12, P191, DOI 10.1017/S026646740000941X; Pelissier R, 1998, J TROP ECOL, V14, P1, DOI 10.1017/S0266467498000017; Pelissier R, 2011, ECOL ARCH, V92, P17; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Poorter L, 2003, PLANT ECOL, V166, P295, DOI 10.1023/A:1023295806147; Poorter L, 2003, ECOLOGY, V84, P602, DOI 10.1890/0012-9658(2003)084[0602:AORFTS]2.0.CO;2; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; Pretzsch H, 2010, CAN J FOREST RES, V40, P370, DOI 10.1139/X09-195; Rai S. N., 1979, Malaysian Forester, V42, P53; Rapp JM, 2012, ECOLOGY, V93, P2061, DOI 10.1890/11-1725.1; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Robert A, 2003, J TROP ECOL, V19, P697, DOI 10.1017/S0266467403006096; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Sack L, 2001, FUNCT ECOL, V15, P145, DOI 10.1046/j.1365-2435.2001.00507.x; Sanchez-Gomez D, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008040; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schnitzer S., 2008, TROPICAL FOREST COMM, P172; Schoonjans F, 2011, EPIDEMIOLOGY, V22, P750, DOI 10.1097/EDE.0b013e318225c1de; Sierra CA, 2009, ECOLOGY, V90, P2711, DOI 10.1890/08-0073.1; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Steneker G. A., 1963, Forestry Chronicle, V39, P334; Sterck FJ, 1998, AM J BOT, V85, P266, DOI 10.2307/2446315; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Team R. Development Core. R, 2012, R LANG ENV STAT COMP; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Uriarte M, 2012, ECOLOGY, V93, P191, DOI 10.1890/10-2422.1; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; WALTERS MB, 1993, OECOLOGIA, V94, P7, DOI 10.1007/BF00317294; Weiskittel AR, 2007, FOREST ECOL MANAG, V250, P266, DOI 10.1016/j.foreco.2007.05.026; WEST PW, 1980, CAN J FOREST RES, V10, P71, DOI 10.1139/x80-012; Westbeek MHM, 1999, OECOLOGIA, V120, P19, DOI 10.1007/s004420050828; Wolf M, 2009, THESIS U GRONINGEN N; Zuur Alain F., 2009, P1	71	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117028	10.1371/journal.pone.0117028	http://dx.doi.org/10.1371/journal.pone.0117028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756212	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700014
J	Li, J; Zhang, MM; Tu, K; Wang, J; Feng, B; Zhang, ZN; Lei, J; Li, YQ; Du, JQ; Chen, T				Li, Jing; Zhang, Ming-Ming; Tu, Ke; Wang, Jian; Feng, Ban; Zhang, Zi-Nan; Lei, Jie; Li, Yun-Qing; Du, Jian-Qing; Chen, Tao			The Excitatory Synaptic Transmission of the Nucleus of Solitary Tract Was Potentiated by Chronic Myocardial Infarction in Rats	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; VESICULAR GLUTAMATE TRANSPORTERS; SPINAL-CORD STIMULATION; LONG-TERM POTENTIATION; CARDIAC SYNDROME-X; AMPA RECEPTORS; FEAR MEMORY; BRAIN-STEM; PAIN; ACTIVATION	Angina pectoris is a common clinical symptom that often results from myocardial infarction. One typical characteristic of angina pectoris is that the pain does not match the severity of the myocardial ischemia. One possible explanation is that the intensity of cardiac nociceptive information could be dynamically regulated by certain brain areas. As an important nucleus for processing cardiac nociception, the nucleus of the solitary tract (NTS) has been studied to some extent. However, until now, the morphological and functional involvement of the NTS in chronic myocardial infarction (CMI) has remained unknown. In the present study, by exploring left anterior descending coronary artery ligation surgery, we found that the number of synaptophysin-immunoreactive puncta and Fos-immunoreactive neurons in the rat NTS two weeks after ligation surgery increased significantly. Excitatory pre- and postsynaptic transmission was potentiated. A bath application of a Ca2+ channel inhibitor GABApentin and Ca2+ permeable AMPA receptor antagonist NASPM could reverse the potentiated pre- and postsynaptic transmission, respectively. Meanwhile, rats with CMI showed significantly increased visceral pain behaviors. Microinjection of GABApentin or NASPM into the NTS decreased the CMI-induced visceral pain behaviors. In sum, our results suggest that the NTS is an important area for the process of cardiac afference in chronic myocardial infarction condition.	[Li, Jing; Li, Yun-Qing; Du, Jian-Qing] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710061, Peoples R China; [Li, Jing; Zhang, Ming-Ming; Tu, Ke; Wang, Jian; Feng, Ban; Zhang, Zi-Nan; Lei, Jie; Li, Yun-Qing; Du, Jian-Qing; Chen, Tao] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Chen, Tao] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Ctr Neuron & Dis, Xian 710061, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University	Du, JQ (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710061, Peoples R China.	dujianq@mail.xjtu.edu.cn; chtkkl@fmmu.edu.cn			National Natural Science Foundation of China [31171068, 31371126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Natural Science Foundation of China (Nos. 31171068 to JQD, 31371126 to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albutaihi IAM, 2004, NEUROSIGNALS, V13, P207, DOI 10.1159/000079336; Balland B, 2006, J PHYSIOL-LONDON, V574, P245, DOI 10.1113/jphysiol.2006.108738; Bayer K, 2004, NEUROPHARMACOLOGY, V46, P743, DOI 10.1016/j.neuropharm.2003.11.010; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Chen T, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-33; Clark CG, 2011, J NEUROSCI, V31, P12318, DOI 10.1523/JNEUROSCI.0746-11.2011; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Corbett EKA, 2005, NEUROSCIENCE, V135, P133, DOI 10.1016/j.neuroscience.2005.06.010; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Favaloro R G, 1968, Ann Thorac Surg, V5, P334; Foreman RD, 1999, ANNU REV PHYSIOL, V61, P143, DOI 10.1146/annurev.physiol.61.1.143; Foreman Robert D, 2009, Cleve Clin J Med, V76 Suppl 2, pS75, DOI 10.3949/ccjm.76.s2.15; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; GULBIS B, 1990, CLIN CHEM, V36, P1784; Hermes SM, 2014, J COMP NEUROL, V522, P642, DOI 10.1002/cne.23438; Hua F, 2004, AM J PHYSIOL-HEART C, V287, pH2728, DOI 10.1152/ajpheart.00180.2004; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Khlaifia A, 2013, J NEUROSCI, V33, P12627, DOI 10.1523/JNEUROSCI.1028-13.2013; Lachamp P, 2003, EUR J NEUROSCI, V17, P892, DOI 10.1046/j.1460-9568.2003.02494.x; Lanza GA, 2005, EUR HEART J, V26, P983, DOI 10.1093/eurheartj/ehi089; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Liu XH, 2012, NEUROSCIENCE, V220, P322, DOI 10.1016/j.neuroscience.2012.05.024; Liu XH, 2012, NEUROSCIENCE, V207, P326, DOI 10.1016/j.neuroscience.2012.01.042; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; MASERI A, 1978, NEW ENGL J MED, V299, P1271, DOI 10.1056/NEJM197812072992303; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530; Rosen SD, 2012, CAN J CARDIOL, V28, pS7, DOI 10.1016/j.cjca.2011.09.010; Sestito A, 2008, PAIN, V139, P82, DOI 10.1016/j.pain.2008.03.015; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Tang XR, 2007, AM J PHYSIOL-REG I, V293, pR2254, DOI 10.1152/ajpregu.00143.2007; WETTERVIK C, 1995, LANCET, V345, P97, DOI 10.1016/S0140-6736(95)90065-9; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wu LJ, 2007, DEV NEUROBIOL, V67, P146, DOI 10.1002/dneu.20331; Zhang J, 1998, J PHYSIOL-LONDON, V511, P733, DOI 10.1111/j.1469-7793.1998.733bg.x; Zhang MM, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-47; Zhang MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059234; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003	43	5	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118827	10.1371/journal.pone.0118827	http://dx.doi.org/10.1371/journal.pone.0118827			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756354	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700026
J	Weiss, CR; Guan, QD; Ma, YB; Qing, GF; Bernstein, CN; Warrington, RJ; Peng, ZK				Weiss, Carolyn R.; Guan, Qingdong; Ma, Yanbing; Qing, Gefei; Bernstein, Charles N.; Warrington, Richard J.; Peng, Zhikang			The Potential Protective Role of Caveolin-1 in Intestinal Inflammation in TNBS-Induced Murine Colitis	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; E-DEFICIENT MICE; BOWEL-DISEASE; ULCERATIVE-COLITIS; CRITICAL REGULATOR; INSULIN-RECEPTOR; TISSUE FIBROSIS; CROHNS-DISEASE; BREAST-CANCER; MOUSE MODEL	Background Caveolin-1 (Cav-1) is a multifunctional scaffolding protein serving as a platform for the cell's signal-transduction and playing an important role in inflammation. However, its role in inflammatory bowel disease is not clear. A recent study showed that Cav-1 is increased and mediates angiogenesis in dextran sodium sulphate-induced colitis, which are contradictory to our pilot findings in 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis. In the present study, we further clarified the role of Cav-1 in TNBS-induced colitis. Methods In BALB/c mice, acute colitis was induced by intra-rectal administration of one dose TNBS, while chronic colitis was induced by administration of TNBS once a week for 7 weeks. To assess the effects of complete loss of Cav-1, Cav-1 knockout (Cav-1(-/-)) and control wildtype C57 mice received one TNBS administration. Body weight and clinical scores were monitored. Colon Cav-1 and pro-inflammatory cytokine levels were quantified through ELI-SAs. Inflammation was evaluated through histological analysis. Results Colon Cav-1 levels were significantly decreased in TNBS-induced colitis mice when compared to normal mice and also inversely correlated with colon inflammation scores and proinflammatory cytokine levels (IL-17, IFN-gamma and TNF) significantly. Furthermore, after administration of TNBS, Cav-1(-/-) mice showed significantly increased clinical and colon inflammatory scores and body weight loss when compared with control mice. Conclusions and Significance Cav-1 may play a protective role in the development of TNBS-induced colitis. Our findings raise an important issue in the evaluation of specific molecules in animal models that different models may exhibit opposite results because of the different mechanisms involved.	[Weiss, Carolyn R.; Guan, Qingdong; Warrington, Richard J.; Peng, Zhikang] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Weiss, Carolyn R.; Guan, Qingdong; Ma, Yanbing; Peng, Zhikang] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Qing, Gefei] Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada; [Bernstein, Charles N.; Warrington, Richard J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3T 2N2, Canada; [Bernstein, Charles N.] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Peng, ZK (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	zpeng@mich.ca	Guan, Qingdong/C-9631-2018	Guan, Qingdong/0000-0003-1972-487X	CIHR [ROP-92387]; Children's Hospital Research Institute of Manitoba	CIHR(Canadian Institutes of Health Research (CIHR)); Children's Hospital Research Institute of Manitoba	This study was supported by grants from the CIHR (http://www.cihr-irsc.gc.ca/e/193.html) (ROP-92387 to ZP) and the Children's Hospital Research Institute of Manitoba (http://chrim.ca/)(to ZP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Bender FC, 2000, CANCER RES, V60, P5870; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bouras T, 2004, CANCER BIOL THER, V3, P931, DOI 10.4161/cbt.3.10.1147; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Chidlow JH, 2009, GASTROENTEROLOGY, V136, P575, DOI 10.1053/j.gastro.2008.10.085; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Das M, 2012, ANN MED, V44, P530, DOI 10.3109/07853890.2011.577445; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Feng H, 2010, J BIOL CHEM, V285, P25154, DOI 10.1074/jbc.M110.116897; Fernandez-Hernando C, 2010, AM J PATHOL, V177, P998, DOI 10.2353/ajpath.2010.091287; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Guan QD, 2011, MOL MED, V17, P646, DOI 10.2119/molmed.2010.00252; Guan QD, 2009, VACCINE, V27, P7096, DOI 10.1016/j.vaccine.2009.09.058; Halayko Andrew J, 2008, Proc Am Thorac Soc, V5, P80, DOI 10.1513/pats.200705-057VS; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Hu Q, 2010, J VASC RES, V47, P69, DOI 10.1159/000235927; Ito Y, 2002, BRIT J CANCER, V86, P912, DOI 10.1038/sj.bjc.6600172; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Juhasz M, 2003, J CANCER RES CLIN, V129, P493, DOI 10.1007/s00432-003-0468-0; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; KIM HS, 1992, SCAND J GASTROENTERO, V27, P529, DOI 10.3109/00365529209000116; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Krajewska WM, 2004, CELL MOL BIOL LETT, V9, P195; Le Saux CJ, 2008, J BIOL CHEM, V283, P5760, DOI 10.1074/jbc.M701572200; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Ma YB, 2010, INFLAMM BOWEL DIS, V16, P1040, DOI 10.1002/ibd.21167; Maul J, 2012, LANGENBECK ARCH SURG, V397, P1, DOI 10.1007/s00423-011-0789-4; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; Monteleone G, 2006, CURR OPIN GASTROEN, V22, P361, DOI 10.1097/01.mog.0000231808.10773.8e; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Pizarro TT, 2007, ANNU REV MED, V58, P433, DOI 10.1146/annurev.med.58.121205.100607; Pojoga LH, 2010, ENDOCRINOLOGY, V151, P1236, DOI 10.1210/en.2009-0514; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sainz-Jaspeado M, 2011, ONCOTARGET, V2, P305; Tang HQ, 2010, J IMMUNOL, V185, P2563, DOI 10.4049/jimmunol.0903664; Thompson TC, 2010, PROSTATE CANCER P D, V13, P6, DOI 10.1038/pcan.2009.29; Tsai TH, 2011, SHOCK, V35, P92, DOI 10.1097/SHK.0b013e3181ea45ca; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Watanabe S, 2014, J GASTROENTEROL, V49, P270, DOI 10.1007/s00535-013-0901-3; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto A, 2013, PHARMACOLOGY, V92, P108, DOI 10.1159/000353192; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962	58	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119004	10.1371/journal.pone.0119004	http://dx.doi.org/10.1371/journal.pone.0119004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756273	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700035
J	Azuma, K; Casey, SC; Urano, T; Horie-Inoue, K; Ouchi, Y; Blumberg, B; Inoue, S				Azuma, Kotaro; Casey, Stephanie C.; Urano, Tomohiko; Horie-Inoue, Kuniko; Ouchi, Yasuyoshi; Blumberg, Bruce; Inoue, Satoshi			Pregnane X Receptor Knockout Mice Display Aging-Dependent Wearing of Articular Cartilage	PLOS ONE			English	Article							VITAMIN-K; AMELOGENESIS IMPERFECTA; OSTEOARTHRITIS; SXR; TRANSCRIPTION; ASSOCIATION; EXPRESSION; FRACTURES; FAM20A; HAND	Steroid and xenobiotic receptor (SXR) and its murine ortholog, pregnane X receptor (PXR), are nuclear receptors that are expressed at high levels in the liver and the intestine where they function as xenobiotic sensors that induce expression of genes involved in detoxification and drug excretion. Recent evidence showed that SXR and PXR are also expressed in bone tissue where they mediate bone metabolism. Here we report that systemic deletion of PXR results in aging-dependent wearing of articular cartilage of knee joints. Histomorphometrical analysis showed remarkable reduction of width and an enlarged gap between femoral and tibial articular cartilage in PXR knockout mice. We hypothesized that genes induced by SXR in chondrocytes have a protective effect on articular cartilage and identified Fam20a (family with sequence similarity 20a) as an SXR-dependent gene induced by the known SXR ligands, rifampicin and vitamin K2. Lastly, we demonstrated the biological significance of Fam20a expression in chondrocytes by evaluating osteoarthritis-related gene expression of primary articular chondrocytes. Consistent with epidemiological findings, our results indicate that SXR/PXR protects against aging-dependent wearing of articular cartilage and that ligands for SXR/PXR have potential role in preventing osteoarthritis caused by aging.	[Azuma, Kotaro; Urano, Tomohiko; Ouchi, Yasuyoshi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Casey, Stephanie C.; Blumberg, Bruce] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan; [Horie-Inoue, Kuniko; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Hidaka, Saitama 3501241, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Minato Ku, Tokyo 1058470, Japan	University of Tokyo; University of California System; University of California Irvine; University of Tokyo; Saitama Medical University; Toranomon Hospital	Inoue, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	INOUE-GER@h.u-tokyo.ac.jp	Urano, Tomohiko/AFS-9574-2022		Cell Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science, Research [24659126]; Ministry of Health, Labor and Welfare; National Institute of Environmental Health Sciences [R01ES021832]; NIH Predoctoral Cancer Biology Training Grant [T32CA9054]; National Cancer Institute; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021832] Funding Source: NIH RePORTER	Cell Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science, Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Predoctoral Cancer Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by: 1) Cell Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology (http://cellinnovation.nig.ac.jp/mext-life/english/html/program/theme.html) (SI); 2) Grants from the Japan Society for the Promotion of Science, Research Project number: 24659126 (http://kaken.nii.ac.jp/d/p/24659126.en.html) (SI); 3) Grants-in-Aid from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo16/0501.html) (SI); 4) Grant from the National Institute of Environmental Health Sciences, Grant number R01ES021832 (http://tools.niehs.nih.gov/portfolio/index.cfm/portfolio/grantDetail/grant_number/R01ES021832) (BB); 5) NIH Predoctoral Cancer Biology Training Grant, T32CA9054, National Cancer Institute (SCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2014, GERIATR GERONTOL INT, V14, P1, DOI 10.1111/ggi.12060; Azuma K, 2010, J ENDOCRINOL, V207, P257, DOI 10.1677/JOE-10-0208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P2613, DOI 10.1002/art.10576; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Misra D, 2013, AM J MED, V126, P243, DOI 10.1016/j.amjmed.2012.10.011; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Neogi T, 2008, ANN RHEUM DIS, V67, P1570, DOI 10.1136/ard.2008.094771; Neogi T, 2006, ARTHRITIS RHEUM, V54, P1255, DOI 10.1002/art.21735; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Oka H, 2009, J ORTHOP SCI, V14, P687, DOI 10.1007/s00776-009-1395-y; Shiraki M, 2000, J BONE MINER RES, V15, P515, DOI 10.1359/jbmr.2000.15.3.515; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Thirion S, 2004, METH MOLEC MED, V100, P1; Urano T, 2007, GERIATR GERONTOL INT, V7, P104, DOI 10.1111/j.1447-0594.2007.00394.x; VILLANUEVA AR, 1989, STAIN TECHNOL, V64, P129, DOI 10.3109/10520298909106985; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001	28	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119177	10.1371/journal.pone.0119177	http://dx.doi.org/10.1371/journal.pone.0119177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749104	Green Published, gold			2022-12-26	WOS:000350689400055
J	Han, M; Kim, J				Han, Murui; Kim, Jonghan			Effect of Dietary Iron Loading on Recognition Memory in Growing Rats	PLOS ONE			English	Article							BRAIN IRON; DEFICIENCY ALTERS; NEUROBEHAVIORAL DYSFUNCTIONS; HIPPOCAMPAL-NEURONS; OBJECT RECOGNITION; SUBSTANTIA-NIGRA; NITRIC-OXIDE; METABOLISM; RECEPTORS; ADULT	While nutritional and neurobehavioral problems are associated with both iron deficiency during growth and overload in the elderly, the effect of iron loading in growing ages on neurobehavioral performance has not been fully explored. To characterize the role of dietary iron loading in memory function in the young, weanling rats were fed iron-loading diet (10,000 mg iron/kg diet) or iron-adequate control diet (50 mg/kg) for one month, during which a battery of behavioral tests were conducted. Iron-loaded rats displayed elevated non-heme iron levels in serum and liver, indicating a condition of systemic iron overload. In the brain, non-heme iron was elevated in the prefrontal cortex of iron-loaded rats compared with controls, whereas there was no difference in iron content in other brain regions between the two diet groups. While iron loading did not alter motor coordination or anxiety-like behavior, iron-loaded rats exhibited a better recognition memory, as represented by an increased novel object recognition index (22% increase from the reference value) than control rats (12% increase; P=0.047). Western blot analysis showed an up-regulation of dopamine receptor 1 in the prefrontal cortex from iron-loaded rats (142% increase; P=0.002). Furthermore, levels of glutamate receptors (both NMDA and AMPA) and nicotinic acetylcholine receptor (nAChR) were significantly elevated in the prefrontal cortex of iron-loaded rats (62% increase in NR1; 70% increase in Glu1A; 115% increase in nAChR). Dietary iron loading also increased the expression of NMDA receptors and nAChR in the hippocampus. These results support the idea that iron is essential for learning and memory and further reveal that iron supplementation during developmental and rapidly growing periods of life improves memory performance. Our investigation also demonstrates that both cholinergic and glutamatergic neurotransmission pathways are regulated by dietary iron and provides a molecular basis for the role of iron loading in improved memory.	[Han, Murui; Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA	Northeastern University	Kim, J (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.	j.kim@neu.edu			NIH [R00 ES017781]; Northeastern University Startup; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017781] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University Startup; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIH R00 ES017781 and Northeastern University Startup (J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47; Batra Jyoti, 2002, Indian J Clin Biochem, V17, P108, DOI 10.1007/BF02867982; Beard JL, 2006, BEHAV BRAIN RES, V170, P224, DOI 10.1016/j.bbr.2006.02.024; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; BEARD JL, 1994, PHARMACOL BIOCHEM BE, V48, P621, DOI 10.1016/0091-3057(94)90323-9; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; BENSHACHAR D, 1991, J NEUROCHEM, V57, P2133, DOI 10.1111/j.1471-4159.1991.tb06432.x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brain JD, 2006, AM J RESP CELL MOL, V34, P330, DOI 10.1165/rcmb.2005-0101OC; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Cass WA, 2007, NEUROBIOL AGING, V28, P258, DOI 10.1016/j.neurobiolaging.2005.12.010; Castro-Caraballo F, 1992, Invest Clin, V33, P121; CHEN Q, 1995, J NUTR BIOCHEM, V6, P486, DOI 10.1016/0955-2863(95)00074-A; Choi BR, 2013, NEUROSCIENCE, V253, P214, DOI 10.1016/j.neuroscience.2013.08.043; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Connor JR, 2006, J ALZHEIMERS DIS, V10, P267; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; de Lima MNM, 2007, EUR J PHARMACOL, V570, P111, DOI 10.1016/j.ejphar.2007.06.002; de Lima MNM, 2005, EUR J NEUROSCI, V21, P2521, DOI 10.1111/j.1460-9568.2005.04083.x; de Lima MNM, 2005, BEHAV BRAIN RES, V156, P139, DOI 10.1016/j.bbr.2004.05.016; DEINARD A, 1981, PEDIATRICS, V68, P828; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025324; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1971, BIOL NEONATE, V19, P363, DOI 10.1159/000240430; Erikson KM, 2000, J NUTR, V130, P2831, DOI 10.1093/jn/130.11.2831; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Erikson KM, 2001, PHARMACOL BIOCHEM BE, V69, P409, DOI 10.1016/S0091-3057(01)00563-9; FINDLAY E, 1981, PHYSIOL BEHAV, V27, P1089, DOI 10.1016/0031-9384(81)90375-9; Fredriksson A, 1999, TOXICOL APPL PHARM, V159, P25, DOI 10.1006/taap.1999.8711; Fredriksson A, 2000, DEV BRAIN RES, V119, P65, DOI 10.1016/S0165-3806(99)00160-1; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HILL JM, 1985, BRAIN RES, V342, P18, DOI 10.1016/0006-8993(85)91348-4; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Huang K, 2012, BIOL TRACE ELEM RES, V146, P79, DOI 10.1007/s12011-011-9230-7; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Kim J, 2013, FASEB J, V27, P1657, DOI 10.1096/fj.12-224386; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033533; Kim J, 2011, AM J PHYSIOL-LUNG C, V300, pL659, DOI 10.1152/ajplung.00343.2010; Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233; Li Y, 2011, J NUTR, V141, P2133, DOI 10.3945/jn.111.145946; Lozoff B, 1998, CHILD DEV, V69, P24, DOI 10.1111/j.1467-8624.1998.tb06130.x; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Maaroufi K, 2009, PHYSIOL BEHAV, V96, P343, DOI 10.1016/j.physbeh.2008.10.019; Maelicke A, 2001, BIOL PSYCHIAT, V49, P279, DOI 10.1016/S0006-3223(00)01109-4; MANEV H, 1989, MOL PHARMACOL, V36, P106; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Morgan EH, 2002, DEV NEUROSCI-BASEL, V24, P106, DOI 10.1159/000065699; Moriguchi S, 2004, J PHARMACOL EXP THER, V310, P933, DOI 10.1124/jpet.104.067603; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Nandar W, 2011, J NUTR, V141, p729S, DOI 10.3945/jn.110.130351; Nelson C, 1997, J NUTR, V127, P2282, DOI 10.1093/jn/127.12.2282; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Perez VP, 2010, CURR NEUROVASC RES, V7, P15, DOI 10.2174/156720210790820172; Pinero DJ, 2000, J NUTR, V130, P254, DOI 10.1093/jn/130.2.254; Puig MV, 2012, NEURON, V74, P874, DOI 10.1016/j.neuron.2012.04.018; RAO J, 1995, LAB ANIM SCI, V45, P393; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Schroder N, 2001, BEHAV BRAIN RES, V124, P77, DOI 10.1016/S0166-4328(01)00236-4; SENGSTOCK GJ, 1994, EXP NEUROL, V130, P82, DOI 10.1006/exnr.1994.1187; SENGSTOCK GJ, 1993, J NEUROSCI RES, V35, P67, DOI 10.1002/jnr.490350109; Sobotka TJ, 1996, PHYSIOL BEHAV, V59, P213, DOI 10.1016/0031-9384(95)02030-6; Sripetchwandee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085115; Subramaniam S, 2011, NEUROPHARMACOLOGY, V60, P1187, DOI 10.1016/j.neuropharm.2010.10.025; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TAYLOR EM, 1990, DEV BRAIN RES, V55, P35, DOI 10.1016/0165-3806(90)90103-6; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Wang L, 2008, NEUROSCIENCE, V155, P24, DOI 10.1016/j.neuroscience.2008.03.091; Ward KL, 2007, J NUTR, V137, P1043, DOI 10.1093/jn/137.4.1043; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; WHITTAKER P, 1994, J TRACE ELEM EXP MED, V7, P19; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; YEHUDA S, 1986, PHARMACOL BIOCHEM BE, V25, P141, DOI 10.1016/0091-3057(86)90244-3; YOUDIM MBH, 1978, P NUTR SOC, V37, P173, DOI 10.1079/PNS19780022; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1	91	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120609	10.1371/journal.pone.0120609	http://dx.doi.org/10.1371/journal.pone.0120609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746420	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400097
J	Rout, SP; Charles, CJ; Garratt, EJ; Laws, AP; Gunn, J; Humphreys, PN				Rout, Simon P.; Charles, Christopher J.; Garratt, Eva J.; Laws, Andrew P.; Gunn, John; Humphreys, Paul N.			Evidence of the Generation of Isosaccharinic Acids and Their Subsequent Degradation by Local Microbial Consortia within Hyper-Alkaline Contaminated Soils, with Relevance to Intermediate Level Radioactive Waste Disposal	PLOS ONE			English	Article							SP-NOV.; GEN. NOV.; ACCUMULATING ORGANISMS; SODA LAKE; BACTERIUM; REDUCTION; CELLULOSE; IDENTIFICATION; PROPIONATE; METHANOGEN	The contamination of surface environments with hydroxide rich wastes leads to the formation of high pH (>11.0) soil profiles. One such site is a legacy lime works at Harpur Hill, Derbyshire where soil profile indicated in-situ pH values up to pH 12. Soil and porewater profiles around the site indicated clear evidence of the presence of the a and beta stereoisomers of isosaccharinic acid (ISA) resulting from the anoxic, alkaline degradation of cellulosic material. ISAs are of particular interest with regards to the disposal of cellulosic materials contained within the intermediate level waste (ILW) inventory of the United Kingdom, where they may influence radionuclide mobility via complexation events occurring within a geological disposal facility (GDF) concept. The mixing of uncontaminated soils with the alkaline leachate of the site resulted in ISA generation, where the rate of generation in-situ is likely to be dependent upon the prevailing temperature of the soil. Microbial consortia present in the uncontaminated soil were capable of surviving conditions imposed by the alkaline leachate and demonstrated the ability to utilise ISAs as a carbon source. Leachate-contaminated soil was sub-cultured in a cellulose degradation product driven microcosm operating at pH 11, the consortia present were capable of the degradation of ISAs and the generation of methane from the resultant H-2/CO2 produced from fermentation processes. Following microbial community analysis, fermentation processes appear to be predominated by Clostridia from the genus Alkaliphilus sp, with methanogenesis being attributed to Methanobacterium and Methanomassiliicoccus sp. The study is the first to identify the generation of ISA within an anthropogenic environment and advocates the notion that microbial activity within an ILW-GDF is likely to influence the impact of ISAs upon radionuclide migration.	[Rout, Simon P.; Charles, Christopher J.; Garratt, Eva J.; Laws, Andrew P.; Humphreys, Paul N.] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Gunn, John] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England	University of Huddersfield; University of Birmingham	Humphreys, PN (corresponding author), Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England.	p.n.humphreys@hud.ac.uk		Rout, Simon/0000-0001-5778-6145; Humphreys, Paul/0000-0003-3431-7930	Engineering and Physical Sciences Research council [EP/I036354/1]; Radioactive Waste Management Ltd.; University of Huddersfield; Engineering and Physical Sciences Research Council [EP/I036354/1] Funding Source: researchfish; EPSRC [EP/I036354/1] Funding Source: UKRI	Engineering and Physical Sciences Research council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Radioactive Waste Management Ltd.; University of Huddersfield; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was partially supported by both the Engineering and Physical Sciences Research council under grant EP/I036354/1 and by Radioactive Waste Management Ltd. The remaining funds being provided by the University of Huddersfield. The funders had no role in study design, data collection and analysis associated with the paper. RWM ltd did review the paper prior to submission.	Alexander WR, 2011, CYPR NAT AN PROJ CNA; [Anonymous], 2005, 103902005 BS ISO; B.S.I, 2005, 148532005 BS ISO; Bassil NM, 2014, ISME J; BOYER EW, 1973, INT J SYST BACTERIOL, V23, P238, DOI 10.1099/00207713-23-3-238; Burke IT, 2012, GEOMICROBIOL J, V29, P769, DOI 10.1080/01490451.2011.619638; Cao XH, 2003, INT J SYST EVOL MICR, V53, P971, DOI 10.1099/ijs.0.02373-0; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Eaton A. D., 2005, STANDARD METHODS EXA; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Glaus MA, 1999, ANAL CHIM ACTA, V398, P111, DOI 10.1016/S0003-2670(99)00371-2; Greenfield B, 1997, NSSR375 AEA TECHN; Humphreys P. N., 2010, SERCOTAS002274001; Kotelnikova S, 1998, INT J SYST BACTERIOL, V48, P357, DOI 10.1099/00207713-48-2-357; Montero B, 2009, WASTE MANAGE, V29, P1144, DOI 10.1016/j.wasman.2008.08.010; NDA, 2010, NDARWMD033; NDA, 2011, 2010 UK RAD WAST INV; Oehmen A, 2005, BIOTECHNOL BIOENG, V91, P162, DOI 10.1002/bit.20500; Oehmen A, 2006, MICROBIOL-SGM, V152, P2767, DOI 10.1099/mic.0.28065-0; Rai DP, 1998, J SOLUTION CHEM, V27, P1109, DOI 10.1023/A:1022610001043; Randall M, 2013, NSSR375 AEA TECHN; Roh Y, 2007, GEOSCI J, V11, P415, DOI 10.1007/BF02857056; Rout SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107433; Rout SP, 2015, UNDERSTANDING EFFECT; Savage D, 2011, MINERAL MAG, V75, P1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw PB, 2012, CARBOHYD RES, V349, P6, DOI 10.1016/j.carres.2011.11.022; Simmons Ardyth M., 2010, 1779 US GEOL SURV; Takai K, 2001, INT J SYST EVOL MICR, V51, P1245, DOI 10.1099/00207713-51-4-1245; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; VanLoon LR, 1997, J ENVIRON POLYM DEGR, V5, P97; VanLoon LR, 1997, ENVIRON SCI TECHNOL, V31, P1243, DOI 10.1021/es960505i; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Virden BT, 2010, ASTR SCI C 2010 LEAG; Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12; Wong MT, 2004, MICROBIOL-SGM, V150, P3741, DOI 10.1099/mic.0.27291-0; WORAKIT S, 1986, INT J SYST BACTERIOL, V36, P380, DOI 10.1099/00207713-36-3-380; Wu XY, 2010, INT J SYST EVOL MICR, V60, P2898, DOI 10.1099/ijs.0.014084-0; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004; Zavarzina DG, 2009, MICROBIOLOGY+, V78, P723, DOI 10.1134/S0026261709060095; Zhilina TN, 2009, MICROBIOLOGY+, V78, P445, DOI 10.1134/S0026261709040080; Zhu JX, 2011, INT J SYST EVOL MICR, V61, P2974, DOI 10.1099/ijs.0.027540-0	43	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119164	10.1371/journal.pone.0119164	http://dx.doi.org/10.1371/journal.pone.0119164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748643	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000350689400053
J	Krizbai, IA; Gasparics, A; Nagyoszi, P; Fazakas, C; Molnar, J; Wilhelm, I; Bencs, R; Rosivall, L; Sebe, A				Krizbai, Istvan A.; Gasparics, Akos; Nagyoszi, Peter; Fazakas, Csilla; Molnar, Judit; Wilhelm, Imola; Bencs, Rita; Rosivall, Laszlo; Sebe, Attila			Endothelial-Mesenchymal Transition of Brain Endothelial Cells: Possible Role during Metastatic Extravasation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-METASTASIS; MELANOMA-CELLS; TRANSENDOTHELIAL MIGRATION; TRANSCRIPTION FACTOR; CANCER METASTASIS; N-CADHERIN; IN-VITRO; ADHESION; EXPRESSION	Cancer progression towards metastasis follows a defined sequence of events described as the metastatic cascade. For extravasation and transendothelial migration metastatic cells interact first with endothelial cells. Yet the role of endothelial cells during the process of metastasis formation and extravasation is still unclear, and the interaction between metastatic and endothelial cells during transendothelial migration is poorly understood. Since tumor cells are well known to express TGF-beta, and the compact endothelial layer undergoes a series of changes during metastatic extravasation (cell contact disruption, cytoskeletal reorganization, enhanced contractility), we hypothesized that an EndMT may be necessary for metastatic extravasation. We demonstrate that primary cultured rat brain endothelial cells (BEC) undergo EndMT upon TGF-beta 1 treatment, characterized by the loss of tight and adherens junction proteins, expression of fibronectin, beta 1-integrin, calponin and a-smooth muscle actin (SMA). B16/F10 cell line conditioned and activated medium (ACM) had similar effects: claudin-5 down-regulation, fibronectin and SMA expression. Inhibition of TGF-beta signaling during B16/F10 ACM stimulation using SB-431542 maintained claudin-5 levels and mitigated fibronectin and SMA expression. B16/F10 ACM stimulation of BECs led to phosphorylation of Smad2 and Smad3. SB-431542 prevented SMA up-regulation upon stimulation of BECs with A2058, MCF-7 and MDA-MB231 ACM as well. Moreover, B16/F10 ACM caused a reduction in trans-endothelial electrical resistance, enhanced the number of melanoma cells adhering to and transmigrating through the endothelial layer, in a TGF-beta-dependent manner. These effects were not confined to BECs: HUVECs showed TGF-beta-dependent SMA expression when stimulated with breast cancer cell line ACM. Our results indicate that an EndMT may be necessary for metastatic transendothelial migration, and this transition may be one of the potential mechanisms occurring during the complex phenomenon known as metastatic extravasation.	[Krizbai, Istvan A.; Nagyoszi, Peter; Fazakas, Csilla; Molnar, Judit; Wilhelm, Imola] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6726 Szeged, Hungary; [Krizbai, Istvan A.] Vasile Goldis Western Univ Arad, Inst Life Sci, Arad 310414, Romania; [Gasparics, Akos; Bencs, Rita; Rosivall, Laszlo; Sebe, Attila] Semmelweis Univ, Dept Pathophysiol, H-1089 Budapest, Hungary; [Rosivall, Laszlo] Hungarian Acad Sci, Pediat & Nephrol Res Grp, H-1089 Budapest, Hungary; [Rosivall, Laszlo] Semmelweis Univ, H-1089 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Vasile Goldis Western University of Arad; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Sebe, A (corresponding author), Semmelweis Univ, Dept Pathophysiol, Nagyvarad Sq 4, H-1089 Budapest, Hungary.	sebe.attila@med.semmelweis-univ.hu	Sebe, Attila/K-2644-2017; Sebe, Attila/GXV-5092-2022	Sebe, Attila/0000-0001-7814-5144; Sebe, Attila/0000-0001-7814-5144; Krizbai, Istvan/0000-0002-0764-1527	Hungarian Research Fund [OTKA PD-100958, K-100807]; National Development Agency (Hungary-Romania Cross-Border Co-operation Programme) [HURO/1101/173/2.2.1, TAMOP-4.2.2.A-11/1/KONV-2012-0052]; Hungarian Kidney Foundation; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences; European Union; State of Hungary; European Social Fund, 'National Excellence Program' [TAMOP-4.2.4.A/ 2-11/1-2012-0001]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency (Hungary-Romania Cross-Border Co-operation Programme); Hungarian Kidney Foundation; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); State of Hungary; European Social Fund, 'National Excellence Program'	This work was supported by grants from the Hungarian Research Fund (OTKA PD-100958, K-100807), the National Development Agency (Hungary-Romania Cross-Border Co-operation Programme 2007-2013: HURO/1101/173/2.2.1; and the TAMOP-4.2.2.A-11/1/KONV-2012-0052 project) and the Hungarian Kidney Foundation. I. Wilhelm was supported by the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences. The research of C. Fazakas was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/ 2-11/1-2012-0001 'National Excellence Program'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Auguste P, 2007, AM J PATHOL, V170, P1781, DOI 10.2353/ajpath.2007.060886; Barthel SR, 2013, CANCER RES, V73, P942, DOI 10.1158/0008-5472.CAN-12-3264; Bodor C, 2012, AM J PHYSIOL-CELL PH, V302, pC267, DOI 10.1152/ajpcell.00138.2011; Dasgupta S, 2006, J CELL BIOCHEM, V97, P1036, DOI 10.1002/jcb.20647; DiChiara MR, 2000, J EXP MED, V192, P695, DOI 10.1084/jem.192.5.695; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fintha A, 2013, AM J PATHOL, V182, P388, DOI 10.1016/j.ajpath.2012.10.009; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; Heyder C, 2002, J CANCER RES CLIN, V128, P533, DOI 10.1007/s00432-002-0377-7; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P3725, DOI 10.1073/pnas.1100446108; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Krasagakis K, 1998, BRIT J CANCER, V77, P1492, DOI 10.1038/bjc.1998.245; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Medici D, 2012, SEMIN CANCER BIOL, V22, P379, DOI 10.1016/j.semcancer.2012.04.004; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Platta CS, 2010, AM J CLIN ONCOL-CANC, V33, P398, DOI 10.1097/COC.0b013e318194f744; Price EA, 1996, BRIT J CANCER, V74, P1762, DOI 10.1038/bjc.1996.627; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Sebe A, 2010, NEPHRON EXP NEPHROL, V114, pE117, DOI 10.1159/000265550; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Teti A, 1997, INT J CANCER, V72, P1013; Tulley S, 2014, J BIOL CHEM, V289, P15280, DOI 10.1074/jbc.M114.568501; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vonach C, 2011, BRIT J CANCER, V105, P263, DOI 10.1038/bjc.2011.194; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Wen P.Y., 2001, CANC PRINCIPLES PRAC, P2655; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Wilhelm I, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12169; Wilhelm I, 2013, INT J MOL SCI, V14, P1383, DOI 10.3390/ijms14011383; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	50	43	43	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119655	10.1371/journal.pone.0119655	http://dx.doi.org/10.1371/journal.pone.0119655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742314	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100125
J	Maruyama, S; Shoguchi, E; Satoh, N; Minagawa, J				Maruyama, Shinichiro; Shoguchi, Eiichi; Satoh, Nori; Minagawa, Jun			Diversification of the Light-Harvesting Complex Gene Family via Intra- and Intergenic Duplications in the Coral Symbiotic Alga Symbiodinium	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; BINDING-PROTEIN; PHOTOSYSTEM-I; HEAT-STRESS; EVOLUTION; PHOTOPROTECTION; ANTENNA; MECHANISMS; ALIGNMENT; GENOME	The light-harvesting complex (LHC) is an essential component in light energy capture and transduction to facilitate downstream photosynthetic reactions in plant and algal chloroplasts. The unicellular dinoflagellate alga Symbiodinium is an endosymbiont of cnidarian animals, including corals and sea anemones, and provides carbohydrates generated through photosynthesis to host animals. Although Symbiodinium possesses a unique LHC gene family, called chlorophyll a-chlorophyll c(2)-peridinin protein complex (acpPC), its genome-level diversity and evolutionary trajectories have not been investigated. Here, we describe a phylogenetic analysis revealing that many of the LHCs are encoded by highly duplicated genes with multi-subunit polyprotein structures in the nuclear genome of Symbiodinium minutum. This analysis provides an extended list of the LHC gene family in a single organism, including 80 loci encoding polyproteins composed of 145 LHC subunits recovered in the phylogenetic tree. In S. minutum, 5 phylogenetic groups of the Lhcf-type gene family, which is exclusively conserved in algae harboring secondary plastids of red algal origin, were identified. Moreover, 5 groups of the Lhcr-type gene family, of which members are known to be associated with PSI in red algal plastids and secondary plastids of red algal origin, were identified. Notably, members classified within a phylogenetic group of the Lhcf-type (group F1) are highly duplicated, which may explain the presence of an unusually large number of LHC genes in this species. Some gene units were homologous to other units within single loci of the polyprotein genes, whereas intergenic homologies between separate loci were conspicuous in other cases, implying that gene unit 'shuffling' by gene conversion and/or genome rearrangement might have been a driving force for diversification. These results suggest that vigorous intra-and intergenic gene duplication events have resulted in the genomic framework of photosynthesis in coral symbiont dinoflagellate algae.	[Maruyama, Shinichiro; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 444, Japan; [Shoguchi, Eiichi; Satoh, Nori] Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa, Japan; [Minagawa, Jun] Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan; [Minagawa, Jun] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okinawa Institute of Science & Technology Graduate University; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 444, Japan.	minagawa@nibb.ac.jp	Satoh, Nori/C-4123-2009; Maruyama, Shinichiro/AAO-4764-2021	Satoh, Nori/0000-0002-4480-3572; Minagawa, Jun/0000-0002-3028-3203	JSPS KAKENHI Grant [26251033, 25891027, 26117731]; National Institute for Basic Biology; New Energy and Industrial Technology Development Organization; Institute for Fermentation, Osaka	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute for Basic Biology(National Institutes of Natural Sciences (NINS) - Japan); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO))	This work was supported by JSPS KAKENHI Grant Numbers 26251033 (to JM), 25891027 and 26117731 (to SM) (http://www.jsps.go.jp/english/index.htm), the research fund for environmental adaptation strategy of living organisms from the National Institute for Basic Biology, and a research fund from the New Energy and Industrial Technology Development Organization to JM, funding from the Institute for Fermentation, Osaka, to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Barshis DJ, 2014, MOL BIOL EVOL, V31, P1343, DOI 10.1093/molbev/msu107; Boldt L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047456; Busch A, 2010, PLANT J, V62, P886, DOI 10.1111/j.1365-313X.2010.04202.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Gerotto C, 2013, PHYSIOL PLANTARUM, V149, P583, DOI 10.1111/ppl.12070; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; HILLER RG, 1995, FEBS LETT, V363, P175, DOI 10.1016/0014-5793(95)00297-M; Hoffman GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-101; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Jaeckisch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028012; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jansson S, 2006, ADV PHOTO RESPIRAT, V21, P145; Jiang J, 2014, BBA-BIOENERGETICS, V1837, P1904, DOI 10.1016/j.bbabio.2014.07.023; Kanazawa A, 2014, BBA-BIOENERGETICS, V1837, P1227, DOI 10.1016/j.bbabio.2014.03.019; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Koziol AG, 2008, MOL BIOL EVOL, V25, P92, DOI 10.1093/molbev/msm232; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; Lee R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-122; Leggat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026687; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Lukes J, 2009, P NATL ACAD SCI USA, V106, P9963, DOI 10.1073/pnas.0901004106; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Marquardt J, 2001, PHOTOSYNTH RES, V68, P121, DOI 10.1023/A:1011865415369; Maruyama S, 2013, MAR FRESHW BOTANY, P21; Maruyama S, 2014, PLANT CELL PHYSIOL, V55, P1304, DOI 10.1093/pcp/pcu068; Maruyama S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-105; Minagawa J., 2009, CHLAMYDOMONAS SOURCE, V2, P503, DOI DOI 10.1016/B978-0-12-370873-1.00022-8; Minagawa J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00513; Mungpakdee S, 2014, GENOME BIOL EVOL, V6, P1408, DOI 10.1093/gbe/evu109; Niedzwiedzki DM, 2014, PHOTOSYNTH RES, V120, P125, DOI 10.1007/s11120-013-9794-5; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Shinzato C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00336; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sturm S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-159; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Tan S, 1997, PHOTOSYNTH RES, V53, P129, DOI 10.1023/A:1005815321295; ten Lohuis MR, 1998, PLANT PHYSIOL, V117, P189, DOI 10.1104/pp.117.1.189; Veith T, 2009, BBA-BIOENERGETICS, V1787, P905, DOI 10.1016/j.bbabio.2009.04.006; Xie G, 2002, GENOME BIOL, V3; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	54	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119406	10.1371/journal.pone.0119406	http://dx.doi.org/10.1371/journal.pone.0119406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741697	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100108
J	Medina-Andres, R; Solano-Peralta, A; Saucedo-Vazquez, JP; Napsucialy-Mendivil, S; Pimentel-Cabrera, JA; Sosa-Torres, ME; Dubrovsky, JG; Lira-Ruan, V				Medina-Andres, Rigoberto; Solano-Peralta, Alejandro; Pablo Saucedo-Vazquez, Juan; Napsucialy-Mendivil, Selene; Arturo Pimentel-Cabrera, Jaime; Elena Sosa-Torres, Martha; Dubrovsky, Joseph G.; Lira-Ruan, Veroica			The Nitric Oxide Production in the Moss Physcomitrella patens Is Mediated by Nitrate Reductase	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; IN-VIVO; SUBCELLULAR-LOCALIZATION; XANTHINE OXIDOREDUCTASE; NO PRODUCTION; SYNTHASE; GROWTH; EMISSION; PLANTS; SIGNAL	During the last 20 years multiple roles of the nitric oxide gas (center dot NO) have been uncovered in plant growth, development and many physiological processes. In seed plants the enzymatic synthesis of center dot NO is mediated by a nitric oxide synthase (NOS)-like activity performed by a still unknown enzyme(s) and nitrate reductase (NR). In green algae the center dot NO production has been linked only to NR activity, although a NOS gene was reported for Ostreococcus tauri and O. lucimarinus, no other Viridiplantae species has such gene. As there is no information about center dot NO synthesis neither for non-vascular plants nor for non-seed vascular plants, the interesting question regarding the evolution of the enzymatic center dot NO production systems during land plant natural history remains open. To address this issue the endogenous center dot NO production by protonema was demonstrated using Electron Paramagnetic Resonance (EPR). The center dot NO signal was almost eliminated in plants treated with sodium tungstate, which also reduced the NR activity, demonstrating that in P. patens NR activity is the main source for center dot NO production. The analysis with confocal laser scanning microscopy (CLSM) confirmed endogenous NO production and showed that center dot NO signal is accumulated in the cytoplasm of protonema cells. The results presented here show for the first time the center dot NO production in a non-vascular plant and demonstrate that the NR-dependent enzymatic synthesis of center dot NO is common for embryophytes and green algae.	[Medina-Andres, Rigoberto; Lira-Ruan, Veroica] Univ Autonoma Estado Morelos, Lab Fisiol & Desarrollo Vegetal, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico; [Solano-Peralta, Alejandro; Pablo Saucedo-Vazquez, Juan; Elena Sosa-Torres, Martha] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Inorgan & Nucl, Mexico City 04510, DF, Mexico; [Napsucialy-Mendivil, Selene; Dubrovsky, Joseph G.] Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Arturo Pimentel-Cabrera, Jaime] Univ Nacl Autonoma Mexico, Lab Nacl Microscopia Avanzada, Cuernavaca 62191, Morelos, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Lira-Ruan, V (corresponding author), Univ Autonoma Estado Morelos, Lab Fisiol & Desarrollo Vegetal, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico.	katlira@uaem.mx	Dubrovsky, Joseph G./B-9479-2008; Solano-Peralta, Alejandro/V-3992-2019	Dubrovsky, Joseph G./0000-0002-2072-4650; Solano-Peralta, Alejandro/0000-0001-9158-423X; Lira Ruan, Veronica/0000-0003-3085-5838; Pimentel Cabrera, Jaime Arturo/0000-0001-8569-0466; Saucedo-Vazquez, Juan Pablo/0000-0002-4314-6363; Sosa-Torres, Martha E./0000-0003-3464-1044	Consejo Nacional de Ciencia y Tecnologia [180226, 128921, 441239]; DGAPA project [IN231111]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA project	This research was funded by Consejo Nacional de Ciencia y Tecnologia, grant 180226 to VLR, grant no 128921 to MEST, and a graduate fellowship no 441239 to RMA (http://www.conacyt.mx). This work was also funded by DGAPA project No IN231111 to MEST (http://dgapa.unam.mx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abied M, 2012, PLANT J, V71, P787, DOI 10.1111/j.1365-313X.2012.05032.x; Barroso JB, 1999, J BIOL CHEM, V274, P36729, DOI 10.1074/jbc.274.51.36729; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Besson-Bard A, 2009, PLANT SCI, V177, P302, DOI 10.1016/j.plantsci.2009.06.006; Chen YR, 2012, P NATL ACAD SCI USA, V109, P8310, DOI 10.1073/pnas.1201744109; Chiariello N. R., 1989, Plant physiological ecology: field methods and instrumentation., P327; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Lombardo MC, 2006, PLANT SIGNAL BEHAV, V1, P28, DOI 10.4161/psb.1.1.2398; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; DEAN JV, 1986, PLANT PHYSIOL, V82, P718, DOI 10.1104/pp.82.3.718; Decker EL, 2006, PLANT BIOLOGY, V8, P397, DOI 10.1055/s-2006-923952; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Doel JJ, 2001, BBA-GEN SUBJECTS, V1527, P81, DOI 10.1016/S0304-4165(01)00148-9; Durner J, 1999, CURR OPIN PLANT BIOL, V2, P369, DOI 10.1016/S1369-5266(99)00007-2; Foissner I, 2000, PLANT J, V23, P817, DOI 10.1046/j.1365-313X.2000.00835.x; Foresi N, 2010, PLANT CELL, V22, P3816, DOI 10.1105/tpc.109.073510; Garcia-Mata C, 2001, PLANT PHYSIOL, V123, P1196; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Hancock JT, 2012, PERIOD BIOL, V114, P19; Hayat S, 2012, HORTIC ENVIRON BIOTE, V53, P362, DOI 10.1007/s13580-012-0481-9; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Hogg N, 2010, FREE RADICAL BIO MED, V49, P122, DOI 10.1016/j.freeradbiomed.2010.03.009; Hung KT, 2003, J PLANT PHYSIOL, V160, P871, DOI 10.1078/0176-1617-01118; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Kojima H, 2000, ADV MATER, V12, P763, DOI 10.1002/(SICI)1521-4095(200005)12:10<763::AID-ADMA763>3.0.CO;2-R; Kolbert Z, 2010, J PLANT PHYSIOL, V167, P77, DOI 10.1016/j.jplph.2009.08.013; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lea US, 2004, PLANTA, V219, P59, DOI 10.1007/s00425-004-1209-6; Lehner C, 2009, J PLANT PHYSIOL, V166, P117, DOI 10.1016/j.jplph.2008.02.012; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Mallick N, 2000, J PLANT PHYSIOL, V156, P423, DOI 10.1016/S0176-1617(00)80084-X; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Medina-Andres Rigoberto, 2012, Commun Integr Biol, V5, P19; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Meyer C, 2005, PHOTOSYNTH RES, V83, P181, DOI 10.1007/s11120-004-3548-3; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Mishler BD, 2009, ANNU PLANT REV, V36, P1, DOI 10.1111/b.9781405181891.2009.00001.x; Modolo LV, 2006, PLANT SCI, V171, P34, DOI 10.1016/j.plantsci.2006.02.010; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; Nemie-Feyissa D, 2013, J PLANT PHYSIOL, V170, P662, DOI 10.1016/j.jplph.2012.12.010; Palavan-Unsal N, 2009, BOT REV, V75, P203, DOI 10.1007/s12229-009-9031-2; Pedroso MC, 2000, J EXP BOT, V51, P1027, DOI 10.1093/jexbot/51.347.1027; Perchepied L, 2010, MOL PLANT MICROBE IN, V23, P846, DOI 10.1094/MPMI-23-7-0846; Pires ND, 2013, P NATL ACAD SCI USA, V110, P9571, DOI 10.1073/pnas.1305457110; Planchet E, 2005, PLANT J, V41, P732, DOI 10.1111/j.1365-313X.2005.02335.x; Rasul S, 2012, PLANT CELL ENVIRON, V35, P1483, DOI 10.1111/j.1365-3040.2012.02505.x; RESKI R, 1985, PLANTA, V165, P354, DOI 10.1007/BF00392232; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; Rockel Peter, 2002, Journal of Experimental Botany, V53, P103, DOI 10.1093/jexbot/53.366.103; Sakihama Y, 2002, PLANT CELL PHYSIOL, V43, P290, DOI 10.1093/pcp/pcf034; Samouilov A, 2002, METHOD ENZYMOL, V352, P506; Scheible WR, 1997, PLANT J, V11, P671, DOI 10.1046/j.1365-313X.1997.11040671.x; Seligman K, 2008, PLANT CELL PHYSIOL, V49, P1112, DOI 10.1093/pcp/pcn089; Shaw J, 2004, AM J BOT, V91, P1557, DOI 10.3732/ajb.91.10.1557; Silveira V, 2006, PLANT SCI, V171, P91, DOI 10.1016/j.plantsci.2006.02.015; Simontacchi M, 2013, PLANT CELL REP, V32, P853, DOI 10.1007/s00299-013-1434-1; Tischner R, 2004, FEBS LETT, V576, P151, DOI 10.1016/j.febslet.2004.09.004; Tun NN, 2001, FEBS LETT, V509, P174, DOI 10.1016/S0014-5793(01)03164-7; Vandelle E, 2008, METHOD ENZYMOL, V437, P575, DOI 10.1016/S0076-6879(07)37029-8; Wang JW, 2005, PLANT CELL PHYSIOL, V46, P923, DOI 10.1093/pcp/pci098; Wang YH, 2009, NEW PHYTOL, V182, P851, DOI 10.1111/j.1469-8137.2009.02820.x; WILKINSON JQ, 1993, MOL GEN GENET, V239, P289, DOI 10.1007/BF00281630; Xie YJ, 2013, J EXP BOT, V64, P3045, DOI 10.1093/jxb/ert149; Xiong J, 2012, J EXP BOT, V63, P33, DOI 10.1093/jxb/err268; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417; Yamasaki H, 2000, FEBS LETT, V468, P89, DOI 10.1016/S0014-5793(00)01203-5; Yu LZ, 2012, PLANT CELL REP, V31, P1813, DOI 10.1007/s00299-012-1294-0; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996	69	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119400	10.1371/journal.pone.0119400	http://dx.doi.org/10.1371/journal.pone.0119400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742644	gold, Green Published			2022-12-26	WOS:000350688100107
J	Hammar, L; Eggertsen, L; Andersson, S; Ehnberg, J; Arvidsson, R; Gullstrom, M; Molander, S				Hammar, Linus; Eggertsen, Linda; Andersson, Sandra; Ehnberg, Jimmy; Arvidsson, Rickard; Gullstrom, Martin; Molander, Sverker			A Probabilistic Model for Hydrokinetic Turbine Collision Risks: Exploring Impacts on Fish	PLOS ONE			English	Article							RENEWABLE ENERGY; BLADE-STRIKE; GENERATING ELECTRICITY; BEHAVIOR; SPEED; POWER; PERFORMANCE; VESSEL; LIGHT	A variety of hydrokinetic turbines are currently under development for power generation in rivers, tidal straits and ocean currents. Because some of these turbines are large, with rapidly moving rotor blades, the risk of collision with aquatic animals has been brought to attention. The behavior and fate of animals that approach such large hydrokinetic turbines have not yet been monitored at any detail. In this paper, we conduct a synthesis of the current knowledge and understanding of hydrokinetic turbine collision risks. The outcome is a generic fault tree based probabilistic model suitable for estimating population-level ecological risks. New video-based data on fish behavior in strong currents are provided and models describing fish avoidance behaviors are presented. The findings indicate low risk for small-sized fish. However, at large turbines (>= 5 m), bigger fish seem to have high probability of collision, mostly because rotor detection and avoidance is difficult in low visibility. Risks can therefore be substantial for vulnerable populations of large-sized fish, which thrive in strong currents. The suggested collision risk model can be applied to different turbine designs and at a variety of locations as basis for case-specific risk assessments. The structure of the model facilitates successive model validation, refinement and application to other organism groups such as marine mammals.	[Hammar, Linus; Ehnberg, Jimmy; Arvidsson, Rickard; Molander, Sverker] Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden; [Eggertsen, Linda; Gullstrom, Martin] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Andersson, Sandra] Marine Monitoring AB, Lysekil, Sweden	Chalmers University of Technology; Stockholm University	Hammar, L (corresponding author), Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden.	linus.hammar@chalmers.se	Arvidsson, Rickard/AAV-7598-2020; Molander, Sverker/E-1462-2012	Arvidsson, Rickard/0000-0002-9258-0641; Molander, Sverker/0000-0002-9081-8847	Chalmersska Research Foundation [Dnr CS2010/53]; Aforsk foundation; Adlerbertska Research Foundation	Chalmersska Research Foundation; Aforsk foundation; Adlerbertska Research Foundation	The study received financial support from the Chalmersska Research Foundation (Dnr CS2010/53), the Aforsk foundation (http://www.aforsk.se/in-english.php), and the Adlerbertska Research Foundation (http://adlerbertska.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1994, ICES J MAR SCI, V51, P207, DOI 10.1006/jmsc.1994.1021; Bahaj AS, 2011, RENEW SUST ENERG REV, V15, P3399, DOI 10.1016/j.rser.2011.04.032; Barreiros JP, 2002, CYBIUM, V26, P83; Bedford T., 2001, PROBABILISTIC RISK A; Boehlert GW, 2010, OCEANOGRAPHY, V23, P68, DOI 10.5670/oceanog.2010.46; Broadhurst M, 2011, SHORT TERM TEMPORAL; Burgman M., 2005, RISKS DECISIONS CONS; Busch DS, 2013, CONSERV BIOL, V27, P1190, DOI 10.1111/cobi.12164; Cada G, 2007, FISHERIES, V32, P174, DOI 10.1577/1548-8446(2007)32[174:PIOHAW]2.0.CO;2; Copping A, 2013, ENV EFFECTS MARINE E, DOI [10.1097/ACC.0b013e3182973a4f, DOI 10.1097/ACC.0B013E3182973A4F]; Corwin J, 1981, HEARING SOUND COMMUN, P91; DADSWELL MJ, 1986, FISHERIES, V11, P26, DOI 10.1577/1548-8446(1986)011<0026:PIOLTP>2.0.CO;2; Deng ZQ, 2007, ECOL MODEL, V208, P165, DOI 10.1016/j.ecolmodel.2007.05.019; Deng ZQ, 2011, ENERGIES, V4, P57, DOI 10.3390/en4010057; Domenici P, 1997, J EXP BIOL, V200, P1165; Douglas R.H., 1990, P373; EPRI, 2011, EV FISH INJ MORT ASS; EPRI, 2005, OC TID WAV EN REN EN; Fraenkel PL, 2002, P I MECH ENG A-J POW, V216, P1, DOI 10.1243/095765002760024782; Frid C, 2012, ENVIRON IMPACT ASSES, V32, P133, DOI 10.1016/j.eiar.2011.06.002; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; GLASS CW, 1989, FISH RES, V7, P249, DOI 10.1016/0165-7836(89)90059-3; Halvorsen M.B., 2011, EFFECTS TIDAL TURBIN; Hammar L., 2013, P 10 EUR WAV TID EN; Hammar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084141; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Handegard NO, 2005, CAN J FISH AQUAT SCI, V62, P2409, DOI 10.1139/F05-131; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Hawkins A.D., 1981, HEARING SOUND COMMUN, P109, DOI DOI 10.1007/978-1-4615-7186-5_6; Hazel Julia, 2007, Endangered Species Research, V3, P105, DOI 10.3354/esr003105; Henkel SK, 2014, HUMANIT SEA, P93, DOI 10.1007/978-94-017-8002-5_8; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Iosilevskii G, 2008, J R SOC INTERFACE, V5, P329, DOI 10.1098/rsif.2007.1073; Johansen JL, 2007, CORAL REEFS, V26, P577, DOI 10.1007/s00338-007-0217-y; Kastelein RA, 2008, MAR ENVIRON RES, V65, P369, DOI 10.1016/j.marenvres.2008.01.001; KENDALL DG, 1949, J R STAT SOC B, V11, P230; Khan J, 2009, OCEAN ENERGY GLOBAL; Khan MJ, 2008, RENEW SUST ENERG REV, V12, P2177, DOI 10.1016/j.rser.2007.04.016; Kibel P., 2008, ARCHIMEDES SCREW TUR; Knight K, 2011, J EXPT BIOL, V214, pi; Langton R, 2011, MAR POLICY, V35, P623, DOI 10.1016/j.marpol.2011.02.002; LEVY DA, 1995, CAN J FISH AQUAT SCI, V52, P1, DOI 10.1139/f95-001; LEWIS SL, 1969, T AM FISH SOC, V98, P14, DOI 10.1577/1548-8659(1969)98[14:PFIFPI]2.0.CO;2; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lloyd T, 2011, PREDICTING TIDAL TUR; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; McGowin C., 2005, OCEAN TIDAL WAVE ENE; Minesto, 2014, HIGH EFF LOW IMP; Mitson RB, 2003, AQUAT LIVING RESOUR, V16, P255, DOI 10.1016/S0990-7440(03)00021-4; Muntz W.R.A., 1990, P491; Nedwell J, 2007, VALIDATION DBHT MEAS, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Normandeau Associates, 2009, EST SURV INJ FISH PA; Pearson J, 2010, COLLISION RISK FISH; Pine MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051790; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Ren HY, 2012, 2012 OCEANS, DOI 10.1109/OCEANS.2012.6405010; Romero-Gomez P, 2014, RENEW ENERG, V71, P401, DOI 10.1016/j.renene.2014.05.051; Rourke FO, 2010, APPL ENERG, V87, P398, DOI 10.1016/j.apenergy.2009.08.014; Sand O, 1981, HEARING SOUND COMMUN, P459, DOI [10.1007/978-1-4615-7186-5_23, DOI 10.1007/978-1-4615-7186_23]; Schweizer PE, 2011, ESTIMATION RISKS COL, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Smit C.F., 2003, S AFRICAN J STAT, V37, P59; Soule M., 1987, VIABLE POPULATIONS C; Sparling C, 2013, COLLISION RISK MODEL, DOI [10.1097/ACC.0b013e3182973a4f, DOI 10.1097/ACC.0B013E3182973A4F]; THIEL R, 1995, J FISH BIOL, V46, P47, DOI 10.1111/j.1095-8649.1995.tb05946.x; Turnpenny A., 2000, RISK ASSESSMENT FISH; Urick R., 1983, PRINCIPLES UNDERWATE, P99; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Verdant Power, 2010, FIN KIN HYDR PIL LIC; Viehman HA, 2012, THESIS U MAINE ORONO; Von Raben K., 1957, WASSERWIRTSCHAFT, V4, P97; Wardle CS, 1986, BEHAV TELEOST FISHES, P469; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wilson B, 2007, COLLISION RISKS MARI, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Wilson B., 2013, USE ACOUSTIC DEVICES	76	28	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117756	10.1371/journal.pone.0117756	http://dx.doi.org/10.1371/journal.pone.0117756			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730314	Green Published, gold, Green Submitted			2022-12-26	WOS:000350684900015
J	Cunha, AF; Genzano, GN; Marques, AC				Cunha, Amanda F.; Genzano, Gabriel N.; Marques, Antonio C.			Reassessment of Morphological Diagnostic Characters and Species Boundaries Requires Taxonomical Changes for the Genus Orthopyxis L. Agassiz, 1862 (Campanulariidae, Hydrozoa) and Some Related Campanulariids	PLOS ONE			English	Article							MAR-DEL-PLATA; HYDROIDS CNIDARIA; MOLECULAR EVIDENCE; THECATE HYDROIDS; OBELIA CNIDARIA; LIFE-CYCLE; MITOCHONDRIAL; EVOLUTION; PHYLOGENY; PHYLOGEOGRAPHY	The genus Orthopyxis is widely known for its morphological variability, making species identification particularly difficult. A number of nominal species have been recorded in the southwestern Atlantic, although most of these records are doubtful. The goal of this study was to infer species boundaries in the genus Orthopyxis from the southwestern Atlantic using an integrative approach. Intergeneric limits were also tested using comparisons with specimens of the genus Campanularia. We performed DNA analyses using the mitochondrial genes 16S and COI and the nuclear ITS1 and ITS2 regions. Orthopyxis was monophyletic in maximum likelihood analyses using the combined dataset and in analyses with 16S alone. Four lineages of Orthopyxis were retrieved for all analyses, corresponding morphologically to the species Orthopyxis sargassicola (previously known in the area), Orthopyxis crenata (first recorded for the southwestern Atlantic), Orthopyxis caliculata (= Orthopyxis minuta Vannucci, 1949 and considered a synonym of O. integra by some authors), and Orthopyxis mianzani sp. nov. A re- evaluation of the traditional morphological diagnostic characters, guided by our molecular analyses, revealed that O. integra does not occur in the study area, and O. caliculata is the correct identification of one of the lineages occurring in this region, corroborating the validity of that species. Orthopyxis mianzani sp. nov. resembles O. caliculata with respect to gonothecae morphology and a smooth hydrothecae rim, although it shows significant differences for other characters, such as perisarc thickness, which has traditionally been thought to have wide intraspecific variation. The species O. sargassicola is morphologically similar to O. crenata, although they differ in gonothecae morphology, and these species can only be reliably identified when this structure is present.	[Cunha, Amanda F.; Marques, Antonio C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Genzano, Gabriel N.] Univ Nacl Mar del Plata, CONICET, IIMyC, Estn Costera Nagera,Dept Cs Marinas, Mar Del Plata, Buenos Aires, Argentina; [Marques, Antonio C.] Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil	Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; Universidade de Sao Paulo	Cunha, AF (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	amanfcunha@gmail.com	Fapesp, Biota/F-8655-2017; Cunha, Amanda F/R-3863-2017; Marques, Antonio Carlos/E-8049-2011	Fapesp, Biota/0000-0002-9887-8449; Cunha, Amanda F/0000-0003-3276-2651; Marques, Antonio Carlos/0000-0002-2884-0541	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES); CAPES Procad; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [562143/2010-6, 563106/2010-7, 564945/2010-2, 477156/2011-8, 458555/2013-4, 305805/2013-4]; Sao Paulo Research Foudation (FAPESP) [2004/09961-4, 2010/52324-6, 2011/50242-5, 2013/50484-4, 2011/22260-9]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0152 CONICET]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES Procad(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foudation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES) (AFC), CAPES Procad (ACM), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant no. 562143/2010-6; 563106/2010-7; 564945/2010-2; 477156/2011-8; 458555/2013-4; 305805/2013-4) (ACM), Sao Paulo Research Foudation (FAPESP) (grant no. 2004/09961-4; 2010/52324-6; 2011/50242-5; 2013/50484-4 - ACM, 2011/22260-9 - AFC), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (grant no. PIP 0152 CONICET) (GNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, B MAR SCI, V81, P335; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alurralde G, 2013, POLAR BIOL, V36, P957, DOI 10.1007/s00300-013-1319-3; Arai MN, 1980, CAN BULL FISH AQUAT, V204; BALE W. M., 1934, PROC LINNEAN SOC N S WALES, V59, P273; Bale WM, 1914, P ROYAL SOC VICTORIA, V27, P72; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; BLANCO O M, 1984, Revista del Museo de La Plata Seccion Zoologia, V13, P261; Blanco O.M., 1976, Revista del Museo de La Plata Seccion Zoologia, V12, P27; Blanco O. M., 1968, Revista del Museo de La Plata Zoologia, V10, P195; BLANCO O M, 1967, REVISTA DEL MUSEO DE LA PLATA SECCION ZOOLOGIA, V9, P243; Blanco Olga, 1994, Revista del Museo de La Plata Seccion Zoologia, V14, P181; Blanco OM, 1964, REV MUS LA PLATA, V7, P149; Bo M, 2012, ZOOL J LINN SOC-LOND, V166, P1, DOI 10.1111/j.1096-3642.2012.00834.x; Boero F, 2007, MAR ECOL-EVOL PERSP, V28, P178, DOI 10.1111/j.1439-0485.2007.00164.x; Bouillon J., 1985, Indo-Malayan Zoology, V2, P29; Broch H., 1948, Scientific Results of the Norwegian Antarctic Expedition 1927-1928 Oslo, VNo. 28, P1; BROCH H, 1909, FAUNA ARCTICA, V5, P129; Broch H, 1918, DANISH INGOLF EXPED, V5; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; CALDER DR, 1970, J FISH RES BOARD CAN, V27, P1501, DOI 10.1139/f70-175; Calder DR, 2014, AQUAT INVASIONS IN P, V9; Calder DR, 1991, R ONT MUS LIFE SCI C, V154; Cantero ALP, 2004, J NAT HIST, V38, P2269, DOI 10.1080/00222930310001647361; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Chen SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008116; Clark SF, 1877, P ACAD NAT SCI PHILA, V1876, P209; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2005, ZOOL SCR, V34, P91, DOI 10.1111/j.1463-6409.2005.00172.x; Collins AG, 2000, SCI MAR, V64, P5, DOI 10.3989/scimar.2000.64s15; Collins AG, 2011, ZOOTAXA, P53; CORNELIUS P F S, 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P249; Cornelius P.F.S., 1982, Bulletin of the British Museum (Natural History) Zoology, V42, P37; Cornelius P.F.S., 1995, SYNOPSES BRIT FAUNA, V50, P1; CORNELIUS PFS, 1990, J NAT HIST, V24, P535, DOI 10.1080/00222939000770381; Cunha AF, 2010, ZOOLOGIA-CURITIBA, V27, P945, DOI 10.1590/S1984-46702010000600016; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; El Beshbeeshy M, 1991, THESIS; El Beshbeeshy Mohamed, 2011, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P19; Meretta PE, 2015, MAR BIOL RES, V11, P294, DOI 10.1080/17451000.2014.923101; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraser CM, 1944, HYDROIDS OF THE ATLA; Fritz GB, 2009, J LIMNOL, V68, P46, DOI 10.4081/jlimnol.2009.46; Galea HR, 2007, ZOOTAXA, P39; Galea HR, 2012, ZOOTAXA, P19, DOI 10.11646/zootaxa.3296.1.2; Galea HR, 2007, ZOOTAXA, P1; Galea HR, 2009, ZOOTAXA, P1; Genzano G., 1992, Thalassas, V9, P63; Genzano G.N., 1990, Neritica, V5, P35; Genzano G. N., 1995, Miscellania Zoologica (Barcelona), V18, P1; Genzano G. N., 1998, Miscellania Zoologica (Barcelona), V21, P21; Genzano G, 2011, LAT AM J AQUAT RES, V39, P553, DOI [10.4067/S0718-560X2011000300015, 10.3856/vol39-issue3-fulltext-15]; Genzano G, 2008, LAT AM J AQUAT RES, V36, P301, DOI [10.3856/vol36-issue2-fulltext-11, 10.4067/S0718-560X2008000200011]; Genzano Gabriel N., 1994, Iheringia Serie Zoologia, V76, P3; Genzano GN, 2009, MAR ECOL-EVOL PERSP, V30, P33, DOI 10.1111/j.1439-0485.2008.00247.x; Genzano GN, 2002, OCEANOL ACTA, V25, P303, DOI 10.1016/S0399-1784(02)01197-0; Genzano GN, 2002, OPHELIA, V56, P161, DOI 10.1080/00785236.2002.10409496; Genzano GN, 1997, CIENC MAR, V23, P285; GILI J-M, 1989, Scientia Marina, V53, P67; Goloboff P, 2008, CLADISTICS, V24, P91; Govindarajan AF, 2006, MOL PHYLOGENET EVOL, V38, P820, DOI 10.1016/j.ympev.2005.11.012; Govindarajan AF, 2005, INVERTEBR BIOL, V124, P1, DOI 10.1111/j.1744-7410.2005.1241-01.x; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; Grohmann P.A., 1997, P227; Grohmann PA, 2003, ZOOTAXA, V299, P1, DOI DOI 10.11646/ZOOTAXA.299.1.1; Grohmann PA, 2011, BIOTA NEOTROP, V11, P193, DOI 10.1590/S1676-06032011000200020; Haddad MA, 2000, AN 5 S EC BRAS CONS, V2, P101; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; HARTLAUB C, 1905, ZOOLOGISCHE JB S, V6, P497; HARTLAUB C, 1901, ZOOLOGISCHE JB ABTEI, V14, P349; He J, 2014, J MAR BIOL ASSOC UK, P1; Hincks T., 1853, ANN MAG NAT HIST, V11, P178; Hincks T., 1868, HIST BRIT HYDROID ZO, V1; Hirohito ES, 1995, THE HYDROIDS OF SAGA; Jaderholm E, 1917, REDOGORELSE NORRKOPI, V1916-1917, P1; Jaderholm E., 1905, WISSENSCHAFTLICHE ER, V5, P1; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Johnston G., 1847, HIST BRIT ZOOPHYTES, V1; Jolliffe I.T., 2002, SPRINGER SERIES IN S; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kelmo F, 2003, REV BIOL TROP, V51, P123; Ki JS, 2008, ICES J MAR SCI, V65, P443, DOI 10.1093/icesjms/fsn018; Kramp P. L., 1935, Danmarks Fauna, V41, P1; Lamouroux JVF., 1824, VOYAGE AUTOUR MONDE, P603; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Leloup E., 1935, Mem Mus Hist Nat Belg (2), V2, P1; LELOUP E, 1974, SARSIA, P1; Levinsen G.M.R., 1893, VIDENSKABELIGE MEDDE, V4, P215; Lindner A, 2002, J MAR BIOL ASSOC UK, V82, P541, DOI 10.1017/S0025315402005866; Lindner A, 2011, ZOOTAXA, P23; Gappa JL, 2007, POLAR BIOL, V30, P679, DOI 10.1007/s00300-006-0225-3; MacGillivray J, 1842, ANN MAG NAT HIST, V9, P462, DOI [10.1080/03745484209445365, DOI 10.1080/03745484209445365]; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Marques Antonio C., 2003, Biota Neotrop., V3, P1, DOI 10.1590/S1676-06032003000200007; Marques Antonio Carlos, 1996, Journal of Comparative Biology, V1, P153; Martinez DE, 2010, MOL PHYLOGENET EVOL, V57, P403, DOI 10.1016/j.ympev.2010.06.016; Matejusova I, 2001, INT J PARASITOL, V31, P738, DOI 10.1016/S0020-7519(01)00176-X; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miglietta MP, 2009, ZOOL SCR, V38, P403, DOI 10.1111/j.1463-6409.2008.00376.x; Migotto A.E., 1996, Zoologische Verhandelingen (Leiden), V306, P1; Migotto Alvaro E., 2002, Biota Neotrop., V2, P1, DOI 10.1590/S1676-06032002000100010; Millard N.A.H., 1971, P396; Millard NAH, 1975, ANN S AFR MUS, V68, P1; Milstein A., 1976, Dusenia, V9, P77; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; Miranda TP, 2011, BIOTA NEOTROP, V11, P331, DOI 10.1590/S1676-06032011000300027; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Moura CJ, 2012, ZOOL SCR, V41, P79, DOI 10.1111/j.1463-6409.2011.00503.x; Moura CJ, 2011, ZOOL SCR, V40, P520, DOI 10.1111/j.1463-6409.2011.00489.x; Naumov DV, 1969, HYDROIDS AND HYDROME; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; Nogueira C.C., 1997, P 6 INT C COEL BIOL, V1995, P365; Nutting CC, 1915, AMERICAN HYDROIDS PA; Oliveira OMP, 2003, THESIS; Oliveira Otto M.P., 2007, Check List, V3, P21; Ostman C., 1999, Zoosystematica Rossica Supplement, V1, P17; OSTMAN C, 1982, ZOOL SCR, V11, P227, DOI 10.1111/j.1463-6409.1982.tb00536.x; De Oliveira OMP, 2011, MAR BIOL RES, V7, P786, DOI 10.1080/17451000.2011.578647; Pena Cantero AL, 2002, ZOOLOGISCHE VERHANDE, V337, P1, DOI DOI 10.1007/S00300-004-0654-9; Cantero ALP, 2010, POLAR BIOL, V33, P41, DOI 10.1007/s00300-009-0683-5; RALPH PATRICIA M., 1957, TRANS ROY SOC NEW ZEALAND, V84, P811; Ritchie J., 1907, T ROY SOC EDINBURGH, V45, P519, DOI DOI 10.1017/S0080456800022821; Rosso S, 1997, PROC 6TH INTL CONF C, V1995, P145; Schierwater B, 2000, SCI MAR, V64, P117, DOI 10.3989/scimar.2000.64s1117; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Schuchert P, 2005, MOL PHYLOGENET EVOL, V36, P194, DOI 10.1016/j.ympev.2005.03.021; Schuchert Peter, 2001, Meddelelser om Gronland Bioscience, V53, P1; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seo M, 2003, THESIS; Silveira M, 2011, BIOTA NEOTROP, V11, P173, DOI 10.1590/S1676-06032011000100017; Stechow E., 1919, Zoologische Jahrbuecher (Systematik), V42; Stechow E., 1924, Zoologischer Anzeiger Leipzig, V59, P57; Stechow E., 1914, ZOOL ANZ, V45, P120; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; Vannucci M., 1951, Boletim do Instituto Paulista de Oceanografia, V2, P69; Vannucci M., 1949, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo Zoologica, V14, P219; Vannucci M., 1951, Boletim do Instituto Paulista de Oceanografia, V2, P105; Vannucci M, 1954, BOLM INST OCEANOGR, V5, P95; Vannucci Mendes M., 1946, ARQUIVOS ZOOLOGIA ES, V4, P535; Vervoort W., 1993, Zoologische Mededelingen (Leiden), V67, P537; Vervoort W., 1946, Fauna van Nederland Leiden, V14, P1; Vervoort W., 1972, Zoologische Verh Leiden, VNo. 120, P1; Vervoort W., 1949, Zoologische Mededeelingen Leiden, V30, P133; VERVOORT W, 2003, NIWA BIODIVERSITY ME, V119; VOGLER AP, 1994, MOL BIOL EVOL, V11, P393; Watson J.E., 2005, MARINE FLORA FAUNA E, P495; Wei NWV, 2006, ZOOL STUD, V45, P404; Zamponi MO, 1998, RUSSIAN J MARINE BIO, V24, P7; Zhou KL, 2013, J MAR BIOL ASSOC UK, V93, P2075, DOI 10.1017/S0025315413000969	155	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117553	10.1371/journal.pone.0117553	http://dx.doi.org/10.1371/journal.pone.0117553			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723572	Green Published, gold, Green Submitted			2022-12-26	WOS:000350251200034
J	Gui, Y; Yeganeh, M; Donates, YC; Tobelaim, WS; Chababi, W; Mayhue, M; Yoshimura, A; Ramanathan, S; Saucier, C; Ilangumaran, S				Gui, Y.; Yeganeh, M.; Donates, Y-C; Tobelaim, W-S; Chababi, W.; Mayhue, M.; Yoshimura, A.; Ramanathan, S.; Saucier, C.; Ilangumaran, S.			Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma	ONCOGENE			English	Article							LIVER-REGENERATION; GROWTH-FACTOR; DOWN-REGULATION; TARGETING MET; TPR-MET; C-CBL; CANCER; INHIBITORS; PATHWAY; UBIQUITINATION	Suppressor of cytokine signaling 1 (SOCS1) is considered as a tumor suppressor protein in hepatocellular carcinoma (HCC), but the underlying mechanisms remain unclear. Previously, we have shown that SOCS1-deficient hepatocytes displayed increased responsiveness to hepatocyte growth factor (HGF) due to enhanced signaling via the MET receptor tyrosine kinase. As aberrant MET activation occurs in many tumors including HCC, here we elucidated the mechanisms of SOCS1-mediated regulation. SOCS1 attenuated HGF-induced proliferation of human and mouse HCC cell lines and their growth as tumors in NOD. scid. gamma mice. Tumors formed by SOCS1 expressing HCC cells showed significantly reduced MET expression, indicating that SOCS1 not only attenuates MET signaling but also regulates MET expression. Mechanistically, SOCS1 interacted with MET via the Src homology 2 domain and this interaction was promoted by MET tyrosine kinase activity. The SOCS1-mediated reduction in MET expression does not require the juxtamembrane Y1003 residue implicated in Cbl-mediated downmodulation. Moreover, the proteasome inhibitor MG-132, but not the inhibitors of lysosomal degradation bafilomycin and chloroquine, reversed the SOCS1-mediated reduction in MET expression, indicating that this process is distinct from Cbl-mediated downmodulation. Accordingly, SOCS1 promoted polyubiquitination of MET via K48-dependent but not K63-mediated ubiquitin chain elongation. Furthermore, siRNA-mediated downmodulation of Cbl did not abolish SOCS1-mediated reduction in MET expression in HCC cells. SOCS1-dependent ubiquitination of endogenous MET receptor occurred rapidly following HGF stimulation in HCC cells, leading to proteasomal degradation of phosphorylated MET receptor. These findings indicate that SOCS1 mediates its tumor suppressor functions, at least partly, by binding to MET and interfering with downstream signaling pathways as well as by promoting the turnover of the activated MET receptor. We propose that loss of this control mechanism due to epigenetic repression of SOCS1 could contribute to oncogenic MET signaling in HCC and other cancers, and that MET inhibitors might be useful in treating these patients.	[Gui, Y.; Yeganeh, M.; Donates, Y-C; Mayhue, M.; Ramanathan, S.; Ilangumaran, S.] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Fac Med & Hlth Sci, Immunol Div,Dept Pediat,Ctr Hosp, Sherbrooke, PQ J1H 5N4, Canada; [Tobelaim, W-S; Chababi, W.; Saucier, C.] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Fac Med & Hlth Sci, Dept Anat & Cell Biol,Ctr Hosp, Sherbrooke, PQ J1H 5N4, Canada; [Yoshimura, A.] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	University of Sherbrooke; University of Sherbrooke; Keio University	Ilangumaran, S (corresponding author), Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Fac Med & Hlth Sci, Immunol Div,Dept Pediat,Ctr Hosp, 3001 North 12th Ave, Sherbrooke, PQ J1H 5N4, Canada.	Subburaj.Ilangumaran@Usherbrooke.ca	Yoshimura, Akihiko/K-5515-2013; Saucier, Caroline/Q-9250-2019	Saucier, Caroline/0000-0001-7678-9886; Ilangumaran, Subburaj/0000-0002-7563-576X	Cancer Research Society, Montreal, Canada; Centre de Recherche Clinique du CHUS	Cancer Research Society, Montreal, Canada; Centre de Recherche Clinique du CHUS	We thank Dr Morag Park for generously providing CSF-MET and Tpr-MET expression plasmids. Centre de Recherche Clinique du CHUS is an FRSQ-funded research center. This work was supported by the Cancer Research Society, Montreal, Canada (SI and CS).	Abella JV, 2010, J BIOL CHEM, V285, P24956, DOI 10.1074/jbc.M110.127985; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; De Sepulveda P, 1999, EMBO J, V18, P904; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fukushima N, 2003, BRIT J CANCER, V89, P338, DOI 10.1038/sj.bjc.6601039; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Grassian AR, 2011, J BIOL CHEM, V286, P79, DOI 10.1074/jbc.M110.169821; Gui YR, 2011, J HEPATOL, V55, P1300, DOI 10.1016/j.jhep.2011.03.027; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Ilangumaran S, 2002, J IMMUNOL, V169, P5010, DOI 10.4049/jimmunol.169.9.5010; Inagaki-Ohara Kyoko, 2013, JAKSTAT, V2, pe24053, DOI 10.4161/jkst.24053; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Karamouzis MV, 2009, LANCET ONCOL, V10, P709, DOI 10.1016/S1470-2045(09)70137-8; Kazi JU, 2014, CELL MOL LIFE SCI, V71, P3297, DOI 10.1007/s00018-014-1619-y; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Kobayashi N, 2012, ONCOTARGET, V3, P1455; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Mak HHL, 2007, ONCOGENE, V26, P7213, DOI 10.1038/sj.onc.1210522; Okumura F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00010; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Seki E, 2008, J HEPATOL, V48, P237, DOI 10.1016/j.jhep.2007.08.020; Shakya R, 2013, CANCER RES, V73, P885, DOI 10.1158/0008-5472.CAN-12-1880; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshida T, 2004, J EXP MED, V199, P1701, DOI 10.1084/jem.20031675; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023936; ZHU H, 1994, CELL GROWTH DIFFER, V5, P359	46	33	33	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2015	34	46					5718	5728		10.1038/onc.2015.20	http://dx.doi.org/10.1038/onc.2015.20			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GC	25728680				2022-12-26	WOS:000364594600004
J	Deng, XD; Walker, RG; Morris, J; Davidson, WS; Thompson, TB				Deng, Xiaodi; Walker, Ryan G.; Morris, Jamie; Davidson, W. Sean; Thompson, Thomas B.			Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; CROSS-LINKING; EXCHANGEABLE APOLIPOPROTEINS; CRYSTAL-STRUCTURE; N-TERMINI; DOMAIN; CONFORMATION; REVEALS; HDL; SCATTERING	Apolipoprotein (apo)A-IV is a lipid emulsifying protein linked to a range of protective roles in obesity, diabetes, and cardiovascular disease. It exists in several states in plasma including lipid-bound in HDL and chylomicrons and as monomeric and dimeric lipid-free/poor forms. Our recent x-ray crystal structure of the central domain of apoA-IV shows that it adopts an elongated helical structure that dimerizes via two long reciprocating helices. A striking feature is the alignment of conserved proline residues across the dimer interface. We speculated that this plays important roles in the structure of the lipid-free protein and its ability to bind lipid. Here we show that the systematic conversion of these prolines to alanine increased the thermodynamic stability of apoA-IV and its propensity to oligomerize. Despite the structural stabilization, we noted an increase in the ability to bind and reorganize lipids and to promote cholesterol efflux from cells. The novel properties of these mutants allowed us to isolate the first trimeric form of an exchangeable apolipoprotein and characterize it by small-angle x-ray scattering and chemical cross-linking. The results suggest that the reciprocating helix interaction is a common feature of all apoA-IV oligomers. We propose a model of how self-association of apoA-IV can result in spherical lipoprotein particles, a model that may have broader applications to other exchangeable apolipoprotein family members.	[Deng, Xiaodi; Walker, Ryan G.; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA; [Morris, Jamie; Davidson, W. Sean; Thompson, Thomas B.] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Davidson, WS (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, 2120 Galbraith Rd, Cincinnati, OH 45237 USA.	Sean.Davidson@UC.edu; Tom.Thompson@uc.edu	Regan, Clinton/E-6250-2012	Thompson, Thomas/0000-0002-7041-5047; Davidson, William/0000-0003-2756-2989; Walker, Ryan/0000-0001-6160-8026	National Institutes of Health [GM098458, HL67093]; National Institutes of Health Training Grant [T32 HL007382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067093, T32HL007382, R01HL082734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants GM098458 (to T. B. T. and W. S. D.) and HL67093 (to W. S. D.) and by National Institutes of Health Training Grant T32 HL007382 (to X. D.).	Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Deng XD, 2013, J BIOL CHEM, V288, P4854, DOI 10.1074/jbc.M112.436709; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; ELSHOURBAGY NA, 1986, J BIOL CHEM, V261, P1998; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HIGUCHI K, 1986, FEBS LETT, V207, P23, DOI 10.1016/0014-5793(86)80006-0; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koppaka V, 1999, J BIOL CHEM, V274, P14541, DOI 10.1074/jbc.274.21.14541; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li XM, 2014, J BIOL CHEM, V289, P2396, DOI 10.1074/jbc.M113.511766; Luo B, 2008, AM J NEPHROL, V28, P347, DOI 10.1159/000111828; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Miller M, 1998, ARTERIOSCL THROM VAS, V18, P1242, DOI 10.1161/01.ATV.18.8.1242; Mitani A, 2011, J ATHEROSCLER THROMB, V18, P531, DOI 10.5551/jat.7377; Murphy CL, 2004, AM J KIDNEY DIS, V44, P1103, DOI 10.1053/j.ajkd.2004.08.033; Oikawa S, 1997, J AM SOC NEPHROL, V8, P820; Pearson K, 2005, J BIOL CHEM, V280, P38576, DOI 10.1074/jbc.M506802200; Pearson K, 2004, BIOCHEMISTRY-US, V43, P10719, DOI 10.1021/bi048978m; Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1992, J LIPID RES, V33, P141; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tso P, 2004, PHYSIOL BEHAV, V83, P631, DOI 10.1016/j.physbeh.2004.07.032; Tubb MR, 2008, J BIOL CHEM, V283, P17314, DOI 10.1074/jbc.M800036200; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; UTERMANN G, 1984, EUR J BIOCHEM, V144, P325, DOI 10.1111/j.1432-1033.1984.tb08467.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Walker RG, 2014, J BIOL CHEM, V289, P5596, DOI 10.1074/jbc.M113.541037; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	43	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10689	10702		10.1074/jbc.M115.637058	http://dx.doi.org/10.1074/jbc.M115.637058			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25733664	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000353404500012
J	Dunn, TN; Akiyama, T; Lee, HW; Kim, JB; Knotts, TA; Smith, SR; Sears, DD; Carstens, E; Adams, SH				Dunn, Tamara N.; Akiyama, Tasuku; Lee, Hyun Woo; Kim, Jae Bum; Knotts, Trina A.; Smith, Steven R.; Sears, Dorothy D.; Carstens, Earl; Adams, Sean H.			Evaluation of the Synuclein-gamma (SNCG) Gene as a PPAR gamma Target in Murine Adipocytes, Dorsal Root Ganglia Somatosensory Neurons, and Human Adipose Tissue	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ATTENUATES TACTILE ALLODYNIA; DIET-INDUCED OBESITY; PARKINSONS-DISEASE; CHOLESTEROL EFFLUX; INSULIN; PIOGLITAZONE; ALPHA; EXPRESSION; LEPTIN	Recent evidence in adipocytes points to a role for synuclein-gamma in metabolism and lipid droplet dynamics, but interestingly this factor is also robustly expressed in peripheral neurons. Specific regulation of the synuclein-gamma gene (Sncg) by PPAR gamma requires further evaluation, especially in peripheral neurons, prompting us to test if Sncg is a bona fide PPAR gamma target in murine adipocytes and peripheral somatosensory neurons derived from the dorsal root ganglia (DRG). Sncg mRNA was decreased in 3T3-L1 adipocytes (similar to 68%) by rosiglitazone, and this effect was diminished by the PPAR gamma. antagonist T0070907. Chromatin immunoprecipitation experiments confirmed PPAR gamma protein binding at two promoter sequences of Sncg during 3T3-L1 adipogenesis. Rosiglitazone did not affect Sncg mRNA expression in murine cultured DRG neurons. In subcutaneous human WAT samples from two cohorts treated with pioglitazone (> 11 wks), SNCG mRNA expression was reduced, albeit highly variable and most evident in type 2 diabetes. Leptin (Lep) expression, thought to be coordinately-regulated with Sncg based on correlations in human adipose tissue, was also reduced in 3T3-L1 adipocytes by rosiglitazone. However, Lep was unaffected by PPAR. antagonist, and the LXR agonist T0901317 significantly reduced Lep expression (similar to 64%) while not impacting Sncg. The results support the concept that synuclein-gamma shares some, but not all, gene regulators with leptin and is a PPAR gamma target in adipocytes but not DRG neurons. Regulation of synuclein-gamma by cues such as PPAR gamma agonism in adipocytes is logical based on recent evidence for an important role for synuclein-gamma in the maintenance and dynamics of adipocyte lipid droplets.	[Dunn, Tamara N.; Adams, Sean H.] Univ Calif Davis, Grad Grp Nutr Biol, Davis, CA 95616 USA; [Dunn, Tamara N.; Knotts, Trina A.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Akiyama, Tasuku; Carstens, Earl] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Lee, Hyun Woo; Kim, Jae Bum] Seoul Natl Univ, Natl Creat Res Initiat Ctr Adipose Tissue Remodel, Inst Mol Biol & Genet, Dept Biol Sci, Seoul, South Korea; [Knotts, Trina A.; Adams, Sean H.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Knotts, Trina A.; Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Smith, Steven R.] Florida Hosp, Sanford Burnham Med Res Inst, Orlando, FL USA; [Smith, Steven R.] Florida Hosp, Translat Res Inst, Orlando, FL USA; [Sears, Dorothy D.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Seoul National University (SNU); University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Adventist Health Services; AdventHealth; Sanford Burnham Prebys Medical Discovery Institute; Adventist Health Services; AdventHealth; University of California System; University of California San Diego	Adams, SH (corresponding author), Univ Calif Davis, Grad Grp Nutr Biol, Davis, CA 95616 USA.	shadams@uams.edu	Song, Minsun/I-5701-2015; Smith, Steven/HDM-9496-2022; Sears, Dorothy D/AHE-5524-2022; ADAMS, SEAN/N-9262-2018; Akiyama, Tasuku/AFN-8329-2022	Sears, Dorothy D/0000-0002-9260-3540; ADAMS, SEAN/0000-0002-9515-2319; KIM, Jae Bum/0000-0003-2337-6935; Akiyama, Tasuku/0000-0001-7155-4228; Smith, Steven/0000-0002-5098-8147	intramural USDA-ARS Projects [530651530-016-00D, 5306-51530-019-00D]; Vitamin Cases Consumer Settlement Fund [CHNR08-801]; Takeda Pharmaceuticals North America; Korean government (Ministry of Education, Science, and Technology) [2012-0001241]	intramural USDA-ARS Projects; Vitamin Cases Consumer Settlement Fund; Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Korean government (Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was funded in part by the following: intramural USDA-ARS Projects [530651530-016-00D] and [5306-51530-019-00D] (S.H.A.), the Vitamin Cases Consumer Settlement Fund [CHNR08-801] (to S.H.A.), an unrestricted grant from Takeda Pharmaceuticals North America (to S.R.S.), and a grant from the Korean government (Ministry of Education, Science, and Technology [2012-0001241], to J.B.K.). The USDA is an equal opportunity provider and employer.	Akiyama T, 2012, NEUROSCIENCE, V226, P305, DOI 10.1016/j.neuroscience.2012.09.019; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Bogacka I, 2004, DIABETES CARE, V27, P1660, DOI 10.2337/diacare.27.7.1660; Buchman VL, 1998, NAT NEUROSCI, V1, P101, DOI 10.1038/349; Buchman VL, 1998, J NEUROSCI, V18, P9335; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carta AR, 2011, NEUROSCIENCE, V194, P250, DOI 10.1016/j.neuroscience.2011.07.046; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Davidson EP, 2010, DIABETES-METAB RES, V26, P306, DOI 10.1002/dmrr.1088; de Lartigue G, 2011, AM J PHYSIOL-ENDOC M, V301, pE187, DOI 10.1152/ajpendo.00056.2011; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Dunn TN, 2014, ADV NUTR, V5, P386, DOI 10.3945/an.113.005439; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Guschina I, 2011, LIPIDS, V46, P121, DOI 10.1007/s11745-010-3486-0; Hammarstedt A, 2005, PROSTAG LEUKOTR ESS, V73, P65, DOI 10.1016/j.plefa.2005.04.008; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwai S, 2008, DRUG DISCOV THER, V2, P353; Jia TL, 1999, CANCER RES, V59, P742; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Knotts TA, 2009, PPAR RES, V2009, DOI 10.1155/2009/867678; Lavedan C, 1998, GENOMICS, V54, P173, DOI 10.1006/geno.1998.5556; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lee YS, 2007, MOL CELL BIOL, V27, P438, DOI 10.1128/MCB.00490-06; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Liu C, 2014, CELL METAB, V19, P722, DOI 10.1016/j.cmet.2014.01.021; Lu AP, 2002, J BIOL CHEM, V277, P31364, DOI 10.1074/jbc.M201060200; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Maeda T, 2008, J PHARMACOL SCI, V108, P341, DOI 10.1254/jphs.08207FP; Millership S, 2012, P NATL ACAD SCI USA, V109, P20943, DOI 10.1073/pnas.1210022110; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Oort PJ, 2008, J NUTR, V138, P841, DOI 10.1093/jn/138.5.841; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Paulino G, 2009, AM J PHYSIOL-ENDOC M, V296, pE898, DOI 10.1152/ajpendo.90796.2008; Petrofsky J, 2005, MED SCI MONITOR, V11, pCR562; Petrofsky JS, 2005, MED SCI MONITOR, V11, pPI43; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Raybould HE, 2008, J PHYSIOL BIOCHEM, V64, P349, DOI 10.1007/BF03174091; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Song CK, 2009, AM J PHYSIOL-REG I, V296, pR501, DOI 10.1152/ajpregu.90786.2008; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Strand DW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.99; Surgucheva IG, 2003, ARCH BIOCHEM BIOPHYS, V410, P167, DOI 10.1016/S0003-9861(02)00664-1; Surgucheva I, 2008, J MOL NEUROSCI, V35, P267, DOI 10.1007/s12031-008-9074-6; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tung YCL, 2008, J NEUROSCI, V28, P12419, DOI 10.1523/JNEUROSCI.3412-08.2008; van Baak M A, 2001, Obes Rev, V2, P3; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Vaughan CH, 2011, BRAIN RES, V1411, P17, DOI 10.1016/j.brainres.2011.07.003; Wellhoener P, 2000, J CLIN ENDOCR METAB, V85, P1267, DOI 10.1210/jc.85.3.1267; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-283	64	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0115830	10.1371/journal.pone.0115830	http://dx.doi.org/10.1371/journal.pone.0115830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756178	gold, Green Published			2022-12-26	WOS:000351275700003
J	Chen, WY; Cui, YH; Zheng, SH; Huang, JH; Li, P; Simoncini, T; Zhang, YF; Fu, XD				Chen, Weiyu; Cui, Yuhong; Zheng, Shuhui; Huang, Jinghe; Li, Ping; Simoncini, Tommaso; Zhang, Yongfu; Fu, Xiaodong			2-Methoxyestradiol Induces Vasodilation by Stimulating NO Release via PPAR gamma/PI3K/Akt Pathway	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ESTRADIOL METABOLITES; POSTMENOPAUSAL WOMEN; HYDROGEN-SULFIDE; CANCER CELLS; ESTROGEN; 17-BETA-ESTRADIOL; INHIBITION; DEFICIENCY; ACTIVATION	The endogenous estradiol metabolite 2-methoxyestradiol (2-ME) reduces atherosclerotic lesion formation, while the underlying mechanisms remain obscure. In this work, we investigated the vasodilatory effect of 2-ME and the role of nitric oxide (NO) involved. In vivo studies using noninvasive tail-cuff methods showed that 2-ME decreased blood pressure in Sprague Dawley rats. Furthermore, in vitro studies showed that cumulative addition of 2-ME to the aorta caused a dose- and endothelium-dependent vasodilation. This effect was unaffected by the pretreatment with the pure estrogen receptor antagonist ICI 182,780, but was largely impaired by endothelial nitric oxide synthase ( eNOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) or by phosphoinositide 3-kinase (PI3K) inhibitor wortmannin (WM). Moreover, 2-ME (10(-7) (similar to) 10(-5) M) enhanced phosphorylation of Akt and eNOS and promoted NO release from cultured human umbilical endothelial cells (HUVECs). These effects were blocked by PI3K inhibitor WM, or by the transfection with Akt specific siRNA, indicating that endothelial Akt/eNOS/NO cascade plays a crucial role in 2-ME-induced vasodilation. The peroxisome proliferator-activated receptor. (PPAR.) mRNA and protein expression were detected in HUVECs and the antagonist GW9662 or the transfection with specific PPAR. siRNA inhibited 2-ME-induced eNOS and Akt phosphorylation, leading to the impairment of NO production and vasodilation. In conclusion, 2-ME induces vasodilation by stimulating NO release. These actions may be mediated by PPAR. and the subsequent activation of Akt/eNOS cascade in vascular endothelial cells.	[Chen, Weiyu; Cui, Yuhong; Li, Ping; Fu, Xiaodong] Guangzhou Med Univ, Sch Basic Sci, Guangzhou 510182, Guangdong, Peoples R China; [Chen, Weiyu; Huang, Jinghe] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou 510080, Guangdong, Peoples R China; [Zheng, Shuhui] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China; [Simoncini, Tommaso] Univ Pisa, Dept Reprod Med & Child Dev, Mol & Cellular Gynecol Endocrinol Lab, I-56100 Pisa, Italy; [Zhang, Yongfu] Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510180, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; University of Pisa	Zhang, YF (corresponding author), Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510180, Guangdong, Peoples R China.	zyongfu@126.com; fuxiaodong27@hotmail.com	Simoncini, Tommaso/AAC-1879-2019	Simoncini, Tommaso/0000-0002-2971-0079; Fu, Xiaodong/0000-0003-2754-8976	National Natural Science Foundation [81270669]; Foundation of Guangzhou Pearl River Science New Star [2011J2200094]; Guangdong Natural Science Foundation [S2013010016548]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation of Guangzhou Pearl River Science New Star; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation (To X.D. Fu., No. 81270669), by the Foundation of Guangzhou Pearl River Science New Star (To X.D. Fu., No: 2011J2200094) and by the Guangdong Natural Science Foundation (To X.D. Fu., No: S2013010016548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Balakumar P, 2012, BRIT J PHARMACOL, V166, P1981, DOI 10.1111/j.1476-5381.2012.01938.x; Barchiesi F, 2006, CIRC RES, V99, P266, DOI 10.1161/01.RES.0000233318.85181.2e; Barchiesi F, 2010, HYPERTENSION, V56, P964, DOI 10.1161/HYPERTENSIONAHA.110.152298; Bonacasa B, 2008, MATURITAS, V61, P310, DOI 10.1016/j.maturitas.2008.09.028; Bourghardt J, 2007, ENDOCRINOLOGY, V148, P4128, DOI 10.1210/en.2007-0259; Dubey RK, 2009, TRENDS ENDOCRIN MET, V20, P374, DOI 10.1016/j.tem.2009.04.007; Dubey RK, 2004, J PHARMACOL EXP THER, V308, P403, DOI 10.1124/jpet.103.058057; Fenoy FJ, 2010, NITRIC OXIDE-BIOL CH, V23, P12, DOI 10.1016/j.niox.2010.03.002; Genazzani AR, 2013, NAT REV ENDOCRINOL, V9, P5, DOI 10.1038/nrendo.2012.228; Gui Y, 2008, AM J PHYSIOL-HEART C, V295, pH1935, DOI 10.1152/ajpheart.00723.2008; Lin HL, 2007, INT J CANCER, V121, P2547, DOI 10.1002/ijc.22963; Hill BJF, 2010, CAN J PHYSIOL PHARM, V88, P147, DOI 10.1139/Y09-120; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kaufmann BA, 2010, ARTERIOSCL THROM VAS, V30, P54, DOI 10.1161/ATVBAHA.109.196386; Kublickiene K, 2008, J CLIN ENDOCR METAB, V93, P1874, DOI 10.1210/jc.2007-2651; Liao WY, 2013, MOL BIOL REP, V40, P6729, DOI 10.1007/s11033-013-2788-8; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Salama S, 2011, INT J RADIAT ONCOL, V80, P231, DOI 10.1016/j.ijrobp.2010.10.080; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Seeger H, 1999, LIFE SCI, V65, pPL167, DOI 10.1016/S0024-3205(99)00383-5; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wang GD, 2013, ONCOL REP, V30, P357, DOI 10.3892/or.2013.2469; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yu ZR, 2014, CHEM COMMUN, V50, P2728, DOI 10.1039/c3cc48152b; Zhou KW, 2013, MOL HUM REPROD, V19, P169, DOI 10.1093/molehr/gas044	29	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118902	10.1371/journal.pone.0118902	http://dx.doi.org/10.1371/journal.pone.0118902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748432	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400029
J	Degen, CV; Bishu, K; Zakeri, R; Ogut, O; Redfield, MM; Brozovich, FV				Degen, Chantal V.; Bishu, Kalkidan; Zakeri, Rosita; Ogut, Ozgur; Redfield, Margaret M.; Brozovich, Frank V.			The Emperor's New Clothes: PDE5 and the Heart	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; PULMONARY ARTERIAL-HYPERTENSION; PROTEIN-KINASE I; SMOOTH-MUSCLE; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; CHRONIC INHIBITION; CLINICAL STATUS; FAILURE; SILDENAFIL	Phosphodiesterase-5 (PDE5) is highly expressed in the pulmonary vasculature, but its expression in the myocardium is controversial. Cyclic guanosine monophosphate (cGMP) activates protein kinase G (PKG), which has been hypothesized to blunt cardiac hypertrophy and negative remodeling in heart failure. Although PDE5 has been suggested to play a significant role in the breakdown of cGMP in cardiomyocytes and hence PKG regulation in the myocardium, the RELAX trial, which tested effect of PDE5 inhibition on exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF) failed to show a beneficial effect. These results highlight the controversy regarding the role and expression of PDE5 in the healthy and failing heart. This study used one-and two-dimensional electrophoresis and Western blotting to examine PDE5 expression in mouse (before and after trans-aortic constriction), dog (control and HFpEF) as well as human (healthy and failing) heart. We were unable to detect PDE5 in any cardiac tissue lysate, whereas PDE5 was present in the murine and bovine lung samples used as positive controls. These results indicate that if PDE5 is expressed in cardiac tissue, it is present in very low quantities, as PDE5 was not detected in either humans or any model of heart failure examined. Therefore in cardiac muscle, it is unlikely that PDE5 is involved the regulation of cGMP-PKG signaling, and hence PDE5 does not represent a suitable drug target for the treatment of cardiac hypertrophy. These results highlight the importance of rigorous investigation prior to clinical trial design.	[Degen, Chantal V.; Bishu, Kalkidan; Zakeri, Rosita; Ogut, Ozgur; Redfield, Margaret M.; Brozovich, Frank V.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Brozovich, FV (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, Rochester, MN 55905 USA.	brozovich.frank@mayo.edu		Zakeri, Rosita/0000-0002-4225-3693	Mayo Foundation for Medical Research and Education; National Institutes of Health [R01 HL105418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105418, U10HL110262] Funding Source: NIH RePORTER	Mayo Foundation for Medical Research and Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the Mayo Foundation for Medical Research and Education (FVB) and the National Institutes of Health, R01 HL105418 (MMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MJ, 2013, CIRCULATION, V127, P1200, DOI 10.1161/CIRCULATIONAHA.112.000056; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Bishu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081325; Bishu K, 2011, CIRCULATION, V124, P2882, DOI 10.1161/CIRCULATIONAHA.111.048520; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Chen HH, 2002, J CARD FAIL, V8, P279, DOI 10.1054/jcaf.2002.128871; Corbin J, 2003, CURR MED RES OPIN, V19, P747, DOI 10.1185/030079903125002522; Corbin JD, 2005, BIOCHEM BIOPH RES CO, V334, P930, DOI 10.1016/j.bbrc.2005.06.183; EGHBALI M, 1988, J MOL CELL CARDIOL, V20, P267, DOI 10.1016/S0022-2828(88)80059-2; FRANCIS GS, 1990, FASEB J, V4, P3068, DOI 10.1096/fasebj.4.13.2210153; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353; Lu ZB, 2010, CIRCULATION, V121, P1474, DOI 10.1161/CIRCULATIONAHA.109.906818; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Mohammed SF, 2012, CARDIOVASC PATHOL, V21, P188, DOI 10.1016/j.carpath.2011.05.002; Mohammed SF, 2010, CIRCULATION, V122, P370, DOI 10.1161/CIRCULATIONAHA.109.915215; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; Senzaki H, 2001, FASEB J, V15, P1718, DOI 10.1096/fj.00-0538com; Shan XY, 2012, CIRC-HEART FAIL, V5, P79, DOI 10.1161/CIRCHEARTFAILURE.111.961706; Shapiro BP, 2008, CIRCULATION, V118, P1002, DOI 10.1161/CIRCULATIONAHA.108.777326; Shapiro BP, 2007, HYPERTENSION, V50, P503, DOI 10.1161/HYPERTENSIONAHA.107.090092; Sitbon O, 1998, EUR RESPIR J, V12, P265, DOI 10.1183/09031936.98.12020265; Takimoto E, 2005, CIRC RES, V96, P100, DOI 10.1161/01.RES.0000152262.22968.72; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2007, CIRCULATION, V115, P2159, DOI 10.1161/CIRCULATIONAHA.106.643536; Vandeput F, 2009, J PHARMACOL EXP THER, V330, P884, DOI 10.1124/jpet.109.154468; Wallis RM, 1999, AM J CARDIOL, V83, p3C; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009; Zhang M, 2008, CELL SIGNAL, V20, P2231, DOI 10.1016/j.cellsig.2008.08.012	43	25	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118664	10.1371/journal.pone.0118664	http://dx.doi.org/10.1371/journal.pone.0118664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747598	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400024
J	Ling, AL; Robertson, CE; Harris, JK; Frank, DN; Kotter, CV; Stevens, MJ; Pace, NR; Hernandez, MT				Ling, Alison L.; Robertson, Charles E.; Harris, J. Kirk; Frank, Daniel N.; Kotter, Cassandra V.; Stevens, Mark J.; Pace, Norman R.; Hernandez, Mark T.			High-Resolution Microbial Community Succession of Microbially Induced Concrete Corrosion in Working Sanitary Manholes	PLOS ONE			English	Article							CORRODING CONCRETE; OXIDIZING BACTERIA; SEWER SYSTEMS; DIVERSITY; BIODETERIORATION; BIOFILMS; PIPE	Microbially-induced concrete corrosion in headspaces threatens wastewater infrastructure worldwide. Models for predicting corrosion rates in sewer pipe networks rely largely on information from culture-based investigations. In this study, the succession of microbes associated with corroding concrete was characterized over a one-year monitoring campaign using rRNA sequence-based phylogenetic methods. New concrete specimens were exposed in two highly corrosive manholes (high concentrations of hydrogen sulfide and carbon dioxide gas) on the Colorado Front Range for up to a year. Community succession on corroding surfaces was assessed using Illumina MiSeq sequencing of 16S bacterial rRNA amplicons and Sanger sequencing of 16S universal rRNA clones. Microbial communities associated with corrosion fronts presented distinct succession patterns which converged to markedly low a-diversity levels (< 10 taxa) in conjunction with decreasing pH. The microbial community succession pattern observed in this study agreed with culture-based models that implicate acidophilic sulfur-oxidizer Acidithiobacillus spp. in advanced communities, with two notable exceptions. Early communities exposed to alkaline surface pH presented relatively high a-diversity, including heterotrophic, nitrogen-fixing, and sulfur-oxidizing genera, and one community exposed to neutral surface pH presented a diverse transition community comprised of less than 20% sulfur-oxidizers.	[Ling, Alison L.; Hernandez, Mark T.] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Harris, J. Kirk; Stevens, Mark J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Frank, Daniel N.; Kotter, Cassandra V.] Univ Colorado, Sch Med, Dept Infect Dis, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hernandez, MT (corresponding author), Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA.	mark.hernandez@colorado.edu		Ling, Alison/0000-0002-5461-1945; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202	Department of Energy Office of Science Graduate Research Fellowship; Alfred P. Sloan Foundation	Department of Energy Office of Science Graduate Research Fellowship; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Alison Ling was supported by the Department of Energy Office of Science Graduate Research Fellowship. Sequencing was further supported by an Alfred P. Sloan Foundation Grant to Norman Pace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALNOR D, 1994, CLIN INFECT DIS, V18, P914, DOI 10.1093/clinids/18.6.914; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 2013, R LANG ENV STAT COMP; ASCE, 2013, 2013 REP CARD AM INF; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Cayford BI, 2012, APPL ENVIRON MICROB, V78, P7160, DOI 10.1128/AEM.01582-12; CHO KS, 1995, WATER SCI TECHNOL, V31, P263, DOI 10.1016/0273-1223(95)00343-L; Davis JL, 1998, INT BIODETER BIODEGR, V42, P75, DOI 10.1016/S0964-8305(98)00049-3; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Domingo JWS, 2011, BIOFOULING, V27, P993, DOI 10.1080/08927014.2011.618637; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gomez-Alvarez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-122; Gu JD, 1998, INT BIODETER BIODEGR, V41, P101, DOI 10.1016/S0964-8305(98)00034-1; HARRISON AP, 1984, ANNU REV MICROBIOL, V38, P265, DOI 10.1146/annurev.mi.38.100184.001405; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; ISLANDER RL, 1991, J ENVIRON ENG-ASCE, V117, P751, DOI 10.1061/(ASCE)0733-9372(1991)117:6(751); Ismail N., 1993, DOBOKU GAKKAI RONBUN, V1993, P133, DOI DOI 10.2208/JSCEJ.1993.474_133; Jensen HS, 2008, WATER SCI TECHNOL, V57, P1721, DOI 10.2166/wst.2008.293; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Lemos LN, 2012, FOLIA MICROBIOL, V57, P409, DOI 10.1007/s12223-012-0155-0; Ling AL, 2014, ENVIRON SCI TECHNOL, V48, P7357, DOI 10.1021/es500763e; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Ngom A, 2004, J GEN APPL MICROBIOL, V50, P17, DOI 10.2323/jgam.50.17; Nica D, 2000, INT BIODETER BIODEGR, V46, P61, DOI 10.1016/S0964-8305(00)00064-0; Okabe S, 2005, APPL ENVIRON MICROB, V71, P2520, DOI 10.1128/AEM.71.5.2520-2529.2005; Okabe S, 2007, APPL ENVIRON MICROB, V73, P971, DOI 10.1128/AEM.02054-06; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCL ACIDS RES, V41; Roberts DJ, 2002, INT BIODETER BIODEGR, V49, P227, DOI 10.1016/S0964-8305(02)00049-5; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; SAND W, 1984, ENVIRON TECHNOL LETT, V5, P517, DOI 10.1080/09593338409384307; Sand W., 1988, Biodeterioration 7. Selected papers presented at the 7th International Biodeterioration Symposium, Cambridge, UK, September 1987., P113; Satoh H, 2009, WATER RES, V43, P4729, DOI 10.1016/j.watres.2009.07.035; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; USEPA, 2009, REHABILITATION OF WA; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296	45	26	29	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116400	10.1371/journal.pone.0116400	http://dx.doi.org/10.1371/journal.pone.0116400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748024	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400005
J	Gori, Y; Wehrens, R; La Porta, N; Camin, F				Gori, Yuri; Wehrens, Ron; La Porta, Nicola; Camin, Federica			Oxygen and Hydrogen Stable Isotope Ratios of Bulk Needles Reveal the Geographic Origin of Norway Spruce in the European Alps	PLOS ONE			English	Article							LIGNIN METHOXYL GROUPS; TREE-RINGS; WOOD; PRECIPITATION; CLIMATE; CELLULOSE; HOMOGENIZATION; CERTIFICATION; TEMPERATURES; AUTHENTICITY	Background Tracking timber is necessary in order to prevent illegal logging and protect local timber production, but there is as yet no suitable analytical traceability method. Stable isotope ratios in plants are known to reflect geographical variations. In this study we analysed four stable isotope ratios in order to develop a model able to identify the geographic origin of Norway spruce in the European Alps. Methodology and Principal Findings delta O-18, delta H-2, delta C-13 and delta N-15 were measured in bulk needles of Picea abies sampled in 20 sites in and around the European Alps. Environmental and spatial variables were found to be related to the measured isotope ratios. An ordinary least squares regression was used to identify the most important factor in stable isotope variability in bulk needles. Spatial autocorrelation was tested for all isotope ratios by means of Moran's I. delta O-18, delta H-2 and delta N-15 values differed significantly between sites. Distance from the coast had the greatest influence on delta H-2, while latitude and longitude were strongly related to delta O-18. delta C-13 values did not appear to have any relationship with geographical position, while delta N-15 values were influenced by distance from the motorway. The regression model improved the explanatory power of the spatial and environmental variables. Positive spatial autocorrelations were found for delta O-18 and delta H-2 values. Conclusions The delta O-18, delta H-2 and delta N-15 values in P. abies bulk needles are a suitable proxy to identify geographic origin as they vary according to geographical position. Although the regression model showed the explanatory variables to have significant power and stability, we conclude that our model might be improved by multivariate spatial interpolation of the delta O-18 and delta H-2 values.	[Gori, Yuri; Wehrens, Ron; La Porta, Nicola; Camin, Federica] Edmund Mach Fdn FEM, Res & Innovat Ctr, Via E Mach 1, I-38010 San Michele All Adige, Trento, Italy	Fondazione Edmund Mach	Gori, Y (corresponding author), Edmund Mach Fdn FEM, Res & Innovat Ctr, Via E Mach 1, I-38010 San Michele All Adige, Trento, Italy.	yuri.gori@gmail.com	La Porta, Nicola/G-8461-2011; Wehrens, Ron/P-4845-2019; Wehrens, Ron/M-8781-2015	La Porta, Nicola/0000-0002-7080-3349; Wehrens, Ron/0000-0002-8798-5599; Wehrens, Ron/0000-0002-8798-5599; Camin, Federica/0000-0003-0509-6745				Ammann M, 1999, OECOLOGIA, V118, P124, DOI 10.1007/s004420050710; Araguas-Araguas L, 2000, HYDROL PROCESS, V14, P1341, DOI 10.1002/1099-1085(20000615)14:8&lt;1341::AID-HYP983&gt;3.0.CO;2-Z; Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Auld G, 2008, ANNU REV ENV RESOUR, V33, P187, DOI 10.1146/annurev.environ.33.013007.103754; Bank TW, 2006, GUIDELINES FORMULATI; Battipaglia G, 2010, SCI TOTAL ENVIRON, V408, P586, DOI 10.1016/j.scitotenv.2009.09.036; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Boner M, 2004, ANAL BIOANAL CHEM, V378, P301, DOI 10.1007/s00216-003-2347-6; Bontempo L, 2009, RAPID COMMUN MASS SP, V23, P1043, DOI 10.1002/rcm.3968; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Boyle EA, 1997, GEOPHYS RES LETT, V24, P273, DOI 10.1029/97GL00081; Brand WA, 2014, PURE APPL CHEM, V86, P425, DOI 10.1515/pac-2013-1023; Brendel O, 2003, ANN FOREST SCI, V60, P97, DOI 10.1051/forest:2003001; Camin F, 2007, ANAL BIOANAL CHEM, V389, P309, DOI 10.1007/s00216-007-1302-3; Cashore B, 2012, FOREST POLICY ECON, V18, P13, DOI [10.1016/j.forpol.2011.12.005, 10.1016/j.forpol.2012.03.001]; Cressie N., 2011, STAT SPATIO TEMPORAL; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson T.E, 2007, STABLE ISOTOPES INDI; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Degen B, 2007, P INT WORKSH FING ME; Deguilloux MF, 2004, ANN FOREST SCI, V61, P97, DOI 10.1051/forest:2003089; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Douglas J, 2010, WORLD FOR; Dudley N, 1995, BAD HARVEST TIMBER T; Eccel E, 2012, THEOR APPL CLIMATOL, V110, P345, DOI 10.1007/s00704-012-0624-z; Ehleringer JR, 2000, NATURE, V408, P311, DOI 10.1038/35042680; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; FREYER HD, 1991, TELLUS B, V43, P30, DOI 10.1034/j.1600-0889.1991.00003.x; Gori Y, 2013, RAPID COMMUN MASS SP, V27, P265, DOI 10.1002/rcm.6446; Hawkins BA, 2007, ECOGRAPHY, V30, P375, DOI 10.1111/j.2007.0906-7590.05117.x; Hofstra N, 2010, CLIM DYNAM, V35, P841, DOI 10.1007/s00382-009-0698-1; HOLDSWORTH G, 1991, J GEOPHYS RES-ATMOS, V96, P7483, DOI 10.1029/91JD00048; Horacek M, 2009, RAPID COMMUN MASS SP, V23, P3688, DOI 10.1002/rcm.4309; Jaggi M, 2003, NEW PHYTOL, V158, P51, DOI 10.1046/j.1469-8137.2003.00711.x; Jaggi M, 2002, OECOLOGIA, V131, P325, DOI 10.1007/s00442-002-0881-0; Kagawa A, 2010, J WOOD SCI, V56, P175, DOI 10.1007/s10086-009-1085-6; Keppler F, 2007, NEW PHYTOL, V176, P600, DOI 10.1111/j.1469-8137.2007.02213.x; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Larcher W., 1995, PHYSL PLANT ECOLOGY; Laumer W, 2009, RAPID COMMUN MASS SP, V23, P1934, DOI 10.1002/rcm.4105; Manca G, 2001, J AGR FOOD CHEM, V49, P1404, DOI 10.1021/jf000706c; Mansfield TA, 1981, PHYSL BIOCH DROUGHT; Masson-Delmotte V., 2013, CLIM CHANG 2013 PHYS; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; Nielsen LR, 2008, TRACING TIMBER FORES; Pendall E, 2000, GLOB CHANGE BIOL, V6, P287, DOI 10.1046/j.1365-2486.2000.00304.x; Pierrehumbert RT, 1999, GEOPHYS RES LETT, V26, P1345, DOI 10.1029/1999GL900183; R Development Core Team, 2010, LANG ENV STAT COMP, V333, P852, DOI DOI 10.1038/333852A0; ROBARDS K, 1995, ANALYST, V120, P1, DOI 10.1039/an9952000001; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800; ROZANSKI K, 1982, TELLUS, V34, P142, DOI 10.1111/j.2153-3490.1982.tb01801.x; Saurer M, 2004, ATMOS ENVIRON, V38, P2779, DOI 10.1016/j.atmosenv.2004.02.037; Tacconi L., 2007, ILLEGAL LOGGING LAW; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Tjoelker M.G., 2007, BIOL ECOLOGY NORWAY; Vogel B, 2000, ATMOS ENVIRON, V34, P2437, DOI 10.1016/S1352-2310(99)00422-7; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Weber HE, 2000, J VEG SCI, V11, P739, DOI 10.2307/3236580; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	63	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118941	10.1371/journal.pone.0118941	http://dx.doi.org/10.1371/journal.pone.0118941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742601	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100064
J	Sugahara, R; Jouraku, A; Nakakura, T; Kusakabe, T; Yamamoto, T; Shinohara, Y; Miyoshi, H; Shiotsuki, T				Sugahara, Ryohei; Jouraku, Akiya; Nakakura, Takayo; Kusakabe, Takahiro; Yamamoto, Takenori; Shinohara, Yasuo; Miyoshi, Hideto; Shiotsuki, Takahiro			Two Adenine Nucleotide Translocase Paralogues Involved in Cell Proliferation and Spermatogenesis in the Silkworm Bombyx mori	PLOS ONE			English	Article							MITOCHONDRIAL ADP/ATP CARRIER; ADP ATP TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; SPECIES LACKING; GENE; EXPRESSION; ISOFORM; TRANSCRIPTION; CHROMOSOME; PROTEIN	Mitochondrial adenine nucleotide translocase (ANT) specifically acts in ADP/ATP exchange through the mitochondrial inner membrane. This transporter protein thereby plays a significant role in energy metabolism in eukaryotic cells. Most mammals have four paralogous ANT genes (ANT1-4) and utilize these paralogues in different types of cells. The fourth paralogue of ANT (ANT4) is present only in mammals and reptiles and is exclusively expressed in testicular germ cells where it is required for meiotic progression in the spermatocytes. Here, we report that silkworms harbor two ANT paralogues, the homeostatic paralogue (BmANTI1) and the testis-specific paralogue (BmANTI2). The BmANTI2 protein has an N-terminal extension in which the positions of lysine residues in the amino acid sequence are distributed as in human ANT4. An expression analysis showed that BmANTI2 transcripts were restricted to the testis, suggesting the protein has a role in the progression of spermatogenesis. By contrast, BmANTI1 was expressed in all tissues tested, suggesting it has an important role in homeostasis. We also observed that cultured silkworm cells required BmANTI1 for proliferation. The ANTI1 protein of the lepidopteran Plutella xylostella (PxANTI1), but not those of other insect species (or PxANTI2), restored cell proliferation in BmANTI1-knockdown cells suggesting that ANTI1 has similar energy metabolism functions across the Lepidoptera. Our results suggest that BmANTI2 is evolutionarily divergent from BmANTI1 and has developed a specific role in spermatogenesis similar to that of mammalian ANT4.	[Sugahara, Ryohei; Nakakura, Takayo; Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan; [Jouraku, Akiya] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan; [Kusakabe, Takahiro] Kyushu Univ, Lab Silkworm Sci, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan; [Yamamoto, Takenori; Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Kyushu University; Tokushima University; Kyoto University	Shiotsuki, T (corresponding author), Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan.	shiotsuk@affrc.go.jp		Sugahara, Ryohei/0000-0001-6603-9029; Jouraku, Akiya/0000-0003-3264-8293	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; science and technology research promotion program for agriculture, forestry, fisheries and food industry [26021A]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; science and technology research promotion program for agriculture, forestry, fisheries and food industry	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, and science and technology research promotion program for agriculture, forestry, fisheries and food industry, to YS, HM, and TS (Grant 26021A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; AUSTIN J, 1983, ARCH BIOCHEM BIOPHYS, V222, P321, DOI 10.1016/0003-9861(83)90529-5; Barath P, 1999, EXP CELL RES, V248, P583, DOI 10.1006/excr.1999.4432; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; BRUNI A, 1964, NATURE, V201, P1219, DOI 10.1038/2011219a0; Chevrollier A, 2005, J BIOENERG BIOMEMBR, V37, P307, DOI 10.1007/s10863-005-8642-5; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Doerner A, 1997, FEBS LETT, V414, P258, DOI 10.1016/S0014-5793(97)01000-4; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Dupont PY, 2011, GENE, V487, P38, DOI 10.1016/j.gene.2011.07.024; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Gavurnikova G, 1996, EUR J BIOCHEM, V239, P759, DOI 10.1111/j.1432-1033.1996.0759u.x; Gotoh T, 2007, EXP APPL ACAROL, V42, P1, DOI 10.1007/s10493-007-9072-3; Hamazaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019250; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; Hatanaka T, 2001, BIOL PHARM BULL, V24, P595, DOI 10.1248/bpb.24.595; HOMYK T, 1980, MOL GEN GENET, V177, P553; Kawamura N, 1998, PROTOPLASMA, V202, P223, DOI 10.1007/BF01282550; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; LI K, 1989, J BIOL CHEM, V264, P13998; Lim CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023122; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Mikhaylova LM, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-29; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Mitsunobu Hitoshi, 2006, Journal of Insect Biotechnology and Sericology, V75, P141; Mon H, 2014, INSECT BIOCHEM MOLEC, V45, P40, DOI 10.1016/j.ibmb.2013.11.007; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Ogura Ichiro, 2001, Journal of Insect Biotechnology and Sericology, V70, P121; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; OSANAI M, 1993, AMINO ACIDS, V5, P341, DOI 10.1007/BF00806952; OSANAI M, 1987, J MORPHOL, V193, P1, DOI 10.1002/jmor.1051930102; OSANAI M, 1989, INVERTEBR REPROD DEV, V15, P97, DOI 10.1080/07924259.1989.9672029; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PFAFF E, 1965, BIOCHIM BIOPHYS ACTA, V104, P312, DOI 10.1016/0304-4165(65)90258-8; SABOVA L, 1993, EUR J BIOCHEM, V213, P547, DOI 10.1111/j.1432-1033.1993.tb17793.x; Sado T., 1963, Journal of the Faculty of Agriculture Kyushu University Fukuoka, V12, P359; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Sugahara R, 2014, INSECT MOL BIOL, V23, P185, DOI 10.1111/imb.12072; Sugahara R, 2012, GENE, V501, P180, DOI 10.1016/j.gene.2012.03.071; Tanaka S, 2010, J INSECT PHYSIOL, V56, P911, DOI 10.1016/j.jinsphys.2010.05.013; Tatsuke T, 2009, J FAC AGR KYUSHU U, V54, P397; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Yang ZQ, 2013, OXID MED CELL LONGEV, V2013, DOI [10.1155/2013/146860, 10.1155/2013/329183]; Zhang YQ, 1999, GENETICS, V153, P891	56	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119429	10.1371/journal.pone.0119429	http://dx.doi.org/10.1371/journal.pone.0119429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742135	gold, Green Submitted, Green Published			2022-12-26	WOS:000350688100110
J	Yue, RQ; Tie, SG; Sun, T; Zhang, L; Yang, YJ; Qi, JS; Yan, SF; Han, XH; Wang, HZ; Shen, CJ				Yue, Runqing; Tie, Shuanggui; Sun, Tao; Zhang, Lei; Yang, Yanjun; Qi, Jianshuang; Yan, Shufeng; Han, Xiaohua; Wang, Huizhong; Shen, Chenjia			Genome-Wide Identification and Expression Profiling Analysis of ZmPIN, ZmPILS, ZmLAX and ZmABCB Auxin Transporter Gene Families in Maize (Zea mays L.) under Various Abiotic Stresses	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SALT STRESS; SIGNALING PATHWAYS; ROOT DEVELOPMENT; POLAR TRANSPORT; P-GLYCOPROTEIN; ARABIDOPSIS; PIN; PROTEINS; ABC	The auxin influx carriers auxin resistant 1/like aux 1 (AUX/LAX), efflux carriers pin-formed (PIN) (together with PIN-like proteins) and efflux/conditional P-glycoprotein (ABCB) are major protein families involved in auxin polar transport. However, how they function in responses to exogenous auxin and abiotic stresses in maize is largely unknown. In this work, the latest updated maize (Zea mays L.) reference genome sequence was used to characterize and analyze the ZmLAX, ZmPIN, ZmPILS and ZmABCB family genes from maize. The results showed that five ZmLAXs, fifteen ZmPINs, nine ZmPILSs and thirty-five ZmABCBs were mapped on all ten maize chromosomes. Highly diversified gene structures, nonconservative transmembrane helices and tissue-specific expression patterns suggested the possibility of function diversification for these genes. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to analyze the expression patterns of ZmLAX, ZmPIN, ZmPILS and ZmABCB genes under exogenous auxin and different environmental stresses. The expression levels of most ZmPIN, ZmPILS, ZmLAX and ZmABCB genes were induced in shoots and were reduced in roots by various abiotic stresses (drought, salt and cold stresses). The opposite expression response patterns indicated the dynamic auxin transport between shoots and roots under abiotic stresses. Analysis of the expression patterns of ZmPIN, ZmPILS, ZmLAX and ZmABCB genes under drought, salt and cold treatment may help us to understand the possible roles of maize auxin transporter genes in responses and tolerance to environmental stresses.	[Yue, Runqing; Tie, Shuanggui; Qi, Jianshuang; Yan, Shufeng; Han, Xiaohua] Henan Acad Agr Sci, Zhengzhou 450002, Peoples R China; [Sun, Tao; Yang, Yanjun; Wang, Huizhong; Shen, Chenjia] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Lei] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Henan Academy of Agricultural Sciences; Hangzhou Normal University; Washington State University	Tie, SG (corresponding author), Henan Acad Agr Sci, Zhengzhou 450002, Peoples R China.	tieshuanggui308@126.com; whz62@163.com; shencj@hznu.edu.cn			National Natural Science Foundation of China [31401935, 31200913]; Zhejiang Provincial Natural Science Foundation of China [LQ14C060001, LQ13H28006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the National Natural Science Foundation of China (31401935; 31200913) and Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ14C060001 and LQ13H28006.	Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Balzan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00393; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; Barbez E, 2012, NATURE, V485, P119, DOI 10.1038/nature11001; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Carraro N, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00017; Cazzonelli CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070069; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen MK, 2013, PLANT PHYSIOL, V162, P1978, DOI 10.1104/pp.113.218198; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Forestan C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00016; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2010, EUR J CELL BIOL, V89, P231, DOI 10.1016/j.ejcb.2009.11.003; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fukaki H, 1996, PLANT PHYSIOL, V110, P933, DOI 10.1104/pp.110.3.933; Ganguly A, 2014, PLANT CELL, V26, P1570, DOI 10.1105/tpc.113.118422; Ganguly A, 2010, PLANT PHYSIOL, V153, P1046, DOI 10.1104/pp.110.156505; Garay-Arroyo A, 2013, EMBO J, V32, P2884, DOI 10.1038/emboj.2013.216; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; Hochholdinger F, 2000, J PLANT PHYSIOL, V157, P315, DOI 10.1016/S0176-1617(00)80053-X; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hoyerova K, 2008, PLANT PHYSIOL, V146, P1128, DOI 10.1104/pp.107.109371; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jansen L, 2012, PHILOS T R SOC B, V367, P1525, DOI 10.1098/rstb.2011.0239; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Knoller AS, 2010, J EXP BOT, V61, P3689, DOI 10.1093/jxb/erq180; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; LIU ZB, 1994, PLANT CELL, V6, P645, DOI 10.1105/tpc.6.5.645; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; Nakamura A, 2004, BIOSCI BIOTECH BIOCH, V68, P952, DOI 10.1271/bbb.68.952; Nisar N, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27898; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Pang KY, 2013, GENE, V526, P411, DOI 10.1016/j.gene.2013.05.051; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Peret B, 2012, PLANT CELL, V24, P2874, DOI 10.1105/tpc.112.097766; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Rahman A, 2013, PHYSIOL PLANTARUM, V147, P28, DOI 10.1111/j.1399-3054.2012.01617.x; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Robert HS, 2013, CURR BIOL, V23, P2506, DOI 10.1016/j.cub.2013.09.039; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shen CJ, 2010, FEBS J, V277, P2954, DOI 10.1111/j.1742-4658.2010.07706.x; Shen J, 2015, PROTOPLASMA, V252, P173, DOI 10.1007/s00709-014-0669-1; Shibasaki K, 2009, PLANT CELL, V21, P3823, DOI 10.1105/tpc.109.069906; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; WILLIAMS ME, 1992, PLANT CELL, V4, P485, DOI 10.1105/tpc.4.4.485; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Wyatt SE, 2002, PLANT PHYSIOL, V130, P1426, DOI 10.1104/pp.102.010579; Xia ZL, 2012, GENE, V495, P146, DOI 10.1016/j.gene.2011.12.028; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Xu WF, 2012, J EXP BOT, V63, P6105, DOI 10.1093/jxb/ers259; Xu YX, 2014, PLANT J, V79, P106, DOI 10.1111/tpj.12544; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Ye LF, 2013, BIOCHEM BIOPH RES CO, V441, P782, DOI 10.1016/j.bbrc.2013.10.136; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Zahir ZA, 2010, J MICROBIOL BIOTECHN, V20, P1288, DOI 10.4014/jmb.1002.02010; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4; Zhang YF, 2014, APPL THERM ENG, V65, P1, DOI 10.1016/j.applthermaleng.2013.12.069; Zhao JL, 2015, PHYSIOL PLANTARUM, V154, P381, DOI 10.1111/ppl.12291; Zhao Y, 2014, PLANT CELL PHYSIOL, V55, P1142, DOI 10.1093/pcp/pcu054; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x; Zorb C, 2013, J PLANT PHYSIOL, V170, P220, DOI 10.1016/j.jplph.2012.09.012; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290	88	52	57	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118751	10.1371/journal.pone.0118751	http://dx.doi.org/10.1371/journal.pone.0118751			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742625	gold, Green Submitted, Green Published			2022-12-26	WOS:000350688100043
J	Ahmed, HA; MacLeod, ET; Welburn, SC; Picozzi, K				Ahmed, Heba A.; MacLeod, Ewan T.; Welburn, Susan C.; Picozzi, Kim			Development of Real Time PCR to Study Experimental Mixed Infections of T. congolense Savannah and T. b. brucei in Glossina morsitans morsitans	PLOS ONE			English	Article							RICKETTSIA-LIKE ORGANISMS; TRYPANOSOMA-BRUCEI; TSETSE-FLIES; SUSCEPTIBILITY; TRANSMISSION; BLOOD	Tsetse flies are able to acquire mixed infections naturally or experimentally either simultaneously or sequentially. Traditionally, natural infection rates in tsetse flies are estimated by microscopic examination of different parts of the fly after dissection, together with the isolation of the parasite in vivo. However, until the advent of molecular techniques it was difficult to speciate trypanosomes infections and to quantify trypanosome numbers within tsetse flies. Although more expensive, qPCR allows the quantification of DNA and is less time consuming due to real time visualization and validation of the results. The current study evaluated the application of qPCR to quantify the infection load of tsetse flies with T. b. brucei and T. congolense savannah and to study the possibility of competition between the two species. The results revealed that the two qPCR reactions are of acceptable efficiency (99.1% and 95.6%, respectively), sensitivity and specificity and can be used for quantification of infection load with trypanosomes in experimentally infected Glossina morsitans morsitans. The mixed infection of laboratory Glossina species and quantification of the infection suggests the possibility that a form of competition exists between the isolates of T. b. brucei and T. congolense savannah that we used when they co-exist in the fly midgut.	[Ahmed, Heba A.; MacLeod, Ewan T.; Welburn, Susan C.; Picozzi, Kim] Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Ahmed, Heba A.] Zagazig Univ, Fac Vet Med, Zagazig, Ash Sharqiyah, Egypt	University of Edinburgh; Egyptian Knowledge Bank (EKB); Zagazig University	Picozzi, K (corresponding author), Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland.	kim.picozzi@ed.ac.uk	Abdallah, Heba ahmed/J-4996-2019; macleod, ewan/AAG-1005-2019	Abdallah, Heba ahmed/0000-0002-3615-9385; macleod, ewan/0000-0002-5517-0619	European Union's Seventh Framework Program (FP7) under ICONZ (Integrated Control of Neglected Zoonoses) [221948]; 'Dynamic Drivers of Disease in Africa Consortium', NERC project [NE-J001570-1]; Ecosystem Services for Poverty Alleviation Programme (ESPA); Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC), as part of the UK's Living with Environmental Change Programme (LWEC); BBSRC through CIDLID; Biotechnology and Biological Sciences Research Council [BB/H009213/1] Funding Source: researchfish; BBSRC [BB/H009213/1] Funding Source: UKRI	European Union's Seventh Framework Program (FP7) under ICONZ (Integrated Control of Neglected Zoonoses); 'Dynamic Drivers of Disease in Africa Consortium', NERC project; Ecosystem Services for Poverty Alleviation Programme (ESPA); Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC), as part of the UK's Living with Environmental Change Programme (LWEC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC through CIDLID(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated Control of Neglected Zoonoses). In addition, these findings were produced with support from the 'Dynamic Drivers of Disease in Africa Consortium', NERC project no. NE-J001570-1, funded with support from the Ecosystem Services for Poverty Alleviation Programme (ESPA). The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC), as part of the UK's Living with Environmental Change Programme (LWEC). Support from the BBSRC through CIDLID is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 2004, DIAGN MICR INFEC DIS, V50, P193, DOI 10.1016/j.diagmicrobio.2004.07.001; Boulanger N, 2002, INSECT BIOCHEM MOLEC, V32, P369, DOI 10.1016/S0965-1748(02)00029-2; GIBSON W, 1992, ACTA TROP, V50, P345, DOI 10.1016/0001-706X(92)90070-E; GIBSON WC, 1986, MOL BIOCHEM PARASIT, V18, P127, DOI 10.1016/0166-6851(86)90033-2; Haines LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000793; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Kubi C, 2005, J MED ENTOMOL, V42, P1035, DOI 10.1603/0022-2585(2005)042[1035:AOTTFD]2.0.CO;2; MacLeod ET, 2007, PARASITOLOGY, V134, P827, DOI 10.1017/S0031182007002247; MacLeod ET, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-5; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Maudlin I, 1996, MOL BIOL INSECT DIS, P136; MENSAWILMOT K, 1990, MOL CELL BIOL, V10, P720, DOI 10.1128/MCB.10.2.720; MIHOK S, 1993, PARASITOLOGY, V107, P41, DOI 10.1017/S0031182000079385; MOLOO SK, 1988, TROP MED PARASITOL, V39, P211; MOLOO SK, 1982, ACTA TROP, V39, P303; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; MURRAY W, 1993, COMP CONT EDUC PRACT, V15, P1665; Oberle M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001023; Peacock Lori, 2007, Kinetoplastid Biology and Disease, V6, pUnpaginated, DOI 10.1186/1475-9292-6-4; Picozzi K, 2008, EXP PARASITOL, V118, P41, DOI 10.1016/j.exppara.2007.05.014; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; SEED JR, 1978, J PROTOZOOL, V25, P526, DOI 10.1111/j.1550-7408.1978.tb04179.x; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Van den Bossche P, 2004, VET PARASITOL, V121, P79, DOI 10.1016/j.vetpar.2004.02.011; Van den Bossche P, 2004, VET PARASITOL, V119, P147, DOI 10.1016/j.vetpar.2003.11.008; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825; WELBURN SC, 1991, PARASITOLOGY, V102, P201, DOI 10.1017/S0031182000062491; Welburn SC, 1997, MED VET ENTOMOL, V11, P286, DOI 10.1111/j.1365-2915.1997.tb00408.x; WELBURN SC, 1993, PARASITOLOGY, V107, P141, DOI 10.1017/S003118200006724X; WELBURN SC, 1989, MED VET ENTOMOL, V3, P77, DOI 10.1111/j.1365-2915.1989.tb00477.x; WELBURN SC, 1992, ANN TROP MED PARASIT, V86, P529, DOI 10.1080/00034983.1992.11812703	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117147	10.1371/journal.pone.0117147	http://dx.doi.org/10.1371/journal.pone.0117147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738803	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900014
J	Cornford, CS; Close, HJ; Bray, R; Beere, D; Mason, JM				Cornford, Charles S.; Close, Helen J.; Bray, Roz; Beere, Deborah; Mason, James M.			Contraceptive Use and Pregnancy Outcomes among Opioid Drug-Using Women: A Retrospective Cohort Study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; REPRODUCTIVE HEALTH; BARRIERS; NEEDS; RISK; SEX	Objective The contraceptive needs of illicit opioid users differ from non-drug users but are poorly understood. The aim of this study was to describe contraceptive use and pregnancy outcomes in opioid-using women, and to examine their association with a range of risk factors. Method This retrospective cohort study used UK general practice records, Treatment Outcomes Profile and National Drug Treatment Monitoring System data, and a nested data validation exercise. A cohort of 376 women aged 20-61 years were in active treatment for opioid addiction in October 2010 at two specialised primary care practices in North-East England. Outcomes were age-adjusted prevalence estimates for contraceptive use and pregnancy outcomes in users of illicit opioids. The association between lifestyle-related risk factors and contraception was explored. Results Drug-using women made lower use of planned (non-condom) contraception (24% vs 50%, p<0.001), had more frequent pregnancy terminations (0.46 vs. 0.025, p = 0.004) and higher annual incidence of chlamydia (1.1% vs. 0.33%, p<0.001), when compared with age-matched population data. Specifically, there was low use of oral contraceptives (4% vs. 25%, p<0.001), IUCD (1% vs. 6%, p<0.001), and sterilisation (7% vs. 6%, p = 0.053), but higher rates of injectable contraceptives (6% vs. 3%, p = 0.003). A total of 64% of children aged <16 years born to this group did not live with their mother. No individual risk factor (such as sex-working) significantly explained the lower use or type of non-condom contraception. Conclusions This is the first study to describe planned contraceptive use among drug-users, as well as the association with a range of risk factors and pregnancy outcomes. The low uptake of planned contraception, set against high rates of terminations and sexually transmitted disease demonstrates the urgent clinical need to improve contraceptive services, informed by qualitative work to explore the values and beliefs influencing low contraceptive uptake.	[Cornford, Charles S.] Fulcrum Med Practice, Middlesbrough, Cleveland, England; [Close, Helen J.; Mason, James M.] Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Stockton On Tees, England; [Bray, Roz] St George Hosp, Clin Blood Sci, London, England; [Beere, Deborah] Northern Reg Gender Dysphoria Serv, Newcastle Upon Tyne, Tyne & Wear, England	Durham University; St Georges University London	Cornford, CS (corresponding author), Fulcrum Med Practice, Acklam Rd, Middlesbrough, Cleveland, England.	charles.cornford@nhs.net	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082				Advisory Council on the Misuse of Drugs, 2003, HIDD HARM RESP NEEDS; ARMSTRONG KA, 1991, FAM PLANN PERSPECT, V23, P264, DOI 10.2307/2135777; Banwell C, 2003, AUST NZ J PUBL HEAL, V27, P620, DOI 10.1111/j.1467-842X.2003.tb00609.x; Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931; Clarke JG, 2006, AM J PUBLIC HEALTH, V96, P834, DOI 10.2105/AJPH.2004.060236; Cornford CS, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613115; Cotten-Oldenburg NU, 1999, AM J DRUG ALCOHOL AB, V25, P129, DOI 10.1081/ADA-100101850; Crosby R, 2004, AM J PREV MED, V27, P404, DOI 10.1016/j.amepre.2004.07.017; Family Planning Association, 2007, CONTR PATT US; Harding Catherine, 2003, Aust J Rural Health, V11, P2, DOI 10.1046/j.1440-1584.2003.00477.x; HAY G, 2013, NATL REGIONAL ESTIMA; Health and Social Care Information Centre, 2012, CERV SCREEN PROGR EN; Jeal N, 2007, BJOG-INT J OBSTET GY, V114, P875, DOI 10.1111/j.1471-0528.2007.01379.x; Jessup MA, 2005, J ADDICT NURS, V16, P97, DOI 10.1080/10884500500196693; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kearney MH, 1994, QUALITATIVE HLTH RES, V4, P142, DOI DOI 10.1177/104973239400400202; Kidorf M, 2004, DRUG ALCOHOL DEPEN, V74, P115, DOI 10.1016/j.drugalcdep.2003.11.014; Leppo A, 2012, INT J DRUG POLICY, V23, P365, DOI 10.1016/j.drugpo.2012.01.004; Marsden J, 2008, ADDICTION, V103, P1450, DOI 10.1111/j.1360-0443.2008.02284.x; May T., 2006, SEX WORK NOW; Office for National Statistics, 2009, CONTR SEX HEATH 2008; Office for National Statistics, 2010, CHAR MOTH 2 ENGL WAL; Plugge E, 2004, J MED SCREEN, V11, P48, DOI 10.1258/096914104772950763; Public Health England, 2012, SEX TRANSM INF ANN D; Public Health England, 2014, DRUGS ALC NAT DRUG T; RALPH N, 1986, AM J PUBLIC HEALTH, V76, P1016, DOI 10.2105/AJPH.76.8.1016; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Sharpe TT, 2008, J WOMENS HEALTH, V17, P1339, DOI 10.1089/jwh.2008.0828; Sinha C, 2007, J FAM PLAN REPROD H, V33, P31, DOI 10.1783/147118907779399738; United Nations, 2013, POP FACTS TRENDS CON	30	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116231	10.1371/journal.pone.0116231	http://dx.doi.org/10.1371/journal.pone.0116231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25739018	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000350685900008
J	Martinet, B; Lecocq, T; Smet, J; Rasmont, P				Martinet, Baptiste; Lecocq, Thomas; Smet, Jeremy; Rasmont, Pierre			A Protocol to Assess Insect Resistance to Heat Waves, Applied to Bumblebees (Bombus Latreille, 1802)	PLOS ONE			English	Article							CRITICAL THERMAL LIMITS; TEMPERATURE EXTREMES; CLIMATE-CHANGE; HYMENOPTERA; ENERGETICS; TOLERANCE; RESPONSES; APIDAE	Insect decline results from numerous interacting factors including climate change. One of the major phenomena related to climate change is the increase of the frequency of extreme events such as heat waves. Since heat waves are suspected to dramatically increase insect mortality, there is an urgent need to assess their potential impact. Here, we determined and compared the resistance to heat waves of insects under hyperthermic stress through their time before heat stupor (THS) when they are exposed to an extreme temperature (40 degrees C). For this, we used a new experimental standardised device available in the field or in locations close to the field collecting sites. We applied this approach on different Arctic, Boreo-Alpine and Widespread bumblebee species in order to predict consequences of heat waves. Our results show a heat resistance gradient: the heat stress resistance of species with a centred arctic distribution is weaker than the heat resistance of the Boreo-Alpine species with a larger distribution which is itself lower than the heat stress resistance of the ubiquitous species.	[Martinet, Baptiste; Lecocq, Thomas; Smet, Jeremy; Rasmont, Pierre] Univ Mons, Res Inst Biosci, Zool Lab, B-7000 Mons, Belgium	University of Mons	Martinet, B (corresponding author), Univ Mons, Res Inst Biosci, Zool Lab, Pl Parc 20, B-7000 Mons, Belgium.	Baptiste.martinet@student.umons.ac.be		Lecocq, Thomas/0000-0002-4947-0332	INTERACT FP-7 EU project; FP-7 STEP Collaborative Project [244090]	INTERACT FP-7 EU project; FP-7 STEP Collaborative Project	INTERACT FP-7 EU project and FP-7 STEP Collaborative Project (grant agreement number: 244090) funded the collection of data (travel costs and accomodation) in Scandinavia and France. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Albright TP, 2011, REMOTE SENS ENVIRON, V115, P245, DOI 10.1016/j.rse.2010.08.024; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Bodenheimer F. S., 1930, Zeitschrift fuer Vergleichende Physiologie Berlin, V11, P345; Brett JR, 1944, SOME LETHAL TEMPERAT; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Franzen M, 2012, J INSECT CONSERV, V16, P227, DOI 10.1007/s10841-011-9410-y; Franzen M, 2012, BIODIVERS CONSERV, V21, P517, DOI 10.1007/s10531-011-0197-7; FRY F. E. J., 1957, ANNEE BIOL, V33, P205; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; HEINRICH B, 1972, J COMP PHYSIOL, V77, P49, DOI 10.1007/BF00696519; Heinrich B., 1979, BUMBLEBEE EC; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Huang SP, 2006, J THERM BIOL, V31, P378, DOI 10.1016/j.jtherbio.2005.11.032; HUTCHISON VH, 1979, AM J PHYSIOL, V237, pR367, DOI 10.1152/ajpregu.1979.237.5.R367; Infoclimat, TEMP MAX; Infoclimat, POURC HUM REL; Jacq F, 2012, B CLIMATIQUE JUILLET; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Kingsolver JG, 2013, FUNCT ECOL, V27, P1415, DOI 10.1111/1365-2435.12145; Klok CJ, 2003, BIOL J LINN SOC, V78, P401, DOI 10.1046/j.1095-8312.2003.00154.x; Klok CJ, 1997, J INSECT PHYSIOL, V43, P685, DOI 10.1016/S0022-1910(97)00001-2; Lecocq T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-263; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Martinez-Porchas M, 2010, TROP ZOOL, V23, P139; McFarlane R.W., 1976, S SERIES NATL TECHNI, P10; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Morritt D, 2000, J EXP MAR BIOL ECOL, V255, P215, DOI 10.1016/S0022-0981(00)00299-9; MULLER P., 1974, ASPECTS ZOOGEOGRAPHY; Murrell P, 2005, COMPUETR SCI DATA AN; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Nyamukondiwa C, 2013, J INSECT PHYSIOL, V59, P1199, DOI 10.1016/j.jinsphys.2013.09.004; Pachauri RK, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, pVII; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pottier N, 2007, PHYS STATIQUE HORS E; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmont P., 1988, THESIS FAC SCI AGR E; Rasmont P, 2014, TERTIARY ATLAS EUROP; Rasmont P, 2012, ANN SOC ENTOMOL FR, V48, P275, DOI 10.1080/00379271.2012.10697776; Ribeiro PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032083; Siegel S, 1988, NONP STAT BEH SCI; SVENSSON BG, 1979, J CHEM ECOL, V5, P603, DOI 10.1007/BF00987845; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1; Weatheronline Ltd, CLIM DAT; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; WILLIAMS PH, 1986, BEE WORLD, V67, P50, DOI 10.1080/0005772X.1986.11098871; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x	50	43	44	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118591	10.1371/journal.pone.0118591	http://dx.doi.org/10.1371/journal.pone.0118591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738862	gold, Green Published			2022-12-26	WOS:000350685900051
J	Selvakumar, N; Kumar, V; Balaji, S; Prabuseenivasan, S; Radhakrishnan, R; Sekar, G; Chandrasekaran, V; Kannan, T; Thomas, A; Arunagiri, S; Dewan, P; Swaminathan, S				Selvakumar, N.; Kumar, Vanaja; Balaji, S.; Prabuseenivasan, S.; Radhakrishnan, R.; Sekar, Gomathi; Chandrasekaran, V.; Kannan, T.; Thomas, Aleyamma; Arunagiri, S.; Dewan, Puneet; Swaminathan, Soumya			High Rates of Ofloxacin Resistance in Mycobacterium tuberculosis among Both New and Previously Treated Patients in Tamil Nadu, South India	PLOS ONE			English	Article							DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; NATIONAL-SURVEY; SURVEILLANCE; PREVALENCE; CHINA; HIV	Periodic drug resistance surveillance provides useful information on trends of drug resistance and effectiveness of tuberculosis (TB) control measures. The present study determines the prevalence of drug resistance among new sputum smear positive (NSP) and previously treated (PT) pulmonary TB patients, diagnosed at public sector designated microscopy centers (DMCs) in the state of Tamil Nadu, India. In this single-stage cluster-sampling prevalence survey, 70 of 700 DMCs were randomly selected using a probability-proportional to size method. A cluster size of 24 for NSP and a varying size of 0 to 99 for PT cases were fixed for each selected DMC. Culture and drug susceptibility testing was done on Lowenstein-Jensen medium using the economic variant of proportion sensitivity test for isoniazid (INH), rifampicin (RMP), ofloxacin (OFX) and kanamycin (KAN). Human Immunodeficiency Virus (HIV) status was collected from patient records. From June 2011 to August 2012, 1524 NSP and 901 PT patients were enrolled. Any RMP resistance and any INH resistance were observed in 2.6% and 15.1%, and in 10.4% and 30% respectively in NSP and PT cases. Among PT patients, multi drug resistant TB (MDR-TB) was highest in the treatment failure (35%) group, followed by relapse (13%) and treatment after default (10%) groups. Extensively drug resistant TB (XDRTB) was seen in 4.3% of MDR-TB cases. Any OFX resistance was seen in 10.4% of NSP, 13.9% of PT and 29% of PT MDR-TB patients. The HIV status of the patient had no impact on drug resistance levels. RMP resistance was present in 2.6% of new and 15.1% of previously treated patients in Tamil Nadu. Rates of OFX resistance were high among NSP and PT patients, especially among those with MDR-TB, a matter of concern for development of new treatment regimens for TB.	[Selvakumar, N.; Kumar, Vanaja; Balaji, S.; Prabuseenivasan, S.; Radhakrishnan, R.; Sekar, Gomathi; Chandrasekaran, V.; Kannan, T.; Thomas, Aleyamma; Swaminathan, Soumya] Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India; [Arunagiri, S.] Govt Tamil Nadu, State TB Cell, Chennai, Tamil Nadu, India; [Dewan, Puneet] WHO India, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Swaminathan, S (corresponding author), Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India.	doctorsoumya@yahoo.com	Thiruvengadam, Kannan/AAQ-8532-2021; Nagamiah, Selvakumar/AHB-2651-2022	Thiruvengadam, Kannan/0000-0002-3758-1094; 	United States Agency for International Development (USAID), through the World Health Organization (WHO), South-East Asia Regional Office (SEARO), New Delhi	United States Agency for International Development (USAID), through the World Health Organization (WHO), South-East Asia Regional Office (SEARO), New Delhi(United States Agency for International Development (USAID))	This study is supported by the United States Agency for International Development (USAID), through the World Health Organization (WHO), South-East Asia Regional Office (SEARO), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Assam-Assam JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-94; Blondal K, 2013, INT J TUBERC LUNG D, V17, P961, DOI 10.5588/ijtld.12.0946; Bozeman L, 2005, CLIN INFECT DIS, V40, P386, DOI 10.1086/427292; Central TB Division (CTD, 2009, REV NAT TB CONTR PRO; Chandrasekaran S., 1992, Indian Journal of Tuberculosis, V39, P171; CTD, 2011, CENTR TB DIV NAT SCA; CTD, 2005, CENTR TB DIV MOD LAB; Daniel O, 2011, AFRICAN J RES ME MAR, P18; Ginsburg AS, 2003, NEW ENGL J MED, V349, P1977, DOI 10.1056/NEJM200311133492023; GUPTA PR, 1993, INDIAN J MED RES-A, V97, P102; Hu Y, 2008, MICROB DRUG RESIST, V14, P227, DOI 10.1089/mdr.2008.0823; Ioannidis P, 2011, J CLIN MICROBIOL, V49, P3068, DOI 10.1128/JCM.00718-11; Kart Levent, 2002, Ann Clin Microbiol Antimicrob, V1, P6, DOI 10.1186/1476-0711-1-6; Klinkenberg E, 2012, INT J TUBERC LUNG D, V16, P615, DOI 10.5588/ijtld.11.0262; Mahadev B., 2005, Indian Journal of Tuberculosis, V52, P5; Myneedu V P, 2011, Indian J Tuberc, V58, P160; O'Donnell MR, 2011, EMERG INFECT DIS, V17, P1942, DOI 10.3201/eid1710.110105; Paramasivan C. N., 2000, Indian Journal of Tuberculosis, V47, P27; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Paramasivan CN, 2002, INT J TUBERC LUNG D, V6, P479; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Swaminathan S, 2005, INT J TUBERC LUNG D, V9, P896; Umubyeyi AN, 2007, J ANTIMICROB CHEMOTH, V59, P1031, DOI 10.1093/jac/dkm038; WHO, 2009, WHOHTMTB2009411; WHO, 2009, WHOHTMTB2009422; *WHO, 2005, WHOHTMTB2005349; *WHO, 2008, WHOHTMTB2008394; World Health Organization, 2001, WHOCDSTB2001288; World Health Organization, 2010, WHOHTMTB20103; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	32	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117421	10.1371/journal.pone.0117421	http://dx.doi.org/10.1371/journal.pone.0117421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738956	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900016
J	Steer, CD; Bolton, P; Golding, J				Steer, Colin D.; Bolton, Patrick; Golding, Jean			Preconception and Prenatal Environmental Factors Associated with Communication Impairments in 9 Year Old Children Using an Exposome-Wide Approach	PLOS ONE			English	Article							MATERNAL DEPRESSION; LANGUAGE IMPAIRMENT; PREGNANCY; STRESS; LOCUS; PRESCHOOL; EXPOSURE; HEALTH; HERITABILITY; PARENTS	Although speech and language deficits are common in children and strongly associated with poor educational and social outcomes, little attention has been paid to the antecedents. In this study we used the information from the Avon Longitudinal Study of Parents and Children to examine preconception and prenatal environmental risk factors that were related to communication difficulties in children using the Children's Communication Checklist (CCC). We used an exposome-wide approach to identify environmental factors univariably associated with the CCC. Taking account of the False Discovery rate, we used a P value of 0.000157 to identify 621 of 3855 items tested. These were then subjected to a series of stepwise linear regression analyses, firstly within 10 domains: personal characteristics, health, development, education, socio-economic variables, lifestyle, home and social environments, life events and chemical and other exposures; and then with the predictive variables from each domain. The final model consisted of 19 variables independently associated with the communication scale. These variables suggested 6 possible mechanisms: stressors primarily associated with socio-economic disadvantage although other lifestyle choices such as a social network of family or friends can ameliorate these effects; indicators of future parenting skills primarily associated with aspects of parental personality; aspects of the home environment; poor maternal health with a novel finding concerning maternal hearing loss; and maternal education which was partially mediated by the child's IQ. Finally, there may be a mechanism via the maternal diet in pregnancy in particular the consumption of fatty or processed foods. This is the subject of ongoing investigation.	[Steer, Colin D.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Bolton, Patrick] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Golding, Jean] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Bristol; University of London; King's College London; University of Bristol	Steer, CD (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England.	Colin.Steer@bristol.ac.uk		Golding, Jean/0000-0003-2826-3307	UK Medical Research Council (MRC); Wellcome Trust; University of Bristol; UK MRC [G0800523]; NIHR Biomedical Research Centre in Mental Health at the South London AMP; Maudsley Hospital; Waterloo Foundation; MRC [G1100226, G0400085, G0800523] Funding Source: UKRI; Medical Research Council [G0800523, G1100226, MC_PC_15018, G9817803B, G0400085] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre in Mental Health at the South London AMP; Maudsley Hospital; Waterloo Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This study was funded by the UK MRC-grant G0800523. Patrick Bolton was supported by The NIHR Biomedical Research Centre in Mental Health at the South London & Maudsley Hospital. Version 3.01 of the exposome was partially funded by the Waterloo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2003, THORAX, V58, P846, DOI 10.1136/thorax.58.10.846; Bandstra ES, 2002, NEUROTOXICOL TERATOL, V24, P297, DOI 10.1016/S0892-0362(02)00192-7; Belsky J, 2007, EUR J PUBLIC HEALTH, V17, P508, DOI 10.1093/eurpub/ckl261; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bert SC, 2009, FAM RELAT, V58, P176, DOI 10.1111/j.1741-3729.2008.00545.x; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Bishop DVM, 2008, GENES BRAIN BEHAV, V7, P365, DOI 10.1111/j.1601-183X.2007.00360.x; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bishop DVM, 2006, BEHAV GENET, V36, P173, DOI 10.1007/s10519-005-9020-0; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; Bishop DVM, 2001, DEV MED CHILD NEUROL, V43, P809, DOI 10.1017/S0012162201001475; BOYCE P, 1989, AUST NZ J PSYCHIAT, V23, P341; Bronfenbrenner U., 1992, 6 THEORY CHILD DEV R, P187, DOI DOI 10.1006/0BHD.1998.2813; Buss C, 2010, PSYCHONEUROENDOCRINO, V35, P141, DOI 10.1016/j.psyneuen.2009.07.010; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Crown S, 1979, MANUAL CROWN CRISP E; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; Eicher JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063762; Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044; Fernandez S, 2008, INT J EARLY CHILD, V40, P85, DOI DOI 10.1007/BF03168487; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fried PA, 1997, NEUROTOXICOL TERATOL, V19, P171, DOI 10.1016/S0892-0362(97)00015-9; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Graves SB, 1986, J INSTR PSYCHOL, V13, P153; Hammer CS, 2001, INT J LANG COMM DIS, V36, P185, DOI 10.1080/13682820010019919; HELM JM, 1990, FAM RELAT, V39, P432, DOI 10.2307/585224; HOUCK GM, 1991, INF MENTAL HLTH J, V12, P347, DOI 10.1002/1097-0355(199124)12:4<347::AID-IMHJ2280120408>3.0.CO;2-9; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; JOHNSON JH, 1978, J PSYCHOSOM RES, V22, P205, DOI 10.1016/0022-3999(78)90025-9; Kass GV, 1980, J R STAT SOC C-APPL, P119; Kelly L E, 1995, J Pediatr Nurs, V10, P105, DOI 10.1016/S0882-5963(05)80006-5; Kolominsky Y, 1999, J CHILD PSYCHOL PSYC, V40, P299, DOI 10.1111/1469-7610.00444; Kotchick B.A., 2002, J CHILD FAM STUD, V11, P255, DOI [10.1023/A:1016863921662, DOI 10.1023/A:1016863921662]; La Paro KM, 2004, AM J SPEECH-LANG PAT, V13, P291, DOI 10.1044/1058-0360(2004/030); Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Lencova E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-208; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Lewis BA, 2013, J SPEECH LANG HEAR R, V56, P1662, DOI 10.1044/1092-4388(2013/12-0119); Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; MAISTO AA, 1981, J PSYCHOL, V109, P213, DOI 10.1080/00223980.1981.9915308; Manfreda J, 2001, CAN MED ASSOC J, V164, P995; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marra JV, 2009, AM J ORTHOPSYCHIAT, V79, P348, DOI 10.1037/a0017241; Marton K, 2003, J SPEECH LANG HEAR R, V46, P1138, DOI 10.1044/1092-4388(2003/089); Milevsky A., 2007, J CHILD FAM STUD, V16, P39, DOI [DOI 10.1007/S10826-006-9066-5, 10.1007/s10826-006-9066-5]; Miller GW, 2014, TOXICOL SCI, V137, P1, DOI 10.1093/toxsci/kft251; Nadebaum C, 2011, NEUROLOGY, V76, P719, DOI 10.1212/WNL.0b013e31820d62c7; Northstone K, 2008, EUR J CLIN NUTR, V62, P471, DOI 10.1038/sj.ejcn.1602741; NOWICKI S, 1974, J PERS ASSESS, V38, P136, DOI 10.1080/00223891.1974.10119950; O'Donnell KJ, 2002, DEV MED CHILD NEUROL, V44, P76, DOI 10.1017/S0012162201001712; OPCS, 1991, STAND OCC CLASS, V3; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50; Ruser TF, 2007, J AUTISM DEV DISORD, V37, P1323, DOI 10.1007/s10803-006-0274-z; Sanchez-Villegas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016268; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; SCOLNIK D, 1994, JAMA-J AM MED ASSOC, V271, P767, DOI 10.1001/jama.271.10.767; SEXTON M, 1990, INT J EPIDEMIOL, V19, P72, DOI 10.1093/ije/19.1.72; Steer CD, 2006, J EXPO SCI ENV EPID, V16, P251, DOI 10.1038/sj.jea.7500455; Steer CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012633; Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC; TINSLEY BJ, 1989, J DEV BEHAV PEDIATR, V10, P236; Tomblin JB, 1997, J COMMUN DISORD, V30, P325, DOI 10.1016/S0021-9924(97)00015-4; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Wechsler D., 1992, WECHSLER INTELLIGENC; Whitehouse AJO, 2010, EARLY HUM DEV, V86, P487, DOI 10.1016/j.earlhumdev.2010.06.009; Whitehouse AJO, 2010, PSYCHONEUROENDOCRINO, V35, P1259, DOI 10.1016/j.psyneuen.2010.02.007; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201; Woolfson L, 2006, CHILD CARE HLTH DEV, V32, P177, DOI 10.1111/j.1365-2214.2006.00603.x; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	75	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118701	10.1371/journal.pone.0118701	http://dx.doi.org/10.1371/journal.pone.0118701			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25739097	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900063
J	Arevalo, RC; Kumar, P; Urbach, JS; Blair, DL				Arevalo, Richard C.; Kumar, Pramukta; Urbach, Jeffrey S.; Blair, Daniel L.			Stress Heterogeneities in Sheared Type-I Collagen Networks Revealed by Boundary Stress Microscopy	PLOS ONE			English	Article							ELASTICITY; DEFORMATION; RHEOLOGY; MATRICES	Disordered fiber networks provide structural support to a wide range of important materials, and the combination of spatial and dynamic complexity may produce large inhomogeneities in mechanical properties, an effect that is largely unexplored experimentally. In this work, we introduce Boundary Stress Microscopy to quantify the non-uniform surface stresses in sheared collagen gels. We find local stresses exceeding average stresses by an order of magnitude, with variations over length scales much larger than the network mesh size. The strain stiffening behavior observed over a wide range of network mesh sizes can be parameterized by a single characteristic strain and associated stress, which describes both the strain stiffening regime and network yielding. The characteristic stress is approximately proportional to network density, but the peak boundary stress at both the characteristic strain and at yielding are remarkably insensitive to concentration.	[Urbach, Jeffrey S.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; Georgetown Univ, Inst Soft Matter Synth & Metrol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Urbach, JS (corresponding author), Georgetown Univ, Dept Phys, Washington, DC 20057 USA.	urbachj@georgetown.edu; Daniel.Blair@georgetown.edu	Blair, Daniel/C-7911-2017	Urbach, Jeffrey/0000-0002-1593-520X	National Science Foundation [DMR-0804782]; AFOSR [FA9550-07-1-0130]	National Science Foundation(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work is supported by the National Science Foundation through grant DMR-0804782 and the AFOSR through grant FA9550-07-1-0130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664; Arevalo RC, 2011, CHAOS, V21, DOI 10.1063/1.3666225; Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008; Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; Broedersz CP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.078102; Buxton GA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238103; Conti E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088102; DiDonna BA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066619; Dutta S, 2013, REV SCI INS IN PRESS; Erk KA, 2010, BIOMACROMOLECULES, V11, P1358, DOI 10.1021/bm100136y; Forgacs G, 2003, BIOPHYS J, V84, P1272, DOI 10.1016/S0006-3495(03)74942-X; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Hall MS, 2013, EXP CELL RES, V319, P2396, DOI 10.1016/j.yexcr.2013.06.009; Hatami-Marbini H, 2009, ACTA MECH, V205, P77, DOI 10.1007/s00707-009-0170-7; Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907; Heussinger C, 2007, EUR PHYS J E, V24, P47, DOI 10.1140/epje/i2007-10209-1; Heussinger C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105501; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kouwer PHJ, 2013, NATURE, V493, P651, DOI 10.1038/nature11839; Kurniawan NA, 2012, BIOMACROMOLECULES, V13, P691, DOI 10.1021/bm2015812; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Motte S, 2013, BIOPOLYMERS, V99, P35, DOI 10.1002/bip.22133; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Picu RC, 2011, SOFT MATTER; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Stein A, 2010, COMPLEXITY, V00, P1; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Takigawa T, 1996, POLYM GELS NETW, V4, P1, DOI 10.1016/0966-7822(95)00013-5; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; WALTON AG, 1973, BIOPOLYMERS; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14964, DOI 10.1073/pnas.1005537107; Yao NY, 2010, BIOPHYS J, V98, P2147, DOI 10.1016/j.bpj.2010.01.062; Zagar G, 2011, MACROMOLECULES, V44, P7026, DOI 10.1021/ma201257v	40	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118021	10.1371/journal.pone.0118021	http://dx.doi.org/10.1371/journal.pone.0118021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734484	Green Submitted, Green Published, gold			2022-12-26	WOS:000350314700013
J	Knezevic, J; Pfefferle, AD; Petrovic, I; Greene, SB; Perou, CM; Rosen, JM				Knezevic, J.; Pfefferle, A. D.; Petrovic, I.; Greene, S. B.; Perou, C. M.; Rosen, J. M.			Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TUMOR-INITIATING CELLS; DOWN-REGULATION; ANGIOGENESIS; FAMILY; ZEB1; GENE; IDENTIFICATION; PLASTICITY; SUBTYPE	Claudin-low tumors are a highly aggressive breast cancer subtype with no targeted treatments and a clinically documented resistance to chemotherapy. They are significantly enriched in cancer stem cells (CSCs), which makes claudin-low tumor models particularly attractive for studying CSC behavior and developing novel approaches to minimize CSC therapy resistance. One proposed mechanism by which CSCs arise is via an epithelial-mesenchymal transition (EMT), and reversal of this process may provide a potential therapeutic approach for increasing tumor chemosensitivity. Therefore, we investigated the role of known EMT regulators, miR-200 family of microRNAs in controlling the epithelial state, stem-like properties and therapeutic response in an in vivo primary, syngeneic p53(null) claudin-low tumor model that is normally deficient in miR-200 expression. Using an inducible lentiviral approach, we expressed the miR-200c cluster in this model and found that it changed the epithelial state, and consequently, impeded CSC behavior in these mesenchymal tumors. Moreover, these state changes were accompanied by a decrease in proliferation and an increase in the differentiation status. miR-200c expression also forced a significant reorganization of tumor architecture, affecting important cellular processes involved in cell-cell contact, cell adhesion and motility. Accordingly, induced miR200c expression significantly enhanced the chemosensitivity and decreased the metastatic potential of this p53null claudin-low tumor model. Collectively, our data suggest that miR-200c expression in claudin-low tumors offers a potential therapeutic application to disrupt the EMT program on multiple fronts in this mesenchymal tumor subtype, by altering tumor growth, chemosensitivity and metastatic potential in vivo.	[Knezevic, J.; Petrovic, I.; Rosen, J. M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Pfefferle, A. D.; Perou, C. M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Pfefferle, A. D.; Perou, C. M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Greene, S. B.] Epic Sci Inc, San Diego, CA USA; [Perou, C. M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rosen, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza M638a, Houston, TX 77030 USA.	jrosen@bcm.edu	Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247	National Cancer Institute [CA148761]; CPRIT [RP130485, RP140102]; Baylor College of Medicine [P30 AI036211, P30 CA125123, S10 RR024574, P30-CA125123]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA148761, P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT; Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by grants CA148761 (JMR and CP) from the National Cancer Institute and RP130485 (JMR) and RP140102 (JK) from CPRIT. This project was supported by the following core facilities and their funding: Biostatistics and Informatics (P30-CA125123) and Cytometry and Cell Sorting Core at Baylor College of Medicine (P30 AI036211, P30 CA125123 and S10 RR024574). RPPA arrays were performed at the MD Anderson Cancer Center RPPA Core Facility-Functional Proteomics. We thank Drs Kevin Roarty Amy Shore and Michael Toneff for helpful discussions and paper editing, Dr Jason Herschkowitz for help and advice, and Ms Shirley Small for animal husbandry.	Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cui JG, 2014, J CELL BIOCHEM, V115, P1033, DOI 10.1002/jcb.24754; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Humphries B, 2014, CARCINOGENESIS, P1; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kopp F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050469; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Pfefferle AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r125; Pinto CA, 2013, CANCER LETT, V341, P56, DOI 10.1016/j.canlet.2013.06.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Usary J, 2013, CLIN CANCER RES, V19, P4889, DOI 10.1158/1078-0432.CCR-13-0522; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wu SY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008362; Yin JH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-71; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013	51	80	84	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2015	34	49					5997	6006		10.1038/onc.2015.48	http://dx.doi.org/10.1038/onc.2015.48			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RO	25746005	Green Accepted, Green Submitted			2022-12-26	WOS:000366113500006
J	Poirier, JT; Gardner, EE; Connis, N; Moreira, AL; de Stanchina, E; Hann, CL; Rudin, CM				Poirier, J. T.; Gardner, E. E.; Connis, N.; Moreira, A. L.; de Stanchina, E.; Hann, C. L.; Rudin, C. M.			DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2	ONCOGENE			English	Article							GENE; INACTIVATION; LANDSCAPE; CARCINOMA; MODEL; LINES	Small cell lung cancer (SCLC) is an aggressive malignancy characterized by early metastasis, rapid development of resistance to chemotherapy and genetic instability. This study profiles DNA methylation in SCLC, patient-derived xenografts (PDX) and cell lines at single-nucleotide resolution. DNA methylation patterns of primary samples are distinct from those of cell lines, whereas PDX maintain a pattern closely consistent with primary samples. Clustering of DNA methylation and gene expression of primary SCLC revealed distinct disease subtypes among histologically indistinguishable primary patient samples with similar genetic alterations. SCLC is notable for dense clustering of high-level methylation in discrete promoter CpG islands, in a pattern clearly distinct from other lung cancers and strongly correlated with high expression of the E2F target and histone methyltransferase gene EZH2. Pharmacologic inhibition of EZH2 in a SCLC PDX markedly inhibited tumor growth.	[Poirier, J. T.; Gardner, E. E.; Rudin, C. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Gardner, E. E.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [Connis, N.; Hann, C. L.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA; [Moreira, A. L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [de Stanchina, E.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudin, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 300 E 66th St,Room 1203, New York, NY 10065 USA.	rudinc@mskcc.org	Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465; Gardner, Eric/0000-0002-1552-2675; Poirier, John/0000-0001-9795-5644; Connis, Nick/0000-0001-5725-0674	 [SU2C];  [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Inna Kodos in the Sloan Kettering Antitumor Assessment Core for her technical expertise. We are grateful to all members of the Rudin and Hann labs for thoughtful discussions. SU2C, P30 CA008748 gave financial support.	Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; CARNEY DN, 1985, CANCER RES, V45, P2913; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Gardner EE, 2014, CANCER RES, V74, P2846, DOI 10.1158/0008-5472.CAN-13-3460; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hann CL, 2007, TRENDS MOL MED, V13, P150, DOI 10.1016/j.molmed.2007.02.003; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalari S, 2013, ONCOGENE, V32, P3559, DOI 10.1038/onc.2012.362; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; MADRIGAL PA, 1982, CANCER CHEMOTH PHARM, V7, P203; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oze I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007835; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Poirier JT, 2013, JNCI-J NATL CANCER I, V105, P1059, DOI 10.1093/jnci/djt130; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wee ZN, 2014, CELL REP, V8, P204, DOI 10.1016/j.celrep.2014.05.045; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	38	139	141	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2015	34	48					5869	5878		10.1038/onc.2015.38	http://dx.doi.org/10.1038/onc.2015.38			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CX1CO	25746006	Green Accepted			2022-12-26	WOS:000365434000002
J	Tang, WG; Song, P; Cao, ZY; Wang, P; Zhu, GP				Tang, Wang-Gang; Song, Ping; Cao, Zheng-Yu; Wang, Peng; Zhu, Guo-Ping			A unique homodimeric NAD(+)-linked isocitrate dehydrogenase from the smallest autotrophic eukaryote Ostreococcus tauri	FASEB JOURNAL			English	Article						adaptation; coenzyme specificity determinants; kinetics; phylogenetic analysis	INDUCED OXIDATIVE DAMAGE; MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; CELLULAR DEFENSE; CLUSTAL-W; NAD; IDENTIFICATION; CHLAMYDOMONAS; SUBUNIT; PROTEIN	In eukaryotes, NAD(+)-dependent isocitrate dehydrogenase (IDH) is strictly mitochondrial and is a key enzyme in the Krebs cycle. To date, all known NAD(+)-specific IDHs (NAD-IDHs) in the mitochondria are believed to be heteromeric in solution. Here, a unique homodimeric NAD-IDH from Ostreococcus tauri (OtIDH), the smallest autotrophic picoeukaryote, was unveiled. Active OtIDH has a molecular weight of similar to 93 kDa with each subunit of 46.7 kDa. In the presence of Mn2+ and Mg2+, OtIDH displayed 42-fold and 51-fold preference for NAD(+) over NADP(+), respectively. Interestingly, OtIDH exhibited a sigmoidal kinetic behavior in response to isocitrate unlike other homodimeric homologs, and a remarkably high affinity for isocitrate (S-0.5 < 10 mu M) unlike other heterooligomeric homologs. Furthermore, its coenzyme specificity can be completely converted from NAD(+) (ancient trait) to NADP(+) (adaptive trait) by rational mutagenesis based on the evolutionary trace. Mutants D344R and D344R/M345H displayed a 15-fold and 72-fold preference for NADP(+) over NAD(+), respectively, indicating that D344 and M345 are the determinants of NAD(+) specificity. These findings also suggest that OtIDH may be an ancestral form of type II IDHs (all reported members are NADP(+)-linked enzymes) and may have evolved into NADP(+)-dependent IDH for adaptation to the increased demand of NADPH under carbon starvation.	[Tang, Wang-Gang; Song, Ping; Cao, Zheng-Yu; Wang, Peng; Zhu, Guo-Ping] Anhui Normal Univ, Coll Life Sci, Inst Mol Biol & Biotechnol, Wuhu 241000, Peoples R China	Anhui Normal University	Zhu, GP (corresponding author), Anhui Normal Univ, Coll Life Sci, Inst Mol Biol & Biotechnol, Wuhu 241000, Peoples R China.	gpz1996@yahoo.com	Wang, Peng/AAW-9052-2020; Tang, Wang-gang/AAO-6768-2021; Wang, Peng/I-8770-2018	Wang, Peng/0000-0002-5598-0996; Tang, Wang-gang/0000-0002-1440-1847; Wang, Peng/0000-0002-5598-0996; Zhu, Guo-ping/0000-0002-1877-4501	National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [31170005, 31400003]; Natural Science Foundation of Anhui Province of China [1308085QC67]; Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China [KJ2013A128]; Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (Chinese Academy of Sciences) [GRE-KF11-07]; Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources	National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province); Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China; Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (Chinese Academy of Sciences); Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources	The authors are grateful to J.-Y. Zang and M.-H. Wu (University of Science and Technology of China, Hefei, China) for their help with protein structure homology modeling. This work was supported by the National High Technology Research and Development Program ("863" Program: 2012AA02A708), the National Natural Science Foundation of China (31170005; 31400003), the Natural Science Foundation of Anhui Province of China (1308085QC67), the Provincial Project of Natural Science Research for Colleges and Universities of Anhui Province of China (KJ2013A128), the Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (Chinese Academy of Sciences) (GRE-KF11-07), and Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources.	Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Corpas FJ, 1999, PLANT PHYSIOL, V121, P921, DOI 10.1104/pp.121.3.921; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Dange M, 2010, J BIOL CHEM, V285, P20520, DOI 10.1074/jbc.M110.115386; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; FIEUW S, 1995, PLANT PHYSIOL, V107, P905, DOI 10.1104/pp.107.3.905; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; Imada K, 2008, PROTEINS, V70, P63, DOI 10.1002/prot.21486; Inoue H, 2002, FEMS MICROBIOL LETT, V214, P127, DOI 10.1111/j.1574-6968.2002.tb11335.x; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; KEYS DA, 1990, J BACTERIOL, V172, P4280, DOI 10.1128/jb.172.8.4280-4287.1990; Kim HJ, 2005, FREE RADICAL RES, V39, P441, DOI 10.1080/10715760500066265; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Kim YO, 1999, J BIOL CHEM, V274, P36866, DOI 10.1074/jbc.274.52.36866; Lancien M, 1998, PLANT J, V16, P325, DOI 10.1046/j.1365-313x.1998.00305.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemaitre T, 2007, PLANT PHYSIOL, V144, P1546, DOI 10.1104/pp.107.100677; Lemaitre T, 2006, PLANT CELL PHYSIOL, V47, P634, DOI 10.1093/pcp/pcj030; Lin AP, 2011, BIOCHEMISTRY-US, V50, P230, DOI 10.1021/bi101401h; Lin AP, 2003, J BIOL CHEM, V278, P12864, DOI 10.1074/jbc.M300154200; Martinez-Rivas JM, 1998, PLANT PHYSIOL, V118, P249, DOI 10.1104/pp.118.1.249; MARTINEZRIVAS JM, 1994, J PLANT PHYSIOL, V143, P129, DOI 10.1016/S0176-1617(11)81676-7; MCINTOSH CA, 1992, PLANT PHYSIOL, V100, P69, DOI 10.1104/pp.100.1.69; Mondal S., 2013, ADV BIOSCI BIOTECHNO, V4, P751, DOI DOI 10.4236/abb.2013.46099; Peers G, 2008, PLANT CELL, V20, P502, DOI 10.1105/tpc.107.056556; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodriguez-Arnedo A, 2005, PROTEIN J, V24, P259, DOI 10.1007/s10930-005-6746-8; Schrodinger L. L. C, 2010, PYMOL MOL GRAPHICS S; Soundar S, 2006, J BIOL CHEM, V281, P21073, DOI 10.1074/jbc.M602956200; Steen IH, 2002, ARCH MICROBIOL, V178, P297, DOI 10.1007/s00203-002-0439-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEZUKA T, 1983, PLANT PHYSIOL, V72, P959, DOI 10.1104/pp.72.4.959; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058918; Wang P, 2012, FEMS MICROBIOL LETT, V327, P134, DOI 10.1111/j.1574-6968.2011.02467.x; Wrenger C, 2003, EUR J BIOCHEM, V270, P1775, DOI 10.1046/j.1432-1033.2003.03536.x; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	48	13	14	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2462	2472		10.1096/fj.14-257014	http://dx.doi.org/10.1096/fj.14-257014			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25724193				2022-12-26	WOS:000355209500023
J	Vanacloig-Pedros, E; Bets-Plasencia, C; Pascual-Ahuir, A; Proft, M				Vanacloig-Pedros, Elena; Bets-Plasencia, Carolina; Pascual-Ahuir, Amparo; Proft, Markus			Coordinated Gene Regulation in the Initial Phase of Salt Stress Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Glycerol; Saccharomyces cerevisiae; Stress Response; Transcription Regulation; Vacuolar ATPase; Hog1; Osmotic Stress	VACUOLAR H+-ATPASE; RNA POL-II; SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; MAP KINASE; 2 ISOENZYMES; HOG PATHWAY; EXPRESSION; YEAST; GLYCEROL	Stress triggers complex transcriptional responses, which include both gene activation and repression. We used time-resolved reporter assays in living yeast cells to gain insights into the coordination of positive and negative control of gene expression upon salt stress. We found that the repression of housekeeping genes coincides with the transient activation of defense genes and that the timing of this expression pattern depends on the severity of the stress. Moreover, we identified mutants that caused an alteration in the kinetics of this transcriptional control. Loss of function of the vacuolar H+-ATPase (vma1) or a defect in the biosynthesis of the osmolyte glycerol (gpd1) caused a prolonged repression of housekeeping genes and a delay in gene activation at inducible loci. Both mutants have a defect in the relocation of RNA polymerase II complexes at stress defense genes. Accordingly salt-activated transcription is delayed and less efficient upon partially respiratory growth conditions in which glycerol production is significantly reduced. Furthermore, the loss of Hog1 MAP kinase function aggravates the loss of RNA polymerase II from housekeeping loci, which apparently do not accumulate at inducible genes. Additionally the Def1 RNA polymerase II degradation factor, but not a high pool of nuclear polymerase II complexes, is needed for efficient stress-induced gene activation. The data presented here indicate that the finely tuned transcriptional control upon salt stress is dependent on physiological functions of the cell, such as the intracellular ion balance, the protective accumulation of osmolyte molecules, and the RNA polymerase II turnover.	[Proft, Markus] Univ Politecn Valencia, Dept Mech Plant Stress Responses, Consejo Super Invest Cient, Valencia 46022, Spain; [Vanacloig-Pedros, Elena; Bets-Plasencia, Carolina; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Dept Biotechnol, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Pascual-Ahuir, A (corresponding author), Univ Politecn Valencia, Dept Biotechnol, Inst Biol Mol & Celular Plantas, Ingeniero Fausto Elio S-N, Valencia 46022, Spain.	apascual@ibmcp.upv.es; mproft@ibmcp.upv.es	Pascual-ahuir, Amparo/K-1338-2014; Proft, Markus/K-2323-2014	Proft, Markus/0000-0002-6788-5830; PASCUAL-AHUIR, AMPARO/0000-0001-6173-1526	Ministerio de Economia y Competitividad [BFU2011-23326]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad Grant BFU2011-23326 (to M. P.).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Arino J, 2014, ADV MICROB PHYSIOL, V64, P1, DOI 10.1016/B978-0-12-800143-1.00001-4; Babazadeh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080901; Berry DB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002353; Bouwman J, 2011, YEAST, V28, P43, DOI 10.1002/yea.1819; Cook KE, 2012, G3-GENES GENOM GENET, V2, P1129, DOI 10.1534/g3.112.003251; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Esberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020829; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Guan QN, 2012, GENETICS, V192, P495, DOI 10.1534/genetics.112.143016; Hamilton CA, 2002, FEMS MICROBIOL LETT, V208, P227, DOI 10.1111/j.1574-6968.2002.tb11086.x; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Li SC, 2012, EUKARYOT CELL, V11, P282, DOI 10.1128/EC.05198-11; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Martinez-Montanes F, 2010, OMICS, V14, P619, DOI 10.1089/omi.2010.0046; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Nadal-Ribelles M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r106; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Ostergaard S, 2000, NAT BIOTECHNOL, V18, P1283, DOI 10.1038/82400; Petelenz-Kurdziel E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003084; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Rep M, 1999, MICROBIOL-UK, V145, P715, DOI 10.1099/13500872-145-3-715; Rep M, 1999, MOL CELL BIOL, V19, P5474; Rienzo A, 2012, YEAST, V29, P219, DOI 10.1002/yea.2905; Rios G, 1997, YEAST, V13, P515, DOI 10.1002/(SICI)1097-0061(199705)13:6<515::AID-YEA102>3.0.CO;2-X; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Wilson MD, 2013, CELL, V154, P983, DOI 10.1016/j.cell.2013.07.028; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	49	19	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10163	10175		10.1074/jbc.M115.637264	http://dx.doi.org/10.1074/jbc.M115.637264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25745106	Green Published, hybrid			2022-12-26	WOS:000353241100023
J	Fischer, C; Hofmann, M; Danzer, M; Hofer, K; Kaar, J; Gabriel, C				Fischer, Carina; Hofmann, Martina; Danzer, Martin; Hofer, Katja; Kaar, Jennifer; Gabriel, Christian			Seroprevalence and Incidence of hepatitis E in Blood Donors in Upper Austria	PLOS ONE			English	Article							E VIRUS-INFECTION; DEVELOPED-COUNTRIES; GERMANY; TRANSFUSION; PREVALENCE; ANTIBODIES; FRANCE; PLASMA; TRANSMISSION; ENGLAND	Background In recent years various studies showed, that hepatitis E virus (HEV) is a growing public health problem in many developed countries. Therefore, HEV infections might bear a transmission risk by blood transfusions. The clinical relevance still requires further investigations. The aim of this study was to provide an overview of acute HEV infections in Upper Austrian blood donors as well as a risk estimation of this transfusion-related infection. Methods and Findings A total of 58,915 blood donors were tested for HEV RNA using a commercial HEV RTPCR Kit. 7 of these donors (0.01%) were PCR-positive with normal laboratory parameters in absence of clinical signs of hepatitis. Viral load determined by quantitative real-time PCR showed a HEV nucleic acid concentration of 2,217 293,635 IU/ml. At follow-up testing (2-11 weeks after donation) all blood donors had negative HEV RNA results. Additionally, genotyping was performed by amplification and sequencing of the ORF1 or ORF2 region of the HEV genome. All HEV RNA positive donor samples revealed a genotype 3 isolate. For the antibody screening, anti-HEV IgM and IgG were detected by ELISA. Follow up serological testing revealed that no donor was seropositive for HEV IgM or IgG antibodies at time of donation. Moreover, we verified the prevalence of anti-HEV IgG in 1,203 of the HEV RNA negative tested blood donors. Overall 13.55% showed positive results for anti-HEV IgG. Conclusions In the presented study, we investigated HEV infections in blood donations of Upper Austria over 1 year. We concluded that 1 out of 8,416 blood donations is HEV RNA positive. Seroprevalence of anti HEV IgG results in an age-related increase of 13.55%. Therefore, based on this data, we recommend HEV-PCR screening to prevent transmission of hepatitis E virus by transfusion.	[Fischer, Carina; Hofmann, Martina; Danzer, Martin; Hofer, Katja; Kaar, Jennifer; Gabriel, Christian] Red Cross Transfus Serv Upper Austria, Linz, Austria		Fischer, C (corresponding author), Red Cross Transfus Serv Upper Austria, Linz, Austria.	carinafischer@gmx.at	Gabriel, Christian/A-1689-2014	Gabriel, Christian/0000-0003-2043-9320	Landsteiner Fonds of the Austrian Red Cross	Landsteiner Fonds of the Austrian Red Cross	This research was partially funded by a grant from the Landsteiner Fonds of the Austrian Red Cross. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Baylis SA, 2011, J CLIN MICROBIOL, V49, P1234, DOI 10.1128/JCM.02578-10; Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Chaussade H, 2013, J CLIN VIROL, V58, P504, DOI 10.1016/j.jcv.2013.08.030; Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056; Colson P, 2007, EMERG INFECT DIS, V13, P648, DOI 10.3201/eid1304.061387; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; de NA, 2012, NETH J MED, V70, P261; Dreier J, 2014, TRANSFUS MED HEMOTH, V41, P29, DOI 10.1159/000357098; Echevarria JM, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/481016; Faber MS, 2012, EMERG INFECT DIS, V18, P1654, DOI 10.3201/eid1810.111756; Gupta E, 2013, J CLIN VIROL, V58, P374, DOI 10.1016/j.jcv.2013.07.019; Hauser L, 2014, BLOOD, V123, P796, DOI 10.1182/blood-2013-09-524348; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Huzly D, 2014, EUROSURVEILLANCE, V19; Ijaz S, 2012, VOX SANG, V102, P272, DOI 10.1111/j.1423-0410.2011.01554.x; Krumbholz A, 2014, MED MICROBIOL IMMUN, V203, P273, DOI 10.1007/s00430-014-0336-3; Lagler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087669; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Olsen BR, 2006, SCAND J INFECT DIS, V38, P55, DOI 10.1080/00365540500321470; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Preiss JC, 2006, INFECTION, V34, P173, DOI 10.1007/s15010-006-4132-x; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Riezebos-Brilman A, 2013, J CLIN VIROL, V58, P509, DOI 10.1016/j.jcv.2013.08.022; Rutjes SA, 2009, EMERG INFECT DIS, V15, P381, DOI 10.3201/eid1503.071472; Schielke A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-58; Shata MT, 2008, CLIN INFECT DIS, V47, P1032, DOI 10.1086/591971; STATISTIK AUSTRIA, AS2010 HALT SCHW; STATISTIK AUSTRIA, SCHWEIN NACH BUND 19; Teshale EH, 2011, WORLD J HEPATOL, V3, P285, DOI 10.4254/wjh.v3.i12.285; Vollmer T, 2014, J CLIN MICROBIOL, V52, P2150, DOI 10.1128/JCM.03578-13; Vollmer T, 2012, J CLIN MICROBIOL, V50, P2708, DOI 10.1128/JCM.01119-12; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; Zwettler D, 2012, BERL MUNCH TIERARZTL, V125, P281, DOI 10.2376/0005-9366-125-281	41	69	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119576	10.1371/journal.pone.0119576	http://dx.doi.org/10.1371/journal.pone.0119576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751574	Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700027
J	Billings, SD; Boctor, EM; Taylor, RH				Billings, Seth D.; Boctor, Emad M.; Taylor, Russell H.			Iterative Most-Likely Point Registration (IMLP): A Robust Algorithm for Computing Optimal Shape Alignment	PLOS ONE			English	Article							EM-ICP; 2D	We present a probabilistic registration algorithm that robustly solves the problem of rigid-body alignment between two shapes with high accuracy, by aptly modeling measurement noise in each shape, whether isotropic or anisotropic. For point-cloud shapes, the probabilistic framework additionally enables modeling locally-linear surface regions in the vicinity of each point to further improve registration accuracy. The proposed Iterative Most-Likely Point (IMLP) algorithm is formed as a variant of the popular Iterative Closest Point (ICP) algorithm, which iterates between point-correspondence and point-registration steps. IMLP's probabilistic framework is used to incorporate a generalized noise model into both the correspondence and the registration phases of the algorithm, hence its name as a most-likely point method rather than a closest-point method. To efficiently compute the most-likely correspondences, we devise a novel search strategy based on a principal direction (PD)-tree search. We also propose a new approach to solve the generalized total-least-squares (GTLS) sub-problem of the registration phase, wherein the point correspondences are registered under a generalized noise model. Our GTLS approach has improved accuracy, efficiency, and stability compared to prior methods presented for this problem and offers a straightforward implementation using standard least squares. We evaluate the performance of IMLP relative to a large number of prior algorithms including ICP, a robust variant on ICP, Generalized ICP (GICP), and Coherent Point Drift (CPD), as well as drawing close comparison with the prior anisotropic registration methods of GTLS-ICP and A-ICP. The performance of IMLP is shown to be superior with respect to these algorithms over a wide range of noise conditions, outliers, and misalignments using both mesh and point-cloud representations of various shapes.	[Billings, Seth D.; Boctor, Emad M.; Taylor, Russell H.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Boctor, Emad M.] Johns Hopkins Med Inst, Dept Radiol, Div Med Imaging Phys, Baltimore, MD 21205 USA; [Boctor, Emad M.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Billings, SD (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	sbillin3@jhu.edu			National Science Foundation Graduate Research Fellowship Program (NSF GRFP); National Institutes of Health Graduate Partnership Program (NIH GPP); Hopkins University	National Science Foundation Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health Graduate Partnership Program (NIH GPP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins University(Johns Hopkins University)	Funding and support for this work was provided by: National Science Foundation Graduate Research Fellowship Program (NSF GRFP, http://www.nsfgrfp.org), National Institutes of Health Graduate Partnership Program (NIH GPP, http://www.nih.gov), a gift from Intuitive Surgical (http://www.intuitivesurgical.com), and Johns Hopkins University internal funds (http://www.jhu.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesto L, 2010, IEEE INT CONF ROBOT, P1367, DOI 10.1109/ROBOT.2010.5509371; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Balachandran R, 2009, SPIE MED IMAGING INT; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Chui HL, 2000, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P190, DOI 10.1109/MMBIA.2000.852377; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Combes B, 2010, LECT NOTES COMPUT SC, V6362, P594; Craig J.J., 2005, INTRO ROBOTICS MECH; Danilchenko A, 2011, IEEE T MED IMAGING, V30, P679, DOI 10.1109/TMI.2010.2091513; Deguet A., 2008, MIDAS J SYST ARCH CO, P1; Eberly D.H., 2010, GAME PHYS, DOI 10.1201/b18213; Estepar RSJ, 2004, LECT NOTES COMPUT SC, V3216, P234; FIEDLER M, 1971, P AM MATH SOC, V30, P27, DOI 10.2307/2038212; Fitzgibbon AW, 2003, IMAGE VISION COMPUT, V21, P1145, DOI 10.1016/j.imavis.2003.09.004; Gold S, 1998, PATTERN RECOGN, V31, P1019, DOI 10.1016/S0031-3203(98)80010-1; Granger S, 2002, LECT NOTES COMPUT SC, V2353, P418; Horn BKP, 1987, CLOSED FORM SOLUTION, V4; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Kanatani K., 2005, STAT OPTIMIZATION GE; Larsson Thomas, 2008, Journal of Graphics Tools, V13, P31; Maier-Hein L, 2012, IEEE T PATTERN ANAL, V34, P1520, DOI 10.1109/TPAMI.2011.248; Matei BC, 2006, IEEE T PATTERN ANAL, V28, P1537, DOI 10.1109/TPAMI.2006.205; Maurer CR, 1996, IEEE T MED IMAGING, V15, P836, DOI 10.1109/42.544501; Minguez J, 2006, IEEE T ROBOT, V22, P1047, DOI 10.1109/TRO.2006.878961; Moghari MH, 2007, IEEE T MED IMAGING, V26, P1708, DOI 10.1109/TMI.2007.901984; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Nazem F, 2014, INT J COMPUT ASS RAD, V9, P39, DOI 10.1007/s11548-013-0907-6; Ohta N, 1998, IEICE T INF SYST, VE81D, P1247; Pennec X, 1997, INT J COMPUT VISION, V25, P203, DOI 10.1023/A:1007976002485; Ramsey PH, 1994, TECHNOMETRICS, V36, P430, DOI [10.1080/ 00401706.1994.10485864, DOI 10.1080/00401706.1994.10485864]; Rice J.A., 2006, MATH STAT DATA ANAL; Samet H., 2006, FDN MULTIDIMENSIONAL; Segal A., 2009, ROBOT SCI SYST, V2; Sharp GC, 2002, IEEE T PATTERN ANAL, V24, P90, DOI 10.1109/34.982886; Tamaki T., 2010, Proceedings 2010 First International Conference on Networking and Computing (ICNC 2010), P179, DOI 10.1109/IC-NC.2010.60; Tsin Y, 2004, LECT NOTES COMPUT SC, V3023, P558; Verma N., 2009, P MONTR QUE 25 C UNC, P565; WALKER MW, 1991, CVGIP-IMAG UNDERSTAN, V54, P358, DOI 10.1016/1049-9660(91)90036-O; WENTWORTH WE, 1965, J CHEM EDUC, V42, P96, DOI 10.1021/ed042p96; Williams J. R., 1997, Paper - American Society of Agricultural Engineers, P1; Yildirim EA, 2006, SIAM J OPTIMIZ, V17, P621, DOI 10.1137/050622560; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149	43	43	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0117688	10.1371/journal.pone.0117688	http://dx.doi.org/10.1371/journal.pone.0117688			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748700	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400010
J	Karim, ZA; Vemana, HP; Khasawneh, FT				Karim, Zubair A.; Vemana, Hari Priya; Khasawneh, Fadi T.			MALT1-Ubiquitination Triggers Non-Genomic NF-kappa B/IKK Signaling upon Platelet Activation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; B ACTIVATION; ARTERIAL THROMBOSIS; KINASE; MALT1; BCL10; EXPRESSION; INHIBITOR; PROTEIN; NEMO	We have recently shown that IKK complex plays an important non-genomic role in platelet function, i.e., regulates SNARE machinery-dependent membrane fusion. In this connection, it is well known that MALT1, whose activity is modulated by proteasome, plays an important role in the regulation of IKK complex. Therefore, the present studies investigated the mechanism by which IKK signaling is regulated in the context of the platelet proteasome. It was found that platelets express a functional proteasome, and form CARMA/MALT1/Bcl10 (CBM) complex when activated. Using a pharmacological inhibitor, the proteasome was found to regulate platelet function (aggregation, integrin activation, secretion, phosphatidylserine exposure and changes in intracellular calcium). It was also found to regulate thrombogenesis and physiologic hemostasis. We also observed, upon platelet activation, that MALT1 is ubiquitinated, and this coincides with the activation of the IKK/NF-kappa B-signaling pathway. Finally, we observed that the proteasome inhibitor blocks CBM complex formation and the interaction of IKK gamma and MALT1; abrogates SNARE formation, and the association of MALT1 with TAK1 and TAB2, which are upstream of the CBM complex. Thus, our data demonstrate that MALT1 ubiquitination is critical for the engagement of CBM and IKK complexes, thereby directing platelet signals to the NF-kappa B pathway.	[Karim, Zubair A.; Vemana, Hari Priya; Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Karim, ZA (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	zkarim@westernu.edu			College of Pharmacy, Western University of Health Sciences, Pomona, CA	College of Pharmacy, Western University of Health Sciences, Pomona, CA	This work was supported by funds from the College of Pharmacy, Western University of Health Sciences, Pomona, CA (to F.T.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell RA, 2014, J CLIN INVEST, V124, P3757, DOI DOI 10.1172/JCI75247; Conner EM, 1997, J PHARMACOL EXP THER, V282, P1615; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Daniel J, 2010, NY TIMES BK REV, P6; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Lang F, 2013, THROMB HAEMOSTASIS, V110, P925, DOI 10.1160/TH13-02-0176; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nayak MK, 2013, J BIOL CHEM, V288, P6826, DOI 10.1074/jbc.M112.403154; Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Ostrowska JK, 2004, THROMB HAEMOSTASIS, V92, P171, DOI 10.1160/TH03-11-0707; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; READ MA, 1995, IMMUNITY, V2, P493, DOI 10.1016/1074-7613(95)90030-6; Rosebeck S, 2011, FUTURE ONCOL, V7, P613, DOI [10.2217/fon.11.35, 10.2217/FON.11.35]; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shi DS, 2014, J CLIN INVEST, V124, P3757, DOI 10.1172/JCI75247; Staal J, 2011, CELL RES, V21, P40, DOI 10.1038/cr.2010.168; STULL JT, 1993, MOL CELL BIOCHEM, V128, P229, DOI 10.1007/BF01076774; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Suzuki-Inoue K, 2007, THROMB RES, V120, P251, DOI 10.1016/j.thromres.2006.09.003; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wei SJ, 2013, ARTERIOSCL THROM VAS, V33, P241, DOI 10.1161/ATVBAHA.112.300781; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia LJ, 1998, BLOOD, V91, P1625, DOI 10.1182/blood.V91.5.1625.1625_1625_1632	45	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119363	10.1371/journal.pone.0119363	http://dx.doi.org/10.1371/journal.pone.0119363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748427	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400069
J	Luyet, C; Schulze, K; Sayar, BS; Howald, D; Muller, EJ; Galichet, A				Luyet, Camille; Schulze, Katja; Sayar, Beyza S.; Howald, Denise; Mueller, Eliane J.; Galichet, Arnaud			Preclinical Studies Identify Non-Apoptotic Low-Level Caspase-3 as Therapeutic Target in Pemphigus Vulgaris	PLOS ONE			English	Article							CELL-DEATH; TERMINAL DIFFERENTIATION; B IRRADIATION; ULTRAVIOLET-B; MOUSE MODEL; GRANZYME-B; C-MYC; ACTIVATION; MECHANISM; KERATINOCYTES	The majority of pemphigus vulgaris (PV) patients suffer from a live-threatening loss of intercellular adhesion between keratinocytes (acantholysis). The disease is caused by autoantibodies that bind to desmosomal cadherins desmoglein (Dsg) 3 or Dsg3 and Dsg1 in mucous membranes and skin. A currently unresolved controversy in PV is whether apoptosis is involved in the pathogenic process. The objective of this study was to perform preclinical studies to investigate apoptotic pathway activation in PV pathogenesis with the goal to assess its potential for clinical therapy. For this purpose, we investigated mouse and human skin keratinocyte cultures treated with PV antibodies (the experimental Dsg3 monospecific antibody AK23 or PV patients IgG), PV mouse models (passive transfer of AK23 or PVIgG into adult and neonatal mice) as well as PV patients' biopsies (n= 6). A combination of TUNEL assay, analyses of membrane integrity, early apoptotic markers such as cleaved poly-ADP-ribose polymerase (PARP) and the collapse of actin cytoskeleton failed to provide evidence for apoptosis in PV pathogenesis. However, the in vitro and in vivo PV models, allowing to monitor progression of lesion formation, revealed an early, transient and low-level caspase-3 activation. Pharmacological inhibition confirmed the functional implication of caspase-3 in major events in PV such as shedding of Dsg3, keratin retraction, proliferation including c-Myc induction, p38MAPK activation and acantholysis. Together, these data identify low-level caspase-3 activation downstream of disrupted Dsg3 trans-or cis-adhesion as a major event in PV pathogenesis that is non-synonymous with apoptosis and represents, unlike apoptotic components, a promising target for clinical therapy. At a broader level, these results posit that an impairment of adhesive functions in concert with low-level, non-lethal caspase-3 activation can evoke profound cellular changes which may be of relevance for other diseases including cancer.	[Luyet, Camille; Schulze, Katja; Sayar, Beyza S.; Howald, Denise; Mueller, Eliane J.; Galichet, Arnaud] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Mol Dermatol, Bern, Switzerland; [Luyet, Camille; Schulze, Katja; Sayar, Beyza S.; Howald, Denise; Mueller, Eliane J.; Galichet, Arnaud] Univ Bern, Vetsuisse Fac, DermFocus, Bern, Switzerland; [Mueller, Eliane J.] Univ Hosp Bern, Dept Dermatol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern	Galichet, A (corresponding author), Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Mol Dermatol, Bern, Switzerland.	arnaud.galichet@vetsuisse.unibe.ch			Coordination Theme I (Health) of the European Community's FP7 [HEALTH-F2-2008-200515]; Swiss National Science Foundation [31003A_135689]; Martha Stiftung Zurich; Novartis Research Fund, Basel, Switzerland	Coordination Theme I (Health) of the European Community's FP7; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Martha Stiftung Zurich; Novartis Research Fund, Basel, Switzerland	Financial support for CL, BS and AG from "Coordination Theme I (Health) of the European Community's FP7, grant agreement number HEALTH-F2-2008-200515", for CL, BS, KS also from the Swiss National Science Foundation grant 31003A_135689 and the Martha Stiftung Zurich and for KS from the Novartis Research Fund, Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis Foundation for biological-medical research is not a commercial source but a Foundation with no rights on generated data or material (please consult the home page http://www.stiftungmedbiol.novartis.com/index.html). This funding does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; [Anonymous], 2006, EMBO J; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Caldelari R, 2010, METHODS MOL BIOL, V633, P125, DOI 10.1007/978-1-59745-019-5_10; Cirillo N, 2008, EXP DERMATOL, V17, P858, DOI 10.1111/j.1600-0625.2008.00719.x; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; Daher A, 2006, EXP DERMATOL, V15, P23, DOI 10.1111/j.0906-6705.2005.00384.x; de Bruin A, 2007, EXP DERMATOL, V16, P468, DOI 10.1111/j.1600-0625.2007.00557.x; Demeret C, 2003, ONCOGENE, V22, P168, DOI 10.1038/sj.onc.1206108; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Fischer U, 2005, CELL DEATH DIFFER, V12, P942, DOI 10.1038/sj.cdd.4401556; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Gniadecki R, 1998, ARCH DERMATOL RES, V290, P528, DOI 10.1007/s004030050347; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Hanakawa Y, 2004, J INVEST DERMATOL, V123, P817, DOI 10.1111/j.0022-202X.2004.23479.x; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Hsu SL, 2006, APOPTOSIS, V11, P765, DOI 10.1007/s10495-006-5880-x; Ishii K, 1997, J IMMUNOL, V159, P2010; Janse IC, 2014, J INVEST DERMATOL, V134, P2039, DOI 10.1038/jid.2014.60; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Kim SM, 2009, TOXICOL APPL PHARM, V241, P210, DOI 10.1016/j.taap.2009.08.024; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Koch PJ, 1998, J CELL SCI, V111, P2529; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Li N, 2009, J IMMUNOL, V182, P711, DOI 10.4049/jimmunol.182.1.711; Lotti R, 2012, CURR PHARM BIOTECHNO, V13, P1877, DOI 10.2174/138920112802273236; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mao XM, 2014, J INVEST DERMATOL, V134, P68, DOI 10.1038/jid.2013.224; McComb S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015328; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Pacheco-Tovar D, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/563091; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perfettini JL, 2003, NAT IMMUNOL, V4, P308, DOI 10.1038/ni0403-308; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Puga I, 2008, IMMUNITY, V29, P193, DOI 10.1016/j.immuni.2008.06.010; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Rodeck U, 1997, J CELL SCI, V110, P113; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Sayar BS, 2014, EXP DERMATOL, V23, P33, DOI 10.1111/exd.12290; Schmidt E, 2009, AUTOIMMUN REV, V8, P533, DOI 10.1016/j.autrev.2009.01.011; Schmidt E, 2009, AM J PHYSIOL-CELL PH, V296, pC162, DOI 10.1152/ajpcell.00161.2008; Schulze K, 2012, J INVEST DERMATOL, V132, P346, DOI 10.1038/jid.2011.299; Seiffert-Sinha K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106895; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Suter MM, 1998, ADVANCES IN VETERINARY DERMATOLOGY, VOL 3, P321; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Veraitch O, 2013, J EUR ACAD DERMATOL, V27, P86, DOI 10.1111/j.1468-3083.2011.04363.x; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Wu NL, 2011, J INVEST DERMATOL, V131, P874, DOI 10.1038/jid.2010.402; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	74	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119809	10.1371/journal.pone.0119809	http://dx.doi.org/10.1371/journal.pone.0119809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748204	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400088
J	Torres, LG; Sutton, PJH; Thompson, DR; Delord, K; Weimerskirch, H; Sagar, PM; Sommer, E; Dilley, BJ; Ryan, PG; Phillips, RA				Torres, Leigh G.; Sutton, Philip J. H.; Thompson, David R.; Delord, Karine; Weimerskirch, Henri; Sagar, Paul M.; Sommer, Erica; Dilley, Ben J.; Ryan, Peter G.; Phillips, Richard A.			Poor Transferability of Species Distribution Models for a Pelagic Predator, the Grey Petrel, Indicates Contrasting Habitat Preferences across Ocean Basins	PLOS ONE			English	Article							MARINE PREDATOR; SOUTHERN-OCEAN; REGRESSION; PREDICTION; ACCURACY; SENSITIVITY; SEABIRDS; BEHAVIOR; SUCCESS; REGIONS	Species distribution models (SDMs) are increasingly applied in conservation management to predict suitable habitat for poorly known populations. High predictive performance of SDMs is evident in validations performed within the model calibration area (interpolation), but few studies have assessed SDM transferability to novel areas (extrapolation), particularly across large spatial scales or pelagic ecosystems. We performed rigorous SDM validation tests on distribution data from three populations of a long-ranging marine predator, the grey petrel Procellaria cinerea, to assess model transferability across the Southern Hemisphere (25-65 degrees S). Oceanographic data were combined with tracks of grey petrels from two remote sub-Antarctic islands (Antipodes and Kerguelen) using boosted regression trees to generate three SDMs: one for each island population, and a combined model. The predictive performance of these models was assessed using withheld tracking data from within the model calibration areas (interpolation), and from a third population, Marion Island (extrapolation). Predictive performance was assessed using k-fold cross validation and point biserial correlation. The two population-specific SDMs included the same predictor variables and suggested birds responded to the same broad-scale oceanographic influences. However, all model validation tests, including of the combined model, determined strong interpolation but weak extrapolation capabilities. These results indicate that habitat use reflects both its availability and bird preferences, such that the realized distribution patterns differ for each population. The spatial predictions by the three SDMs were compared with tracking data and fishing effort to demonstrate the conservation pitfalls of extrapolating SDMs outside calibration regions. This exercise revealed that SDM predictions would have led to an underestimate of overlap with fishing effort and potentially misinformed bycatch mitigation efforts. Although SDMs can elucidate potential distribution patterns relative to large-scale climatic and oceanographic conditions, knowledge of local habitat availability and preferences is necessary to understand and successfully predict region-specific realized distribution patterns.	[Torres, Leigh G.] Oregon State Univ, Dept Fisheries & Wildlife, Marine Mammal Inst, Newport, OR 97365 USA; [Sutton, Philip J. H.; Thompson, David R.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Delord, Karine; Weimerskirch, Henri] Ctr Etud Biol Chize, CNRS UPR 1934, Villiers En Bois, France; [Sagar, Paul M.] Natl Inst Water & Atmospher Res Ltd, Christchurch, New Zealand; [Sommer, Erica] Denny Ecol, Cambridge, England; [Dilley, Ben J.; Ryan, Peter G.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Phillips, Richard A.] NERC, British Antarctic Survey, Cambridge, England	Oregon State University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Centre National de la Recherche Scientifique (CNRS); National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Research Foundation - South Africa; University of Cape Town; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Torres, LG (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Marine Mammal Inst, Newport, OR 97365 USA.	leigh.torres@oregonstate.edu	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019; Thompson, David R/E-2431-2018	Weimerskirch, Henri/0000-0002-0457-586X; Thompson, David R/0000-0001-8518-6307; Sutton, Phil/0000-0003-2936-0918	National Institute of Water and Atmospheric Research, Ltd. (NIWA); New Zealand Ministry for Primary Industries [PRO2006-01]; Institut Polaire Francais Paul-Emile Victor (IPEV, programme) [109]; Prince Albert II de Monaco Foundation; Program ANR Biodiversite REMIGE; Program ANR 07 Biodiv 'Glides'; South African National Antarctic Programme; BirdLife International's Seabird Tracking Fund; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	National Institute of Water and Atmospheric Research, Ltd. (NIWA); New Zealand Ministry for Primary Industries; Institut Polaire Francais Paul-Emile Victor (IPEV, programme); Prince Albert II de Monaco Foundation; Program ANR Biodiversite REMIGE(French National Research Agency (ANR)); Program ANR 07 Biodiv 'Glides'(French National Research Agency (ANR)); South African National Antarctic Programme; BirdLife International's Seabird Tracking Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding and support for this study was provided by the National Institute of Water and Atmospheric Research, Ltd. (NIWA), the New Zealand Ministry for Primary Industries (PRO2006-01), the Institut Polaire Francais Paul-Emile Victor (IPEV, programme no. 109, HW), the Prince Albert II de Monaco Foundation, Program ANR Biodiversite 2005-11 REMIGE, and Program ANR 07 Biodiv 'Glides'. Research at Marion Island is supported by the South African National Antarctic Programme and GLS loggers for this colony were sponsored by BirdLife International's Seabird Tracking Fund. Denny Ecology provided support in the form of a salary for author ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aarts G, 2013, J ANIM ECOL, V82, P1135, DOI 10.1111/1365-2656.12061; Barbraud C, 2009, ANIM CONSERV, V12, P258, DOI 10.1111/j.1469-1795.2009.00248.x; BARTLE J A, 1990, Notornis, V37, P146; Bell E, 2002, GREY PETRELS PROCELL; Bester MN, 2002, S AFR J WILDL RES, V32, P65; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Birdlife International, 2013, SEAB TRACK DAT; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Compton TJ, 2013, J BIOGEOGR, V40, P75, DOI 10.1111/j.1365-2699.2012.02761.x; Dunn JR, 2002, DEEP-SEA RES PT I, V49, P591, DOI 10.1016/S0967-0637(01)00069-3; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gille ST, 2003, J PHYS OCEANOGR, V33, P1167, DOI 10.1175/1520-0485(2003)033<1167:FOOTSO>2.0.CO;2; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hyrenbach KD, 2006, MAR ECOL PROG SER, V324, P271, DOI 10.3354/meps324271; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Leftwich KN, 1997, T AM FISH SOC, V126, P725, DOI 10.1577/1548-8659(1997)126<0725:FIBATO>2.3.CO;2; Louzao M, 2012, ECOGRAPHY, V35, P1; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Martin J, 2012, J APPL ECOL, V49, P621, DOI 10.1111/j.1365-2664.2012.02139.x; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; Merow C, 2014, ECOGRAPHY; Moore JE, 2008, ANIM CONSERV, V11, P257, DOI 10.1111/j.1469-1795.2008.00197.x; Murray JV, 2011, AUSTRAL ECOL, V36, P76, DOI 10.1111/j.1442-9993.2010.02122.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Oppel S, 2012, BIOL CONSERV, V156, P94, DOI 10.1016/j.biocon.2011.11.013; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Ridgeway G, 2007, GEN BOOSTED REGRESSI; Ridoux Vincent, 1994, Marine Ornithology, V22, P1; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Ryan PG., 2008, PRINCE EDWARD ISLAND, P121, DOI [DOI 10.18820/9781928357063/06, https://doi.org/10.18820/9781928357063/06]; Soanes LM, 2013, J APPL ECOL, V50, P671, DOI 10.1111/1365-2664.12069; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Sommer E, 2010, ANTIPODES ISLAND WHI; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thiebot JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071429; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Torres LG, 2013, DIVERS DISTRIB, V19, P1138, DOI 10.1111/ddi.12069; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Vanreusel W, 2007, CONSERV BIOL, V21, P201, DOI 10.1111/j.1523-1739.2006.00577.x; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Whittingham MJ, 2003, ECOGRAPHY, V26, P521, DOI 10.1034/j.1600-0587.2003.03522.x; Xavier JC, 2013, ICES J MAR SCI, V70, P46, DOI 10.1093/icesjms/fss167; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004; Zharikov Y, 2007, J APPL ECOL, V44, P748, DOI 10.1111/j.1365-2664.2007.01319.x; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x; Zydelis R, 2011, P ROY SOC B-BIOL SCI, V278, P3191, DOI 10.1098/rspb.2011.0330	61	59	61	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120014	10.1371/journal.pone.0120014	http://dx.doi.org/10.1371/journal.pone.0120014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748948	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000350689400092
J	Zhang, ZL; Bai, ZH; Wang, XB; Bai, L; Miao, F; Pei, HH				Zhang, Zheng-liang; Bai, Zheng-hai; Wang, Xiao-bo; Bai, Ling; Miao, Fei; Pei, Hong-hong			miR-186 and 326 Predict the Prognosis of Pancreatic Ductal Adenocarcinoma and Affect the Proliferation and Migration of Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; MICRORNA; EXPRESSION; SURVIVAL; INVASION; TARGETS; ASSOCIATION; DIAGNOSIS; ACTS	MicroRNAs can function as key tumor suppressors or oncogenes and act as biomarkers for cancer diagnosis or prognosis. Although high-throughput assays have revealed many miRNA biomarkers for pancreatic ductal adenocarcinoma (PDAC), only a few have been validated in independent populations or investigated for functional significance in PDAC pathogenesis. In this study, we correlated the expression of 36 potentially prognostic miRNAs within PDAC tissue with clinico-pathological features and survival in 151 Chinese patients. We then analyzed the functional roles and target genes of two miRNAs in PDAC development. We found that high expression of miR-186 and miR-326 predict poor and improved survival, respectively. miR-186 was over-expressed in PDAC patients compared with controls, especially in patients with large tumors (> 2 cm), lymph node metastasis, or short-term survival (< 24 months). In contrast, miR-326 was down-regulated in patients compared with controls and displayed relatively increased expression in the patients with long-term survival or without venous invasion. Functional experiments revealed that PDAC cell proliferation and migration was decreased following inhibition and enhanced following over-expression of miR-186. In contrast, it was enhanced following inhibition and decreased after over-expression of miR-326. A luciferase assay indicated that miR-186 can bind directly to the 3'-UTR of NR5A2 to repress gene expression. These findings suggest that miR-186 over-expression contributes to the invasive potential of PDAC, likely via suppression of NR5A2, thereby leading to a poor prognosis; high miR-326 expression prolongs survival likely via the decreasing invasive potential of PDAC cells. These two miRNAs can be used as markers for clinical diagnosis and prognosis, and they represent therapeutic targets for PDAC.	[Zhang, Zheng-liang; Bai, Zheng-hai; Wang, Xiao-bo; Bai, Ling; Miao, Fei; Pei, Hong-hong] Xi An Jiao Tong Univ, Affiliated Hosp 2, Emergency Dept, Xian 710004, Shaan Xi, Peoples R China	Xi'an Jiaotong University	Pei, HH (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Emergency Dept, Xian 710004, Shaan Xi, Peoples R China.	peihonghongtwoyuan@163.com			Social Development Guide Plan of Xi'an [5F1203(5)]; Support Project for Youth of The Second Affiliated Hospital of Xi'an Jiaotong University [YJ(QN) 201204]	Social Development Guide Plan of Xi'an; Support Project for Youth of The Second Affiliated Hospital of Xi'an Jiaotong University	The project was supported by the Social Development Guide Plan of Xi'an (5F1203(5)) and the Support Project for Youth of The Second Affiliated Hospital of Xi'an Jiaotong University (YJ(QN) 201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2013, INDIAN J MED RES, V137, P680; Ben-Moshe NB, 2012, NUCLEIC ACIDS RES, V40, P10614, DOI 10.1093/nar/gks841; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat K, 2012, CURR PHARM DESIGN, V18, P2439, DOI 10.2174/13816128112092439; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Dayem Ullah AZ, 2014, INDIAN J MED RES, V42, pD944, DOI [10.1093/0343959, DOI 10.1093/0343959]; Erdmann K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-82; Flandez M, 2014, GUT, V63, P647, DOI 10.1136/gutjnl-2012-304381; Giovannetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049145; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Jiao LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032068; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Laurila EM, 2012, GENE CHROMOSOME CANC, V51, P557, DOI 10.1002/gcc.21941; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HL, 2013, CARCINOGENESIS, V34, P2145, DOI 10.1093/carcin/bgt158; Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99; Long J, 2014, CANCER LETT, V346, P273, DOI 10.1016/j.canlet.2014.01.004; Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360; Nagao Y, 2012, MODERN PATHOL, V25, P112, DOI 10.1038/modpathol.2011.142; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Saif MW, 2006, J PANCREAS, V7, P337; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; Wang S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0373-y; Xue Y, 2013, CANCER GENET-NY, V206, P217, DOI 10.1016/j.cancergen.2013.05.020; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	37	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118814	10.1371/journal.pone.0118814	http://dx.doi.org/10.1371/journal.pone.0118814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742499	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100049
J	Braun, FK; Mathur, R; Sehgal, L; Wilkie-Grantham, R; Chandra, J; Berkova, Z; Samaniego, F				Braun, Frank K.; Mathur, Rohit; Sehgal, Lalit; Wilkie-Grantham, Rachel; Chandra, Joya; Berkova, Zuzana; Samaniego, Felipe			Inhibition of Methyltransferases Accelerates Degradation of cFLIP and Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis	PLOS ONE			English	Article							C-FLIP; DEATH RECEPTORS; KAPPA-B; CANCER; METHYLATION; TARGETS; EZH2; REGULATORS; RITUXIMAB; MICRORNAS	Non-Hodgkin lymphomas (NHLs) are characterized by specific abnormalities that alter cell cycle regulation, DNA damage response, and apoptotic signaling. It is believed that cancer cells are particularly sensitive to cell death induced by tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL). However, many cancer cells show blocked TRAIL signaling due to up-regulated expression of anti-apoptotic factors, such as cFLIP. This hurdle to TRAIL's tumor cytotoxicity might be overcome by combining TRAIL-based therapy with drugs that reverse blockages of its apoptotic signaling. In this study, we investigated the impact of a pan-methyltransferase inhibitor (3-deazaneplanocin A, or DZNep) on TRAIL-induced apoptosis in aggressive B-cell NHLs: mantle cell, Burkitt, and diffuse large B-cell lymphomas. We characterized TRAIL apoptosis regulation and caspase activation in several NHL-derived cell lines pre-treated with DZNep. We found that DZNep increased cancer cell sensitivity to TRAIL signaling by promoting caspase-8 processing through accelerated cFLIP degradation. No change in cFLIP mRNA level indicated independence of promoter methylation alterations in methyltransferase activity induced by DZNep profoundly affected cFLIP mRNA stability and protein stability. This appears to be in part through increased levels of cFLIP-targeting microRNAs (miR-512-3p and miR-346). However, additional microRNAs and cFLIP-regulating mechanisms appear to be involved in DZNep-mediated enhanced response to extrinsic apoptotic stimuli. The capacity of DZNep to target cFLIP expression on multiple levels underscores DZNep's potential in TRAIL-based therapies for B-cell NHLs.	[Braun, Frank K.; Mathur, Rohit; Sehgal, Lalit; Berkova, Zuzana; Samaniego, Felipe] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Chandra, Joya] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Wilkie-Grantham, Rachel] Sanford Burnham Med Res Inst, La Jolla, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Sanford Burnham Prebys Medical Discovery Institute	Samaniego, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.	fsamaniego@mdanderson.org	Chandra, Joya/ABC-7869-2021; Berkova, Zuzana/E-9010-2018	Chandra, Joya/0000-0002-2077-9715; Berkova, Zuzana/0000-0001-8196-6517; Mathur, Rohit/0000-0001-5453-3353; Sehgal, lalit/0000-0002-1151-5427	Richard Spencer Lewis Memorial Foundation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Richard Spencer Lewis Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Elsa Flores, MD Anderson Cancer Center, for supplying constructs encoding for shRNA against DICER. This work was supported in part by the Richard Spencer Lewis Memorial Foundation and patients' families.	Al-Yacoub N, 2012, J INVEST DERMATOL, V132, P2263, DOI 10.1038/jid.2012.125; Antonov AV, 2014, ONCOGENE, V33, P1621, DOI 10.1038/onc.2013.119; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cardesa-Salzmann TM, 2011, HAEMATOL-HEMATOL J, V96, P996, DOI 10.3324/haematol.2010.037408; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen F, 2010, ONCOL REP, V23, P1457, DOI 10.3892/or_00000784; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2014, CURR PHARM DESIGN, V20, P5328, DOI 10.2174/1381612820666140128211346; God JM, 2010, J ONCOL, V2010, P1; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howlader N, 2014, SEER CANCER STATISTI; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jakopovic M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00261; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mair B, 2014, TRENDS PHARMACOL SCI, V35, P136, DOI 10.1016/j.tips.2014.01.001; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Menon MP, 2012, CANCER J, V18, P411, DOI 10.1097/PPO.0b013e31826aee97; Micheau O, 2013, BRIT J PHARMACOL, V169, P1723, DOI 10.1111/bph.12238; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Murphy TM, 2011, PROSTATE, V71, P1, DOI 10.1002/pros.21212; Nilsen TW, 2014, SCIENCE, V343, P1207, DOI 10.1126/science.1249340; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roue G, 2007, J IMMUNOL, V178, P1923, DOI 10.4049/jimmunol.178.3.1923; Ruan J, 2009, ONCOLOGY-NY, V23, P683; Ryan RJH, 2012, SCIENCE, V336, P1513, DOI 10.1126/science.1223730; Safa A. R., 2012, Experimental Oncology, V34, P176; Sehgal L, 2014, LEUKEMIA, V28, P2376, DOI 10.1038/leu.2014.126; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Van Rechem C, 2014, BBA-GENE REGUL MECH, V1839, P1463, DOI 10.1016/j.bbagrm.2014.05.014; Vecchio L, 2013, BBA-REV CANCER, V1836, P90, DOI 10.1016/j.bbcan.2013.04.001; Wang J, 2013, INT J ORAL MAX SURG, V42, P949, DOI 10.1016/j.ijom.2013.04.016; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wee S, 2014, ANN NY ACAD SCI, V1309, P30, DOI 10.1111/nyas.12356; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Wilkie-Grantham RP, 2013, J BIOL CHEM, V288, P12777, DOI 10.1074/jbc.M112.431320; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531; Xiao YT, 2011, INT J BIOCHEM CELL B, V43, P474, DOI 10.1016/j.biocel.2011.01.005; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Younes A, 2011, NAT REV CLIN ONCOL, V8, P124, DOI 10.1038/nrclinonc.2011.20; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	61	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117994	10.1371/journal.pone.0117994	http://dx.doi.org/10.1371/journal.pone.0117994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738497	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900020
J	Li, W; Yu, J; Lian, BF; Sun, H; Li, J; Zhang, MH; Li, L; Li, YX; Liu, Q; Xie, L				Li, Wei; Yu, Jian; Lian, Baofeng; Sun, Han; Li, Jing; Zhang, Menghuan; Li, Ling; Li, Yixue; Liu, Qian; Xie, Lu			Identifying Prognostic Features by Bottom-Up Approach and Correlating to Drug Repositioning	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; STAGING-SYSTEM; SURVIVAL; METASTASIS; INHIBITION; SIGNATURE; SCORE; HEPATOCARCINOGENESIS	Background Traditionally top-down method was used to identify prognostic features in cancer research. That is to say, differentially expressed genes usually in cancer versus normal were identified to see if they possess survival prediction power. The problem is that prognostic features identified from one set of patient samples can rarely be transferred to other datasets. We apply bottom-up approach in this study: survival correlated or clinical stage correlated genes were selected first and prioritized by their network topology additionally, then a small set of features can be used as a prognostic signature. Methods Gene expression profiles of a cohort of 221 hepatocellular carcinoma (HCC) patients were used as a training set, 'bottom-up' approach was applied to discover gene-expression signatures associated with survival in both tumor and adjacent non-tumor tissues, and compared with 'top-down' approach. The results were validated in a second cohort of 82 patients which was used as a testing set. Results Two sets of gene signatures separately identified in tumor and adjacent non-tumor tissues by bottom-up approach were developed in the training cohort. These two signatures were associated with overall survival times of HCC patients and the robustness of each was validated in the testing set, and each predictive performance was better than gene expression signatures reported previously. Moreover, genes in these two prognosis signature gave some indications for drug-repositioning on HCC. Some approved drugs targeting these markers have the alternative indications on hepatocellular carcinoma. Conclusion Using the bottom-up approach, we have developed two prognostic gene signatures with a limited number of genes that associated with overall survival times of patients with HCC. Furthermore, prognostic markers in these two signatures have the potential to be therapeutic targets.	[Li, Wei; Li, Jing; Liu, Qian] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan 430074, Peoples R China; [Li, Wei; Yu, Jian; Lian, Baofeng; Sun, Han; Li, Jing; Zhang, Menghuan; Li, Ling; Li, Yixue; Xie, Lu] Shanghai Acad Sci & Technol, Shanghai Inst Biomed, Shanghai Ctr Bioinformat Technol, Shanghai 201203, Peoples R China; [Li, Wei; Li, Jing; Liu, Qian] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Lian, Baofeng; Zhang, Menghuan; Li, Yixue] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, Shanghai 200240, Peoples R China; [Sun, Han; Li, Yixue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Huazhong University of Science & Technology; Shanghai Jiao Tong University; Chinese Academy of Sciences	Liu, Q (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan 430074, Peoples R China.	qianliu@mail.hust.edu.cn; xielu@scbit.org	liu, qian/HDM-2936-2022; Liu, Qian/D-8184-2011; Qian, Liu/GYU-5886-2022	Liu, Qian/0000-0002-8398-1021; 	Key Infectious Disease Project [2012ZX10002012-014]; National Hi-Tech Program [2012AA020201]; National Key Basic Research Program [2010CB912702]	Key Infectious Disease Project; National Hi-Tech Program; National Key Basic Research Program(National Basic Research Program of China)	his research was supported by the Key Infectious Disease Project (2012ZX10002012-014), http://www.nmp.gov.cn/zxjs/crb/201012/t20101208 2127.htm; National Hi-Tech Program (2012AA020201), http://www.863.gov.cn/0/7/index.htm; National Key Basic Research Program (2010CB912702), http://www.nsfc.gov.cn/nsfc/cen/xmzn/2013xmzn/03/index.html. LX received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armananzas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062819; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bao ZS, 2014, CNS NEUROSCI THER, V20, P112, DOI 10.1111/cns.12171; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Berasain Carmen, 2011, Cancers (Basel), V3, P2444, DOI 10.3390/cancers3022444; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cho EJ, 2013, CLIN CANCER RES, V19, P4218, DOI 10.1158/1078-0432.CCR-12-3443; COX DR, 1972, J R STAT SOC B, V34, P187; Dancik GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085249; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Gruden G, 2005, J AM SOC NEPHROL, V16, P688, DOI 10.1681/ASN.2004030251; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Kim SM, 2012, HEPATOLOGY, V55, P1443, DOI 10.1002/hep.24813; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Louafi S, 2007, CANCER-AM CANCER SOC, V109, P1384, DOI 10.1002/cncr.22532; Manghisi G, 1998, HEPATOLOGY, V28, P751; Martinez-Balibrea E, 2010, BRIT J CANCER, V103, P581, DOI 10.1038/sj.bjc.6605776; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Nault JC, 2013, GASTROENTEROLOGY, V145, P176, DOI 10.1053/j.gastro.2013.03.051; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Raman Karthik, 2010, Autom Exp, V2, P2, DOI 10.1186/1759-4499-2-2; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schaefer KL, 2005, CANCER RES, V65, P2251, DOI 10.1158/0008-5472.CAN-04-3037; Schimanski CC, 2006, BRIT J CANCER, V95, P210, DOI 10.1038/sj.bjc.6603251; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao RX, 2005, WORLD J GASTROENTERO, V11, P1995; Toshima T, 2013, J GASTROENTEROL; Tsuchiya M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-74; Tsuchiya N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-150; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wei L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S13; Yu J, 2010, HEPATOLOGY, V51, P2008, DOI 10.1002/hep.23550; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x; Yuan JM, 2007, HEPATOLOGY, V46, P749, DOI 10.1002/hep.21735; Zeng LY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S14; Zhang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100854; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	56	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118672	10.1371/journal.pone.0118672	http://dx.doi.org/10.1371/journal.pone.0118672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738841	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900060
J	Tilic, E; Lehrke, J; Bartolomaeus, T				Tilic, Ekin; Lehrke, Janina; Bartolomaeus, Thomas			Homology and Evolution of the Chaetae in Echiura (Annelida)	PLOS ONE			English	Article							NERVOUS-SYSTEM; PHYLOGENETIC SIGNIFICANCE; DEVELOPMENTAL STAGES; HOODED HOOKS; ULTRASTRUCTURE; CHAETOGENESIS; POLYCHAETA; SETAE; TREE	Echiura is traditionally regarded as a small phylum of unsegmented spiralian worms. Molecular analyses, however, provide unquestionable evidence that Echiura are derived annelids that lost segmentation. Like annelids, echiurans possess chaetae, a single ventral pair in all species and one or two additional caudal hemi-circles of chaetae in two subgroups, but their evolutionary origin and affiliation to annelid chaetae are unresolved. Since annelids possess segmental pairs of dorsal (notopodial) and ventral (neuropodial) chaetae that are arranged in a row, the ventral chaetae in Echiura either represent a single or a paired neuropodial group of chaetae, while the caudal circle may represent fused rows of chaetae. In annelids, chaetogenesis is generally restricted to the ventral part of the notopodial chaetal sac and to the dorsal part of the neuropodial chaetal sac. We used the exact position of the chaetal formation site in the echiuran species, Thalassema thalassemum (Pallas, 1766) and Echiurus echiurus (Pallas, 1767), to test different hypotheses of the evolution of echiurid chaetae. As in annelids, a single chaetoblast is responsible for chaetogenesis in both species. Each chaeta of the ventral pair arises from its own chaetal sac and possesses a lateral formation site, evidencing that the pair of ventral chaetae in Echiura is homologous to a pair of neuropodia that fused on the ventral side, while the notopodia were reduced. Both caudal hemi-circles of chaetae in Echiurus echiurus are composed of several individual chaetal sacs, each with its own formative site. This finding argues against a homology of these hemi-circles of chaetae and annelids' rows of chaetae and leads to the hypothesis that the caudal chaetal rings evolved once within the Echiura by multiplication of ventral chaetae.	[Tilic, Ekin; Lehrke, Janina; Bartolomaeus, Thomas] Univ Bonn, Inst Evolutionary Biol & Anim Ecol, Bonn, Germany	University of Bonn	Tilic, E (corresponding author), Univ Bonn, Inst Evolutionary Biol & Anim Ecol, Bonn, Germany.	etilic@evolution.uni-bonn.de	Tilic, Ekin/K-6317-2019	Tilic, Ekin/0000-0003-0463-322X				Baltzer F., 1931, P62; Bartolomaeus T, 2005, HYDROBIOLOGIA, V535, P341, DOI 10.1007/s10750-004-1847-5; BARTOLOMAEUS T, 1995, ZOOMORPHOLOGY, V115, P161, DOI 10.1007/BF00403171; Bartolomaeus T, 1997, INVERTEBR BIOL, V116, P227, DOI 10.2307/3226899; Bartolomaeus T, 1998, ZOOLOGY, V100, P348; Biseswar R, 2012, ZOOTAXA, P69; Biseswar R, 2010, ZOOTAXA, P21; Biseswar R, 2009, ZOOTAXA, P17, DOI 10.11646/zootaxa.2222.1.2; Bleidorn C, 2003, J ZOOL SYST EVOL RES, V41, P186, DOI 10.1046/j.1439-0469.2003.00212.x; Bleidorn C, 2003, MOL PHYLOGENET EVOL, V29, P279, DOI 10.1016/S1055-7903(03)00107-6; Blumer MJF, 2002, J NEUROSCI METH, V120, P11, DOI 10.1016/S0165-0270(02)00166-8; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Goto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056809; Grobe P., 2009, MORPH D BASE 2 0 PUB; Hausen H, 2005, HYDROBIOLOGIA, V535, P37, DOI 10.1007/s10750-004-1836-8; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hessling R, 2003, HYDROBIOLOGIA, V496, P225, DOI 10.1023/A:1026153016913; Hessling R, 2002, J MORPHOL, V252, P100, DOI 10.1002/jmor.1093; Hessling R, 2002, ZOOMORPHOLOGY, V121, P221, DOI 10.1007/s00435-002-0059-7; Kato C, 2011, ZOOMORPHOLOGY, V130, P97, DOI 10.1007/s00435-011-0124-1; Korn H, 1982, MORPHOGENESE TIERE D; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lehrke J, 2012, THESIS U BONN; Lehrke J, 2011, ZOOMORPHOLOGY, V130, P39, DOI 10.1007/s00435-011-0121-4; McHugh D, 1999, CLADISTICS, V15, P85, DOI 10.1006/clad.1999.0086; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; McKenzie JD, 1999, INVERTEBR BIOL, V118, P296, DOI 10.2307/3226999; Meyer K, 1996, CAN J ZOOL, V74, P2143, DOI 10.1139/z96-243; O'Clair R, 1974, CELL TISSUE RES, P157; ORRHAGE L, 1971, Acta Zoologica (Stockholm), V52, P157; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Schweigkofler M, 1998, ZOOMORPHOLOGY, V118, P117, DOI 10.1007/s004350050062; SPECHT A, 1988, ZOOMORPHOLOGY, V107, P371, DOI 10.1007/BF00312220; Spengel JW., 1880, Z WISS ZOOL, V34, P460; Stephen A. C., 1972, PHYLA SIPUNCULA ECHI; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tilic E, 2014, INVERTEBR BIOL, V133, P354, DOI 10.1111/ivb.12066; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	41	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0120002	10.1371/journal.pone.0120002	http://dx.doi.org/10.1371/journal.pone.0120002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734664	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700065
J	Kim, RK; Suh, Y; Hwang, E; Yoo, KC; Choi, KS; An, S; Hwang, SG; Kim, IG; Kim, MJ; Lee, HJ; Lee, SJ				Kim, R-K; Suh, Y.; Hwang, E.; Yoo, K-C; Choi, K-S; An, S.; Hwang, S-G; Kim, I-G; Kim, M-J; Lee, H-J; Lee, S-J			PKC delta maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback	ONCOGENE			English	Article							PROTEIN-KINASE-C; CANCER STEM-CELLS; GROWTH-FACTOR; GLIOMA; BRAIN; ACTIVATION; SURVIVAL; PATHWAY; IDENTIFICATION; POPULATION	The existence of tumor initiating cells (TICs) has been emerged as a good therapeutic target for treatment of glioblastoma that is the most aggressive brain tumor with poor prognosis. However, the molecular mechanisms that regulate the phenotypes of TICs still remain obscure. In this study, we found that PKC delta, among PKC isoforms, is preferentially activated in TICs and acts as a critical regulator for the maintenance of TICs in glioblastoma. By modulating the expression levels or activity of PKC delta, we demonstrated that PKC delta promotes self-renewal and tumorigenic potentials of TICs. Importantly, we found that the activation of PKC delta persists in TICs through an autocrine loop with positive feedback that was driven by PKC delta/STAT3/IL-23/JAK signaling axis. Moreover, for phenotypes of TICs, we showed that PKC delta activates AKT signaling component by phosphorylation specifically on Ser473. Taken together, we proposed that TICs regulate their own population in glioblastoma through an autocrine loop with positive feedback that is driven by PKC delta-dependent secretion of cytokines.	[Kim, R-K; Suh, Y.; Hwang, E.; Yoo, K-C; Kim, M-J; Lee, S-J] Hanyang Univ, Lab Mol Biochem, Dept Life Sci, Res Inst Nat Sci, Seoul 133791, South Korea; [Choi, K-S] Sungkyunkwan Univ, Mol & Cellular Imaging Ctr, Samsung Biomed Res Inst, Sch Med, Seoul, South Korea; [An, S.] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul, South Korea; [Hwang, S-G] Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul, South Korea; [Kim, I-G] Korea Atom Energy Res Inst, Dept Radiat Biol, Environm Radiat Res Grp, Taejon, South Korea; [Kim, M-J] Korea Inst Radiol & Med Sci, Lab Radiat Exposure & Therapeut, Natl Radiat Emergency Med Ctr, Seoul, South Korea; [Lee, H-J] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul, South Korea	Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Konkuk University; Korea Institute of Radiological & Medical Sciences; Korea Atomic Energy Research Institute (KAERI); Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Lee, SJ (corresponding author), Hanyang Univ, Lab Mol Biochem, Dept Life Sci, Res Inst Nat Sci, 17 Haengdang Dong, Seoul 133791, South Korea.	sj0420@hanyang.ac.kr			National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean government, through its National Nuclear Technology Program [NRF-2012M2B2B1055639, NRF-2013M2A2A7066345]	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean government, through its National Nuclear Technology Program	We thank Dr Akio Soeda (Department of Neurological Surgery, University of Virginia, USA) for providing patient-derived glioma cells. This work was supported by the National Research Foundation (NRF) and Ministry of Science, ICT and Future Planning, Korean government, through its National Nuclear Technology Program (NRF-2012M2B2B1055639 and NRF-2013M2A2A7066345).	Auf G, 2010, P NATL ACAD SCI USA, V107, P15553, DOI 10.1073/pnas.0914072107; Basu A, 2003, J CELL MOL MED, V7, P341, DOI 10.1111/j.1582-4934.2003.tb00237.x; Basu A, 2010, THESCIENTIFICWORLDJO, V10, P2272, DOI 10.1100/tsw.2010.214; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Carrillo-Garcia C, 2010, MOL CELL NEUROSCI, V44, P318, DOI 10.1016/j.mcn.2010.04.003; Chen ZH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-90; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Hernandez-Maqueda JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058540; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Inagaki A, 2007, BIOCHEM BIOPH RES CO, V361, P586, DOI 10.1016/j.bbrc.2007.07.037; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kim NH, 2013, BMB REP, V46, P59, DOI 10.5483/BMBRep.2013.46.1.123; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lu F, 2005, RADIAT RES, V163, P63, DOI 10.1667/RR3285; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Mandil R, 2001, CANCER RES, V61, P4612; Mauro LV, 2010, PANCREAS, V39, pE31, DOI 10.1097/MPA.0b013e3181bce796; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perletti GP, 1999, ONCOGENE, V18, P1251, DOI 10.1038/sj.onc.1202408; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Suh Y, 2009, MOL CELL NEUROSCI, V42, P308, DOI 10.1016/j.mcn.2009.08.003; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Yoon CH, 2012, ONCOGENE, V31, P4655, DOI 10.1038/onc.2011.634; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	57	6	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2015	34	46					5749	5759		10.1038/onc.2015.29	http://dx.doi.org/10.1038/onc.2015.29			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GC	25746003				2022-12-26	WOS:000364594600007
J	Cho, JH; Dimri, M; Dimri, GP				Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.			MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Histone Deacetylase Inhibitor (HDAC Inhibitor) (HDI); MicroRNA (miRNA); Polycomb; Senescence; bmi1	POLYCOMB GROUP PROTEIN; BREAST-CANCER CELLS; MAMMARY EPITHELIAL-CELLS; DOWN-REGULATION; TUMOR-SUPPRESSOR; LIFE-SPAN; IN-VIVO; H-RAS; EXPRESSION; BMI-1	Background: Histone deacetylase inhibitor (HDACi) inhibits expression of polycomb group proteins and can differentially regulate expression of miRNAs. Results: HDACi up-regulated expression of miR-31, which down-regulated BMI1 and induced cellular senescence. Conclusion: miR-31 is a novel target of HDACi, and is a novel regulator of cellular senescence. Significance: HDACi can be used to induce miR-31, which in turn can cause senescence in cancer cells. MicroRNAs (miRNAs) have emerged as important regulators of tumorigenesis. Several miRNAs, which can function either as oncomiRs or tumor suppressive miRs are deregulated in cancer cells. The microRNA-31 (miR-31) has been shown to be overexpressed in metastatic breast cancer. It promotes multiple oncogenic phenotypes, including proliferation, motility, and invasion of cancer cells. Using a breast cancer-related miRNA array analysis, we identified miR-31 as a novel target of histone deacetylase inhibitors (HDACi) in breast cancer cells. Specifically, we show that sodium butyrate (NaB) and panobinostat (LBH589), two broad-spectrum HDAC inhibitors up-regulate hsa-miR-31 (miR-31). The up-regulation of miR-31 was accompanied by repression of the polycomb group (PcG) protein BMI1 and induction of cellular senescence. We further show that inhibition of miR-31 overcomes the senescence-inducing effect of HDACi, and restores expression of the PcG protein BMI1. Interestingly, BMI1 also acts as a repressor of miR-31 transcription, suggesting a cross-negative feedback loop between the expression of miR-31 and BMI1. Our data suggest that miR-31 is an important physiological target of HDACi, and that it is an important regulator of senescence relevant to cancer. These studies further suggest that manipulation of miR-31 expression can be used to modulate senescence-related pathological conditions such as cancer, and the aging process.	[Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	George Washington University	Dimri, M (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA.	mdimri@gwu.edu; gdimri@gwu.edu	Dimri, Goberdhan/AAO-4210-2021		National Institutes of Health from the NCI [RO1 CA094150]; NATIONAL CANCER INSTITUTE [R01CA094150] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA094150 from the NCI (to G. P. D.)	Asangani IA, 2012, ONCOTARGET, V3, P1011, DOI 10.18632/oncotarget.622; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Chatterjee N, 2013, CANCER BIOL THER, V14, P658, DOI 10.4161/cbt.25088; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dimri GP, 2002, CANCER RES, V62, P4736; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dimri M, 2015, J BIOL CHEM, V290, P3033, DOI 10.1074/jbc.M114.615179; Dimri M, 2013, CELL CYCLE, V12, P3537, DOI 10.4161/cc.26592; Dutton A, 2007, BLOOD, V109, P2597, DOI 10.1182/blood-2006-05-020545; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Laurila EM, 2013, GENE CHROMOSOME CANC, V52, P1103, DOI 10.1002/gcc.22107; Lee JY, 2014, ONCOGENE, V33, P1325, DOI 10.1038/onc.2013.53; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Rhodes LV, 2012, ONCOL REP, V27, P10, DOI 10.3892/or.2011.1488; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Valastyan S, 2011, GENE DEV, V25, P646, DOI 10.1101/gad.2004211; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.79; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015	58	58	62	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10555	10567		10.1074/jbc.M114.624361	http://dx.doi.org/10.1074/jbc.M114.624361			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737447	Green Published, hybrid			2022-12-26	WOS:000353241100053
J	Danielson, BT; Knudson, CB; Knudson, W				Danielson, Ben T.; Knudson, Cheryl B.; Knudson, Warren			Extracellular Processing of the Cartilage Proteoglycan Aggregate and Its Effect on CD44-mediated Internalization of Hyaluronan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; AGE-RELATED-CHANGES; RECEPTOR-MEDIATED ENDOCYTOSIS; SWARM RAT CHONDROSARCOMA; SMOOTH-MUSCLE-CELLS; PERICELLULAR MATRIX; G1 DOMAIN; IN-VIVO; CHONDROITIN SULFATE; SYNOVIAL-FLUID	In many cells hyaluronan receptor CD44 mediates the endocytosis of hyaluronan and its delivery to endosomes/lysosornes. The regulation of this process remains largely unknown. In most extracellular matrices hyaluronan is not present as a free polysaccharide but often is found in complex with other small proteins and macromolecules such as proteoglycans. This is especially true in cartilage, where hyaluronan assembles into an aggregate structure with the large proteoglycan termed aggrecan. In this study when purified aggrecan was added to FITC-conjugated hyaluronan, no internalization of hyaluronan was detected. This suggested that the overall size of the aggregate prevented hyaluronan endocytosis and furthermore that proteolysis of the aggrecan was a required prerequisite for local, cell-based turnover of hyaluronan. To test this hypothesis, limited C-terminal digestion of aggrecan was performed to determine whether a size range of aggrecan exists that permits hyaluronan endocytosis. Our data demonstrate that only limited degradation of the aggrecan monomer was required to allow for hyaluronan internalization. When hyaluronan was combined with partially degraded, dansyl chloride-labeled aggrecan, blue fluorescent aggrecan was also visualized within intracellular vesicles. It was also determined that sonicated hyaluronan of smaller molecular size was internalized more readily than high molecular mass hyaluronan. However, the addition of intact aggrecan to hyaluronan chains sonicated for 5 and 10 s reblocked their endocytosis, whereas aggregates containing 15-s sonicated hyaluronan were internalized. These data suggest that hyaluronan endocytosis is regulated in large part by the extracellular proteolytic processing of hyaluronan-bound proteoglycan.	[Danielson, Ben T.; Knudson, Cheryl B.; Knudson, Warren] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Knudson, W (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA.	knudsonw@ecu.edu			National Institutes of Health [R01-AR43384, R21 AR066581-01, R01-AR39507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043384, R21AR066581, R01AR039507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR43384 (to W. K.), R21 AR066581-01 (to W. K.), and R01-AR39507 (to C. B. K.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Aguiar DJ, 1999, EXP CELL RES, V252, P292, DOI 10.1006/excr.1999.4641; Ariyoshi W, 2010, J BIOL CHEM, V285, P36216, DOI 10.1074/jbc.M110.129270; Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; Bartzatt R, 2001, J BIOCHEM BIOPH METH, V47, P189, DOI 10.1016/S0165-022X(00)00136-6; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; BUCKWALTER JA, 1985, J ORTHOP RES, V3, P251, DOI 10.1002/jor.1100030301; BUCKWALTER JA, 1982, J BIOL CHEM, V257, P9830; CAPUTO CB, 1980, ARCH BIOCHEM BIOPHYS, V204, P220, DOI 10.1016/0003-9861(80)90027-2; CHOI HU, 1971, P NATL ACAD SCI USA, V68, P877, DOI 10.1073/pnas.68.5.877; Cowman MK, 2011, ANAL BIOCHEM, V417, P50, DOI 10.1016/j.ab.2011.05.023; CULTY M, 1994, J CELL PHYSIOL, V160, P275, DOI 10.1002/jcp.1041600209; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P98, DOI 10.1016/j.joca.2007.05.002; Embry JJ, 2003, ARTHRITIS RHEUM-US, V48, P3431, DOI 10.1002/art.11323; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FLANNERY CR, 1992, J BIOL CHEM, V267, P1008; Flory JJE, 2006, ARTHRITIS RHEUM-US, V54, P443, DOI 10.1002/art.21623; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Guzik K, 2007, CELL DEATH DIFFER, V14, P171, DOI 10.1038/sj.cdd.4401927; Haapala J, 1996, J RHEUMATOL, V23, P1586; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; HASCALL VC, 1976, J BIOL CHEM, V251, P3511; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; HUA Q, 1993, J CELL SCI, V106, P365; Hudson KS, 2010, ANAT REC, V293, P1669, DOI 10.1002/ar.21235; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Jiang H, 2001, ARTHRITIS RHEUM-US, V44, P2599, DOI 10.1002/1529-0131(200111)44:11<2599::AID-ART440>3.0.CO;2-Y; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; KNUDSON CB, 1985, J CELL BIOL, V100, P1753, DOI 10.1083/jcb.100.5.1753; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; KUCHARSKA AM, 1990, J ORTHOPAED RES, V8, P781, DOI 10.1002/jor.1100080602; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; LOHMANDER LS, 1993, ARTHRITIS RHEUM-US, V36, P181, DOI 10.1002/art.1780360207; MCGUIRE PG, 1987, J CELL PHYSIOL, V133, P267, DOI 10.1002/jcp.1041330210; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; MORALES TI, 1988, J BIOL CHEM, V263, P3632; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P1315, DOI 10.1002/1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-#; PITA JC, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P455; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Roughley PJ, 2006, EUR SPINE J, V15, pS326, DOI 10.1007/s00586-006-0127-7; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stupka N, 2013, J BIOL CHEM, V288, P1907, DOI 10.1074/jbc.M112.429647; SWEET MBE, 1979, ARCH BIOCHEM BIOPHYS, V198, P439, DOI 10.1016/0003-9861(79)90518-6; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; TENGBLAD A, 1979, BIOCHIM BIOPHYS ACTA, V578, P281, DOI 10.1016/0005-2795(79)90158-2; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	71	13	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9555	9570		10.1074/jbc.M115.643171	http://dx.doi.org/10.1074/jbc.M115.643171			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25733665	hybrid, Green Published			2022-12-26	WOS:000352729400022
J	Cramer, JM; Thompson, T; Geskin, A; LaFramboise, W; Lagasse, E				Cramer, Julie M.; Thompson, Timothy; Geskin, Albert; LaFramboise, William; Lagasse, Eric			Distinct Human Stem Cell Populations in Small and Large Intestine	PLOS ONE			English	Article							EPITHELIAL-CELLS; COLON-CANCER; HEMATOPOIETIC STEM; LIMITING DILUTION; PROGENITOR CELLS; IN-VITRO; MARKER; LGR5; DIFFERENTIATION; WNT	The intestine is composed of an epithelial layer containing rapidly proliferating cells that mature into two regions, the small and the large intestine. Although previous studies have identified stem cells as the cell-of-origin for intestinal epithelial cells, no studies have directly compared stem cells derived from these anatomically distinct regions. Here, we examine intrinsic differences between primary epithelial cells isolated from human fetal small and large intestine, after in vitro expansion, using the Wnt agonist R-spondin 2. We utilized flow cytometry, fluorescence-activated cell sorting, gene expression analysis and a three-dimensional in vitro differentiation assay to characterize their stem cell properties. We identified stem cell markers that separate subpopulations of colony-forming cells in the small and large intestine and revealed important differences in differentiation, proliferation and disease pathways using gene expression analysis. Single cells from small and large intestine cultures formed organoids that reflect the distinct cellular hierarchy found in vivo and respond differently to identical exogenous cues. Our characterization identified numerous differences between small and large intestine epithelial stem cells suggesting possible connections to intestinal disease.	[Cramer, Julie M.; Lagasse, Eric] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Cramer, Julie M.; Lagasse, Eric] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA; [Thompson, Timothy] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Geskin, Albert; LaFramboise, William] Univ Pittsburgh, Shadyside Hosp, Dept Pathol, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lagasse, E (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.	lagasse@pitt.edu			National Institutes of Health [DK085711]; National Cancer Institute Cancer Center Support grant [P30 CA 47904]; National Institute of Biomedical Imaging and Bioengineering [T32EB001026-06]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK085711 (EL) and National Cancer Institute Cancer Center Support grant P30 CA 47904 (WL). The project described was also supported by Award Number T32EB001026-06 from the National Institute of Biomedical Imaging and Bioengineering. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Biomedical Imaging and Bioengineering or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Chan CHF, 2006, CARCINOGENESIS, V27, P1909, DOI 10.1093/carcin/bgl040; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; EHMANN UK, 1984, J CELL BIOL, V98, P1026, DOI 10.1083/jcb.98.3.1026; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Francipane Maria Giovanna, 2013, Curr Pathobiol Rep, V1, P111; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gemei M, 2012, CANCER; Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755; Howlader N, 2013, SEER CANC STAT REV 1; Hsu HC, 2013, INT J COLORECTAL DIS, V28, P1535, DOI 10.1007/s00384-013-1721-x; Huang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047901; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kazanjian A, 2011, CURR COLORECT CANC R, V7, P121, DOI 10.1007/s11888-011-0090-5; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Mentlein R, 2004, INT REV CYTOL, V235, P165, DOI 10.1016/S0074-7696(04)35004-7; Modica S, 2009, GUT, V58, P1250, DOI 10.1136/gut.2008.158386; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Quintero M, 2004, EJSO-EUR J SURG ONC, V30, P465, DOI 10.1016/j.ejso.2004.03.008; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; WALDMANN H, 1975, IMMUNOLOGY, V28, P1135; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Wang LK, 2010, J GASTROINTEST SURG, V14, P74, DOI 10.1007/s11605-009-1035-z; WEILBAECHER K, 1991, BLOOD, V78, P945; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	51	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118792	10.1371/journal.pone.0118792	http://dx.doi.org/10.1371/journal.pone.0118792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751518	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700010
J	Ngo, CT; Aujoulat, F; Veas, F; Jumas-Bilak, E; Manguin, S				Chung Thuy Ngo; Aujoulat, Fabien; Veas, Francisco; Jumas-Bilak, Estelle; Manguin, Sylvie			Bacterial Diversity Associated with Wild Caught Anopheles Mosquitoes from Dak Nong Province, Vietnam Using Culture and DNA Fingerprint	PLOS ONE			English	Article							THORSELLIA-ANOPHELIS; DIPTERA-CULICIDAE; SEQUENCE-ANALYSIS; GENOMIC ANALYSIS; MIDGUT BACTERIA; GUT MICROBIOTA; GENUS ASAIA; SP. NOV.; IDENTIFICATION; TRANSMISSION	Background Microbiota of Anopheles midgut can modulate vector immunity and block Plasmodium development. Investigation on the bacterial biodiversity in Anopheles, and specifically on the identification of bacteria that might be used in malaria transmission blocking approaches, has been mainly conducted on malaria vectors of Africa. Vietnam is an endemic country for both malaria and Bancroftian filariasis whose parasitic agents can be transmitted by the same Anopheles species. No information on the microbiota of Anopheles mosquitoes in Vietnam was available previous to this study. Method The culture dependent approach, using different mediums, and culture independent (16S rRNA PCR - TTGE) method were used to investigate the bacterial biodiversity in the abdomen of 5 Anopheles species collected from Dak Nong Province, central-south Vietnam. Molecular methods, sequencing and phylogenetic analysis were used to characterize the microbiota. Results and Discussion The microbiota in wild-caught Anopheles was diverse with the presence of 47 bacterial OTUs belonging to 30 genera, including bacterial genera impacting Plasmodium development. The bacteria were affiliated with 4 phyla, Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria, the latter being the dominant phylum. Four bacterial genera are newly described in Anopheles mosquitoes including Coxiella, Yersinia, Xanthomonas, and Knoellia. The bacterial diversity per specimen was low ranging from 1 to 4. The results show the importance of pairing culture and fingerprint methods to better screen the bacterial community in Anopheles mosquitoes. Conclusion Sampled Anopheles species from central-south Vietnam contained a diverse bacterial microbiota that needs to be investigated further in order to develop new malaria control approaches. The combination of both culture and DNA fingerprint methods allowed a thorough and complementary screening of the bacterial community in Anopheles mosquitoes.	[Chung Thuy Ngo; Veas, Francisco; Manguin, Sylvie] UMR, Fac Pharm, MD3, IRD, Montpellier, France; [Chung Thuy Ngo] Natl Inst Vet Res, Hanoi, Vietnam; [Aujoulat, Fabien; Jumas-Bilak, Estelle] Univ Montpellier I, Fac Pharm, Equipe Pathogenes & Environm, UMR ECOSYM 5119, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Manguin, S (corresponding author), UMR, Fac Pharm, MD3, IRD, Montpellier, France.	sylvie.manguin@ird.fr	Manguin, Sylvie/G-1787-2015; Manguin, Sylvie/GOE-5338-2022	Manguin, Sylvie/0000-0002-5925-7164; Manguin, Sylvie/0000-0002-5925-7164; Aujoulat, Fabien/0000-0001-6180-6903	IRD-DPF, Marseille, France	IRD-DPF, Marseille, France	This study was made possible through support as a PhD research grant (ARTS) provided to CTN by IRD-DPF, Marseille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2012, ACTA TROP, V121, P71, DOI 10.1016/j.actatropica.2011.11.001; Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; [Anonymous], 2008, BIODIVERSITY MALARIA; [Anonymous], 2013, SE ASIAN J TROP MED, V44, P307; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Bando H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01641; Bergey DH, 1984, BERGEYS MANUAL OF SY; Bernardet JF, 2005, SYST APPL MICROBIOL, V28, P640, DOI 10.1016/j.syapm.2005.03.016; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Brewster JD, 2013, ANAL BIOCHEM, V442, P107, DOI 10.1016/j.ab.2013.07.013; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015; Ngo CT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-316; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Gan HM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-431; Garros C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-11; Gendrin M, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P525, DOI 10.5772/55107; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gundi VAKB, 2009, INT J SYST EVOL MICR, V59, P2956, DOI 10.1099/ijs.0.002865-0; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Kampfer P, 2006, INT J SYST EVOL MICR, V56, P335, DOI 10.1099/ijs.0.63999-0; Kommanee J, 2010, J GEN APPL MICROBIOL, V56, P81, DOI 10.2323/jgam.56.81; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Li W, 2014, MICROB ECOL, V67, P679, DOI 10.1007/s00248-013-0345-6; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Manguin S, 2008, INFECT GENET EVOL, V8, P489, DOI 10.1016/j.meegid.2007.11.004; Manguin S, 2010, INFECT GENET EVOL, V10, P159, DOI 10.1016/j.meegid.2009.11.014; Manguin S, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P549, DOI 10.5772/55610; Michel C, 2005, J APPL MICROBIOL, V99, P323, DOI 10.1111/j.1365-2672.2005.02592.x; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Narciso-da-Rocha C, 2014, SCI TOTAL ENVIRON, V466, P127, DOI 10.1016/j.scitotenv.2013.06.109; Ogier JC, 2002, APPL ENVIRON MICROB, V68, P3691, DOI 10.1128/AEM.68.8.3691-3701.2002; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Roh SW, 2008, J MICROBIOL, V46, P525, DOI 10.1007/s12275-008-0189-9; Roudiere L, 2009, J MICROBIOL METH, V79, P156, DOI 10.1016/j.mimet.2009.08.005; Sharma P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-235; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Sturm G, 2011, INT J SYST EVOL MICR, V61, P956, DOI 10.1099/ijs.0.022780-0; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Villegas LM, 2014, MEM I OSWALDO CRUZ, V109, P672, DOI 10.1590/0074-0276140194; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001; Wang S, 2012, P NATL ACAD SCI USA, V109, P9; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Xue D, 2013, WORLD J MICROBIOL BI; Zhang W, 2010, INT J SYST EVOL MICR, V60, P2665, DOI 10.1099/ijs.0.017400-0	68	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118634	10.1371/journal.pone.0118634	http://dx.doi.org/10.1371/journal.pone.0118634			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747513	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400023
J	Guedes-Martins, L; Gaio, R; Saraiva, J; Cerdeira, S; Matos, L; Silva, E; Macedo, F; Almeida, H				Guedes-Martins, Luis; Gaio, Rita; Saraiva, Joaquim; Cerdeira, Sofia; Matos, Liliana; Silva, Elisabete; Macedo, Filipe; Almeida, Henrique			Reference Ranges for Uterine Artery Pulsatility Index during the Menstrual Cycle: A Cross-Sectional Study	PLOS ONE			English	Article							BLOOD-FLOW; OVULATION INDUCTION; DOPPLER ASSESSMENT; MATERNAL AGE; WAVE-FORMS; PREGNANCY; OVARIAN; WOMEN; ENDOMETRIAL; VELOCITY	Background Cyclic endometrial neoangiogenesis contributes to changes in local vascular patterns and is amenable to non-invasive assessment with Doppler sonography. We hypothesize that the uterine artery (UtA) impedance, measured by its pulsatility index (PI), exhibits a regular pattern during the normal menstrual cycle. Therefore, the main study objective was to derive normative new day-cycle-based reference ranges for the UtA-PI during the entire cycle from days 1 to 34 according to the isolated time effect and potential confounders such as age and parity. Methods From January 2009 to December 2012, a cross-sectional study of 1,821 healthy women undergoing routine gynaecological ultrasound was performed. The Doppler flow of the right and left UtA-PI was studied transvaginally by colour and pulsed Doppler imaging. The mean right and left values and the presence or absence of a bilateral protodiastolic notch were recorded. Reference intervals for the PI according to the cycle day were generated by classical linear regression. Results The majority of patients (97.5%) presented unilateral or bilateral UtA notches. The crude 5th, 50th, and 95th reference percentile curves of the UtA-PI at 1-34 days of the normal menstrual cycle were derived. In all curves, a progressive significant decrease occurred during the first 13 days, followed by an increase and recovery in the UtA-PI. The adjusted 5th, 50th, and 95th reference percentile curves for the effects of age and parity were also obtained. These two conditions generated an approximately identical UtA-PI pattern during the cycle, except with small but significant reductions at the temporal extremes. Conclusions The median, 5th, and the 95th percentiles of the UtA-PI decrease during the first third of the menstrual cycle and recover to their initial values during the last two thirds of the cycle. The rates of decrease and recovery depend significantly on age and parity.	[Guedes-Martins, Luis; Saraiva, Joaquim; Matos, Liliana; Silva, Elisabete; Almeida, Henrique] Univ Porto, Fac Med, Dept Expt Biol, P-4200319 Oporto, Portugal; [Guedes-Martins, Luis; Matos, Liliana; Silva, Elisabete; Almeida, Henrique] Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Guedes-Martins, Luis; Saraiva, Joaquim] Ctr Hosp Porto EPE, Dept Mulher & Med Reprod, P-4099001 Oporto, Portugal; [Gaio, Rita] Univ Porto, Fac Sci, Dept Math, P-4169007 Oporto, Portugal; [Gaio, Rita] Univ Porto, Ctr Math, CMUP, P-4169007 Oporto, Portugal; [Saraiva, Joaquim] Private Hosp Trofa, Obstet Gynecol, P-4785409 Trofa, Portugal; [Cerdeira, Sofia] Gulbenkian Program Adv Med Educ, P-1067001 Lisbon, Portugal; [Cerdeira, Sofia] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Matos, Liliana] Univ Porto, Fac Nutr & Food Sci, P-4200465 Oporto, Portugal; [Macedo, Filipe] Univ Porto, Fac Med, Dept Cardiol, P-4200319 Oporto, Portugal; [Almeida, Henrique] Hosp CUF Porto, Obstet Gynecol, P-4100180 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade do Porto; Universidade do Porto	Guedes-Martins, L (corresponding author), Univ Porto, Fac Med, Dept Expt Biol, P-4200319 Oporto, Portugal.	luis.guedes.martins@gmail.com	da Silva Moura, Elisabete Ferreira/L-9184-2014; Macedo, Filipe/AAU-5442-2020; Matos, Liliana/H-5515-2013; Macedo, Filipe/AAL-7675-2020; Matos, Liliana/V-2512-2019	da Silva Moura, Elisabete Ferreira/0000-0002-6736-3469; Macedo, Filipe/0000-0003-3829-9426; Matos, Liliana/0000-0003-4188-532X; Almeida, Henrique/0000-0002-3036-3211; Guedes-Martins, Luis/0000-0002-0491-0752; Cerdeira, A. Sofia/0000-0002-7643-3537; Gaio, Rita/0000-0003-3906-0775				ALTMAN DG, 1993, STAT MED, V12, P917, DOI 10.1002/sim.4780121003; Arrowsmith S, 2012, J MUSCLE RES CELL M, V33, P209, DOI 10.1007/s10974-012-9300-2; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BOSSMAR T, 1995, BRIT J OBSTET GYNAEC, V102, P907, DOI 10.1111/j.1471-0528.1995.tb10880.x; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Chien LW, 2004, ULTRASOUND OBST GYN, V23, P496, DOI 10.1002/uog.975; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Crawford BS, 1997, OBSTET GYNECOL, V90, P210, DOI 10.1016/S0029-7844(97)00225-1; Dal J, 2005, FERTIL STERIL, V84, P224, DOI 10.1016/j.fertnstert.2004.12.059; Dechaud H, 2008, REPROD BIOMED ONLINE, V16, P368, DOI 10.1016/S1472-6483(10)60598-6; DOWNING SJ, 1981, J PHYSIOL-LONDON, V317, P425, DOI 10.1113/jphysiol.1981.sp013834; Everett TR, 2012, PLACENTA, V33, P893, DOI 10.1016/j.placenta.2012.07.011; Ferreira AM, 2007, INT J GYNECOL OBSTET, V98, P115, DOI 10.1016/j.ijgo.2007.05.006; Gomez O, 2008, ULTRASOUND OBST GYN, V32, P128, DOI 10.1002/uog.5315; Gordan PL, 1997, BIOL REPROD, V57, P597, DOI 10.1095/biolreprod57.3.597; Groutz A, 1997, J ULTRAS MED, V16, P455; Guedes-Martins L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03785; Guedes-Martins L, 2014, PRENATAL DIAG, V34, P719, DOI 10.1002/pd.4325; Haavaldsen C, 2011, BJOG-INT J OBSTET GY, V118, P1470, DOI 10.1111/j.1471-0528.2011.03053.x; Hafner E, 2000, ULTRASOUND OBST GYN, V16, P625, DOI 10.1046/j.1469-0705.2000.00290.x; Harrington K, 1997, ULTRASOUND OBST GYN, V9, P94, DOI 10.1046/j.1469-0705.1997.09020094.x; Hernandez-Andrade E, 2002, ULTRASOUND OBST GYN, V19, P438, DOI 10.1046/j.1469-0705.2002.00665.x; Hynek M, 2010, EUR J BIOMED INFORM, V6, P43; Ivanovski M, 2012, Akush Ginekol (Sofiia), V51, P55; JAFFA AJ, 1995, GYNECOL OBSTET INVES, V40, P80, DOI 10.1159/000292310; Jokubkiene L, 2006, ULTRASOUND OBST GYN, V27, P672, DOI 10.1002/uog.2742; Khong TY, 2003, PLACENTA, V24, P348, DOI 10.1053/plac.2002.0922; Liedman R, 2008, EUR J OBSTET GYN R B, V137, P189, DOI 10.1016/j.ejogrb.2007.10.015; Meyer MC, 1997, AM J PHYSIOL-HEART C, V272, pH2264, DOI 10.1152/ajpheart.1997.272.5.H2264; Oloyede OA, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.87.2321; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P456, DOI 10.1046/j.0960-7692.2001.00578.x; Park YW, 2000, AM J OBSTET GYNECOL, V182, P1204, DOI 10.1067/mob.2000.104840; Pirhonen J, 2005, J CLIN ULTRASOUND, V33, P14, DOI 10.1002/jcu.20079; Prefumo F, 2004, ULTRASOUND OBST GYN, V23, P46, DOI 10.1002/uog.908; R Core Team, 2018, R LANG ENV STAT COMP; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; SCHULMAN H, 1986, AM J OBSTET GYNECOL, V155, P1031, DOI 10.1016/0002-9378(86)90340-6; SERAFINI P, 1994, FERTIL STERIL, V62, P815; Silverwood RJ, 2007, ULTRASOUND OBST GYN, V29, P6, DOI 10.1002/uog.3911; SLADKEVICIUS P, 1993, ULTRASOUND OBST GYN, V3, P199, DOI 10.1046/j.1469-0705.1993.03030199.x; STEER CV, 1990, HUM REPROD, V5, P391, DOI 10.1093/oxfordjournals.humrep.a137109; STEER CV, 1995, HUM REPROD, V10, P479, DOI 10.1093/oxfordjournals.humrep.a135966; Suzuki S, 2006, J MATERN-FETAL NEO M, V19, P193, DOI 10.1080/14767050600587850; Tan SL, 1996, AM J OBSTET GYNECOL, V175, P625; Turan OM, 2008, ULTRASOUND OBST GYN, V32, P849, DOI 10.1002/uog.5354; Vedernikov YP, 2003, EUR J OBSTET GYN R B, V108, P59, DOI 10.1016/S0301-2115(02)00415-3; Wahab H, 2001, MIDDLE E FERTILITY S, V16, P209; Wakeman S, 2009, FERTIL STERIL, V91, P2726, DOI 10.1016/j.fertnstert.2008.03.069; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wang LN, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-122; Yildiz G, 2012, CLIN EXP OBSTET GYN, V39, P326; Ziegler WF, 1999, OBSTET GYNECOL, V94, P695, DOI 10.1016/S0029-7844(99)00397-X	53	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119103	10.1371/journal.pone.0119103	http://dx.doi.org/10.1371/journal.pone.0119103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742286	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100083
J	Oh, DY; Barr, IG; Hurt, AC				Oh, Ding Yuan; Barr, Ian G.; Hurt, Aeron C.			A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity	PLOS ONE			English	Article							VIRUS; OSELTAMIVIR; PROTECTION; DISEASE; TRANSMISSION; H1N1; PATHOGENESIS; REGIMENS; EFFICACY	Ferrets are the preferred animal model to assess influenza virus infection, virulence and transmission as they display similar clinical symptoms and pathogenesis to those of humans. Measures of disease severity in the ferret include weight loss, temperature rise, sneezing, viral shedding and reduced activity. To date, the only available method for activity measurement has been the assignment of an arbitrary score by a 'blind' observer based on pre-defined responsiveness scale. This manual scoring method is subjective and can be prone to bias. In this study, we described a novel video-tracking methodology for determining activity changes in a ferret model of influenza infection. This method eliminates the various limitations of manual scoring, which include the need for a sole 'blind' observer and the requirement to recognise the 'normal' activity of ferrets in order to assign relative activity scores. In ferrets infected with an A(H1N1) pdm09 virus, video-tracking was more sensitive than manual scoring in detecting ferret activity changes. Using this video-tracking method, oseltamivir treatment was found to ameliorate the effect of influenza infection on activity in ferret. Oseltamivir treatment of animals was associated with an improvement in clinical symptoms, including reduced inflammatory responses in the upper respiratory tract, lower body weight loss and a smaller rise in body temperature, despite there being no significant reduction in viral shedding. In summary, this novel video-tracking is an easy-to-use, objective and sensitive methodology for measuring ferret activity.	[Oh, Ding Yuan; Barr, Ian G.; Hurt, Aeron C.] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic 3000, Australia; [Oh, Ding Yuan; Barr, Ian G.] Federat Univ, Sch Appl & Biomed Sci, Churchill, Vic 3842, Australia; [Hurt, Aeron C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia	Victorian Infectious Diseases Reference Laboratory; World Health Organization; Federation University Australia; University of Melbourne	Oh, DY (corresponding author), Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic 3000, Australia.	dingthomas.oh@influenzacentre.org		Barr, Ian/0000-0002-7351-418X; Oh, Ding Yuan/0000-0003-0695-8490; Hurt, Aeron/0000-0003-1826-4314	National Health and Medical Research Council of Australia /A<SUP>star</SUP>STAR grant [1055793]; Australian Government Department of Health	National Health and Medical Research Council of Australia /A<SUP>star</SUP>STAR grant; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by a combined National Health and Medical Research Council of Australia /A<SUP>star</SUP>STAR grant (1055793). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartal IB, 2014, ELIFE, V3, DOI 10.7554/eLife.01385; Boltz DA, 2008, J INFECT DIS, V197, P1315, DOI 10.1086/586711; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Darnell MER, 2007, J INFECT DIS, V196, P1329, DOI 10.1086/522431; Dimmock NJ, 2012, ANTIVIR RES, V96, P376, DOI 10.1016/j.antiviral.2012.09.017; Duclot F, 2013, J NEUROSCI, V33, P11048, DOI 10.1523/JNEUROSCI.0199-13.2013; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; Horn CC, 2012, PHYSIOL BEHAV, V106, P562, DOI 10.1016/j.physbeh.2012.03.031; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kim HM, 2013, VIROLOGY, V444, P394, DOI 10.1016/j.virol.2013.07.006; Long JP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00972; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; MONTO AS, 1981, J CLIN MICROBIOL, V13, P54, DOI 10.1128/JCM.13.1.54-57.1981; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Oh DY, 2014, J ANTIMICROB CHEMOTH, V69, P2458, DOI 10.1093/jac/dku146; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Pallister JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-237; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Stark GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058337; WHO/GIP, 2014, CUM NUMB CONF HUM CA; WHO/HQ, 2014, WHO HQ PER REP, V18; Wong SS, 2014, VACCINE, V32, P4571, DOI 10.1016/j.vaccine.2014.06.016; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532	29	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118780	10.1371/journal.pone.0118780	http://dx.doi.org/10.1371/journal.pone.0118780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738900	Green Published, gold			2022-12-26	WOS:000350685900070
J	Wall-Scheffler, CM; Wagnild, J; Wagler, E				Wall-Scheffler, Cara M.; Wagnild, Janelle; Wagler, Emily			Human Footprint Variation while Performing Load Bearing Tasks	PLOS ONE			English	Article							PLEISTOCENE FOSSIL HOMINIDS; AUSTRALOPITHECUS-AFARENSIS; BODY-MASS; HUNTER-GATHERERS; ENERGETIC COST; HUMAN WALKING; NORTHERN TANZANIA; LOCOMOTOR ANATOMY; SEXUAL-DIMORPHISM; OLDER-ADULTS	Human footprint fossils have provided essential evidence about the evolution of human bipedalism as well as the social dynamics of the footprint makers, including estimates of speed, sex and group composition. Generally such estimates are made by comparing footprint evidence with modern controls; however, previous studies have not accounted for the variation in footprint dimensions coming from load bearing activities. It is likely that a portion of the hominins who created these fossil footprints were carrying a significant load, such as offspring or foraging loads, which caused variation in the footprint which could extend to variation in any estimations concerning the footprint's maker. To identify significant variation in footprints due to load-bearing tasks, we had participants (N = 30, 15 males and 15 females) walk at a series of speeds carrying a 20kg pack on their back, side and front. Paint was applied to the bare feet of each participant to create footprints that were compared in terms of foot length, foot width and foot area. Female foot length and width increased during multiple loaded conditions. An appreciation of footprint variability associated with carrying loads adds an additional layer to our understanding of the behavior and morphology of extinct hominin populations.	[Wall-Scheffler, Cara M.] Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA; [Wall-Scheffler, Cara M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Wagnild, Janelle] Univ Durham, Dept Anthropol, Durham, England; [Wagler, Emily] Arizona Sch Podiatr Med, Glendale, AZ USA	University of Washington; University of Washington Seattle; Durham University	Wall-Scheffler, CM (corresponding author), Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA.	cwallsch@spu.edu		Wagnild, Janelle/0000-0003-3933-6380	3M Faculty/Student Collaborative Grant [212607]; National Center for Research Resources (NCRR) [1 ULJRR033183-01]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [8 ULJTR0001 14-02]	3M Faculty/Student Collaborative Grant; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The DEXA data were paid for by a 3M Faculty/Student Collaborative Grant (#212607). Additionally, the DEXA lab was supported by Grant Number 1 ULJRR033183-01 from the National Center for Research Resources (NCRR) and by Grant Number 8 ULJTR0001 14-02 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) to the University of Minnesota Clinical and Translational Science Institute (CTSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2004, APPL ERGON, V35, P329, DOI 10.1016/j.apergo.2004.03.008; Abe D, 2008, APPL ERGON, V39, P392, DOI 10.1016/j.apergo.2007.07.001; Aiello L., 2002, INTRO HUMAN EVOLUTIO; Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Alcantara E, 2002, J APPL BIOMECH, V18, P345, DOI 10.1123/jab.18.4.345; Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; BENTLEY GR, 1985, HUM ECOL, V13, P79, DOI 10.1007/BF01531090; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Blurton Jones N. G., 1989, COMP SOCIOECOLOGY BE, P367; Boening D., 1977, PHYS THER, V57; Brightman R, 1996, COMP STUD SOC HIST, V38, P687, DOI 10.1017/S0010417500020508; Brown LA, 2006, GAIT POSTURE, V24, P418, DOI 10.1016/j.gaitpost.2005.09.013; Brown LA, 2006, GAIT POSTURE, V24, P397, DOI 10.1016/j.gaitpost.2005.04.013; CHARTERIS J, 1981, NATURE, V290, P496, DOI 10.1038/290496a0; CHARTERIS J, 1982, AM J PHYS ANTHROPOL, V58, P133, DOI 10.1002/ajpa.1330580205; Chow DHK, 2005, ERGONOMICS, V48, P642, DOI 10.1080/00140130500070921; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; CLARKSON BH, 1983, PHYS THER, V63, P345, DOI 10.1093/ptj/63.3.345; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; DAY MH, 1980, NATURE, V286, P385, DOI 10.1038/286385a0; Demura T, 2010, J PHYSIOL ANTHROPOL, V29, P29, DOI 10.2114/jpa2.29.29; DeSilva JM, 2013, AM J PHYS ANTHROPOL, V151, P495, DOI 10.1002/ajpa.22287; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; FELDESMAN MR, 1988, J HUM EVOL, V17, P583, DOI 10.1016/0047-2484(88)90086-3; FELDESMAN MR, 1990, AM J PHYS ANTHROPOL, V83, P359, DOI 10.1002/ajpa.1330830309; Fessler DMT, 2005, ANN HUM BIOL, V32, P44, DOI 10.1080/03014460400027581; Filler Aaron G, 2007, Neurosurg Focus, V23, pE4; Garciaguirre JS, 2007, CHILD DEV, V78, P664, DOI 10.1111/j.1467-8624.2007.01020.x; GHORI GMU, 1985, EUR J APPL PHYSIOL O, V54, P145, DOI 10.1007/BF02335921; GOODMAN MJ, 1985, SEX ROLES, V12, P1199, DOI 10.1007/BF00287829; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; GRINE FE, 1995, AM J PHYS ANTHROPOL, V97, P151, DOI 10.1002/ajpa.1330970207; HARRIS JWK, 1978, GEOLOGICAL BACKGROUN, P529; Harris LJ, 2010, LATERALITY, V15, P56, DOI 10.1080/13576500802584371; Hatala KG, 2013, J HUM EVOL, V65, P21, DOI 10.1016/j.jhevol.2013.03.009; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hilton C. E, 1997, THESIS U NEW MEXICO THESIS U NEW MEXICO; Hilton CE, 2004, FROM BIPED TO STRIDER, P163; Hilton CE, 2008, CURR ANTHROPOL, V49, P144, DOI 10.1086/524760; HURTADO AM, 1985, HUM ECOL, V13, P1, DOI 10.1007/BF01531086; Isaac G.L., 1977, OLORGESAILIE; JONES NB, 1994, J ANTHROPOL RES, V50, P217, DOI 10.1086/jar.50.3.3630178; Jungers W.L., 1988, P115; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; JUNGERS WL, 1988, AM J PHYS ANTHROPOL, V76, P227, DOI 10.1002/ajpa.1330760211; Kanchan T, 2008, FORENSIC SCI INT, V179, P241, DOI 10.1016/j.forsciint.2008.04.029; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Konner M. J., 2005, HUNTER GATHERER CHIL, P19, DOI DOI 10.4324/9780203789445-3; Kramer PA, 1998, AM J PHYS ANTHROPOL, V107, P71; Kramer PA, 1999, J EXP BIOL, V202, P2807; Kramer PA, 2004, FROM BIPED TO STRIDER, P101; Krishan K, 2008, FORENSIC SCI INT, V179, P63, DOI 10.1016/j.forsciint.2008.04.015; LaFiandra M, 2003, J BIOMECH, V36, P87, DOI 10.1016/S0021-9290(02)00243-9; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MD, 1979, NATL GEOGR, V155, P446; Lee R. B., 1979, KUNG SAN MEN WOMEN W; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; Lloyd R, 2010, APPL ERGON, V41, P522, DOI 10.1016/j.apergo.2009.11.001; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lupo KD, 2006, J ARCHAEOL METHOD TH, V13, P19, DOI 10.1007/s10816-006-9000-6; MALOIY GMO, 1986, NATURE, V319, P668, DOI 10.1038/319668a0; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; MCHENRY HM, 1991, J HUM EVOL, V20, P21, DOI 10.1016/0047-2484(91)90043-U; McVea DA, 2007, INTEGR COMP BIOL, V47, P457, DOI 10.1093/icb/icm053; Meldrum DJ, 2004, FROM BIPED TO STRIDER, P63; Naples Virginia L., 2004, Anatomical Record Part B:The New Anatomist, V279, P9, DOI 10.1002/ar.b.20025; National Geographic Society US,, 1988, BAKA PEOPL FOR; OCONNELL JF, 1988, CURR ANTHROPOL, V29, P356, DOI 10.1086/203648; Ogg HL, 1963, PHYS THER, V43, P717; PANTERBRICK C, 1992, EUR J APPL PHYSIOL O, V64, P477, DOI 10.1007/BF00625071; Pascoe DD, 1997, ERGONOMICS, V40, P631, DOI 10.1080/001401397187928; Pinnington HC, 2005, EUR J APPL PHYSIOL, V94, P242, DOI 10.1007/s00421-005-1323-6; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Potts R., 1988, EARLY HOMINID ACTIVI; PROST JH, 1980, AM J PHYS ANTHROPOL, V52, P175, DOI 10.1002/ajpa.1330520204; Racic V, 2009, J SOUND VIB, V326, P1, DOI 10.1016/j.jsv.2009.04.020; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Reno PL, 2010, PHILOS T R SOC B, V365, P3355, DOI 10.1098/rstb.2010.0086; REYNOLDS TR, 1987, AM J PHYS ANTHROPOL, V72, P101, DOI 10.1002/ajpa.1330720113; Rosenberg KR, 2004, BEHAV BRAIN SCI, V27, P522, DOI 10.1017/S0140525X04430118; Ross C, 2001, INT J PRIMATOL, V22, P749, DOI 10.1023/A:1012065332758; Ruff CB, 2000, AM J PHYS ANTHROPOL, V113, P507, DOI 10.1002/1096-8644(200012)113:4<507::AID-AJPA5>3.0.CO;2-F; RUFF CB, 1991, AM J PHYS ANTHROPOL, V86, P397, DOI 10.1002/ajpa.1330860306; Schmid P, 2004, FROM BIPED TO STRIDER, P49; SCHMID P, 1986, Vierteljahrsschrift der Naturforschenden Gesellschaft in Zuerich, V131, P145; SCOTT SH, 1993, J BIOMECH, V26, P1091, DOI 10.1016/S0021-9290(05)80008-9; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Steudel K, 1996, AM J PHYS ANTHROPOL, V99, P345; Steudel-Numbers KL, 2004, J HUM EVOL, V47, P95, DOI 10.1016/j.jhevol.2004.06.002; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Tanaka J., 1980, SAN HUNTER GATHERERS; Taylor AJ, 2004, GAIT POSTURE, V20, P232, DOI 10.1016/j.gaitpost.2003.02.001; Tong J., 2003, FOOT, V13, P83, DOI DOI 10.1016/S0958-2592(02)00149-9; Tuttle R, 2008, ICHNOS, V15, P158, DOI 10.1080/10420940802467892; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; Wall-Scheffler CM, 2012, ANNU REV ANTHROPOL, V41, P71, DOI 10.1146/annurev-anthro-092611-145739; Wall-Scheffler CM, 2012, AM J PHYS ANTHROPOL, V147, P296; Wall-Scheffler CM, 2010, AM J PHYS ANTHROPOL, V143, P601, DOI 10.1002/ajpa.21356; Wall-Scheffler CM., 2012, J ANTHR, V2012, P1, DOI DOI 10.1155/2012/340493; Wang WJ, 2004, J ANAT, V204, P417, DOI 10.1111/j.0021-8782.2004.00295.x; Watson J, 2009, FOLIA PRIMATOL, V80, P309, DOI 10.1159/000258646; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Webb D, 2011, AM J PHYS ANTHROPOL, V144, P307; Weijers RE, 2003, FOOT, V13, P70; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Whiting J.W.M., 1994, CULTURE HUMAN DEV PP, P107; Wickler SJ, 2001, J APPL PHYSIOL, V90, P1548, DOI 10.1152/jappl.2001.90.4.1548; Witana CP, 2006, INT J IND ERGONOM, V36, P789, DOI 10.1016/j.ergon.2006.06.004; Zeanah DW, 2004, J ANTHROPOL ARCHAEOL, V23, P1, DOI 10.1016/S0278-4165(03)00061-8; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297	121	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118619	10.1371/journal.pone.0118619	http://dx.doi.org/10.1371/journal.pone.0118619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738496	Green Published, Green Accepted, gold			2022-12-26	WOS:000350685900056
J	Zhang, SP; Tang, FT; Yang, YH; Lu, ML; Luan, AN; Zhang, J; Yang, J; Wang, HX				Zhang, Suping; Tang, Futian; Yang, Yuhong; Lu, Meili; Luan, Aina; Zhang, Jing; Yang, Juan; Wang, Hongxin			Astragaloside IV Protects against Isoproterenol-Induced Cardiac Hypertrophy by Regulating NF-kappa B/PGC-1 alpha Signaling Mediated Energy Biosynthesis	PLOS ONE			English	Article							FACTOR-KAPPA-B; FATTY-ACID OXIDATION; HEART-FAILURE; TRANSCRIPTIONAL CONTROL; MYOCARDIAL HYPERTROPHY; ERR-ALPHA; METABOLISM; PGC-1-ALPHA; RECEPTOR; ACTIVATION	We previously reported that Astragaloside IV (ASIV), a major active constituent of Astragalus membranaceus (Fisch) Bge protects against cardiac hypertrophy in rats induced by isoproterenol (Iso), however the mechanism underlying the protection remains unknown. Dysfunction of cardiac energy biosynthesis contributes to the hypertrophy and Nuclear Factor kappa B (NF-kappa B)/Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1 alpha (PGC-1 alpha) signaling gets involved in the dysfunction. The present study was designed to investigate the mechanism by which ASIV improves the cardiac hypertrophy with focuses on the NF-kappa B/PGC-1 alpha signaling mediated energy biosynthesis. Sprague-Dawley (SD) rats or Neonatal Rat Ventricular Myocytes (NRVMs) were treated with Iso alone or in combination with ASIV. The results showed that combination with ASIV significantly attenuated the pathological changes, reduced the ratios of heart weight/body weight and Left ventricular weight/body weight, improved the cardiac hemodynamics, down-regulated mRNA expression of Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP), increased the ratio of ATP/AMP, and decreased the content of Free Fat Acid (FFA) in heart tissue of rats compared with Iso alone. In addition, pretreatment with ASIV significantly decreased the surface area and protein content, down-regulated mRNA expression of ANP and BNP, increased the ratio of ATP/AMP, and decreased the content of FFA in NRVMs compared with Iso alone. Furthermore, ASIV increased the protein expression of ATP5D, subunit of ATP synthase and PGC-1 alpha, inhibited translocation of p65, subunit of NF-kappa B into nuclear fraction in both rats and NRVMs compared with Iso alone. Parthenolide (Par), the specific inhibitor of p65, exerted similar effects as ASIV in NRVMs. Knockdown of p65 with siRNA decreased the surface areas and increased PGC-1 alpha expression of NRVMs compared with Iso alone. The results suggested that ASIV protects against Iso-induced cardiac hypertrophy through regulating NF-kappa B/PGC-1 alpha signaling mediated energy biosynthesis.	[Zhang, Suping; Tang, Futian; Yang, Yuhong; Lu, Meili; Luan, Aina; Zhang, Jing; Yang, Juan; Wang, Hongxin] Liaoning Med Univ, Inst Drug Res, Key Lab Cardiovasc & Cerebrovasc Drug Res Liaonin, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University	Wang, HX (corresponding author), Liaoning Med Univ, Inst Drug Res, Key Lab Cardiovasc & Cerebrovasc Drug Res Liaonin, Jinzhou, Liaoning, Peoples R China.	hongxinwang@lnmu.edu.cn			National Natural Science Foundation of the People's Republic of China [81374008]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation (No. 81374008) of the People's Republic of China.	ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Boucher FR, 2010, CARDIOVASC RES, V87, P403, DOI 10.1093/cvr/cvq185; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; KAGAYA Y, 1990, CIRCULATION, V81, P1353, DOI 10.1161/01.CIR.81.4.1353; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lu ML, 2014, PLANTA MED, V80, P63, DOI 10.1055/s-0033-1360129; Lu ML, 2012, PHARMAZIE, V67, P182, DOI 10.1691/ph.2011.1622; Nichtova Z, 2012, GEN PHYSIOL BIOPHYS, V31, P141, DOI 10.4149/gpb_2012_015; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Planavila A, 2006, MINI-REV MED CHEM, V6, P357, DOI 10.2174/138955706776073457; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; SCHULTHEISS HP, 1992, BASIC RES CARDIOL, V87, P311; Taegtmeyer H, 2002, CLIN EXP PHARMACOL P, V29, P346, DOI 10.1046/j.1440-1681.2002.03656.x; Tang D.-X., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/480597; Tu L, 2013, MICROCIRCULATION, V20, P736, DOI 10.1111/micc.12074; UNVERFERTH DV, 1988, AM HEART J, V115, P139, DOI 10.1016/0002-8703(88)90529-7; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; van Bilsen M, 1998, PFLUG ARCH EUR J PHY, V437, P2, DOI 10.1007/s004240050739; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Yang J, 2013, J ETHNOPHARMACOL, V150, P1062, DOI 10.1016/j.jep.2013.10.017; Yndestad Arne, 2007, Curr Cardiol Rep, V9, P236, DOI 10.1007/BF02938356; Zhang J, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/378298; Zhang WD, 2006, LIFE SCI, V79, P808, DOI 10.1016/j.lfs.2006.02.032; Zuo YM, 2011, PHYTOTHER RES, V25, P732, DOI 10.1002/ptr.3331	35	32	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118759	10.1371/journal.pone.0118759	http://dx.doi.org/10.1371/journal.pone.0118759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738576	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900066
J	Zhuang, GZ; Keeler, B; Grant, J; Bianchi, L; Fu, ES; Zhang, YP; Erasso, DM; Cul, JG; Wiltshire, T; Li, QZ; Hao, SL; Sarantopoulos, KD; Candiotti, K; Wishnek, SM; Smith, SB; Maixner, W; Diatchenko, L; Martin, ER; Levitt, RC				Zhuang, Gerald Z.; Keeler, Benjamin; Grant, Jeff; Bianchi, Laura; Fu, Eugene S.; Zhang, Yan Ping; Erasso, Diana M.; Cul, Jian-Guo; Wiltshire, Tim; Li, Qiongzhen; Hao, Shuanglin; Sarantopoulos, Konstantinos D.; Candiotti, Keith; Wishnek, Sarah M.; Smith, Shad B.; Maixner, William; Diatchenko, Luda; Martin, Eden R.; Levitt, Roy C.			Carbonic Anhydrase-8 Regulates Inflammatory Pain by Inhibiting the ITPR1-Cytosolic Free Calcium Pathway	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; DEPENDENT-PROTEIN-KINASE; FAMILIAL ALZHEIMERS-DISEASE; CHRONIC CONSTRICTION INJURY; PRIMARY SENSORY NEURONS; LONG-TERM POTENTIATION; SPINAL NERVE LIGATION; TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; MECHANICAL ALLODYNIA	Calcium dysregulation is causally linked with various forms of neuropathology including seizure disorders, multiple sclerosis, Huntington's disease, Alzheimer's, spinal cerebellar ataxia (SCA) and chronic pain. Carbonic anhydrase-8 (Car8) is an allosteric inhibitor of inositol trisphosphate receptor-1 (ITPR1), which regulates intracellular calcium release fundamental to critical cellular functions including neuronal excitability, neurite outgrowth, neurotransmitter release, mitochondrial energy production and cell fate. In this report we test the hypothesis that Car8 regulation of ITPR1 and cytoplasmic free calcium release is critical to nociception and pain behaviors. We show Car8 null mutant mice (MT) exhibit mechanical allodynia and thermal hyperalgesia. Dorsal root ganglia (DRG) from MT also demonstrate increased steady-state ITPR1 phosphorylation (pITPR1) and cytoplasmic free calcium release. Overexpression of Car8 wildtype protein in MT nociceptors complements Car8 deficiency, down regulates pITPR1 and abolishes thermal and mechanical hypersensitivity. We also show that Car8 nociceptor overexpression alleviates chronic inflammatory pain. Finally, inflammation results in downregulation of DRG Car8 that is associated with increased pITPR1 expression relative to ITPR1, suggesting a possible mechanism of acute hypersensitivity. Our findings indicate Car8 regulates the ITPR1-cytosolic free calcium pathway that is critical to nociception, inflammatory pain and possibly other neuropathological states. Car8 and ITPR1 represent new therapeutic targets for chronic pain.				rlevitt@med.miami.edu	Smith, Shad/AAO-8760-2020		National Institutes of Health, National Institute of Craniofacial and Dental Research [R01DE022903]; NIDA National Institutes of Health, National Institute of Drug Abuse [R031410]; Algynomics Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022903] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Craniofacial and Dental Research; NIDA National Institutes of Health, National Institute of Drug Abuse; Algynomics Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding provided by R01DE022903, National Institutes of Health, National Institute of Craniofacial and Dental Research (RCL, ERM, WM, LD, SS); NIDA R031410 National Institutes of Health, National Institute of Drug Abuse (SH). Algynomics Inc. provided support in the form of salaries for authors SS, WM, LD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen PL, 2003, CELL MOL NEUROBIOL, V23, P205, DOI 10.1023/A:1022902006434; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bengtson CP, 2010, BIOPHYS J, V99, P4066, DOI 10.1016/j.bpj.2010.10.044; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Carrasco MA, 2004, BIOL RES, V37, P701, DOI 10.4067/S0716-97602004000400028; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fairless R, 2014, CELL TISSUE RES, V357, P455, DOI 10.1007/s00441-013-1758-8; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Gunter TE, 2001, IUBMB LIFE, V52, P197, DOI 10.1080/15216540152846000; Hamamoto DT, 2007, EUR J PHARMACOL, V558, P73, DOI 10.1016/j.ejphar.2006.11.062; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Hirasawa M, 2007, MOL CELL NEUROSCI, V35, P161, DOI 10.1016/j.mcn.2007.02.013; Hirota J, 2003, BIOCHEM J, V372, P435, DOI 10.1042/BJ20030110; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Jones TL, 2007, ANESTH ANALG, V105, P1650, DOI 10.1213/01.ane.0000287644.00420.49; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Kim HY, 2011, J NEUROSCI, V31, P12982, DOI 10.1523/JNEUROSCI.3093-11.2011; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Mikoshiba K, 1997, CURR OPIN NEUROBIOL, V7, P339, DOI 10.1016/S0959-4388(97)80061-X; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Obata K, 2003, PAIN, V101, P65, DOI 10.1016/S0304-3959(02)00296-8; ONEILL C, 2001, BIOCH SOC S, V67, P177, DOI DOI 10.1042/BSS0670177; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; RANDIC M, 1993, J NEUROSCI, V13, P5228, DOI 10.1523/JNEUROSCI.13-12-05228.1993; RANG HP, 1988, J NEUROSCI, V8, P2606; Rizzuto R, 2001, CURR OPIN NEUROBIOL, V11, P306, DOI 10.1016/S0959-4388(00)00212-9; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Ruscheweyh R, 2007, J COMP NEUROL, V502, P325, DOI 10.1002/cne.21311; SCHEPELMANN K, 1993, EXP BRAIN RES, V92, P391; Schmitz-Hubsch T, 2010, MOVEMENT DISORD, V25, P587, DOI 10.1002/mds.22740; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Sjoblom B, 1996, FEBS LETT, V398, P322, DOI 10.1016/S0014-5793(96)01263-X; Storek B, 2008, P NATL ACAD SCI USA, V105, P1055, DOI 10.1073/pnas.0708003105; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Tertyshnikova S, 1998, P NATL ACAD SCI USA, V95, P1613, DOI 10.1073/pnas.95.4.1613; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Verkhratsky A, 2004, BIOL RES, V37, P693; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Xu Y, 2003, HUM GENE THER, V14, P897, DOI 10.1089/104303403765701187; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Yule DI, 2003, BIOCHEM SOC T, V31, P954; Zeitz KP, 2004, NEUROSCIENCE, V128, P889, DOI 10.1016/j.neuroscience.2004.07.029; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Zhuo M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-4	89	24	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118273	10.1371/journal.pone.0118273	http://dx.doi.org/10.1371/journal.pone.0118273			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734498	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700020
J	Williams, JA; Ni, HM; Haynes, A; Manley, S; Li, Y; Jaeschke, H; Ding, WX				Williams, Jessica A.; Ni, Hong-Min; Haynes, Anna; Manley, Sharon; Li, Yuan; Jaeschke, Hartmut; Ding, Wen-Xing			Chronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL KINASE; JNK ACTIVATION; AUTOPHAGY; MITOCHONDRIA; MECHANISM; APOPTOSIS; PROMOTES; MCL-1; GENE; NIX	We previously demonstrated that pharmacological induction of autophagy protected against acetaminophen (APAP)-induced liver injury in mice by clearing damaged mitochondria. However, the mechanism for removal of mitochondria by autophagy is unknown. Parkin, an E3 ubiquitin ligase, has been shown to be required for mitophagy induction in cultured mammalian cells following mitochondrial depolarization, but its role in vivo is not clear. The purpose of this study was to investigate the role of Parkin-mediated mitophagy in protection against APAP-induced liver injury. We found that Parkin translocated to mitochondria in mouse livers after APAP treatment followed by mitochondrial protein ubiquitination and mitophagy induction. To our surprise, we found that mitophagy still occurred in Parkin knock-out (KO) mice after APAP treatment based on electron microscopy analysis and Western blot analysis for some mitochondrial proteins, and Parkin KO mice were protected against APAP-induced liver injury compared with wild type mice. Mechanistically, we found that Parkin KO mice had decreased activated c-Jun N-terminal kinase (JNK), increased induction of myeloid leukemia cell differentiation protein (Mcl-1) expression, and increased hepatocyte proliferation after APAP treatment in their livers compared with WT mice. In contrast to chronic deletion of Parkin, acute knockdown of Parkin in mouse livers using adenovirus shRNA reduced mitophagy and Mcl-1 expression but increased JNK activation after APAP administration, which exacerbated APAP-induced liver injury. Therefore, chronic deletion (KO) and acute knockdown of Parkin have differential responses to APAP-induced mitophagy and liver injury in mice.	[Williams, Jessica A.; Ni, Hong-Min; Haynes, Anna; Manley, Sharon; Li, Yuan; Jaeschke, Hartmut; Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu	Li, Yuan/J-7786-2019; Regan, Clinton/E-6250-2012; Jaeschke, Hartmut/J-6285-2013	Li, Yuan/0000-0002-3171-8053; Manley, Sharon/0000-0002-2411-9706	National Institutes of Health COBRE Grant [9P20GM104936]; National Institutes of Health [S10RR027564]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027564, P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P20GM103549, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA020518, R01AA020518] Funding Source: NIH RePORTER	National Institutes of Health COBRE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We acknowledge the Electron Microscopy Research Lab Facility for assistance with the electron microscopy. The EMRL is supported in part by National Institutes of Health COBRE Grant 9P20GM104936, The JEOL JEM-1400 TEM used in the study was purchased with funds from National Institutes of Health Grant S10RR027564. We thank Margitta Lebofsky for technical assistance for the measurement of hepatic GSH.	Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Ding W. X., 2012, J BIOL CHEM, V287, P42379; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doddareddy MR, 2012, CURR MED CHEM, V19, P163; Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Getachew Y, 2010, BIOCHEM PHARMACOL, V79, P1363, DOI 10.1016/j.bcp.2009.12.019; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Hwang S, 2010, MOL CELLS, V29, P575, DOI 10.1007/s10059-010-0068-1; JAESCHKE H, 1990, METHOD ENZYMOL, V186, P752; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Larson Anne M, 2007, Clin Liver Dis, V11, P525, DOI 10.1016/j.cld.2007.06.006; Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McGill M. R., 2013, PHARM RES, V30, P2174; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Ni HM, 2013, REDOX BIOL, V1, P427, DOI 10.1016/j.redox.2013.08.005; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P156272, DOI 10.1155/2012/156272; Ryan PM, 2012, CHEM RES TOXICOL, V25, P83, DOI 10.1021/tx2003992; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Sharma M, 2012, MOL PHARMACOL, V82, P1001, DOI 10.1124/mol.112.079863; Shinohara M, 2010, J BIOL CHEM, V285, P8244, DOI 10.1074/jbc.M109.054999; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Wang W, 2014, MOL CANCER THER, V13, P1480, DOI 10.1158/1535-7163.MCT-13-0629; Warr MR, 2008, CURR MOL MED, V8, P138; Williams JA, 2013, PHARM RES-DORDR, V30, P2279, DOI 10.1007/s11095-013-1139-8; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2008, AUTOPHAGY, V4, P354, DOI 10.4161/auto.5552	56	58	62	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10934	10946		10.1074/jbc.M114.602284	http://dx.doi.org/10.1074/jbc.M114.602284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752611	Green Published, hybrid			2022-12-26	WOS:000353404500031
J	Yuan, L; Seong, E; Beuscher, JL; Arikkath, J				Yuan, Li; Seong, Eunju; Beuscher, James L.; Arikkath, Jyothi			delta-Catenin Regulates Spine Architecture via Cadherin and PDZ-dependent Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DU-CHAT SYNDROME; REPEAT PROTEIN/DELTA-CATENIN; DENDRITIC SPINE; N-CADHERIN; INTELLECTUAL DISABILITY; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; NEURONAL DENSITY; AMPA RECEPTORS; SYNAPSES	The ability of neurons to maintain spine architecture and modulate it in response to synaptic activity is a crucial component of the cellular machinery that underlies information storage in pyramidal neurons of the hippocampus. Here we show a critical role for delta-catenin, a component of the cadherin-catenin cell adhesion complex, in regulating spine head width and length in pyramidal neurons of the hippocampus. The loss of Ctnnd2, the gene encoding delta-catenin, has been associated with the intellectual disability observed in the cri du chat syndrome, suggesting that the functional roles of delta-catenin are vital for neuronal integrity and higher order functions. We demonstrate that loss of delta-catenin in a mouse model or knockdown of delta-catenin in pyramidal neurons compromises spine head width and length, without altering spine dynamics. This is accompanied by a reduction in the levels of synaptic N-cadherin. The ability of delta-catenin to modulate spine architecture is critically dependent on its ability to interact with cadherin and PDZ domain-containing proteins. We propose that loss of delta-catenin during development perturbs synaptic architecture leading to developmental aberrations in neural circuit formation that contribute to the learning disabilities in a mouse model and humans with cri du chat syndrome.	[Yuan, Li; Arikkath, Jyothi] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Seong, Eunju; Beuscher, James L.; Arikkath, Jyothi] Univ Nebraska Med Ctr, Dev Neurosci, Munroe Meyer Inst, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Arikkath, J (corresponding author), Univ Nebraska Med Ctr, Dev Neurosci, Munroe Meyer Inst, Omaha, NE 68198 USA.	Jyothi.arikkath@unmc.edu	Seong, Eunju/ABH-2705-2020		National Institutes of Health Institutional Development Award (IDeA) from the NIGMS [5P20GM103471-10]; Munroe-Meyer Institute; Alzheimer's Association; Nebraska Research Initiative; Nebraska EPSCoR [EPS-1004094]; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471, P30GM110768] Funding Source: NIH RePORTER	National Institutes of Health Institutional Development Award (IDeA) from the NIGMS; Munroe-Meyer Institute; Alzheimer's Association(Alzheimer's Association); Nebraska Research Initiative; Nebraska EPSCoR; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Institutional Development Award (IDeA) Grant 5P20GM103471-10 from the NIGMS, start up funds from the Munroe-Meyer Institute, and grants from the Alzheimer's Association, The Nebraska Research Initiative, and Nebraska EPSCoR Grant EPS-1004094.; Supported by a graduate student fellowship from the University of Nebraska Medical Center.	Araya R, 2014, P NATL ACAD SCI USA, V111, pE2895, DOI 10.1073/pnas.1321869111; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arikkath J, 2008, J NEUROSCI, V28, P7047, DOI 10.1523/JNEUROSCI.0451-08.2008; Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Biffi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083899; Boda B, 2014, EUR J NEUROSCI, V39, P1130, DOI 10.1111/ejn.12488; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Chiurazzi P, 2000, CURR OPIN PEDIATR, V12, P529, DOI 10.1097/00008480-200012000-00003; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Heisler FF, 2014, P NATL ACAD SCI USA, V111, P5030, DOI 10.1073/pnas.1304301111; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim H, 2012, BBA-MOL BASIS DIS, V1822, P509, DOI 10.1016/j.bbadis.2011.12.015; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Mysore SP, 2008, FRONT NEUROSCI-SWITZ, V2, P168, DOI 10.3389/neuro.01.035.2008; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Oe Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01957; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Pavlowsky A, 2012, MOL PSYCHIATR, V17, P682, DOI 10.1038/mp.2011.139; Pielarski KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054105; Reines A, 2012, J NEUROSCI, V32, P6323, DOI 10.1523/JNEUROSCI.0916-12.2012; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Sardina JM, 2014, AM J MED GENET A, V164, P1761, DOI 10.1002/ajmg.a.36494; Sheng M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0138; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; VanLeeuwen JE, 2012, J NEUROCHEM, V123, P781, DOI 10.1111/j.1471-4159.2012.07899.x; Verpelli C, 2013, EUR J PHARMACOL, V719, P112, DOI 10.1016/j.ejphar.2013.07.023; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Yam PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079679; Yuan Y, 2013, NEUROSCI LETT, V536, P10, DOI 10.1016/j.neulet.2013.01.002; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762	56	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10947	10957		10.1074/jbc.M114.632679	http://dx.doi.org/10.1074/jbc.M114.632679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25724647	Green Published, hybrid			2022-12-26	WOS:000353404500032
J	Liu, ML; Chen, HZ; Wei, L; Hu, DR; Dong, K; Jia, WP; Dong, LQ; Liu, F				Liu, Meilian; Chen, Hongzhi; Wei, Li; Hu, Derong; Dong, Kun; Jia, Weiping; Dong, Lily Q.; Liu, Feng			Endoplasmic Reticulum (ER) Localization Is Critical for DsbA-L Protein to Suppress ER Stress and Adiponectin Down-regulation in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adiponectin; Endoplasmic Reticulum (ER); Endoplasmic Reticulum Stress (ER Stress); Endoplasmic Reticulum-associated Protein Degradation (ERAD); Mitochondria; DsbA-L; ER Localization	GLUTATHIONE-S-TRANSFERASE; SIGNALING PATHWAY; ENDOCRINE ORGAN; ADIPOSE-TISSUE; CLASS-KAPPA; MULTIMERIZATION; KINASE; ACRP30/ADIPONECTIN; MITOCHONDRIA; ACTIVATION	Adiponectin is an adipokine with insulin-sensitizing and anti-inflammatory functions. We previously reported that adiponectin multimerization and stability are promoted by the disulfide bond A oxidoreductase-like protein (DsbA-L) in cells and in vivo. However, the precise mechanism by which DsbA-L regulates adiponectin biosynthesis remains elusive. Here we show that DsbA-L is co-localized with the endoplasmic reticulum (ER) marker protein disulfide isomerase and the mitochondrial marker MitoTracker. In addition, DsbA-L interacts with the ER chaperone protein Ero1-L in 3T3-L1 adipocytes. In silico analysis and truncation mapping studies revealed that DsbA-L contains an ER targeting signal at its N terminus. Deletion of the first 6 residues at the N terminus greatly impaired DsbA-L localization in the ER. Overexpression of the wild type but not the ER localization-defective mutant of DsbA-L protects against thapsigargin-induced ER stress and adiponectin down-regulation in 3T3-L1 adipocytes. In addition, overexpression of the wild type but not the ER localization-defective mutant of DsbA-L promotes adiponectin multimerization. Together, our results reveal that DsbA-L is localized in both the mitochondria and the ER in adipocytes and that its ER localization plays a critical role in suppressing ER stress and promoting adiponectin biosynthesis and secretion.	[Liu, Meilian; Chen, Hongzhi; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha 410011, Hunan, Peoples R China; [Liu, Meilian] Univ New Mexico, Dept Biochem, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Liu, Meilian] Univ New Mexico, Dept Mol Biol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Wei, Li; Hu, Derong; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Chen, Hongzhi; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Dong, Kun; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Wei, Li; Dong, Kun; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200025, Peoples R China	Central South University; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University	Liu, F (corresponding author), Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha 410011, Hunan, Peoples R China.	LiuF@uthscsa.edu	Liu, Feng/CAG-8962-2022	Chen, Hongzhi/0000-0001-6060-3776	National Institutes of Health [R01 DK76902, R01 DK080344]; American Diabetes Association [1-12-BS-115, 1-13-JF-37]; American Heart Association (AHA) [11PRE7970021]; Translational Science Training (TST) Across Disciplines program at the University of Texas Health Science Center at San Antonio; University of Texas System Graduate Programs Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076902, R01DK080344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association (AHA)(American Heart Association); Translational Science Training (TST) Across Disciplines program at the University of Texas Health Science Center at San Antonio; University of Texas System Graduate Programs Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK76902 (to F. L.) and R01 DK080344 (to L. Q. D). This work was also supported by a Research Award (1-12-BS-115 to F. L.) and a Junior Faculty Research Award (1-13-JF-37 to M. L.) from the American Diabetes Association.; Supported by a predoctoral fellowship from the American Heart Association (AHA) (11PRE7970021) and a fellowship from the Translational Science Training (TST) Across Disciplines program at the University of Texas Health Science Center at San Antonio, with funding provided by the University of Texas System Graduate Programs Initiative.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Germain M., 2003, SCI STKE, pe10; HARRIS JM, 1991, BIOCHEM J, V278, P137, DOI 10.1042/bj2780137; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Jowsey IR, 2003, BIOCHEM J, V373, P559, DOI 10.1042/BJ20030415; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Liu ML, 2012, DIABETES, V61, P2776, DOI 10.2337/db12-0169; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Nebert Daniel W., 2004, Human Genomics, V1, P460; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Thomson RE, 2004, J HISTOCHEM CYTOCHEM, V52, P653, DOI 10.1177/002215540405200509; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	26	27	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10143	10148		10.1074/jbc.M115.645416	http://dx.doi.org/10.1074/jbc.M115.645416			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739441	hybrid, Green Published			2022-12-26	WOS:000353241100021
J	Wang, X; Wu, SS; MacIntyre, CR; Zhang, HB; Shi, WX; Peng, XM; Duan, W; Yang, P; Zhang, Y; Wang, QY				Wang, Xiaoli; Wu, Shuangsheng; MacIntyre, C. Raina; Zhang, Hongbin; Shi, Weixian; Peng, Xiaomin; Duan, Wei; Yang, Peng; Zhang, Yi; Wang, Quanyi			Using an Adjusted Serfling Regression Model to Improve the Early Warning at the Arrival of Peak Timing of Influenza in Beijing	PLOS ONE			English	Article							SURVEILLANCE; MORTALITY; EPIDEMICS; IMPACT	Serfling-type periodic regression models have been widely used to identify and analyse epidemic of influenza. In these approaches, the baseline is traditionally determined using cleaned historical non-epidemic data. However, we found that the previous exclusion of epidemic seasons was empirical, since year-year variations in the seasonal pattern of activity had been ignored. Therefore, excluding fixed 'epidemic' months did not seem reasonable. We made some adjustments in the rule of epidemic-period removal to avoid potentially subjective definition of the start and end of epidemic periods. We fitted the baseline iteratively. Firstly, we established a Serfling regression model based on the actual observations without any removals. After that, instead of manually excluding a predefined 'epidemic' period (the traditional method), we excluded observations which exceeded a calculated boundary. We then established Serfling regression once more using the cleaned data and excluded observations which exceeded a calculated boundary. We repeated this process until the R-2 value stopped to increase. In addition, the definitions of the onset of influenza epidemic were heterogeneous, which might make it impossible to accurately evaluate the performance of alternative approaches. We then used this modified model to detect the peak timing of influenza instead of the onset of epidemic and compared this model with traditional Serfling models using observed weekly case counts of influenza-like illness (ILIs), in terms of sensitivity, specificity and lead time. A better performance was observed. In summary, we provide an adjusted Serfling model which may have improved performance over traditional models in early warning at arrival of peak timing of influenza.	[Wang, Xiaoli; Wu, Shuangsheng; Shi, Weixian; Peng, Xiaomin; Duan, Wei; Yang, Peng; Zhang, Yi; Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [MacIntyre, C. Raina] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Zhang, Hongbin] Univ Elect Sci & Technol China, Sch Elect Engn, Chengdu 610054, Peoples R China	University of New South Wales Sydney; University of Electronic Science & Technology of China	Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China.	bjcdcxm@126.com		MacIntyre, C Raina/0000-0002-3060-0555	Beijing Municipal Science & Technology Commission [Z131100005613048]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This study was supported by Beijing Municipal Science & Technology Commission (No. Z131100005613048) http://www.bjkw.gov.cn/ n8785584/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	an der Heiden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064593; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Bock D, 2008, BIOMETRICAL J, V50, P71, DOI 10.1002/bimj.200610362; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; Centre for Health Protection DoH, 2005, WORK GROUP REP COMP; Conway JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-932; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Cowling BJ, 2013, HONG KONG MED J X S4, V19, pS4; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Lederman R P, 1993, MCN Am J Matern Child Nurs, V18, P283, DOI 10.1097/00005721-199309000-00015; Muscatello DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064734; Muscatello DJ, 2008, COMMUN DIS INTELL, V32, P435; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Viboud Cecile, 2010, PLoS Curr, V2, pRRN1153; Watkins RE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-263; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Yang L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-133; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040	29	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119923	10.1371/journal.pone.0119923	http://dx.doi.org/10.1371/journal.pone.0119923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756205	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700054
J	Gasanov, EV; Rafieva, LM; Korzh, VP				Gasanov, Eugene V.; Rafieva, Lola M.; Korzh, Vladimir P.			BDNF-TrkB Axis Regulates Migration of the Lateral Line Primordium and Modulates the Maintenance of Mechanoreceptor Progenitors	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; INNER-EAR; IN-VIVO; ENDOTHELIAL-CELLS; ZEBRAFISH GENES; MOLECULAR-BASIS; HAIR-CELLS; BRAIN; EXPRESSION; RECEPTORS	BDNF and its specialized receptor TrkB are expressed in the developing lateral line system of zebrafish, but their role in this organ is unknown. To tackle this problem in vivo, we used transgenic animals expressing fluorescent markers in different cell types of the lateral line and combined a BDNF gain-of-function approach by BDNF mRNA overexpression and by soaking embryos in a solution of BDNF, with a loss-of-function approach by injecting the antisence ntrk2b-morpholino and treating embryos with the specific Trk inhibitor K252a. Subsequent analysis demonstrated that the BDNF-TrkB axis regulates migration of the lateral line primordium. In particular, BDNF-TrkB influences the expression level of components of chemokine signaling including Cxcr4b, and the generation of progenitors of mechanoreceptors, at the level of expression of Atoh1a-Atp2b1a.	[Gasanov, Eugene V.; Rafieva, Lola M.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Korzh, Vladimir P.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Korzh, Vladimir P.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Russian Academy of Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Korzh, VP (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.	vlad@imcb.a-star.edu.sg	Korzh, Vladimir P/H-1596-2011; Gasanov, Eugene/U-7902-2018	Korzh, Vladimir P/0000-0002-6580-7986; Gasanov, Eugene/0000-0002-5020-9406	Institute of Molecular Genetics of the Russian Academy of Science; Russian Foundation for Basic Research (RFBR) [11-08-01046-a, 13-04-01009-a]; Agency for Science, Technology and Research of Singapore	Institute of Molecular Genetics of the Russian Academy of Science; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	EG and LR were supported by the Institute of Molecular Genetics of the Russian Academy of Science and a grant from the Russian Foundation for Basic Research (RFBR). The grant numbers are 11-08-01046-a and 13-04-01009-a. VK was supported by a grant of the Agency for Science, Technology and Research of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04733; Bartkowska K, 2010, ACTA NEUROBIOL EXP, V70, P454; Bianchi LM, 1996, DEVELOPMENT, V122, P1965; Budenz CL, 2012, ANAT REC, V295, P1896, DOI 10.1002/ar.22586; Cao L, 2012, J CELL MOL MED, V16, P3105, DOI 10.1111/j.1582-4934.2012.01621.x; Chen CC, 2014, BRAIN STRUCT FUNCT; Chen D, 2014, AM J PHYSIOL-RENAL, V307, pF64, DOI 10.1152/ajprenal.00547.2013; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Douglas-Escobar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051706; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; FUKUZONO S, 1995, BIOSCI BIOTECH BIOCH, V59, P1727, DOI 10.1271/bbb.59.1727; Germana A, 2010, CELL MOL NEUROBIOL, V30, P787, DOI 10.1007/s10571-010-9506-z; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Gilmour D, 2004, NEURON, V34, P577; Go W, 2010, CELL CALCIUM, V48, P302, DOI 10.1016/j.ceca.2010.09.012; Grade S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055039; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Jansson LC, 2012, NEUROSCIENCE, V224, P223, DOI 10.1016/j.neuroscience.2012.08.038; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Komisarczuk AZ, 2008, DEV DYNAM, V237, P2594, DOI 10.1002/dvdy.21689; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Kotlyanskaya L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003824; Loh SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04289; Lum T, 2001, INT J DEV NEUROSCI, V19, P569, DOI 10.1016/S0736-5748(01)00041-7; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; MARTIN SC, 1995, DEV BIOL, V169, P745, DOI 10.1006/dbio.1995.1184; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Radeloff A, 2006, ACTA OTO-LARYNGOL, V126, P452, DOI 10.1080/00016480500437344; Ramekers D, 2012, HEARING RES, V288, P19, DOI 10.1016/j.heares.2012.03.002; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Safina D R, 2008, Bioorg Khim, V34, P327; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Suenaga M, 1998, BIOTECHNOL APPL BIOC, V28, P119; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Thisse B, 2001, RR15402 NIH R01 ZFIN; Usui T, 2014, ACTA PHYSIOL, V211, P385, DOI 10.1111/apha.12249; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Van de Water TR, 1999, ANN NY ACAD SCI, V884, P345, DOI 10.1111/j.1749-6632.1999.tb08653.x; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Xu H, 2013, SMALL, V9, P585, DOI 10.1002/smll.201202208; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	52	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119711	10.1371/journal.pone.0119711	http://dx.doi.org/10.1371/journal.pone.0119711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751404	Green Submitted, gold, Green Published			2022-12-26	WOS:000350692700032
J	Khater, F; Balestrino, D; Charbonnel, N; Dufayard, JF; Brisse, S; Forestier, C				Khater, Fida; Balestrino, Damien; Charbonnel, Nicolas; Dufayard, Jean Francois; Brisse, Sylvain; Forestier, Christiane			In Silico Analysis of Usher Encoding Genes in Klebsiella pneumoniae and Characterization of Their Role in Adhesion and Colonization	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; TYPE-3 FIMBRIAE; PHASE VARIATION; MRKD; IDENTIFICATION; ANNOTATION; DIVERSITY; INFECTION; VIRULENCE	Chaperone/usher (CU) assembly pathway is used by a wide range of Enterobacteriaceae to assemble adhesive surface structures called pili or fimbriae that play a role in bacteria-host cell interactions. In silico analysis revealed that the genome of Klebsiella pneumoniae LM21 harbors eight chromosomal CU loci belonging gamma kappa and. clusters. Of these, only two correspond to previously described operons, namely type 1 and type 3-encoding operons. Isogenic usher deletion mutants of K. pneumoniae LM21 were constructed for each locus and their role in adhesion to animal (Intestine 407) and plant (Arabidopsis thaliana) cells, biofilm formation and murine intestinal colonization was investigated. Type 3 pili usher deleted mutant was impaired in all assays, whereas type 1 pili usher deleted mutant only showed attenuation in adhesion to plant cells and in intestinal colonization. The LM21 Delta kpjC mutant was impaired in its capacity to adhere to Arabidopsis cells and to colonize the murine intestine, either alone or in co-inoculation experiments. Deletion of LM21kpgC induced a significant decrease in biofilm formation, in adhesion to animal cells and in colonization of the mice intestine. The LM21. kpaC and LM21. kpeC mutants were only attenuated in biofilm formation and the adhesion abilities to Arabidopsis cells, respectively. No clear in vitro or in vivo effect was observed for LM21. kpbC and LM21. kpdC mutants. The multiplicity of CU loci in K. pneumoniae genome and their specific adhesion pattern probably reflect the ability of the bacteria to adhere to different substrates in its diverse ecological niches.	[Khater, Fida; Balestrino, Damien; Charbonnel, Nicolas; Forestier, Christiane] LMGE UMR CNRS 6023 Clermont Ferrand, F-63000 Clermont Ferrand, France; [Dufayard, Jean Francois] CIRAD, UMR AGAP 1334, F-34398 Montpellier, France; [Brisse, Sylvain] Inst Pasteur, Microbial Evolutionary Genom, F-75015 Paris, France; [Brisse, Sylvain] CNRS, UMR 3525, Paris, France	CIRAD; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Forestier, C (corresponding author), LMGE UMR CNRS 6023 Clermont Ferrand, F-63000 Clermont Ferrand, France.	Christiane.forestier@udamail.fr	Dufayard, Jean-François/AAC-7013-2020; Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; KHATER, Fida/0000-0003-2810-3928; BALESTRINO, Damien/0000-0001-5378-0379				ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Bialek-Davenet S, 2014, EMERG INFEC IN PRESS; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Boddicker JD, 2006, INFECT IMMUN, V74, P4590, DOI 10.1128/IAI.00129-06; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; CHEN TH, 1977, INFECT IMMUN, V15, P972, DOI 10.1128/IAI.15.3.972-977.1977; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clegg S, 2011, J BACTERIOL, V193, P2081, DOI 10.1128/JB.00071-11; Criscuolo A, 2013, GENOMICS, V102, P500, DOI 10.1016/j.ygeno.2013.07.011; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; DUGUID JP, 1959, J GEN MICROBIOL, V21, P271, DOI 10.1099/00221287-21-1-271; Felek S, 2011, MICROBIOL-SGM, V157, P805, DOI 10.1099/mic.0.044826-0; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAAHTELA K, 1986, APPL ENVIRON MICROB, V52, P1074, DOI 10.1128/AEM.52.5.1074-1079.1986; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; HORNICK DB, 1992, INFECT IMMUN, V60, P1577, DOI 10.1128/IAI.60.4.1577-1588.1992; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Lavender HF, 2004, INFECT IMMUN, V72, P4888, DOI 10.1128/IAI.72.8.4888-4890.2004; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Ong CLY, 2008, J BACTERIOL, V190, P1054, DOI 10.1128/JB.01523-07; Ong CLY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-183; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rosen DA, 2008, INFECT IMMUN, V76, P3337, DOI 10.1128/IAI.00090-08; Sahly H, 1997, CLIN DIAGN LAB IMMUN, V4, P393, DOI 10.1128/CDLI.4.4.393-399.1997; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2001, MOL MICROBIOL, V41, P1419, DOI 10.1046/j.1365-2958.2001.02613.x; Schroll C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-179; SCHURTZ TA, 1994, INFECT IMMUN, V62, P4186, DOI 10.1128/IAI.62.10.4186-4191.1994; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Struve C, 2009, INFECT IMMUN, V77, P5016, DOI 10.1128/IAI.00585-09; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; van Aartsen JJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-59; van der Velden AWM, 1998, INFECT IMMUN, V66, P2803, DOI 10.1128/IAI.66.6.2803-2808.1998; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; Wu CC, 2010, MICROBIOL-SGM, V156, P1983, DOI 10.1099/mic.0.038158-0; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Yue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038596	64	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0116215	10.1371/journal.pone.0116215	http://dx.doi.org/10.1371/journal.pone.0116215			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751658	Green Submitted, Green Published, gold			2022-12-26	WOS:000350692700002
J	Gounaris, E; Heiferman, MJ; Heiferman, JR; Shrivastav, M; Vitello, D; Blatner, NR; Knab, LM; Phillips, JD; Cheon, EC; Grippo, PJ; Khazaie, K; Munshi, HG; Bentrem, DJ				Gounaris, Elias; Heiferman, Michael J.; Heiferman, Jeffrey R.; Shrivastav, Manisha; Vitello, Dominic; Blatner, Nichole R.; Knab, Lawrence M.; Phillips, Joseph D.; Cheon, Eric C.; Grippo, Paul J.; Khazaie, Khashayarsha; Munshi, Hidayatullah G.; Bentrem, David J.			Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic Inflammation	PLOS ONE			English	Article							MAST-CELLS; COLORECTAL-CANCER; ANGIOGENESIS; PREVENTION; CELECOXIB; BEVACIZUMAB; CONTRIBUTES; EXPRESSION; FOLFOX4	Purpose Leukotrienes and prostaglandins, products of arachidonic acid metabolism, sustain both systemic and lesion-localized inflammation. Tumor-associated Inflammation can also contribute to the pathogenesis of colon cancer. Patients with inflammatory bowel disease (IBD) have increased risk of developing colon cancer. The levels of 5-lipoxygenase (5-LO), the key enzyme for leukotrienes production, are increased in colon cancer specimens and colonic dysplastic lesions. Here we report that Zileuton, a specific 5-LO inhibitor, can prevent polyp formation by efficiently reducing the tumor-associated and systemic inflammation in APC(Delta 468) mice. Experimental Design In the current study, we inhibited 5-LO by dietary administration of Zileuton in the APC.468 mouse model of polyposis and analyzed the effect of in vivo 5-LO inhibition on tumor-associated and systemic inflammation. Results Zileuton-fed mice developed fewer polyps and displayed marked reduction in systemic and polyp-associated inflammation. Pro-inflammatory cytokines and pro-inflammatory innate and adaptive immunity cells were reduced both in the lesions and systemically. As part of tumor-associated inflammation Leukotriene B4 (LTB4), product of 5-LO activity, is increased focally in human dysplastic lesions. The 5-LO enzymatic activity was reduced in the serum of Zileuton treated polyposis mice. Conclusions This study demonstrates that dietary administration of 5-LO specific inhibitor in the polyposis mouse model decreases polyp burden, and suggests that Zileuton may be a potential chemo-preventive agent in patients that are high-risk of developing colon cancer.	[Gounaris, Elias; Heiferman, Michael J.; Heiferman, Jeffrey R.; Shrivastav, Manisha; Vitello, Dominic; Knab, Lawrence M.; Phillips, Joseph D.; Cheon, Eric C.; Grippo, Paul J.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Gounaris, Elias; Blatner, Nichole R.; Khazaie, Khashayarsha; Munshi, Hidayatullah G.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bentrem, David J.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Gounaris, E (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA.	gounaris@northwestern.edu; dbentrem@nmff.org	Gounaris, Elias/B-3184-2011	Vitello, Dominic/0000-0002-4163-7759	Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility; National Institutes of Health (NIH) [1R01CA160436-01]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA160436] Funding Source: NIH RePORTER	Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility; and National Institutes of Health (NIH) grant 1R01CA160436-01 (to KK and DJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bertran X, 1996, GUT, V38, P899, DOI 10.1136/gut.38.6.899; Cathcart MC, 2011, CANCER METAST REV, V30, P363, DOI 10.1007/s10555-011-9324-x; Chen QY, 2013, J IMMUNOL, V190, P1048, DOI 10.4049/jimmunol.1202455; Cheon EC, 2011, CANCER RES, V71, P1627, DOI 10.1158/0008-5472.CAN-10-1923; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Cohen MH, 2007, ONCOLOGIST, V12, P356, DOI 10.1634/theoncologist.12-3-356; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Gounaris E, 2013, INFLAMM BOWEL DIS, V19, P1339, DOI 10.1097/MIB.0b013e318281f3f8; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; Gunning WT, 2002, CANCER RES, V62, P4199; Hu B, 2010, P NATL ACAD SCI US; Khazaie K, 2011, CANCER METAST REV, V30, P45, DOI 10.1007/s10555-011-9286-z; Kim GY, 2009, ARTERIOSCL THROM VAS, V29, P915, DOI 10.1161/ATVBAHA.109.185793; KIM GY, 2010, J IMMUNOL, V184, P3946, DOI DOI 10.4049/JIMMUN0L.0901735; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peters-Golden M, 2001, FEBS LETT, V487, P323, DOI 10.1016/S0014-5793(00)02374-7; Pulendran B, 2008, NAT MED, V14, P489, DOI 10.1038/nm0508-489; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Rossi A, 2010, BRIT J PHARMACOL, V161, P555, DOI 10.1111/j.1476-5381.2010.00930.x; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tripodo C, 2010, AM J PATHOL, V177, P792, DOI 10.2353/ajpath.2010.091286; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Ye YN, 2005, EUR J PHARMACOL, V519, P52, DOI 10.1016/j.ejphar.2005.07.009; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; ZINGARELLI B, 1993, AGENTS ACTIONS, V39, P150, DOI 10.1007/BF01998968	43	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0121402	10.1371/journal.pone.0121402	http://dx.doi.org/10.1371/journal.pone.0121402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747113	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400100
J	MacRaild, CA; Zachrdla, M; Andrew, D; Krishnarjuna, B; Novacek, J; Zidek, L; Sklenar, V; Richards, JS; Beeson, JG; Anders, RF; Norton, RS				MacRaild, Christopher A.; Zachrdla, Milan; Andrew, Dean; Krishnarjuna, Bankala; Novacek, Jiri; Zidek, Lukas; Sklenar, Vladimir; Richards, Jack S.; Beeson, James G.; Anders, Robin F.; Norton, Raymond S.			Conformational Dynamics and Antigenicity in the Disordered Malaria Antigen Merozoite Surface Protein 2	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PAPUA-NEW-GUINEA; CLINICAL MALARIA; HUMORAL RESPONSE; CIRCUMSPOROZOITE PROTEIN; MONOCLONAL-ANTIBODIES; STRUCTURAL DIVERSITY; INTRINSIC DISORDER; LIPID INTERACTIONS; CROSS-REACTIVITY	Merozoite surface protein 2 (MSP2) of Plasmodium falciparum is an abundant, intrinsically disordered protein that is GPI-anchored to the surface of the invasive blood stage of the malaria parasite. Recombinant MSP2 has been trialled as a component of a malaria vaccine, and is one of several disordered proteins that are candidates for inclusion in vaccines for malaria and other diseases. Nonetheless, little is known about the implications of protein disorder for the development of an effective antibody response. We have therefore undertaken a detailed analysis of the conformational dynamics of the two allelic forms of MSP2 (3D7 and FC27) using NMR spectroscopy. Chemical shifts and NMR relaxation data indicate that conformational and dynamic properties of the N- and C-terminal conserved regions in the two forms of MSP2 are essentially identical, but significant variation exists between and within the central variable regions. We observe a strong relationship between the conformational dynamics and the antigenicity of MSP2, as assessed with antisera to recombinant MSP2. Regions of increased conformational order in MSP2, including those in the conserved regions, are more strongly antigenic, while the most flexible regions are minimally antigenic. This suggests that modifications that increase conformational order may offer a means to tune the antigenicity of MSP2 and other disordered antigens, with implications for vaccine design.	[MacRaild, Christopher A.; Krishnarjuna, Bankala; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Zachrdla, Milan; Novacek, Jiri; Zidek, Lukas; Sklenar, Vladimir] Masaryk Univ, Fac Sci, NCBR, Brno 62500, Czech Republic; [Zachrdla, Milan; Novacek, Jiri; Zidek, Lukas; Sklenar, Vladimir] Masaryk Univ, CEITEC, Brno 62500, Czech Republic; [Andrew, Dean; Richards, Jack S.; Beeson, James G.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic 3004, Australia; [Anders, Robin F.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia	Monash University; Masaryk University Brno; Masaryk University Brno; Burnet Institute; La Trobe University	MacRaild, CA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia.	chris.macraild@monash.edu	Sklenar, Vladimir/F-9118-2011; Sklenar, Vladimir/R-4602-2019; Novacek, Jiri/D-8551-2012; Zidek, Lukas/D-7112-2012; Krishnarjuna, Bankala/H-4562-2013; Novacek, Jiri/AAQ-4739-2021; Zidek, Lukas/AAB-6109-2020	Sklenar, Vladimir/0000-0001-9988-4093; Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336; Krishnarjuna, Bankala/0000-0002-4575-0011; Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336; Anders, Robin/0000-0002-0693-4547; Norton, Raymond/0000-0001-8893-0584; Richards, Jack/0000-0001-5786-6989; MacRaild, Christopher/0000-0002-3694-3989	Australian National Health and Medical Research Council (NHMRC) [1042520]; project "CEITEC - Central European Institute of Technology" from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; NHMRC; NHMRC Infrastructure for Independent Research Institutes Support Scheme; Victoria State Government Operational Infrastructure Support	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); project "CEITEC - Central European Institute of Technology" from European Regional Development Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Infrastructure for Independent Research Institutes Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Victoria State Government Operational Infrastructure Support	This work was supported in part by an Australian National Health and Medical Research Council (NHMRC) project grant (1042520) and by the project "CEITEC - Central European Institute of Technology" (grant CZ.1.05/1.1.00/02.0068) from European Regional Development Fund. JSR, JGB, and RSN acknowledge fellowship support from the NHMRC. The Burnet Institute is supported by funding from the NHMRC Infrastructure for Independent Research Institutes Support Scheme, and Victoria State Government Operational Infrastructure Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2012, INFECT IMMUN, V80, P4177, DOI 10.1128/IAI.00665-12; Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; ALYAMAN F, 1994, AM J TROP MED HYG, V51, P593, DOI 10.4269/ajtmh.1994.51.593; ALYAMAN F, 1995, PARASITE IMMUNOL, V17, P493, DOI 10.1111/j.1365-3024.1995.tb00920.x; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; Anders RF, 2010, HUM VACCINES, V6, P39, DOI 10.4161/hv.6.1.10712; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Boyle MJ, 2014, INFECT IMMUN, V82, P924, DOI 10.1128/IAI.00866-13; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; Chaudhury S, 2014, J IMMUNOL, V193, P2073, DOI 10.4049/jimmunol.1401054; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P7828, DOI 10.1021/bi00486a008; Ekala MT, 2002, CLIN EXP IMMUNOL, V129, P326, DOI 10.1046/j.1365-2249.2002.01904.x; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; FENTON B, 1991, MOL CELL BIOL, V11, P963, DOI 10.1128/MCB.11.2.963; Ferrage F, 2009, J AM CHEM SOC, V131, P6048, DOI 10.1021/ja809526q; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Foucault M, 2010, PROTEINS, V78, P1441, DOI 10.1002/prot.22661; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Jensen MR, 2014, CHEM REV, V114, P6632, DOI 10.1021/cr400688u; Kaderavek P, 2014, J BIOMOL NMR, V58, P193, DOI 10.1007/s10858-014-9816-4; Kazimierczuk K, 2010, J MAGN RESON, V205, P286, DOI 10.1016/j.jmr.2010.05.012; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lawrence N, 2000, PARASITE IMMUNOL, V22, P211, DOI 10.1046/j.1365-3024.2000.00293.x; Low A, 2007, BIOPOLYMERS, V87, P12, DOI 10.1002/bip.20764; MacRaild CA, 2012, BBA-BIOMEMBRANES, V1818, P2572, DOI 10.1016/j.bbamem.2012.06.015; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Motackova V, 2010, J BIOMOL NMR, V48, P169, DOI 10.1007/s10858-010-9447-3; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Osier FHA, 2010, PARASITE IMMUNOL, V32, P193, DOI 10.1111/j.1365-3024.2009.01178.x; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pavlovic MD, 2014, J IMMUNOL METHODS, V407, P90, DOI 10.1016/j.jim.2014.03.027; Pelupessy P, 2003, J MAGN RESON, V161, P258, DOI 10.1016/S1090-7807(02)00190-8; Pelupessy P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715583; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Putaporntip C, 2008, GENE, V427, P51, DOI 10.1016/j.gene.2008.09.009; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; SAUL A, 1989, PARASITE IMMUNOL, V11, P593, DOI 10.1111/j.1365-3024.1989.tb00923.x; Scopel KKG, 2007, AM J TROP MED HYG, V76, P1084, DOI 10.4269/ajtmh.2007.76.1084; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SMYTHE JA, 1990, MOL BIOCHEM PARASIT, V39, P227, DOI 10.1016/0166-6851(90)90061-P; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; STAHL HD, 1984, P NATL ACAD SCI-BIOL, V81, P2456, DOI 10.1073/pnas.81.8.2456; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stubbs J, 2011, INFECT IMMUN, V79, P1143, DOI 10.1128/IAI.01034-10; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; TAYLOR RR, 1995, INFECT IMMUN, V63, P4382, DOI 10.1128/IAI.63.11.4382-4388.1995; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V43, P211, DOI 10.1016/0166-6851(90)90146-D; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Xue B, 2014, CHEM REV, V114, P6880, DOI 10.1021/cr4005692; Yagi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098460; Yang XD, 2010, BIOCHIMIE, V92, P1287, DOI 10.1016/j.biochi.2010.06.001; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	74	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119899	10.1371/journal.pone.0119899	http://dx.doi.org/10.1371/journal.pone.0119899			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742002	Green Published, gold			2022-12-26	WOS:000350688100130
J	Kroll, MH; Bi, CX; Garber, CC; Kaufman, HW; Liu, DG; Caston-Balderrama, A; Zhang, K; Clarke, N; Xie, MG; Reitz, RE; Suffin, SC; Holick, MF				Kroll, Martin H.; Bi, Caixia; Garber, Carl C.; Kaufman, Harvey W.; Liu, Dungang; Caston-Balderrama, Anne; Zhang, Ke; Clarke, Nigel; Xie, Minge; Reitz, Richard E.; Suffin, Stephen C.; Holick, Michael F.			Temporal Relationship between Vitamin D Status and Parathyroid Hormone in the United States	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATIONS; J-SHAPED ASSOCIATION; ALL-CAUSE MORTALITY; SEASONAL-VARIATION; D DEFICIENCY; SERUM CONCENTRATIONS; D METABOLITES; POPULATION	Background Interpretation of parathyroid hormone (iPTH) requires knowledge of vitamin D status that is influenced by season. Objective Characterize the temporal relationship between 25-hydroxyvitamin D-3 levels [25(OH)D-3] and intact iPTH for several seasons, by gender and latitude in the U. S. and relate 25-hydrovitamin D-2 [25(OH)D-2] levels with PTH levels and total 25(OH)D levels. Method We retrospectively determined population weekly-mean concentrations of unpaired [25(OH)D-2 and 25(OH)D-3] and iPTH using 3.8 million laboratory results of adults. The 25(OH)D-3 and iPTH distributions were normalized and the means fit with a sinusoidal function for both gender and latitudes: North >40, Central 32-40 and South <32 degrees. We analyzed PTH and total 25(OH) D separately in samples with detectable 25(OH)D-2 (>= 4 ng/mL). Findings Seasonal variation was observed for all genders and latitudes. 25(OH)D-3 peaks occurred in September and troughs in March. iPTH levels showed an inverted pattern of peaks and troughs relative to 25(OH)D-3, with a delay of 4 weeks. Vitamin D deficiency and insufficiency was common (33% <20 ng/mL; 60% <30 ng/mL) as was elevated iPTH levels (33%>65 pg/mL). The percentage of patients deficient in 25(OH)D-3 seasonally varied from 21% to 48% and the percentage with elevated iPTH reciprocally varied from 28% to 38%. Patients with detectable 25(OH)D-2 had higher PTH levels and 57% of the samples with a total 25(OH)D > 50 ng/mL had detectable 25(OH)D-2. Interpretation 25(OH)D-3 and iPTH levels vary in a sinusoidal pattern throughout the year, even in vitamin D-2 treated patients; 25(OH)D-3, being higher in the summer and lower in the winter months, with iPTH showing the reverse pattern. A large percentage of the tested population showed vitamin D deficiency and secondary hyperparathyroidism. These observations held across three latitudinal regions, both genders, multiple-years, and in the presence or absence of detectable 25(OH)D-2, and thus are applicable for patient care.	[Kroll, Martin H.; Bi, Caixia; Garber, Carl C.; Kaufman, Harvey W.; Suffin, Stephen C.] Quest Diagnost, Giralda Farms 3, Madison, NJ 07940 USA; [Caston-Balderrama, Anne; Zhang, Ke; Clarke, Nigel; Reitz, Richard E.] Quest Diagnost Nichols Inst, San Juan, CA USA; [Xie, Minge] Rutgers State Univ, Dept Stat & Biostat, Off Stat Consulting, Piscataway, NJ USA; [Liu, Dungang] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Holick, Michael F.] Boston Univ, Sch Med, Dept Med Physiol & Biophys, Boston, MA 02118 USA	Nichols Institute; Rutgers State University New Brunswick; Yale University; Boston University	Kroll, MH (corresponding author), Quest Diagnost, Giralda Farms 3, Madison, NJ 07940 USA.	Martin.H.Kroll@questdiagnostics.com; mfholick@bu.edu			Quest Diagnostics	Quest Diagnostics	This work was funded by Quest Diagnostics. All authors received salary support or consulting support from Quest Diagnostics. Quest Diagnostics provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	ADAMS JS, 1982, NEW ENGL J MED, V306, P722, DOI 10.1056/NEJM198203253061206; Amrein K, 2014, J CLIN ENDOCRINOL ME; Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; CHAPUY MC, 1983, J GERONTOL, V38, P19, DOI 10.1093/geronj/38.1.19; Davies PSW, 1999, EUR J CLIN NUTR, V53, P195, DOI 10.1038/sj.ejcn.1600697; DawsonHughes B, 1997, AM J CLIN NUTR, V65, P67, DOI 10.1093/ajcn/65.1.67; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; HEGARTY V, 1994, AGE AGEING, V23, P478, DOI 10.1093/ageing/23.6.478; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Holick MF, 2008, NUTR REV, V66, pS182, DOI 10.1111/j.1753-4887.2008.00104.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Itoh H, 2011, IND HEALTH, V49, P475, DOI 10.2486/indhealth.MS1255; JUTTMANN JR, 1981, BRIT MED J, V282, P1349, DOI 10.1136/bmj.282.6273.1349; Kasahara AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065785; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; KRALL EA, 1989, NEW ENGL J MED, V321, P1777, DOI 10.1056/NEJM198912283212602; Levis S, 2005, J CLIN ENDOCR METAB, V90, P1557, DOI 10.1210/jc.2004-0746; LIPS P, 1983, J CLIN ENDOCR METAB, V57, P204, DOI 10.1210/jcem-57-1-204; Looker AC, 2011, NCHS DATA BRIEF, V59, P1; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Melin A, 2001, J AM GERIATR SOC, V49, P1190, DOI 10.1046/j.1532-5415.2001.49236.x; Need AG, 2000, AM J CLIN NUTR, V71, P1577; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Sachs MC, 2013, AM J CLIN NUTR; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; STRYD RP, 1979, J CLIN ENDOCR METAB, V48, P771, DOI 10.1210/jcem-48-5-771; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; TJELLESEN L, 1983, SCAND J CLIN LAB INV, V43, P85; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S	34	101	108	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118108	10.1371/journal.pone.0118108	http://dx.doi.org/10.1371/journal.pone.0118108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738588	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900021
J	Woolfit, M; Algama, M; Keith, JM; McGraw, EA; Popovici, J				Woolfit, Megan; Algama, Manjula; Keith, Jonathan M.; McGraw, Elizabeth A.; Popovici, Jean			Discovery of Putative Small Non-Coding RNAs from the Obligate Intracellular Bacterium Wolbachia pipientis	PLOS ONE			English	Article							DOMAIN-ENCODING GENES; IV SECRETION; BAYESIAN SEGMENTATION; EXPRESSION; DROSOPHILA; GENOME; SEQUENCE; STRAIN; DENGUE; VIRULENCE	Wolbachia pipientis is an endosymbiotic bacterium that induces a wide range of effects in its insect hosts, including manipulation of reproduction and protection against pathogens. Little is known of the molecular mechanisms underlying the insect-Wolbachia interaction, though it is likely to be mediated via the secretion of proteins or other factors. There is an increasing amount of evidence that bacteria regulate many cellular processes, including secretion of virulence factors, using small non-coding RNAs (sRNAs), but sRNAs have not previously been described from Wolbachia. We have used two independent approaches, one based on comparative genomics and the other using RNA-Seq data generated for gene expression studies, to identify candidate sRNAs in Wolbachia. We experimentally characterized the expression of one of these candidates in four Wolbachia strains, and showed that it is differentially regulated in different host tissues and sexes. Given the roles played by sRNAs in other host-associated bacteria, the conservation of the candidate sRNAs between different Wolbachia strains, and the sex-and tissue-specific differential regulation we have identified, we hypothesise that sRNAs may play a significant role in the biology of Wolbachia, and in particular in its interactions with its host.	[Woolfit, Megan; McGraw, Elizabeth A.; Popovici, Jean] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Algama, Manjula; Keith, Jonathan M.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia	Monash University; Monash University	Popovici, J (corresponding author), Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.	jean.o.popovici@gmail.com	McGraw, Elizabeth/GRF-0434-2022; Popovici, Jean/K-7192-2014; McGraw, Elizabeth/A-6658-2012	Popovici, Jean/0000-0002-3135-1175; McGraw, Elizabeth/0000-0001-7973-088X; Keith, Jonathan/0000-0002-9675-3976	National Health and Medical Research Council of Australia; Australian Research Council [DP1095849]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by a grant from the National Health and Medical Research Council of Australia and by a grant from the Australian Research Council (DP1095849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Algama M, 2014, COMPUT STRUCT BIOTEC, V10, P107, DOI 10.1016/j.csbj.2014.08.003; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Boughammoura A, 2008, J BACTERIOL, V190, P1518, DOI 10.1128/JB.01640-07; Bradley ES, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002126; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Darby AC, 2014, ISME J, V8, P925, DOI 10.1038/ismej.2013.192; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Degnan PH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002252; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gerhart E, 2008, HDB RNA BIOCH; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Iturbe-Ormaetxe I, 2011, J MICROBIOL METH, V84, P134, DOI 10.1016/j.mimet.2010.10.019; Keith JM, 2004, METHODOL COMPUT APPL, V6, P29, DOI 10.1023/B:MCAP.0000012414.14405.15; Keith JM, 2008, J COMPUT BIOL, V15, P407, DOI 10.1089/cmb.2007.0173; Keith JM, 2006, J COMPUT BIOL, V13, P1369, DOI 10.1089/cmb.2006.13.1369; Keith Jonathan M., 2008, V452, P207, DOI 10.1007/978-1-60327-159-2_11; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Kumar Nikhil, 2012, BMC Res Notes, V5, P230, DOI 10.1186/1756-0500-5-230; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Oldmeadow C, 2011, BIOINFORMATICS, V27, P604, DOI 10.1093/bioinformatics/btq716; Osei-Amo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050049; Papafotiou G, 2011, RES MICROBIOL, V162, P764, DOI 10.1016/j.resmic.2011.06.012; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Podkaminski D, 2010, MOL MICROBIOL, V78, P1327, DOI 10.1111/j.1365-2958.2010.07428.x; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Shelby KS, 2007, J INVERTEBR PATHOL, V95, P77, DOI 10.1016/j.jip.2007.01.001; Siozios S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055390; Skippington E, 2012, GENOME BIOL EVOL, V4, P330, DOI 10.1093/gbe/evs001; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sutton ER, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-928; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Woolfit M, 2009, MOL BIOL EVOL, V26, P367, DOI 10.1093/molbev/msn253; Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	60	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118595	10.1371/journal.pone.0118595	http://dx.doi.org/10.1371/journal.pone.0118595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739023	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900053
J	Chitwood, MC; Lashley, MA; Kilgo, JC; Pollock, KH; Moorman, CE; DePerno, CS				Chitwood, M. Colter; Lashley, Marcus A.; Kilgo, John C.; Pollock, Kenneth H.; Moorman, Christopher E.; DePerno, Christopher S.			Do Biological and Bedsite Characteristics Influence Survival of Neonatal White-Tailed Deer?	PLOS ONE			English	Article							COYOTE PREDATION; FAWNS; MORTALITY; POPULATIONS; NUTRITION; RATES; RISK; AGE	Coyotes recently expanded into the eastern U.S. and potentially have caused localized white-tailed deer population declines. Research has focused on quantifying coyote predation on neonates, but little research has addressed the potential influence of bedsite characteristics on survival. In 2011 and 2012, we radiocollared 65 neonates, monitored them intensively for 16 weeks, and assigned mortality causes. We used Program MARK to estimate survival to 16 weeks and included biological covariates (i.e., sex, sibling status [whether or not it had a sibling], birth weight, and Julian date of birth). Survival to 16 weeks was 0.141 (95% CI = 0.075-0.249) and the top model included only sibling status, which indicated survival was lower for neonates that had a sibling. Predation was the leading cause of mortality (35 of 55; 64%) and coyotes were responsible for the majority of depredations (30 of 35; 86%). Additionally, we relocated neonates for the first 10 days of life and measured distance to firebreak, visual obstruction, and plant diversity at bedsites. Survival of predation to 10 days (0.726; 95% CI = 0.586-0.833) was weakly associated with plant diversity at bedsites but not related to visual obstruction. Our results indicate that neonate survival was low and coyote predation was an important source of mortality, which corroborates several recent studies from the region. Additionally, we detected only weak support for bedsite cover as a covariate to neonate survival, which indicates that mitigating effects of coyote predation on neonates may be more complicated than simply managing for increased hiding cover.	[Chitwood, M. Colter; Lashley, Marcus A.; Moorman, Christopher E.; DePerno, Christopher S.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Kilgo, John C.] US Forest Serv, USDA, Southern Res Stn, New Ellenton, SC USA; [Pollock, Kenneth H.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Forest Service; University of North Carolina; North Carolina State University	Chitwood, MC (corresponding author), N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	colter_chitwood@ncsu.edu		Chitwood, Colter/0000-0001-7240-7430	United States Department of Defense; Fort Bragg Wildlife Branch	United States Department of Defense(United States Department of Defense); Fort Bragg Wildlife Branch	The authors thank the United States Department of Defense and Fort Bragg Wildlife Branch for financial contributions to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard WB, 1999, J WILDLIFE MANAGE, V63, P574, DOI 10.2307/3802645; BARTUSH W S, 1981, Proceedings of the Oklahoma Academy of Science, V61, P23; BEALE DM, 1973, J WILDLIFE MANAGE, V37, P343, DOI 10.2307/3800125; Bishop CJ, 2008, J WILDLIFE MANAGE, V72, P1085, DOI 10.2193/2007-423; Bishop CJ, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2008-107; Bowman JL, 1998, WILDLIFE SOC B, V26, P295; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carstensen M, 2003, WILDLIFE SOC B, V31, P634; Chitwood MC, 2014, SOUTHEAST NAT, V13, pN30, DOI 10.1656/058.013.0316; Chitwood MC, 2014, SOUTHEAST NAT, V13, pN6, DOI 10.1656/058.013.0202; Chitwood MC, 2015, J WILDLIFE MANAGE, V79, P211, DOI 10.1002/jwmg.835; COOK RS, 1971, J WILDLIFE MANAGE, V35, P47, DOI 10.2307/3799870; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; DeYoung RW, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P311; Diefenbach DR, 2003, WILDLIFE SOC B, V31, P756; Epstein M.B., 1983, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V37, P161; FAIRBANKS WS, 1993, J MAMMAL, V74, P129, DOI 10.2307/1381911; Garner G.W., 1976, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V30, P493; Gompper ME, 2002, BIOSCIENCE, V52, P185, DOI 10.1641/0006-3568(2002)052[0185:TCITSE]2.0.CO;2; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; HARRISON DJ, 1985, J MAMMAL, V66, P712, DOI 10.2307/1380797; HILL EP, 1987, WILDLIFE SOC B, V15, P521; HUEGEL CN, 1985, J WILDLIFE MANAGE, V49, P377, DOI 10.2307/3801536; Jackson AM, 2013, AM MIDL NAT, V170, P184, DOI 10.1674/0003-0031-170.1.184; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Kilgo JC, 2010, J WILDLIFE MANAGE, V74, P929, DOI 10.2193/2009-263; Labisky RF, 1998, AM MIDL NAT, V139, P275, DOI 10.1674/0003-0031(1998)139[0275:BOBPOW]2.0.CO;2; Langenau E. E. Jr., 1976, Applied Animal Ethology, V2, P207, DOI 10.1016/0304-3762(76)90053-5; Lashley MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090652; Lashley MA, 2014, ECOL INDIC, V38, P212, DOI 10.1016/j.ecolind.2013.11.006; Long RA, 1998, WILDLIFE BIOL, V4, P237, DOI 10.2981/wlb.1998.021; Miller K. V., 1995, QUALITY WHITETAILS W; Nowak R.M., 1979, University of Kansas Museum of Natural History Monograph, P1; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; O'Gara B.W., 1978, Proceedings of the Pronghorn Antelope Workshop, V8, P380; OZOGA JJ, 1988, J WILDLIFE MANAGE, V52, P549, DOI 10.2307/3801608; Parker G.R., 1995, E COYOTE STORY ITS S; Powell MC, 2005, WILDLIFE SOC B, V33, P643, DOI 10.2193/0091-7648(2005)33[643:LROMAI]2.0.CO;2; Burroughs JP, 2006, J WILDLIFE MANAGE, V70, P743, DOI 10.2193/0022-541X(2006)70[743:CMASOW]2.0.CO;2; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Roberts SB, 2007, THESIS U GEORGIA; Robinson KF, 2014, J WILDLIFE MANAGE, V78, P571, DOI 10.1002/jwmg.693; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; Rosenberry CS, 2011, WILDLIFE SOC B, V35, P461, DOI 10.1002/wsb.81; Saalfeld ST, 2007, J WILDLIFE MANAGE, V71, P940, DOI 10.2193/2006-116; Sams MG, 1996, WILDLIFE SOC B, V24, P53; Smith BL, 1998, J WILDLIFE MANAGE, V62, P1036, DOI 10.2307/3802556; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; Warren RJ, 1997, WILDLIFE SOC B, V25, P213; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHITE M, 1973, J MAMMAL, V54, P291, DOI 10.2307/1378900	54	44	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119070	10.1371/journal.pone.0119070	http://dx.doi.org/10.1371/journal.pone.0119070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734333	Green Submitted, gold, Green Published			2022-12-26	WOS:000350314700053
J	He, F; Fu, Y; Chen, Q; Ruan, Z; Hua, XT; Zhou, H; Yu, YS				He, Fang; Fu, Ying; Chen, Qiong; Ruan, Zhi; Hua, Xiaoting; Zhou, Hua; Yu, Yunsong			Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae	PLOS ONE			English	Article							ANTIMICROBIAL DRUG SUSCEPTIBILITY; DECREASED SUSCEPTIBILITY; MULTIDRUG-RESISTANCE; RAMA; EXPRESSION; ACRAB; 1-(1-NAPHTHYLMETHYL)-PIPERAZINE; ENTEROBACTERIACEAE; INHIBITOR; REGULATOR	KPC-producing Klebsiella pneumoniae isolates have emerged as important pathogens of nosocomial infections, and tigecycline is one of the antibiotics recommended for severe infections caused by KPC-producing K. pneumoniae. To identify the susceptibility profile of KPC-producing K. pneumoniae to tigecycline and investigate the role of efflux pumps in tigecycline resistance, a total of 215 KPC-producing K. pneumoniae isolates were collected. The minimum inhibitory concentration (MIC) of tigecycline was determined by standard broth microdilution tests. Isolates showing resistance to tigecycline underwent susceptibility test with efflux pump inhibitors. Expression levels of efflux pump genes (acrB and oqxB) and their regulators (ramA, marA, soxS and rarA) were examined by real-time PCR, and the correlation between tigecycline MICs and gene expression levels were analysed. Our results show that the tigecycline resistance rate in these isolates was 11.2%. Exposure of the tigecycline-resistant isolates to the efflux pump inhibitor NMP resulted in an obvious decrease in MICs and restored susceptibility to tigecycline in 91.7% of the isolates. A statistically significant association between acrB expression and tigecycline MICs was observed, and overexpression of ramA was found in three tigecycline-resistant isolates, further analysis confirmed ramRmutations existed in these isolates. Transformation of one mutant with wild-type ramR restored susceptibility to tigecycline and repressed overexpression of ramA and acrB. These data indicate that efflux pump AcrAB, which can be up-regulated by ramR mutations and subsequent ramA activation, contributed to tigecycline resistance in K. pneumoniae clinical isolates.	[He, Fang; Fu, Ying; Chen, Qiong; Ruan, Zhi; Hua, Xiaoting; Yu, Yunsong] Zhejiang Univ, Sch Med, Dept Infect Dis, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China; [Zhou, Hua] Zhejiang Univ, Dept Resp Dis, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Sch Med, Dept Infect Dis, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China.	yvys119@163.com	Hua, Xiaoting/B-5786-2011; Ruan, Zhi/P-3987-2015	Hua, Xiaoting/0000-0001-8215-916X; Ruan, Zhi/0000-0001-8648-4592; He, Fang/0000-0002-7002-2382	National Natural Science Foundation of China [NSFC81230039, NSFC81000757]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Natural Science Foundation of China (No. NSFC81230039 and No. NSFC81000757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialek-Davenet S, 2011, ANTIMICROB AGENTS CH, V55, P2795, DOI 10.1128/AAC.00156-11; Bratu S, 2009, J ANTIMICROB CHEMOTH, V64, P278, DOI 10.1093/jac/dkp186; De Majumdar S, 2013, ANTIMICROB AGENTS CH, V57, P1603, DOI 10.1128/AAC.01998-12; DiPersio JR, 2007, INT J ANTIMICROB AG, V29, P518, DOI 10.1016/j.ijantimicag.2006.10.019; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; EUCAST (European Committee on Antimicrobial Susceptibility Testing), 2013, BREAKP TABL INT MICS; Vazquez MF, 2008, INT J ANTIMICROB AG, V32, P541, DOI 10.1016/j.ijantimicag.2008.06.024; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Keeney D, 2008, J ANTIMICROB CHEMOTH, V61, P46, DOI 10.1093/jac/dkm397; Keeney D, 2007, MICROB DRUG RESIST, V13, P1, DOI 10.1089/mdr.2006.9990; Kern WV, 2006, J ANTIMICROB CHEMOTH, V57, P339, DOI 10.1093/jac/dki445; Nigo M, 2013, ANTIMICROB AGENTS CH, V57, P5743, DOI 10.1128/AAC.00827-13; Pankey GA, 2005, J ANTIMICROB CHEMOTH, V56, P470, DOI 10.1093/jac/dki248; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Ricci V, 2014, J ANTIMICROB CHEMOTH, V69, P643, DOI 10.1093/jac/dkt432; Rodriguez-Avial C, 2012, CLIN MICROBIOL INFEC, V18, P61, DOI 10.1111/j.1469-0691.2011.03482.x; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P1017, DOI 10.1128/AAC.49.3.1017-1022.2005; Ruzin A, 2008, ANTIMICROB AGENTS CH, V52, P3430, DOI 10.1128/AAC.00591-08; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; Shen P, 2009, ANTIMICROB AGENTS CH, V53, P4333, DOI 10.1128/AAC.00260-09; Tsai HY, 2012, J INFECTION, V65, P584, DOI 10.1016/j.jinf.2012.09.007; Van Duin D, 2014, CLIN MICROBIOL INFEC; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4466, DOI 10.1128/AAC.06224-11	27	61	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119064	10.1371/journal.pone.0119064	http://dx.doi.org/10.1371/journal.pone.0119064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734903	Green Submitted, Green Published, gold			2022-12-26	WOS:000350314700052
J	Krol, K; Brozda, I; Skoneczny, M; Bretne, M; Skoneczna, A				Krol, Kamil; Brozda, Izabela; Skoneczny, Marek; Bretne, Maria; Skoneczna, Adrianna			A Genomic Screen Revealing the Importance of Vesicular Trafficking Pathways in Genome Maintenance and Protection against Genotoxic Stress in Diploid Saccharomyces cerevisiae Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GROSS-CHROMOSOMAL REARRANGEMENTS; NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE; WIDE SCREEN; HOMOLOGOUS RECOMBINATION; PROTEASOMAL DEGRADATION; DIFFERENTIAL REGULATION; CELLULAR-RESPONSE; UV-IRRADIATION	The ability to survive stressful conditions is important for every living cell. Certain stresses not only affect the current well-being of cells but may also have far-reaching consequences. Uncurbed oxidative stress can cause DNA damage and decrease cell survival and/or increase mutation rates, and certain substances that generate oxidative damage in the cell mainly act on DNA. Radiomimetic zeocin causes oxidative damage in DNA, predominantly by inducing single- or double-strand breaks. Such lesions can lead to chromosomal rearrangements, especially in diploid cells, in which the two sets of chromosomes facilitate excessive and deleterious recombination. In a global screen for zeocin-oversensitive mutants, we selected 133 genes whose deletion reduces the survival of zeocin-treated diploid Saccharomyces cerevisiae cells. The screen revealed numerous genes associated with stress responses, DNA repair genes, cell cycle progression genes, and chromatin remodeling genes. Notably, the screen also demonstrated the involvement of the vesicular trafficking system in cellular protection against DNA damage. The analyses indicated the importance of vesicular system integrity in various pathways of cellular protection from zeocin-dependent damage, including detoxification and a direct or transitional role in genome maintenance processes that remains unclear. The data showed that deleting genes involved in vesicular trafficking may lead to Rad52 focus accumulation and changes in total DNA content or even cell ploidy alterations, and such deletions may preclude proper DNA repair after zeocin treatment. We postulate that functional vesicular transport is crucial for sustaining an integral genome. We believe that the identification of numerous new genes implicated in genome restoration after genotoxic oxidative stress combined with the detected link between vesicular trafficking and genome integrity will reveal novel molecular processes involved in genome stability in diploid cells.	[Krol, Kamil; Brozda, Izabela; Skoneczna, Adrianna] Polish Acad Sci, Lab Mutagenesis & DNA Repair, Inst Biochem & Biophys, Warsaw, Poland; [Skoneczny, Marek] Polish Acad Sci, Dept Genet, Inst Biochem & Biophys, Warsaw, Poland; [Bretne, Maria] Warsaw Univ Technol, Fac Chem, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Warsaw University of Technology	Skoneczna, A (corresponding author), Polish Acad Sci, Lab Mutagenesis & DNA Repair, Inst Biochem & Biophys, Warsaw, Poland.	ada@ibb.waw.pl	Skoneczna, Adrianna/H-1734-2011; Skoneczny, Marek/S-5390-2019	Skoneczna, Adrianna/0000-0003-4059-2146; Skoneczny, Marek/0000-0001-9922-2276; Rumienczyk, Izabela/0000-0002-2957-8952	Polish National Science Center [2011/03/B/NZ2/00293]	Polish National Science Center	This work was supported by the Polish National Science Center grant 2011/03/B/NZ2/00293 (https://www.ncn.gov.pl/) to AS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AT, 2003, CHEM BIOL, V10, P45, DOI 10.1016/S1074-5521(02)00306-X; Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Alabrudzinska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021124; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Bailly AP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001025; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Blanco MG, 2014, MOL CELL, V54, P94, DOI 10.1016/j.molcel.2014.02.011; Bonetti D, 2013, EMBO J, V32, P275, DOI 10.1038/emboj.2012.327; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Chambers AL, 2012, GENE DEV, V26, P2590, DOI 10.1101/gad.199976.112; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302; Chiu J, 2011, J BIOL CHEM, V286, P5204, DOI 10.1074/jbc.M110.172973; Clerici M, 2004, MOL CELL BIOL, V24, P10126, DOI 10.1128/MCB.24.23.10126-10144.2004; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Davermann D, 2002, FREE RADICAL BIO MED, V33, P1209, DOI 10.1016/S0891-5849(02)00984-X; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Dotiwala F, 2013, P NATL ACAD SCI USA, V110, pE41, DOI 10.1073/pnas.1218065109; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; FOX KR, 1987, BIOCHEM J, V243, P847, DOI 10.1042/bj2430847; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Grenon M, 2006, FEMS YEAST RES, V6, P836, DOI 10.1111/j.1567-1364.2006.00076.x; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Heidenreich E, 2003, EMBO J, V22, P2274, DOI 10.1093/emboj/cdg203; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hiraoka M, 2000, GENETICS, V156, P1531; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Huang Y, 2011, DNA REPAIR, V10, P629, DOI 10.1016/j.dnarep.2011.04.010; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Ju DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009877; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kaliraman V, 2002, CURR GENET, V41, P389, DOI 10.1007/s00294-002-0319-6; Kanaar R, 2008, EMBO J, V27, P581, DOI 10.1038/emboj.2008.11; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Kiel JAKW, 2010, PHILOS T R SOC B, V365, P819, DOI 10.1098/rstb.2009.0237; Kitagawa T, 2007, INFECT IMMUN, V75, P1393, DOI 10.1128/IAI.01321-06; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Krol K, 2015, PLOS ONE; Lesuisse E, 2005, GENETICS, V169, P107, DOI 10.1534/genetics.104.035873; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Lim HH, 1996, MOL GEN GENET, V253, P138, DOI 10.1007/s004380050306; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu H, 2011, GENETICS, V187, P397, DOI 10.1534/genetics.110.125468; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Lyons NA, 2011, MOL CELL, V42, P378, DOI 10.1016/j.molcel.2011.03.023; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Maringele Laura, 2006, Methods Mol Biol, V313, P65; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Novick P, 1989, GENETICS, V121, P659; Ogiwara H, 2007, NUCLEIC ACIDS RES, V35, P4989, DOI 10.1093/nar/gkm523; Ohnishi G, 2004, BIOCHEM BIOPH RES CO, V325, P928, DOI 10.1016/j.bbrc.2004.10.120; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; POVIRK LF, 1979, BIOCHEMISTRY-US, V18, P96, DOI 10.1021/bi00568a015; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RAD MR, 1994, YEAST, V10, P1217, DOI 10.1002/yea.320100910; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Ristic D, 2003, NUCLEIC ACIDS RES, V31, P5229, DOI 10.1093/nar/gkg729; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rog O, 2005, CURR GENET, V47, P18, DOI 10.1007/s00294-004-0548-y; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Saito TL, 2004, NUCLEIC ACIDS RES, V32, pD319, DOI 10.1093/nar/gkh113; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Skoneczna A, 2007, J MOL BIOL, V366, P1074, DOI 10.1016/j.jmb.2006.11.093; SLEIGH MJ, 1976, NUCLEIC ACIDS RES, V3, P891, DOI 10.1093/nar/3.4.891; Song W, 2012, GENETICS, V191, P279, DOI 10.1534/genetics.111.138180; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Wasko BM, 2009, DNA REPAIR, V8, P162, DOI 10.1016/j.dnarep.2008.09.010; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; Yu Y, 2011, MOL CELL BIOL, V31, P2311, DOI 10.1128/MCB.01432-10; Yuan DS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni105	107	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120702	10.1371/journal.pone.0120702	http://dx.doi.org/10.1371/journal.pone.0120702			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756177	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275700073
J	Buch, F; Kaman, WE; Bikker, FJ; Yilamujiang, A; Mithofer, A				Buch, Franziska; Kaman, Wendy E.; Bikker, Floris J.; Yilamujiang, Ayufu; Mithoefer, Axel			Nepenthesin Protease Activity Indicates Digestive Fluid Dynamics in Carnivorous Nepenthes Plants	PLOS ONE			English	Article							ASPARTIC PROTEINASES; UNIQUE MEMBER; VENUS FLYTRAP; PITCHERS; ENZYMES; EXPRESSION; SUBFAMILY; BLANCO; TRAPS	Carnivorous plants use different morphological features to attract, trap and digest prey, mainly insects. Plants from the genus Nepenthes possess specialized leaves called pitchers that function as pitfall-traps. These pitchers are filled with a digestive fluid that is generated by the plants themselves. In order to digest caught prey in their pitchers, Nepenthes plants produce various hydrolytic enzymes including aspartic proteases, nepenthesins (Nep). Knowledge about the generation and induction of these proteases is limited. Here, by employing a FRET (fluorescent resonance energy transfer)-based technique that uses a synthetic fluorescent substrate an easy and rapid detection of protease activities in the digestive fluids of various Nepenthes species was feasible. Biochemical studies and the heterologously expressed Nep II from Nepenthes mirabilis proved that the proteolytic activity relied on aspartic proteases, however an acid-mediated auto-activation mechanism was necessary. Employing the FRET-based approach, the induction and dynamics of nepenthesin in the digestive pitcher fluid of various Nepenthes plants could be studied directly with insect (Drosophila melanogaster) prey or plant material. Moreover, we observed that proteolytic activity was induced by the phytohormone jasmonic acid but not by salicylic acid suggesting that jasmonate-dependent signaling pathways are involved in plant carnivory.	[Buch, Franziska; Yilamujiang, Ayufu; Mithoefer, Axel] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Kaman, Wendy E.] Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 CE Rotterdam, Netherlands; [Kaman, Wendy E.; Bikker, Floris J.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, NL-1081 LA Amsterdam, Netherlands; [Kaman, Wendy E.; Bikker, Floris J.] Vrije Univ Amsterdam, NL-1081 LA Amsterdam, Netherlands	Max Planck Society; Erasmus University Rotterdam; Erasmus MC; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Mithofer, A (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Hans Knoll Str 8, D-07745 Jena, Germany.	amithoefer@ice.mpg.de	Bikker, Floris/B-1187-2012; Bikker, Floris/R-1941-2019; Kaman, Wendy/B-2976-2012	Bikker, Floris/0000-0002-9453-4630; 				An CI, 2002, PLANTA, V214, P661, DOI 10.1007/s004250100665; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Buch F, 2014, PHYTOCHEMISTRY, V100, P43, DOI 10.1016/j.phytochem.2014.01.014; Buch F, 2013, ANN BOT-LONDON, V111, P375, DOI 10.1093/aob/mcs287; Darwin C., 1875, INSECTIVOROUS PLANTS; Eilenberg H, 2006, J EXP BOT, V57, P2775, DOI 10.1093/jxb/erl048; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Gupta R, 2004, PREDICTION N GLYCOSY; Hepburn J. S., 1918, P AM PHILOS SOC, V57, P112; Heslop-Harrison Y, 1975, Front Biol, V43, P525; JENTSCH J, 1972, FEBS LETT, V21, P273, DOI 10.1016/0014-5793(72)80181-9; Juniper B. E., 1989, CARNIVOROUS PLANTS; Kadek A, 2014, PROTEIN EXPRES PURIF, V95, P121, DOI 10.1016/j.pep.2013.12.005; Kaman WE, 2013, ANAL BIOCHEM, V441, P38, DOI 10.1016/j.ab.2013.06.015; Kaman WE, 2011, ANAL CHEM, V83, P2511, DOI 10.1021/ac102764v; Libiakova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104424; LUTTGE U, 1964, PLANTA, V63, P103, DOI 10.1007/BF01894990; Mithofer A, 2014, PLANT BIOLOGY, V16, P982, DOI 10.1111/plb.12148; Mithofer A, 2011, PHYTOCHEMISTRY, V72, P1678, DOI 10.1016/j.phytochem.2010.11.024; Nakamura Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0228; NAKAYAMA S, 1968, P JPN ACAD, V44, P358, DOI 10.2183/pjab1945.44.358; Pavlovic A, 2011, PLANT CELL ENVIRON, V34, P1865, DOI 10.1111/j.1365-3040.2011.02382.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Renner T, 2013, CURR OPIN PLANT BIOL, V16, P436, DOI 10.1016/j.pbi.2013.06.009; Rottloff S, 2011, J EXP BOT, V62, P4639, DOI 10.1093/jxb/err173; Rottloff S, 2009, ANAL BIOCHEM, V394, P135, DOI 10.1016/j.ab.2009.07.013; RUNEBERGROOS P, 1991, EUR J BIOCHEM, V202, P1021, DOI 10.1111/j.1432-1033.1991.tb16465.x; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Simoes I, 2004, EUR J BIOCHEM, V271, P2067, DOI 10.1111/j.1432-1033.2004.04136.x; Stephenson P, 2006, INT J PLANT SCI, V167, P239, DOI 10.1086/499284; Takahashi K, 2005, CURR PROTEIN PEPT SC, V6, P513, DOI 10.2174/138920305774933259; Takahashi K, 2006, CARNIV PL NEWSLETT, V36, P73; Takahashi K, 2011, BIOSCI BIOTECH BIOCH, V75, P346, DOI 10.1271/bbb.100546; TOKES ZA, 1974, PLANTA, V119, P39, DOI 10.1007/BF00390820; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vines S.H., 1897, ANN BOT, V11, P563, DOI 10.1093/oxfordjournals.aob.a088707; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	37	33	34	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118853	10.1371/journal.pone.0118853	http://dx.doi.org/10.1371/journal.pone.0118853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750992	Green Published, gold			2022-12-26	WOS:000350692700012
J	Duggimpudi, S; Larsson, E; Nabhani, S; Borkhardt, A; Hoell, JI				Duggimpudi, Sujitha; Larsson, Erik; Nabhani, Schafiq; Borkhardt, Arndt; Hoell, Jessica I.			The Cell Cycle Regulator CCDC6 Is a Key Target of RNA-Binding Protein EWS	PLOS ONE			English	Article							SARCOMA; GENE; TRANSCRIPTION; EXPRESSION; FAMILY; MDM2; DEGRADATION; H4(D10S170); CARCINOMAS; MECHANISMS	Genetic translocation of EWSR1 to ETS transcription factor coding region is considered as primary cause for Ewing sarcoma. Previous studies focused on the biology of chimeric transcription factors formed due to this translocation. However, the physiological consequences of heterozygous EWSR1 loss in these tumors have largely remained elusive. Previously, we have identified various mRNAs bound to EWS using PAR-CLIP. In this study, we demonstrate CCDC6, a known cell cycle regulator protein, as a novel target regulated by EWS. siRNA mediated down regulation of EWS caused an elevated apoptosis in cells in a CCDC6-dependant manner. This effect was rescued upon re-expression of CCDC6. This study provides evidence for a novel functional link through which wild-type EWS operates in a target-dependant manner in Ewing sarcoma.	[Duggimpudi, Sujitha; Nabhani, Schafiq; Borkhardt, Arndt; Hoell, Jessica I.] Univ Dusseldorf, Fac Med, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	Heinrich Heine University Dusseldorf; University of Gothenburg	Hoell, JI (corresponding author), Univ Dusseldorf, Fac Med, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany.	Jessica.hoell@med.uni-duesseldorf.de	Larsson Lekholm, Erik/AHE-0932-2022; Hoell, Jessica/J-8136-2016; Larsson Lekholm, Erik/HDM-8032-2022	Larsson Lekholm, Erik/0000-0003-1400-0119; Hoell, Jessica/0000-0002-5532-9845; Larsson Lekholm, Erik/0000-0003-1400-0119	"Forschungsstipendium der Vereinigung rheinisch-westfalischer Kinder- und Jugendarzte und Kinderchirurgen" fellowship; Elterninitiative Kinderkrebsklinik e.V. Dusseldorf	"Forschungsstipendium der Vereinigung rheinisch-westfalischer Kinder- und Jugendarzte und Kinderchirurgen" fellowship; Elterninitiative Kinderkrebsklinik e.V. Dusseldorf	This work was supported by a "Forschungsstipendium der Vereinigung rheinisch-westfalischer Kinder- und Jugendarzte und Kinderchirurgen" fellowship and Elterninitiative Kinderkrebsklinik e.V. Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2008, HUM MUTAT, V29, P390, DOI 10.1002/humu.20653; Azuma M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000979; Ballarino M, 2013, ONCOGENE, V32, P4646, DOI 10.1038/onc.2012.490; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Gimenez DG, 2010, PLANTA MED, V76, P133, DOI 10.1055/s-0029-1186048; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L, 2012, CANCER RES, V72, P1260, DOI 10.1158/0008-5472.CAN-11-2254; Kaufmann B, 2004, GLYCOBIOLOGY, V14, P609, DOI 10.1093/glycob/cwh063; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kovar H., 2011, SARCOMA, V2011, DOI DOI 10.1155/2011/837474; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; Leone V, 2010, ONCOGENE, V29, P4341, DOI 10.1038/onc.2010.179; Lezon-Geyda K, 2001, LEUKEMIA, V15, P954, DOI 10.1038/sj.leu.2402108; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Li Y, 2010, CANCER LETT, V294, P57, DOI 10.1016/j.canlet.2010.01.022; Lin PP, 2008, CANCER RES, V68, P8968, DOI 10.1158/0008-5472.CAN-08-0573; Merolla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036177; Paronetto MP, 2014, CELL REP, V7, P1211, DOI 10.1016/j.celrep.2014.03.077; Park H, 2014, CELL CYCLE, V13, P2391, DOI 10.4161/cc.29337; Paronetto Maria Paola, 2013, Int J Cell Biol, V2013, P642853, DOI 10.1155/2013/642853; Pishas KI, 2011, CLIN CANCER RES, V17, P494, DOI 10.1158/1078-0432.CCR-10-1587; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; Rodriguez-Galindo C, 2003, MED PEDIATR ONCOL, V40, P276, DOI 10.1002/mpo.10240; Sangle NA, 2011, ARCH PATHOL LAB MED, V135, P1504, DOI 10.5858/arpa.2010-0482-RS; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Sohn EJ, 2010, CANCER RES, V70, P1154, DOI 10.1158/0008-5472.CAN-09-1993; Spitzer JI, 2011, GENE CHROMOSOME CANC, V50, P338, DOI 10.1002/gcc.20858; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Thanasopoulou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031007; Thanasopoulou A, 2012, ANTICANCER RES, V32, P907; Ulaner GA, 2004, GENE CHROMOSOME CANC, V41, P155, DOI 10.1002/gcc.20074; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Xia SJ, 2005, EUR J CANCER, V41, P2513, DOI 10.1016/j.ejca.2005.08.003; Zhao JG, 2012, FEBS LETT, V586, P4257, DOI 10.1016/j.febslet.2012.10.029	44	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119066	10.1371/journal.pone.0119066	http://dx.doi.org/10.1371/journal.pone.0119066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751255	Green Submitted, gold, Green Published			2022-12-26	WOS:000350692700014
J	Debnath, T; Ghosh, S; Potlapuvu, US; Kona, L; Kamaraju, SR; Sarkar, S; Gaddam, S; Chelluri, LK				Debnath, Tanya; Ghosh, Sutapa; Potlapuvu, Usha Shalini; Kona, Lakshmi; Kamaraju, Suguna Ratnakar; Sarkar, Suprabhat; Gaddam, Sumanlatha; Chelluri, Lakshmi Kiran			Proliferation and Differentiation Potential of Human Adipose-Derived Stem Cells Grown on Chitosan Hydrogel	PLOS ONE			English	Article							BONE-MARROW; TISSUE; BIOMATERIALS; SCAFFOLD	Applied tissue engineering in regenerative medicine warrants our enhanced understanding of the biomaterials and its function. The aim of this study was to evaluate the proliferation and differentiation potential of human adipose-derived stem cells (hADSCs) grown on chitosan hydrogel. The stability of this hydrogel is pH-dependent and its swelling property is pivotal in providing a favorable matrix for cell growth. The study utilized an economical method of cross linking the chitosan with 0.5% glutaraldehyde. Following the isolation of hADSCs from omentum tissue, these cells were cultured and characterized on chitosan hydrogel. Subsequent assays that were performed included JC-1 staining for the mitochondrial integrity as a surrogate marker for viability, cell proliferation and growth kinetics by MTT assay, lineage specific differentiation under two-dimensional culture conditions. Confocal imaging, scanning electron microscopy (SEM), and flow cytometry were used to evaluate these assays. The study revealed that chitosan hydrogel promotes cell proliferation coupled with > 90% cell viability. Cytotoxicity assays demonstrated safety profile. Furthermore, glutaraldehyde cross linked chitosan showed < 5% cytotoxicity, thus serving as a scaffold and facilitating the expansion and differentiation of hADSCs across endoderm, ectoderm and mesoderm lineages. Additional functionalities can be added to this hydrogel, particularly those that regulate stem cell fate.	[Debnath, Tanya; Potlapuvu, Usha Shalini; Kamaraju, Suguna Ratnakar; Chelluri, Lakshmi Kiran] Global Hosp, Transplant Immunol & Stem Cell Lab, Hyderabad, Andhra Pradesh, India; [Ghosh, Sutapa; Sarkar, Suprabhat] Indian Inst Chem Technol, I&PC Div, Nanomat Lab, Hyderabad 500007, Andhra Pradesh, India; [Kona, Lakshmi] Global Hosp, Dept Bariatr Surg, Hyderabad, Andhra Pradesh, India; [Gaddam, Sumanlatha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Osmania University	Ghosh, S (corresponding author), Indian Inst Chem Technol, I&PC Div, Nanomat Lab, Hyderabad 500007, Andhra Pradesh, India.	sutapa69arun@gmail.com; lkiran@globalhospitalsindia.com						Beahm EK, 2003, CLIN PLAST SURG, V30, P547, DOI 10.1016/S0094-1298(03)00072-5; Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9; Bissell M J, 1987, Prog Clin Biol Res, V249, P251; Cheburu CN, 2011, MED-SURG J, V115, P864; Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI [10.1089/ten.tea.2009.0229, 10.1089/ten.TEA.2009.0229]; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dhanasekaran M, 2012, CYTOTECHNOLOGY, V64, P497, DOI 10.1007/s10616-012-9427-4; Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI 10.1089/ten.TEA.2009.0398; Distantina S, 2013, ENG J-THAIL, V17, P57, DOI 10.4186/ej.2013.17.3.57; Gomathysankar S, 2014, ARCH PLAST SURG-APS, V41, P452, DOI 10.5999/aps.2014.41.5.452; Gonçalves Vanessa L., 2005, Polímeros, V15, P6, DOI 10.1590/S0104-14282005000100005; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hassan W, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt182; Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001; Ikeda T, 2014, BIOMED RES INT, V2014, P8; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kang YM, 2010, INT J MOL SCI, V11, P4140, DOI 10.3390/ijms11104140; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim KS, 2009, TISSUE ENG PT A, V15, P3201, DOI [10.1089/ten.tea.2008.0704, 10.1089/ten.TEA.2008.0704]; Koppula PR, 2009, CELL IMMUNOL, V259, P61, DOI 10.1016/j.cellimm.2009.05.014; Lakshmi KC, 2012, STEM CELLS EXTRACELL; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li B, 2013, MAR DRUGS, V11, P1534, DOI 10.3390/md11051534; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naderi-Meshkin H, 2014, CELL BIOL INT, V38, P72, DOI 10.1002/cbin.10181; Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022; Patel PN, 2005, J BIOMED MATER RES A, V73A, P313, DOI 10.1002/jbm.a.30291; Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8; ROSSMURPHY SB, 1994, POLYM GELS NETW, V2, P229, DOI 10.1016/0966-7822(94)90007-8; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; Salamon A, 2014, MATERIALS, V7, P1342, DOI 10.3390/ma7021342; Song KD, 2010, J MATER SCI-MATER M, V21, P2835, DOI 10.1007/s10856-010-4131-4; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wang LY, 2006, COLLOID SURFACE B, V50, P126, DOI 10.1016/j.colsurfb.2006.05.006; Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003; Zamora DO, 2012, JOVE-J VIS EXP, DOI 10.3791/3624; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	43	41	42	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120803	10.1371/journal.pone.0120803	http://dx.doi.org/10.1371/journal.pone.0120803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746846	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400099
J	Hong, ZK; Reeves, KJ; Sun, Z; Li, ZH; Brown, NJ; Meininger, GA				Hong, Zhongkui; Reeves, Kimberley J.; Sun, Zhe; Li, Zhaohui; Brown, Nicola J.; Meininger, Gerald A.			Vascular Smooth Muscle Cell Stiffness and Adhesion to Collagen I Modified by Vasoactive Agonists	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; INTEGRIN-MEDIATED MECHANOTRANSDUCTION; ACTIN POLYMERIZATION; AORTIC STIFFNESS; N-WASP; ACTIVATION; CONTRACTION; ELASTICITY; SUBUNIT; BINDING	In vascular smooth muscle cells (VSMCs) integrin-mediated adhesion to extracellular matrix (ECM) proteins play important roles in sustaining vascular tone and resistance. The main goal of this study was to determine whether VSMCs adhesion to type I collagen (COL-I) was altered in parallel with the changes in the VSMCs contractile state induced by vasoconstrictors and vasodilators. VSMCs were isolated from rat cremaster skeletal muscle arterioles and maintained in primary culture without passage. Cell adhesion and cell E-modulus were assessed using atomic force microscopy (AFM) by repetitive nano-indentation of the AFM probe on the cell surface at 0.1 Hz sampling frequency and 3200 nm Z-piezo travelling distance (approach and retraction). AFM probes were tipped with a 5 mu m diameter microbead functionalized with COL-I (1mg\ml). Results showed that the vasoconstrictor angiotensin II (ANG-II; 10(-6)) significantly increased (p<0.05) VSMC E-modulus and adhesion probability to COL-I by approximately 35% and 33%, respectively. In contrast, the vasodilator adenosine (ADO; 10(-4)) significantly decreased (p<0.05) VSMC E-modulus and adhesion probability by approximately -33% and -17%, respectively. Similarly, the NO donor (PANOate, 10(-6) M), a potent vasodilator, also significantly decreased (p<0.05) the VSMC E-modulus and COL-I adhesion probability by -38% and -35%, respectively. These observations support the hypothesis that integrin-mediated VSMC adhesion to the ECM protein COL-I is dynamically regulated in parallel with VSMC contractile activation. These data suggest that the signal transduction pathways modulating VSMC contractile activation and relaxation, in addition to ECM adhesion, interact during regulation of contractile state.	[Hong, Zhongkui; Reeves, Kimberley J.; Sun, Zhe; Li, Zhaohui; Meininger, Gerald A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Brown, Nicola J.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Hong, Zhongkui; Sun, Zhe; Meininger, Gerald A.] Univ Missouri, Dept Physiol & Pharmacol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Sheffield; University of Missouri System; University of Missouri Columbia	Meininger, GA (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	Meiningerg@missouri.edu	Hong, Zhongkui/AAQ-1787-2021	Brown, Nicola/0000-0002-2100-1905	National Institutes of Health [P01HL095486]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health P01HL095486 to Gerald A. Meininger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian L, 2007, AM J PHYSIOL-REG I, V293, pR1586, DOI 10.1152/ajpregu.00025.2007; BRIESEWITZ R, 1993, J BIOL CHEM, V268, P2989; Butt H-J, 1995, NANOTECHNOLOGY, V6, P7; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680; DEAN DC, 1993, AM REV RESPIR DIS, V148, pS43, DOI 10.1164/ajrccm/148.6_Pt_2.S43; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Goldschmidt ME, 2001, CIRC RES, V88, P674, DOI 10.1161/hh0701.089749; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Heerkens EHJ, 2006, HYPERTENSION, V47, P281, DOI 10.1161/01.HYP.0000198428.45132.02; Hillis GS, 1998, BASIC RES CARDIOL, V93, P295, DOI 10.1007/s003950050098; Hong ZK, 2014, J PHYSIOL-LONDON, V592, P1249, DOI 10.1113/jphysiol.2013.264929; Hong ZK, 2012, CARDIOVASC RES, V96, P73, DOI 10.1093/cvr/cvs239; Hutter J.L.A.B., 1993, REV SCI INSTRUM, V64, P6; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kucik DF, 2001, MOL BIOL CELL, V12, P1509, DOI 10.1091/mbc.12.5.1509; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Martinez-Lemus LA, 2005, AM J PHYSIOL-HEART C, V289, pH322, DOI 10.1152/ajpheart.00923.2003; Min J, 2012, J CELL PHYSL; Moreno-Dominguez A, 2014, J BIOL CHEM; Poythress RH, 2013, AM J PHYSIOL-CELL PH, V305, pC215, DOI 10.1152/ajpcell.00103.2013; Prockop J D, 1995, ANNU REV BIOCHEM, V64, P403; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Sehgel NL, 2013, AM J PHYSIOL-HEART C, V305, pH1281, DOI 10.1152/ajpheart.00232.2013; Sun Z, 2005, AM J PHYSIOL-HEART C, V289, pH2526, DOI 10.1152/ajpheart.00658.2004; Sun Z, 2008, AM J PHYSIOL-CELL PH, V295, pC268, DOI 10.1152/ajpcell.00516.2007; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Vargas-Pinto R, 2013, BIOPHYS J, V105, P300, DOI 10.1016/j.bpj.2013.05.034; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2007, J BIOL CHEM, V282, P34568, DOI 10.1074/jbc.M704966200; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhu Y, 2012, AGING CELL, V11, P741, DOI 10.1111/j.1474-9726.2012.00840.x	40	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119533	10.1371/journal.pone.0119533	http://dx.doi.org/10.1371/journal.pone.0119533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745858	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000350689400076
J	Jiang, JM; Zhou, CF; Gao, SL; Tian, Y; Wang, CY; Wang, L; Gu, HF; Tang, XQ				Jiang, Jia-Mei; Zhou, Cheng-Fang; Gao, Sheng-Lan; Tian, Ying; Wang, Chun-Yan; Wang, Li; Gu, Hong-Feng; Tang, Xiao-Qing			BDNF-TrkB Pathway Mediates Neuroprotection of Hydrogen Sulfide against Formaldehyde-Induced Toxicity to PC12 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED OXIDATIVE DAMAGE; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; INDUCED APOPTOSIS; INDUCED NEUROTOXICITY; NEURONAL APOPTOSIS; PREFRONTAL CORTEX; UP-REGULATION; NITRIC-OXIDE	Formaldehyde (FA) is a common environmental contaminant that has toxic effects on the central nervous system (CNS). Our previous data demonstrated that hydrogen sulfide (H2S), the third endogenous gaseous mediator, has protective effects against FA-induced neurotoxicity. As is known to all, Brain-derived neurotropic factor (BDNF), a member of the neurotrophin gene family, mediates its neuroprotective properties via various intracellular signaling pathways triggered by activating the tyrosine kinase receptor B (TrkB). Intriguingly, our previous data have illustrated the upregulatory role of H2S on BDNF protein expression in the hippocampus of rats. Therefore, in this study, we hypothesized that H2S provides neuroprotection against FA toxicity by regulating BDNF-TrkB pathway. In the present study, we found that NaHS, a donor of H2S, upregulated the level of BDNF protein in PC12 cells, and significantly rescued FA-induced downregulation of BDNF levels. Furthermore, we found that pretreatment of PC12 cells with K252a, an inhibitor of the BDNF receptor TrkB, markedly reversed the inhibition of NaHS on FA-induced cytotoxicity and ablated the protective effects of NaHS on FA-induced oxidative stress, including the accumulation of intracellular reactive oxygen species (ROS), 4-hydroxy-2-trans-nonenal (4-HNE), and malondialdehyde (MDA). We also showed that K252a abolished the inhibition of NaHS on FA-induced apoptosis, as well as the activation of caspase-3 in PC12 cells. In addition, K252a reversed the protection of H2S against FA-induced downregulation of Bcl-2 protein expression and upregulation of Bax protein expression in PC12 cells. These data indicate that the BDNF-TrkB pathway mediates the neuroprotection of H2S against FA-induced cytotoxicity, oxidative stress and apoptosis in PC12 cells. These findings provide a novel mechanism underlying the protection of H2S against FA-induced neurotoxicity.	[Jiang, Jia-Mei; Zhou, Cheng-Fang; Gao, Sheng-Lan; Gu, Hong-Feng; Tang, Xiao-Qing] Univ South China, Coll Med, Dept Physiol, Hengyang 421001, Hunan, Peoples R China; [Jiang, Jia-Mei; Zhou, Cheng-Fang; Gao, Sheng-Lan; Gu, Hong-Feng; Tang, Xiao-Qing] Univ South China, Coll Med, Inst Neurosci, Hengyang 421001, Hunan, Peoples R China; [Jiang, Jia-Mei; Gao, Sheng-Lan; Gu, Hong-Feng; Tang, Xiao-Qing] Univ South China, Key Lab Cognit Disorders & Neurodegenerat Dis, Hengyang 421001, Hunan, Peoples R China; [Tian, Ying] Univ South China, Coll Med, Dept Biochem, Hengyang 421001, Hunan, Peoples R China; [Wang, Chun-Yan] Univ South China, Coll Med, Dept Pathophysiol, Hengyang 421001, Hunan, Peoples R China; [Wang, Li] Univ South China, Coll Med, Dept Anthropot, Hengyang 421001, Hunan, Peoples R China	University of South China; University of South China; University of South China; University of South China; University of South China; University of South China	Tian, Y (corresponding author), Univ South China, Coll Med, Dept Biochem, Hengyang 421001, Hunan, Peoples R China.	uscty@163.com; tangxq01001@foxmail.com		Zhou, Chengfang/0000-0001-9716-8181	Natural Science Foundation of China [81202518, 81200985]; Natural Science Foundation of Hunan Province, China [11JJ3117, 12JJ9032]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [[2011]508]; construct program of the key discipline in Hunan province	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); construct program of the key discipline in Hunan province	This study was supported by Natural Science Foundation of China (81200985 and 81202518), Natural Science Foundation of Hunan Province, China (11JJ3117 and 12JJ9032), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry ([2011]508) and the construct program of the key discipline in Hunan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Arici S, 2014, HUM EXP TOXICOL; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Boyadjieva NI, 2013, ALCOHOL CLIN EXP RES, V37, P1370, DOI 10.1111/acer.12104; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Conner JM, 1997, J NEUROSCI, V17, P2295; Degos V, 2013, ANESTHESIOLOGY, V118, P1123, DOI 10.1097/ALN.0b013e318286cf36; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Flo-Neyret C, 2001, BRAZ J MED BIOL RES, V34, P639, DOI 10.1590/S0100-879X2001000500012; FLYVHOLM MA, 1993, AM J IND MED, V24, P533, DOI 10.1002/ajim.4700240505; Fournet G, 2013, CURR MED CHEM, V20, P527; Franklin P, 2000, AM J RESP CRIT CARE, V161, P1757, DOI 10.1164/ajrccm.161.5.9905061; Fukamachi Y, 1998, BIOCHEM BIOPH RES CO, V246, P364, DOI 10.1006/bbrc.1998.8621; Gabaizadeh R, 1997, MOL BRAIN RES, V50, P71, DOI 10.1016/S0169-328X(97)00173-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gurel A, 2005, J CHEM NEUROANAT, V29, P173, DOI 10.1016/j.jchemneu.2005.01.001; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Han H, 2001, J BIOL CHEM, V276, P26357, DOI 10.1074/jbc.M011136200; Huang YZ, 2012, J NEUROSCI, V32, P15521, DOI 10.1523/JNEUROSCI.0755-12.2012; Jia J, 2013, NEUROCHEM INT, V62, P1072, DOI 10.1016/j.neuint.2013.04.001; Jourdi H, 2009, NEUROPHARMACOLOGY, V56, P876, DOI 10.1016/j.neuropharm.2009.01.015; Kamat PK, 2013, NEUROSCIENCE, V252, P302, DOI 10.1016/j.neuroscience.2013.07.051; KILBURN KH, 1994, ARCH ENVIRON HEALTH, V49, P37, DOI 10.1080/00039896.1994.9934412; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795; Kong SZ, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/310146; Konstantinidou AE, 2007, APOPTOSIS, V12, P695, DOI 10.1007/s10495-006-0001-4; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lauterbach EC, 2013, INT J MOL SCI, V14, P22558, DOI 10.3390/ijms141122558; Lee M, 2013, GLIA, V61, P1724, DOI 10.1002/glia.22553; Li RX, 1998, GLYCOBIOLOGY, V8, P597, DOI 10.1093/glycob/8.6.597; Li Wei-Wei, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3017; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Liu Y, 2010, NEUROSCIENCE, V169, P1248, DOI 10.1016/j.neuroscience.2010.05.061; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Luo FC, 2012, NEUROTOXICOLOGY, V33, P290, DOI 10.1016/j.neuro.2012.02.004; MESSIHA FS, 1983, NEUROBEH TOXICOL TER, V5, P251; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Okoye G, 2003, J NEUROSCI, V23, P4164; Ozen OA, 2008, SYST BIOL REPROD MED, V54, P169, DOI 10.1080/19396360802422402; Pandya CD, 2013, ASIAN J PSYCHIATR, V6, P22, DOI 10.1016/j.ajp.2012.08.010; Sakamoto K, 2014, EXP EYE RES, V120, P90, DOI 10.1016/j.exer.2014.01.008; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shearn C.T., 2014, J BIOL CHEM; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Songur A, 2010, REV ENVIRON CONTAM T, V203, P105, DOI 10.1007/978-1-4419-1352-4_3; Su B, 2014, J BIOL CHEM, V289, P1213, DOI 10.1074/jbc.M113.526129; Tamagno E, 2003, EXP NEUROL, V180, P144, DOI 10.1016/S0014-4886(02)00059-6; Tang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054829; Tang XQ, 2013, J MOL NEUROSCI, V49, P140, DOI 10.1007/s12031-012-9912-4; Tang XQ, 2012, NEUROCHEM INT, V61, P16, DOI 10.1016/j.neuint.2012.04.011; Tang XQ, 2011, CLIN EXP PHARMACOL P, V38, P208, DOI 10.1111/j.1440-1681.2011.05485.x; TAPLEY P, 1992, ONCOGENE, V7, P371; Tulpule K, 2013, J NEUROCHEM, V127, P7, DOI 10.1111/jnc.12356; Usanmaz SE, 2002, ENVIRON TOXICOL PHAR, V11, P93, DOI 10.1016/S1382-6689(01)00109-0; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang S, 2009, J NEUROSCI RES, V87, P1938, DOI 10.1002/jnr.21999; Wei HJ, 2014, ACTA PHARMACOL SIN, V35, P707, DOI 10.1038/aps.2013.197; Yan Q, 1997, J COMP NEUROL, V378, P135; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yin WL, 2009, LIFE SCI, V85, P269, DOI 10.1016/j.lfs.2009.05.023; Yu J, 2014, NEUROSCI BULL, V30, P172, DOI 10.1007/s12264-013-1416-x; Zararsiz I, 2007, CELL BIOCHEM FUNCT, V25, P413, DOI 10.1002/cbf.1315; Zararsiz I, 2006, CELL BIOCHEM FUNCT, V24, P237, DOI 10.1002/cbf.1204; Zhang JY, 2011, INT J CLIN EXP PATHO, V4, P496; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang R, 2010, J TOXICOL ENV HEAL A, V73, P1477, DOI 10.1080/15287394.2010.511564; Zhao X, 2008, J ALZHEIMERS DIS, V15, P397	73	25	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119478	10.1371/journal.pone.0119478	http://dx.doi.org/10.1371/journal.pone.0119478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749582	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400075
J	Broadhurst, L				Broadhurst, Linda			Pollen Dispersal in Fragmented Populations of the Dioecious Wind-Pollinated Tree, Allocasuarina verticillata (Drooping Sheoak, Drooping She-Oak; Allocasuarinaceae)	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; CHRONIC HABITAT FRAGMENTATION; MEDIATED GENE FLOW; REPRODUCTIVE SUCCESS; INBREEDING DEPRESSION; FOREST FRAGMENTATION; PATERNITY ANALYSIS; COMPUTER-PROGRAM; MATING PATTERNS; SEED DISPERSAL	Vegetation clearing, land modification and agricultural intensification have impacted on many ecological communities around the world. Understanding how species respond to fragmentation and the scales over which functionality is retained, can be critical for managing biodiversity in agricultural landscapes. Allocasuarina verticillata (drooping sheoak, drooping she-oak) is a dioecious, wind-pollinated and -dispersed species with key conservation values across southeastern Australia. But vegetation clearing associated with agricultural expansion has reduced the abundance and spatial distribution of this species in many regions. Spatial genetic structure, relatedness among trees, pollen dispersal and mating patterns were examined in fragmented A. verticillata populations selected to represent the types of remnants that now characterise this species. Short scale spatial genetic structure (5-25 m) and relatedness among trees were observed in most populations. Unexpectedly, the two male trees closest to each female did not have a reproductive advantage accounting for only 4-15% of the seed produced in larger populations. Biparental inbreeding was also generally low (<4%) with limited evidence of seed crop domination by some male trees. More male trees contributed to seed crops in linear remnants (mean 17) compared to those from patch remnants (mean 11.3) which may reflect differences in pollen dispersal within the two remnant types. On average, pollen travels similar to 100 m irrespective of remnant type but was also detected to have dispersed as far as 1 km in open landscapes. Low biparental inbreeding, limited reproductive assurance for near-neighbour and probably related males and variability in the distances over which females sample pollen pools suggest that some mechanism to prevent matings between relatives exists in this species.	CSIRO, Ctr Australian Natl Biodivers Res, Natl Res Collect, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Broadhurst, L (corresponding author), CSIRO, Ctr Australian Natl Biodivers Res, Natl Res Collect, Canberra, ACT, Australia.	Linda.Broadhurst@csiro.au	Broadhurst, Linda/J-6907-2012	Broadhurst, Linda/0000-0002-9853-3328	CSIRO; Department of Primary Industries Victoria; Greening Australia Victoria	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Department of Primary Industries Victoria; Greening Australia Victoria	This project was jointly funded by CSIRO, Department of Primary Industries Victoria and Greening Australia Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 1996, ECOLOGY, V77, P1779, DOI 10.2307/2265783; Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Albaladejo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049012; Albaladejo RG, 2009, MOL ECOL, V18, P5195, DOI 10.1111/j.1365-294X.2009.04415.x; ANTONOVICS J, 1980, ANNU REV ECOL SYST, V11, P411, DOI 10.1146/annurev.es.11.110180.002211; AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Bacles CFE, 2011, TRENDS PLANT SCI, V16, P13, DOI 10.1016/j.tplants.2010.10.002; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Blundell MJ, 2010, J CEREAL SCI, V52, P187, DOI 10.1016/j.jcs.2010.05.002; Bram MR, 2002, J TORREY BOT SOC, V129, P298, DOI 10.2307/3088701; Broadhurst LM, 2006, BIOL CONSERV, V133, P512, DOI 10.1016/j.biocon.2006.08.004; Broadhurst LM, 2013, BIOL CONSERV, V161, P48, DOI 10.1016/j.biocon.2013.02.016; Broadhurst LM, 2011, AUST J BOT, V59, P770, DOI 10.1071/BT11253; BROWN AHD, 1970, GENETICS, V66, P133; Burczyk J, 2004, FOREST ECOL MANAG, V197, P39, DOI 10.1016/j.foreco.2004.05.003; Burczyk J, 1996, HEREDITY, V77, P251, DOI 10.1038/hdy.1996.139; Burczyk JL, 1997, HEREDITY, V79, P638, DOI 10.1038/hdy.1997.210; Buza L, 2000, BIOL CONSERV, V93, P177, DOI 10.1016/S0006-3207(99)00150-0; Collin CL, 2009, AM J BOT, V96, P2279, DOI 10.3732/ajb.0900073; *COR CATCHM MAN AU, 2003, COR REG CATCHM STRAT; Craft KJ, 2010, AM J BOT, V97, P1999, DOI 10.3732/ajb.0900390; Crowley GM, 2001, AUSTRAL ECOL, V26, P116, DOI 10.1046/j.1442-9993.2001.01093.x; Davies SD, 2013, HEREDITY ADV, DOI [10.1038/hdy.2013.95, DOI 10.1038/HDY.2013.95]; De-Lucas AI, 2009, MOL ECOL, V18, P4564, DOI 10.1111/j.1365-294X.2009.04372.x; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dubreuil M, 2010, AM J BOT, V97, P303, DOI 10.3732/ajb.0900148; Eppley SM, 2009, HEREDITY, V102, P600, DOI 10.1038/hdy.2009.21; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gordon DR, 1998, RESTOR ECOL, V6, P166, DOI 10.1111/j.1526-100X.1998.00627.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Helenurm K, 1998, CONSERV BIOL, V12, P118, DOI 10.1046/j.1523-1739.1998.96316.x; Herrera CM, 2010, ECOLOGY, V91, P422, DOI 10.1890/09-0849.1; Jump AS, 2007, MOL ECOL, V16, P925, DOI 10.1111/j.1365-294X.2006.03203.x; Jump AS, 2006, P NATL ACAD SCI USA, V103, P8096, DOI 10.1073/pnas.0510127103; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kettle CJ, 2007, MOL ECOL, V16, P3581, DOI 10.1111/j.1365-294X.2007.03419.x; Knapp EE, 2001, OECOLOGIA, V128, P48, DOI 10.1007/s004420000623; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Marcar N, 2004, TREES SALINE LANDSCA; Marchelli P, 2012, TREE GENET GENOMES, V8, P1123, DOI 10.1007/s11295-012-0500-0; Mathiasen P, 2007, CONSERV BIOL, V21, P232, DOI 10.1111/j.1523-1739.2006.00565.x; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; O'Connell LM, 2006, CAN J BOT, V84, P956, DOI 10.1139/B06-051; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pepper JW, 2000, AUSTRAL ECOL, V25, P16, DOI 10.1111/j.1442-9993.2000.tb00003.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Provan J, 2008, CONSERV GENET, V9, P1521, DOI 10.1007/s10592-007-9484-y; Raduski AR, 2012, EVOLUTION, V66, P1275, DOI 10.1111/j.1558-5646.2011.01505.x; Reed MS, 2011, LAND DEGRAD DEV, V22, P261, DOI 10.1002/ldr.1087; RITLAND K, 1990, J HERED, V81, P235; RITLAND K, 1989, EVOLUTION, V43, P848, DOI [10.2307/2409312, 10.1111/j.1558-5646.1989.tb05182.x]; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Seltmann P, 2007, FLORA, V202, P547, DOI 10.1016/j.flora.2006.12.002; Seltmann P, 2009, PLANT ECOL, V205, P155, DOI 10.1007/s11258-009-9605-4; Shohami D, 2014, MOL ECOL, V23, P70, DOI 10.1111/mec.12506; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2001, EVOLUTION, V55, P260; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; Steven JC, 2007, PLANT ECOL, V190, P131, DOI 10.1007/s11258-006-9196-2; Teixeira S, 2009, HEREDITY, V102, P101, DOI 10.1038/hdy.2008.86; Teixeira S, 2008, OIKOS, V117, P1594, DOI 10.1111/j.0030-1299.2008.16450.x; Ward M, 2005, OIKOS, V108, P253, DOI 10.1111/j.0030-1299.2005.13468.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 2000, CONSERV BIOL SER, V4, P335	74	15	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119498	10.1371/journal.pone.0119498	http://dx.doi.org/10.1371/journal.pone.0119498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742183	Green Submitted, gold, Green Published			2022-12-26	WOS:000350688100117
J	Hong, JW; Ku, CR; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Hong, Jae Won; Ku, Cheol Ryong; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Association between Low-Grade Albuminuria and Cardiovascular Risk in Korean Adults: The 2011-2012 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MICROALBUMINURIA; MORTALITY; HYPERTENSION; INDIVIDUALS; PROTEINURIA; EXCRETION; EVENTS; DEATH	Background Recent studies have indicated that low UACR levels (< 30 mu g/mg) previously considered to be in the normal range ('low-grade albuminuria') are associated with cardiovascular morbidity and mortality in the general population. Methods We studied 9,736 participants with albuminuria in the normal range from the 2011-2012 Korea National Health and Nutrition Examination Survey (KNHANES). Results The weighted prevalences of metabolic syndrome (MS) and the 10-year risk for coronary heart disease measured using the Framingham risk score (FRS) >= 20% (high risk) were 22.5 +/- 0.7% and 14.5 +/- 0.7%, respectively, in males and 23.3 +/- 0.8% and 8.5 +/- 0.4%, respectively in females. Weighted comparisons among the tertiles of UACR revealed that the prevalences of MS and high-risk FRS increased with increasing UACR (MS: males, 15.9 +/- 1.1, 20.2 +/- 1.2, 32.4 +/- 1.5%, respectively; P < 0.001; and females, 17.6 +/- 1.0, 22.7 +/- 1.0, 30.2 +/- 1.4%, respectively; P < 0.001. High-risk FRS: males, 9.5 +/- 0.7, 12.3 +/- 0.9, 22.5 +/- 1.2, respectively; P < 0.001; and females, 5.8 +/- 0.6, 7.9 +/- 0.7, 12.0 +/- 0.9%, respectively; P < 0.001). The positive association persisted after adjusting for hypertension and diabetes. The weighted comparisons among the deciles of UACR revealed that the prevalences of MS and high-risk FRS began to increase at the ranges of 3.89-5.15 and 5.16-7.36 mg/g Cr, respectively. Conclusion Low-grade albuminuria was significantly associated with estimated cardiovascular risk and MS in a nationally representative sample of Koreans.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea; [Ku, Cheol Ryong] Yonsei Univ, Coll Med, Endocrinol, Seoul, South Korea; [Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Cardiovasc & Metab Dis Ctr, Coll Med, Dept Internal Med,Sanggye Paik Hosp, Seoul, South Korea	Inje University; Yonsei University; Yonsei University Health System; Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/ABD-9067-2021; Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515; Ku, Cheol Ryong/0000-0001-8693-9630				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Baron AD, 1997, CIRCULATION, V96, P725; Danziger J, 2008, MAYO CLIN PROC, V83, P806, DOI 10.4065/83.7.806; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Gerstein HC, 2000, DIABETES CARE, V23, pB35; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hemann Brian A, 2007, Am Heart Hosp J, V5, P91; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Huang Y, 2010, J CLIN ENDOCR METAB, V95, P5122, DOI 10.1210/jc.2010-0544; Katz DH, 2014, CIRCULATION, V129, P42, DOI 10.1161/CIRCULATIONAHA.113.003429; KCDC, KOR NAT HLTH NUTR EX; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lalwani AK, 2013, LARYNGOSCOPE, V123, P3178, DOI 10.1002/lary.24244; Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936; Lee YH, 2012, KIDNEY BLOOD PRESS R, V36, P290, DOI 10.1159/000343418; Lieb W, 2006, NEPHROL DIAL TRANSPL, V21, P2780, DOI 10.1093/ndt/gfl364; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; Ruggenenti P, 2006, KIDNEY INT, V70, P1214, DOI 10.1038/sj.ki.5001729; Sung KC, 2008, ATHEROSCLEROSIS, V196, P320, DOI 10.1016/j.atherosclerosis.2006.11.004; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zhang J, 2013, PLOS ONE, V8	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118866	10.1371/journal.pone.0118866	http://dx.doi.org/10.1371/journal.pone.0118866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742159	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100054
J	Allen, KL; Cooke, SB; Gonzales, LA; Kay, RF				Allen, Kari L.; Cooke, Siobhan B.; Gonzales, Lauren A.; Kay, Richard F.			Dietary Inference from Upper and Lower Molar Morphology in Platyrrhine Primates	PLOS ONE			English	Article							MONKEYS LAGOTHRIX-LAGOTRICHA; WOOLLY SPIDER MONKEYS; DOLICHOCEBUS-GAIMANENSIS; ENAMEL THICKNESS; FEEDING ECOLOGY; PARTICLE-SIZE; BODY-SIZE; MIOCENE; ADAPTATIONS; EVOLUTION	The correlation between diet and dental topography is of importance to paleontologists seeking to diagnose ecological adaptations in extinct taxa. Although the subject is well represented in the literature, few studies directly compare methods or evaluate dietary signals conveyed by both upper and lower molars. Here, we address this gap in our knowledge by comparing the efficacy of three measures of functional morphology for classifying an ecologically diverse sample of thirteen medium-to large-bodied platyrrhines by diet category (e.g., folivore, frugivore, hard object feeder). We used Shearing Quotient (SQ), an index derived from linear measurements of molar cutting edges and two indices of crown surface topography, Occlusal Relief (OR) and Relief Index (RFI). Using SQ, OR, and RFI, individuals were then classified by dietary category using Discriminate Function Analysis. Both upper and lower molar variables produce high classification rates in assigning individuals to diet categories, but lower molars are consistently more successful. SQs yield the highest classification rates. RFI and OR generally perform above chance. Upper molar RFI has a success rate below the level of chance. Adding molar length enhances the discriminatory power for all variables. We conclude that upper molar SQs are useful for dietary reconstruction, especially when combined with body size information. Additionally, we find that among our sample of platyrrhines, SQ remains the strongest predictor of diet, while RFI is less useful at signaling dietary differences in absence of body size information. The study demonstrates new ways for inferring the diets of extinct platyrrhine primates when both upper and lower molars are available, or, for taxa known only from upper molars. The techniques are useful in reconstructing diet in stem representatives of anthropoid clade, who share key aspects of molar morphology with extant platyrrhines.	[Allen, Kari L.] Washington Univ, Dept Anat & Neurobiol, Sch Med, St Louis, MO 63110 USA; [Cooke, Siobhan B.] NE Illinois Univ, Dept Anthropol, Chicago, IL 60625 USA; [Gonzales, Lauren A.; Kay, Richard F.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA	Washington University (WUSTL); Duke University	Allen, KL (corresponding author), Washington Univ, Dept Anat & Neurobiol, Sch Med, 660 S Euclid Ave,Box 8108, St Louis, MO 63110 USA.	kari.allen@wustl.edu		Gonzales, Lauren/0000-0003-3304-0634; Cooke, Siobhan/0000-0001-8265-6705	NSF [NSF BNS-0851272, NSF EAR 1338694, NSF DDIG 40761-0001]	NSF(National Science Foundation (NSF))	This research was supported by NSF grants NSF BNS-0851272 and NSF EAR 1338694 to RFK and NSF DDIG 40761-0001 to SBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2012, P ROY SOC B-BIOL SCI, V279, P715, DOI 10.1098/rspb.2011.1311; Anthony MRL, 1994, MOLAR WEAR MOLAR FUN; AYRES JM, 1989, J HUM EVOL, V18, P697, DOI 10.1016/0047-2484(89)90101-2; Ayres JM, 1986, UAKARIES AMAZONIAN F; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; Beard KC, 2004, J HUM EVOL, V46, P401, DOI 10.1016/j.jhevol.2004.01.002; Beard KC, 2002, CAM S BIO EVOL ANTHR, V33, P133; Boyer DM, 2015, AM J PHYS ANTHROPOL, V156, P166, DOI 10.1002/ajpa.22619; Boyer DM, 2008, J HUM EVOL, V55, P1118, DOI 10.1016/j.jhevol.2008.08.002; Bunn JM, 2011, AM J PHYS ANTHROPOL, V145, P247, DOI 10.1002/ajpa.21489; Bush EC, 2004, ANAT REC PART A, V281A, P1083, DOI 10.1002/ar.a.20113; BUTLER PM, 1972, EVOLUTION, V26, P474, DOI 10.1111/j.1558-5646.1972.tb01951.x; Cant J.G.H., 1990, Human Evolution, V5, P269, DOI 10.1007/BF02437243; Cartmill M., 1972, FUNCTIONAL EVOLUTION, P97, DOI DOI 10.4324/9781315132129; Cartmill Matt, 1992, Evolutionary Anthropology, V1, P105, DOI 10.1002/evan.1360010308; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; Cooke SB, 2011, ANAT REC, V294, P2073, DOI 10.1002/ar.21502; CROMPTON AW, 1969, NATURE, V222, P678, DOI 10.1038/222678b0; de Carvalho S, 2004, PRIMATES, V45, P201, DOI 10.1007/s10329-004-0079-7; Defler TR, 1996, INT J PRIMATOL, V17, P161, DOI 10.1007/BF02735446; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FLEAGLE JG, 1989, AM J PHYS ANTHROPOL, V78, P221; GAULIN S J C, 1982, International Journal of Primatology, V3, P1, DOI 10.1007/BF02693488; Harmon L, 2009, GEIGER ANAL EVOLUTIO; HLADICK A, 1969, Terre et la Vie, V116, P25; HLADIK CM, 1971, FOLIA PRIMATOL, V16, P85, DOI 10.1159/000155393; JULLIOT C, 1993, INT J PRIMATOL, V14, P527, DOI 10.1007/BF02215446; Kaiser TM, 2011, MAMMAL REV, V2011, P1; Kay R.F., 1980, International Journal of Primatology, V1, P21, DOI 10.1007/BF02692256; Kay R.F., 1984, P21; Kay R.F., 1978, P309; Kay R.F., 1984, FOOD ACQUISITION PRO, P467, DOI DOI 10.1007/978-1-4757-5244-1_21; KAY RF, 1990, AM J PHYS ANTHROPOL, V81, P248; KAY RF, 1977, NATURE, V268, P628, DOI 10.1038/268628a0; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Kay RF, 2001, ADV PRIMATO, P339; KAY RF, 1987, J HUM EVOL, V16, P173, DOI 10.1016/0047-2484(87)90075-3; KAY RF, 1979, AM J PHYS ANTHROPOL, V50, P301, DOI 10.1002/ajpa.1330500303; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; KAY RF, 1977, AM J PHYS ANTHROPOL, V46, P327, DOI 10.1002/ajpa.1330460213; Kay RFD, 1999, AM J PRIMATOL, V47, P347; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kay RF, 2013, CAM S BIO EVOL ANTHR, V65, P3; Kay RF, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P306; Kay Richard F., 2010, P220; KINZEY WG, 1993, INT J PRIMATOL, V14, P207, DOI 10.1007/BF02192632; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; Kirk EC, 2000, J HUM EVOL, V40, P203; Ledogar JA, 2013, AM J PHYS ANTHROPOL, V150, P107, DOI 10.1002/ajpa.22181; Lee-Thorp JA, 2010, PHILOS T R SOC B, V365, P3389, DOI 10.1098/rstb.2010.0059; Lima EM, 2003, FOLIA PRIMATOL, V74, P150, DOI 10.1159/000070648; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; LUCHTERHAND K, 1986, CR ACAD SCI II, V303, P1753; M'Kirera F, 2003, AM J PRIMATOL, V60, P31, DOI 10.1002/ajp.10077; Martin LB, 2003, J HUM EVOL, V45, P351, DOI 10.1016/j.jhevol.2003.08.005; MILTON K, 1984, INT J PRIMATOL, V5, P491, DOI 10.1007/BF02692271; Milton K., 1980, FORAGING STRATEGIES; Nadjafzadeh MN, 2008, AM J PHYS ANTHROPOL, V135, P56, DOI 10.1002/ajpa.20704; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Orme D, 2010, CAPER COMP ANAL PHYL; Palminteri S., 2013, EVOLUTIONARY BIOL CO; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; PERES CA, 1994, INT J PRIMATOL, V15, P333, DOI 10.1007/BF02696098; Ravosa MJ, 1999, FOLIA PRIMATOL, V70, P65, DOI 10.1159/000021678; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Remis MJ, 2000, AM J PHYS ANTHROPOL, V112, P171, DOI 10.1002/(SICI)1096-8644(2000)112:2<171::AID-AJPA4>3.0.CO;2-F; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rezende EL, 2012, COMPR PHYSIOL, V2, P639, DOI 10.1002/cphy.c100079; Rodman P.S., 1984, P1; ROSENBERGER AL, 1976, AM J PHYS ANTHROPOL, V45, P281, DOI 10.1002/ajpa.1330450214; Russo SE, 2005, INT J PRIMATOL, V26, P1017, DOI 10.1007/s10764-005-6456-2; Sears KE, 2008, AM MUS NOVIT, P1, DOI 10.1206/627.1; SHEINE WS, 1982, J MORPHOL, V172, P139, DOI 10.1002/jmor.1051720202; SHEINE WS, 1977, AM J PHYS ANTHROPOL, V47, P15, DOI 10.1002/ajpa.1330470106; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Simons EL, 2007, P NATL ACAD SCI USA, V104, P8731, DOI 10.1073/pnas.0703129104; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Sokal RR, 1995, BIOMETRY; STEVENSON PR, 1994, AM J PRIMATOL, V32, P123, DOI 10.1002/ajp.1350320205; Strait SG, 2001, J VERTEBR PALEONTOL, V21, P322, DOI 10.1671/0272-4634(2001)021[0322:DROSBO]2.0.CO;2; STRIER KB, 1991, AM J PRIMATOL, V23, P113, DOI 10.1002/ajp.1350230205; SUSSMAN RW, 1991, AM J PRIMATOL, V23, P209, DOI 10.1002/ajp.1350230402; Takai M, 1996, AM J PHYS ANTHROPOL, V99, P301; TAKAI M, 1994, J HUM EVOL, V27, P329, DOI 10.1006/jhev.1994.1049; Teaford MF, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P433; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Ungar P, 1998, EVOLUTIONAR IN PRESS; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; VANROOSMALEN MGM, 1988, AM J PRIMATOL, V14, P11, DOI 10.1002/ajp.1350140103; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Williams BA, 2010, P NATL ACAD SCI USA, V107, P4797, DOI 10.1073/pnas.0908320107; Winchester JM, 2014, AM J PHYS ANTHROPOL, V153, P29, DOI 10.1002/ajpa.22398; Wright P., 1981, ECOLOGY BEHAVIOUR NE, P211; Yamashita N, 1998, AM J PHYS ANTHROPOL, V106, P169, DOI 10.1002/(SICI)1096-8644(199806)106:2<169::AID-AJPA5>3.3.CO;2-O; Youlatos D, 2004, AM J PHYS ANTHROPOL, V123, P181, DOI 10.1002/ajpa.10307	102	68	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118732	10.1371/journal.pone.0118732	http://dx.doi.org/10.1371/journal.pone.0118732			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738266	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900064
J	Chakr, RMD; Brenol, JCT; Behar, M; Mendonca, JA; Kohem, CL; Monticielo, OA; Brenol, CV; Xavier, RM				da Silva Chakr, Rafael Mendonca; Tavares Brenol, Joao Carlos; Behar, Marina; Mendonca, Jose Alexandre; Kohem, Charles Lubianca; Monticielo, Odirlei Andre; Brenol, Claiton Viegas; Xavier, Ricardo Machado			Is Ultrasound a Better Target than Clinical Disease Activity Scores in Rheumatoid Arthritis with Fibromyalgia? A Case-Control Study	PLOS ONE			English	Article							AMERICAN-COLLEGE; SCORING SYSTEMS; ULTRASONOGRAPHY; RELIABILITY; SYNOVITIS; JOINTS; RECOMMENDATIONS; CRITERIA; TREAT	Objectives Our goal is to study the correlations among gray-scale seven-joint ultrasound score (GS-US7), power Doppler seven-joint ultrasound score (PD-US7), disease activity score-28 joints (DAS28), simplified disease activity index (SDAI) and clinical disease activity index (CDAI) in patients with and without fibromyalgia (FM). Methods A matched case-control study included all patients consecutively seen in the Rheumatoid Arthritis (RA) Clinic. Participants were allocated into one of two groups: RA with FM and RA without FM. Ultrasound (US) and clinical scoring were blinded for the presence of FM. Medians and proportions were compared by Mann-Whitney's test and McNemar's test, respectively. Spearman's rank correlation coefficients (r(s)) were calculated among clinical and US scores and differences were tested by r-to-z transformation test. Results Seventy-two women were included, out of 247 RA patients, mostly white, with median (IQR) age of 57.5 (49.3-66.8) years, with RA symptoms for 13.0 (6.0-19.0) years and FM symptoms for 6.0 (2.0-15.0) years. Disease-modifying antirheumatic drugs, non-steroidal anti-inflammatory drugs and prednisone use was comparable between groups. Objective activity parameters were not different between groups. RA patients with FM had greater DAS28, SDAI and CDAI but similar GS-US7 and PD-US7. GS-US7 correlated with DAS28, SDAI and CDAI in patients with and without FM (r(s)=0.36-0.57), while PD-US7 correlated with clinical scores only in patients without FM (r(s)=0.35-0.38). Conclusion To our knowledge, this is the first study to demonstrate that ultrasound synovitis scores are not affected by FM in RA patients. PD-US7 performed better than GS-US7 in long-standing RA patients with DAS28, SDAI or CDAI allegedly overestimated due to FM. Since sonographic synovitis predicts erosion better than swollen joint count, C-reactive protein and erythrocyte sedimentation rate, US should be considered a promising treatment target in RA patients with FM.	[da Silva Chakr, Rafael Mendonca; Tavares Brenol, Joao Carlos; Behar, Marina; Kohem, Charles Lubianca; Monticielo, Odirlei Andre; Brenol, Claiton Viegas; Xavier, Ricardo Machado] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Mendonca, Jose Alexandre] Pontificia Univ Catolica Campinas, Campinas, SP, Brazil	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica de Campinas	Chakr, RMD (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	rafaelchakr@gmail.com	Brenol, Claiton V/D-5235-2009; Brenol, João Carlos Tavares/V-7062-2019; Monticielo, Odirlei/H-3880-2013; Xavier, Ricardo Machado/G-4426-2012; Chakr, Rafael/C-6963-2014; Kohem, Charles/U-4139-2019; Mendonça, José Alexandre/AAL-3443-2020; Mendonça, José Alexandre/AAX-2346-2021	Brenol, Claiton V/0000-0003-0229-7912; Brenol, João Carlos Tavares/0000-0002-8745-566X; Monticielo, Odirlei/0000-0003-0720-2097; Xavier, Ricardo Machado/0000-0001-6570-4533; Chakr, Rafael/0000-0002-8677-2479; Mendonça, José Alexandre/0000-0003-1689-6705	Fundo de Incentivo a Pesquisa e Eventos of Hospital de Clinicas de Porto Alegre	Fundo de Incentivo a Pesquisa e Eventos of Hospital de Clinicas de Porto Alegre	This study was funded by Fundo de Incentivo a Pesquisa e Eventos of Hospital de Clinicas de Porto Alegre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; Cheung PP, 2010, ARTHRIT CARE RES, V62, P323, DOI 10.1002/acr.20102; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Chakr RMD, 2013, CLIN RHEUMATOL, V32, P1249, DOI 10.1007/s10067-013-2291-6; Dale J, 2014, ARTHRIT CARE RES, V66, P19, DOI 10.1002/acr.22218; Damjanov N, 2012, RHEUMATOLOGY, V51, P120, DOI 10.1093/rheumatology/ker255; Dougados M, 2010, ANN RHEUM DIS, V69, P828, DOI 10.1136/ard.2009.115493; Hameed S, 2008, RHEUMATOLOGY, V47, P476, DOI 10.1093/rheumatology/kem383; Mandl P, 2011, J RHEUMATOL, V38, P2055, DOI 10.3899/jrheum.110424; Ohrndorf S, 2012, ARTHRIT CARE RES, V64, P1238, DOI 10.1002/acr.21679; Ohrndorf S, 2013, ANN RHEUM DIS, V72, P69, DOI 10.1136/annrheumdis-2012-202197; Pincus T, 2012, CLIN EXP RHEUMATOL, V30, pS10; Ranzolin A, 2009, ARTHRIT RHEUM-ARTHR, V61, P794, DOI 10.1002/art.24430; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	18	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118620	10.1371/journal.pone.0118620	http://dx.doi.org/10.1371/journal.pone.0118620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738587	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900057
J	Zhou, YY; Kang, L; Liao, SY; Pan, Q; Ge, XH; Li, ZY				Zhou, Yingying; Kang, Lei; Liao, Shiying; Pan, Qi; Ge, Xianhong; Li, Zaiyun			Transcriptomic Analysis Reveals Differential Gene Expressions for Cell Growth and Functional Secondary Metabolites in Induced Autotetraploid of Chinese Woad (Isatis indigotica Fort.)	PLOS ONE			English	Article							BRASSICA-NAPUS; HYBRIDS; POLYPLOIDY; SIZE; EVOLUTION; AUTOPOLYPLOIDY; TETRAPLOIDS; MECHANISMS; GENERATION; INDUCTION	The giant organs and enhanced concentrations of secondary metabolites realized by autopolyploidy are attractive for breeding the respective medicinal and agricultural plants and studying the genetic mechanisms. The traditional medicinal plant Chinese woad (Isatis indigotica Fort., 2n = 2x = 14) is now still largely used for the diseases caused by bacteria and viruses in China. In this study, its autopolyploids (3x, 4x) were produced and characterized together with the 2x donor for their phenotype and transcriptomic alterations by using high-throughput RNA sequencing. With the increase of genome dosage, the giantism in cells and organs was obvious and the photosynthetic rate was higher. The 4x plants showed predominantly the normal meiotic chromosome pairing (bivalents and quadrivalents) and equal segregation and then produced the majority of 4x progeny. The total 70136 All-unigenes were de novo assembled, and 56,482 (80.53%) unigenes were annotated based on BLASTx searches of the public databases. From pair-wise comparisons between transcriptomic data of 2x, 3x, 4x plants, 1856 (2.65%)(2x vs 4x), 693(0.98%)(2x vs 3x), 1045(1.48%)(3x vs 4x) unigenes were detected to differentially expressed genes (DEGs), including both up-and down-regulated ones. These DEGs were mainly involved in cell growth (synthesis of expansin and pectin), cell wall organization, secondary metabolite biosynthesis, response to stress and photosynthetic pathways. The up-regulation of some DEGs for metabolic pathways of functional compounds in the induced autotetraploids substantiates the promising new type of this medicinal plant with the increased biomass and targeted metabolites.	[Zhou, Yingying; Kang, Lei; Liao, Shiying; Pan, Qi; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Ctr Crop Mol Breeding Technol, Natl Key Lab Crop Genet Improvement, Natl Ctr Oil Crop Improvement Wuhan,Coll Plant Sc, Wuhan, Peoples R China	Huazhong Agricultural University	Li, ZY (corresponding author), Huazhong Agr Univ, Natl Ctr Crop Mol Breeding Technol, Natl Key Lab Crop Genet Improvement, Natl Ctr Oil Crop Improvement Wuhan,Coll Plant Sc, Wuhan, Peoples R China.	lizaiyun@mail.hzau.edu.cn			National Natural Science Foundation of China [31071451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) project (No. 31071451). YZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Banyai W, 2010, PLANT BIOTECHNOL-NAR, V27, P427, DOI 10.5511/plantbiotechnology.10.0726a; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dhawan OP, 1996, EUPHYTICA, V87, P81, DOI 10.1007/BF00021879; FANKHAUSER G, 1952, INT REV CYTOL, V1, P165, DOI 10.1016/S0074-7696(08)60010-8; Ge XH, 2013, PLANT CELL REP, V32, P1661, DOI 10.1007/s00299-013-1475-5; Gu XF, 2005, PLANT CELL REP, V24, P671, DOI 10.1007/s00299-005-0017-1; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hollister JD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003093; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kang L, 2014, PLANT CELL REP, V33, P1355, DOI 10.1007/s00299-014-1621-8; Kawade K, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-143; Lavania UC, 2012, PLANT J, V71, P539, DOI 10.1111/j.1365-313X.2012.05006.x; Levan A, 1939, HEREDITAS, V25, P109; Li B, 2000, J 2 MIL MED U, V21, P207; Li B, 2000, ACTA PHARM SIN, V35, P508, DOI [10.16438/j.0513-4870.2000.07.008, DOI 10.16438/J.0513-4870.2000.07.008]; [李彬 Li Bin], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P326; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Liu SY, 2011, SCI HORTIC-AMSTERDAM, V127, P411, DOI 10.1016/j.scienta.2010.10.012; Lu BB, 2006, PLANT MOL BIOL REP, V24, P197, DOI 10.1007/BF02914058; Lysak MA, 2009, MOL BIOL EVOL, V26, P85, DOI 10.1093/molbev/msn223; Meng HB, 2011, AGR SCI CHINA, V10, P363, DOI 10.1016/S1671-2927(11)60015-1; Mohn T, 2009, PHYTOCHEMISTRY, V70, P924, DOI 10.1016/j.phytochem.2009.04.019; MORRISON JW, 1960, NATURE, V187, P528, DOI 10.1038/187528a0; Mu HZ, 2012, INT J MOL SCI, V13, P13012, DOI 10.3390/ijms131013012; Muntzing A., 1936, HEREDITAS, V21, P263, DOI DOI 10.1111/J.1601-5223.1936.TB03204.X; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; National Pharmacopoeia Council, 2010, PHARM CHIN 2010 ED, P191; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Pagliarini MS, 2008, EUPHYTICA, V164, P181, DOI 10.1007/s10681-008-9697-2; Pan XZ, 2008, BIOLOGIA, V63, P535, DOI 10.2478/s11756-008-0094-z; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiao CZ, 1995, CHIN TRADIT HERB DRU, V26, P423; Rieseberg LH, 2001, CURR BIOL, V11, pR925, DOI 10.1016/S0960-9822(01)00556-5; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Roy AT, 2001, PLANT CELL REP, V20, P489, DOI 10.1007/s002990100364; Rudd JJ, 2001, NEW PHYTOL, V151, P7, DOI 10.1046/j.1469-8137.2001.00173.x; Santos JL, 2003, GENETICS, V165, P1533; Siedlecka A, 2008, PLANT PHYSIOL, V146, P554, DOI 10.1104/pp.107.111963; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Sugiyama SI, 2005, ANN BOT-LONDON, V96, P931, DOI 10.1093/aob/mci245; Taschetto Onildes Maria, 2004, Acta Botanica Croatica, V63, P17; Tsukaya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083729; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Tu YQ, 2010, GENOME, V53, P146, DOI [10.1139/G09-093, 10.1139/g09-093]; Tu YQ, 2008, PLANT CELL REP, V27, P873, DOI 10.1007/s00299-008-0513-1; WANG QY, 1988, ACTA AGR BOREALI SIN, V3, P92; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Yin, 2000, Zhongguo Zhongyao Zazhi, V25, P327; WARNER DA, 1993, PHOTOSYNTH RES, V35, P135, DOI 10.1007/BF00014744; WARNER DA, 1989, PLANT PHYSIOL, V91, P1143, DOI 10.1104/pp.91.3.1143; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094779; Yao H, 2011, PLANT MOL BIOL, V75, P237, DOI 10.1007/s11103-010-9722-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107; Zhang XS, 2014, INT J MOL SCI, V15, P5079, DOI 10.3390/ijms15035079; Zhu GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103832	68	41	42	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116392	10.1371/journal.pone.0116392	http://dx.doi.org/10.1371/journal.pone.0116392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739089	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900009
J	Hori, Y; Miyabe, K; Yoshida, M; Nakazawa, T; Hayashi, K; Naitoh, I; Shimizu, S; Kondo, H; Nishi, Y; Umemura, S; Kato, A; Ohara, H; Inagaki, H; Joh, T				Hori, Yasuki; Miyabe, Katsuyuki; Yoshida, Michihiro; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Kato, Akihisa; Ohara, Hirotaka; Inagaki, Hiroshi; Joh, Takashi			Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; P53 CODON-72; CANCER RISK; LUNG-CANCER; ARG72PRO POLYMORPHISMS; PROMOTER POLYMORPHISM; DISEASE PROGRESSION; GENE POLYMORPHISMS; COLORECTAL-CANCER	Single-nucleotide polymorphisms (SNPs) of TP53 (codon 72, rs1042522) and MDM2 promoter (SNP 309, rs2279744) have been associated with risk for various human cancers. However, studies analyzing these polymorphisms in pancreatic ductal adenocarcinoma (PDAC) are lacking. We investigated TP53 codon 72 and MDM2 SNP 309 polymorphisms in 32 patients with PDAC, 16 patients with chronic pancreatitis (CP), and 32 normal controls, using formalin-fixed paraffin-embedded tissue. We also examined TP53 and MDM2 protein immunohistochemistry (IHC) to assess the involvement of these differences in malignant transformation and disease progression. TP53 Pro/Pro genotype was significantly more frequent in PDAC patients than in controls (65.6 vs. 15.6%, p < 0.001) and no significant difference was found between CP patients (37.5%) and controls. In MDM2 SNP 309, there were no significant differences among the three groups. Based on the Kaplan-Meier analysis, overall survival was significantly shorter in MDM2 G/G genotypes compared with other genotypes (G/T and T/T) (359 vs. 911 days, p = 0.016) whereas no significant differences in TP53 genotypes were observed (638 vs. 752 days, p = 0.471). Although TP53 IHC was frequent in PDAC patients (53.1%), TP53 and MDM2 protein expression was not correlated with polymorphisms. Our study demonstrated TP53 codon 72 polymorphism is potentially a genetic predisposing factor while MDM2 SNP 309 polymorphism might be useful in predicting survival outcome.	[Hori, Yasuki; Miyabe, Katsuyuki; Yoshida, Michihiro; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi, Japan; [Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University	Miyabe, K (corresponding author), Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan.	kmiyabe@med.nagoya-cu.ac.jp	Naitoh, Itaru/AAB-7252-2020	Naitoh, Itaru/0000-0001-8342-886X; Miyabe, Katsuyuki/0000-0002-4915-9835	Aichi Cancer Research Foundation	Aichi Cancer Research Foundation(Aichi Cancer Research Foundation)	This study was supported by a research grant from Aichi Cancer Research Foundation (http:// www.acrf.or.jp/, no grant number) and the internal source of Nagoya City University Graduate School of Medical Sciences. The funders had no rule in study design, data collection and analysis, employment of any individuals, decision to publish, or preparation of the manuscript.	Ammann RW, 1997, PANCREAS, V14, P215, DOI 10.1097/00006676-199704000-00001; Asomaning K, 2008, CLIN CANCER RES, V14, P4010, DOI 10.1158/1078-0432.CCR-07-4187; BARTEK J, 1993, J PATHOL, V169, P27, DOI 10.1002/path.1711690106; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Dong M, 2003, J SURG ONCOL, V82, P111, DOI 10.1002/jso.10186; Dong M, 2005, WORLD J GASTROENTERO, V11, P2162, DOI 10.3748/wjg.v11.i14.2162; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fan R, 2000, CANCER EPIDEM BIOMAR, V9, P1037; Grochola LF, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001032; Grochola LF, 2010, PANCREAS, V39, P76, DOI 10.1097/MPA.0b013e3181b9f105; Grochola LF, 2011, PANCREAS, V40, P265, DOI 10.1097/MPA.0b013e3181f95104; Hishida A, 2004, LEUKEMIA LYMPHOMA, V45, P957, DOI 10.1080/10428190310001638878; Horikawa Y, 2008, ONCOL REP, V20, P49; Joshi AM, 2011, JPN J CLIN ONCOL, V41, P232, DOI 10.1093/jjco/hyq200; Kalemi TG, 2005, CANCER LETT, V222, P57, DOI 10.1016/j.canlet.2004.11.025; Kiyohara C, 2010, ONCOL REP, V23, P1361, DOI 10.3892/or_00000772; Kuroda Y, 2003, CANCER LETT, V189, P77, DOI 10.1016/S0304-3835(02)00518-9; Kuroda Y, 2007, ORAL ONCOL, V43, P1043, DOI 10.1016/j.oraloncology.2006.12.001; Langerod A, 2002, CANCER EPIDEM BIOMAR, V11, P1684; Lee JM, 2000, INT J CANCER, V89, P458, DOI 10.1002/1097-0215(20000920)89:5<458::AID-IJC10>3.0.CO;2-R; Li DH, 2006, CANCER RES, V66, P3323, DOI 10.1158/0008-5472.CAN-05-3032; Mabuchi F, 2009, MOL VIS, V15, P1045; Mahasneh AA, 2004, SAUDI MED J, V25, P1568; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Nakashima M, 2008, ACTA OTO-LARYNGOL, V128, P808, DOI 10.1080/00016480701724904; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; SARNER M, 1984, GUT, V25, P756, DOI 10.1136/gut.25.7.756; Shaib Y, 2007, AM J GASTROENTEROL, V102, P1377, DOI 10.1111/j.1572-0241.2007.01202.x; Shen HB, 2002, CANCER LETT, V183, P123, DOI 10.1016/S0304-3835(02)00117-9; Sonoyama T, 2011, MOL MED REP, V4, P489, DOI 10.3892/mmr.2011.449; Soulitzis N, 2002, CANCER LETT, V179, P175, DOI 10.1016/S0304-3835(01)00867-9; Sugano N, 2010, GENE CHROMOSOME CANC, V49, P620, DOI 10.1002/gcc.20774; Takeuchi S, 2005, BRIT J HAEMATOL, V131, P552, DOI 10.1111/j.1365-2141.2005.05798.x; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Tsai MH, 2002, LARYNGOSCOPE, V112, P116, DOI 10.1097/00005537-200201000-00020; WU WJ, 1995, JPN J CANCER RES, V86, P730, DOI 10.1111/j.1349-7006.1995.tb02461.x; Yoneda T, 2013, ONCOL REP, V30, P25, DOI 10.3892/or.2013.2433; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330; Zehbe I, 1999, LANCET, V354, P218, DOI 10.1016/S0140-6736(99)01914-5; Zhang JG, 2002, IEEE CIRCUITS DEVICE, V18, P18	45	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118829	10.1371/journal.pone.0118829	http://dx.doi.org/10.1371/journal.pone.0118829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734904	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700045
J	Misawa, K; Misawa, Y; Kondo, H; Mochizuki, D; Imai, A; Fukushima, H; Uehara, T; Kanazawa, T; Mineta, H				Misawa, Kiyoshi; Misawa, Yuki; Kondo, Haruki; Mochizuki, Daiki; Imai, Atsushi; Fukushima, Hirofumi; Uehara, Takayuki; Kanazawa, Takeharu; Mineta, Hiroyuki			Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; PROMOTER METHYLATION; POTENTIAL BIOMARKER; PROSTATE-CANCER; TACHYKININ-1; GALANIN; HYPERMETHYLATION; EXPRESSION; PATHOGENESIS; ASSOCIATION	Purpose The aim of this study was to define somatostatin (SST) and somatostatin receptor type 1 (SSTR1) methylation profiles for head and neck squamous cell carcinoma (HNSCC) tumors at diagnosis and follow up and to evaluate their prognostic significance and value as a biomarker. Methods Gene expression was measured by quantitative RT-PCR. Promoter methylation status was determined by quantitative methylation-specific PCR (Q-MSP) in HNSCC. Results Methylation was associated with transcription inhibition. SST methylation in 81% of HNSCC tumor specimens significantly correlated with tumor size (P = 0.043), stage (P = 0.008), galanin receptor type 2 (GALR2) methylation (P = 0.041), and tachykinin-1 (TAC1) (P = 0.040). SSTR1 hypermethylation in 64% of cases was correlated with tumor size (P = 0.037), stage (P = 0.037), SST methylation (P < 0.001), and expression of galanin (P = 0.03), GALR2 (P = 0.014), TAC1 (P = 0.023), and tachykinin receptor type 1 (TACR1) (P = 0.003). SST and SSTR1 promoter hypermethylation showed highly discriminating receiver operator characteristic curve profiles, which clearly distinguished HNSCC from adjacent normal mucosal tissues. Concurrent hypermethylation of galanin and SSTR1 promoters correlated with reduced disease-free survival (log-rank test, P = 0.0001). Among patients with oral cavity and oropharynx cancer, methylation of both SST and SSTR1 promoters correlated with reduced disease-free survival (log-rank test, P = 0.028). In multivariate logistic-regression analysis, concomitant methylation of galanin and SSTR1 was associated with an odds ratio for recurrence of 12.53 ( 95% CI, 2.62 to 59.8; P = 0.002). Conclusions CpG hypermethylation is a likely mechanism of SST and SSTR1 gene inactivation, supporting the hypothesis that SST and SSTR1 play a role in the tumorigenesis of HNSCC and that this hypermethylation may serve as an important biomarker.	[Misawa, Kiyoshi; Misawa, Yuki; Kondo, Haruki; Mochizuki, Daiki; Imai, Atsushi; Mineta, Hiroyuki] Hamamatsu Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Shizuoka, Japan; [Fukushima, Hirofumi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Head & Neck, Tokyo, Japan; [Uehara, Takayuki] Univ Ryukyus, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Nishihara, Okinawa 90301, Japan; [Kanazawa, Takeharu] Jichi Med Univ, Dept Otolaryngol Head & Neck Surg, Shimotsuke, Japan	Hamamatsu University School of Medicine; Japanese Foundation for Cancer Research; University of the Ryukyus; Jichi Medical University	Misawa, K (corresponding author), Hamamatsu Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Shizuoka, Japan.	kiyoshim@hama-med.ac.jp		MOCHIZUKI, DAIKI/0000-0002-4561-3404	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24592594, 25861485, 26462599, 26462600, 26861367]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A Grant-in-Aid for Scientific Research (No. 24592594, 25861485, 26462599, 26462600 and 26861367) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chen LF, 2010, CLIN CANCER RES, V16, P2489, DOI 10.1158/1078-0432.CCR-09-2318; David S, 2009, BIOCHEM BIOPH RES CO, V378, P605, DOI 10.1016/j.bbrc.2008.11.078; Gu J, 2006, CLIN CANCER RES, V12, P7329, DOI 10.1158/1078-0432.CCR-06-0894; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Jackson K, 2011, DIGEST DIS SCI, V56, P125, DOI 10.1007/s10620-010-1422-z; Jeschke J, 2012, EPIGENETICS-US, V7, P701, DOI 10.4161/epi.20445; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Jin Z, 2008, CANCER-AM CANCER SOC, V112, P43, DOI 10.1002/cncr.23135; Jin Z, 2007, CLIN CANCER RES, V13, P6293, DOI 10.1158/1078-0432.CCR-07-0818; Kanazawa T, 2010, EXPERT OPIN THER TAR, V14, P289, DOI 10.1517/14728221003598922; Katz MH., 2011, MULTIVARIABLE ANAL A; Kharmate G, 2011, BBA-MOL CELL RES, V1813, P1172, DOI 10.1016/j.bbamcr.2011.03.006; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Malik N, 2013, COMP BIOCHEM PHYS B, V165, P260, DOI 10.1016/j.cbpb.2013.05.006; Misawa K, 2013, TRANSL ONCOL, V6, P338, DOI 10.1593/tlo.13115; Misawa K, 2013, J CANCER RES CLIN, V139, P879, DOI 10.1007/s00432-013-1393-5; Misawa K, 2008, CLIN CANCER RES, V14, P7604, DOI 10.1158/1078-0432.CCR-07-4673; Misawa Y, 2014, CANCER-AM CANCER SOC, V120, P205, DOI 10.1002/cncr.28411; Mizutani G, 2012, ACTA HISTOCHEM CYTOC, V45, P167, DOI 10.1267/ahc.12006; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; REUBI JC, 1995, TRENDS PHARMACOL SCI, V16, P110, DOI 10.1016/S0165-6147(00)88992-0; Ricketts CJ, 2012, EPIGENETICS-US, V7, P278, DOI 10.4161/epi.7.3.19103; Schartinger VH, 2012, J LARYNGOL OTOL, V126, P1261, DOI 10.1017/S0022215112002265; Stafford ND, 2003, CLIN OTOLARYNGOL, V28, P314, DOI 10.1046/j.1365-2273.2003.00711.x; Stewart GD, 2013, J UROLOGY, V189, P1110, DOI 10.1016/j.juro.2012.08.219; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Watt Heather L, 2012, J Signal Transduct, V2012, P282050, DOI 10.1155/2012/282050; Zhao J, 2013, BRIT J CANCER, V108, P2557, DOI 10.1038/bjc.2013.263	34	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118588	10.1371/journal.pone.0118588	http://dx.doi.org/10.1371/journal.pone.0118588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734919	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700038
J	Fuentes-Julian, S; Arnalich-Montiel, F; Jaumandreu, L; Leal, M; Casado, A; Garcia-Tunon, I; Hernandez-Jimenez, E; Lopez-Collazo, E; De Miguel, MP				Fuentes-Julian, Sherezade; Arnalich-Montiel, Francisco; Jaumandreu, Laia; Leal, Marina; Casado, Alfonso; Garcia-Tunon, Ignacio; Hernandez-Jimenez, Enrique; Lopez-Collazo, Eduardo; De Miguel, Maria P.			Adipose-Derived Mesenchymal Stem Cell Administration Does Not Improve Corneal Graft Survival Outcome	PLOS ONE			English	Article							HIGH-RISK KERATOPLASTY; VERSUS-HOST-DISEASE; STROMAL CELLS; MYCOPHENOLATE-MOFETIL; ALLOGRAFT-REJECTION; INTERFERON-GAMMA; UP-REGULATION; ISLET GRAFTS; TISSUE; THERAPY	The effect of local and systemic injections of mesenchymal stem cells derived from adipose tissue (AD-MSC) into rabbit models of corneal allograft rejection with either normal-risk or high-risk vascularized corneal beds was investigated. The models we present in this study are more similar to human corneal transplants than previously reported murine models. Our aim was to prevent transplant rejection and increase the length of graft survival. In the normal-risk transplant model, in contrast to our expectations, the injection of AD-MSC into the graft junction during surgery resulted in the induction of increased signs of inflammation such as corneal edema with increased thickness, and a higher level of infiltration of leukocytes. This process led to a lower survival of the graft compared with the sham-treated corneal transplants. In the high-risk transplant model, in which immune ocular privilege was undermined by the induction of neovascularization prior to graft surgery, we found the use of systemic rabbit AD-MSCs prior to surgery, during surgery, and at various time points after surgery resulted in a shorter survival of the graft compared with the non-treated corneal grafts. Based on our results, local or systemic treatment with AD-MSCs to prevent corneal rejection in rabbit corneal models at normal or high risk of rejection does not increase survival but rather can increase inflammation and neovascularization and break the innate ocular immune privilege. This result can be partially explained by the immunomarkers, lack of immunosuppressive ability and immunophenotypical secretion molecules characterization of AD-MSC used in this study. Parameters including the risk of rejection, the inflammatory/vascularization environment, the cell source, the time of injection, the immunosuppression, the number of cells, and the mode of delivery must be established before translating the possible benefits of the use of MSCs in corneal transplants to clinical practice.	[Fuentes-Julian, Sherezade; Garcia-Tunon, Ignacio; De Miguel, Maria P.] Hosp La Paz, Res Inst, IdiPAZ, Cell Engn Lab, Madrid, Spain; [Arnalich-Montiel, Francisco; Jaumandreu, Laia; Leal, Marina; Casado, Alfonso] Ramon y Cajal Hosp Res Inst, Dept Ophthalmol, Madrid, Spain; [Hernandez-Jimenez, Enrique; Lopez-Collazo, Eduardo] IdiPAZ, Tumor Immunol Dept, Madrid, Spain; [Hernandez-Jimenez, Enrique; Lopez-Collazo, Eduardo] IdiPAZ, Innate Immun Grp, Madrid, Spain	Hospital Universitario La Paz	De Miguel, MP (corresponding author), Hosp La Paz, Res Inst, IdiPAZ, Cell Engn Lab, Madrid, Spain.	mariapdemiguel@gmail.com	García-Tuñón Llanio, Ignacio/K-9901-2014; Arnalich, Francisco/K-7723-2014; Casado, Alfonso/AAI-9951-2020; Lopez-Collazo, Eduardo/U-6634-2018	García-Tuñón Llanio, Ignacio/0000-0003-4758-2151; Casado, Alfonso/0000-0002-3402-7311; Hernandez Jimenez, Enrique/0000-0002-8232-8151; Lopez-Collazo, Eduardo/0000-0003-1957-877X; Arnalich-Montiel, Francisco/0000-0002-1229-2018	Ministry of Health and Social Politics, Spain [EC-11]; Ministry of Economy and Competitiveness, Spain [SAF2010-19230]; Ministry of Education, Culture and Sports [AP2010-0659]; BioMedical Foundations Mutua Madrilena and Marato TV3, Spain	Ministry of Health and Social Politics, Spain; Ministry of Economy and Competitiveness, Spain; Ministry of Education, Culture and Sports; BioMedical Foundations Mutua Madrilena and Marato TV3, Spain	This work was supported by grants EC-11 from the Ministry of Health and Social Politics, Spain; SAF2010-19230 from the Ministry of Economy and Competitiveness, Spain; AP2010-0659 fellowship to SF-J from the Ministry of Education, Culture and Sports; and from the BioMedical Foundations Mutua Madrilena and Marato TV3, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EYE BANK STAT REP; Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Birnbaum F, 2005, TRANSPLANTATION, V79, P964, DOI 10.1097/01.TP.0000158022.62059.F2; Birnbaum F, 2009, EYE, V23, P2063, DOI 10.1038/eye.2008.402; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chong Eva-Marie, 2008, International Ophthalmology, V28, P209, DOI 10.1007/s10792-007-9099-9; Crop MJ, 2011, CELL TRANSPLANT, V20, P1547, DOI 10.3727/096368910X564076; De Miguel MP, 2012, CURR MOL MED, V12, P574; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Engela AU, 2013, CELL TRANSPLANT, V22, P41, DOI 10.3727/096368912X636984; Fang BJ, 2007, PEDIATR TRANSPLANT, V11, P814, DOI 10.1111/j.1399-3046.2007.00780.x; Francois M, 2009, BLOOD, V114, P2632, DOI 10.1182/blood-2009-02-207795; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; HAUNER H, 1987, KLIN WOCHENSCHR, V65, P803, DOI 10.1007/BF01727474; Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jia Z, 2012, EXP EYE RES, V102, P44, DOI 10.1016/j.exer.2012.06.008; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Katz AJ, 1999, CLIN PLAST SURG, V26, P587; Kim YH, 2011, MOL MED, V17, P697, DOI 10.2119/molmed.2010.00098; Kuo YR, 2011, PLAST RECONSTR SURG, V128, p661E, DOI 10.1097/PRS.0b013e318230c60b; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2014, P NATL ACAD SCI US; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Lin YF, 2006, MOL CELL BIOCHEM, V285, P69, DOI 10.1007/s11010-005-9056-8; Menard C, 2013, STEM CELLS DEV, V22, P1789, DOI 10.1089/scd.2012.0594; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Niederkorn JY, 2010, OCUL IMMUNOL INFLAMM, V18, P162, DOI 10.3109/09273948.2010.486100; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2009, VET OPHTHALMOL, V12, P35, DOI 10.1111/j.1463-5224.2009.00724.x; Ohmura Y, 2010, TRANSPLANTATION, V90, P1366, DOI 10.1097/TP.0b013e3181ffba31; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Rigol M, 2014, EUR J CLIN INVEST, V44, P83, DOI 10.1111/eci.12195; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Seifert M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00202; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Shi WY, 2006, INVEST OPHTH VIS SCI, V47, P3339, DOI 10.1167/iovs.05-1425; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Tavandzi U, 2007, TRANSPLANTATION, V83, P1401, DOI 10.1097/01.tp.0000261711.08833.a1; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zhang W, 2007, TRANSPL P, V39, P3404, DOI 10.1016/j.transproceed.2007.06.092; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	55	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117945	10.1371/journal.pone.0117945	http://dx.doi.org/10.1371/journal.pone.0117945			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730319	gold, Green Published, Green Submitted			2022-12-26	WOS:000350684900016
J	Proctor, MJ; McMillan, DC; Horgan, PG; Fletcher, CD; Talwar, D; Morrison, DS				Proctor, Michael J.; McMillan, Donald C.; Horgan, Paul G.; Fletcher, Colin D.; Talwar, Dinesh; Morrison, David S.			Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PROGNOSTIC SCORE; ISCHEMIC-STROKE; FOLLOW-UP; CANCER; ASSOCIATION; DISEASE; ALBUMIN; COUNTS; TUMOR	Introduction Markers of the systemic inflammatory response, including C-reactive protein and albumin (combined to form the modified Glasgow Prognostic Score), as well as neutrophil, lymphocyte and platelet counts have been shown to be prognostic of survival in patients with cancer. The aim of the present study was to examine the prognostic relationship between these markers of the systemic inflammatory response and all-cause, cancer, cardiovascular and cerebrovascular mortality in a large incidentally sampled cohort. Methods Patients (n = 160 481) who had an incidental blood sample taken between 2000 and 2008 were studied for the prognostic value of C-reactive protein (> 10mg/l, albumin (> 35mg/l), neutrophil (> 7.5x10(9)/l) lymphocyte and platelet counts. Also, patients (n = 52 091) sampled following the introduction of high sensitivity C-reactive protein (> 3mg/l) measurements were studied. A combination of these markers, to make cumulative inflammation-based scores, were investigated. Results In all patients (n = 160 481) C-reactive protein (> 10mg/l) (HR 2.71, p < 0.001), albumin (> 35mg/l) (HR 3.68, p < 0.001) and neutrophil counts (HR 2.18, p < 0.001) were independently predictive of all-cause mortality. These associations were also observed in cancer, cardiovascular and cerebrovascular mortality before and after the introduction of high sensitivity C-reactive protein measurements (> 3mg/l) (n = 52 091). A combination of high sensitivity C-reactive protein (> 3mg/l), albumin and neutrophil count predicted all-cause (HR 7.37, p < 0.001, AUC 0.723), cancer (HR 9.32, p < 0.001, AUC 0.731), cardiovascular (HR 4.03, p < 0.001, AUC 0.650) and cerebrovascular (HR 3.10, p < 0.001, AUC 0.623) mortality. Conclusion The results of the present study showed that an inflammation-based prognostic score, combining high sensitivity C-reactive protein, albumin and neutrophil count is prognostic of all-cause mortality.	[Proctor, Michael J.; McMillan, Donald C.; Horgan, Paul G.] Univ Glasgow, Acad Surg Unit, Sch Med, Glasgow, Lanark, Scotland; [Fletcher, Colin D.; Talwar, Dinesh] Royal Infirm, Dept Clin Biochem, Glasgow G31 2ER, Lanark, Scotland; [Morrison, David S.] Univ Glasgow, West Scotland Canc Surveillance Unit, Glasgow, Lanark, Scotland	University of Glasgow; Royal Infirmary of Edinburgh; University of Glasgow	Proctor, MJ (corresponding author), Univ Glasgow, Acad Surg Unit, Sch Med, Glasgow, Lanark, Scotland.	m.proctor@nhs.net		McMillan, Donald/0000-0003-4260-5334; Morrison, David/0000-0002-0617-3047				Acanfora D, 2001, AM HEART J, V142, P167, DOI 10.1067/mhj.2001.115792; Bishop J, 2004, DEPRIVATION URBAN RU; den Hertog HM, 2009, J NEUROL, V256, P2003, DOI 10.1007/s00415-009-5228-x; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Gakis G, 2011, BJU INT, V108, P1800, DOI 10.1111/j.1464-410X.2011.10234.x; Gay JL, 2013, J IMMIGR MINOR HLTH; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grimm G, 2009, EUR J CLIN INVEST, V39, P860, DOI 10.1111/j.1365-2362.2009.02189.x; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Inoue Y, 2013, ONCOLOGY-BASEL, V84, P100, DOI 10.1159/000343822; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Ko YJ, 2012, CANCER EPIDEM BIOMAR, V21, P2076, DOI 10.1158/1055-9965.EPI-12-0611; Lamb GWA, 2012, BRIT J CANCER, V106, P279, DOI 10.1038/bjc.2011.556; Lee S, 2011, J EPIDEMIOL, V21, P161, DOI 10.2188/jea.JE20100128; Maestripieri D, 2011, DEV PSYCHOPATHOL, V23, P1187, DOI 10.1017/S0954579411000551; Marsik C, 2008, CLIN CHEM, V54, P343, DOI 10.1373/clinchem.2007.091959; McMillan DC, 2013, BRIT J CANCER, V109, P529, DOI 10.1038/bjc.2013.418; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Phillips AC, 2011, QJM-INT J MED, V104, P319, DOI 10.1093/qjmed/hcq199; Pietila KO, 1996, EUR HEART J, V17, P1345; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ridker PM, 2008, CLIN CHEM, V54, P234, DOI 10.1373/clinchem.2007.099465; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Sokunbi D O, 1994, Adv Perit Dial, V10, P77; Van Hemelrijck M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-895; Zacho J, 2010, EUR HEART J, V31, P1624, DOI 10.1093/eurheartj/ehq103; Zamani P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003103	32	85	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0116206	10.1371/journal.pone.0116206	http://dx.doi.org/10.1371/journal.pone.0116206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730322	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000350684900009
J	Woods, DL; Arbogast, T; Doss, Z; Younus, M; Herron, TJ; Yund, EW				Woods, David L.; Arbogast, Tanya; Doss, Zoe; Younus, Masood; Herron, Timothy J.; Yund, E. William			Aided and Unaided Speech Perception by Older Hearing Impaired Listeners	PLOS ONE			English	Article							CONSONANT RECOGNITION; MULTICHANNEL COMPRESSION; COGNITIVE-FACTORS; NOISE; IDENTIFICATION; BENEFIT; AMPLIFICATION; PERFORMANCE; ADULTS; QUIET	The most common complaint of older hearing impaired (OHI) listeners is difficulty understanding speech in the presence of noise. However, tests of consonant-identification and sentence reception threshold (SeRT) provide different perspectives on the magnitude of impairment. Here we quantified speech perception difficulties in 24 OHI listeners in unaided and aided conditions by analyzing (1) consonant-identification thresholds and consonant confusions for 20 onset and 20 coda consonants in consonant-vowel-consonant (CVC) syllables presented at consonant-specific signal-to-noise (SNR) levels, and (2) SeRTs obtained with the Quick Speech in Noise Test (QSIN) and the Hearing in Noise Test (HINT). Compared to older normal hearing (ONH) listeners, nearly all unaided OHI listeners showed abnormal consonant-identification thresholds, abnormal consonant confusions, and reduced psychometric function slopes. Average elevations in consonant-identification thresholds exceeded 35 dB, correlated strongly with impairments in mid-frequency hearing, and were greater for hard-to-identify consonants. Advanced digital hearing aids (HAs) improved average consonant-identification thresholds by more than 17 dB, with significant HA benefit seen in 83% of OHI listeners. HAs partially normalized consonant-identification thresholds, reduced abnormal consonant confusions, and increased the slope of psychometric functions. Unaided OHI listeners showed much smaller elevations in SeRTs (mean 6.9 dB) than in consonant-identification thresholds and SeRTs in unaided listening conditions correlated strongly (r = 0.91) with identification thresholds of easily identified consonants. HAs produced minimal SeRT benefit (2.0 dB), with only 38% of OHI listeners showing significant improvement. HA benefit on SeRTs was accurately predicted (r = 0.86) by HA benefit on easily identified consonants. Consonant-identification tests can accurately predict sentence processing deficits and HA benefit in OHI listeners.	[Woods, David L.; Arbogast, Tanya; Doss, Zoe; Younus, Masood; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X	VA Research Service grant [1I01CX000583]; Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	VA Research Service grant; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by VA Research Service grant 1I01CX000583 to DLW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom JB, 2014, EAR HEARING, V35, P72, DOI 10.1097/AUD.0b013e3182a02274; Ahlstrom JB, 2009, EAR HEARING, V30, P203, DOI 10.1097/AUD.0b013e31819769c1; Benichov J, 2012, EAR HEARING, V33, P262, DOI 10.1097/AUD.0b013e31822f680f; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; BILGER RC, 1976, J SPEECH HEAR RES, V19, P718, DOI 10.1044/jshr.1904.718; Bonatti LL, 2005, PSYCHOL SCI, V16, P451, DOI 10.1111/j.0956-7976.2005.01556.x; Boothroyd A, 2008, EAR HEARING, V29, P479, DOI 10.1097/AUD.0b013e318174f067; Bosman AJ, 1995, AUDIOLOGY, V34, P260; COX RM, 1991, J SPEECH HEAR RES, V34, P904, DOI 10.1044/jshr.3404.904; Dawes P, 2014, EAR HEARING, V35, P203, DOI 10.1097/AUD.0b013e3182a8eda4; DIRKS DD, 1969, J SPEECH HEAR RES, V12, P650, DOI 10.1044/jshr.1203.650; DRESCHLER WA, 1986, AUDIOLOGY, V25, P19; DRESCHLER WA, 1989, AUDIOLOGY, V28, P49; DUBNO JR, 1989, J ACOUST SOC AM, V85, P347, DOI 10.1121/1.397686; DUBNO JR, 1982, J SPEECH HEAR RES, V25, P141, DOI 10.1044/jshr.2501.141; Feng YM, 2010, EAR HEARING, V31, P115, DOI 10.1097/AUD.0b013e3181bb69be; Flynn MC, 1998, J SPEECH LANG HEAR R, V41, P285, DOI 10.1044/jslhr.4102.285; Fogerty D, 2012, J ACOUST SOC AM, V132, P1667, DOI 10.1121/1.4739463; GIVENS G D, 1981, Journal of Auditory Research, V21, P279; Gordon-Salant S, 2010, J ACOUST SOC AM, V128, P3152, DOI 10.1121/1.3495940; GORDONSALANT S, 1987, EAR HEARING, V8, P270, DOI 10.1097/00003446-198710000-00003; GORDONSALANT S, 1984, J SPEECH HEAR RES, V27, P483, DOI 10.1044/jshr.2704.483; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hafter ER, 2010, J AM ACAD AUDIOL, V21, P594, DOI 10.3766/jaaa.21.9.5; Hedrick MS, 2003, J SPEECH LANG HEAR R, V46, P636, DOI 10.1044/1092-4388(2003/050); Hillock-Dunn A, 2014, EAR HEAR; Hopkins K, 2014, INT J AUDIOL, V53, P219, DOI 10.3109/14992027.2013.873956; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; Humes LE, 2010, HEARING RES, V264, P30, DOI 10.1016/j.heares.2009.09.010; Humes LE, 2009, SCAND J PSYCHOL, V50, P485, DOI 10.1111/j.1467-9450.2009.00740.x; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kochkin S., 2010, HEAR J, V63, P19, DOI [10.1097/01.HJ.0000366912.40173.76, DOI 10.1097/01.HJ.0000366912.40173.76]; Kochkin S, 2010, THE HEARING JOURNAL, V63, P30, DOI DOI 10.1097/1001.HJ.0000366912.0000340173.0000366976; Kuk F, 2010, EAR HEARING, V31, P779, DOI 10.1097/AUD.0b013e3181e97bfb; Kuk F, 2009, J AM ACAD AUDIOL, V20, P465, DOI 10.3766/jaaa.20.8.2; Li FP, 2012, J ACOUST SOC AM, V132, P2663, DOI 10.1121/1.4747008; Lunner T, 2003, INT J AUDIOL, V42, pS49; Mackersie Carol L, 2004, J Am Acad Audiol, V15, P498, DOI 10.3766/jaaa.15.7.4; McArdle RA, 2012, J AM ACAD AUDIOL, V23, P171, DOI 10.3766/jaaa.23.3.4; Mendel Lisa Lucks, 2007, Am J Audiol, V16, P118, DOI 10.1044/1059-0889(2007/016); Munro KJ, 2003, J ACOUST SOC AM, V114, P484, DOI 10.1121/1.1577556; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; OCHS MT, 1989, J SPEECH HEAR RES, V32, P133, DOI 10.1044/jshr.3201.133; ORCHIK DJ, 1980, J SPEECH HEAR DISORD, V45, P401, DOI 10.1044/jshd.4503.401; OWENS E, 1977, J SPEECH HEAR RES, V20, P463, DOI 10.1044/jshr.2003.463; OWENS E, 1968, J SPEECH HEAR RES, V11, P648, DOI 10.1044/jshr.1103.648; OWENS E, 1978, J SPEECH HEAR DISORD, V43, P331, DOI 10.1044/jshd.4303.331; Phatak SA, 2009, J ACOUST SOC AM, V126, P2683, DOI 10.1121/1.3238257; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Piquado T, 2012, INT J AUDIOL, V51, P576, DOI 10.3109/14992027.2012.684403; PLOMP R, 1978, J ACOUST SOC AM, V63, P533, DOI 10.1121/1.381753; Plyler Patrick N, 2002, J Am Acad Audiol, V13, P154; Ricketts TA, 2005, EAR HEARING, V26, P473, DOI 10.1097/01.aud.0000179691.21547.01; Rudner M, 2011, J AM ACAD AUDIOL, V22, P156, DOI 10.3766/jaaa.22.3.4; Sammeth C A, 1996, J Am Acad Audiol, V7, P240; Saripella R, 2011, J ACOUST SOC AM, V130, P3028, DOI 10.1121/1.3641407; Saunders GH, 2006, EAR HEARING, V27, P229, DOI 10.1097/01.aud.0000215976.64444.e6; Saunders GH, 1997, EAR HEARING, V18, P129, DOI 10.1097/00003446-199704000-00005; Schafer AJ, 2000, J PSYCHOLINGUIST RES, V29, P169, DOI 10.1023/A:1005192911512; SCHWARTZ DM, 1979, AUDIOLOGY, V18, P157; SHER AE, 1974, J SPEECH HEAR RES, V17, P669, DOI 10.1044/jshr.1704.669; SILMAN S, 1993, J REHABIL RES DEV, V30, P326; Stewart R, 2009, J AM ACAD AUDIOL, V20, P147, DOI 10.3766/jaaa.20.2.7; Strelcyk O, 2013, J ACOUST SOC AM, V133, P1598, DOI 10.1121/1.4789894; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Valente M, 2008, INT J AUDIOL, V47, P329, DOI 10.1080/14992020801894832; VANROOIJ JCGM, 1990, J ACOUST SOC AM, V88, P2611, DOI 10.1121/1.399981; Walden BE, 2001, EAR HEARING, V22, P333, DOI 10.1097/00003446-200108000-00007; WANG MD, 1978, J SPEECH HEAR RES, V21, P5, DOI 10.1044/jshr.2101.05; Whittaker J., 1990, GRAPHICAL MODELS APP; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); Woods DL, 2012, J REHABIL RES DEV, V49, P1277, DOI 10.1682/JRRD.2011.08.0150; Woods DL, 2010, J REHABIL RES DEV, V47, P243, DOI 10.1682/JRRD.2009.04.0040; Woods DL, 2010, J ACOUST SOC AM, V127, P1609, DOI 10.1121/1.3293005; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P460, DOI 10.1044/1092-4388(2011/10-0239); Yund EW, 2006, J REHABIL RES DEV, V43, P517, DOI 10.1682/JRRD.2005.06.0099; YUND EW, 1995, J ACOUST SOC AM, V97, P1224, DOI 10.1121/1.412232; YUND EW, 1995, J ACOUST SOC AM, V97, P1206, DOI 10.1121/1.413093; ZENG FG, 1990, J SPEECH HEAR RES, V33, P440, DOI 10.1044/jshr.3303.440	80	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0114922	10.1371/journal.pone.0114922	http://dx.doi.org/10.1371/journal.pone.0114922			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730423	Green Published, gold, Green Submitted			2022-12-26	WOS:000350684900003
J	Leroy, C; Shen, Q; Strande, V; Meyer, R; McLaughlin, ME; Lezan, E; Bentires-Alj, M; Voshol, H; Bonenfant, D; Gaither, LA				Leroy, C.; Shen, Q.; Strande, V.; Meyer, R.; McLaughlin, M. E.; Lezan, E.; Bentires-Alj, M.; Voshol, H.; Bonenfant, D.; Gaither, L. Alex			CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases	ONCOGENE			English	Article							TYROSINE PHOSPHORYLATION; PKC-DELTA; METASTASIS; CDCP1; EPITHELIA; MIGRATION; INVASION; REVEALS; FYN	The transmembrane glycoprotein, CUB (complement C1r/C1s, Uegf, Bmp1) domain-containing protein 1 (CDCP1) is overexpressed in several cancer types and is a predictor of poor prognosis for patients on standard of care therapies. Phosphorylation of CDCP1 tyrosine sites is induced upon loss of cell adhesion and is thought to be linked to metastatic potential of tumor cells. Using a tyrosine-phosphoproteomics screening approach, we characterized the phosphorylation state of CDCP1 across a panel of breast cancer cell lines. We focused on two phospho-tyrosine pTyr peptides of CDCP1, containing Tyr707 and Tyr806, which were identified in all six lines, with the human epidermal growth factor 2-positive HCC1954 cells showing a particularly high phosphorylation level. Pharmacological modulation of tyrosine phosphorylation indicated that, the Src family kinases (SFKs) were found to phosphorylate CDCP1 at Tyr707 and Tyr806 and play a critical role in CDCP1 activity. We demonstrated that CDCP1 overexpression in HEK293 cells increases global phosphotyrosine content, promotes anchorage-independent cell growth and activates several SFK members. Conversely, CDCP1 downregulation in multiple solid cancer cell lines decreased both cell growth and SFK activation. Analysis of primary human tumor samples demonstrated a correlation between CDCP1 expression, SFK and protein kinase C (PKC) activity. Taken together, our results suggest that CDCP1 overexpression could be an interesting therapeutic target in multiple solid cancers and a good biomarker to stratify patients who could benefit from an anti-SFK-targeted therapy. Our data also show that multiple tyrosine phosphorylation sites of CDCP1 are important for the functional regulation of SFKs in several tumor types.	[Leroy, C.; Strande, V.; Lezan, E.; Voshol, H.; Bonenfant, D.] Novartis Inst BioMed Res, Basel, Switzerland; [Shen, Q.; Meyer, R.; McLaughlin, M. E.; Gaither, L. Alex] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA; [Bentires-Alj, M.] Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research	Gaither, LA (corresponding author), Novartis Inst BioMed Res Inc, 500 Technol Sq, Cambridge, MA 02139 USA.	alex.gaither@novartis.com	Bentires-Alj, Mohamed/F-4484-2015	Bentires-Alj, Mohamed/0000-0001-6344-1127				Alajati A, 2013, CANCER RES, V73, P5320, DOI 10.1158/0008-5472.CAN-12-3186; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Manes G, 2000, MOL CELL BIOL, V20, P3396, DOI 10.1128/MCB.20.10.3396-3406.2000; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sirvent A, 2010, ONCOGENE, V29, P1303, DOI 10.1038/onc.2009.450; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Uekita T, 2011, CANCER SCI, V102, P1943, DOI 10.1111/j.1349-7006.2011.02052.x; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198	20	25	25	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2015	34	44					5593	5598		10.1038/onc.2015.19	http://dx.doi.org/10.1038/onc.2015.19			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9FX	25728678	hybrid, Green Published			2022-12-26	WOS:000364594000008
J	Yang, XM; Li, HY; Lai, TP; Sun, HZ				Yang, Xinming; Li, Hongyan; Lai, Tsz-Pui; Sun, Hongzhe			UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UREASE ACCESSORY PROTEIN; HISTIDINE-RICH PROTEIN; METAL-BINDING SITES; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; BACILLUS-PASTEURII; FACTOR-HYPB; HPN-LIKE; HYDROGENASE; MATURATION	The pathogenicity of Helicobacter pylori relies heavily on urease, which converts urea to ammonia to neutralize the stomach acid. Incorporation of Ni2+ into the active site of urease requires a battery of chaperones. Both metallochaperones UreE and UreG play important roles in the urease activation. In this study, we demonstrate that, in the presence of GTP and Mg2+, UreG binds Ni2+ with an affinity (K-d) of similar to 0.36 mu M. The GTPase activity of Ni2+-UreG is stimulated by both K+ (or NH4+) and HCO3- to a biologically relevant level, suggesting that K+/NH4+ and HCO3- might serve as GTPase elements of UreG. We show that complexation of UreE and UreG results in two protein complexes, i.e. 2E-2G and 2E-G, with the former being formed only in the presence of both GTP and Mg2+. Mutagenesis studies reveal that Arg-101 on UreE and Cys-66 on UreG are critical for stabilization of 2E-2G complex. Combined biophysical and bio-assay studies show that the formation of 2E-2G complex not only facilitates nickel transfer from UreE to UreG, but also enhances the binding of GTP. This suggests that UreE might also serve as a structural scaffold for recruitment of GTP to UreG. Importantly, we demonstrate for the first time that UreE serves as a bridge to grasp Ni2+ from HypA, subsequently donating it to UreG. The study expands our horizons on the molecular details of nickel translocation among metallochaperones UreE, UreG, and HypA, which further extends our knowledge on the urease maturation process.	[Yang, Xinming; Li, Hongyan; Lai, Tsz-Pui; Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Sun, HZ (corresponding author), Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	hsun@hku.hk	/D-3123-2009	/0000-0001-6697-6899; YANG, Xinming/0000-0001-6240-5212	Research Grants of Council of Hong Kong [704909, N_HKU75209, 704612, 703913, HKU6/11G]; University of Hong Kong	Research Grants of Council of Hong Kong; University of Hong Kong(University of Hong Kong)	This work was supported by the Research Grants of Council of Hong Kong (Grants 704909, N_HKU75209, 704612, 703913, and HKU6/11G) and the University of Hong Kong (for an emerging Strategic Research Theme on Integrative Biology).	Banaszak K, 2012, BIOCHEM J, V441, P1017, DOI 10.1042/BJ20111659; Bellucci M, 2009, BIOCHEM J, V422, P91, DOI 10.1042/BJ20090434; Benoit SL, 2007, MICROBIOL-SGM, V153, P3748, DOI 10.1099/mic.0.2007/010520-0; Benoit SL, 2012, BBA-GEN SUBJECTS, V1820, P1519, DOI 10.1016/j.bbagen.2012.06.002; Boer JL, 2012, BIOCHEMISTRY-US, V51, P2298, DOI 10.1021/bi3000897; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Carter EL, 2009, METALLOMICS, V1, P207, DOI 10.1039/b903311d; Casalot L, 2001, TRENDS MICROBIOL, V9, P228, DOI 10.1016/S0966-842X(01)02009-1; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032592; Cheng TF, 2013, METALLOMICS, V5, P804, DOI 10.1039/c3mt00014a; Cheng TF, 2012, J BIOL INORG CHEM, V17, P331, DOI 10.1007/s00775-011-0855-y; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cun SJ, 2008, J BIOL CHEM, V283, P15142, DOI 10.1074/jbc.M800591200; Cun SJ, 2010, P NATL ACAD SCI USA, V107, P4943, DOI 10.1073/pnas.0913970107; Douglas CD, 2013, BIOCHEMISTRY-US, V52, P6030, DOI 10.1021/bi400812r; EVANS DJ, 1991, MICROB PATHOGENESIS, V10, P15, DOI 10.1016/0882-4010(91)90062-F; Fong YH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001678; Garner JA, 1996, INFECT IMMUN, V64, P4197, DOI 10.1128/IAI.64.10.4197-4203.1996; Ge RG, 2006, BIOCHEM J, V393, P285, DOI 10.1042/BJ20051160; Ge RG, 2006, J AM CHEM SOC, V128, P11330, DOI 10.1021/ja062589t; Kaluarachchi H, 2012, J MOL BIOL, V417, P28, DOI 10.1016/j.jmb.2012.01.037; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Maier RJ, 1996, FEMS MICROBIOL LETT, V141, P71; Martin-Diaconescu V, 2012, J BIOL INORG CHEM, V17, P353, DOI 10.1007/s00775-011-0857-9; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Mehta N, 2003, MICROB PATHOGENESIS, V35, P229, DOI 10.1016/S0882-4010(03)00151-7; Moncrief MBC, 1997, J BACTERIOL, V179, P4081, DOI 10.1128/jb.179.13.4081-4086.1997; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Park IS, 1996, BIOCHEMISTRY-US, V35, P5345, DOI 10.1021/bi952894j; PARK IS, 1995, J BACTERIOL, V177, P1947, DOI 10.1128/jb.177.8.1947-1951.1995; Real-Guerra R, 2012, PLANT MOL BIOL, V78, P461, DOI 10.1007/s11103-012-9878-1; Remaut H, 2001, J BIOL CHEM, V276, P49365, DOI 10.1074/jbc.M108304200; RYAN DK, 1982, ANAL CHEM, V54, P986, DOI 10.1021/ac00243a033; Shi R, 2010, BIOCHEMISTRY-US, V49, P7080, DOI 10.1021/bi100372h; Song HK, 2001, J BIOL CHEM, V276, P49359, DOI 10.1074/jbc.M108619200; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Stola M, 2006, BIOCHEMISTRY-US, V45, P6495, DOI 10.1021/bi0601003; Sydor AM, 2014, J BIOL CHEM, V289, P3828, DOI 10.1074/jbc.M113.502781; Sydor AM, 2013, METAL IONS LIFE SCI, V12, P375, DOI 10.1007/978-94-007-5561-1_11; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; WARREN JR, 1983, LANCET, V1, P1273; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; Xia W, 2012, J BIOL CHEM, V287, P6753, DOI 10.1074/jbc.M111.287581; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Yang XM, 2014, METALLOMICS, V6, P1731, DOI 10.1039/c4mt00134f; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205; Zambelli B, 2007, BIOCHEMISTRY-US, V46, P3171, DOI 10.1021/bi6024676; Zambelli B, 2014, J BIOL INORG CHEM, V19, P319, DOI 10.1007/s00775-013-1068-3; Zambelli B, 2011, ACCOUNTS CHEM RES, V44, P520, DOI 10.1021/ar200041k; Zeng YB, 2008, J BIOL INORG CHEM, V13, P1121, DOI 10.1007/s00775-008-0397-0; Zeng YB, 2011, CHEM-EUR J, V17, P5852, DOI 10.1002/chem.201100279	55	43	44	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12474	12485		10.1074/jbc.M114.632364	http://dx.doi.org/10.1074/jbc.M114.632364			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25752610	Green Published, hybrid			2022-12-26	WOS:000354569000004
J	Manhart, CM; McHenry, CS				Manhart, Carol M.; McHenry, Charles S.			Identification of Subunit Binding Positions on a Model Fork and Displacements That Occur during Sequential Assembly of the Escherichia coli Primosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; CRYSTAL-STRUCTURE; RESTART PRIMOSOME; LEADING-STRAND; PRIA HELICASE; PROTEIN PRIB; COMPLEXES; MECHANISM; RELEASE	When replication stalls and forks disassemble, the restart primosome is required to reload the replicative helicase so that chromosomal replication can be reinitiated. We have taken a photo-cross-linking approach, using model replication forks containing a phenyl diazirine placed at single locations, to determine the positions of primosomal protein binding and changes in interactions that occur during the assembly reaction. This approach revealed a novel mode for single-stranded DNA-binding protein (SSB)-DNA binding, in which SSB interacts with both the leading and lagging single-strand segments and the parental duplex of the fork. Cross-linking to a novel region within SSB is observed only when it is bound to forked structures. This binding mode is also followed by PriB. PriA binds to the fork, excluding SSB and PriB, interacting with the primer terminus, single-stranded leading and lagging strands and duplex in immediate proximity of the fork. SSB binds to flanking single-stranded segments distal to the fork in the presence of PriA. The addition of PriB or DnaT to a PriA-SSB-fork complex does not lead to cross-linking or displacement, suggesting that their association is through protein-protein interactions at early stages of the reaction. Upon addition of DnaC and the DnaB helicase in the presence of ATP gamma S, helicase is assembled, leading to contacts within the duplex region on the tracking (lagging) strand and strong contacts with the displaced leading single strand near the fork. PriA is displaced from DNA upon helicase assembly.	[Manhart, Carol M.; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave,UCB596, Boulder, CO 80303 USA.	charles.mchenry@colorado.edu	Manhart, Carol/AAQ-4938-2020		National Science Foundation [MCB-1329285]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1329285.	Aarattuthodiyil S, 2014, NUCLEIC ACIDS RES, V42, P11707, DOI 10.1093/nar/gku845; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dohrmann PR, 2011, J MOL BIOL, V414, P15, DOI 10.1016/j.jmb.2011.09.039; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P837, DOI 10.1111/gtc.12001; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; LEE MS, 1989, J BIOL CHEM, V264, P14531; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Lopper M, 2004, STRUCTURE, V12, P1967, DOI 10.1016/j.str.2004.09.004; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Manhart CM, 2013, J BIOL CHEM, V288, P3989, DOI 10.1074/jbc.M112.435966; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; MOK M, 1987, J BIOL CHEM, V262, P16644; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; OUZOUNIS CA, 1991, NUCLEIC ACIDS RES, V19, P6953, DOI 10.1093/nar/19.24.6953; Ponomarev VA, 2003, J MOL MICROB BIOTECH, V5, P225, DOI 10.1159/000071074; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WU CA, 1992, J BIOL CHEM, V267, P4030; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yuan Q, 2009, J BIOL CHEM, V284, P31672, DOI 10.1074/jbc.M109.050740	36	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10828	10839		10.1074/jbc.M115.642066	http://dx.doi.org/10.1074/jbc.M115.642066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25745110	Green Published, hybrid			2022-12-26	WOS:000353404500023
J	Kaiyala, KJ; Ogimoto, K; Nelson, JT; Schwartz, MW; Morton, GJ				Kaiyala, Karl J.; Ogimoto, Kayoko; Nelson, Jarrell T.; Schwartz, Michael W.; Morton, Gregory J.			Leptin Signaling Is Required for Adaptive Changes in Food Intake, but Not Energy Expenditure, in Response to Different Thermal Conditions	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; OB-OB MICE; BODY-WEIGHT; UNCOUPLING PROTEIN; COLD-ACCLIMATION; CIRCADIAN-RHYTHM; OBESE; THERMOGENESIS; IDENTIFICATION; TEMPERATURE	Survival of free-living animals depends on the ability to maintain core body temperature in the face of rapid and dramatic changes in their thermal environment. If food intake is not adjusted to meet the changing energy demands associated with changes of ambient temperature, a serious challenge to body energy stores can occur. To more fully understand the coupling of thermoregulation to energy homeostasis in normal animals and to investigate the role of the adipose hormone leptin to this process, comprehensive measures of energy homeostasis and core temperature were obtained in leptin-deficient ob/ob mice and their wild-type (WT) littermate controls when housed under cool (14 degrees C), usual (22 degrees C) or similar to thermoneutral (30 degrees C) conditions. Our findings extend previous evidence that WT mice robustly defend normothermia in response to either a lowering (14 degrees C) or an increase (30 degrees C) of ambient temperature without changes in body weight or body composition. In contrast, leptin-deficient, ob/ob mice fail to defend normothermia at ambient temperatures lower than thermoneutrality and exhibit marked losses of both body fat and lean mass when exposed to cooler environments (14 degrees C). Our findings further demonstrate a strong inverse relationship between ambient temperature and energy expenditure in WT mice, a relationship that is preserved in ob/ob mice. However, thermal conductance analysis indicates defective heat retention in ob/ob mice, irrespective of temperature. While a negative relationship between ambient temperature and energy intake also exists in WT mice, this relationship is disrupted in ob/ob mice. Thus, to meet the thermoregulatory demands of different ambient temperatures, leptin signaling is required for adaptive changes in both energy intake and thermal conductance. A better understanding of the mechanisms coupling thermoregulation to energy homeostasis may lead to the development of new approaches for the treatment of obesity.	[Kaiyala, Karl J.] Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Ogimoto, Kayoko; Nelson, Jarrell T.; Schwartz, Michael W.; Morton, Gregory J.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Morton, GJ (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98105 USA.	gjmorton@u.washington.edu			National Institutes of Health Grants [DK089056, DK083042, DK090320]; NIDDK-funded Nutrition Obesity Research Center (NORC) [DK035816]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101997, R01DK090320, R01DK089056, R01DK083042, P30DK035816, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK-funded Nutrition Obesity Research Center (NORC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK089056 (G.J.M), DK083042 and DK090320 (M.W.S) and by the NIDDK-funded Nutrition Obesity Research Center (NORC, DK035816).	ARMITAGE G, 1984, J PHYSIOL-LONDON, V350, P197, DOI 10.1113/jphysiol.1984.sp015196; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; CHLOUVERAKIS C, 1970, EXPERIENTIA, V26, P1262, DOI 10.1007/BF01898005; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAUNCEY MJ, 1986, EXPERIENTIA, V42, P547, DOI 10.1007/BF01946696; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; HIMMSHAGEN J, 1985, INT J OBESITY, V9, P17; HIMMSHAGEN J, 1985, AM J PHYSIOL, V248, pE531, DOI 10.1152/ajpendo.1985.248.5.E531; HOGAN S, 1980, AM J PHYSIOL, V239, pE301; JANSKY L, 1967, PHYSIOL BOHEMOSLOV, V16, P366; Kaiyala KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103301; Kaiyala KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041473; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lichtenbelt WV, 2014, TRENDS ENDOCRIN MET, V25, P165, DOI 10.1016/j.tem.2014.01.001; MCNAB BK, 1980, PHYSIOL ZOOL, V53, P145, DOI 10.1086/physzool.53.2.30152577; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; MORRISON SD, 1968, J PHYSIOL-LONDON, V197, P305, DOI 10.1113/jphysiol.1968.sp008561; Morton GJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE134, DOI 10.1152/ajpendo.00296.2011; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876; Ravussin Y, 2012, AM J PHYSIOL-REG I, V303, pR438, DOI 10.1152/ajpregu.00092.2012; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Refinetti R, 2010, FRONT BIOSCI-LANDMRK, V15, P564, DOI 10.2741/3634; Rezai-Zadeh K, 2013, PHYSIOL BEHAV, V121, P49, DOI 10.1016/j.physbeh.2013.02.014; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; ROMSOS DR, 1985, METABOLISM, V34, P931, DOI 10.1016/0026-0495(85)90141-6; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schleucher E, 2001, COMP BIOCHEM PHYS A, V129, P821, DOI 10.1016/S1095-6433(01)00356-7; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SMITH CK, 1984, METABOLISM, V33, P853, DOI 10.1016/0026-0495(84)90114-8; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thorogood A, 2011, AM J MED, V124, P747, DOI 10.1016/j.amjmed.2011.02.037; THURLBY PL, 1979, BRIT J NUTR, V42, P377, DOI 10.1079/BJN19790127; TRAYHURN P, 1976, P NUTR SOC, V35, pA133; TRAYHURN P, 1978, PFLUG ARCH EUR J PHY, V373, P189, DOI 10.1007/BF00584859; TRAYHURN P, 1977, NATURE, V266, P60, DOI 10.1038/266060a0; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; VINTER J, 1988, INT J OBESITY, V12, P111; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	56	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119391	10.1371/journal.pone.0119391	http://dx.doi.org/10.1371/journal.pone.0119391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756181	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275700043
J	Ratti, PL; Sierra-Pena, M; Manni, R; Simonetta-Moreau, M; Bastin, J; Mace, H; Rascol, O; David, O				Ratti, Pietro-Luca; Sierra-Pena, Maria; Manni, Raffaele; Simonetta-Moreau, Marion; Bastin, Julien; Mace, Harrison; Rascol, Olivier; David, Olivier			Distinctive Features of NREM Parasomnia Behaviors in Parkinson's Disease and Multiple System Atrophy	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; REM-SLEEP; LEWY BODIES; EYE-MOVEMENT; SPATIAL ATTENTION; OVERLAP DISORDER; ACUTE DELIRIUM; DEMENTIA; SLEEPWALKING; TERRORS	Objective To characterize parasomnia behaviors on arousal from NREM sleep in Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Methods From 30 patients with PD, Dementia with Lewy Bodies/Dementia associated with PD, or MSA undergoing nocturnal video-polysomnography for presumed dream enactment behavior, we were able to select 2 PD and 2 MSA patients featuring NREM Parasomnia Behviors (NPBs). We identified episodes during which the subjects seemed to enact dreams or presumed dream-like mentation (NPB arousals) versus episodes with physiological movements (no-NPB arousals). A time-frequency analysis (Morlet Wavelet Transform) of the scalp EEG signals around each NPB and no-NPB arousal onset was performed, and the amplitudes of the spectral frequencies were compared between NPB and no-NPB arousals. Results 19 NPBs were identified, 12 of which consisting of 'elementary' NPBs while 7 resembling confusional arousals. With quantitative EEG analysis, we found an amplitude reduction in the 5-6 Hz band 40 seconds before NPBs arousal as compared to no-NPB arousals at F4 and C4 derivations (p< 0.01). Conclusions Many PD and MSA patients feature various NREM sleep-related behaviors, with clinical and electrophysiological differences and similarities with arousal parasomnias in the general population.	[Ratti, Pietro-Luca; Rascol, Olivier] Toulouse Univ Hosp, Dept Clin Pharmacol, Toulouse, France; [Ratti, Pietro-Luca; Sierra-Pena, Maria; Simonetta-Moreau, Marion] Paul Sabatier Univ, Toulouse, France; [Ratti, Pietro-Luca; Simonetta-Moreau, Marion; Rascol, Olivier] INSERM, UMR Brain Imaging & Neurol Dysfunct 825, Toulouse, France; [Ratti, Pietro-Luca] Civic Hosp EOC Lugano, Sleep & Epilepsy Ctr, Neuroctr Southern Switzerland, Lugano, Switzerland; [Sierra-Pena, Maria; Simonetta-Moreau, Marion] Toulouse Univ Hosp, Dept Neurol, Toulouse, France; [Manni, Raffaele] C Mondino Natl Neurol Inst, Sleep Med & Epilepsy Unit, Pavia, Italy; [Bastin, Julien; Mace, Harrison; Rascol, Olivier] Grenoble Inst Neurosci, Brain Funct & Neuromodulat, Grenoble, France; [Bastin, Julien; David, Olivier] Joseph Fourier Univ, Grenoble, France; [Rascol, Olivier] Toulouse Univ Hosp, Reference Ctr Multiple Syst Atrophy, Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; IRCCS Fondazione Casimiro Mondino; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU de Toulouse	Ratti, PL (corresponding author), Toulouse Univ Hosp, Dept Clin Pharmacol, Toulouse, France.	pietroluca.ratti@eoc.ch	David, Olivier/S-9463-2019; bastin, julien JDP/H-8785-2017; David, Olivier/A-6068-2009; manni, raffaele/AAB-8804-2019	David, Olivier/0000-0003-0776-0216; bastin, julien JDP/0000-0002-0533-7564; David, Olivier/0000-0003-0776-0216; Ratti, Pietro Luca/0000-0002-9941-6721				[Anonymous], 2014, AASM INT CLASS SLEEP, DOI [10.5665/sleep.3420, DOI 10.5665/SLEEP.3420]; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Bliwise DL, 2000, SLEEP, V23, P671; BOKEY K, 1993, AUST NZ J PSYCHIAT, V27, P694, DOI 10.3109/00048679309075833; Cicolin A, 2011, SLEEP MED, V12, P523, DOI 10.1016/j.sleep.2011.02.002; Di Fabio N, 2013, EUR NEUROL, V70, P297, DOI 10.1159/000353378; Dumitrascu O, 2013, SLEEP MED, V14, P1217, DOI 10.1016/j.sleep.2013.06.012; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Espa F, 2002, SLEEP, V25, P871; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Ferrara M, 2006, BEHAV BRAIN RES, V167, P237, DOI 10.1016/j.bbr.2005.09.012; Flink BJ, 2012, ANESTHESIOLOGY, V116, P788, DOI 10.1097/ALN.0b013e31824b94fc; Frauscher B, 2008, SLEEP, V31, P724, DOI 10.1093/sleep/31.5.724; Frauscher B, 2013, SLEEP MED, V14, P729, DOI 10.1016/j.sleep.2012.09.028; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Iber C., 2007, AASM MANUAL SCORING; Iranzo A, 2005, SLEEP, V28, P203, DOI 10.1093/sleep/28.2.203; Iranzo A, 2011, SLEEP MED, V12, P284, DOI 10.1016/j.sleep.2010.04.021; ISHIGOOKA J, 1985, BIOL PSYCHIAT, V20, P1003, DOI 10.1016/0006-3223(85)90198-2; Jaar O, 2010, SLEEP, V33, P1511, DOI 10.1093/sleep/33.11.1511; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; KUSHIDA CA, 1995, SLEEP, V18, P757; Lee JWY, 1998, GEN HOSP PSYCHIAT, V20, P120, DOI 10.1016/S0163-8343(98)00006-1; Limousin N, 2009, SLEEP MED, V10, P1059, DOI 10.1016/j.sleep.2008.12.006; Lombardi C, 2004, J NEUROL NEUROSUR PS, V75, P341; Manni R, 2013, SLEEP MED, V14, P387, DOI 10.1016/j.sleep.2013.02.007; Manni R, 2010, MOVEMENT DISORD, V25, P985, DOI 10.1002/mds.22990; Manni Raffaele, 2005, Curr Psychiatry Rep, V7, P196, DOI 10.1007/s11920-005-0053-0; Marzano C, 2011, NEUROSCIENCE, V176, P308, DOI 10.1016/j.neuroscience.2010.12.014; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Munoz X, 1998, AM J RESP CRIT CARE, V158, P1306, DOI 10.1164/ajrccm.158.4.9801005; Nielsen TA, 2000, BEHAV BRAIN SCI, V23, P851, DOI 10.1017/S0140525X0000399X; Oberholzer M, 2011, J NEUROL, V258, P1261, DOI 10.1007/s00415-011-5922-3; Pao WC, 2013, NEUROLOGIST, V19, P1, DOI 10.1097/NRL.0b013e31827c6bdd; Poryazova R, 2007, ARCH NEUROL-CHICAGO, V64, P1524, DOI 10.1001/archneur.64.10.1524; Ratti PL, 2012, SLEEP MED, V13, P926, DOI 10.1016/j.sleep.2012.04.015; Schenck CH, 1997, SLEEP, V20, P972, DOI 10.1093/sleep/20.11.972; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Tassinari CA, 2009, REV NEUROL-FRANCE, V165, P762, DOI 10.1016/j.neurol.2009.08.002; Terzaghi M, 2013, MOVEMENT DISORD, V28, P1416, DOI 10.1002/mds.25523; Terzaghi M, 2010, MOVEMENT DISORD, V25, P647, DOI 10.1002/mds.22726; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Uguccioni G, 2013, SLEEP MED, V14, P391, DOI 10.1016/j.sleep.2013.01.014; Vetrugno R, 2009, SLEEP MED, V10, P247, DOI 10.1016/j.sleep.2008.01.009; Wenning GK, 2004, MOVEMENT DISORD, V19, P1391, DOI 10.1002/mds.20255; Whitney JF, 1996, AM J EMERG MED, V14, P270, DOI 10.1016/S0735-6757(96)90174-6; Zadra A, 2004, J SLEEP RES, V13, P279, DOI 10.1111/j.1365-2869.2004.00404.x	50	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120973	10.1371/journal.pone.0120973	http://dx.doi.org/10.1371/journal.pone.0120973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756280	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700075
J	Anchan, R; Gerami-Naini, B; Lindsey, JS; Ho, JWK; Kiezun, A; Lipskind, S; Ng, N; LiCausi, JA; Kim, CS; Brezina, P; Tuschl, T; Maas, R; Kearns, WG; Williams, Z				Anchan, Raymond; Gerami-Naini, Behzad; Lindsey, Jennifer S.; Ho, Joshua W. K.; Kiezun, Adam; Lipskind, Shane; Ng, Nicholas; LiCausi, Joseph A.; Kim, Chloe S.; Brezina, Paul; Tuschl, Thomas; Maas, Richard; Kearns, William G.; Williams, Zev			Efficient Differentiation of Steroidogenic and Germ-Like Cells from Epigenetically-Related iPSCs Derived from Ovarian Granulosa Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; COPY NUMBER; TRANSDIFFERENTIATION; GENERATION; MEMORY; CHEMOTHERAPY; FIBROBLASTS; NUCLEAR; CUMULUS	To explore restoration of ovarian function using epigenetically-related, induced pluripotent stem cells (iPSCs), we functionally evaluated the epigenetic memory of novel iPSC lines, derived from mouse and human ovarian granulosa cells (GCs) using c-Myc, Klf4, Sox2 and Oct4 retroviral vectors. The stem cell identity of the mouse and human GC-derived iPSCs (mGriPSCs, hGriPSCs) was verified by demonstrating embryonic stem cell (ESC) antigen expression using immunocytochemistry and RT-PCR analysis, as well as formation of embryoid bodies (EBs) and teratomas that are capable of differentiating into cells from all three germ layers. GriPSCs' gene expression profiles associate more closely with those of ESCs than of the originating GCs as demonstrated by genome-wide analysis of mRNA and microRNA. A comparative analysis of EBs generated from three different mouse cell lines (mGriPSCs; fibroblast-derived iPSC, mFiPSCs; G4 embryonic stem cells, G4 mESCs) revealed that differentiated mGriPSC-EBs synthesize 10-fold more estradiol (E2) than either differentiated FiPSC- or mESC-EBs under identical culture conditions. By contrast, mESC-EBs primarily synthesize progesterone (P4) and FiPSC-EBs produce neither E2 nor P4. Differentiated mGriPSC-EBs also express ovarian markers (AMHR, FSHR, Cyp19a1, ER and Inha) as well as markers of early gametogenesis (Mvh, Dazl, Gdf9, Boule and Zp1) more frequently than EBs of the other cell lines. These results provide evidence of preferential homotypic differentiation of mGriPSCs into ovarian cell types. Collectively, our data support the hypothesis that generating iPSCs from the desired tissue type may prove advantageous due to the iPSCs' epigenetic memory.	[Anchan, Raymond; Lindsey, Jennifer S.; Lipskind, Shane; Ng, Nicholas; LiCausi, Joseph A.] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Reprod Endocrinol & Infertil,Med Sch, Boston, MA 02115 USA; [Gerami-Naini, Behzad; Kim, Chloe S.; Maas, Richard] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Genet,Med Sch, Boston, MA 02115 USA; [Ho, Joshua W. K.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Ho, Joshua W. K.] Univ New S Wales, Sydney, NSW, Australia; [Kiezun, Adam] Broad Inst MIT & Harvard, Computat Methods Dev, Canc Genome Anal, Cambridge, MA USA; [Brezina, Paul; Kearns, William G.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Brezina, Paul; Kearns, William G.] LabCorp, Ctr Preimplantat Genet, Rockville, MD USA; [Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; [Williams, Zev] Albert Einstein Coll Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Anchan, R (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Reprod Endocrinol & Infertil,Med Sch, Boston, MA 02115 USA.	ranchan@partners.org	Kearns, William/AAE-7699-2020; Ho, Joshua W. K./AAK-7759-2020	Ho, Joshua W. K./0000-0003-2331-7011	Presidential New Investigator Award/Klarman Family Foundation; Brigham and Women's Hospital (BWH); Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology BWH; NIH [K12HD001255]	Presidential New Investigator Award/Klarman Family Foundation; Brigham and Women's Hospital (BWH); Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology BWH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided to RA by the Presidential New Investigator Award/Klarman Family Foundation, Brigham and Women's Hospital (BWH), support from the Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology BWH, and NIH K12HD001255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Anchan RM, 2010, CRIT REV ONCOL HEMAT, V74, P175, DOI 10.1016/j.critrevonc.2009.09.006; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; BOLAND NI, 1993, BIOL REPROD, V48, P798, DOI 10.1095/biolreprod48.4.798; Brown Miguel, 2013, Frontiers in Genetics, V4, P145, DOI 10.3389/fgene.2013.00145; Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cooke JP, 2013, CIRC RES, V112, P748, DOI 10.1161/CIRCRESAHA.113.301053; De la Fuente R, 2001, DEV BIOL, V229, P224, DOI 10.1006/dbio.2000.9947; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dzafic E, 2013, J ASSIST REPROD GEN, V30, P1255, DOI 10.1007/s10815-013-0068-0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Halley-Stott RP, 2013, BRIEF FUNCT GENOMICS, V12, P164, DOI 10.1093/bfgp/elt011; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Krishnakumar R, 2013, CURR OPIN GENET DEV, V23, P548, DOI 10.1016/j.gde.2013.06.005; Lan CW, 2013, J CLIN ENDOCR METAB, V98, P3713, DOI 10.1210/jc.2012-4302; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lipskind S, 2013, SOC GYN INV 2013 M O; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maatouk DM, 2013, DEV BIOL, V383, P295, DOI 10.1016/j.ydbio.2013.08.026; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Minton Susan E, 2002, Cancer Control, V9, P466; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Oki Y, 2012, BIOCHEM J, V447, P239, DOI 10.1042/BJ20120172; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Society for Assisted Reproductive Technology CORS, 2013, CLIN REP SUMM 2011 A; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Stoilova B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065169; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; VANDERHYDEN BC, 1995, BIOL REPROD, V53, P1243, DOI 10.1095/biolreprod53.6.1243; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Woods DC, 2013, REPROD SCI, V20, P524, DOI 10.1177/1933719113483017; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2013, ACTA BIOCH BIOPH SIN, V45, P289, DOI 10.1093/abbs/gmt008	60	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119275	10.1371/journal.pone.0119275	http://dx.doi.org/10.1371/journal.pone.0119275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751620	Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700019
J	Williams, RR; Venkatesh, I; Pearse, DD; Udvadia, AJ; Bunge, MB				Williams, Ryan R.; Venkatesh, Ishwariya; Pearse, Damien D.; Udvadia, Ava J.; Bunge, Mary Bartlett			MASH1/Ascl1a Leads to GAP43 Expression and Axon Regeneration in the Adult CNS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LOOP-HELIX PROTEINS; SPINAL-CORD; GENE-EXPRESSION; NEURONAL DIFFERENTIATION; DOPAMINERGIC-NEURONS; DIRECT CONVERSION; HUMAN FIBROBLASTS; HAIR-CELLS; GROWTH	Unlike CNS neurons in adult mammals, neurons in fish and embryonic mammals can regenerate their axons after injury. These divergent regenerative responses are in part mediated by the growth-associated expression of select transcription factors. The basic helixloop-helix (bHLH) transcription factor, MASH1/Ascl1a, is transiently expressed during the development of many neuronal subtypes and regulates the expression of genes that mediate cell fate determination and differentiation. In the adult zebrafish (Danio rerio), Ascl1a is also transiently expressed in retinal ganglion cells (RGCs) that regenerate axons after optic nerve crush. Utilizing transgenic zebrafish with a 3.6 kb GAP43 promoter that drives expression of an enhanced green fluorescent protein (EGFP), we observed that knock-down of Ascl1a expression reduces both regenerative gap43 gene expression and axonal growth after injury compared to controls. In mammals, the development of noradrenergic brainstem neurons requires MASH1 expression. In contrast to zebrafish RGCs, however, MASH1 is not expressed in the mammalian brainstem after spinal cord injury (SCI). Therefore, we utilized adeno-associated viral (AAV) vectors to overexpress MASH1 in four month old rat (Rattus norvegicus) brainstem neurons in an attempt to promote axon regeneration after SCI. We discovered that after complete transection of the thoracic spinal cord and implantation of a Schwann cell bridge, animals that express MASH1 exhibit increased noradrenergic axon regeneration and improvement in hindlimb joint movements compared to controls. Together these data demonstrate that MASH1/Ascl1a is a fundamental regulator of axonal growth across vertebrates and can induce modifications to the intrinsic state of neurons to promote functional regeneration in response to CNS injury.	[Williams, Ryan R.; Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Venkatesh, Ishwariya; Udvadia, Ava J.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	University of Miami; University of Wisconsin System; University of Wisconsin Milwaukee; University of Miami; University of Miami	Bunge, MB (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	MBunge@miami.edu	Pearse, Damien D/D-3176-2011; Udvadia, Ava J/W-8127-2018	Pearse, Damien D/0000-0003-1783-221X; Udvadia, Ava J/0000-0002-8678-252X	National Institute of Neurological Disorders and Stroke [09923, 056281]; Miami Project to Cure Paralysis; Buoniconti Fund to Cure Paralysis; Christine E. Lynn Distinguished Professorship in Neuroscience; Shaw Scientist Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923, R01NS056281] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; Buoniconti Fund to Cure Paralysis; Christine E. Lynn Distinguished Professorship in Neuroscience; Shaw Scientist Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institute of Neurological Disorders and Stroke grants 09923 (MBB) and 056281 (DDP and MBB). The Miami Project to Cure Paralysis, the Buoniconti Fund to Cure Paralysis, Christine E. Lynn Distinguished Professorship in Neuroscience (MBB), and the Shaw Scientist Award (AJU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cau E, 2003, DEVELOPMENT, V130, P2455, DOI 10.1242/dev.00452; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Chiaramello A, 1996, J BIOL CHEM, V271, P22035, DOI 10.1074/jbc.271.36.22035; Farah MH, 2000, DEVELOPMENT, V127, P693; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; Fujimori KE, 2008, BRAIN RES, V1245, P1, DOI 10.1016/j.brainres.2008.09.071; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; Ghil SH, 2002, EXP MOL MED, V34, P367, DOI 10.1038/emm.2002.52; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hamada M, 2006, NEUROBIOL DIS, V22, P509, DOI 10.1016/j.nbd.2005.12.020; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; HOULE JD, 1988, J COMP NEUROL, V269, P535, DOI 10.1002/cne.902690406; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kabos P, 2002, NEUROREPORT, V13, P2385, DOI 10.1097/00001756-200212200-00002; KALIL K, 1979, SCIENCE, V205, P1158, DOI 10.1126/science.472734; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kusik BW, 2010, DEV DYNAM, V239, P482, DOI 10.1002/dvdy.22190; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo LC, 1998, DEVELOPMENT, V125, P609; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Nicholls J, 1996, TRENDS NEUROSCI, V19, P229, DOI 10.1016/0166-2236(96)10021-7; Obayashi S, 2009, CELL MOL NEUROBIOL, V29, P423, DOI 10.1007/s10571-008-9338-2; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Rossignol S, 1998, ANN NY ACAD SCI, V860, P346, DOI 10.1111/j.1749-6632.1998.tb09061.x; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Stanke M, 2004, MOL CELL NEUROSCI, V25, P374, DOI 10.1016/j.mcn.2003.10.021; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; Udvadia AJ, 2001, DEVELOPMENT, V128, P1175; Udvadia AJ, 2008, GENE EXPR PATTERNS, V8, P382, DOI 10.1016/j.gep.2008.05.002; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wiliams RR, 2012, PROG BRAIN RES, V201, P295, DOI 10.1016/B978-0-444-59544-7.00014-7; Williams RR, 2015, CELL TRANSPLANT, V24, P115, DOI 10.3727/096368913X674657; Williams RR, 2012, J GENE MED, V14, P20, DOI 10.1002/jgm.1628; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Yu PP, 2011, EXP NEUROL, V231, P38, DOI 10.1016/j.expneurol.2011.05.013; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zou SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057280	76	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118918	10.1371/journal.pone.0118918	http://dx.doi.org/10.1371/journal.pone.0118918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751153	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700013
J	Andreeva, N; Trilisenko, L; Eldarov, M; Kulakovskaya, T				Andreeva, Nadezhda; Trilisenko, Ludmila; Eldarov, Mikhail; Kulakovskaya, Tatiana			Polyphosphatase PPN1 of Saccharomyces cerevisiae: Switching of Exopolyphosphatase and Endopolyphosphatase Activities	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; PURIFICATION; PHOSPHATE; GROWTH; KINASE; OVEREXPRESSION; MINERALIZATION; COMPARTMENTS; CYTOSOL; PPX1	The polyphosphatase PPN1 of Saccharomyces cerevisiae shows an exopolyphosphatase activity splitting phosphate from chain end and an endopolyphosphatase activity fragmenting high molecular inorganic polyphosphates into shorter polymers. We revealed the compounds switching these activities of PPN1. Phosphate release and fragmentation of high molecular polyphosphate prevailed in the presence of Co2+ and Mg2+, respectively. Phosphate release and polyphosphate chain shortening in the presence of Co2+ were inhibited by ADP but not affected by ATP and arginine. The polyphosphate chain shortening in the presence of Mg2+ was activated by ADP and arginine but inhibited by ATP.	[Andreeva, Nadezhda; Trilisenko, Ludmila; Kulakovskaya, Tatiana] Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pushchino 142290, Russia; [Eldarov, Mikhail] Russian Acad Sci, Ctr Bioengn, Moscow 117312, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences	Kulakovskaya, T (corresponding author), Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pr Nauki 5, Pushchino 142290, Russia.	alla@ibpm.pushchino.ru	Kulakovskaya, Tatiana/R-2803-2018	Kulakovskaya, Tatiana/0000-0001-8556-809X	Russian Basic Research Foundation [14-04-00515]	Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Basic Research Foundation (Grant 14-04-00515).	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Albi T, 2014, MICROBIOL-SGM, V160, P2067, DOI 10.1099/mic.0.080952-0; Andreeva NA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P975, DOI 10.1134/S0006297906090045; Andreeva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P387, DOI 10.1023/B:BIRY.0000026193.44046.29; ANDREEVA NA, 1993, YEAST, V9, P127, DOI 10.1002/yea.320090204; Andreeva NA, 1998, FEBS LETT, V429, P194, DOI 10.1016/S0014-5793(98)00591-2; Andreeva N, 2015, J BIOSCI BIOENG, V119, P52, DOI 10.1016/j.jbiosc.2014.06.006; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Castrol CD, 1999, BIOTECHNOL PROGR, V15, P65, DOI 10.1021/bp9800743; Drozd M, 2014, VIRULENCE, V5, P680, DOI 10.4161/viru.34348; Eldarov MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P946, DOI 10.1134/S0006297913080129; GREENFIELD NJ, 1987, BIOCHIM BIOPHYS ACTA, V926, P205, DOI 10.1016/0304-4165(87)90205-4; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; HSIEH PC, 1993, PROTEIN EXPRES PURIF, V4, P76, DOI 10.1006/prep.1993.1012; Kulakovskaya T. V., 1997, BIOCHEMISTRY-MOSCOW, V62, P1180; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lichko LP, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1404, DOI 10.1134/S0006297910110131; Lichko L, 2006, BIOSCIENCE REP, V26, P45, DOI 10.1007/s10540-006-9003-2; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; MATILE P, 1978, ANNU REV PLANT PHYS, V29, P193, DOI 10.1146/annurev.pp.29.060178.001205; Morimoto D, 2010, J BONE MINER METAB, V28, P418, DOI 10.1007/s00774-010-0157-4; Motomura K, 2014, APPL ENVIRON MICROB, V80, P2602, DOI 10.1128/AEM.03971-13; NORRIS PR, 1977, J GEN MICROBIOL, V99, P317, DOI 10.1099/00221287-99-2-317; OKOROKOV LA, 1980, J BACTERIOL, V144, P661, DOI 10.1128/JB.144.2.661-665.1980; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Shi XB, 2005, FEBS LETT, V579, P2014, DOI 10.1016/j.febslet.2005.02.032; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Shulman RG, 2005, METABOLOMICS BY IN VIVO NMR, P149, DOI 10.1002/0470011505.ch11; Smith SA, 2014, CURR OPIN HEMATOL, V21, P388, DOI 10.1097/MOH.0000000000000069; Stotz SC, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-42; Trilisenko LV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P478, DOI 10.1134/S0006297914050125; Vagabov VM, 1998, MICROBIOLOGY+, V67, P153; VAGABOV VM, 1990, DOKL AKAD NAUK SSSR+, V311, P991; Wang XH, 2014, BIOCHEM PHARMACOL, V89, P413, DOI 10.1016/j.bcp.2014.03.020; WILLIAMS SP, 1993, BIOCHEMISTRY-US, V32, P4895, DOI 10.1021/bi00069a026; Ytting CK, 2012, INTEGR BIOL-UK, V4, P99, DOI 10.1039/c1ib00108f	41	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119594	10.1371/journal.pone.0119594	http://dx.doi.org/10.1371/journal.pone.0119594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742176	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100124
J	Greenberg, DC; Lophatananon, A; Wright, KA; Muir, KR; Gnanapragasam, VJ				Greenberg, David C.; Lophatananon, Artitaya; Wright, Karen A.; Muir, Kenneth R.; Gnanapragasam, Vincent J.			Trends and Outcome from Radical Therapy for Primary Non-Metastatic Prostate Cancer in a UK Population	PLOS ONE			English	Article							RADIOTHERAPY; RISK; ENGLAND; MEN	Background Increasing proportions of men diagnosed with prostate cancer in the UK are presenting with non-metastatic disease. We investigated how treatment trends in this demographic have changed. Patient and Methods Non-metastatic cancers diagnosed from 2000-2010 in the UK Anglian Cancer network stratified by age and risk group were analysed [n = 10,365]. Radiotherapy [RT] and prostatectomy [RP] cancer specific survival [CSS] were further compared [n = 4755]. Results Over the decade we observed a fall in uptake of primary androgen deprivation therapy but a rise in conservative management [CM] and radical therapy [p<0.0001]. CM in particular has become the primary management for low-risk disease by the decade end [p<0.0001]. In high-risk disease however both RP and RT uptake increased significantly but in an age dependent manner [p<0.0001]. Principally, increased RP in younger men and increased RT in men >= 70y. In multivariate analysis of radically treated men both high-risk disease [HR 8.0 [2.9-22.2], p<0.0001] and use of RT [HR 1.9 [1.0-3.3], p = 0.024] were significant predictors of a poorer CSM. In age-stratified analysis however, the trend to benefit of RP over RT was seen only in younger men [<= 60 years] with high-risk disease [p = 0.07]. The numbers needed to treat by RP instead of RT to save one cancer death was 19 for this group but 67 for the overall cohort. Conclusion This study has identified significant shifts in non-metastatic prostate cancer management over the last decade. Low-risk disease is now primarily managed by CM while high-risk disease is increasingly treated radically. Treatment of high-risk younger men by RP is supported by evidence of better CSM but this benefit is not evident in older men.	[Greenberg, David C.; Wright, Karen A.] Natl Canc Registrat Serv, Eastern Off, Publ Hlth England, Cambridge, England; [Lophatananon, Artitaya; Muir, Kenneth R.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick, England; [Lophatananon, Artitaya; Muir, Kenneth R.] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Gnanapragasam, Vincent J.] Univ Cambridge, Dept Surg & Oncol, Acad Urol Grp, Cambridge, England; [Gnanapragasam, Vincent J.] Univ Cambridge, Hutchison MRC Res Ctr, Translat Prostate Canc Grp, Cambridge, England	Public Health England; University of Warwick; University of Manchester; University of Cambridge; University of Cambridge	Gnanapragasam, VJ (corresponding author), Univ Cambridge, Dept Surg & Oncol, Acad Urol Grp, Cambridge, England.	vjg29@cam.ac.uk						Arcangeli G, 2009, INT J RADIAT ONCOL, V75, P975, DOI 10.1016/j.ijrobp.2008.12.045; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Briganti A, 2013, EUR UROL, V63, P693, DOI 10.1016/j.eururo.2012.08.054; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; Dinan MA, 2012, INT J RADIAT ONCOL, V82, pE781, DOI 10.1016/j.ijrobp.2011.11.024; Evans SM, 2013, MED J AUSTRALIA, V198, P540, DOI 10.5694/mja12.11241; Fairley L, 2009, BRIT J CANCER, V101, P1839, DOI 10.1038/sj.bjc.6605424; Gnanapragasam VJ, 2012, BJU INT, V109, P648, DOI 10.1111/j.1464-410X.2011.10596.x; Hoskin PJ, 2012, RADIOTHER ONCOL, V103, P217, DOI 10.1016/j.radonc.2012.01.007; Jacobs BL, 2013, JAMA-J AM MED ASSOC, V309, P2587, DOI 10.1001/jama.2013.6882; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Moore AL, 2009, BJU INT, V104, P1592, DOI 10.1111/j.1464-410X.2009.08652.x; Oliver SE, 2003, BJU INT, V91, P331, DOI 10.1046/j.1464-410X.2003.04083.x; Petrelli F, 2014, CLIN GENITOURIN CANC, V12, P215, DOI 10.1016/j.clgc.2014.01.010; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1502; van Tol-Geerdink JJ, 2013, BRIT J CANCER, V108, P1784, DOI 10.1038/bjc.2013.181; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	21	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119494	10.1371/journal.pone.0119494	http://dx.doi.org/10.1371/journal.pone.0119494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742020	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100116
J	Mamad, O; Delaville, C; Benjelloun, W; Benazzouz, A				Mamad, Omar; Delaville, Claire; Benjelloun, Wail; Benazzouz, Abdelhamid			Dopaminergic Control of the Globus Pallidus through Activation of D2 Receptors and Its Impact on the Electrical Activity of Subthalamic Nucleus and Substantia Nigra Reticulata Neurons	PLOS ONE			English	Article							SINGLE-UNIT-ACTIVITY; BASAL GANGLIA; FUNCTIONAL-ANATOMY; PARS RETICULATA; INHIBITION; PATTERN; GABA; INNERVATION; DEPLETION; PATHWAYS	The globus pallidus (GP) receives dopaminergic afferents from the pars compacta of substantia nigra and several studies suggested that dopamine exerts its action in the GP through presynaptic D2 receptors (D2Rs). However, the impact of dopamine in GP on the pallido-subthalamic and pallido-nigral neurotransmission is not known. Here, we investigated the role of dopamine, through activation of D2Rs, in the modulation of GP neuronal activity and its impact on the electrical activity of subthalamic nucleus (STN) and substantia nigra reticulata (SNr) neurons. Extracellular recordings combined with local intracerebral microinjection of drugs were done in male Sprague-Dawley rats under urethane anesthesia. We showed that dopamine, when injected locally, increased the firing rate of the majority of neurons in the GP. This increase of the firing rate was mimicked by quinpirole, a D2R agonist, and prevented by sulpiride, a D2R antagonist. In parallel, the injection of dopamine, as well as quinpirole, in the GP reduced the firing rate of majority of STN and SNr neurons. However, neither dopamine nor quinpirole changed the tonic discharge pattern of GP, STN and SNr neurons. Our results are the first to demonstrate that dopamine through activation of D2Rs located in the GP plays an important role in the modulation of GP-STN and GP-SNr neurotransmission and consequently controls STN and SNr neuronal firing. Moreover, we provide evidence that dopamine modulate the firing rate but not the pattern of GP neurons, which in turn control the firing rate, but not the pattern of STN and SNr neurons.	[Mamad, Omar; Delaville, Claire; Benazzouz, Abdelhamid] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Mamad, Omar; Delaville, Claire; Benazzouz, Abdelhamid] CNRS, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Mamad, Omar; Benjelloun, Wail] Univ Mohamed V Agdal, Fac Sci, Equipe Rythmes Biol Neurosci & Environm, Rabat 10000, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Mohammed V University in Rabat	Benazzouz, A (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France.	Abdelhamid.Benazzouz@u-bordeaux.fr	Benazzouz, Abdelhamid/E-5050-2016	Mamad, Omar/0000-0002-4517-3381	Universite de Bordeaux; exchange grants of the "Groupement de Recherche International" [GDRI N198]; exchange grants of the "Groupement de Recherche International" (CNRS INSERM France); exchange grants of the "Groupement de Recherche International" (CNRST Morocco); Egide-Volubilis [20565ZM]; CNRS-CNRST Convention Adivmar [22614]; NEUROMED	Universite de Bordeaux; exchange grants of the "Groupement de Recherche International"; exchange grants of the "Groupement de Recherche International" (CNRS INSERM France); exchange grants of the "Groupement de Recherche International" (CNRST Morocco); Egide-Volubilis; CNRS-CNRST Convention Adivmar; NEUROMED	This study was supported by the "Universite de Bordeaux" and exchange grants of the "Groupement de Recherche International" (GDRI N198, CNRS & INSERM France, and CNRST Morocco), Egide-Volubilis No 20565ZM, CNRS-CNRST Convention Adivmar 22614 and NEUROMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi PM, 2013, NEUROSCIENCE, V236, P289, DOI 10.1016/j.neuroscience.2013.01.043; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Baufreton J, 2005, J NEUROSCI, V25, P8505, DOI 10.1523/JNEUROSCI.1163-05.2005; Belujon P, 2007, J NEUROSCI, V27, P9595, DOI 10.1523/JNEUROSCI.2583-07.2007; Benazzouz A, 2002, MOVEMENT DISORD, V17, pS145, DOI 10.1002/mds.10156; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGSTROM DA, 1984, BRAIN RES, V310, P23, DOI 10.1016/0006-8993(84)90006-4; Bevan MD, 2006, CURR OPIN NEUROBIOL, V16, P621, DOI 10.1016/j.conb.2006.10.003; Bevan MD, 2002, J NEUROPHYSIOL, V87, P1348, DOI 10.1152/jn.00582.2001; Billings LM, 2003, BRAIN RES, V964, P237, DOI 10.1016/S0006-8993(02)04060-X; Bouali-Benazzouz R, 2009, NEUROSCIENCE, V164, P588, DOI 10.1016/j.neuroscience.2009.07.034; Chetrit J, 2013, J NEUROSCI, V33, P14840, DOI 10.1523/JNEUROSCI.0453-13.2013; Chetrit J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006208; Cooper AJ, 2001, NEUROPHARMACOLOGY, V41, P62, DOI 10.1016/S0028-3908(01)00038-7; Delaville C, 2012, NEUROBIOL DIS, V47, P322, DOI 10.1016/j.nbd.2012.05.019; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Floran B, 1997, NEUROSCI LETT, V237, P1, DOI 10.1016/S0304-3940(97)00784-2; Hadipour-Niktarash A, 2012, J NEUROPHYSIOL, V107, P1500, DOI 10.1152/jn.00348.2011; Hallworth NE, 2005, J NEUROSCI, V25, P6304, DOI 10.1523/JNEUROSCI.0450-05.2005; Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8; Hauber W, 1999, BEHAV BRAIN RES, V106, P143, DOI 10.1016/S0166-4328(99)00102-3; Hernandez A, 2006, J NEUROPHYSIOL, V96, P2877, DOI 10.1152/jn.00664.2006; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; KINCAID AE, 1991, BRAIN RES, V553, P18, DOI 10.1016/0006-8993(91)90224-J; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; LINDVALL O, 1979, BRAIN RES, V172, P169, DOI 10.1016/0006-8993(79)90907-7; Loucif KC, 2005, J PHYSIOL-LONDON, V567, P977, DOI 10.1113/jphysiol.2005.093807; Murer MG, 1997, SYNAPSE, V27, P278, DOI 10.1002/(SICI)1098-2396(199712)27:4<278::AID-SYN2>3.3.CO;2-S; Ni ZG, 2001, BRAIN RES, V899, P142, DOI 10.1016/S0006-8993(01)02219-3; Ni ZG, 2000, EUR J NEUROSCI, V12, P4338, DOI 10.1111/j.1460-9568.2000.01346.x; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Querejeta E, 2001, NEUROSCI LETT, V300, P79, DOI 10.1016/S0304-3940(01)01550-6; RICHFIELD EK, 1987, J COMP NEUROL, V262, P446, DOI 10.1002/cne.902620308; Rommelfanger KS, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00139; Smith Y, 1998, NEUROSCIENCE, V86, P353; Smith Y, 2008, MOVEMENT DISORD, V23, pS534, DOI 10.1002/mds.22027	39	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119152	10.1371/journal.pone.0119152	http://dx.doi.org/10.1371/journal.pone.0119152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742005	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100088
J	Colvin, ME; Peterson, JT; Kent, ML; Schreck, CB				Colvin, Michael E.; Peterson, James T.; Kent, Michael L.; Schreck, Carl B.			Occupancy Modeling for Improved Accuracy and Understanding of Pathogen Prevalence and Dynamics	PLOS ONE			English	Article							MYXOBOLUS-CEREBRALIS; WHIRLING DISEASE; COHO SALMON; IMPERFECT; SENSITIVITY; WILD; TRANSLOCATION; SPECIFICITY; INFECTION; FRAMEWORK	Most pathogen detection tests are imperfect, with a sensitivity < 100%, thereby resulting in the potential for a false negative, where a pathogen is present but not detected. False negatives in a sample inflate the number of non-detections, negatively biasing estimates of pathogen prevalence. Histological examination of tissues as a diagnostic test can be advantageous as multiple pathogens can be examined and providing important information on associated pathological changes to the host. However, it is usually less sensitive than molecular or microbiological tests for specific pathogens. Our study objectives were to 1) develop a hierarchical occupancy model to examine pathogen prevalence in spring Chinook salmon Oncorhynchus tshawytscha and their distribution among host tissues 2) use the model to estimate pathogen-specific test sensitivities and infection rates, and 3) illustrate the effect of using replicate within host sampling on sample sizes required to detect a pathogen. We examined histological sections of replicate tissue samples from spring Chinook salmon O. tshawytscha collected after spawning for common pathogens seen in this population: Apophallus/echinostome metacercariae, Parvicapsula minibicornis, Nanophyetus salmincola/metacercariae, and Renibacterium salmoninarum. A hierarchical occupancy model was developed to estimate pathogen and tissue-specific test sensitivities and unbiased estimation of host-and organ-level infection rates. Model estimated sensitivities and host-and organ-level infections rates varied among pathogens and model estimated infection rate was higher than prevalence unadjusted for test sensitivity, confirming that prevalence unadjusted for test sensitivity was negatively biased. The modeling approach provided an analytical approach for using hierarchically structured pathogen detection data from lower sensitivity diagnostic tests, such as histology, to obtain unbiased pathogen prevalence estimates with associated uncertainties. Accounting for test sensitivity using within host replicate samples also required fewer individual fish to be sampled. This approach is useful for evaluating pathogen or microbe community dynamics when test sensitivity is <100%.	[Colvin, Michael E.] Oregon State Univ, Dept Fisheries & Wildlife, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Peterson, James T.; Schreck, Carl B.] Oregon State Univ, Oregon Cooperat Fish & Wildlife Res Unit, US Geol Survey, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Kent, Michael L.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey; Oregon State University	Colvin, ME (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, POB 9690, Mississippi State, MS 39762 USA.	Michael.colvin@msstate.edu		Colvin, Michael/0000-0002-6581-4764	US Army Corps of Engineers, Military Interdepartmental Purchase Request [W66QKZ20836465]; U.S. Geological Survey; U.S. Fish and Wildlife Service; Oregon Department of Fish and Wildlife, Oregon State University; Wildlife Management Institute	US Army Corps of Engineers, Military Interdepartmental Purchase Request; U.S. Geological Survey(United States Geological Survey); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Oregon Department of Fish and Wildlife, Oregon State University; Wildlife Management Institute	This study was funded by the US Army Corps of Engineers, Military Interdepartmental Purchase Request Number W66QKZ20836465. The Oregon Cooperative Fish and Wildlife Research Unit is jointly sponsored by the U.S. Geological Survey, the U.S. Fish and Wildlife Service, the Oregon Department of Fish and Wildlife, Oregon State University, and the Wildlife Management Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; AFS-FHS (American Fisheries Society-Fish Health Section), 2010, AFS FHS BLUE BOOK SU; Allen TJ, 1986, T NE SECT WILDL SOC, V43, P64; [Anonymous], 2010, R LANG ENV STAT COMP; ANTHONY JA, 1990, J WILDLIFE DIS, V26, P170, DOI 10.7589/0090-3558-26.2.170; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Chen PC, 2011, J NEMATOL, V43, P16; Cooch Evan G., 2012, Journal of Ornithology, V152, pS485, DOI 10.1007/s10336-010-0636-3; Courcoul A, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115916, DOI 10.1371/JOURNAL.PONE.0115916]; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Ferguson JA, 2011, J PARASITOL, V97, P1085, DOI 10.1645/GE-2757.1; Gelman A, 2007, DATA ANAL USING REGR, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Guillera-Arroita G, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0117679, DOI 10.1371/JOURNAL.PONE.0117679]; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hanna SE, 2005, J FOOD SCI, V70, pR49; Hiner M, 2001, J AQUAT ANIM HEALTH, V13, P124, DOI 10.1577/1548-8667(2001)013&lt;0124:VIIOMC&gt;2.0.CO;2; Jacobson KC, 2008, MAR ECOL PROG SER, V354, P235, DOI 10.3354/meps07232; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kent ML, 2013, J VET DIAGN INVEST, V25, P341, DOI 10.1177/1040638713482124; Kent ML, 1998, J AQUAT ANIM HEALTH, V10, P211, DOI 10.1577/1548-8667(1998)010&lt;0211:SOSPIO&gt;2.0.CO;2; Kock RA, 2010, REV SCI TECH OIE, V29, P329, DOI 10.20506/rst.29.2.1980; Koponen K, 2001, AMBIO, V30, P122, DOI 10.1639/0044-7447(2001)030[0122:HOFFFA]2.0.CO;2; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Leighton FA, 2002, REV SCI TECH OIE, V21, P187; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; National Research Council, 2011, GUIDE CARE USE LAB A; Nehring RB, 1996, FISHERIES, V21, P28; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; NMFS (National Marine Fisheries Service), 1999, FED REGISTER, V64, P14308; NRC ( National Research Council), 2008, BRUC GREAT YELL AR; Pascho RJ, 1997, J AQUAT ANIM HEALTH, V9, P99, DOI 10.1577/1548-8667(1997)009&lt;0099:EBELIA&gt;2.3.CO;2; Poulin R, 2013, PARASITOLOGY, V140, P541, DOI 10.1017/S0031182012002053; Rodnick KJ, 2008, T AM FISH SOC, V137, P1571, DOI 10.1577/T07-138.1; Saksida SM, 2012, J FISH DIS, V35, P137, DOI 10.1111/j.1365-2761.2011.01330.x; Schreck CB, 2013, ANN REPORT US ARMY C; Shea CP, 2012, FRESHWATER BIOL, P382, DOI [10.1182/asheducation-2012.1.382, DOI 10.1182/ASHEDUCATION-2012.1.382]; Starliper CE, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P606, DOI 10.1079/9781845935542.0606; Stentiford GD, 2003, MAR ENVIRON RES, V55, P137, DOI 10.1016/S0141-1136(02)00212-X; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tamhane A, 2008, CLIN INFECT DIS, V46, P474, DOI 10.1086/524893; Thompson KG, 2007, J AQUAT ANIM HEALTH, V19, P8, DOI 10.1577/H06-016.1; Vincent ER, 1996, FISHERIES, V21, P32; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wilcox TM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Williams CJ, 2010, ECOL INFORM, V5, P273, DOI 10.1016/j.ecoinf.2010.04.003; Williams CJ, 2005, J AQUAT ANIM HEALTH, V17, P386, DOI 10.1577/H04-066.1	57	16	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116605	10.1371/journal.pone.0116605	http://dx.doi.org/10.1371/journal.pone.0116605			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738709	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900013
J	Jia, R; Ding, SL; Pan, QH; Liu, SL; Qiao, WT; Liang, C				Jia, Rui; Ding, Shilei; Pan, Qinghua; Liu, Shan-Lu; Qiao, Wentao; Liang, Chen			The C-Terminal Sequence of IFITM1 Regulates Its Anti-HIV-1 Activity	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; WEST NILE VIRUS; INTERFERON; INFLUENZA; PROTEINS; INFECTION; IDENTIFICATION; REPLICATION; INHIBITION; RESTRICTS	The interferon-inducible transmembrane (IFITM) proteins inhibit a wide range of viruses. We previously reported the inhibition of human immunodeficiency virus type 1 (HIV-1) strain BH10 by human IFITM1, 2 and 3. It is unknown whether other HIV-1 strains are similarly inhibited by IFITMs and whether there exists viral countermeasure to overcome IFITM inhibition. We report here that the HIV-1 NL4-3 strain (HIV-1(NL4-3)) is not restricted by IFITM1 and its viral envelope glycoprotein is partly responsible for this insensitivity. However, HIV-1(NL-43) is profoundly inhibited by an IFITM1 mutant, known as Delta(117-125), which is deleted of 9 amino acids at the C-terminus. In contrast to the wild type IFITM1, which does not affect HIV-1 entry, the Delta(117-125) mutant diminishes HIV-1(NL4-3) entry by 3-fold. This inhibition correlates with the predominant localization of Delta(117-125) to the plasma membrane where HIV-1 entry occurs. In spite of strong conservation of IFITM1 among most species, mouse IFITM1 is 19 amino acids shorter at its C-terminus as compared to human IFITM1 and, like the human IFITM1 mutant Delta(117-125), mouse IFITM1 also inhibits HIV-1 entry. This is the first report illustrating the role of viral envelope protein in overcoming IFITM1 restriction. The results also demonstrate the importance of the C-terminal region of IFITM1 in modulating the antiviral function through controlling protein subcellular localization.	[Jia, Rui; Qiao, Wentao] Nankai Univ, Minist Educ, Key Lab Mol Microbiol & Biotechnol, Tianjin 300071, Peoples R China; [Jia, Rui; Qiao, Wentao] Nankai Univ, Key Lab Microbial Funct Genom Tianjin, Coll Life Sci, Tianjin 300071, Peoples R China; [Jia, Rui; Ding, Shilei; Pan, Qinghua; Liang, Chen] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Ding, Shilei; Liang, Chen] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Liu, Shan-Lu] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Bond Life Sci Ctr, Columbia, MO 65211 USA	Nankai University; Nankai University; Lady Davis Institute; McGill University; McGill University; University of Missouri System; University of Missouri Columbia	Liang, C (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	chen.liang@mcgill.ca	Liu, Shan-Lu/L-5923-2016	Liu, Shan-Lu/0000-0003-1620-3817; Jia, Rui/0000-0002-1797-4069	National Institutes of Health [AI112381, AI105584, AI109464, AI107095]; Canadian Institutes of Health Research [MOP-133479]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112381, R21AI109464, R21AI105584, R56AI107095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from National Institutes of Health to SLL (AI112381, AI105584, AI109464, and AI107095) and funding from Canadian Institutes of Health Research to CL (MOP-133479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber D, 1996, J INTERF CYTOK RES, V16, P375, DOI 10.1089/jir.1996.16.375; Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Ding SL, 2014, VIROLOGY, V454, P11, DOI 10.1016/j.virol.2014.01.020; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Martensen PM, 2004, J INTERF CYTOK RES, V24, P1, DOI 10.1089/107999004772719864; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; TANG BL, 1992, J BIOL CHEM, V267, P7072; Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003	40	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118794	10.1371/journal.pone.0118794	http://dx.doi.org/10.1371/journal.pone.0118794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738301	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900073
J	Korda, RJ; Joshy, G; Paige, E; Butler, JRG; Jorm, LR; Liu, B; Bauman, AE; Banks, E				Korda, Rosemary J.; Joshy, Grace; Paige, Ellie; Butler, James R. G.; Jorm, Louisa R.; Liu, Bette; Bauman, Adrian E.; Banks, Emily			The Relationship between Body Mass Index and Hospitalisation Rates, Days in Hospital and Costs: Findings from a Large Prospective Linked Data Study	PLOS ONE			English	Article							HEALTH-CARE COSTS; ECONOMIC BURDEN; OBESITY; OVERWEIGHT; COMORBIDITIES; EXPENDITURE; MORTALITY; WEIGHT; HEIGHT; BMI	Background Internationally there is limited empirical evidence on the impact of overweight and obesity on health service use and costs. We estimate the burden of hospitalisation-admissions, days and costs-associated with above-normal BMI. Methods Population-based prospective cohort study involving 224,254 adults aged >= 45y in Australia (45 and Up Study). Baseline questionnaire data (2006-2009) were linked to hospitalisation and death records (median follow-up 3.42y) and hospital cost data. The relationships between BMI and hospital admissions and days were modelled using zero-inflated negative binomial regression; generalised gamma models were used to model costs. Analyses were stratified by sex and age (45-64, 65-79, >= 80y), and adjusted for age, area of residence, education, income, smoking, alcohol-intake and private health insurance status. Population attributable fractions were also calculated. Results There were 459,346 admissions (0.55/person-year) and 1,483,523 hospital days (1.76/person- year) during follow-up. For ages 45-64y and 65-79y, rates of admissions, days and costs increased progressively with increments of above-normal BMI. Compared to BMI 22.5-<25kg/m(2), rates of admissions and days were 1.64-2.54 times higher for BMI 40-50kg/m(2); costs were 1.14-1.24 times higher for BMI 27.5-<30kg/m(2), rising to 1.77-2.15 times for BMI 40-50kg/m(2). The BMI-hospitalisation relationship was less clear for >= 80y. We estimated that among Australians 45-79y, around 1 in every 8 admissions are attributable to overweight and obesity (2% to overweight, 11% to obesity), as are 1 in every 6 days in hospital (2%, 16%) and 1 in every 6 dollars spent on hospitalisation (3%, 14%). Conclusions The dose-response relationship between BMI and hospital use and costs in mid-age and older Australians in the above-normal BMI range suggests even small downward shifts in BMI among these people could result in considerable reductions in their annual health care costs; whether this would result in long-term savings to the health care system is not known from this study.	[Korda, Rosemary J.; Joshy, Grace; Paige, Ellie; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Butler, James R. G.] Australian Natl Univ, Australian Ctr Econ Res Hlth, Canberra, ACT, Australia; [Jorm, Louisa R.] Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia; [Liu, Bette] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Liu, Bette; Banks, Emily] Sax Inst, Sydney, NSW, Australia; [Bauman, Adrian E.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	Australian National University; Australian National University; Western Sydney University; University of New South Wales Sydney; University of Sydney; University of Sydney	Korda, RJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Rosemary.Korda@anu.edu.au	Jorm, Louisa/AAN-6874-2020	Jorm, Louisa/0000-0003-0390-661X; Banks, Emily/0000-0002-4617-1302; Joshy, Grace/0000-0002-0718-6368; Korda, Rosemary/0000-0002-9390-2171; Paige, Ellie/0000-0003-0855-9872	Australian National Health and Medical Research Council [585402]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australian National Health and Medical Research Council [Grant No. 585402]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; [Anonymous], 2008, GROWING COST OBESITY, DOI DOI 10.1097/SAP.0B013-31816FCAC418434822; Australian Bureau of Statistics, 2011, 4338 0 PROF HLTH; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Australian Government Department of Health and Ageing, ROUND 14 2009 10 NAT; Australian Institute of Health and Welfare, 2004, AUSTR I HLTH WELF RU, V4; Australian Institute of Health and Welfare, 2013, HLTH SERV SER, V50; Australian Institute of Health and Welfare, 2013, HLTH EXO AUSTR 2011, V50; Australian Institute of Health and Welfare, 2013, AUSTR I HLTH WELF HL, V50; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bell JF, 2011, OBESITY, V19, P228, DOI 10.1038/oby.2010.104; Birmingham CL, 1999, CAN MED ASSOC J, V160, P483; Borg S, 2005, VALUE HEALTH, V8, P562, DOI 10.1111/j.1524-4733.2005.00048.x; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P150, DOI 10.1111/j.1753-6405.2008.00192.x; Colagiuri S, 2010, MED J AUSTRALIA, V192, P260, DOI 10.5694/j.1326-5377.2010.tb03503.x; Darrow LA, 2011, EPIDEMIOLOGY, V22, P53, DOI 10.1097/EDE.0b013e3181fce49b; Dee Anne, 2014, BMC Res Notes, V7, P242, DOI 10.1186/1756-0500-7-242; Detournay B, 2000, INT J OBESITY, V24, P151, DOI 10.1038/sj.ijo.0801099; Fay MP, 1997, STAT MED, V16, P791; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Glick H, 2007, EC EVALUATION CLIN T; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Joshy G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088641; Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9; Knai C, 2007, ECON HUM BIOL, V5, P392, DOI 10.1016/j.ehb.2007.08.002; Korda RJ, 2012, INT J OBES LOND; Kuriyama S, 2002, INT J OBESITY, V26, P1069, DOI 10.1038/sj.ijo.0802021; Lal A, 2012, AUST NZ J PUBL HEAL, V36, P550, DOI 10.1111/j.1753-6405.2012.00931.x; Luchsinger JA, 2003, J AM GERIATR SOC, V51, P1615, DOI 10.1046/j.1532-5415.2003.51513.x; National Casemix and Classification Centre, 2012, IND HOSP PRIC AUTH A; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Organisation for Economic Co-operation and Development, 2010, OB EC PREV FIT NOT F; Ostbye T, 2014, OBESITY, V22, P1179, DOI 10.1002/oby.20669; Pan WH, 2012, ASIA PAC J CLIN NUTR, V21, P577; Pi-Sunyer FX, 1999, MED SCI SPORT EXER, V31, pS602, DOI 10.1097/00005768-199911001-00019; Reeves GK, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-45; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Tarride JE, 2012, CLINICOECONOMIC OUTC, V4, P21, DOI 10.2147/CEOR.S24192; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, 2006, WHO GLOB DAT BOD MAS; Zhao W, 2008, OBES REV, V9, P62, DOI 10.1111/j.1467-789X.2007.00440.x	48	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118599	10.1371/journal.pone.0118599	http://dx.doi.org/10.1371/journal.pone.0118599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739093	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900054
J	Li, Y; Maki, M				Li, Yue; Maki, Masayuki			Variation in the Frequency and Extent of Hybridization between Leucosceptrum japonicum and L. stellipilum (Lamiaceae) in the Central Japanese Mainland	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; AMPLIFIED POLYMORPHIC DNA; REPRODUCTIVE ISOLATION; HYBRID ZONES; NATURAL HYBRIDIZATION; SILENE-DIOICA; ECOLOGICAL DIFFERENTIATION; PHYLLODOCE-ALEUTICA; QUERCUS-CRASSIFOLIA; POLLEN PERFORMANCE	Variations in the frequency and extent of hybridization among mixed populations located in the same contact zone provide natural laboratories for the study of extrinsic reproductive isolation maintaining species integrity. In this study, we examined the pattern of hybridization between L. japonicum and L. stellipilum among mixed populations in different localities of a contact zone. The genetic structures from three sympatric populations and six mixed populations in the hybrid zone, and five reference populations far from the contact zone, were characterized using 10 neutral nuclear microsatellite markers. Evidence from genetic distance-based clustering analysis, the frequency distribution of admixture proportion values, and the hybrid category assignment approaches indicated that the frequency and extent of hybridization varied considerably among populations in the contact zone between L. japonicum and L. stellipilum. One likely explanation is that variation in exogenous (ecological) selection among populations might contribute to differences in frequency and extent of hybridization. The present study will facilitate future research exploring the evolution of reproductive isolation between L. japonicum and L. stellipilum.	[Li, Yue] Tohoku Univ, Div Plant Evolutionary Biol, Dept Environm Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Li, Yue; Maki, Masayuki] Tohoku Univ, Bot Gardens, Aoba Ku, Sendai, Miyagi 9800862, Japan	Tohoku University; Tohoku University	Li, Y (corresponding author), Tohoku Univ, Div Plant Evolutionary Biol, Dept Environm Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	yueli@life.biology.tohoku.ac.jp			Japan Society for the Promotion of Science [JSPS KAKENHI 21570086]; Tohoku University Global Centre of Excellence (GCOE) Program "Centre for ecosystem management adapting to global change" [J03]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University Global Centre of Excellence (GCOE) Program "Centre for ecosystem management adapting to global change"	This study was supported by a Grant-in-Aid to MM from the Japan Society for the Promotion of Science (JSPS KAKENHI 21570086, http://www.jsps.go.jp) and Tohoku University Global Centre of Excellence (GCOE) Program "Centre for ecosystem management adapting to global change" (J03). The stay of YL in Japan was supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Albaladejo RG, 2007, ANN BOT-LONDON, V100, P735, DOI 10.1093/aob/mcm154; Albaladejo RG, 2004, BOT J LINN SOC, V145, P97, DOI 10.1111/j.1095-8339.2003.00266.x; Aldridge G, 2006, AM J BOT, V93, P903, DOI 10.3732/ajb.93.6.903; Aldridge G, 2005, NEW PHYTOL, V167, P279, DOI 10.1111/j.1469-8137.2005.01413.x; Aldridge G, 2009, HEREDITY, V102, P257, DOI 10.1038/hdy.2008.112; Aldridge G, 2007, EVOLUTION, V61, P99, DOI 10.1111/j.1558-5646.2007.00008.x; ANDERSON E, 1948, EVOLUTION, V2, P1, DOI 10.2307/2405610; Anderson EC, 2002, GENETICS, V160, P1217; Anderson EC, 2008, PHILOS T R SOC B, V363, P2841, DOI 10.1098/rstb.2008.0043; Boecklen WJ, 1997, ECOLOGY, V78, P2611, DOI 10.1890/0012-9658(1997)078[2611:GAOHZN]2.0.CO;2; Burgess KS, 2005, MOL ECOL, V14, P3471, DOI 10.1111/j.1365-294X.2005.02670.x; Chung MY, 2005, MOL ECOL, V14, P4389, DOI 10.1111/j.1365-294X.2005.02738.x; CRUZAN MB, 1993, EVOLUTION, V47, P1432, DOI 10.1111/j.1558-5646.1993.tb02165.x; De Hert K, 2012, ANN BOT-LONDON, V109, P709, DOI 10.1093/aob/mcr305; Delph LF, 1997, ECOLOGY, V78, P1632, DOI 10.1890/0012-9658(1997)078[1632:HEFAPP]2.0.CO;2; Durrett R, 2000, HEREDITY, V84, P9, DOI 10.1046/j.1365-2540.2000.00566.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson CJ, 1999, PLANT SYST EVOL, V218, P153, DOI 10.1007/BF01087043; Field DL, 2009, CONSERV GENET, V10, P881, DOI 10.1007/s10592-008-9649-3; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Goulson D, 1997, OIKOS, V79, P115, DOI 10.2307/3546096; Goulson D, 2009, PLANT ECOL, V205, P201, DOI 10.1007/s11258-009-9610-7; HAMRICK JL, 1979, EVOLUTION, V33, P521, DOI 10.1111/j.1558-5646.1979.tb04707.x; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; HARRISON RG, 1986, HEREDITY, V56, P337, DOI 10.1038/hdy.1986.55; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Johanet A, 2011, HEREDITY, V106, P962, DOI 10.1038/hdy.2010.144; Johnston JA, 2001, AM J BOT, V88, P933, DOI 10.2307/2657046; Kameyama Y, 2008, J EVOLUTION BIOL, V21, P588, DOI 10.1111/j.1420-9101.2007.01476.x; Kameyama Y, 2011, PLANT SPEC BIOL, V26, P93, DOI 10.1111/j.1442-1984.2010.00301.x; Karrenberg S, 2008, EVOLUTION, V62, P763, DOI 10.1111/j.1558-5646.2008.00330.x; Kuehn MM, 1999, MOL ECOL, V8, P1981, DOI 10.1046/j.1365-294x.1999.00792.x; Langella O., 1999, POPULATIONS 1 2 32; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; LEVIN D A, 1971, Taxon, V20, P91, DOI 10.2307/1218538; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Li Y, 2014, PLANT SYST EVOL, P1; Li Y, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300038; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; Maechler M, 2009, DIPTEST HARTIGANS DI; Maki M, 1999, MOL ECOL, V8, P145, DOI 10.1046/j.1365-294X.1999.00517.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Marques I, 2007, AM J BOT, V94, P1352, DOI 10.3732/ajb.94.8.1352; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; McIntosh EJ, 2014, ANN BOT-LONDON, V113, P861, DOI 10.1093/aob/mct314; Milne RI, 2003, MOL ECOL, V12, P2719, DOI 10.1046/j.1365-294X.2003.01942.x; Mimura M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0209-9; Minder AM, 2007, MOL ECOL, V16, P2504, DOI 10.1111/j.1365-294X.2007.03292.x; Moccia MD, 2007, MOL ECOL, V16, P2855, DOI 10.1111/j.1365-294X.2007.03240.x; MURATA G., 1993, FLORA JAPAN A, VIIIa, P84; Naisbit RE, 2003, EVOL DEV, V5, P269, DOI 10.1046/j.1525-142X.2003.03034.x; NASON JD, 1992, AM J BOT, V79, P101, DOI 10.2307/2445203; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; Oberprieler C, 2011, PLANT SYST EVOL, V293, P177, DOI 10.1007/s00606-011-0431-5; Ohwi J, 1965, FLORA JAPAN; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Ren GP, 2012, HEREDITY, V108, P552, DOI 10.1038/hdy.2011.123; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ruane LG, 2007, AM J BOT, V94, P219, DOI 10.3732/ajb.94.2.219; Silvertown J, 2005, HEREDITY, V95, P198, DOI 10.1038/sj.hdy.6800710; Sun M, 2011, PLOS ONE, V6; SUZUKI K, 1984, BOT MAG TOKYO, V97, P381, DOI 10.1007/BF02488670; Swenson NG, 2008, WEST N AM NATURALIST, V68, P498, DOI 10.3398/1527-0904-68.4.498; Tagane S, 2008, J PLANT RES, V121, P387, DOI 10.1007/s10265-008-0167-7; Thomas DT, 2008, INT J PLANT SCI, V169, P647, DOI 10.1086/533605; Tovar-Sanchez E, 2006, OECOLOGIA, V147, P702, DOI 10.1007/s00442-005-0328-5; Tovar-Sanchez E, 2004, AM J BOT, V91, P1352, DOI 10.3732/ajb.91.9.1352; Travers SE, 1999, ECOLOGY, V80, P2427, DOI 10.1890/0012-9658(1999)080[2427:PPOPIR]2.0.CO;2; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Droogenbroeck B, 2006, ANN BOT-LONDON, V97, P793, DOI 10.1093/aob/mcl038; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westberg E, 2010, BIOL J LINN SOC, V101, P526, DOI 10.1111/j.1095-8312.2010.01487.x; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Yost JM, 2012, AM J BOT, V99, P890, DOI 10.3732/ajb.1100521; Zeng YF, 2011, MOL ECOL, V20, P4995, DOI 10.1111/j.1365-294X.2011.05354.x; Zha HG, 2010, ANN BOT-LONDON, V105, P89, DOI 10.1093/aob/mcp267	98	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116411	10.1371/journal.pone.0116411	http://dx.doi.org/10.1371/journal.pone.0116411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738505	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900011
J	Regan, JF; Kamitaki, N; Legler, T; Cooper, S; Klitgord, N; Karlin-Neumann, G; Wong, C; Hodges, S; Koehler, R; Tzonev, S; McCarroll, SA				Regan, John F.; Kamitaki, Nolan; Legler, Tina; Cooper, Samantha; Klitgord, Niels; Karlin-Neumann, George; Wong, Catherine; Hodges, Shawn; Koehler, Ryan; Tzonev, Svilen; McCarroll, Steven A.			A Rapid Molecular Approach for Chromosomal Phasing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CYSTIC-FIBROSIS GENE; NUCLEOTIDE-BINDING FOLD; DE-NOVO MUTATIONS; REGULATORY VARIATION; GENOMIC DNA; COPY NUMBER; DIGITAL PCR; HUMAN-CELLS; STEM-CELLS	Determining the chromosomal phase of pairs of sequence variants - the arrangement of specific alleles as haplotypes - is a routine challenge in molecular genetics. Here we describe Drop-Phase, a molecular method for quickly ascertaining the phase of pairs of DNA sequence variants (separated by 1-200 kb) without cloning or manual single-molecule dilution. In each Drop-Phase reaction, genomic DNA segments are isolated in tens of thousands of nanoliter-sized droplets together with allele-specific fluorescence probes, in a single reaction well. Physically linked alleles partition into the same droplets, revealing their chromosomal phase in the co-distribution of fluorophores across droplets. We demonstrated the accuracy of this method by phasing members of trios (revealing 100% concordance with inheritance information), and demonstrate a common clinical application by phasing CFTR alleles at genomic distances of 11-116 kb in the genomes of cystic fibrosis patients. Drop-Phase is rapid (requiring less than 4 hours), scalable (to hundreds of samples), and effective at long genomic distances (200 kb).	[Regan, John F.; Legler, Tina; Cooper, Samantha; Klitgord, Niels; Karlin-Neumann, George; Hodges, Shawn; Koehler, Ryan; Tzonev, Svilen] Digital Biol Ctr, Biorad Labs, Pleasanton, CA 94588 USA; [Kamitaki, Nolan; Wong, Catherine; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kamitaki, Nolan; McCarroll, Steven A.] Program Med & Populat Genet, Cambridge, MA USA; [Kamitaki, Nolan; McCarroll, Steven A.] Stanley Ctr Psychiat Res, Cambridge, MA USA	Harvard University; Harvard Medical School	Regan, JF (corresponding author), Digital Biol Ctr, Biorad Labs, Pleasanton, CA 94588 USA.	jack_regan@bio-rad.com; mccarroll@genetics.med.harvard.edu		Kamitaki, Nolan/0000-0003-0614-0189	Broad Institute	Broad Institute	This work was supported by Broad Institute (http://www.broadinstitute.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Chen N, 2011, GENET MED, V13, P1025, DOI 10.1097/GIM.0b013e3182272e0b; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; Ding CM, 2003, P NATL ACAD SCI USA, V100, P7449, DOI 10.1073/pnas.1232475100; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; LOGAN J, 1994, J CLIN INVEST, V94, P228, DOI 10.1172/JCI117311; Londin ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013443; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McDonald OG, 2002, PHARMACOGENETICS, V12, P93, DOI 10.1097/00008571-200203000-00003; OSBORNE L, 1991, AM J HUM GENET, V48, P608; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Paul P, 2005, BIOTECHNIQUES, V38, P553, DOI 10.2144/05384ST01; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Pont-Kingdon G, 2004, J MOL DIAGN, V6, P264, DOI 10.1016/S1525-1578(10)60520-X; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUANO G, 1989, NUCLEIC ACIDS RES, V17, P8392, DOI 10.1093/nar/17.20.8392; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8	38	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118270	10.1371/journal.pone.0118270	http://dx.doi.org/10.1371/journal.pone.0118270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739099	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900027
J	Profant, O; Tintera, J; Balogova, Z; Ibrahim, I; Jilek, M; Syka, J				Profant, Oliver; Tintera, Jaroslav; Balogova, Zuzana; Ibrahim, Ibrahim; Jilek, Milan; Syka, Josef			Functional Changes in the Human Auditory Cortex in Ageing	PLOS ONE			English	Article							AGE-RELATED-CHANGES; HEARING-LOSS; HEMISPHERIC-ASYMMETRY; SPEECH-PERCEPTION; WORKING-MEMORY; PRESBYCUSIS; RECOGNITION; IMPAIRMENT; LATERALIZATION; DISCRIMINATION	Hearing loss, presbycusis, is one of the most common sensory declines in the ageing population. Presbycusis is characterised by a deterioration in the processing of temporal sound features as well as a decline in speech perception, thus indicating a possible central component. With the aim to explore the central component of presbycusis, we studied the function of the auditory cortex by functional MRI in two groups of elderly subjects (>65 years) and compared the results with young subjects (<lt;30 years). The elderly group with expressed presbycusis (EP) differed from the elderly group with mild presbycusis (MP) in hearing thresholds measured by pure tone audiometry, presence and amplitudes of transient oto acoustic emissions (TEOAE) and distortion-product oto-acoustic emissions (DPOAE), as well as in speech-understanding under noisy conditions. Acoustically evoked activity (pink noise centered around 350 Hz, 700 Hz, 1.5 kHz, 3 kHz, 8 kHz), recorded by BOLD fMRI from an area centered on Heschl's gyrus, was used to determine age-related changes at the level of the auditory cortex. The fMRI showed only minimal activation in response to the 8 kHz stimulation, despite the fact that all subjects heard the stimulus. Both elderly groups showed greater activation in response to acoustical stimuli in the temporal lobes in comparison with young subjects. In addition, activation in the right temporal lobe was more expressed than in the left temporal lobe in both elderly groups, whereas in the young control subjects (YC) leftward lateralization was present. No statistically significant differences in activation of the auditory cortex were found between the MP and EP groups. The greater extent of cortical activation in elderly subjects in comparison with young subjects, with an asymmetry towards the right side, may serve as a compensatory mechanism for the impaired processing of auditory information appearing as a consequence of ageing.	[Profant, Oliver; Balogova, Zuzana; Jilek, Milan; Syka, Josef] Acad Sci Czech Republ, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic; [Tintera, Jaroslav; Ibrahim, Ibrahim] Inst Clin & Expt Med, Dept Diagnost & Intervent Radiol, MR Unit, Prague, Czech Republic; [Profant, Oliver; Balogova, Zuzana] Charles Univ Prague, Univ Hosp Motol, Fac Med 1, Dept Otorhinolaryngol Head & Neck Surg, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Motol University Hospital	Profant, O (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic.	profant@biomed.cas.cz	Balogova, Zuzana/R-1146-2018	Ibrahim, Ibrahim/0000-0003-3530-5165	GACR (Czech acronym of the Czech Science Foundation) [P304/10/1872]; GACR [P304/12/G069]; PRVOUK (Czech acronym of the Charles University Research Development Schemes) [P27]	GACR (Czech acronym of the Czech Science Foundation); GACR(Grant Agency of the Czech Republic); PRVOUK (Czech acronym of the Charles University Research Development Schemes)	This research was supported by the grant GACR (Czech acronym of the Czech Science Foundation) P304/10/1872, GACR P304/12/G069, PRVOUK (Czech acronym of the Charles University Research Development Schemes) P27 and Institutional Support 00023001IKEM of the Ministry of Health of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J ACOUST SOC AM, V83, P859; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Burianova J, 2009, EXP GERONTOL, V44, P161, DOI 10.1016/j.exger.2008.09.012; Burkard R F, 2001, Am J Audiol, V10, P53, DOI 10.1044/1059-0889(2001/008); Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2001, SCAND J PSYCHOL, V42, P277, DOI 10.1111/1467-9450.00237; Canlon B, 2010, SPRINGER HANDB AUDIT, V34, P39, DOI 10.1007/978-1-4419-0993-0_3; Caspary DM, 2005, J NEUROSCI, V25, P10952, DOI 10.1523/JNEUROSCI.2451-05.2005; Caspary DM, 2008, J EXP BIOL, V211, P1781, DOI 10.1242/jeb.013581; DAVIS AC, 1991, ACTA OTO-LARYNGOL, P23; Dlouha O, 2011, OTORINOLARINGOLOGIE, V3, P125; Eckert MA, 2008, JARO-J ASSOC RES OTO, V9, P252, DOI 10.1007/s10162-008-0113-3; Eckert MA, 2012, JARO-J ASSOC RES OTO, V13, P703, DOI 10.1007/s10162-012-0332-5; Foo C, 2007, J AM ACAD AUDIOL, V18, P618, DOI 10.3766/jaaa.18.7.8; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1991, ACTA OTO-LARYNGOL, V111, P240, DOI 10.3109/00016489109137382; GORDONSALANT S, 1993, J SPEECH HEAR RES, V36, P1276, DOI 10.1044/jshr.3606.1276; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5; Humes LE, 2010, SPRINGER HANDB AUDIT, V34, P211, DOI 10.1007/978-1-4419-0993-0_8; Humes LE, 1996, J SPEECH HEAR RES, V39, P923, DOI 10.1044/jshr.3905.923; Kidd AR, 2012, GERONTOLOGY, V58, P490, DOI 10.1159/000338588; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Laplante-Levesque A, 2010, J AGING HEALTH, V22, P143, DOI 10.1177/0898264309352731; Lin JFL, 2012, CEREB CORTEX, V22, P1851, DOI 10.1093/cercor/bhr263; Lutz J, 2007, ACAD RADIOL, V14, P692, DOI 10.1016/j.acra.2007.02.014; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Manly JJ, 2003, J CLIN EXP NEUROPSYC, V25, P680, DOI 10.1076/jcen.25.5.680.14579; Mazelova J, 2003, EXP GERONTOL, V38, P87, DOI 10.1016/S0531-5565(02)00155-9; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Moffat SD, 2006, NEUROBIOL AGING, V27, P965, DOI 10.1016/j.neurobiolaging.2005.05.011; MOORE BCJ, 1988, J ACOUST SOC AM, V83, P1093, DOI 10.1121/1.396054; Mutter SA, 2006, Q J EXP PSYCHOL, V59, P1556, DOI 10.1080/17470210500343546; Nash SD, 2011, ARCH OTOLARYNGOL, V137, P432, DOI 10.1001/archoto.2011.15; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Ouda L, 2008, EXP GERONTOL, V43, P782, DOI 10.1016/j.exger.2008.04.001; Persad CC, 2002, J GERONTOL B-PSYCHOL, V57, pP223, DOI 10.1093/geronb/57.3.P223; PETERS CA, 1988, J AM GERIATR SOC, V36, P981, DOI 10.1111/j.1532-5415.1988.tb04363.x; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Profant O, 2014, NEUROSCIENCE, V260, P87, DOI 10.1016/j.neuroscience.2013.12.010; Profant O, 2013, EXP GERONTOL, V48, P795, DOI 10.1016/j.exger.2013.04.012; Raji CA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.010; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Riecker A, 2003, J CEREBR BLOOD F MET, V23, P565, DOI 10.1097/01.WCB.0000056063.25434.04; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; Salvi RJ, 2002, HEARING RES, V170, P96, DOI 10.1016/S0378-5955(02)00386-6; Schonwiesner M, 2007, CEREB CORTEX, V17, P492, DOI 10.1093/cercor/bhj165; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Sprinzl GM, 2010, GERONTOLOGY, V56, P351, DOI 10.1159/000275062; Syka J, 2010, HEARING RES, V264, P70, DOI 10.1016/j.heares.2009.11.003; Tadros SF, 2005, AUDIOL NEURO-OTOL, V10, P44, DOI 10.1159/000082307; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Tramo MJ, 2005, ANN NY ACAD SCI, V1060, P148, DOI 10.1196/annals.1360.011; Tucker-Drob EM, 2011, NEUROPSYCHOLOGY, V25, P368, DOI 10.1037/a0022348; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; VANROOIJ JCGM, 1990, J ACOUST SOC AM, V88, P2611, DOI 10.1121/1.399981; Walton JP, 2002, J NEUROPHYSIOL, V88, P565, DOI 10.1152/jn.2002.88.2.565; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Willott JF, 2001, AUDIOL NEURO-OTOL, V6, P231, DOI 10.1159/000046129; Wingfield A, 2005, CURR DIR PSYCHOL SCI, V14, P144, DOI 10.1111/j.0963-7214.2005.00356.x; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075)	70	36	36	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0116692	10.1371/journal.pone.0116692	http://dx.doi.org/10.1371/journal.pone.0116692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734519	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700006
J	Chua, JS; Liew, HP; Guo, L; Lane, DP				Chua, J. S.; Liew, H. P.; Guo, L.; Lane, D. P.			Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish	ONCOGENE			English	Article							ZINC-FINGER NUCLEASES; LI-FRAUMENI-SYNDROME; ACTIVITY IN-VIVO; EMBRYONIC LETHALITY; MDM4-NULL MICE; CELL-DEATH; PROTEIN; RESCUE; UBIQUITINATION; ONCOPROTEIN	In mice, the deletion of either Mdm2 or Mdm4 results in a p53-dependent embryonic lethality. We used zinc-finger nucleases to construct mutations in the mdm2 and mdm4 genes of zebrafish. Although the loss of mdm2 results in a p53-dependent early embryonic lethality, mdm4 mutant fish are viable and grow to adulthood. We also found that an in-frame five-amino acid deletion in mdm2 creates a novel hypomorphic allele. The lethal phenotype observed in the mdm2 mutant fish could be partially rescued by injecting mRNA encoding functional Mdm2, and this required the E3 ligase activity of the protein. Complete rescue was obtained by crossing the mdm2 mutant fish onto a p53M214K mutant background. Although p53 mutant fish on a wild-type mdm2 background were shown to accumulate high levels of p53 protein specifically in tumor tissues, we detected extensive staining of p53 in many normal tissues of the mdm2-p53M214K double-mutant fish. Our results are suggestive of the hypothesis that p53 protein accumulates during tumor formation as a result of tumor-specific inactivation of the Mdm2 pathway.	[Chua, J. S.; Liew, H. P.; Lane, D. P.] ASTAR, Inst Biomed Sci, Lab p53, Singapore 138648, Singapore; [Guo, L.] Aegis Biotech, Singapore, Singapore	Agency for Science Technology & Research (A*STAR)	Lane, DP (corresponding author), ASTAR, Inst Biomed Sci, Lab p53, 06-04-05 Immunos, Singapore 138648, Singapore.	dplane@p53lab.a-star.edu.sg		Lane, David/0000-0003-0551-3545	Biomedical Research Council of Singapore	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of Singapore. We thank Dr Verma Chandra, Bioinformatics Institute, Singapore, for the homology modeling of Mdm4 and p53; Dr Venkatesh Byrappa, Institute of Molecular and Cell Biology, Singapore, for scouring the databases for zebrafish Mdm4 homologs; Dr Julin Wong for growing the hybridomas for the p53-5.1 and p53-9.1 antibodies; and our students who helped with genotyping of the zebrafish. The zebrafish p53M214K mutant line was provided by Professor A. Thomas Look (Dana Farber Cancer Institute, Boston, MA, USA). Adult zebrafish were processed and paraffin embedded at the Advanced Molecular Pathology Laboratory, IMCB, A*STAR, Singapore. All the adult zebrafish were maintained by the Zebrafish Facility at the Institute of Molecular and Cell Biology.	Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Chavez-Reyes A, 2003, CANCER RES, V63, P8664; Doumont G, 2005, EMBO J, V24, P3093, DOI 10.1038/sj.emboj.7600769; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finch RA, 2002, CANCER RES, V62, P3221; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Guo L, 2013, ONCOGENE, V32, P4009, DOI 10.1038/onc.2012.409; HALL PA, 1994, J PATHOL, V172, P1, DOI 10.1002/path.1711720103; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Lane David P, 2012, Genes Cancer, V3, P320, DOI 10.1177/1947601912458285; Lane DP, 2010, CELL CYCLE, V9, P540, DOI 10.4161/cc.9.3.10516; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; LUNA RMD, 1995, NATURE, V378, P203; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Peller S, 1998, SEMIN CANCER BIOL, V8, P379, DOI 10.1006/scbi.1998.0100; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Steinman HA, 2005, ONCOGENE, V24, P7935, DOI 10.1038/sj.onc.1208930; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Zhang Y, 2014, J PATHOL, V233, P380, DOI 10.1002/path.4368	42	14	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2015	34	48					5933	5941		10.1038/onc.2015.57	http://dx.doi.org/10.1038/onc.2015.57			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CX1CO	25746004	Green Published, hybrid			2022-12-26	WOS:000365434000008
J	Dwyer, CA; Katoh, T; Tiemeyer, M; Matthews, RT				Dwyer, Chrissa A.; Katoh, Toshihiko; Tiemeyer, Michael; Matthews, Russell T.			Neurons and Glia Modify Receptor Protein-tyrosine Phosphatase zeta (RPTP zeta)/Phosphacan with Cell-specific O-Mannosyl Glycans in the Developing Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Extracellular Matrix; Glycosylation; Muscular Dystrophy; Proteoglycan; Cat-315; O-Glycan; O-Mannose; POMGnT1; RPTPzeta; Phosphacan	CHONDROITIN SULFATE PROTEOGLYCAN; CONGENITAL MUSCULAR-DYSTROPHY; REDUCTIVE ALKALINE-HYDROLYSIS; ALPHA-DYSTROGLYCAN; DEVELOPMENTAL EXPRESSION; ADHESION MOLECULES; MOUSE-BRAIN; STEM-CELLS; RAT-BRAIN; RPTP-BETA	Protein O-mannosylation is a glycan modification that is required for normal nervous system development and function. Mutations in genes involved in protein O-mannosyl glycosylation give rise to a group of neurodevelopmental disorders known as congenital muscular dystrophies (CMDs) with associated CNS abnormalities. Our previous work demonstrated that receptor protein-tyrosine phosphatase (RPTP)/phosphacan is hypoglycosylated in a mouse model of one of these CMDs, known as muscle-eye-brain disease, a disorder that is caused by loss of an enzyme (protein O-mannose -1,2-N-acetylglucosaminyltransferase 1) that modifies O-mannosyl glycans. In addition, monoclonal antibodies Cat-315 and 3F8 were demonstrated to detect O-mannosyl glycan modifications on RPTP/phosphacan. Here, we show that O-mannosyl glycan epitopes recognized by these antibodies define biochemically distinct glycoforms of RPTP/phosphacan and that these glycoforms differentially decorate the surface of distinct populations of neural cells. To provide a further structural basis for immunochemically based glycoform differences, we characterized the O-linked glycan heterogeneity of RPTP/phosphacan in the early postnatal mouse brain by multidimensional mass spectrometry. Structural characterization of the O-linked glycans released from purified RPTP/phosphacan demonstrated that this protein is a significant substrate for protein O-mannosylation and led to the identification of several novel O-mannose-linked glycan structures, including sulfo-N-acetyllactosamine containing modifications. Taken together, our results suggest that specific glycan modifications may tailor the function of this protein to the unique needs of specific cells. Furthermore, their absence in CMDs suggests that hypoglycosylation of RPTP/phosphacan may have different functional consequences in neurons and glia.	[Dwyer, Chrissa A.; Matthews, Russell T.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Katoh, Toshihiko; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University System of Georgia; University of Georgia	Matthews, RT (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, 750 E Adams St, Syracuse, NY 13210 USA.	matthewr@upstate.edu		Dwyer, Chrissa/0000-0003-4565-2558	National Institutes of Health (NIH), NINDS [NS069660]; NIH, NCRR [P41RR018502]; NIH, NIGMS [P41GM103490]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069660] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NINDS, Grant NS069660 (to R. T. M.). Support and access to instrumentation was also provided through NIH, NCRR, Grant P41RR018502 and NIH, NIGMS, Grant P41GM103490.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Alvarez-Manilla G, 2010, GLYCOBIOLOGY, V20, P166, DOI 10.1093/glycob/cwp158; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; BARNEA G, 1994, J BIOL CHEM, V269, P14349; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; FINNE J, 1979, J BIOL CHEM, V254, P295; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; Goldberg HA, 1997, ANAL BIOCHEM, V251, P227, DOI 10.1006/abio.1997.2252; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hayashi N, 2005, NEUROSCIENCE, V131, P331, DOI 10.1016/j.neuroscience.2004.11.017; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2013, GLYCOBIOLOGY, V23, P295, DOI 10.1093/glycob/cws152; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Kogelberg H, 2001, CARBOHYD RES, V331, P393, DOI 10.1016/S0008-6215(01)00051-9; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; KRUSIUS T, 1987, BIOCHEM J, V245, P229, DOI 10.1042/bj2450229; Kumagai T, 2013, ANAL CHEM, V85, P8692, DOI 10.1021/ac4015935; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Lander C, 1998, J NEUROSCI, V18, P174; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; MAUREL P, 1995, DNA SEQUENCE, V5, P323, DOI 10.3109/10425179509030989; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; McClain CR, 2012, J NEUROSCI, V32, P15066, DOI 10.1523/JNEUROSCI.1320-12.2012; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; RAUCH U, 1991, J BIOL CHEM, V266, P14785; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; SHITARA K, 1994, J BIOL CHEM, V269, P20189; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Viapiano MS, 2003, J BIOL CHEM, V278, P33239, DOI 10.1074/jbc.M303480200; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Yagi H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03288; Yaji S, 2015, GLYCOBIOLOGY, V25, P376, DOI 10.1093/glycob/cwu118; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200	64	24	25	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10256	10273		10.1074/jbc.M114.614099	http://dx.doi.org/10.1074/jbc.M114.614099			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737452	Green Published, hybrid			2022-12-26	WOS:000353241100031
J	Kim, S; Lee, H; Lee, S; Yoon, Y; Choi, KH				Kim, Sejeong; Lee, Heeyoung; Lee, Soomin; Yoon, Yohan; Choi, Kyoung-Hee			Antimicrobial Action of Oleanolic Acid on Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; URSOLIC ACIDS; EPIDEMIOLOGY; PREVALENCE; RESISTANCE; LACTATE; MODE	This study investigated the antimicrobial action of oleanolic acid against Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis. To determine the cytotoxicity of oleanolic acid, HEp-2 cells were incubated with oleanolic acid at 37 degrees C. MICs (minimal inhibition concentrations) for Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis were determined using two-fold microdilutions of oleanolic acid, and bacterial cell viability was then assessed by exposing the bacteria to oleanolic acid at 2 x MIC. To investigate the mode of antimicrobial action of oleanolic acid, we measured leakage of compounds absorbing at 280 nm, along with propidium iodide uptake. Scanning electron microscope (SEM) images were also analysed. The viability of HEp-2 cells decreased (P < 0.05) at oleanolic acid concentrations greater than 128 mu g mL(-1). The MICs were 16-32 mu g mL(-1) for Listeria monocytogenes and 32-64 mu g mL(-1) for Enterococcus faecium and Enterococcus faecalis, and bacterial cell viability decreased (P < 0.05) about 3-4 log CFU mL(-1) after exposure to 2 x MIC of oleanolic acid. Leakage of 280 nm absorbing materials and propidium iodide uptake was higher in oleanolic acid-treated cells than in the control. The cell membrane was damaged in oleanolic acid-treated cells, but the control group had intact cell membrane in SEM images. The results indicate that oleanolic acid can kill Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis by destroying the bacterial cell membrane.	[Kim, Sejeong; Lee, Heeyoung; Lee, Soomin; Yoon, Yohan] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Choi, Kyoung-Hee] Wonkwang Univ, Coll Dent, Dept Oral Microbiol, Iksan, Jeonbuk, South Korea	Sookmyung Women's University; Wonkwang University	Yoon, Y (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	yyoon@sookmyung.ac.kr; kheechoi@wku.ac.kr		Kim, Sejeong/0000-0001-9741-8056	Wonkwang University	Wonkwang University	This paper was supported by Wonkwang University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzitey F, 2013, FOOD CONTROL, V32, P607, DOI 10.1016/j.foodcont.2012.12.016; Bereksi N, 2002, J APPL MICROBIOL, V92, P556, DOI 10.1046/j.1365-2672.2002.01564.x; Cox SD, 2000, J APPL MICROBIOL, V88, P170, DOI 10.1046/j.1365-2672.2000.00943.x; de Gonzalez MTN, 2004, J FOOD PROTECT, V67, P915; Ennaji Hayat, 2008, Infect Drug Resist, V1, P45; Fontanay S, 2008, J ETHNOPHARMACOL, V120, P272, DOI 10.1016/j.jep.2008.09.001; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Gelsomino R, 2002, APPL ENVIRON MICROB, V68, P3560, DOI 10.1128/AEM.68.7.3560-3565.2002; Horiuchi K, 2007, BIOL PHARM BULL, V30, P1147, DOI 10.1248/bpb.30.1147; Hung CY, 2001, LEBENSM-WISS TECHNOL, V34, P306, DOI 10.1006/fstl.2001.0775; Hunt CP, 1998, BRIT J BIOMED SCI, V55, P149; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Jimenez-Arellanes A, 2007, J ETHNOPHARMACOL, V111, P202, DOI 10.1016/j.jep.2006.11.033; Kinjo J, 1999, CHEM PHARM BULL, V47, P290, DOI 10.1248/cpb.47.290; Kozai K, 1999, MICROBIOS, V97, P179; Kurek A, 2014, POL J MICROBIOL, V63, P21; Kurek A, 2010, ANTON LEEUW INT J G, V97, P61, DOI 10.1007/s10482-009-9388-6; LEE BL, 1991, ANTIMICROB AGENTS CH, V35, P2505, DOI 10.1128/AAC.35.12.2505; Madlala HP, 2012, RENAL FAILURE, V34, P767, DOI 10.3109/0886022X.2012.678172; Majhenic AC, 2005, INT J FOOD MICROBIOL, V102, P239, DOI 10.1016/j.ijfoodmicro.2004.12.021; Mbandi E, 2002, INT J FOOD MICROBIOL, V76, P191, DOI 10.1016/S0168-1605(02)00026-0; Mellegard H, 2011, INT J FOOD MICROBIOL, V148, P48, DOI 10.1016/j.ijfoodmicro.2011.04.023; Ovesna Z, 2004, NEOPLASMA, V51, P327; Rahimi E, 2012, J FOOD PROTECT, V75, P2223, DOI 10.4315/0362-028X.JFP-11-565; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Reddy MV, 2010, EUR J MED CHEM, V45, P3125, DOI 10.1016/j.ejmech.2010.03.049; Saavedra L, 2003, INT J FOOD MICROBIOL, V88, P241, DOI 10.1016/S0168-1605(03)00186-7; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Szakiel A, 2008, PLANTA MED, V74, P1709, DOI 10.1055/s-0028-1088315; Templer SP, 2008, J FOOD PROTECT, V71, P2100, DOI 10.4315/0362-028X-71.10.2100; Tyagi AK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/382927; Wang X, 2010, CHEM-BIOL INTERACT, V184, P328, DOI 10.1016/j.cbi.2010.01.034; Wolska KI, 2010, CENT EUR J BIOL, V5, P543, DOI 10.2478/s11535-010-0045-x; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yan SL, 2010, TOXICOL IN VITRO, V24, P842, DOI 10.1016/j.tiv.2009.12.008; Yoon Y, 2010, KOREAN J FOOD SCI AN, V30, P717, DOI 10.5851/kosfa.2010.30.5.717; Zhou K, 2008, FOOD CONTROL, V19, P817, DOI 10.1016/j.foodcont.2007.08.008; 윤요한, 2010, [Journal of Life Science, 생명과학회지], V20, P321	38	29	33	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118800	10.1371/journal.pone.0118800	http://dx.doi.org/10.1371/journal.pone.0118800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756202	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700024
J	Tsai, YL; Wang, MC; Hsueh, PR; Liu, MC; Hu, RM; Wu, YJ; Liaw, SJ				Tsai, Yi-Lin; Wang, Min-Cheng; Hsueh, Po-Ren; Liu, Ming-Che; Hu, Rouh-Mei; Wu, Yue-Jin; Liaw, Shwu-Jen			Overexpression of an Outer Membrane Protein Associated with Decreased Susceptibility to Carbapenems in Proteus mirabilis	PLOS ONE			English	Article							ESCHERICHIA-COLI; BETA-LACTAMASE; IMIPENEM RESISTANCE; STRESS RESPONSES; ENTEROBACTERIACEAE; IDENTIFICATION; MECHANISMS; KLEBSIELLA; EXPRESSION; MUTANTS	Proteus mirabilis isolates commonly have decreased susceptibility to imipenem. Previously, we found P. mirabilis hfq mutant was more resistant to imipenem and an outer membrane protein (OMP) could be involved. Therefore, we investigated the role of this OMP in carbapenem susceptibility. By SDS-PAGE we found this OMP (named ImpR) was increased in hfq mutant and LC-MS/MS revealed it to be the homologue of Salmonella YbfM, which is a porin for chitobiose and subject to MicM (a small RNA) regulation. We demonstrated that ImpR overexpression resulted in increased carbapenem MICs in the laboratory strain and clinical isolates. Chitobiose induced expression of chb (a chitobiose utilization operon). Real-time RT-PCR and SDS-PAGE were performed to elucidate the relationship of hfq, impR, chb and MicM in P. mirabilis. We found MicM RNA was decreased in hfq mutant and chbBC-intergenic region (chbBC-IGR) overexpression strain (chbIGRov), while impR mRNA was increased in hfq mutant, micM mutant and chbIGRov strain. In addition, mutation of hfq or micM and overexpression of chbBC-IGR increased ImpR protein level. Accordingly, chitobiose made wild-type have higher levels of ImpR protein and are more resistant to carbapenems. Hfq- and MicM-complemented strains restored wild-type MICs. Mutation of both impR and hfq eliminated the increase in carbapenem MICs observed in hfq mutant and ImpR-complementation of hfq/impR double mutant resulted in MICs as hfq mutant, indicating that the ImpR-dependent decreased carbapenem susceptibility of hfq mutant. These indicate MicM was antisense to impR mRNA and was negatively-regulated by chbBC-IGR. Together, overexpression of ImpR contributed to the decreased carbapenem susceptibility in P. mirabilis.	[Tsai, Yi-Lin; Wang, Min-Cheng; Liu, Ming-Che; Liaw, Shwu-Jen] Natl Taiwan Univ, Coll Med, Dept & Grad Inst, Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Hsueh, Po-Ren; Liaw, Shwu-Jen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Lab Med & Internal Med, Taipei, Taiwan; [Hu, Rouh-Mei] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wu, Yue-Jin] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Asia University Taiwan; National Yang Ming Chiao Tung University	Liaw, SJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst, Clin Lab Sci & Med Biotechnol, Taipei, Taiwan.	sjliaw@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	HSUEH, PO-REN/0000-0002-7502-9225; LIAW, SHWU-JEN/0000-0002-2666-5284	National Science Council [NSC 101-2320-B-002-028]; National Taiwan University Hospital, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC 101-2320-B-002-028) and National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott I, 2013, EXPERT REV ANTI-INFE, V11, P395, DOI [10.1586/ERI.13.21, 10.1586/eri.13.21]; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Clinical and Laboratory Standards Institute, 2012, M07A9 CLIN LAB STAND; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Fernandez-Cuenca F, 2003, J ANTIMICROB CHEMOTH, V51, P565, DOI 10.1093/jac/dkg097; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Gupta N, 2013, MICROBIOL-SGM, V159, P205, DOI 10.1099/mic.0.061937-0; Huang YW, 2013, J ANTIMICROB CHEMOTH, V68, P1987, DOI 10.1093/jac/dkt148; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Lin HH, 2011, J BACTERIOL, V193, P5833, DOI 10.1128/JB.05359-11; MEHTAR S, 1991, J ANTIMICROB CHEMOTH, V28, P612, DOI 10.1093/jac/28.4.612; NEUWIRTH C, 1995, J ANTIMICROB CHEMOTH, V36, P335, DOI 10.1093/jac/36.2.335; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Overturf GD, 2010, PEDIATR INFECT DIS J, V29, P68, DOI 10.1097/INF.0b013e3181c9c118; Pagani L, 2002, J CLIN MICROBIOL, V40, P1549, DOI 10.1128/JCM.40.4.1549-1552.2002; Perez F, 2013, CLEV CLIN J MED, V80, P225, DOI 10.3949/ccjm.80a.12182; Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Tenover FC, 2009, J CLIN MICROBIOL, V47, P294, DOI 10.1128/JCM.01797-08; Tibbetts R, 2008, J CLIN MICROBIOL, V46, P3080, DOI 10.1128/JCM.00979-08; Tomas MDM, 2005, ANTIMICROB AGENTS CH, V49, P5172, DOI 10.1128/AAC.49.12.5172-5175.2005; Verma SC, 2012, J BACTERIOL, V194, P4959, DOI 10.1128/JB.00533-12; Villar HE, 1997, J ANTIMICROB CHEMOTH, V40, P365, DOI 10.1093/jac/40.3.365; Vogel J, 2009, MOL MICROBIOL, V73, P737, DOI 10.1111/j.1365-2958.2009.06806.x; Vourli S, 2006, CLIN MICROBIOL INFEC, V12, P691, DOI 10.1111/j.1469-0691.2006.01489.x; Wang MC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085626, 10.1371/journal.pone.0111040]; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wu YJ, 2009, J CHIN CHEM SOC-TAIP, V56, P688, DOI 10.1002/jccs.200900103	36	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120395	10.1371/journal.pone.0120395	http://dx.doi.org/10.1371/journal.pone.0120395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756370	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700066
J	Vergauwen, H; Tambuyzer, B; Jennes, K; Degroote, J; Wang, W; De Smet, S; Michiels, J; Van Ginneken, C				Vergauwen, Hans; Tambuyzer, Bart; Jennes, Karen; Degroote, Jeroen; Wang, Wei; De Smet, Stefaan; Michiels, Joris; Van Ginneken, Chris			Trolox and Ascorbic Acid Reduce Direct and Indirect Oxidative Stress in the IPEC-J2 Cells, an In Vitro Model for the Porcine Gastrointestinal Tract	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TYROSINE PHOSPHORYLATION; BARRIER DISRUPTION; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; DNA-DAMAGE; GLUTATHIONE; LINE; PATHOGENESIS; PROTEIN	Oxidative stress in the small intestinal epithelium is a major cause of barrier malfunction and failure to regenerate. This study presents a functional in vitro model using the porcine small intestinal epithelial cell line IPEC-J2 to examine the effects of oxidative stress and to estimate the antioxidant and regenerative potential of Trolox, ascorbic acid and glutathione monoethyl ester. Hydrogen peroxide and diethyl maleate affected the tight junction (zona occludens-1) distribution, significantly increased intracellular oxidative stress (CM-H(2)DCFDA) and decreased the monolayer integrity (transepithelial electrical resistance and FD-4 permeability), viability (neutral red) and wound healing capacity (scratch assay). Trolox (2 mM) and 1 mM ascorbic acid pre-treatment significantly reduced intracellular oxidative stress, increased wound healing capacity and reduced FD-4 permeability in oxidatively stressed IPEC-J2 cell monolayers. All antioxidant pre-treatments increased transepithelial electrical resistance and viability only in diethyl maleate-treated cells. Glutathione monoethyl ester (10 mM) pretreatment significantly decreased intracellular oxidative stress and monolayer permeability only in diethyl maleate-treated cells. These data demonstrate that the IPEC-J2 oxidative stress model is a valuable tool to screen antioxidants before validation in piglets.	[Vergauwen, Hans; Tambuyzer, Bart; Jennes, Karen; Van Ginneken, Chris] Univ Antwerp, Fac Biomed Pharmaceut & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium; [Degroote, Jeroen; Wang, Wei; Michiels, Joris] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, B-9000 Ghent, Belgium; [Degroote, Jeroen; Wang, Wei; De Smet, Stefaan; Michiels, Joris] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual LANUPRO, Melle, Belgium	University of Antwerp; Ghent University; Ghent University	Van Ginneken, C (corresponding author), Univ Antwerp, Fac Biomed Pharmaceut & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium.	chris.vanginneken@uantwerpen.be	DeSmet, Stefaan/N-7576-2017; Van Ginneken, Chris/AAK-2559-2020	DeSmet, Stefaan/0000-0003-1422-805X; Van Ginneken, Chris/0000-0002-1622-9120	IWT_LO by the agency for Innovation by Science and Technology [100856]	IWT_LO by the agency for Innovation by Science and Technology	This work was supported by the IWT_LO 100856 project provided by the agency for Innovation by Science and Technology. (http://www.iwt.be/) (CVG SDS JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J NUTR; [Anonymous], 2004, BRIT J PHARMACOL; Banan A, 2000, FREE RADICAL BIO MED, V28, P727, DOI 10.1016/S0891-5849(00)00160-X; BERSCHNEIDER H M, 1989, Gastroenterology, V96, pA41; Bizzozero OA, 2007, NEUROCHEM RES, V32, P2114, DOI 10.1007/s11064-007-9377-y; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; BRITT SG, 1992, J RECEPTOR RES, V12, P181, DOI 10.3109/10799899209074791; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Cai X, 2013, MOL CELLULAR BIOCH; Carrasco-Pozo C, 2013, J AGR FOOD CHEM; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Dolara P, 2012, EUR J NUTR, V51, P769, DOI 10.1007/s00394-012-0389-2; Dymkowska D, 2009, ACTA BIOCHIM POL, V56, P711; Ebert B, 2007, TOXICOL SCI, V96, P227, DOI 10.1093/toxsci/kfl147; Fagundes DS, 2011, REV ESP ENFERM DIG, V103, P396, DOI 10.4321/s1130-01082011000800002; Geens MM, 2011, CYTOTECHNOLOGY, V63, P415, DOI 10.1007/s10616-011-9362-9; Guellich A, 2007, AM J PHYSIOL-HEART C, V293, pH93, DOI 10.1152/ajpheart.00037.2007; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Herring TA, 2007, DIGEST DIS SCI, V52, P3005, DOI 10.1007/s10620-006-9663-6; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Kale G, 2003, BIOCH BIOPHYSICAL RE, V302, P324; Kaurinovic B, 2012, MOLECULES, V17, P11156, DOI 10.3390/molecules170911156; Kim M, 2012, SURG INFECT, V13, P18, DOI 10.1089/sur.2011.057; Kumar A, 2012, J CANCER RES THER, V8, P254, DOI 10.4103/0973-1482.98980; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Mariani V, 2009, VET IMMUNOL IMMUNOP, V131, P278, DOI 10.1016/j.vetimm.2009.04.006; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Nogueira V, 2013, CLIN CANC RES OFF J; Ozhegov EV, 2012, B EXP BIOL MED+, V152, P420, DOI 10.1007/s10517-012-1543-9; Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x; Paszti-Gere E, 2013, ACTA PHYSIOL HUNG, V100, P89, DOI 10.1556/APhysiol.100.2013.1.9; Paszti-Gere E, 2012, INFLAMMATION, V35, P994, DOI 10.1007/s10753-011-9403-8; Rao R, 1999, BIOCHEM PHARMACOL, V57, P685, DOI 10.1016/S0006-2952(98)00333-5; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Rao RK, 1997, AM J PHYSIOL-GASTR L, V273, pG812, DOI 10.1152/ajpgi.1997.273.4.G812; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Rosignoli P, 2001, CARCINOGENESIS, V22, P1675, DOI 10.1093/carcin/22.10.1675; Samarasinghe DA, 2000, HEPATOLOGY, V31, P160, DOI 10.1002/hep.510310124; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Seth A, 2009, FASEB J, V23; SPECTOR A, 1987, EXP EYE RES, V45, P453, DOI 10.1016/S0014-4835(87)80130-6; STADDON JM, 1995, J CELL SCI, V108, P609; Testa MP, 2011, JOVE-J VIS EXP, DOI 10.3791/2841; Trombino S, 2012, MOLECULES, V17, P12734, DOI 10.3390/molecules171112734; Tupe RS, 2010, EUR J NUTR, V49, P53, DOI 10.1007/s00394-009-0048-4; Wang N, 2012, DIGEST DIS SCI, V57, P1792, DOI 10.1007/s10620-012-2094-7; Yoshida T, 1996, J CHROMATOGR B, V678, P157, DOI 10.1016/0378-4347(95)00489-0; Yu Linda Chia-Hui, 2012, World J Gastrointest Pathophysiol, V3, P27, DOI 10.4291/wjgp.v3.i1.27; Zafrilla P, 2006, CURR MED CHEM, V13, P1075, DOI 10.2174/092986706776360978; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004	58	44	46	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120485	10.1371/journal.pone.0120485	http://dx.doi.org/10.1371/journal.pone.0120485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745867	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400096
J	Yamauchi, T; Kuroda, Y; Morita, T; Shichinohe, H; Houkin, K; Dezawa, M; Kuroda, S				Yamauchi, Tomohiro; Kuroda, Yasumasa; Morita, Takahiro; Shichinohe, Hideo; Houkin, Kiyohiro; Dezawa, Mari; Kuroda, Satoshi			Therapeutic Effects of Human Multilineage-Differentiating Stress Enduring (MUSE) Cell Transplantation into Infarct Brain of Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; PLURIPOTENT STEM-CELLS; CEREBRAL INFARCT; ISCHEMIC-STROKE; RAT MODEL; SPINAL-CORD; DISEASE; INJURY; MIGRATION; RECOVERY	Objective Bone marrow stromal cells (BMSCs) are heterogeneous and their therapeutic effect is pleiotropic. Multilineage-differentiating stress enduring (Muse) cells are recently identified to comprise several percentages of BMSCs, being able to differentiate into triploblastic lineages including neuronal cells and act as tissue repair cells. This study was aimed to clarify how Muse and non-Muse cells in BMSCs contribute to functional recovery after ischemic stroke. Methods Human BMSCs were separated into stage specific embryonic antigen-3-positive Muse cells and -negative non-Muse cells. Immunodeficient mice were subjected to permanent middle cerebral artery occlusion and received transplantation of vehicle, Muse, non-Muse or BMSCs (2.5x10(4) cells) into the ipsilateral striatum 7 days later. Results Motor function recovery in BMSC and non-Muse groups became apparent at 21 days after transplantation, but reached the plateau thereafter. In Muse group, functional recovery was not observed for up to 28 days post-transplantation, but became apparent at 35 days post-transplantation. On immunohistochemistry, only Muse cells were integrated into peri-infarct cortex and differentiate into Tuj-1- and NeuN-expressing cells, while negligible number of BMSCs and non-Muse cells remained in the peri-infarct area at 42 days post-transplantation. Conclusions These findings strongly suggest that Muse cells and non-Muse cells may contribute differently to tissue regeneration and functional recovery. Muse cells may be more responsible for replacement of the lost neurons through their integration into the peri-infarct cortex and spontaneous differentiation into neuronal marker-positive cells. Non-Muse cells do not remain in the host brain and may exhibit trophic effects rather than cell replacement.	[Yamauchi, Tomohiro; Shichinohe, Hideo; Houkin, Kiyohiro; Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Kuroda, Yasumasa; Morita, Takahiro; Dezawa, Mari] Tohoku Univ, Grad Sch Med, Dept Stem Cell Biol & Histol, Sendai, Miyagi 980, Japan; [Kuroda, Satoshi] Toyama Univ, Grad Sch Med & Pharmacol Sci, Dept Neurosurg, Toyama 930, Japan	Hokkaido University; Tohoku University; University of Toyama	Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.	skuroda@med.u-toyama.ac.jp			Grants-in-Aid for Scientific Research [25293305] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Kalaria RN, 2012, STROKE, V43, P2526, DOI 10.1161/STROKEAHA.112.655803; Kawabori M, 2013, NEUROPATHOLOGY, V33, P140, DOI 10.1111/j.1440-1789.2012.01335.x; Kuroda S, 2013, ACTA NEUROBIOL EXP, V73, P57; Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2014, NEUROREHABIL NEURAL; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2010, DEMENT GERIATR COGN, V30, P293, DOI 10.1159/000320486; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Taguchi Akihiko, 2010, J Exp Stroke Transl Med, V3, P28; Takasaki K, 2011, J PHARMACOL SCI, V116, P232, DOI 10.1254/jphs.11013FP; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; Wakao Shohei, 2012, Cells, V1, P1045, DOI 10.3390/cells1041045; Wakao S, 2014, PATHOL INT, V64, P1, DOI 10.1111/pin.12129; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Wang LQ, 2013, NEUROL RES, V35, P470, DOI 10.1179/1743132813Y.0000000210; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Yang ZZ, 2014, NEUROSCI BULL, V30, P524, DOI 10.1007/s12264-013-1431-y	32	47	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116009	10.1371/journal.pone.0116009	http://dx.doi.org/10.1371/journal.pone.0116009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747577	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400002
J	Zhao, ST; Li, JC				Zhao, Shitao; Li, Jincheng			Sphingosine-1-Phosphate Induces the Migration of Thyroid Follicular Carcinoma Cells through the MicroRNA-17/PTK6/ERK1/2 Pathway	PLOS ONE			English	Article							BRK TYROSINE KINASE; BREAST-TUMOR KINASE; CANCER CELLS; SPHINGOSINE 1-PHOSPHATE; MICRORNA PRECURSORS; NUCLEAR EXPORT; EXPRESSION; CLUSTER; RECEPTORS; SURVIVAL	Sphingosine-1-phosphate (S1P) is a bioactive lipid known to play a role in tumorigenesis and cancer progression. However, the molecular mechanisms of S1P regulated migration of papillary thyroid cancer cells are still unknown. In this study, we showed that S1P induced PTK6 mRNA and protein expression in two thyroid follicular cancer cell lines (ML-1 and FTC-133). Further studies demonstrated that induced PTK6 and its downstream signal component (ERK1/2) are involved in S1P-induced migration. Upon investigating the mechanisms behind this event, we found that miR-17 inhibited the expression of PTK6 through direct binding to its 3'-UTR. Through overexpression and knockdown studies, we found that miR-17 can significantly inhibit S1P-induced migration in thyroid follicular cancer cells. Interestingly, overexpression or knockdown of PTK6 or ERK1/2 effectively removed the inhibition of S1P-induced migration by miR-17. Furthermore, we showed that S1P decreased miR-17 expression levels. Meanwhile, in papillary thyroid cancers, miR-17 is downregulated and negatively associated with clinical staging, whereas PTK6 is upregulated and positively associated with clinical stages. Collectively, our work defines a novel signaling pathway implicated in the control of thyroid cancer migration.	[Zhao, Shitao; Li, Jincheng] Liaoning Med Univ, Affiliated Hosp 1, Dept Breast & Thyroid Sugery, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University	Li, JC (corresponding author), Liaoning Med Univ, Affiliated Hosp 1, Dept Breast & Thyroid Sugery, Jinzhou, Liaoning, Peoples R China.	liaoyiruxian@163.com			Social Development Research Plan of the Liaoning Province Science and Technology Department [2010225034]	Social Development Research Plan of the Liaoning Province Science and Technology Department	This work was supported by the Social Development Research Plan of the Liaoning Province Science and Technology Department (Grant No. 2010225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai MD, 2013, CANCER BIOL THER, V14, P237, DOI 10.4161/cbt.23295; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chang CC, 2013, ORAL ONCOL, V49, P923, DOI 10.1016/j.oraloncology.2013.03.430; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Kalhori V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066189; LEE ST, 1993, ONCOGENE, V8, P3403; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Liu XK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-59; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Murphy BL, 2013, CANCER RES, V73, P7068, DOI 10.1158/0008-5472.CAN-13-0927; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Ono H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096060; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Peng M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.43; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhao C, 2013, ONCOTARGETS THER, V6, P183, DOI 10.2147/OTT.S41283	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119148	10.1371/journal.pone.0119148	http://dx.doi.org/10.1371/journal.pone.0119148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748447	Green Submitted, Green Published, gold			2022-12-26	WOS:000350689400050
J	Gendronneau, G; Sanii, S; Dang, T; Deshayes, F; Delacour, D; Pichard, E; Advedissian, T; Sidhu, SS; Viguier, M; Magnaldo, T; Poirier, F				Gendronneau, Gaelle; Sanii, Sadaf; Dang, Tien; Deshayes, Frederique; Delacour, Delphine; Pichard, Evelyne; Advedissian, Tamara; Sidhu, Sukhvinder S.; Viguier, Mireille; Magnaldo, Thierry; Poirier, Francoise			Overexpression of Galectin-7 in Mouse Epidermis Leads to Loss of Cell Junctions and Defective Skin Repair	PLOS ONE			English	Article							TUMOR PROGRESSION; INCREASED EXPRESSION; LECTINS; CANCER; ADHESION; BINDING; HYPOPHARYNGEAL; KERATINOCYTES; METASTASIS; MODULATORS	Background The proteins of the galectin family are implicated in many cellular processes, including cell interactions, polarity, intracellular trafficking, and signal transduction. In human and mouse, galectin-7 is almost exclusively expressed in stratified epithelia, notably in the epidermis. Galectin-7 expression is also altered in several human tumors of epithelial origin. This study aimed at dissecting the consequences of galectin-7 overexpression on epidermis structure and functions in vivo. Methods We established transgenic mice specifically overexpressing galectin-7 in the basal epidermal keratinocytes and analyzed the consequences on untreated skin and after UVB irradiation or mechanical injury. Results The intercellular cohesion of the epidermis is impaired in transgenic animals, with gaps developing between adjacent keratinocytes, associated with loss of adherens junctions. The epidermal architecture is aberrant with perturbations in the multilayered cellular organisation of the tissue, and structural defects in the basement membrane. These transgenic animals displayed a reduced re-epithelialisation potential following superficial wound, due to a defective collective migration of keratinocytes. Finally, a single mild dose of UVB induced an abnormal apoptotic response in the transgenic epidermis. Conclusion These results indicate that an excess of galectin-7 leads to a destabilisation of adherens junctions associated with defects in epidermal repair. As this phenotype shares similarities with that of galectin-7 null mutant mice, we conclude that a critical level of this protein is required for maintaining proper epidermal homeostasis. This study brings new insight into the mode of action of galectins in normal and pathological situations.	[Gendronneau, Gaelle; Sanii, Sadaf; Dang, Tien; Deshayes, Frederique; Delacour, Delphine; Pichard, Evelyne; Advedissian, Tamara; Sidhu, Sukhvinder S.; Viguier, Mireille; Poirier, Francoise] Paris Diderot Univ, Inst Jacques Monod, UMR CNRS 7592, Paris, France; [Magnaldo, Thierry] CNRS, INSERM, UNS UMR 7284, IRCAN,U 1081, F-06034 Nice, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Poirier, F (corresponding author), Paris Diderot Univ, Inst Jacques Monod, UMR CNRS 7592, Paris, France.	poirier@ijm.univ-paris-diderot.fr		Sidhu, Sukhvinder/0000-0002-2999-4358; Thierry, Magnaldo/0000-0001-9174-8599; Delacour, Delphine/0000-0001-8202-4425	MENRT; ARC; GEFLUC; LNCC; Foundation de l'Avenir	MENRT; ARC(Australian Research Council); GEFLUC; LNCC; Foundation de l'Avenir	This work was supported by MENRT (www.enseignementsup-recherche.gouv.fr), ARC (www.recherche.cancer.net), GEFLUC (wwwgefluc.org/paris-ile-de-france.html), LNCC (www.ligue-cancer.net), and Foundation de l'Avenir (http//www.fondationdelavenir.org/portail/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brewer CF, 2002, BBA-GEN SUBJECTS, V1572, P255, DOI 10.1016/S0304-4165(02)00312-4; Campion CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072468; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Etienne-Manneville Sandrine, 2012, Subcell Biochem, V60, P225, DOI 10.1007/978-94-007-4186-7_10; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Hughes RC, 2001, BIOCHIMIE, V83, P667; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim HJ, 2013, ANTICANCER RES, V33, P1555; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Menkhorst EM, 2014, PLACENTA, V35, P195, DOI 10.1016/j.placenta.2014.01.004; Nakahara S, 2008, ANTI-CANCER AGENT ME, V8, P22; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Saussez S, 2008, HISTOPATHOLOGY, V52, P483, DOI 10.1111/j.1365-2559.2008.02973.x; Saussez S, 2006, ANN SURG ONCOL, V13, P999, DOI 10.1245/ASO.2006.08.033; Timmons PM, 1999, INT J DEV BIOL, V43, P229; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATT FM, 1993, J CELL SCI, V106, P175; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560	36	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119031	10.1371/journal.pone.0119031	http://dx.doi.org/10.1371/journal.pone.0119031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741714	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100073
J	Hara, T; Kobayashi, E; Ohtsubo, K; Kumada, S; Kanazawa, M; Abe, T; Itoh, RD; Fujiwara, MT				Hara, Takuya; Kobayashi, Emi; Ohtsubo, Kohei; Kumada, Shogo; Kanazawa, Mikako; Abe, Tomoko; Itoh, Ryuuichi D.; Fujiwara, Makoto T.			Organ-Level Analysis of Idioblast Patterning in Egeria densa Planch. Leaves	PLOS ONE			English	Article							MYROSIN CELLS; ARABIDOPSIS; ULTRASTRUCTURE; TANNINS; PATHWAY; ELODEA; PLANTS; FAMA; FATE	Leaf tissues of plants usually contain several types of idioblasts, defined as specialized cells whose shape and contents differ from the surrounding homogeneous cells. The spatial patterning of idioblasts, particularly of trichomes and guard cells, across the leaf epidermis has received considerable attention as it offers a useful biological model for studying the intercellular regulation of cell fate and patterning. Excretory idioblasts in the leaves of the aquatic monocotyledonous plant Egeria densa produced light blue autofluorescence when irradiated with ultraviolet light. The use of epifluorescence microscopy to detect this autofluorescence provided a simple and convenient method for detecting excretory idioblasts and allowed tracking of those cells across the leaf surfaces, enabling quantitative measurement of the clustering and spacing patterns of idioblasts at the whole leaf level. Occurrence of idioblasts was coordinated along the proximal-distal, medial-lateral, and adaxial-abaxial axes, producing a recognizable consensus spatial pattern of idioblast formation among fully expanded leaves. Idioblast clusters, which comprised up to nine cells aligned along the proximal-distal axis, showed no positional bias or regularity in idioblast-forming areas when compared with singlet idioblasts. Up to 75% of idioblasts existed as clusters on every leaf side examined. The idioblast-forming areas varied between leaves, implying phenotypic plasticity. Furthermore, in young expanding leaves, autofluorescence was occasionally detected in a single giant vesicle or else in one or more small vesicles, which eventually grew to occupy a large portion of the idioblast volume as a central vacuole. Differentiation of vacuoles by accumulating the fluorescence substance might be an integral part of idioblast differentiation. Red autofluorescence from chloroplasts was not detected in idioblasts of young expanding leaves, suggesting idioblast differentiation involves an arrest in chloroplast development at a very early stage, rather than transdifferentiation of chloroplastcontaining epidermal cells.	[Hara, Takuya; Kobayashi, Emi; Ohtsubo, Kohei; Kumada, Shogo; Kanazawa, Mikako; Fujiwara, Makoto T.] Sophia Univ, Dept Biol, Chiyoda Ku, Tokyo 1028554, Japan; [Abe, Tomoko; Fujiwara, Makoto T.] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan; [Itoh, Ryuuichi D.] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9031213, Japan	Sophia University; RIKEN; University of the Ryukyus	Fujiwara, MT (corresponding author), Sophia Univ, Dept Biol, Chiyoda Ku, Tokyo 1028554, Japan.	mtf1@mac.com	Itoh, Ryuuichi D/B-1167-2008; Fujiwara, Makoto T/A-2122-2008	Itoh, Ryuuichi D/0000-0002-5786-2176; Fujiwara, Makoto T/0000-0002-4668-276X	Ministry of Education, Culture, Sports, Science and Technology of Japan [22780087, 25450136]; Grants-in-Aid for Scientific Research [25450136, 26440152] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (nos. 22780087 and 25450136 to MTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Barlow PW, 2008, RUSS J PLANT PHYSL+, V55, P149, DOI 10.1134/S1021443708020015; Brillouet JM, 2013, ANN BOT-LONDON, V112, P1003, DOI 10.1093/aob/mct168; COOK CDK, 1984, AQUAT BOT, V19, P73, DOI 10.1016/0304-3770(84)90009-3; CORDES WC, 1960, STAIN TECHNOL, V35, P191, DOI 10.3109/10520296009114736; CORDES WC, 1959, PHYSIOL PLANTARUM, V12, P62, DOI 10.1111/j.1399-3054.1959.tb07885.x; Csurhes S., 2008, PEST PLANT RISK ASSE; Evert R.F., 2006, ESAUS PLANT ANATOMY, Vthird, P624, DOI [10.1093/aob/mcm015, DOI 10.1093/AOB/MCM015]; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; FOSTER AS, 1956, PROTOPLASMA, V46, P184, DOI 10.1007/BF01248877; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; HARAMOTO T, 1988, AQUAT BOT, V30, P389, DOI 10.1016/0304-3770(88)90070-8; KUROIWA T, 1991, INT REV CYTOL, V128, P1; Larkin JC, 1997, PLANT CELL, V9, P1109, DOI 10.1105/tpc.9.7.1109; Li M, 2014, PLANT CELL, V26, P4053, DOI 10.1105/tpc.114.129726; Marinho CR, 2011, FLORA, V206, P1052, DOI 10.1016/j.flora.2011.07.011; Martin C, 2007, CURR OPIN PLANT BIOL, V10, P70, DOI 10.1016/j.pbi.2006.11.004; Momose T, 1995, P ANN M BOT SOC JAPA, V59, P315; Pasqua G, 2004, EUR J HISTOCHEM, V48, P321; PLATT KA, 1992, INT J PLANT SCI, V153, P301, DOI 10.1086/297033; Shirakawa M, 2014, PLANT CELL, V26, P4039, DOI 10.1105/tpc.114.129874; Solereder H., 1913, BOT CENTRALBL S, V30, P24; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Stadelmann EJ, 1972, METHODS CELL PHYSL, V5, P325, DOI DOI 10.1016/S0091-679X(08)60717-7; TAKADA HIDEO, 1952, JOUR INST POLYTECH [OSAKA CITY UNIV] SER D BIOL, V3, P31; Tomlinson PB., 1982, ANAL MONOCOTYLEDONS, P126; TRACHTENBERG S, 1981, BOT GAZ, V142, P206, DOI 10.1086/337215; Tretyn A, 1996, PROTOPLASMA, V191, P205, DOI 10.1007/BF01281818; Ueda H, 2006, PLANT CELL PHYSIOL, V47, P164, DOI 10.1093/pcp/pci232; WERKER E, 1974, PLANTA, V116, P243, DOI 10.1007/BF00390230; Yarrow M, 2009, REV CHIL HIST NAT, V82, P299, DOI 10.4067/S0716-078X2009000200010; YOSHIDA YOSHIO, 1958, JOUR FAC SCI NIIGATA UNIV SER N BIOL GEOL AND MINERALOGY, V2, P173; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x	33	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118965	10.1371/journal.pone.0118965	http://dx.doi.org/10.1371/journal.pone.0118965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742311	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100069
J	Mozhui, K; Smith, AK; Tylavsky, FA				Mozhui, Khyobeni; Smith, Alicia K.; Tylavsky, Frances A.			Ancestry Dependent DNA Methylation and Influence of Maternal Nutrition	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; VITAMIN-D; AFRICAN-AMERICAN; GLUCOCORTICOID-RECEPTOR; RACIAL-DIFFERENCES; WHITE WOMEN; CANCER; HEALTH; FOLATE; AGE	There is extensive variation in DNA methylation between individuals and ethnic groups. These differences arise from a combination of genetic and non-genetic influences and potential modifiers include nutritional cues, early life experience, and social and physical environments. Here we compare genome-wide DNA methylation in neonatal cord blood from African American (AA; N = 112) and European American (EA; N = 91) participants of the CANDLE Study (Conditions Affecting Neurocognitive Development and Learning in Early Childhood). Our goal is to determine if there are replicable ancestry-specific methylation patterns that may implicate risk factors for diseases that have differential prevalence between populations. To identify the most robust ancestry-specific CpG sites, we replicate our results in lymphoblastoid cell lines from Yoruba African and CEPH European panels of HapMap. We also evaluate the influence of maternal nutrition-specifically, plasma levels of vitamin D and folate during pregnancy-on methylation in newborns. We define stable ancestry-dependent methylation of genes that include tumor suppressors and cell cycle regulators (e.g., APC, BRCA1, MCC). Overall, there is lower global methylation in African ancestral groups. Plasma levels of 25-hydroxy vitamin D are also considerably lower among AA mothers and about 60% of AA and 40% of EA mothers have concentrations below 20 ng/ml. Using a weighted correlation analysis, we define a network of CpG sites that is jointly modulated by ancestry and maternal vitamin D. Our results show that differences in DNA methylation patterns are remarkably stable and maternal micronutrients can exert an influence on the child epigenome.	[Mozhui, Khyobeni; Tylavsky, Frances A.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Smith, Alicia K.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	University of Tennessee System; University of Tennessee Health Science Center; Emory University	Mozhui, K (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA.	kmozhui@uthsc.edu	Smith, Alicia/W-6809-2019	Smith, Alicia/0000-0002-8537-5156	US National Institute of Child Health and Human Development [HD055462, HD060713]; US National Institute of the Heart, Lung and Blood [1R01HL109977]; US National Institute on Minority Health and Health Disparities [R01MD009064]; Children's Foundation Research Center of Memphis, University of Tennessee Health Science Center's Clinical Translational Science Institute; Urban Child Institute, Memphis, TN; US National Center for Research [M01-RR00211]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055462] Funding Source: NIH RePORTER	US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institute of the Heart, Lung and Blood; US National Institute on Minority Health and Health Disparities; Children's Foundation Research Center of Memphis, University of Tennessee Health Science Center's Clinical Translational Science Institute; Urban Child Institute, Memphis, TN; US National Center for Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the Grants HD055462 and HD060713 from the US National Institute of Child Health and Human Development; 1R01HL109977 US National Institute of the Heart, Lung and Blood and R01MD009064 from the US National Institute on Minority Health and Health Disparities; Children's Foundation Research Center of Memphis, University of Tennessee Health Science Center's Clinical Translational Science Institute; by the grant from the Urban Child Institute, Memphis, TN; and by the Grant M01-RR00211 from the US National Center for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2012, CHEM BIODIVERS, V9, P888, DOI 10.1002/cbdv.201100395; Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Barres R, 2013, CELL REP, V3, P1020, DOI 10.1016/j.celrep.2013.03.018; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Braveman Paula, 2009, Pediatrics, V124 Suppl 3, pS163, DOI 10.1542/peds.2009-1100D; Choi SW, 2010, ADV NUTR, V1, P8, DOI 10.3945/an.110.1004; DeSantis C, 2013, CA-CANCER J CLIN, V63, P151, DOI 10.3322/caac.21173; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fetahu IS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00164; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Guenard F, 2013, P NATL ACAD SCI USA, V110, P11439, DOI 10.1073/pnas.1216959110; Hoeft B, 2012, INT J VITAM NUTR RES, V82, P316, DOI 10.1024/0300-9831/a000125; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kitabchi AE, 2013, DIABETES CARE, V36, P1919, DOI 10.2337/dc12-1912; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Krushkal J, 2014, BEHAV GENET, V44, P113, DOI 10.1007/s10519-014-9641-2; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Looker Anne C, 2011, NCHS Data Brief, P1; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Maloney CA, 2007, BRIT J NUTR, V97, P1090, DOI 10.1017/S0007114507670834; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McGowan PO, 2008, BRAIN RES, V1237, P12, DOI 10.1016/j.brainres.2008.07.074; McKay JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033290; McKay JA, 2011, GENES NUTR, V6, P189, DOI 10.1007/s12263-010-0199-1; Millen AE, 2008, AM J CLIN NUTR, V87, p1102S, DOI 10.1093/ajcn/87.4.1102S; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Nestor CE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004059; Novakovic B, 2012, AM J CLIN NUTR, V96, P188, DOI 10.3945/ajcn.112.035683; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Palmer FB, 2013, J PEDIATR-US, V163, P1733, DOI 10.1016/j.jpeds.2013.08.030; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Porter PL, 2004, CANCER-AM CANCER SOC, V100, P2533, DOI 10.1002/cncr.20279; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Robinson MD, 2010, EPIGENOMICS-UK, V2, P587, DOI 10.2217/EPI.10.36; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; Sabounchi S, 2012, CLIN COLORECTAL CANC, V11, P66, DOI 10.1016/j.clcc.2011.03.026; SCOTT JM, 1974, AM J MED TECHNOL, V40, P125; Simon MS, 2011, CANCER EPIDEM BIOMAR, V20, P1368, DOI 10.1158/1055-9965.EPI-11-0027; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Smith AK, 2012, EPIGENETICS-US, V7, P458, DOI 10.4161/epi.19617; Tapp HS, 2013, AGING CELL, V12, P148, DOI 10.1111/acel.12030; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Wiencke JK, 2004, NAT REV CANCER, V4, P79, DOI 10.1038/nrc1257; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhu HD, 2013, J PEDIATR-US, V162, P1004, DOI 10.1016/j.jpeds.2012.10.059	80	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118466	10.1371/journal.pone.0118466	http://dx.doi.org/10.1371/journal.pone.0118466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742137	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100019
J	Serena, C; Calvo, E; Clares, MP; Diaz, ML; Chicote, JU; Beltran-Debon, R; Fontova, R; Rodriguez, A; Garcia-Espana, E; Garcia-Espana, A				Serena, Carolina; Calvo, Enrique; Paz Clares, Mari; Luisa Diaz, Mara; Chicote, Javier U.; Beltran-Debon, Raul; Fontova, Ramon; Rodriguez, Alejandro; Garcia-Espana, Enrique; Garcia-Espana, Antonio			Significant In Vivo Anti-Inflammatory Activity of Pytren4Q-Mn a Superoxide Dismutase 2 (SOD2) Mimetic Scorpiand-Like Mn (II) Complex	PLOS ONE			English	Article							OXIDATIVE STRESS; BREAST-CANCER; SEPTIC SHOCK; MOUSE MODELS; THP-1 CELLS; INHIBITION; ACTIVATION; MECHANISMS; EXPRESSION; THERAPY	Background The clinical use of purified SOD enzymes has strong limitations due to their large molecular size, high production cost and immunogenicity. These limitations could be compensated by using instead synthetic SOD mimetic compounds of low molecular weight. Background/Methodology We have recently reported that two SOD mimetic compounds, the Mn-II complexes of the polyamines Pytren2Q and Pytren4Q, displayed high antioxidant activity in bacteria and yeast. Since frequently molecules with antioxidant properties or free-radical scavengers also have anti-inflammatory properties we have assessed the anti-inflammatory potential of Pytren2Q and Pytren4Q Mn-II complexes, in cultured macrophages and in a murine model of inflammation, by measuring the degree of protection they could provide against the cellular injury produced by lipopolisacharide, a bacterial endotoxin. Principal Findings In this report we show that the Mn-II complex of Pytren4Q but not that of Pytren2Q effectively protected human cultured THP-1 macrophages and whole mice from the inflammatory effects produced by LPS. These results obtained with two molecules that are isomers highlight the importance of gathering experimental data from animal models of disease in assessing the potential of candidate molecules. Conclusion/Significance The effective anti-inflammatory activity of the Mn-II complex of Pytren4Q in addition to its low toxicity, water solubility and ease of production would suggest it is worth taking into consideration for future pharmacological studies.	[Serena, Carolina; Calvo, Enrique; Chicote, Javier U.; Beltran-Debon, Raul; Garcia-Espana, Antonio] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Res Unit, E-43007 Tarragona, Spain; [Paz Clares, Mari; Garcia-Espana, Enrique] Univ Valencia, Dept Quim Inorgan, Inst Ciencia Mol, Valencia, Spain; [Luisa Diaz, Mara] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Dept Pathol, E-43007 Tarragona, Spain; [Fontova, Ramon] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Dept Rheumatol, E-43007 Tarragona, Spain; [Rodriguez, Alejandro] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Crit Care Dept, E-43007 Tarragona, Spain; [Rodriguez, Alejandro] ISC III, CIBER Enfermedades Resp CIBERES, Bunyola, Palma De Mallor, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Valencia; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Garcia-Espana, A (corresponding author), Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Res Unit, E-43007 Tarragona, Spain.	uroteli@iispv.cat	Serena, Carolina/J-5687-2014; Serena, Carolina/AAQ-6831-2021; garcia-españa, antonio/I-4756-2015; Calvo, Enrique/K-8680-2014; García-España, Enrique V./F-5473-2016; Beltrán-Debón, Raúl/A-9287-2014; Clares, M Paz/AAG-5694-2019	Serena, Carolina/0000-0003-2251-0856; Serena, Carolina/0000-0003-2251-0856; garcia-españa, antonio/0000-0002-9957-3161; Calvo, Enrique/0000-0002-2468-0931; García-España, Enrique V./0000-0002-4601-6505; Beltrán-Debón, Raúl/0000-0001-9691-1906; Clares, M Paz/0000-0002-9154-8842; Diaz, Maria Luisa/0000-0003-0303-9077; Fontova Garrofe, Ramon/0000-0002-0592-2018; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584	MINECO CONSOLIDER INGENIO [CSD2010-00065]; GENERALITAT VALENCIANA PROMETEO GVA [2011-008]	MINECO CONSOLIDER INGENIO; GENERALITAT VALENCIANA PROMETEO GVA	This work was supported by MINECO CONSOLIDER INGENIO CSD2010-00065 (A.G-E; E.G-E); GENERALITAT VALENCIANA PROMETEO GVA 2011-008 (E.G-E).	Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; CALANDRA T, 1991, AM J MED, V91, P23, DOI 10.1016/0002-9343(91)90069-A; Choi YY, 2013, INHIBITORY EFFECT CO; Cuadrado I, 2012, TOXICOL APPL PHARM, V258, P109, DOI 10.1016/j.taap.2011.10.013; Cuzzocrea S, 2005, ARTHRITIS RHEUM-US, V52, P1929, DOI 10.1002/art.21044; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Garcia-Espana A, 2005, CANCER RES, V65, P1150, DOI 10.1158/0008-5472.CAN-04-2074; Garcia-Espana E., 2011, Patent WO, Patent No. [WO2011/033163 A2, 2011033163, 2011/033163 A2]; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Hong TH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-146; Inclan M, 2012, J AM CHEM SOC, V134, P9644, DOI 10.1021/ja300538s; Jiang SR, 2013, INT IMMUNOPHARMACOL, V16, P100, DOI 10.1016/j.intimp.2013.03.024; Kanno S, 2006, LIFE SCI, V78, P673, DOI 10.1016/j.lfs.2005.04.051; Lawton JA, 2003, CURR OPIN CHEM BIOL, V7, P446, DOI 10.1016/S1367-5931(03)00077-2; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Opal SM, 2007, CRIT CARE MED, V35, P387, DOI 10.1097/01.CCM.0000253810.08230.83; Clares MP, 2015, J INORG BIOCHEM, V143, P1, DOI 10.1016/j.jinorgbio.2014.11.001; Clares MP, 2011, CHEM COMMUN, V47, P5988, DOI 10.1039/c1cc10526d; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Raju H, 2011, RECENT PAT ANTI-CANC, V6, P186, DOI 10.2174/157489211795328459; Riley DP, 1999, CHEM REV, V99, P2573, DOI 10.1021/cr980432g; Rull A, 2007, EXP MOL PATHOL, V83, P361, DOI 10.1016/j.yexmp.2007.08.003; Salvemini D, 2002, PULM PHARMACOL THER, V15, P439, DOI 10.1006/pupt.2002.0374; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Toyokuni S, 2008, IUBMB LIFE, V60, P441, DOI 10.1002/iub.61; Warren HS, 2009, J LEUKOCYTE BIOL, V86, P199, DOI 10.1189/jlb.0309210; You R, 2013, J MED CHEM, V56, P1984, DOI 10.1021/jm301652t	34	15	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119102	10.1371/journal.pone.0119102	http://dx.doi.org/10.1371/journal.pone.0119102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742129	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100082
J	Zhang, MM; Kothari, P; Lampson, MA				Zhang, Maomao; Kothari, Priyanka; Lampson, Michael A.			Spindle Assembly Checkpoint Acquisition at the Mid-Blastula Transition	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; ZEBRAFISH MIDBLASTULA TRANSITION; MAJOR DEVELOPMENTAL TRANSITION; EARLY XENOPUS-EMBRYOS; CELL-CYCLE; ACTIVATION; CHK1; PHOSPHORYLATION; TRANSCRIPTION; KINASE	The spindle assembly checkpoint (SAC) maintains the fidelity of chromosome segregation during mitosis. Nonpathogenic cells lacking the SAC are typically only found in cleavage stage metazoan embryos, which do not acquire functional checkpoints until the mid-blastula transition (MBT). It is unclear how proper SAC function is acquired at the MBT, though several models exist. First, SAC acquisition could rely on transcriptional activity, which increases dramatically at the MBT. Embryogenesis prior to the MBT relies primarily on maternally loaded transcripts, and if SAC signaling components are not maternally supplied, the SAC would depend on zygotic transcription at the MBT. Second, checkpoint acquisition could depend on the Chk1 kinase, which is activated at the MBT to elongate cell cycles and is required for the SAC in somatic cells. Third, SAC function could depend on a threshold nuclear to cytoplasmic (N:C) ratio, which increases during pre-MBT cleavage cycles and dictates several MBT events like zygotic transcription and cell cycle remodeling. Finally, the SAC could by regulated by a timer mechanism that coincides with other MBT events but is independent of them. Using zebrafish embryos we show that SAC acquisition at the MBT is independent of zygotic transcription, indicating that the checkpoint program is maternally supplied. Additionally, by precociously lengthening cleavage cycles with exogenous Chk1 activity, we show that cell cycle lengthening and Chk1 activity are not sufficient for SAC acquisition. Furthermore, we find that SAC acquisition can be uncoupled from the N: C ratio. Together, our findings indicate that SAC acquisition is regulated by a maternally programmed developmental timer.	[Zhang, Maomao; Kothari, Priyanka; Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Zhang, Maomao; Lampson, Michael A.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lampson, MA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	lampson@sas.upenn.edu		Kothari, Priyanka/0000-0002-1791-5093	National Institutes of Health [T32HD007516, GM083988]; Searle Scholar award; Penn Genome Frontiers Institute; Pennsylvania Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar award; Penn Genome Frontiers Institute; Pennsylvania Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grants T32HD007516 to M. Z. and GM083988 to M. A. L.), a Searle Scholar award to M. A. L., and the Penn Genome Frontiers Institute and a grant with the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Carrassa L, 2009, J CELL MOL MED, V13, P1565, DOI [10.1111/j.1582-4934.2008.00362.x, 10.1111/j.1582-4934.2009.00362.x]; CLUTE P, 1992, DEV GROWTH DIFFER, V34, P27; Clute P, 1995, DEV BIOL, P273; Clute P, 1997, DEV BIOL, V13, P1; Collart C, 2013, SCIENCE, V341, P893, DOI 10.1126/science.1241530; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HOWE JA, 1995, GENE DEV, V9, P1164, DOI 10.1101/gad.9.10.1164; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; Ikegami R, 1997, ZYGOTE, V5, P329, DOI 10.1017/S0967199400003919; KANE DA, 1993, DEVELOPMENT, V119, P447; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Kisielewska J, 2005, BIOL CELL, V97, P221; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; MEINECKE B, 1993, J REPROD FERTIL, V98, P195; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nogare DED, 2009, DEV BIOL, V326, P131, DOI 10.1016/j.ydbio.2008.11.002; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; Petsalaki E, 2011, J CELL BIOL, V195, P449, DOI 10.1083/jcb.201104023; Pritchard DK, 1996, GENE DEV, V10, P1131, DOI 10.1101/gad.10.9.1131; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang MM, 2014, CELL CYCLE, V13, P3828, DOI 10.4161/15384101.2014.967066	34	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119285	10.1371/journal.pone.0119285	http://dx.doi.org/10.1371/journal.pone.0119285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741707	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100101
J	Hamilton, SE; Lovette, J				Hamilton, Stuart E.; Lovette, John			Ecuador's Mangrove Forest Carbon Stocks: A Spatiotemporal Analysis of Living Carbon Holdings and Their Depletion since the Advent of Commercial Aquaculture	PLOS ONE			English	Article							TROPICAL DEFORESTATION; ABOVEGROUND BIOMASS; DIOXIDE EMISSIONS; RIVER ESTUARY; PRODUCTIVITY; DYNAMICS; PATTERNS	In this paper we estimate the living carbon lost from Ecuador's mangrove forests since the advent of export-focused shrimp aquaculture. We use remote sensing techniques to delineate the extent of mangroves and aquaculture at approximately decadal periods since the arrival of aquaculture in each Ecuadorian estuary. We then spatiotemporally calculate the carbon values of the mangrove forests and estimate the amount of carbon lost due to direct displacement by aquaculture. Additionally, we calculate the new carbon stocks generated due to mangrove reforestation or afforestation. This research introduces time and LUCC (land use/land cover change) into the tropical forest carbon literature and examines forest carbon loss at a higher spatiotemporal resolution than in many earlier analyses. We find that 80 percent, or 7,014,517 t of the living carbon lost in Ecuadorian mangrove forests can be attributed to direct displacement of mangrove forests by shrimp aquaculture. We also find that IPCC (Intergovernmental Panel on Climate Change) compliant carbon grids within Ecuador's estuaries overestimate living carbon levels in estuaries where substantial LUCC has occurred. By approaching the mangrove forest carbon loss question from a LUCC perspective, these findings allow for tropical nations and other intervention agents to prioritize and target a limited set of land transitions that likely drive the majority of carbon losses. This singular cause of transition has implications for programs that attempt to offset or limit future forest carbon losses and place value on forest carbon or other forest good and services.	[Hamilton, Stuart E.] Salisbury Univ, Dept Geog & Geosci, Salisbury, MD 21801 USA; [Lovette, John] Univ N Carolina, Dept Geog, Chapel Hill, NC USA	University System of Maryland; Salisbury University; University of North Carolina; University of North Carolina Chapel Hill	Hamilton, SE (corresponding author), Salisbury Univ, Dept Geog & Geosci, Salisbury, MD 21801 USA.	stuartehamilton@gmail.com	Hamilton, Stuart E./A-4297-2013	Hamilton, Stuart E./0000-0001-8114-7247				Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/CMT.12.20, 10.4155/cmt.12.20]; [Anonymous], 1974, ANN REV ECOL SYST, DOI DOI 10.1146/ANNUREV.ES.05.110174.000351; [Anonymous], 2008, NEW IPCC TIER 1 GLOB; [Anonymous], 2014, GLOB; [Anonymous], 1997, WORLD MANGROVE ATLAS; Arriaga L, 1999, OCEAN COAST MANAGE, V42, P229, DOI 10.1016/S0964-5691(98)00055-6; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Chen RH, 1999, ESTUARIES, V22, P955, DOI 10.2307/1353075; Coello S, 1993, SPECIAL AREA MANAGEM; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; FAO Fisheries and Aquaculture Department, 2014, GLOB AQ STAT UPD 201; FAO Fisheries and Aquaculture Department, 2014, GLOB CAPT PROD STAT; Fisheries FAO and Department Aquaculture, 2010, STAT WORLD FISH AQ; Fromard F, 1998, OECOLOGIA, V115, P39, DOI 10.1007/s004420050489; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hamilton S, 2013, B MAR SCI, V89, P585, DOI 10.5343/bms.2012.1069; Hamilton SE, 2012, J LAND USE SCI, V7, P177, DOI 10.1080/1747423X.2010.550694; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Kauffman J. B, 2012, PROTOCOLS MEASUREMEN; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Ladd B, 2013, GLOBAL ECOL BIOGEOGR, V22, P461, DOI 10.1111/j.1466-8238.2012.00799.x; MADSEN JE, 2001, FLORA PUNA ISLAND PL; Melillo JM, 1996, ANNU REV ENERG ENV, V21, P293, DOI 10.1146/annurev.energy.21.1.293; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 1998, SCIENCE, V282, P883, DOI 10.1126/science.282.5390.883; Naylor R, 2011, FOOD SECUR, V3, P233, DOI 10.1007/s12571-011-0123-6; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SAENGER P, 1993, OECOLOGIA, V96, P293, DOI 10.1007/BF00317496; Sherman RE, 2003, ECOSYSTEMS, V6, P384, DOI 10.1007/s10021-002-0191-8; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Snedaker S. C., 1982, Contributions to the ecology of halophytes., P111; Soares MLG, 2005, ESTUAR COAST SHELF S, V65, P1, DOI 10.1016/j.ecss.2005.05.001; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; Watson RT., 2001, CONTRIBUTION WORKING, P1; Zarin DJ, 2012, SCIENCE, V336, P1518, DOI 10.1126/science.1223251	42	23	24	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118880	10.1371/journal.pone.0118880	http://dx.doi.org/10.1371/journal.pone.0118880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738286	Green Submitted, gold, Green Published			2022-12-26	WOS:000350685900082
J	Bolandzadeh, N; Kording, K; Salowitz, N; Davis, JC; Hsu, L; Chan, A; Sharma, D; Blohm, G; Liu-Ambrose, T				Bolandzadeh, Niousha; Kording, Konrad; Salowitz, Nicole; Davis, Jennifer C.; Hsu, Liang; Chan, Alison; Sharma, Devika; Blohm, Gunnar; Liu-Ambrose, Teresa			Predicting Cognitive Function from Clinical Measures of Physical Function and Health Status in Older Adults	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; WHITE-MATTER CHANGES; EXECUTIVE FUNCTION; FALLS RISK; WALK TEST; DECLINE; GAIT; PERFORMANCE; SPEED; CIRCUMFERENCE	Introduction Current research suggests that the neuropathology of dementia-including brain changes leading to memory impairment and cognitive decline-is evident years before the onset of this disease. Older adults with cognitive decline have reduced functional independence and quality of life, and are at greater risk for developing dementia. Therefore, identifying biomarkers that can be easily assessed within the clinical setting and predict cognitive decline is important. Early recognition of cognitive decline could promote timely implementation of preventive strategies. Methods We included 89 community-dwelling adults aged 70 years and older in our study, and collected 32 measures of physical function, health status and cognitive function at baseline. We utilized an L1-L2 regularized regression model (elastic net) to identify which of the 32 baseline measures were strongly predictive of cognitive function after one year. We built three linear regression models: 1) based on baseline cognitive function, 2) based on variables consistently selected in every cross-validation loop, and 3) a full model based on all the 32 variables. Each of these models was carefully tested with nested crossvalidation. Results Our model with the six variables consistently selected in every cross-validation loop had a mean squared prediction error of 7.47. This number was smaller than that of the full model (115.33) and the model with baseline cognitive function (7.98). Our model explained 47% of the variance in cognitive function after one year. Discussion We built a parsimonious model based on a selected set of six physical function and health status measures strongly predictive of cognitive function after one year. In addition to reducing the complexity of the model without changing the model significantly, our model with the top variables improved the mean prediction error and R-squared. These six physical function and health status measures can be easily implemented in a clinical setting.	[Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Expt Med Program, Vancouver, BC V5Z 1M9, Canada; [Bolandzadeh, Niousha; Hsu, Liang; Chan, Alison; Sharma, Devika; Liu-Ambrose, Teresa] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Bolandzadeh, Niousha; Hsu, Liang; Chan, Alison; Sharma, Devika; Liu-Ambrose, Teresa] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Bolandzadeh, Niousha; Davis, Jennifer C.; Hsu, Liang; Chan, Alison; Sharma, Devika; Liu-Ambrose, Teresa] Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Kording, Konrad] Northwestern Univ, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Salowitz, Nicole] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Davis, Jennifer C.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Davis, Jennifer C.] Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Blohm, Gunnar] Queens Univ, Dept Biomed & Mol Sci, Kingstone, ON, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; Northwestern University; Shirley Ryan AbilityLab; Marquette University; University of British Columbia; Queens University - Canada	Liu-Ambrose, T (corresponding author), Univ British Columbia, Expt Med Program, Vancouver, BC V5Z 1M9, Canada.	tlambrose@exchange.ubc.ca	Liu-Ambrose, Teresa/W-2332-2019; Hsu, Chun Liang/AAN-4254-2021; Kording, Konrad/A-1233-2007	Liu-Ambrose, Teresa/0000-0002-8297-5308; Hsu, Chun Liang/0000-0003-2090-1001; Kording, Konrad/0000-0001-8408-4499; Blohm, Gunnar/0000-0002-2297-3271	Canadian Institutes of Health Research [MOB-93373]; Heart and Stroke Foundation of Canada's (HSFC) Henry JM Barnett's Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada's (HSFC) Henry JM Barnett's Scholarship	TLA is funded by the Canadian Institutes of Health Research (MOB-93373). TLA is a Canada Research Chair in Physical Activity, Mobility, and Cognitive Neuroscience, a Michael Smith Foundation for Health Research (MSFHR) Scholar, a Canadian Institutes of Health Research (CIHR) New Investigator, and a Heart and Stroke Foundation of Canada's (HSFC) Henry JM Barnett's Scholarship recipient. JCD is a MSFHR and a CIHR Post-Doctoral Fellow. NB is a HSFC Doctoral trainee. CLH is an Alzheimer's Society Research Program Doctoral trainee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2006, J AM GERIATR SOC, V54, P1169, DOI 10.1111/j.1532-5415.2006.00813.x; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Bruce-Keller AJ, 2012, J ALZHEIMERS DIS, V30, P899, DOI 10.3233/JAD-2012-120025; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Camicioli R, 1998, NEUROLOGY, V50, P1496, DOI 10.1212/WNL.50.5.1496; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Delbaere K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4165; Dobbelsteyn CJ, 2001, INT J OBESITY, V25, P652, DOI 10.1038/sj.ijo.0801582; Elmstahl S, 1997, DEMENT GERIATR COGN, V8, P180, DOI 10.1159/000106629; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1097/00005768-200301000-00025; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; LORD SR, 1991, AGE AGEING, V20, P175, DOI 10.1093/ageing/20.3.175; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; ODENHEIMER G, 1994, ARCH NEUROL-CHICAGO, V51, P573, DOI 10.1001/archneur.1994.00540180051013; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Ritchie K, 2002, LANCET, V360, P1759, DOI 10.1016/S0140-6736(02)11667-9; Roe CM, 2013, NEUROLOGY, V80, P1784, DOI 10.1212/WNL.0b013e3182918ca6; Rubin EH, 1998, ARCH NEUROL-CHICAGO, V55, P395, DOI 10.1001/archneur.55.3.395; Sattler C, 2011, J ALZHEIMERS DIS, V26, P709, DOI 10.3233/JAD-2011-110548; Small GW, 2012, ARCH NEUROL-CHICAGO, V69, P215, DOI 10.1001/archneurol.2011.559; Springer S, 2006, MOV DISORD; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; van Boxtel MPJ, 1998, J GERONTOL A-BIOL, V53, pM147; Verdelho A, 2010, NEUROLOGY, V75, P160, DOI 10.1212/WNL.0b013e3181e7ca05; Walter S, 2009, EUR J EPIDEMIOL, V24, P733, DOI 10.1007/s10654-009-9411-2; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Woodard JL, 2010, J ALZHEIMERS DIS, V21, P871, DOI 10.3233/JAD-2010-091693; World Health Organization Alzheimer's Disease International, 2012, DEM PUBL HLTH AUTH; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	62	20	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119075	10.1371/journal.pone.0119075	http://dx.doi.org/10.1371/journal.pone.0119075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734446	Green Submitted, gold, Green Published			2022-12-26	WOS:000350314700054
J	Bos, AC; van Holsbeke, C; de Backer, JW; van Westreenen, M; Janssens, HM; Vos, WG; Tiddens, HAWM				Bos, Aukje C.; van Holsbeke, Cedric; de Backer, Jan W.; van Westreenen, Mireille; Janssens, Hettie M.; Vos, Wim G.; Tiddens, Harm A. W. M.			Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?	PLOS ONE			English	Article							INHALED AZTREONAM LYSINE; COMPUTATIONAL FLUID-DYNAMICS; PSEUDOMONAS-AERUGINOSA INFECTION; COMPUTED-TOMOGRAPHY; PK/PD TERMINOLOGY; REFERENCE RANGES; DEPOSITION; SAFETY; PHARMACOKINETICS; STANDARDIZATION	Background Pseudomonas aeruginosa (Pa) infection is an important contributor to the progression of cystic fibrosis (CF) lung disease. The cornerstone treatment for Pa infection is the use of inhaled antibiotics. However, there is substantial lung disease heterogeneity within and between patients that likely impacts deposition patterns of inhaled antibiotics. Therefore, this may result in airways below the minimal inhibitory concentration of the inhaled agent. Very little is known about antibiotic concentrations in small airways, in particular the effect of structural lung abnormalities. We therefore aimed to develop a patient-specific airway model to predict concentrations of inhaled antibiotics and to study the impact of structural lung changes and breathing profile on local concentrations in airways of patients with CF. Methods In-and expiratory CT-scans of children with CF (5-17 years) were scored (CF-CT score), segmented and reconstructed into 3D airway models. Computational fluid dynamic (CFD) simulations were performed on 40 airway models to predict local Aztreonam lysine for inhalation (AZLI) concentrations. Patient-specific lobar flow distribution and nebulization of 75 mg AZLI through a digital Pari eFlow model with mass median aerodynamic diameter range were used at the inlet of the airway model. AZLI concentrations for central and small airways were computed for different breathing patterns and airway surface liquid thicknesses. Results In most simulated conditions, concentrations in both central and small airways were well above the minimal inhibitory concentration. However, small airways in more diseased lobes were likely to receive suboptimal AZLI. Structural lung disease and increased tidal volumes, respiratory rates and larger particle sizes greatly reduced small airway concentrations. Conclusions CFD modeling showed that concentrations of inhaled antibiotic delivered to the small airways are highly patient specific and vary throughout the bronchial tree. These results suggest that anti-Pa treatment of especially the small airways can be improved.				h.tiddens@erasmusmc.nl	Van Holsbeke, Cedric/I-4308-2013	Van Holsbeke, Cedric/0000-0003-0248-841X; VOS, WIM/0000-0003-0827-421X	Gilead Sciences Inc	Gilead Sciences Inc(Gilead Sciences)	This was an investigator initiated study. FluidDA nv received an unconditional grant from Gilead Sciences Inc. This grant was used for the Fluid dynamic modeling (JdB, CvH, WV). FluidDA NV covered the salary costs of the PhD student (AB) for the length of this study. Author Cedric van Holsbeke and Wim G. Vos are employed by FluidDA nv. J. de Backer and Wim G. Vos are shareholders of FluidDA NV, a company that commercializes some of the techniques used in this manuscript. FluidDA and investigators AB, HT and HJ have jointly developed the study design. AB, HT, MvW and HJ have acted as an independent party for this study. Study CT selection and assessment of lung disease severity was done by AB independently of FluidDA. FluidDA employees CvH and WV and investigators AB, HT and HJ have jointly analyzed the data and have jointly written the manuscript. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker EM, 2011, EUR RESPIR J, V38, P1328, DOI 10.1183/09031936.00006211; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burgel PR, 2007, THORAX, V62, P153, DOI 10.1136/thx.2006.062190; Cazzola Mario, 2002, Am J Respir Med, V1, P261; Chiu Loretta M, 2002, Am J Respir Med, V1, P201; Chrystyn H, 2001, BRIT J CLIN PHARMACO, V51, P289, DOI 10.1046/j.1365-2125.2001.01304.x; Dalhoff A, 2014, CLIN MICROBIOL REV, V27, P753, DOI 10.1128/CMR.00022-14; Darquenne C, 2012, J AEROSOL MED PULM D, V25, P140, DOI 10.1089/jamp.2011.0916; Davis SD, 2013, NEW ENGL J MED, V368, P2026, DOI 10.1056/NEJMe1303487; De Backer JW, 2008, MED ENG PHYS, V30, P872, DOI 10.1016/j.medengphy.2007.11.002; De Backer JW, 2008, J BIOMECH, V41, P106, DOI 10.1016/j.jbiomech.2007.07.009; De Backer JW, 2010, RADIOLOGY, V257, P854, DOI 10.1148/radiol.10100322; De Backer LA, 2012, EUR RESPIR J, V40, P298, DOI 10.1183/09031936.00072511; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Elborn JS, 2010, EXPERT OPIN PHARMACO, V11, P1373, DOI 10.1517/14656566.2010.482102; Geller DE, 2008, PEDIATR PULM, V43, pS5, DOI 10.1002/ppul.20860; Gibson RL, 2006, PEDIATR PULM, V41, P656, DOI 10.1002/ppul.20429; Hasan MA, 2007, J AEROSOL MED, V20, P282, DOI 10.1089/jam.2007.0603; Hutchinson D, 2013, EXPERT OPIN PHARMACO, V14, P2115, DOI 10.1517/14656566.2013.831070; King P, 2010, ANTIMICROB AGENTS CH, V54, P143, DOI 10.1128/AAC.00248-09; Lenney W, 2011, J CYST FIBROS, V10, P9, DOI 10.1016/j.jcf.2010.08.019; Loeve M, 2009, THORAX, V64, P876, DOI 10.1136/thx.2008.110908; Loeve M, 2013, EUR RESPIR J, V42, P844, DOI 10.1183/09031936.00051512; Maiz L, 2013, EXPERT OPIN PHARMACO, V14, P1135, DOI 10.1517/14656566.2013.790366; Mccoy KS, 2008, AM J RESP CRIT CARE, V178, P921, DOI 10.1164/rccm.200712-1804OC; Mott LS, 2013, J PEDIATR-US, V163, P243, DOI 10.1016/j.jpeds.2012.12.042; Mouton JW, 2005, J ANTIMICROB CHEMOTH, V55, P601, DOI 10.1093/jac/dki079; Mouton JW, 2002, INT J ANTIMICROB AG, V19, P355, DOI 10.1016/S0924-8579(02)00031-6; Nair CG, 2013, LETT APPL MICROBIOL, V56, P149, DOI 10.1111/lam.12032; Oermann CM, 2010, PEDIATR PULM, V45, P1121, DOI 10.1002/ppul.21301; Phalen RF, 1988, ANN OCCUP HYG     S1, V32, P11; Ratjen F, 2012, J AEROSOL MED PULM D, V25, P261, DOI 10.1089/jamp.2011.0923; Retsch-Bogart GZ, 2009, CHEST, V135, P1223, DOI 10.1378/chest.08-1421; Rodvold KA, 2011, CLIN PHARMACOKINET, V50, P689, DOI 10.2165/11592900-000000000-00000; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Talma H., 2010, GROEIDIAGRAMMEN 2010; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thompson RB, 2012, J AEROSOL MED PULM D, V25, P55, DOI 10.1089/jamp.2011.0897; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Tiddens HAWM, 2000, EUR RESPIR J, V15, P735, DOI 10.1034/j.1399-3003.2000.15d18.x; Vinchurkar S, 2012, INHAL TOXICOL, V24, P81, DOI 10.3109/08958378.2011.644351; Vos W, 2013, RESPIRATION, V86, P393, DOI 10.1159/000347120; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954; Wallis LA, 2005, ARCH DIS CHILD, V90, P1117, DOI 10.1136/adc.2004.068718; Wang HZ, 2013, ANTIMICROB AGENTS CH, V57, P196, DOI 10.1128/AAC.01393-12; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yamazaki K, 2003, AM J RESP CRIT CARE, V168, P1304, DOI 10.1164/rccm.200301-111OC; Zapletal A, 1992, Cesk Pediatr, V47, P520	51	37	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118454	10.1371/journal.pone.0118454	http://dx.doi.org/10.1371/journal.pone.0118454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734630	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700029
J	Roberts, T; Barratt, J; Sandaradura, I; Lee, R; Harkness, J; Marriott, D; Ellis, J; Stark, D				Roberts, Tamalee; Barratt, Joel; Sandaradura, Indy; Lee, Rogan; Harkness, John; Marriott, Deborah; Ellis, John; Stark, Damien			Molecular Epidemiology of Imported Cases of Leishmaniasis in Australia from 2008 to 2014	PLOS ONE			English	Article							WORLD CUTANEOUS LEISHMANIASIS; INTERNAL TRANSCRIBED SPACER; POLYMERASE-CHAIN-REACTION; TOXOPLASMA-GONDII; CLINICAL-SAMPLES; RIBOSOMAL DNA; PCR ASSAY; INFECTION; DISCRIMINATION; HETEROGENEITY	Leishmaniasis is a vector borne disease caused by protozoa of the genus Leishmania. Human leishmaniasis is not endemic in Australia though imported cases are regularly encountered. This study aimed to provide an update on the molecular epidemiology of imported leishmaniasis in Australia. Of a total of 206 biopsies and bone marrow specimens submitted to St Vincent's Hospital Sydney for leishmaniasis diagnosis by PCR, 55 were found to be positive for Leishmania DNA. All PCR products were subjected to restriction fragment length polymorphism analysis for identification of the causative species. Five Leishmania species/species complexes were identified with Leishmania tropica being the most common (30/55). Travel or prior residence in a Leishmania endemic region was the most common route of acquisition with similar to 47% of patients having lived in or travelled to Afghanistan. Cutaneous leishmaniasis was the most common manifestation (94%) with only 3 cases of visceral leishmaniasis and no cases of mucocutaneous leishmaniasis encountered. This report indicates that imported leishmaniasis is becoming increasingly common in Australia due to an increase in global travel and immigration. As such, Australian clinicians must be made aware of this trend and consider leishmaniasis in patients with suspicious symptoms and a history of travel in endemic areas. This study also discusses the recent identification of a unique Leishmania species found in native kangaroos and a potential vector host which could create the opportunity for the establishment of a local transmission cycle within humans.	[Roberts, Tamalee; Sandaradura, Indy; Harkness, John; Marriott, Deborah; Stark, Damien] St Vincents Hosp, Dept Microbiol, SydPath, Darlinghurst, NSW, Australia; [Roberts, Tamalee; Barratt, Joel; Ellis, John] Univ Technol Sydney, Sch Med & Mol Sci, Ultimo, NSW, Australia; [Barratt, Joel] Univ Technol Sydney, Inst i3, Ultimo, NSW, Australia; [Lee, Rogan] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR, Westmead, NSW 2145, Australia	St Vincents Hospital Sydney; University of Technology Sydney; University of Technology Sydney; University of Sydney	Roberts, T (corresponding author), St Vincents Hosp, Dept Microbiol, SydPath, Victoria St, Darlinghurst, NSW, Australia.	tamalee.roberts@svha.org.au	Ellis, John T/L-6988-2016; Sandaradura, Indy/AAY-5046-2020; Roberts, Tamalee/GOE-6303-2022	Ellis, John T/0000-0001-7328-4831; Sandaradura, Indy/0000-0002-9457-8262; Roberts, Tamalee/0000-0001-8599-737X; Barratt, Joel/0000-0001-8711-2408				Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Antinori S, 2005, CLIN MICROBIOL INFEC, V11, P343, DOI 10.1111/j.1469-0691.2004.01046.x; Armed Forces Health Surveillance Center, 2002, MED SURVEILL MON REP, V14, P2; Bailey MS, 2012, J ROY ARMY MED CORPS, V158, P225, DOI 10.1136/jramc-158-03-16; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Barratt JLN, 2010, CLIN MICROBIOL REV, V23, P795, DOI 10.1128/CMR.00001-10; Barratt J, 2008, MOL CELL PROBE, V22, P228, DOI 10.1016/j.mcp.2008.03.001; Bart A, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.30.20544; Bensoussan E, 2006, J CLIN MICROBIOL, V44, P1435, DOI 10.1128/JCM.44.4.1435-1439.2006; Blonski KM, 2012, APMIS, V120, P591, DOI 10.1111/j.1600-0463.2012.02875.x; BOOTHROYD JC, 1987, NUCLEIC ACIDS RES, V15, P4065, DOI 10.1093/nar/15.10.4065; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P131; Diniz MMCDL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-139; Dostalova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-276; Dougall A, 2009, EPIDEMIOL INFECT, V137, P1516, DOI 10.1017/S0950268809002313; Dougall AM, 2011, INT J PARASITOL, V41, P571, DOI 10.1016/j.ijpara.2010.12.008; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; Ghatee MA, 2014, EXP PARASITOL, V144, P44, DOI 10.1016/j.exppara.2014.06.003; GUAY JM, 1992, GENE, V114, P165, DOI 10.1016/0378-1119(92)90570-F; Haouas N, 2010, DIAGN MICR INFEC DIS, V68, P152, DOI 10.1016/j.diagmicrobio.2010.06.011; Harms G, 2003, EMERG INFECT DIS, V9, P872; Harms G, 2011, INT J DERMATOL, V50, P1336, DOI 10.1111/j.1365-4632.2011.04987.x; HEPBURN NC, 1993, BRIT J DERMATOL, V128, P63, DOI 10.1111/j.1365-2133.1993.tb00149.x; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Homan WL, 1997, PARASITOL RES, V83, P285, DOI 10.1007/s004360050248; Ju O, 2004, MED J AUSTRALIA, V181, P446, DOI 10.5694/j.1326-5377.2004.tb06372.x; Khairnar K, 2013, PARASITOL RES; Konecny P, 2007, MED J AUSTRALIA, V186, P315, DOI 10.5694/j.1326-5377.2007.tb00910.x; Kumar A, 2010, ACTA TROP, V113, P202, DOI 10.1016/j.actatropica.2009.10.006; Lachaud L, 2013, Euro Surveill, V18, P20534, DOI 10.2807/1560-7917.ES2013.18.29.20534; Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127; Maguire GP, 1998, PATHOLOGY, V30, P73, DOI 10.1080/00313029800169715; Morizot G, 2013, CLIN INFECT DIS, V57, P370, DOI 10.1093/cid/cit269; Morizot G, 2007, AM J TROP MED HYG, V76, P48; Pita-Pereira D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-15; Poeppl W, 2013, TRAVEL MED INFECT DI, V11, P90, DOI 10.1016/j.tmaid.2013.03.002; Rose K, 2004, AUST VET J, V82, P440, DOI 10.1111/j.1751-0813.2004.tb11138.x; Rose K, 2004, INT J PARASITOL, V34, P655, DOI 10.1016/j.ijpara.2004.03.001; Scarisbrick J J, 2006, Travel Med Infect Dis, V4, P14, DOI 10.1016/j.tmaid.2004.11.002; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Schwartz E, 2006, LANCET INFECT DIS, V6, P342, DOI 10.1016/S1473-3099(06)70492-3; Scope A, 2003, J AM ACAD DERMATOL, V49, P672, DOI 10.1067/S0190-9622(03)01576-7; Seaton RA, 1999, QJM-MON J ASSOC PHYS, V92, P659, DOI 10.1093/qjmed/92.11.659; Seblova V, 2012, J MED ENTOMOL, V49, P967, DOI 10.1603/ME12053; Seblova V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-222; Solomon M, 2007, J AM ACAD DERMATOL, V56, P612, DOI 10.1016/j.jaad.2006.06.044; Stark D, 2006, J CLIN MICROBIOL, V44, P1178, DOI 10.1128/JCM.44.3.1178-1180.2006; Stark D, 2008, J TRAVEL MED, V15, P351, DOI 10.1111/j.1708-8305.2008.00223.x; Storer Emma, 2005, Australas J Dermatol, V46, P80, DOI 10.1111/j.1440-0960.2005.00146.x; van Thiel PPAM, 2011, TRAVEL MED INFECT DI, V9, P153, DOI 10.1016/j.tmaid.2011.03.001; Wall EC, 2012, AM J TROP MED HYG, V86, P115, DOI 10.4269/ajtmh.2012.10-0558; Weina PJ, 2004, CLIN INFECT DIS, V39, P1674, DOI 10.1086/425747; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; Zeegelaar JE, 2005, CLIN EXP DERMATOL, V30, P1, DOI 10.1111/j.1365-2230.2004.01677.x	55	18	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119212	10.1371/journal.pone.0119212	http://dx.doi.org/10.1371/journal.pone.0119212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734905	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700059
J	Xie, JX; Feng, Y; Yuan, JM; You, ZD; Lin, HY; Lu, CL; Xu, JJ				Xie, Jia-Xin; Feng, Yu; Yuan, Jian-Min; You, Zhen-Dong; Lin, Hai-Yan; Lu, Chang-Lin; Xu, Jia-Jun			Positive Effects of bFGF Modified Rat Amniotic Epithelial Cells Transplantation on Transected Rat Optic Nerve	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; RETINAL GANGLION-CELLS; INJURY; REGENERATION; PROTEIN; GAP-43; LESION; DEATH; MODEL; AXONS	Purpose Effective therapy for visual loss caused by optic nerve injury or diseases has not been achieved even though the optic nerve has the regeneration potential after injury. This study was designed to modify amniotic epithelial cells (AECs) with basic fibroblast growth factor (bFGF) gene, preliminarily investigating its effect on transected optic nerve. Methods A human bFGF gene segment was delivered into rat AECs (AECs/hbFGF) by lentiviral vector, and the gene expression was examined by RT-PCR and ELISA. The AECs/hbFGF and untransfected rat AECs were transplanted into the transected site of the rat optic nerve. At 28 days post transplantation, the survival and migration of the transplanted cells was observed by tracking labeled cells; meanwhile retinal ganglion cells (RGCs) were observed and counted by employing biotin dextran amine (BDA) and Nissl staining. Furthermore, the expression of growth associated protein 43 (GAP-43) within the injury site was examined with immunohistochemical staining. Results The AECs/hbFGF was proven to express bFGF gene and secrete bFGF peptide. Both AECs/hbFGF and AECs could survive and migrate after transplantation. RGCs counting implicated that RGCs numbers of the cell transplantation groups were significantly higher than that of the control group, and the AECs/hbFGF group was significantly higher than that of the AECs group. Moreover GAP-43 integral optical density value in the control group was significantly lower than that of the cell transplantation groups, and the value in the AECs/hbFGF group was significantly higher than that of the AECs group. Conclusions AECs modified with bFGF could reduce RGCs loss and promote expression of GAP-43 in the rat optic nerve transected model, facilitating the process of neural restoration following injury.	[Xie, Jia-Xin; Yuan, Jian-Min; Lin, Hai-Yan; Xu, Jia-Jun] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [You, Zhen-Dong; Lu, Chang-Lin] Second Mil Med Univ, Dept Neurobiol, Shanghai, Peoples R China; [Xie, Jia-Xin] Second Mil Med Univ, Dept Orthopaed, Changzheng Hosp, Shanghai, Peoples R China; [Xie, Jia-Xin; Feng, Yu] Kunming Gen Hosp Chengdu Mil Command, Peoples Liberat Army Clin Ctr Spinal Cord Injury, Kunming, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Kunming General Hospital	Xu, JJ (corresponding author), Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China.	xujiajunsmmu@163.com						AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berry M, 2008, RESTOR NEUROL NEUROS, V26, P147; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Blanco RE, 2000, J COMP NEUROL, V423, P646; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Hicks D, 1998, SEMIN CELL DEV BIOL, V9, P263, DOI 10.1006/scdb.1998.0230; HILL DJ, 1993, PLACENTA, V14, P1, DOI 10.1016/S0143-4004(05)80244-9; Kaneda M, 2008, NEUROSCI RES, V61, P281, DOI 10.1016/j.neures.2008.03.008; Kaneda M, 2010, ADV EXP MED BIOL, V664, P97, DOI 10.1007/978-1-4419-1399-9_12; Klocker N, 2001, J NEUROSCI METH, V110, P147, DOI 10.1016/S0165-0270(01)00435-6; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Kreutz MR, 1999, RESTOR NEUROL NEUROS, V14, P127; Meng XT, 2008, CELL BIOL INT, V32, P1546, DOI 10.1016/j.cellbi.2008.09.001; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Okawa H, 2001, NEUROREPORT, V12, P4003, DOI 10.1097/00001756-200112210-00030; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Sadler TW, 2003, LANGMANS MED EMBRYOL, P51; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Selhorst JB, 2009, SEMIN NEUROL, V29, P29, DOI 10.1055/s-0028-1124020; Selles-Navarro I, 2001, EXP NEUROL, V167, P282, DOI 10.1006/exnr.2000.7573; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; Solomon AS, 1996, J NEUROSCI METH, V70, P21, DOI 10.1016/S0165-0270(96)00098-2; Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U	28	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119119	10.1371/journal.pone.0119119	http://dx.doi.org/10.1371/journal.pone.0119119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734497	gold, Green Published, Green Submitted			2022-12-26	WOS:000350314700055
J	Papageorgiou, A; Ziogas, DC; Mavragani, CP; Zintzaras, E; Tzioufas, AG; Moutsopoulos, HM; Voulgarelis, M				Papageorgiou, Aristea; Ziogas, Dimitrios C.; Mavragani, Clio P.; Zintzaras, Elias; Tzioufas, Athanasios G.; Moutsopoulos, Haralampos M.; Voulgarelis, Michael			Predicting the Outcome of Sjogren's Syndrome-Associated Non-Hodgkin's Lymphoma Patients	PLOS ONE			English	Article							TISSUE LYMPHOMA; AUTOIMMUNE-DISEASES; MALIGNANT-LYMPHOMA; RESPONSE CRITERIA; RISK; MORTALITY; COHORT; CLASSIFICATION; MORBIDITY; PATTERNS	Background Non-Hodgkin's lymphoma (NHL) development in Sjogren's syndrome (SS) remains a potentially lethal complication and efforts should focus on the identification of predictors that could aid in appropriate therapeutic decisions. Methods In order to identify potential prognostic factors for outcome in SS-associated NHL, we retrospectively analyzed a cohort of 77 patients, diagnosed with NHL according to WHO classification criteria and meeting the American-European Consensus Classification (AECC) criteria for SS and examined the effect of SS-activity (defined as the EULAR SS disease activity index-ESSDAI) in the prognosis of SS-related NHLs, as defined in terms of overall and event-free survivals (OS and EFS). An event was defined as lymphoma relapse, treatment failure, disease progression, histological transformation or death. The effect of NHL clinical and laboratory characteristics was also investigated. Results MALT lymphomas constituted the majority (66.2%) of lymphomas. During the follow-up (median = 57.93 months), the 5-year OS was 90.91% (95% CI: 82.14-95.80%) and the EFS was 77.92% (95% CI: 67.37-85.82%). Patients with high ESSDAI score at lymphoma diagnosis had a greater risk for death (OR = 5.241, 95% CI: 1.034-26.568) or for event (OR = 4.317, 95% CI: 1.146-9.699, p = 0.008). These patients had also significantly worse EFS (HR = 4.541, 95% CI: 1.772-11.637) and OS (HR = 5.946, 95% CI: 1.259-28.077). In addition, post-chemotherapy ESSDAI improvement was significantly lower in patients who had experienced an event (p = 0.005). An unfavorable International prognostic index (IPI) score (high-intermediate/high) was associated with high risk of death and event (OR = 13.867, 95% CI: 2.656-72.387 and OR = 12.589, 95% CI: 3.911-40.526, respectively), worse EFS (log-rank p < 0.001, HR = 8.718, 95% CI: 3.477-21.858), as well as with worse OS (log-rank p < 0.001, HR = 11.414, 95% CI: 2.414-53.974). After adjustment for identified risk factors, IPI score retained a significant prognostic role following by a strong effect of ESSDAI in survival outcomes. Conclusions At the point of NHL diagnosis, IPI and ESSDAI might be proved useful predictive tools in SS-associated lymphoma prognosis, directing to a more patient-tailored approach.	[Papageorgiou, Aristea; Ziogas, Dimitrios C.; Tzioufas, Athanasios G.; Moutsopoulos, Haralampos M.; Voulgarelis, Michael] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [Mavragani, Clio P.] Univ Athens, Sch Med, Dept Physiol, GR-11527 Athens, Greece; [Zintzaras, Elias] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; University of Thessaly	Voulgarelis, M (corresponding author), Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece.	mvoulgar@med.uoa.gr	Mavrogeni, Sophie/AAV-2105-2021; TZIOUFAS, ATHANASIOS G/A-1690-2008	Tzioufas, Athanasios/0000-0001-6666-8642; Ziogas, Dimitrios C./0000-0003-2620-4004				Ambrosetti A, 2004, BRIT J HAEMATOL, V126, P43, DOI 10.1111/j.1365-2141.2004.04993.x; Anderson LA, 2009, INT J CANCER, V125, P398, DOI 10.1002/ijc.24287; Baimpa E, 2009, MEDICINE, V88, P284, DOI 10.1097/MD.0b013e3181b76ab5; Brito-Zeron P, 2007, RHEUMATOLOGY, V46, P1359, DOI 10.1093/rheumatology/kem079; Brkic Z, 2013, ANN RHEUM DIS, V72, P728, DOI 10.1136/annrheumdis-2012-201381; CARBONE PP, 1971, CANCER RES, V31, P1860; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; DANIELS TE, 1994, ARTHRITIS RHEUM-US, V37, P869, DOI 10.1002/art.1780370615; Gill H, 2011, ANN HEMATOL, V90, P1399, DOI 10.1007/s00277-011-1226-z; Gottenberg JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059868; Hernandez JA, 1996, SCAND J RHEUMATOL, V25, P396; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; KASSAN SS, 1978, ANN INTERN MED, V89, P888, DOI 10.7326/0003-4819-89-6-888; Kruize AA, 1996, ARTHRITIS RHEUM-US, V39, P297, DOI 10.1002/art.1780390219; Martens PB, 1999, J RHEUMATOL, V26, P1296; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pollard RPE, 2011, J RHEUMATOL, V38, P2198, DOI 10.3899/jrheum.110077; Ramos-Casals M, 2005, RHEUMATOLOGY, V44, P89, DOI 10.1093/rheumatology/keh407; Ramos-Casals M, 2014, RHEUMATOLOGY, V53, P321, DOI 10.1093/rheumatology/ket349; Risselada AP, 2013, SEMIN ARTHRITIS RHEU, V43, P171, DOI 10.1016/j.semarthrit.2013.03.001; Royer B, 1997, BLOOD, V90, P766, DOI 10.1182/blood.V90.2.766; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Skopouli FN, 2000, SEMIN ARTHRITIS RHEU, V29, P296, DOI 10.1016/S0049-0172(00)80016-5; Smedby KE, 2008, BLOOD, V111, P4029, DOI 10.1182/blood-2007-10-119974; Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/djj004; Solans-Laque R, 2011, SEMIN ARTHRITIS RHEU, V41, P415, DOI 10.1016/j.semarthrit.2011.04.006; Sutcliffe N, 1998, SEMIN ARTHRITIS RHEU, V28, P80, DOI 10.1016/S0049-0172(98)80040-1; Theander E, 2004, ARTHRITIS RHEUM-US, V50, P1262, DOI 10.1002/art.20176; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Thieblemont C, 2000, BLOOD, V95, P802, DOI 10.1182/blood.V95.3.802.003k19_802_806; Thieblemont Catherine, 2005, Hematology Am Soc Hematol Educ Program, P307, DOI 10.1182/asheducation-2005.1.307; Tobon GJ, 2013, ARTHRITIS RHEUM-US, V65, P3218, DOI 10.1002/art.38129; Troch M, 2010, ANTICANCER RES, V30, P635; Tzioufas AG, 1996, ARTHRITIS RHEUM, V39, P767, DOI 10.1002/art.1780390508; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Voulgarelis M, 1999, ARTHRITIS RHEUM-US, V42, P1765, DOI 10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V; Voulgarelis M, 2012, MEDICINE, V91, P1, DOI 10.1097/MD.0b013e31824125e4; Wohrer S, 2007, LEUKEMIA, V21, P1812, DOI 10.1038/sj.leu.2404782; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337; Zinzani PL, 1999, J CLIN ONCOL, V17, P1254, DOI 10.1200/JCO.1999.17.4.1254; Zucca E, 2003, BLOOD, V101, P2489, DOI 10.1182/blood-2002-04-1279; Zufferey P, 1995, SCAND J RHEUMATOL, V24, P342, DOI 10.3109/03009749509095178	45	62	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116189	10.1371/journal.pone.0116189	http://dx.doi.org/10.1371/journal.pone.0116189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723713	Green Published, gold, Green Submitted			2022-12-26	WOS:000350251200014
J	Schmockel, SM; Garcia, AF; Berger, B; Tester, M; Webb, AAR; Roy, SJ				Schmoeckel, Sandra M.; Garcia, Alexandre F.; Berger, Bettina; Tester, Mark; Webb, Alex A. R.; Roy, Stuart J.			Different NaCl-Induced Calcium Signatures in the Arabidopsis thaliana Ecotypes Col-0 and C24	PLOS ONE			English	Article							SALT TOLERANCE; FREE CA2+; CELL; DROUGHT; STRESS; STIMULUS; SIGNALS; ENCODES; INTACT; SOS1	A common feature of stress signalling pathways are alterations in the concentration of cytosolic free calcium ([Ca2+](cyt)), which allow the specific and rapid transmission of stress signals through a plant after exposure to a stress, such as salinity. Here, we used an aequorin based bioluminescence assay to compare the NaCl-induced changes in [Ca2+](cyt) of the Arabidopsis ecotypes Col-0 and C24. We show that C24 lacks the NaCl specific component of the [Ca2+](cyt) signature compared to Col-0. This phenotypic variation could be exploited as a screening methodology for the identification of yet unknown components in the early stages of the salt signalling pathway.	[Schmoeckel, Sandra M.; Garcia, Alexandre F.; Roy, Stuart J.] Australian Ctr Plant Funct Genom, Adelaide, SA, Australia; [Schmoeckel, Sandra M.; Garcia, Alexandre F.; Roy, Stuart J.] Univ Adelaide, Adelaide, SA, Australia; [Schmoeckel, Sandra M.; Tester, Mark] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal, Saudi Arabia; [Garcia, Alexandre F.; Berger, Bettina] Australian Plant Phen Facil, Adelaide, SA, Australia; [Garcia, Alexandre F.; Berger, Bettina] Univ Adelaide, Adelaide, SA, Australia; [Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Adelaide; King Abdullah University of Science & Technology; University of Adelaide; University of Cambridge	Roy, SJ (corresponding author), Australian Ctr Plant Funct Genom, Adelaide, SA, Australia.	stuart.roy@acpfg.com.au	Tester, Mark/J-2368-2017; Berger, Bettina/AAH-1190-2021	Tester, Mark/0000-0002-5085-8801; Berger, Bettina/0000-0003-1195-4478; Webb, Alex/0000-0003-0261-4375; Schmoeckel, Sandra Manuela/0000-0001-5974-5136; Roy, Stuart/0000-0003-0411-9431	Brenda Nettle Travel Award; King Abdullah University for Science and Technology	Brenda Nettle Travel Award; King Abdullah University for Science and Technology	The authors would like to thank the Australian Centre for Plant Functional Genomics, Australian Research Council, The Grains Research and Development Corporation, The Waite Research Institute, the Barr Smith Travel Scholarship in Agriculture, the Brenda Nettle Travel Award and King Abdullah University for Science and Technology for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Choi WG, 2014, P NATL ACAD SCI USA, V111, P6497, DOI 10.1073/pnas.1319955111; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; FAO, 2008, FAO LAND PLANT NUTR; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Knight H, 2000, INT REV CYTOL, V195, P269; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; MAATHUIS FJM, 1993, PLANTA, V191, P302, DOI 10.1007/BF00195686; Marti MC, 2013, PLANT PHYSIOL, V163, P625, DOI 10.1104/pp.113.222901; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; MUNNS R, 1984, AUST J PLANT PHYSIOL, V11, P497, DOI 10.1071/PP9840497; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ng CKY, 2001, NEW PHYTOL, V151, P109, DOI 10.1046/j.1469-8137.2001.00152.x; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; R Core Team, 2021, R LANGUAGE ENV STAT; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; Stoffer D, 2012, ASTSA APPL STAT TIME; Tracy FE, 2008, PLANT CELL ENVIRON, V31, P1063, DOI 10.1111/j.1365-3040.2008.01817.x; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu XH, 2013, MOL PLANT, V6, P444, DOI 10.1093/mp/sst013	36	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117564	10.1371/journal.pone.0117564	http://dx.doi.org/10.1371/journal.pone.0117564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723668	Green Published, gold, Green Submitted			2022-12-26	WOS:000350251200035
J	Yu, XY; Lu, CH				Yu, Xinyang; Lu, Changhe			Alpine Glacier Change in the Eastern Altun Mountains of Northwest China during 1972-2010	PLOS ONE			English	Article							CLIMATE-CHANGE	Accurately mapping and monitoring glacier changes over decades is important for providing information to support sustainable use of water resource in arid regions of northwest China. Since 1970, glaciers in the Eastern Altun Mountains showed remarkable recession. Further study is indispensable to indicate the extent and amplitude of glacial change at basin and individual glacier scale. In this study, spatiotemporal glacier changes referring to the year 1972, 1990, 2000 and 2010 were studied for the Eastern Altun Mountains using Landsat MSS/TM/ETM+ images and glacier volume-area scaling. The results demonstrated that the total area and volume of glaciers in EAMs decreased significantly by 10.70 +/- 0.57 km(2) (19.56 +/- 10.41%) and 0.61 +/- 0.03 km(3) (23.19 +/- 11.40%) during 1972-2010, respectively. More than half of the total receding area occurred during 1990-2000, primarily due to higher temperature increasing. However, varied response of individual glaciers indicated that glacier change was also affected by glacier dynamics, which was related to local topography. In addition, five glaciers unrecorded in the glacier inventory of China were reported in this study.	[Yu, Xinyang; Lu, Changhe] Chinese Acad Sci, Key Lab Land Surface Pattern & Simulat, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Yu, Xinyang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, CH (corresponding author), Chinese Acad Sci, Key Lab Land Surface Pattern & Simulat, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	luch@igsnrr.ac.cn			National Basic Research Program of China [2012CB955304]	National Basic Research Program of China(National Basic Research Program of China)	The authors' work was supported by the National Basic Research Program of China (No. 2012CB955304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshire JB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024028; Bahr DB, 1997, J GLACIOL, V43, P557, DOI 10.3189/S0022143000035164; Barry RG, 2006, PROG PHYS GEOG, V30, P285, DOI 10.1191/0309133306pp478ra; Bolch T, 2007, GLOBAL PLANET CHANGE, V56, P1, DOI 10.1016/j.gloplacha.2006.07.009; Bolch T, 2008, J GLACIOL, V54, P592, DOI 10.3189/002214308786570782; Chen J., 1990, IAHS PUBLICATION, V193, P127; Farinotti D, 2009, GLOBAL PLANET CHANGE, V68, P225, DOI 10.1016/j.gloplacha.2009.05.004; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; Huang J, 2012, ATMOS CHEM PHYS, V12, P5391, DOI 10.5194/acp-12-5391-2012; Johannes O, 1994, SCIENCE, V264, P243; Kotlyakov VM, 2008, ANN GLACIOL-SER, V48, P125, DOI 10.3189/172756408784700608; Lanzhou Institute of Glaciology and Geocryology, 1981, GLAC INV CHIN, P4; Liu S, 1999, CHINESE GEOGR SCI, V9, P134, DOI [10.1007/bf02791363., DOI 10.1007/BF02791363]; [刘时银 Liu Shiyin], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P227; Lu AiGang, 2009, Arid Land Geography, V32, P506; MEIER MF, 1996, GLACIERS ICE SHEETS, P89; Narama C, 2010, GLOBAL PLANET CHANGE, V71, P42, DOI 10.1016/j.gloplacha.2009.08.002; Qian Y. L., 2010, J METEOROL ENV, V26, P7; Shangguan D, 2009, PROG NAT SCI-MATER, V19, P727, DOI 10.1016/j.pnsc.2008.11.002; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Wang SJ, 2011, J GEOGR SCI, V21, P263, DOI 10.1007/s11442-011-0843-8; Ye ZhaoXia, 2009, Arid Land Geography, V32, P841; Zhang D, 2013, ADV WATER SCI, V24, P17; [张明军 ZHANG Mingjun], 2011, [地理学报, Acta Geographica Sinica], V66, P1155; Zhang Y., 1998, B GLACIER RES, V16, P1, DOI DOI 10.1142/9789812839718_0001; Zhu H, 2012, GEOGRAPHICAL RES, V32, P1430	26	4	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117262	10.1371/journal.pone.0117262	http://dx.doi.org/10.1371/journal.pone.0117262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723669	gold, Green Published, Green Submitted			2022-12-26	WOS:000350251200027
J	Wang, J; Tang, X; Weng, W; Qiao, Y; Lin, J; Liu, W; Liu, R; Ma, L; Yu, W; Yu, Y; Pan, Q; Sun, F				Wang, J.; Tang, X.; Weng, W.; Qiao, Y.; Lin, J.; Liu, W.; Liu, R.; Ma, L.; Yu, W.; Yu, Y.; Pan, Q.; Sun, F.			The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma	ONCOGENE			English	Article							YES-ASSOCIATED PROTEIN; LONG NONCODING RNA; LIVER-CANCER CELLS; TRANSLATION INITIATION; MUTUAL INTERACTION; YAP; GROWTH; TRANSCRIPTION; ACTIVATION; INHIBITION	Yes-associated protein (YAP) is overexpressed and has an oncogenic role in hepatocellular carcinoma (HCC). However, whether membrane protein can serve not only as a tumor marker that reflects YAP function but also as a therapeutic target that stimulates tumorigenesis in HCC remains unknown. Here we report that the membrane protein melanoma cell adhesion molecule (MCAM) was under positive regulation by YAP and was highly elevated in HCC cells. Within the MCAM promoter, we found the presence of a cAMP Response Element (CRE; -32 to -25 nt), which is conserved among species and is essential for YAP-and CREB-dependent regulation. Moreover, the interaction between CREB and YAP at the CRE site was dependent on PTPIY-WW domain interactions. However, MCAM expression was low and could not be regulated by YAP in breast and colon cancer cells because of the low levels of the acetyltransferase p300. In HCC cells, high levels of p300 facilitated the binding of YAP to the MCAM promoter, which in turn enhanced histone acetylation and polymerase II recruitment through the dissociation of the deacetylase Sirt1. These results suggest that MCAM is an HCC-specific target of YAP. In clinical serum samples, we found that the serum levels of MCAM were highly elevated in patients with HCC compared with healthy controls and with patients with cirrhosis, hepatitis, colon cancer and breast cancer. MCAM levels were shown to be a slightly better indicator than serum alpha-fetoprotein for predicting HCC. We further demonstrated that MCAM is essential for the survival and transformation of HCC. Mechanistically, MCAM induced translation initiation and the transcriptional activities of c-Jun/c-Fos. In addition, AKT activation had an essential role in the MCAM-promoted binding of eukaryotic initiation factor 4E to c-Jun/c-Fos mRNA. In conclusion, we demonstrated that MCAM may be a potential tumor marker and therapeutic target for the diagnosis and treatment of HCC.	[Wang, J.; Tang, X.; Weng, W.; Liu, W.; Ma, L.; Yu, W.; Sun, F.] Tongji Univ, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China; [Qiao, Y.] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China; [Lin, J.] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Clin Lab Med, Shanghai, Peoples R China; [Liu, R.] Tongji Univ, Shanghai Peoples Hosp 10, Dept Sci & Res, Shanghai 200072, Peoples R China; [Yu, Y.] Shanghai TCM Univ, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai, Peoples R China; [Pan, Q.] Tongji Univ, Shanghai Peoples Hosp 10, Dept Cent Lab, Shanghai 200072, Peoples R China	Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; Tongji University	Sun, F (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Clin Lab Med, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	panqiuhui@263.net; sunfenyong@126.com		Wang, Jiayi/0000-0003-1688-2864	China National 973 Project [2012CB966904, 20110402]; National Natural Science Foundation of China [81301689, 81201884]; Yangfan Project of the Shanghai Committee of Science and Technology [14YF1412300]; Outstanding Youth Training Program of Tongji University [1501219080]; Shanghai Tenth People's Hospital Climbing Training Program [04.01.13024]	China National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yangfan Project of the Shanghai Committee of Science and Technology; Outstanding Youth Training Program of Tongji University; Shanghai Tenth People's Hospital Climbing Training Program	This work was supported by the China National 973 Project (2012CB966904 and 20110402), the National Natural Science Foundation of China (81301689 and 81201884), the Yangfan Project of the Shanghai Committee of Science and Technology (14YF1412300), the Outstanding Youth Training Program of Tongji University (1501219080) and the Shanghai Tenth People's Hospital Climbing Training Program (04.01.13024).	Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Bardin N, 1998, FEBS LETT, V421, P12, DOI 10.1016/S0014-5793(97)01455-5; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Iatropoulos MJ, 1996, EXP TOXICOL PATHOL, V48, P175, DOI 10.1016/S0940-2993(96)80039-X; LEHMANN JM, 1987, CANCER RES, V47, P841; Li G, 2003, ONCOGENE, V22, P6891, DOI 10.1038/sj.onc.1206819; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Li LL, 2013, FEBS LETT, V587, P3921, DOI 10.1016/j.febslet.2013.10.042; Ma LF, 2014, J BIOL CHEM, V289, P6921, DOI 10.1074/jbc.M113.524819; Mills L, 2002, CANCER RES, V62, P5106; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Quan TH, 2010, J INVEST DERMATOL, V130, P1697, DOI 10.1038/jid.2010.29; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Sudol Marius, 2010, Genes Cancer, V1, P1115, DOI 10.1177/1947601911401911; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Wang JY, 2014, CELL SIGNAL, V26, P1048, DOI 10.1016/j.cellsig.2014.01.022; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xue HP, 2011, INT J BIOCHEM CELL B, V43, P348, DOI 10.1016/j.biocel.2010.11.002; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Yu WJ, 2014, CELL SIGNAL, V26, P2961, DOI 10.1016/j.cellsig.2014.09.011; Zhang H, 2012, CELL SIGNAL, V24, P224, DOI 10.1016/j.cellsig.2011.09.004; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	39	34	37	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2015	34	47					5781	5795		10.1038/onc.2015.36	http://dx.doi.org/10.1038/onc.2015.36			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW5KV	25728681				2022-12-26	WOS:000365035200002
J	Xu, TP; Liu, XX; Xia, R; Yin, L; Kong, R; Chen, WM; Huang, MD; Shu, YQ				Xu, T-P; Liu, X-X; Xia, R.; Yin, L.; Kong, R.; Chen, W-M; Huang, M-D; Shu, Y-Q			SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SP1; KRUPPEL-LIKE FACTOR-2; POOR-PROGNOSIS; DECREASED EXPRESSION; REPRESSION; INHIBITORS; HALLMARKS; SURVIVAL; NCRNAS; DECAY	The long noncoding RNA TINCR shows aberrant expression in human squamous carcinomas. However, its expression and function in gastric cancer remain unclear. We report that TINCR is strongly upregulated in human gastric carcinoma (GC), where it was found to contribute to oncogenesis and cancer progression. We also revealed that TINCR overexpression is induced by nuclear transcription factor SP1. Silencing TINCR expression inhibited cell proliferation, colony formation, tumorigenicity and apoptosis promotion, whereas TINCR overexpression promoted cell growth, as documented in the SGC7901 and BGC823 cell lines. Mechanistic analyses indicated that TINCR could bind to STAU1 (staufen1) protein, and influence KLF2 mRNA stability and expression, then KLF2 regulated cyclin-dependent kinase genes CDKN1A/P21 and CDKN2B/P15 transcription and expression, thereby affecting the proliferation and apoptosis of GC cells. Together, our findings suggest that TINCR contributes to the oncogenic potential of GC and may constitute a potential therapeutic target in this disease.	[Xu, T-P; Xia, R.; Yin, L.; Chen, W-M; Shu, Y-Q] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing 210029, Jiangsu, Peoples R China; [Liu, X-X] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Gastrointestinal Surg, Sch Clin Med, Yangzhou 225009, Jiangsu, Peoples R China; [Kong, R.] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Clin Med Examinat Ctr, Sch Clin Med, Yangzhou 225009, Jiangsu, Peoples R China; [Huang, M-D] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Med Oncol, Huaian, Peoples R China	Nanjing Medical University; Yangzhou University; Yangzhou University; Nanjing Medical University	Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	yongqian_shu@163.com	Shu, Yongqian/ABD-5698-2021		National Natural Science Foundation of China [81172140, 81272532]; Jiangsu Province Clinical Science and Technology projects (Clinical Research Center) [BL2012008]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine) [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Clinical Science and Technology projects (Clinical Research Center); Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	We thank Dr Taniguchi (First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan) for the kind gift of KLF2-FLAG expression vector, Dr Wei-liang Xiong (Department of Biochemistry and The Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University) for the help of RNA pull down assay, and Professor Wei De and Dr Ming Sun (Department of Biochemistry and Molecular Biology, Nanjing Medical University) for the help of assay design. This study was supported by the National Natural Science Foundation of China (81172140, 81272532), Jiangsu Province Clinical Science and Technology projects (Clinical Research Center, BL2012008) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine, JX10231801).	Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Cesana M, 2011, CELL, V147, P947, DOI 10.1016/j.cell.2011.10.031; Cho H, 2012, MOL CELL, V46, P495, DOI 10.1016/j.molcel.2012.03.009; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Gong CG, 2011, CELL CYCLE, V10, P1882, DOI 10.4161/cc.10.12.15589; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Muers M, 2011, NAT REV GENET, V12, DOI 10.1038/nrg3088; Okugawa Y, 2014, CARCINOGENESIS; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sun M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wan DF, 2004, P NATL ACAD SCI USA, V101, P17565, DOI 10.1073/pnas.0408124101; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Xu TP, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0063-7; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Zhang SZ, 2005, MOL CANCER THER, V4, P1577, DOI 10.1158/1535-7163.MCT-05-0106; Zhuang M, 2014, BIOCHEM BIOPH RES CO, V448, P315, DOI 10.1016/j.bbrc.2013.12.126	38	201	209	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 5	2015	34	45					5648	5661		10.1038/onc.2015.18	http://dx.doi.org/10.1038/onc.2015.18			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GA	25728677				2022-12-26	WOS:000364594300006
J	Bikkavilli, RK; Avasarala, S; Van Scoyk, M; Arcaroli, J; Brzezinski, C; Zhang, W; Edwards, M; Rathinam, MKK; Zhou, T; Tauler, J; Borowicz, S; Lussier, Y; Parr, BA; Cool, CD; Winn, RA				Bikkavilli, R. K.; Avasarala, S.; Van Scoyk, M.; Arcaroli, J.; Brzezinski, C.; Zhang, W.; Edwards, M. G.; Rathinam, M. K. K.; Zhou, T.; Tauler, J.; Borowicz, S.; Lussier, Y. A.; Parr, B. A.; Cool, C. D.; Winn, R. A.			Wnt7a is a novel inducer of beta-catenin-independent tumor-suppressive cellular senescence in lung cancer	ONCOGENE			English	Article							ATYPICAL ADENOMATOUS HYPERPLASIA; ONCOGENIC RAS; CELLS; SKP2; ACTIVATION; INACTIVATION; ACCUMULATION; PROGRESSION; REGULATOR; LIGASE	Cellular senescence is an initial barrier for carcinogenesis. However, the signaling mechanisms that trigger cellular senescence are incompletely understood, particularly in vivo. Here we identify Wnt7a as a novel upstream inducer of cellular senescence. In two different mouse strains (C57Bl/6J and FVB/NJ), we show that the loss of Wnt7a is a major contributing factor for increased lung tumorigenesis owing to reduced cellular senescence, and not reduced apoptosis, or autophagy. Wnt7a-null mice under de novo conditions and in both the strains display E-cadherin-to-N-cadherin switch, reduced expression of cellular senescence markers and reduced expression of senescence-associated secretory phenotype, indicating a genetic predisposition of these mice to increased carcinogen-induced lung tumorigenesis. Interestingly, Wnt7a induced an alternate senescence pathway, which was independent of beta-catenin, and distinct from that of classical oncogene-induced senescence mediated by the well-known p16(INK4a) and p19(ARF) pathways. Mechanistically, Wnt7a induced cellular senescence via inactivation of S-phase kinase-associated protein 2, an important alternate regulator of cellular senescence. Additionally, we identified Iloprost, a prostacyclin analog, which initiates downstream signaling cascades similar to that of Wnt7a, as a novel inducer of cellular senescence, presenting potential future clinical translational strategies. Thus pro-senescence therapies using either Wnt7a or its mimic, Iloprost, might represent a new class of therapeutic treatments for lung cancer.	[Bikkavilli, R. K.; Avasarala, S.; Van Scoyk, M.; Brzezinski, C.; Rathinam, M. K. K.; Zhou, T.; Tauler, J.; Winn, R. A.] Univ Illinois, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Arcaroli, J.] Univ Colorado, Sch Med, Div Med Oncol, Aurora, CO USA; [Zhang, W.] Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA; [Edwards, M. G.] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Edwards, M. G.] Univ Illinois, Coll Med, Dept Hematol & Oncol, Chicago, IL USA; [Lussier, Y. A.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Parr, B. A.] Albany State Univ, Ctr Funct Gen, Rensselaer, NY USA; [Cool, C. D.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Winn, R. A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Winn, RA (corresponding author), Univ Illinois, Dept Pulm Crit Care Sleep & Allergy, Coll Med Res Bldg, Chicago, IL USA.	rwinn@uic.edu	Lussier, Yves/N-4891-2017	Lussier, Yves/0000-0001-9854-1005	US Department of Veterans Affairs; NIH [R01CA138528]; NATIONAL CANCER INSTITUTE [P50CA058187, P30CA046934, R01CA138528] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are immensely grateful to Dr Judith Campisi (Buck Institute for Research on Aging) for her critical reading of this manuscript. We thank Dr Bifeng Gao, Katrina Diener and Dr Ken Jones of the Genomics and Microarray core, University of Colorado Denver, for their expert help in RNA sequencing. We also thank Dr Meredith Tennis, Dr Lora Wilson, Marybeth Sechler and Nicole Kelley for their helpful suggestions on this manuscript. This study was supported by a Merit Award from the US Department of Veterans Affairs and NIH grants R01CA138528 to RW.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bitler BG, 2011, CANCER RES, V71, P6184, DOI 10.1158/0008-5472.CAN-11-1341; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chan CH, 2014, CELL CYCLE, V13, P679, DOI 10.4161/cc.27853; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Keith RL, 2004, CANCER RES, V64, P5897, DOI 10.1158/0008-5472.CAN-04-1070; Keith RL, 2011, CANCER PREV RES, V4, P793, DOI 10.1158/1940-6207.CAPR-11-0057; Keith RL, 2010, LUNG CANCER, V70, P37, DOI 10.1016/j.lungcan.2010.01.004; Kondratov AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047012; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Malbon CC, 2004, FRONT BIOSCI-LANDMRK, V9, P1048, DOI 10.2741/1308; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Mori M, 2001, MODERN PATHOL, V14, P72, DOI 10.1038/modpathol.3880259; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nomori H, 2001, JPN J CLIN ONCOL, V31, P514, DOI 10.1093/jjco/hye103; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Parr BA, 1998, DEV BIOL, V202, P228, DOI 10.1006/dbio.1998.9007; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rodier Francis, 2013, Methods Mol Biol, V965, P165, DOI 10.1007/978-1-62703-239-1_10; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Romanov VS, 2010, CELL CYCLE, V9, P3945, DOI 10.4161/cc.9.19.13160; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shigemitsu K, 2001, ONCOGENE, V20, P4249, DOI 10.1038/sj.onc.1204557; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; te Poele RH, 2002, CANCER RES, V62, P1876; Tennis M, 2010, NEOPLASIA, V12, P244, DOI 10.1593/neo.91690; Tennis MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032921; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; Vikis Haris G, 2013, Front Biosci (Elite Ed), V5, P939; Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200	55	31	34	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5317	5328		10.1038/onc.2015.2	http://dx.doi.org/10.1038/onc.2015.2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25728679	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000363479200002
J	Kankipati, HN; Rubio-Texeira, M; Castermans, D; Diallinas, G; Thevelein, JM				Kankipati, Harish Nag; Rubio-Texeira, Marta; Castermans, Dries; Diallinas, George; Thevelein, Johan M.			Sul1 and Sul2 Sulfate Transceptors Signal to Protein Kinase A upon Exit of Sulfur Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Membrane Transport; Protein Kinase A (PKA); Signaling; Transporter; Symporter; Signaling Agonist; Stationary Phase; Sulfate Sensing; Sulfate Transporter	AMINO-ACID PERMEASE; YEAST SACCHAROMYCES-CEREVISIAE; NUTRIENT-INDUCED ACTIVATION; DOWN-REGULATION; MUTATIONAL ANALYSIS; PLASMA-MEMBRANE; BINDING-SITE; HOST STRAINS; TRANSPORTER; PHOSPHATE	Background: Transceptors are transporters with an additional receptor function. Results: Sul1 and Sul2 signal to PKA in the absence of sulfate transport. Conclusion: Yeast Sul1 and Sul2 are sulfate transceptors. Significance: Transceptors could be a universal class of nutrient sensors. Sulfate is an essential nutrient with pronounced regulatory effects on cellular metabolism and proliferation. Little is known, however, about how sulfate is sensed by cells. Sul1 and Sul2 are sulfate transporters in the yeast Saccharomyces cerevisiae, strongly induced upon sulfur starvation and endocytosed upon the addition of sulfate. We reveal Sul1,2-dependent activation of PKA targets upon sulfate-induced exit from growth arrest after sulfur starvation. We provide two major arguments in favor of Sul1 and Sul2 acting as transceptors for signaling to PKA. First, the sulfate analogue, d-glucosamine 2-sulfate, acted as a non-transported agonist of signaling by Sul1 and Sul2. Second, mutagenesis to Gln of putative H+-binding residues, Glu-427 in Sul1 or Glu-443 in Sul2, abolished transport without affecting signaling. Hence, Sul1,2 can function as pure sulfate sensors. Sul1(E427Q) and Sul2(E443Q) are also deficient in sulfate-induced endocytosis, which can therefore be uncoupled from signaling. Overall, our data suggest that transceptors can undergo independent conformational changes, each responsible for triggering different downstream processes. The Sul1 and Sul2 transceptors are the first identified plasma membrane sensors for extracellular sulfate. High affinity transporters induced upon starvation for their substrate may generally act as transceptors during exit from starvation.	[Kankipati, Harish Nag; Rubio-Texeira, Marta; Castermans, Dries; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Leuven Heverlee, Flanders, Belgium; [Kankipati, Harish Nag; Rubio-Texeira, Marta; Castermans, Dries; Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Leuven Heverlee, Flanders, Belgium; [Diallinas, George] Univ Athens, Fac Biol, Athens 15784, Greece	KU Leuven; Flanders Institute for Biotechnology (VIB); National & Kapodistrian University of Athens	Thevelein, JM (corresponding author), KU Leuven VIB, Inst Bot & Microbiol, Mol Cell Biol Lab, Kasteelpk Arenberg 31, B-3001 Leuven Heverlee, Flanders, Belgium.	johan.thevelein@mmbio.vib-kuleuven.be	Diallinas, George/AAE-8457-2019; Thevelein, Johan M./AAK-4203-2021	Diallinas, George/0000-0002-3426-726X; 	DBOF Ph.D. fellowship from the KU Leuven Research Fund; VIB postdoctoral position; EC-Marie-Curie fellowship; FWO visiting fellowship; Fund for Scientific Research-Flanders; Interuniversity Attraction Poles Network [P6/14, P7/40]; Research Fund of KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders)	DBOF Ph.D. fellowship from the KU Leuven Research Fund; VIB postdoctoral position; EC-Marie-Curie fellowship(European CommissionEuropean Commission Joint Research Centre); FWO visiting fellowship; Fund for Scientific Research-Flanders(FWO); Interuniversity Attraction Poles Network(Belgian Federal Science Policy Office); Research Fund of KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders)	This work was supported by a DBOF Ph.D. fellowship from the KU Leuven Research Fund (to H. N. K.); a VIB postdoctoral position, an EC-Marie-Curie fellowship, and an FWO visiting fellowship (to M. R. T.); and grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P6/14 and P7/40, the Research Fund of KU Leuven (Concerted Research Actions), and the Hercules Foundation (Flanders) (to J. M. T.).	Adams A., 1996, METHODS YEAST GENETI; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; BRETON A, 1977, J BACTERIOL, V132, P224, DOI 10.1128/JB.132.1.224-232.1977; Cain NE, 2011, MOL BIOL CELL, V22, P1919, DOI 10.1091/mbc.E10-10-0800; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Cherest H, 1997, GENETICS, V145, P627; CHEREST H, 1992, GENETICS, V130, P51; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Diallinas G, 2013, BIOCHIMIE, V95, P1755, DOI 10.1016/j.biochi.2013.05.013; Diallinas G, 2008, CHANNELS, V2, P363, DOI 10.4161/chan.2.5.6902; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Frillingos Stathis, 2012, Int J Biochem Mol Biol, V3, P250; Garczarek F, 2004, BIOPHYS J, V87, P2676, DOI 10.1529/biophysj.104.046433; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Gournas C, 2010, MOL MICROBIOL, V75, P246, DOI 10.1111/j.1365-2958.2009.06997.x; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Iraqui I, 1999, MOL CELL BIOL, V19, P989; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Jennings ML, 2012, BIOPHYS J, V102, P768, DOI 10.1016/j.bpj.2012.01.005; Jensen LT, 2009, MOL BIOL CELL, V20, P2810, DOI 10.1091/mbc.E08-10-1084; Jiang X, 2010, METALLOMICS, V2, P211, DOI 10.1039/b920471g; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kosti V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041939; Lagerstedt JO, 2002, FEBS LETT, V526, P31, DOI 10.1016/S0014-5793(02)03109-5; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Liu XF, 1999, J MOL BIOL, V289, P885, DOI 10.1006/jmbi.1999.2815; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Perez-Torras S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.173; Petersson J, 1999, FEBS LETT, V462, P37, DOI 10.1016/S0014-5793(99)01471-4; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; ROOMANS GM, 1979, BIOCHIM BIOPHYS ACTA, V551, P197, DOI 10.1016/0005-2736(79)90365-1; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; Samyn DR, 2012, BIOCHEM J, V445, P413, DOI 10.1042/BJ20112086; Schepers W, 2012, J BIOL CHEM, V287, P44130, DOI 10.1074/jbc.M112.421503; Schothorst J, 2013, CURR GENET, V59, P197, DOI 10.1007/s00294-013-0413-y; Seron K, 1999, J BACTERIOL, V181, P1793; SIKORSKI RS, 1989, GENETICS, V122, P19; Smirnova IN, 2008, P NATL ACAD SCI USA, V105, P8896, DOI 10.1073/pnas.0803577105; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; Takahashi H, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00119; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2014, MOL MICROBIOL, V93, P213, DOI 10.1111/mmi.12654; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; Walch-Liu P, 2008, PLANT J, V54, P820, DOI 10.1111/j.1365-313X.2008.03443.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang B, 2014, PLANT J, V77, P185, DOI 10.1111/tpj.12376	70	35	35	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10430	10446		10.1074/jbc.M114.629022	http://dx.doi.org/10.1074/jbc.M114.629022			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724649	hybrid, Green Published			2022-12-26	WOS:000353241100043
J	Halvorson, KG; Barton, KL; Schroeder, K; Misuraca, KL; Hoeman, C; Chung, A; Crabtree, DM; Cordero, FJ; Singh, R; Spasojevic, I; Berlow, N; Pal, R; Becher, OJ				Halvorson, Kyle G.; Barton, Kelly L.; Schroeder, Kristin; Misuraca, Katherine L.; Hoeman, Christine; Chung, Alex; Crabtree, Donna M.; Cordero, Francisco J.; Singh, Raj; Spasojevic, Ivan; Berlow, Noah; Pal, Ranadip; Becher, Oren J.			A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; BRAIN-STEM GLIOMAS; ACTIVATING ACVR1 MUTATIONS; RAT GLIOBLASTOMA CELLS; HIGH-GRADE GLIOMAS; PEDIATRIC GLIOBLASTOMA; GENE-EXPRESSION; HISTONE H3.3; RECEPTOR; CANCER	Diffuse intrinsic pontine gliomas (DIPGs) represent a particularly lethal type of pediatric brain cancer with no effective therapeutic options. Our laboratory has previously reported the development of genetically engineered DIPG mouse models using the RCAS/tv-a system, including a model driven by PDGF-B, H3.3K27M, and p53 loss. These models can serve as a platform in which to test novel therapeutics prior to the initiation of human clinical trials. In this study, an in vitro high-throughput drug screen as part of the DIPG preclinical consortium using cell-lines derived from our DIPG models identified BMS-754807 as a drug of interest in DIPG. BMS-754807 is a potent and reversible small molecule multi-kinase inhibitor with many targets including IGF-1R, IR, MET, TRKA, TRKB, AURKA, AURKB. In vitro evaluation showed significant cytotoxic effects with an IC50 of 0.13 mu M, significant inhibition of proliferation at a concentration of 1.5 mu M, as well as inhibition of AKT activation. Interestingly, IGF-1R signaling was absent in serum-free cultures from the PDGF-B; H3.3K27M; p53 deficient model suggesting that the antitumor activity of BMS-754807 in this model is independent of IGF-1R. In vivo, systemic administration of BMS-754807 to DIPG-bearing mice did not prolong survival. Pharmacokinetic analysis demonstrated that tumor tissue drug concentrations of BMS-754807 were well below the identified IC50, suggesting that inadequate drug delivery may limit in vivo efficacy. In summary, an unbiased in vitro drug screen identified BMS-754807 as a potential therapeutic agent in DIPG, but BMS-754807 treatment in vivo by systemic delivery did not significantly prolong survival of DIPGbearing mice.	[Halvorson, Kyle G.; Barton, Kelly L.; Schroeder, Kristin; Hoeman, Christine; Chung, Alex; Crabtree, Donna M.; Cordero, Francisco J.; Singh, Raj; Becher, Oren J.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Halvorson, Kyle G.; Barton, Kelly L.; Hoeman, Christine; Chung, Alex; Crabtree, Donna M.; Cordero, Francisco J.; Singh, Raj; Becher, Oren J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Halvorson, Kyle G.; Schroeder, Kristin; Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Halvorson, Kyle G.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Misuraca, Katherine L.] Duke Univ, Grad Program Mol Canc Biol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ, Dept Med Oncol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Canc Inst, PK PD Core Lab, Pharmaceut Serv, Durham, NC USA; [Berlow, Noah; Pal, Ranadip] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Texas Tech University System; Texas Tech University	Becher, OJ (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.	oren.becher@duke.edu	Becher, Oren/AAI-7495-2020; Pal, Ranadip/F-3905-2012	Becher, Oren/0000-0003-4016-8492; Pal, Ranadip/0000-0002-9311-5901	Rory David Deutsch Foundation; Department of Defense award [W81XWH-11-1-0608]; Joshua's Wish Foundation Summer Research Grant; Children's Oncology Group (COG) CNS Committee; DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer-Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation); Accelerate Brain Cancer Cures Foundation [ABC2]; Lyla Nsouli Foundation; CureSearch for Childhood Cancer; Team Julian Foundation; COG Chair's [5UOCA098543];  [T32];  [R25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER	Rory David Deutsch Foundation; Department of Defense award(United States Department of Defense); Joshua's Wish Foundation Summer Research Grant; Children's Oncology Group (COG) CNS Committee; DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer-Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation); Accelerate Brain Cancer Cures Foundation; Lyla Nsouli Foundation; CureSearch for Childhood Cancer; Team Julian Foundation; COG Chair's; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Rory David Deutsch Foundation, and a Department of Defense award (W81XWH-11-1-0608) to OJB. KS was supported by a T32 award (PI Henry Friedman). KH was supported by a R25 award (PI John Sampson). RS was supported by a Joshua's Wish Foundation Summer Research Grant. The drug screen was supported by the Children's Oncology Group (COG) CNS Committee, The DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer-Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation), Accelerate Brain Cancer Cures Foundation (ABC2), The Lyla Nsouli Foundation, CureSearch for Childhood Cancer, The Team Julian Foundation and the COG Chair's Grant (5UOCA098543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026; Awasthi N, 2012, MOL CANCER THER, V11, P2644, DOI 10.1158/1535-7163.MCT-12-0447; Barton KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077639; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; BERGER MS, 1983, NEUROSURGERY, V12, P298, DOI 10.1227/00006123-198303000-00008; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Buczkowicz P, 2013, BRAIN PATHOL, V23, P244, DOI 10.1111/j.1750-3639.2012.00633.x; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950; Freeman CR, 1998, INT J RADIAT ONCOL, V40, P265, DOI 10.1016/S0360-3016(97)00572-5; Grill J, 2012, PEDIATR BLOOD CANCER, V58, P489, DOI 10.1002/pbc.24060; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Hou XN, 2011, CANCER RES, V71, P7597, DOI 10.1158/0008-5472.CAN-11-1080; Huang F, 2010, CANCER RES, V70, P7221, DOI 10.1158/0008-5472.CAN-10-0391; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kolb EA, 2011, PEDIATR BLOOD CANCER, V56, P595, DOI 10.1002/pbc.22741; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; LITTMAN P, 1980, CANCER, V45, P2787, DOI 10.1002/1097-0142(19800601)45:11<2787::AID-CNCR2820451113>3.0.CO;2-V; Minturn JE, 2013, CURR TREAT OPTION NE, V15, P316, DOI 10.1007/s11940-013-0225-x; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; RESNICOFF M, 1994, CANCER RES, V54, P2218; RESNICOFF M, 1994, LAB INVEST, V71, P657; Ries L.A.G., 1999, CANC INCIDENCE SURVI; Roujeau T, 2007, J NEUROSURG, V107, P1, DOI 10.3171/PED-07/07/001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Scotlandi K, 2002, INT J CANCER, V101, P11, DOI 10.1002/ijc.10537; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; Wojtalla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047109; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yin SC, 2010, NEURO-ONCOLOGY, V12, P19, DOI 10.1093/neuonc/nop008; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	41	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118926	10.1371/journal.pone.0118926	http://dx.doi.org/10.1371/journal.pone.0118926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748921	Green Published, gold, Green Submitted			2022-12-26	WOS:000350689400032
J	Arriaran, S; Agnelli, S; Sabater, D; Remesar, X; Fernandez-Lopez, JA; Alemany, M				Arriaran, Sofia; Agnelli, Silvia; Sabater, David; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria			Evidences of Basal Lactate Production in the Main White Adipose Tissue Sites of Rats. Effects of Sex and a Cafeteria Diet	PLOS ONE			English	Article							BLOOD-FLOW; NITRIC-OXIDE; INSULIN-RESISTANCE; METABOLIC SYNDROME; HUMAN ADIPOCYTES; SKELETAL-MUSCLE; GENE-EXPRESSION; CANCER-CELLS; ACID CYCLE; HYPOXIA	Female and male adult Wistar rats were fed standard chow or a simplified cafeteria diet for one month. Then, the rats were killed and the white adipose tissue (WAT) in four sites: perigonadal, retroperitoneal, mesenteric and subcutaneous (inguinal) were sampled and frozen. The complete WAT weight in each site was measured. Gene expression analysis of key lipid and glucose metabolism enzymes were analyzed, as well as tissue and plasma lactate and the activity of lactate dehydrogenase. Lactate gradients between WAT and plasma were estimated. The influence of sex and diet (and indirectly WAT mass) on lactate levels and their relationships with lactate dehydrogenase activity and gene expressions were also measured. A main conclusion is the high production of lactate by WAT, practically irrespective of site, diet or sex. Lactate production is a direct correlate of lactate dehydrogenase activity in the tissue. Furthermore, lactate dehydrogenase activity is again directly correlated with the expression of the genes Ldha and Ldhb for this enzyme. In sum, the ability to produce lactate by WAT is not directly dependent of WAT metabolic state. We postulate that, in WAT, a main function of the lactate dehydrogenase path may be that of converting excess available glucose to 3C fragments, as a way to limit tissue self-utilization as substrate, to help control glycaemia and/or providing short chain substrates for use as energy source elsewhere. More information must be gathered before a conclusive role of WAT in the control of glycaemia, and the full existence of a renewed glucose-lactate-fatty acid cycle is definitely established.	[Arriaran, Sofia; Agnelli, Silvia; Sabater, David; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Sabater, David; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] CIBER Obes & Nutr, Barcelona, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Fernandez-Lopez, JA (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	josfernandez@ub.edu	Remesar, Xavier/G-5703-2013; Alemany, Marià/H-5224-2011; López, José Antonio Fernández/C-5467-2017; Remesar, Xavier/L-4555-2019	Remesar, Xavier/0000-0002-9707-7287; Alemany, Marià/0000-0002-9783-8293; López, José Antonio Fernández/0000-0002-2856-7223; Remesar, Xavier/0000-0002-9707-7287; Arriaran, Sofia/0000-0003-2151-1232; Sabater Martinez, David/0000-0001-8113-8594	Plan Nacional de Investigacion en Biomedicina of the Government of Spain [SAF2012-34895]; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain [AGL-2011-23635]; CIBER-OBN (Institute of Health Carlos III); Leonardo da Vinci fellowship; Catalan Government	Plan Nacional de Investigacion en Biomedicina of the Government of Spain(Spanish Government); Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain; CIBER-OBN (Institute of Health Carlos III); Leonardo da Vinci fellowship; Catalan Government	This study was done with the partial support of grants of the Plan Nacional de Investigacion en Biomedicina (SAF2012-34895) and the Plan Nacional de Ciencia y Tecnologia de los Alimentos (AGL-2011-23635) of the Government of Spain, as well as of CIBER-OBN (Institute of Health Carlos III). S. Agnelli was the recipient of a Leonardo da Vinci fellowship, and S. Arriaran a predoctoral fellowship of the Catalan Government, in both cases covering part of the time invested in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany M, 2011, J ENDOCRINOL METAB, V1, P155, DOI 10.4021/jem52w; Alemany M, 2012, HORM-INT J ENDOCRINO, V11, P272, DOI 10.14310/horm.2002.1356; Alemany M, 2012, FREE RADICAL BIO MED, V52, P2108, DOI 10.1016/j.freeradbiomed.2012.03.003; Alemany M, 2011, J CLIN ENDOCR METAB, V96, P66, DOI 10.1210/jc.2010-2541; Alemany M, 2006, CURR NUTR FOOD SCI, V2, P141, DOI 10.2174/157340106776818817; Andersson J, 2012, INT J OBESITY, V36, P783, DOI 10.1038/ijo.2011.152; Ardilouze JL, 2004, CIRCULATION, V109, P47, DOI 10.1161/01.CIR.0000105681.70455.73; Bamias G, 2013, INFLAMM BOWEL DIS, V19, P2840, DOI 10.1097/01.MIB.0000435440.22484.e8; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Codoner-Franch P, 2011, ATHEROSCLEROSIS, V215, P475, DOI 10.1016/j.atherosclerosis.2010.12.035; Cori C F, 1981, Curr Top Cell Regul, V18, P377; CRANDALL DL, 1983, HORM METAB RES, V15, P326, DOI 10.1055/s-2007-1018710; DAVIDSON MB, 1993, AM J PHYSIOL, V264, pE18, DOI 10.1152/ajpendo.1993.264.1.E18; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Romero MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090995; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; DRINGEN R, 1993, BIOL CHEM H-S, V374, P343, DOI 10.1515/bchm3.1993.374.1-6.343; Ellmerer M, 1998, J CLIN ENDOCR METAB, V83, P4394, DOI 10.1210/jc.83.12.4394; FELIPE A, 1991, BIOCHEM J, V273, P195, DOI 10.1042/bj2730195; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; FREMINET A, 1975, FEBS LETT, V60, P431, DOI 10.1016/0014-5793(75)80765-4; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; GARDINER SM, 1990, HYPERTENSION, V15, P486, DOI 10.1161/01.HYP.15.5.486; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRANATA AL, 1976, PFLUG ARCH EUR J PHY, V366, P247, DOI 10.1007/BF00585885; HAGSTROM E, 1990, AM J PHYSIOL, V258, pE888, DOI 10.1152/ajpendo.1990.258.5.E888; Heinonen I, 2014, CIRC J, V78, P1501, DOI 10.1253/circj.CJ-13-1273; Herschap B, 2011, INT J SURG PATHOL, V19, P190, DOI 10.1177/1066896910397611; Hodson L, 2013, DIABETES, V62, P1417, DOI 10.2337/db12-1032; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIN AD, 1994, INT J OBESITY, V18, P79; Mather KJ, 2004, DIABETES, V53, P2060, DOI 10.2337/diabetes.53.8.2060; Munoz S, 2010, DIABETOLOGIA, V53, P2417, DOI 10.1007/s00125-010-1840-7; NADALGINARD B, 1978, J BIOL CHEM, V253, P170; Nadra K, 2012, J NEUROCHEM, V123, P662, DOI 10.1111/j.1471-4159.2012.07896.x; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117; RAFECAS I, 1992, INT J OBESITY, V16, P775; RANDLE PJ, 1963, LANCET, V1, P785; RAPOPORT TA, 1976, BIOCHEM J, V154, P449, DOI 10.1042/bj1540449; Ribiere C, 1996, BIOCHEM BIOPH RES CO, V222, P706, DOI 10.1006/bbrc.1996.0824; ROGNSTAD R, 1982, ARCH BIOCHEM BIOPHYS, V217, P498, DOI 10.1016/0003-9861(82)90530-6; Romero MD, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-26; ROSS BD, 1967, BIOCHEM J, V102, P942, DOI 10.1042/bj1020942; Sabater D, 2014, SCI REP-UK, V4, DOI 10.1038/srep03663; Saggerson ED, 1998, BIOCHEM J, V251, P701; SAHLIN K, 1989, J APPL PHYSIOL, V67, P2640, DOI 10.1152/jappl.1989.67.6.2640a; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; Slade JM, 2012, J DIABETES COMPLICAT, V26, P1, DOI 10.1016/j.jdiacomp.2011.11.001; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; SOLEY M, 1980, J BIOCHEM BIOPH METH, V2, P207, DOI 10.1016/0165-022X(80)90035-4; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; TAEGTMEYER H, 1980, BIOCHEM J, V186, P701, DOI 10.1042/bj1860701; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; TANAKA K, 1983, EUR J APPL PHYSIOL O, V52, P51, DOI 10.1007/BF00429025; Taylor CT, 2014, BIOCHEM BIOPH RES CO, V447, P660, DOI 10.1016/j.bbrc.2014.04.062; Toda N, 2013, J CLIN PHARMACOL, V53, P1228, DOI 10.1002/jcph.179; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; van den Borst B, 2013, J APPL PHYSIOL, V114, P1619, DOI 10.1152/japplphysiol.00460.2012; Van der Merwe MT, 1998, J CLIN ENDOCR METAB, V83, P4084, DOI 10.1210/jc.83.11.4084; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118; VYTASEK R, 1982, ANAL BIOCHEM, V120, P243, DOI 10.1016/0003-2697(82)90342-6; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014	74	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119572	10.1371/journal.pone.0119572	http://dx.doi.org/10.1371/journal.pone.0119572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741703	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100122
J	Asakawa, S; Kishimoto, Y; Takano, T; Okita, K; Takakuwa, S; Sato, T; Hiratsuka, M; Takeuchi, O; Hirasawa, N				Asakawa, Sanki; Kishimoto, Yu; Takano, Takayuki; Okita, Kiyuki; Takakuwa, Shiho; Sato, Taiki; Hiratsuka, Masahiro; Takeuchi, Osamu; Hirasawa, Noriyasu			Nickel Ions Selectively Inhibit Lipopolysaccharide-Induced Interleukin-6 Production by Decreasing Its mRNA Stability	PLOS ONE			English	Article							INNATE IMMUNITY; KAPPA-B; RECEPTOR; INDUCTION; DIFFERENTIATION; EXPRESSION; PROMOTES; ALLERGY; COBALT; INFLAMMATION	Nickel (Ni) ions easily elute from many alloys and elicit inflammation and allergies. Previous studies have shown that infections due to the implantation of medical devices cause inflammation and enhance the elution of Ni ions (Ni2+). However, cross-talk between infection- and Ni2+-induced signaling pathways has not yet been elucidated in detail. In the present study, we investigated the effects of Ni2+ on the lipopolysaccharide (LPS)-induced production of cytokines in a LPS-induced air pouch-type inflammation model in BALB/c mice and the murine macrophage cell line RAW264. We demonstrated that Ni2+ inhibited the LPS-induced production of interleukin (IL)-6, but not that of tumor necrosis factor (TNF)-alpha both in vivo and in vitro. This inhibitory effect was also observed with cobalt ion (Co2+), but not with chloride ion (Cl-), zinc ion (Zn2+), or palladium ion (Pd2+), and was highly selective to the production of IL-6. Ni2+ did not inhibit the activation of ERK1/2, p38 MAPK, or JNK. Although Ni2+ decreased IL-6 mRNA levels, it failed to inhibit the LPS-induced activation of the IL-6 promoter. An experiment using actinomycin D, a transcription inhibitor, revealed that Ni2+ decreased the stability of IL-6 mRNA. Moreover, Ni2+ inhibited the LPS-induced expression of Arid5a, but not regnase-1. These results demonstrated that Ni2+ may have selectively inhibited the LPS-induced production of IL-6 by decreasing the Arid5a-dependent stabilization of IL-6 mRNA.	[Asakawa, Sanki; Kishimoto, Yu; Takano, Takayuki; Okita, Kiyuki; Takakuwa, Shiho; Sato, Taiki; Hiratsuka, Masahiro; Hirasawa, Noriyasu] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 606, Japan	Tohoku University; Kyoto University	Hirasawa, N (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan.	hirasawa@m.tohoku.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Hiratsuka, Masahiro/AAO-8082-2020	Takeuchi, Osamu/0000-0002-1260-6232; Hiratsuka, Masahiro/0000-0002-3767-7686; Hirasawa, Noriyasu/0000-0002-8062-4838	Frontier Research Institute for Interdisciplinary Science, Tohoku University; Japan Society for the Promotion of Science [25670034]; Japan Science Society [26-431]	Frontier Research Institute for Interdisciplinary Science, Tohoku University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This study was supported in part by a grant from the Frontier Research Institute for Interdisciplinary Science, Tohoku University (http://www.fris.tohoku.ac.jp/fris/english/index.html) and a Grant-in-aid for Challenging Exploratory Research (25670034) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). SA was supported by the Sasakawa Scientific Research Grant (26-431) from The Japan Science Society (http://www.jss.or.jp/ikusei/sasakawa/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 1999, J IMMUNOL, V162, P494; Antoine F, 2013, INT IMMUNOPHARMACOL, V17, P1101, DOI 10.1016/j.intimp.2013.09.024; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brant KA, 2009, TOXICOL SCI, V107, P227, DOI 10.1093/toxsci/kfn208; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Heiss K, 2005, PROTEOMICS, V5, P3614, DOI 10.1002/pmic.200401215; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kamachi F, 2007, J PHARMACOL EXP THER, V321, P345, DOI 10.1124/jpet.106.116251; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kinbara M, 2011, BRIT J DERMATOL, V164, P356, DOI 10.1111/j.1365-2133.2010.10016.x; Klouche M, 1999, J IMMUNOL, V163, P4583; Kuroishi T, 2013, TOXICOL SCI, V135, P119, DOI 10.1093/toxsci/kft142; Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Medici S, 2013, MOLECULES, V18, P12396, DOI 10.3390/molecules181012396; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shawish HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100933; Shionome T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068257; Sun XS, 2013, METALLOMICS, V5, P928, DOI 10.1039/c3mt00126a; Tanaka R, 2011, J DERMATOL SCI, V62, P50, DOI 10.1016/j.jdermsci.2010.12.006; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; Thyssen JP, 2010, CONTACT DERMATITIS, V63, P151, DOI 10.1111/j.1600-0536.2010.01767.x; Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726; Van den Broeke LT, 1999, IMMUNOLOGY, V96, P578; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	48	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119428	10.1371/journal.pone.0119428	http://dx.doi.org/10.1371/journal.pone.0119428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742007	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100109
J	Armstead, AL; Minarchick, VC; Porter, DW; Nurkiewicz, TR; Li, BY				Armstead, Andrea L.; Minarchick, Valerie C.; Porter, Dale W.; Nurkiewicz, Timothy R.; Li, Bingyun			Acute Inflammatory Responses of Nanoparticles in an Intra-Tracheal Instillation Rat Model	PLOS ONE			English	Article							METAL LUNG-DISEASE; CERIUM DIOXIDE NANOPARTICLES; DUST WC-CO; HARD-METAL; IN-VITRO; TUNGSTEN CARBIDE; PARTICLE-SIZE; NITRIC-OXIDE; PULMONARY TOXICITY; INTRATRACHEAL INSTILLATION	Exposure to hard metal tungsten carbide cobalt (WC-Co) "dusts" in enclosed industrial environments is known to contribute to the development of hard metal lung disease and an increased risk for lung cancer. Currently, the influence of local and systemic inflammation on disease progression following WC-Co exposure remains unclear. To better understand the relationship between WC-Co nanoparticle (NP) exposure and its resultant effects, the acute local pulmonary and systemic inflammatory responses caused by WC-Co NPs were explored using an intra-tracheal instillation (IT) model and compared to those of CeO2 (another occupational hazard) NP exposure. Sprague-Dawley rats were given an IT dose (0-500 mu g per rat) of WC-Co or CeO2 NPs. Following 24-hr exposure, broncho-alveolar lavage fluid and whole blood were collected and analyzed. A consistent lack of acute local pulmonary inflammation was observed in terms of the broncho-alveolar lavage fluid parameters examined (i.e. LDH, albumin, and macrophage activation) in animals exposed to WCCo NP; however, significant acute pulmonary inflammation was observed in the CeO2 NP group. The lack of acute inflammation following WC-Co NP exposure contrasts with earlier in vivo reports regarding WC-Co toxicity in rats, illuminating the critical role of NP dose and exposure time and bringing into question the potential role of impurities in particle samples. Further, we demonstrated that WC-Co NP exposure does not induce acute systemic effects since no significant increase in circulating inflammatory cytokines were observed. Taken together, the results of this in vivo study illustrate the distinct differences in acute local pulmonary and systemic inflammatory responses to NPs composed of WC-Co and CeO2; therefore, it is important that the outcomes of pulmonary exposure to one type of NPs may not be implicitly extrapolated to other types of NPs.	[Armstead, Andrea L.; Li, Bingyun] W Virginia Univ, Sch Med, Dept Orthopaed, Biomat Bioengn & Nanotechnol Lab, Morgantown, WV 26506 USA; [Armstead, Andrea L.; Li, Bingyun] W Virginia Univ, Sch Pharm, Pharmaceut & Pharmacol Sci Grad Program, Morgantown, WV 26506 USA; [Minarchick, Valerie C.; Porter, Dale W.; Nurkiewicz, Timothy R.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, WV USA; [Minarchick, Valerie C.; Nurkiewicz, Timothy R.] W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA; [Porter, Dale W.; Nurkiewicz, Timothy R.; Li, Bingyun] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Morgantown, WV USA; [Li, Bingyun] Mary Babb Randolph Canc Ctr, Morgantown, WV USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Li, BY (corresponding author), W Virginia Univ, Sch Med, Dept Orthopaed, Biomat Bioengn & Nanotechnol Lab, Morgantown, WV 26506 USA.	bili@hsc.wvu.edu		Li, Bingyun/0000-0002-5766-5666	American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship in Pharmaceutical Sciences; West Virginia NANOSAFE graduate fellowship program [NSF-1003907]; West Virginia Higher Education Policy Commission Division of Science Research PUI Incubator program;  [R01-ES015022];  [DGE-1144676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015022] Funding Source: NIH RePORTER	American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship in Pharmaceutical Sciences; West Virginia NANOSAFE graduate fellowship program; West Virginia Higher Education Policy Commission Division of Science Research PUI Incubator program; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	ALA acknowledges the American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship in Pharmaceutical Sciences for support (2012-14). VCM acknowledges the West Virginia NANOSAFE graduate fellowship program (NSF-1003907) and TRN acknowledges NSF-1003907, R01-ES015022, and DGE-1144676 for financial support. BL acknowledges the support of the West Virginia Higher Education Policy Commission Division of Science Research PUI Incubator program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis Z, 1997, ANN OCCUP HYG, V41, P515, DOI 10.1016/S0003-4878(97)00014-8; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; ALLEN RC, 1977, INFECT IMMUN, V15, P828, DOI 10.1128/IAI.15.3.828-833.1977; Anard D, 1997, CARCINOGENESIS, V18, P177, DOI 10.1093/carcin/18.1.177; Antonini JM, 2000, IN VITRO MOL TOXICOL, V13, P5; Armstead AL, 2014, TOXICOL APPL PHARM, V278, P1, DOI 10.1016/j.taap.2014.04.008; BALMES JR, 1987, OCCUP MED, V2, P327; Bastian S, 2009, ENVIRON HEALTH PERSP, V117, P530, DOI 10.1289/ehp.0800121; Bernstein DM, 2004, INHAL TOXICOL, V16, P675, DOI 10.1080/08958370490476587; Blum JL, 2014, INHAL TOXICOL, V26, P48, DOI 10.3109/08958378.2013.851746; Borm PJA, 2004, INT J CANCER, V110, P3, DOI 10.1002/ijc.20064; Borm PYA, 2000, INHAL TOXICOL, V12, P1, DOI 10.1080/08958370050029725; Cassee FR, 2002, ARCH TOXICOL, V76, P277, DOI 10.1007/s00204-002-0344-8; Castranova V, 1998, ENVIRON HEALTH PERSP, V106, P1165, DOI 10.2307/3433980; Castranova V, 2011, J OCCUP ENVIRON MED, V53, pS14, DOI 10.1097/JOM.0b013e31821b1e5a; Cattaneo AG, 2010, J APPL TOXICOL, V30, P730, DOI 10.1002/jat.1609; Courbiere B, 2013, INT J MOL SCI, V14, P21613, DOI 10.3390/ijms141121613; CUGELL DW, 1992, CLIN CHEST MED, V13, P269; De Boeck M, 2003, CARCINOGENESIS, V24, P1793, DOI 10.1093/carcin/bgg146; De Boeck M, 2003, MUTAGENESIS, V18, P177, DOI 10.1093/mutage/18.2.177; Donaldson K, 2013, ACCOUNTS CHEM RES, V46, P723, DOI 10.1021/ar300092y; Du ZJ, 2013, CARDIOVASC TOXICOL, V13, P194, DOI 10.1007/s12012-013-9198-y; DULIN AM, 1982, J DAIRY SCI, V65, P1247, DOI 10.3168/jds.S0022-0302(82)82337-0; Dunlop P, 2005, J THORAC IMAG, V20, P301, DOI 10.1097/01.rti.0000181523.87391.a9; EDEL J, 1990, SCI TOTAL ENVIRON, V95, P107, DOI 10.1016/0048-9697(90)90056-Z; Fedan JS, 2001, TOXICOL APPL PHARM, V174, P199, DOI 10.1006/taap.2001.9205; Gaiser BK, 2012, ENVIRON TOXICOL CHEM, V31, P144, DOI 10.1002/etc.703; Gaiser BK, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S2; Geiser M, 2002, MICROSC RES TECHNIQ, V57, P512, DOI 10.1002/jemt.10105; Geraets L, 2012, TOXICOL SCI, V127, P463, DOI 10.1093/toxsci/kfs113; Guadagnini R, 2013, NANOTOXICOLOGY, DOI [10.3109/17435390.17432013.17829590, DOI 10.3109/17435390.17432013.17829590]; Gustafsson A, 2011, J IMMUNOTOXICOL, V8, P111, DOI 10.3109/1547691X.2010.546382; Haberl N, 2013, BEILSTEIN J NANOTECH, V4, P933, DOI 10.3762/bjnano.4.105; He XA, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/28/285103; HENDERSON RF, 1995, FUND APPL TOXICOL, V24, P183, DOI 10.1006/faat.1995.1022; HUAUX F, 1995, TOXICOL APPL PHARM, V132, P53, DOI 10.1006/taap.1995.1086; Hubbs AF, 2011, TOXICOL PATHOL, V39, P301, DOI 10.1177/0192623310390705; Hussain S, 2012, ACS NANO, V6, P5820, DOI 10.1021/nn302235u; KERFOOT EJ, 1975, AM IND HYG ASSOC J, V36, P17, DOI 10.1080/0002889758507202; Kim KP, 2006, HEALTH PHYS, V91, P58, DOI 10.1097/01.HP.0000200261.96014.6c; KITAMURA H, 1980, ACTA PATHOL JAPON, V30, P241; Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708; Knuckles TL, 2012, NANOTOXICOLOGY, V6, P724, DOI 10.3109/17435390.2011.606926; Kraus T, 2001, OCCUP ENVIRON MED, V58, P631, DOI 10.1136/oem.58.10.631; LASFARGUES G, 1992, TOXICOL APPL PHARM, V112, P41, DOI 10.1016/0041-008X(92)90277-Y; Lasfargues G, 1995, ENVIRON RES, V69, P108, DOI 10.1006/enrs.1995.1032; LeBlanc AJ, 2010, CARDIOVASC TOXICOL, V10, P27, DOI 10.1007/s12012-009-9060-4; Li JJ, 2010, EXP BIOL MED, V235, P1025, DOI 10.1258/ebm.2010.010021; LISON D, 1992, TOXICOL LETT, V60, P203, DOI 10.1016/0378-4274(92)90275-O; LISON D, 1990, ENVIRON RES, V52, P187, DOI 10.1016/S0013-9351(05)80253-1; LISON D, 1993, ARCH TOXICOL, V67, P347, DOI 10.1007/BF01973706; Lombaert N, 2004, TOXICOL LETT, V154, P23, DOI 10.1016/j.toxlet.2004.06.009; Lombaert N, 2008, TOXICOL APPL PHARM, V227, P299, DOI 10.1016/j.taap.2007.11.002; Ma JY, 2011, NANOTOXICOLOGY, V5, P312, DOI 10.3109/17435390.2010.519835; McKinney W, 2012, INHAL TOXICOL, V24, P447, DOI 10.3109/08958378.2012.685111; Minarchick VC, 2013, CARDIOVASC TOXICOL, V13, P323, DOI 10.1007/s12012-013-9213-3; Miyata R, 2011, TOXICOL APPL PHARM, V257, P209, DOI 10.1016/j.taap.2011.09.007; Moriyama H, 2007, AM J RESP CRIT CARE, V176, P70, DOI 10.1164/rccm.200601-134OC; Muhlfeld C, 2008, AM J PHYSIOL-LUNG C, V294, pL817, DOI 10.1152/ajplung.00442.2007; Naqvi AH, 2008, ARCH ENVIRON OCCUP H, V63, P51, DOI 10.3200/AEOH.63.2.51-70; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nemery B, 2001, SEMIN RESP CRIT CARE, V22, P435, DOI 10.1055/s-2001-17386; Nemery B, 2007, AM J RESP CRIT CARE, V176, P2, DOI 10.1164/rccm.200704-527ED; Nurkiewicz Timothy R, 2011, Res Rep Health Eff Inst, P3; Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Nurkiewicz TR, 2004, ENVIRON HEALTH PERSP, V112, P1299, DOI 10.1289/ehp.7001; Pauluhn J, 2012, J APPL TOXICOL, V32, P488, DOI 10.1002/jat.1668; Pauluhn J, 2011, INHAL TOXICOL, V23, P763, DOI 10.3109/08958378.2011.606431; Porter DW, 2007, TOXICOL PATHOL, V35, P702, DOI 10.1080/01926230701481915; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Porter DW, 2006, TOXICOL SCI, V90, P188, DOI 10.1093/toxsci/kfj075; Rengasamy A, 1999, TOXICOL APPL PHARM, V157, P178, DOI 10.1006/taap.1999.8668; Renwick LC, 2004, OCCUP ENVIRON MED, V61, P442, DOI 10.1136/oem.2003.008227; Roesems G, 2000, TOXICOL APPL PHARM, V162, P2, DOI 10.1006/taap.1999.8824; Schrand AM, 2012, ADV EXP MED BIOL, V745, P58, DOI 10.1007/978-1-4614-3055-1_5; Seale-Goldsmith MM, 2009, WIRES NANOMED NANOBI, V1, P553, DOI 10.1002/wnan.49; Silva RM, 2013, J TOXICOL ENV HEAL A, V76, P953, DOI 10.1080/15287394.2013.826567; SJOGREN I, 1980, THORAX, V35, P653, DOI 10.1136/thx.35.9.653; Song YG, 2011, TOXICOL PATHOL, V39, P841, DOI 10.1177/0192623311413787; Srimok B, 2011, RADIAT PROT DOSIM, V147, P439, DOI 10.1093/rpd/ncq488; Stapleton PA, 2012, MICROCIRCULATION, V19, P126, DOI 10.1111/j.1549-8719.2011.00137.x; Stefaniak AB, 2007, IND HEALTH, V45, P793, DOI 10.2486/indhealth.45.793; Stefaniak AB, 2009, J EXPO SCI ENV EPID, V19, P475, DOI 10.1038/jes.2008.37; Tada Y, 2012, J TOXICOL PATHOL, V25, P233, DOI 10.1293/tox.25.233; Toya T, 2010, IND HEALTH, V48, P3, DOI 10.2486/indhealth.48.3; Verstraelen S, 2014, TOXICOL LETT, V228, P157, DOI 10.1016/j.toxlet.2014.05.006; Warheit DB, 2010, ANAL BIOANAL CHEM, V398, P607, DOI 10.1007/s00216-010-4000-5; Yao Z., 1998, METAL POWDER REP, V53, P26, DOI [10.1016/S0026-0657(97)89643-9, DOI 10.1016/S0026-0657(97)89643-9]; Zhang XD, 2010, J ENVIRON PATHOL TOX, V29, P31, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i1.60; Zhou XY, 2013, J NANOSCI NANOTECHNO, V13, P204, DOI 10.1166/jnn.2013.6788; Zhu MT, 2009, TOXICOL SCI, V107, P342, DOI 10.1093/toxsci/kfn245	92	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118778	10.1371/journal.pone.0118778	http://dx.doi.org/10.1371/journal.pone.0118778			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738830	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900069
J	Pinheiro, HT; Mazzei, E; Moura, RL; Amado, GM; Carvalho, A; Braga, AC; Costa, PAS; Ferreira, BP; Ferreira, CEL; Floeter, SR; Francini, RB; Gasparini, JL; Macieira, RM; Martins, AS; Olavo, G; Pimentel, CR; Rocha, LA; Sazima, I; Simon, T; Teixeira, JB; Xavier, LB; Joyeux, JC				Pinheiro, Hudson T.; Mazzei, Eric; Moura, Rodrigo L.; Amado-Filho, Gilberto M.; Carvalho-Filho, Alfredo; Braga, Adriana C.; Costa, Paulo A. S.; Ferreira, Beatrice P.; Ferreira, Carlos Eduardo L.; Floeter, Sergio R.; Francini-Filho, Ronaldo B.; Gasparini, Joao Luiz; Macieira, Raphael M.; Martins, Agnaldo S.; Olavo, George; Pimentel, Caio R.; Rocha, Luiz A.; Sazima, Ivan; Simon, Thiony; Teixeira, Joao Batista; Xavier, Lucas B.; Joyeux, Jean-Christophe			Fish Biodiversity of the Vitoria-Trindade Seamount Chain, Southwestern Atlantic: An Updated Database	PLOS ONE			English	Article							REEF-FISH; SHORE FISHES; DISTRIBUTION PATTERNS; COMMUNITY STRUCTURE; MIDOCEAN RIDGE; SOUTH ATLANTIC; BRAZIL BASIN; ASSEMBLAGES; ISLANDS; OCEAN	Despite a strong increase in research on seamounts and oceanic islands ecology and biogeography, many basic aspects of their biodiversity are still unknown. In the southwestern Atlantic, the Vitoria-Trindade Seamount Chain (VTC) extends ca. 1,200 km offshore the Brazilian continental shelf, from the Vitoria seamount to the oceanic islands of Trindade and Martin Vaz. For a long time, most of the biological information available regarded its islands. Our study presents and analyzes an extensive database on the VTC fish biodiversity, built on data compiled from literature and recent scientific expeditions that assessed both shallow to mesophotic environments. A total of 273 species were recorded, 211 of which occur on seamounts and 173 at the islands. New records for seamounts or islands include 191 reef fish species and 64 depth range extensions. The structure of fish assemblages was similar between islands and seamounts, not differing in species geographic distribution, trophic composition, or spawning strategies. Main differences were related to endemism, higher at the islands, and to the number of endangered species, higher at the seamounts. Since unregulated fishing activities are common in the region, and mining activities are expected to drastically increase in the near future (carbonates on seamount summits and metals on slopes), this unique biodiversity needs urgent attention and management.	[Pinheiro, Hudson T.; Gasparini, Joao Luiz; Martins, Agnaldo S.; Pimentel, Caio R.; Simon, Thiony; Xavier, Lucas B.; Joyeux, Jean-Christophe] Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil; [Mazzei, Eric; Teixeira, Joao Batista] Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Ilheus, BA, Brazil; [Moura, Rodrigo L.] Univ Fed Rio de Janeiro, Inst Biol, BR-21941 Rio De Janeiro, RJ, Brazil; [Moura, Rodrigo L.] Univ Fed Rio de Janeiro, SAGE COPPE, BR-21941 Rio De Janeiro, RJ, Brazil; [Amado-Filho, Gilberto M.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Carvalho-Filho, Alfredo] Fish Bizz Ltda, Sao Paulo, Brazil; [Braga, Adriana C.; Costa, Paulo A. S.] Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, RJ, Brazil; [Ferreira, Beatrice P.] Univ Fed Pernambuco, Dept Oceanog, Recife, PE, Brazil; [Ferreira, Carlos Eduardo L.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil; [Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Francini-Filho, Ronaldo B.] Univ Fed Paraiba, Ctr Ciencias Aplicadas & Educacao, Rio Tinto, PB, Brazil; [Olavo, George] Univ Estadual Feira de Santana, Lab Biol Pesqueira, Feira De Santana, BA, Brazil; [Rocha, Luiz A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Sazima, Ivan] Univ Estadual Campinas, Museu Zool, Campinas, SP, Brazil	Universidade Federal do Espirito Santo; Universidade Estadual de Santa Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal de Pernambuco; Universidade Federal Fluminense; Universidade Federal de Santa Catarina (UFSC); Universidade Federal da Paraiba; Universidade Estadual de Feira de Santana; California Academy of Sciences; Universidade Estadual de Campinas	Pinheiro, HT (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	htpinheiro@gmail.com	Martins, Agnaldo/F-1615-2011; Francini-Filho, Ronaldo/I-5708-2012; Pinheiro, Hudson/A-4065-2019; Teixeira, João Batista/W-6935-2019; Ferreira, Beatrice P/A-5786-2013; de Moura, Rodrigo Leao/AAL-5781-2020; Pimentel, Caio R/B-2808-2014; Macieira, Raphael/G-2808-2011; Rocha, Luiz/T-6326-2019; Floeter, S. R./B-1438-2012	Martins, Agnaldo/0000-0003-2160-1326; Francini-Filho, Ronaldo/0000-0002-7678-6797; Pinheiro, Hudson/0000-0002-3143-1474; de Moura, Rodrigo Leao/0000-0002-5597-6196; Pimentel, Caio R/0000-0003-4110-1249; Macieira, Raphael/0000-0002-8871-8724; Floeter, S. R./0000-0002-3201-6504; Rocha, Luiz/0000-0003-4011-569X; Ferreira, Carlos Eduardo/0000-0002-4311-0491; Costa, Paulo A. S./0000-0002-7939-6428	CNPq [470725/2009-5, 557043/2009-3, 405360/2012-6, 405419/2012-0, GDE 202475/2011-5]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work is funded by CNPq (http://www.cnpq.br) through projects "Vitoria-Trindade Chain: testing the theory for stepping-stone connectivity in reef fishes" (grant 470725/2009-5 to JCJ), "Reef fishes of the insular complex Trindade-Martin Vaz, Vitoria, ES: status, recruitment and evolution of assemblages" (grant 557043/2009-3 to JCJ), Vitoria-Trindade Chain mesophotic reefs: characterization of marine communities and reef health evaluation (grant 405360/2012-6 to GAF) and Paleoceanographic reconstruction of the Vitoria-Trindade Chain based in calcareous algae records (grant 405419/2012-0 to AB). HTP (Ciencia sem Fronteiras; GDE 202475/2011-5) and TS are recipients of doctoral fellowships from CNPq and CAPES (http://capes.gov.br), respectively, and EFM of a MSc fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida F.F.M., 2006, TERRAE DID ATICA, V2, P3, DOI [10.1007/BF01915460, DOI 10.20396/TD.V2I1.8637462]; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Andrade ACS, 2003, AN ACAD BRAS CIENC, V75, P357, DOI 10.1590/S0001-37652003000300008; Andrade L, 2004, HYDROBIOLOGIA, V511, P103, DOI 10.1023/B:HYDR.0000014033.81848.48; Andreata Jose V., 1995, Revista Brasileira de Zoologia, V12, P579; [Anonymous], 2010, OCEANOGRAPHY, V23, P210; Bailey DM, 2009, P ROY SOC B-BIOL SCI, V276, P1965, DOI 10.1098/rspb.2009.0098; Bazilevskaya ES, 2011, DOKL EARTH SCI, V439, P1039, DOI 10.1134/S1028334X11080010; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Bergstad OA, 2012, DEEP-SEA RES PT I, V61, P74, DOI 10.1016/j.dsr.2011.12.002; Bouchon-Navaro Y, 2005, J EXP MAR BIOL ECOL, V315, P31, DOI 10.1016/j.jembe.2004.08.028; Braga AC, 2007, BIODIVERSIDADE FAUNA, P63; Braga AD, 2014, LAT AM J AQUAT RES, V42, P245, DOI 10.3856/vol42-issue1-fulltext-20; Brandley MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011375; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Carvalho, 1950, B I PAULIST OCEANOGR, V1, P97, DOI [10.1590/S0100-42391950000100008, DOI 10.1590/S0100-42391950000100008]; Carvalho-Filho A., 1999, PEIXES COSTA BRASILE; Castro C.B., 2006, BIODIVERSIDADE BENTO, V18, P147; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; CGEE, 2007, MAR AMB COST; Clark M, 2000, J NW ATL FISH SCI, V31, P441; Clark MR, 2012, ENVIRON CONSERV, V39, P204, DOI 10.1017/S0376892912000021; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2010.00392.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2006, SEAMOUNTS DEEP SEA C, DOI [10.1016/S0378-777X(80)80057-6, DOI 10.1016/S0378-777X(80)80057-6]; Dennis GD, 2005, CARIBB J SCI, V41, P716; ERIKSEN CC, 1991, J GEOPHYS RES-OCEANS, V96, P15227, DOI 10.1029/91JC01176; Etnoyer PJ, 2010, OCEANOGRAPHY, V23, P206, DOI 10.5670/oceanog.2010.96; FAINSTEIN R, 1982, MAR GEOL, V46, P199, DOI 10.1016/0025-3227(82)90080-9; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fodor RV, 2000, LITHOS, V51, P293, DOI 10.1016/S0024-4937(00)00002-5; Fossen I, 2008, DEEP-SEA RES PT II, V55, P203, DOI 10.1016/j.dsr2.2007.09.004; FREELAND H, 1994, DEEP-SEA RES PT I, V41, P1715, DOI 10.1016/0967-0637(94)90069-8; Gaeta SA, 1999, ARCH FISH MAR RES, V47, P253; Gasparini JL, 2001, J NAT HIST, V35, P1639, DOI 10.1080/002229301317092379; Goncalves JMS, 2004, ARCH FISH MAR RES, V51, P233; Gubbay S., 2003, SEAMOUNTS N E ATLANT; Halfar J, 2007, SCIENCE, V316, P987, DOI 10.1126/science.1138289; Hart PJB, 2011, MAR ECOL PROG SER, V430, P281, DOI 10.3354/meps08948; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hobbs JPA, 2012, J BIOGEOGR, V39, P130, DOI 10.1111/j.1365-2699.2011.02576.x; Humann P., 2002, REEF FISH IDENTIFICA; Jacobs CL, 2010, PREPARATION BATHYMET; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Luiz O, 2011, BIOL CONSERV, P1; Lundsten L, 2009, MAR ECOL PROG SER, V389, P223, DOI 10.3354/meps08181; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Macieira RM, 2015, ENVIRON BIOL FISH, V98, P385, DOI 10.1007/s10641-014-0269-0; Martins A, 2005, PESCA POTENCIAIS EXP, V128, P109; Martins AS, 2007, BIODIVERSIDADE FAUNA, V61, P45; Maxfield JM, 2012, MOL PHYLOGENET EVOL, V64, P416, DOI 10.1016/j.ympev.2012.04.016; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; Morato TF, 2004, SEAMOUNTS BIODIVERSI; Motoki A, 2012, REV BRAS GEOMORFOL, V13, P151; Moura RL, 2011, ESTUAR COAST SHELF S, V95, P274, DOI 10.1016/j.ecss.2011.08.010; Murray G, 1902, GEOGR J, V19, P423, DOI 10.2307/1775240; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nichols JT, 1913, B AM MUS NAT HIST, V7, P261; Nogueria C, 2009, MEGADIVERS, V5, P43; Nonaka RH, 2000, FISH B-NOAA, V98, P767; Olavo G., 2005, SERIE LIVROS, P167; Olavo G, 2011, AQUAT CONSERV, V21, P199, DOI 10.1002/aqc.1174; Parrish FA, 2004, MAR BIOL, V144, P1065, DOI 10.1007/s00227-003-1288-0; Pellissier L, 2014, SCIENCE, V344, P1016, DOI 10.1126/science.1249853; Pereira GH, 2012, J COASTAL RES, V28, P261, DOI 10.2112/11T-00007.1; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; PEREZ JAA, 2009, MAR FISH REV, V71, P24; Pinault M, 2013, J FISH BIOL, V82, P1821, DOI 10.1111/jfb.12110; Pinheiro HT, 2014, CORAL REEFS, V33, P1113, DOI 10.1007/s00338-014-1211-9; Pinheiro HT, 2011, J FISH BIOL, V79, P1984, DOI 10.1111/j.1095-8649.2011.03138.x; Pinheiro HT, 2009, ZOOTAXA, P45, DOI 10.11646/zootaxa.2298.1.3; Pinheiro HT, 2010, ZOOTAXA, P59; Pinheiro HT, 2010, BRAZ ARCH BIOL TECHN, V53, P1417, DOI 10.1590/S1516-89132010000600018; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Ribeiro A. de M., 1919, Archivos do Museu Rio de Janeiro, V22; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2001, J FISH BIOL, V58, P985, DOI 10.1006/jfbi.2000.1504; Rocha LA, 2010, ZOOTAXA, P22; Rodriguez-Romero J, 2005, B MAR SCI, V77, P33; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2010.00396.x; SCHMID C, 1995, J PHYS OCEANOGR, V25, P2532, DOI 10.1175/1520-0485(1995)025<2532:TVEAIR>2.0.CO;2; Scott SD, 2007, PROCEEDINGS OF THE SEVENTH (2007) ISOPE OCEAN MINING (& GAS HYDRATES) SYMPOSIUM, P6; SERET B, 1992, Cybium, V16, P81; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; Siebel W, 2000, J S AM EARTH SCI, V13, P79, DOI 10.1016/S0895-9811(00)00015-8; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Simon T, 2013, J FISH BIOL, V82, P2113, DOI 10.1111/jfb.12126; Skolotnev SG, 2010, DOKL EARTH SCI, V431, P435, DOI 10.1134/S1028334X10040057; Smith W., 1997, SCIENCE, V2, P209; Stocks K, 2009, P COL OC DAT S, P77; Taranto GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042950; VASCONCELOS Y., 2012, REV PESQUISA FAPESP, V197, P62; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676; WIRTZ P, 2014, J MAR BIOL ASSOC UK, V2014, P1; Zar JH., 2010, BIOSTAT ANAL, V5th	102	76	79	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118180	10.1371/journal.pone.0118180	http://dx.doi.org/10.1371/journal.pone.0118180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738798	gold, Green Submitted, Green Published			2022-12-26	WOS:000350685900023
J	Sutherland, JJ; Daly, TM; Liu, X; Goldstein, K; Johnston, JA; Ryan, TP				Sutherland, Jeffrey J.; Daly, Thomas M.; Liu, Xiong; Goldstein, Keith; Johnston, Joseph A.; Ryan, Timothy P.			Co-Prescription Trends in a Large Cohort of Subjects Predict Substantial Drug-Drug Interactions	PLOS ONE			English	Article							GENERAL-PRACTICE; ANTIDEPRESSANTS; INHIBITOR; EVENTS; ALERTS; ENZYME; CARE	Pharmaceutical prescribing and drug-drug interaction data underlie recommendations on drug combinations that should be avoided or closely monitored by prescribers. Because the number of patients taking multiple medications is increasing, a comprehensive view of prescribing patterns in patients is important to better assess real world pharmaceutical response and evaluate the potential for multi-drug interactions. We obtained self-reported prescription data from NHANES surveys between 1999 and 2010, and confirm the previously reported finding of increasing drug use in the elderly. We studied co-prescription drug trends by focusing on the 2009-2010 survey, which contains prescription data on 690 drugs used by 10,537 subjects. We found that medication profiles were unique for individuals aged 65 years or more, with >= 98 unique drug regimens encountered per 100 subjects taking 3 or more medications. When drugs were viewed by therapeutic class, it was found that the most commonly prescribed drugs were not the most commonly co-prescribed drugs for any of the 16 drug classes investigated. We cross-referenced these medication lists with drug interaction data from Drugs.com to evaluate the potential for drug interactions. The number of drug alerts rose proportionally with the number of co-prescribed medications, rising from 3.3 alerts for individuals prescribed 5 medications to 11.7 alerts for individuals prescribed 10 medications. We found 22% of elderly subjects taking both a substrate and inhibitor of a given cytochrome P450 enzyme, and 4% taking multiple inhibitors of the same enzyme simultaneously. By examining drug pairs prescribed in 0.1% of the population or more, we found low agreement between co-prescription rate and co-discussion in the literature. These data show that prescribing trends in treatment could drive a large extent of individual variability in drug response, and that current pairwise approaches to assessing drug-drug interactions may be inadequate for predicting real world outcomes.	[Sutherland, Jeffrey J.; Liu, Xiong] Eli Lilly & Co, Lilly Res Labs IT, Indianapolis, IN 46285 USA; [Daly, Thomas M.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Goldstein, Keith] Eli Lilly & Co, Drug Disposit & Toxicol, Indianapolis, IN 46285 USA; [Johnston, Joseph A.] Eli Lilly & Co, Global Patient Outcomes & Real World Evidence, Indianapolis, IN 46285 USA; [Ryan, Timothy P.] Sano Informed Prescribing, Brentwood, TN USA	Eli Lilly; Cleveland Clinic Foundation; Eli Lilly; Eli Lilly	Sutherland, JJ (corresponding author), Eli Lilly & Co, Lilly Res Labs IT, Indianapolis, IN 46285 USA.	sutherlandje@lilly.com; tim@thinksano.com	Liu, Xiong/O-3480-2019	Liu, Xiong/0000-0003-4522-7228	Eli Lilly; Sano	Eli Lilly(Eli Lilly); Sano	Eli Lilly and Sano Informed Prescribing provided support in the form of salaries and benefits for authors Jeffrey J. Sutherland, Xiong Liu, Keith Goldstein, Joseph A. Johnston, and Timothy P. Ryan, but did not have any additional role in the study design, decision to publish, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Bowlin SJ, 2013, MAYO CLIN PROC, V88, P139, DOI 10.1016/j.mayocp.2012.10.020; Duke JD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002614; ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d; Flockhart DA., 2007, DRUG INTERACTIONS CY; Gokula M, 2012, CLIN GERIATR MED, V28, P323, DOI 10.1016/j.cger.2012.01.011; Gu Qiuping, 2010, NCHS Data Brief, P1; Harpaz R, 2012, CLIN PHARMACOL THER, V91, P1010, DOI 10.1038/clpt.2012.50; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kerr KP, 2014, J CLIN PHARM THER, V39, P383, DOI 10.1111/jcpt.12163; Kootstra-Ros JE, 2006, J CLIN PHARMACOL, V46, P1320, DOI 10.1177/0091270006293754; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Moura C, 2009, J PHARM PHARM SCI, V12, P266, DOI 10.18433/J35C7Z; Muscatello MR, 2012, HUM PSYCHOPHARM CLIN, V27, P239, DOI 10.1002/hup.2217; Paterno MD, 2009, J AM MED INFORM ASSN, V16, P40, DOI 10.1197/jamia.M2808; Preskorn Sheldon H, 2007, J Psychiatr Pract, V13, P5, DOI 10.1097/00131746-200701000-00002; Raschetti R, 1999, EUR J CLIN PHARMACOL, V54, P959, DOI 10.1007/s002280050582; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Shah NR, 2006, J AM MED INFORM ASSN, V13, P5, DOI 10.1197/jamia.M1868; Tamblyn RM, 1996, CAN MED ASSOC J, V154, P1177; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Tragni E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078827; van Baal PH, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-51; Verger P, 2008, CAN J PSYCHIAT, V53, P94, DOI 10.1177/070674370805300204; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548	24	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118991	10.1371/journal.pone.0118991	http://dx.doi.org/10.1371/journal.pone.0118991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739022	Green Published, gold, Green Submitted			2022-12-26	WOS:000350685900089
J	Grijalva, CG; Goeyvaerts, N; Verastegui, H; Edwards, KM; Gil, AI; Lanata, CF; Hens, N				Grijalva, Carlos G.; Goeyvaerts, Nele; Verastegui, Hector; Edwards, Kathryn M.; Gil, Ana I.; Lanata, Claudio F.; Hens, Niel		RESPIRA PERU Project	A Household-Based Study of Contact Networks Relevant for the Spread of Infectious Diseases in the Highlands of Peru	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; TRANSMISSION; PARAMETERS; INFLUENZA; MODELS	Background Few studies have quantified social mixing in remote rural areas of developing countries, where the burden of infectious diseases is usually the highest. Understanding social mixing patterns in those settings is crucial to inform the implementation of strategies for disease prevention and control. We characterized contact and social mixing patterns in rural communities of the Peruvian highlands. Methods and Findings This cross-sectional study was nested in a large prospective household-based study of respiratory infections conducted in the province of San Marcos, Cajamarca-Peru. Members of study households were interviewed using a structured questionnaire of social contacts (conversation or physical interaction) experienced during the last 24 hours. We identified 9015 reported contacts from 588 study household members. The median age of respondents was 17 years (interquartile range [IQR] 4-34 years). The median number of reported contacts was 12 (IQR 8-20) whereas the median number of physical (i.e. skin-to-skin) contacts was 8.5 (IQR 5-14). Study participants had contacts mostly with people of similar age, and with their offspring or parents. The number of reported contacts was mainly determined by the participants' age, household size and occupation. School-aged children had more contacts than other age groups. Within-household reciprocity of contacts reporting declined with household size (range 70%-100%). Ninety percent of household contact networks were complete, and furthermore, household members' contacts with non-household members showed significant overlap (range 33%-86%), indicating a high degree of contact clustering. A two-level mixing epidemic model was simulated to compare within-household mixing based on observed contact networks and within-household random mixing. No differences in the size or duration of the simulated epidemics were revealed. Conclusion This study of rural low-density communities in the highlands of Peru suggests contact patterns are highly assortative. Study findings support the use of within-household homogenous mixing assumptions for epidemic modeling in this setting.				Carlos.grijalva@vanderbilt.edu	Lanata, Claudio F./N-7997-2018; Hens, Niel/M-4445-2017	Lanata, Claudio F./0000-0002-6994-7425; Hens, Niel/0000-0003-1881-0637; Grijalva, Carlos/0000-0002-2329-7797; Goeyvaerts, Nele/0000-0003-0526-5318	National Institutes of Health [UL1 RR024975]; Pfizer [IIR WS1898786(0887X1-4492)]; Thrasher Research Fund [02832-9]; AXA Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Thrasher Research Fund; AXA Research Fund(AXA Research Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Vanderbilt University CTSA grant UL1 RR024975 from National Institutes of Health, an investigator initiated research grant from Pfizer (IIR WS1898786(0887X1-4492), (http://www.pfizer.com) and grant 02832-9 from the Thrasher Research Fund (www.thrasherresearch.org/default.aspx). NG is beneficiary of a postdoctoral grant from the AXA Research Fund (http://www.axa-research. org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball F, 1997, ANN APPL PROBAB, V7, P46; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Budge PJ, 2014, PEDIATR INFECT DIS J, V33, P443, DOI 10.1097/INF.0000000000000135; Budge PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091247; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Grijalva CG, 2014, INT J EPIDEMIOL, V43, P1021, DOI 10.1093/ije/dyt065; Grijalva CG, 2014, CLIN INFECT DIS, V58, P1369, DOI 10.1093/cid/ciu148; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Huicho L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-47; Instituto Nacional de Estadistica e Informatica (INEI), SIST DIF CENS NAC; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Potter GE, 2013, J R STAT SOC C-APPL, V62, P629, DOI 10.1111/rssc.12011; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; United Nations Development Program-Peru, 2013, INF DES HUM PER 2013; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Willem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048695	26	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118457	10.1371/journal.pone.0118457	http://dx.doi.org/10.1371/journal.pone.0118457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734772	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700030
J	Eriksen, A; Tillin, T; O'Connor, L; Brage, S; Hughes, A; Mayet, J; McKeigue, P; Whincup, P; Chaturvedi, N; Forouhi, NG				Eriksen, Anne; Tillin, Therese; O'Connor, Laura; Brage, Soren; Hughes, Alun; Mayet, Jamil; McKeigue, Paul; Whincup, Peter; Chaturvedi, Nish; Forouhi, Nita G.			The Impact of Health Behaviours on Incident Cardiovascular Disease in Europeans and South Asians - A Prospective Analysis in the UK SABRE Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIFE-STYLE FACTORS; RISK-FACTORS; PRIMARY PREVENTION; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; ALCOHOL-CONSUMPTION; VEGETABLE INTAKE; UNITED-KINGDOM; 52 COUNTRIES	Background There is consistent evidence on the impact of health behaviours on risk of cardiovascular disease (CVD) in European populations. As South Asians in the UK have an excess risk of CVD and coronary heart disease (CHD) compared to Europeans, we investigated whether a similar association between combined health behaviours and risk of CVD and CHD among this high-risk group exists, and estimated the population impact. Methods and Findings In a prospective cohort of 1090 Europeans and 1006 South Asians (40-69 y) without prevalent CVD at baseline (1988-1990), followed up for 21 years to 2011, there were 601 incident CVD events [Europeans n = 255; South Asians n = 346] of which 520 were CHD events [n = 207 and 313 respectively]. Participants scored between 0 to 4 points for a composite score including four baseline healthy behaviours (non-smoker, moderate alcohol intake, physically active, frequent fruit/vegetable intake). Adjusted hazard ratios (95% confidence intervals) for incident CHD in Europeans who had three, two, one, and zero compared to four health behaviours were 1.33 (0.78-2.29), 1.96 (1.15-3.33), 1.36 (0.74-2.48) and 2.45 (1.18-5.10), respectively, p-trend = 0.025. In South Asians, corresponding HRs were 2.88 (1.33-6.24), 2.28 (1.06-4.91), 3.36 (1.53-7.39) and 3.48 (1.38-8.81), p-trend = 0.022. The results were similar for incident CVD; Europeans HR 2.12 (1.14-3.94), p-trend = 0.014; South Asians HR 2.73 (1.20-6.21), p-trend = 0.018. The population attributable fraction in Europeans was 43% for CHD and 28% for CVD. In South Asians it was 63% and 51% respectively. Conclusions Lack of adherence to four combined health behaviours was associated with 2 to 3-fold increased risk of incident CVD in Europeans and South Asians. A substantial population impact in the South Asian group indicates important potential for disease prevention in this high-risk group by adherence to healthy behaviours.	[Eriksen, Anne; O'Connor, Laura; Brage, Soren; Chaturvedi, Nish; Forouhi, Nita G.] Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC,Inst Metab Sci, Cambridge, England; [Tillin, Therese; Hughes, Alun] UCL, London Inst Cardiovasc Sci, London, England; [Mayet, Jamil] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Int Ctr Circulatory Hlth, London, England; [McKeigue, Paul] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Whincup, Peter] Univ London, Populat Hlth Res Ctr, London, England	University of Cambridge; University of London; University College London; Imperial College London; University of Edinburgh; University of London	Forouhi, NG (corresponding author), Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC,Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England.	nita.forouhi@mrc-epid.cam.ac.uk	Brage, Soren/C-6415-2013; O'Connor, Laura/ABD-7999-2021; Hughes, Alun David/N-3781-2013	Brage, Soren/0000-0002-1265-7355; O'Connor, Laura/0000-0002-6022-2022; Hughes, Alun David/0000-0001-5432-5271; Forouhi, Nita/0000-0002-5041-248X; Whincup, Peter/0000-0002-5589-4107; Eriksen, Anne Kirstine/0000-0002-4535-3788	Wellcome Trust [082464/Z/07/Z]; British Heart Foundation [SP/07/001/23603]; NIHR Biomedical Research Centre funding scheme; MRC Epidemiology Unit [MC_UU_12015/5]; MRC [MC_UP_A100_1003, MC_UU_12015/5, MC_U106179473, MC_UU_12015/3] Funding Source: UKRI; British Heart Foundation [PG/08/103/26133, CS/13/1/30327] Funding Source: researchfish; Medical Research Council [MC_UP_A100_1003, MC_U106179473, MC_UU_12015/3, MC_UU_12015/5] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); NIHR Biomedical Research Centre funding scheme(National Institute for Health Research (NIHR)); MRC Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The SABRE study was funded by the Wellcome Trust (082464/Z/07/Z) and British Heart Foundation (SP/07/001/23603). Support from NIHR Biomedical Research Centre funding scheme as well as the MRC Epidemiology Unit (MC_UU_12015/5 to NGF) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan SN, 2006, CAN J PUBLIC HEALTH, V97, P271, DOI 10.1007/BF03405602; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eguchi E, 2012, EUR HEART J, V33, P467, DOI 10.1093/eurheartj/ehr429; European Heart Network and European Society of Cardiology, 2012, EUROPEAN CARDIOVASCU; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Harding S, 2008, INT J EPIDEMIOL, V37, P162, DOI 10.1093/ije/dym252; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Health Survey for England, 1999, HLTH MIN ETHN GROUPS; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Kurth T, 2006, ARCH INTERN MED, V166, P1403, DOI 10.1001/archinte.166.13.1403; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; Mukamal KJ, 2006, ARCH INTERN MED, V166, P2145, DOI 10.1001/archinte.166.19.2145; Myint PK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b349; National Health Service UK, PHYS ACT GUID AD; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Office of Population Censuses and Surveys, 1980, CLASS OCC COD IND; PASSMORE R, 1955, PHYSIOL REV, V35, P801, DOI 10.1152/physrev.1955.35.4.801; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sesso HD, 1999, AM J EPIDEMIOL, V150, P408; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Sports Council and Health Education Authority, 1990, ALL DUNB NAT FITN SU; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; *STAT CAN, 2002, HLTH IND; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Tillin T, 2012, INT J EPIDEMIOL, V41, P33, DOI 10.1093/ije/dyq175; van der Linde RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065290; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Williams ED, 2011, HEART, V97, P655, DOI 10.1136/hrt.2010.201012; World Health Organization, INT CLASS DIS ICD; World Health Organization, 2010, ATLAS HEART DIS STRO; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117364	10.1371/journal.pone.0117364	http://dx.doi.org/10.1371/journal.pone.0117364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730129	Green Published, gold			2022-12-26	WOS:000350684900013
J	Rouet, R; Dudgeon, K; Christie, M; Langley, D; Christ, D				Rouet, Romain; Dudgeon, Kip; Christie, Mary; Langley, David; Christ, Daniel			Fully Human V-H Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotechnology; Monoclonal Antibody; Phage Display; Protein Engineering; Protein Structure; Camelid Antibodies; Cleft Binding; Single Domains	COMPLEMENTARITY-DETERMINING REGIONS; BIOPHYSICAL PROPERTIES; CRYSTAL-STRUCTURE; VARIABLE DOMAINS; PHAGE DISPLAY; LIGHT-CHAINS; VHH DOMAINS; AGGREGATION; LIBRARIES; BINDING	Background: Camelid antibody domains are naturally stable and capable of cleft binding. Results: Protein engineering can endow human antibody domains with such properties. Conclusion: Our strategy does not require undesirable antibody framework changes. Significance: Robust building blocks for human therapeutic applications. Human V-H single domains represent a promising class of antibody fragments with applications as therapeutic modalities. Unfortunately, isolated human V-H domains also generally display poor biophysical properties and a propensity to aggregate. This has encouraged the development of non-human antibody domains as alternative means of antigen recognition and, in particular, camelid (VHH) domains. Naturally devoid of light chain partners, these domains are characterized by favorable biophysical properties and propensity for cleft binding, a highly desirable characteristic, allowing the targeting of cryptic epitopes. In contrast, previously reported structures of human V-H single domains had failed to recapitulate this property. Here we report the engineering and characterization of phage display libraries of stable human V-H domains and the selection of binders against a diverse set of antigens. Unlike camelized human domains, the domains do not rely on potentially immunogenic framework mutations and maintain the structure of the V-H/V-L interface. Structure determination in complex with hen egg white lysozyme revealed an extended V-H binding interface, with complementarity-determining region 3 deeply penetrating into the active site cleft, highly reminiscent of what has been observed for camelid domains. Taken together, our results demonstrate that fully human V-H domains can be constructed that are not only stable and well expressed but also rival the cleft binding properties of camelid antibodies.	[Rouet, Romain; Dudgeon, Kip; Christie, Mary; Langley, David; Christ, Daniel] Garvan Inst Med Res, Dept Immunol, Sydney, NSW 2010, Australia; [Christie, Mary; Christ, Daniel] Univ New S Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Christ, D (corresponding author), Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia.	d.christ@garvan.org.au	Christ, Daniel/C-1861-2018; Rouet, Romain/U-3511-2019; Langley, David B/B-1861-2009	Christ, Daniel/0000-0002-7313-3977; Langley, David B/0000-0003-2752-0041; Rouet, Romain/0000-0003-4210-9613; Christie, Mary/0000-0002-0955-665X	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council and the Australian Research Council.	Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christ D., 2011, International Patent, Patent No. [WO/2011/047442 A1, 2011047442]; De Genest E, 2005, J BIOL CHEM, V280, P14114, DOI 10.1074/jbc.M413011200; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; De Genst E, 2004, J BIOL CHEM, V279, P53593, DOI 10.1074/jbc.M407843200; De Genst E, 2013, J PHYS CHEM B, V117, P13245, DOI 10.1021/jp403425z; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dudgeon K, 2013, PROTEIN ENG DES SEL, V26, P671, DOI 10.1093/protein/gzt019; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1992, SEQUENCES PROTEINS I; Kim DY, 2012, PROTEIN ENG DES SEL, V25, P581, DOI 10.1093/protein/gzs055; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lowe D, 2011, ADV PROTEIN CHEM STR, V84, P41, DOI 10.1016/B978-0-12-386483-3.00004-5; Lulf S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-24; Ma XL, 2013, J MOL BIOL, V425, P2247, DOI 10.1016/j.jmb.2013.03.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; O'Connell D, 2002, J MOL BIOL, V321, P49, DOI 10.1016/S0022-2836(02)00561-2; Olichon A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-7; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6; Rouet R, 2014, NAT BIOTECHNOL, V32, P136, DOI 10.1038/nbt.2812; Rouet R, 2014, FEBS LETT, V588, P269, DOI 10.1016/j.febslet.2013.11.029; Rouet Romain, 2012, Methods Mol Biol, V907, P195, DOI 10.1007/978-1-61779-974-7_10; Rouet R, 2012, NAT PROTOC, V7, P364, DOI 10.1038/nprot.2011.448; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yu GW, 2009, J MOL BIOL, V385, P1578, DOI 10.1016/j.jmb.2008.11.043	61	35	40	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11905	11917		10.1074/jbc.M114.614842	http://dx.doi.org/10.1074/jbc.M114.614842			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25737448	Green Published, hybrid			2022-12-26	WOS:000354388600009
J	Zhang, YH; Shetty, K; Surleac, MD; Petrescu, AJ; Schatz, DG				Zhang, Yu-Hang; Shetty, Keerthi; Surleac, Marius D.; Petrescu, Andrei J.; Schatz, David G.			Mapping and Quantitation of the Interaction between the Recombination Activating Gene Proteins RAG1 and RAG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Biosensor; DNA Recombination; Protein Structure; Protein-Protein Interaction; DNA Cleavage; RAG1; RAG2; V(D)J Recombination	SECONDARY STRUCTURE PREDICTION; V(D)J RECOMBINATION; TCRB RECOMBINATION; SIGNAL COMPLEXES; DNA TRANSPOSASE; ACTIVE-SITE; SERVER; IDENTIFICATION; INITIATION; SEQUENCE	Background: The RAG1-RAG2 interaction is critical for V(D)J recombination but is poorly understood. Results: The RAG1-RAG2 interaction has a binding constant of approximate to 0.4 m and requires only a small portion of RAG1. Conclusion: RAG1 and RAG2 interact with modest affinity using regions of RAG1 flanking the RAG1 catalytic region. Significance: Inefficient association of RAG1 with RAG2 could help limit damage to the genome. The RAG endonuclease consists of RAG1, which contains the active site for DNA cleavage, and RAG2, an accessory factor whose interaction with RAG1 is critical for catalytic function. How RAG2 activates RAG1 is not understood. Here, we used biolayer interferometry and pulldown assays to identify regions of RAG1 necessary for interaction with RAG2 and to measure the RAG1-RAG2 binding affinity (K-D approximate to 0.4 m) (where RAG1 and RAG2 are recombination activating genes 1 or 2). Using the Hermes transposase as a guide, we constructed a 36-kDa mini RAG1 capable of interacting robustly with RAG2. Mini-RAG1 consists primarily of the catalytic center and the residues N-terminal to it, but it lacks a zinc finger region in RAG1 previously implicated in binding RAG2. The ability of Mini-RAG1 to interact with RAG2 depends on a predicted -helix (amino acids 997-1008) near the RAG1 C terminus and a region of RAG1 from amino acids 479 to 559. Two adjacent acidic amino acids in this region (Asp-546 and Glu-547) are important for both the RAG1-RAG2 interaction and recombination activity, with Asp-546 of particular importance. Structural modeling of Mini-RAG1 suggests that Asp-546/Glu-547 lie near the predicted 997-1008 -helix and components of the active site, raising the possibility that RAG2 binding alters the structure of the RAG1 active site. Quantitative Western blotting allowed us to estimate that mouse thymocytes contain on average approximate to 1,800 monomers of RAG1 and approximate to 15,000 molecules of RAG2, implying that nuclear concentrations of RAG1 and RAG2 are below the K-D value for their interaction, which could help limit off-target RAG activity.	[Zhang, Yu-Hang; Shetty, Keerthi; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Zhang, Yu-Hang; Shetty, Keerthi; Schatz, David G.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Surleac, Marius D.; Petrescu, Andrei J.] Acad Romana, Inst Biochem, Dept Bioinformat & Struct Biochem, Bucharest 060031, Romania; [Schatz, David G.] Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Howard Hughes Medical Institute	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunol, Box 208011, New Haven, CT 06520 USA.	david.schatz@yale.edu	Surleac, Marius D/C-6182-2017; Regan, Clinton/E-6250-2012; Petrescu, Andrei-Jose J/G-4576-2016; Surleac, Marius/M-2859-2019	Surleac, Marius D/0000-0003-3218-4644; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Surleac, Marius/0000-0003-3218-4644	National Institutes of Health [R37 AI32524, T32GM007223]; Executive Agency for Funding Higher Education, Research, Development, and Innovation [ID 3-0342-181/2011, PT-PCCA-4-0930-120/2014]; Romanian Academy of Institute of Biochemistry of the Romanian Academy; National Science Foundation Graduate Research Fellowship [DGE-1122492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Executive Agency for Funding Higher Education, Research, Development, and Innovation; Romanian Academy of Institute of Biochemistry of the Romanian Academy; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AI32524 (to D. G. S.). This work was also supported by Executive Agency for Funding Higher Education, Research, Development, and Innovation Grants ID 3-0342-181/2011 and PT-PCCA-4-0930-120/2014, and Romanian Academy Projects 1 and 3 of Institute of Biochemistry of the Romanian Academy (to A. J. P. and M. D. S.).; Supported in part by National Institutes of Health Grant T32GM007223 and by National Science Foundation Graduate Research Fellowship under Grant DGE-1122492.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Aidinis V, 2000, J IMMUNOL, V164, P5826, DOI 10.4049/jimmunol.164.11.5826; Arbuckle JL, 2001, J BIOL CHEM, V276, P37093, DOI 10.1074/jbc.M105988200; Banerjee JK, 2014, MOL CELL BIOL, V34, P2566, DOI 10.1128/MCB.00411-14; Bergeron S, 2006, METHOD ENZYMOL, V408, P511, DOI 10.1016/S0076-6879(06)08032-3; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Chan EAW, 2013, P NATL ACAD SCI USA, V110, pE4628, DOI 10.1073/pnas.1310846110; Chaumeil J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3231; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coster G, 2012, J BIOL CHEM, V287, P36488, DOI 10.1074/jbc.M112.402487; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Do T, 2008, PROTEIN EXPRES PURIF, V60, P147, DOI 10.1016/j.pep.2008.04.009; Eastman QM, 1999, MOL CELL BIOL, V19, P3788; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; Guermeur Y, 1997, THESIS U PIERRE MARI; Hanganu Andrei, 2009, Romanian Journal of Biochemistry, V46, P123; Hencken CG, 2012, NAT STRUCT MOL BIOL, V19, P834, DOI 10.1038/nsmb.2338; Hickman AB, 2005, NAT STRUCT MOL BIOL, V12, P715, DOI 10.1038/nsmb970; Hickman AB, 2014, CELL, V158, P353, DOI 10.1016/j.cell.2014.05.037; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Ko JE, 2004, J BIOL CHEM, V279, P7715, DOI 10.1074/jbc.M311471200; LEU TMJ, 1995, MOL CELL BIOL, V15, P5657; McMahan CJ, 1997, J IMMUNOL, V158, P2202; Pawlowski M, 2013, NUCLEIC ACIDS RES, V41, pW389, DOI 10.1093/nar/gkt408; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodgers KK, 1999, NUCLEIC ACIDS RES, V27, P2938, DOI 10.1093/nar/27.14.2938; Roman CAJ, 1997, IMMUNITY, V7, P13, DOI 10.1016/S1074-7613(00)80506-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Wang ZY, 2011, PROTEOMICS, V11, P3786, DOI 10.1002/pmic.201100196; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Zhao SY, 2009, J MOL BIOL, V387, P744, DOI 10.1016/j.jmb.2009.02.020; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	49	13	13	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11802	11817		10.1074/jbc.M115.638627	http://dx.doi.org/10.1074/jbc.M115.638627			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25745109	Green Published, hybrid			2022-12-26	WOS:000354388600001
J	Brennenstuhl, C; Tanimoto, N; Burkard, M; Wagner, R; Bolz, S; Trifunovic, D; Kabagema-Bilan, C; Paquet-Durand, F; Beck, SC; Huber, G; Seeliger, MW; Ruth, P; Wissinger, B; Lukowski, R				Brennenstuhl, Christina; Tanimoto, Naoyuki; Burkard, Markus; Wagner, Rebecca; Bolz, Sylvia; Trifunovic, Dragana; Kabagema-Bilan, Clement; Paquet-Durand, Francois; Beck, Susanne C.; Huber, Gesine; Seeliger, Mathias W.; Ruth, Peter; Wissinger, Bernd; Lukowski, Robert			Targeted Ablation of the Pde6h Gene in Mice Reveals Cross-species Differences in Cone and Rod Phototransduction Protein Isoform Inventory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Mouse Genetics; Phosphodiesterases; Retina; Retinal Degeneration; Second Messenger; Vision	MEMBRANE GUANYLYL CYCLASE; AUTOSOMAL-DOMINANT CONE; RECESSIVE RETINITIS-PIGMENTOSA; CGMP-PHOSPHODIESTERASE; GAMMA-SUBUNIT; PHOTORECEPTOR CELLS; ALPHA-SUBUNIT; MOUSE RETINA; ACTIVATING PROTEIN-1; MAMMALIAN RETINAS	Phosphodiesterase-6 (PDE6) is a multisubunit enzyme that plays a key role in the visual transduction cascade in rod and cone photoreceptors. Each type of photoreceptor utilizes discrete catalytic and inhibitory PDE6 subunits to fulfill its physiological tasks, i.e. the degradation of cyclic guanosine-3,5-monophosphate at specifically tuned rates and kinetics. Recently, the human PDE6H gene was identified as a novel locus for autosomal recessive (incomplete) color blindness. However, the three different classes of cones were not affected to the same extent. Short wave cone function was more preserved than middle and long wave cone function indicating that some basic regulation of the PDE6 multisubunit enzyme was maintained albeit by a unknown mechanism. To study normal and disease-related functions of cone Pde6h in vivo, we generated Pde6h knock-out (Pde6h(-/-)) mice. Expression of PDE6H in murine eyes was restricted to both outer segments and synaptic terminals of short and long/middle cone photoreceptors, whereas Pde6h(-/-) retinae remained PDE6H-negative. Combined in vivo assessment of retinal morphology with histomorphological analyses revealed a normal overall integrity of the retinal organization and an unaltered distribution of the different cone photoreceptor subtypes upon Pde6h ablation. In contrast to human patients, our electroretinographic examinations of Pde6h(-/-) mice suggest no defects in cone/rod-driven retinal signaling and therefore preserved visual functions. To this end, we were able to demonstrate the presence of rod PDE6G in cones indicating functional substitution of PDE6. The disparities between human and murine phenotypes caused by mutant Pde6h/PDE6H suggest species-to-species differences in the vulnerability of biochemical and neurosensory pathways of the visual signal transduction system.	Univ Tubingen, Ctr Ophthalmol, Inst Pharm, D-72076 Tubingen, Germany; [Brennenstuhl, Christina; Burkard, Markus; Wagner, Rebecca; Kabagema-Bilan, Clement; Ruth, Peter; Lukowski, Robert] Univ Tubingen, Ctr Ophthalmol, Dept Pharmacol Toxicol & Clin Pharm, D-72076 Tubingen, Germany; [Tanimoto, Naoyuki; Beck, Susanne C.; Huber, Gesine; Seeliger, Mathias W.] Univ Tubingen, Ctr Ophthalmol, Div Ocular Neurodegenerat, D-72076 Tubingen, Germany; [Bolz, Sylvia; Trifunovic, Dragana; Paquet-Durand, Francois] Univ Tubingen, Ctr Ophthalmol, Div Expt Ophthalmol, D-72076 Tubingen, Germany; [Wissinger, Bernd] Univ Tubingen, Mol Genet Lab, Ctr Ophthalmol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wissinger, B (corresponding author), Univ Tubingen, Mol Genet Lab, Ctr Ophthalmol, D-72076 Tubingen, Germany.	bernd.wissinger@uni-tuebingen.de; robert.lukowski@uni-tuebingen.de	Paquet-Durand, Francois/G-6709-2015; Trifunovic, Dragana/ABB-8165-2020; Trifunovic, Dragana/AAA-1823-2020	Paquet-Durand, Francois/0000-0001-7355-5742; Trifunovic, Dragana/0000-0003-3168-4196; Burkard, Markus/0000-0001-6113-2275	Deutsche Forschungsgemeinschaft [KFO134, Ru573/5, KFO134-Se837/5-2, Se837/6-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KFO134 and Ru573/5 (to P. R. and B. W.) and KFO134-Se837/5-2 and Se837/6-2 (to M. W. S.).	Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen CK, 2001, MOL VIS, V7, P305; Chrispell JD, 2009, J BIOL CHEM, V284, P21468, DOI 10.1074/jbc.M109.020966; Cooper N, 1995, J MOL NEUROSCI, V6, P211, DOI 10.1007/BF02736766; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Deng WT, 2013, J NEUROSCI, V33, P11745, DOI 10.1523/JNEUROSCI.1536-13.2013; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P96; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; GAL A, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551c; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Grau T, 2011, HUM MOL GENET, V20, P719, DOI 10.1093/hmg/ddq517; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Karan S, 2010, MOL CELL BIOCHEM, V334, P141, DOI 10.1007/s11010-009-0322-z; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kemp-Harper Barbara, 2009, V191, P447, DOI 10.1007/978-3-540-68964-5_19; Kleppisch Thomas, 2009, V191, P549, DOI 10.1007/978-3-540-68964-5_24; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Kolandaivelu S, 2011, J BIOL CHEM, V286, P33252, DOI 10.1074/jbc.M111.259101; Leiss V, 2014, BIOCHEM BIOPH RES CO, V452, P151, DOI 10.1016/j.bbrc.2014.08.071; Leiss V, 2011, DIABETES, V60, P148, DOI 10.2337/db10-0595; Lev S, 2001, CELL MOL NEUROBIOL, V21, P575, DOI 10.1023/A:1015183500719; Liu JW, 2005, INVEST OPHTH VIS SCI, V46, P3836, DOI 10.1167/iovs.04-1283; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Lukowski R, 2008, ARTERIOSCL THROM VAS, V28, P1244, DOI 10.1161/ATVBAHA.108.166405; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Mavlyutov TA, 2002, HUM MOL GENET, V11, P1899, DOI 10.1093/hmg/11.16.1899; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Miyake Y, 1996, JPN J OPHTHALMOL, V40, P511; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; NIHIRA M, 1995, INVEST OPHTH VIS SCI, V36, P1259; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Pfeiffer-Guglielmi B, 2005, GLIA, V49, P84, DOI 10.1002/glia.20102; Sahaboglu A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.12; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Shen J, 2005, MOL CELL BIOL, V25, P3639, DOI 10.1128/MCB.25.9.3639-3647.2005; ShimizuMatsumoto A, 1996, GENOMICS, V32, P121, DOI 10.1006/geno.1996.0085; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Wen XH, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00045; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	83	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10242	10255		10.1074/jbc.M114.611921	http://dx.doi.org/10.1074/jbc.M114.611921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739440	Green Published, hybrid			2022-12-26	WOS:000353241100030
J	Aso, T; Matsuo, M; Kiyohara, H; Taguchi, K; Rikimaru, F; Shimokawa, M; Segawa, Y; Higaki, Y; Umeno, H; Nakashima, T; Masuda, M				Aso, Takeichiro; Matsuo, Mioko; Kiyohara, Hideyuki; Taguchi, Kenichi; Rikimaru, Fumihide; Shimokawa, Mototsugu; Segawa, Yuichi; Higaki, Yuichiro; Umeno, Hirohito; Nakashima, Tadashi; Masuda, Muneyuki			Induction of CD44 Variant 9-Expressing Cancer Stem Cells Might Attenuate the Efficacy of Chemoradioselection and Worsens the Prognosis of Patients with Advanced Head and Neck Cancer	PLOS ONE			English	Article							LOCOREGIONALLY ADVANCED HEAD; ORGAN PRESERVATION; CHEMOTHERAPY; CHEMORADIOTHERAPY; CHEMORADIATION; CHEMOSELECTION; FLUOROURACIL; RADIOTHERAPY; EXPRESSION; DOCETAXEL	Background At our institute, a chemoradioselection strategy has been used to select patients for organ preservation on the basis of response to an initial 30-40 Gy concurrent chemoradiotherapy (CCRT). Patients with a favorable response (i.e., chemoradioselected; CRS) have demonstrated better outcomes than those with an unfavorable response (i.e., nonchemoradioselected; N-CRS). Successful targeting of molecules that attenuate the efficacy of chmoradioselection may improve results. Thus, the aim of this study was to evaluate the association of a novel cancer stem cell (CSC) marker, CD44 variant 9 (CD44v9), with cellular refractoriness to chemoradioselection in advanced head and neck squamous cell carcinoma (HNSCC). Materials and Methods Through a medical chart search, 102 patients with advanced HNSCC treated with chemoradioselection from 1997 to 2008 were enrolled. According to our algorithm, 30 patients were CRC following induction CCRT and 72 patients were N-CRS. Using the conventional immunohistochemical technique, biopsy specimens and surgically removed tumor specimens were immunostained with the anti-CD44v9 specific antibodies. Results The intrinsic expression levels of CD44v9 in the biopsy specimens did not correlate with the chemoradioselection and patient survival. However, in N-CRS patients, the CD44v9-positive group demonstrated significantly (P = 0.008) worse prognosis, than the CD44v9-negative group. Multivariate analyses demonstrated that among four candidate factors (T, N, response to CCRT, and CD44v9), CD44v9 positivity (HR: 3.145, 95% CI: 1.235-8.008, P = 0.0163) was significantly correlated with the poor prognosis, along with advanced N stage (HR: 3.525, 95% CI: 1.054-9.060, P = 0.0228). Furthermore, the survival rate of the CD44v9-induced group was significantly (P = 0.04) worse than the CD44v9-non-induced group. Conclusions CCRT-induced CD44v9-expressing CSCs appear to be a major hurdle to chemoradioselection. CD44v9-targeting seems to be a promising strategy to enhance the efficacy of chemoradioselection and consequent organ preservation and survival.	[Aso, Takeichiro; Matsuo, Mioko; Kiyohara, Hideyuki; Rikimaru, Fumihide; Higaki, Yuichiro; Masuda, Muneyuki] Kyushu Natl Canc Ctr, Dept Head & Neck Surg, Minami Ku, Fukuoka 8111395, Japan; [Taguchi, Kenichi] Kyushu Natl Canc Ctr, Dept Pathol, Minami Ku, Fukuoka 8111395, Japan; [Shimokawa, Mototsugu] Kyushu Natl Canc Ctr, Dept Canc Informat Res, Minami Ku, Fukuoka 8111395, Japan; [Segawa, Yuichi] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol & Head & Neck Surg, Higashi Ku, Fukuoka 8128582, Japan; [Umeno, Hirohito; Nakashima, Tadashi] Kurume Univ, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Fukuoka 8300011, Japan	Kyushu University; Kurume University	Masuda, M (corresponding author), Kyushu Natl Canc Ctr, Dept Head & Neck Surg, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	mmuneyuki@jcom.home.ne.jp		Masuda, Muneyuki/0000-0002-7479-8356; Kiyohara, Hideyuki/0000-0003-0048-5039	Grants-in-Aid for Scientific Research [24592600] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adelstein DJ, 2006, J CLIN ONCOL, V24, P1064, DOI 10.1200/JCO.2005.01.5867; Argiris A, 2004, CLIN CANCER RES, V10, P1956, DOI 10.1158/1078-0432.CCR-03-1077; Bankfalvi A, 2002, J PATHOL, V198, P343, DOI 10.1002/path.1204; Corry J, 2010, LANCET ONCOL, V11, P287, DOI 10.1016/S1470-2045(09)70384-5; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Hanna GJ, 2013, ONCOLOGIST, V18, P288, DOI 10.1634/theoncologist.2012-0286; Hirata K, 2013, BRIT J CANCER, V109, P379, DOI 10.1038/bjc.2013.314; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Imai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062002; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Kumamoto Y, 2002, HEAD NECK-J SCI SPEC, V24, P637, DOI 10.1002/hed.10114; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Masuda M, 2012, CLIN APPL RECENT APP; Masuda M, HEAD NECK; Masuda M, 2013, MOL ONCOL, V7, P14, DOI 10.1016/j.molonc.2012.10.009; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Oh SY, 2013, EUR J CANCER, V49, P272, DOI 10.1016/j.ejca.2012.06.004; Posner MR, 2010, ANN ONCOL, V21, P246, DOI 10.1093/annonc/mdq291; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Urba S, 2006, J CLIN ONCOL, V24, P593, DOI 10.1200/JCO.2005.01.2047; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Worden FP, 2009, LARYNGOSCOPE, V119, P1510, DOI 10.1002/lary.20294; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0116596	10.1371/journal.pone.0116596	http://dx.doi.org/10.1371/journal.pone.0116596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751671	Green Published, Green Submitted, gold			2022-12-26	WOS:000350692700003
J	Kim, S; Lee, Y; Koo, JS				Kim, Sewha; Lee, YuKyung; Koo, Ja Seung			Differential Expression of Lipid Metabolism-Related Proteins in Different Breast Cancer Subtypes	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; PROGNOSTIC-FACTORS; ANDROGEN RECEPTOR; MOLECULAR SUBTYPE; GENE-EXPRESSION; 2-DEOXY-D-GLUCOSE; INHIBITION; MEMBRANE; ENERGY; TUMORS	Purpose This study aimed to determine the expression and clinical significance of proteins that are involved in lipid metabolism in human breast tumors. Methods Tumors from 476 breast cancer patients were used to construct tissue microarrays. Then, immunohistochemistry (IHC) for hormone-sensitive lipase (HSL), Perilipin 1 (PLIN1), fatty acid binding protein 4 (FABP4), carnitine palmitoyltransferase IA (CPT-1A), acyl-CoA oxidase 1 (ACOX-1), and fatty acid synthase (FASN) was performed on these microarrays. Results Breast tumors were classified into 4 subtypes: luminal A (n = 242; 50.8%), luminal B (n = 134; 28.2%), human epidermal growth factor receptor 2 (HER2) (n = 50; 10.5%), and triple negative breast cancer (TNBC) (n = 50; 10.5%). The expression of PLIN1 (p < 0.001), FABP4 (p = 0.029), CPT-1A (p = 0.001), ACOX-1 (p < 0.001), and FASN (p < 0.001) differed significantly among these tumor subtypes. Notably, PLIN1, CPT-1A, and FASN expression was highest in HER2 tumors and lowest in TNBC tumors. Similarly, the expression of FABP4 and ACOX-1 was highest in HER2 tumors and lowest in luminal A tumors. In addition, ACOX-1 positivity was associated with significantly shorter overall survival (p = 0.018). When tumor subtype was considered, FABP4 positivity was associated with significantly shorter disease-free survival (p = 0.005) and overall survival (p = 0.041) in TNBC. Conclusion Lipid metabolism-related proteins are differentially expressed in different IHC subtypes of breast cancer and some are associated with decreased survival rates.	[Kim, Sewha; Lee, YuKyung; Koo, Ja Seung] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Koo, JS (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, 50 Yonsei Ro, Seoul 120752, South Korea.	kjs1976@yuhs.ac		koo, ja seung/0000-0003-4546-4709	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1420080]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1420080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bieche I, 2001, CARCINOGENESIS, V22, P1521, DOI 10.1093/carcin/22.9.1521; Brglez V, 2014, BIOCHIMIE; Brglez V, 2014, BIOCHEM BIOPH RES CO, V445, P230, DOI 10.1016/j.bbrc.2014.01.182; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chang H, 2003, BIOCHEM BIOPH RES CO, V302, P95, DOI 10.1016/S0006-291X(03)00111-6; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; ISOLA JJ, 1993, J PATHOL, V170, P31, DOI 10.1002/path.1711700106; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; Jones C, 2001, BRIT J CANCER, V85, P422, DOI 10.1054/bjoc.2001.1869; Kim SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101004; Kim S, 2013, ENDOCR-RELAT CANCER, V20, P339, DOI 10.1530/ERC-12-0398; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Lee JS, 2013, PHYTOTHER RES, V27, P713, DOI 10.1002/ptr.4778; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Pucer A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-111; Puig T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3077; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Uehara H, 2014, INT J CANC; Vullo D, 2003, BIOORG MED CHEM LETT, V13, P1005, DOI 10.1016/S0960-894X(03)00091-X; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; Yang Ming, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P257, DOI 10.3760/cma.j.issn.0529-5807.2013.04.010; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	41	89	90	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119473	10.1371/journal.pone.0119473	http://dx.doi.org/10.1371/journal.pone.0119473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751270	Green Submitted, Green Published, gold			2022-12-26	WOS:000350692700024
J	Hosnjak, L; Kocjan, BJ; Pirs, B; Seme, K; Poljak, M				Hosnjak, Lea; Kocjan, Bostjan J.; Pirs, Branko; Seme, Katja; Poljak, Mario			Characterization of Two Novel Gammapapillomaviruses, HPV179 and HPV184, Isolated from Common Warts of a Renal-Transplant Recipient	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; HIGH VIRAL LOAD; GENETIC DIVERSITY; ANOGENITAL HAIRS; DNA; INFECTION; PCR; SPECTRUM; BETAPAPILLOMAVIRUS; CLASSIFICATION	Gammapapillomavirus (Gamma-PV) is a diverse and rapidly expanding PV-genus, currently consisting of 76 fully characterized human papillomavirus (HPV) types. In this study, DNA genomes of two novel HPV types, HPV179 and HPV184, obtained from two distinct facial verrucae vulgares specimens of a 64 year-old renal-transplant recipient, were fully cloned, sequenced and characterized. HPV179 and HPV184 genomes comprise 7,228-bp and 7,324-bp, respectively, and contain four early (E1, E2, E6 and E7) and two late genes (L1 and L2); the non-coding region is typically positioned between L1 and E6 genes. Phylogenetic analysis of the L1 nucleotide sequence placed both novel types within the Gamma-PV genus: HPV179 was classified as a novel member of species Gamma-15, additionally containing HPV135 and HPV146, while HPV184 was classified as a single member of a novel species Gamma-25. HPV179 and HPV184 type-specific quantitative real-time PCRs were further developed and used in combination with human beta-globin gene quantitative real-time PCR to determine the prevalence and viral load of the novel types in the patient's facial warts and several follow-up skin specimens, and in a representative collection, a total of 569 samples, of HPV-associated benign and malignant neoplasms, hair follicles and anal and oral mucosa specimens obtained from immunocompetent individuals. HPV179 and HPV184 viral loads in patients' facial warts were estimated to be 2,463 and 3,200 genome copies per single cell, respectively, suggesting their active role in the development of common warts in organ-transplant recipients. In addition, in this particular patient, both novel types had established a persistent infection of the skin for more than four years. Among immunocompetent individuals, HPV179 was further detected in low-copy numbers in a few skin specimens, indicating its cutaneous tissue tropism, while HPV184 was further detected in low-copy numbers in one mucosal and a few skin specimens, suggesting its dual tissue tropism.	[Hosnjak, Lea; Kocjan, Bostjan J.; Seme, Katja; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Pirs, Branko] Private Ctr Laser & Aesthet Dermatol, Ljubljana, Slovenia	University of Ljubljana	Poljak, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si			European Union; European Social Fund; Republic of Slovenia, Ministry for Education, Science and Sport	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Republic of Slovenia, Ministry for Education, Science and Sport	This article is a result of doctoral research, in part financed by the European Union, European Social Fund and the Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational Programme for Human Resources development for the period 2007 - 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bao YM, 2014, ARCH VIROL, V159, P3293, DOI 10.1007/s00705-014-2197-x; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Chen G, 2001, J VIROL, V75, P292, DOI 10.1128/JVI.75.1.292-302.2001; Chouhy D, 2013, J GEN VIROL, V94, P2480, DOI 10.1099/vir.0.055137-0; Chouhy D, 2013, J GEN VIROL, V94, P524, DOI 10.1099/vir.0.048157-0; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Doorbar J., 1996, HUMAN PAPILLOMAVIRUS, P58; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Forslund O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; Jancar N, 2009, EUR J OBSTET GYN R B, V145, P184, DOI 10.1016/j.ejogrb.2009.04.030; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kocjan Bogtjan J., 2005, Infection Genetics and Evolution, V5, P255, DOI 10.1016/j.meegid.2004.05.009; Kohler A, 2009, BRIT J DERMATOL, V161, P528, DOI 10.1111/j.1365-2133.2009.09297.x; Kohler A, 2010, VIROLOGY, V399, P129, DOI 10.1016/j.virol.2009.12.023; Komlos KF, 2013, ACTA DERMATOVEN ALP, V21, P31, DOI 10.2478/v10162-012-0028-x; Komlos KF, 2012, J MED VIROL, V84, P1233, DOI 10.1002/jmv.23318; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Leiding JW, 2012, J ALLERGY CLIN IMMUN, V130, P1030, DOI 10.1016/j.jaci.2012.07.049; Li LL, 2009, J GEN VIROL, V90, P2413, DOI 10.1099/vir.0.012344-0; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Ma YF, 2014, J VIROL, V88, P4786, DOI 10.1128/JVI.00093-14; Martin E, 2014, J CLIN VIROL, V59, P30, DOI 10.1016/j.jcv.2013.10.028; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; MATSUKURA T, 1992, VIROLOGY, V190, P561, DOI 10.1016/0042-6822(92)91254-R; Milosevic M, 2010, CENT EUR J MED, V5, P698, DOI 10.2478/s11536-010-0019-4; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; OBALEK S, 1992, J INVEST DERMATOL, V98, P936, DOI 10.1111/1523-1747.ep12460892; Odar K, 2014, J CELL MOL MED, V18, P635, DOI 10.1111/jcmm.12211; Poljak M, 2009, J INFECT DIS, V199, P1270, DOI 10.1086/597619; Potocnik M, 2007, ACTA DERMATOVEN ALP, V16, P91; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Quint KD, 2015, J PATHOL, V235, P342, DOI 10.1002/path.4425; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; SHAMANIN V, 1994, J GEN VIROL, V75, P1149, DOI 10.1099/0022-1317-75-5-1149; Sichero L, 2013, VIROLOGY, V443, P214, DOI 10.1016/j.virol.2013.04.024; Silling S, 2014, EMERG INFECT DIS, V20, P142, DOI 10.3201/eid2001.130999; Sri JC, 2012, J AM ACAD DERMATOL, V66, P292, DOI 10.1016/j.jaad.2010.12.011; Staheli JP, 2009, METHODS, V49, P32, DOI 10.1016/j.ymeth.2009.05.011; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas M, 2008, VIROLOGY, V376, P371, DOI 10.1016/j.virol.2008.03.021; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Ure AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089342; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; van Duin M, 2002, INT J CANCER, V98, P590, DOI 10.1002/ijc.10232; Venuti A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-140	60	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119154	10.1371/journal.pone.0119154	http://dx.doi.org/10.1371/journal.pone.0119154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748516	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400052
J	Klassen, R; Grunewald, P; Thuring, KL; Eichler, C; Helm, M; Schaffrath, R				Klassen, Roland; Grunewald, Pia; Thuering, Kathrin L.; Eichler, Christian; Helm, Mark; Schaffrath, Raffael			Loss of Anticodon Wobble Uridine Modifications Affects tRNA(Lys) Function and Protein Levels in Saccharomyces cerevisiae	PLOS ONE			English	Article							KLUYVEROMYCES-LACTIS ZYMOCIN; TRANSFER-RNA MODIFICATION; ELONGATOR FUNCTION; KILLER TOXIN; YEAST; GENE; COMPLEX; TARGET; IDENTIFICATION; CASSETTES	In eukaryotes, wobble uridines in the anticodons of tRNA(UUU)(Lys), tRNA(UUC)(Glu) and tRNA(UUG)(Gln) are modified to 5-methoxy-carbonyl-methyl-2-thio-uridine (mcm(5)s(2)U). While mutations in subunits of the Elongator complex (Elp1-Elp6), which disable mcm(5) side chain formation, or removal of components of the thiolation pathway (Ncs2/Ncs6, Urm1, Uba4) are individually tolerated, the combination of both modification defects has been reported to have lethal effects on Saccharomyces cerevisiae. Contrary to such absolute requirement of mcm(5)s(2)U for viability, we demonstrate here that in the S. cerevisiae S288C-derived background, both pathways can be simultaneously inactivated, resulting in combined loss of tRNA anticodon modifications (mcm(5)U and s(2)U) without a lethal effect. However, an elp3 disruption strain displays synthetic sick interaction and synergistic temperature sensitivity when combined with either uba4 or urm1 mutations, suggesting major translational defects in the absence of mcm(5)s(2)U modifications. Consistent with this notion, we find cellular protein levels drastically decreased in an elp3uba4 double mutant and show that this effect as well as growth phenotypes can be partially rescued by excess of tRNA(UUU)(Lys). These results may indicate a global translational or protein homeostasis defect in cells simultaneously lacking mcm(5) and s(2) wobble uridine modification that could account for growth impairment and mainly originates from tRNA(UUU)(Lys) hypomodification and malfunction.	[Klassen, Roland; Grunewald, Pia; Eichler, Christian; Schaffrath, Raffael] Univ Kassel, Fachgebiet Mikrobiol, Inst Biol, D-34125 Kassel, Germany; [Thuering, Kathrin L.; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany	Universitat Kassel; Johannes Gutenberg University of Mainz	Klassen, R (corresponding author), Univ Kassel, Fachgebiet Mikrobiol, Inst Biol, D-34125 Kassel, Germany.	roland.klassen@uni-kassel.de; schaffrath@uni-kassel.de	Helm, Mark/AAD-5433-2022	Klassen, Roland/0000-0002-0809-0050; Helm, Mark/0000-0002-0154-0928	Zentrale Forschungsforderung Universitat Kassel, Germany [SysTRAM 4-5595-02]; Deutsche Forschungsgemeinschaft Bonn Bad-Godesberg, Germany [SCHA750/15-1, HE 3397/8]; FCI (Fonds der Chemischen Industrie) fellowship	Zentrale Forschungsforderung Universitat Kassel, Germany; Deutsche Forschungsgemeinschaft Bonn Bad-Godesberg, Germany(German Research Foundation (DFG)); FCI (Fonds der Chemischen Industrie) fellowship	The authors gratefully acknowledge support by the Zentrale Forschungsforderung Universitat Kassel, Germany (www.uni-kassel.de/uni/?zff; grant number SysTRAM 4-5595-02 to RS) and the Deutsche Forschungsgemeinschaft Bonn Bad-Godesberg, Germany (www.dfg.de; grant numbers SCHA750/15-1 to RS and HE 3397/8 to MH). KT was supported by an FCI (Fonds der Chemischen Industrie, www.vci.de) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alings F, 2015, RNA, V21, P202, DOI 10.1261/rna.048199.114; Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; Bauer F, 2012, CELL REPORTS, V1, P424, DOI 10.1016/j.celrep.2012.04.001; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE RL, 1983, J BIOL CHEM, V258, P2193; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020783; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Damon JR, 2014, MOL BIOL CELL; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Fichtner L, 2002, MOL MICROBIOL, V43, P783, DOI 10.1046/j.1365-2958.2002.02794.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Han L, 2015, RNA, V21, P188, DOI 10.1261/rna.048173.114; HEINISCH J, 1986, MOL GEN GENET, V202, P75, DOI 10.1007/BF00330520; Helm M, 2014, CHEM BIOL, V21, P174, DOI 10.1016/j.chembiol.2013.10.015; Hoyt MA, 2008, YEAST, V25, P199, DOI 10.1002/yea.1579; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Huang Q, 2012, NUCLEIC ACIDS RES, V40, P10463, DOI 10.1093/nar/gks783; Jablonowski D, 2007, BIOCHEM SOC T, V35, P1533, DOI 10.1042/BST0351533; Jablonowski D, 2006, MOL MICROBIOL, V59, P677, DOI 10.1111/j.1365-2958.2005.04972.x; Jablonowski D, 2004, MOL BIOL CELL, V15, P1459, DOI 10.1091/mbc.E03-10-0750; Jablonowski D, 2001, MOL MICROBIOL, V42, P1095, DOI 10.1046/j.1365-2958.2001.02705.x; Jablonowski D, 2009, EUKARYOT CELL, V8, P1637, DOI 10.1128/EC.00205-09; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Kellner S, 2014, CHEM COMMUN, V50, P3516, DOI 10.1039/c3cc49114e; Kemp AJ, 2013, MOL MICROBIOL, V87, P284, DOI 10.1111/mmi.12096; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Mehlgarten C, 2003, MOL GENET GENOMICS, V269, P188, DOI 10.1007/s00438-003-0807-5; Mehlgarten C, 2010, MOL MICROBIOL, V76, P1082, DOI 10.1111/j.1365-2958.2010.07163.x; Mehlgarten C, 2009, MOL MICROBIOL, V73, P869, DOI 10.1111/j.1365-2958.2009.06811.x; Patil A, 2012, RNA BIOL, V9, P990, DOI 10.4161/rna.20531; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Scheidt V, 2014, MICROB CELL, V1, P416, DOI 10.15698/mic2014.12.179; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Zabel R, 2008, MOL MICROBIOL, V69, P175, DOI 10.1111/j.1365-2958.2008.06273.x; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675	54	44	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119261	10.1371/journal.pone.0119261	http://dx.doi.org/10.1371/journal.pone.0119261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747122	gold, Green Published			2022-12-26	WOS:000350689400061
J	Bekrater-Bodmann, R; Schredl, M; Diers, M; Reinhard, I; Foell, J; Trojan, J; Fuchs, X; Flor, H				Bekrater-Bodmann, Robin; Schredl, Michael; Diers, Martin; Reinhard, Iris; Foell, Jens; Trojan, Joerg; Fuchs, Xaver; Flor, Herta			Post-Amputation Pain Is Associated with the Recall of an Impaired Body Representation in Dreams-Results from a Nation-Wide Survey on Limb Amputees	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHANTOM PAIN; AFFECTIVE DISTRESS; SENSATIONS; FREQUENCY; PEOPLE; BIAS	The experience of post-amputation pain such as phantom limb pain (PLP) and residual limb pain (RLP), is a common consequence of limb amputation, and its presence has negative effects on a person's well-being. The continuity hypothesis of dreams suggests that the presence of such aversive experiences in the waking state should be reflected in dream content, with the recalled body representation reflecting a cognitive proxy of negative impact. In the present study, we epidemiologically assessed the presence of post-amputation pain and other amputation-related information as well as recalled body representation in dreams in a sample of 3,234 unilateral limb amputees. Data on the site and time of amputation, residual limb length, prosthesis use, lifetime prevalence of mental disorders, presence of post-amputation pain, and presence of non-painful phantom phenomena were included in logistic regression analyses using recalled body representation in dreams (impaired, intact, no memory) as dependent variable. The effects of age, sex, and frequency of dream recall were controlled for. About 22% of the subjects indicated that they were not able to remember their body representation in dreams, another 24% of the amputees recalled themselves as always intact, and only a minority of less than 3% recalled themselves as always impaired. Almost 35% of the amputees dreamed of themselves in a mixed fashion. We found that lower-limb amputation as well as the presence of PLP and RLP was positively associated with the recall of an impaired body representation in dreams. The presence of nonpainful phantom phenomena, however, had no influence. These results complement previous findings and indicate complex interactions of physical body appearance and mental body representation, probably modulated by distress in the waking state. The findings are discussed against the background of alterations in cognitive processes after amputation and hypotheses suggesting an innate body model.	[Bekrater-Bodmann, Robin; Diers, Martin; Foell, Jens; Trojan, Joerg; Fuchs, Xaver; Flor, Herta] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Schredl, Michael] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Sleep Lab, Mannheim, Germany; [Reinhard, Iris] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Div Biostat, Mannheim, Germany; [Foell, Jens] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Trojan, Joerg] Univ Koblenz Landau, Dept Psychol, Landau, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; State University System of Florida; Florida State University; University of Koblenz & Landau	Bekrater-Bodmann, R (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany.	r.bekrater-bodmann@zi-mannheim.de	Trojan, Jörg/C-1616-2009; Fuchs, Xaver/HCI-1160-2022; Diers, Martin/M-9155-2013	Trojan, Jörg/0000-0003-4110-2647; Diers, Martin/0000-0002-3257-7299; Flor, Herta/0000-0003-4809-5398	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND) project - European Community's Seventh Framework Programme (FP7)/ERC [230249]	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND) project - European Community's Seventh Framework Programme (FP7)/ERC	This research was supported by the 'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND) project awarded to HF, which receives research funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 230249. The views expressed in this manuscript are those of the authors and do not reflect the official policy of the European Community. The European Community had no influence on collection, analysis, and interpretation of the data as well as the decision to submit the paper for publication. No one except the specified persons has been involved in the preparation of the manuscript.	Alessandria M, 2011, CONSCIOUS COGN, V20, P1831, DOI 10.1016/j.concog.2011.06.013; BRADLEY B, 1983, BRIT J CLIN PSYCHOL, V22, P173, DOI 10.1111/j.2044-8260.1983.tb00598.x; Brugger P, 2008, CONSCIOUS COGN, V17, P1272, DOI 10.1016/j.concog.2008.01.005; Claudio V, 2012, CLIN PSYCHOL PSYCHOT, V19, P375, DOI 10.1002/cpp.751; CRONHOLM B, 1951, Acta Psychiatr Neurol Scand Suppl, V72, P1; Darnall BD, 2005, ARCH PHYS MED REHAB, V86, P650, DOI 10.1016/j.apmr.2004.10.028; Demet K, 2003, DISABIL REHABIL, V25, P480, DOI 10.1080/0963828031000090434; Desmond DM, 2007, J PSYCHOSOM RES, V62, P15, DOI 10.1016/j.jpsychores.2006.07.027; Desmond DM, 2006, J PAIN SYMPTOM MANAG, V31, P362, DOI 10.1016/j.jpainsymman.2005.08.014; Dijkstra PU, 2002, J PAIN SYMPTOM MANAG, V24, P578, DOI 10.1016/S0885-3924(02)00538-9; Ehde DM, 2000, ARCH PHYS MED REHAB, V81, P1039, DOI 10.1053/apmr.2000.7583; Ephraim PL, 2005, ARCH PHYS MED REHAB, V86, P1910, DOI 10.1016/j.apmr.2005.03.031; FRANK B, 1989, PSYCHOPATHOLOGY, V22, P182, DOI 10.1159/000284594; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Hanley MA, 2009, AM J PHYS MED REHAB, V88, P742, DOI 10.1097/PHM.0b013e3181b306ec; HOUGHTON AD, 1994, ANN ROY COLL SURG, V76, P22; Kern U, 2009, SCHMERZ, V23, P479, DOI 10.1007/s00482-009-0786-5; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; Mulder T, 2008, CONSCIOUS COGN, V17, P1266, DOI 10.1016/j.concog.2007.04.001; NEWTON PM, 1970, J ABNORM PSYCHOL, V76, P134, DOI 10.1037/h0029666; Pesant N, 2006, J CLIN PSYCHOL, V62, P111, DOI 10.1002/jclp.20212; POHJOLAINEN T, 1991, PROSTHET ORTHOT INT, V15, P178; Sato H, 2011, ANXIETY STRESS COPIN, V24, P359, DOI 10.1080/10615806.2010.543132; Saurat MT, 2011, CONSCIOUS COGN, V20, P1425, DOI 10.1016/j.concog.2011.05.015; Schley MT, 2008, J TRAUMA, V65, P858, DOI 10.1097/TA.0b013e31812eed9e; Schredl M, 2002, DREAMING, V12, P17, DOI 10.1023/A:1013890421674; Schredl M, 2004, PERCEPT MOTOR SKILL, V98, P1422, DOI 10.2466/pms.98.3c.1422-1426; Schredl M, 1997, PERCEPT MOTOR SKILL, V84, P1305, DOI 10.2466/pms.1997.84.3c.1305; Schredl M, 1998, CONSCIOUS COGN, V7, P634, DOI 10.1006/ccog.1998.0356; Schredl M., 2008, TRAUM; Schredl M., 2007, NEW SCI DREAMING VOL, P79; Schredl M., 2013, INT J DREAM RES, V6, P119, DOI DOI 10.11588/IJODR.2013.2.11127; Schredl M, 2011, SLEEP HYPN, V13, P1; Schredl M, 2006, SLEEP HYPNOSIS, V5; Schredl M, 2003, SLEEP HYPNOSIS, P14; Schredl M, 2008, PERCEPT MOTOR SKILL, V106, P699, DOI 10.2466/PMS.106.3.699-702; Schredl M, 2009, SLEEP MED REV, V13, P215, DOI 10.1016/j.smrv.2008.06.002; SHERMAN RA, 1984, PAIN, V18, P83, DOI 10.1016/0304-3959(84)90128-3; SHUKLA GD, 1982, BRIT J PSYCHIAT, V141, P54, DOI 10.1192/bjp.141.1.54; Sinha R, 2011, PROSTHET ORTHOT INT, V35, P90, DOI 10.1177/0309364610397087; Statistisches Bundesamt, 2014, STAT SCHWERB MENSCH; Tran TB, 2011, EMOTION, V11, P145, DOI 10.1037/a0021754; van der Schans CP, 2002, J PAIN SYMPTOM MANAG, V24, P429, DOI 10.1016/S0885-3924(02)00511-0; Vetrugno R, 2008, J NEUROL NEUROSUR PS, V79, P481, DOI 10.1136/jnnp.2007.129783; Voss U, 2011, CONSCIOUS COGN, V20, P673, DOI 10.1016/j.concog.2010.10.020; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Wartan SW, 1997, BRIT J ANAESTH, V78, P652, DOI 10.1093/bja/78.6.652; Winter C, 2001, SCHMERZ, V15, P172, DOI 10.1007/s004820170019	49	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119552	10.1371/journal.pone.0119552	http://dx.doi.org/10.1371/journal.pone.0119552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742626	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100120
J	Cresawn, SG; Pope, WH; Jacobs-Sera, D; Bowman, CA; Russell, DA; Dedrick, RM; Adair, T; Anders, KR; Ball, S; Bollivar, D; Breitenberger, C; Burnett, SH; Butela, K; Byrnes, D; Carzo, S; Cornely, KA; Cross, T; Daniels, RL; Dunbar, D; Findley, AM; Gissendanner, CR; Golebiewska, UP; Hartzog, GA; Hatherill, JR; Hughes, LE; Jalloh, CS; De Los Santos, C; Ekanem, K; Khambule, SL; King, RA; King-Smith, C; Klyczek, K; Krukonis, GP; Laing, C; Lapin, JS; Lopez, AJ; Mkhwanazi, SM; Molloy, SD; Moran, D; Munsamy, V; Pacey, E; Plymale, R; Poxleitner, M; Reyna, N; Schildbach, JF; Stukey, J; Taylor, SE; Ware, VC; Wellmann, AL; Westholm, D; Wodarski, D; Zajko, M; Zikalala, TS; Hendrix, RW; Hatfull, GF				Cresawn, Steven G.; Pope, Welkin H.; Jacobs-Sera, Deborah; Bowman, Charles A.; Russell, Daniel A.; Dedrick, Rebekah M.; Adair, Tamarah; Anders, Kirk R.; Ball, Sarah; Bollivar, David; Breitenberger, Caroline; Burnett, Sandra H.; Butela, Kristen; Byrnes, Deanna; Carzo, Sarah; Cornely, Kathleen A.; Cross, Trevor; Daniels, Richard L.; Dunbar, David; Findley, Ann M.; Gissendanner, Chris R.; Golebiewska, Urszula P.; Hartzog, Grant A.; Hatherill, J. Robert; Hughes, Lee E.; Jalloh, Chernoh S.; De Los Santos, Carla; Ekanem, Kevin; Khambule, Sphindile L.; King, Rodney A.; King-Smith, Christina; Klyczek, Karen; Krukonis, Greg P.; Laing, Christian; Lapin, Jonathan S.; Lopez, A. Javier; Mkhwanazi, Sipho M.; Molloy, Sally D.; Moran, Deborah; Munsamy, Vanisha; Pacey, Eddie; Plymale, Ruth; Poxleitner, Marianne; Reyna, Nathan; Schildbach, Joel F.; Stukey, Joseph; Taylor, Sarah E.; Ware, Vassie C.; Wellmann, Amanda L.; Westholm, Daniel; Wodarski, Donna; Zajko, Michelle; Zikalala, Thabiso S.; Hendrix, Roger W.; Hatfull, Graham F.			Comparative Genomics of Cluster O Mycobacteriophages	PLOS ONE			English	Article							TRANSFER-RNA GENES; REVEALS; PROTEIN; BACTERIOPHAGE; PHAGE; SEQUENCES; HOMOLOGY; PROGRAM; GROWTH; BPS	Mycobacteriophages - viruses of mycobacterial hosts - are genetically diverse but morphologically are all classified in the Caudovirales with double-stranded DNA and tails. We describe here a group of five closely related mycobacteriophages - Corndog, Catdawg, Dylan, Firecracker, and YungJamal - designated as Cluster O with long flexible tails but with unusual prolate capsids. Proteomic analysis of phage Corndog particles, Catdawg particles, and Corndog-infected cells confirms expression of half of the predicted gene products and indicates a non-canonical mechanism for translation of the Corndog tape measure protein. Bioinformatic analysis identifies 8-9 strongly predicted SigA promoters and all five Cluster O genomes contain more than 30 copies of a 17 bp repeat sequence with dyad symmetry located throughout the genomes. Comparison of the Cluster O phages provides insights into phage genome evolution including the processes of gene flux by horizontal genetic exchange.	[Cresawn, Steven G.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Pope, Welkin H.; Jacobs-Sera, Deborah; Bowman, Charles A.; Russell, Daniel A.; Dedrick, Rebekah M.; Lapin, Jonathan S.; Pacey, Eddie; Hendrix, Roger W.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Adair, Tamarah] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Anders, Kirk R.; Poxleitner, Marianne] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Ball, Sarah; Breitenberger, Caroline] Ohio State Univ, Ctr Life Sci Educ, Columbus, OH 43210 USA; [Bollivar, David] Illinois Wesleyan Univ, Dept Biol, Bloomington, IL 61701 USA; [Burnett, Sandra H.] Brigham Young Univ, Dept Mol Biol & Microbiol, Provo, UT 84602 USA; [Butela, Kristen] Seton Hill Univ, Dept Biol, Greensburg, PA USA; [Byrnes, Deanna] Carthage Coll, Dept Biol, Kenosha, WI USA; [Cornely, Kathleen A.] Providence Coll, Dept Chem & Biochem, Providence, RI 02918 USA; [Daniels, Richard L.] Coll Idaho, Dept Biol, Caldwell, NJ USA; [Carzo, Sarah; Cross, Trevor; Dunbar, David; Moran, Deborah; Wodarski, Donna; Zajko, Michelle] Cabrini Coll, Dept Biol, Radnor, PA USA; [Findley, Ann M.] Univ Louisiana Monroe, Sch Sci, Monroe, LA USA; [Gissendanner, Chris R.] Univ Louisiana Monroe, Sch Pharm, Monroe, LA USA; [Golebiewska, Urszula P.] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, New York, NY 11364 USA; [Hartzog, Grant A.; De Los Santos, Carla; Ekanem, Kevin] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Hatherill, J. Robert] Del Mar Coll, Dept Nat Sci, Corpus Christi, TX 78404 USA; [Hughes, Lee E.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Jalloh, Chernoh S.; Khambule, Sphindile L.; Mkhwanazi, Sipho M.; Wellmann, Amanda L.; Zikalala, Thabiso S.] Univ QwaZulu Natal, Sch Life Sci, Durban, South Africa; [King, Rodney A.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [King-Smith, Christina] St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA; [Klyczek, Karen] Univ Wisconsin, Dept Biol, River Falls, WI 54022 USA; [Krukonis, Greg P.] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA; [Laing, Christian] Wilkes Univ, Dept Math & Comp Sci, Wilkes Barre, PA 18766 USA; [Lopez, A. Javier] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Molloy, Sally D.] Univ Maine, Dept Mol & Biomed Sci, Honors Coll, Orono, ME USA; [Munsamy, Vanisha] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Plymale, Ruth; Reyna, Nathan] Ouachita Baptist Univ, Dept Biol Sci, Arkadelphia, AR USA; [Schildbach, Joel F.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Stukey, Joseph] Hope Coll, Dept Biol, Holland, MI 49423 USA; [Taylor, Sarah E.] Brown Univ, Dept Biol, Providence, RI 02912 USA; [Ware, Vassie C.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Westholm, Daniel] Coll St Scholast, Dept Biol, Duluth, MN USA	James Madison University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; Gonzaga University; University System of Ohio; Ohio State University; Illinois Wesleyan University; Brigham Young University; Providence College; University of Louisiana System; University of Louisiana Monroe; University of Louisiana System; University of Louisiana Monroe; City University of New York (CUNY) System; University of California System; University of California Santa Cruz; University of North Texas System; University of North Texas Denton; Western Kentucky University; Saint Joseph's University; University of Wisconsin System; Gettysburg College; Wilkes University; Carnegie Mellon University; University of Maine System; University of Maine Orono; Johns Hopkins University; Hope College; Brown University; Lehigh University	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Breitenberger, Caroline/O-6176-2014	Breitenberger, Caroline/0000-0001-6001-156X; Moran, Deborah/0000-0002-9396-4145; Plymale, Ruth/0000-0001-6122-1905; Anders, Kirk/0000-0002-3372-1379; Butela, Kristen/0000-0003-1463-5288; Schildbach, Joel/0000-0002-3038-9745; Daniels, Richard/0000-0003-2477-6025; Bollivar, David/0000-0002-9378-3408; Klyczek, Karen/0000-0001-7882-0429; Dedrick, Rebekah/0000-0002-3666-711X; Adair, Tamarah/0000-0002-4656-6769; Reyna, Nathan/0000-0003-3430-0282	National Institutes of Health [GM51975]; Howard Hughes Medical Institute [54308198]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408, R01GM051975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM51975) and from the Howard Hughes Medical Institute (54308198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Brown KL, 1997, EMBO J, V16, P5914, DOI 10.1093/emboj/16.19.5914; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Czyz A, 2014, MBIO, V5, DOI 10.1128/mBio.00931-14; Dedrick RM, 2013, MOL MICROBIOL, V88, P577, DOI 10.1111/mmi.12210; Duda RL, 2013, J MOL BIOL, V425, P2765, DOI 10.1016/j.jmb.2013.05.002; FORSMAN P, 1993, ARCH VIROL, V132, P321, DOI 10.1007/BF01309542; Gill JJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-542; Hatfull GF, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0032-2013; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hendrix R.W., 2013, FIELDS VIROLOGY; Hendrix RW, 2012, ADV EXP MED BIOL, V726, P351, DOI 10.1007/978-1-4614-0980-9_15; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HUANG WM, 1988, SCIENCE, V239, P1005, DOI 10.1126/science.2830666; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Jordan TC, 2014, MBIO, V5, DOI 10.1128/mBio.01051-13; Kala S, 2014, P NATL ACAD SCI USA, V111, P6022, DOI 10.1073/pnas.1320952111; Kim BJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00604-13; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luque A, 2010, BIOPHYS J, V98, P2993, DOI 10.1016/j.bpj.2010.02.051; NESBIT CE, 1995, MOL MICROBIOL, V17, P1045, DOI 10.1111/j.1365-2958.1995.mmi_17061045.x; Oh B, 2014, VIROLOGY, V456, P171, DOI 10.1016/j.virol.2014.03.022; Oldfield LM, 2014, J BACTERIOL, V196, P3589, DOI 10.1128/JB.01801-14; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pitcher RS, 2006, MOL CELL, V23, P743, DOI 10.1016/j.molcel.2006.07.009; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; Pope WH, 2014, MBIO, V5, DOI 10.1128/mBio.02145-14; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026750; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Riipinen KA, 2011, ARCH VIROL, V156, P1217, DOI 10.1007/s00705-011-0980-5; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Singh S, 2014, J MOL BIOL, V426, P412, DOI 10.1016/j.jmb.2013.10.002; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STOLT P, 1994, BIOL CHEM H-S, V375, P747, DOI 10.1515/bchm3.1994.375.11.747; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	45	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118725	10.1371/journal.pone.0118725	http://dx.doi.org/10.1371/journal.pone.0118725			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742016	Green Published, gold, Green Accepted			2022-12-26	WOS:000350688100039
J	Fujikawa, A; Matsumoto, M; Kuboyama, K; Suzuki, R; Noda, M				Fujikawa, Akihiro; Matsumoto, Masahito; Kuboyama, Kazuya; Suzuki, Ryoko; Noda, Masaharu			Specific Dephosphorylation at Tyr-554 of Git1 by Ptprz Promotes Its Association with Paxillin and Hic-5	PLOS ONE			English	Article							RECEPTOR-TYPE-Z; PROTEIN-TYROSINE PHOSPHATASES; REGULATES PROTRUSIVE ACTIVITY; SUBSTRATE-TRAPPING SYSTEM; GTPASE-ACTIVATING PROTEIN; ZETA RPTP-BETA; SYNAPSE FORMATION; SPINE MORPHOGENESIS; FOCAL ADHESIONS; ZETA/RPTP-BETA	G protein-coupled receptor kinase-interactor 1 (Git1) is involved in cell motility control by serving as an adaptor that links signaling proteins such as Pix and PAK to focal adhesion proteins. We previously demonstrated that Git1 was a multiply tyrosine-phosphorylated protein, its primary phosphorylation site was Tyr-554 in the vicinity of the focal adhesion targeting-homology (FAH) domain, and this site was selectively dephosphorylated by protein tyrosine phosphatase receptor type Z (Ptprz). In the present study, we showed that Tyr-554 phosphorylation reduced the association of Git1 with the FAH-domain-binding proteins, paxillin and Hic-5, based on immunoprecipitation experiments using the Tyr-554 mutants of Git1. The Tyr-554 phosphorylation of Git1 was higher, and its binding to paxillin was consistently lower in the brains of Ptprz-deficient mice than in those of wild-type mice. We then investigated the role of Tyr-554 phosphorylation in cell motility control using three different methods: random cell motility, wound healing, and Boyden chamber assays. The shRNA-mediated knockdown of endogenous Git1 impaired cell motility in A7r5 smooth muscle cells. The motility defect was rescued by the exogenous expression of wild-type Git1 and a Git1 mutant, which only retained Tyr-554 among the multiple potential tyrosine phosphorylation sites, but not by the Tyr-554 phosphorylation-defective or phosphorylation-state mimic Git1 mutant. Our results suggested that cyclic phosphorylation-dephosphorylation at Tyr-554 of Git1 was crucial for dynamic interactions between Git1 and paxillin/Hic-5 in order to ensure coordinated cell motility.	[Fujikawa, Akihiro; Matsumoto, Masahito; Kuboyama, Kazuya; Suzuki, Ryoko; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan; [Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan.	madon@nibb.ac.jp	Fujikawa, Akihiro/K-9805-2015; Noda, Masaharu/D-7146-2016; Matsumoto, Masahito/ABB-3002-2021	Fujikawa, Akihiro/0000-0002-3950-0550; Noda, Masaharu/0000-0002-3796-524X; Kuboyama, Kazuya/0000-0002-9878-1209	Ministry of Education, Science, Sports and Culture of Japan (MEXT); Grants-in-Aid for Scientific Research [26110722] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797; Lafont D, 2009, BEHAV BRAIN RES, V201, P29, DOI 10.1016/j.bbr.2009.01.025; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Manabe R, 2002, J CELL SCI, V115, P1497; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Pang JJ, 2013, ARTERIOSCL THROM VAS, V33, P999, DOI 10.1161/ATVBAHA.112.300966; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Schmalzigaug R, 2009, NEUROSCI LETT, V458, P79, DOI 10.1016/j.neulet.2009.04.037; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Thomaidou D, 2001, J NEUROCHEM, V78, P767, DOI 10.1046/j.1471-4159.2001.00454.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Totaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093199; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Yin GY, 2005, J BIOL CHEM, V280, P27705, DOI 10.1074/jbc.M502271200; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	44	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119361	10.1371/journal.pone.0119361	http://dx.doi.org/10.1371/journal.pone.0119361			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742295	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100104
J	Hu, AH; Diener, BL; Josephson, MB; Grunstein, MM				Hu, Aihua; Diener, Barry L.; Josephson, Maureen B.; Grunstein, Michael M.			Constitutively Active Signaling by the G Protein beta gamma-Subunit Mediates Intrinsically Increased Phosphodiesterase-4 Activity in Human Asthmatic Airway Smooth Muscle Cells	PLOS ONE			English	Article							SMALL-MOLECULE DISRUPTION; RAS-DEPENDENT ACTIVATION; COUPLED RECEPTOR; ADRENOCEPTOR RESPONSIVENESS; UP-REGULATION; KINASE; MECHANISM; ROFLUMILAST; HYPERRESPONSIVENESS; DESENSITIZATION	Signaling by the G beta gamma subunit of Gi protein, leading to downstream c-Src-induced activation of the Ras/c-Raf1/MEK-ERK1/2 signaling pathway and its upregulation of phosphodiesterase-4 (PDE4) activity, was recently shown to mediate the heightened contractility in proasthmatic sensitized isolated airway smooth muscle (ASM), as well as allergen-induced airway hyperresponsiveness and inflammation in an in vivo animal model of allergic asthma. This study investigated whether cultured human ASM (HASM) cells derived from asthmatic donor lungs exhibit constitutively increased PDE activity that is attributed to intrinsically upregulated G beta gamma signaling coupled to c-Src activation of the Ras/MEK/ERK1/2 cascade. We show that, relative to normal cells, asthmatic HASM cells constitutively exhibit markedly increased intrinsic PDE4 activity coupled to heightened G beta gamma-regulated phosphorylation of c-Src and ERK1/2, and direct co-localization of the latter with the PDE4D isoform. These signaling events and their induction of heightened PDE activity are acutely suppressed by treating asthmatic HASM cells with a G beta gamma inhibitor. Importantly, along with increased G beta gamma activation, asthmatic HASM cells also exhibit constitutively increased direct binding of the small Rap1 GTPase-activating protein, Rap1GAP, to the alpha-subunit of Gi protein, which serves to cooperatively facilitate Ras activation and, thereby, enable enhanced G beta gamma-regulated ERK1/2-stimulated PDE activity. Collectively, these data are the first to identify that intrinsically increased signaling via the G beta gamma subunit, facilitated by Rap1GAP recruitment to the alpha-subunit, mediates the constitutively increased PDE4 activity detected in asthmatic HASM cells. These new findings support the notion that interventions targeted at suppressing G beta gamma signaling may lead to novel approaches to treat asthma.	[Hu, Aihua; Diener, Barry L.; Josephson, Maureen B.; Grunstein, Michael M.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Grunstein, Michael M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Grunstein, MM (corresponding author), Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.	mgrun@med.upenn.edu			National Institutes of Health Heart, Lung, Blood Institute [HL-097739]; Jacqueline E. Swartz Endowed Fellowship in Pediatric Pulmonology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097739] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jacqueline E. Swartz Endowed Fellowship in Pediatric Pulmonology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Heart, Lung, Blood Institute grant HL-097739 to MMG, and the Jacqueline E. Swartz Endowed Fellowship in Pediatric Pulmonology to MBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman ED, 2006, ANN ALLERG ASTHMA IM, V96, P679, DOI 10.1016/S1081-1206(10)61065-4; Billington CK, 2008, AM J RESP CELL MOL, V38, P1, DOI 10.1165/rcmb.2007-0171OC; Billington CK, 2003, RESP RES, V4; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Chang M, 2000, J BIOL CHEM, V275, P7021, DOI 10.1074/jbc.275.10.7021; Chapman RW, 2007, EUR J PHARMACOL, V571, P215, DOI 10.1016/j.ejphar.2007.05.074; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Gerthoffer WT, 2003, RESP PHYSIOL NEUROBI, V137, P237, DOI 10.1016/S1569-9048(03)00150-2; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Hakonarson H, 2003, RESP PHYSIOL NEUROBI, V137, P263, DOI 10.1016/S1569-9048(03)00152-6; HAKONARSON H, 1995, AM J PHYSIOL-LUNG C, V269, pL645, DOI 10.1152/ajplung.1995.269.5.L645; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Hu AH, 2009, AM J PHYSIOL-LUNG C, V296, pL790, DOI 10.1152/ajplung.90572.2008; Kanehiro A, 2001, AM J RESP CRIT CARE, V163, P173, DOI 10.1164/ajrccm.163.1.2001118; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Louw C, 2007, RESPIRATION, V74, P411, DOI 10.1159/000095677; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Nino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032078; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Okada S, 1998, EMBO J, V17, P2554, DOI 10.1093/emboj/17.9.2554; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun JG, 2006, LIFE SCI, V79, P2077, DOI 10.1016/j.lfs.2006.07.001; Tang HF, 2005, AM J RESP CRIT CARE, V171, P823, DOI 10.1164/rccm.200406-771OC; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; van Dam Teunis J P, 2011, Small GTPases, V2, P4; van Schalkwyk E, 2005, J ALLERGY CLIN IMMUN, V116, P292, DOI 10.1016/j.jaci.2005.04.023; Willard FS, 2007, CELL SIGNAL, V19, P428, DOI 10.1016/j.cellsig.2006.07.013	45	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118712	10.1371/journal.pone.0118712	http://dx.doi.org/10.1371/journal.pone.0118712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742624	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100036
J	Hwang, B; Phan, FP; McCool, K; Choi, EY; You, JS; Johnson, A; Audhya, A; Miyamoto, S				Hwang, Byounghoon; Phan, Funita P.; McCool, Kevin; Choi, Eun Young; You, Jinsam; Johnson, Adam; Audhya, Anjon; Miyamoto, Shigeki			Quantification of Cellular NEMO Content and Its Impact on NF-kappa B Activation by Genotoxic Stress	PLOS ONE			English	Article							UBIQUITIN CHAINS; POSTTRANSLATIONAL MODIFICATIONS; KINASE COMPLEX; IKK-GAMMA; MODULATOR; COMPONENT; PATHWAY; BINDING; PROTEIN; DOMAIN	NF-kappa B essential modulator, NEMO, plays a key role in canonical NF-kappa B signaling induced by a variety of stimuli, including cytokines and genotoxic agents. To dissect the different biochemical and functional roles of NEMO in NF-kappa B signaling, various mutant forms of NEMO have been previously analyzed. However, transient or stable overexpression of wild-type NEMO can significantly inhibit NF-kappa B activation, thereby confounding the analysis of NEMO mutant phenotypes. What levels of NEMO overexpression lead to such an artifact and what levels are tolerated with no significant impact on NEMO function in NF-kappa B activation are currently unknown. Here we purified full-length recombinant human NEMO protein and used it as a standard to quantify the average number of NEMO molecules per cell in a 1.3E2 NEMO-deficient murine pre-B cell clone stably reconstituted with full-length human NEMO (C5). We determined that the C5 cell clone has an average of 4 x 10(5) molecules of NEMO per cell. Stable reconstitution of 1.3E2 cells with different numbers of NEMO molecules per cell has demonstrated that a 10-fold range of NEMO expression (0.6-6x10(5) molecules per cell) yields statistically equivalent NF-kappa B activation in response to the DNA damaging agent etoposide. Using the C5 cell line, we also quantified the number of NEMO molecules per cell in several commonly employed human cell lines. These results establish baseline numbers of endogenous NEMO per cell and highlight surprisingly normal functionality of NEMO in the DNA damage pathway over a wide range of expression levels that can provide a guideline for future NEMO reconstitution studies.	[Hwang, Byounghoon; Phan, Funita P.; McCool, Kevin; Choi, Eun Young; Miyamoto, Shigeki] Univ Wisconsin, Dept Oncol, Madison, WI 53706 USA; [Phan, Funita P.; Johnson, Adam; Miyamoto, Shigeki] Univ Wisconsin, Integrated Program Biochem, Madison, WI USA; [McCool, Kevin; Miyamoto, Shigeki] Univ Wisconsin, Mol & Cellular Pharmacol, Madison, WI USA; [Johnson, Adam; Audhya, Anjon] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [You, Jinsam] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University-Purdue University Indianapolis	Miyamoto, S (corresponding author), Univ Wisconsin, Dept Oncol, Madison, WI 53706 USA.	smiyamot@wisc.edu			NIH [R01 GM083681, R01 CA077474]; NCI Training in Cancer Biology [T32 CA009135]; NATIONAL CANCER INSTITUTE [R01CA077474, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110567, R01GM083681, T32GM008692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Training in Cancer Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grants R01 GM083681 and R01 CA077474 to SM and NCI Training in Cancer Biology T32 CA009135 to FPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Choudhary A, 2013, P NATL ACAD SCI USA, V110, P13026, DOI 10.1073/pnas.1308203110; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cote SM, 2013, BIOCHEMISTRY-US, V52, P9141, DOI 10.1021/bi401368r; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Higgs RE, 2007, J PROTEOME RES, V6, P1758, DOI 10.1021/pr0605320; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Park A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095101; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rudolph D, 2000, GENE DEV, V14, P854; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0116374	10.1371/journal.pone.0116374	http://dx.doi.org/10.1371/journal.pone.0116374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742655	Green Published, gold			2022-12-26	WOS:000350688100002
J	Kang, J; Lee, HJ; Kim, J; Lee, JJ; Maeng, LS				Kang, Jun; Lee, Hee Jin; Kim, Jiyoung; Lee, Jae Jun; Maeng, Lee-so			Dysregulation of X Chromosome Inactivation in High Grade Ovarian Serous Adenocarcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; BARR BODY; XIST RNA; CANCER; BRCA1; BREAST; ABNORMALITIES; IMPACT	Background One of the two copies of the X chromosome is randomly inactivated in females as a means of dosage compensation. Loss of X chromosome inactivation (XCI) is observed in breast and ovarian cancers, and is frequent in basal-like subtype and BRCA1 mutation-associated breast cancers. We investigated the clinical implications of the loss of XCI in ovarian cancer and the association between the loss of XCI and BRCA1 dysfunction. Materials and Methods We used open source data generated by The Cancer Genome Atlas (TCGA) Genome Data Analysis Centers. Ward's hierarchical clustering method was used to classify the methylation status of the X chromosome. Results We grouped 584 high grade serous ovarian adenocarcinomas (HG-SOA) according to methylation status, loss of heterozygosity and deletion or gain of X chromosome into the following five groups: preserved inactivated X chromosome (Xi) group (n = 175), partial reactivation of Xi group (n = 100), p arm deletion of Xi group (n = 35), q arm deletion of Xi group (n = 44), and two copies of active X group (n = 230). We found four genes (XAGE3, ZNF711, MAGEA4, and ZDHHC15) that were up-regulated by loss of XCI. HG-SOA with loss of XCI showed aggressive behavior (overall survival of partial reactivation of Xi group: HR 1.7, 95% CI 1.1-2.5, two copies of active X group: HR 1.4, 95% CI 1.0-1.9). Mutation and hypermethylation of BRCA1 were not frequent in HG-SOA with loss of XCI. Conclusions Loss of XCI is common in HG-SOA and is associated with poor clinical outcome. The role of BRCA1 in loss of XCI might be limited. XCI induced aberrant expression of cancer-testis antigens, which may have a role in tumor aggressiveness.	[Kang, Jun; Kim, Jiyoung; Lee, Jae Jun; Maeng, Lee-so] Catholic Univ Korea, Inchun St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea; [Lee, Hee Jin] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea	Catholic University of Korea; University of Ulsan	Kang, J (corresponding author), Catholic Univ Korea, Inchun St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea.	jkang.alien@gmail.com						Ahn J., 2008, NAT ED, V1, P24; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benoit MH, 2007, INT J ONCOL, V30, P5; BORAH V, 1980, J SURG ONCOL, V13, P1, DOI 10.1002/jso.2930130102; Cheng PC, 1996, J NATL CANCER I, V88, P510, DOI 10.1093/jnci/88.8.510; Forghanifard MM, 2011, CANCER BIOL THER, V12, P191, DOI 10.4161/cbt.12.3.15949; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Huang KC, 2002, MOL CANCER THER, V1, P769; Jacobsen A, 2013, CGDSR R BASED API AC; Kurman RJ, 2013, ANN ONCOL, V24, P16, DOI 10.1093/annonc/mdt463; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lose F, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn345; Manoukian S, 2013, EUR J CANCER, V49, P1136, DOI 10.1016/j.ejca.2012.10.013; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pageau GJ, 2007, J CELL BIOCHEM, V100, P835, DOI 10.1002/jcb.21188; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Silver DP, 2007, CELL, V128, P991, DOI 10.1016/j.cell.2007.02.025; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xiao CY, 2007, CELL, V128, P977, DOI 10.1016/j.cell.2007.01.034; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034	28	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118927	10.1371/journal.pone.0118927	http://dx.doi.org/10.1371/journal.pone.0118927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742136	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100061
J	Prykhozhij, SV; Rajan, V; Gaston, D; Berman, JN				Prykhozhij, Sergey V.; Rajan, Vinothkumar; Gaston, Daniel; Berman, Jason N.			CRISPR MultiTargeter: A Web Tool to Find Common and Unique CRISPR Single Guide RNA Targets in a Set of Similar Sequences	PLOS ONE			English	Article							CONSERVED SYNTENY; ZEBRAFISH GENOME; CAS9; SPECIFICITY; BACTERIA; DEFENSE; SYSTEMS	Genome engineering has been revolutionized by the discovery of clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR-associated system genes (Cas) in bacteria. The type IIB Streptococcus pyogenes CRISPR/Cas9 system functions in many species and additional types of CRISPR/Cas systems are under development. In the type II system, expression of CRISPR single guide RNA (sgRNA) targeting a defined sequence and Cas9 generates a sequence-specific nuclease inducing small deletions or insertions. Moreover, knock-in of large DNA inserts has been shown at the sites targeted by sgRNAs and Cas9. Several tools are available for designing sgRNAs that target unique locations in the genome. However, the ability to find sgRNA targets common to several similar sequences or, by contrast, unique to each of these sequences, would also be advantageous. To provide such a tool for several types of CRISPR/Cas system and many species, we developed the CRISPR MultiTargeter software. Similar DNA sequences in question are duplicated genes and sets of exons of different transcripts of a gene. Thus, we implemented a basic sgRNA target search of input sequences for single-sgRNA and two-sgRNA/Cas9 nickase targeting, as well as common and unique sgRNA target searches in 1) a set of input sequences; 2) a set of similar genes or transcripts; or 3) transcripts a single gene. We demonstrate potential uses of the program by identifying unique isoform-specific sgRNA sites in 71% of zebrafish alternative transcripts and common sgRNA target sites in approximately 40% of zebrafish duplicated gene pairs. The design of unique targets in alternative exons is helpful because it will facilitate functional genomic studies of transcript isoforms. Similarly, its application to duplicated genes may simplify multi-gene mutational targeting experiments. Overall, this program provides a unique interface that will enhance use of CRISPR/Cas technology.	[Prykhozhij, Sergey V.; Berman, Jason N.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Rajan, Vinothkumar; Berman, Jason N.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Gaston, Daniel; Berman, Jason N.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Prykhozhij, SV (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.	s.prykhozhij@gmail.com	Rajan, Vinothkumar/K-4955-2019; Rajan, Vinothkumar/U-9687-2019	Rajan, Vinothkumar/0000-0003-3323-181X	IGNITE (Orphan Diseases: Identifying Genes and Novel Therapeutics to Enhance Treatment) project grant from Genome Atlantic and Canadian Institutes of Health Research operating grant [287512]	IGNITE (Orphan Diseases: Identifying Genes and Novel Therapeutics to Enhance Treatment) project grant from Genome Atlantic and Canadian Institutes of Health Research operating grant	Although this project was not specifically funded by any grant, the authors gratefully acknowledge the grant support by the IGNITE (Orphan Diseases: Identifying Genes and Novel Therapeutics to Enhance Treatment) project grant from Genome Atlantic and Canadian Institutes of Health Research operating grant 287512.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL; Dumousseau M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kuraku S, 2012, METHODS MOL BIOL, V855, P385, DOI 10.1007/978-1-61779-582-4_14; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Menke DB, 2013, GENESIS, V51, P605, DOI 10.1002/dvg.22422; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Naito Y, 2014, BIOINFORMATICS, P1, DOI [10.1093/biainformatics/1408743, DOI 10.1093/BIAINF0RMATICS/1408743]; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Walsh RM, 2013, P NATL ACAD SCI USA, V110, P15514, DOI 10.1073/pnas.1314697110; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu K., 2014, CELL MOL LIFE SCI; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	41	82	104	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119372	10.1371/journal.pone.0119372	http://dx.doi.org/10.1371/journal.pone.0119372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742428	Green Published, gold			2022-12-26	WOS:000350688100105
J	Sun, Y; Lee, R; Chen, Y; Collinson, S; Thakor, N; Bezerianos, A; Sim, K				Sun, Yu; Lee, Renick; Chen, Yu; Collinson, Simon; Thakor, Nitish; Bezerianos, Anastasios; Sim, Kang			Progressive Gender Differences of Structural Brain Networks in Healthy Adults: A Longitudinal, Diffusion Tensor Imaging Study	PLOS ONE			English	Article							SEX-DIFFERENCES; GRAY-MATTER; WHITE-MATTER; SMALL-WORLD; CONNECTIVITY PATTERNS; CORTICAL NETWORKS; CEREBRAL-CORTEX; YOUNG-ADULTS; AGE; VOLUMES	Sexual dimorphism in the brain maturation during childhood and adolescence has been repeatedly documented, which may underlie the differences in behaviors and cognitive performance. However, our understanding of how gender modulates the development of structural connectome in healthy adults is still not entirely clear. Here we utilized graph theoretical analysis of longitudinal diffusion tensor imaging data over a five-year period to investigate the progressive gender differences of brain network topology. The brain networks of both genders showed prominent economical "small-world" architecture (high local clustering and short paths between nodes). Additional analysis revealed a more economical "small-world" architecture in females as well as a greater global efficiency in males regardless of scan time point. At the regional level, both increased and decreased efficiency were found across the cerebral cortex for both males and females, indicating a compensation mechanism of cortical network reorganization over time. Furthermore, we found that weighted clustering coefficient exhibited significant gender-time interactions, implying different development trends between males and females. Moreover, several specific brain regions (e.g., insula, superior temporal gyrus, cuneus, putamen, and parahippocampal gyrus) exhibited different development trajectories between males and females. Our findings further prove the presence of sexual dimorphism in brain structures that may underlie gender differences in behavioral and cognitive functioning. The sex-specific progress trajectories in brain connectome revealed in this work provide an important foundation to delineate the gender related pathophysiological mechanisms in various neuropsychiatric disorders, which may potentially guide the development of sex-specific treatments for these devastating brain disorders.	[Sun, Yu; Thakor, Nitish; Bezerianos, Anastasios] Natl Univ Singapore, Ctr Life Sci, Singapore Inst Neurotechnol SINAPSE, Singapore 117548, Singapore; [Lee, Renick] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Chen, Yu] Natl Univ Singapore, Dept Engn Sci, Singapore 117548, Singapore; [Collinson, Simon] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Sim, Kang] Inst Mental Hlth, Dept Gen Psychiat, Singapore, Singapore; [Sim, Kang] Inst Mental Hlth, Dept Res, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Sun, Y (corresponding author), Natl Univ Singapore, Ctr Life Sci, Singapore Inst Neurotechnol SINAPSE, Singapore 117548, Singapore.	lsisu@nus.edu.sg; kang_sim@imh.com.sg	Thakor, Nitish/G-9110-2015; Collinson, Simon Lowes/HHZ-6965-2022; Thakor, Nitish V/A-5878-2008; Chen, Yu/F-8340-2017; Bezerianos, Tasos/AAC-2499-2022	Thakor, Nitish/0000-0002-9981-9395; Collinson, Simon Lowes/0000-0001-9232-9732; Chen, Yu/0000-0003-0247-3146; Bezerianos, Tasos/0000-0002-8199-6000; Sim, Kang/0000-0003-3209-9626; SUN, Yu/0000-0002-6666-8586	National Healthcare Group [NHG 11003, 12003]; Agency for Science, Technology, Research/Singapore BioImaging Consortium [ASTAR/SBIC 009/2006]; National University of Singapore [R-719-001-102-232]	National Healthcare Group; Agency for Science, Technology, Research/Singapore BioImaging Consortium(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	The authors thank the National Healthcare Group (NHG 11003, 12003 awarded to KS) and Agency for Science, Technology, Research/Singapore BioImaging Consortium (ASTAR/SBIC 009/2006 awarded to KS) for funding support and the National University of Singapore for supporting the Cognitive Engineering Group at the Singapore Institute for Neurotechnology (SINAPSE) under grant number R-719-001-102-232. The authors are very grateful to all the participants and to Dr. Chan Yiong Huak for his insightful advice in relation to the statistical aspects of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert M. L, 2011, CLIN NEUROLOGY AGING; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Buchanan CR, 2014, NEUROIMAGE, V86, P231, DOI 10.1016/j.neuroimage.2013.09.054; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Ellison A, 2004, BRAIN, V127, P2307, DOI 10.1093/brain/awh244; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gur RC, 1999, J NEUROSCI, V19, P4065; Gur RC, 2002, CEREB CORTEX, V12, P998, DOI 10.1093/cercor/12.9.998; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton C., 2008, COGNITION SEX DIFFER; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Li WJ, 2014, HUM BRAIN MAPP, V35, P238, DOI 10.1002/hbm.22168; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Luders E, 2009, J NEUROSCI, V29, P14265, DOI 10.1523/JNEUROSCI.2261-09.2009; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Paus T, 1996, J COMP NEUROL, V376, P664, DOI 10.1002/(SICI)1096-9861(19961223)376:4<664::AID-CNE12>3.0.CO;2-M; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Raz N, 2011, PSYCHOL BULL, V137, P790, DOI 10.1037/a0024503; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sommer IEC, 2004, BRAIN, V127, P1845, DOI 10.1093/brain/awh207; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096505; Taki Y, 2013, HUM BRAIN MAPP, V34, P2292, DOI 10.1002/hbm.22067; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00113; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	65	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118857	10.1371/journal.pone.0118857	http://dx.doi.org/10.1371/journal.pone.0118857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742013	Green Published, Green Submitted, gold			2022-12-26	WOS:000350688100053
J	Wang, LR; Santella, AJ; Huang, RZ; Kou, LL; You, LJ; Zhang, XN; Wang, S; Wang, JY; Gao, LF; Yin, J; Zhuang, GH				Wang, Lirong; Santella, Anthony J.; Huang, Ruizhe; Kou, Lingling; You, Lijuan; Zhang, Xiaona; Wang, Shu; Wang, Jingyao; Gao, Longfei; Yin, Juan; Zhuang, Guihua			Knowledge of HIV and Willingness to Conduct Oral Rapid HIV Testing among Dentists in Xi'an China	PLOS ONE			English	Article							PERSONS AWARE; TRANSMISSION; HIV/AIDS; RISK; ATTITUDES; UNAWARE; INTERVENTION; PREVENTION; RETENTION; EVOLUTION	Introduction China is considered a country of low HIV prevalence (780,000 people living with HIV), however, HIV infections among high-risk populations continue to grow at alarming rates. Voluntary Counseling and Testing services were first implemented in 2003, and oral rapid HIV testing (ORHT) began in 2012. Dentists, as oral health experts, would be well placed to conduct ORHT. We assessed willingness of dentists to undertake ORHT in their clinical practice. Methods A cross-sectional, paper-based survey of dentists from the Xi'an region of China was conducted from April to June 2013. Dentists were recruited from Shaanxi Stomatological Association using a stratified sampling methodology. A 40-item survey was used to measure knowledge of HIV, attitudes toward people living with HIV and willingness to conduct ORHT. Results 477 dentists completed the survey with a mean HIV knowledge test score of 13.2/18 (SD 1.9). If made available in the dental setting, 276 (57.9%) preferred to use blood to diagnose HIV, only 190 (39.8%) preferred saliva or both. Four hundred and thirty-five (91.2%) thought that ORHT was needed in dental clinics. Female dentists felt more accepting of ORHT than males (93.8% vs. 87.8%; chi(2)=5.145; p<0.05). 42.6% of the participants who responded thought that lack of education on ORHT for dentists was the most urgent problem to solve for ORHT, 144 (31.3%) thought that lack of support for ORHT from patients was the most urgent problem. There was statistically significant difference among dental hospital, dentistry and department of dentistry (chi(2)=24.176; p<0.05). Conclusions The majority of Chinese dentists thought that ORHT was needed in the dental setting. Providing opportunities for dentists and dental students to learn about HIV testing guidelines and practices is needed as well as feasibility and implementation science research.	[Wang, Lirong; Kou, Lingling; You, Lijuan; Zhang, Xiaona; Wang, Shu; Wang, Jingyao; Gao, Longfei; Yin, Juan; Zhuang, Guihua] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Xian 710049, Shaanxi, Peoples R China; [Santella, Anthony J.] Univ Sydney, Sydney Med Sch, Western Sydney Sexual Hlth Ctr, Sydney, NSW 2006, Australia; [Huang, Ruizhe] Xi An Jiao Tong Univ, Hlth Sci Ctr, Stomatol Hosp, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; University of Sydney; Xi'an Jiaotong University	Zhuang, GH (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Xian 710049, Shaanxi, Peoples R China.	zhuanggh@mail.xjtu.edu.cn						Aggarwal A, 2013, J DENT EDUC, V77, P1209; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dietz CA, 2008, AIDS PATIENT CARE ST, V22, P205, DOI 10.1089/apc.2007.0235; Glick M, 2005, J AM DENT ASSOC, V136, P1541, DOI 10.14219/jada.archive.2005.0084; Glick M, 2005, J AM DENT ASSOC, V136, P1206, DOI 10.14219/jada.archive.2005.0326; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hutchinson MK, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-11; Khosravanifard B., 2012, Eastern Mediterranean Health Journal, V18, P928; Li L, 2012, CHINA BUSINESS  1202; Li N, 2014, INT J ENV RES PUB HE, V11, P4528, DOI 10.3390/ijerph110404528; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; Ministry of Health of the People's Republic of China, 2012, HIV CHIN FACTS FIG; Morin SF, 2008, JAIDS-J ACQ IMM DEF, V49, P544, DOI 10.1097/QAI.0b013e31818d5def; Pai NP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000367; Park JC, 2011, J PERIODONTAL IMPLAN, V41, P3, DOI [10.5051/jpis.2011.41.1.3, 10.5051/jpis.2010.40.1.3]; Pollack HA, 2014, AM J PUBLIC HEALTH, V104, P872, DOI 10.2105/AJPH.2013.301700; Pollack HA, 2010, AM J PUBLIC HEALTH, V100, P88, DOI 10.2105/AJPH.2008.157230; Reznik D, 2006, DIMENS DENT HYG, V4, P14; Santella AJ, 2013, INT J DENT HYG, V11, P287, DOI 10.1111/idh.12022; Santella Anthony J, 2012, J Dent Hyg, V86, P265; Seipone K., 2004, Morbidity and Mortality Weekly Report, V53, P1083; Shah SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-269; Siegel K, 2012, AM J PUBLIC HEALTH, V102, P625, DOI 10.2105/AJPH.2011.300509; Sun XH, 2010, INT J EPIDEMIOL, V39, pII4, DOI 10.1093/ije/dyq217; Tang Hou-lin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P1004; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; van Wijk PTL, 2010, EUR J PUBLIC HEALTH, V20, P281, DOI 10.1093/eurpub/ckp163; Vernillo AT, 2007, J DENT EDUC, V71, P1534; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Zhang DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086609; Zhang YaLan, 2013, Journal of Tropical Medicine (Guangzhou), V13, P1385	35	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119274	10.1371/journal.pone.0119274	http://dx.doi.org/10.1371/journal.pone.0119274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742600	Green Submitted, gold, Green Published			2022-12-26	WOS:000350688100099
J	Williams, K; Williams, K; Baucher, HM; Plenefisch, J				Williams, Kyle; Williams, Kristen; Baucher, Hallie M.; Plenefisch, John			The Tail Domain Is Essential but the Head Domain Dispensable for C. elegans Intermediate Filament IFA-2 Function	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MUSCLE-CELL ATTACHMENT; IN-VITRO; END DOMAINS; TRANSMEMBRANE PROTEIN; ASSEMBLY PROPERTIES; TISSUE INTEGRITY; VIMENTIN; KERATINS; ROD	The intermediate filament protein IFA-2 is essential for the structural integrity of the Caenorhabditis elegans epidermis. It is one of the major components of the fibrous organelle, an epidermal structure comprised of apical and basal hemidesmosomes linked by cytoplasmic intermediate filaments that serve to transmit force from the muscle to the cuticle. Mutations of IFA-2 result in epidermal fragility and separation of the apical and basal epidermal surfaces during postembryonic growth. An IFA-2 lacking the head domain fully rescues the IFA-2 null mutant, whereas an IFA-2 lacking the tail domain cannot. Conversely, an isolated IFA-2 head was able to localize to fibrous organelles whereas the tail was not. Taken together these results suggest that the head domain contains redundant signals for IF localization, whereas non-redundant essential functions map to the IFA-2, tail, although the tail is unlikely to be directly involved in fibrous organelle localization.	[Williams, Kyle; Williams, Kristen; Baucher, Hallie M.; Plenefisch, John] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Plenefisch, J (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	john.plenefisch@utoledo.edu			National Institutes of Health [1R15GM086807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM086807] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health grant 1R15GM086807 to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREOLI JM, 1994, EXP CELL RES, V214, P177, DOI 10.1006/excr.1994.1247; BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293; Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bercher M, 2001, J CELL BIOL, V154, P415, DOI 10.1083/jcb.200103035; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; Ching GY, 1999, J CELL SCI, V112, P2233; COULOMBE PA, 1990, J CELL BIOL, V111, P3049, DOI 10.1083/jcb.111.6.3049; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Godsel LM, 2008, TRENDS CELL BIOL, V18, P28, DOI 10.1016/j.tcb.2007.11.004; Gu L, 2004, EXP CELL RES, V298, P249, DOI 10.1016/j.yexcr.2004.04.020; Gupta Bhagwati P, 2012, WormBook, P1, DOI 10.1895/wormbook.1.152.1; Hapiak V, 2003, DEV BIOL, V263, P330, DOI 10.1016/j.ydbio.2003.08.001; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Karabinos A, 2004, EUR J CELL BIOL, V83, P457, DOI 10.1078/0171-9335-00407; Karabinos A, 2003, J MOL BIOL, V333, P307, DOI 10.1016/j.jmb.2003.08.041; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lowrie DJ, 2000, J STRUCT BIOL, V132, P83, DOI 10.1006/jsbi.2000.4315; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miao LQ, 2013, J CELL SCI, V126, P427, DOI 10.1242/jcs.105817; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Peixoto CA, 1998, J PARASITOL, V84, P45, DOI 10.2307/3284528; Plenefisch JD, 2000, DEVELOPMENT, V127, P1197; Shoeman RL, 2002, EXP CELL RES, V279, P344, DOI 10.1006/excr.2002.5618; Waterston R., 1988, NEMATODE C ELEGANS, P281; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	43	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119282	10.1371/journal.pone.0119282	http://dx.doi.org/10.1371/journal.pone.0119282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742641	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100100
J	Wu, Z; Matsui, O; Kitao, A; Kozaka, K; Koda, W; Kobayashi, S; Ryu, Y; Minami, T; Sanada, J; Gabata, T				Wu, Zhuo; Matsui, Osamu; Kitao, Azusa; Kozaka, Kazuto; Koda, Wataru; Kobayashi, Satoshi; Ryu, Yasuji; Minami, Tetsuya; Sanada, Junichiro; Gabata, Toshifumi			Hepatitis C Related Chronic Liver Cirrhosis: Feasibility of Texture Analysis of MR Images for Classification of Fibrosis Stage and Necroinflammatory Activity Grade	PLOS ONE			English	Article							MEDICAL IMAGES; SEGMENTATION; DIAGNOSIS; FEATURES; MODELS; VIRUS	Purpose To assess the feasibility of texture analysis for classifying fibrosis stage and necroinflammatory activity grade in patients with chronic hepatitis C on T2-weighted (T2W), T1-weighted (T1W) and Gd-EOB-DTPA-enhanced hepatocyte-phase (EOB-HP) imaging. Materials and methods From April 2008 to June 2012, MR images from 123 patients with pathologically proven chronic hepatitis C were retrospectively analyzed. Texture parameters derived from histogram, gradient, run-length matrix, co-occurrence matrix, autoregressive model and wavelet transform methods were estimated with imaging software. Fisher, probability of classification error and average correlation, and mutual information coefficients were used to extract subsets of optimized texture features. Linear discriminant analysis in combination with 1-nearest neighbor classifier (LDA/1-NN) was used for lesion classification. In compliance with the software requirement, classification was performed based on datasets from all patients, the patient group with necroinflammatory activity grade 1, and that with fibrosis stage 4, respectively. Results Based on all patient dataset, LDA/1-NN produced misclassification rates of 28.46%, 35.77% and 20.33% for fibrosis staging and 34.15%, 25.20% and 28.46% for necroinflammatory activity grading in T2W, T1W and EOB-HP images. In the patient group with necroinflammatory activity grade 1, LDA/1-NN yielded misclassification rates of 5.00%, 0% and 12.50% for fibrosis staging in T2W, T1W and EOB-HP images respectively. In the patient group with fibrosis stage 4, LDA/1-NN yielded misclassification rates of 5.88%, 12.94% and 11.76% for necroinflammatory activity grading in T2W, T1W and EOB-HP images respectively. Conclusion Texture quantitative parameters of MR images facilitate classification of the fibrosis stage as well as necroinflammatory activity grade in chronic hepatitis C, especially after categorizing the input dataset according to the activity or fibrosis degree in order to remove the interference between the fibrosis stage and necroinflammatory activity grade on texture features.	[Wu, Zhuo; Matsui, Osamu; Kitao, Azusa; Kozaka, Kazuto; Koda, Wataru; Kobayashi, Satoshi; Ryu, Yasuji; Minami, Tetsuya; Sanada, Junichiro; Gabata, Toshifumi] Kanazawa Univ, Dept Radiol, Grad Sch Med Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan; [Wu, Zhuo] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiol, Guangzhou 510120, Guangdong, Peoples R China	Kanazawa University; Sun Yat Sen University	Wu, Z (corresponding author), Kanazawa Univ, Dept Radiol, Grad Sch Med Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	vojoan@hotmail.com	Kobayashi, Satoshi/C-4645-2015	Kobayashi, Satoshi/0000-0001-7759-399X; Kitao, Azusa/0000-0002-5597-9346	Japan China Sasakawa Medical Fellowship	Japan China Sasakawa Medical Fellowship	This study was supported by Japan China Sasakawa Medical Fellowship. The fellowship fund sponsored 1 year of research for Zhuo Wu in Japan, and had the role in study design, data collection and analysis.	Amin A, 2009, FOOD CHEM TOXICOL, V47, P2111, DOI 10.1016/j.fct.2009.05.038; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; CHEN PC, 1979, COMPUT VISION GRAPH, V10, P172, DOI 10.1016/0146-664X(79)90049-2; Duan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078176; Fukunaga K., 1991, INTRO STAT PATTERN R, Vsecond; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Guido M, 2011, DIGEST LIVER DIS, V43, pS331, DOI 10.1016/S1590-8658(11)60589-6; Hajek M., 2006, TEXTURE ANAL MAGNETI; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harrison LCV, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-87; Harrison LC, 2010, ACAD RADIOL, V7, P696, DOI [d oi: 10.1016/f .acra. 2010.01.005 PM ID: 20457414, DOI 10.1016/F]; Herlidou S, 2004, MAGN RESON IMAGING, V22, P237, DOI 10.1016/j.mri.2003.07.007; HU Y, 1994, IEE P-VIS IMAGE SIGN, V141, P413, DOI 10.1049/ip-vis:19941548; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Jirak D, 2002, J MAGN RESON IMAGING, V15, P68, DOI 10.1002/jmri.10042; KASHYAP RL, 1983, IEEE T INFORM THEORY, V29, P60, DOI 10.1109/TIT.1983.1056610; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Kato H, 2007, AM J ROENTGENOL, V189, P117, DOI 10.2214/AJR.07.2070; LAINE A, 1993, IEEE T PATTERN ANAL, V15, P1186, DOI 10.1109/34.244679; Mahmoud-Ghoneim D, 2006, MAGN RESON IMAGING, V24, P167, DOI 10.1016/j.mri.2005.10.002; MALLAT SG, 1989, IEEE T ACOUST SPEECH, V37, P2091, DOI 10.1109/29.45554; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Materka A., 2006, MAZDA MANUAL; Mayerhoefer ME, 2010, J MAGN RESON IMAGING, V32, P352, DOI 10.1002/jmri.22268; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Rahn S B, 2001, J Insur Med, V33, P110; Semelka RC, 2001, J MAGN RESON IMAGING, V13, P385, DOI 10.1002/jmri.1055; Strzelecki M, 2013, NUCL INSTRUM METH A, V702, P137, DOI 10.1016/j.nima.2012.09.006; Szczypinski PM, 2007, 2007 INTERNATIONAL SYMPOSIUM ON INFORMATION TECHNOLOGY CONVERGENCE, PROCEEDINGS, P245, DOI 10.1109/ISITC.2007.15; Szczypinski PM, 2009, COMPUT METH PROG BIO, V94, P66, DOI 10.1016/j.cmpb.2008.08.005; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; West J, 2010, GASTROENTEROLOGY, V139, P1230, DOI 10.1053/j.gastro.2010.06.015; Wong VS, 1996, J CLIN PATHOL, V49, P465, DOI 10.1136/jcp.49.6.465; Zhang YY, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/762804	35	27	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118297	10.1371/journal.pone.0118297	http://dx.doi.org/10.1371/journal.pone.0118297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742285	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100013
J	Fang, Z; Zhou, LN; Jiang, SM; Cao, LH; Yu, L				Fang, Zhou; Zhou, Linuo; Jiang, Songmin; Cao, Lihuan; Yu, Long			UNC50 Prompts G1/S Transition and Proliferation in HCC by Regulation of Epidermal Growth Factor Receptor Trafficking	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; PROTEIN; CANCER; CELLS; LIVER; FIBROBLASTS; GEFITINIB; ERLOTINIB	Background UNC50 has long been recognized as a Golgi apparatus protein in yeast, and is involved in nicotinic receptor trafficking in Caenorhabditis elegans, but little is known about UNC50 gene function in human biology despite it being conserved from yeast to high eukaryotes. Objectives We investigated the relation between UNC50 and human hepatocellular carcinoma (HCC) and the potential mechanisms underlying HCC development. Methods UNC50 mRNA expression patterns in 12 HCC and adjacent non-cancerous tissues determined using northern blotting were confirmed by real-time PCR in another 44 paired tissues. Microarray experiments were used to screen for global effects of UNC50 knockdown in the Hep3B cell line, and were confirmed by real-time PCR, western blotting, flow cytometry, and tetrazolium assay in both UNC50 overexpression and knockdown Hep3B cells. Results UNC50 expression levels were upregulated in HCC tissues in comparison with the adjacent non-cancerous tissues. UNC50 knockdown reduced mRNA levels of the downstream targets of the epidermal growth factor receptor (EGFR) pathway: cyclin D1 (CCND1), EGF, matrix metalloproteinase-7 (MMP7), aldose reductase-like 1 (AKR1B10), cell surface-associated mucin 1 (MUC1), and gastrin (GAST). Moreover, UNC50 influenced EGF, inducing cell cycle entry by affecting cell surface EGFR amounts. Conclusions UNC50 may plays some roles in HCC progression by affecting the EGFR pathway.	[Fang, Zhou; Jiang, Songmin; Cao, Lihuan; Yu, Long] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhou, Linuo] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Cao, LH (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lihuancao@fudan.edu.cn; longyu@fudan.edu.cn	CAO, LIHUAN/AAA-3557-2020	cao, lihuan/0000-0002-9722-4611; Fang, Zhou/0000-0002-5231-6539	National 863 Project of China [2006AA020501]; National Key Sci-Tech Special Project of China [2008ZX10002-020]; Project of the Shanghai Municipal Science and Technology Commission [03dz14086]; National Natural Science Foundation of China [30024001, 30771188]	National 863 Project of China(National High Technology Research and Development Program of China); National Key Sci-Tech Special Project of China; Project of the Shanghai Municipal Science and Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 863 Project of China (2006AA020501), the National Key Sci-Tech Special Project of China (2008ZX10002-020), the Project of the Shanghai Municipal Science and Technology Commission (03dz14086) and the National Natural Science Foundation of China (30024001, 30771188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cury PR, 2007, ARCH ORAL BIOL, V52, P585, DOI 10.1016/j.archoralbio.2006.11.006; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Dharmaraj N, 2013, J CELL BIOCHEM, V114, P2314, DOI 10.1002/jcb.24580; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fitzgerald J, 2000, BRAIN RES, V877, P110, DOI 10.1016/S0006-8993(00)02692-5; Ford MG, 1997, J CLIN INVEST, V99, P2762, DOI 10.1172/JCI119466; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Kim HJ, 2007, CELL TISSUE RES, V327, P25, DOI 10.1007/s00441-006-0304-3; LEWIS JA, 1980, GENETICS, V95, P905; Liu ZW, 2012, BIOCHEM J, V442, P273, DOI 10.1042/BJ20111322; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Philip PA, 2005, J CLIN ONCOL, V23, P6657, DOI 10.1200/JCO.2005.14.696; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; STOSCHECK CM, 1984, J CELL PHYSIOL, V120, P296, DOI 10.1002/jcp.1041200306; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Thomas MB, 2007, CANCER-AM CANCER SOC, V110, P1059, DOI 10.1002/cncr.22886; Wang YC, 2014, J GASTROEN HEPATOL, V29, P597, DOI 10.1111/jgh.12461; Yang YY, 2014, HEPATOL RES, V44, P542, DOI 10.1111/hepr.12151	26	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119338	10.1371/journal.pone.0119338	http://dx.doi.org/10.1371/journal.pone.0119338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738771	Green Submitted, Green Published, gold			2022-12-26	WOS:000350685900104
J	Rau, A; Ritschl, LM; Mucke, T; Wolff, KD; Loeffelbein, DJ				Rau, Andrea; Ritschl, Lucas M.; Muecke, Thomas; Wolff, Klaus-Dietrich; Loeffelbein, Denys J.			Nasoalveolar Molding in Cleft Care-Experience in 40 Patients from a Single Centre in Germany	PLOS ONE			English	Article							UNILATERAL CLEFT; NONSURGICAL CORRECTION; NASAL SYMMETRY; LIP; PALATE; NOSE; DEFORMITY; INFANTS; REPAIR	Nasoalveolar molding (NAM) has gained wide acceptance and evidence in cleft therapy. However, standardized treatment protocols and experiences recorded from European centres are lacking. The results of 40 infants with cleft lip and palate treated with presurgical NAM according to the Grayson technique were analyzed. Standardized parameters of cleft width and nasal symmetry were measured in pre-and posttreatment plaster casts and in digitalized 3-dimensional STL models. Statistical analyses were performed by using Student ' s t-test in a per-protocol manner. 27 out of 40 infants completed NAM and were analyzed. In 13 patients NAM was either temporarily interrupted or terminated prematurely due to skin irritations or lack of parental support. These cases were excluded from statistical analysis, resulting in a drop-out rate of 32.5%. Intersegmental alveolar distance (ISAD), intersegmental lip distance (ISLD), nostril height (NH), nostril width (NW) and columella deviation angle (CDA) were significantly changed in unilateral cleft lip and palate (UCLP) (n = 8). In unilateral cleft lip (UCL) (n = 9), only ISLD, NH and CDA were significantly changed. ISAD of the right and left side, ISLD of the right and left side, premaxilla deviation angle, nostril height and columella length were changed significantly in bilateral cleft lip and palate (BCLP) cases (n = 10). NAM is a suitable presurgical treatment modality. A positive effect has been seen in UCLP and BCLP infants, as compared with their birth status.	[Rau, Andrea; Ritschl, Lucas M.; Muecke, Thomas; Wolff, Klaus-Dietrich; Loeffelbein, Denys J.] Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany	Technical University of Munich	Rau, A (corresponding author), Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany.	rau@mkg.med.tum.de	Mücke, Thomas/K-7106-2015; Loeffelbein, Denys/AAF-3231-2019	Mücke, Thomas/0000-0003-3561-1277; 	German Research Foundation (DFG); Bavarian Research Foundation (Bayerische Forschungsstiftung); Technische Universitat Munchen within the funding program Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Bavarian Research Foundation (Bayerische Forschungsstiftung); Technische Universitat Munchen within the funding program Open Access Publishing	None of the authors had any financial and personal relationships with other people or organizations that could have inappropriately influenced this work. The concept of integrating NAM into the cleft treatment protocol was financially supported by the German Research Foundation (DFG, Nasoalveolar Molding (NAM) in cleft patients) and the Bavarian Research Foundation (Bayerische Forschungsstiftung, Rehabilitation of pediatric facial deformities) through travelling sponsorships of D.J.L. Furthermore, this work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MM, 2012, PLAST RECONSTR SURG, V130, P659, DOI 10.1097/PRS.0b013e31825dc10a; Ahmed Mohammad M, 2012, Pediatr Dent, V34, pe209; Barillas I, 2009, PLAST RECONSTR SURG, V123, P1002, DOI 10.1097/PRS.0b013e318199f46e; Bennun RD, 1999, PLAST RECONSTR SURG, V104, P616, DOI 10.1097/00006534-199909030-00002; Chang CS, 2010, PLAST RECONSTR SURG, V126, P1276, DOI 10.1097/PRS.0b013e3181ec21e4; Figueroa A., 2006, PLAST SURG-CHIR PLAS, Vsecond, P271; Garfinkle JS, 2011, PLAST RECONSTR SURG, V127, P1659, DOI 10.1097/PRS.0b013e31820a64d7; GEORGIADE NG, 1975, PLAST RECONSTR SURG, V56, P52, DOI 10.1097/00006534-197507000-00011; Grayson BH, 1999, CLEFT PALATE-CRAN J, V36, P486, DOI 10.1597/1545-1569_1999_036_0486_pnmiiw_2.3.co_2; GRAYSON BH, 1993, PLAST RECONSTR SURG, V92, P1422; Lee CTH, 2008, PLAST RECONSTR SURG, V122, P1131, DOI 10.1097/PRS.0b013e318184590c; Levy-Bercowski D, 2009, CLEFT PALATE-CRAN J, V46, P521, DOI 10.1597/07-236.1; Liao YF, 2012, PLAST RECONSTR SURG, V130, P1289, DOI 10.1097/PRS.0b013e31826d16f3; Loeffelbein DJ, 2013, BR J ORAL MAXILLOFAC; MATSUO K, 1984, PLAST RECONSTR SURG, V73, P38, DOI 10.1097/00006534-198401000-00009; MATSUO K, 1989, PLAST RECONSTR SURG, V83, P25, DOI 10.1097/00006534-198901000-00006; Mitsuyoshi I, 2004, BRIT J ORAL MAX SURG, V42, P578, DOI 10.1016/j.bjoms.2004.06.002; Oosterkamp BCM, 2005, CLEFT PALATE-CRAN J, V42, P239, DOI 10.1597/03-109.1; Penfold C, 2011, BRIT J ORAL MAX SURG, V49, P165, DOI 10.1016/j.bjoms.2010.01.017; Singh GD, 2007, ORTHOD CRANIOFAC RES, V10, P161, DOI 10.1111/j.1601-6343.2007.00390.x; Singh GD, 2005, CLEFT PALATE-CRAN J, V42, P403, DOI 10.1597/04-063.1; Sischo L, 2012, CLEFT PALATE-CRAN J, V49, P270, DOI 10.1597/11-053; Spengler AL, 2006, CLEFT PALATE-CRAN J, V43, P321; Suri S, 2010, PLAST RECONSTR SURG, V125, p112E, DOI 10.1097/PRS.0b013e3181cb66e0; van der Heijden P, 2013, PLAST RECONSTR SURG, V131, p62E, DOI 10.1097/PRS.0b013e318267d4a5	25	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118103	10.1371/journal.pone.0118103	http://dx.doi.org/10.1371/journal.pone.0118103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734535	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700014
J	Lee, KM; Nam, K; Oh, S; Lim, J; Kim, RK; Shim, D; Choi, JH; Lee, SJ; Yu, JH; Lee, JW; Ahn, SH; Shin, I				Lee, K-m; Nam, K.; Oh, S.; Lim, J.; Kim, R. K.; Shim, D.; Choi, J-h; Lee, S-J; Yu, J-H; Lee, J. W.; Ahn, S. H.; Shin, I.			ECM1 regulates tumor metastasis and CSC-like property through stabilization of beta-catenin	ONCOGENE			English	Article							EXTRACELLULAR-MATRIX PROTEIN-1; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; LYMPHATIC METASTASIS; SELF-RENEWAL; CANCER; EXPRESSION; IDENTIFICATION; ACTIVATION	Extracellular Matrix Protein 1 (ECM1) is a marker for tumorigenesis and is correlated with invasiveness and poor prognosis in various types of cancer. However, the functional role of ECM1 in cancer metastasis is unclear. Here, we detected high ECM1 level in breast cancer patient sera that was associated with recurrence of tumor. The modulation of ECM1 expression affected not only cell migration and invasion, but also sphere-forming ability and drug resistance in breast cancer cell lines. In addition, ECM1 regulated the gene expression associated with the epithelial to mesenchymal transition (EMT) progression and cancer stem cell (CSC) maintenance. Interestingly, ECM1 increased beta-catenin expression at the post-translational level through induction of MUC1, which was physically associated with beta-catenin. Indeed, the association between beta-catenin and the MUC1 cytoplasmic tail was increased by ECM1. Furthermore, forced expression of beta-catenin altered the gene expression that potentiated EMT progression and CSC phenotype maintenance in the cells. These data provide evidence that ECM1 has an important role in cancer metastasis through beta-catenin stabilization.	[Lee, K-m; Nam, K.; Oh, S.; Lim, J.; Kim, R. K.; Shim, D.; Choi, J-h; Lee, S-J; Shin, I.] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Yu, J-H; Lee, J. W.; Ahn, S. H.] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; [Yu, J-H; Lee, J. W.; Ahn, S. H.] Asan Med Ctr, Seoul, South Korea; [Shin, I.] Hanyang Univ, Nat Sci Inst, Seoul 133791, South Korea	Hanyang University; University of Ulsan; Hanyang University	Shin, I (corresponding author), Hanyang Univ, Dept Life Sci, Haengdang 1 Dong, Seoul 133791, South Korea.	incheol@hanyang.ac.kr	Lee, kyung-min/ABH-7692-2020; Choi, Jae-Hoon/R-6224-2016	Lee, kyung-min/0000-0001-8381-2423; Choi, Jae-Hoon/0000-0002-5265-3463	NRF grant from the Korea Research Foundation [2013-059143]; Converging Research Center Program [2014048814]	NRF grant from the Korea Research Foundation; Converging Research Center Program	This work was supported by an NRF grant (2013-059143) from the Korea Research Foundation and Converging Research Center Program (2014048814).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alam M, 2014, ONCOTARGET, V5, P2622, DOI 10.18632/oncotarget.1848; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Gilles C, 1997, CLIN EXP METASTAS, V15, P519, DOI 10.1023/A:1018427027270; Gu MZ, 2013, INT J CLIN EXP PATHO, V6, P1132; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Horvay K, 2011, STEM CELLS DEV, V20, P737, DOI 10.1089/scd.2010.0188; Howe LR, 2003, CANCER RES, V63, P1906; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kebebew E, 2005, ANN SURG, V242, P353, DOI 10.1097/sla.0000179623.87329.6b; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lal G, 2009, ANN SURG ONCOL, V16, P2280, DOI 10.1245/s10434-009-0533-2; Lee KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0479-6; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Liu W, 2012, J INVEST DERMATOL, V132, P2828, DOI 10.1038/jid.2012.211; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MATHIEU E, 1994, J BONE MINER RES, V9, P903; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Raina D, 2014, ONCOGENE, V33, P3422, DOI 10.1038/onc.2013.308; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tanida S, 2014, BBA-GEN SUBJECTS, V1840, P1790, DOI 10.1016/j.bbagen.2014.02.008; Wang LP, 2003, CANCER LETT, V200, P57, DOI 10.1016/S0304-3835(03)00350-1; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Wu QW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-47; Wu QW, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-132; Xiong GP, 2012, NEOPLASMA, V59, P409, DOI 10.4149/neo_2012_053; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	46	54	57	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2015	34	50					6055	6065		10.1038/onc.2015.54	http://dx.doi.org/10.1038/onc.2015.54			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RQ	25746001				2022-12-26	WOS:000366113800003
J	Cao, K; Wang, G; Li, W; Zhang, L; Wang, R; Huang, Y; Du, L; Jiang, J; Wu, C; He, X; Roberts, AI; Li, F; Rabson, AB; Wang, Y; Shi, Y				Cao, K.; Wang, G.; Li, W.; Zhang, L.; Wang, R.; Huang, Y.; Du, L.; Jiang, J.; Wu, C.; He, X.; Roberts, A. I.; Li, F.; Rabson, A. B.; Wang, Y.; Shi, Y.			Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity	ONCOGENE			English	Article							T-CELLS; MEDIATED APOPTOSIS; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; CANCER PROGRESSION; CYCLOSPORINE-A; EXPRESSION; THERAPY; TUMORS; ANTIBODY	The poor efficacy of the in vivo anti-tumor immune response has been partially attributed to ineffective T-cell responses mounted against the tumor. Fas-FasL-dependent activation-induced cell death (AICD) of T cells is believed to be a major contributor to compromised anti-tumor immunity. The molecular mechanisms of AICD are well-investigated, yet the possibility of regulating AICD for cancer therapy remains to be explored. In this study, we show that histone deacetylase inhibitors (HDACIs) can inhibit apoptosis of CD4(+) T cells within the tumor, thereby enhancing anti-tumor immune responses and suppressing melanoma growth. This inhibitory effect is specific for AICD through suppressing NFAT1-regulated FasL expression on activated CD4(+) T cells. In gld/gld mice with mutation in FasL, the beneficial effect of HDACIs on AICD of infiltrating CD4(+) T cells is not seen, confirming the critical role of FasL regulation in the anti-tumor effect of HDACIs. Importantly, we found that the co-administration of HDACIs and anti-CTLA4 could further enhance the infiltration of CD4(+) T cells and achieve a synergistic therapeutic effect on tumor. Therefore, our study demonstrates that the modulation of AICD of tumor-infiltrating CD4(+) T cells using HDACIs can enhance anti-tumor immune responses, uncovering a novel mechanism underlying the anti-tumor effect of HDACIs.	[Cao, K.; Wang, G.; Li, W.; Huang, Y.; Du, L.; Li, F.; Wang, Y.; Shi, Y.] Shanghai Jiao Tong Univ Med, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai, Peoples R China; [Zhang, L.; Roberts, A. I.; Rabson, A. B.; Shi, Y.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Zhang, L.; Shi, Y.] Soochow Univ, Affiliated Hosp 1, Inst Translat Med, Suzhou 215123, Peoples R China; [Wang, R.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res, Los Angeles, CA 90048 USA; [Jiang, J.; Wu, C.; He, X.] Soochow Univ, Affiliated Hosp 3, Changzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Soochow University - China; Cedars Sinai Medical Center; Soochow University - China	Shi, Y (corresponding author), Soochow Univ, Affiliated Hosp 1, Inst Translat Med, 199 Renai Rd, Suzhou 215123, Peoples R China.	yingwang@sibs.ac.cn; yfshi@suda.edu.cn	cao, kai/AAG-6833-2021; Shi, Yufang/AAE-4431-2020; HUANG, YIN/AAH-6871-2020; Du, Liming/M-8227-2019	Shi, Yufang/0000-0001-8964-319X; HUANG, YIN/0000-0001-5602-9871; Du, Liming/0000-0002-0527-3556; cao, kai/0000-0002-7939-7279; wang, ying/0000-0002-2571-9367	Scientific Innovation Project of the Chinese Academy of Science [XDA 01040107, XDA 01040110]; Programs of National Natural Science of China [81330046]; Ministry of Science and Technology of China [2015CB964400]; External Cooperation Program of BIC, Chinese Academy of Sciences [GJHZ201307]; Shanghai Municipal Key Projects of Basic Research [12JC1409200]; Shanghai Rising-Star Program [14QA1404200]; Robert Wood Johnson Foundation [67038]	Scientific Innovation Project of the Chinese Academy of Science; Programs of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); External Cooperation Program of BIC, Chinese Academy of Sciences; Shanghai Municipal Key Projects of Basic Research; Shanghai Rising-Star Program; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was supported by grants from the Scientific Innovation Project of the Chinese Academy of Science (XDA 01040107 and XDA 01040110), the Programs of National Natural Science of China (81330046), the Ministry of Science and Technology of China (2015CB964400), the External Cooperation Program of BIC, Chinese Academy of Sciences (GJHZ201307), Shanghai Municipal Key Projects of Basic Research (12JC1409200), Shanghai Rising-Star Program (14QA1404200). The Child Health Institute of New Jersey is supported by a grant from the Robert Wood Johnson Foundation (grant number 67038).	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Boni A, 2008, BLOOD, V112, P4746, DOI 10.1182/blood-2008-07-169797; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brunner T, 1996, INT IMMUNOL, V8, P1017, DOI 10.1093/intimm/8.7.1017; Butler LM, 2000, CANCER RES, V60, P5165; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; Dangond F, 1998, BIOCHEM BIOPH RES CO, V247, P833, DOI 10.1006/bbrc.1998.8891; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geng L, 2006, CANCER RES, V66, P11298, DOI 10.1158/0008-5472.CAN-06-0049; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jacobson M.D., 1996, BIOCH SCI, V21, P83, DOI DOI 10.1016/S0968-0004(96)20008-8; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Liu FY, 2012, J BIOL CHEM, V287, P25530, DOI 10.1074/jbc.M112.356279; Maecker HL, 2002, CANCER CELL, V2, P139, DOI 10.1016/S1535-6108(02)00095-8; Manicassainy S, 2007, J IMMUNOL, V178, P312, DOI 10.4049/jimmunol.178.1.312; Marks PA, 2005, CELL CYCLE, V4, P549, DOI 10.4161/cc.4.4.1564; MERION RM, 1984, NEW ENGL J MED, V310, P148, DOI 10.1056/NEJM198401193100303; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moreira JMA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-30; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tanaka T, 2002, CANCER LETT, V181, P165, DOI 10.1016/S0304-3835(01)00799-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; Wang RX, 1998, J IMMUNOL, V161, P2201; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029	49	51	51	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2015	34	49					5960	5970		10.1038/onc.2015.46	http://dx.doi.org/10.1038/onc.2015.46			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RO	25745993	Green Published, hybrid			2022-12-26	WOS:000366113500003
J	Ghosh, A; Jana, M; Modi, K; Gonzalez, FJ; Sims, KB; Berry-Kravis, E; Pahan, K				Ghosh, Arunava; Jana, Malabendu; Modi, Khushbu; Gonzalez, Frank J.; Sims, Katherine B.; Berry-Kravis, Elizabeth; Pahan, Kalipada			Activation of Peroxisome Proliferator-activated Receptor alpha Induces Lysosomal Biogenesis in Brain Cells IMPLICATIONS FOR LYSOSOMAL STORAGE DISORDERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocyte; Lysosomal Storage Disease; Neurodegeneration; Peroxisome proliferator-activated Receptor (PPAR); Retinoic Acid	RETINOID-X-RECEPTOR; LIPID-LOWERING DRUG; GENE-EXPRESSION; CELLULAR CLEARANCE; ADOPTIVE TRANSFER; MESSENGER-RNAS; UP-REGULATION; GEMFIBROZIL; AUTOPHAGY; GAMMA	Lysosomes are ubiquitous membrane-enclosed organelles filled with an acidic interior and are central to the autophagic, endocytic, or phagocytic pathway. In contrast to its classical function as the waste management machinery, lysosomes are now considered to be an integral part of various cellular signaling processes. The diverse functionality of this single organelle requires a very complex and coordinated regulation of its activity with transcription factor EB (TFEB), a master regulator of lysosomal biogenesis, at its core. However, mechanisms by which TFEB is regulated are poorly understood. This study demonstrates that gemfibrozil, an agonist of peroxisome proliferator-activated receptor (PPAR) , alone and in conjunction with all-trans-retinoic acid is capable of enhancing TFEB in brain cells. We also observed that PPAR, but not PPAR and PPAR, is involved in gemfibrozil-mediated up-regulation of TFEB. Reporter assay and chromatin immunoprecipitation studies confirmed the recruitment of retinoid X receptor , PPAR, and PGC1 on the PPAR-binding site on the Tfeb promoter as well. Subsequently, the drug-mediated induction of TFEB caused an increase in lysosomal protein and the lysosomal abundance in cell. Collectively, this study reinforces the link between lysosomal biogenesis and lipid metabolism with TFEB at the crossroads. Furthermore, gemfibrozil may be of therapeutic value in the treatment of lysosomal storage disorders in which autophagy-lysosome pathway plays an important role.	[Ghosh, Arunava; Jana, Malabendu; Modi, Khushbu; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Pediat Neurol Sci & Biochem, Chicago, IL 60612 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sims, Katherine B.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Pahan, Kalipada] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA	Rush University; Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 West Harrison St,Ste Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		GHOSH, ARUNAVA/0000-0002-8471-8161	National Institutes of Health [AT6681, NS083054]; Veteran Affairs [I01BX003033-01]; Noah's Hope, Hope for Bridgett, Cures Within Reach, and Two Hearts Rock; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083054] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs; Noah's Hope, Hope for Bridgett, Cures Within Reach, and Two Hearts Rock; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681 and NS083054. This work was also supported by Merit Award I01BX003033-01 from Veteran Affairs and funds from Noah's Hope, Hope for Bridgett, Cures Within Reach, and Two Hearts Rock.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bai J, 2013, J GENE MED, V15, P182, DOI 10.1002/jgm.2707; Boitier Eric, 2003, Comp Hepatol, V2, P3, DOI 10.1186/1476-5926-2-3; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Brignull LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-853; Brun S, 1999, DIABETES, V48, P1217, DOI 10.2337/diabetes.48.6.1217; Chen MH, 2008, INVEST OPHTH VIS SCI, V49, P4760, DOI 10.1167/iovs.08-2020; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; DE DUVE CHRISTIAN, 1963, SCI AMER, V208, P64; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; Fuster JJ, 2010, FASEB J, V24, P2998, DOI 10.1096/fj.09-138255; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074/jbc.M112.365148; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Jana M, 2012, NEUROCHEM RES, V37, P1718, DOI 10.1007/s11064-012-0781-6; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Karageorgos LE, 1997, EXP CELL RES, V234, P85, DOI 10.1006/excr.1997.3581; Kelly DP, 2001, CIRC RES, V89, P935, DOI 10.1161/res.89.11.935; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; Marcus Sandra L., 1995, Gene Expression, V4, P227; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Moskot M, 2014, J BIOL CHEM, V289, P17054, DOI 10.1074/jbc.M114.555300; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Nishizawa H, 2003, J REPROD DEVELOP, V49, P539, DOI 10.1262/jrd.49.539; Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; RUBINS HB, 1992, J INTERN MED, V231, P421, DOI 10.1111/j.1365-2796.1992.tb00954.x; Saftig P., 2006, FABRY DIS PERSPECTIV; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2012, INT J CELL BIOL, DOI DOI 10.1155/2012/282041; Song WS, 2014, J BIOL CHEM, V289, P10211, DOI 10.1074/jbc.M113.506246; Song WS, 2013, HUM MOL GENET, V22, P1994, DOI 10.1093/hmg/ddt052; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; WEISSMANN G, 1967, ANNU REV MED, V18, P97, DOI 10.1146/annurev.me.18.020167.000525; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; Xu JH, 2006, J NEUROIMMUNOL, V176, P95, DOI 10.1016/j.jneuroim.2006.04.019; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	69	80	84	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10309	10324		10.1074/jbc.M114.610659	http://dx.doi.org/10.1074/jbc.M114.610659			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25750174	hybrid, Green Published			2022-12-26	WOS:000353241100034
J	Goto, M; Goto, A; Ikeda, N; Noda, H; Shibuya, K; Noda, M				Goto, Maki; Goto, Atsushi; Ikeda, Nayu; Noda, Hiroyuki; Shibuya, Kenji; Noda, Mitsuhiko			Factors Associated with Untreated Diabetes: Analysis of Data from 20,496 Participants in the Japanese National Health and Nutrition Survey	PLOS ONE			English	Article							ENDOGENOUS SEX-HORMONES; SCREENING SCORE; MELLITUS; RISK; POPULATION; COMPLICATIONS; HEMOGLOBIN; DIAGNOSIS; COSTS; A1C	Objective We aimed to examine factors associated with untreated diabetes in a nationally representative sample of the Japanese population. Research Design and Methods We pooled data from the Japanese National Health and Nutrition Survey from 2005 to 2009 (n = 20,496). Individuals aged 20 years and older were included in the analysis. We classified participants as having diabetes if they had HbA1c levels >= 6.5% (>= 48 mmol/mol). People with diabetes who self-reported that they were not currently receiving diabetic treatment were considered to be untreated. We conducted a multinomial logistic regression analysis to determine factors associated with untreated diabetes relative to non-diabetic individuals. Results Of 20,496 participants who were included in the analysis, untreated diabetes was present in 748 (3.6%). Among participants with untreated diabetes, 48.3% were previously diagnosed with diabetes, and 46.5% had HbA1c levels >= 7.0% (>= 53 mmol/mol). Participants with untreated diabetes were significantly more likely than non-diabetic participants to be male, older, and currently smoking, have lower HDL cholesterol levels and higher BMI, non-HDL cholesterol levels, and systolic blood pressure. Conclusions A substantial proportion of people in Japan with untreated diabetes have poor glycemic control. Targeting relevant factors for untreated diabetes in screening programs may be effective to enhance the treatment and control of diabetes.	[Goto, Maki; Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan; [Ikeda, Nayu] Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo 162, Japan; [Noda, Hiroyuki] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Publ Hlth, Osaka, Japan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Institute of Health & Nutrition - Japan; Osaka University; University of Tokyo	Noda, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.	mnoda@hosp.ncgm.go.jp	Noda, Hiroyuki/ABC-1692-2021; Noda, Mitsuhiko/W-3905-2019; Ikeda, Nayu/J-9890-2019	Noda, Hiroyuki/0000-0001-9086-3771; Noda, Mitsuhiko/0000-0003-0413-4631; Ikeda, Nayu/0000-0002-3424-1991; Shibuya, Kenji/0000-0003-2528-7530	Japan Society for the Promotion of Science [24590785]; Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) from the Ministry of Health, Labour and Welfare of Japan [H22-019, H25-016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) from the Ministry of Health, Labour and Welfare of Japan	This study was funded by the Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (No. 24590785), and Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H22-019 and H25-016) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Choi KM, 2005, J CLIN ENDOCR METAB, V90, P175, DOI 10.1210/jc.2004-1795; Clarke P, 2003, DIABETIC MED, V20, P442, DOI 10.1046/j.1464-5491.2003.00972.x; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Heianza Y, 2013, J CLIN ENDOCR METAB, V98, P1051, DOI 10.1210/jc.2012-3092; Herman WH, 2013, DIABETES CARE, V36, P775, DOI 10.2337/dc13-0270; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Katanoda K, 2002, J NUTR SCI VITAMINOL, V48, P423, DOI 10.3177/jnsv.48.423; Katanoda K, 2005, NUTRITION, V21, P964, DOI 10.1016/j.nut.2005.02.004; Lauruschkat AH, 2005, CIRCULATION, V112, P2397, DOI 10.1161/CIRCULATIONAHA.105.534545; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Ministry of Health Labour and Welfare, 2011, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2012, REF DAT HLTH JAP 21; Nakamura M, 2013, J EPIDEMIOL, V23, P28, DOI 10.2188/jea.JE20120032; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Tekumit H, 2010, ANN THORAC SURG, V89, P1482, DOI 10.1016/j.athoracsur.2009.11.033; Tokudome S, 2012, LANCET, V379, pE44, DOI 10.1016/S0140-6736(12)60466-8; Vaidya D, 2008, METABOLISM, V57, P782, DOI 10.1016/j.metabol.2008.01.019; Yoshiike N, 1998, J Epidemiol, V8, P160	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118749	10.1371/journal.pone.0118749	http://dx.doi.org/10.1371/journal.pone.0118749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756183	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700023
J	Kuczius, T; Zhang, WL; Merkel, V; Mellmann, A; Tarr, PI; Karch, H				Kuczius, Thorsten; Zhang, Wenlan; Merkel, Viktor; Mellmann, Alexander; Tarr, Phillip I.; Karch, Helge			Agitation Down-Regulates Immunoglobulin Binding Protein EibG Expression in Shiga Toxin-Producing Escherichia coli (STEC)	PLOS ONE			English	Article							TRIMERIC AUTOTRANSPORTER ADHESINS; CYTOLETHAL DISTENDING TOXIN; AEROMONAS-SALMONICIDA; BIOFILM FORMATION; TYPE-1 FIMBRIAE; FC-RECEPTORS; GROUP-A; IGG FC; HETEROGENEITY; STREPTOCOCCI	Shiga toxin (Stx)-producing Escherichia coli (STEC) carrying eibG synthesize Escherichia coli immunoglobulin binding protein (EibG). EibG nonspecifically binds to immunoglobulins and tends to aggregate in multimers but is poorly expressed in wild-type strains. To study synthesis of the proteins and their regulation in the pathogens, we identified natural growth conditions that increased EibG synthesis. EibG proteins as well as corresponding mRNA were highly expressed under static growth conditions while shearing stress created by agitation during growth repressed protein synthesis. Further regulation effects were driven by reduced oxygen tension, and pH up-regulated EibG expression, but to a lesser extent than growth conditions while decreased temperature down-regulated EibG. Bacteria with increased EibG expression during static growth conditions showed a distinct phenotype with chain formation and biofilm generation, which disappeared with motion. High and low EibG expression was reversible indicating a process with up- and down-regulation of the protein expression. Our findings indicate that shear stress represses EibG expression and might reduce bacterial attachments to cells and surfaces.	[Kuczius, Thorsten; Zhang, Wenlan; Merkel, Viktor; Mellmann, Alexander; Karch, Helge] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Kuczius, Thorsten; Zhang, Wenlan; Merkel, Viktor; Mellmann, Alexander; Karch, Helge] Univ Hosp Munster, D-48149 Munster, Germany; [Tarr, Phillip I.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63105 USA	University of Munster; University of Munster; Washington University (WUSTL)	Kuczius, T (corresponding author), Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany.	tkuczius@uni-muenster.de		Mellmann, Alexander/0000-0002-0649-5185	Federal Ministry of Education and Research Network Zoonoses [01KI1012B]; Interdisciplinary Center of Clinical Research (IZKF) Munster [Me2/021/12, Muth2/028/10]; Medical Faculty Munster [BD9817044]	Federal Ministry of Education and Research Network Zoonoses; Interdisciplinary Center of Clinical Research (IZKF) Munster; Medical Faculty Munster	Funding provided by Federal Ministry of Education and Research Network Zoonoses (no. 01KI1012B); Interdisciplinary Center of Clinical Research (IZKF) Munster, no. Me2/021/12 and Muth2/028/10; Medical Faculty Munster (BD9817044). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardiau M, 2010, J APPL MICROBIOL, V109, P2214, DOI 10.1111/j.1365-2672.2010.04855.x; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Bielaszewska M, 2009, J CLIN MICROBIOL, V47, P2061, DOI 10.1128/JCM.00201-09; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; BOUVET JP, 1994, INT J IMMUNOPHARMACO, V16, P419, DOI 10.1016/0192-0561(94)90031-0; Brockmeyer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006100; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Colon-Gonzalez M, 2004, RES MICROBIOL, V155, P514, DOI 10.1016/j.resmic.2004.03.004; FORSGREN A, 1966, J IMMUNOL, V97, P822; Ghumra A, 2007, MOL IMMUNOL, V44, P2144, DOI 10.1016/j.molimm.2006.09.019; GROVER S, 1991, J IMMUNOL METHODS, V141, P187, DOI 10.1016/0022-1759(91)90145-6; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; House B, 2009, MICROBIOL-SGM, V155, P2907, DOI 10.1099/mic.0.025171-0; KARCH H, 1989, J CLIN MICROBIOL, V27, P1180, DOI 10.1128/JCM.27.6.1180-1186.1989; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KRONVALL G, 1973, J IMMUNOL, V111, P1401; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Leo JC, 2011, STRUCTURE, V19, P1021, DOI 10.1016/j.str.2011.03.021; Leo JC, 2009, MOL IMMUNOL, V46, P1860, DOI 10.1016/j.molimm.2009.02.024; Lu Y, 2006, INFECT IMMUN, V74, P5747, DOI 10.1128/IAI.00724-06; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Merkel V, 2010, INFECT IMMUN, V78, P3625, DOI 10.1128/IAI.00006-10; Mikula KM, 2012, J BACTERIOL, V194, P827, DOI 10.1128/JB.05322-11; MUNN CB, 1982, INFECT IMMUN, V36, P1069, DOI 10.1128/IAI.36.3.1069-1075.1982; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; PHIPPS BM, 1988, J BIOL CHEM, V263, P9298; Pleass RJ, 2009, MOL IMMUNOL, V46, P2439, DOI 10.1016/j.molimm.2009.04.023; Raeder R, 1996, J INFECT DIS, V173, P888, DOI 10.1093/infdis/173.4.888; RAEDER R, 1993, INFECT IMMUN, V61, P1378, DOI 10.1128/IAI.61.4.1378-1384.1993; Sandt CH, 2000, INFECT IMMUN, V68, P2205, DOI 10.1128/IAI.68.4.2205-2214.2000; Sandt CH, 2001, INFECT IMMUN, V69, P7293, DOI 10.1128/IAI.69.12.7293-7203.2001; Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0; SOKURENKO EV, 1992, INFECT IMMUN, V60, P4709, DOI 10.1128/IAI.60.11.4709-4719.1992; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; Zavyalov VP, 1996, FEMS IMMUNOL MED MIC, V14, P53, DOI 10.1111/j.1574-695X.1996.tb00267.x	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119583	10.1371/journal.pone.0119583	http://dx.doi.org/10.1371/journal.pone.0119583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746924	Green Submitted, gold, Green Published			2022-12-26	WOS:000350689400080
J	Purahong, W; Stempfhuber, B; Lentendu, G; Francioli, D; Reitz, T; Buscot, F; Schloter, M; Kruger, D				Purahong, Witoon; Stempfhuber, Barbara; Lentendu, Guillaume; Francioli, Davide; Reitz, Thomas; Buscot, Francois; Schloter, Michael; Krueger, Dirk			Influence of Commonly Used Primer Systems on Automated Ribosomal Intergenic Spacer Analysis of Bacterial Communities in Environmental Samples	PLOS ONE			English	Article							DIVERSITY; SETS	Due to the high diversity of bacteria in many ecosystems, their slow generation times, specific but mostly unknown nutrient requirements and syntrophic interactions, isolation based approaches in microbial ecology mostly fail to describe microbial community structure. Thus, cultivation independent techniques, which rely on directly extracted nucleic acids from the environment, are a well-used alternative. For example, bacterial automated ribosomal intergenic spacer analysis (B-ARISA) is one of the widely used methods for fingerprinting bacterial communities after PCR-based amplification of selected regions of the operon coding for rRNA genes using community DNA. However, B-ARISA alone does not provide any taxonomic information and the results may be severely biased in relation to the primer set selection. Furthermore, amplified DNA stemming from mitochondrial or chloroplast templates might strongly bias the obtained fingerprints. In this study, we determined the applicability of three different B-ARISA primer sets to the study of bacterial communities. The results from in silico analysis harnessing publicly available sequence databases showed that all three primer sets tested are specific to bacteria but only two primers sets assure high bacterial taxa coverage (1406f/23Sr and ITSF/ITSReub). Considering the study of bacteria in a plant interface, the primer set ITSF/ITSReub was found to amplify (in silico) sequences of some important crop species such as Sorghum bicolor and Zea mays. Bacterial genera and plant species potentially amplified by different primer sets are given. These data were confirmed when DNA extracted from soil and plant samples were analyzed. The presented information could be useful when interpreting existing B-ARISA results and planning B-ARISA experiments, especially when plant DNA can be expected.	[Purahong, Witoon; Lentendu, Guillaume; Francioli, Davide; Reitz, Thomas; Buscot, Francois; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Purahong, Witoon; Schloter, Michael] Tech Univ Munich, Chair Soil Sci, Oberschleissheim, Germany; [Stempfhuber, Barbara; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Oberschleissheim, Germany; [Lentendu, Guillaume; Buscot, Francois] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Buscot, Francois] German Ctr Integrat Biodivers Res IDiv, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University	Purahong, W (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany.	witoon.purahong@ufz.de; schloter@helmholtz-muenchen.de	Schloter, 1Michael/H-9151-2013; Francioli, Davide/AAR-1035-2020; Reitz, Thomas/AFP-6355-2022; Purahong, Witoon/AAX-8455-2021; Lentendu, Guillaume/ABF-4468-2020; Buscot, Francois/A-4125-2016; Kruger, Dirk/C-3316-2012	Francioli, Davide/0000-0001-6572-3574; Purahong, Witoon/0000-0002-4113-6428; Lentendu, Guillaume/0000-0003-3826-6253; Buscot, Francois/0000-0002-2364-0006; Kruger, Dirk/0000-0002-7305-5104	DFG Priority Program 'Infrastructure-Biodiversity-Exploratories' [KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2, 1374]; Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	DFG Priority Program 'Infrastructure-Biodiversity-Exploratories'(German Research Foundation (DFG)); Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	This work was funded in part by the DFG Priority Program 1374 on 'Infrastructure-Biodiversity-Exploratories' (KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2). W. Purahong also was kindly supported by the Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders DFG and HIGRADE had no input into the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Frossard A, 2012, ENVIRON MICROBIOL, V14, P2971, DOI 10.1111/j.1462-2920.2012.02865.x; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Jones SE, 2007, APPL ENVIRON MICROB, V73, P659, DOI 10.1128/AEM.02130-06; Merbach I, 2013, ARCH AGRON SOIL SCI, V59, P1041, DOI 10.1080/03650340.2012.702895; Petric I, 2011, J MICROBIOL METH, V84, P454, DOI 10.1016/j.mimet.2011.01.016; Ranjard L, 2000, APPL ENVIRON MICROB, V66, P5334, DOI 10.1128/AEM.66.12.5334-5339.2000; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	13	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118967	10.1371/journal.pone.0118967	http://dx.doi.org/10.1371/journal.pone.0118967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749323	Green Published, gold			2022-12-26	WOS:000350689400034
J	Seiffert, J; Hussain, F; Wiegman, C; Li, F; Bey, L; Baker, W; Porter, A; Ryan, MP; Chang, Y; Gow, A; Zhang, JF; Zhu, J; Tetley, TD; Chung, KF				Seiffert, Joanna; Hussain, Farhana; Wiegman, Coen; Li, Feng; Bey, Leo; Baker, Warren; Porter, Alexandra; Ryan, Mary P.; Chang, Yan; Gow, Andrew; Zhang, Junfeng; Zhu, Jie; Tetley, Terry D.; Chung, Kian Fan			Pulmonary Toxicity of Instilled Silver Nanoparticles: Influence of Size, Coating and Rat Strain	PLOS ONE			English	Article							BROWN-NORWAY RATS; CONSUMER SPRAY PRODUCTS; ION RELEASE KINETICS; INTRATRACHEAL INSTILLATION; AIRWAY HYPERRESPONSIVENESS; NANO-SILVER; INHALATION; INFLAMMATION; EXPOSURE; CELLS	Particle size and surface chemistry are potential determinants of silver nanoparticle (AgNP) respiratory toxicity that may also depend on the lung inflammatory state. We compared the effects of intratracheally-administered AgNPs (20nm and 110nm; polyvinylpyrrolidone (PVP) and citrate-capped; 0.1 mg/Kg) in Brown-Norway (BN) and Sprague-Dawley (SD) rats. In BN rats, there was both a neutrophilic and eosinophilic response, while in SD rats, there was a neutrophilic response at day 1, greatest for the 20nm citrate-capped AgNPs. Eosinophilic cationic protein was increased in bronchoalveolar lavage (BAL) in BN and SD rats on day 1. BAL protein and malondialdehyde levels were increased in BN rats at 1 and 7 days, and BAL KC, CCL11 and IL-13 levels at day 1, with increased expression of CCL11 in lung tissue. Pulmonary resistance increased and compliance decreased at day 1, with persistence at day 7. The 20nm, but not the 110 nm, AgNPs increased bronchial hyperresponsiveness on day 1, which continued at day 7 for the citrate-capped AgNPs only. The 20nm versus the 110 nm size were more proinflammatory in terms of neutrophil influx, but there was little difference between the citrate-capped versus the PVP-capped AgNPs. AgNPs can induce pulmonary eosinophilic and neutrophilic inflammation with bronchial hyperresponsiveness, features characteristic of asthma.	[Seiffert, Joanna; Hussain, Farhana; Wiegman, Coen; Li, Feng; Baker, Warren; Zhu, Jie; Tetley, Terry D.; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis, London, England; [Bey, Leo; Porter, Alexandra; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, Dept Mat Sci Chem, Chem, London, England; [Bey, Leo; Porter, Alexandra; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, London Ctr Nanotechnol, London, England; [Bey, Leo] Univ Malaya, Fac Engn Bldg, Dept Mech Engn, Kuala Lumpur, Malaysia; [Chang, Yan] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gow, Andrew] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Zhang, Junfeng] Duke Univ, Nicholas Sch Environm, Durham, NC 27706 USA; [Zhang, Junfeng] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA	Imperial College London; Imperial College London; Imperial College London; University of London; University College London; Universiti Malaya; University of Southern California; Rutgers State University New Brunswick; Duke University; Duke University	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis, London, England.	f.chung@imperial.ac.uk	Gow, Andrew/N-8566-2013; Zhang, Junfeng/AAJ-9183-2020; Chung, Kian Fan/B-1872-2012; Tetley, Teresa D/B-3288-2016; Gow, Andrew/AAR-2309-2020	Gow, Andrew/0000-0003-0876-5158; Zhang, Junfeng/0000-0003-3759-6672; Chung, Kian Fan/0000-0001-7101-1426; Gow, Andrew/0000-0003-0876-5158; Wiegman, Coen/0000-0001-9161-0581	US National Institute for Environmental Health Sciences [U19ES019536]; UK National Environmental Research Council [NE/H012893]; Medical Research Council [G0700926] Funding Source: researchfish; Natural Environment Research Council [NE/H012893/1] Funding Source: researchfish; MRC [G0700926] Funding Source: UKRI; NERC [NE/H012893/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019536] Funding Source: NIH RePORTER	US National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UK National Environmental Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by grants from US National Institute for Environmental Health Sciences grant number U19ES019536 (http://www.niehs.nih.gov/research/supported/index.cfm), and from the UK National Environmental Research Council grant NE/H012893 (http://www.nerc.ac.uk/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Bae E, 2010, ENVIRON TOXICOL CHEM, V29, P2154, DOI 10.1002/etc.278; Baisch BL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-5; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; Braydich-Stolle LK, 2010, TOXICOL SCI, V116, P577, DOI 10.1093/toxsci/kfq148; Careau E, 2002, AM J RESP CELL MOL, V26, P579, DOI 10.1165/ajrcmb.26.5.4737; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cho WS, 2012, NANOTOXICOLOGY, V6, P22, DOI 10.3109/17435390.2011.552810; Cho WS, 2010, ENVIRON HEALTH PERSP, V118, P1699, DOI 10.1289/ehp.1002201; ELWOOD W, 1992, INT ARCH ALLERGY IMM, V99, P91, DOI 10.1159/000236340; ELWOOD W, 1991, J ALLERGY CLIN IMMUN, V88, P951, DOI 10.1016/0091-6749(91)90253-K; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Haberl N, 2013, BEILSTEIN J NANOTECH, V4, P933, DOI 10.3762/bjnano.4.105; HACZKU A, 1995, IMMUNOLOGY, V85, P598; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Huang YS, 2007, BURNS, V33, P161, DOI 10.1016/j.burns.2006.06.020; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim YS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-20; Kittler CG S., 2010, JOURNAL OF MATERIAL, V20, P512; Lankveld DPK, 2010, BIOMATERIALS, V31, P8350, DOI 10.1016/j.biomaterials.2010.07.045; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Leo BF, 2013, ENVIRON SCI TECHNOL, V47, P11232, DOI 10.1021/es403377p; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Loeschner K, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-18; Ma R, 2012, ENVIRON SCI TECHNOL, V46, P752, DOI 10.1021/es201686j; Nazarenko Y, 2011, J EXPO SCI ENV EPID, V21, P515, DOI 10.1038/jes.2011.10; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OLIVENSTEIN R, 1993, J CLIN INVEST, V92, P1477, DOI 10.1172/JCI116725; Park EJ, 2011, ARCH PHARM RES, V34, P299, DOI 10.1007/s12272-011-0216-y; Park EJ, 2010, ENVIRON TOXICOL PHAR, V30, P162, DOI 10.1016/j.etap.2010.05.004; PRITCHARD JN, 1985, ENVIRON RES, V36, P268, DOI 10.1016/0013-9351(85)90025-8; Quadros ME, 2011, ENVIRON SCI TECHNOL, V45, P10713, DOI 10.1021/es202770m; Stebounova LV, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-5; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Sung JH, 2009, TOXICOL SCI, V108, P452, DOI 10.1093/toxsci/kfn246; Suresh AK, 2012, LANGMUIR, V28, P2727, DOI 10.1021/la2042058; Thorley AJ, 2013, PHARMACOL THERAPEUT, V140, P176, DOI 10.1016/j.pharmthera.2013.06.008; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; WASERMAN S, 1992, J ALLERGY CLIN IMMUN, V90, P661, DOI 10.1016/0091-6749(92)90140-W; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhang W, 2011, ENVIRON SCI TECHNOL, V45, P4422, DOI 10.1021/es104205a	44	77	81	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119726	10.1371/journal.pone.0119726	http://dx.doi.org/10.1371/journal.pone.0119726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747867	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400086
J	Janata, J; Kadlcik, S; Koberska, M; Ulanova, D; Kamenik, Z; Novak, P; Kopecky, J; Novotna, J; Radojevic, B; Plhackova, K; Gazak, R; Najmanova, L				Janata, Jiri; Kadlcik, Stanislav; Koberska, Marketa; Ulanova, Dana; Kamenik, Zdenek; Novak, Petr; Kopecky, Jan; Novotna, Jitka; Radojevic, Bojana; Plhackova, Kamila; Gazak, Radek; Najmanova, Lucie			Lincosamide Synthetase-A Unique Condensation System Combining Elements of Nonribosomal Peptide Synthetase and Mycothiol Metabolism	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; MOLECULAR-WEIGHT THIOL; PHOSPHOPANTETHEINYL TRANSFERASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; SEQUENCE-ANALYSIS; LINCOMYCIN; ENZYME; INTERMEDIATE; SUPERFAMILY	In the biosynthesis of lincosamide antibiotics lincomycin and celesticetin, the amino acid and amino sugar units are linked by an amide bond. The respective condensing enzyme lincosamide synthetase (LS) is expected to be an unusual system combining nonribosomal peptide synthetase (NRPS) components with so far unknown amino sugar related activities. The biosynthetic gene cluster of celesticetin was sequenced and compared to the lincomycin one revealing putative LS coding ORFs shared in both clusters. Based on a bioassay and production profiles of S. lincolnensis strains with individually deleted putative LS coding genes, the proteins LmbC, D, E, F and V were assigned to LS function. Moreover, the newly recognized N-terminal domain of LmbN (LmbN-CP) was also assigned to LS as a NRPS carrier protein (CP). Surprisingly, the homologous CP coding sequence in celesticetin cluster is part of ccbZ gene adjacent to ccbN, the counterpart of lmbN, suggesting the gene rearrangement, evident also from still active internal translation start in lmbN, and indicating the direction of lincosamide biosynthesis evolution. The in vitro test with LmbN-CP, LmbC and the newly identified S. lincolnensis phosphopantetheinyl transferase Slp, confirmed the cooperation of the previously characterized NRPS A-domain LmbC with a holo-LmbN-CP in activation of a 4-propyl-L-proline precursor of lincomycin. This result completed the functional characterization of LS subunits resembling NRPS initiation module. Two of the four remaining putative LS subunits, LmbE/CcbE and LmbV/CcbV, exhibit low but significant homology to enzymes from the metabolism of mycothiol, the NRPS-independent system processing the amino sugar and amino acid units. The functions of particular LS subunits as well as cooperation of both NRPS-based and NRPS-independent LS blocks are discussed. The described condensing enzyme represents a unique hybrid system with overall composition quite dissimilar to any other known enzyme system.	[Janata, Jiri; Kadlcik, Stanislav; Koberska, Marketa; Ulanova, Dana; Kamenik, Zdenek; Novak, Petr; Kopecky, Jan; Novotna, Jitka; Radojevic, Bojana; Plhackova, Kamila; Gazak, Radek; Najmanova, Lucie] Acad Sci Czech Republ, Inst Microbiol, Vvi, Prague, Czech Republic; [Ulanova, Dana] Kochi Univ, Ctr Sci Res, Oceanog Sect, IMT MEXT, Nankoku, Kochi 7838505, Japan	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Kochi University	Janata, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Vvi, Prague, Czech Republic.	janata@biomed.cas.cz	Najmanova, Lucie/H-3663-2014; Janata, Jiri/K-4554-2014; Novak, Petr/F-9655-2014; Kamenik, Zdenek/A-6620-2010; Kadlčík, Stanislav/K-8851-2014; Koběrská, Markéta/AAE-4877-2019; Radojevic, Bojana/K-5245-2014; Novotna, Jitka/G-2891-2017; Gažák, Radek/H-2443-2014; Kopecky, Jan/C-7400-2013	Najmanova, Lucie/0000-0003-0691-7250; Janata, Jiri/0000-0002-4582-2062; Novak, Petr/0000-0001-8688-529X; Kadlčík, Stanislav/0000-0001-8989-7157; Koběrská, Markéta/0000-0002-9787-4227; Novotna, Jitka/0000-0002-5636-0609; Gažák, Radek/0000-0003-3881-0327; Kopecky, Jan/0000-0002-3437-257X	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund in the Czech Republic [CZ.1.05/1.1.00/02.0109]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund in the Czech Republic	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic projects CZ.1.07/2.3.00/20.0055 and CZ.1.07/2.3.00/30.0003 and BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University No. CZ.1.05/1.1.00/02.0109, from the European Regional Development Fund in the Czech Republic.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Allali N, 2002, J BACTERIOL, V184, P3224, DOI 10.1128/JB.184.12.3224-3231.2002; Atlas RM., 2004, HDB MICROBIOLOGICAL; Bauer J, 2014, ACTA CRYSTALLOGR D, V70, P943, DOI 10.1107/S139900471303397X; BRAHME NM, 1984, J AM CHEM SOC, V106, P7878, DOI 10.1021/ja00337a039; Bunet R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087607; Chen L, 2011, CHEM BIOENG, V28, P37; CHUNG ST, 1997, BIOTECHNOLOGY IND AN, P165; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; Ferrer S, 2012, PHYS CHEM CHEM PHYS, V14, P3482, DOI 10.1039/c2cp23149b; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Garneau S, 2005, BIOCHEMISTRY-US, V44, P2770, DOI 10.1021/bi0476329; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Grammel N, 2002, EUR J BIOCHEM, V269, P347, DOI 10.1046/j.0014-2956.2001.02657.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Hong HJ, 2005, J BIOL CHEM, V280, P13055, DOI 10.1074/jbc.M413801200; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Janata J, 2001, ANTON LEEUW INT J G, V79, P277, DOI 10.1023/A:1012034421088; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Kadlcik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084902; Kamenik Z, 2009, ANAL BIOANAL CHEM, V393, P1779, DOI 10.1007/s00216-009-2605-3; Kerbarh O, 2005, J BACTERIOL, V187, P5061, DOI 10.1128/JB.187.15.5061-5066.2005; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; Ku J, 1997, CHEM BIOL, V4, P203, DOI 10.1016/S1074-5521(97)90289-1; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; Lin CI, 2014, J AM CHEM SOC, V136, P906, DOI 10.1021/ja412194w; Marahiel MA, 2009, METHOD ENZYMOL, V458, P337, DOI 10.1016/S0076-6879(09)04813-7; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; Mejean A, 2010, BIOCHEMISTRY-US, V49, P103, DOI 10.1021/bi9018785; Najmanova L, 2014, FOLIA MICROBIOL, V59, P543, DOI 10.1007/s12223-014-0339-x; Najmanova L, 2013, CHEMBIOCHEM, V14, P2259, DOI 10.1002/cbic.201300389; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2011, BIOCHEMISTRY-US, V50, P10751, DOI 10.1021/bi201460j; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Novotna J, 2004, EUR J BIOCHEM, V271, P3678, DOI 10.1111/j.1432-1033.2004.04308.x; Novotna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079974; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; PESCHKE U, 1995, MOL MICROBIOL, V16, P1137, DOI 10.1111/j.1365-2958.1995.tb02338.x; Piepersberg W, 1995, Biotechnology, V28, P531; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Rubio MA, 2004, FEBS LETT, V577, P371, DOI 10.1016/j.febslet.2004.09.087; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u; Sasaki E, 2012, J AM CHEM SOC, V134, P17432, DOI 10.1021/ja308221z; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Stanley AE, 2006, CHEM COMMUN, P3981, DOI 10.1039/b609556a; Ulanova D, 2010, ANTIMICROB AGENTS CH, V54, P927, DOI 10.1128/AAC.00918-09; Wang R, 2007, J BIOL CHEM, V282, P16288, DOI 10.1074/jbc.M610347200; Wilkinson B, 2009, METHOD ENZYMOL, V458, P353, DOI 10.1016/S0076-6879(09)04814-9; Zengliang W, 2010, BIOTECHNOLOGY B, V11, P038	60	21	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118850	10.1371/journal.pone.0118850	http://dx.doi.org/10.1371/journal.pone.0118850			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741696	gold, Green Published, Green Submitted			2022-12-26	WOS:000350688100052
J	Morales, DM; Holubkov, R; Inder, TE; Ahn, HC; Mercer, D; Rao, R; McAllister, JP; Holtzman, DM; Limbrick , DD				Morales, Diego M.; Holubkov, Richard; Inder, Terri E.; Ahn, Haejun C.; Mercer, Deanna; Rao, Rakesh; McAllister, James P., II; Holtzman, David M.; Limbrick, David D., Jr.			Cerebrospinal Fluid Levels of Amyloid Precursor Protein Are Associated with Ventricular Size in Post-Hemorrhagic Hydrocephalus of Prematurity	PLOS ONE			English	Article							X-LINKED HYDROCEPHALUS; CELL-ADHESION MOLECULES; BIRTH-WEIGHT INFANTS; CLINICAL ARTICLE; NEURONAL MIGRATION; ALZHEIMERS-DISEASE; PRETERM INFANTS; L1 SYNDROME; MECHANISMS; MUTATIONS	Background Neurological outcomes of preterm infants with post-hemorrhagic hydrocephalus (PHH) remain among the worst in infancy, yet there remain few instruments to inform the treatment of PHH. We previously observed PHH-associated elevations in cerebrospinal fluid (CSF) amyloid precursor protein (APP), neural cell adhesion molecule-L1 (L1CAM), neural cell adhesion molecule-1 (NCAM-1), and other protein mediators of neurodevelopment. Objective The objective of this study was to examine the association of CSF APP, L1CAM, and NCAM-1 with ventricular size as an early step toward developing CSF markers of PHH. Methods CSF levels of APP, L1CAM, NCAM-1, and total protein (TP) were measured in 12 preterm infants undergoing PHH treatment. Ventricular size was determined using cranial ultrasounds. The relationships between CSF APP, L1CAM, and NCAM-1, occipitofrontal circumference (OFC), volume of CSF removed, and ventricular size were examined using correlation and regression analyses. Results CSF levels of APP, L1CAM, and NCAM-1 but not TP paralleled treatment-related changes in ventricular size. CSF APP demonstrated the strongest association with ventricular size, estimated by frontal-occipital horn ratio (FOR) (Pearson R = 0.76, p = 0.004), followed by NCAM-1 (R = 0.66, p = 0.02) and L1CAM (R = 0.57, p = 0.055). TP was not correlated with FOR (R = 0.02, p = 0.95). Conclusions Herein, we report the novel observation that CSF APP shows a robust association with ventricular size in preterm infants treated for PHH. The results from this study suggest that CSF APP and related proteins at once hold promise as biomarkers of PHH and provide insight into the neurological consequences of PHH in the preterm infant.	[Morales, Diego M.; Ahn, Haejun C.; Mercer, Deanna; McAllister, James P., II; Limbrick, David D., Jr.] Washington Univ, Dept Neurol Surg, Sch Med, St Louis, MO 63130 USA; [Holubkov, Richard] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Inder, Terri E.; Limbrick, David D., Jr.] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63130 USA; [Rao, Rakesh] Washington Univ, Sch Med, Dept Newborn Med, St Louis, MO USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Holtzman, David M.; Limbrick, David D., Jr.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Utah System of Higher Education; University of Utah; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Morales, DM (corresponding author), Washington Univ, Dept Neurol Surg, Sch Med, St Louis, MO 63130 USA.	moralesd@wudosis.wustl.edu	McAllister, James P./N-9657-2019	Holubkov, Richard/0000-0003-0431-3381; Morales, Diego/0000-0001-6672-9046	NIH/NINDS [K23 NS075151]; Washington University Intellectual and Developmental Disabilities Research Center (NIH/NICHD) [P30 HD0627171]; Women's and Infant's Health Specimen Consortium; Children's Surgical Sciences Institute, St. Louis Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS075151] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Washington University Intellectual and Developmental Disabilities Research Center (NIH/NICHD); Women's and Infant's Health Specimen Consortium; Children's Surgical Sciences Institute, St. Louis Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by a career development award to D.D.L. (NIH/NINDS K23 NS075151), the Washington University Intellectual and Developmental Disabilities Research Center (NIH/NICHD P30 HD0627171), the Women's and Infant's Health Specimen Consortium, and a grant from the Children's Surgical Sciences Institute, St. Louis Children's Hospital (D.D.L.). The authors would like to thank the families who generously participated in this study.	Adams-Chapman I, 2008, PEDIATRICS, V121, pE1167, DOI 10.1542/peds.2007-0423; ALLSOP D, 1983, BRAIN RES, V259, P348, DOI 10.1016/0006-8993(83)91273-8; Dallerac G, 2013, NEUROCHEM RES, V38, P1163, DOI 10.1007/s11064-013-1007-2; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; EDELMAN GM, 1990, COLD SH Q B, V55, P303; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; JOUET M, 1995, AM J HUM GENET, V56, P1304; Kamiguchi H, 2003, MOL NEUROBIOL, V28, P219, DOI 10.1385/MN:28:3:219; Kanemura Y, 2006, J NEUROSURG, V105, P403, DOI 10.3171/ped.2006.105.5.403; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Limbrick DD, 2010, J NEUROSURG-PEDIATR, V6, P224, DOI 10.3171/2010.5.PEDS1010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Manktelow BN, 2010, ARCH DIS CHILD-FETAL, V95, pF9, DOI 10.1136/adc.2008.148015; Morales DM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011973; Murphy BP, 2002, ARCH DIS CHILD-FETAL, V87, pF37, DOI 10.1136/fn.87.1.F37; Nybroe O, 1990, Adv Exp Med Biol, V265, P185; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Persson EK, 2005, ACTA PAEDIATR, V94, P726, DOI 10.1080/08035250510027336; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sylvie NTT, 2011, ARCH PEDIAT ADOL MED, V165, P216, DOI 10.1001/archpediatrics.2011.9; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Weller S, 2001, HUM MUTAT, V18, P1, DOI 10.1002/humu.1144; Wellons JC, 2013, J NEUROSURG-PEDIATR, V11, P12, DOI 10.3171/2012.10.PEDS12329; Wellons JC, 2009, J NEUROSURG-PEDIATR, V4, P50, DOI 10.3171/2009.2.PEDS08400	36	20	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115045	10.1371/journal.pone.0115045	http://dx.doi.org/10.1371/journal.pone.0115045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738507	Green Published, Green Submitted, gold			2022-12-26	WOS:000350685900002
J	Yokoyama, JS; Lee, AKL; Takada, LT; Busovaca, E; Bonham, LW; Chao, SZ; Tse, M; He, J; Schwarz, CG; Carmichael, OT; Matthews, BR; Karydas, A; Weiner, MW; Coppola, G; DeCarli, CS; Miller, BL; Rosen, HJ				Yokoyama, Jennifer S.; Lee, Allen K. L.; Takada, Leonel T.; Busovaca, Edgar; Bonham, Luke W.; Chao, Steven Z.; Tse, Marian; He, Jing; Schwarz, Christopher G.; Carmichael, Owen T.; Matthews, Brandy R.; Karydas, Anna; Weiner, Michael W.; Coppola, Giovanni; DeCarli, Charles S.; Miller, Bruce L.; Rosen, Howard J.			Apolipoprotein epsilon 4 Is Associated with Lower Brain Volume in Cognitively Normal Chinese but Not White Older Adults	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATIENTS; LATE-ONSET; MEMORY DECLINE; E POLYMORPHISM; TYPE-4 ALLELE; GENETIC RISK; PUERTO-RICAN; DEMENTIA; IMPAIRMENT; AGE	Studying ethnically diverse groups is important for furthering our understanding of biological mechanisms of disease that may vary across human populations. The epsilon 4 allele of apolipoprotein E (APOE epsilon 4) is a well-established risk factor for Alzheimer's disease (AD), and may confer anatomic and functional effects years before clinical signs of cognitive decline are observed. The allele frequency of APOE epsilon 4 varies both across and within populations, and the size of the effect it confers for dementia risk may be affected by other factors. Our objective was to investigate the role APOE epsilon 4 plays in moderating brain volume in cognitively normal Chinese older adults, compared to older white Americans. We hypothesized that carrying APOE epsilon 4 would be associated with reduced brain volume and that the magnitude of this effect would be different between ethnic groups. We performed whole brain analysis of structural MRIs from Chinese living in America (n = 41) and Shanghai (n = 30) and compared them to white Americans (n = 71). We found a significant interaction effect of carrying APOE epsilon 4 and being Chinese. The APOE epsilon 4xChinese interaction was associated with lower volume in bilateral cuneus and left middle frontal gyrus (P-uncorrected<0.001), with suggestive findings in right entorhinal cortex and left hippocampus (P-uncorrected<0.01), all regions that are associated with neurodegeneration in AD. After correction for multiple testing, the left cuneus remained significantly associated with the interaction effect (P-FWE = 0.05). Our study suggests there is a differential effect of APOE epsilon 4 on brain volume in Chinese versus white cognitively normal elderly adults. This represents a novel finding that, if verified in larger studies, has implications for how biological, environmental and/or lifestyle factors may modify APOE epsilon 4 effects on the brain in diverse populations.	[Yokoyama, Jennifer S.; Lee, Allen K. L.; Takada, Leonel T.; Busovaca, Edgar; Bonham, Luke W.; Tse, Marian; Karydas, Anna; Miller, Bruce L.; Rosen, Howard J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Takada, Leonel T.] Univ Sao Paulo, Sch Med, Hosp Clin, Sao Paulo, Brazil; [Chao, Steven Z.] Vet Affairs Hlth Care Syst, Dept Neurol, Palo Alto, CA USA; [Chao, Steven Z.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [He, Jing; Carmichael, Owen T.; DeCarli, Charles S.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Schwarz, Christopher G.] Mayo Clin & Mayo Fdn, Dept Radiol, Rochester, MN USA; [Carmichael, Owen T.] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Matthews, Brandy R.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Weiner, Michael W.] Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Neurol, Los Angeles, CA 90024 USA	University of California System; University of California San Francisco; Universidade de Sao Paulo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; University of California System; University of California Davis; Mayo Clinic; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Yokoyama, JS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	jyokoyama@memory.ucsf.edu	Schwarz, Christopher G./AAF-2719-2021; DeCarli, Charles/B-5541-2009; Carmichael, Owen/N-1955-2017; Takada, Leonel/H-7124-2013	Schwarz, Christopher G./0000-0002-1466-8357; Takada, Leonel/0000-0002-0121-9253; Carmichael, Owen/0000-0002-0576-0047	National Institute on Aging-National Institutes of Health (NIH) [P50 AG023501-08S1]; Larry L. Hillblom Foundation [2012-A-015-FEL]; NIH [P50 AG023501, R21 AG028182, P30 AG10129, HD042971, AG012435, AG024904, AG10129, AG030514, RC1 AG035610]; Hillblom Aging Network; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, P01AG019724, K01AG030514, P01AG012435, R21AG028182, RC1AG035610, K24AG045333, P50AG023501, U19AG024904, K01AG049152, U01AG024904, R01AG042292] Funding Source: NIH RePORTER	National Institute on Aging-National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Larry L. Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Aging Network; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J. S. Y. is funded by a diversity supplement from the National Institute on Aging-National Institutes of Health (NIH) (P50 AG023501-08S1, PI: Miller, BL) and by the Larry L. Hillblom Foundation (2012-A-015-FEL). Additional support for this study was provided by NIH grants P50 AG023501 (B. L. M.); R21 AG028182 and P30 AG10129 (C. S. D.); HD042971, AG012435, AG024904, AG10129, and AG030514 (O. T. C.); RC1 AG035610 (G. C.); and the Hillblom Aging Network (B. L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDERESCHI M, 1994, NEUROLOGY, V44, P239, DOI 10.1212/WNL.44.2.239; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Caroli A, 2007, J NEUROL, V254, P1698, DOI 10.1007/s00415-007-0631-7; Caselli RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1231, DOI 10.1001/archneurol.2008.1; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chao SZ, 2011, GERONTOLOGIST, V51, pS125, DOI 10.1093/geront/gnr033; CHESSON AL, 1983, BRAIN LANG, V19, P306, DOI 10.1016/0093-934X(83)90073-1; Choudhry S, 2005, AM J RESP CRIT CARE, V171, P563, DOI 10.1164/rccm.200409-1286OC; Chuang WL, 2010, J GERIATR PSYCH NEUR, V23, P42, DOI 10.1177/0891988709351804; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crean S, 2011, DEMENT GERIATR COGN, V31, P20, DOI 10.1159/000321984; Crinion JT, 2009, HUM BRAIN MAPP, V30, P4108, DOI 10.1002/hbm.20832; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Fan M, 2010, NEUROSCI LETT, V479, P332, DOI 10.1016/j.neulet.2010.05.092; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Filbey FM, 2006, NEUROREPORT, V17, P1585, DOI 10.1097/01.wnr.0000234745.27571.d1; Filippini N, 2009, J MAGN RESON IMAGING, V29, P1021, DOI 10.1002/jmri.21757; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; He J, 2010, ARCH NEUROL-CHICAGO, V67, P1231, DOI 10.1001/archneurol.2010.230; Hong CJ, 1996, NEUROLOGY, V46, P1749, DOI 10.1212/WNL.46.6.1749; HOSTAGE CA, 2013, PLOS ONE, V8; Hou CE, 2006, DEMENT GERIATR COGN, V22, P42, DOI 10.1159/000093217; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Kinkingnehum S, 2008, NEUROLOGY, V70, P2201, DOI 10.1212/01.wnl.0000303960.01039.43; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Kwon OD, 2010, DEMENT GERIATR COGN, V30, P486, DOI 10.1159/000322368; Lung FW, 2005, ACTA PSYCHIAT SCAND, V111, P38, DOI 10.1111/j.1600-0447.2004.00394.x; Ma F, 2011, NEUROPSYCHOBIOLOGY, V64, P102, DOI 10.1159/000324991; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MURDOCH BE, 1987, BRAIN LANG, V31, P122, DOI 10.1016/0093-934X(87)90064-2; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Rosen HJ, 2010, NEUROIMAGE, V49, P3358, DOI 10.1016/j.neuroimage.2009.11.041; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Scarmeas Nikolaos, 2006, Curr Psychiatry Rep, V8, P11, DOI 10.1007/s11920-006-0076-1; Schwarz C, 2009, LECT NOTES COMPUT SC, V5636, P239, DOI 10.1007/978-3-642-02498-6_20; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sturm VE, 2013, P NATL ACAD SCI USA, V110, P9944, DOI 10.1073/pnas.1301119110; Tang MX, 1996, AM J HUM GENET, V58, P574; Venketasubramanian N., 2011, DEMENTIA GERIATRIC C, V30, P492, DOI DOI 10.1159/000321675; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wang PN, 2006, NEUROBIOL AGING, V27, P1797, DOI 10.1016/j.neurobiolaging.2005.10.002; Wang PN, 2011, J NEUROL NEUROSUR PS, V82, P165, DOI 10.1136/jnnp.2010.209122; Wilson SM, 2009, BRAIN, V132, P71, DOI 10.1093/brain/awn300; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Xu GF, 2009, BRAIN, V132, P383, DOI 10.1093/brain/awn254; YOSHIZAWA T, 1994, ANN NEUROL, V36, P656, DOI 10.1002/ana.410360416; Zhao SJ, 2011, J CLIN NEUROSCI, V18, P774, DOI 10.1016/j.jocn.2010.07.149	61	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118338	10.1371/journal.pone.0118338	http://dx.doi.org/10.1371/journal.pone.0118338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738563	Green Published, gold			2022-12-26	WOS:000350685900030
J	Lee, JH; Hwang, I; Kang, YN; Choi, IJ; Kim, DK				Lee, Jae-Ho; Hwang, Ilseon; Kang, Yu-Na; Choi, In-Jang; Kim, Dae-Kwang			Genetic Characteristics of Mitochondrial DNA Was Associated with Colorectal Carcinogenesis and Its Prognosis	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; COPY NUMBER; D-LOOP; GENOME INSTABILITY; SOMATIC MUTATIONS; SERRATED POLYPS; CANCER; BRAF; PREVALENCE; ADENOMAS	Clinical value of mitochondrial DNA has been described in colorectal cancer (CRC). To clarify its role in colorectal carcinogenesis, mitochondrial microsatellite instability (mtMSI) and other markers were investigated in CRCs and their precancerous lesions, as a multitier genetic study. DNA was isolated from paired normal and tumoral tissues in 78 tubular adenomas (TAs), 34 serrated polyps (SPs), and 100 CRCs. mtMSI, nucleus microsatellite instability (nMSI), KRAS mutation, and BRAF mutation were investigated in these tumors and their statistical analysis was performed. mtMSI was found in 30% of CRCs and 21.4% of precancerous lesions. Mitochondrial copy number was higher in SPs than TAs and it was associated with mtMSI in low grade TAs. KRAS and BRAF mutations were mutually exclusive in TAs and SPs. CRCs with mtMSI showed shorter overall survival times than the patients without mtMSI. In CRCs without nMSI or BRAF mutation, mtMSI was a more accurate marker for predicting prognosis. The genetic change of mitochondrial DNA is an early and independent event in colorectal precancerous lesions and mtMSI and mitochondrial contents are associated with the tubular adenoma-carcinoma sequence, resulting in poor prognosis. This result suggested that the genetic change in mitochondrial DNA appears to be a possible prognosis marker in CRC.	[Lee, Jae-Ho; Choi, In-Jang] Keimyung Univ, Sch Med, Dept Anat, Daegu, South Korea; [Hwang, Ilseon; Kang, Yu-Na] Keimyung Univ, Sch Med, Dept Pathol, Daegu, South Korea; [Kim, Dae-Kwang] Keimyung Univ, Sch Med, Dept Med Genet, Daegu, South Korea; [Kim, Dae-Kwang] City Womens Clin, Hanvit Inst Med Genet, Daegu, South Korea	Keimyung University; Keimyung University; Keimyung University	Kim, DK (corresponding author), Keimyung Univ, Sch Med, Dept Med Genet, Daegu, South Korea.	dkkimmd@kmu.ac.kr	Lee, Jae-Ho/I-1935-2019	Lee, Jae-Ho/0000-0002-5562-0720; Hwang, Ilseon/0000-0002-6122-4417	Keimyung University Medical Research Promoting Grant	Keimyung University Medical Research Promoting Grant	This study was supported by the research promoting grant from the Keimyung University Medical Research Promoting Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6; Boland CR, 1998, CANCER RES, V58, P5248; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brennetot C, 2005, INT J CANCER, V113, P446, DOI 10.1002/ijc.20586; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Chang SC, 2009, INT J COLORECTAL DIS, V24, P623, DOI 10.1007/s00384-009-0663-9; Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8; Cunningham JM, 1998, CANCER RES, V58, P3455; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Goldstein NS, 2003, AM J CLIN PATHOL, V119, P778, DOI 10.1309/DRFQ0WFUF1G13CTK; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Guo W, 2013, MOL BIOL REP, V40, P13, DOI 10.1007/s11033-012-1939-7; Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112; Hawkins NJ, 2002, PATHOLOGY, V34, P548, DOI 10.1080/0031302021000035965; Howell N, 1996, AM J HUM GENET, V59, P501; Jass JR, 2006, HISTOPATHOLOGY, V49, P121, DOI 10.1111/j.1365-2559.2006.02466.x; Jass JR, 1999, J PATHOL, V187, P499, DOI 10.1002/(SICI)1096-9896(199904)187:5<499::AID-PATH309>3.0.CO;2-B; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; Jeong CW, 2010, CANCER EPIDEMIOL, V34, P323, DOI 10.1016/j.canep.2010.03.015; KERN SE, 1989, JAMA-J AM MED ASSOC, V261, P3099, DOI 10.1001/jama.261.21.3099; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lee JH, 2011, PATHOL ONCOL RES, V17, P201, DOI 10.1007/s12253-010-9297-z; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Lim SW, 2012, INT J CANCER, V131, P1332, DOI 10.1002/ijc.27375; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Paabo S, 1996, AM J HUM GENET, V59, P493; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Pinheiro M, 2009, CANCER LETT, V280, P38, DOI 10.1016/j.canlet.2009.02.009; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Richard SM, 2000, CANCER RES, V60, P4231; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Shim JI, 2010, CANCER RES TREAT, V42, P191, DOI 10.4143/crt.2010.42.4.191; Soreide K, 2006, BRIT J SURG, V93, P395, DOI 10.1002/bjs.5328; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Tsai MH, 2009, ANN SURG ONCOL, V16, P2918, DOI 10.1245/s10434-009-0581-7; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang Y, 2005, ANN NY ACAD SCI, V1042, P123, DOI 10.1196/annals.1338.012; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838	51	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118612	10.1371/journal.pone.0118612	http://dx.doi.org/10.1371/journal.pone.0118612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734426	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700040
J	Nakano, T; Otsuka, M; Yoshimoto, J; Doya, K				Nakano, Takashi; Otsuka, Makoto; Yoshimoto, Junichiro; Doya, Kenji			A Spiking Neural Network Model of Model-Free Reinforcement Learning with High-Dimensional Sensory Input and Perceptual Ambiguity	PLOS ONE			English	Article							REPRESENTATION; CATEGORIES	A theoretical framework of reinforcement learning plays an important role in understanding action selection in animals. Spiking neural networks provide a theoretically grounded means to test computational hypotheses on neurally plausible algorithms of reinforcement learning through numerical simulation. However, most of these models cannot handle observations which are noisy, or occurred in the past, even though these are inevitable and constraining features of learning in real environments. This class of problem is formally known as partially observable reinforcement learning (PORL) problems. It provides a generalization of reinforcement learning to partially observable domains. In addition, observations in the real world tend to be rich and high-dimensional. In this work, we use a spiking neural network model to approximate the free energy of a restricted Boltzmann machine and apply it to the solution of PORL problems with high-dimensional observations. Our spiking network model solves maze tasks with perceptually ambiguous high-dimensional observations without knowledge of the true environment. An extended model with working memory also solves history-dependent tasks. The way spiking neural networks handle PORL problems may provide a glimpse into the underlying laws of neural information processing which can only be discovered through such a top-down approach.	[Nakano, Takashi] Okinawa Inst Sci & Technol, Neurobiol Res Unit, Kunigami, Okinawa 9040495, Japan; [Otsuka, Makoto; Yoshimoto, Junichiro; Doya, Kenji] Okinawa Inst Sci & Technol, Neural Computat Unit, Kunigami, Okinawa 9040495, Japan	Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University	Nakano, T (corresponding author), Okinawa Inst Sci & Technol, Neurobiol Res Unit, 1919-1 Tancha, Kunigami, Okinawa 9040495, Japan.	nakano@oist.jp	Yoshimoto, Junichiro/B-5884-2015; Yoshimoto, Junichiro/ABI-8028-2020; Nakano, Takashi/B-6061-2015; Doya, Kenji/B-5841-2015	Yoshimoto, Junichiro/0000-0001-7995-0321; Yoshimoto, Junichiro/0000-0001-7995-0321; Nakano, Takashi/0000-0003-0707-4486; Doya, Kenji/0000-0002-2446-6820	Okinawa Institute of Science and Technology Graduate University	Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University)	This study was supported by Okinawa Institute of Science and Technology Graduate University. A part of this study is the result of "Bioinformatics for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://brainprogram. mext. go. jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belavkin RV, 2011, COGN SYST RES, V12, P93, DOI 10.1016/j.cogsys.2010.08.003; Boerlin M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001080; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Elfwing S, 2010, LECT NOTES COMPUT SC, V6443, P215, DOI 10.1007/978-3-642-17537-4_27; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gerstner W, 2002, SPIKING NEURON MODEL; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hollensen P, 2011, 21 ANN C JAP NEUR NE; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Kwee I, 2001, LECT NOTES COMPUT SC, V2130, P865; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Otsuka M., 2010, P EUR S ART NEUR NET, P541; Otsuka M, 2008, LECT NOTES COMPUT SC, V5163, P377, DOI 10.1007/978-3-540-87536-9_39; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rezende DJ, 2014, FRONTIERS COMPUTATIO, V8; Roberts PD, 2008, BIOL CYBERN, V99, P517, DOI 10.1007/s00422-008-0265-6; Saeb S, 2009, NEURAL NETWORKS, V22, P586, DOI 10.1016/j.neunet.2009.06.049; Sallans B, 2004, J MACH LEARN RES, V5, P1063; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schmidhuber J., 2014, ABS14047828 CORR; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; WHITEHEAD SD, 1995, ARTIF INTELL, V73, P271, DOI 10.1016/0004-3702(94)00012-P	29	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0115620	10.1371/journal.pone.0115620	http://dx.doi.org/10.1371/journal.pone.0115620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734662	Green Published, Green Submitted, gold			2022-12-26	WOS:000350314700002
J	Takemoto, K; Ishihara, S; Mizutai, T; Kawabata, K; Haga, H				Takemoto, Kenji; Ishihara, Seiichiro; Mizutai, Takeomi; Kawabata, Kazushige; Haga, Hisashi			Compressive Stress Induces Dephosphorylation of the Myosin Regulatory Light Chain via RhoA Phosphorylation by the Adenylyl Cyclase/Protein Kinase A Signaling Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE MYOSIN; ACTIN-FILAMENTS; MEDIATED ENDOCYTOSIS; PROTEIN PHOSPHATASE; CYCLIC-AMP; CYCLASE; SUBUNIT; FORCE; BINDING; PURIFICATION	Mechanical stress that arises due to deformation of the extracellular matrix (ECM) either stretches or compresses cells. The cellular response to stretching has been actively studied. For example, stretching induces phosphorylation of the myosin regulatory light chain (MRLC) via the RhoA/RhoA-associated protein kinase (ROCK) pathway, resulting in increased cellular tension. In contrast, the effects of compressive stress on cellular functions are not fully resolved. The mechanisms for sensing and differentially responding to stretching and compressive stress are not known. To address these questions, we investigated whether phosphorylation levels of MRLC were affected by compressive stress. Contrary to the response in stretching cells, MRLC was dephosphorylated 5 min after cells were subjected to compressive stress. Compressive loading induced activation of myosin phosphatase mediated via the dephosphorylation of myosin phosphatase targeting subunit 1 (Thr853). Because myosin phosphatase targeting subunit 1 (Thr853) is phosphorylated only by ROCK, compressive loading may have induced inactivation of ROCK. However, GTP-bound RhoA (active form) increased in response to compressive stress. The compression- induced activation of RhoA and inactivation of its effector ROCK are contradictory. This inconsistency was due to phosphorylation of RhoA (Ser188) that reduced affinity of RhoA to ROCK. Treatment with the inhibitor of protein kinase A that phosphorylates RhoA (Ser188) induced suppression of compression-stimulated MRLC dephosphorylation. Incidentally, stretching induced phosphorylation of MRLC, but did not affect phosphorylation levels of RhoA (Ser188). Together, our results suggest that RhoA phosphorylation is an important process for MRLC dephosphorylation by compressive loading, and for distinguishing between stretching and compressing cells.	[Takemoto, Kenji; Ishihara, Seiichiro; Mizutai, Takeomi; Kawabata, Kazushige; Haga, Hisashi] Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan; [Ishihara, Seiichiro; Haga, Hisashi] Hokkaido Univ, Grad Sch Med, Res Ctr Cooperat Projects, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Haga, H (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan.	haga@sci.hokudai.ac.jp	Haga, Hisashi/E-6931-2010	Haga, Hisashi/0000-0001-9464-6723	JSPS KAKENHI [26430104, 26106702, 25127701, 24370069, 26106704, 25287106]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26430104] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers 26430104, 26106702, 25127701, 24370069 to H.H., 26106704 to T.M., 25287106 to K.K. This study was also partly supported by Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science" to H.H. granted by Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburima A, 2013, BLOOD, V122, P3533, DOI 10.1182/blood-2013-03-487850; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; GRUNSPANSWIRSKY A, 1978, IMMUNOPHARMACOLOGY, V1, P71, DOI 10.1016/0162-3109(78)90010-3; Gschwend S, 2003, BRIT J PHARMACOL, V139, P1317, DOI 10.1038/sj.bjp.0705367; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hara F, 2001, J ORTHOPAED RES, V19, P126, DOI 10.1016/S0736-0266(00)00011-5; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Hirano K, 1997, J BIOL CHEM, V272, P3683, DOI 10.1074/jbc.272.6.3683; Hobert O, 1996, ONCOGENE, V12, P1577; Hudson CA, 2012, MOL HUM REPROD, V18, P265, DOI 10.1093/molehr/gar078; Ichikawa K, 1996, BIOCHEMISTRY-US, V35, P6313, DOI 10.1021/bi960208q; IKEBE M, 1985, J BIOL CHEM, V260, P27; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Izzard AS, 2003, AM J PHYSIOL-HEART C, V285, pH1489, DOI 10.1152/ajpheart.00352.2003; Kawamoto T, 2008, JPN J APPL PHYS, V47, P6173, DOI 10.1143/JJAP.47.6173; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kiss E, 2002, BIOCHEM J, V365, P79, DOI 10.1042/BJ20011295; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; KUO L, 1993, CIRC RES, V72, P607, DOI 10.1161/01.RES.72.3.607; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Liu YF, 2013, STAT INTERFACE, V6, P1; Mabuchi Y, 2010, BIOCHEMISTRY-US, V49, P2903, DOI 10.1021/bi901963e; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Mizutani T, 2004, CELL MOTIL CYTOSKEL, V59, P242, DOI 10.1002/cm.20037; Mizutani T, 2009, CELL MOTIL CYTOSKEL, V66, P389, DOI 10.1002/cm.20378; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; Pinto C, 2008, J PHARMACOL EXP THER, V325, P27, DOI 10.1124/jpet.107.131904; RISER BL, 1992, J CLIN INVEST, V90, P1932, DOI 10.1172/JCI116071; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Steffen A, 2013, J CELL SCI, V126, P4572, DOI 10.1242/jcs.118232; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Tamura K, 2011, ACTA BIOMATER, V7, P3766, DOI 10.1016/j.actbio.2011.06.013; Tian YR, 2001, DIABETES, V50, P2505, DOI 10.2337/diabetes.50.11.2505; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P369	58	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117937	10.1371/journal.pone.0117937	http://dx.doi.org/10.1371/journal.pone.0117937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734240	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700011
J	Takeuchi, M; Takino, J; Furuno, S; Shirai, H; Kawakami, M; Muramatsu, M; Kobayashi, Y; Yamagishi, S				Takeuchi, Masayoshi; Takino, Jun-ichi; Furuno, Satomi; Shirai, Hikari; Kawakami, Mihoko; Muramatsu, Michiru; Kobayashi, Yuka; Yamagishi, Sho-ichi			Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan	PLOS ONE			English	Article							DIABETIC VASCULAR COMPLICATIONS; ENDPRODUCTS AGES; IMMUNOLOGICAL DETECTION; ADVANCED GLYCOSYLATION; LIQUID-CHROMATOGRAPHY; CARBOXYMETHYL-LYSINE; OXIDATIVE STRESS; DIETARY-INTAKE; SERUM; PATHOGENESIS	Dietary consumption has recently been identified as a major environmental source of pro-inflammatory advanced glycation end-products (AGEs) in humans. It is disputed whether dietary AGEs represent a risk to human health. N-epsilon-(carboxymethyl) lysine (CML), a representative AGE compound found in food, has been suggested to make a significant contribution to circulating CML levels. However, recent studies have found that the dietary intake of AGEs is not associated with plasma CML concentrations. We have shown that the serum levels of glyceraldehyde-derived AGEs (Glycer-AGEs), but not hemoglobin A1c, glucose- derived AGEs (Glu-AGEs), or CML, could be used as biomarkers for predicting the progression of atherosclerosis and future cardiovascular events. We also detected the production/accumulation of Glycer-AGEs in normal rats administered Glu-AGE-rich beverages. Therefore, we assessed the concentrations of various AGEs in a total of 1,650 beverages and foods that are commonly consumed in Japan. The concentrations of four kinds of AGEs (Glu-AGEs, fructose-derived AGEs (Fru-AGEs), CML, and Glycer-AGEs) were measured with competitive enzyme-linked immunosorbent assays involving immunoaffinity-purified specific antibodies. The results of the latter assays indicated that Glu-AGEs and Fru-AGEs (especially Glu-AGEs), but not CML or Glycer-AGEs, are present at appreciable levels in beverages and foods that are commonly consumed by Japanese. Glu-AGEs, Fru-AGEs, CML, and Glycer-AGEs exhibited concentrations of >= 85%, 2-12%, <3%, and trace amounts in the examined beverages and >= 82%, 5-15%, <3%, and trace amounts in the tested foods, respectively. The results of the present study indicate that some lactic acid bacteria beverages, carbonated drinks, sugar-sweetened fruit drinks, sports drinks, mixed fruit juices, confectionery (snacks), dried fruits, cakes, cereals, and prepared foods contain markedly higher Glu-AGE levels than other classes of beverages and foods. We provide useful data on the concentrations of various AGEs, especially Glu-AGEs, in commonly consumed beverages and foods.	[Takeuchi, Masayoshi] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Uchinada, Ishikawa 92002, Japan; [Takino, Jun-ichi] Hiroshima Int Univ, Fac Pharmaceut Sci, Biochem Lab, Kure, Hiroshima, Japan; [Furuno, Satomi; Shirai, Hikari; Kawakami, Mihoko; Muramatsu, Michiru; Kobayashi, Yuka] Hokuriku Univ, Fac Pharmaceut Sci, Dept Pathophysiol Sci, Kanazawa, Ishikawa 92011, Japan; [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan	Kanazawa Medical University; Hokuriku University; Kurume University	Takeuchi, M (corresponding author), Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Uchinada, Ishikawa 92002, Japan.	takeuchi@kanazawa-med.ac.jp			Japan Society for the Promotion of Science (JSPS, KAKENHI) [19300254, 22300264, 25282029]	Japan Society for the Promotion of Science (JSPS, KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for the Promotion of Science (JSPS, KAKENHI Grant Numbers 19300254, 22300264, & 25282029 for MT). The funders had no role in the study design, data collection or analysis, the decision to publish, or the preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2005, MOL NUTR FOOD RES, V49, P691, DOI 10.1002/mnfr.200500008; Alamir I, 2013, AMINO ACIDS, V44, P1441, DOI 10.1007/s00726-012-1427-3; Assar SH, 2009, AMINO ACIDS, V36, P317, DOI 10.1007/s00726-008-0071-4; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bucala R, 1992, Adv Pharmacol, V23, P1; Fukushima Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-5; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; Kellow NJ, 2013, EUR J CLIN NUTR, V67, P239, DOI 10.1038/ejcn.2012.220; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Sato T, 2009, EUR J NUTR, V48, P6, DOI 10.1007/s00394-008-0753-4; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Sebekova K, 2007, MOL NUTR FOOD RES, V51, P1079, DOI 10.1002/mnfr.200700035; Semba RD, 2012, EUR J CLIN NUTR, V66, P3, DOI 10.1038/ejcn.2011.139; Semba RD, 2014, J NUTR, V144, P1037, DOI 10.3945/jn.113.189480; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Takeuchi M, 1999, MOL MED, V5, P393, DOI 10.1007/BF03402128; Takeuchi M, 2004, MED HYPOTHESES, V63, P449, DOI 10.1016/j.mehy.2004.02.042; Takeuchi M, 2001, MOL MED, V7, P783, DOI 10.1007/BF03401969; Takeuchi M, 2000, MOL MED, V6, P114, DOI 10.1007/BF03401779; Takeuchi Masayoshi, 2001, Current Molecular Medicine (Hilversum), V1, P305, DOI 10.2174/1566524013363735; Takeuchi M, 2010, CURR DRUG TARGETS, V11, P1468, DOI 10.2174/1389450111009011468; Takeuchi M, 2010, LAB INVEST, V90, P1117, DOI 10.1038/labinvest.2010.62; Takeuchi M, 2009, J ALZHEIMERS DIS, V16, P845, DOI 10.3233/JAD-2009-0974; Tsunosue M, 2010, CLIN EXP MED, V10, P139, DOI 10.1007/s10238-009-0074-9; Ueda S, 2006, MOL MED, V12, P180, DOI 10.2119/2005-00034.Ueda; Ueda S, 2012, CARDIOVASC THER, V30, P249, DOI 10.1111/j.1755-5922.2011.00264.x; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; VLASSARA H, 1994, LAB INVEST, V70, P138; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; Zhang QB, 2009, J PROTEOME RES, V8, P754, DOI 10.1021/pr800858h	38	45	45	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118652	10.1371/journal.pone.0118652	http://dx.doi.org/10.1371/journal.pone.0118652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730321	Green Published, gold, Green Submitted			2022-12-26	WOS:000350684900023
J	de Groot, JHB; Smeets, MAM; Semin, GR				de Groot, Jasper H. B.; Smeets, Monique A. M.; Semin, Gun R.			Rapid Stress System Drives Chemical Transfer of Fear from Sender to Receiver	PLOS ONE			English	Article							FACIAL EXPRESSIONS; ASPERGER-SYNDROME; ODOR; CHEMOSIGNALS; ANXIETY; COMMUNICATION; RECOGNITION; PERFORMANCE; AMYGDALA; SIGNALS	Humans can register another person's fear not only with their eyes and ears, but also with their nose. Previous research has demonstrated that exposure to body odors from fearful individuals elicited implicit fear in others. The odor of fearful individuals appears to have a distinctive signature that can be produced relatively rapidly, driven by a physiological mechanism that has remained unexplored in earlier research. The apocrine sweat glands in the armpit that are responsible for chemosignal production contain receptors for adrenalin. We therefore expected that the release of adrenalin through activation of the rapid stress response system (i.e., the sympathetic-adrenal medullary system) is what drives the release of fear sweat, as opposed to activation of the slower stress response system (i.e., hypothalamus-pituitary-adrenal axis). To test this assumption, sweat was sampled while eight participants prepared for a speech. Participants had higher heart rates and produced more armpit sweat in the fast stress condition, compared to baseline and the slow stress condition. Importantly, exposure to sweat from participants in the fast stress condition induced in receivers (N = 31) a simulacrum of the state of the sender, evidenced by the emergence of a fearful facial expression (facial electromyography) and vigilant behavior (i.e., faster classification of emotional facial expressions).	[de Groot, Jasper H. B.; Smeets, Monique A. M.; Semin, Gun R.] Univ Utrecht, Dept Social & Org Psychol, Fac Social & Behav Sci, Utrecht, Netherlands; [Semin, Gun R.] Koc Univ, Dept Psychol, Istanbul, Turkey; [Semin, Gun R.] Inst Univ, ISPA, Lisbon, Portugal	Utrecht University; Koc University; Instituto Superior Psicologia Aplicada (ISPA); Instituto Universitario de Lisboa	de Groot, JHB (corresponding author), Univ Utrecht, Dept Social & Org Psychol, Fac Social & Behav Sci, Utrecht, Netherlands.	j.h.b.degroot@uu.nl	Semin, Gun/J-4046-2013	Semin, Gun/0000-0002-5304-5566	Netherlands Organization for Scientific Research award [406-11-078/MaGW]	Netherlands Organization for Scientific Research award(Netherlands Organization for Scientific Research (NWO))	This research was supported by a Research Talent grant (406-11-078/MaGW) from the Netherlands Organization for Scientific Research (http://www.nwo.nl/en) awarded to JHBG, GRS, and MAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Adolph D, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00425, 10.3389/fnhum.2013.00283]; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Albrecht J, 2011, CHEM SENSES, V36, P19, DOI 10.1093/chemse/bjq087; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barrett LF, 2009, PERSPECT PSYCHOL SCI, V4, P326, DOI 10.1111/j.1745-6924.2009.01134.x; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Biehle-Hulette SJ, 2014, INT J COSMETIC SCI, V36, P102, DOI 10.1111/ics.12103; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; CACIOPPO JT, 1990, AM PSYCHOL, V45, P16, DOI 10.1037/0003-066X.45.1.16; Cannon W. B., 1932, THE WISDOM OF THE BO; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; Cohen J., 1988, STAT POWER ANAL BEHA, p[281, 284, 285]; Dalton P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077144; de Groot JHB, 2014, J EXP PSYCHOL GEN, V143, P1515, DOI 10.1037/a0035950; de Groot JHB, 2014, J EXP PSYCHOL GEN, V143, P825, DOI 10.1037/a0033731; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; Delplanque S, 2009, EMOTION, V9, P316, DOI 10.1037/a0015369; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Doty RL, 2010, THE GREAT PHEROMONE, P1; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Ekman P., 2003, EMOTIONS REVEALED, V2; Estes WK, 1997, PSYCHON B REV, V4, P330, DOI 10.3758/BF03210790; Eysenck H. J., 1991, MANUAL OF THE EYSENC; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A, 2009, DISCOVERING STAT USI, V153; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Haegler K, 2010, NEUROPSYCHOLOGIA, V48, P3901, DOI 10.1016/j.neuropsychologia.2010.09.019; Harker M, 2013, SKIN PHARMACOL PHYS, V26, P92, DOI 10.1159/000346930; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jones F., 2001, STRESS MYTH THEORY R; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kirschbaum C., 2000, ENCY STRESS, V3, P379, DOI DOI 10.1159/000118611; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lindsay SL, 2008, BRIT J DERMATOL, V159, P653, DOI 10.1111/j.1365-2133.2008.08740.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lorig TS, 1999, NEUROSCI BIOBEHAV R, V23, P391, DOI 10.1016/S0149-7634(98)00041-4; Martin A, 2011, INT J COSMETIC SCI, V33, P90, DOI 10.1111/j.1468-2494.2010.00596.x; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Molina PE, 2006, ENDOCRINE PHYSIOLOGY; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Natsch A, 2006, CHEM BIODIVERS, V3, P1, DOI 10.1002/cbdv.200690015; Olsson MJ, 2014, PSYCHOL SCI, V25, P817, DOI 10.1177/0956797613515681; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010342; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Radulescu AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068485; Rubin D, 2012, SOC COGN AFFECT NEUR, V7, P208, DOI 10.1093/scan/nsq097; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Sanderman R, 1995, HET METEN VAN DE PER; Schmidt-Rose T, 2013, INT J COSMETIC SCI, V35, P622, DOI 10.1111/ics.12086; Sela L, 2010, EXP BRAIN RES, V205, P13, DOI 10.1007/s00221-010-2348-6; Semin GR, 2013, TRENDS COGN SCI, V17, P427, DOI 10.1016/j.tics.2013.05.008; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Van Hout D, 2011, J SENS STUD, V26, P311, DOI 10.1111/j.1745-459X.2011.00346.x; Van Strien, 1992, NEDERLANDS TIJDSCHRI, V47, P88; VINING RF, 1987, J STEROID BIOCHEM, V27, P81, DOI 10.1016/0022-4731(87)90297-4; Wilson D.A., 2006, LEARNING SMELL OLFAC; Wilson-Mendenhall CD, 2013, PSYCHOL SCI, V24, P947, DOI 10.1177/0956797612464242; Wintermann GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074655; Wolfensberger M, 2000, ACTA OTO-LARYNGOL, V120, P303, DOI 10.1080/000164800750001134; Wysocki CJ, 2009, FLAVOUR FRAG J, V24, P209, DOI 10.1002/ffj.1927; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; ZENG XN, 1992, J CHEM ECOL, V18, P1039, DOI 10.1007/BF00980061; Zernecke R, 2011, J PSYCHOPHYSIOL, V25, P116, DOI 10.1027/0269-8803/a000047; Zhou W, 2011, SOC NEUROSCI-UK, V6, P270, DOI 10.1080/17470919.2010.523537; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	86	14	14	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118211	10.1371/journal.pone.0118211	http://dx.doi.org/10.1371/journal.pone.0118211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723720	Green Published, gold			2022-12-26	WOS:000350251200049
J	Jiang, Y; Yan, B; Lai, W; Shi, Y; Xiao, D; Jia, J; Liu, S; Li, H; Lu, J; Li, Z; Chen, L; Chen, X; Sun, L; Muegge, K; Cao, Y; Tao, Y				Jiang, Y.; Yan, B.; Lai, W.; Shi, Y.; Xiao, D.; Jia, J.; Liu, S.; Li, H.; Lu, J.; Li, Z.; Chen, L.; Chen, X.; Sun, L.; Muegge, K.; Cao, Y.; Tao, Y.			Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8	ONCOGENE			English	Article							RNA-POLYMERASE-II; DNA METHYLATION; EXPRESSION; DEMETHYLATION; POLYCOMB; HISTONE; CELLS; 5-HYDROXYMETHYLCYTOSINE; TRANSCRIPTION; EPIGENETICS	Epstein-Barr virus (EBV) causes human lymphoid malignancies, and the EBV product latent membrane protein 1 (LMP1) has been identified as an oncogene in epithelial carcinomas such as nasopharyngeal carcinoma (NPC). EBV can epigenetically reprogram lymphocyte-specific processes and induce cell immortalization. However, the interplay between LMP1 and the NPC host cell remains largely unknown. Here, we report that LMP1 is important to establish the Hox gene expression signature in NPC cell lines and tumor biopsies. LMP1 induces repression of several Hox genes in part via stalling of RNA polymerase II (RNA Pol II). Pol II stalling can be overcome by irradiation involving the epigenetic regulator TET3. Furthermore, we report that HoxC8, one of the genes silenced by LMP1, has a role in tumor growth. Ectopic expression of HoxC8 inhibits NPC cell growth in vitro and in vivo, modulates glycolysis and regulates the expression of tricarboxylic acid (TCA) cycle-related genes. We propose that viral latency products may repress via stalling key mediators that in turn modulate glycolysis.	[Jiang, Y.; Yan, B.; Lai, W.; Shi, Y.; Jia, J.; Li, H.; Lu, J.; Chen, L.; Chen, X.; Cao, Y.; Tao, Y.] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Jiang, Y.; Yan, B.; Lai, W.; Shi, Y.; Li, H.; Lu, J.; Chen, L.; Chen, X.; Cao, Y.; Tao, Y.] Cent S Univ, Ctr Mol Imaging, Changsha 410078, Hunan, Peoples R China; [Xiao, D.] Cent S Univ, Xiangya Hosp, Dept Pathol, Changsha 410078, Hunan, Peoples R China; [Jia, J.; Liu, S.] Cent S Univ, Xiangya Hosp, Ctr Med Res, Changsha 410078, Hunan, Peoples R China; [Sun, L.] Cent S Univ, Xiangya Hosp, Ctr Mol Med, Changsha 410078, Hunan, Peoples R China; [Muegge, K.] NCI, Mouse Canc Genet Program, Basic Sci Program, Leidos Biomed Res Inc,Frederick Natl Lab Canc Res, Frederick, MD 21701 USA	Central South University; Central South University; Central South University; Central South University; Central South University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cao, Y (corresponding author), Cent S Univ, Xiangya Sch Med, Xiangya Rd 110, Changsha 410078, Hunan, Peoples R China.	ycao98@vip.sina.com; taoyong@csu.edu.cn	Lu, Jianhong/AAM-8841-2020	Lu, Jianhong/0000-0002-4436-1217; Jiang, Yiqun/0000-0003-3262-9498	National Basic Research Program of China [2011CB504300, 2015CB553903]; Hunan Natural Science Foundation of China [12JJ1013]; Fundamental Research Funds for the Central Universities [2011JQ019, 2013ZZTS074, 2013ZZTS284]; National Natural Science Foundation of China [81171881, 81372427, 81271763, 81302354]; Hunan Provincial Innovation Foundation For Postgraduate [71380100002]; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010014] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Hunan Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation For Postgraduate; Frederick National Laboratory for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Basic Research Program of China (2011CB504300 (YT); 2015CB553903 (YT)); the Hunan Natural Science Foundation of China (12JJ1013 (YT)); the Fundamental Research Funds for the Central Universities (2011JQ019 (YT), 2013ZZTS074 (BY), 2013ZZTS284 (WL)); and the National Natural Science Foundation of China (81171881 and 81372427 (YT), 81271763 (SL), 81302354 (YS)); and the Hunan Provincial Innovation Foundation For Postgraduate (71380100002 (YJ)). This project has been funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Adwan H, 2011, BRIT J CANCER, V105, P288, DOI 10.1038/bjc.2011.217; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bijl J, 2008, ONCOGENE, V27, P6356, DOI 10.1038/onc.2008.233; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen J, 2013, CANCER LETT, V330, P217, DOI 10.1016/j.canlet.2012.11.051; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Du YB, 2014, J SURG RES, V188, P442, DOI 10.1016/j.jss.2014.01.017; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hau PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021176; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Hyland PL, 2011, J VIROL, V85, P10999, DOI 10.1128/JVI.00160-11; Carmona FJ, 2012, J PATHOL, V228, P230, DOI 10.1002/path.4011; Jiang YQ, 2013, BBA-REV CANCER, V1835, P155, DOI 10.1016/j.bbcan.2012.12.003; Klein E, 2007, ONCOGENE, V26, P1297, DOI 10.1038/sj.onc.1210240; Lai WW, 2013, INT J MOL SCI, V14, P2355, DOI 10.3390/ijms14022355; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li L, 2012, ONCOGENE, V31, P3901, DOI 10.1038/onc.2011.541; Li Y, 2014, ONCOTARGET, V5, P2596, DOI 10.18632/oncotarget.1841; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lin XC, 2012, CANCER SCI, V103, P993, DOI 10.1111/j.1349-7006.2012.02271.x; Liu S, 2013, BIOL REV, V88, P40, DOI 10.1111/j.1469-185X.2012.00237.x; Liu S, 2012, MOL BIOL REP, V39, P6179, DOI 10.1007/s11033-011-1435-5; Ma XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024647; Marra L, 2013, CURR MED CHEM, V20, P833; McLaughlin-Drubin ME, 2011, P NATL ACAD SCI USA, V108, P2130, DOI 10.1073/pnas.1009933108; Merrifield Matt, 2013, Frontiers in Genetics, V4, P40, DOI 10.3389/fgene.2013.00040; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Niller HH, 2009, SEMIN CANCER BIOL, V19, P158, DOI 10.1016/j.semcancer.2009.02.012; Oermann EK, 2012, SEMIN CELL DEV BIOL, V23, P370, DOI 10.1016/j.semcdb.2012.01.013; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Palermo RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002334; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Poteet E, 2013, J BIOL CHEM, V288, P9153, DOI 10.1074/jbc.M112.440354; Raab-Traub Nancy, 2009, P259, DOI 10.1007/978-0-387-68945-6_12; Rodini CO, 2012, INT J ONCOL, V40, P1180, DOI 10.3892/ijo.2011.1321; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shi Y, 2012, CARCINOGENESIS, V33, P1468, DOI 10.1093/carcin/bgs171; Skalska L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000951; Smits KM, 2014, RADIOTHER ONCOL, V111, P168, DOI 10.1016/j.radonc.2014.05.001; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Tao YG, 2011, NUCLEIC ACIDS RES, V39, P9508, DOI 10.1093/nar/gkr611; Tao YG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009163; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu JW, 2002, J VIROL, V76, P4080, DOI 10.1128/JVI.76.8.4080-4086.2002; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	70	41	45	4	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2015	34	50					6079	6091		10.1038/onc.2015.53	http://dx.doi.org/10.1038/onc.2015.53			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RQ	25745994	Green Accepted			2022-12-26	WOS:000366113800005
J	Bianchetti, CM; Takasuka, TE; Deutsch, S; Udell, HS; Yik, EJ; Bergeman, LF; Fox, BG				Bianchetti, Christopher M.; Takasuka, Taichi E.; Deutsch, Sam; Udell, Hannah S.; Yik, Eric J.; Bergeman, Lai F.; Fox, Brian G.			Active Site and Laminarin Binding in Glycoside Hydrolase Family 55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genomics; Glycoside Hydrolase; Hydrolase; Proteomics; X-ray Crystallography; -1; 3-Glucanase; GH55; Cell-free Translation; Exo-glucanase; Proteomics	AROMATIC-CARBOHYDRATE INTERACTIONS; FUNCTIONAL-ANALYSIS; TRICHODERMA-REESEI; CLONING; GENE; EXPRESSION; BIOMASS; ENZYME; ENDO-BETA-1,3-GLUCANASE; BETA-1,3-GLUCANASE	Background: SacteLam55A is a GH55 enzyme from highly cellulolytic Streptomyces sp. SirexAA-E. Results: Substrate-bound structures identify residues involved in binding, catalysis, enforcement of reaction specificity, and possibly processivity. Conclusion: Natural GH55 are exo--1,3-glucanases with a broad range of temperature and pH optima. Significance: Experimental annotation of GH phylogenetic space by use of bioinformatics, high throughput cell-free translation, biochemical assay, and structure determination is feasible. The Carbohydrate Active Enzyme (CAZy) database indicates that glycoside hydrolase family 55 (GH55) contains both endo- and exo--1,3-glucanases. The founding structure in the GH55 is PcLam55A from the white rot fungus Phanerochaete chrysosporium (Ishida, T., Fushinobu, S., Kawai, R., Kitaoka, M., Igarashi, K., and Samejima, M. (2009) Crystal structure of glycoside hydrolase family 55 -1,3-glucanase from the basidiomycete Phanerochaete chrysosporium. J. Biol. Chem. 284, 10100-10109). Here, we present high resolution crystal structures of bacterial SacteLam55A from the highly cellulolytic Streptomyces sp. SirexAA-E with bound substrates and product. These structures, along with mutagenesis and kinetic studies, implicate Glu-502 as the catalytic acid (as proposed earlier for Glu-663 in PcLam55A) and a proton relay network of four residues in activating water as the nucleophile. Further, a set of conserved aromatic residues that define the active site apparently enforce an exo-glucanase reactivity as demonstrated by exhaustive hydrolysis reactions with purified laminarioligosaccharides. Two additional aromatic residues that line the substrate-binding channel show substrate-dependent conformational flexibility that may promote processive reactivity of the bound oligosaccharide in the bacterial enzymes. Gene synthesis carried out on approximate to 30% of the GH55 family gave 34 active enzymes (19% functional coverage of the nonredundant members of GH55). These active enzymes reacted with only laminarin from a panel of 10 different soluble and insoluble polysaccharides and displayed a broad range of specific activities and optima for pH and temperature. Application of this experimental method provides a new, systematic way to annotate glycoside hydrolase phylogenetic space for functional properties.	[Bianchetti, Christopher M.; Takasuka, Taichi E.; Udell, Hannah S.; Bergeman, Lai F.; Fox, Brian G.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Bianchetti, Christopher M.] Univ Wisconsin, Dept Chem, Oshkosh, WI 54901 USA; [Takasuka, Taichi E.] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Deutsch, Sam] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Yik, Eric J.] Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92831 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; Hokkaido University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; California State University System; California State University Fullerton	Fox, BG (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Deutsch, Samuel/0000-0001-9456-7101	Department of Energy Great Lakes Bioenergy Research Center BER Office of Science [DE-FC02-07ER64494]; U.S. Department of Energy, Basic Energy Sciences, Offices of Science [W-31-109-ENG-38]; College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]	Department of Energy Great Lakes Bioenergy Research Center BER Office of Science(United States Department of Energy (DOE)); U.S. Department of Energy, Basic Energy Sciences, Offices of Science(United States Department of Energy (DOE)); College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant	This work was supported by Department of Energy Great Lakes Bioenergy Research Center BER Office of Science Grant DE-FC02-07ER64494. The use of Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Offices of Science Contract W-31-109-ENG-38. Use of the Life Science Collaborative Access Team at the Advanced Photon Source was supported by the College of Agricultural and Life Sciences, Department of Biochemistry, the Graduate School of the University of Wisconsin, the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aylward FO, 2014, MBIO, V5, DOI 10.1128/mBio.02077-14; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bianchetti CM, 2013, J BIOL CHEM, V288, P18574, DOI 10.1074/jbc.M113.475848; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel Paul G., 2009, V498, P55, DOI 10.1007/978-1-59745-196-3_4; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Cockburn D, 2014, BIOLOGIA, V69, P705, DOI 10.2478/s11756-014-0373-9; Cohen-Kupiec R, 1999, GENE, V226, P147, DOI 10.1016/S0378-1119(98)00583-6; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; Donzelli BGG, 2001, GENE, V277, P199, DOI 10.1016/S0378-1119(01)00681-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Giczey G, 2001, APPL ENVIRON MICROB, V67, P865, DOI 10.1128/AEM.67.2.865-871.2001; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Huang EL, 2014, ENV MICROBIOL REP, V6, P389, DOI 10.1111/1758-2229.12163; Igarashi Y, 2007, BIOORG MED CHEM LETT, V17, P3702, DOI 10.1016/j.bmcl.2007.04.039; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kallimanis A, 2009, INT J SYST EVOL MICR, V59, P275, DOI 10.1099/ijs.0.000984-0; Kawai R, 2006, BIOTECHNOL LETT, V28, P365, DOI 10.1007/s10529-005-6179-7; Kim DJ, 2002, CURR GENET, V40, P374, DOI 10.1007/s00294-001-0267-6; Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUKOR JJ, 1983, SCIENCE, V220, P1161, DOI 10.1126/science.220.4602.1161; Labourel A, 2014, J BIOL CHEM, V289, P2027, DOI 10.1074/jbc.M113.538843; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Ludwiczek ML, 2007, J MOL BIOL, V373, P337, DOI 10.1016/j.jmb.2007.07.057; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakamura A, 2013, J BIOL CHEM, V288, P13503, DOI 10.1074/jbc.M113.452623; Nobe R, 2004, BIOSCI BIOTECH BIOCH, V68, P2111, DOI 10.1271/bbb.68.2111; Nobe R, 2003, BIOSCI BIOTECH BIOCH, V67, P1349, DOI 10.1271/bbb.67.1349; Okazaki K, 2007, BIOSCI BIOTECH BIOCH, V71, P1568, DOI 10.1271/bbb.70030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PEAT S, 1958, J CHEM SOC, P729, DOI 10.1039/jr9580000729; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ramadhar TR, 2014, J ANTIBIOT, V67, P53, DOI 10.1038/ja.2013.77; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Savatin DV, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00470; SCHAEFFER HJ, 1994, APPL ENVIRON MICROB, V60, P594, DOI 10.1128/AEM.60.2.594-598.1994; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Takasuka TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094166; Takasuka TE, 2014, METHODS MOL BIOL, V1118, P71, DOI 10.1007/978-1-62703-782-2_5; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Vuong TV, 2009, FEBS J, V276, P4261, DOI 10.1111/j.1742-4658.2009.07097.x; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wojtkowiak A, 2013, ACTA CRYSTALLOGR D, V69, P52, DOI 10.1107/S0907444912042175; Wu HM, 2009, J BIOL CHEM, V284, P26708, DOI 10.1074/jbc.M109.010983; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	75	24	25	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11819	11832		10.1074/jbc.M114.623579	http://dx.doi.org/10.1074/jbc.M114.623579			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25752603	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000354388600002
J	Tossounian, MA; Pedre, B; Wahni, K; Erdogan, H; Vertommen, D; Van Molle, I; Messens, J				Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Vertommen, Didier; Van Molle, Inge; Messens, Joris			Corynebacterium diphtheriae Methionine Sulfoxide Reductase A Exploits a Unique Mycothiol Redox Relay Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; THIOL; GLUTATHIONE; OXIDATION; PHENIX	Methionine sulfoxide reductases are conserved enzymes that reduce oxidized methionines in proteins and play a pivotal role in cellular redox signaling. We have unraveled the redox relay mechanisms of methionine sulfoxide reductase A of the pathogen Corynebacterium diphtheriae (Cd-MsrA) and shown that this enzyme is coupled to two independent redox relay pathways. Steady-state kinetics combined with mass spectrometry of Cd-MsrA mutants give a view of the essential cysteine residues for catalysis. Cd-MsrA combines a nucleophilic cysteine sulfenylation reaction with an intramolecular disulfide bond cascade linked to the thioredoxin pathway. Within this cascade, the oxidative equivalents are transferred to the surface of the protein while releasing the reduced substrate. Alternatively, MsrA catalyzes methionine sulfoxide reduction linked to the mycothiol/mycoredoxin-1 pathway. After the nucleophilic cysteine sulfenylation reaction, MsrA forms a mixed disulfide with mycothiol, which is transferred via a thiol disulfide relay mechanism to a second cysteine for reduction by mycoredoxin-1. With x-ray crystallography, we visualize two essential intermediates of the thioredoxin relay mechanism and a cacodylate molecule mimicking the substrate interactions in the active site. Theinterplay of both redox pathways in redox signaling regulation forms the basis for further research into the oxidative stress response of this pathogen.	[Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Van Molle, Inge; Messens, Joris] Vlaams Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Van Molle, Inge; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Van Molle, Inge; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Catholique Louvain	Van Molle, I (corresponding author), Vrije Univ Brussel, Struct Biol Res Ctr, Oxidat Stress Signaling Lab, VIB, Pl Laan 2, B-1050 Brussels, Belgium.	Inge.VanMolle@vib-vub.be; joris.messens@vib-vub.be	Pedre, Brandan/E-7591-2013; Messens, Joris/AAH-3008-2020; Dagdas, Huriye Erdogan/AAH-6098-2019; Erdogan, Huriye/AAV-7170-2020	Pedre, Brandan/0000-0003-2158-2807; Messens, Joris/0000-0002-2128-8264; Erdogan, Huriye/0000-0003-0057-5579; Van Molle, Inge/0000-0003-0114-9379; Tossounian, Maria-Armineh/0000-0003-3679-7376; Vertommen, Didier/0000-0001-7648-8282	Agentschap voor Innovatie door Wetenschap en Technologie (IWT); Vlaams Instituut voor Biotechnologie (VIB); HOA project of the onderzoeksraad of the Vrije Universiteit Brussel (VUB); Omics@VIB Marie Curie COFUND fellowship; VUB bridging grant; VUB Strategic Research Program [SRP34]; Hercules Foundation [HERC16, UABR/09/005]	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaams Instituut voor Biotechnologie (VIB); HOA project of the onderzoeksraad of the Vrije Universiteit Brussel (VUB); Omics@VIB Marie Curie COFUND fellowship; VUB bridging grant; VUB Strategic Research Program; Hercules Foundation	This work was supported by Agentschap voor Innovatie door Wetenschap en Technologie (IWT), Vlaams Instituut voor Biotechnologie (VIB), the HOA project of the onderzoeksraad of the Vrije Universiteit Brussel (VUB), an Omics@VIB Marie Curie COFUND fellowship, a VUB bridging grant, VUB Strategic Research Program Grant SRP34, and Hercules Foundation Equipment Grants HERC16 and UABR/09/005.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Boschi-Muller S, 2014, BIOORG CHEM, V57, P222, DOI 10.1016/j.bioorg.2014.07.002; Chi BK, 2014, ANTIOXID REDOX SIGN, V20, P589, DOI 10.1089/ars.2013.5423; Coudevylle N, 2007, J MOL BIOL, V366, P193, DOI 10.1016/j.jmb.2006.11.042; Couturier J, 2012, FEBS LETT, V586, P3894, DOI 10.1016/j.febslet.2012.09.020; Drazic A, 2014, BBA-PROTEINS PROTEOM, V1844, P1367, DOI 10.1016/j.bbapap.2014.01.001; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Jacob C, 2011, FEBS LETT, V585, P1905, DOI 10.1016/j.febslet.2011.04.070; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kriznik A, 2014, ARCH BIOCHEM BIOPHYS, V548, P54, DOI 10.1016/j.abb.2014.03.002; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lim JC, 2013, FREE RADICAL BIO MED, V61, P257, DOI 10.1016/j.freeradbiomed.2013.04.004; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mouaheb N, 1998, P NATL ACAD SCI USA, V95, P3312, DOI 10.1073/pnas.95.6.3312; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Si MR, 2015, APPL ENVIRON MICROB, V81, P2781, DOI 10.1128/AEM.04221-14; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985	41	20	20	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11365	11375		10.1074/jbc.M114.632596	http://dx.doi.org/10.1074/jbc.M114.632596			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25752606	Green Published, hybrid			2022-12-26	WOS:000353719400013
J	Mastrocola, R; Collino, M; Nigro, D; Chiazza, F; D'Antona, G; Aragno, M; Minetto, MA				Mastrocola, Raffaella; Collino, Massimo; Nigro, Debora; Chiazza, Fausto; D'Antona, Giuseppe; Aragno, Manuela; Minetto, Marco A.			Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle	PLOS ONE			English	Article							GENE-EXPRESSION; VASCULAR COMPLICATIONS; INSULIN-RESISTANCE; LIPID-SYNTHESIS; FATTY LIVER; RECEPTOR; RAGE; AGES; MICE; SREBP-1C	Aim of this study was to investigate whether advanced glycation end-products (AGEs) accumulate in skeletal myofibers of two different animal models of diabesity and whether this accumulation could be associated to myosteatosis. Male C57Bl/6j mice and leptin-deficient ob/ob mice were divided into three groups and underwent 15 weeks of dietary manipulation: standard diet-fed C57 group (C57, n = 10), high-fat high-sugar diet-fed C57 group (HFHS, n = 10), and standard diet-fed ob/ob group (OB/OB, n = 8). HFHS mice and OB/OB mice developed glycometabolic abnormalities in association with decreased mass of the gastrocnemius muscle, fast-to-slow transition of muscle fibers, and lipid accumulation (that occurred preferentially in slow compared to fast fibers). Moreover, we found in muscle fibers of HFHS and OB/OB mice accumulation of AGEs that was preferential for the lipid-accumulating cells, increased expression of the lipogenic pathway SCAP/SREBP, and co-localisation between AGEs and SCAP-(hyper) expressing cells (suggestive for SCAP glycosylation). The increased expression of the SCAP/SREBP lipogenic pathway in muscle fibers is a possible mechanism underlying lipid accumulation and linking myosteatosis to muscle fiber atrophy and fast-to-slow transition that occur in response to diabesity.	[Mastrocola, Raffaella; Nigro, Debora; Aragno, Manuela] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Collino, Massimo; Chiazza, Fausto] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [D'Antona, Giuseppe] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Minetto, Marco A.] Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy	University of Turin; University of Turin; University of Pavia; University of Turin	Minetto, MA (corresponding author), Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy.	marco.minetto@unito.it	Chiazza, Fausto/I-5559-2015; Collino, Massimo/AAK-8532-2020	Collino, Massimo/0000-0001-8782-3496; ARAGNO, Manuela/0000-0002-0453-5235; Mastrocola, Raffaella/0000-0002-0104-6129; D'Antona, Giuseppe/0000-0002-0683-5565; Chiazza, Fausto/0000-0001-7273-0051	bank foundation "Fondazione CARIPLO" of Milano, Italy; University of Turin	bank foundation "Fondazione CARIPLO" of Milano, Italy; University of Turin	This study was supported by the bank foundation "Fondazione CARIPLO" of Milano, Italy (Project: "Steroid myopathy: Molecular, Histopathological, and Electrophysiological Characterization") and by a grant (ex 60%) from the University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/509502; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bifulco M, 2007, J AM DIET ASSOC, V107, P2058, DOI 10.1016/j.jada.2007.09.012; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Chen HB, 2014, MOL CELL ENDOCRINOL, V395, P69, DOI 10.1016/j.mce.2014.07.021; Chilelli NC, 2013, NUTR METAB CARDIOVAS, V23, P913, DOI 10.1016/j.numecd.2013.04.004; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Collino M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/569623; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; El-Bassossy HM, 2014, TOXICOL MECH METHOD, V24, P536, DOI 10.3109/15376516.2014.945109; Endo M, 2007, EXP BIOL MED, V232, P614; Filhoulaud G, 2013, TRENDS ENDOCRIN MET, V24, P257, DOI 10.1016/j.tem.2013.01.003; Gumucio JP, 2014, J SHOULDER ELB SURG, V23, P99, DOI 10.1016/j.jse.2013.04.011; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kemp JG, 2009, INT J OBESITY, V33, P831, DOI 10.1038/ijo.2009.100; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lee TW, 2014, INT J CARDIOL, V173, P236, DOI 10.1016/j.ijcard.2014.02.041; Mahajan N, 2013, INT J CARDIOL, V168, P1788, DOI 10.1016/j.ijcard.2013.05.013; Mastrocola R, 2013, AM J PHYSIOL-GASTR L, V305, pG398, DOI 10.1152/ajpgi.00450.2012; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Miljkovic I, 2010, CURR OPIN CLIN NUTR, V13, P260, DOI 10.1097/MCO.0b013e328337d826; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Puddu Alessandra, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P132; Ramamurthy B, 2013, BIOGERONTOLOGY, V14, P293, DOI 10.1007/s10522-013-9430-y; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Song F, 2012, ARTERIOSCL THROM VAS, V32, P1760, DOI 10.1161/ATVBAHA.111.241877; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Tsintzas K, 2013, CLIN SCI, V124, P675, DOI 10.1042/CS20120481; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Yamagishi S, 2011, CURR DRUG TARGETS, V12, P2096, DOI 10.2174/138945011798829456; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yang DH, 2014, INT J MED SCI, V11, P453, DOI 10.7150/ijms.8172; Yuan Y, 2011, AM J PHYSIOL-RENAL, V301, pF236, DOI 10.1152/ajprenal.00646.2010	48	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119587	10.1371/journal.pone.0119587	http://dx.doi.org/10.1371/journal.pone.0119587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750996	Green Published, gold, Green Submitted			2022-12-26	WOS:000350692700028
J	Herbeck, J; Ghorai, S; Chen, LN; Rinaldo, CR; Margolick, JB; Detels, R; Jacobson, L; Wolinsky, S; Mullins, JI				Herbeck, Joshua; Ghorai, Suvankar; Chen, Lennie; Rinaldo, Charles R.; Margolick, Joseph B.; Detels, Roger; Jacobson, Lisa; Wolinsky, Steven; Mullins, James I.			p21(WAF1/CIP1) RNA Expression in Highly HIV-1 Exposed, Uninfected Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIGEN CLASS-I; T-CELLS; INFECTION; POLYMORPHISM; RESTRICTION; ASSOCIATION; RESISTANCE; AIDS; SUSCEPTIBILITY	Some individuals remain HIV-1 antibody and PCR negative after repeated exposures to the virus, and are referred to as HIV-exposed seronegatives (HESN). However, the causes of resistance to HIV-1 infection in cases other than those with a homozygous CCR5 Delta 32 deletion are unclear. We hypothesized that human p21(WAF1/CIP1) (a cyclin-dependent kinase inhibitor) could play a role in resistance to HIV-1 infection in HESN, as p21 expression has been associated with suppression of HIV-1 in elite controllers and reported to block HIV-1 integration in cell culture. We measured p21 RNA expression in PBMC from 40 HESN and 40 low exposure HIV-1 seroconverters (LESC) prior to their infection using a real-time PCR assay. Comparing the 20 HESN with the highest exposure risk (median = 111 partners/2.5 years prior to the 20 LESC with the lowest exposure risk (median = 1 partner/2.5 years prior), p21 expression trended higher in HESN in only one of two experiments (P = 0.11 vs. P = 0.80). Additionally, comparison of p21 expression in the top 40 HESN (median = 73 partners/year) and lowest 40 LESC (median = 2 partners/year) showed no difference between the groups (P = 0.84). There was a weak linear trend between risk of infection after exposure and increasing p21 gene expression (R-2 = 0.02, P = 0.12), but again only in one experiment. Hence, if p21 expression contributes to the resistance to viral infection in HESN, it likely plays a minor role evident only in those with extremely high levels of exposure to HIV-1.	[Herbeck, Joshua] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ghorai, Suvankar; Chen, Lennie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Pittsburgh, PA USA; [Margolick, Joseph B.] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Detels, Roger] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Jacobson, Lisa] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Wolinsky, Steven] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of California System; University of California Los Angeles; Johns Hopkins University; Northwestern University	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu	Wolinsky, Steven/B-2893-2012	GHORAI, SUVANKAR/0000-0003-0800-3970; Jacobson, Lisa P./0000-0003-1722-6826; Wolinsky, Steven/0000-0002-9625-6697	National Institutes of Health [R37-047734, U01-AI35041, U01-AI35042, U01-AI35040, UM1-AI35043, U01-AI35039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, U01AI035040, UM1AI035043, U01AI035039, U01AI035042, U01AI035041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by the National Institutes of Health (J.I.M; R37-047734) (C.R.R.; U01-AI35041) (J.B.M., U01-AI35042) (R.D.; U01-AI35040) (L.J.; UM1-AI35043) (S.W.; U01-AI35039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouch A, 2013, P NATL ACAD SCI USA, V110, pE3997, DOI 10.1073/pnas.1306719110; Arias CF, 2007, J IMMUNOL, V178, P2296, DOI 10.4049/jimmunol.178.4.2296; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Bergamaschi A, 2009, J VIROL, V83, P12253, DOI 10.1128/JVI.01395-09; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Castedo M, 2005, BIOCHEM BIOPH RES CO, V331, P701, DOI 10.1016/j.bbrc.2005.03.188; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Clark E, 2000, J VIROL, V74, P5040, DOI 10.1128/JVI.74.11.5040-5052.2000; Colobran R, 2005, J IMMUNOL, V174, P5655, DOI 10.4049/jimmunol.174.9.5655; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DETELS R, 1994, J ACQ IMMUN DEF SYND, V7, P1263; Gandhi SK, 2008, J VIROL, V82, P3125, DOI 10.1128/JVI.01533-07; Garden GA, 2005, BIOCHEM BIOPH RES CO, V331, P799, DOI 10.1016/j.bbrc.2005.03.185; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lederman MM, 2010, J INFECT DIS, V202, pS333, DOI 10.1086/655967; Liu CL, 2003, J INFECT DIS, V187, P1404, DOI 10.1086/374394; Mackelprang RD, 2014, J INFECT DIS, V209, P1623, DOI 10.1093/infdis/jit807; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Nakayama EE, 2013, AIDS RES HUM RETROVI; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Valcke HS, 2006, AIDS, V20, P1984, DOI 10.1097/01.aids.0000247124.35129.e1; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119218	10.1371/journal.pone.0119218	http://dx.doi.org/10.1371/journal.pone.0119218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746435	Green Published, Green Accepted, gold			2022-12-26	WOS:000350689400058
J	Cairns, JM; Peng, Y; Yee, VC; Lou, ZK; Wang, LW				Cairns, Junmei; Peng, Yi; Yee, Vivien C.; Lou, Zhenkun; Wang, Liewei			Bora Downregulation Results in Radioresistance by Promoting Repair of Double Strand Breaks	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HISTONE H2AX; IONIZING-RADIATION; CHECKPOINT CONTROL; MITOTIC ENTRY; KINASE AURORA; RECOGNITION; ACTIVATION; PROTEINS; BRCA1	Following DNA double-strand breaks cells activate several DNA-damage response protein kinases, which then trigger histone H2AX phosphorylation and the accumulation of proteins such as MDC1, p53-binding protein 1, and breast cancer gene 1 at the damage site to promote DNA double-strand breaks repair. We identified a novel biomarker, Bora (previously called C13orf34), that is associated with radiosensitivity. In the current study, we set out to investigate how Bora might be involved in response to irradiation. We found a novel function of Bora in DNA damage repair response. Bora down-regulation increased colony formation in cells exposed to irradiation. This increased resistance to irradiation in Bora-deficient cells is likely due to a faster rate of double-strand breaks repair. After irradiation, Bora-knockdown cells displayed increased G2-M cell cycle arrest and increased Chk2 phosphorylation. Furthermore, Bora specifically interacted with the tandem breast cancer gene 1 C-terminal domain of MDC1 in a phosphorylation dependent manner, and overexpression of Bora could abolish irradiation induced MDC1 foci formation. In summary, Bora may play a significant role in radiosensitivity through the regulation of MDC1 and DNA repair.	[Cairns, Junmei; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Peng, Yi; Yee, Vivien C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Lou, Zhenkun] Mayo Clin, Dept Oncol & Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Case Western Reserve University; Mayo Clinic	Wang, LW (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	wang.liewei@mayo.edu		Cairns, Junmei/0000-0002-3941-4564	National Institutes of Health [U19 GM61388, R01 CA138461]; NATIONAL CANCER INSTITUTE [R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LW received funding from National Institutes of Health U19 GM61388 (The Pharmacogenomics Research Network, PGRN) and R01 CA138461. www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Harris PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-80; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Ismail IH, 2005, J BIOL CHEM, V280, P4649, DOI 10.1074/jbc.M411588200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lee YC, 2013, CELL CYCLE, V12, P953, DOI 10.4161/cc.23945; Liu QH, 2000, GENE DEV, V14, P1448; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Qin B, 2013, J BIOL CHEM, V288, P16139, DOI 10.1074/jbc.M113.456780; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wilson KA, 2008, CELL CYCLE, V7, P3584, DOI 10.4161/cc.7.22.7102; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou JQ, 2013, CELL CYCLE, V12, P2255, DOI 10.4161/cc.25349; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119208	10.1371/journal.pone.0119208	http://dx.doi.org/10.1371/journal.pone.0119208			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742493	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100091
J	Leeder, WM; Reuss, AJ; Brecht, M; Kratz, K; Wachtveitl, J; Goringer, HU				Leeder, W. -Matthias; Reuss, Andreas J.; Brecht, Michael; Kratz, Katja; Wachtveitl, Josef; Goeringer, H. Ulrich			Charge Reduction and Thermodynamic Stabilization of Substrate RNAs Inhibit RNA Editing	PLOS ONE			English	Article							A-SITE; AMINOGLYCOSIDE BINDING; AFRICAN TRYPANOSOMES; MAJOR GROOVE; CONFORMATIONAL FLEXIBILITY; DISCOVERY; NEOMYCIN; RECOGNITION; LIGASE; DUPLEX	African trypanosomes cause a parasitic disease known as sleeping sickness. Mitochondrial transcript maturation in these organisms requires a RNA editing reaction that is characterized by the insertion and deletion of U-nucleotides into otherwise non-functional mRNAs. Editing represents an ideal target for a parasite-specific therapeutic intervention since the reaction cycle is absent in the infected host. In addition, editing relies on a macromolecular protein complex, the editosome, that only exists in the parasite. Therefore, all attempts to search for editing interfering compounds have been focused on molecules that bind to proteins of the editing machinery. However, in analogy to other RNA-driven biochemical pathways it should be possible to stall the reaction by targeting its substrate RNAs. Here we demonstrate inhibition of editing by specific aminoglycosides. The molecules bind into the major groove of the gRNA/pre-mRNA editing substrates thereby causing a stabilization of the RNA molecules through charge compensation and an increase in stacking. The data shed light on mechanistic details of the editing process and identify critical parameters for the development of new trypanocidal compounds.	[Leeder, W. -Matthias; Brecht, Michael; Kratz, Katja; Goeringer, H. Ulrich] Tech Univ Darmstadt, Mol Genet, Darmstadt, Germany; [Reuss, Andreas J.; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, Frankfurt, Germany	Technical University of Darmstadt; Goethe University Frankfurt	Goringer, HU (corresponding author), Tech Univ Darmstadt, Mol Genet, Darmstadt, Germany.	goringer@bio.tu-darmstadt.de	Wachtveitl, Josef/A-7590-2017	Wachtveitl, Josef/0000-0002-8496-8240; Leeder, Wolf-Matthias/0000-0001-5258-1255	Deutsche Forschungsgemeinschaft [DFG-SFB902]; Illing Foundation for Macromolecular Chemistry	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Illing Foundation for Macromolecular Chemistry	The work was supported by the Deutsche Forschungsgemeinschaft (DFG-SFB902) to HUG and JW and the Illing Foundation for Macromolecular Chemistry to HUG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Aphasizhev R, 2014, BIOCHIMIE, V100, P125, DOI 10.1016/j.biochi.2014.01.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Bernacchi S, 2007, NUCLEIC ACIDS RES, V35, P7128, DOI 10.1093/nar/gkm856; Bohm C, 2012, J BIOL CHEM, V287, P26268, DOI 10.1074/jbc.M112.365916; Bou-Abdallah F, 2005, BIOCHEMISTRY-US, V44, P13837, DOI 10.1021/bi0514212; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen Q, 1997, BIOCHEMISTRY-US, V36, P11402, DOI 10.1021/bi970756j; Clark CL, 1997, NUCLEIC ACIDS RES, V25, P4098, DOI 10.1093/nar/25.20.4098; Demir O, 2014, CHEM BIOL DRUG DES, V84, P131, DOI 10.1111/cbdd.12302; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, P522; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000803; Ennifar E, 2013, ACS CHEM BIOL, V8, P2509, DOI 10.1021/cb400498n; Fourmy D, 1998, J MOL BIOL, V277, P347, DOI 10.1006/jmbi.1997.1552; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; Freire F, 2007, CHEM COMMUN, P174, DOI 10.1039/b611597g; Goringer HU, 2012, ANNU REV MICROBIOL, V66, P65, DOI 10.1146/annurev-micro-092611-150150; Goringer HU, 2012, TRENDS PARASITOL, V28, P106, DOI 10.1016/j.pt.2011.12.005; Hamilton PL, 2012, NAT PROD REP, V29, P134, DOI 10.1039/c1np00054c; Hermann T, 1999, J MOL BIOL, V294, P829, DOI 10.1006/jmbi.1999.3312; Hermann T, 2002, BIOCHIMIE, V84, P869, DOI 10.1016/S0300-9084(02)01460-8; Hermann T, 2000, ANGEW CHEM INT EDIT, V39, P1891; Homann M, 2001, BIOORGAN MED CHEM, V9, P2571, DOI 10.1016/S0968-0896(01)00032-3; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Jin E, 2000, J MOL BIOL, V298, P95, DOI 10.1006/jmbi.2000.3639; Katari VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083796; Kaul M, 2003, J MOL BIOL, V326, P1373, DOI 10.1016/S0022-2836(02)01452-3; Koumoto K, 2008, CHEM LETT, V37, P864, DOI 10.1246/cl.2008.864; Kruse E, 2013, BBA-GENE REGUL MECH, V1829, P835, DOI 10.1016/j.bbagrm.2013.04.003; Le VH, 2013, ANAL BIOCHEM, V434, P233, DOI 10.1016/j.ab.2012.11.030; Li F, 2011, P NATL ACAD SCI USA, V108, P3542, DOI 10.1073/pnas.1014152108; Liang SA, 2010, RNA, V16, P2435, DOI 10.1261/rna.2347310; Lorger M, 2003, EUKARYOT CELL, V2, P84, DOI 10.1128/EC.2.1.84-94.2003; Mikkelsen NE, 1999, P NATL ACAD SCI USA, V96, P6155, DOI 10.1073/pnas.96.11.6155; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moshiri H, 2011, J BIOL CHEM, V286, P14178, DOI 10.1074/jbc.M110.199646; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Pramanik S, 2011, J PHYS CHEM B, V115, P13862, DOI 10.1021/jp207856p; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rogers J, 1996, J MOL BIOL, V259, P916, DOI 10.1006/jmbi.1996.0369; Salavati R, 2012, INT J PARASITOL-DRUG, V2, P36, DOI 10.1016/j.ijpddr.2011.10.003; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Scheunemann AE, 2010, NUCLEIC ACIDS RES, V38, P3094, DOI 10.1093/nar/gkp1253; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; STAGE TK, 1995, RNA, V1, P95; Stampfl S, 2007, CHEMBIOCHEM, V8, P1137, DOI 10.1002/cbic.200700030; Stelzer AC, 2011, NAT CHEM BIOL, V7, P553, DOI [10.1038/NCHEMBIO.596, 10.1038/nchembio.596]; Steverding D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-15; Stich A, 2013, LANCET INFECT DIS, V13, P733, DOI 10.1016/S1473-3099(13)70191-9; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Tor Y, 2003, CHEMBIOCHEM, V4, P998, DOI 10.1002/cbic.200300680; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varani L, 2000, NUCLEIC ACIDS RES, V28, P710, DOI 10.1093/nar/28.3.710; VERSPIEREN P, 1987, GENE, V61, P307, DOI 10.1016/0378-1119(87)90194-6; Walter F, 2002, EMBO J, V21, P760, DOI 10.1093/emboj/21.4.760; Westhof E, 1993, WATER BIOL MACROMOLE, P226, DOI DOI 10.1007/978-1-349-12359-9_7; Xi HJ, 2011, BIOCHEMISTRY-US, V50, P9088, DOI 10.1021/bi201077h; Zhao F, 2005, ANGEW CHEM INT EDIT, V44, P5329, DOI 10.1002/anie.200500903	65	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118940	10.1371/journal.pone.0118940	http://dx.doi.org/10.1371/journal.pone.0118940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742417	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100063
J	Horner, SM; Wilkins, C; Badil, S; Iskarpatyoti, J; Gale, M				Horner, Stacy M.; Wilkins, Courtney; Badil, Samantha; Iskarpatyoti, Jason; Gale, Michael, Jr.			Proteomic Analysis of Mitochondrial-Associated ER Membranes (MAM) during RNA Virus Infection Reveals Dynamic Changes in Protein and Organelle Trafficking	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; ENDOPLASMIC-RETICULUM; RIG-I; RAT-LIVER; STATISTICAL-MODEL; INNATE IMMUNITY; CONTACT SITES; REPLICATION; ACTIVATION; FRACTION	RIG-I pathway signaling of innate immunity against RNA virus infection is organized between the ER and mitochondria on a subdomain of the ER called the mitochondrial-associated ER membrane (MAM). The RIG-I adaptor protein MAVS transmits downstream signaling of antiviral immunity, with signaling complexes assembling on the MAM in association with mitochondria and peroxisomes. To identify components that regulate MAVS signalosome assembly on the MAM, we characterized the proteome of MAM, ER, and cytosol from cells infected with either chronic (hepatitis C) or acute (Sendai) RNA virus infections, as well as mock-infected cells. Comparative analysis of protein trafficking dynamics during both chronic and acute viral infection reveals differential protein profiles in the MAM during RIG-I pathway activation. We identified proteins and biochemical pathways recruited into and out of the MAM in both chronic and acute RNA viral infections, representing proteins that drive immunity and/or regulate viral replication. In addition, by using this comparative proteomics approach, we identified 3 new MAVS-interacting proteins, RAB1B, VTN, and LONP1, and defined LONP1 as a positive regulator of the RIG-I pathway. Our proteomic analysis also reveals a dynamic cross-talk between subcellular compartments during both acute and chronic RNA virus infection, and demonstrates the importance of the MAM as a central platform that coordinates innate immune signaling to initiate immunity against RNA virus infection.	[Horner, Stacy M.; Wilkins, Courtney; Badil, Samantha; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Iskarpatyoti, Jason] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Washington; University of Washington Seattle; Duke University; Duke University	Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	stacy.horner@duke.edu		Wilkins, Courtney/0000-0003-4001-7686; Horner, Stacy/0000-0002-9351-7409; Gale, Michael/0000-0002-6332-7436	NIH [R01AI060389, U19AI88778, F32AI088856]; Irvington Institute Fellowship Program of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060389, K22AI100935, U19AI083019, F32AI088856, U19AI088778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute Fellowship Program of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grants R01AI060389 and U19AI88778 (MG), F32AI088856 (CW) and the Irvington Institute Fellowship Program of the Cancer Research Institute, http://www.cancerresearch.org/grants-programs/grants-fellowships/cri-irvington-postdoctoralfellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2003, SYNTHESE, V134, P1; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bosch M, 2011, TRAFFIC, V12, P1483, DOI 10.1111/j.1600-0854.2011.01259.x; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bozidis P, 2010, J VIROL, V84, P7898, DOI 10.1128/JVI.00885-10; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Bozym RA, 2012, CELL HOST MICROBE, V11, P153, DOI 10.1016/j.chom.2012.01.008; Bravo-Sagua R, 2014, INT J BIOCHEM CELL B, V50, P55, DOI 10.1016/j.biocel.2014.01.019; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; CUI Z, 1993, J BIOL CHEM, V268, P16655; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Hajnoczky G, 2000, J PHYSIOL-LONDON, V529, P69, DOI 10.1111/j.1469-7793.2000.00069.x; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Horner SM, 2011, P NATL ACAD SCI US; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Jacobs JL, 2014, J BIOL CHEM, V289, P1604, DOI 10.1074/jbc.M113.520254; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285; Klug L, 2013, BIOCHIM BIOPHYS ACTA, V1841, P215; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Poston CN, 2013, J PROTEOMICS; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Raturi A, 2012, BIOCH BIOPHYS ACTA; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schon EA, 2012, MOL CELL NEUROSCI; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; van Zuylen WJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002747; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Zhang AP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009936; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	89	64	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117963	10.1371/journal.pone.0117963	http://dx.doi.org/10.1371/journal.pone.0117963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734423	Green Published, gold			2022-12-26	WOS:000350314700012
J	Chen, Q; Zhang, LP; de Crombrugghe, B; Krahe, R				Chen, Qin; Zhang, Liping; de Crombrugghe, Benoit; Krahe, Ralf			Mesenchyme-specific overexpression of nucleolar protein 66 in mice inhibits skeletal growth and bone formation	FASEB JOURNAL			English	Article						histone demethylase; transgenic mice; IGF1R/Akt signaling pathway; osterix	TRANSCRIPTION FACTOR OSTERIX; OSTEOBLAST DIFFERENTIATION; LUNG-CANCER; EXPRESSION; INSULIN; PATHWAYS; CBFA1; CELLS; SOX9; NO66	Previous studies showed that nucleolar protein 66 (NO66), the Jumonji C-domain-containing histone demethylase for methylated histone H3K4 and H3K36 (H3K36me), negatively regulates osteoblast differentiation in vitro by inhibiting the activity of transcription factor osterix (Osx). However, whether NO66 affects mammalian skeletogenesis in vivo is not yet known. Here, we generated transgenic (TG) mice overexpressing a flag-tagged NO66 transgene driven by the Prx1 (paired related homeobox 1) promoter. We found that NO66 overexpression in Prx1-expressing mesenchymal cells inhibited skeletal growth and bone formation. The inhibitory phenotype was associated with >50% decreases in chondrocyte/osteoblast proliferation and differentiation. Moreover, we found that in bones of NO66-TGmice, expression of Igf1, Igf1 receptor (Igf1r), runt-related transcription factor 2, and Osx was significantly down-regulated (P < 0.05). Consistent with these results, we observed >50% reduction in levels of phosphorylated protein kinase B (Akt) and H3K36me3 in bones of NO66-TG mice, suggesting an inverse correlation between NO66 histone demethylase and the activity of IGF1R/Akt signaling. This correlation was further confirmed by in vitro assays of C2C12 cells with NO66 overexpression. We propose that the decrease in the IGF1R/Akt signaling pathway in mice with mesenchymal overexpression of NO66 may contribute in part to the inhibition of skeletal growth and bone formation.	[Chen, Qin; Zhang, Liping; de Crombrugghe, Benoit; Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	qchen1@mdanderson.org			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [R01 AR49072]; Cancer Prevention & Research Institute of Texas Grant [CPRIT-IIRA RP130054]; MD Anderson Cancer Center Support Grant [CA016672]; Rolanette and Berdon Lawrence Bone Research Award; Children Sarcoma Initiative; Triumph Over Kid Cancer Foundation; Dr. and Mrs. Harold Selzman; Satellite Health and American Diabetic Association [1-11-BS-194]; Pilot/Feasibility award of the Diabetes Research Center at Baylor College of Medicine [P30-DK079638]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; Cancer Prevention & Research Institute of Texas Grant; MD Anderson Cancer Center Support Grant; Rolanette and Berdon Lawrence Bone Research Award; Children Sarcoma Initiative; Triumph Over Kid Cancer Foundation; Dr. and Mrs. Harold Selzman; Satellite Health and American Diabetic Association; Pilot/Feasibility award of the Diabetes Research Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Zhaoping Zhang for microinjection, Dr. James Martin for providing the paired related homeobox 1-promoter plasmid and paired related homeobox 1-Cre mice, and Jiangling Dong (Northwest University for Nationalities, Lanzhou, China) for technical assistance. This study was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01 AR49072 (to B.D.C.), the Cancer Prevention & Research Institute of Texas Grant CPRIT-IIRA RP130054 (to R.K.), the MD Anderson Cancer Center Support Grant CA016672, the 2012 Rolanette and Berdon Lawrence Bone Research Award (to Q.C.), the Children Sarcoma Initiative and the Triumph Over Kid Cancer Foundation (to Q.C.), the Dr. and Mrs. Harold Selzman, the Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association (1-11-BS-194), and the Pilot/Feasibility award of the Diabetes Research Center (P30-DK079638) at Baylor College of Medicine (to L.Z.). B.D.C. and R.K. shared senior authorship of this work.	BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chen Q, 2004, J BIOL CHEM, V279, P17667, DOI 10.1074/jbc.M311678200; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058104; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dong QZ, 2013, AM J PATHOL, V182, P954, DOI 10.1016/j.ajpath.2012.11.019; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eilbracht J, 2004, MOL BIOL CELL, V15, P1816, DOI 10.1091/mbc.e03-08-0623; Ge WS, 2011, STEM CELLS, V29, P1112, DOI 10.1002/stem.663; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Suzuki C, 2007, MOL CANCER THER, V6, P542, DOI 10.1158/1535-7163.MCT-06-0659; Wang YM, 2011, J BONE MINER RES, V26, P1437, DOI 10.1002/jbmr.359; Zhang W, 2012, CELL BIOCHEM FUNCT, V30, P297, DOI 10.1002/cbf.2801; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	30	6	6	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2555	2565		10.1096/fj.14-258970	http://dx.doi.org/10.1096/fj.14-258970			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25746793	Green Published			2022-12-26	WOS:000355209500032
J	Geilfus, CM; Ober, D; Eichacker, LA; Muhling, KH; Zorb, C				Geilfus, Christoph-Martin; Ober, Dietrich; Eichacker, Lutz A.; Muehling, Karl Hermann; Zoerb, Christian			Down-Regulation of ZmEXPB6 (Zea mays beta-Expansin 6) Protein Is Correlated with Salt-mediated Growth Reduction in the Leaves of Z. mays L.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAIZE LEAF ELONGATION; TRITICUM-AESTIVUM L.; DEEP-WATER RICE; CELL-WALL; VICIA-FABA; HOMOSPERMIDINE SYNTHASE; PRIMARY ROOT; NACL STRESS; GENE; EXPRESSION	The salt-sensitive crop Zea mays L. shows a rapid leaf growth reduction upon NaCl stress. There is increasing evidence that salinity impairs the ability of the cell walls to expand, ultimately inhibiting growth. Wall-loosening is a prerequisite for cell wall expansion, a process that is under the control of cell wall-located expansin proteins. In this study the abundance of those proteins was analyzed against salt stress using gel-based two-dimensional proteomics and two-dimensional Western blotting. Results show that ZmEXPB6 (Z. mays beta-expansin 6) protein is lacking in growth-inhibited leaves of salt-stressed maize. Of note, the exogenous application of heterologously expressed and metal-chelate-affinity chromatography-purified ZmEXPB6 on growth-reduced leaves that lack native ZmEXPB6 under NaCl stress partially restored leaf growth. In vitro assays on frozen- thawed leaf sections revealed that recombinant ZmEXPB6 acts on the capacity of the walls to extend. Our results identify expansins as a factor that partially restores leaf growth of maize in saline environments.	[Geilfus, Christoph-Martin; Muehling, Karl Hermann; Zoerb, Christian] Univ Kiel, Inst Plant Nutr & Soil Sci, D-24118 Kiel, Germany; [Ober, Dietrich] Univ Kiel, Inst Bot, D-24118 Kiel, Germany; [Ober, Dietrich] Univ Kiel, Bot Gardens, Biochem Ecol & Mol Evolut, D-24118 Kiel, Germany; [Eichacker, Lutz A.] Univ Stavanger, Ctr Organelle Res CORE, N-4021 Stavanger, Norway; [Zoerb, Christian] Univ Hohenheim, Inst Crop Sci, Qual Plant Prod, D-70593 Stuttgart, Germany	University of Kiel; University of Kiel; University of Kiel; Universitetet i Stavanger; University Hohenheim	Geilfus, CM (corresponding author), Univ Kiel, Inst Plant Nutr & Soil Sci, Hermann Rodewald Str 2, D-24118 Kiel, Germany.	cmgeilfus@plantnutrition.uni-kiel.de	Mühling, Karl H./L-6443-2014	Mühling, Karl H./0000-0002-9922-6581				[Anonymous], 2010, Plant, Cell and Environment, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; [Anonymous], 1953, COLLECTED WORKS JW T; BERNSTEIN N, 1993, PLANTA, V191, P433, DOI 10.1007/BF00195744; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Cho HT, 1998, PLANT J, V15, P805, DOI 10.1046/j.1365-313X.1998.00258.x; Cho HT, 1997, PLANT PHYSIOL, V113, P1137, DOI 10.1104/pp.113.4.1137; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; CRAMER GR, 1991, J EXP BOT, V42, P1417, DOI 10.1093/jxb/42.11.1417; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Downes BP, 2001, PLANT PHYSIOL, V126, P244, DOI 10.1104/pp.126.1.244; Geilfus CM, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-31; Geilfus CM, 2013, NEW PHYTOL, V197, P1117, DOI 10.1111/nph.12046; Geilfus CM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00013; Geilfus CM, 2012, PLANT CELL ENVIRON, V35, P578, DOI 10.1111/j.1365-3040.2011.02437.x; Geilfus CM, 2011, J PLANT GROWTH REGUL, V30, P387, DOI 10.1007/s00344-011-9201-4; Geilfus CM, 2010, PLANT PHYSIOL BIOCH, V48, P993, DOI 10.1016/j.plaphy.2010.09.011; Geilfus CM, 2010, J IMMUNOL METHODS, V362, P89, DOI 10.1016/j.jim.2010.09.006; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; HAGER A, 1971, PLANTA, V100, P47, DOI 10.1007/BF00386886; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; Hu YC, 2000, INT J PLANT SCI, V161, P575, DOI 10.1086/314280; Hutsch BW, 2014, J PLANT NUTR SOIL SC, V177, P278, DOI 10.1002/jpln.201300345; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Jones L, 2004, FEBS LETT, V559, P61, DOI 10.1016/S0014-5793(04)00023-7; Kaltenegger E, 2013, PLANT CELL, V25, P1213, DOI 10.1105/tpc.113.109744; Kohler W., 1984, EINFUHRUNG STAT BIOL, P101; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; Magneschi L, 2009, J PLANT PHYSIOL, V166, P1576, DOI 10.1016/j.jplph.2009.03.008; MCQUEENMASON SJ, 1995, J EXP BOT, V46, P1639, DOI 10.1093/jxb/46.11.1639; Moll S, 2002, PLANT PHYSIOL, V130, P47, DOI 10.1104/pp.004259; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NEUMANN PM, 1988, PLANT PHYSIOL, V88, P233, DOI 10.1104/pp.88.1.233; Ploscher M, 2011, J PROTEOMICS, V74, P1256, DOI 10.1016/j.jprot.2011.03.020; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Rozema J, 2008, SCIENCE, V322, P1478, DOI 10.1126/science.1168572; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Shonjani S., 2002, THESIS JUSTUS LIEBIG; Sumer A, 2004, J APPL BOT FOOD QUAL, V78, P135; VANVOLKENBURGH E, 1985, PLANT PHYSIOL, V77, P190, DOI 10.1104/pp.77.1.190; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250; Zorb C, 2004, PLANT SCI, V167, P91, DOI [10.1016/S0168-9452(04)00111-6, 10.1016/j.plantsci.2004.03.004]	54	18	20	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11235	11245		10.1074/jbc.M114.619718	http://dx.doi.org/10.1074/jbc.M114.619718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25750129	Green Published, hybrid			2022-12-26	WOS:000353719400003
J	Chang, AN; Battiprolu, PK; Cowley, PM; Chen, GH; Gerard, RD; Pinto, JR; Hill, JA; Baker, AJ; Kamm, KE; Stull, JT				Chang, Audrey N.; Battiprolu, Pavan K.; Cowley, Patrick M.; Chen, Guohua; Gerard, Robert D.; Pinto, Jose R.; Hill, Joseph A.; Baker, Anthony J.; Kamm, Kristine E.; Stull, James T.			Constitutive Phosphorylation of Cardiac Myosin Regulatory Light Chain in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-C; SMOOTH-MUSCLE MYOSIN; PERFUSED RAT-HEART; SKELETAL-MUSCLE; TROPONIN-I; HYPERTROPHIC CARDIOMYOPATHY; MYOFILAMENT PHOSPHORYLATION; DIFFERENTIAL ROLES; TARGET SUBUNIT; KINASE	In beating hearts, phosphorylation of myosin regulatory light chain (RLC) at a single site to 0.45 mol of phosphate/mol by cardiac myosin light chain kinase (cMLCK) increases Ca2+ sensitivity of myofilament contraction necessary for normal cardiac performance. Reduction of RLC phosphorylation in conditional cMLCK knock-out mice caused cardiac dilation and loss of cardiac performance by 1 week, as shown by increased left ventricular internal diameter at end-diastole and decreased fractional shortening. Decreased RLC phosphorylation by conventional or conditional cMLCK gene ablation did not affect troponin-I or myosin-binding protein-C phosphorylation in vivo. The extent of RLC phosphorylation was not changed by prolonged infusion of dobutamine or treatment with a beta-adrenergic antagonist, suggesting that RLC is constitutively phosphorylated to maintain cardiac performance. Biochemical studies with myofilaments showed that RLC phosphorylation up to 90% was a random process. RLC is slowly dephosphorylated in both noncontracting hearts and isolated cardiac myocytes from adult mice. Electrically paced ventricular trabeculae restored RLC phosphorylation, which was increased to 0.91 mol of phosphate/mol of RLC with inhibition of myosin light chain phosphatase (MLCP). The two RLCs in each myosin appear to be readily available for phosphorylation by a soluble cMLCK, but MLCP activity limits the amount of constitutive RLC phosphorylation. MLCP with its regulatory subunit MYPT2 bound tightly to myofilaments was constitutively phosphorylated in beating hearts at a site that inhibits MLCP activity. Thus, the constitutive RLC phosphorylation is limited physiologically by low cMLCK activity in balance with low MLCP activity.	[Chang, Audrey N.; Chen, Guohua; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Battiprolu, Pavan K.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept lnternal Med Cardiol, Dallas, TX 75390 USA; [Gerard, Robert D.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Cowley, Patrick M.; Baker, Anthony J.] Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Gerard, Robert D.; Baker, Anthony J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Pinto, Jose R.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; State University System of Florida; Florida State University	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu	Pinto, Jose Renato/H-2631-2017; Regan, Clinton/E-6250-2012	Pinto, Jose Renato/0000-0001-9092-4976; 	National Institutes of Health [HL080536, HL06296, HL103840]; Department of Veterans Affairs Merit Review Award [I01BX000740]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080536, K99HL103840, P01HL006296, R00HL103840] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536 (to J. T. S.), HL06296 (to R. D. G.), and HL103840 (to J. R. P.). This work was also supported by Department of Veterans Affairs Merit Review Award I01BX000740 (to A. J. B.), the Moss Heart Fund (to J. T. S.), and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.).	BENSON ES, 1955, CIRC RES, V3, P221, DOI 10.1161/01.RES.3.2.221; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066720; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Colson BA, 2012, P NATL ACAD SCI USA, V109, P20437, DOI 10.1073/pnas.1213027109; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Dweck D, 2014, J BIOL CHEM, V289, P23097, DOI 10.1074/jbc.M114.561472; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Grimm M, 2005, CARDIOVASC RES, V65, P211, DOI 10.1016/j.cardiores.2004.09.019; Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353; HERRING BP, 1986, BIOCHEM J, V240, P205, DOI 10.1042/bj2400205; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; JEACOCKE SA, 1980, BIOCHEM J, V188, P763, DOI 10.1042/bj1880763; KAMM KE, 1989, J BIOL CHEM, V264, P21223; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Kuster DWD, 2012, J MUSCLE RES CELL M, V33, P43, DOI 10.1007/s10974-011-9280-7; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Lin PJ, 1997, J BIOL CHEM, V272, P7412, DOI 10.1074/jbc.272.11.7412; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Metzger JM, 1997, TRENDS CARDIOVAS MED, V7, P63, DOI 10.1016/S1050-1738(96)00138-7; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Moss RL, 2015, CIRC RES, V116, P183, DOI 10.1161/CIRCRESAHA.116.300561; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Orsi B A, 1979, Methods Enzymol, V63, P159; PERSECHINI A, 1983, BIOCHEMISTRY-US, V22, P470, DOI 10.1021/bi00271a033; PERSECHINI A, 1984, BIOCHEMISTRY-US, V23, P4144, DOI 10.1021/bi00313a021; Petzhold D, 2014, BIOCHEM BIOPH RES CO, V449, P284, DOI 10.1016/j.bbrc.2014.05.040; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sheikh F, 2014, TRENDS CARDIOVAS MED, V24, P133, DOI 10.1016/j.tcm.2013.07.004; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Toepfer C, 2013, J BIOL CHEM, V288, P13446, DOI 10.1074/jbc.M113.455444; TRYBUS KM, 1985, J BIOL CHEM, V260, P5988; Tsai MH, 2014, J PHYSIOL-LONDON, V592, P3031, DOI 10.1113/jphysiol.2014.273011; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; Wang YH, 2014, J MOL CELL CARDIOL, V72, P231, DOI 10.1016/j.yjmcc.2014.03.022; Wang YC, 2012, J BIOL CHEM, V287, P2156, DOI 10.1074/jbc.M111.294306; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	61	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10703	10716		10.1074/jbc.M115.642165	http://dx.doi.org/10.1074/jbc.M115.642165			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25733667	hybrid, Green Published			2022-12-26	WOS:000353404500013
J	Lazard, M; Dauplais, M; Blanquet, S; Plateau, P				Lazard, Myriam; Dauplais, Marc; Blanquet, Sylvain; Plateau, Pierre			Trans-sulfuration Pathway Seleno-amino Acids Are Mediators of Selenomethionine Toxicity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CANCER PREVENTION; DNA-DAMAGE; YEAST; METABOLISM; METHIONINE; SUPEROXIDE; CYSTEINE; GENES; SELENOPROTEINS	Toxicity of selenomethionine, an organic derivative of selenium widely used as supplement in human diets, was studied in the model organism Saccharomyces cerevisiae. Several DNA repair-deficient strains hypersensitive to selenide displayed wild-type growth rate properties in the presence of selenomethionine indicating that selenide and selenomethionine exert their toxicity via distinct mechanisms. Cytotoxicity of selenomethionine decreased when the extracellular concentration of methionine or S-adenosylmethionine was increased. This protection resulted from competition between the S-and Se-compounds along the downstream metabolic pathways inside the cell. By comparing the sensitivity to selenomethionine of mutants impaired in the sulfur amino acid pathway, we excluded a toxic effect of Se-adenosylmethionine, Se-adenosylhomocysteine, or of any compound in the methionine salvage pathway. Instead, we found that selenomethionine toxicity is mediated by the trans-sulfuration pathway amino acids selenohomocysteine and/or selenocysteine. Involvement of superoxide radicals in selenomethionine toxicity in vivo is suggested by the hypersensitivity of a Delta sod1 mutant strain, increased resistance afforded by the superoxide scavenger manganese, and inactivation of aconitase. In parallel, we showed that, in vitro, the complete oxidation of the selenol function of selenocysteine or selenohomocysteine by dioxygen is achieved within a few minutes at neutral pH and produces superoxide radicals. These results establish a link between superoxide production and trans-sulfuration pathway seleno-amino acids and emphasize the importance of the selenol function in the mechanism of organic selenium toxicity.	[Lazard, Myriam; Dauplais, Marc; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, Biochim Lab, CNRS, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Lazard, M (corresponding author), Ecole Polytech, Biochim Lab, F-91128 Palaiseau, France.	myriam.lazard@polytechnique.edu		Lazard, Myriam/0000-0002-7154-1352				Arnaudguilhem C, 2012, ANAL CHIM ACTA, V757, P26, DOI 10.1016/j.aca.2012.10.029; Azad GK, 2014, FEBS OPEN BIO, V4, P77, DOI 10.1016/j.fob.2014.01.002; Bierla K, 2013, J PROTEOMICS, V87, P26, DOI 10.1016/j.jprot.2013.05.010; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Chan G, 2007, J BIOCHEM MOL TOXIC, V21, P252, DOI 10.1002/jbt.20189; CHAUDIERE J, 1992, ARCH BIOCHEM BIOPHYS, V296, P328, DOI 10.1016/0003-9861(92)90580-P; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; DICKSON RC, 1969, ARCH BIOCHEM BIOPHYS, V130, P547, DOI 10.1016/0003-9861(69)90068-X; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Gopalakrishna R, 2001, NUTR CANCER, V40, P55, DOI 10.1207/S15327914NC401_11; Hiraishi H, 2008, CURR GENET, V53, P225, DOI 10.1007/s00294-008-0181-2; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Imura N., 1989, SE BIOL MED, P70, DOI [10.1007/978-3-642-74421-1_14, DOI 10.1007/978-3-642-74421-1_14]; Izquierdo A, 2010, MICROBIOL-SGM, V156, P2608, DOI 10.1099/mic.0.039719-0; Kade IJ, 2008, NEUROCHEM RES, V33, P167, DOI 10.1007/s11064-007-9432-8; KAJANDER EO, 1990, BIOCHEM J, V267, P767, DOI 10.1042/bj2670767; Kanai M, 2013, APPL MICROBIOL BIOT, V97, P1183, DOI 10.1007/s00253-012-4261-3; Kitajima T, 2012, J BIOL CHEM, V287, P10032, DOI 10.1074/jbc.M111.324244; Kitajima T, 2010, APPL ENVIRON MICROB, V76, P6351, DOI 10.1128/AEM.01026-10; Larabee JL, 2009, J INORG BIOCHEM, V103, P419, DOI 10.1016/j.jinorgbio.2008.12.007; Lazard M, 2011, FEBS J, V278, P4112, DOI 10.1111/j.1742-4658.2011.08318.x; Letauayova L, 2006, DNA REPAIR, V5, P602, DOI 10.1016/j.dnarep.2006.01.004; Letavayova L, 2008, MUTAT RES-GEN TOX EN, V652, P198, DOI 10.1016/j.mrgentox.2008.03.001; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Lewinska A, 2008, FUNGAL GENET BIOL, V45, P1182, DOI 10.1016/j.fgb.2008.05.011; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; Manikova D, 2012, CHEM RES TOXICOL, V25, P1598, DOI 10.1021/tx300061n; Misra S, 2010, METALLOMICS, V2, P710, DOI 10.1039/c0mt00008f; Okuno T, 2001, TOXICOL APPL PHARM, V176, P18, DOI 10.1006/taap.2001.9260; Palace VP, 2004, ECOTOX ENVIRON SAFE, V58, P17, DOI 10.1016/j.ecoenv.2003.08.019; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Park HS, 2000, J BIOL CHEM, V275, P2527, DOI 10.1074/jbc.275.4.2527; Peyroche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036343; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Rahmanto AS, 2012, IUBMB LIFE, V64, P863, DOI 10.1002/iub.1084; SAEZ G, 1982, BIOCHIM BIOPHYS ACTA, V719, P24, DOI 10.1016/0304-4165(82)90302-6; Sanchez RJ, 2005, J BIOL INORG CHEM, V10, P913, DOI 10.1007/s00775-005-0044-y; Seitomer E, 2008, MOL NUTR FOOD RES, V52, P1305, DOI 10.1002/mnfr.200700347; Seko Y, 1997, BIOMED ENVIRON SCI, V10, P333; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; SODA K, 1967, AGR BIOL CHEM TOKYO, V31, P1054, DOI 10.1080/00021369.1967.10858916; SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Spallholz JE, 2004, BIOCHEM PHARMACOL, V67, P547, DOI 10.1016/j.bcp.2003.09.004; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Valdiglesias V, 2010, ARCH TOXICOL, V84, P337, DOI 10.1007/s00204-009-0505-0; Van Hoewyk D, 2013, ANN BOT-LONDON, V112, P965, DOI 10.1093/aob/mct163; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; Wallenberg M, 2014, BASIC CLIN PHARMACOL, V114, P377, DOI 10.1111/bcpt.12207; Weekley CM, 2013, CHEM SOC REV, V42, P8870, DOI 10.1039/c3cs60272a; YAMAGATA S, 1993, J BACTERIOL, V175, P4800, DOI 10.1128/JB.175.15.4800-4808.1993; Zhou ZS, 2000, BIOORG MED CHEM LETT, V10, P2471, DOI 10.1016/S0960-894X(00)00498-4	59	28	29	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10741	10750		10.1074/jbc.M115.640375	http://dx.doi.org/10.1074/jbc.M115.640375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25745108	Green Published, hybrid			2022-12-26	WOS:000353404500016
J	Guo, SL; Ku, LX; Qi, JS; Tian, ZQ; Han, T; Zhang, LK; Su, HH; Ren, ZZ; Chen, YH				Guo, Shulei; Ku, Lixia; Qi, Jianshuang; Tian, Zhiqiang; Han, Tuo; Zhang, Liangkun; Su, Huihui; Ren, Zhenzhen; Chen, Yanhui			Genetic Analysis and Major Quantitative Trait Locus Mapping of Leaf Widths at Different Positions in Multiple Populations	PLOS ONE			English	Article							MENDELIAN FACTORS; MAIZE; GROWTH; ARCHITECTURE; COACTIVATOR; YIELD	Background Leaf width is an important agricultural trait in maize. Leaf development is dependent on cell proliferation and expansion, and these processes exhibit polarity with respect to the longitudinal and transverse axes of the leaf. However, the molecular mechanism of the genetic control of seed vigor remains unknown in maize, and a better understanding of this mechanism is required. Methodology/Principal Findings To reveal the genetic architecture of leaf width, a comprehensive evaluation using four RIL populations was performed, followed by a meta-analysis. Forty-six QTLs associated with the widths of leaves at different positions above the uppermost ear were detected in the four RIL populations in three environments. The individual effects of the QTLs ranged from 4.33% to 18.01% of the observed phenotypic variation, with 14 QTLs showing effects of over 10%. We identified three common QTLs associated with leaf width at all of the examined positions, in addition to one common QTL associated with leaf width at three of the positions and six common QTLs associated with leaf width at two of the positions. The results indicate that leaf width at different leaf positions may be affected by one QTL or several of the same QTLs. Such traits may also be regulated by many different QTLs. Thirty-one of the forty-six initial QTLs were integrated into eight mQTLs through a meta-analysis, and 10 of the 14 initial QTLs presenting an R2> 10% were integrated into six mQTLs. Conclusions/Significance mQTL1-2, mQTL3-1, mQTL7, and mQTL8 were composed of the initial QTLs showing an R2> 10% and included four to six of the initial QTLs that were associated with two to four positions in a single population. Therefore, these four chromosome regions may be hot spots for important QTLs for these traits. Thus, they warrant further studies and may be useful for marker-assisted breeding.	[Guo, Shulei; Ku, Lixia; Tian, Zhiqiang; Han, Tuo; Zhang, Liangkun; Su, Huihui; Ren, Zhenzhen; Chen, Yanhui] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China; [Guo, Shulei; Ku, Lixia; Tian, Zhiqiang; Han, Tuo; Zhang, Liangkun; Su, Huihui; Ren, Zhenzhen; Chen, Yanhui] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China; [Qi, Jianshuang] Henan Acad Agr Sci, Res Inst Food Crops, Zhengzhou 450002, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Academy of Agricultural Sciences	Chen, YH (corresponding author), Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China.	chy9890@163.com			National Natural Science Foundation of China [31230055]; Science and Technology Innovation Talents of Henan University [13HASTIT002]; Corn Industry Technology System in Henan Province [S2010-02]; Key Base Research Project of Henan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Talents of Henan University; Corn Industry Technology System in Henan Province; Key Base Research Project of Henan Province	This work was supported by grants from the National Natural Science Foundation of China (No. 31230055), the Science and Technology Innovation Talents of Henan University (No. 13HASTIT002), the Corn Industry Technology System in Henan Province (S2010-02), and the Key Base Research Project of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2010, THEOR APPL GENET; [Anonymous], 2012, J EXP BOT; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Doerge RW, 1996, GENETICS, V142, P285; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; DUVICK DN, 1992, MAYDICA, V37, P69; DUVICK DN, 1977, MAYDICA, V22, P187; Fujino K, 2008, MOL GENET GENOMICS, V279, P499, DOI 10.1007/s00438-008-0328-3; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Goffinet B, 2000, GENETICS, V155, P463; Henderson DC, 2005, DEV BIOL, V282, P455, DOI 10.1016/j.ydbio.2005.03.027; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Knapp SJ., 1985, CROP SCI, V25, P192, DOI [10.2135/cropsci1985.0011183X002500010046x, DOI 10.2135/cropsci1985.0011183X002500010046x]; LANDER ES, 1989, GENETICS, V121, P185; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Lynch M., 1998, GENETICS ANAL QUANTI; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Sazuka T, 2009, PLANT J, V60, P227, DOI 10.1111/j.1365-313X.2009.03952.x; Scanlon MJ, 2000, CURR OPIN PLANT BIOL, V3, P31, DOI 10.1016/S1369-5266(99)00040-0; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; Scanlon MJ, 2000, GENETICS, V155, P1379; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Timmermans MCP, 1998, DEVELOPMENT, V125, P2813; Trachsel S, 2009, THEOR APPL GENET, V119, P1413, DOI 10.1007/s00122-009-1144-9; Tsiantis M, 2001, PLANT CELL, V13, P733, DOI 10.1105/tpc.13.4.733; Tsukaya H, 2002, ARABIDOPSIS BOOK; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; ZENG ZB, 1994, GENETICS, V136, P1457	35	11	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119095	10.1371/journal.pone.0119095	http://dx.doi.org/10.1371/journal.pone.0119095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756495	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700037
J	Pfarr, K; Danciu, C; Arlt, O; Neske, C; Dehelean, C; Pfeilschifter, JM; Radeke, HH				Pfarr, Kathrin; Danciu, Corina; Arlt, Olga; Neske, Christina; Dehelean, Cristina; Pfeilschifter, Josef M.; Radeke, Heinfried H.			Simultaneous and Dose Dependent Melanoma Cytotoxic and Immune Stimulatory Activity of Betulin	PLOS ONE			English	Article							ISOFLAVONE GENISTEIN; CELL-DEATH; T-CELLS; ACID; CANCER; SPHINGOSINE-1-PHOSPHATE; FINGOLIMOD; DISCOVERY; CARCINOMA; APOPTOSIS	Conventional cytostatic cancer treatments rarely result in the complete eradication of tumor cells. Therefore, new therapeutic strategies focus on antagonizing the immunosuppressive activity of established tumors. In particular, recent studies of antigen-loaded dendritic cells (DCs) eliciting a specific antitumor immune response has raised the hopes of achieving the complete elimination of tumor tissue. Genistein, fingolimod and betulin have already been described as active compounds in different types of cancer. Herein, we applied an integrated screening approach to characterize both their cytostatic and their immune-modulating properties side-by-side. As will be described in detail, our data confirmed that all three compounds exerted proapoptotic and antiproliferative activity in different B16 melanoma cell lines to a given extent, as revealed by an MTT assay, CFSE and DAPI staining. However, while genistein and fingolimod also affected the survival of primary bone marrow (BM) derived DCs of C57BL/6 mice, betulin exhibited a lower cytotoxicity for BMDCs in comparison to the melanoma cells. Moreover, we could show for the first time, that only betulin caused a simultaneous, highly specific immune-stimulating activity, as measured by the IL-12p70 release of Toll-like receptor 4-stimulated BMDCs by ELISA, which was due to increased IL-12p35 mRNA expression. Interestingly, the activation of DCs resulted in enhanced T lymphocyte stimulation, indicated by increased IL-2 and IFN-gamma production of cytotoxic T cells in spleen cell co-culture assays which led to a decreased viability of B16 cells in an antigen specific model system. This may overcome the immunosuppressive environment of a tumor and destroy tumor cells more effectively in vivo if the immune response is specific targeted against the tumor tissue by antigen-loaded dendritic cells. In summary, cytostatic agents, such as betulin, that simultaneously exhibit immune stimulatory activity may serve as lead compounds and hold great promise as a novel approach for an integrated cancer therapy.	[Pfarr, Kathrin; Arlt, Olga; Neske, Christina; Pfeilschifter, Josef M.; Radeke, Heinfried H.] Goethe Univ Frankfurt, Inst Gen Pharmacol & Toxicol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Danciu, Corina; Dehelean, Cristina] Univ Med & Farm Timisoara, Fac Pharm, Dept Pharmacognosy, Timisoara, Romania; [Danciu, Corina; Dehelean, Cristina] Univ Med & Farm Timisoara, Fac Pharm, Dept Toxicol, Timisoara, Romania	Goethe University Frankfurt; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Radeke, HH (corresponding author), Goethe Univ Frankfurt, Inst Gen Pharmacol & Toxicol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	radeke@em.uni-frankfurt.de	Radeke, Heinfried H/E-3772-2013	Radeke, Heinfried H/0000-0002-4499-2510; Multhoff, Gabriele/0000-0002-2616-3137; Danciu, Corina/0000-0001-5999-1214	DFG Graduate School [1172]; European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/S/136893]	DFG Graduate School(German Research Foundation (DFG)); European Social Fund, Human Resources Development Operational Programme	This project was made possible by a grant to HHR of Merck KGaA to the DFG Graduate School 1172 in support of the PhD thesis of KP. CD was supported by the European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/136893. Both funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaker H, 2013, ADV CANCER RES, V117, P143, DOI 10.1016/B978-0-12-394274-6.00006-6; Bajetta E, 2002, SEMIN ONCOL, V29, P427, DOI 10.1053/sonc.2002.35238; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Chiba K, 2012, FUTURE MED CHEM, V4, P771, DOI [10.4155/FMC.12.25, 10.4155/fmc.12.25]; Danciu C, 2013, NAT PROD COMMUN, V8, P343; Danciu C, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-58; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Dehelean CA, 2013, J BIOMED NANOTECHNOL, V9, P577, DOI 10.1166/jbn.2013.1563; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Enzenmuller S, 2013, CANCER LETT, V329, P27, DOI 10.1016/j.canlet.2012.09.007; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Fulda S, 2008, INT J MOL SCI, V9, P1096, DOI 10.3390/ijms9061096; Fulda S, 2009, DRUG DISCOV TODAY, V14, P885, DOI 10.1016/j.drudis.2009.05.015; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Li CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032380; Li Y, 2010, MOL CARCINOGEN, V49, P630, DOI 10.1002/mc.20638; Liu Y, 2012, MOL CELLS, V33, P517, DOI 10.1007/s10059-012-0022-5; Mahmoud AM, 2014, J STEROID BIOCHEM, V140, P116, DOI 10.1016/j.jsbmb.2013.12.010; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Mullauer FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005361; Nagahara Y, 2001, JPN J CANCER RES, V92, P680, DOI 10.1111/j.1349-7006.2001.tb01148.x; Oaks JJ, 2013, BLOOD, V122, P1923, DOI 10.1182/blood-2013-03-492181; Pernmpongkosol S, 2002, INT J CANCER, V98, P167, DOI 10.1002/ijc.10178; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Pradere J, 2013, ONCOGENE; Rigel D. S., 2011, CANC SKIN; Schroder M, 2011, MOL IMMUNOL, V48, P1139, DOI 10.1016/j.molimm.2011.02.007; Sharma N, 2013, J LEUKOCYTE BIOL, V93, P521, DOI 10.1189/jlb.0712328; Shi MQ, 2006, J LEUKOCYTE BIOL, V80, P1354, DOI 10.1189/jlb.0506321; Sodhi A, 2011, IMMUNOBIOLOGY, V216, P358, DOI 10.1016/j.imbio.2010.07.002; Soica CM, 2012, NAT PROD RES, V26, P968, DOI 10.1080/14786419.2010.545352; Szuster-Ciesielska A, 2011, TOXICOLOGY, V280, P152, DOI 10.1016/j.tox.2010.12.006; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Wan Y, 2013, INT IMMUNOPHARMACOL, V17, P184, DOI 10.1016/j.intimp.2013.06.012; Wei HC, 1998, CARCINOGENESIS, V19, P1509, DOI 10.1093/carcin/19.8.1509; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047979; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Zeng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034830; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614; Zhou X, 2014, NUTRITION, V30, P90, DOI 10.1016/j.nut.2013.06.006; Zitvogel L, 1996, J EXP MED, V183, P87, DOI 10.1084/jem.183.1.87; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	46	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118802	10.1371/journal.pone.0118802	http://dx.doi.org/10.1371/journal.pone.0118802			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756279	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275700025
J	Chausse, B; Vieira-Lara, MA; Sanchez, AB; Medeiros, MHG; Kowaltowski, AJ				Chausse, Bruno; Vieira-Lara, Marcel A.; Sanchez, Angelica B.; Medeiros, Marisa H. G.; Kowaltowski, Alicia J.			Intermittent Fasting Results in Tissue-Specific Changes in Bioenergetics and Redox State	PLOS ONE			English	Article							ONSET DIETARY RESTRICTION; OXIDATIVE DNA-DAMAGE; CALORIC RESTRICTION; RADICAL PRODUCTION; STRESS; INCREASE; RAT; ENZYMES; EVERY; ASSAY	Intermittent fasting (IF) is a dietary intervention often used as an alternative to caloric restriction (CR) and characterized by 24 hour cycles alternating ad libitum feeding and fasting. Although the consequences of CR are well studied, the effects of IF on redox status are not. Here, we address the effects of IF on redox state markers in different tissues in order to uncover how changes in feeding frequency alter redox balance in rats. IF rats displayed lower body mass due to decreased energy conversion efficiency. Livers in IF rats presented increased mitochondrial respiratory capacity and enhanced levels of protein carbonyls. Surprisingly, IF animals also presented an increase in oxidative damage in the brain that was not related to changes in mitochondrial bioenergetics. Conversely, IF promoted a substantial protection against oxidative damage in the heart. No difference in mitochondrial bioenergetics or redox homeostasis was observed in skeletal muscles of IF animals. Overall, IF affects redox balance in a tissue-specific manner, leading to redox imbalance in the liver and brain and protection against oxidative damage in the heart.	[Chausse, Bruno; Vieira-Lara, Marcel A.; Sanchez, Angelica B.; Medeiros, Marisa H. G.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo	Kowaltowski, AJ (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	Kowaltowski, Alicia J/H-8698-2012; Medeiros, Marisa H. G./A-5212-2008; de Medeiros, Marisa Helena Gennari/AAA-8015-2019; Chausse, Bruno/D-7449-2015; Sanchez, Angélica/ABD-4656-2020	Medeiros, Marisa H. G./0000-0002-5438-1174; de Medeiros, Marisa Helena Gennari/0000-0002-5438-1174; Vieira-Lara, Marcel/0000-0003-3115-3520; Sanchez, Angelica Bianchini/0000-0001-7107-7193	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51906]; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma) [13/07937-8]; John Simon Guggenheim Memorial Foundation; FAPESP [13/14203-0]; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma); John Simon Guggenheim Memorial Foundation; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant 10/51906, Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma), Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma), Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma) grant 13/07937-8, and the John Simon Guggenheim Memorial Foundation. MAVL (grant 13/14203-0) is supported by an undergraduate fellowship from FAPESP. BC is supported by a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Armeni T, 1998, MECH AGEING DEV, V101, P101, DOI 10.1016/S0047-6374(97)00167-X; Cardoso AR, 2012, FREE RADICAL BIO MED, V52, P2201, DOI 10.1016/j.freeradbiomed.2012.03.008; Carlson Anton J., 1946, JOUR NUTRITION, V31, P363, DOI 10.1093/jn/31.3.363; Caro P, 2008, REJUV RES, V11, P621, DOI 10.1089/rej.2008.0704; Castello L, 2010, FREE RADICAL BIO MED, V48, P47, DOI 10.1016/j.freeradbiomed.2009.10.003; Cerqueira FM, 2013, AGEING RES REV, V12, P22, DOI 10.1016/j.arr.2012.03.009; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094; Chausse B, 2014, ENDOCRINOLOGY, V155, P2456, DOI 10.1210/en.2013-2057; Esworthy RS, 1999, CURRENT PROTOCOLS TO; Ferranti R, 2003, FEBS LETT, V536, P51, DOI 10.1016/S0014-5793(03)00007-3; GOLDSTEI.DB, 1968, ANAL BIOCHEM, V24, P431, DOI 10.1016/0003-2697(68)90148-6; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3; Kowaltowski AJ, 2011, REDOX REP, V16, P237, DOI 10.1179/1351000211Y.0000000014; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Nicholls DG, 2002, BIOENERGETICS, V3; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Radak Z, 2002, EXP GERONTOL, V37, P1423, DOI 10.1016/S0531-5565(02)00116-X; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Sharma S, 2010, BIOGERONTOLOGY, V11, P197, DOI 10.1007/s10522-009-9240-4; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Walsh ME, 2014, FREE RADICAL BIO MED, V66, P88, DOI 10.1016/j.freeradbiomed.2013.05.037; Wolf FI, 2005, EXP GERONTOL, V40, P181, DOI 10.1016/j.exger.2004.11.002	40	42	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120413	10.1371/journal.pone.0120413	http://dx.doi.org/10.1371/journal.pone.0120413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749501	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400095
J	Chen, L; Yu, B; Zhang, YF; Gao, X; Zhu, L; Ma, TH; Yang, H				Chen, Lei; Yu, Bo; Zhang, Yaofang; Gao, Xin; Zhu, Liang; Ma, Tonghui; Yang, Hong			Bioactivity-Guided Fractionation of an Antidiarrheal Chinese Herb Rhodiola kirilowii (Regel) Maxim Reveals (-)-Epicatechin-3-Gallate and (-)-Epigallocatechin-3-Gallate as Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator	PLOS ONE			English	Article							NATURAL-PRODUCTS; CFTR INHIBITORS; MOLECULAR-BASIS; CHOLERA-TOXIN; CHANNEL; THERAPY; DISCOVERY; EGCG; ACTIVATORS; RESOURCES	Cystic fibrosis transmembrane conductance regulator (CFTR) is the principal apical route for transepithelial fluid transport induced by enterotoxin. Inhibition of CFTR has been confirmed as a pharmaceutical approach for the treatment of secretory diarrhea. Many traditional Chinese herbal medicines, like Rhodiola kirilowii (Regel) Maxim, have long been used for the treatment of secretory diarrhea. However, the active ingredients responsible for their therapeutic effectiveness remain unknown. The purpose of this study is to identify CFTR inhibitors from Rhodiola kirilowii (Regel) Maxim via bioactivity-directed isolation strategy. We first identified fractions of Rhodiola kirilowii (Regel) Maxim that inhibited CFTR Cl- channel activity. Further bioactivity-directed fractionation led to the identification of (-)-epigallocatechin-3-gallate (EGCG) as CFTR Cl- channel inhibitor. Analysis of 5 commercially available EGCG analogs including (+)-catechins (C), (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin-3-gallate (ECG) and EGCG revealed that ECG also had CFTR inhibitory activity. EGCG dose-dependently and reversibly inhibited CFTR Cl- channel activity in transfected FRT cells with an IC50 value around 100 mu M. In ex vivo studies, EGCG and ECG inhibited CFTR-mediated short-circuit currents in isolated rat colonic mucosa in a dose-dependent manner. In an intestinal closed-loop model in mice, intraluminal application of EGCG (10 mu g) and ECG (10 mu g) significantly reduced cholera toxin-induced intestinal fluid secretion. CFTR Cl-channel is a molecular target of natural compounds EGCG and ECG. CFTR inhibition may account, at least in part, for the antidiarrheal activity of Rhodiola kirilowii (Regel) Maxim. EGCG and ECG could be new lead compounds for development of CFTR-related diseases such as secretory diarrhea.	[Chen, Lei; Yu, Bo; Ma, Tonghui; Yang, Hong] Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian 116029, Peoples R China; [Zhang, Yaofang; Zhu, Liang; Ma, Tonghui] Dalian Med Univ, Coll Basic Med Sci, Dalian 116044, Peoples R China; [Gao, Xin] Yanbian Univ, Sch Med, Yanji 133002, Peoples R China	Liaoning Normal University; Dalian Medical University; Yanbian University	Yang, H (corresponding author), Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian 116029, Peoples R China.	hyanglnnu@gmail.com		Ma, Tonghui/0000-0001-9338-1030	National Natural Science Foundation of China [81473265, 31471099, 81173109, 30973577]; Specialized Research Fund for the Doctoral Program of Higher Education [20112136110002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (No. 81473265; 31471099; 81173109; 30973577), Specialized Research Fund for the Doctoral Program of Higher Education (20112136110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; He CY, 2004, CHEM RES CHINESE U, V20, P334; Hsiao WLW, 2010, PLANTA MED, V76, P1118, DOI 10.1055/s-0030-1250186; Huang ZJ, 2011, MINI-REV MED CHEM, V11, P1122, DOI 10.2174/138955711797655362; Jiang MA, 2010, PLANTA MED, V76, P2048, DOI 10.1055/s-0030-1250456; Li T, 2013, ANTIVIR RES, V97, P1, DOI 10.1016/j.antiviral.2012.10.006; Li XM, 2011, MT SINAI J MED, V78, P697, DOI 10.1002/msj.20294; Luzhetskyy A, 2007, CURR OPIN INVEST DR, V8, P608; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; May BH, 2012, J ALTERN COMPLEM MED, V18, P1101, DOI 10.1089/acm.2011.0587; Moran O, 2008, J CYST FIBROS, V7, P483, DOI 10.1016/j.jcf.2008.05.003; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Muanprasat C, 2007, BIOL PHARM BULL, V30, P502, DOI 10.1248/bpb.30.502; Muanprasat C, 2012, J PHARMACOL SCI, V118, P82, DOI 10.1254/jphs.11153FP; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Reygaert W, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00162; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Smith AJ, 2013, MOL PHARMACEUT, V10, P2948, DOI 10.1021/mp4000794; Thiagarajah JR, 2012, CLIN PHARMACOL THER, V92, P287, DOI 10.1038/clpt.2012.114; Thiagarajah JR, 2013, CURR OPIN PHARMACOL, V13, P888, DOI 10.1016/j.coph.2013.08.005; Thiagarajah JR, 2005, TRENDS PHARMACOL SCI, V26, P172, DOI 10.1016/j.tips.2005.02.003; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; TODA M, 1992, MICROBIOL IMMUNOL, V36, P999, DOI 10.1111/j.1348-0421.1992.tb02103.x; Velazquez C, 2009, J ETHNOPHARMACOL, V126, P455, DOI 10.1016/j.jep.2009.09.016; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wang XF, 2004, EXP PHYSIOL, V89, P417, DOI 10.1113/expphysiol.2003.027003; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yang SP, 2012, ACTA PHARMACOL SIN, V33, P1147, DOI 10.1038/aps.2012.105; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094302	42	21	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119122	10.1371/journal.pone.0119122	http://dx.doi.org/10.1371/journal.pone.0119122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747701	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400045
J	Chen, TS; Liu, JN; Li, N; Wang, SJ; Liu, H; Li, JY; Zhang, Y; Bu, PL				Chen, Tongshuai; Liu, Junni; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili			Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart through the Deacetylation of LCAD	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; FATTY-ACID OXIDATION; DEPENDENT DEACETYLASE; LYSINE ACETYLATION; WALL STRESS; MITOCHONDRIAL; HOMOLOG; GENE; METABOLISM; ACTIVATION	Cardiac hypertrophy is an adaptive response to pressure, volume stress, and loss of contractile mass from prior infarction. Metabolic changes in cardiac hypertrophy include suppression of fatty acid oxidation and enhancement of glucose utilization, which could result in lipid accumulation in the heart. SIRT3, a mitochondrial NAD+-dependent deacetylase, has been demonstrated to play a crucial role in controlling the acetylation status of many enzymes participating in energy metabolism. However, the role of SIRT3 in the pathogenesis of hypertrophy-related lipid accumulation remains unclear. In this study, hypertrophy-related lipid accumulation was investigated using a mouse cardiac hypertrophy model induced by transverse aortic constriction (TAC). We showed that mice developed heart failure six weeks after TAC. Furthermore, abnormal lipid accumulation and decreased palmitate oxidation rates were observed in the hypertrophic hearts, and these changes were particularly significant in SIRT3-KO mice. We also demonstrated that the short form of SIRT3 was downregulated in wild-type (WT) hypertrophic hearts and that this change was accompanied by a higher acetylation level of long-chain acyl CoA dehydrogenase (LCAD), which is a key enzyme participating in fatty acid oxidation. In addition, SIRT3 may play an essential role in attenuating lipid accumulation in the heart through the deacetylation of LCAD.	[Chen, Tongshuai; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Chen, Tongshuai; Liu, Junni; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Chen, Tongshuai; Liu, Junni; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Bu, PL (corresponding author), Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China.	bupeili@gmail.com.cn			National Natural Science Foundation of China [81170133, 81070074]; National 973 Basic Research Program of China [2012CB722406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81170133, 81070074) and the National 973 Basic Research Program of China (No. 2012CB722406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; CHVAPIL M, 1984, PLAST RECONSTR SURG, V73, P438, DOI 10.1097/00006534-198403000-00018; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Fang ZQ, 2014, FOOD CHEM TOXICOL, V66, P210, DOI 10.1016/j.fct.2014.01.049; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOOD WP, 1968, AM J CARDIOL, V22, P550, DOI 10.1016/0002-9149(68)90161-6; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lehman John J, 2002, Heart Fail Rev, V7, P175; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; LITWIN SE, 1990, AM J PHYSIOL, V258, pH51, DOI 10.1152/ajpheart.1990.258.1.H51; Liu JN, 2013, INT J MOL SCI, V14, P5633, DOI 10.3390/ijms14035633; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Ohsawa S, 2006, FEBS LETT, V580, P5875, DOI 10.1016/j.febslet.2006.09.051; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; SANDLER H, 1963, CIRC RES, V13, P91, DOI 10.1161/01.RES.13.2.91; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	96	100	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118909	10.1371/journal.pone.0118909	http://dx.doi.org/10.1371/journal.pone.0118909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748450	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400030
J	Mallol, A; Santalo, J; Ibanez, E				Mallol, Anna; Santalo, Josep; Ibanez, Elena			Improved Development of Somatic Cell Cloned Mouse Embryos by Vitamin C and Latrunculin A	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; IN-VITRO DEVELOPMENT; L-ASCORBIC-ACID; HISTONE DEACETYLASE; DNA DEMETHYLATION; BOVINE EMBRYOS; MAMMALIAN DEVELOPMENT; ALPHA-TOCOPHEROL; PORCINE OOCYTES; VALPROIC ACID	Impaired development of embryos produced by somatic cell nuclear transfer (SCNT) is mostly associated with faulty reprogramming of the somatic nucleus to a totipotent state and can be improved by treatment with epigenetic modifiers. Here we report that addition of 100 mu M vitamin C (VitC) to embryo culture medium for at least 16 h post-activation significantly increases mouse blastocyst formation and, when combined with the use of latrunculin A (LatA) during micromanipulation and activation procedures, also development to term. In spite of this, no significant effects on pluripotency (OCT4 and NANOG) or nuclear reprogramming markers (H3K14 acetylation, H3K9 methylation and DNA methylation and hydroxymethylation) could be detected. The use of LatA alone significantly improved in vitro development, but not full-term development. On the other hand, the simultaneous treatment of cloned embryos with VitC and the histone deacetylase inhibitor psammaplin A (PsA), in combination with the use of LatA, resulted in cloning efficiencies equivalent to those of VitC or PsA treatments alone, and the effects on pluripotency and nuclear reprogramming markers were less evident than when only the PsA treatment was applied. These results suggest that although both epigenetic modifiers improve cloning efficiencies, possibly through different mechanisms, they do not show an additive effect when combined. Improvement of SCNT efficiency is essential for its applications in reproductive and therapeutic cloning, and identification of molecules which increase this efficiency should facilitate studies on the mechanism of nuclear reprogramming and acquisition of totipotency.	[Mallol, Anna; Santalo, Josep; Ibanez, Elena] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Cellular Fisiol & Immunol, Bellaterra, Spain	Autonomous University of Barcelona	Ibanez, E (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Cellular Fisiol & Immunol, Bellaterra, Spain.	elena.ibanez@uab.cat	Santalo, Josep/K-4979-2014; Mallol, Anna/L-2393-2017; Ibáñez, Elena/K-4320-2014; Santalo, Josep/AAE-8022-2020	Santalo, Josep/0000-0002-1698-9699; Mallol, Anna/0000-0001-7366-0980; Ibáñez, Elena/0000-0002-0275-6958; Santalo, Josep/0000-0002-1698-9699	Spanish Ministerio de Ciencia e Innovacion [AGL 2011-23784]; Generalitat de Catalunya [2009 SGR 282]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (AGL 2011-23784) and the Generalitat de Catalunya (2009 SGR 282). AM is a predoctoral fellow of the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, BIOL REPROD; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cavaleri FM, 2008, MECH DEVELOP, V125, P153, DOI 10.1016/j.mod.2007.09.007; Chan MM, 2012, NAT GENET, V44, P978, DOI 10.1038/ng.2382; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chawalit S, 2012, REPROD SCI, V19, P976, DOI 10.1177/1933719112440049; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gurdon JB, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002659; Himaki T, 2010, CELL REPROGRAM, V12, P127, DOI 10.1089/cell.2009.0066; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huang YY, 2011, BIOCHEM BIOPH RES CO, V411, P397, DOI 10.1016/j.bbrc.2011.06.160; Jafari S, 2011, MOL REPROD DEV, V78, P576, DOI 10.1002/mrd.21344; Jeong YW, 2006, THERIOGENOLOGY, V66, P2104, DOI 10.1016/j.theriogenology.2006.06.007; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kere M, 2013, J REPROD DEVELOP, V59, P78; Kim DH, 2007, EXP MOL MED, V39, P47, DOI 10.1038/emm.2007.6; Kim DY, 1999, ARCH PHARM RES, V22, P25, DOI 10.1007/BF02976431; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Krishnakumar R, 2013, CURR OPIN GENET DEV, V23, P548, DOI 10.1016/j.gde.2013.06.005; Lee AR, 2010, DIFFERENTIATION, V80, pS28, DOI 10.1016/j.diff.2010.09.041; Li Q, 2014, CELL REPROGRAM, V16, P290, DOI 10.1089/cell.2013.0088; Maalouf WE, 2008, EPIGENETICS-US, V3, P199, DOI 10.4161/epi.3.4.6497; Maalouf WE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-11; Mallol A, 2014, CELL REPROGRAM, V16, P392, DOI 10.1089/cell.2014.0012; Mallol A, 2013, SYST BIOL REPROD MED, V59, P117, DOI 10.3109/19396368.2012.760120; Mason K, 2012, ANIM REPROD SCI, V134, P45, DOI 10.1016/j.anireprosci.2012.08.010; Meng QG, 2008, CLONING STEM CELLS, V10, P429, DOI 10.1089/clo.2008.0003; Miyoshi K, 2010, CELL REPROGRAM, V12, P67, DOI 10.1089/cell.2009.0032; Monfort A, 2013, EMBO REP, V14, P337, DOI 10.1038/embor.2013.29; Moreira PN, 2003, MOL REPROD DEV, V66, P98, DOI 10.1002/mrd.10335; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Park SJ, 2012, CELL REPROGRAM, V14, P398, DOI 10.1089/cell.2012.0007; Tao Y, 2004, REPROD DOMEST ANIM, V39, P52, DOI 10.1046/j.1439-0531.2003.00478.x; Tatemoto H, 2001, BIOL REPROD, V65, P1800, DOI 10.1095/biolreprod65.6.1800; Terashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078380; Terashita Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098764; Tsuji Y, 2009, ZYGOTE, V17, P109, DOI 10.1017/S0967199408005133; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang X, 2002, FERTIL STERIL, V78, P1272, DOI 10.1016/S0015-0282(02)04236-X; Wongsrikeao P, 2007, MOL REPROD DEV, V74, P694, DOI 10.1002/mrd.20640; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038	58	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120033	10.1371/journal.pone.0120033	http://dx.doi.org/10.1371/journal.pone.0120033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749170	Green Published, Green Submitted, gold			2022-12-26	WOS:000350689400093
J	Narihiro, T; Kim, NK; Mei, R; Nobu, MK; Liu, WT				Narihiro, Takashi; Kim, Na-Kyung; Mei, Ran; Nobu, Masaru K.; Liu, Wen-Tso			Microbial Community Analysis of Anaerobic Reactors Treating Soft Drink Wastewater	PLOS ONE			English	Article							IMMOBILIZED CELL BIOREACTORS; SP-NOV.; METHANOGENIC CONSORTIA; POLYETHYLENE-GLYCOL; TROPHIC GROUPS; GEN.-NOV.; INDUSTRY; BACTERIUM; DIGESTION; SLUDGE	The anaerobic packed-bed (AP) and hybrid packed-bed (HP) reactors containing methanogenic microbial consortia were applied to treat synthetic soft drink wastewater, which contains polyethylene glycol (PEG) and fructose as the primary constituents. The AP and HP reactors achieved high COD removal efficiency (>95%) after 80 and 33 days of the operation, respectively, and operated stably over 2 years. 16S rRNA gene pyrotag analyses on a total of 25 biofilm samples generated 98,057 reads, which were clustered into 2,882 operational taxonomic units (OTUs). Both AP and HP communities were predominated by Bacteroidetes, Chloroflexi, Firmicutes, and candidate phylum KSB3 that may degrade organic compound in wastewater treatment processes. Other OTUs related to uncharacterized Geobacter and Spirochaetes clades and candidate phylum GN04 were also detected at high abundance; however, their relationship to wastewater treatment has remained unclear. In particular, KSB3, GN04, Bacteroidetes, and Chloroflexi are consistently associated with the organic loading rate (OLR) increase to 1.5 g COD/L-d. Interestingly, KSB3 and GN04 dramatically decrease in both reactors after further OLR increase to 2.0 g COD/L-d. These results indicate that OLR strongly influences microbial community composition. This suggests that specific uncultivated taxa may take central roles in COD removal from soft drink wastewater depending on OLR.	[Narihiro, Takashi; Kim, Na-Kyung; Mei, Ran; Nobu, Masaru K.; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Narihiro, Takashi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Higashi Ku, Tsukuba, Ibaraki 3058566, Japan	University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Advanced Industrial Science & Technology (AIST)	Liu, WT (corresponding author), Univ Illinois, Dept Civil & Environm Engn, 205 North Mathews Ave, Urbana, IL 61801 USA.	wtliu@illinois.edu	Narihiro, Takashi/L-8617-2016; Liu, Wen-Tso/C-8788-2011	Narihiro, Takashi/0000-0003-2936-7204; Liu, Wen-Tso/0000-0002-8700-9803; Mei, Ran/0000-0002-6464-6519	PepsiCo Inc.; Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign	PepsiCo Inc.; Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign	This study was supported by PepsiCo Inc., and Masaru Nobu was supported by the Teracon fellowship from the Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign. Takashi Narihiro was a visiting scholar from Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, Japan. The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript in this study.	[Anonymous], 1997, CHEMICAL OXYGEN DEMA; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Blanc FC, 1984, PROCEEDINGS OF THE 3, P243; BORJA R, 1994, J CHEM TECHNOL BIOT, V60, P327, DOI 10.1002/jctb.280600314; BORJA R, 1993, BIOTECHNOL LETT, V15, P767, DOI 10.1007/BF01080153; Camperos ER, 2004, WATER SCI TECHNOL, V50, P107, DOI 10.2166/wst.2004.0101; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen J. P., 2006, WASTE TREATMENT IN T, P255; Chen SY, 2005, INT J SYST EVOL MICR, V55, P2257, DOI 10.1099/ijs.0.63807-0; Coates JD, 2001, INT J SYST EVOL MICR, V51, P581, DOI 10.1099/00207713-51-2-581; COLWELL R. K., 2013, ESTIMATES STATISTICA; De Vuyst L, 2011, INT J FOOD MICROBIOL, V149, P73, DOI 10.1016/j.ijfoodmicro.2011.03.003; DWYER DF, 1986, APPL ENVIRON MICROB, V52, P852, DOI 10.1128/AEM.52.4.852-856.1986; DWYER DF, 1983, APPL ENVIRON MICROB, V46, P185, DOI 10.1128/AEM.46.1.185-190.1983; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eeckhaut V, 2010, INT J SYST EVOL MICR, V60, P1108, DOI 10.1099/ijs.0.015289-0; Euromonitor International, 2014, PASSPORT GLOBAL MARK; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia-Morales MA, 2012, J ENVIRON SCI HEAL A, V47, P22, DOI 10.1080/10934529.2012.629575; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004; Grady JLCP, 1999, BIOLOGICAL WASTEWATE; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HANOVER LM, 1993, AM J CLIN NUTR, V58, P724, DOI 10.1093/ajcn/58.5.724S; Haroon H, 2013, J CHEM SOC PAKISTAN, V35, P5; Harper SR, 1997, WATER SCI TECHNOL, V36, P33, DOI 10.1016/S0273-1223(97)00504-0; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Hemm D, 2001, US Patent, Patent No. [6,108,578, 6108578]; HOUSLEY JN, 1994, J INST WATER ENV MAN, V8, P239; Hsine EA, 2005, ENVIRON TECHNOL, V26, P1309, DOI 10.1080/09593332608618605; Ito T, 2012, BIORESOURCE TECHNOL, V123, P599, DOI 10.1016/j.biortech.2012.07.108; Kalyuzhnyi SV, 1997, APPL BIOCHEM BIOTECH, V66, P291, DOI 10.1007/BF02785595; Kampmann K, 2012, APPL ENVIRON MICROB, V78, P2106, DOI 10.1128/AEM.06394-11; Kato S, 2012, ENVIRON MICROBIOL, V14, P1646, DOI 10.1111/j.1462-2920.2011.02611.x; Kato S, 2010, MICROBES ENVIRON, V25, P145, DOI 10.1264/jsme2.ME10122; Lee SH, 2013, BIORESOURCE TECHNOL, V145, P25, DOI 10.1016/j.biortech.2013.02.070; Leps J., 2003, MULTIVARIATE ANALYSI; Mata-Alvarez J, 2000, BIORESOURCE TECHNOL, V74, P3, DOI 10.1016/S0960-8524(00)00023-7; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MIN H, 1989, APPL ENVIRON MICROB, V55, P488, DOI 10.1128/AEM.55.2.488-491.1989; Miyaki H, 2000, DESALINATION, V131, P47, DOI 10.1016/S0011-9164(00)90005-5; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; Narihiro T, 2015, ENVIRON MICROBIOL, V17, P1707, DOI 10.1111/1462-2920.12616; Narihiro T, 2012, WATER RES, V46, P2167, DOI 10.1016/j.watres.2012.01.034; Narihiro T, 2009, MICROBES ENVIRON, V24, P88, DOI 10.1264/jsme2.ME08561; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Ng KK, 2011, WATER RES, V45, P4269, DOI 10.1016/j.watres.2011.05.031; Peixoto G, 2011, INT J HYDROGEN ENERG, V36, P8953, DOI 10.1016/j.ijhydene.2011.05.014; Pons M.-N., 2004, COMPUTER APPLICATION, V37, P299, DOI [10.1016/S1474-6670(17)32597-1, DOI 10.1016/S1474-6670(17)32597-1]; Qiu YL, 2014, ARCH MICROBIOL, V196, P149, DOI 10.1007/s00203-013-0951-1; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHINK B, 1983, APPL ENVIRON MICROB, V45, P1905, DOI 10.1128/AEM.45.6.1905-1913.1983; Schink B., 2013, PROKARYOTES PROKARYO, P471, DOI DOI 10.1007/978-3-642-30123-0_59; Sekiguchi Y, 2004, STRICT AND FACULTATIVE ANAEROBES: MEDICAL AND ENVIRONMENTAL ASPECTS, P361; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; TEBAI L, 1992, WATER SCI TECHNOL, V25, P45, DOI 10.2166/wst.1992.0008; Ueki A, 2006, INT J SYST EVOL MICR, V56, P39, DOI 10.1099/ijs.0.63896-0; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yamada T, 2007, ISME J, V1, P246, DOI 10.1038/ismej.2007.28; Yamada T, 2011, APPL ENVIRON MICROB, V77, P2081, DOI 10.1128/AEM.02475-10; Zheng D, 2006, BIOTECHNOL BIOENG, V94, P458, DOI 10.1002/bit.20870	65	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119131	10.1371/journal.pone.0119131	http://dx.doi.org/10.1371/journal.pone.0119131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748027	gold, Green Published, Green Submitted			2022-12-26	WOS:000350689400047
J	Chow, CY; Avila, FW; Clark, AG; Wolfner, MF				Chow, Clement Y.; Avila, Frank W.; Clark, Andrew G.; Wolfner, Mariana F.			Induction of Excessive Endoplasmic Reticulum Stress in the Drosophila Male Accessory Gland Results in Infertility	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SEMINAL PROTEINS; GENE-EXPRESSION; ER STRESS; MELANOGASTER; FEMALE; REVEALS; IRE1; FATE	Endoplasmic reticulum (ER) stress occurs when misfolded proteins accumulate in the lumen of the ER. A cell responds to ER stress with the unfolded protein response (UPR), a complex program of transcriptional and translational changes aimed at clearing misfolded proteins. Secretory tissues and cells are particularly well adapted to respond to ER stress because their function requires high protein production and secretory load. The insect male accessory gland (AG) is a secretory tissue involved in male fertility. The AG secretes many seminal fluid proteins (SFPs) essential for male reproduction. Among adult Drosophila tissues, we find that genes upregulated by ER stress are most highly expressed in the AG, suggesting that the AG is already undergoing high levels of ER stress due to its normal secretory functions. We hypothesized that induction of excessive ER stress in the AG above basal levels, would perturb normal function and provide a genetic tool for studying AG and SFP biology. To test this, we genetically induced excessive ER stress in the AG by conditional 1) expression of a misfolded protein or 2) knockdown of the UPR regulatory protein, BiP. Both genetic manipulations induced excessive ER stress in the AG, as indicated by the increase in Xbp1 splicing, a marker of ER stress. Both models resulted in a large decrease in or loss of SFP production and male infertility. Sperm production, motility, and transfer appeared unaffected. The induction of strong ER stress in the insect male AG may provide a simple way for studying or manipulating male fertility, as it eliminates AG function while preserving sperm production.	[Chow, Clement Y.; Avila, Frank W.; Clark, Andrew G.; Wolfner, Mariana F.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Cornell University	Chow, CY (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	cyc8@cornell.edu	Avila, Frank/AAH-9459-2021	Clark, Andrew/0000-0001-7159-8511; Avila, Frank/0000-0002-7278-0646	National Institutes of Health [R01-HD059060, R01-HD038921]; National Institutes of Health/National Institute of Child Health and Human Development training grant in reproductive genomics [T32-HD052471]; National Institutes of Health/National Research Service Award fellowship [1F32GM093663-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471, R01HD038921, R01HD059060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Child Health and Human Development training grant in reproductive genomics; National Institutes of Health/National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-HD059060 to AGC and MFW and R01-HD038921 to MW. For part of this research, CYC was supported by a traineeship under a National Institutes of Health/National Institute of Child Health and Human Development training grant in reproductive genomics (T32-HD052471). Subsequently he was supported by a National Institutes of Health/National Research Service Award fellowship 1F32GM093663-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EM, 2007, J INSECT PHYSIOL, V53, P319, DOI 10.1016/j.jinsphys.2006.12.003; Alfonso-Parra C, 2014, J INSECT PHYSIOL, V70, P117, DOI 10.1016/j.jinsphys.2014.07.004; Appocher C, 2014, HUM MOL GENET, V23, P6762, DOI 10.1093/hmg/ddu393; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Avila FW, 2009, P NATL ACAD SCI USA, V106, P15796, DOI 10.1073/pnas.0904029106; BERTRAM MJ, 1992, MECH DEVELOP, V38, P33, DOI 10.1016/0925-4773(92)90036-J; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chow CY, 2013, P NATL ACAD SCI USA, V110, P9013, DOI 10.1073/pnas.1307125110; DIBENEDETTO AJ, 1990, DEV BIOL, V139, P134, DOI 10.1016/0012-1606(90)90284-P; Findlay GD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004108; FOWLER GL, 1973, ADV GENET, V17, P293, DOI 10.1016/S0065-2660(08)60173-X; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; GILBERT DG, 1981, J INSECT PHYSIOL, V27, P641, DOI 10.1016/0022-1910(81)90112-8; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Gligorov D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003395; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2013, BIOCHIM BIOPHYS ACTA; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; KALB JM, 1993, P NATL ACAD SCI USA, V90, P8093, DOI 10.1073/pnas.90.17.8093; Kang MJ, 2012, NAT CELL BIOL, V14, P409, DOI 10.1038/ncb2447; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Kaufmann P, 1942, AM NAT, V76, P445, DOI 10.1086/281068; LaFlamme BA, 2014, GENETICS, V196, P1117, DOI 10.1534/genetics.113.160101; LEFEVRE G, 1962, GENETICS, V42, P1719; Manier MK, 2010, SCIENCE, V328, P354, DOI 10.1126/science.1187096; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; MONSMA SA, 1990, DEV BIOL, V142, P465, DOI 10.1016/0012-1606(90)90368-S; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Moustaqim-Barrette A, 2014, HUM MOL GENET, V23, P1975, DOI 10.1093/hmg/ddt594; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Ram KR, 2009, P NATL ACAD SCI USA, V106, P15384, DOI 10.1073/pnas.0902923106; Ram KR, 2006, P NATL ACAD SCI USA, V103, P18674, DOI 10.1073/pnas.0606228103; Rosenbaum EE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004349; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Ryoo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075774; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069147; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wolfner M.F., 2007, P183; Xue L, 2002, DEVELOPMENT, V129, P339; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	46	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119386	10.1371/journal.pone.0119386	http://dx.doi.org/10.1371/journal.pone.0119386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742606	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100106
J	Puig, KL; Manocha, GD; Combs, CK				Puig, Kendra L.; Manocha, Gunjan D.; Combs, Colin K.			Amyloid Precursor Protein Mediated Changes in Intestinal Epithelial Phenotype In Vitro	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; BETA-PROTEIN; ALZHEIMERS-DISEASE; PROINFLAMMATORY CYTOKINE; MOUSE MODELS; WEIGHT-LOSS; CELLS; EXPRESSION; ACTIVATION; RELEASE	Background Although APP and its proteolytic metabolites have been well examined in the central nervous system, there remains limited information of their functions outside of the brain. For example, amyloid precursor protein (APP) and amyloid beta (A beta) immunoreactivity have both been demonstrated in intestinal epithelial cells. Based upon the critical role of these cells in absorption and secretion, we sought to determine whether APP or its metabolite amyloid beta (A beta), had a definable function in these cells. Methodology/Principal Findings The human colonic epithelial cell line, Caco-2 cells, were cultured to examine APP expression and A beta secretion, uptake, and stimulation. Similar to human colonic epithelium stains, Caco-2 cells expressed APP. They also secreted A beta 1-40 and A beta 1-42, with LPS stimulating higher concentrations of A beta 1-40 secretion. The cells also responded to A beta 1-40 stimulation by increasing IL-6 cytokine secretion and decreasing cholesterol uptake. Conversely, stimulation with a sAPP-derived peptide increased cholesterol uptake. APP was associated with CD36 but not FATP4 in co-IP pull down experiments from the Caco-2 cells. Moreover, stimulation of APP with an agonist antibody acutely decreased CD36-mediated cholesterol uptake. Conclusions/Significance APP exists as part of a multi-protein complex with CD36 in human colonic epithelial cells where its proteolytic fragments have complex, reciprocal roles in regulating cholesterol uptake. A biologically active peptide fragment from the N-terminal derived, sAPP, potentiated cholesterol uptake while the beta secretase generated product, A beta 1-40, attenuated it. These data suggest that APP is important in regulating intestinal cholesterol uptake in a fashion dependent upon specific proteolytic pathways. Moreover, this biology may be applicable to cells beyond the gastrointestinal tract.	[Puig, Kendra L.; Manocha, Gunjan D.; Combs, Colin K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Combs, CK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA.	colin.combs@med.und.edu	Manocha, Gunjan/AAF-2471-2020	Manocha, Gunjan/0000-0003-4488-6627	National Institutes of Health [5R01AG042819-03]; NATIONAL INSTITUTE ON AGING [R01AG042819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health 5R01AG042819-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2008, MICROBIOL IMMUNOL, V52, P429, DOI 10.1111/j.1348-0421.2008.00054.x; Ano Y, 2009, HISTOL HISTOPATHOL, V24, P283, DOI 10.14670/HH-24.283; ARAI H, 1991, ANN NEUROL, V30, P686, DOI 10.1002/ana.410300509; Ariga T, 2001, J MOL NEUROSCI, V17, P371, DOI 10.1385/JMN:17:3:371; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgess BL, 2006, NEUROBIOL DIS, V24, P114, DOI 10.1016/j.nbd.2006.06.007; CABAL A, 1995, BRAIN RES BULL, V38, P417, DOI 10.1016/0361-9230(95)02006-D; Castellano J, 2014, J VASC RES, V51, P58, DOI 10.1159/000356334; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Chong YH, 2001, J BIOL CHEM, V276, P23511, DOI 10.1074/jbc.M009466200; Combs CK, 2001, J NEUROSCI, V21, P1179; Ebert EC, 2008, AM J GASTROENTEROL, V103, P776, DOI 10.1111/j.1572-0241.2007.01669.x; Fernandez PL, 2013, J ALZHEIMERS DIS, V33, P297, DOI 10.3233/JAD-2012-121222; Gakis G, 2009, AUTON NEUROSCI-BASIC, V148, P63, DOI 10.1016/j.autneu.2009.03.004; Galloway S, 2007, J NUTR BIOCHEM, V18, P279, DOI 10.1016/j.jnutbio.2006.07.003; Galloway S, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-15; Galloway S, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-46; Ge YM, 2000, J INFECT DIS, V182, P873, DOI 10.1086/315784; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Imaeda H, 2002, HISTOCHEM CELL BIOL, V118, P381, DOI 10.1007/s00418-002-0458-3; Inelmen EM, 2010, AGING CLIN EXP RES, V22, P192, DOI [10.3275/6677, 10.1007/BF03324796]; James AP, 2003, J ALZHEIMERS DIS, V5, P179, DOI 10.3233/JAD-2003-5302; Jijon HB, 2005, EUR J IMMUNOL, V35, P718, DOI 10.1002/eji.200425688; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOHANSON JF, 1992, DIGEST DIS SCI, V37, P179, DOI 10.1007/BF01308169; KLEGERIS A, 1994, BIOCHEM BIOPH RES CO, V199, P984, DOI 10.1006/bbrc.1994.1326; Koudinov AR, 1997, CELL BIOL INT, V21, P265, DOI 10.1006/cbir.1996.0126; Koudinova NV, 1996, FEBS LETT, V395, P204, DOI 10.1016/0014-5793(96)01042-3; Lam V, 2011, NEUROSCI LETT, V492, P160, DOI 10.1016/j.neulet.2011.02.001; Lorton D, 1997, MECH AGEING DEV, V94, P199, DOI 10.1016/S0047-6374(96)01847-7; Lorton D, 1996, J NEUROIMMUNOL, V67, P21, DOI 10.1016/S0165-5728(96)00030-6; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Pallebage-Gamarallage MM, 2009, BRIT J NUTR, V101, P340, DOI 10.1017/S0007114508012269; Puig KL, 2012, J NEUROIMMUNE PHARM, V7, P215, DOI 10.1007/s11481-011-9327-y; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Santaolalla R, 2011, CURR OPIN GASTROEN, V27, P125, DOI 10.1097/MOG.0b013e3283438dea; Sattianayagam PT, 2009, NAT REV GASTRO HEPAT, V6, P608, DOI 10.1038/nrgastro.2009.147; Semar S, 2013, J ALZHEIMERS DIS, V36, P7, DOI 10.3233/JAD-120511; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; SHANKLE WR, 1993, MODERN PATHOL, V6, P10; Shifrin DA, 2012, CURR BIOL, V22, P627, DOI 10.1016/j.cub.2012.02.022; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sondag CM, 2006, J NEUROCHEM, V97, P449, DOI 10.1111/j.1471-4159.2006.03759.x; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; SONNENBERG A, 1994, AM J GASTROENTEROL, V89, P62; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Takechi R, 2008, ATHEROSCLEROSIS SUPP, V9, P19, DOI 10.1016/j.atherosclerosissup.2008.05.010; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Van Vickle GD, 2007, BIOCHEMISTRY-US, V46, P10317, DOI 10.1021/bi700951u; Wiskur Brandt, 2010, Curr Gastroenterol Rep, V12, P507, DOI 10.1007/s11894-010-0139-7; Yagi Seiji, 2002, Fukuoka Igaku Zasshi, V93, P38; Yang JH, 2012, EXP NEUROL, V236, P199, DOI 10.1016/j.expneurol.2012.05.008; Yates SL, 2000, J NEUROCHEM, V74, P1017, DOI 10.1046/j.1471-4159.2000.0741017.x; Zaheer A, 2008, BRAIN RES, V1208, P192, DOI 10.1016/j.brainres.2008.02.093	61	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119534	10.1371/journal.pone.0119534	http://dx.doi.org/10.1371/journal.pone.0119534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742317	Green Published, gold, Green Submitted			2022-12-26	WOS:000350688100118
J	Wang, LJ; Zhao, CY; Li, J; Liu, ZH; Wang, JH				Wang, Lijuan; Zhao, Chengyi; Li, Jun; Liu, Zhihui; Wang, Jianghong			Root Plasticity of Populus euphratica Seedlings in Response to Different Water Table Depths and Contrasting Sediment Types	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; TAMARIX-RAMOSISSIMA; GROWTH; PLANT; RIVER; CONSEQUENCES; ADAPTATION; ELONGATION; MANAGEMENT; EVOLUTION	Riparian plants in arid regions face a highly variable water environment controlled by hydrological processes. To understand whether riparian plants adapt to such environments through plastic responses, we compared the root traits, biomass allocation and growth of Populus euphratica Oliv. Seedlings grown in lysimeters filled with clay or clay/river sand sediments under inundation and varying water table conditions. We hypothesized that adaptive phenotypic plasticity is likely to develop or be advantageous in seedlings of this species to allow them to adapt desert floodplain environments. Growth was significantly reduced by inundation. However, rather than following relatively fixed trait and allocation patterns, the seedlings displayed adaptive mechanisms involving the development of adventitious roots to enhance plant stability and obtain oxygen, together with a lower proportion of root biomass. At the whole-plant level, at deeper water table depths, seedlings allocated more biomass to the roots, and total root length increased with decreasing water table depths, regardless of the sediment, consistent with optimal partitioning theory. The sediment type had a significant effect on seedling root traits. P. euphratica displayed very different root traits in different sediment types under the same hydrological conditions, showing a greater first-order root number in clay sediment under shallower water table conditions, whereas rooting depth was greater in clay/river sand sediment under deep water table conditions. In clay sediment, seedlings responded to lower water availability via greater root elongation, while the root surface area was increased through increasing the total root length in clay/river sand sediment, suggesting that seedlings facing deeper water tables are not always likely to increase their root surface area to obtain more water. Our results indicate that P. euphratica seedlings are able to adapt to a range of water table conditions through plastic responses in root traits and biomass allocation.	[Wang, Lijuan; Zhao, Chengyi; Li, Jun] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Wang, Lijuan; Liu, Zhihui] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Wang, Lijuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Jianghong] Bayingol Mongolian Autonomous Prefecture Environm, Korla, Xinjiang, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Xinjiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, CY (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	zcy@ms.xjb.ac.cn			National Natural Science Foundation of China [41171095]; National 973 project [2013CB429905-05]; National Science & Technology Pillar Program of China [2013BAC10B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 project(National Basic Research Program of China); National Science & Technology Pillar Program of China	This research was funded by the National Natural Science Foundation of China (Grant no. 41171095; CYZ) (http://www.nsfc.gov.cn), the National 973 project (2013CB429905-05; CYZ) (http://www.973.gov.cn/Default_3.aspx) and National Science & Technology Pillar Program (2013BAC10B01: CYZ) (http://kjzc.jhgl.org) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; Cao DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039121; Capon SJ, 2009, ENVIRON EXP BOT, V66, P178, DOI 10.1016/j.envexpbot.2009.02.012; Chen HJ, 2002, ENVIRON EXP BOT, V48, P119, DOI 10.1016/S0098-8472(02)00018-7; Chen X, 2011, NEW PHYTOL, V190, P409, DOI 10.1111/j.1469-8137.2010.03639.x; Cooper DJ, 1999, REGUL RIVER, V15, P419, DOI 10.1002/(SICI)1099-1646(199909/10)15:5&lt;419::AID-RRR555&gt;3.0.CO;2-Y; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Fan J, 2005, CHIN AGR SCI B, V21, P184; FENNER M, 1987, NEW PHYTOL, V106, P35, DOI 10.1111/j.1469-8137.1987.tb04681.x; Gedroc JJ, 1996, FUNCT ECOL, V10, P44, DOI 10.2307/2390260; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gindaba J, 2004, FOREST ECOL MANAG, V201, P121, DOI 10.1016/j.foreco.2004.07.009; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Gries D, 2003, PLANT CELL ENVIRON, V26, P725, DOI 10.1046/j.1365-3040.2003.01009.x; Guevara A, 2010, PLANT SOIL, V330, P447, DOI 10.1007/s11104-009-0218-4; Guilloy H, 2011, WETLANDS, V31, P1249, DOI 10.1007/s13157-011-0238-8; HUANG P, 1986, ACTA PHYTOECOL GEOBO, V10, P302; Hughes FMR, 2000, HYDROL PROCESS, V14, P3075, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;3075::AID-HYP135&gt;3.0.CO;2-L; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Imada S, 2008, FUNCT ECOL, V22, P1018, DOI 10.1111/j.1365-2435.2008.01454.x; Imada S, 2010, TREES-STRUCT FUNCT, V24, P1163, DOI 10.1007/s00468-010-0492-z; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Li J, 2013, TREE PHYSIOL, V33, P57, DOI 10.1093/treephys/tps120; Lloret F, 1999, AM J BOT, V86, P1655, DOI 10.2307/2656663; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Padilla FM, 2007, PLANT SOIL, V296, P103, DOI 10.1007/s11104-007-9294-5; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; Picotte JJ, 2007, OECOLOGIA, V153, P821, DOI 10.1007/s00442-007-0794-z; Pugnaire FI, 2006, J ARID ENVIRON, V65, P591, DOI 10.1016/j.jaridenv.2005.10.002; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ruger N, 2005, ECOL MODEL, V184, P313, DOI 10.1016/j.ecolmodel.2004.10.010; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Sher AA, 2003, AM J BOT, V90, P413, DOI 10.3732/ajb.90.3.413; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Stromberg JC, 2001, J ARID ENVIRON, V49, P17, DOI 10.1006/jare.2001.0833; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Thevs N, 2008, PHYTOCOENOLOGIA, V38, P65, DOI 10.1127/0340-269X/2008/0038-0065; Thevs N, 2008, FORESTRY, V81, P45, DOI 10.1093/forestry/cpm043; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Visser EJW, 2000, PLANT CELL ENVIRON, V23, P1237, DOI 10.1046/j.1365-3040.2000.00628.x; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; WALKER KF, 1995, REGUL RIVER, V11, P85, DOI 10.1002/rrr.3450110108; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053021; Zhuang L, 2010, CHINESE SCI BULL, V55, P4097, DOI 10.1007/s11434-010-4252-7	46	8	11	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118691	10.1371/journal.pone.0118691	http://dx.doi.org/10.1371/journal.pone.0118691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742175	Green Submitted, Green Published, gold			2022-12-26	WOS:000350688100033
J	Vasiliu, D; Clamons, S; McDonough, M; Rabe, B; Saha, M				Vasiliu, Daniel; Clamons, Samuel; McDonough, Molly; Rabe, Brian; Saha, Margaret			A Regression-Based Differential Expression Detection Algorithm for Microarray Studies with Ultra-Low Sample Size	PLOS ONE			English	Article							PENALIZED LOGISTIC-REGRESSION; FALSE DISCOVERY RATE; CLASSIFICATION; SELECTION; HOMOLOG; TESTS; NOTCH	Global gene expression analysis using microarrays and, more recently, RNA-seq, has allowed investigators to understand biological processes at a system level. However, the identification of differentially expressed genes in experiments with small sample size, high dimensionality, and high variance remains challenging, limiting the usability of these tens of thousands of publicly available, and possibly many more unpublished, gene expression datasets. We propose a novel variable selection algorithm for ultra-low-n microarray studies using generalized linear model-based variable selection with a penalized binomial regression algorithm called penalized Euclidean distance (PED). Our method uses PED to build a classifier on the experimental data to rank genes by importance. In place of cross-validation, which is required by most similar methods but not reliable for experiments with small sample size, we use a simulation-based approach to additively build a list of differentially expressed genes from the rank-ordered list. Our simulation-based approach maintains a low false discovery rate while maximizing the number of differentially expressed genes identified, a feature critical for downstream pathway analysis. We apply our method to microarray data from an experiment perturbing the Notch signaling pathway in Xenopus laevis embryos. This dataset was chosen because it showed very little differential expression according to limma, a powerful and widely-used method for microarray analysis. Our method was able to detect a significant number of differentially expressed genes in this dataset and suggest future directions for investigation. Our method is easily adaptable for analysis of data from RNA-seq and other global expression experiments with low sample size and high dimensionality.	[Vasiliu, Daniel] Coll William & Mary, Dept Math, Williamsburg, VA 23185 USA; [Clamons, Samuel; McDonough, Molly; Rabe, Brian; Saha, Margaret] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA	William & Mary; William & Mary	Saha, M (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	mssaha@wm.edu			National Science Foundation [IOS-1257895]; National Institutes of Health [R15 NS067566-01]; Howard Hughes Medical Institute Undergraduate Science Education Program [52005868]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS067566] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Science Education Program(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by grants from the National Science Foundation IOS-1257895 (www.nsf.gov) and National Institutes of Health R15 NS067566-01 (www.grants.nih.gov) to MSS and by a grant from the Howard Hughes Medical Institute Undergraduate Science Education Program to the College of William and Mary (52005868) (www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2013, WILEY INTERDISCIP RE, V5, DOI 10.1002/wics.1260; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder H, 2011, BIOMETRICAL J, V53, P170, DOI 10.1002/bimj.201000152; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Du DJ, 2014, NEUROCOMPUTING, V133, P446, DOI 10.1016/j.neucom.2013.12.012; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan J, 2014, SIS SURE INDEPENDENC; Fort G, 2005, BIOINFORMATICS, V21, P1104, DOI 10.1093/bioinformatics/bti114; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gramacy BR, 2014, ESTIMATION MULTIVARI; Han F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097530; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Kaeser GE, 2011, DEV DYNAM, V240, P862, DOI 10.1002/dvdy.22580; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Lewis AS, 2008, NONSMOOTH OPTIMIZATI; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; Mazumdar M, 2010, METHODS MOL BIOL, V620, P563, DOI 10.1007/978-1-60761-580-4_22; Murie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-45; Neiuwkoop P, 1994, SYSTEMATIC CHRONOLOG; Owzar K, 2011, CTS-CLIN TRANSL SCI, V4, P466, DOI 10.1111/j.1752-8062.2011.00309.x; Papp K, 2012, CELL MOL LIFE SCI, V69, P2717, DOI 10.1007/s00018-012-0947-z; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Singhal S, 2003, CANCER BIOL THER, V2, P383, DOI 10.4161/cbt.2.4.431; Sive H, 2000, EARLY DEVELOPMENT OF; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Suarez E, 2009, P R HEALTH SCI J, V28, P89; Tan YD, 2011, BIOINFORMATION, V7, P400; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; Vasiliu D, 2014, PENALIZED EUCLIDEAN; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	44	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118198	10.1371/journal.pone.0118198	http://dx.doi.org/10.1371/journal.pone.0118198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738861	gold, Green Published, Green Submitted			2022-12-26	WOS:000350685900024
J	Irshad, K; Mohapatra, SK; Srivastava, C; Garg, H; Mishra, S; Dikshit, B; Sarkar, C; Gupta, D; Chandra, PS; Chattopadhyay, P; Sinha, S; Chosdol, K				Irshad, Khushboo; Mohapatra, Saroj Kant; Srivastava, Chitrangda; Garg, Harshit; Mishra, Seema; Dikshit, Bhawana; Sarkar, Chitra; Gupta, Deepak; Chandra, Poodipedi Sarat; Chattopadhyay, Parthaprasad; Sinha, Subrata; Chosdol, Kunzang			A Combined Gene Signature of Hypoxia and Notch Pathway in Human Glioblastoma and Its Prognostic Relevance	PLOS ONE			English	Article							GLIOMA-CELL-LINES; STEM-CELLS; IN-VITRO; MONOCLONAL-ANTIBODY; EXPRESSION; CANCER; HIF-1-ALPHA; SURVIVAL; ACTIVATION; MIGRATION	Hypoxia is a hallmark of solid tumors including glioblastoma (GBM). Its synergism with Notch signaling promotes progression in different cancers. However, Notch signaling exhibits pleiotropic roles and the existing literature lacks a comprehensive understanding of its perturbations under hypoxia in GBM with respect to all components of the pathway. We identified the key molecular cluster(s) characteristic of the Notch pathway response in hypoxic GBM tumors and gliomaspheres. Expression of Notch and hypoxia genes was evaluated in primary human GBM tissues by q-PCR. Clustering and statistical analyses were applied to identify the combination of hypoxia markers correlated with upregulated Notch pathway components. We found well-segregated tumor-clusters representing high and low HIF-1 alpha/PGK1-expressors which accounted for differential expression of Notch signaling genes. In combination, a five-hypoxia marker set (HIF-1 alpha/PGK1/VEGF/CA9/OPN) was determined as the best predictor for induction of Notch1/DII1/Hes1/Hes6/Hey1/Hey2. Similar Notch-axis genes were activated in gliomaspheres, but not monolayer cultures, under moderate/severe hypoxia (2%/0.2% O-2). Preliminary evidence suggested inverse correlation between patient survival and increased expression of constituents of the hypoxia-Notch gene signature. Together, our findings delineated the Notch-axis maximally associated with hypoxia in resected GBM, which might be prognostically relevant. Its upregulation in hypoxia- exposed gliomaspheres signify them as a better in-vitro model for studying hypoxia-Notch interactions than monolayer cultures.				sub_sinha@hotmail.com; kunzangchosdol@yahoo.com	Irshad, Khushboo/AAT-6842-2020	Irshad, Khushboo/0000-0002-1552-3686; chosdol, kunzang/0000-0002-7065-3395; Srivastava, Chitrangda/0000-0001-5513-9198; Mohapatra, Saroj Kant/0000-0003-4723-5109; GARG, HARSHIT/0000-0002-4762-2523	Department of Biotechnology, India [BT/PR13645/Med/30/290/2010]; Indian Council of Medical Research, India; All India Institute of Medical Sciences, India; Kishore Vaigyanik Protsahan Yojana, Department of Science and Technology, India; Council of Scientific and Industrial Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); All India Institute of Medical Sciences, India; Kishore Vaigyanik Protsahan Yojana, Department of Science and Technology, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	Support was provided by: grant from Department of Biotechnology, India (BT/PR13645/Med/30/290/2010) to KC and institutional support from National Brain Research Centre, India, to SS; Research fellowships from Indian Council of Medical Research, India to KI; All India Institute of Medical Sciences, India to C. Srivastava; Kishore Vaigyanik Protsahan Yojana, Department of Science and Technology, India to HG; and Council of Scientific and Industrial Research, India to BD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Choy MK, 2010, J CELL PHYSIOL, V222, P635, DOI 10.1002/jcp.21980; Chung FY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-241; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cornero A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S13; Dai Chen-Xin, 2009, BMC Cancer, V9, P418, DOI 10.1186/1471-2407-9-418; Datta K, 2002, INT J BIOCHEM CELL B, V34, P148, DOI 10.1016/S1357-2725(01)00106-6; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Flynn JR, 2008, CANCER-AM CANCER SOC, V113, P1032, DOI 10.1002/cncr.23678; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hu YY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-82; Huang XD, 2012, ASIAN PAC J CANCER P, V13, P4793, DOI 10.7314/APJCP.2012.13.9.4793; Iacopino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105166; Kamat CD, 2007, CANCER LETT, V249, P209, DOI 10.1016/j.canlet.2006.08.017; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kesari S, 2011, SEMIN ONCOL, V38, pS2, DOI 10.1053/j.seminoncol.2011.09.005; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Li ZQ, 2011, ASIAN PAC J CANCER P, V12, P215; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Martinez-Gonzalez A, 2012, B MATH BIOL, V74, P2875, DOI 10.1007/s11538-012-9786-1; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mimeault M, 2013, J CELL MOL MED; Nakajima T, 2012, J THORAC ONCOL, V7, P1661, DOI 10.1097/JTO.0b013e318265b4df; Palanichamy JK, 2010, MOL CANCER THER, V9, P2114, DOI 10.1158/1535-7163.MCT-09-0977; Persano L, 2011, THESCIENTIFICWORLDJO, V11, P1829, DOI 10.1100/2011/736480; Phung YT, 2011, J CANCER, V2, P507, DOI 10.7150/jca.2.507; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Ruano Y, 2008, CANCER-AM CANCER SOC, V112, P1575, DOI 10.1002/cncr.23338; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Said HM, 2007, RADIOTHER ONCOL, V83, P398, DOI 10.1016/j.radonc.2007.05.003; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shahi MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-614; Sharma A, 2012, MOL CANCER THER, V11, P77, DOI 10.1158/1535-7163.MCT-11-0508; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wong DJ, 2008, CANCER RES, V68, P369, DOI 10.1158/0008-5472.CAN-07-0382; Wos Jan, 2011, Otolaryngol Pol, V65, P102; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105; Zheng Y, 2013, ONCOL LETT, V5, P1285, DOI 10.3892/ol.2013.1185; Zhu YH, 2005, ONCOGENE, V24, P6555, DOI 10.1038/sj.onc.1208800	56	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118201	10.1371/journal.pone.0118201	http://dx.doi.org/10.1371/journal.pone.0118201			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734817	Green Submitted, gold, Green Published			2022-12-26	WOS:000350314700017
J	Lin, CC; Lee, IT; Hsu, CH; Hsu, CK; Chi, PL; Hsiao, LD; Yang, CM				Lin, Chih-Chung; Lee, I-Ta; Hsu, Chun-Hao; Hsu, Chih-Kai; Chi, Pei-Ling; Hsiao, Li-Der; Yang, Chuen-Mao			Sphingosine-1-Phosphate Mediates ICAM-1-Dependent Monocyte Adhesion through p38 MAPK and p42/p44 MAPK-Dependent Akt Activation	PLOS ONE			English	Article							KAPPA-B ACTIVATION; SPHINGOSINE 1-PHOSPHATE; ICAM-1 EXPRESSION; MATRIX-METALLOPROTEINASE-9 EXPRESSION; UP-REGULATION; AIRWAY; INFLAMMATION; RECEPTORS; ERK; SRC	Up-regulation of intercellular adhesion molecule-1 (ICAM-1) is frequently implicated in lung inflammation. Sphingosine-1-phosphate (S1P) has been shown to play a key role in inflammation via adhesion molecules induction, and then causes lung injury. However, the mechanisms underlying S1P-induced ICAM-1 expression in human pulmonary alveolar epithelial cells (HPAEpiCs) remain unclear. The effect of S1P on ICAM-1 expression was determined by Western blot and real-time PCR. The involvement of signaling pathways in these responses was investigated by using the selective pharmacological inhibitors and transfection with siRNAs. S1P markedly induced ICAM-1 expression and monocyte adhesion which were attenuated by pretreatment with the inhibitor of S1PR1 (W123), S1PR3 (CAY10444), c-Src (PP1), EGFR (AG1478), PDGFR (AG1296), MEK1/2 (U0126), p38 MAPK (SB202190), JNK1/2 (SP600125), PI3K (LY294002), or AP-1 (Tanshinone IIA) and transfection with siRNA of S1PR1, S1PR3, c-Src, EGFR, PDGFR, p38, p42, JNK1, c-Jun, or c-Fos. We observed that S1P-stimulated p42/p44 MAPK and p38 MAPK activation was mediated via a c-Src/EGFR and PDGFR-dependent pathway. S1P caused the c-Src/EGFR/PDGFR complex formation. On the other hand, we demonstrated that S1P induced p42/p44 MAPK and p38 MAPK-dependent Akt activation. In addition, S1P-stimulated JNK1/2 phosphorylation was attenuated by SP600125 or PP1. Finally, S1P enhanced c-Fos mRNA levels and c-Jun phosphorylation. S1P-induced c-Jun activation was reduced by PP1, AG1478, AG1296, U0126, SP600125, SB202190, or LY294002. These results demonstrated that S1P-induced ICAM-1 expression and monocyte adhesion were mediated through S1PR1/3/c-Src/EGFR, PDGFR/p38 MAPK, p42/p44 MAPK/Akt-dependent AP-1 activation.				chuenmao@mail.cgu.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438; Chi, Belinda/0000-0003-0332-6682	National Science Council, Taiwan [NSC102-2321-B-182-011, NSC101-2320-B-182-039-MY3, NSC101-2314-B-182-182A-112]; Ministry of Education, Taiwan [EMRPD1D0231, EMRPD1D0241]; Chang Gung Medical Research Foundation, Taiwan [CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPD1B0331, CMRPG3C1301, CMRPG3B1092]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC102-2321-B-182-011, NSC101-2320-B-182-039-MY3, and NSC101-2314-B-182-182A-112 from National Science Council, Taiwan; EMRPD1D0231 and EMRPD1D0241 from Ministry of Education, Taiwan; and CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPD1B0331, CMRPG3C1301, and CMRPG3B1092 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi JJ, 2011, J DENT RES, V90, P841, DOI 10.1177/0022034510389178; Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Beckham TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076593; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Chang YJ, 2004, MOL PHARMACOL, V65, P589, DOI 10.1124/mol.65.3.589; Costello RW, 2011, INT J MOL SCI, V12, P3237, DOI 10.3390/ijms12053237; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kim JI, 2003, J BIOL CHEM, V278, P31731, DOI 10.1074/jbc.M300625200; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072783; Lee IT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/791231; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Lin CC, 2007, J CELL PHYSIOL, V211, P771, DOI 10.1002/jcp.20987; Matsuzaki E, 2013, BONE, V55, P315, DOI 10.1016/j.bone.2013.04.008; Milara J, 2009, EUR J PHARMACOL, V609, P132, DOI 10.1016/j.ejphar.2009.03.012; Ryan JJ, 2008, DRUG NEWS PERSPECT, V21, P89, DOI 10.1358/dnp.2008.21.2.1188195; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Sun XG, 2013, AM J PHYSIOL-LUNG C, V305, pL467, DOI 10.1152/ajplung.00010.2013; Takahashi M, 2003, HEPATOL RES, V26, P232, DOI 10.1016/S1386-6346(03)00112-8; Thamilselvan V, 2002, IN VITRO CELL DEV-AN, V38, P246; Yang CM, 2013, BIOCHEM PHARMACOL, V85, P1115, DOI 10.1016/j.bcp.2013.01.013; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yu HS, 2013, INT J MOL SCI, V14, P13329, DOI 10.3390/ijms140713329; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	28	17	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118473	10.1371/journal.pone.0118473	http://dx.doi.org/10.1371/journal.pone.0118473			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734900	Green Published, gold, Green Submitted			2022-12-26	WOS:000350314700031
J	Pal, D; Sharma, U; Singh, SK; Kakkar, N; Prasad, R				Pal, Deeksha; Sharma, Ujjawal; Singh, Shrawan Kumar; Kakkar, Nandita; Prasad, Rajendra			Over-Expression of Telomere Binding Factors (TRF1 & TRF2) in Renal Cell Carcinoma and Their Inhibition by Using SiRNA Induce Apoptosis, Reduce Cell Proliferation and Migration Invitro	PLOS ONE			English	Article							GENE-EXPRESSION; TIN2; DNA	Telomere binding factors viz. TRF1 and TRF2 are a part of sheltrin complex that are present exclusively at the ends of chromosomes. These factors play an important role in maintaining chromosomal integrity at the ends. However, their status and role are not clear in renal cell carcinoma (RCC). Therefore, the present study was conducted to evaluate TRF1 and TRF2 expressions in RCC tissues. Further, the role of these factors involved in tumorigenesis was elucidated by gene silencing using siRNA in RCC cell line (A498). The present study documented a significant over-expression of TRF1 (P = 0.005) and TRF2 (P = 0.0048) mRNAs by real time PCR in RCC tissues as compared with adjacent normal kidney tissues. Immunohistochemistry studies also revealed higher expression of TRF1 and TRF2 proteins in RCC. Moreover, TRF1 or TRF2 gene silencing using siRNA showed marked reduction in proliferation of RCC cells (P = 0.000). Further, significantly induced cell cycle arrest (P = 0.000) and apoptosis of RCC cells (P = 0.000) was documented upon TRF1 or TRF2 gene silencing. Henceforth, the results deduce that TRF1 or TRF2 inhibitions play an important role in the induction of apoptosis in A498 cells, which may serve as a potential therapeutic target in RCC.	[Pal, Deeksha; Sharma, Ujjawal; Prasad, Rajendra] PGIMER, Dept Biochem, Chandigarh, India; [Singh, Shrawan Kumar] PGIMER, Dept Urol, Chandigarh, India; [Kakkar, Nandita] PGIMER, Dept Histopathol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Prasad, R (corresponding author), PGIMER, Dept Biochem, Chandigarh, India.	fateh1977@yahoo.com	Sharma, Ujjawal/E-7097-2013	Sharma, Ujjawal/0000-0002-2087-080X	Council of Scientific and Industrial Research, New Delhi, India [27/0218/09/EMR-II]; Indian council of medical research, New Delhi, India [3/1/3/JRF-2010/HRD-67 (11065)]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Indian council of medical research, New Delhi, India(Indian Council of Medical Research (ICMR))	This is a part of a research project funded by Council of Scientific and Industrial Research, New Delhi, India (vide letter no. 27/0218/09/EMR-II). The authors are thankful to Indian council of medical research, New Delhi, India for awarding junior and senior research fellowship (3/1/3/JRF-2010/HRD-67 (11065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2000, SEMIN ONCOL, V27, P177; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Biroccio A, 2013, NAT CELL BIOL, V15, P818, DOI 10.1038/ncb2774; Dong WJ, 2009, CANCER BIOL THER, V8, P2165, DOI 10.4161/cbt.8.22.9880; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Ganesamoni R, 2012, J UROLOGY, V187, P1172, DOI 10.1016/j.juro.2011.11.105; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Lin JG, 2014, NUCLEIC ACIDS RES, V42, P2493, DOI 10.1093/nar/gkt1132; Matsutani N, 2001, INT J ONCOL, V19, P507; Miyachi K, 2002, J EXP CLIN CANC RES, V21, P269; Nakanishi K, 2003, CLIN CANCER RES, V9, P1105; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Reuter VE, 2000, SEMIN ONCOL, V27, P124; Saito K, 2002, JPN J CANCER RES, V93, P253, DOI 10.1111/j.1349-7006.2002.tb02166.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma U, 2014, BIOCHIMIE, V104, P27, DOI 10.1016/j.biochi.2014.05.011; Sharma U, 2012, MOL CELL BIOCHEM, V369, P287, DOI 10.1007/s11010-012-1391-y; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sobin L., 1997, UICC TNM CLASSIFICAT, P184; Stansel RM, 2001, EMBO J, V20, P5532; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Yamada K, 2002, ANTICANCER RES, V22, P1315	26	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115651	10.1371/journal.pone.0115651	http://dx.doi.org/10.1371/journal.pone.0115651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730259	gold, Green Submitted, Green Published			2022-12-26	WOS:000350684900007
J	Rac, M; Krupka, M; Binder, S; Sedlarova, M; Matuskova, Z; Raska, M; Pospisil, P				Rac, Marek; Krupka, Michal; Binder, Svatopluk; Sedlarova, Michaela; Matuskova, Zuzana; Raska, Milan; Pospisil, Pavel			Oxidative Damage of U937 Human Leukemic Cells Caused by Hydroxyl Radical Results in Singlet Oxygen Formation	PLOS ONE			English	Article							LIPID-PEROXIDATION; DNA-DAMAGE; ACID HYDROPEROXIDE; MOLECULAR-OXYGEN; REACTIVE OXYGEN; STRESS; BIOMARKERS; MECHANISM; DISEASE; LINE	The exposure of human cells to oxidative stress leads to the oxidation of biomolecules such as lipids, proteins and nuclei acids. In this study, the oxidation of lipids, proteins and DNA was studied after the addition of hydrogen peroxide and Fenton reagent to cell suspension containing human leukemic monocyte lymphoma cell line U937. EPR spin-trapping data showed that the addition of hydrogen peroxide to the cell suspension formed hydroxyl radical via Fenton reaction mediated by endogenous metals. The malondialdehyde HPLC analysis showed no lipid peroxidation after the addition of hydrogen peroxide, whereas the Fenton reagent caused significant lipid peroxidation. The formation of protein carbonyls monitored by dot blot immunoassay and the DNA fragmentation measured by comet assay occurred after the addition of both hydrogen peroxide and Fenton reagent. Oxidative damage of biomolecules leads to the formation of singlet oxygen as conformed by EPR spin-trapping spectroscopy and the green fluorescence of singlet oxygen sensor green detected by confocal laser scanning microscopy. It is proposed here that singlet oxygen is formed by the decomposition of high-energy intermediates such as dioxetane or tetroxide formed by oxidative damage of biomolecules.	[Rac, Marek; Pospisil, Pavel] Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, Fac Sci, Olomouc 78371, Czech Republic; [Krupka, Michal; Raska, Milan] Palacky Univ, Dept Immunol, Fac Med & Dent, Olomouc 77515, Czech Republic; [Binder, Svatopluk] Palacky Univ, Fac Med & Dent, Dept Med Biophys, Olomouc 77515, Czech Republic; [Sedlarova, Michaela] Palacky Univ, Dept Bot, Fac Sci, Olomouc 78371, Czech Republic; [Matuskova, Zuzana] Palacky Univ, Fac Med & Dent, Dept Pharmacol, Olomouc 77515, Czech Republic; [Matuskova, Zuzana] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77515, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Pospisil, P (corresponding author), Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, Fac Sci, Slechtitelu 11, Olomouc 78371, Czech Republic.	pavel.pospisil@upol.cz	Raska, Milan/E-9813-2013; POSPÍŠIL, Pavel/AAH-4451-2019; SEDLÁŘOVÁ, Michaela/L-2055-2018	Raska, Milan/0000-0002-8572-7246; POSPÍŠIL, Pavel/0000-0001-9126-2011; SEDLÁŘOVÁ, Michaela/0000-0003-2319-1033; Krupka, Michal/0000-0002-9699-7903; Racova, Zuzana/0000-0001-9478-9513; Rac, Marek/0000-0003-0226-6796	Ministry of Education, Youth and Sports of the Czech Republic [LO1204, CZ.1.07/2.3.00/20.0057, CZ.1.07/2.3.00/30.0041]; Czech Science Foundation [GP13-29294S];  [IGA_LF_2014_020];  [OPVK 2.3 (CZ.1.07/2.3.00/30.0004)];  [NPU I MSMT-7778/2014];  [PrF-2013-003]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); ; ; ; 	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grants no. LO1204 (National Program of Sustainability I), no. CZ.1.07/2.3.00/20.0057 (Progress and Internationalization of Biophysical Research at the Faculty of Science, Palacky University) and no. CZ.1.07/2.3.00/30.0041 (Support for Building Excellent Research Teams and Intersectoral Mobility at Palacky University), the Czech Science Foundation grant no. GP13-29294S and by the IGA_LF_2014_020, OPVK 2.3 (CZ.1.07/2.3.00/30.0004), NPU I MSMT-7778/2014, and PrF-2013-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam W, 1982, CHEM BIOL GENERATION; Ahmad R, 2008, IN VIVO, V22, P525; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BRITIGAN BE, 1988, J EXP MED, V168, P2367, DOI 10.1084/jem.168.6.2367; Cadet J, 2013, COLD SPRING HARBOR P, V5, DOI [10.1101/cshperspect.a019836, DOI 10.1101/CSHPERSPECT.A019836]; COUDRAY C, 1993, BIOL TRACE ELEM RES, V38, P273, DOI 10.1007/BF02785311; Dean RT, 1997, BIOCHEM J, V324, P1; Garry BR, MOL TARGETS PHOTOSEN; GOLDSTEIN S, 1993, FREE RADICAL BIO MED, V15, P435, DOI 10.1016/0891-5849(93)90043-T; Gollmer A, 2011, PHOTOCHEM PHOTOBIOL, V87, P671, DOI 10.1111/j.1751-1097.2011.00900.x; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Halliwell B, 2007, FREE RADICAL BIO MED, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Kanofsky JR, 2011, PHOTOCHEM PHOTOBIOL, V87, P14, DOI 10.1111/j.1751-1097.2010.00855.x; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; MINISINI MP, 1994, MUTAT RES-DNA REPAIR, V315, P169, DOI 10.1016/0921-8777(94)90016-7; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; MOAN J, 1979, NATURE, V279, P450, DOI 10.1038/279450a0; NIU EP, 1991, AUST J CHEM, V44, P695, DOI 10.1071/CH9910695; PIKE MC, 1980, CLIN RES, V28, pA507; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; POU TE, 1984, J ELECTROCHEM SOC, V131, P1243, DOI 10.1149/1.2115795; Prado FM, 2009, FREE RADICAL BIO MED, V47, P401, DOI 10.1016/j.freeradbiomed.2009.05.001; RUSSELL GA, 1957, J AM CHEM SOC, V79, P3871, DOI 10.1021/ja01571a068; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; SCHLESINGER JJ, 1980, CLIN RES, V28, pA644; Shen Y, 2011, LASER PHYS LETT, V8, P232, DOI 10.1002/lapl.201010113; Sun SN, 2007, BIOCHEMISTRY-US, V46, P6668, DOI 10.1021/bi700178u; Timmins GS, 1997, CHEM RES TOXICOL, V10, P1090, DOI 10.1021/tx970075p; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; Wei SH, 2006, DYES PIGMENTS, V71, P61, DOI 10.1016/j.dyepig.2005.06.016; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu TY, 2004, CANCER EPIDEM BIOMAR, V13, P1399	39	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0116958	10.1371/journal.pone.0116958	http://dx.doi.org/10.1371/journal.pone.0116958			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730422	Green Published, Green Submitted, gold			2022-12-26	WOS:000350684900010
J	Yuan, QL; Guo, TM; Liu, L; Sun, F; Zhang, YG				Yuan, Qi-ling; Guo, Tuan-mao; Liu, Liang; Sun, Fu; Zhang, Yin-gang			Traditional Chinese Medicine for Neck Pain and Low Back Pain: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; CHRONIC SPINAL PAIN; TERM-FOLLOW-UP; ACUPUNCTURE TREATMENT; COMPARING ACUPUNCTURE; THERAPY; EXERCISE; ACUPRESSURE; EFFICACY; PLACEBO	Background Neck pain (NP) and low back pain (LBP) are common symptoms bothering people in daily life. Traditional Chinese medicine (TCM) has been used to treat various symptoms and diseases in China and has been demonstrated to be effective. The objective of the present study was to review and analyze the existing data about pain and disability in TCM treatments for NP and LBP. Methods Studies were identified by a comprehensive search of databases, such as MEDLINE, EMBASE, and Cochrane Library, up to September 1, 2013. A meta-analysis was performed to evaluate the efficacy and safety of TCM in managing NP and LBP. Results Seventy five randomized controlled trials (n = 11077) were included. Almost all of the studies investigated individuals experiencing chronic NP (CNP) or chronic LBP (CLBP). We found moderate evidence that acupuncture was more effective than sham-acupuncture in reducing pain immediately post-treatment for CNP (visual analogue scale (VAS) 10 cm, mean difference (MD) = -0.58 (-0.94, -0.22), 95% confidence interval, p = 0.01), CLBP (standardized mean difference = -0.47 (-0.77, -0.17), p = 0.003), and acute LBP (VAS 10 cm, MD = -0.99 (-1.24, -0.73), p < 0.001). Cupping could bemore effective than waitlist in VAS (100mm) (MD = -19.10 (-27.61, -10.58), p < 0.001) for CNP or medications (e.g. NSAID) for CLBP (MD = -5.4 (-8.9, -0.19), p = 0.003). No serious or life-threatening adverse effects were found. Conclusions Acupuncture, acupressure, and cupping could be efficacious in treating the pain and disability associated with CNP or CLBP in the immediate term. Gua sha, tai chi, qigong, and Chinese manipulation showed fair effects, but we were unable to draw any definite conclusions, and further research is still needed. The efficacy of tuina and moxibustion is unknown because no direct evidence was obtained. These TCM modalities are relatively safe.	[Yuan, Qi-ling; Liu, Liang; Sun, Fu; Zhang, Yin-gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Orthopaed, Xian 710061, Peoples R China; [Guo, Tuan-mao] Xianyang Cent Hosp, Dept Orthopaed 2, Xianyang 712000, Shaanxi, Peoples R China; [Sun, Fu] Xian Med Coll, Affiliated Hosp, Dept Orthopaed, Xian 710077, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University	Zhang, YG (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Orthopaed, Xian 710061, Peoples R China.	zyingang@mail.xjtu.edu.cn	Yuan, Qiling/AGX-7768-2022	Yuan, Qiling/0000-0002-4822-2513; Guo, Meiting/0000-0002-1497-7053	Natural Scientific Fund of China [81371987, 81171761]	Natural Scientific Fund of China	The authors are grateful for the support of the Natural Scientific Fund of China (no. 81371987, 81171761). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 1997, ADULT SPINE PRINCIPL; Birch S, 1998, CLIN J PAIN, V14, P248, DOI 10.1097/00002508-199809000-00012; Braun M, 2011, PAIN MED, V12, P362, DOI 10.1111/j.1526-4637.2011.01053.x; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Chen J, 2009, CHIN J TRADIT MED TR, V17, P32; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Cho YJ, 2013, SPINE, V38, P549, DOI 10.1097/BRS.0b013e318275e601; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; COAN RM, 1981, AM J CHINESE MED, V9, P326, DOI 10.1142/S0192415X81000433; COAN RM, 1980, AM J CHINESE MED, V8, P181, DOI 10.1142/S0192415X80000141; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Cramer H, 2011, FORSCH KOMPLEMENTMED, V18, P327, DOI 10.1159/000335294; D'Sylva J, 2010, MANUAL THER, V15, P415, DOI 10.1016/j.math.2010.04.003; Farhadi K, 2009, COMPLEMENT THER MED, V17, P9, DOI 10.1016/j.ctim.2008.05.003; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fu LM, 2009, J ALTERN COMPLEM MED, V15, P133, DOI 10.1089/acm.2008.0135; Fu WB, 2009, CHIN J INTEGR MED, V15, P426, DOI 10.1007/s11655-009-0426-z; Furlan AD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/953139; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gao S, 1993, ZHONG YI YAO DONG TA, V4, P25, DOI 1016/j.math.2010.04.003; Geng M, 1989, ZHEN JIU XUE BAO, V3, P29; Giles LGF, 2003, SPINE, V28, P1490, DOI 10.1097/00007632-200307150-00003; Giles LGF, 1999, J MANIP PHYSIOL THER, V22, P376, DOI 10.1016/S0161-4754(99)70082-5; Grant DJ, 1999, PAIN, V82, P9, DOI 10.1016/S0304-3959(99)00027-5; Gross A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub3; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hasegawa TM, 2013, ACUPUNCT MED; Hayden J, 2011, COCHRANE DB SYST REV; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; [洪永锋 HONG Yongfeng], 2006, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V21, P340; Hsieh LLC, 2006, BMJ-BRIT MED J, V332, P696, DOI 10.1136/bmj.38744.672616.AE; Hsieh LLC, 2004, PREV MED, V39, P168, DOI 10.1016/j.ypmed.2004.01.036; Hunter RF, 2012, CLIN J PAIN, V28, P259, DOI 10.1097/AJP.0b013e3182274018; Inoue Motohiro, 2006, Acupunct Med, V24, P103; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; Itoh K, 2007, COMPLEMENT THER MED, V15, P172, DOI 10.1016/j.ctim.2006.05.003; Itoh Kazunori, 2006, Acupunct Med, V24, P5; Itoh Kazunori, 2004, Acupunct Med, V22, P170; Itoh Kazunori, 2009, Complement Ther Clin Pract, V15, P22, DOI 10.1016/j.ctcp.2008.09.003; Jacobs WCH, 2013, EUR SPINE J, V22, P1936, DOI 10.1007/s00586-013-2823-4; Kennedy S, 2008, COMPLEMENT THER MED, V16, P139, DOI 10.1016/j.ctim.2007.03.001; Kim JI, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-146; Kim TH, 2012, J OCCUP HEALTH, V54, P416, DOI 10.1539/joh.12-0133-OA; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Lansinger B, 2007, SPINE, V32, P2415, DOI 10.1097/BRS.0b013e3181573b4b; Lao L., 2012, INTEGRATIVE PEDIAT O, P125; Lauche R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065378; Lauche R, 2012, AM J CHINESE MED, V40, P905, DOI 10.1142/S0192415X1250067X; Lauche R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429718; Lauche R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-63; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Leibing E, 2002, PAIN, V96, P189, DOI 10.1016/S0304-3959(01)00444-4; Li D, 2006, FLORA CHINA, V22, P7; Li JY, 2009, NEI MONGOL J TRADIT, V14, P31; Li Q, 2007, CHIN J CLIN REHABIL, V11, P4531; Liang ZH, 2011, COMPLEMENT THER MED, V19, pS26, DOI 10.1016/j.ctim.2010.11.005; Lin JH, 2013, MANUAL THER, V18, P308, DOI 10.1016/j.math.2012.11.005; Liu BX, 2008, CHINESE J REHABILITA, V14, P572; Macedo LG, 2013, PHYS THER, V93, P1587, DOI 10.2522/ptj.20120464; MAKELA M, 1991, AM J EPIDEMIOL, V134, P1356; Meng CF, 2003, RHEUMATOLOGY, V42, P1508, DOI 10.1093/rheumatology/keg405; Miyazaki S, 2009, CLIN J PAIN, V25, P438, DOI 10.1097/AJP.0b013e318193a6e1; Molsberger AF, 2002, PAIN, V99, P579, DOI 10.1016/S0304-3959(02)00269-5; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Muller R, 2005, J MANIP PHYSIOL THER, V28, P3, DOI 10.1016/j.jmpt.2004.12.004; Nabeta T, 2002, COMPLEMENT THER MED, V10, P217, DOI 10.1016/S0965-2299(02)00082-1; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; PETRIE JP, 1986, BRIT J RHEUMATOL, V25, P271; Rendant D, 2011, SPINE, V36, P419, DOI 10.1097/BRS.0b013e3181d51fca; Roelofs PD, 2011, COCHRANE DB SYST REV; Sahin N, 2010, ACUPUNCTURE ELECTRO, V35, P17, DOI 10.3727/036012910803860959; Sator-Katzenschlager SM, 2004, ANESTH ANALG, V98, P1359, DOI 10.1213/01.ANE.0000107941.16173.F7; Shankar Nilima, 2011, Indian J Physiol Pharmacol, V55, P25; Sherwin D C, 1992, Rehabil Nurs, V17, P253; Su Jiang-tao, 2010, Zhongguo Zhen Jiu, V30, P617; Suen Lorna K P, 2007, Complement Ther Clin Pract, V13, P63, DOI 10.1016/j.ctcp.2006.10.005; THOMAS M, 1991, AM J CHINESE MED, V19, P95, DOI 10.1142/S0192415X91000156; Trinh K, 2007, SPINE, V32, P236, DOI 10.1097/01.brs.0000252100.61002.d4; Tsui MLK, 2004, J ALTERN COMPLEM MED, V10, P803; Vas J, 2006, PAIN, V126, P245, DOI 10.1016/j.pain.2006.07.002; Vas J, 2012, PAIN, V153, P1883, DOI 10.1016/j.pain.2012.05.033; Vas Jorge, 2006, BMC Complement Altern Med, V6, P14, DOI 10.1186/1472-6882-6-14; von Trott P, 2009, J PAIN, V10, P501, DOI 10.1016/j.jpain.2008.11.004; Wang B. X., 2004, CHINESE J CLIN REHAB, V8, P3413; Weiss J, 2013, J ALTERN COMPLEMENT; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Witt CM, 2006, AM J EPIDEMIOL, V164, P487, DOI 10.1093/aje/kwj224; Xu M, 2009, LIAONING J TRADITION, V36, P1007; Xu M, 2013, AM J CHINESE MED, V41, P1, DOI 10.1142/S0192415X13500018; Xu Y, 1977, CHI JIAO YI SHENG ZA, V1, P34; Yang BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035032; Yeh CH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/196978; Yeung CKN, 2003, J ALTERN COMPLEM MED, V9, P479, DOI 10.1089/107555303322284767; Yip Y B, 2006, Complement Ther Clin Pract, V12, P18, DOI 10.1016/j.ctcp.2005.09.005; Yip YB, 2004, COMPLEMENT THER MED, V12, P28, DOI 10.1016/j.ctim.2003.12.003; Yun MD, 2012, J ALTERN COMPLEM MED, V18, P130, DOI 10.1089/acm.2010.0779; Zaringhalam Jalal, 2010, Chin Med, V5, P15, DOI 10.1186/1749-8546-5-15; [张洪来 Zhang Honglai], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P637; Zhu LG, 2005, CHIN J ORTHOP TRAUMA, V18, P489; Zhu XM, 2002, AM J CHINESE MED, V30, P13, DOI 10.1142/S0192415X02000028	105	176	193	8	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117146	10.1371/journal.pone.0117146	http://dx.doi.org/10.1371/journal.pone.0117146			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25738838	Green Published, gold, Green Submitted			2022-12-26	WOS:000350683900024
